data_2ezc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ezc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.518 -0.549 . . . . 4.0700000000000003 109.518 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.07 103.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 1.5 109.361 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -93.08 120.22 33.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.329 -0.857 . . . . 1.8 110.033 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.67 -160.19 11.6 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 108.41 -1.876 . . . . 0.92000000000000004 108.41 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.0 mt -93.55 -9.96 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.995 -1.297 . . . . 1.5 109.029 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' ILE . 14.2 tp 56.94 107.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 1.3999999999999999 109.306 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.52 -53.61 4.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.081 -1.012 . . . . 1.26 108.318 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.95 146.16 25.0 Favored Pre-proline 0 N--CA 1.494 1.741 0 N-CA-C 108.582 -0.896 . . . . 1.95 108.582 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.3 153.37 31.37 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.069 1.846 . . . . 0.93999999999999995 113.148 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 151.68 124.1 1.1 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.051 -1.22 . . . . 0.78000000000000003 110.051 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 11' ' ' ILE . 72.7 mt -89.36 129.01 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.132 -1.216 . . . . 1.29 109.566 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.16 149.22 49.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.383 -0.823 . . . . 1.1499999999999999 109.572 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.9 m-85 -117.87 140.06 50.24 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.626 -0.879 . . . . 0.71999999999999997 108.626 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.65 163.47 29.96 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.725 -1.702 . . . . 0.5 111.24 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -78.57 151.71 32.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.991 . . . . 2.3599999999999999 109.902 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.21 129.32 34.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 1.1599999999999999 111.114 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -111.82 90.84 3.45 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.193 -1.41 . . . . 1.24 107.193 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.38 128.72 34.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.059 -1.025 . . . . 1.3100000000000001 110.687 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.2 mt -96.88 93.99 6.97 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.454 0.645 . . . . 1.3100000000000001 109.854 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -93.07 156.35 16.93 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.54 -0.911 . . . . 2.3500000000000001 108.54 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.02 131.3 44.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.247 -0.908 . . . . 2.5800000000000001 109.036 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.92 138.63 38.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.148 -0.97 . . . . 2.1400000000000001 108.924 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.23 140.68 58.9 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.45 -0.781 . . . . 1.9299999999999999 109.282 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mt -91.69 132.96 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.215 -0.928 . . . . 1.28 109.917 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.8 t -106.61 111.98 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.637 -0.875 . . . . 1.3700000000000001 108.637 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.2 mt -85.07 152.2 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.941 . . . . 1.3300000000000001 109.586 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -90.89 107.54 19.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.497 -0.752 . . . . 1.3700000000000001 109.927 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.478 ' NH1' ' CB ' ' A' ' 102' ' ' ALA . 20.4 mmm180 -95.46 24.57 5.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.277 -0.889 . . . . 3.1899999999999999 108.754 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -85.85 144.04 27.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.371 -0.831 . . . . 2.8100000000000001 109.79 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -86.72 123.97 32.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.213 -0.929 . . . . 2.8300000000000001 108.824 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.2 pt -87.22 174.89 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.16 -0.962 . . . . 1.3400000000000001 110.599 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 34' ' ' ASP . 52.2 p -100.84 156.41 17.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.842 -0.799 . . . . 1.3500000000000001 108.842 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.9 -8.44 0.99 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 1.6100000000000001 109.47 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 32' ' ' SER . 6.7 m-20 -83.95 -21.28 31.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 2.4700000000000002 109.898 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -105.9 -1.36 24.22 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.329 -0.857 . . . . 2.0699999999999998 109.327 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -64.95 -44.85 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.975 . . . . 1.3300000000000001 108.742 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -52.34 -36.46 53.57 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.262 -0.899 . . . . 1.46 109.19 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -69.46 -34.3 74.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.476 -0.765 . . . . 2.9399999999999999 110.152 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.433 ' OE2' ' NH2' ' A' ' 42' ' ' ARG . 80.4 mm-40 -62.55 -43.34 99.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.999 -1.063 . . . . 1.3 109.715 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 44' ' ' LEU . 82.2 t -59.84 -48.58 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 1.3300000000000001 110.035 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -66.55 -44.77 81.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.012 -1.055 . . . . 1.5 108.991 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.433 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 72.1 mtm180 -61.36 -33.97 74.53 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.108 -0.995 . . . . 3.1499999999999999 108.895 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -86.35 -54.43 4.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.92000000000000004 108.945 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 40' ' ' VAL . 57.3 tp -51.01 -66.77 0.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.469 -0.77 . . . . 1.4099999999999999 109.493 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 t -63.19 -30.15 71.35 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.952 -1.093 . . . . 1.22 108.154 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.85 -8.01 51.34 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 107.347 -2.301 . . . . 0.58999999999999997 107.347 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.2 OUTLIER -85.02 -29.02 25.31 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.126 -1.805 . . . . 3.3900000000000001 106.126 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.36 64.17 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.941 -1.133 . . . . 1.26 107.941 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -84.91 -64.22 1.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.919 -0.771 . . . . 2.9900000000000002 108.919 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.32 -41.89 51.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.978 . . . . 1.1399999999999999 109.514 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.9 m -63.36 -37.93 89.18 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.011 -1.107 . . . . 1.8400000000000001 108.011 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.36 -21.51 60.51 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.401 -0.592 . . . . 1.22 109.401 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.649 HE22 ' ND2' ' A' ' 140' ' ' ASN . 74.0 mt-30 -73.45 -68.35 0.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 2.0 109.471 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 58' ' ' LYS . 13.7 mt -48.93 -42.52 37.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.064 -1.022 . . . . 1.99 108.839 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -50.55 -48.76 57.3 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.448 -0.945 . . . . 1.27 108.448 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -61.96 -40.37 95.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 1.24 109.053 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.6 mt -74.71 -25.14 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 1.21 108.879 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.589 ' HZ1' ' CG ' ' A' ' 70' ' ' GLU . 13.3 ttpp -64.31 -52.52 58.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.564 -0.71 . . . . 1.53 110.219 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.33 -25.45 63.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.968 -1.083 . . . . 1.24 109.794 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -71.63 -24.12 61.81 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.904 -1.122 . . . . 2.3199999999999998 108.029 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.74 -32.87 60.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.367 -0.975 . . . . 1.1699999999999999 108.367 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.73 -28.77 28.35 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.842 -1.303 . . . . 0.57999999999999996 109.842 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -86.42 -14.99 41.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.28 . . . . 1.3899999999999999 108.784 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.2 m -92.84 -51.4 5.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 1.3600000000000001 110.054 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -106.85 -21.77 12.91 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.305 -0.872 . . . . 1.1399999999999999 110.44 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.87 153.6 9.1 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 109.77 -1.332 . . . . 0.59999999999999998 109.77 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -48.87 -8.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.508 -0.995 . . . . 2.5899999999999999 110.464 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 66' ' ' GLY . 39.8 tt0 -63.91 -42.61 97.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 2.2000000000000002 110.377 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -90.81 -10.01 44.37 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.014 -1.054 . . . . 2.3599999999999999 110.494 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.589 ' CG ' ' HZ1' ' A' ' 58' ' ' LYS . 34.1 tt0 -67.04 -31.04 71.29 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.942 -1.099 . . . . 1.54 110.809 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.91 68.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.097 -1.002 . . . . 1.24 110.41 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.482 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 39.7 mt -72.04 -42.56 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.036 -1.04 . . . . 1.24 109.771 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -76.71 -19.21 57.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.097 -1.002 . . . . 0.80000000000000004 109.307 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.07 -49.32 72.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.26 -0.9 . . . . 1.23 108.704 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.38 82.17 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.312 -1.515 . . . . 0.56000000000000005 109.312 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.482 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 23.5 m170 -60.57 -24.39 65.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -1.204 . . . . 2.0600000000000001 110.036 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.5 mt -81.15 -36.18 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.727 -1.233 . . . . 1.24 108.546 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.9 ttp -58.02 -43.84 86.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.537 -0.912 . . . . 2.4500000000000002 108.537 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -57.31 -42.52 81.98 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.757 -0.831 . . . . 1.21 108.757 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.12 -41.48 77.32 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.352 -0.842 . . . . 1.1200000000000001 109.258 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -85.4 8.39 19.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.414 -0.803 . . . . 1.24 110.225 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 59.5 t0 -50.05 123.44 8.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.947 -1.096 . . . . 1.3100000000000001 109.484 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.55 -22.67 65.39 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.301 -0.875 . . . . 1.3500000000000001 108.911 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.403 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 45.3 mm-40 -76.76 -49.52 15.75 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.393 -0.817 . . . . 2.1600000000000001 109.318 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.9 mt -64.28 -15.32 59.95 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.292 -0.963 . . . . 1.24 109.242 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -82.9 -46.4 13.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 1.28 110.458 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -62.41 -30.19 71.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.13 -0.981 . . . . 1.79 109.906 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -73.29 -43.57 60.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.023 -1.048 . . . . 1.29 109.01 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.06 -56.96 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.492 -0.929 . . . . 1.1399999999999999 108.492 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.0 mt -48.9 -66.17 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.696 -0.627 . . . . 1.3200000000000001 110.417 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -43.1 -58.9 2.26 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.44 -0.788 . . . . 1.3700000000000001 110.876 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.0 mt -45.87 -54.35 8.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.317 -0.864 . . . . 1.3999999999999999 110.024 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.1 mt -50.86 -41.2 21.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.07 -1.019 . . . . 1.23 109.757 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -85.76 -38.53 18.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.277 -0.889 . . . . 2.5099999999999998 111.594 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -82.22 -40.25 21.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.901 -1.124 . . . . 1.5900000000000001 111.912 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -108.03 16.54 23.29 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.721 -1.237 . . . . 2.3799999999999999 110.162 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.9 m80 44.85 48.76 9.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.205 -0.935 . . . . 1.6200000000000001 109.525 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.7 mtt -100.72 147.47 25.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 1.8899999999999999 109.261 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.1 p -75.68 143.75 41.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.313 -0.867 . . . . 1.27 109.164 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.12 -25.62 2.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 1.1599999999999999 108.887 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.55 -48.97 23.71 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.534 -0.913 . . . . 2.0 108.534 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.478 ' CB ' ' NH1' ' A' ' 28' ' ' ARG . . . -70.51 -53.61 15.53 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.779 -0.575 . . . . 1.25 110.013 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.68 -46.7 77.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 1.1299999999999999 109.411 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.89 66.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 1.0800000000000001 109.478 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -69.75 -36.47 75.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 2.02 109.567 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -53.67 -50.54 65.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.832 . . . . 1.26 110.314 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.16 -49.02 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.975 -1.078 . . . . 1.1799999999999999 109.601 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -63.12 -19.27 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.429 -0.794 . . . . 1.1899999999999999 109.046 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -73.85 -37.53 64.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.992 . . . . 2.2000000000000002 109.952 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.02 -26.57 31.0 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.524 -1.322 . . . . 0.85999999999999999 112.619 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -67.68 -47.05 70.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.528 -1.572 . . . . 2.0 108.948 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.04 -50.38 23.36 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.604 -0.685 . . . . 1.3200000000000001 109.218 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -59.27 -42.28 90.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.78 . . . . 2.1400000000000001 110.039 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.3 86.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.125 -0.984 . . . . 1.3799999999999999 110.905 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.3 -29.59 68.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.735 -1.228 . . . . 1.3500000000000001 109.426 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -67.54 -15.87 63.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.935 . . . . 1.95 109.627 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.43 -9.06 59.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.94 . . . . 1.71 109.278 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.36 146.54 25.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 1.71 108.636 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 20.5 p-10 -100.6 62.71 1.05 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.45 -0.781 . . . . 2.8300000000000001 109.311 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 122' ' ' TYR . 44.7 t0 -150.08 113.5 4.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 1.5800000000000001 109.522 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -53.6 -12.28 0.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 2.7999999999999998 109.607 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.411 ' H ' ' C ' ' A' ' 120' ' ' ASP . 1.1 t80 -79.74 -62.19 1.76 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.933 . . . . 1.27 109.072 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.6 mt -71.01 -27.47 63.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.88 . . . . 1.5800000000000001 109.599 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -68.08 -52.52 34.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.061 -1.024 . . . . 2.9199999999999999 108.831 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.28 -20.9 58.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.423 -0.954 . . . . 2.2000000000000002 108.423 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.555 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -72.55 -26.96 61.93 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.485 -1.672 . . . . 2.5299999999999998 106.485 178.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.24 -44.09 92.35 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.284 -1.006 . . . . 1.45 108.284 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.09 80.82 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.818 -0.808 . . . . 1.5 108.818 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -70.07 -32.17 70.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.42 -0.8 . . . . 1.3500000000000001 109.371 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.2 t -77.83 -45.99 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 1.23 108.37 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -57.48 -39.97 77.58 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.263 -1.014 . . . . 3.73 108.263 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.51 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 14.5 t70 -56.27 -39.32 72.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.563 -0.71 . . . . 1.3200000000000001 109.637 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.47 -20.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.163 -0.96 . . . . 1.2 108.881 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.69 -53.53 4.27 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.943 -1.263 . . . . 0.48999999999999999 109.943 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -49.04 -39.48 27.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.012 -1.287 . . . . 3.1099999999999999 108.832 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' A' ' 136' ' ' ARG . 3.1 mtt-85 -65.16 -45.97 82.78 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.282 -1.007 . . . . 2.9500000000000002 108.282 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.5 tp -53.61 -45.13 69.98 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.042 -0.725 . . . . 1.73 109.042 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 140' ' ' ASN . 18.2 mt -60.41 -60.2 4.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 1.22 109.435 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -43.97 -20.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 2.7799999999999998 110.324 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.649 ' ND2' HE22 ' A' ' 53' ' ' GLN . 1.8 m120 -85.4 -49.92 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 2.0299999999999998 109.665 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -61.91 -35.43 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 1.2 109.541 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.6 mt -88.49 -4.45 58.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.871 . . . . 1.28 109.17 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.67 22.54 46.94 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.466 -1.854 . . . . 0.68999999999999995 108.466 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.02 162.46 14.03 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.538 -0.977 . . . . 1.3100000000000001 109.318 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -65.06 151.21 46.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 2.8799999999999999 109.528 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.3 mt -107.62 144.36 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 109.166 -0.679 . . . . 1.3600000000000001 109.166 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.1 mm -76.77 100.54 2.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.236 -0.915 . . . . 1.9299999999999999 109.138 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.71 92.7 6.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.407 -0.808 . . . . 1.54 109.591 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.484 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 34.2 mt -79.56 -11.8 59.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 1.3400000000000001 108.924 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.8 p -86.37 47.16 1.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 1.98 108.768 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.08 16.6 3.25 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.382 -0.823 . . . . 1.3799999999999999 110.199 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.484 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 2.4 mp -69.04 151.79 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.856 -1.152 . . . . 1.3999999999999999 108.884 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -133.28 -22.32 1.99 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.05 -0.722 . . . . 2.7400000000000002 109.05 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.97 151.36 36.88 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.68 -0.859 . . . . 1.4099999999999999 108.68 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.61 124.73 24.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 1.3 109.835 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.2 m -148.27 167.71 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.199 -0.938 . . . . 1.28 109.339 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.6 mt -89.5 156.99 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.789 -1.189 . . . . 1.1499999999999999 107.789 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.6 tp -107.23 121.67 45.0 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.732 0.777 . . . . 1.2 109.69 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.16 128.6 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.659 -0.867 . . . . 1.1599999999999999 108.659 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.74 152.29 13.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 1.2 109.9 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.77 -43.1 94.49 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.374 -1.453 . . . . 1.3200000000000001 107.949 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -172.34 153.27 2.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 2.3399999999999999 109.458 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.1 mt -125.69 133.89 52.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.571 -0.706 . . . . 1.26 109.399 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.4 p -93.04 154.39 41.71 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.822 . . . . 1.3600000000000001 109.084 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -33.9 -51.33 0.56 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.808 2.339 . . . . 0.63 112.948 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.7 m -50.03 -50.35 47.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.099 -1.001 . . . . 1.0700000000000001 109.289 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.99 -42.28 98.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.855 . . . . 1.25 109.846 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.4 p -70.49 -31.34 68.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 1.1799999999999999 109.563 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.62 -29.74 68.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 1.1399999999999999 110.011 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -103.53 -4.31 24.11 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.25 -0.906 . . . . 1.71 110.15 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 tp -57.71 153.14 14.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.91 -1.118 . . . . 1.22 108.275 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.682 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.2 OUTLIER -99.5 90.55 4.55 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.147 -0.971 . . . . 2.5499999999999998 110.3 -178.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.56 32.18 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 1.96 108.674 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 172' ' ' ASN . 67.6 mttm -111.12 -24.55 10.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.63 -0.669 . . . . 2.46 109.811 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -132.13 6.64 4.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.473 -0.767 . . . . 2.4199999999999999 109.796 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 39.4 t -79.27 154.78 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.087 -1.008 . . . . 1.1599999999999999 109.031 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.38 -28.21 8.31 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.714 -0.616 . . . . 1.95 110.154 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -176.91 177.96 48.16 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.91 -1.276 . . . . 0.41999999999999998 109.91 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -129.36 125.53 36.85 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.519 -0.989 . . . . 0.52000000000000002 110.022 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 16.8 mt -128.15 118.99 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.635 -1.246 . . . . 1.1599999999999999 107.635 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 203' ' ' VAL . 20.8 p -141.83 152.53 43.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.54 -0.725 . . . . 1.22 111.169 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 26.5 p30 -87.66 45.06 1.24 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.991 -1.068 . . . . 2.2400000000000002 110.823 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.95 0 O-C-N 120.961 -1.087 . . . . 1.6499999999999999 109.326 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 12.9 t60 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.182 0.515 . . . . 1.0600000000000001 110.044 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.7 t -46.91 -25.87 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 2.0899999999999999 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.0 p -78.92 -45.88 19.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 1.8799999999999999 109.884 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.5 mt -52.49 -32.58 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 2.0099999999999998 109.674 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.9 mtp -71.46 -51.91 21.28 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.363 -1.347 . . . . 1.27 107.363 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.71 58.82 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.628 -0.714 . . . . 1.1799999999999999 109.573 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.468 ' HG2' HH11 ' A' ' 195' ' ' ARG . 17.3 mtt-85 -76.95 -50.87 12.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 3.5800000000000001 109.904 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 61.1 m -68.7 -35.33 77.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 1.1399999999999999 109.738 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' A' ' 199' ' ' LEU . 27.2 mt -87.13 1.49 52.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.265 -0.897 . . . . 1.28 109.092 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 49.19 3.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.559 -0.713 . . . . 1.49 111.631 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 197' ' ' LEU . 40.7 mt -66.01 169.82 6.24 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.491 -1.381 . . . . 1.28 108.382 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -89.86 141.7 3.79 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.249 1.966 . . . . 0.69999999999999996 111.054 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.08 179.74 7.29 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.468 -1.293 . . . . 1.1899999999999999 110.65 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 203' ' ' VAL . 70.6 mt -147.66 160.93 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 106.82 -1.548 . . . . 1.25 106.82 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 183' ' ' ALA . 18.1 m -141.58 -28.17 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.873 -1.142 . . . . 1.29 110.918 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.36 38.5 3.18 Favored Glycine 0 N--CA 1.496 2.667 0 O-C-N 120.888 -1.132 . . . . 0.92000000000000004 110.987 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 20.1 p -67.2 -29.11 68.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.67 -1.488 . . . . 1.3100000000000001 108.77 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 76.7 -98.69 1.3 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.788 -1.196 . . . . 1.0 111.238 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.9 p -113.27 43.47 1.73 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.001 -1.294 . . . . 1.9199999999999999 112.395 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.8 -28.51 15.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.651 -1.281 . . . . 1.27 107.65 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.4 p -64.71 -12.98 52.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.287 -0.883 . . . . 1.3400000000000001 108.917 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.1 p -108.51 17.1 22.41 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.662 -0.866 . . . . 2.0699999999999998 108.662 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -131.55 -16.19 3.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.668 -0.645 . . . . 2.8599999999999999 109.668 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 71.1 t -120.38 164.07 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.457 -0.777 . . . . 1.3 109.597 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.465 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 0.5 OUTLIER -126.58 174.21 8.86 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.841 -1.54 . . . . 2.48 106.841 178.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 214' ' ' ASN . 1.4 p-10 -75.02 145.74 42.18 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.786 -1.197 . . . . 2.6200000000000001 109.824 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.6 OUTLIER 80.38 -12.12 1.07 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.803 -0.561 . . . . 2.3999999999999999 110.249 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -57.25 150.95 16.78 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.002 -1.061 . . . . 1.99 108.429 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -87.29 110.71 20.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.91 -1.119 . . . . 1.54 108.887 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 16.2 mt -106.22 160.92 14.97 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.89 0.853 . . . . 1.25 109.65 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.2 mt -141.94 107.75 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.725 -1.213 . . . . 1.26 107.725 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.5 tp -86.49 126.44 34.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.79 -0.818 . . . . 1.1799999999999999 108.79 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.0 -53.64 4.18 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.541 -0.911 . . . . 2.2200000000000002 108.541 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.422 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 58.51 22.87 10.14 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.413 -0.804 . . . . 1.2 109.24 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.0 t -117.83 -56.14 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.11 -1.441 . . . . 1.48 107.11 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -96.41 13.25 28.46 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.539 -1.282 . . . . 2.8199999999999998 107.539 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 59.81 60.19 2.26 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.074 0.464 . . . . 2.1099999999999999 109.916 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -157.08 147.62 21.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 2.6499999999999999 110.52 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.8 t -109.72 131.17 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.678 -0.86 . . . . 1.29 108.678 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -103.66 131.31 50.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.203 -0.936 . . . . 1.4199999999999999 109.344 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.5 t -102.97 114.8 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.446 -0.784 . . . . 1.26 109.716 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 36.8 t30 45.24 60.88 12.82 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.424 -0.798 . . . . 2.1499999999999999 110.571 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.35 165.06 32.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.283 1.989 . . . . 0.81999999999999995 111.415 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.9 m -72.27 158.04 36.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 2.1099999999999999 109.804 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -64.48 -22.35 66.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 3.1699999999999999 109.031 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 234' ' ' GLU . 0.8 OUTLIER -66.91 -36.8 83.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.434 -0.791 . . . . 3.0600000000000001 109.129 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 68.7 t -79.01 -48.94 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.248 -0.908 . . . . 1.6499999999999999 108.704 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.93 -59.09 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.408 -0.807 . . . . 1.47 109.651 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -52.12 -41.3 62.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 2.54 109.961 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -66.84 -37.65 84.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 3.0 109.739 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' MET . . . . . 0.504 ' O ' ' N ' ' A' ' 243' ' ' GLN . 28.5 mtm -81.94 -32.96 30.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.908 . . . . 1.6299999999999999 109.676 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -53.81 -40.03 66.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 3.1600000000000001 109.087 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.48 -51.65 12.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 2.0899999999999999 109.421 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.4 -47.11 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 2.5699999999999998 109.527 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 239' ' ' MET . 3.1 tm0? -47.56 -57.45 5.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 3.5899999999999999 109.818 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--N 1.299 -1.614 0 O-C-N 121.439 -0.788 . . . . 1.76 110.732 -178.755 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.569 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.9 mpt? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.56 -0.533 . . . . 4.0700000000000003 109.56 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.23 94.18 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.584 -0.895 . . . . 1.5 108.584 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.7 m -96.16 115.86 28.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.31 -0.869 . . . . 1.8 109.894 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.8 -163.5 21.41 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.332 -1.907 . . . . 0.92000000000000004 108.332 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.1 mt -95.88 -6.15 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -1.171 . . . . 1.5 108.427 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 tp 60.21 107.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.419 -0.801 . . . . 1.3999999999999999 108.915 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.63 -55.58 3.92 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.982 -1.118 . . . . 1.26 107.982 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.23 150.27 37.44 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.32 -0.993 . . . . 1.95 108.32 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.47 154.18 21.07 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.087 1.858 . . . . 0.93999999999999995 113.954 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.08 -176.07 37.69 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.666 -1.373 . . . . 0.78000000000000003 109.666 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.7 mt -146.18 121.72 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.726 -1.455 . . . . 1.29 109.171 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.72 162.54 34.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.267 -0.896 . . . . 1.1499999999999999 109.733 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.9 m-85 -129.34 140.25 51.45 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.196 -1.039 . . . . 0.71999999999999997 108.196 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.18 159.76 28.15 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 118.612 -1.756 . . . . 0.5 111.319 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -78.47 150.81 32.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.615 -0.933 . . . . 2.3599999999999999 109.724 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.42 127.95 34.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.284 -0.885 . . . . 1.1599999999999999 110.913 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.6 85.35 2.18 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.472 -1.307 . . . . 1.24 107.472 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 15.6 tp -82.01 132.23 35.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.055 -1.028 . . . . 1.3100000000000001 110.617 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.3 mt -94.92 94.35 7.97 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.551 0.691 . . . . 1.3100000000000001 109.931 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.415 ' CB ' ' HZ1' ' A' ' 20' ' ' LYS . 6.3 mtmp? -94.23 142.04 27.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.782 -0.821 . . . . 2.3500000000000001 108.782 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -128.74 135.37 49.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 2.5800000000000001 108.729 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -78.03 136.7 37.98 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.168 -0.958 . . . . 2.1400000000000001 109.007 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -60.79 143.88 53.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 1.9299999999999999 109.109 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.54 133.97 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.43 -0.793 . . . . 1.28 109.906 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.4 t -106.78 113.72 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 1.3700000000000001 109.183 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.4 mt -87.69 134.83 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 1.3300000000000001 109.045 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -89.23 113.28 24.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 1.3700000000000001 109.638 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.424 HH11 ' HG3' ' A' ' 28' ' ' ARG . 14.1 mmm-85 -96.06 26.25 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 3.1899999999999999 108.845 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -83.56 146.03 28.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -0.814 . . . . 2.8100000000000001 109.748 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -85.08 118.41 24.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.394 -0.965 . . . . 2.8300000000000001 108.394 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 pt -81.54 173.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 1.3400000000000001 109.977 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.8 p -97.87 161.15 13.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.031 -0.729 . . . . 1.3500000000000001 109.031 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.0 -16.67 32.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.112 -0.993 . . . . 1.6100000000000001 109.283 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.16 -7.43 59.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 2.4700000000000002 109.265 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -114.96 -13.52 11.91 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.849 -0.797 . . . . 2.0699999999999998 108.849 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.9 t -65.66 -45.38 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 1.3300000000000001 109.402 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -54.94 -33.28 62.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 1.46 109.293 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -69.92 -33.99 72.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 2.9399999999999999 110.26 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -62.8 -43.57 98.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 1.3 109.688 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 44' ' ' LEU . 96.1 t -60.1 -46.94 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.41 -0.806 . . . . 1.3300000000000001 109.828 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.91 -43.39 88.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 1.5 108.883 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -65.18 -30.99 71.94 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.813 -0.81 . . . . 3.1499999999999999 108.813 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -86.39 -58.33 2.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.92000000000000004 109.266 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 40' ' ' VAL . 14.5 tp -52.48 -58.94 5.14 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.289 -0.882 . . . . 1.4099999999999999 109.287 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 t -63.76 -30.5 71.59 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.334 -0.987 . . . . 1.22 108.334 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.81 -54.6 35.41 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 107.977 -2.049 . . . . 0.58999999999999997 107.977 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 29.8 ttm-85 -49.47 -30.52 8.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.535 -0.98 . . . . 3.3900000000000001 109.074 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.99 -40.59 81.08 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.551 -0.907 . . . . 1.26 108.551 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -80.96 -59.34 2.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.667 -0.646 . . . . 2.9900000000000002 109.302 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.85 -40.83 57.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.032 . . . . 1.1399999999999999 110.205 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.459 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 29.2 t -62.32 -37.46 85.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.956 -1.09 . . . . 1.8400000000000001 108.183 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.58 -31.31 63.53 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.158 0.504 . . . . 1.22 109.732 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -75.86 -65.95 0.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 2.0 109.589 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 54' ' ' LEU . 9.7 mp -50.12 -27.02 5.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 1.99 109.332 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 51' ' ' SER . 4.1 mm-40 -71.76 -42.22 67.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 1.27 108.646 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 m -61.64 -37.16 83.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 1.24 109.435 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.32 -25.79 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 1.21 109.117 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.471 ' NZ ' ' OE1' ' A' ' 70' ' ' GLU . 9.9 ttpp -61.17 -46.88 88.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 1.53 110.2 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.18 -30.81 68.03 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.128 -0.983 . . . . 1.24 109.844 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.423 ' O ' ' OG1' ' A' ' 64' ' ' THR . 37.8 mttp -70.43 -18.89 63.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.695 -1.253 . . . . 2.3199999999999998 108.123 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.79 -33.42 30.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.567 -0.901 . . . . 1.1699999999999999 108.567 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.88 -28.42 28.92 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.192 -1.163 . . . . 0.57999999999999996 110.192 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.14 -15.09 42.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.016 -1.285 . . . . 1.3899999999999999 109.0 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 90.8 m -95.37 -48.37 5.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.24 -0.912 . . . . 1.3600000000000001 110.179 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -106.33 -21.73 13.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.339 -0.851 . . . . 1.1399999999999999 110.124 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 121.5 147.12 7.58 Favored Glycine 0 N--CA 1.503 3.13 0 N-CA-C 110.082 -1.207 . . . . 0.59999999999999998 110.082 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -48.49 -11.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.606 -0.938 . . . . 2.5899999999999999 110.197 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 66' ' ' GLY . 63.0 mt-10 -63.99 -29.61 70.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.089 -1.007 . . . . 2.2000000000000002 110.802 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -91.82 -7.65 48.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.8 -1.188 . . . . 2.3599999999999999 111.087 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.471 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 56.3 mt-10 -63.85 -24.52 67.78 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.732 -1.23 . . . . 1.54 110.598 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.67 -28.36 69.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.02 -1.05 . . . . 1.24 110.508 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.37 -44.25 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.011 -1.055 . . . . 1.24 110.064 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.55 -21.47 45.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.088 -1.007 . . . . 0.80000000000000004 109.845 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -64.93 -44.16 90.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 1.23 109.571 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.35 -37.22 59.1 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.66 -1.376 . . . . 0.56000000000000005 109.66 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -61.37 -20.55 63.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.294 -1.121 . . . . 2.0600000000000001 110.455 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.0 mt -85.79 -37.04 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.592 -1.317 . . . . 1.24 108.393 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.8 ttt -58.78 -42.25 88.56 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.224 -1.028 . . . . 2.4500000000000002 108.224 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.12 -37.23 84.34 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.358 -0.978 . . . . 1.21 108.358 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.452 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 23.8 tp -69.55 -43.97 71.86 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.649 -0.821 . . . . 1.1200000000000001 109.151 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -85.41 7.12 23.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 1.24 110.222 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.419 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 57.3 t0 -47.06 122.55 4.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.012 -1.055 . . . . 1.3100000000000001 109.695 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.66 -24.81 66.33 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.726 -0.842 . . . . 1.3500000000000001 108.726 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 18.7 mp0 -76.14 -49.53 17.06 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.783 -0.767 . . . . 2.1600000000000001 109.205 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.2 mt -63.75 -13.96 48.27 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.823 -1.151 . . . . 1.24 108.715 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -79.2 -56.18 4.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.508 -0.745 . . . . 1.28 109.836 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -63.33 -26.27 68.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 1.79 109.977 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.42 -44.05 62.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.101 -0.999 . . . . 1.29 108.673 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.1 mt -60.7 -56.49 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.097 -1.075 . . . . 1.1399999999999999 108.097 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -47.16 -53.0 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.635 -0.666 . . . . 1.3200000000000001 109.543 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.69 -44.41 93.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 1.3700000000000001 109.227 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.8 mt -57.97 -56.85 16.64 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.168 -1.049 . . . . 1.3999999999999999 108.168 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.6 mt -51.2 -39.84 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 1.23 110.073 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -85.34 -36.4 20.8 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.086 -1.008 . . . . 2.5099999999999998 111.681 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 91' ' ' ALA . 22.1 t70 -82.75 -43.55 16.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.798 -1.189 . . . . 1.5900000000000001 111.486 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -102.07 12.2 37.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.768 -1.208 . . . . 2.3799999999999999 109.538 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 45.59 48.57 11.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.371 -0.831 . . . . 1.6200000000000001 109.368 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtp -101.41 152.19 21.03 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.092 -0.706 . . . . 1.8899999999999999 109.092 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 p -76.31 145.05 39.84 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.436 -0.79 . . . . 1.27 109.462 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.44 29.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.166 -0.959 . . . . 1.1599999999999999 108.797 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -72.71 -45.99 55.95 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.28 -1.007 . . . . 2.0 108.28 179.049 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.1 -51.42 21.57 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.391 0.615 . . . . 1.25 109.973 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.34 -50.92 71.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 1.1299999999999999 109.647 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.37 -34.15 64.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.194 -0.941 . . . . 1.0800000000000001 109.799 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -69.03 -31.48 70.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 2.02 109.229 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.5 tt0 -71.59 -57.63 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 1.26 109.892 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 t -55.2 -49.9 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 1.1799999999999999 109.811 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.1 mm -64.68 -70.16 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 1.1899999999999999 109.613 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.46 ' OE2' ' NE ' ' A' ' 131' ' ' ARG . 18.1 tp10 -50.55 -45.3 56.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.826 -1.171 . . . . 2.2000000000000002 108.992 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -45.04 -40.07 6.92 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.11 -1.596 . . . . 0.85999999999999999 109.11 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -69.17 -59.41 3.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.343 -1.092 . . . . 2.0 108.29 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.74 -43.5 37.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.809 -0.812 . . . . 1.3200000000000001 108.809 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.8 m -59.99 -37.04 78.5 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.305 -0.872 . . . . 2.1400000000000001 109.186 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.54 84.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 1.3799999999999999 109.878 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.81 -29.48 67.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.929 -1.107 . . . . 1.3500000000000001 108.677 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.54 -17.13 62.48 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.455 -0.943 . . . . 1.95 108.455 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -82.42 -1.01 48.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.567 -0.708 . . . . 1.71 109.481 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -83.77 158.72 21.63 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.136 -0.978 . . . . 1.71 109.209 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -100.5 50.56 0.89 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.891 -0.781 . . . . 2.8300000000000001 108.891 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -146.56 119.21 8.56 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.222 -0.924 . . . . 1.5800000000000001 109.612 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.71 -19.3 58.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.372 -0.83 . . . . 2.7999999999999998 109.501 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.22 -65.21 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 1.27 109.275 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.8 mt -47.58 -31.29 4.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.09 -1.006 . . . . 1.5800000000000001 109.624 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 127' ' ' ALA . 1.9 ttmp? -65.52 -39.97 92.43 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.918 -1.113 . . . . 2.9199999999999999 108.319 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -58.13 -23.41 55.03 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.392 -0.966 . . . . 2.2000000000000002 108.392 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -72.99 -27.26 61.69 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.537 -1.653 . . . . 2.5299999999999998 106.537 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -57.67 -39.83 77.96 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.098 -1.075 . . . . 1.45 108.098 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.07 -36.42 81.98 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.793 -0.817 . . . . 1.5 108.793 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.45 -36.94 77.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.348 -0.845 . . . . 1.3500000000000001 109.254 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.4 t -76.65 -44.24 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.04 -1.096 . . . . 1.23 108.04 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.46 ' NE ' ' OE2' ' A' ' 109' ' ' GLU . 42.4 ttm180 -60.55 -34.7 74.53 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.925 -1.139 . . . . 3.73 107.925 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -58.94 -35.55 73.32 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.502 -0.749 . . . . 1.3200000000000001 109.17 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.19 -26.51 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 1.2 108.528 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.29 -42.64 14.6 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.145 -1.582 . . . . 0.48999999999999999 109.145 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -55.42 -54.09 48.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.545 -0.973 . . . . 3.1099999999999999 109.986 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.523 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 34.4 mtm180 -63.56 -38.79 92.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.176 -0.952 . . . . 2.9500000000000002 108.697 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 41.5 tp -61.83 -40.34 94.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.437 -0.79 . . . . 1.73 109.719 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.8 mt -67.54 -54.8 16.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.05 -1.031 . . . . 1.22 109.335 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -49.16 -19.0 0.39 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 2.7799999999999998 109.529 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -84.24 -39.9 18.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 2.0299999999999998 109.586 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.14 -40.3 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.005 . . . . 1.2 109.693 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.9 mt -88.72 2.11 53.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.158 -0.964 . . . . 1.28 109.272 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.64 29.23 48.27 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.422 -1.871 . . . . 0.68999999999999995 108.422 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.9 tp -58.52 148.14 29.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.595 -0.944 . . . . 1.3100000000000001 109.542 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.31 132.64 47.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.942 . . . . 2.8799999999999999 109.786 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.4 mt -110.47 144.12 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 109.172 -0.677 . . . . 1.3600000000000001 109.172 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.499 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.2 mp -78.54 133.21 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.072 -1.017 . . . . 1.9299999999999999 109.768 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.96 87.85 3.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.502 -0.749 . . . . 1.54 109.408 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.45 -22.22 44.44 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.241 -0.912 . . . . 1.3400000000000001 109.586 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.437 ' HG ' HD22 ' A' ' 172' ' ' ASN . 7.5 t -80.8 17.81 1.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.151 -0.968 . . . . 1.98 109.446 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.08 29.19 2.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.389 -0.819 . . . . 1.3799999999999999 109.416 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.59 153.14 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.293 -0.879 . . . . 1.3999999999999999 108.985 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -132.96 -2.1 3.26 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.394 -0.816 . . . . 2.7400000000000002 109.245 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -129.8 125.74 36.47 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.821 -0.807 . . . . 1.4099999999999999 108.821 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.68 129.19 38.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 1.3 109.714 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.32 175.79 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 1.28 108.806 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.8 mt -89.31 149.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.891 -1.151 . . . . 1.1499999999999999 107.891 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.3 tp -104.73 119.85 39.97 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.534 -0.729 . . . . 1.2 109.612 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.0 125.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.99 -0.744 . . . . 1.1599999999999999 108.99 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.5 147.06 12.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 1.2 109.816 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.38 -38.15 71.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.745 -1.222 . . . . 1.3200000000000001 108.131 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -173.97 147.66 1.32 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.428 -0.795 . . . . 2.3399999999999999 109.651 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.2 mt -117.68 136.53 53.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.634 -0.667 . . . . 1.26 109.383 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.6 p -94.06 152.19 40.24 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.222 -0.924 . . . . 1.3600000000000001 109.296 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -36.21 -39.38 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.442 2.095 . . . . 0.63 112.567 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.523 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 1.4 m -56.83 -57.23 13.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.138 -0.976 . . . . 1.0700000000000001 109.13 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -60.01 -41.99 93.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.474 -0.767 . . . . 1.25 109.79 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.0 p -71.17 -19.78 62.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.052 -1.03 . . . . 1.1799999999999999 109.409 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.3 -25.48 33.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 1.1399999999999999 109.745 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -103.47 -18.9 14.6 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.26 -0.9 . . . . 1.71 109.209 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.78 144.51 48.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.121 -1.066 . . . . 1.22 108.121 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.528 ' OD1' ' NZ ' ' A' ' 175' ' ' LYS . 1.7 m120 -95.64 134.79 38.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.0 -1.062 . . . . 2.5499999999999998 108.587 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.1 mt -78.66 -42.95 27.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.391 -0.818 . . . . 1.96 111.654 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -80.0 -8.82 59.56 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.672 -1.267 . . . . 2.46 111.767 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.528 ' NZ ' ' OD1' ' A' ' 172' ' ' ASN . 58.6 mttp -99.98 -7.3 25.28 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.694 -1.253 . . . . 2.4199999999999999 108.721 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.423 ' CG1' ' N ' ' A' ' 177' ' ' LEU . 54.3 t -98.32 162.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.488 -0.757 . . . . 1.1599999999999999 109.057 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.423 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 8.5 tp -115.2 -20.09 10.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.555 -0.716 . . . . 1.95 109.954 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.9 174.58 42.57 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.406 -1.478 . . . . 0.41999999999999998 109.406 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 1.3 m-85 -128.07 124.16 36.36 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.346 -1.091 . . . . 0.52000000000000002 110.156 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.8 mt -121.19 109.96 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 106.92 -1.511 . . . . 1.1599999999999999 106.92 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.604 ' O ' ' O ' ' A' ' 203' ' ' VAL . 31.2 p -140.58 154.99 46.7 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.119 -0.988 . . . . 1.22 112.578 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 182' ' ' ASP . 42.6 t0 -80.18 40.94 0.5 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.823 -0.626 . . . . 2.2400000000000002 110.831 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.305 0 O-C-N 120.229 -1.544 . . . . 1.6499999999999999 110.544 -178.819 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 75.4 t60 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.972 -0.751 . . . . 1.0600000000000001 108.972 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.8 p -50.54 -36.99 36.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 2.0899999999999999 109.147 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.1 m -62.01 -41.31 97.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.337 -0.852 . . . . 1.8799999999999999 109.35 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.5 mt -58.01 -24.76 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 2.0099999999999998 109.478 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.3 mtp -71.81 -58.83 3.13 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.689 -1.226 . . . . 1.27 107.689 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.22 -41.71 62.97 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.325 0.583 . . . . 1.1799999999999999 109.722 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 20.5 mtt-85 -69.02 -50.67 46.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 3.5800000000000001 109.882 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.5 m -69.12 -38.44 78.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.051 -1.031 . . . . 1.1399999999999999 109.906 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 199' ' ' LEU . 22.3 mt -87.81 3.39 48.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.106 -0.996 . . . . 1.28 108.858 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 44.02 11.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.741 -0.6 . . . . 1.49 112.019 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 197' ' ' LEU . 17.1 mt -68.98 169.51 11.16 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.372 -1.455 . . . . 1.28 108.495 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.88 139.64 3.86 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.345 2.03 . . . . 0.69999999999999996 110.907 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.37 -172.96 2.64 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.19 -1.404 . . . . 1.1899999999999999 111.595 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.2 mt -149.12 153.1 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.248 -1.39 . . . . 1.25 107.248 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.604 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.7 m -138.22 -39.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.874 -1.141 . . . . 1.29 111.113 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -71.45 39.96 0.61 Allowed Glycine 0 C--N 1.285 -2.276 0 N-CA-C 108.599 -1.8 . . . . 0.92000000000000004 108.599 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 203' ' ' VAL . 47.1 p -67.38 -18.29 65.07 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.106 -1.232 . . . . 1.3100000000000001 109.531 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.419 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 62.64 -101.08 0.36 Allowed Glycine 0 N--CA 1.484 1.859 0 C-N-CA 119.392 -1.385 . . . . 1.0 110.121 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.2 m -117.55 45.61 1.89 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.301 -1.117 . . . . 1.9199999999999999 112.331 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 62.6 t -74.82 -26.73 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.454 -1.403 . . . . 1.27 107.786 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.7 p -68.28 -12.75 61.54 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.738 . . . . 1.3400000000000001 109.599 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.9 m -102.4 9.34 39.79 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.416 -0.802 . . . . 2.0699999999999998 109.049 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -131.17 -5.78 3.86 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.569 -0.707 . . . . 2.8599999999999999 109.195 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 23.3 t -122.64 148.57 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.649 -0.871 . . . . 1.3 108.649 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -121.54 -174.29 2.83 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.619 -1.623 . . . . 2.48 106.619 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.6 m120 -79.51 150.52 31.15 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.776 -1.202 . . . . 2.6200000000000001 109.839 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.7 m-20 81.07 -14.42 0.83 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.052 -0.405 . . . . 2.3999999999999999 110.94 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.64 128.2 35.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.755 -1.215 . . . . 1.99 108.355 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -86.62 119.11 26.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.868 -1.145 . . . . 1.54 108.883 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.7 mt -119.62 163.29 17.58 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.666 0.746 . . . . 1.25 110.124 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 219' ' ' ILE . 71.1 mt -128.68 118.96 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.742 -1.207 . . . . 1.26 107.742 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.6 tp -87.18 120.61 28.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.425 -0.954 . . . . 1.1799999999999999 108.425 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.4 t0 -95.97 -31.07 13.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.212 -0.93 . . . . 2.2200000000000002 108.838 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 38.17 28.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.456 0.645 . . . . 1.2 110.248 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.6 t -123.9 -67.36 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.821 -1.548 . . . . 1.48 106.821 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 224' ' ' ASN . 19.9 t-20 -84.12 10.95 8.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.218 -1.401 . . . . 2.8199999999999998 107.218 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 58.22 61.99 2.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.906 -0.496 . . . . 2.1099999999999999 110.092 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -156.8 147.89 22.01 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.122 -0.986 . . . . 2.6499999999999999 110.673 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.47 141.5 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.663 -0.866 . . . . 1.29 108.663 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -104.62 127.77 52.46 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.177 -0.952 . . . . 1.4199999999999999 109.408 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.42 120.59 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.48 -0.762 . . . . 1.26 110.358 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 43.5 t30 55.55 74.37 0.72 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 2.1499999999999999 110.314 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -87.05 149.16 8.14 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.018 2.479 . . . . 0.81999999999999995 112.148 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.2 m -72.14 160.99 31.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.258 -0.901 . . . . 2.1099999999999999 109.966 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -64.37 -30.67 71.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -0.799 . . . . 3.1699999999999999 109.758 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -67.11 -37.61 84.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 3.0600000000000001 109.165 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.65 -32.59 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 1.6499999999999999 108.941 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt -72.88 -61.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 1.47 109.209 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -53.61 -41.49 66.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.498 -0.751 . . . . 2.54 110.106 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -66.34 -34.86 78.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.09 -1.006 . . . . 3.0 109.439 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 57.1 mtp -81.68 -39.37 24.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.89 . . . . 1.6299999999999999 109.437 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.404 ' O ' ' OE1' ' A' ' 244' ' ' GLU . 16.6 mmt180 -49.35 -47.25 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.139 -0.976 . . . . 3.1600000000000001 109.546 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.03 -64.11 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -0.963 . . . . 2.0899999999999999 110.671 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 24.4 t -59.68 -52.7 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 2.5699999999999998 111.201 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' A' ' 239' ' ' MET . 41.4 tp60 -54.78 -41.08 70.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.672 -1.267 . . . . 3.5899999999999999 109.925 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.404 ' OE1' ' O ' ' A' ' 240' ' ' ARG . 62.0 mt-10 . . . . . 0 C--N 1.302 -1.47 0 O-C-N 120.623 -1.298 . . . . 1.76 109.881 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.372 -0.603 . . . . 4.0700000000000003 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.6 mt -129.95 91.54 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.809 -0.811 . . . . 1.5 108.809 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m -91.68 117.03 29.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.185 -0.947 . . . . 1.8 110.049 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.95 -159.54 11.98 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 108.149 -1.98 . . . . 0.92000000000000004 108.149 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.1 mt -97.63 -10.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.133 -1.216 . . . . 1.5 109.04 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 tp 60.3 103.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.343 -0.848 . . . . 1.3999999999999999 108.901 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.97 -48.43 7.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.997 -1.064 . . . . 1.26 108.974 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.98 145.8 26.15 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.411 -0.805 . . . . 1.95 108.975 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.47 153.48 23.79 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.32 2.014 . . . . 0.93999999999999995 113.748 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.75 177.12 32.55 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.959 -1.256 . . . . 0.78000000000000003 109.959 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mt -143.86 120.74 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.974 -1.309 . . . . 1.29 109.776 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.23 140.55 30.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.124 -0.985 . . . . 1.1499999999999999 109.399 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.7 m-85 -105.87 151.37 24.62 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.689 -0.856 . . . . 0.71999999999999997 108.689 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.58 166.38 31.05 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 118.66 -1.733 . . . . 0.5 111.467 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -81.92 153.34 26.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.653 -0.91 . . . . 2.3599999999999999 110.377 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.06 126.22 30.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.774 . . . . 1.1599999999999999 111.642 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.7 tp -108.13 89.26 2.94 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 107.52 -1.289 . . . . 1.24 107.52 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.0 tp -81.26 129.39 34.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.011 -1.055 . . . . 1.3100000000000001 110.206 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.9 mt -96.39 94.41 7.41 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.413 0.625 . . . . 1.3100000000000001 110.433 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.56 ' CB ' ' HZ1' ' A' ' 20' ' ' LYS . 8.0 mtpm? -97.16 157.68 15.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.726 -0.842 . . . . 2.3500000000000001 108.726 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -130.77 134.26 46.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.25 -0.906 . . . . 2.5800000000000001 108.87 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -79.31 137.76 37.47 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.173 -0.955 . . . . 2.1400000000000001 109.368 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.74 141.67 58.7 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.541 -0.724 . . . . 1.9299999999999999 109.136 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 24' ' ' ILE . 68.1 mt -89.36 138.32 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 1.28 109.586 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.04 114.83 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.505 -0.747 . . . . 1.3700000000000001 109.179 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.1 mt -87.43 133.88 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.912 . . . . 1.3300000000000001 109.611 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.78 120.41 31.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.462 -0.774 . . . . 1.3700000000000001 108.998 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -99.92 32.02 3.07 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.229 -0.92 . . . . 3.1899999999999999 109.444 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -83.31 138.53 33.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.044 -1.035 . . . . 2.8100000000000001 110.284 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -84.77 134.69 34.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.309 -0.997 . . . . 2.8300000000000001 108.309 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.9 pt -97.74 176.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.159 -0.963 . . . . 1.3400000000000001 110.841 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 34' ' ' ASP . 36.3 p -98.37 153.26 18.68 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.394 -0.965 . . . . 1.3500000000000001 108.394 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.34 -7.75 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 1.6100000000000001 110.139 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 32' ' ' SER . 17.7 t70 -84.78 -21.76 29.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.905 -1.122 . . . . 2.4700000000000002 110.323 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -106.41 -3.81 20.61 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.193 -0.942 . . . . 2.0699999999999998 109.531 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.7 -43.69 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 1.3300000000000001 109.237 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -53.79 -34.59 59.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.284 -0.885 . . . . 1.46 109.184 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -69.47 -33.3 72.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 2.9399999999999999 109.698 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -61.65 -46.64 88.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.007 -1.058 . . . . 1.3 109.68 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.78 -45.41 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 1.3300000000000001 109.693 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.28 -39.62 92.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.108 -0.995 . . . . 1.5 108.334 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -65.11 -32.75 74.61 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.949 -0.76 . . . . 3.1499999999999999 108.949 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -86.62 -57.68 2.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.144 -0.973 . . . . 0.92000000000000004 108.476 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -49.32 -61.93 1.82 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.73 -0.841 . . . . 1.4099999999999999 108.73 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 t -65.2 -33.82 76.91 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.312 -0.995 . . . . 1.22 108.312 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.27 -54.46 35.61 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 107.927 -2.069 . . . . 0.58999999999999997 107.927 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -48.63 -30.11 5.07 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.384 -1.068 . . . . 3.3900000000000001 108.561 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.43 70.21 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.897 -1.149 . . . . 1.26 107.897 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 mttt -79.17 -58.61 3.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.805 -0.813 . . . . 2.9900000000000002 108.805 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.35 -40.52 62.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 1.1399999999999999 109.937 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 t -62.23 -38.25 88.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.952 -1.093 . . . . 1.8400000000000001 108.498 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.82 -36.33 67.48 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.378 -0.601 . . . . 1.22 109.378 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -65.57 -62.76 1.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.351 -0.843 . . . . 2.0 109.535 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.08 -38.89 62.92 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.304 -0.873 . . . . 1.99 109.161 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -59.92 -46.88 87.97 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.591 -0.892 . . . . 1.27 108.591 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.5 m -61.99 -37.7 85.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.485 -0.759 . . . . 1.24 109.332 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.2 mt -73.3 -29.3 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.821 . . . . 1.21 109.151 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -63.94 -43.32 96.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -0.819 . . . . 1.53 109.03 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.2 m -72.34 -26.99 62.14 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.365 -0.834 . . . . 1.24 109.538 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.407 ' O ' ' OG1' ' A' ' 64' ' ' THR . 62.7 mttm -72.82 -30.04 63.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.638 -1.245 . . . . 2.3199999999999998 107.638 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.28 63.68 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.111 -1.07 . . . . 1.1699999999999999 108.111 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.12 -28.21 28.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.608 -1.397 . . . . 0.57999999999999996 109.608 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -86.54 -16.06 38.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.812 -1.404 . . . . 1.3899999999999999 108.462 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 99.2 m -94.44 -49.27 5.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 1.3600000000000001 110.36 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.508 ' C ' ' H ' ' A' ' 67' ' ' GLU . 53.0 m-85 -107.11 -33.21 7.52 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.156 -0.965 . . . . 1.1399999999999999 110.241 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.48 -29.92 0.71 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.179 -1.168 . . . . 0.59999999999999998 110.179 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 69' ' ' LYS . 38.4 mt-10 -52.85 179.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -1.157 . . . . 2.5899999999999999 110.3 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -68.36 40.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.518 -0.738 . . . . 2.2000000000000002 109.532 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' A' ' 67' ' ' GLU . 35.1 mmtt -85.03 -17.26 38.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.639 -0.874 . . . . 2.3599999999999999 108.639 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.78 -34.8 77.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.614 -0.679 . . . . 1.54 110.517 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.79 -27.15 67.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 1.24 110.817 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.9 mt -71.79 -46.73 59.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.849 -1.157 . . . . 1.24 109.782 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -74.98 -21.66 59.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.085 -1.009 . . . . 0.80000000000000004 109.757 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.6 -41.62 92.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.146 -0.971 . . . . 1.23 109.383 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.25 -37.47 63.3 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.483 -1.447 . . . . 0.56000000000000005 109.483 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -58.89 -21.37 57.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -1.15 . . . . 2.0600000000000001 109.3 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -85.15 -34.39 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.064 -1.022 . . . . 1.24 108.473 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.3 ttt -60.61 -44.93 95.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -0.972 . . . . 2.4500000000000002 108.511 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.79 -40.38 83.87 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.215 -1.032 . . . . 1.21 108.215 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.5 tp -65.87 -43.99 86.7 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.672 -0.811 . . . . 1.1200000000000001 108.858 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -85.84 9.48 16.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.191 -0.943 . . . . 1.24 110.363 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -50.47 119.92 4.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.77 -1.206 . . . . 1.3100000000000001 109.264 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.06 -22.97 67.05 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.245 -0.909 . . . . 1.3500000000000001 108.838 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.14 -51.87 12.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.412 -0.805 . . . . 2.1600000000000001 109.392 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.78 -12.28 45.91 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.208 -0.997 . . . . 1.24 109.224 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -79.7 -50.24 10.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.431 -0.793 . . . . 1.28 110.365 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -62.37 -31.96 72.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.128 -0.982 . . . . 1.79 110.099 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.02 -44.64 68.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 1.29 109.291 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.04 -58.53 6.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.576 -0.898 . . . . 1.1399999999999999 108.576 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 90' ' ' ILE . 70.7 mt -48.75 -61.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.686 -0.634 . . . . 1.3200000000000001 110.576 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -53.19 -45.31 68.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.024 -1.048 . . . . 1.3700000000000001 110.403 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 mt -56.23 -56.13 24.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.127 -0.983 . . . . 1.3999999999999999 108.663 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.8 mt -54.73 -47.54 73.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.187 -0.946 . . . . 1.23 110.57 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -78.32 -36.62 46.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.058 -1.026 . . . . 2.5099999999999998 111.302 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' ALA . 9.4 t70 -82.09 -40.51 21.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.901 -1.125 . . . . 1.5900000000000001 112.055 -176.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -109.84 21.29 17.06 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.752 -1.218 . . . . 2.3799999999999999 110.689 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.522 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 0.3 OUTLIER 42.73 55.19 4.38 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.299 -0.875 . . . . 1.6200000000000001 110.473 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.8 mtt -103.91 147.38 27.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.601 -0.889 . . . . 1.8899999999999999 108.601 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.2 p -77.68 150.5 34.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 1.27 109.87 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.42 -31.67 6.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 1.1599999999999999 108.892 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -77.08 -43.15 35.39 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.777 -0.823 . . . . 2.0 108.777 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.62 9.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.572 -0.705 . . . . 1.25 109.871 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.06 -48.28 78.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.859 . . . . 1.1299999999999999 109.466 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.5 64.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 1.0800000000000001 109.858 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.495 ' O ' ' N ' ' A' ' 109' ' ' GLU . 76.4 t60 -67.93 -51.09 51.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.999 -1.063 . . . . 2.02 109.727 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.11 -62.21 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.338 -0.851 . . . . 1.26 110.502 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 43.7 t -52.75 -54.18 17.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.804 -1.185 . . . . 1.1799999999999999 109.302 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.36 -23.19 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 1.1899999999999999 109.664 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 105' ' ' HIS . 45.8 tp10 -73.08 -30.45 63.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.025 -1.047 . . . . 2.2000000000000002 110.069 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.26 -27.97 29.12 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.114 -1.517 . . . . 0.85999999999999999 111.985 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -67.06 -45.35 77.61 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.425 -1.633 . . . . 2.0 108.035 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.16 -55.72 5.45 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.917 -0.489 . . . . 1.3200000000000001 110.698 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.9 p -56.97 -41.25 78.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 2.1400000000000001 110.215 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.97 81.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.085 -1.009 . . . . 1.3799999999999999 110.277 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.71 -30.38 70.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.761 -1.212 . . . . 1.3500000000000001 109.319 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.58 -18.94 65.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.095 . . . . 1.95 109.726 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -82.93 -9.24 59.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 1.71 109.385 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.8 138.45 31.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.264 -1.013 . . . . 1.71 108.264 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 22.8 p-10 -96.02 63.41 2.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 2.8300000000000001 109.154 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -148.79 108.7 4.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.317 -0.864 . . . . 1.5800000000000001 109.48 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -50.35 -15.85 0.28 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.569 -0.707 . . . . 2.7999999999999998 110.009 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -78.3 -60.92 2.18 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.242 -0.911 . . . . 1.27 109.353 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 mt -67.19 -31.52 71.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.262 -0.899 . . . . 1.5800000000000001 109.254 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -68.24 -49.54 59.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.991 . . . . 2.9199999999999999 109.234 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -61.14 -18.68 59.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.277 -1.008 . . . . 2.2000000000000002 108.277 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.422 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 26.1 ttt-85 -75.46 -28.24 59.21 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.093 -1.447 . . . . 2.5299999999999998 107.093 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.82 97.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.698 -0.853 . . . . 1.45 108.698 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.9 -35.08 79.98 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.247 -1.02 . . . . 1.5 108.247 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 2.8 m-20 -71.97 -32.2 67.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 1.3500000000000001 109.122 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.422 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 42.8 t -77.03 -45.6 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 1.23 108.95 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -60.19 -36.92 78.72 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.117 -0.989 . . . . 3.73 108.37 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.49 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 30.7 t70 -58.92 -36.5 74.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.5 -0.75 . . . . 1.3200000000000001 109.486 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.07 -26.08 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.058 -1.026 . . . . 1.2 108.803 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.34 -47.39 5.75 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.26 -1.536 . . . . 0.48999999999999999 109.26 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -51.58 -43.91 62.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -1.173 . . . . 3.1099999999999999 109.119 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.508 ' CG ' HH11 ' A' ' 136' ' ' ARG . 6.2 mtt-85 -65.51 -42.7 91.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.206 -1.035 . . . . 2.9500000000000002 108.206 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.77 -51.3 70.57 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.474 -0.565 . . . . 1.73 109.474 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.6 mt -53.13 -58.06 8.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 1.22 109.279 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -51.01 -21.4 1.77 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.882 . . . . 2.7799999999999998 109.673 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 136' ' ' ARG . 5.1 m120 -85.84 -42.05 14.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.03 . . . . 2.0299999999999998 109.111 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.89 -47.49 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.081 -1.012 . . . . 1.2 108.294 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 58.8 mt -90.76 -7.81 51.45 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.777 -0.823 . . . . 1.28 108.777 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 144' ' ' LEU . . . 60.99 26.08 65.09 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.239 -1.944 . . . . 0.68999999999999995 108.239 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.44 ' HG ' ' H ' ' A' ' 145' ' ' LYS . 3.1 tp -52.84 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.605 -0.938 . . . . 1.3100000000000001 109.095 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.44 ' H ' ' HG ' ' A' ' 144' ' ' LEU . 47.5 tttp -69.0 137.5 53.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.127 -0.983 . . . . 2.8799999999999999 110.429 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 75.1 mt -106.49 137.49 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.491 -0.929 . . . . 1.3600000000000001 108.491 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mm -75.79 116.65 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.073 -1.017 . . . . 1.9299999999999999 108.877 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -98.58 82.88 2.91 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.263 -0.898 . . . . 1.54 109.89 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.3 mt -84.51 -14.08 50.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 1.3400000000000001 109.103 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.7 p -84.3 -13.8 51.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 1.98 109.891 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.96 42.8 1.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.27 -0.894 . . . . 1.3799999999999999 110.862 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.6 mm -73.49 149.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.658 -1.276 . . . . 1.3999999999999999 108.738 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -136.78 -2.29 2.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.389 -0.819 . . . . 2.7400000000000002 109.466 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -125.45 127.93 47.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.512 -0.742 . . . . 1.4099999999999999 109.495 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.49 118.56 8.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.308 -0.87 . . . . 1.3 108.9 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -151.26 176.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 1.28 108.765 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 mt -89.5 156.49 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.136 -1.061 . . . . 1.1499999999999999 108.136 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 18.6 tp -108.89 123.01 48.4 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.512 0.672 . . . . 1.2 109.693 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.83 133.01 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.213 -0.662 . . . . 1.1599999999999999 109.213 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.99 145.67 10.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.073 -1.017 . . . . 1.2 109.918 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.19 -34.56 75.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.343 -1.473 . . . . 1.3200000000000001 108.039 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -173.19 154.06 2.62 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.296 -0.631 . . . . 2.3399999999999999 109.296 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.4 mt -128.37 130.65 48.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.484 -0.76 . . . . 1.26 109.126 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.5 p -89.74 152.49 46.88 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 1.3600000000000001 109.259 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -34.26 -41.8 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.713 2.276 . . . . 0.63 113.235 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 m -57.4 -60.31 3.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.819 -1.175 . . . . 1.0700000000000001 109.45 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -55.61 -36.27 66.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.472 -0.768 . . . . 1.25 110.352 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.8 p -73.73 -32.6 63.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.124 -0.985 . . . . 1.1799999999999999 110.055 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.33 -31.53 64.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.952 . . . . 1.1399999999999999 110.794 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -101.63 1.61 37.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.103 -0.998 . . . . 1.71 109.901 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.2 tp -54.28 160.96 1.47 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.089 -1.007 . . . . 1.22 109.054 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.563 ' C ' ' H ' ' A' ' 174' ' ' LYS . 15.6 t30 -100.73 79.7 2.1 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.39 -0.819 . . . . 2.5499999999999998 109.928 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 14.9 mt -74.81 28.65 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 1.96 108.642 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 172' ' ' ASN . 31.7 mtpt -106.71 -30.7 8.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 2.46 110.187 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.495 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 27.1 mtmm -133.2 14.32 4.2 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.232 -0.918 . . . . 2.4199999999999999 110.028 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 177' ' ' LEU . 14.7 t -79.02 161.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 1.1599999999999999 109.098 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.437 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 7.7 tp -112.98 -25.37 9.01 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.62 -0.675 . . . . 1.95 110.058 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.57 -179.43 45.9 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.64 -1.384 . . . . 0.41999999999999998 109.64 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.82 126.84 35.31 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.399 -1.06 . . . . 0.52000000000000002 110.199 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.84 123.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.993 -1.114 . . . . 1.1599999999999999 107.993 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 203' ' ' VAL . 59.0 p -141.75 148.29 38.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.184 -0.948 . . . . 1.22 111.352 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.423 ' OD2' ' CG2' ' A' ' 209' ' ' THR . 1.6 p30 -100.53 50.37 0.89 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.367 -0.975 . . . . 2.2400000000000002 108.367 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.457 -0.777 . . . . 1.6499999999999999 110.077 -178.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 12.6 t60 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.315 0.579 . . . . 1.0600000000000001 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 70.5 p -46.95 -44.76 20.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 2.0899999999999999 109.657 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.4 t -64.83 -43.66 92.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.467 -0.771 . . . . 1.8799999999999999 110.248 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 64.7 mt -46.36 -35.8 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.971 -1.08 . . . . 2.0099999999999998 109.999 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.5 mtm -74.14 -58.5 3.26 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.898 -1.149 . . . . 1.27 107.898 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.23 -31.19 19.82 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.612 -0.68 . . . . 1.1799999999999999 110.223 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -81.17 -46.54 14.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.045 -1.034 . . . . 3.5800000000000001 110.187 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 38.2 m -70.75 -36.34 73.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.927 -1.108 . . . . 1.1399999999999999 110.383 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.512 ' C ' ' H ' ' A' ' 199' ' ' LEU . 18.6 mt -84.83 -0.43 53.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.949 -1.094 . . . . 1.28 109.119 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 53.5 1.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 1.49 111.419 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 197' ' ' LEU . 55.6 mt -64.37 171.34 2.78 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.434 -1.416 . . . . 1.28 107.606 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -88.43 141.32 4.78 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.305 2.003 . . . . 0.69999999999999996 111.469 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.21 176.58 9.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.675 -1.266 . . . . 1.1899999999999999 111.513 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.6 mt -150.52 159.22 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.06 -1.459 . . . . 1.25 107.06 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.4 m -141.23 -28.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.697 -1.252 . . . . 1.29 111.186 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.61 29.49 6.23 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.139 -0.976 . . . . 0.92000000000000004 111.664 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 11.8 p -55.03 -37.79 67.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.319 -1.695 . . . . 1.3100000000000001 108.18 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.32 -37.01 0.26 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.751 -0.738 . . . . 1.0 113.481 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 40.4 p -131.06 -6.71 3.9 Favored 'General case' 0 N--CA 1.516 2.854 0 CA-C-N 119.657 1.728 . . . . 1.9199999999999999 113.332 -177.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 5.4 t -48.51 -57.15 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.156 -1.59 . . . . 1.27 110.593 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.423 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 26.8 p -53.06 -16.75 1.2 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.562 -1.336 . . . . 1.3400000000000001 110.4 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.1 t -103.92 11.09 35.95 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.191 -0.943 . . . . 2.0699999999999998 109.27 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -138.93 -13.51 1.22 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.392 -0.818 . . . . 2.8599999999999999 110.243 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.49 154.66 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.324 -0.86 . . . . 1.3 109.417 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -126.08 172.42 10.01 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.882 -1.525 . . . . 2.48 106.882 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 21.9 t-20 -72.71 144.87 47.51 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.864 -1.148 . . . . 2.6200000000000001 110.141 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.9 t70 80.61 -11.6 1.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.881 -0.512 . . . . 2.3999999999999999 110.875 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.25 147.63 34.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.773 -1.204 . . . . 1.99 108.843 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -88.35 123.1 32.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.043 -1.035 . . . . 1.54 108.517 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.7 mt -118.74 168.37 10.8 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.993 0.901 . . . . 1.25 110.608 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 mt -143.6 103.21 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.031 -1.1 . . . . 1.26 108.031 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.1 tp -86.2 123.81 31.9 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.773 -0.825 . . . . 1.1799999999999999 108.773 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 223' ' ' VAL . 50.1 t0 -100.12 -28.44 13.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.43 -0.794 . . . . 2.2200000000000002 109.127 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 38.21 28.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.272 0.558 . . . . 1.2 110.599 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.7 t -120.63 -62.24 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.969 -1.493 . . . . 1.48 106.969 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -83.36 10.36 8.84 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.349 -1.352 . . . . 2.8199999999999998 107.349 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 60.01 54.01 4.38 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.35 -0.611 . . . . 2.1099999999999999 109.35 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -154.42 144.1 21.59 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.849 0.833 . . . . 2.6499999999999999 110.23 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 19.5 t -116.08 132.01 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.924 -1.139 . . . . 1.29 107.924 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 228' ' ' TYR . 48.4 m-85 -100.48 130.89 46.61 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.115 -0.991 . . . . 1.4199999999999999 110.067 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.7 t -107.65 127.46 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.579 -0.7 . . . . 1.26 109.924 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 51.3 t30 47.87 60.6 15.11 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.849 . . . . 2.1499999999999999 110.297 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.56 154.81 35.57 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.381 2.054 . . . . 0.81999999999999995 111.474 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 8.4 m -72.83 157.08 38.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.977 -1.077 . . . . 2.1099999999999999 109.805 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -60.41 -27.32 67.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.427 -0.796 . . . . 3.1699999999999999 109.779 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.36 -39.13 91.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 3.0600000000000001 109.537 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.55 -42.18 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.928 . . . . 1.6499999999999999 109.071 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.68 -58.59 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 1.47 109.113 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.5 -40.65 72.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.547 -0.72 . . . . 2.54 110.389 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -67.12 -38.16 85.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.036 -1.04 . . . . 3.0 110.146 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' MET . . . . . 0.442 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 85.9 mtp -79.43 -32.59 42.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 1.6299999999999999 109.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -54.11 -44.26 71.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.068 -1.02 . . . . 3.1600000000000001 110.108 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.98 -58.69 3.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.018 -1.051 . . . . 2.0899999999999999 110.887 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.2 t -64.33 -53.47 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.128 -0.983 . . . . 2.5699999999999998 110.721 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.442 ' CB ' ' O ' ' A' ' 239' ' ' MET . 39.6 tp60 -52.95 -52.75 56.99 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.0 -1.063 . . . . 3.5899999999999999 109.711 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 . . . . . 0 C--N 1.299 -1.62 0 O-C-N 120.657 -1.277 . . . . 1.76 108.761 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.245 0.545 . . . . 4.0700000000000003 109.565 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.0 mt -84.68 106.21 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.954 . . . . 1.5 109.628 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 m -99.48 110.6 23.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.382 -0.824 . . . . 1.8 109.706 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.89 -169.9 31.07 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.011 -1.636 . . . . 0.92000000000000004 109.011 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' LEU . 56.7 mt -93.08 -7.42 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.043 -1.269 . . . . 1.5 108.614 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.8 tp 54.34 104.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.495 -0.753 . . . . 1.3999999999999999 109.385 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.54 -41.17 12.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.903 -1.123 . . . . 1.26 108.609 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -150.06 148.96 26.2 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.29 -0.881 . . . . 1.95 108.769 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.15 148.22 16.77 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.564 2.176 . . . . 0.93999999999999995 114.092 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.82 176.29 31.73 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.894 -1.282 . . . . 0.78000000000000003 109.894 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 11' ' ' ILE . 97.1 mt -140.13 128.95 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.15 -1.206 . . . . 1.29 109.257 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.88 153.2 49.58 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.281 -0.887 . . . . 1.1499999999999999 109.722 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -123.93 132.86 53.79 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.191 -1.04 . . . . 0.71999999999999997 108.191 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.6 164.94 34.33 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 118.537 -1.792 . . . . 0.5 111.314 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -76.99 149.25 35.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.625 -0.926 . . . . 2.3599999999999999 109.383 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -77.3 132.27 38.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.398 -0.814 . . . . 1.1599999999999999 110.839 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 tp -115.23 89.62 3.14 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.459 -1.312 . . . . 1.24 107.459 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 tp -80.74 122.41 27.1 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.201 1.001 . . . . 1.3100000000000001 110.646 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.0 mt -92.53 98.06 11.22 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.011 -0.736 . . . . 1.3100000000000001 109.011 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -92.26 159.89 15.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 2.3500000000000001 109.665 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -111.71 133.37 54.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.858 -0.793 . . . . 2.5800000000000001 108.858 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' OE1' ' A' ' 21' ' ' GLU . 12.7 m-20 -80.52 124.99 29.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 2.1400000000000001 110.493 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.07 126.47 28.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.431 -0.793 . . . . 1.9299999999999999 109.1 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 80.7 mt -91.09 140.07 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.936 . . . . 1.28 109.502 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.74 115.61 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.486 -0.759 . . . . 1.3700000000000001 108.984 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.0 mt -88.06 133.54 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 1.3300000000000001 109.88 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -91.63 123.33 34.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 1.3700000000000001 109.375 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -96.65 25.16 5.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.173 -0.955 . . . . 3.1899999999999999 109.005 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -86.87 150.71 23.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 2.8100000000000001 110.38 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -93.22 123.05 36.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.923 -0.769 . . . . 2.8300000000000001 108.923 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -83.67 175.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.961 -1.087 . . . . 1.3400000000000001 109.368 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 34' ' ' ASP . 45.3 p -97.24 149.48 21.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.464 -0.772 . . . . 1.3500000000000001 109.121 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.97 -7.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 1.6100000000000001 109.667 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 32' ' ' SER . 29.9 t70 -84.14 -24.21 30.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 2.4700000000000002 109.968 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -103.44 -9.84 19.06 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.134 -0.979 . . . . 2.0699999999999998 109.536 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.15 -41.4 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.092 -1.005 . . . . 1.3300000000000001 109.071 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -54.92 -35.43 64.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.366 -0.834 . . . . 1.46 109.392 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -70.01 -37.82 75.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 2.9399999999999999 110.355 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -58.97 -39.1 80.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 1.3 109.481 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.44 -43.76 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.394 -0.816 . . . . 1.3300000000000001 109.48 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -63.39 -41.86 98.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.189 -0.945 . . . . 1.5 108.461 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.18 -30.25 71.43 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.364 -0.835 . . . . 3.1499999999999999 108.811 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -86.7 -51.81 5.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.854 . . . . 0.92000000000000004 109.49 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 tp -58.12 -63.21 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 1.4099999999999999 109.834 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 t -65.12 -35.6 81.63 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.822 -1.174 . . . . 1.22 109.14 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.36 -9.79 38.64 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.254 -1.938 . . . . 0.58999999999999997 108.254 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -85.72 -28.65 24.49 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.902 -1.518 . . . . 3.3900000000000001 106.902 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.9 -26.65 67.72 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.291 -1.003 . . . . 1.26 108.291 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -85.27 -62.88 1.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.281 -0.637 . . . . 2.9900000000000002 109.281 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.07 -38.07 49.42 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.094 -1.004 . . . . 1.1399999999999999 109.311 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 66.4 m -64.82 -38.56 91.38 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.45 -0.944 . . . . 1.8400000000000001 108.45 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.04 -39.77 65.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.292 0.567 . . . . 1.22 109.863 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -55.47 -74.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 2.0 109.541 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 58' ' ' LYS . 17.8 mt -46.64 -52.42 13.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.158 -0.964 . . . . 1.99 109.508 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 51' ' ' SER . 25.8 mm-40 -47.63 -53.4 14.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.454 -0.779 . . . . 1.27 109.639 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 m -62.34 -37.97 87.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 1.24 109.319 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.6 mt -72.62 -31.1 36.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.301 -0.874 . . . . 1.21 108.787 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 54' ' ' LEU . 15.8 ttpt -55.06 -44.23 74.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.414 -0.804 . . . . 1.53 109.28 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.45 -32.47 70.05 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.255 -0.903 . . . . 1.24 109.47 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.441 ' O ' ' OG1' ' A' ' 64' ' ' THR . 67.9 mttm -70.71 -17.67 62.82 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.906 -1.122 . . . . 2.3199999999999998 108.081 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.6 -34.53 21.39 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.867 -0.79 . . . . 1.1699999999999999 108.867 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.89 -27.69 30.95 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.061 -1.066 . . . . 0.57999999999999996 110.64 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -86.43 -17.66 33.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.688 -1.478 . . . . 1.3899999999999999 109.414 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 23.8 m -94.66 -45.25 7.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.078 -1.014 . . . . 1.3600000000000001 110.396 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -106.11 -18.85 13.89 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.208 -0.933 . . . . 1.1399999999999999 110.38 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 121.26 139.26 5.65 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 109.58 -1.408 . . . . 0.59999999999999998 109.58 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -48.93 -8.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.955 . . . . 2.5899999999999999 110.728 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 66' ' ' GLY . 2.5 pt-20 -66.57 -23.49 66.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.813 -1.179 . . . . 2.2000000000000002 110.298 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -88.81 -10.05 49.51 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.884 -1.135 . . . . 2.3599999999999999 110.074 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -63.55 -23.85 67.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.918 -1.114 . . . . 1.54 110.595 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.22 83.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.081 -1.012 . . . . 1.24 110.274 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.3 mt -70.33 -42.21 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 1.24 109.449 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -76.1 -20.82 57.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.152 -0.967 . . . . 0.80000000000000004 109.622 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -65.4 -38.86 91.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.977 -1.077 . . . . 1.23 108.95 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.74 -36.97 61.58 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.247 -1.541 . . . . 0.56000000000000005 109.247 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -62.42 -21.85 65.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.312 -1.11 . . . . 2.0600000000000001 110.768 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.2 mt -85.37 -39.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.559 -1.338 . . . . 1.24 108.99 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.4 ttt -59.31 -42.23 90.88 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.364 -0.976 . . . . 2.4500000000000002 108.364 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.5 -40.49 82.99 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.45 -0.945 . . . . 1.21 108.45 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.4 tp -65.96 -50.33 64.72 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.439 -0.788 . . . . 1.1200000000000001 109.674 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -85.55 10.48 13.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.162 -0.961 . . . . 1.24 110.976 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -48.46 122.8 5.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.738 -1.226 . . . . 1.3100000000000001 109.376 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -66.29 -25.9 67.07 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.406 -0.809 . . . . 1.3500000000000001 108.959 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -76.45 -49.75 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.458 -0.777 . . . . 2.1600000000000001 109.514 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.0 mt -64.95 -20.71 66.61 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.888 -1.125 . . . . 1.24 108.928 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -70.43 -47.57 60.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.381 -0.824 . . . . 1.28 109.476 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -64.89 -32.18 73.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.522 -0.736 . . . . 1.79 109.815 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -73.09 -48.77 32.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -0.951 . . . . 1.29 109.015 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.18 -57.71 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.75 -0.833 . . . . 1.1399999999999999 108.75 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 91' ' ' ALA . 77.3 mt -53.05 -61.88 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.714 -0.616 . . . . 1.3200000000000001 110.662 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 90' ' ' ILE . . . -40.93 -62.51 0.8 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.388 -0.82 . . . . 1.3700000000000001 110.748 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.4 mt -45.12 -51.11 10.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.376 -0.828 . . . . 1.3999999999999999 110.011 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.5 -41.35 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.929 -1.107 . . . . 1.23 110.011 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -85.16 -42.74 14.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.211 -0.93 . . . . 2.5099999999999998 111.808 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -83.64 -34.06 25.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.669 -1.269 . . . . 1.5900000000000001 111.74 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -104.16 10.7 35.71 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.836 -1.165 . . . . 2.3799999999999999 109.361 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.8 m80 43.77 47.7 6.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.703 . . . . 1.6200000000000001 109.691 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.5 mtp -99.33 154.88 17.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.77 -0.826 . . . . 1.8899999999999999 108.77 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.433 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 3.1 p -75.52 141.29 43.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.273 -0.892 . . . . 1.27 109.163 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.07 -25.98 2.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.155 -0.965 . . . . 1.1599999999999999 109.347 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.83 -45.34 51.85 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.277 -1.009 . . . . 2.0 108.277 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -70.91 -54.4 11.54 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.733 -0.604 . . . . 1.25 109.873 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -52.62 63.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.261 -0.9 . . . . 1.1299999999999999 109.478 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.09 -35.42 64.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.958 . . . . 1.0800000000000001 109.283 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -71.99 -32.41 67.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.853 . . . . 2.02 109.545 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.86 -61.9 2.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 1.26 110.035 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.8 t -53.66 -47.32 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 1.1799999999999999 110.038 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.49 -20.66 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 1.1899999999999999 109.681 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -74.14 -38.26 63.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.022 . . . . 2.2000000000000002 110.161 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.38 -21.84 46.76 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.525 -1.321 . . . . 0.85999999999999999 111.994 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -68.95 -53.48 20.58 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.735 -1.45 . . . . 2.0 108.691 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.66 67.28 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.656 -0.652 . . . . 1.3200000000000001 109.485 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 t -60.69 -43.6 97.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 2.1400000000000001 110.192 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.3 -33.08 75.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.042 . . . . 1.3799999999999999 110.449 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.1 mt -69.38 -27.9 65.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.729 -1.232 . . . . 1.3500000000000001 109.338 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.56 -16.09 64.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 1.95 109.224 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -80.37 -9.06 59.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.374 -0.829 . . . . 1.71 109.004 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.71 141.05 28.9 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.528 -0.915 . . . . 1.71 108.528 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -99.65 65.11 1.33 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.309 -0.869 . . . . 2.8300000000000001 109.186 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -147.18 111.87 5.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 1.5800000000000001 109.354 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -51.49 -17.02 0.69 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.537 -0.727 . . . . 2.7999999999999998 109.815 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -81.21 -63.87 1.31 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 1.27 109.272 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.4 mt -61.76 -31.27 71.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.264 -0.898 . . . . 1.5800000000000001 110.139 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -66.65 -46.43 75.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.856 -1.152 . . . . 2.9199999999999999 109.112 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -61.39 -18.75 60.21 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.512 -0.875 . . . . 2.2000000000000002 108.831 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -74.72 -27.69 60.48 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.678 -1.601 . . . . 2.5299999999999998 106.678 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.71 94.56 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.126 -0.694 . . . . 1.45 109.126 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.99 87.24 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.289 -0.882 . . . . 1.5 109.472 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.8 OUTLIER -70.52 -30.4 67.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.834 . . . . 1.3500000000000001 110.028 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.12 -39.68 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.958 -1.089 . . . . 1.23 108.45 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -61.69 -37.94 85.97 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.216 -1.031 . . . . 3.73 108.216 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.08 -36.37 77.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.535 -0.728 . . . . 1.3200000000000001 109.699 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.03 -27.72 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 1.2 109.771 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.33 -46.67 7.35 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.678 -1.369 . . . . 0.48999999999999999 109.678 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -49.6 -47.75 49.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -1.099 . . . . 3.1099999999999999 109.144 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.484 ' HG2' HH11 ' A' ' 136' ' ' ARG . 12.8 mtt-85 -64.77 -43.42 93.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.143 -0.973 . . . . 2.9500000000000002 108.713 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.6 tp -52.38 -39.99 61.51 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.968 -0.753 . . . . 1.73 108.968 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.41 -59.08 2.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 1.22 109.96 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.405 ' HG2' HH11 ' A' ' 139' ' ' ARG . 30.4 mtt-85 -47.67 -18.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 2.7799999999999998 110.841 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -84.6 -39.83 18.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.837 -1.164 . . . . 2.0299999999999998 108.965 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.61 -38.31 81.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.4 -0.812 . . . . 1.2 109.063 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.9 mt -91.19 -7.3 51.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.345 -0.847 . . . . 1.28 109.016 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.95 20.83 69.09 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.389 -1.884 . . . . 0.68999999999999995 108.389 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tp -57.82 168.29 0.96 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.689 -0.889 . . . . 1.3100000000000001 109.601 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -66.06 143.57 57.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 2.8799999999999999 109.375 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -102.13 147.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.625 -0.88 . . . . 1.3600000000000001 108.625 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.7 mp -79.08 94.02 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.168 -0.957 . . . . 1.9299999999999999 109.193 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -101.0 92.07 4.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.461 -0.774 . . . . 1.54 110.046 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.1 mt -82.56 -17.52 44.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.145 -0.972 . . . . 1.3400000000000001 108.917 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 170' ' ' GLN . 0.8 OUTLIER -82.99 35.34 0.47 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.763 . . . . 1.98 109.608 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.1 24.27 2.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 1.3799999999999999 109.024 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 79.4 mt -73.16 139.84 18.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.483 -0.761 . . . . 1.3999999999999999 109.449 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -118.34 -18.0 9.33 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.519 -0.919 . . . . 2.7400000000000002 108.519 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -117.62 127.73 54.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.982 -0.747 . . . . 1.4099999999999999 108.982 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -61.91 127.71 32.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.814 . . . . 1.3 109.889 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -149.99 176.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.393 -0.817 . . . . 1.28 108.888 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.1 mt -87.9 147.14 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.442 -0.948 . . . . 1.1499999999999999 108.442 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 tp -101.74 117.76 35.54 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.654 -0.869 . . . . 1.2 108.654 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.67 131.96 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.713 -0.847 . . . . 1.1599999999999999 108.713 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.33 149.17 15.29 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.78 -0.768 . . . . 1.2 109.644 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.76 78.46 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 120.682 -1.261 . . . . 1.3200000000000001 107.946 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -173.14 148.33 1.68 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.585 -0.697 . . . . 2.3399999999999999 109.134 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.4 mt -119.59 138.73 53.03 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.383 -0.823 . . . . 1.26 109.619 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.4 p -94.41 153.53 40.41 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 1.3600000000000001 109.243 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 169' ' ' ALA . 69.6 Cg_exo -37.36 -50.55 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.379 2.053 . . . . 0.63 112.482 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 m -49.78 -55.44 14.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 1.0700000000000001 109.281 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.19 -47.52 81.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.907 . . . . 1.25 109.543 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.4 p -67.95 -19.86 65.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 1.1799999999999999 109.778 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -80.09 -29.5 39.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.163 -0.961 . . . . 1.1399999999999999 110.113 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.432 ' O ' ' OG ' ' A' ' 150' ' ' SER . 20.9 pt20 -101.5 -11.66 19.13 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.154 -0.966 . . . . 1.71 109.117 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.89 151.72 21.04 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.538 -0.912 . . . . 1.22 108.538 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -99.57 139.35 35.35 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.407 -0.96 . . . . 2.5499999999999998 108.407 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.3 mm? -88.37 -41.21 12.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 1.96 109.978 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -82.49 -10.72 58.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.019 -1.05 . . . . 2.46 111.667 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -99.9 -17.03 17.79 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.621 -1.3 . . . . 2.4199999999999999 108.763 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 56.6 t -89.7 156.38 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.592 -0.892 . . . . 1.1599999999999999 108.592 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.8 tp -106.08 -20.46 13.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.364 -0.835 . . . . 1.95 109.609 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.4 173.0 41.64 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.095 -1.602 . . . . 0.41999999999999998 109.095 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -128.36 124.33 36.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -1.035 . . . . 0.52000000000000002 109.081 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.0 mt -130.2 131.68 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.017 -1.105 . . . . 1.1599999999999999 108.017 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 23.4 p -139.22 147.41 41.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.36 -0.837 . . . . 1.22 111.336 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 182' ' ' ASP . 7.1 p-10 -84.78 37.32 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.702 -0.624 . . . . 2.2400000000000002 110.09 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.501 2.088 0 O-C-N 121.377 -0.827 . . . . 1.6499999999999999 110.034 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 28.8 t60 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.132 0.491 . . . . 1.0600000000000001 110.427 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.0 m -50.08 -31.04 12.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 2.0899999999999999 109.599 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.9 t -76.47 -39.41 53.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.194 -0.941 . . . . 1.8799999999999999 109.859 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 192' ' ' ILE . 1.5 mp -53.48 -36.43 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.956 . . . . 2.0099999999999998 108.758 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 33.3 mtp -71.13 -52.11 21.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.255 -1.387 . . . . 1.27 107.255 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.33 -46.05 86.96 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.528 -0.76 . . . . 1.1799999999999999 110.243 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -63.89 -48.76 75.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.064 -1.023 . . . . 3.5800000000000001 110.056 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.8 m -68.92 -36.43 77.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.125 -0.984 . . . . 1.1399999999999999 109.5 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 199' ' ' LEU . 21.3 mt -89.37 1.81 55.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.977 . . . . 1.28 109.018 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 194' ' ' ALA . 32.1 mt-10 54.71 2.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.466 -0.771 . . . . 1.49 111.261 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 197' ' ' LEU . 25.2 mt -66.61 168.47 10.11 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.622 -1.299 . . . . 1.28 108.54 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -85.71 144.0 8.59 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.21 1.94 . . . . 0.69999999999999996 111.081 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.36 172.6 17.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.653 -1.279 . . . . 1.1899999999999999 110.965 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.2 mt -150.95 156.0 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.365 -1.717 . . . . 1.25 106.365 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.8 m -143.04 -33.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.812 -1.18 . . . . 1.29 111.703 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -85.89 38.96 3.03 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 120.523 -1.36 . . . . 0.92000000000000004 110.202 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 206' ' ' GLY . 27.5 p -71.21 42.83 0.07 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.831 -1.394 . . . . 1.3100000000000001 109.199 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 39.18 -102.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.272 -1.131 . . . . 1.0 110.272 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.4 m -131.14 42.37 3.23 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.811 -0.817 . . . . 1.9199999999999999 110.039 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.3 t -54.56 -33.57 27.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.868 -1.145 . . . . 1.27 108.438 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.2 p -55.39 -16.48 3.64 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.047 -1.033 . . . . 1.3400000000000001 108.678 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 49.9 m -103.95 12.21 34.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.541 -0.724 . . . . 2.0699999999999998 109.322 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -135.74 -17.3 1.7 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.32 -0.862 . . . . 2.8599999999999999 109.968 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 5.8 t -112.55 141.91 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.637 -0.875 . . . . 1.3 108.637 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -177.92 3.26 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.764 -1.569 . . . . 2.48 106.764 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.3 p-10 -81.06 144.81 31.47 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.033 -1.042 . . . . 2.6200000000000001 110.04 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.8 m-20 81.04 -13.46 0.92 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.074 -0.392 . . . . 2.3999999999999999 110.857 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.51 136.37 56.71 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.854 -1.154 . . . . 1.99 108.416 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -86.7 117.21 25.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.926 -1.109 . . . . 1.54 108.952 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.3 mt -129.38 175.16 8.98 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.654 0.74 . . . . 1.25 109.585 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.6 mt -140.89 126.25 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.755 -0.831 . . . . 1.26 108.755 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.16 126.32 35.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 1.1799999999999999 108.725 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 223' ' ' VAL . 4.1 m-20 -95.38 -34.56 12.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.07 -1.019 . . . . 2.2200000000000002 109.486 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 40.51 21.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.675 -0.641 . . . . 1.2 110.142 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.3 t -115.12 -59.84 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 106.465 -1.68 . . . . 1.48 106.465 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -89.21 11.39 18.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.242 -1.392 . . . . 2.8199999999999998 107.242 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 64.3 t30 57.39 58.26 3.94 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.414 -0.588 . . . . 2.1099999999999999 109.414 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -156.1 151.76 27.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.054 -1.028 . . . . 2.6499999999999999 110.517 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 32.8 t -109.78 139.33 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.721 -0.844 . . . . 1.29 108.721 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -108.88 129.94 55.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.406 -0.809 . . . . 1.4199999999999999 109.555 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 11.3 t -103.18 113.81 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.401 -0.812 . . . . 1.26 109.362 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.1 t30 52.02 63.42 9.18 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.943 . . . . 2.1499999999999999 110.54 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.81 161.6 44.54 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.509 2.14 . . . . 0.81999999999999995 112.019 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.6 p -74.0 160.4 31.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.358 -0.839 . . . . 2.1099999999999999 109.464 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -68.01 -26.68 66.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 3.1699999999999999 109.137 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 234' ' ' GLU . 0.7 OUTLIER -62.05 -37.65 85.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.803 . . . . 3.0600000000000001 109.623 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.58 -45.28 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.007 -1.058 . . . . 1.6499999999999999 109.157 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 236' ' ' ILE . 97.5 mt -54.57 -57.96 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.323 -0.861 . . . . 1.47 109.67 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -53.72 -40.37 66.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.28 -0.887 . . . . 2.54 110.417 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -65.91 -40.23 91.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 3.0 110.279 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 28.9 mtm -80.7 -26.04 37.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.999 -1.063 . . . . 1.6299999999999999 109.911 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.4 ' HG3' ' NH1' ' A' ' 240' ' ' ARG . 15.1 mmm-85 -58.29 -42.16 85.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 3.1600000000000001 109.898 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.24 -52.28 11.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 2.0899999999999999 110.133 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 35.4 t -62.79 -50.23 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.101 -0.999 . . . . 2.5699999999999998 109.862 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -51.71 -59.12 4.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.197 -0.94 . . . . 3.5899999999999999 110.378 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.3 -1.547 0 O-C-N 121.271 -0.893 . . . . 1.76 110.625 -178.388 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' N ' ' A' ' 3' ' ' SER . 21.1 mmt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.255 -0.646 . . . . 4.0700000000000003 109.255 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.59 85.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.092 -1.005 . . . . 1.5 108.649 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 1' ' ' MET . 6.9 m -88.54 114.15 24.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 1.8 109.253 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.55 -163.16 20.7 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 108.859 -1.696 . . . . 0.92000000000000004 108.859 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 65.1 mt -94.84 -6.44 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -1.174 . . . . 1.5 108.553 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 36.5 tp 54.17 104.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.106 -0.702 . . . . 1.3999999999999999 109.106 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.14 -56.0 4.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.064 -1.022 . . . . 1.26 108.345 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.64 145.61 26.3 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.144 -1.058 . . . . 1.95 108.144 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.58 154.19 35.0 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.986 1.79 . . . . 0.93999999999999995 113.499 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.51 133.2 1.81 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.721 -1.351 . . . . 0.78000000000000003 109.721 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.0 mt -94.85 135.65 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.955 -1.321 . . . . 1.29 109.795 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.6 155.42 44.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.216 -0.927 . . . . 1.1499999999999999 109.726 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.577 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -125.38 141.78 51.87 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.338 -0.986 . . . . 0.71999999999999997 108.338 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.24 163.02 28.08 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.127 -1.511 . . . . 0.5 110.887 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -78.51 150.97 32.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.488 -1.007 . . . . 2.3599999999999999 109.559 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.13 127.9 33.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 1.1599999999999999 111.012 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -109.71 91.94 3.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.436 -1.32 . . . . 1.24 107.436 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.61 ' H ' ' ND2' ' A' ' 214' ' ' ASN . 8.6 tp -81.65 126.3 31.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.021 -1.049 . . . . 1.3100000000000001 110.58 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.6 mt -96.43 93.5 6.87 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.905 -0.589 . . . . 1.3100000000000001 110.075 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -92.82 158.22 15.98 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.598 -0.89 . . . . 2.3500000000000001 108.598 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -130.62 135.93 48.36 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.351 -0.843 . . . . 2.5800000000000001 109.322 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.11 133.55 36.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -0.854 . . . . 2.1400000000000001 108.856 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.58 147.69 48.37 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.293 -0.88 . . . . 1.9299999999999999 109.135 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mt -89.27 129.76 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.298 -0.876 . . . . 1.28 109.417 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.4 112.59 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.605 -0.887 . . . . 1.3700000000000001 108.605 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.6 mt -86.56 131.78 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 1.3300000000000001 109.65 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -90.1 114.69 26.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.397 -0.814 . . . . 1.3700000000000001 109.374 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' ' 28' ' ' ARG . 19.9 mmm-85 -95.63 26.16 4.13 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.206 -0.934 . . . . 3.1899999999999999 108.857 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.452 ' CB ' ' HZ1' ' A' ' 29' ' ' LYS . 9.5 mtmp? -79.21 143.26 35.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 2.8100000000000001 109.384 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -84.76 123.63 30.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 2.8300000000000001 109.573 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -90.92 173.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.277 -0.889 . . . . 1.3400000000000001 109.987 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -105.53 172.9 6.55 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.776 -0.578 . . . . 1.3500000000000001 109.603 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.18 -8.55 32.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.815 . . . . 1.6100000000000001 109.722 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -82.84 -16.42 47.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.048 -1.032 . . . . 2.4700000000000002 109.814 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -110.78 -8.27 14.56 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.395 -0.815 . . . . 2.0699999999999998 109.263 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.49 -45.1 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 1.3300000000000001 108.587 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -53.9 -36.09 62.35 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.419 -0.8 . . . . 1.46 109.067 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -70.44 -42.06 72.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.497 -0.752 . . . . 2.9399999999999999 110.51 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -58.66 -45.6 89.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 1.3 109.535 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 44' ' ' LEU . 85.6 t -61.81 -44.21 98.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.192 -0.943 . . . . 1.3300000000000001 109.053 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -65.72 -42.49 90.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.28 -0.887 . . . . 1.5 109.083 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -63.62 -34.89 78.84 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.176 -0.952 . . . . 3.1499999999999999 108.92 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -86.39 -53.09 5.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.394 -0.816 . . . . 0.92000000000000004 109.059 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' VAL . 10.0 tp -53.79 -67.1 0.29 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.731 . . . . 1.4099999999999999 109.731 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.1 t -63.75 -35.07 79.38 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.192 -0.943 . . . . 1.22 108.935 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.55 -53.35 39.25 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.372 -2.291 . . . . 0.58999999999999997 107.372 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -46.74 -32.33 3.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.603 -0.939 . . . . 3.3900000000000001 108.775 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.86 -32.92 69.88 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.869 -1.159 . . . . 1.26 107.869 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 46' ' ' GLY . 16.5 ttmm -83.89 -61.05 1.92 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.021 -0.733 . . . . 2.9900000000000002 109.021 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.09 -45.03 64.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 1.1399999999999999 110.069 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.4 t -63.35 -38.14 89.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.06 -1.025 . . . . 1.8400000000000001 108.409 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 -31.2 65.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.089 -0.708 . . . . 1.22 109.089 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -69.25 -58.68 3.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.801 . . . . 2.0 109.099 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 58' ' ' LYS . 39.4 mt -55.85 -45.38 78.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 1.99 108.718 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -55.27 -48.66 73.7 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.981 -0.748 . . . . 1.27 108.981 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.1 m -63.13 -41.08 99.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 1.24 109.22 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.4 mt -71.53 -37.49 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.375 -0.972 . . . . 1.21 108.375 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 54' ' ' LEU . 11.7 ttpt -49.84 -45.58 50.4 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.57 -0.706 . . . . 1.53 109.408 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -70.95 -27.78 64.0 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.256 -0.902 . . . . 1.24 109.941 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.417 ' O ' ' OG1' ' A' ' 64' ' ' THR . 39.5 mtpt -71.79 -25.37 61.98 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.805 -1.184 . . . . 2.3199999999999998 108.475 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.58 -29.07 33.53 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.647 -0.872 . . . . 1.1699999999999999 108.647 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.21 -32.13 17.85 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.969 -1.11 . . . . 0.57999999999999996 110.653 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -85.88 -15.44 41.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.899 -1.353 . . . . 1.3899999999999999 109.107 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 71.8 m -95.49 -48.81 5.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.332 -0.855 . . . . 1.3600000000000001 110.498 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -106.64 -14.48 15.02 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.13 -0.981 . . . . 1.1399999999999999 110.67 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.81 136.86 5.2 Favored Glycine 0 N--CA 1.502 3.087 0 N-CA-C 109.733 -1.347 . . . . 0.59999999999999998 109.733 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -48.29 -9.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.536 -0.979 . . . . 2.5899999999999999 110.744 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 66' ' ' GLY . 13.6 pt-20 -66.51 -21.86 66.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.952 -1.093 . . . . 2.2000000000000002 110.586 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -87.93 -16.32 34.19 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.92 -1.113 . . . . 2.3599999999999999 109.781 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.15 -20.34 66.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.2 -0.937 . . . . 1.54 110.686 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.75 92.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.852 -1.155 . . . . 1.24 109.531 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.6 mt -71.73 -39.85 69.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.218 -0.926 . . . . 1.24 109.465 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -78.06 -23.53 48.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -0.958 . . . . 0.80000000000000004 108.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -64.7 -33.28 75.59 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.493 -0.928 . . . . 1.23 108.493 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.47 -35.9 35.6 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.048 -1.621 . . . . 0.56000000000000005 109.048 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -60.95 -21.1 63.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.352 -1.087 . . . . 2.0600000000000001 109.829 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 77' ' ' ILE . 91.2 mt -86.42 -42.4 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.9 -1.125 . . . . 1.24 108.76 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.3 ttm -59.88 -41.38 91.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.022 -0.733 . . . . 2.4500000000000002 109.022 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -63.93 -39.31 93.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 1.21 109.127 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -71.83 -42.58 66.81 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.534 -0.866 . . . . 1.1200000000000001 109.431 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -86.24 5.43 34.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 1.24 110.41 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -48.36 122.75 5.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 1.3100000000000001 109.753 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -67.42 -24.32 65.64 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.643 -0.873 . . . . 1.3500000000000001 108.643 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -76.14 -53.39 8.36 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.469 -0.769 . . . . 2.1600000000000001 109.055 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.06 -12.61 52.55 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.972 -1.091 . . . . 1.24 108.707 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -78.16 -53.75 7.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.434 -0.792 . . . . 1.28 109.897 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -62.5 -25.69 68.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 1.79 109.701 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -73.19 -47.04 47.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -0.99 . . . . 1.29 108.812 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 89' ' ' ILE . 79.4 mt -59.61 -56.32 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.441 -0.948 . . . . 1.1399999999999999 108.441 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.401 HD11 HG22 ' A' ' 90' ' ' ILE . 96.9 mt -48.34 -56.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.603 -0.686 . . . . 1.3200000000000001 110.055 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -47.79 -61.96 1.69 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 1.3700000000000001 110.308 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.5 mt -47.8 -52.14 19.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 1.3999999999999999 109.402 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.0 mt -52.2 -46.24 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.077 -1.014 . . . . 1.23 110.193 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -84.85 -35.51 22.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.094 -1.004 . . . . 2.5099999999999998 111.88 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.25 -37.98 22.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.536 -1.352 . . . . 1.5900000000000001 111.732 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -105.23 14.62 28.73 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.729 -1.232 . . . . 2.3799999999999999 109.48 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.8 m80 45.16 42.53 6.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.379 -0.826 . . . . 1.6200000000000001 109.597 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.7 mtt -95.36 149.54 21.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.936 -0.765 . . . . 1.8899999999999999 108.936 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 p -76.62 143.59 40.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.33 -0.856 . . . . 1.27 109.283 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.04 -27.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 1.1599999999999999 109.804 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 1.3 p30 -76.14 -43.85 41.06 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.293 -0.879 . . . . 2.0 108.717 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -70.52 -56.9 5.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.622 -0.674 . . . . 1.25 110.277 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.25 -49.68 68.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 1.1299999999999999 109.758 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.89 -30.94 59.31 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.247 -0.908 . . . . 1.0800000000000001 109.525 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -69.47 -34.63 74.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.991 -1.068 . . . . 2.02 109.873 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -63.78 -45.89 87.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.989 -1.07 . . . . 1.26 109.791 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.51 -47.82 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.825 -1.172 . . . . 1.1799999999999999 108.669 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.74 -18.19 22.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.493 -0.754 . . . . 1.1899999999999999 109.057 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.8 -42.87 73.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 2.2000000000000002 109.572 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.32 -29.32 22.53 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.617 -1.278 . . . . 0.85999999999999999 112.336 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -65.15 -39.45 93.01 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.414 -1.639 . . . . 2.0 108.797 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.67 -51.36 7.8 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.567 -0.708 . . . . 1.3200000000000001 109.178 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -60.34 -44.52 95.44 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.452 -0.78 . . . . 2.1400000000000001 110.149 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -63.89 -37.62 88.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.05 -1.031 . . . . 1.3799999999999999 111.235 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.41 -25.99 66.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.507 -1.371 . . . . 1.3500000000000001 109.216 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -71.63 -21.33 61.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.971 -1.08 . . . . 1.95 109.828 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -81.83 -7.02 59.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.214 -0.929 . . . . 1.71 108.921 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.89 136.86 33.12 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.255 -1.017 . . . . 1.71 108.255 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -94.07 63.43 3.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 2.8300000000000001 108.722 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -146.61 114.27 6.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.81 . . . . 1.5800000000000001 109.28 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.83 -16.01 4.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 2.7999999999999998 109.755 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -81.12 -63.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 1.27 109.368 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 mt -66.55 -31.32 71.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.236 -0.915 . . . . 1.5800000000000001 109.833 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 127' ' ' ALA . 27.6 ttpt -66.69 -50.05 64.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.942 -1.099 . . . . 2.9199999999999999 109.321 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.27 -25.73 49.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.091 -1.006 . . . . 2.2000000000000002 108.702 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -72.56 -23.57 60.99 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.542 -1.651 . . . . 2.5299999999999998 106.542 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.38 -47.83 82.59 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.233 -1.025 . . . . 1.45 108.233 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.41 -35.84 76.13 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.674 -0.641 . . . . 1.5 109.48 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.9 m-20 -68.69 -30.63 69.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.422 -0.799 . . . . 1.3500000000000001 109.733 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.4 t -77.48 -39.48 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.01 -1.056 . . . . 1.23 108.679 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -56.35 -40.93 75.31 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.107 -1.071 . . . . 3.73 108.107 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.61 -38.36 81.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.603 -0.686 . . . . 1.3200000000000001 109.665 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.52 -21.77 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 1.2 109.449 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.09 -58.36 2.99 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.0 -1.095 . . . . 0.48999999999999999 110.496 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -52.67 -42.67 64.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.007 -1.29 . . . . 3.1099999999999999 109.849 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 140' ' ' ASN . 23.2 mtt-85 -65.43 -45.91 82.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.957 -1.089 . . . . 2.9500000000000002 108.423 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.2 tp -55.68 -43.41 76.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.585 -0.697 . . . . 1.73 109.386 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.2 -47.9 75.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 1.22 110.268 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -52.96 -22.35 5.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.061 -1.024 . . . . 2.7799999999999998 110.8 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 70.4 m-80 -83.37 -45.55 13.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.915 -1.116 . . . . 2.0299999999999998 109.091 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.5 mt -53.93 -38.48 36.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.197 -0.94 . . . . 1.2 108.934 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.2 mt -88.15 3.59 48.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.245 -0.909 . . . . 1.28 109.101 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.2 30.88 55.83 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.744 -1.742 . . . . 0.68999999999999995 108.744 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.57 142.35 52.9 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.357 -1.084 . . . . 1.3100000000000001 109.462 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -67.5 136.01 53.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 2.8799999999999999 109.708 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 80.4 mt -106.54 144.6 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.898 -0.779 . . . . 1.3600000000000001 108.898 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.471 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.1 mp -77.92 138.98 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 1.9299999999999999 109.616 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -96.67 86.59 4.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.426 -0.796 . . . . 1.54 109.486 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.412 ' C ' ' H ' ' A' ' 151' ' ' ALA . 64.1 mt -80.17 -29.69 38.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.412 -0.805 . . . . 1.3400000000000001 109.651 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.8 p -79.98 20.64 0.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.933 . . . . 1.98 109.486 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -142.32 35.11 1.49 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.347 -0.845 . . . . 1.3799999999999999 109.714 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 57.7 mt -72.3 158.83 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 1.3999999999999999 109.148 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -134.43 -4.21 2.65 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.293 -0.879 . . . . 2.7400000000000002 109.601 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -125.2 128.34 48.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.533 -0.729 . . . . 1.4099999999999999 109.297 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.52 122.99 18.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 1.3 109.292 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.4 m -148.12 172.97 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.321 -0.862 . . . . 1.28 109.314 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.4 mt -88.85 152.91 3.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.809 -1.182 . . . . 1.1499999999999999 107.809 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.6 tp -105.98 118.76 37.44 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.619 0.724 . . . . 1.2 109.273 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 26.2 t -121.46 128.62 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.815 -0.809 . . . . 1.1599999999999999 108.815 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.67 146.59 11.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.313 -0.867 . . . . 1.2 109.539 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.5 71.72 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.677 -1.265 . . . . 1.3200000000000001 108.015 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -173.21 157.33 3.38 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.598 -0.689 . . . . 2.3399999999999999 109.48 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.7 mt -126.82 137.47 53.2 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.531 -0.731 . . . . 1.26 109.118 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.6 p -92.33 152.74 42.64 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.24 -0.913 . . . . 1.3600000000000001 109.195 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 169' ' ' ALA . 66.0 Cg_exo -35.92 -51.9 1.03 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.561 2.174 . . . . 0.63 112.663 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.5 m -47.92 -54.72 11.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 1.0700000000000001 109.473 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -59.04 -48.07 82.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 1.25 109.811 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.455 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 5.4 p -69.49 -24.33 63.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 1.1799999999999999 109.902 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -77.9 -24.62 48.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 1.1399999999999999 110.086 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -106.95 -15.39 14.71 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.316 -0.865 . . . . 1.71 109.681 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.1 tp -58.81 149.91 25.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.019 -1.051 . . . . 1.22 108.831 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.561 ' ND2' ' H ' ' A' ' 173' ' ' LEU . 2.6 t-20 -99.02 152.57 19.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 2.5499999999999998 108.702 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.561 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 11.8 mt -95.32 -40.84 9.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.177 -0.952 . . . . 1.96 110.938 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -81.79 -14.68 56.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.846 -1.159 . . . . 2.46 112.125 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -95.0 -11.11 29.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.433 -1.417 . . . . 2.4199999999999999 107.869 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.95 163.6 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.799 -1.186 . . . . 1.1599999999999999 107.799 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.404 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -112.18 -26.62 8.71 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.638 -0.875 . . . . 1.95 108.638 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.85 176.28 47.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.156 -1.578 . . . . 0.41999999999999998 109.156 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -128.39 123.45 33.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.438 -1.036 . . . . 0.52000000000000002 109.91 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.6 mt -128.25 129.92 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.492 -1.299 . . . . 1.1599999999999999 107.492 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.2 p -140.24 148.14 41.05 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.235 1.017 . . . . 1.22 111.785 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 1.1 t70 -87.78 38.72 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.77 -0.581 . . . . 2.2400000000000002 109.843 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.503 2.183 0 O-C-N 121.174 -0.954 . . . . 1.6499999999999999 110.287 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.455 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 13.5 t60 . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 107.977 -1.12 . . . . 1.0600000000000001 107.977 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 95.1 m -63.11 -39.73 95.55 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.621 -0.881 . . . . 2.0899999999999999 108.621 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.3 t -57.09 -33.16 67.02 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 1.8799999999999999 109.051 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.87 -37.66 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.293 -0.879 . . . . 2.0099999999999998 110.444 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.7 mtm -71.94 -51.42 22.12 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.785 -1.197 . . . . 1.27 108.238 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.83 -32.33 31.24 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.147 0.498 . . . . 1.1799999999999999 109.705 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -75.52 -46.04 34.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.057 -1.027 . . . . 3.5800000000000001 109.376 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.3 m -70.77 -35.7 72.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.257 -0.902 . . . . 1.1399999999999999 109.63 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.5 mt -89.49 -2.37 58.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 1.28 109.139 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 51.17 10.12 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.562 -0.711 . . . . 1.49 111.783 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.9 mt -68.17 168.41 13.64 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.557 -1.339 . . . . 1.28 108.507 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.14 131.8 5.96 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.121 1.881 . . . . 0.69999999999999996 111.578 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.37 176.39 9.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.794 -1.191 . . . . 1.1899999999999999 111.177 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 11.4 mt -149.64 161.51 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.653 -1.61 . . . . 1.25 106.653 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 181' ' ' THR . 17.1 m -144.63 -31.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.725 -1.234 . . . . 1.29 111.413 -178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.18 31.2 5.5 Favored Glycine 0 N--CA 1.491 2.364 0 O-C-N 120.807 -1.183 . . . . 0.92000000000000004 110.486 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 10.1 p -56.02 -37.27 68.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.787 -1.419 . . . . 1.3100000000000001 108.514 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.43 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 64.94 -35.2 0.1 Allowed Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.923 -0.656 . . . . 1.0 113.522 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.6 m -121.66 16.43 11.13 Favored 'General case' 0 N--CA 1.513 2.704 0 CA-C-N 119.812 1.806 . . . . 1.9199999999999999 112.839 -177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 5.7 t -78.23 -52.54 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.221 -1.549 . . . . 1.27 109.888 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.3 p -53.62 -19.61 4.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.697 -1.252 . . . . 1.3400000000000001 109.961 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.8 m -105.72 14.45 28.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.341 -0.85 . . . . 2.0699999999999998 109.474 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -143.54 -5.6 0.83 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.235 -0.916 . . . . 2.8599999999999999 110.891 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 37.2 t -119.45 157.58 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.16 -0.963 . . . . 1.3 109.957 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 16.0 mmmt -134.34 171.38 14.35 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.813 -1.551 . . . . 2.48 106.813 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.61 ' ND2' ' H ' ' A' ' 18' ' ' LEU . 11.5 t-20 -76.17 143.06 41.36 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.876 -1.14 . . . . 2.6200000000000001 110.539 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.0 t70 80.12 -10.77 1.24 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.712 -0.617 . . . . 2.3999999999999999 110.867 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -57.85 143.62 41.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.772 -1.205 . . . . 1.99 108.657 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -86.08 110.95 19.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.011 -1.055 . . . . 1.54 108.555 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 13.4 mt -123.8 165.4 17.38 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.67 0.747 . . . . 1.25 109.946 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 219' ' ' ILE . 40.6 mt -138.71 125.22 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.833 -1.173 . . . . 1.26 107.833 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.4 tp -86.89 127.35 35.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.2 -0.938 . . . . 1.1799999999999999 108.735 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.7 -46.17 6.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.244 -0.91 . . . . 2.2200000000000002 109.433 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 44.51 23.87 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.513 -0.742 . . . . 1.2 110.165 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 t -115.96 -41.11 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 106.634 -1.617 . . . . 1.48 106.634 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -108.22 13.08 26.08 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.825 -1.546 . . . . 2.8199999999999998 106.825 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 60.66 52.63 4.36 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.964 -0.562 . . . . 2.1099999999999999 109.908 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -157.87 154.92 28.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.972 -1.08 . . . . 2.6499999999999999 110.712 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 87.6 t -107.19 163.21 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.843 -0.799 . . . . 1.29 108.843 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -122.07 116.27 23.96 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.358 -0.839 . . . . 1.4199999999999999 109.147 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.7 t -102.16 120.1 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.406 -0.809 . . . . 1.26 109.871 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 31.8 t30 65.68 74.98 0.36 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.685 -0.634 . . . . 2.1499999999999999 110.452 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -91.56 143.76 3.02 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 123.334 2.689 . . . . 0.81999999999999995 111.929 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 14.5 p -73.34 167.19 21.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 2.1099999999999999 109.714 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -72.4 -34.47 67.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 3.1699999999999999 108.958 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -66.25 -34.3 77.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.504 -0.747 . . . . 3.0600000000000001 109.473 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.1 t -76.03 -30.1 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 1.6499999999999999 109.151 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 69.5 mt -70.88 -56.37 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.311 -0.868 . . . . 1.47 109.074 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.85 -40.22 69.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 2.54 110.228 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -66.98 -40.27 87.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.119 -0.988 . . . . 3.0 110.197 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.8 mtp -81.07 -23.11 38.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.069 -1.019 . . . . 1.6299999999999999 109.692 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -60.02 -44.09 94.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 3.1600000000000001 109.385 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.65 -56.81 4.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 2.0899999999999999 110.019 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 94.0 t -48.81 -61.44 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.256 -0.902 . . . . 2.5699999999999998 110.091 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -49.29 -57.29 7.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.276 -0.89 . . . . 3.5899999999999999 110.223 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--N 1.297 -1.69 0 O-C-N 120.854 -1.153 . . . . 1.76 109.931 -178.725 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 3' ' ' SER . 66.6 mtt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.5 -0.555 . . . . 4.0700000000000003 109.5 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 2' ' ' ILE . 77.2 mt -60.78 83.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 1.5 109.556 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 1' ' ' MET . 50.8 m -94.59 112.12 23.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.963 -1.086 . . . . 1.8 108.696 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.76 -165.04 21.6 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 109.872 -1.291 . . . . 0.92000000000000004 109.872 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' ' 6' ' ' LEU . 58.2 mt -93.07 -6.18 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.249 -1.148 . . . . 1.5 108.595 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' ILE . 18.3 tp 57.16 110.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.538 -0.726 . . . . 1.3999999999999999 109.418 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.55 -45.87 9.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 1.26 109.23 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.51 150.53 31.33 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.241 -0.912 . . . . 1.95 109.384 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -83.01 148.29 13.4 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.478 2.118 . . . . 0.93999999999999995 113.733 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.56 -177.06 34.53 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.421 -1.472 . . . . 0.78000000000000003 109.421 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 mt -147.7 126.89 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.872 -1.37 . . . . 1.29 110.186 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.17 161.49 36.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.34 -0.85 . . . . 1.1499999999999999 109.48 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.474 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 8.1 m-85 -126.9 128.27 46.21 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.656 -0.868 . . . . 0.71999999999999997 108.656 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.77 165.95 38.47 Favored Glycine 0 N--CA 1.502 3.064 0 C-N-CA 118.48 -1.819 . . . . 0.5 111.836 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -82.12 151.45 26.98 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.46 -1.024 . . . . 2.3599999999999999 110.66 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.54 130.76 37.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.448 -0.782 . . . . 1.1599999999999999 111.878 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 tp -111.05 99.86 8.65 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.182 -1.414 . . . . 1.24 107.182 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 tp -85.51 122.55 29.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.785 -1.197 . . . . 1.3100000000000001 110.872 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.48 98.72 11.38 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.791 -0.818 . . . . 1.3100000000000001 108.791 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -89.85 142.52 27.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.433 -0.792 . . . . 2.3500000000000001 109.265 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -110.11 129.68 55.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.487 -0.758 . . . . 2.5800000000000001 109.681 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -78.13 122.26 25.4 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.17 -1.048 . . . . 2.1400000000000001 108.17 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -65.6 134.96 54.41 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.098 -1.001 . . . . 1.9299999999999999 109.765 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.0 mt -91.3 134.47 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.543 -0.723 . . . . 1.28 109.503 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.84 119.52 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.87 -0.789 . . . . 1.3700000000000001 108.87 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.5 mt -90.62 131.51 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.968 -1.082 . . . . 1.3300000000000001 109.41 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -89.69 123.79 34.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.135 -0.978 . . . . 1.3700000000000001 109.508 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -97.11 28.39 3.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.172 -0.955 . . . . 3.1899999999999999 109.185 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -85.72 141.32 29.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 2.8100000000000001 109.691 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -84.87 130.21 34.69 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.487 -0.931 . . . . 2.8300000000000001 108.487 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.3 pt -88.18 172.76 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 1.3400000000000001 110.25 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 34' ' ' ASP . 88.5 p -99.01 161.1 13.81 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.586 -0.894 . . . . 1.3500000000000001 108.586 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.82 -7.06 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.855 -1.153 . . . . 1.6100000000000001 109.893 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 32' ' ' SER . 38.2 m-20 -83.38 -15.01 51.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.978 -1.076 . . . . 2.4700000000000002 110.517 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -117.55 0.46 12.11 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.366 -0.834 . . . . 2.0699999999999998 109.758 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 t -68.64 -49.36 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.937 -1.102 . . . . 1.3300000000000001 109.593 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -59.67 -30.61 68.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.2 -0.937 . . . . 1.46 108.477 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.487 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 1.5 mp0 -70.67 -39.09 73.76 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.254 0.549 . . . . 2.9399999999999999 110.023 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -64.45 -37.13 86.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.105 -0.997 . . . . 1.3 109.5 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.33 -45.55 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.804 . . . . 1.3300000000000001 109.401 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.85 -37.95 89.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 1.5 108.543 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.576 ' CG ' HH11 ' A' ' 42' ' ' ARG . 4.6 mtt-85 -67.05 -41.08 87.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.048 -0.723 . . . . 3.1499999999999999 109.048 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -81.82 -41.93 20.38 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.372 -0.83 . . . . 0.92000000000000004 109.537 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 tp -64.6 -61.34 2.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.166 -0.959 . . . . 1.4099999999999999 108.569 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.0 t -65.4 -36.19 83.2 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.444 -0.785 . . . . 1.22 108.992 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -50.84 -56.97 11.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.302 -1.919 . . . . 0.58999999999999997 108.302 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.423 ' HB3' HH11 ' A' ' 47' ' ' ARG . 1.7 ttt-85 -47.04 -32.42 3.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.565 -0.962 . . . . 3.3900000000000001 108.735 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.21 -32.54 64.5 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.028 -1.101 . . . . 1.26 108.028 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 46' ' ' GLY . 93.5 mttt -81.33 -58.99 2.79 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.026 -0.731 . . . . 2.9900000000000002 109.026 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.93 -44.71 64.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.095 -1.003 . . . . 1.1399999999999999 110.148 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 65.5 p -61.43 -37.62 84.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.159 -0.963 . . . . 1.8400000000000001 108.67 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.455 ' N ' ' HG ' ' A' ' 51' ' ' SER . . . -73.68 -42.12 61.72 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.394 0.616 . . . . 1.22 109.401 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -67.29 -58.49 4.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.813 . . . . 2.0 109.585 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.9 mt -52.35 -47.11 66.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.119 -0.988 . . . . 1.99 108.875 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 51' ' ' SER . 6.2 mm-40 -52.25 -47.27 65.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.555 -0.715 . . . . 1.27 109.196 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m -58.6 -38.12 77.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 1.24 108.83 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.1 mt -75.12 -31.94 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 1.21 108.813 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -54.89 -50.11 69.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.439 -0.788 . . . . 1.53 109.85 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -70.22 -29.92 66.87 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.333 -0.854 . . . . 1.24 110.58 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.453 ' O ' ' OG1' ' A' ' 64' ' ' THR . 91.8 mttt -69.8 -14.92 63.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.712 -1.242 . . . . 2.3199999999999998 108.211 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.48 -36.92 21.94 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.699 -0.852 . . . . 1.1699999999999999 108.699 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.39 -26.64 42.57 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.68 -1.248 . . . . 0.57999999999999996 109.984 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.82 -17.1 34.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.075 -1.25 . . . . 1.3899999999999999 109.413 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 70.9 m -96.3 -47.58 5.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.284 -0.885 . . . . 1.3600000000000001 110.168 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -106.24 -15.57 14.81 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.071 -1.018 . . . . 1.1399999999999999 110.702 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 118.37 140.83 6.51 Favored Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.057 -1.617 . . . . 0.59999999999999998 109.057 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -47.45 -11.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -1.155 . . . . 2.5899999999999999 110.542 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 66' ' ' GLY . 55.0 tt0 -61.27 -30.91 70.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.581 -1.324 . . . . 2.2000000000000002 109.905 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -92.01 -10.47 39.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.891 -1.131 . . . . 2.3599999999999999 110.171 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -66.85 -35.12 79.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.042 -1.036 . . . . 1.54 110.187 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.06 -30.04 70.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 1.24 110.382 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -69.01 -42.76 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.941 -1.099 . . . . 1.24 108.725 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -77.8 -21.68 51.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.888 . . . . 0.80000000000000004 109.53 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.52 -38.05 89.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.12 -0.987 . . . . 1.23 108.662 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.19 -35.76 52.38 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.046 -1.621 . . . . 0.56000000000000005 109.046 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.24 -20.9 64.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -1.117 . . . . 2.0600000000000001 110.339 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.6 mt -84.09 -38.28 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.763 -1.21 . . . . 1.24 108.384 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.4 ttt -59.68 -36.39 76.37 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.272 -0.892 . . . . 2.4500000000000002 108.776 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.3 tp -65.13 -38.82 91.87 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.812 -1.181 . . . . 1.21 107.812 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.0 tp -73.25 -44.08 60.06 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.771 -0.772 . . . . 1.1200000000000001 109.466 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -85.75 5.72 31.06 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.218 -0.927 . . . . 1.24 110.195 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -47.14 123.16 5.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.944 -1.097 . . . . 1.3100000000000001 110.046 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -66.94 -26.07 66.66 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.894 -0.78 . . . . 1.3500000000000001 108.894 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -74.87 -51.09 14.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.427 -0.796 . . . . 2.1600000000000001 109.11 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.68 -17.72 64.81 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.975 -1.09 . . . . 1.24 109.12 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -74.17 -55.7 5.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.089 -1.007 . . . . 1.28 110.399 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -62.25 -29.89 70.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.393 -0.817 . . . . 1.79 110.215 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -72.21 -42.87 65.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 1.29 108.763 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.1 mt -59.85 -59.41 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.36 -1.348 . . . . 1.1399999999999999 107.36 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.1 mt -47.85 -62.77 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.902 -0.498 . . . . 1.3200000000000001 110.193 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -42.7 -63.28 0.81 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.291 -0.881 . . . . 1.3700000000000001 109.932 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.5 mt -46.58 -51.93 14.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 1.3999999999999999 109.688 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 79.5 mt -52.94 -41.93 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 1.23 109.309 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -85.68 -37.18 19.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 2.5099999999999998 111.734 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -86.2 -33.36 20.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.781 -1.199 . . . . 1.5900000000000001 112.416 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 97' ' ' HIS . 53.3 mmtt -109.7 20.06 18.5 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.453 -1.405 . . . . 2.3799999999999999 110.058 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 96' ' ' LYS . 46.9 m80 42.45 46.02 3.98 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.371 -0.831 . . . . 1.6200000000000001 110.158 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 34.8 mtt -98.28 144.77 27.35 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.726 -0.842 . . . . 1.8899999999999999 108.726 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.3 p -75.51 148.3 39.08 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.47 -0.769 . . . . 1.27 110.086 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.29 -31.5 21.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 1.1599999999999999 109.338 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -74.19 -42.2 60.22 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.016 -1.105 . . . . 2.0 108.016 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.26 -55.13 7.69 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.313 -0.555 . . . . 1.25 109.909 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.68 76.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 1.1299999999999999 109.685 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.01 -38.93 73.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 1.0800000000000001 109.623 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' GLU . 49.4 t-80 -67.77 -41.11 83.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.943 . . . . 2.02 109.753 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -48.14 -53.8 15.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 1.26 110.026 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.0 t -57.79 -54.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.047 -1.033 . . . . 1.1799999999999999 109.222 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.8 mm -61.62 -20.31 22.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.355 -0.841 . . . . 1.1899999999999999 109.047 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 105' ' ' HIS . 48.8 tt0 -66.23 -40.69 90.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 2.2000000000000002 110.243 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -86.53 -21.43 51.27 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.38 -1.39 . . . . 0.85999999999999999 111.941 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -67.01 -59.36 3.54 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.526 -1.573 . . . . 2.0 108.208 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.93 -52.03 65.7 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 120.072 -0.651 . . . . 1.3200000000000001 109.473 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.1 m -59.77 -46.4 89.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.122 -0.986 . . . . 2.1400000000000001 110.954 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -62.21 -31.93 72.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.768 -1.208 . . . . 1.3799999999999999 110.632 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 mt -70.11 -28.61 65.53 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.545 -1.262 . . . . 1.3500000000000001 109.512 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -68.74 -20.0 64.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.734 -1.229 . . . . 1.95 109.215 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -81.44 -7.64 59.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 1.71 108.873 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mt -88.91 140.17 29.71 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.217 -1.031 . . . . 1.71 108.217 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -97.18 64.84 1.96 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.332 -0.988 . . . . 2.8300000000000001 108.332 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -146.17 113.72 6.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.351 -0.843 . . . . 1.5800000000000001 110.069 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.555 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 18.7 mp0 -57.23 -16.18 7.67 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.787 -0.82 . . . . 2.7999999999999998 108.787 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -80.23 -63.28 1.44 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.336 -0.853 . . . . 1.27 109.244 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.9 mt -63.6 -23.88 67.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 1.5800000000000001 109.14 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -68.4 -51.13 47.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.053 -1.029 . . . . 2.9199999999999999 108.762 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -58.76 -18.78 34.77 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.27 -0.894 . . . . 2.2000000000000002 108.892 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -74.57 -27.89 60.7 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.638 -1.616 . . . . 2.5299999999999998 106.638 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.02 98.0 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.398 0.618 . . . . 1.45 109.41 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.09 73.97 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.278 -0.889 . . . . 1.5 109.649 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.2 -36.75 66.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 1.3500000000000001 109.375 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.1 t -72.64 -40.82 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.411 -0.806 . . . . 1.23 109.062 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.477 HH12 ' CE ' ' A' ' 135' ' ' LYS . 15.5 ttt-85 -54.38 -40.8 68.51 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.265 -0.897 . . . . 3.73 109.046 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.94 -32.56 73.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.595 -0.691 . . . . 1.3200000000000001 110.245 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 65.0 mt -69.29 -26.51 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.952 -1.093 . . . . 1.2 110.343 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.07 -49.14 6.51 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.438 -1.465 . . . . 0.48999999999999999 109.438 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.477 ' CE ' HH12 ' A' ' 131' ' ' ARG . 1.5 mptp? -51.98 -46.66 64.93 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.519 -0.989 . . . . 3.1099999999999999 109.387 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.453 ' HG2' HH11 ' A' ' 136' ' ' ARG . 6.8 mtt-85 -62.19 -52.31 64.32 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.988 -1.116 . . . . 2.9500000000000002 107.988 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.28 -40.38 34.37 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.794 -0.566 . . . . 1.73 109.609 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 140' ' ' ASN . 23.0 mt -69.08 -58.94 3.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 1.22 110.005 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 144' ' ' LEU . 89.9 mtt180 -44.52 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 2.7799999999999998 110.875 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 138' ' ' LEU . 30.9 m-20 -85.34 -51.15 6.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.815 -1.178 . . . . 2.0299999999999998 109.173 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.5 mt -55.88 -38.13 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 1.2 108.94 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 35.1 mt -86.21 1.29 51.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.486 -0.759 . . . . 1.28 109.006 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.69 30.95 60.12 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.204 -1.958 . . . . 0.68999999999999995 108.204 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 139' ' ' ARG . 4.7 tp -73.78 145.3 45.16 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.559 -0.965 . . . . 1.3100000000000001 109.755 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -67.48 139.52 57.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -0.784 . . . . 2.8799999999999999 110.12 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 mt -109.44 142.79 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.579 -0.897 . . . . 1.3600000000000001 108.579 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.2 mp -75.73 119.94 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 1.9299999999999999 109.773 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.6 OUTLIER -95.85 91.86 6.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.81 . . . . 1.54 109.446 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 151' ' ' ALA . 21.4 mt -79.77 -18.14 51.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.598 -0.689 . . . . 1.3400000000000001 109.276 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.6 p -79.46 23.4 0.4 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.945 . . . . 1.98 109.66 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -139.99 25.9 2.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.053 -1.03 . . . . 1.3799999999999999 110.017 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 74.4 mt -71.75 152.7 8.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.085 -1.009 . . . . 1.3999999999999999 109.351 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -141.11 9.57 2.11 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.594 -0.891 . . . . 2.7400000000000002 108.594 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -123.17 124.88 44.04 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.759 -0.83 . . . . 1.4099999999999999 108.759 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.61 115.35 5.12 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.141 -0.974 . . . . 1.3 108.932 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.8 m -148.31 174.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.169 -0.957 . . . . 1.28 109.431 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 13.9 mt -93.35 160.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.851 -1.166 . . . . 1.1499999999999999 107.851 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.3 tp -108.27 122.86 47.82 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.472 -0.767 . . . . 1.2 109.873 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.89 129.76 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.398 0.618 . . . . 1.1599999999999999 109.713 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -165.99 159.33 15.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 1.2 110.376 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.92 -42.7 94.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.63 -1.294 . . . . 1.3200000000000001 108.1 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 48.1 t0 -171.45 157.94 5.05 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.525 -0.735 . . . . 2.3399999999999999 109.39 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.417 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 27.6 mt -124.43 136.15 53.82 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.547 -0.721 . . . . 1.26 109.539 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.2 p -95.4 152.33 39.23 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.254 -0.904 . . . . 1.3600000000000001 109.661 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -32.83 -54.2 0.38 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.984 2.456 . . . . 0.63 113.219 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.444 ' H ' ' HG ' ' A' ' 166' ' ' SER . 3.7 m -51.06 -57.1 9.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -0.97 . . . . 1.0700000000000001 109.445 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -54.52 -38.22 66.29 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 1.25 109.536 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 33.7 p -76.46 -20.19 57.28 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.317 -0.864 . . . . 1.1799999999999999 109.751 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.46 -23.74 34.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 1.1399999999999999 109.664 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -104.52 -10.23 17.78 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.322 -0.861 . . . . 1.71 110.349 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.7 tp -64.02 144.37 57.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.954 -1.091 . . . . 1.22 108.615 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -95.46 140.71 29.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.876 -1.14 . . . . 2.5499999999999998 108.969 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 9.9 mp -85.65 -41.13 15.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 1.96 111.025 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -77.99 -12.06 59.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.712 -1.243 . . . . 2.46 111.807 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -101.27 -5.83 24.97 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.678 -1.263 . . . . 2.4199999999999999 108.86 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 177' ' ' LEU . 74.1 t -100.52 163.43 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.407 -0.808 . . . . 1.1599999999999999 109.059 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.436 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 4.8 tp -120.38 -17.25 8.24 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.466 -0.771 . . . . 1.95 109.715 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.27 172.71 42.98 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.271 -1.531 . . . . 0.41999999999999998 109.271 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -125.52 121.9 35.04 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.42 -1.047 . . . . 0.52000000000000002 108.962 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.73 125.56 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.313 -1.365 . . . . 1.1599999999999999 107.313 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 203' ' ' VAL . 2.2 p -135.08 141.35 46.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.356 0.598 . . . . 1.22 109.7 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -89.79 37.01 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.505 -0.747 . . . . 2.2400000000000002 109.004 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.501 2.075 0 O-C-N 121.467 -0.771 . . . . 1.6499999999999999 109.542 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.9 t60 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.118 0.485 . . . . 1.0600000000000001 110.025 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 47.1 m -54.8 -31.19 58.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.188 -0.945 . . . . 2.0899999999999999 109.616 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.1 t -68.73 -35.94 77.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.351 -0.843 . . . . 1.8799999999999999 109.224 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.0 mm -60.31 -37.82 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 2.0099999999999998 109.856 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.5 mtm -70.59 -46.56 63.21 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.78 -1.193 . . . . 1.27 107.78 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.0 74.38 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.673 -0.642 . . . . 1.1799999999999999 110.005 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -67.81 -43.54 79.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 3.5800000000000001 109.804 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.2 m -71.44 -37.33 71.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.933 . . . . 1.1399999999999999 109.967 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.559 ' C ' ' H ' ' A' ' 199' ' ' LEU . 23.8 mt -88.03 3.36 49.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.872 . . . . 1.28 109.111 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 50.54 2.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.494 -0.754 . . . . 1.49 110.902 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.559 ' H ' ' C ' ' A' ' 197' ' ' LEU . 79.4 mt -65.88 167.62 11.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.015 -1.476 . . . . 1.28 107.015 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -90.93 145.59 3.65 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 C-N-CA 122.069 1.846 . . . . 0.69999999999999996 111.646 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.57 179.98 6.85 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.579 -1.248 . . . . 1.1899999999999999 111.16 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.401 HG21 ' N ' ' A' ' 203' ' ' VAL . 34.0 mt -149.38 155.6 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.008 -1.849 . . . . 1.25 106.008 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 181' ' ' THR . 15.8 m -137.28 -34.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.023 -1.048 . . . . 1.29 111.915 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.41 45.09 3.1 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 120.469 -1.395 . . . . 0.92000000000000004 111.248 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.6 p -72.56 1.0 8.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.334 -1.686 . . . . 1.3100000000000001 109.76 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.3 -98.78 0.84 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.828 -1.309 . . . . 1.0 109.828 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.7 p -131.19 35.6 3.9 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.422 -1.046 . . . . 1.9199999999999999 111.815 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.0 t -50.47 -28.95 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.356 -1.465 . . . . 1.27 109.077 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 182' ' ' ASP . 5.2 p -65.23 -11.95 46.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.923 -1.11 . . . . 1.3400000000000001 108.775 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -104.67 11.65 33.81 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.892 -0.781 . . . . 2.0699999999999998 108.892 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -128.53 -31.66 2.23 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.477 -0.764 . . . . 2.8599999999999999 110.278 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.4 t -115.39 155.85 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.324 -0.86 . . . . 1.3 110.008 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -114.8 -171.24 1.9 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.27 -1.382 . . . . 2.48 107.27 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.429 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -81.11 149.72 29.05 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.097 -1.002 . . . . 2.6200000000000001 110.648 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.3 m-20 80.91 -12.81 0.98 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 116.067 -0.515 . . . . 2.3999999999999999 110.982 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -56.89 145.76 28.81 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.711 -1.243 . . . . 1.99 107.774 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -88.3 121.29 30.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.869 -1.144 . . . . 1.54 109.636 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.2 mt -123.81 161.9 24.33 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.82 0.819 . . . . 1.25 109.911 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.4 mt -134.86 118.8 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.747 -1.205 . . . . 1.26 107.747 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 8.9 tp -90.08 120.31 31.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.42 -0.8 . . . . 1.1799999999999999 109.528 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 53.6 t0 -94.42 -27.76 15.86 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.224 -1.028 . . . . 2.2200000000000002 108.224 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 37.87 24.25 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.131 0.491 . . . . 1.2 110.709 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 10.5 t -117.14 -62.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 106.733 -1.58 . . . . 1.48 106.733 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -87.35 15.76 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.991 -1.114 . . . . 2.8199999999999998 107.991 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 55.86 54.17 8.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.625 -0.672 . . . . 2.1099999999999999 109.343 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -150.04 144.38 25.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.355 -0.84 . . . . 2.6499999999999999 110.29 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.54 153.39 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.289 -1.004 . . . . 1.29 108.289 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -110.64 126.07 54.1 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.354 -0.841 . . . . 1.4199999999999999 108.882 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.11 118.02 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.509 -0.744 . . . . 1.26 109.939 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 55.14 70.9 1.43 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 2.1499999999999999 110.249 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -90.09 149.51 4.7 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.308 2.672 . . . . 0.81999999999999995 111.986 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.5 m -75.19 163.23 27.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 2.1099999999999999 109.86 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -67.11 -32.22 73.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.343 -0.848 . . . . 3.1699999999999999 110.121 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.48 -35.53 77.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.225 -0.922 . . . . 3.0600000000000001 109.282 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.68 -38.86 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.865 . . . . 1.6499999999999999 109.3 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.548 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 79.4 mt -64.2 -58.57 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -0.902 . . . . 1.47 110.074 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -42.21 75.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 2.54 109.886 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -65.22 -36.09 83.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.946 . . . . 3.0 109.096 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 243' ' ' GLN . 54.4 mtp -79.08 -33.71 44.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 1.6299999999999999 109.041 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -50.07 -43.46 51.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.745 -1.222 . . . . 3.1600000000000001 109.438 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.47 -55.61 6.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 2.0899999999999999 110.156 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.8 t -66.32 -46.94 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 2.5699999999999998 109.77 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 239' ' ' MET . 0.9 OUTLIER -55.14 -57.92 9.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 3.5899999999999999 110.192 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 . . . . . 0 C--N 1.303 -1.413 0 O-C-N 120.879 -1.138 . . . . 1.76 109.705 -179.166 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.582 ' SD ' ' NE2' ' A' ' 226' ' ' GLN . 14.4 mmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.636 -0.505 . . . . 4.0700000000000003 109.636 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.6 mt -67.15 98.39 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.052 -1.03 . . . . 1.5 108.782 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.3 m -98.42 121.86 40.89 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.353 -0.842 . . . . 1.8 109.609 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.705 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -119.89 -160.13 11.13 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.315 -1.514 . . . . 0.92000000000000004 109.315 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.3 mt -95.67 -9.92 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.332 -1.099 . . . . 1.5 108.799 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 tp 60.67 111.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.417 -0.802 . . . . 1.3999999999999999 109.413 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.68 -52.91 5.25 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.325 -0.991 . . . . 1.26 108.325 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.63 146.4 22.22 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 108.5 -0.926 . . . . 1.95 108.5 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.94 149.26 32.78 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.42 2.08 . . . . 0.93999999999999995 114.262 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 159.8 179.77 34.82 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.135 -1.586 . . . . 0.78000000000000003 109.135 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 mt -139.0 130.43 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.13 -1.218 . . . . 1.29 109.495 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.47 151.08 41.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.364 -0.835 . . . . 1.1499999999999999 109.74 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.2 m-85 -122.44 138.24 54.61 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.07 -1.085 . . . . 0.71999999999999997 108.07 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.89 168.46 38.66 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 118.769 -1.681 . . . . 0.5 111.564 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -80.71 147.48 30.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.683 -0.892 . . . . 2.3599999999999999 110.083 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.81 127.58 32.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 1.1599999999999999 111.322 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -105.49 96.99 6.89 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.08 -1.452 . . . . 1.24 107.08 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.672 ' H ' ' ND2' ' A' ' 214' ' ' ASN . 11.9 tp -80.4 120.04 23.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.956 -1.09 . . . . 1.3100000000000001 110.666 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.69 98.57 9.4 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.836 -0.62 . . . . 1.3100000000000001 109.406 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -93.23 159.24 15.36 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.66 -0.867 . . . . 2.3500000000000001 108.66 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -130.45 122.16 27.21 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.243 -0.911 . . . . 2.5800000000000001 109.467 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -81.62 131.76 35.28 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.35 -0.844 . . . . 2.1400000000000001 109.262 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -63.98 147.2 52.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 1.9299999999999999 109.638 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.7 mt -91.87 136.38 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.22 -0.925 . . . . 1.28 109.709 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 t -107.64 121.74 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.394 -0.816 . . . . 1.3700000000000001 109.397 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.3 mt -88.85 145.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 1.3300000000000001 109.94 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.68 120.55 35.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.321 -0.862 . . . . 1.3700000000000001 109.748 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -102.01 29.04 5.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.192 -0.943 . . . . 3.1899999999999999 109.58 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -75.36 147.34 40.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.995 . . . . 2.8100000000000001 110.0 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -87.49 116.18 25.42 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.22 -1.029 . . . . 2.8300000000000001 108.22 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.7 pt -84.18 171.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.897 -1.127 . . . . 1.3400000000000001 110.617 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -98.09 168.48 10.24 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.193 -0.669 . . . . 1.3500000000000001 109.193 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.31 -22.3 66.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 1.6100000000000001 109.581 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.14 -7.39 58.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 2.4700000000000002 108.609 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -107.77 -9.21 15.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.53 -0.915 . . . . 2.0699999999999998 108.53 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -67.93 -47.04 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 1.3300000000000001 108.979 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -51.46 -36.07 42.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 1.46 109.11 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.61 -32.61 71.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 2.9399999999999999 109.928 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -61.8 -47.02 87.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.99 -1.069 . . . . 1.3 109.51 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 44' ' ' LEU . 85.6 t -61.51 -47.19 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.355 -0.84 . . . . 1.3300000000000001 110.016 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.28 -40.65 97.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.058 -1.026 . . . . 1.5 108.367 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -65.86 -32.35 73.81 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.81 -0.811 . . . . 3.1499999999999999 108.81 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -86.37 -56.68 3.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.92000000000000004 108.972 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 40' ' ' VAL . 29.3 tp -51.54 -63.38 1.15 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.821 -0.807 . . . . 1.4099999999999999 108.821 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 t -61.73 -30.27 70.66 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.077 -1.082 . . . . 1.22 108.077 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -58.65 -52.9 50.31 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.422 -2.271 . . . . 0.58999999999999997 107.422 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -48.5 -30.0 4.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.75 -0.853 . . . . 3.3900000000000001 108.76 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.4 85.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.235 -1.024 . . . . 1.26 108.235 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 46' ' ' GLY . 52.3 mttm -81.73 -59.31 2.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.344 -0.613 . . . . 2.9900000000000002 109.344 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.7 -40.29 59.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.11 -0.994 . . . . 1.1399999999999999 109.832 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.7 t -62.75 -37.4 86.46 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.998 -1.064 . . . . 1.8400000000000001 108.221 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.76 -28.23 62.49 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.442 -0.577 . . . . 1.22 109.442 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.601 ' NE2' HD22 ' A' ' 140' ' ' ASN . 26.4 mt-30 -72.07 -62.84 1.28 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.19 -0.944 . . . . 2.0 109.109 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.3 mp -51.93 -48.96 63.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 1.99 108.466 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -49.81 -50.42 45.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.809 . . . . 1.27 109.218 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -63.13 -41.42 99.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 1.24 109.655 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.4 mt -70.63 -34.85 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 1.21 108.994 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -53.9 -45.1 71.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.284 -0.885 . . . . 1.53 109.197 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 m -71.46 -24.26 61.97 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.266 -0.896 . . . . 1.24 109.941 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.43 ' O ' ' OG1' ' A' ' 64' ' ' THR . 29.3 mttp -71.28 -33.11 69.45 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.748 -1.205 . . . . 2.3199999999999998 107.748 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.25 -34.11 76.75 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.793 -0.818 . . . . 1.1699999999999999 108.793 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.17 -30.23 25.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.678 -1.369 . . . . 0.57999999999999996 109.678 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -86.64 -12.3 48.88 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.823 -1.398 . . . . 1.3899999999999999 109.137 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 88.1 m -94.91 -46.96 6.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.2 -0.937 . . . . 1.3600000000000001 110.579 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -107.06 -34.71 7.08 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.111 -0.993 . . . . 1.1399999999999999 110.157 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 80.07 -41.29 2.4 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.969 -1.253 . . . . 0.59999999999999998 109.969 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 69' ' ' LYS . 67.3 mt-10 -50.51 178.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.241 . . . . 2.5899999999999999 109.573 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.62 43.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 2.2000000000000002 109.709 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 67' ' ' GLU . 15.9 mmmt -89.67 -17.91 27.48 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.557 -0.905 . . . . 2.3599999999999999 108.557 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.65 -35.06 74.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.472 -0.767 . . . . 1.54 110.688 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.28 -22.24 66.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -0.978 . . . . 1.24 110.412 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.48 -40.38 55.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.95 -1.094 . . . . 1.24 109.508 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -76.6 -28.33 56.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.925 . . . . 0.80000000000000004 109.616 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.66 -38.42 91.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.941 -1.099 . . . . 1.23 108.61 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.83 -32.38 61.24 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.578 -1.809 . . . . 0.56000000000000005 108.578 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -61.38 -18.79 60.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -1.07 . . . . 2.0600000000000001 109.172 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.5 mt -85.67 -39.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.246 -1.02 . . . . 1.24 108.246 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.3 ttt -58.8 -38.73 79.23 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.992 -0.744 . . . . 2.4500000000000002 108.992 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.9 tp -69.56 -43.76 72.26 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.852 -0.795 . . . . 1.21 108.852 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.0 tp -64.72 -48.01 76.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.44 -0.788 . . . . 1.1200000000000001 109.483 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -84.4 13.14 5.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.836 . . . . 1.24 110.467 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -49.1 125.2 10.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.998 -1.064 . . . . 1.3100000000000001 109.695 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -67.69 -25.03 65.48 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.339 -0.851 . . . . 1.3500000000000001 108.756 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.62 -52.34 9.87 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.436 -0.79 . . . . 2.1600000000000001 109.528 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.7 mt -64.61 -15.65 61.49 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.036 -1.066 . . . . 1.24 109.04 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -77.35 -43.4 33.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 1.28 109.801 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.03 -33.35 75.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -0.91 . . . . 1.79 110.405 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -72.77 -43.88 62.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 1.29 109.654 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.0 mt -57.36 -39.85 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.551 -0.907 . . . . 1.1399999999999999 108.551 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -67.5 -62.43 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.715 -0.615 . . . . 1.3200000000000001 110.27 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -50.07 -38.48 38.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.149 -0.969 . . . . 1.3700000000000001 109.834 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.6 -59.87 4.7 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.268 -0.895 . . . . 1.3999999999999999 108.676 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.7 mt -47.02 -44.26 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 1.23 110.171 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -82.67 -31.44 28.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.161 -0.962 . . . . 2.5099999999999998 111.029 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 91' ' ' ALA . 66.9 t0 -79.25 -48.44 14.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.859 -1.15 . . . . 1.5900000000000001 111.778 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -106.71 21.06 18.09 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.82 -1.175 . . . . 2.3799999999999999 110.046 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 44.07 48.22 7.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -0.905 . . . . 1.6200000000000001 109.927 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtt -102.72 151.04 22.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.485 -0.759 . . . . 1.8899999999999999 109.051 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.7 p -75.28 148.15 39.63 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.567 -0.708 . . . . 1.27 109.354 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.31 18.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.243 -0.911 . . . . 1.1599999999999999 109.167 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.31 -44.54 58.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.041 -1.096 . . . . 2.0 108.041 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.86 -52.92 15.0 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.647 -0.658 . . . . 1.25 109.886 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.15 -49.46 76.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 1.1299999999999999 109.67 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.72 -33.98 61.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 1.0800000000000001 109.893 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -68.97 -36.87 78.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.954 -1.091 . . . . 2.02 109.525 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -58.76 -52.68 64.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.985 . . . . 1.26 109.674 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.1 t -56.41 -49.14 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.105 -0.997 . . . . 1.1799999999999999 109.299 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.41 -17.62 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 1.1899999999999999 109.18 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -73.58 -35.18 65.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.082 -1.011 . . . . 2.2000000000000002 109.976 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.25 -27.13 28.83 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.318 -1.42 . . . . 0.85999999999999999 112.338 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -67.25 -40.24 86.23 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.598 -1.531 . . . . 2.0 109.209 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.22 -52.18 8.49 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.393 -0.817 . . . . 1.3200000000000001 109.632 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.7 p -60.52 -42.13 95.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 2.1400000000000001 110.245 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.54 -35.69 81.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.032 -1.042 . . . . 1.3799999999999999 110.334 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.89 -27.55 65.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.854 -1.154 . . . . 1.3500000000000001 109.599 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -69.14 -18.04 63.9 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.921 -1.112 . . . . 1.95 109.367 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -80.97 -4.81 56.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 1.71 109.348 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.5 mt -83.22 145.61 29.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 1.71 108.487 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -96.68 56.23 1.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.751 -0.833 . . . . 2.8300000000000001 108.751 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -146.25 117.27 7.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.303 -0.873 . . . . 1.5800000000000001 109.23 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.75 -16.77 18.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 2.7999999999999998 109.971 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.96 -65.6 0.95 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.935 . . . . 1.27 109.212 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.2 mt -61.1 -19.42 61.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 1.5800000000000001 109.116 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -67.79 -48.2 66.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.101 -0.999 . . . . 2.9199999999999999 108.36 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 50.3 mt-10 -61.85 -20.27 63.5 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.66 -0.867 . . . . 2.2000000000000002 108.66 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.516 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.5 OUTLIER -71.35 -29.53 65.08 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.6 -1.63 . . . . 2.5299999999999998 106.6 178.029 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.78 -50.66 72.96 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.957 -0.757 . . . . 1.45 108.957 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.68 -37.48 76.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 1.5 110.004 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 -68.18 -29.89 68.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.01 . . . . 1.3500000000000001 109.602 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.94 -40.49 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.221 -1.029 . . . . 1.23 108.221 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -56.0 -38.81 70.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.078 -1.082 . . . . 3.73 108.078 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -61.51 -36.49 80.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.635 -0.666 . . . . 1.3200000000000001 109.93 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.6 mt -68.21 -30.81 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.036 -1.04 . . . . 1.2 109.492 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.49 -46.13 72.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.257 -1.937 . . . . 0.48999999999999999 108.257 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -51.04 -44.61 61.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.78 -0.835 . . . . 3.1099999999999999 109.253 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.568 ' NH2' ' HG ' ' A' ' 166' ' ' SER . 69.4 mtt180 -62.57 -46.93 86.07 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.841 -1.17 . . . . 2.9500000000000002 107.841 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 tt -52.28 -54.29 33.27 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.878 -0.786 . . . . 1.73 108.878 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.93 -56.46 19.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 1.22 109.586 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -44.74 -22.55 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 2.7799999999999998 111.068 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.601 HD22 ' NE2' ' A' ' 53' ' ' GLN . 61.6 m-80 -85.18 -42.48 14.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.801 -1.187 . . . . 2.0299999999999998 110.074 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.35 -34.59 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.04 -1.038 . . . . 1.2 109.496 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.8 mt -90.98 -3.82 56.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.219 -0.926 . . . . 1.28 109.395 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.32 29.99 63.94 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.16 -1.976 . . . . 0.68999999999999995 108.16 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.76 148.83 45.94 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.527 -0.984 . . . . 1.3100000000000001 109.686 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -68.84 147.69 51.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 2.8799999999999999 109.317 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 146' ' ' ILE . 78.0 mt -102.67 157.75 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 1.3600000000000001 108.724 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.6 mm -76.85 104.06 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.057 -1.027 . . . . 1.9299999999999999 109.444 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -102.18 90.3 3.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.564 -0.71 . . . . 1.54 110.276 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.2 mt -80.03 -7.15 58.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 1.3400000000000001 108.703 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.9 t -83.97 40.69 0.77 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -0.792 . . . . 1.98 109.905 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.61 19.09 2.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.218 -0.926 . . . . 1.3799999999999999 109.006 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 60.1 mt -73.76 150.34 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.547 -0.721 . . . . 1.3999999999999999 109.593 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.3 2.36 1.67 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.339 -0.85 . . . . 2.7400000000000002 109.153 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -127.59 132.39 49.83 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.089 -0.708 . . . . 1.4099999999999999 109.089 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -63.04 120.51 11.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.915 . . . . 1.3 109.794 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.0 m -150.3 175.81 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.24 -0.912 . . . . 1.28 109.421 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.2 mt -90.8 157.56 2.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.948 -1.131 . . . . 1.1499999999999999 107.948 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.7 tp -107.64 122.2 46.22 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.547 -0.721 . . . . 1.2 109.212 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.7 t -123.75 132.59 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.311 0.577 . . . . 1.1599999999999999 109.504 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.44 144.84 12.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 1.2 109.491 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.53 -32.82 71.84 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.464 -1.397 . . . . 1.3200000000000001 107.846 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -172.64 155.95 3.44 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.585 -0.697 . . . . 2.3399999999999999 109.413 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.0 mt -130.73 132.08 45.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.553 -0.717 . . . . 1.26 109.319 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 p -92.33 152.89 42.77 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.262 -0.899 . . . . 1.3600000000000001 109.119 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.407 ' O ' ' OG1' ' A' ' 168' ' ' THR . 78.3 Cg_exo -36.36 -43.71 0.83 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.322 2.014 . . . . 0.63 112.189 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.568 ' HG ' ' NH2' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -54.16 -63.7 1.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 1.0700000000000001 108.938 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -48.46 -40.27 25.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 1.25 109.362 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 21.2 p -71.04 -23.52 62.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 1.1799999999999999 109.792 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.55 -29.36 46.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.912 . . . . 1.1399999999999999 110.285 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -104.54 -7.63 19.61 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.275 -0.891 . . . . 1.71 110.077 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.1 tp -57.36 135.67 56.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.822 -1.174 . . . . 1.22 108.08 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -99.89 120.7 40.19 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.221 -0.925 . . . . 2.5499999999999998 110.048 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 7.9 mp -93.58 45.99 1.18 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.843 . . . . 1.96 108.741 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -109.54 -27.47 9.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.404 -0.81 . . . . 2.46 109.02 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -131.2 11.86 5.04 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.439 -0.788 . . . . 2.4199999999999999 109.643 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 66.7 t -82.85 154.29 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.112 -0.993 . . . . 1.1599999999999999 109.494 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.0 tp -117.47 -12.2 10.43 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.719 -0.613 . . . . 1.95 109.547 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 163.99 179.84 38.49 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.61 -1.396 . . . . 0.41999999999999998 109.61 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -130.44 124.95 33.23 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.557 -0.966 . . . . 0.52000000000000002 109.635 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.8 mt -128.54 126.6 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.887 -1.153 . . . . 1.1599999999999999 107.887 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.501 ' O ' ' O ' ' A' ' 203' ' ' VAL . 40.7 p -142.01 149.36 39.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 1.22 110.549 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.436 ' OD2' ' OG1' ' A' ' 209' ' ' THR . 4.6 p30 -100.28 43.69 1.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.323 -0.861 . . . . 2.2400000000000002 109.268 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.211 0 O-C-N 121.424 -0.797 . . . . 1.6499999999999999 110.323 -179.867 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 46.5 t60 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.252 0.549 . . . . 1.0600000000000001 109.95 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.2 p -52.95 -45.43 67.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 2.0899999999999999 109.924 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.5 t -68.31 -39.28 82.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 1.8799999999999999 110.041 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.5 mm -50.44 -38.52 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 2.0099999999999998 110.34 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 mtp -72.05 -59.57 2.67 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.7 -1.222 . . . . 1.27 107.7 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.69 -31.09 35.59 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.761 -0.654 . . . . 1.1799999999999999 109.847 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -78.95 -47.37 16.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 3.5800000000000001 109.898 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.8 m -69.51 -36.17 76.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.031 -1.043 . . . . 1.1399999999999999 109.755 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 199' ' ' LEU . 29.0 mt -86.53 0.06 55.09 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 1.28 108.927 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 47.81 10.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 1.49 111.051 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 197' ' ' LEU . 22.0 mt -66.79 161.01 65.14 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.801 -1.187 . . . . 1.28 108.597 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -79.38 127.88 7.67 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.188 1.259 . . . . 0.69999999999999996 111.172 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.87 179.04 7.32 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.844 -1.142 . . . . 1.1899999999999999 110.871 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.6 mt -146.35 162.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.001 -1.481 . . . . 1.25 107.001 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 181' ' ' THR . 15.6 m -147.84 -28.2 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.718 -1.239 . . . . 1.29 111.408 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.9 26.94 14.18 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 120.901 -1.125 . . . . 0.92000000000000004 110.328 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 30.8 p -52.61 -41.06 63.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.833 -1.392 . . . . 1.3100000000000001 108.738 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 76.92 -38.1 1.51 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 120.781 -0.724 . . . . 1.0 113.837 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 83.8 p -130.19 27.28 5.11 Favored 'General case' 0 N--CA 1.514 2.773 0 CA-C-N 119.939 1.869 . . . . 1.9199999999999999 113.256 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.3 -41.94 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.133 -1.604 . . . . 1.27 110.323 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.436 ' OG1' ' OD2' ' A' ' 182' ' ' ASP . 10.2 p -64.65 -12.89 50.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.668 -1.27 . . . . 1.3400000000000001 110.137 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.8 p -106.17 11.84 30.84 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 2.0699999999999998 109.407 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -144.23 4.63 1.24 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.243 -0.91 . . . . 2.8599999999999999 110.588 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.5 t -126.93 151.37 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.305 -0.872 . . . . 1.3 109.524 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.506 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 42.6 mmtt -129.25 166.85 18.61 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.048 -1.464 . . . . 2.48 107.048 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.672 ' ND2' ' H ' ' A' ' 18' ' ' LEU . 28.3 m120 -64.14 143.47 57.85 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.8 -1.187 . . . . 2.6200000000000001 110.616 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 73.9 -2.44 2.78 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.797 -0.564 . . . . 2.3999999999999999 110.623 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.506 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 44.1 m-20 -57.51 142.26 44.9 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.914 -1.116 . . . . 1.99 108.673 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -86.52 107.22 18.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.44 -0.948 . . . . 1.54 108.44 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 40.8 mt -122.51 154.01 38.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.548 -0.72 . . . . 1.25 110.139 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 49.8 mt -126.04 122.82 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.501 -0.926 . . . . 1.26 108.501 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.5 tp -90.59 120.38 31.62 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.524 -0.917 . . . . 1.1799999999999999 108.524 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.3 m-20 -97.19 -29.79 13.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.215 -0.928 . . . . 2.2200000000000002 109.546 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 39.5 21.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.912 -0.492 . . . . 1.2 110.422 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -115.96 -51.66 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 106.967 -1.494 . . . . 1.48 106.967 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -96.46 10.85 37.0 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.112 -1.44 . . . . 2.8199999999999998 107.112 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.705 HD22 ' H ' ' A' ' 4' ' ' GLY . 34.8 t30 56.23 54.72 7.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.972 -0.751 . . . . 2.1099999999999999 108.972 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.582 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 65.9 tt0 -153.99 150.59 28.44 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.917 0.865 . . . . 2.6499999999999999 110.171 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 78.2 t -115.11 152.22 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.308 -0.997 . . . . 1.29 108.308 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -108.54 121.32 44.74 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.217 -0.927 . . . . 1.4199999999999999 109.45 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.69 114.98 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.574 -0.704 . . . . 1.26 109.518 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 69.02 67.5 0.47 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.659 -0.651 . . . . 2.1499999999999999 109.671 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -86.33 130.42 3.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 123.057 2.505 . . . . 0.81999999999999995 112.498 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.3 p -74.02 162.27 29.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 2.1099999999999999 109.594 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -64.06 -44.03 93.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 3.1699999999999999 109.828 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -53.27 -36.69 61.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.394 -0.816 . . . . 3.0600000000000001 109.384 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.2 t -76.74 -37.1 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.678 -0.86 . . . . 1.6499999999999999 108.678 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 75.3 mt -71.62 -57.4 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 1.47 109.344 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -51.07 -44.89 61.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -0.781 . . . . 2.54 110.014 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -65.33 -32.32 73.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 3.0 108.93 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 243' ' ' GLN . 77.1 mtp -81.94 -42.46 19.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.404 -0.81 . . . . 1.6299999999999999 109.555 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -47.45 -39.28 15.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.035 -1.04 . . . . 3.1600000000000001 109.82 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.36 -63.35 1.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.109 -0.995 . . . . 2.0899999999999999 110.394 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.8 t -66.08 -51.4 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.103 -0.998 . . . . 2.5699999999999998 110.198 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 239' ' ' MET . 45.8 tt0 -47.92 -47.44 32.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.078 -1.014 . . . . 3.5899999999999999 109.635 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 . . . . . 0 C--N 1.3 -1.564 0 O-C-N 120.828 -1.17 . . . . 1.76 108.939 179.703 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 3' ' ' SER . 80.4 mtp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.338 0.59 . . . . 4.0700000000000003 109.494 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.42 81.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 1.5 109.604 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 1' ' ' MET . 1.5 m -98.22 113.79 25.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.259 -0.901 . . . . 1.8 109.725 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.95 -163.62 20.39 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 108.665 -1.774 . . . . 0.92000000000000004 108.665 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 6' ' ' LEU . 59.9 mt -96.96 -6.59 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.033 -1.275 . . . . 1.5 108.918 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.1 tp 53.46 104.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.515 -0.74 . . . . 1.3999999999999999 109.206 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.78 -51.46 6.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.996 . . . . 1.26 109.342 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -144.97 149.48 42.57 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.318 -0.864 . . . . 1.95 109.019 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -80.14 154.78 22.34 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.372 2.048 . . . . 0.93999999999999995 113.732 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.99 138.32 2.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.597 -1.401 . . . . 0.78000000000000003 109.597 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 11' ' ' ILE . 97.2 mt -96.73 132.49 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.186 -1.185 . . . . 1.29 109.388 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.35 157.37 46.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.33 -0.856 . . . . 1.1499999999999999 110.344 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.585 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -130.69 134.73 47.17 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.25 -1.019 . . . . 0.71999999999999997 108.25 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.96 164.66 34.24 Favored Glycine 0 N--CA 1.503 3.102 0 C-N-CA 118.204 -1.95 . . . . 0.5 111.813 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -77.62 146.55 36.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.576 -0.955 . . . . 2.3599999999999999 109.753 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.92 122.36 25.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.709 . . . . 1.1599999999999999 110.981 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 tp -100.82 94.67 6.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.845 -1.168 . . . . 1.24 107.845 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.6 tp -81.97 112.74 19.34 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.01 -1.056 . . . . 1.3100000000000001 109.759 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.89 93.95 6.62 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.661 -0.7 . . . . 1.3100000000000001 109.783 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -92.62 159.16 15.59 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.598 -0.89 . . . . 2.3500000000000001 108.598 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -118.3 131.79 56.32 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.438 -0.789 . . . . 2.5800000000000001 109.678 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.5 127.04 31.64 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.488 -0.93 . . . . 2.1400000000000001 108.488 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -62.74 136.94 58.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 1.9299999999999999 109.292 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.4 mt -90.82 131.33 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.26 -0.9 . . . . 1.28 110.194 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.33 122.77 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.655 -0.868 . . . . 1.3700000000000001 108.655 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -89.6 140.66 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.164 -0.96 . . . . 1.3300000000000001 110.028 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -90.66 128.95 36.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.22 -0.925 . . . . 1.3700000000000001 109.324 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -105.25 30.52 5.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.414 -0.803 . . . . 3.1899999999999999 109.959 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -76.24 144.03 40.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.117 -0.989 . . . . 2.8100000000000001 109.788 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -86.99 124.01 32.72 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.702 -0.851 . . . . 2.8300000000000001 108.702 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -90.64 170.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.102 -0.999 . . . . 1.3400000000000001 110.477 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.3 p -97.24 169.13 9.99 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.486 -0.561 . . . . 1.3500000000000001 109.486 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.25 -25.62 68.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 1.6100000000000001 109.433 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -80.22 -5.11 55.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 2.4700000000000002 109.239 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -109.96 -15.9 13.96 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.019 -1.104 . . . . 2.0699999999999998 108.019 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.29 -42.88 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.102 -0.703 . . . . 1.3300000000000001 109.102 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -53.42 -36.17 61.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 1.46 109.374 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -69.62 -32.69 71.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 2.9399999999999999 109.755 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -63.42 -41.92 98.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.152 -0.967 . . . . 1.3 109.267 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 44' ' ' LEU . 76.5 t -62.48 -49.01 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.412 -0.805 . . . . 1.3300000000000001 110.032 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -65.27 -45.02 86.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.04 . . . . 1.5 108.838 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -64.99 -31.75 73.15 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.704 -0.798 . . . . 3.1499999999999999 109.045 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -86.47 -59.36 2.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.078 -1.014 . . . . 0.92000000000000004 108.733 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 40' ' ' VAL . 30.8 tp -47.94 -65.18 0.61 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.36 0.6 . . . . 1.4099999999999999 109.695 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.1 t -64.28 -37.72 88.49 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.518 -0.919 . . . . 1.22 108.518 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.01 -52.41 49.25 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.355 -2.298 . . . . 0.58999999999999997 107.355 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.403 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.2 ttt-85 -51.41 -26.18 7.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.684 -0.892 . . . . 3.3900000000000001 109.033 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.73 -28.53 61.75 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.987 -1.116 . . . . 1.26 107.987 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 46' ' ' GLY . 33.3 ttmt -75.48 -56.67 4.47 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.082 -0.711 . . . . 2.9900000000000002 109.082 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.42 -30.75 30.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.086 -1.009 . . . . 1.1399999999999999 109.566 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 10.1 p -65.07 -38.67 91.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 1.8400000000000001 108.906 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.87 -28.28 65.52 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.478 0.656 . . . . 1.22 109.336 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -71.81 -67.66 0.51 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.764 . . . . 2.0 109.602 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 54' ' ' LEU . 9.3 mp -51.04 -34.73 30.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 1.99 108.819 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 51' ' ' SER . 9.5 mm-40 -63.88 -51.47 64.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.471 -0.768 . . . . 1.27 109.08 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -60.98 -34.56 74.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 1.24 108.592 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.28 -25.29 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.574 -0.899 . . . . 1.21 108.574 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -65.46 -44.47 87.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.559 -0.713 . . . . 1.53 109.588 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -71.79 -27.15 62.74 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.3 -0.875 . . . . 1.24 109.144 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -72.27 -29.68 64.12 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.769 -1.197 . . . . 2.3199999999999998 107.769 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.81 61.91 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.091 -1.077 . . . . 1.1699999999999999 108.091 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.7 -29.76 28.56 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.433 -1.467 . . . . 0.57999999999999996 109.433 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -86.55 -20.24 28.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -1.202 . . . . 1.3899999999999999 108.595 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -94.36 -46.89 6.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 1.3600000000000001 110.357 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -107.92 -27.16 10.35 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.111 -0.993 . . . . 1.1399999999999999 111.297 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.97 152.98 8.94 Favored Glycine 0 N--CA 1.506 3.337 0 N-CA-C 109.647 -1.381 . . . . 0.59999999999999998 109.647 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -50.2 -12.54 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -1.124 . . . . 2.5899999999999999 110.583 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 66' ' ' GLY . 27.7 tt0 -63.66 -31.22 72.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.988 . . . . 2.2000000000000002 110.454 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -91.08 -17.46 26.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.927 -1.108 . . . . 2.3599999999999999 110.28 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -62.53 -28.87 70.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.986 -1.071 . . . . 1.54 109.941 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.22 -30.36 69.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.179 -0.951 . . . . 1.24 109.604 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.38 -44.05 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -0.876 . . . . 1.24 109.105 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -77.27 -24.49 51.05 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.465 -0.772 . . . . 0.80000000000000004 109.664 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -63.9 -42.36 97.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.965 -1.084 . . . . 1.23 108.9 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.04 -36.24 80.49 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.928 -1.669 . . . . 0.56000000000000005 108.928 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.07 -18.56 61.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.445 -1.032 . . . . 2.0600000000000001 110.661 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.3 mt -85.03 -46.36 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.618 -1.301 . . . . 1.24 108.94 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 42.5 ttp -55.22 -49.16 72.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.36 -0.837 . . . . 2.4500000000000002 108.967 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tp -54.88 -43.44 73.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.407 -0.808 . . . . 1.21 109.171 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.31 -44.1 80.03 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.383 -0.823 . . . . 1.1200000000000001 109.417 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -85.37 8.42 18.88 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.416 -0.803 . . . . 1.24 110.161 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -49.14 121.53 4.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.974 -1.079 . . . . 1.3100000000000001 109.666 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -66.84 -24.26 66.13 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.542 -0.91 . . . . 1.3500000000000001 108.542 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -75.57 -48.89 20.38 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.334 -0.854 . . . . 2.1600000000000001 109.249 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.7 mt -63.68 -15.09 57.46 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.032 -1.067 . . . . 1.24 108.979 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -79.54 -45.64 18.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.438 -0.789 . . . . 1.28 110.041 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -64.56 -28.87 69.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.254 -0.904 . . . . 1.79 110.022 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.21 -46.25 35.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.196 -0.94 . . . . 1.29 109.889 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.7 mt -58.38 -55.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.06 -1.089 . . . . 1.1399999999999999 108.06 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.0 mt -45.14 -58.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.623 -0.673 . . . . 1.3200000000000001 109.872 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -49.04 -57.05 7.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.423 -0.798 . . . . 1.3700000000000001 110.418 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.2 mt -50.54 -56.49 11.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.426 -0.796 . . . . 1.3999999999999999 109.266 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.0 mt -47.4 -41.63 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 1.23 109.784 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -86.19 -33.72 20.71 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.116 -0.99 . . . . 2.5099999999999998 111.974 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -79.34 -44.29 21.86 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.536 -1.353 . . . . 1.5900000000000001 111.757 -176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -105.76 15.47 26.73 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.722 -1.236 . . . . 2.3799999999999999 109.23 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.505 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 1.5 m80 45.41 55.47 6.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.391 -0.818 . . . . 1.6200000000000001 109.54 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 74.1 mtp -102.51 153.65 19.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.571 -0.706 . . . . 1.8899999999999999 109.259 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.7 p -76.16 171.45 14.48 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.486 -0.759 . . . . 1.27 109.389 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.31 -28.47 62.1 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.758 . . . . 1.1599999999999999 109.668 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.13 -45.4 41.21 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.064 -1.087 . . . . 2.0 108.064 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.55 -52.33 22.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.714 -0.616 . . . . 1.25 110.201 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.34 -48.75 80.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 1.1299999999999999 109.754 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.21 -35.25 67.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 1.0800000000000001 109.606 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -68.77 -34.64 75.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.968 -1.082 . . . . 2.02 109.641 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -53.43 -60.94 2.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.375 -0.828 . . . . 1.26 110.118 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.0 t -50.93 -48.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.953 -1.092 . . . . 1.1799999999999999 109.682 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.453 HG22 HD11 ' A' ' 108' ' ' ILE . 49.5 mm -61.73 -20.62 23.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.39 -0.819 . . . . 1.1899999999999999 108.967 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.37 -37.86 74.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.089 -1.007 . . . . 2.2000000000000002 109.779 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.2 -23.95 38.91 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.491 -1.338 . . . . 0.85999999999999999 112.843 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -67.1 -52.82 37.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.343 -1.681 . . . . 2.0 108.746 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.14 -52.44 59.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.563 -0.71 . . . . 1.3200000000000001 109.816 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.8 m -61.63 -32.58 72.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.128 -0.982 . . . . 2.1400000000000001 109.992 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -63.04 -43.65 98.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.825 -1.172 . . . . 1.3799999999999999 110.064 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 mt -67.23 -22.66 65.68 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.541 -1.263 . . . . 1.3500000000000001 109.249 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.82 -23.65 64.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.779 -1.2 . . . . 1.95 109.165 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -82.99 -8.87 59.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -0.847 . . . . 1.71 109.032 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 mt -84.34 148.02 26.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.418 -0.956 . . . . 1.71 108.418 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -98.66 61.3 1.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.751 . . . . 2.8300000000000001 109.927 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -152.09 118.69 5.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.016 -1.053 . . . . 1.5800000000000001 110.11 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -62.27 -13.78 31.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 2.7999999999999998 109.238 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -78.03 -61.15 2.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.499 -0.75 . . . . 1.27 109.251 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.92 -29.33 70.7 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.265 -0.897 . . . . 1.5800000000000001 109.92 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 127' ' ' ALA . 71.5 tttt -66.4 -47.51 73.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.838 -1.164 . . . . 2.9199999999999999 108.162 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -57.67 -24.48 56.88 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.159 -1.052 . . . . 2.2000000000000002 108.159 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.552 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -73.17 -23.79 60.47 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.571 -1.64 . . . . 2.5299999999999998 106.571 178.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -61.0 -45.3 95.39 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.858 -0.793 . . . . 1.45 108.858 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.41 -35.83 80.06 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.863 -0.735 . . . . 1.5 109.025 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.5 m-20 -69.01 -36.3 77.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.418 -0.801 . . . . 1.3500000000000001 109.095 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.87 -42.98 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.995 -1.113 . . . . 1.23 107.995 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.471 ' CG ' ' NH1' ' A' ' 131' ' ' ARG . 1.4 ttt-85 -54.77 -39.15 68.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.608 -0.886 . . . . 3.73 108.608 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -60.18 -35.3 75.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.438 -0.789 . . . . 1.3200000000000001 109.497 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.1 mt -65.81 -26.14 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 1.2 109.053 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.94 -50.62 7.62 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.455 -1.458 . . . . 0.48999999999999999 109.455 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -50.4 -47.36 56.45 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.444 -1.033 . . . . 3.1099999999999999 109.994 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 58.9 mtt-85 -65.21 -46.29 81.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.947 -1.096 . . . . 2.9500000000000002 108.776 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.6 tp -54.19 -33.19 57.59 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.727 -0.608 . . . . 1.73 109.705 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 140' ' ' ASN . 16.8 mt -76.79 -56.6 4.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.819 -1.176 . . . . 1.22 109.687 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -46.24 -17.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.933 . . . . 2.7799999999999998 110.093 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.514 ' ND2' ' N ' ' A' ' 140' ' ' ASN . 1.7 m120 -85.93 -37.14 19.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.978 . . . . 2.0299999999999998 109.633 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.3 mt -72.84 -40.64 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 1.2 109.727 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.5 mt -86.67 1.93 50.25 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.668 -0.864 . . . . 1.28 108.668 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.06 20.39 8.74 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.096 -2.002 . . . . 0.68999999999999995 108.096 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.5 tp -54.84 163.54 0.96 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.645 -0.915 . . . . 1.3100000000000001 109.146 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -68.18 143.62 55.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 2.8799999999999999 110.103 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.3 mt -111.39 137.55 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.508 -0.745 . . . . 1.3600000000000001 109.141 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 mp -77.71 99.48 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 1.9299999999999999 109.085 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -99.38 92.29 5.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.413 -0.805 . . . . 1.54 109.64 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 151' ' ' ALA . 22.0 mt -79.24 -9.71 59.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 1.3400000000000001 109.104 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.2 t -79.77 35.27 0.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 1.98 108.979 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -142.67 18.29 2.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.399 -0.813 . . . . 1.3799999999999999 109.424 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.24 150.97 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 1.3999999999999999 110.13 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -145.86 11.89 1.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.293 -1.002 . . . . 2.7400000000000002 108.293 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -125.36 125.37 43.33 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.336 -0.987 . . . . 1.4099999999999999 108.336 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.82 115.27 4.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.359 -0.838 . . . . 1.3 109.29 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.29 178.62 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 1.28 109.675 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 26.8 mt -93.8 153.14 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.834 -1.173 . . . . 1.1499999999999999 107.834 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 25.4 tp -101.13 115.59 30.84 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.775 -0.824 . . . . 1.2 108.775 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.9 t -121.84 128.96 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.93 -0.767 . . . . 1.1599999999999999 108.93 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.86 149.96 11.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.483 -0.761 . . . . 1.2 109.098 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.09 -35.79 67.42 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.651 -1.281 . . . . 1.3200000000000001 107.928 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -174.9 156.5 2.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.653 -0.654 . . . . 2.3399999999999999 109.243 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.0 mt -123.83 133.73 53.74 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.547 -0.721 . . . . 1.26 109.581 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.8 p -93.57 152.52 40.94 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.921 -0.77 . . . . 1.3600000000000001 108.921 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -34.88 -51.98 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.459 2.106 . . . . 0.63 112.526 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.7 m -51.79 -50.26 61.08 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.179 -0.95 . . . . 1.0700000000000001 108.861 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.03 -35.73 77.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.596 -0.69 . . . . 1.25 109.819 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.7 p -79.94 -28.77 39.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.111 -0.993 . . . . 1.1799999999999999 109.411 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.21 -18.19 59.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.852 . . . . 1.1399999999999999 109.98 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -106.93 -14.52 14.94 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.218 -0.926 . . . . 1.71 109.336 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.2 tp -55.29 134.92 50.23 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.021 -1.103 . . . . 1.22 108.021 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 174' ' ' LYS . 3.3 t-20 -98.49 97.44 8.76 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.209 -0.932 . . . . 2.5499999999999998 109.586 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.6 mp -75.9 44.69 0.31 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.5 -0.75 . . . . 1.96 109.317 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 172' ' ' ASN . 95.4 mttt -106.5 -24.8 12.09 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.572 -0.899 . . . . 2.46 108.572 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -132.28 4.09 4.01 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.757 -0.59 . . . . 2.4199999999999999 110.03 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.1 153.91 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.971 -1.081 . . . . 1.1599999999999999 109.09 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.03 -37.53 5.34 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.659 -0.651 . . . . 1.95 110.003 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.41 -177.95 37.47 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.152 -1.579 . . . . 0.41999999999999998 109.152 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -132.46 127.88 36.25 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.465 -1.021 . . . . 0.52000000000000002 110.008 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.9 mt -127.03 118.55 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.981 -1.488 . . . . 1.1599999999999999 106.981 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 32.0 p -141.03 151.99 44.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.411 -0.805 . . . . 1.22 111.67 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -90.84 42.48 1.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.548 -0.72 . . . . 2.2400000000000002 109.224 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.809 0 O-C-N 120.989 -1.069 . . . . 1.6499999999999999 110.474 -178.299 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.9 t60 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.992 0.425 . . . . 1.0600000000000001 110.12 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.1 m -46.33 -39.39 10.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.993 -1.067 . . . . 2.0899999999999999 109.571 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.0 p -61.04 -45.59 94.17 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.289 -0.882 . . . . 1.8799999999999999 109.003 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 74.1 mt -49.72 -33.05 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.931 . . . . 2.0099999999999998 109.29 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 74.4 mtp -73.62 -65.52 0.81 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.641 -1.244 . . . . 1.27 107.641 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.19 -28.54 7.66 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.679 -0.692 . . . . 1.1799999999999999 110.04 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 31.8 mtt-85 -80.61 -52.32 7.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.869 -1.145 . . . . 3.5800000000000001 110.512 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.6 m -71.14 -33.95 70.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.897 -1.127 . . . . 1.1399999999999999 109.687 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 199' ' ' LEU . 22.3 mt -90.4 -0.44 57.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.23 -0.919 . . . . 1.28 109.126 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 46.34 11.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.345 -0.847 . . . . 1.49 111.284 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 197' ' ' LEU . 17.8 mt -68.31 145.22 97.29 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.815 -1.178 . . . . 1.28 109.45 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -56.63 131.92 48.59 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.091 1.861 . . . . 0.69999999999999996 110.803 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.44 173.04 11.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.597 -1.314 . . . . 1.1899999999999999 111.33 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 202' ' ' ILE . 68.9 mt -143.9 159.45 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.78 -1.563 . . . . 1.25 106.78 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.1 m -143.11 -33.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 120.577 -1.327 . . . . 1.29 111.337 -178.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.76 36.67 2.98 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.075 -1.21 . . . . 0.92000000000000004 110.075 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.9 p -65.94 -31.47 72.41 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.866 -1.373 . . . . 1.3100000000000001 108.604 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.23 -91.04 0.37 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.068 -1.063 . . . . 1.0 111.713 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 10.9 m -111.29 40.51 2.06 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.196 -1.179 . . . . 1.9199999999999999 112.945 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.3 t -76.93 -28.68 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.383 -1.448 . . . . 1.27 107.418 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 29.9 p -66.76 -9.64 38.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.391 -0.818 . . . . 1.3400000000000001 109.179 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 41.3 m -104.85 9.19 34.88 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.302 -0.999 . . . . 2.0699999999999998 108.302 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -134.74 2.25 3.14 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.532 -0.914 . . . . 2.8599999999999999 108.532 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.53 151.87 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.152 -0.684 . . . . 1.3 109.152 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -131.81 162.44 30.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.608 -1.627 . . . . 2.48 106.608 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 60.4 m-80 -63.71 146.86 53.03 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.786 -1.196 . . . . 2.6200000000000001 110.461 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.3 t70 79.4 -20.89 0.36 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.722 -0.611 . . . . 2.3999999999999999 110.431 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.38 126.1 25.78 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.771 -1.206 . . . . 1.99 108.155 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.479 ' HH ' ' CG ' ' A' ' 230' ' ' ASN . 13.4 p90 -87.5 118.97 27.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.787 -1.196 . . . . 1.54 109.723 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.5 mt -113.62 137.35 51.72 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.492 -0.929 . . . . 1.25 108.492 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.31 115.64 47.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.825 -1.176 . . . . 1.26 107.825 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 30.9 tp -83.2 129.77 35.04 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.296 -1.002 . . . . 1.1799999999999999 108.296 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.8 t0 -97.55 -40.0 8.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.408 -0.807 . . . . 2.2200000000000002 109.036 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 39.59 27.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.61 0.719 . . . . 1.2 110.078 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 221' ' ' ASP . 7.8 t -119.47 -45.05 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.419 -1.697 . . . . 1.48 106.419 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -105.27 17.13 24.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.178 -1.416 . . . . 2.8199999999999998 107.178 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 55.8 53.44 9.4 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.597 -0.89 . . . . 2.1099999999999999 108.597 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -155.0 145.63 22.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 2.6499999999999999 110.584 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.0 t -105.39 163.43 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.384 -0.969 . . . . 1.29 108.384 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -129.55 122.74 29.8 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.329 -0.857 . . . . 1.4199999999999999 109.23 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.76 115.46 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.421 -0.799 . . . . 1.26 110.552 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.479 ' CG ' ' HH ' ' A' ' 217' ' ' TYR . 47.2 t-20 53.96 51.33 8.11 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.379 -0.826 . . . . 2.1499999999999999 111.098 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.8 Cg_endo -64.46 158.76 47.71 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.378 2.052 . . . . 0.81999999999999995 111.472 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 78.5 p -71.03 139.51 50.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.094 -1.004 . . . . 2.1099999999999999 109.165 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -53.38 -17.11 1.66 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.197 -0.939 . . . . 3.1699999999999999 109.587 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -68.15 -39.44 82.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 3.0600000000000001 108.755 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.2 t -79.49 -34.27 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 1.6499999999999999 109.011 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 21.4 mt -64.55 -55.23 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.83 . . . . 1.47 109.313 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -53.14 -40.5 64.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -0.795 . . . . 2.54 109.622 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -67.07 -41.18 86.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 3.0 110.084 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 44.0 mtp -79.53 -26.72 41.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.084 -1.01 . . . . 1.6299999999999999 109.708 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.427 ' NH1' ' OE2' ' A' ' 244' ' ' GLU . 13.4 mmm180 -59.47 -41.11 89.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.038 . . . . 3.1600000000000001 109.593 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.07 -60.24 2.35 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.278 -0.889 . . . . 2.0899999999999999 110.226 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.2 t -46.8 -62.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 2.5699999999999998 110.668 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.4 HE21 HD13 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -45.98 -59.19 2.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.027 -1.046 . . . . 3.5899999999999999 109.531 -179.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.427 ' OE2' ' NH1' ' A' ' 240' ' ' ARG . 64.2 mt-10 . . . . . 0 C--N 1.295 -1.789 0 O-C-N 121.338 -0.851 . . . . 1.76 109.776 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 mmt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.321 0.581 . . . . 4.0700000000000003 109.502 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.2 mt 46.58 84.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.374 -0.828 . . . . 1.5 109.961 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m -95.11 113.39 25.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.208 -0.933 . . . . 1.8 109.093 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.24 -161.97 20.74 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.036 -1.626 . . . . 0.92000000000000004 109.036 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mt -95.77 -8.15 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.385 -1.068 . . . . 1.5 109.218 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tp 60.61 106.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -0.999 . . . . 1.3999999999999999 108.843 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.61 -46.02 9.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.779 -1.2 . . . . 1.26 108.444 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.54 142.57 15.66 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.428 -0.795 . . . . 1.95 108.934 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.02 155.63 30.02 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.029 1.82 . . . . 0.93999999999999995 113.814 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 160.78 -173.9 37.35 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.296 -1.522 . . . . 0.78000000000000003 109.296 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.4 mt -148.03 122.15 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.605 -1.527 . . . . 1.29 109.358 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.43 154.27 43.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.161 -0.962 . . . . 1.1499999999999999 110.406 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.495 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 8.7 m-85 -119.23 145.56 45.96 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.351 -0.981 . . . . 0.71999999999999997 108.351 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.4 159.9 22.75 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 118.885 -1.626 . . . . 0.5 111.248 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -78.57 153.45 31.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.99 . . . . 2.3599999999999999 109.638 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.15 121.89 25.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 1.1599999999999999 110.622 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.4 tp -101.73 92.76 4.99 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.518 -1.29 . . . . 1.24 107.518 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.49 127.2 33.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.966 -1.084 . . . . 1.3100000000000001 111.194 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.3 mt -95.26 93.31 7.21 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.511 -0.768 . . . . 1.3100000000000001 109.255 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -92.82 158.06 16.07 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.291 -0.88 . . . . 2.3500000000000001 109.624 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -130.39 135.6 48.19 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.609 -0.886 . . . . 2.5800000000000001 108.609 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.55 135.97 36.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.127 -0.983 . . . . 2.1400000000000001 109.542 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -65.45 132.53 49.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.597 -0.689 . . . . 1.9299999999999999 109.456 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.24 135.46 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.31 -0.869 . . . . 1.28 109.959 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.52 117.85 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.546 -0.721 . . . . 1.3700000000000001 109.364 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 26' ' ' ILE . 65.2 mt -87.01 132.65 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 1.3300000000000001 109.289 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.3 123.28 33.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.252 -0.905 . . . . 1.3700000000000001 109.655 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HG2' HH11 ' A' ' 28' ' ' ARG . 2.8 mmt-85 -96.25 26.05 4.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.248 -0.907 . . . . 3.1899999999999999 108.819 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -90.24 142.73 27.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.463 -0.773 . . . . 2.8100000000000001 110.384 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -88.34 129.16 35.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.252 -0.905 . . . . 2.8300000000000001 108.649 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 31' ' ' ILE . 14.7 pt -92.68 172.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.943 -1.098 . . . . 1.3400000000000001 110.426 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 34' ' ' ASP . 7.9 p -99.18 160.08 14.53 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.621 -0.881 . . . . 1.3500000000000001 108.621 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.3 -7.53 0.89 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.033 -1.042 . . . . 1.6100000000000001 109.373 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 32' ' ' SER . 3.9 m-20 -82.57 -10.03 59.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 2.4700000000000002 110.446 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -120.02 -17.0 8.52 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.158 -0.964 . . . . 2.0699999999999998 109.73 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.6 t -53.89 -36.35 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 1.3300000000000001 109.697 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -54.25 -40.46 67.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 1.46 110.152 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -69.93 -41.54 74.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.219 -0.926 . . . . 2.9399999999999999 110.575 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -59.73 -45.82 91.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.061 . . . . 1.3 109.864 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.1 t -59.27 -45.08 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 1.3300000000000001 109.3 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -60.66 -37.64 82.24 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.505 -0.924 . . . . 1.5 108.505 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -68.83 -31.57 70.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.531 -0.731 . . . . 3.1499999999999999 109.352 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -85.36 -51.26 6.68 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.28 -0.888 . . . . 0.92000000000000004 109.216 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.35 -59.74 4.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.886 . . . . 1.4099999999999999 109.085 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 t -62.78 -38.09 89.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 1.22 108.629 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -55.31 -54.1 36.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 107.325 -2.31 . . . . 0.58999999999999997 107.325 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -45.65 -32.25 2.3 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.341 -0.985 . . . . 3.3900000000000001 108.341 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.13 -34.93 74.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.34 -0.985 . . . . 1.26 108.34 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' GLY . 24.2 ttmt -85.12 -58.43 2.69 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.246 -0.65 . . . . 2.9900000000000002 109.246 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.07 -39.23 63.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.967 . . . . 1.1399999999999999 109.872 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -66.31 -40.01 89.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.102 -0.999 . . . . 1.8400000000000001 108.622 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.08 -35.32 64.21 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.867 -0.52 . . . . 1.22 109.83 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -65.22 -67.27 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 2.0 110.162 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -50.16 -33.96 20.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.865 -1.147 . . . . 1.99 108.899 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.48 -46.22 80.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.401 -0.812 . . . . 1.27 108.919 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -62.53 -37.39 85.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.293 -0.879 . . . . 1.24 109.785 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.42 -33.73 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.962 -1.086 . . . . 1.21 108.854 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -53.78 -44.66 70.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 1.53 109.836 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -71.22 -35.27 71.45 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.199 -0.938 . . . . 1.24 109.741 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.432 ' O ' ' OG1' ' A' ' 64' ' ' THR . 61.4 mttm -69.45 -26.18 64.47 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.563 -1.255 . . . . 2.3199999999999998 107.686 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.51 -33.76 67.13 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.354 -0.98 . . . . 1.1699999999999999 108.354 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -28.83 28.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.792 -1.323 . . . . 0.57999999999999996 109.792 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -86.2 -11.65 51.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.1 -1.235 . . . . 1.3899999999999999 108.764 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 99.3 m -99.16 -51.02 3.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.497 -0.752 . . . . 1.3600000000000001 110.353 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -106.25 -16.29 14.62 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.213 -0.93 . . . . 1.1399999999999999 110.711 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.53 143.79 6.9 Favored Glycine 0 N--CA 1.504 3.214 0 N-CA-C 110.274 -1.13 . . . . 0.59999999999999998 110.274 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -48.77 -9.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.365 -1.079 . . . . 2.5899999999999999 110.166 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 66' ' ' GLY . 35.4 mt-10 -63.72 -31.56 72.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.953 . . . . 2.2000000000000002 110.466 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -88.86 -6.32 57.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.943 -1.098 . . . . 2.3599999999999999 110.624 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.81 -31.33 72.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.642 -1.287 . . . . 1.54 109.983 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.86 -29.57 70.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 1.24 109.586 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.0 mt -73.36 -45.09 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 1.24 109.557 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -76.96 -21.24 55.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.80000000000000004 109.433 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.19 -40.59 94.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.134 -0.979 . . . . 1.23 108.869 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.9 -31.45 64.58 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.699 -1.76 . . . . 0.56000000000000005 108.699 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -62.29 -23.2 66.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.556 -0.967 . . . . 2.0600000000000001 110.162 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.1 mt -84.9 -35.33 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.776 -1.203 . . . . 1.24 108.773 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.8 ttt -57.27 -39.74 76.29 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.353 -0.98 . . . . 2.4500000000000002 108.353 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.99 -39.07 90.01 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.574 -0.899 . . . . 1.21 108.574 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.31 -43.04 53.13 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.617 -0.833 . . . . 1.1200000000000001 109.179 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -85.49 2.89 42.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.2 -0.938 . . . . 1.24 110.419 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -45.34 114.4 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.07 -1.018 . . . . 1.3100000000000001 109.261 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -64.04 -23.51 67.36 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -0.854 . . . . 1.3500000000000001 109.169 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -75.88 -46.78 28.32 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.344 -0.848 . . . . 2.1600000000000001 109.194 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.08 -20.43 66.16 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.935 -1.103 . . . . 1.24 109.554 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.43 -53.47 9.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.361 -0.837 . . . . 1.28 110.736 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -61.88 -29.97 70.55 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.25 -0.906 . . . . 1.79 110.469 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.11 -41.63 61.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.98 -1.075 . . . . 1.29 109.077 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.0 mt -60.55 -57.72 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.868 -1.16 . . . . 1.1399999999999999 107.868 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.9 mt -49.42 -53.63 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.666 -0.646 . . . . 1.3200000000000001 110.05 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.85 -63.3 1.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 1.3700000000000001 110.125 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.1 mt -45.19 -48.48 12.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.541 -0.725 . . . . 1.3999999999999999 110.008 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.3 mt -55.21 -40.84 57.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.157 -0.965 . . . . 1.23 110.004 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -85.61 -39.5 17.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.027 -1.046 . . . . 2.5099999999999998 111.313 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.31 -36.8 26.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.827 -1.171 . . . . 1.5900000000000001 111.54 -176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.65 12.19 33.24 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.919 -1.113 . . . . 2.3799999999999999 109.164 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.3 m80 45.12 44.26 8.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.486 -0.759 . . . . 1.6200000000000001 109.295 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.0 mtp -93.43 154.0 18.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.398 -0.814 . . . . 1.8899999999999999 109.302 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.9 p -79.25 142.47 36.17 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.317 -0.864 . . . . 1.27 109.262 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.16 -26.46 1.91 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 1.1599999999999999 109.646 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -76.19 -42.63 45.67 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.276 -0.89 . . . . 2.0 108.916 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.49 -58.58 3.27 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.726 -0.609 . . . . 1.25 111.175 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.41 -48.68 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.956 -1.09 . . . . 1.1299999999999999 109.804 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.07 -33.8 65.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.199 -0.938 . . . . 1.0800000000000001 109.333 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.478 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 85.5 t60 -70.75 -35.32 72.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 2.02 109.598 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.25 -64.25 0.92 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.363 -0.836 . . . . 1.26 110.47 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -48.54 -47.17 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.985 -1.072 . . . . 1.1799999999999999 109.55 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.58 -21.22 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.482 -0.761 . . . . 1.1899999999999999 109.734 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.478 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 11.9 tp10 -72.95 -38.88 66.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.166 -0.959 . . . . 2.2000000000000002 111.247 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.15 -21.12 55.99 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 118.828 -1.653 . . . . 0.85999999999999999 112.102 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -69.83 -59.41 2.95 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.606 -1.526 . . . . 2.0 108.171 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.71 -49.83 73.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.717 -0.614 . . . . 1.3200000000000001 109.533 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 109' ' ' GLU . 23.8 m -58.93 -35.81 73.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.263 -0.898 . . . . 2.1400000000000001 109.586 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.27 97.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.071 -1.018 . . . . 1.3799999999999999 110.116 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.8 mt -66.64 -27.77 67.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.879 -1.138 . . . . 1.3500000000000001 109.288 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -67.32 -18.29 65.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.113 -0.992 . . . . 1.95 110.011 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.38 -9.85 59.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.063 -1.023 . . . . 1.71 109.282 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mt -89.1 152.23 21.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.627 -0.879 . . . . 1.71 108.627 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -100.8 59.64 0.94 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -0.846 . . . . 2.8300000000000001 108.814 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -143.91 119.1 10.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.284 -0.885 . . . . 1.5800000000000001 109.375 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.481 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.4 pm0 -63.42 -9.28 11.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 2.7999999999999998 109.237 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -76.42 -62.61 1.56 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.35 -0.843 . . . . 1.27 109.938 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.57 -17.12 62.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.738 -1.226 . . . . 1.5800000000000001 109.36 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -69.37 -55.6 9.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.137 -0.977 . . . . 2.9199999999999999 108.778 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -60.48 -21.45 62.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.257 -0.902 . . . . 2.2000000000000002 108.938 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -71.75 -27.24 62.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.631 -1.618 . . . . 2.5299999999999998 106.631 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.27 92.95 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.226 -1.027 . . . . 1.45 108.226 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.09 79.87 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.527 -0.916 . . . . 1.5 108.527 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -32.54 71.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 1.3500000000000001 108.834 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.2 t -80.37 -47.02 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.436 -0.79 . . . . 1.23 108.891 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -64.42 -35.64 81.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.154 -0.966 . . . . 3.73 108.721 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.503 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 13.5 t0 -58.52 -43.52 89.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 1.3200000000000001 109.298 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 133' ' ' ILE . 90.0 mt -67.47 -25.57 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 1.2 108.402 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.08 -52.24 4.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.446 -1.461 . . . . 0.48999999999999999 109.446 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -52.82 -37.32 59.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -1.158 . . . . 3.1099999999999999 109.329 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.503 ' NH2' ' OD1' ' A' ' 132' ' ' ASP . 6.7 mtt-85 -63.46 -42.52 98.63 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.15 -1.055 . . . . 2.9500000000000002 108.15 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.6 tp -59.21 -48.92 79.83 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.57 -0.706 . . . . 1.73 109.291 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.2 mt -52.21 -53.16 46.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 1.22 109.787 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -54.39 -22.96 13.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.097 -1.002 . . . . 2.7799999999999998 110.0 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.415 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 2.6 m120 -83.96 -31.41 25.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 2.0299999999999998 109.047 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.0 mt -66.26 -43.78 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 1.2 108.842 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.6 mt -90.43 -7.14 53.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.211 -0.931 . . . . 1.28 109.397 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 68.73 27.55 73.77 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.578 -1.809 . . . . 0.68999999999999995 108.578 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tp -51.28 166.2 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.529 -0.983 . . . . 1.3100000000000001 109.609 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -67.06 141.25 57.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 2.8799999999999999 109.867 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -109.21 138.78 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.447 -0.783 . . . . 1.3600000000000001 109.135 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.5 mp -78.71 128.68 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.025 -1.047 . . . . 1.9299999999999999 110.03 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -98.13 86.32 3.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.494 -0.754 . . . . 1.54 109.246 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.5 mt -82.41 -33.84 28.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.235 -0.916 . . . . 1.3400000000000001 109.953 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.5 m -82.06 28.49 0.43 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.115 -0.991 . . . . 1.98 109.977 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.18 28.52 2.28 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.073 -1.017 . . . . 1.3799999999999999 109.671 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.9 152.96 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 1.3999999999999999 109.483 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -129.44 -16.02 3.97 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.353 -0.842 . . . . 2.7400000000000002 109.238 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -114.95 126.96 55.38 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.892 -0.781 . . . . 1.4099999999999999 108.892 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.16 124.97 23.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.046 -1.033 . . . . 1.3 109.288 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.3 m -149.33 175.9 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 1.28 108.94 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.2 mt -88.39 156.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.268 -1.012 . . . . 1.1499999999999999 108.268 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tp -107.55 124.92 50.63 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.103 -0.702 . . . . 1.2 109.103 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -124.71 129.27 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.062 -0.718 . . . . 1.1599999999999999 109.062 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.29 146.3 13.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 1.2 109.765 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.52 -34.84 67.41 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.746 -1.221 . . . . 1.3200000000000001 107.847 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -173.49 151.95 2.05 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.164 -0.68 . . . . 2.3399999999999999 109.164 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.2 mt -119.89 130.67 54.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.682 -0.859 . . . . 1.26 108.682 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.2 p -91.12 150.97 42.6 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.133 -0.98 . . . . 1.3600000000000001 109.076 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 169' ' ' ALA . 68.6 Cg_exo -35.41 -51.73 0.86 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 122.527 2.151 . . . . 0.63 112.379 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.8 m -48.0 -54.28 13.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.319 -0.863 . . . . 1.0700000000000001 109.28 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.75 -45.8 88.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.4 -0.813 . . . . 1.25 109.654 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 24.1 p -68.12 -26.06 65.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 1.1799999999999999 109.714 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -74.06 -30.77 62.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.114 -0.991 . . . . 1.1399999999999999 110.148 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -101.41 -14.21 17.66 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.188 -0.945 . . . . 1.71 109.818 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.0 tp -60.51 145.28 49.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.799 -1.188 . . . . 1.22 108.296 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 174' ' ' LYS . 11.7 t-20 -96.51 142.06 29.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.11 -0.994 . . . . 2.5499999999999998 108.497 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.413 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 37.0 mt -90.15 -39.97 12.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 1.96 111.04 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 35.1 mttm -79.94 -11.06 59.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.83 -1.168 . . . . 2.46 111.628 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -101.83 -13.22 17.77 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.857 -1.152 . . . . 2.4199999999999999 109.074 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.5 t -95.88 161.37 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.229 -0.919 . . . . 1.1599999999999999 108.646 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 53.8 tp -111.52 -28.54 8.12 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.25 -0.907 . . . . 1.95 110.119 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -174.32 177.53 46.47 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.714 -1.355 . . . . 0.41999999999999998 109.714 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.53 127.43 33.17 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.405 -1.056 . . . . 0.52000000000000002 109.853 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.6 mt -127.91 122.91 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.762 -1.57 . . . . 1.1599999999999999 106.762 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 38.0 p -140.77 156.23 46.22 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.331 1.063 . . . . 1.22 112.461 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 1.5 m-20 -87.07 37.55 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.692 -0.685 . . . . 2.2400000000000002 109.56 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.081 -1.012 . . . . 1.6499999999999999 110.416 -177.851 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 53.7 t60 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.45 0.643 . . . . 1.0600000000000001 109.89 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 39.0 p -54.08 -45.97 71.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 2.0899999999999999 110.232 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 98.9 p -63.67 -46.4 85.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 1.8799999999999999 110.762 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -50.91 -28.68 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.903 -1.123 . . . . 2.0099999999999998 109.721 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.5 mtp -71.37 -57.0 4.87 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.789 -1.189 . . . . 1.27 107.789 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.83 -43.11 65.75 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.78 -0.645 . . . . 1.1799999999999999 110.076 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -68.1 -46.3 71.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 3.5800000000000001 109.779 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.3 m -70.24 -35.82 74.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 1.1399999999999999 109.727 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 199' ' ' LEU . 28.8 mt -89.76 -1.95 58.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.152 -0.967 . . . . 1.28 109.403 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 56.26 2.23 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 1.49 111.681 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 197' ' ' LEU . 18.2 mt -67.1 169.51 8.23 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.45 -1.406 . . . . 1.28 108.631 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.28 141.84 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.694 2.263 . . . . 0.69999999999999996 111.312 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.26 -178.63 5.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.448 -1.408 . . . . 1.1899999999999999 111.341 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 28.5 mt -148.76 157.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.452 -1.314 . . . . 1.25 107.452 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.0 m -138.35 -39.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.968 -1.083 . . . . 1.29 110.713 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -75.97 41.2 1.48 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.679 -1.368 . . . . 0.92000000000000004 109.679 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 203' ' ' VAL . 20.2 p -68.21 3.57 1.61 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.058 -1.26 . . . . 1.3100000000000001 109.042 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 55.83 -102.22 0.16 Allowed Glycine 0 N--CA 1.483 1.833 0 N-CA-C 109.83 -1.308 . . . . 1.0 109.83 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.5 p -125.49 43.38 3.07 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.403 -1.057 . . . . 1.9199999999999999 111.323 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 26.2 t -62.96 -32.06 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.521 -1.362 . . . . 1.27 107.825 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 p -60.25 -16.28 32.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 1.3400000000000001 109.094 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.7 m -105.67 15.36 27.0 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.876 -0.787 . . . . 2.0699999999999998 108.876 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -133.68 -15.28 2.41 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.554 -0.716 . . . . 2.8599999999999999 109.934 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 51.3 t -123.34 150.57 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.331 -0.856 . . . . 1.3 109.308 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -113.8 -174.74 2.53 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.593 -1.262 . . . . 2.48 107.593 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.46 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 9.6 t30 -80.26 145.41 32.2 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.14 -0.975 . . . . 2.6200000000000001 110.057 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 82.29 -11.77 0.98 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.036 -0.415 . . . . 2.3999999999999999 111.229 178.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -55.46 143.32 29.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.636 -1.29 . . . . 1.99 108.446 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -87.78 125.58 34.52 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.956 -1.09 . . . . 1.54 108.813 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.4 mt -123.7 162.98 22.01 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.841 0.829 . . . . 1.25 110.585 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.7 mt -136.69 107.87 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.775 -1.194 . . . . 1.26 107.775 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.5 tp -87.51 122.04 30.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -0.905 . . . . 1.1799999999999999 109.234 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.8 OUTLIER -101.05 -28.41 12.73 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.33 -0.856 . . . . 2.2200000000000002 109.014 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 37.57 27.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.891 -0.505 . . . . 1.2 111.246 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.2 t -118.25 -58.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 106.602 -1.629 . . . . 1.48 106.602 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -92.02 9.1 34.68 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.643 -1.614 . . . . 2.8199999999999998 106.643 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 60.13 64.63 1.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.211 -0.663 . . . . 2.1099999999999999 109.211 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -153.01 136.1 15.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 2.6499999999999999 110.698 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.3 t -115.18 126.6 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.887 -1.153 . . . . 1.29 107.887 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -96.4 130.71 43.47 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 1.4199999999999999 109.748 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.46 130.54 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.415 -0.587 . . . . 1.26 109.415 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 20.0 t30 55.24 71.62 1.24 Allowed Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.376 -0.828 . . . . 2.1499999999999999 110.229 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.36 146.08 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 123.321 2.681 . . . . 0.81999999999999995 112.06 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.5 p -72.21 177.89 4.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.804 . . . . 2.1099999999999999 109.776 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -76.86 -39.55 50.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 3.1699999999999999 109.553 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.514 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 13.3 mp0 -53.76 -39.12 65.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 3.0600000000000001 109.403 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.46 -39.41 54.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.089 -1.007 . . . . 1.6499999999999999 108.833 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.0 mt -65.94 -64.25 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 1.47 109.305 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -53.77 -44.09 69.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 2.54 110.606 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -65.73 -33.04 74.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.06 -1.025 . . . . 3.0 109.813 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' MET . . . . . 0.456 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 50.8 mtp -80.83 -38.73 27.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.981 -1.075 . . . . 1.6299999999999999 109.467 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -49.07 -50.17 37.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.046 -1.034 . . . . 3.1600000000000001 110.166 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.91 -61.8 1.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.06 -1.025 . . . . 2.0899999999999999 110.96 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.9 t -62.83 -52.44 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.951 -1.093 . . . . 2.5699999999999998 111.167 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 239' ' ' MET . 2.2 tp-100 -54.39 -41.28 69.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.712 -1.242 . . . . 3.5899999999999999 109.72 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 . . . . . 0 C--N 1.301 -1.52 0 O-C-N 120.567 -1.333 . . . . 1.76 108.659 179.833 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.936 -0.764 . . . . 4.0700000000000003 108.936 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.01 97.24 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 1.5 110.007 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.4 m -99.75 110.81 23.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.461 -0.774 . . . . 1.8 109.959 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.564 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -109.45 -162.45 19.62 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.755 -1.738 . . . . 0.92000000000000004 108.755 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' ' 6' ' ' LEU . 89.3 mt -94.82 -6.98 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.052 -1.264 . . . . 1.5 109.096 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' ILE . 5.4 tp 55.39 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.374 -0.829 . . . . 1.3999999999999999 108.878 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.45 -55.1 4.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.097 -1.002 . . . . 1.26 108.606 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.57 144.23 32.63 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.695 -0.854 . . . . 1.95 108.695 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.42 156.05 28.66 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.918 1.745 . . . . 0.93999999999999995 112.634 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.4 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 153.82 129.61 1.36 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.057 -1.217 . . . . 0.78000000000000003 110.057 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 11' ' ' ILE . 56.9 mt -99.6 131.48 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.202 -1.175 . . . . 1.29 110.724 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.26 143.65 29.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 1.1499999999999999 109.16 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.546 ' CZ ' ' OE1' ' A' ' 243' ' ' GLN . 4.2 m-85 -100.69 140.74 34.54 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.493 -1.299 . . . . 0.71999999999999997 107.493 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.56 156.25 19.49 Favored Glycine 0 N--CA 1.5 2.902 0 C-N-CA 118.49 -1.814 . . . . 0.5 111.881 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -78.75 152.09 31.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.846 -0.797 . . . . 2.3599999999999999 110.464 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.18 126.36 30.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.541 -0.724 . . . . 1.1599999999999999 111.119 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 tp -111.15 93.29 4.4 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.86 -1.533 . . . . 1.24 106.86 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.8 tp -80.6 127.51 32.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.782 -1.198 . . . . 1.3100000000000001 111.293 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.7 mt -97.16 94.61 7.23 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.438 0.637 . . . . 1.3100000000000001 109.957 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -92.68 156.89 16.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.412 -0.805 . . . . 2.3500000000000001 109.164 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.84 130.41 53.93 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.646 -0.872 . . . . 2.5800000000000001 108.646 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -76.77 132.77 39.43 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.185 -0.947 . . . . 2.1400000000000001 108.978 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.99 137.88 56.83 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.533 -0.729 . . . . 1.9299999999999999 109.442 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.34 136.08 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.23 -0.919 . . . . 1.28 110.159 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.2 t -102.66 117.53 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 1.3700000000000001 108.93 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.6 mt -90.96 129.73 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.248 -0.907 . . . . 1.3300000000000001 109.119 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -90.68 120.27 31.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 1.3700000000000001 109.922 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -96.11 29.64 2.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.384 -0.822 . . . . 3.1899999999999999 109.444 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -86.56 144.94 26.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.121 -0.987 . . . . 2.8100000000000001 109.442 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -85.84 125.97 33.69 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.984 -1.073 . . . . 2.8300000000000001 109.018 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -82.76 179.15 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.285 -0.884 . . . . 1.3400000000000001 109.535 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.439 ' H ' HE21 ' A' ' 35' ' ' GLN . 60.7 p -98.82 160.62 14.14 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.396 -0.815 . . . . 1.3500000000000001 109.332 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.1 -20.22 51.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 1.6100000000000001 109.307 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -82.53 -12.06 58.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.853 . . . . 2.4700000000000002 109.43 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.439 HE21 ' H ' ' A' ' 32' ' ' SER . 3.2 mt-30 -105.35 -10.13 17.17 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.941 -1.133 . . . . 2.0699999999999998 107.941 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.97 -48.36 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.682 -0.636 . . . . 1.3300000000000001 109.523 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -56.6 -30.04 62.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.085 -1.01 . . . . 1.46 108.942 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -70.37 -35.03 73.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.453 -0.779 . . . . 2.9399999999999999 110.16 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -64.43 -44.31 91.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.105 -0.997 . . . . 1.3 109.589 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 44' ' ' LEU . 83.6 t -58.15 -46.58 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.169 -0.957 . . . . 1.3300000000000001 109.328 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.85 -43.6 87.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.139 -0.976 . . . . 1.5 108.905 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -66.04 -32.09 73.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.568 -0.708 . . . . 3.1499999999999999 109.186 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -86.45 -57.66 2.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.133 -0.98 . . . . 0.92000000000000004 108.739 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 40' ' ' VAL . 34.0 tp -51.92 -60.69 2.89 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.425 -0.797 . . . . 1.4099999999999999 109.235 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 t -66.4 -31.34 72.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -0.891 . . . . 1.22 108.801 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.38 53.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.298 -1.921 . . . . 0.58999999999999997 108.298 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.53 HH22 ' CD ' ' A' ' 86' ' ' GLU . 27.6 ttp180 -60.44 -21.39 62.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -1.116 . . . . 3.3900000000000001 109.505 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.69 -45.59 78.33 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.345 -0.983 . . . . 1.26 108.345 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 52' ' ' ALA . 12.6 ptmt -78.4 -52.93 7.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.483 -0.932 . . . . 2.9900000000000002 108.483 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.74 -33.36 15.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.353 -1.467 . . . . 1.1399999999999999 108.789 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 m -66.54 -36.77 83.49 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.034 -1.098 . . . . 1.8400000000000001 108.034 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -70.46 -19.76 62.93 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.697 -0.853 . . . . 1.22 108.697 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -76.17 -66.06 0.84 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.4 -0.812 . . . . 2.0 109.645 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.9 mt -51.18 -35.6 36.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 1.99 108.867 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -60.74 -51.11 70.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.517 -0.739 . . . . 1.27 109.268 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 m -63.46 -38.25 90.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.157 -0.965 . . . . 1.24 109.088 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.5 mt -69.62 -27.75 34.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.295 -0.878 . . . . 1.21 108.984 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -63.3 -41.57 98.97 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.306 -0.871 . . . . 1.53 109.526 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -71.66 -24.78 61.9 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.51 -0.744 . . . . 1.24 109.264 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.427 ' O ' ' OG1' ' A' ' 64' ' ' THR . 97.0 mttt -72.59 -25.58 61.39 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.738 -1.208 . . . . 2.3199999999999998 107.738 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.98 -32.12 61.6 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.932 -1.136 . . . . 1.1699999999999999 107.932 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.96 -29.12 29.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.915 -1.674 . . . . 0.57999999999999996 108.915 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -86.64 -22.37 26.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.095 -1.238 . . . . 1.3899999999999999 108.638 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 56.5 m -94.67 -45.09 7.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.254 -0.904 . . . . 1.3600000000000001 110.56 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.573 ' C ' ' H ' ' A' ' 67' ' ' GLU . 52.4 m-85 -107.78 -34.17 7.04 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.191 -0.943 . . . . 1.1399999999999999 109.965 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 67.37 -30.21 0.21 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.366 -1.094 . . . . 0.59999999999999998 110.366 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.573 ' H ' ' C ' ' A' ' 65' ' ' PHE . 35.3 mt-10 -51.01 -179.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.03 -1.277 . . . . 2.5899999999999999 110.102 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.15 36.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.56 -0.712 . . . . 2.2000000000000002 109.821 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.556 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.8 mmtp -83.18 -10.48 58.6 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.406 -0.809 . . . . 2.3599999999999999 109.308 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -69.01 -35.96 77.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.246 -0.909 . . . . 1.54 110.292 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.41 68.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 1.24 110.398 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.499 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 11.2 mt -71.52 -46.19 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.079 -1.013 . . . . 1.24 109.821 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -76.19 -26.71 56.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.80000000000000004 109.571 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.84 -59.33 4.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.052 -1.03 . . . . 1.23 109.026 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.92 -33.73 64.22 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.76 -1.336 . . . . 0.56000000000000005 109.76 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.499 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 14.8 m170 -62.1 -22.2 65.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.019 -1.283 . . . . 2.0600000000000001 109.768 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.4 mt -84.81 -36.79 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.976 -1.077 . . . . 1.24 108.365 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.4 ttt -60.84 -44.51 96.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.172 -1.047 . . . . 2.4500000000000002 108.172 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.3 tp -57.59 -40.87 79.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.231 -1.026 . . . . 1.21 108.231 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.5 tp -69.62 -42.75 73.94 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.403 -0.81 . . . . 1.1200000000000001 109.519 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -84.9 9.57 14.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.306 -0.871 . . . . 1.24 110.262 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -49.43 121.78 5.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.015 -1.053 . . . . 1.3100000000000001 110.2 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -67.14 -24.62 65.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.242 -0.911 . . . . 1.3500000000000001 108.986 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -74.2 -49.93 21.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.328 -0.949 . . . . 2.1600000000000001 108.685 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.6 mt -64.17 -15.04 59.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.63 -1.228 . . . . 1.24 108.603 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.53 ' CD ' HH22 ' A' ' 47' ' ' ARG . 28.2 tt0 -77.29 -54.33 6.61 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.806 -1.184 . . . . 1.28 110.136 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.18 -30.79 69.58 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.674 -1.267 . . . . 1.79 110.003 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -71.88 -47.89 49.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.062 -1.024 . . . . 1.29 109.039 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.7 mt -59.5 -53.72 44.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.887 -0.783 . . . . 1.1399999999999999 108.887 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 91' ' ' ALA . 95.9 mt -51.25 -71.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.746 . . . . 1.3200000000000001 110.348 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -40.25 -48.31 2.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.383 -0.823 . . . . 1.3700000000000001 110.631 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.8 mt -55.36 -55.69 28.69 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.652 -0.87 . . . . 1.3999999999999999 108.652 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.1 mt -54.11 -41.89 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.829 . . . . 1.23 110.831 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -85.84 -35.11 20.84 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.03 -1.044 . . . . 2.5099999999999998 111.7 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 91' ' ' ALA . 37.8 t70 -81.94 -38.63 24.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.756 -1.215 . . . . 1.5900000000000001 111.48 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -105.97 12.6 30.35 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.899 -1.126 . . . . 2.3799999999999999 109.462 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.2 m170 46.05 46.35 12.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 1.6200000000000001 109.49 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.0 mtt -96.23 152.41 18.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.481 -0.762 . . . . 1.8899999999999999 109.207 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.8 p -78.53 142.93 37.01 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.61 -0.681 . . . . 1.27 110.183 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.87 -25.44 3.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.189 -0.944 . . . . 1.1599999999999999 108.736 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -75.21 -50.72 15.3 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.316 -0.994 . . . . 2.0 108.316 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.65 -50.1 33.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.64 -0.663 . . . . 1.25 109.813 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.73 -60.28 3.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 1.1299999999999999 109.657 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.5 -33.29 30.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 1.0800000000000001 109.8 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -68.16 -35.01 77.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.915 -1.116 . . . . 2.02 110.055 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.97 -45.05 91.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.121 -0.987 . . . . 1.26 110.814 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -66.72 -48.66 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.051 . . . . 1.1799999999999999 109.412 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -60.87 -23.77 30.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.737 -0.602 . . . . 1.1899999999999999 109.824 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -73.06 -37.39 66.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.104 -0.998 . . . . 2.2000000000000002 110.098 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.68 -22.1 48.06 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.372 -1.395 . . . . 0.85999999999999999 112.406 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.68 -53.37 15.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.711 -1.464 . . . . 2.0 108.79 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.15 71.78 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.652 -0.655 . . . . 1.3200000000000001 109.627 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 m -60.82 -37.43 81.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.444 -0.785 . . . . 2.1400000000000001 110.076 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.39 96.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.299 -0.876 . . . . 1.3799999999999999 111.15 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.8 mt -70.84 -26.58 63.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.451 -1.3 . . . . 1.3500000000000001 108.539 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -67.71 -19.5 65.16 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.606 -0.684 . . . . 1.95 110.41 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -82.5 -6.03 59.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.922 -1.111 . . . . 1.71 109.749 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 31.8 mt -84.32 166.99 16.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.057 -1.027 . . . . 1.71 109.528 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -107.84 47.71 0.88 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.736 -0.603 . . . . 2.8300000000000001 109.906 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -142.82 120.61 11.92 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.017 -1.052 . . . . 1.5800000000000001 109.531 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.69 -8.64 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.601 0.715 . . . . 2.7999999999999998 109.72 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -76.67 -62.03 1.77 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.4 -0.812 . . . . 1.27 109.989 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.5 mt -68.83 -24.7 64.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.024 -1.048 . . . . 1.5800000000000001 109.239 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -66.88 -50.87 61.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -0.879 . . . . 2.9199999999999999 109.083 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.19 -20.95 63.35 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.306 -0.998 . . . . 2.2000000000000002 108.306 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -72.88 -27.77 62.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.745 -1.576 . . . . 2.5299999999999998 106.745 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.09 -42.64 90.93 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.107 -1.071 . . . . 1.45 108.107 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.92 -39.04 79.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.413 -0.804 . . . . 1.5 109.784 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -70.67 -25.96 63.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 1.3500000000000001 109.616 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.62 -47.48 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 1.23 108.705 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -53.21 -39.02 63.39 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.062 -1.024 . . . . 3.73 108.405 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 22.1 t70 -59.4 -40.4 86.47 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -0.897 . . . . 1.3200000000000001 109.633 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.4 mt -66.05 -34.01 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.149 -0.969 . . . . 1.2 109.25 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.32 -44.88 16.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.515 -1.434 . . . . 0.48999999999999999 109.515 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -49.58 -45.9 48.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.411 -1.052 . . . . 3.1099999999999999 109.631 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HG2' HH11 ' A' ' 136' ' ' ARG . 11.0 mtt-85 -65.18 -42.92 93.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.08 . . . . 2.9500000000000002 108.491 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 tt -52.38 -35.88 52.51 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.082 -1.081 . . . . 1.73 108.082 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.64 -58.74 3.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.396 -0.815 . . . . 1.22 110.23 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -46.21 -20.13 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.146 -0.971 . . . . 2.7799999999999998 111.114 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -83.43 -49.73 9.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.88 -1.138 . . . . 2.0299999999999998 109.012 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.0 mt -57.56 -34.1 46.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.067 -1.021 . . . . 1.2 109.116 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 49.4 mt -87.22 0.08 55.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.062 -1.024 . . . . 1.28 108.536 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.23 25.86 12.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.449 -1.861 . . . . 0.68999999999999995 108.449 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.5 tp -57.57 153.5 12.96 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.779 -0.836 . . . . 1.3100000000000001 110.14 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -67.18 146.76 53.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.02 -1.05 . . . . 2.8799999999999999 109.747 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.85 140.13 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.449 -0.782 . . . . 1.3600000000000001 109.449 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.0 mp -78.03 120.15 28.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.225 -0.922 . . . . 1.9299999999999999 109.095 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -93.51 88.17 5.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 1.54 109.912 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 151' ' ' ALA . 27.9 mt -82.0 -24.05 35.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.877 . . . . 1.3400000000000001 108.798 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.0 t -80.44 26.14 0.39 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.457 -0.777 . . . . 1.98 108.945 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -138.5 28.38 2.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 1.3799999999999999 110.125 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 51.2 mt -74.59 152.35 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.869 . . . . 1.3999999999999999 109.127 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -131.76 -6.51 3.61 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.664 -0.865 . . . . 2.7400000000000002 108.664 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -121.82 136.06 54.92 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.954 -0.758 . . . . 1.4099999999999999 108.954 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.54 124.91 25.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 1.3 109.353 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.0 m -147.25 172.54 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.676 -0.861 . . . . 1.28 108.676 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.5 mt -90.19 157.96 2.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.828 -1.175 . . . . 1.1499999999999999 107.828 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.8 tp -108.98 121.36 44.96 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.675 0.75 . . . . 1.2 109.47 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.77 128.09 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.099 -0.704 . . . . 1.1599999999999999 109.099 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.84 151.47 14.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.442 -0.786 . . . . 1.2 109.918 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.35 -41.58 84.98 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.495 -1.378 . . . . 1.3200000000000001 107.895 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -172.94 152.8 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 2.3399999999999999 109.031 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.3 mt -116.06 141.22 48.42 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.365 -0.834 . . . . 1.26 109.867 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 26.2 p -94.97 151.1 38.66 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.315 -0.866 . . . . 1.3600000000000001 108.944 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.415 ' O ' ' OG1' ' A' ' 168' ' ' THR . 47.3 Cg_exo -35.78 -43.75 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.435 2.09 . . . . 0.63 112.243 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.3 m -53.9 -65.37 0.58 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.214 -0.929 . . . . 1.0700000000000001 109.258 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -47.67 -36.78 11.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.3 -0.875 . . . . 1.25 109.773 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 21.3 p -74.14 -20.11 60.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 1.1799999999999999 110.029 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.17 -19.8 27.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.093 -1.004 . . . . 1.1399999999999999 110.102 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -109.81 -16.57 13.86 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.443 -0.786 . . . . 1.71 110.109 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.06 147.86 45.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.908 -1.12 . . . . 1.22 108.556 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 174' ' ' LYS . 12.2 t-20 -96.02 155.35 16.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.973 -1.079 . . . . 2.5499999999999998 108.804 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 9.3 mp -94.53 -42.75 8.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.244 -0.91 . . . . 1.96 110.644 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 53.1 mtpt -79.67 -12.46 59.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.018 -1.051 . . . . 2.46 111.502 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -96.59 -6.16 37.45 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.675 -1.265 . . . . 2.4199999999999999 108.762 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 40.4 t -103.27 155.91 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.804 -0.813 . . . . 1.1599999999999999 108.804 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.5 tp -111.22 -18.09 13.04 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.928 -0.768 . . . . 1.95 108.928 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.46 177.14 42.47 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.073 -1.611 . . . . 0.41999999999999998 109.073 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -130.26 126.3 36.96 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.483 -1.01 . . . . 0.52000000000000002 108.852 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.4 mt -129.17 117.42 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.808 -1.182 . . . . 1.1599999999999999 107.808 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 203' ' ' VAL . 66.0 p -142.74 157.57 44.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.282 -0.886 . . . . 1.22 111.13 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 23.4 p30 -98.01 47.72 1.01 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.675 -0.81 . . . . 2.2400000000000002 110.179 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.973 0 O-C-N 120.869 -1.144 . . . . 1.6499999999999999 110.116 -179.002 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.8 t60 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.565 0.698 . . . . 1.0600000000000001 109.662 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.5 p -51.65 -38.69 55.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.523 -0.736 . . . . 2.0899999999999999 110.454 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 44.0 p -69.09 -42.83 75.64 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.745 -1.222 . . . . 1.8799999999999999 110.031 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 192' ' ' ILE . 96.7 mt -55.48 -29.82 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.052 -1.03 . . . . 2.0099999999999998 109.977 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.7 mtp -70.28 -56.22 7.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.322 -1.362 . . . . 1.27 107.322 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.99 83.77 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.477 -0.783 . . . . 1.1799999999999999 109.417 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -65.76 -47.71 74.3 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.259 -0.901 . . . . 3.5800000000000001 109.659 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.0 m -69.48 -38.06 77.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.923 -1.11 . . . . 1.1399999999999999 110.204 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 199' ' ' LEU . 14.4 mt -91.42 4.26 52.92 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.862 -1.149 . . . . 1.28 109.432 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 47.48 10.77 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 1.49 110.395 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 197' ' ' LEU . 27.3 mt -67.75 150.59 97.74 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.052 -1.03 . . . . 1.28 109.156 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.57 134.92 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.323 1.348 . . . . 0.69999999999999996 110.88 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.96 174.78 11.9 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.353 -1.339 . . . . 1.1899999999999999 111.037 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.3 mt -148.7 158.32 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 106.353 -1.721 . . . . 1.25 106.353 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.9 m -138.9 -32.67 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.01 -1.056 . . . . 1.29 110.776 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.79 40.01 2.97 Favored Glycine 0 N--CA 1.496 2.671 0 O-C-N 121.056 -1.028 . . . . 0.92000000000000004 110.99 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 29.9 p -69.23 -22.67 63.85 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.872 -1.37 . . . . 1.3100000000000001 108.924 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 73.34 -97.18 0.85 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.905 -1.141 . . . . 1.0 111.119 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 51.7 p -119.85 46.37 1.95 Allowed 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.979 -1.307 . . . . 1.9199999999999999 112.263 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 28.4 t -75.33 -28.9 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.639 -1.288 . . . . 1.27 107.879 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.8 p -67.75 -10.47 52.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.424 -0.798 . . . . 1.3400000000000001 109.032 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.9 p -106.76 14.54 26.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.101 -0.703 . . . . 2.0699999999999998 109.101 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -131.61 -25.1 2.16 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.427 -0.796 . . . . 2.8599999999999999 109.33 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.452 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 74.3 t -117.52 164.33 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.558 -0.714 . . . . 1.3 109.115 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.452 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 13.7 mmmt -127.17 -171.87 2.52 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.023 -1.473 . . . . 2.48 107.023 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.533 ' C ' HD21 ' A' ' 214' ' ' ASN . 0.4 OUTLIER -81.68 149.16 28.64 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.469 -1.394 . . . . 2.6200000000000001 110.107 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.2 t0 81.38 -11.61 1.07 Allowed 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.879 -0.513 . . . . 2.3999999999999999 111.495 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 0.8 OUTLIER -57.08 145.22 31.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.664 -1.272 . . . . 1.99 108.432 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -87.28 120.56 28.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.865 -1.147 . . . . 1.54 108.448 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 28.0 mt -123.65 170.19 10.71 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.253 1.025 . . . . 1.25 110.685 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.9 mt -144.74 106.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 106.423 -1.695 . . . . 1.26 106.423 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.4 tp -82.96 127.03 33.16 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.501 -0.926 . . . . 1.1799999999999999 108.501 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 223' ' ' VAL . 17.8 m-20 -97.15 -31.86 12.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.352 -0.843 . . . . 2.2200000000000002 109.453 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 39.62 25.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.428 0.632 . . . . 1.2 110.163 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.5 t -122.41 -51.88 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 106.486 -1.672 . . . . 1.48 106.486 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -97.58 16.04 21.58 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.257 -1.386 . . . . 2.8199999999999998 107.257 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.564 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 49.89 57.96 5.97 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.98 -0.748 . . . . 2.1099999999999999 108.98 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -154.67 143.76 21.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 2.6499999999999999 110.043 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.51 138.17 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.969 -0.752 . . . . 1.29 108.969 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -103.26 129.91 50.36 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.163 -0.961 . . . . 1.4199999999999999 109.511 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.9 t -108.91 122.88 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.775 -0.578 . . . . 1.26 110.198 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 50.31 58.25 17.3 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.903 . . . . 2.1499999999999999 109.607 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.47 159.51 50.17 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.7 2.267 . . . . 0.81999999999999995 112.431 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.8 m -76.28 157.72 32.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 2.1099999999999999 109.875 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -62.16 -25.54 67.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.069 -1.019 . . . . 3.1699999999999999 109.585 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -72.66 -35.73 67.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.305 -0.872 . . . . 3.0600000000000001 110.259 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.56 -45.88 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.892 . . . . 1.6499999999999999 109.808 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.8 mt -48.95 -60.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.218 -0.926 . . . . 1.47 109.005 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.63 -41.94 70.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.686 -0.633 . . . . 2.54 110.066 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -66.99 -35.1 79.19 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.993 -1.067 . . . . 3.0 109.953 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.4 mtp -80.97 -24.88 37.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.953 . . . . 1.6299999999999999 109.631 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -61.65 -45.65 93.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.104 -0.997 . . . . 3.1600000000000001 109.653 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 242' ' ' VAL . . . -74.9 -58.68 3.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.978 -1.076 . . . . 2.0899999999999999 109.011 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 241' ' ' ALA . 80.4 t -42.97 -59.12 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.471 -0.768 . . . . 2.5699999999999998 110.156 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 13' ' ' PHE . 24.8 tt0 -47.07 -62.62 1.33 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.013 -1.055 . . . . 3.5899999999999999 109.911 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 . . . . . 0 C--N 1.297 -1.691 0 O-C-N 121.124 -0.985 . . . . 1.76 110.875 -178.127 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.595 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.357 0.599 . . . . 4.0700000000000003 109.466 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -86.05 97.46 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.935 . . . . 1.5 109.476 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -94.65 108.66 20.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.244 -0.91 . . . . 1.8 109.138 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.17 -170.38 30.8 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.616 -1.394 . . . . 0.92000000000000004 109.616 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.5 mt -96.17 -10.04 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.396 -1.061 . . . . 1.5 109.037 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 tp 64.97 106.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.877 -0.786 . . . . 1.3999999999999999 108.877 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.57 -45.21 11.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.041 -1.096 . . . . 1.26 108.041 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -151.39 149.35 24.24 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.573 -0.899 . . . . 1.95 108.573 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.47 147.89 20.37 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.495 2.13 . . . . 0.93999999999999995 113.454 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.401 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 154.3 -177.78 31.5 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.691 -1.363 . . . . 0.78000000000000003 109.691 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.6 mt -141.45 133.38 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.09 -1.241 . . . . 1.29 109.35 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.72 158.04 44.05 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.338 -0.851 . . . . 1.1499999999999999 110.223 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.1 m-85 -128.64 136.17 50.3 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 107.98 -1.119 . . . . 0.71999999999999997 107.98 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.98 163.11 31.74 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 118.784 -1.675 . . . . 0.5 111.003 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -79.88 148.28 31.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.634 -0.921 . . . . 2.3599999999999999 110.29 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.69 123.64 25.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.558 -0.714 . . . . 1.1599999999999999 111.278 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.0 tp -105.16 91.25 3.71 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.38 -1.341 . . . . 1.24 107.38 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 tp -82.78 136.43 34.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 1.3100000000000001 110.034 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.26 94.4 7.08 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.46 0.647 . . . . 1.3100000000000001 110.444 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -98.94 149.98 22.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.438 -0.789 . . . . 2.3500000000000001 109.184 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -130.42 141.42 50.54 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.259 -0.901 . . . . 2.5800000000000001 109.088 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.83 136.75 36.15 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.108 -0.995 . . . . 2.1400000000000001 109.377 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -67.13 130.84 44.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.462 -0.774 . . . . 1.9299999999999999 109.08 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.2 mt -91.88 137.73 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.238 -0.914 . . . . 1.28 109.544 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.9 t -105.06 117.73 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.515 -0.74 . . . . 1.3700000000000001 109.368 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 26' ' ' ILE . 80.5 mt -88.86 142.57 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.199 -0.938 . . . . 1.3300000000000001 109.266 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -91.06 124.02 34.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.159 -0.963 . . . . 1.3700000000000001 109.935 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -100.48 28.89 4.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.39 -0.819 . . . . 3.1899999999999999 109.206 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.63 144.6 29.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 2.8100000000000001 109.882 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -85.13 124.0 31.29 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.342 -0.984 . . . . 2.8300000000000001 108.342 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.9 pt -88.39 171.2 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.996 . . . . 1.3400000000000001 110.518 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 34' ' ' ASP . 21.3 p -101.35 155.0 18.31 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.94 -0.763 . . . . 1.3500000000000001 108.94 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.96 -5.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 1.6100000000000001 110.167 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 32' ' ' SER . 31.8 t0 -83.94 -28.39 27.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.02 -1.05 . . . . 2.4700000000000002 110.325 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -102.1 -2.98 28.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.144 -0.972 . . . . 2.0699999999999998 109.783 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.49 -44.02 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.087 -1.008 . . . . 1.3300000000000001 108.908 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -51.42 -37.11 46.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.892 . . . . 1.46 109.194 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -69.22 -34.3 74.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 2.9399999999999999 109.892 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -61.42 -46.63 89.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.09 -1.006 . . . . 1.3 109.442 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 44' ' ' LEU . 87.0 t -60.97 -48.4 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 1.3300000000000001 109.534 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -64.06 -39.67 94.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 1.5 108.543 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -64.75 -33.66 76.5 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.621 -0.881 . . . . 3.1499999999999999 108.621 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -86.81 -57.32 3.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.92000000000000004 108.969 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 40' ' ' VAL . 14.9 tp -49.16 -65.21 0.61 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.407 -0.808 . . . . 1.4099999999999999 109.378 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.0 t -64.24 -32.27 73.79 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.788 -0.819 . . . . 1.22 108.788 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -59.1 -54.21 39.91 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 107.612 -2.195 . . . . 0.58999999999999997 107.612 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -50.31 -27.83 6.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.597 -0.943 . . . . 3.3900000000000001 108.904 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.84 76.54 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.021 -1.103 . . . . 1.26 108.021 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 46' ' ' GLY . 24.6 mtpp -80.5 -58.04 3.3 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.843 -0.799 . . . . 2.9900000000000002 108.843 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.94 -36.16 62.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.091 -1.006 . . . . 1.1399999999999999 109.322 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.6 t -63.54 -37.11 86.04 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.35 -0.981 . . . . 1.8400000000000001 108.35 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.15 -32.65 63.23 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.296 -0.631 . . . . 1.22 109.296 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.453 HE22 ' ND2' ' A' ' 140' ' ' ASN . 55.8 mt-30 -68.96 -65.14 0.74 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.57 -0.706 . . . . 2.0 109.541 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 54' ' ' LEU . 9.3 mp -51.9 -27.94 14.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 1.99 109.078 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -73.09 -49.46 28.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 1.27 109.104 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.2 m -58.32 -31.77 67.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.115 -0.991 . . . . 1.24 109.198 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -73.28 -31.19 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.075 -1.016 . . . . 1.21 108.556 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -56.51 -45.4 81.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.504 -0.747 . . . . 1.53 109.319 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -70.71 -27.04 63.69 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.203 -0.935 . . . . 1.24 109.672 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.419 ' O ' ' OG1' ' A' ' 64' ' ' THR . 64.2 mttm -71.23 -34.66 71.0 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.872 -1.143 . . . . 2.3199999999999998 107.95 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.29 -29.05 63.5 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.033 -0.728 . . . . 1.1699999999999999 109.033 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.33 -34.3 12.52 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.917 -1.135 . . . . 0.57999999999999996 110.995 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -85.73 -12.2 51.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.586 -1.538 . . . . 1.3899999999999999 108.849 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 93.1 m -94.22 -52.92 4.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 1.3600000000000001 109.66 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.543 ' C ' ' H ' ' A' ' 67' ' ' GLU . 70.8 m-85 -107.91 -35.91 6.51 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.293 -0.88 . . . . 1.1399999999999999 109.778 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.77 -24.9 0.64 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.896 -1.282 . . . . 0.59999999999999998 109.896 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 69' ' ' LYS . 80.6 mt-10 -53.02 -172.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.252 . . . . 2.5899999999999999 110.323 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.56 34.61 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.468 -0.77 . . . . 2.2000000000000002 109.991 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' A' ' 67' ' ' GLU . 4.4 mmmm -85.12 -17.18 38.08 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.251 -0.906 . . . . 2.3599999999999999 109.305 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.16 -32.11 72.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 1.54 110.285 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.2 -21.38 65.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.197 -0.939 . . . . 1.24 110.597 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.1 mt -69.47 -46.39 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.984 -1.073 . . . . 1.24 109.539 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -76.82 -20.12 56.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.80000000000000004 109.801 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.88 -35.9 82.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 1.23 108.618 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.75 -34.64 24.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.631 -1.387 . . . . 0.56000000000000005 109.631 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -59.78 -20.96 59.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.08 -1.247 . . . . 2.0600000000000001 109.413 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.3 mt -86.44 -42.57 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.124 -1.065 . . . . 1.24 108.124 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.3 ttt -59.41 -43.01 93.09 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.769 -0.826 . . . . 2.4500000000000002 108.769 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -64.57 -45.22 87.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.734 -0.839 . . . . 1.21 108.734 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.1 tp -66.78 -46.91 73.81 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.536 -0.728 . . . . 1.1200000000000001 109.566 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -85.78 9.83 15.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.298 -0.876 . . . . 1.24 110.082 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -47.91 127.36 11.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.959 -1.088 . . . . 1.3100000000000001 109.274 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -65.73 -25.37 67.26 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.732 -0.84 . . . . 1.3500000000000001 108.732 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -77.91 -52.44 8.84 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.333 -0.854 . . . . 2.1600000000000001 109.724 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.74 -18.67 64.28 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.002 -1.061 . . . . 1.24 109.269 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.76 -54.68 6.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 1.28 109.478 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -64.26 -29.63 70.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 1.79 110.022 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.61 -47.58 46.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.094 -1.004 . . . . 1.29 109.005 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.2 mt -58.84 -59.92 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.328 -0.99 . . . . 1.1399999999999999 108.328 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.5 mt -45.29 -39.63 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.574 -0.704 . . . . 1.3200000000000001 109.855 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.35 -60.99 2.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 1.3700000000000001 109.759 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.9 mt -47.83 -50.77 25.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 1.3999999999999999 109.38 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.0 mt -54.45 -49.91 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.905 . . . . 1.23 110.679 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -85.24 -36.78 20.71 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.832 -1.168 . . . . 2.5099999999999998 111.754 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -84.44 -37.51 21.33 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.735 -1.228 . . . . 1.5900000000000001 111.693 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -103.69 14.88 30.13 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.777 -1.202 . . . . 2.3799999999999999 109.432 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.4 m170 44.3 49.17 7.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.412 -0.805 . . . . 1.6200000000000001 110.359 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 31.8 mtt -103.78 150.46 24.07 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.734 -0.839 . . . . 1.8899999999999999 108.734 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.8 p -76.89 148.91 36.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 1.27 109.811 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.25 -31.33 42.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.219 -0.926 . . . . 1.1599999999999999 109.202 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.25 -44.07 54.46 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.755 -0.832 . . . . 2.0 108.755 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.88 -54.2 12.34 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.736 -0.602 . . . . 1.25 110.422 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.7 -50.64 72.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 1.1299999999999999 109.48 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.91 -35.22 61.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.441 -0.787 . . . . 1.0800000000000001 109.73 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.25 -30.05 68.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.932 -1.105 . . . . 2.02 109.727 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 109' ' ' GLU . 79.0 tt0 -66.0 -62.67 1.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 1.26 110.274 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 t -49.95 -47.11 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.059 -1.026 . . . . 1.1799999999999999 109.546 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.32 -16.14 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.447 -0.945 . . . . 1.1899999999999999 108.447 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . 9.5 tp10 -73.46 -35.42 65.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 2.2000000000000002 109.159 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.65 -28.42 24.25 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.573 -1.299 . . . . 0.85999999999999999 112.194 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -65.03 -36.87 85.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.697 -1.472 . . . . 2.0 109.094 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.54 -54.37 5.96 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.975 -0.75 . . . . 1.3200000000000001 108.975 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.9 m -59.41 -37.53 78.25 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.427 -0.796 . . . . 2.1400000000000001 109.853 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -63.76 -41.46 97.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.343 -0.848 . . . . 1.3799999999999999 110.85 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.0 mt -67.02 -28.4 68.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.772 -1.205 . . . . 1.3500000000000001 109.208 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -67.34 -17.5 64.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.948 . . . . 1.95 109.97 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -82.76 -9.02 59.54 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.127 -0.983 . . . . 1.71 109.572 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mt -86.61 145.11 26.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.347 -0.846 . . . . 1.71 108.847 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.88 61.26 2.16 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.435 -0.95 . . . . 2.8300000000000001 108.435 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -149.38 120.46 7.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.783 . . . . 1.5800000000000001 109.763 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.46 -13.36 58.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 2.7999999999999998 109.196 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.61 -65.16 1.0 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.249 -0.907 . . . . 1.27 109.219 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.3 mt -64.04 -32.14 73.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 1.5800000000000001 109.324 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 127' ' ' ALA . 46.4 tttp -66.51 -53.27 36.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.041 . . . . 2.9199999999999999 109.117 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -56.1 -19.45 13.19 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.158 -1.053 . . . . 2.2000000000000002 108.158 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -73.76 -26.83 60.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.104 -1.813 . . . . 2.5299999999999998 106.104 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -57.29 -44.05 83.73 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.056 -1.09 . . . . 1.45 108.056 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.66 88.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.212 -1.033 . . . . 1.5 108.212 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -70.72 -27.59 64.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.479 -0.763 . . . . 1.3500000000000001 109.324 179.222 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.55 -44.41 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.13 -1.063 . . . . 1.23 108.13 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -52.72 -41.25 63.79 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.188 -1.042 . . . . 3.73 108.188 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -62.69 -33.81 75.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.575 -0.703 . . . . 1.3200000000000001 109.479 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.5 -36.01 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.918 -1.114 . . . . 1.2 108.966 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.51 -46.12 16.04 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.937 -1.665 . . . . 0.48999999999999999 108.937 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -55.3 -46.99 76.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.542 -0.975 . . . . 3.1099999999999999 109.538 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.476 ' HG2' HH11 ' A' ' 136' ' ' ARG . 14.4 mtt-85 -65.32 -43.99 89.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 2.9500000000000002 108.993 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.1 tp -54.36 -37.74 65.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 1.73 109.049 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.78 -58.3 7.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 1.22 109.626 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -50.56 -16.54 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.333 -0.854 . . . . 2.7799999999999998 110.195 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.453 ' ND2' HE22 ' A' ' 53' ' ' GLN . 3.0 m120 -84.65 -45.9 12.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.125 -0.984 . . . . 2.0299999999999998 109.425 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.31 -37.71 78.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.198 -0.939 . . . . 1.2 108.854 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 mt -90.67 -1.73 57.86 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 1.28 109.0 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 50.49 22.39 5.38 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.619 -1.793 . . . . 0.68999999999999995 108.619 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.56 166.04 0.34 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.665 -0.903 . . . . 1.3100000000000001 109.494 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -64.65 134.59 54.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.034 -1.041 . . . . 2.8799999999999999 108.647 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 mt -101.56 142.53 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.192 -0.942 . . . . 1.3600000000000001 108.872 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.4 mm -78.32 124.84 37.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.295 -0.878 . . . . 1.9299999999999999 110.05 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -99.18 85.9 3.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.357 -0.839 . . . . 1.54 109.368 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.0 mt -80.09 -7.77 59.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.341 -0.849 . . . . 1.3400000000000001 109.346 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.8 p -89.3 -11.45 43.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.226 -0.921 . . . . 1.98 109.927 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.71 44.56 1.01 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.168 -0.957 . . . . 1.3799999999999999 112.485 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 152' ' ' ILE . 1.5 mp -70.2 154.4 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.489 -1.382 . . . . 1.3999999999999999 107.558 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -130.74 -22.5 2.65 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.324 -0.86 . . . . 2.7400000000000002 109.714 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -122.38 137.48 54.85 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.485 -0.759 . . . . 1.4099999999999999 109.234 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -62.41 129.81 42.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 1.3 109.912 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.7 m -151.05 175.5 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.745 . . . . 1.28 109.251 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 22.9 mt -89.88 158.17 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 107.811 -1.181 . . . . 1.1499999999999999 107.811 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.1 tp -106.87 118.86 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.916 -0.772 . . . . 1.2 108.916 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.2 t -123.55 129.95 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 121.37 0.605 . . . . 1.1599999999999999 109.713 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.82 147.49 10.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 1.2 109.265 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.79 73.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.686 -1.259 . . . . 1.3200000000000001 107.983 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 66.1 t0 -173.63 145.74 1.23 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.482 -0.933 . . . . 2.3399999999999999 108.482 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.506 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.7 mt -117.74 137.47 52.68 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.155 -0.683 . . . . 1.26 109.155 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.6 p -89.36 150.04 43.9 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.353 -0.842 . . . . 1.3600000000000001 108.889 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 169' ' ' ALA . 76.6 Cg_exo -35.51 -46.54 0.82 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.393 2.062 . . . . 0.63 111.898 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 169' ' ' ALA . 38.2 m -52.86 -65.71 0.51 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.409 -0.96 . . . . 1.0700000000000001 108.409 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -44.82 -44.19 9.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.622 -0.674 . . . . 1.25 109.93 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.461 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 6.3 p -71.85 -25.4 61.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.107 -0.995 . . . . 1.1799999999999999 109.564 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 166' ' ' SER . . . -78.69 -29.71 45.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.963 . . . . 1.1399999999999999 110.165 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -100.13 -4.26 30.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.271 -0.893 . . . . 1.71 109.371 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 tp -58.18 147.45 30.16 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.276 -1.009 . . . . 1.22 108.276 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -99.02 106.65 18.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.133 -0.979 . . . . 2.5499999999999998 109.64 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -87.02 37.2 0.75 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -0.856 . . . . 1.96 109.177 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -109.34 -24.47 11.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.537 -0.727 . . . . 2.46 109.436 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -132.82 10.99 4.32 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 2.4199999999999999 110.248 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.9 t -79.28 154.45 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.928 -1.108 . . . . 1.1599999999999999 109.161 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.402 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 13.5 tp -114.9 -19.45 10.97 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.704 -0.623 . . . . 1.95 110.189 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.46 175.1 42.6 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.857 -1.297 . . . . 0.41999999999999998 109.857 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -126.77 122.3 34.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.481 -1.011 . . . . 0.52000000000000002 109.275 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.0 mt -130.33 124.39 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.501 -0.926 . . . . 1.1599999999999999 108.501 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 203' ' ' VAL . 40.6 p -142.68 151.76 41.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 1.22 111.202 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.403 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 1.6 m-20 -87.3 43.77 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 2.2400000000000002 108.996 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.149 0 O-C-N 121.413 -0.805 . . . . 1.6499999999999999 110.214 -179.053 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.461 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 27.9 t60 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.683 -0.858 . . . . 1.0600000000000001 108.683 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.3 p -55.54 -41.86 73.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.391 -0.818 . . . . 2.0899999999999999 109.42 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.2 t -62.48 -31.43 72.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 1.8799999999999999 109.557 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 192' ' ' ILE . 42.0 mm -68.33 -34.77 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.186 -0.946 . . . . 2.0099999999999998 110.143 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.3 mtm -71.41 -54.1 11.81 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.692 -1.225 . . . . 1.27 107.692 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.86 -44.19 70.17 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.392 -0.596 . . . . 1.1799999999999999 109.392 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -66.35 -46.63 76.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.15 -0.969 . . . . 3.5800000000000001 109.498 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.2 m -70.0 -37.13 75.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 1.1399999999999999 110.116 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.519 ' C ' ' H ' ' A' ' 199' ' ' LEU . 26.1 mt -86.61 -0.17 55.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.042 -1.036 . . . . 1.28 109.483 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 51.05 5.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.268 -0.895 . . . . 1.49 110.79 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.519 ' H ' ' C ' ' A' ' 197' ' ' LEU . 66.7 mt -66.76 139.68 95.92 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.747 -1.221 . . . . 1.28 108.65 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.08 131.64 44.65 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.711 1.607 . . . . 0.69999999999999996 111.508 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.52 -179.21 6.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.706 -1.246 . . . . 1.1899999999999999 110.787 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.7 mt -150.45 158.71 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.166 -1.42 . . . . 1.25 107.166 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.1 m -142.84 -25.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 120.771 -1.206 . . . . 1.29 110.703 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.44 27.99 5.48 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.934 -1.266 . . . . 0.92000000000000004 109.934 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 207' ' ' SER . 2.9 p -57.02 -37.27 71.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.678 -1.483 . . . . 1.3100000000000001 108.122 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 60.02 -35.68 0.04 OUTLIER Glycine 0 N--CA 1.492 2.402 0 C-N-CA 121.031 -0.604 . . . . 1.0 113.664 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 205' ' ' THR . 7.0 m -128.88 16.55 6.29 Favored 'General case' 0 N--CA 1.513 2.718 0 CA-C-N 119.749 1.774 . . . . 1.9199999999999999 113.209 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.17 -34.76 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.072 -1.643 . . . . 1.27 110.224 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.2 p -71.53 -21.26 61.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.827 -1.171 . . . . 1.3400000000000001 109.974 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.9 m -104.54 17.17 24.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.415 -0.803 . . . . 2.0699999999999998 109.137 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -139.32 -17.87 1.01 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.364 -0.835 . . . . 2.8599999999999999 110.835 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 55.1 t -119.82 162.47 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.255 -0.903 . . . . 1.3 109.691 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.462 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 13.5 mmtp -126.54 -176.83 3.79 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.165 -1.42 . . . . 2.48 107.165 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.466 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 10.8 p30 -77.01 149.57 35.87 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.74 -1.225 . . . . 2.6200000000000001 110.357 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.7 t70 81.03 -12.89 0.97 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.151 -0.343 . . . . 2.3999999999999999 110.667 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -57.76 140.68 50.98 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.794 -1.192 . . . . 1.99 108.358 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -90.66 109.97 21.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.939 -1.101 . . . . 1.54 108.91 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 7.3 mt -113.11 161.37 17.19 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.193 -0.669 . . . . 1.25 109.193 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 67.5 mt -133.39 120.1 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.617 -1.253 . . . . 1.26 107.617 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.78 127.65 35.32 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.022 -0.732 . . . . 1.1799999999999999 109.022 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 19.5 p-10 -98.01 -30.24 12.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.267 -0.895 . . . . 2.2200000000000002 109.034 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.537 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.76 24.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.387 0.613 . . . . 1.2 110.349 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.7 t -118.04 -59.0 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 106.695 -1.594 . . . . 1.48 106.695 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -94.35 13.17 24.48 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.51 -1.292 . . . . 2.8199999999999998 107.51 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 55.53 62.11 2.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.154 -0.684 . . . . 2.1099999999999999 109.154 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.446 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 53.7 tt0 -155.62 145.82 21.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.14 -0.975 . . . . 2.6499999999999999 110.769 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 76.6 t -106.52 159.98 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.074 -0.713 . . . . 1.29 109.074 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -124.88 114.53 19.31 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.52 -0.919 . . . . 1.4199999999999999 108.52 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.1 123.8 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 1.26 109.942 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.4 t30 69.73 67.84 0.43 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.564 -0.71 . . . . 2.1499999999999999 109.697 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -88.73 134.8 2.8 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 123.355 2.704 . . . . 0.81999999999999995 112.267 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 38.5 p -73.51 156.95 37.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 2.1099999999999999 109.393 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -65.69 -30.84 71.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 3.1699999999999999 109.375 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -56.86 -43.2 80.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.564 -0.71 . . . . 3.0600000000000001 109.724 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.4 t -72.93 -49.31 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 1.6499999999999999 109.608 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 236' ' ' ILE . 84.7 mt -50.57 -59.65 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.287 -0.883 . . . . 1.47 109.381 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -55.46 -36.23 66.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 2.54 110.284 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -64.76 -51.42 62.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 3.0 110.747 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 243' ' ' GLN . 9.1 mtm -79.49 -27.16 41.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.954 -1.091 . . . . 1.6299999999999999 110.339 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.421 HH11 ' HG3' ' A' ' 240' ' ' ARG . 9.9 mmm-85 -53.2 -41.56 65.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.811 -1.181 . . . . 3.1600000000000001 108.785 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.1 -52.44 10.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 2.0899999999999999 110.025 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.3 t -69.81 -51.06 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 2.5699999999999998 110.496 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 239' ' ' MET . 1.5 tm0? -55.56 -53.2 59.4 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.841 -1.162 . . . . 3.5899999999999999 110.321 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.418 ' OE1' ' O ' ' A' ' 240' ' ' ARG . 52.9 mt-10 . . . . . 0 C--N 1.301 -1.504 0 O-C-N 120.981 -1.075 . . . . 1.76 109.397 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.43 ' H3 ' ' NE2' ' A' ' 226' ' ' GLN . 12.6 mmt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.315 -0.624 . . . . 4.0700000000000003 109.315 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.54 94.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 1.5 109.537 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 m -93.96 118.06 30.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.292 -0.88 . . . . 1.8 109.69 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.423 ' N ' HD22 ' A' ' 225' ' ' ASN . . . -113.49 -161.12 14.3 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 108.934 -1.666 . . . . 0.92000000000000004 108.934 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' LEU . 79.5 mt -92.89 -9.79 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.044 -1.268 . . . . 1.5 109.218 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.9 tp 57.54 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.971 . . . . 1.3999999999999999 109.469 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.05 -55.66 3.73 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.208 -1.034 . . . . 1.26 108.208 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.82 148.11 34.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 108.694 -0.854 . . . . 1.95 108.694 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.03 150.36 29.64 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.357 2.038 . . . . 0.93999999999999995 113.337 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 152.02 124.48 1.1 Allowed Glycine 0 N--CA 1.499 2.881 0 N-CA-C 110.17 -1.172 . . . . 0.78000000000000003 110.17 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.19 135.03 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.094 -1.239 . . . . 1.29 110.066 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.5 145.52 35.29 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.397 -0.814 . . . . 1.1499999999999999 110.224 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.8 m-85 -112.7 142.16 45.64 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.837 -1.172 . . . . 0.71999999999999997 107.837 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.22 164.8 30.44 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.424 -1.846 . . . . 0.5 111.732 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -79.33 146.76 32.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.594 -0.945 . . . . 2.3599999999999999 110.338 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.41 120.69 24.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 1.1599999999999999 110.613 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 tp -102.07 91.38 4.3 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.589 -1.263 . . . . 1.24 107.589 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.99 136.81 35.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.116 -0.99 . . . . 1.3100000000000001 110.166 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 mt -94.91 93.4 7.41 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.466 0.651 . . . . 1.3100000000000001 110.617 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -96.83 152.01 19.11 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.533 -0.914 . . . . 2.3500000000000001 108.533 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.88 145.05 51.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.196 -0.94 . . . . 2.5800000000000001 109.587 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.59 134.27 35.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 2.1400000000000001 109.407 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.57 136.45 55.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 1.9299999999999999 109.382 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.5 mt -92.99 135.67 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 1.28 109.457 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.9 t -102.38 119.12 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.336 -0.853 . . . . 1.3700000000000001 108.801 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.7 mt -88.74 137.92 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.809 . . . . 1.3300000000000001 110.115 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -91.23 115.67 28.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.356 -0.84 . . . . 1.3700000000000001 109.429 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 28' ' ' ARG . 14.2 mmm-85 -97.91 27.7 4.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.22 -0.925 . . . . 3.1899999999999999 109.259 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -82.87 147.85 28.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 2.8100000000000001 109.851 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -86.74 136.68 32.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.203 -0.935 . . . . 2.8300000000000001 108.747 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.9 pt -95.84 177.46 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.012 -1.055 . . . . 1.3400000000000001 110.303 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 34' ' ' ASP . 98.8 p -98.97 154.68 17.89 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.66 -0.867 . . . . 1.3500000000000001 108.66 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.11 -8.45 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.064 -1.022 . . . . 1.6100000000000001 109.984 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 32' ' ' SER . 9.6 t70 -82.86 -14.61 53.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 2.4700000000000002 110.078 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -112.86 -2.99 14.22 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.32 -0.862 . . . . 2.0699999999999998 109.688 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.67 -45.09 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.974 -1.079 . . . . 1.3300000000000001 108.728 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -56.66 -35.12 68.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 1.46 109.121 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -69.1 -36.53 77.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 2.9399999999999999 110.212 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -62.63 -45.43 92.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 1.3 109.485 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.31 -46.24 97.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.438 -0.789 . . . . 1.3300000000000001 109.732 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.82 -42.33 81.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 1.5 108.882 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -62.86 -31.7 72.78 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.701 -0.852 . . . . 3.1499999999999999 108.701 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -86.09 -55.79 3.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.92000000000000004 108.692 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.7 tp -51.81 -56.54 13.34 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.135 -1.061 . . . . 1.4099999999999999 108.135 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 t -66.46 -35.94 81.53 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.826 -1.175 . . . . 1.22 107.826 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -55.85 -54.76 32.88 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 107.609 -2.196 . . . . 0.58999999999999997 107.609 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -47.66 -30.82 4.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.407 -1.054 . . . . 3.3900000000000001 108.763 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.26 -32.97 70.48 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.498 -1.297 . . . . 1.26 107.498 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 46' ' ' GLY . 95.7 mttt -81.23 -62.86 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.64 -0.874 . . . . 2.9900000000000002 108.64 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.4 -40.56 26.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.899 . . . . 1.1399999999999999 109.598 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.4 p -62.35 -35.01 77.8 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.745 -1.205 . . . . 1.8400000000000001 107.745 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.82 -21.28 60.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.589 -0.523 . . . . 1.22 109.589 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -76.51 -67.34 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 2.0 109.488 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.59 -39.92 51.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.117 -0.989 . . . . 1.99 108.436 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.99 -48.12 83.02 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.948 -0.76 . . . . 1.27 108.948 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 52' ' ' ALA . 27.0 m -63.06 -38.86 92.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 1.24 108.898 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.36 -37.56 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.921 . . . . 1.21 108.546 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -51.06 -45.82 61.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.624 -0.673 . . . . 1.53 109.715 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -75.19 -23.99 57.74 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.148 -0.97 . . . . 1.24 110.427 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.445 ' O ' ' OG1' ' A' ' 64' ' ' THR . 21.5 mtpp -72.31 -32.63 66.74 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.779 -1.201 . . . . 2.3199999999999998 108.385 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.11 -26.62 42.9 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.507 -0.745 . . . . 1.1699999999999999 109.241 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.27 14.35 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.707 -1.235 . . . . 0.57999999999999996 110.509 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -86.22 -14.9 42.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.827 -1.396 . . . . 1.3899999999999999 109.204 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 68.4 m -96.18 -49.0 5.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.269 -0.894 . . . . 1.3600000000000001 110.654 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -106.37 -18.19 14.06 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.148 -0.97 . . . . 1.1399999999999999 110.38 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.86 143.86 6.85 Favored Glycine 0 N--CA 1.502 3.086 0 N-CA-C 109.686 -1.365 . . . . 0.59999999999999998 109.686 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -49.73 -7.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.469 -1.018 . . . . 2.5899999999999999 110.826 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 66' ' ' GLY . 52.9 tt0 -65.78 -27.89 68.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.872 -1.143 . . . . 2.2000000000000002 111.0 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -90.12 -12.24 38.87 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.799 -1.188 . . . . 2.3599999999999999 110.413 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -62.8 -21.28 65.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.091 -1.005 . . . . 1.54 110.709 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.92 70.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.851 -1.156 . . . . 1.24 110.081 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.2 mt -72.52 -43.81 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.076 -1.015 . . . . 1.24 109.636 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -77.05 -26.47 53.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.851 . . . . 0.80000000000000004 110.325 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.08 -44.19 93.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.903 -1.123 . . . . 1.23 109.262 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.39 -35.84 88.01 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.915 -1.674 . . . . 0.56000000000000005 108.915 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -19.08 63.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.413 -1.051 . . . . 2.0600000000000001 110.215 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.427 HD11 HG22 ' A' ' 77' ' ' ILE . 83.5 mt -83.84 -37.06 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.711 -1.243 . . . . 1.24 108.589 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.4 ttt -58.9 -53.35 59.38 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.769 -0.826 . . . . 2.4500000000000002 108.769 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -52.01 -41.52 62.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.44 -0.788 . . . . 1.21 108.905 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.8 tp -68.65 -44.32 74.39 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 1.1200000000000001 109.675 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -85.92 8.85 18.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.261 -0.899 . . . . 1.24 110.476 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -48.59 121.17 4.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.852 -1.155 . . . . 1.3100000000000001 109.328 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.74 -25.69 66.63 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.286 -0.884 . . . . 1.3500000000000001 108.808 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -76.99 -48.9 16.71 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.324 -0.86 . . . . 2.1600000000000001 109.625 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.64 -16.69 63.16 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.575 -1.25 . . . . 1.24 108.657 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.8 -50.16 18.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.4 -0.812 . . . . 1.28 109.591 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.57 -29.31 70.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 1.79 109.134 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -74.07 -48.15 31.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 1.29 109.104 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 89' ' ' ILE . 59.2 mt -57.31 -43.41 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.379 -0.971 . . . . 1.1399999999999999 108.379 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 90' ' ' ILE . 82.6 mt -62.11 -61.65 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 1.3200000000000001 110.195 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -45.23 -51.19 11.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 1.3700000000000001 110.275 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 49.9 mt -54.1 -55.0 31.75 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.452 -0.899 . . . . 1.3999999999999999 108.941 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.3 mt -51.02 -47.22 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.965 . . . . 1.23 110.377 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -81.94 -33.29 30.4 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.987 -1.071 . . . . 2.5099999999999998 111.441 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.4 t70 -81.31 -45.96 15.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.769 -1.207 . . . . 1.5900000000000001 111.735 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -103.91 17.85 23.24 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.628 -1.295 . . . . 2.3799999999999999 109.866 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.6 m80 45.3 50.91 9.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.177 -0.952 . . . . 1.6200000000000001 109.469 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.6 mtt -99.73 149.01 23.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.52 -0.738 . . . . 1.8899999999999999 109.114 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.3 p -76.15 146.78 38.97 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.399 -0.813 . . . . 1.27 109.21 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.67 -29.1 10.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 1.1599999999999999 108.702 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.37 -44.62 51.45 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.286 -1.005 . . . . 2.0 108.286 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.42 -54.45 12.34 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.313 0.577 . . . . 1.25 110.074 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.29 -50.47 72.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 1.1299999999999999 109.365 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.08 -37.35 69.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 1.0800000000000001 109.73 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -69.59 -35.07 75.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.046 -1.034 . . . . 2.02 109.491 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 109' ' ' GLU . 33.4 tt0 -62.28 -58.35 8.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 1.26 109.612 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.3 t -50.28 -47.11 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.977 -1.077 . . . . 1.1799999999999999 109.221 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.3 mm -65.13 -15.65 18.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.376 -0.828 . . . . 1.1899999999999999 109.007 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 106' ' ' GLU . 24.7 tt0 -75.28 -37.0 61.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 2.2000000000000002 109.706 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.56 -26.5 29.85 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.491 -1.338 . . . . 0.85999999999999999 112.174 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -67.58 -37.91 83.27 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.614 -1.521 . . . . 2.0 108.952 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.34 -51.36 7.03 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.671 -0.643 . . . . 1.3200000000000001 109.581 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.0 p -60.47 -42.79 96.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.317 -0.865 . . . . 2.1400000000000001 110.141 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.0 -38.41 90.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.976 -1.078 . . . . 1.3799999999999999 110.339 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.2 mt -67.72 -26.86 66.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.852 -1.155 . . . . 1.3500000000000001 109.438 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -69.48 -20.45 63.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.035 -1.04 . . . . 1.95 109.607 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -81.36 -6.85 59.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 1.71 109.183 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 mt -85.7 143.18 28.51 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.244 -1.021 . . . . 1.71 108.244 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -96.66 62.04 1.94 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.271 -0.893 . . . . 2.8300000000000001 109.024 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -148.96 115.22 5.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.221 -0.924 . . . . 1.5800000000000001 109.621 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.82 -13.08 3.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 2.7999999999999998 109.433 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.504 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 1.0 OUTLIER -79.92 -63.79 1.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 1.27 109.375 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.6 mt -68.09 -30.81 70.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.215 -0.928 . . . . 1.5800000000000001 109.444 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 127' ' ' ALA . 68.5 tttt -67.01 -51.64 52.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.956 . . . . 2.9199999999999999 109.337 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -57.86 -23.11 51.48 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.195 -0.94 . . . . 2.2000000000000002 108.995 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.504 ' NH2' ' OH ' ' A' ' 122' ' ' TYR . 18.6 ttm180 -73.41 -24.71 60.31 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.408 -1.701 . . . . 2.5299999999999998 106.408 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.08 -42.86 91.42 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.629 -0.878 . . . . 1.45 108.629 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.71 80.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.436 -0.79 . . . . 1.5 109.876 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.13 -25.32 65.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 1.3500000000000001 109.529 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.2 t -76.61 -42.62 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.163 -0.961 . . . . 1.23 108.444 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.419 HH11 ' HG3' ' A' ' 131' ' ' ARG . 16.6 ttm-85 -57.0 -37.69 72.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.223 -0.923 . . . . 3.73 108.68 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -61.06 -38.37 85.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.508 -0.745 . . . . 1.3200000000000001 110.319 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.8 mt -67.97 -26.83 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.018 -1.051 . . . . 1.2 109.975 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.5 -44.08 8.87 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.632 -1.387 . . . . 0.48999999999999999 109.632 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -50.92 -51.68 49.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.371 -1.076 . . . . 3.1099999999999999 109.642 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.532 ' CG ' HH11 ' A' ' 136' ' ' ARG . 4.5 mtt-85 -63.9 -46.21 85.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.109 -0.994 . . . . 2.9500000000000002 108.361 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.9 tp -49.83 -38.38 34.66 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.054 -0.721 . . . . 1.73 109.054 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.8 mt -70.5 -55.01 9.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 1.22 109.495 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -53.49 -17.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 2.7799999999999998 110.293 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 140' ' ' ASN . 2.4 m120 -85.02 -47.4 10.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.992 -1.067 . . . . 2.0299999999999998 109.204 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.27 -37.88 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.899 . . . . 1.2 109.118 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.83 -3.11 58.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 1.28 108.693 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.32 22.62 15.53 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.303 -1.919 . . . . 0.68999999999999995 108.303 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.6 tp -55.58 154.3 6.78 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.625 -0.927 . . . . 1.3100000000000001 109.297 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -66.76 147.55 53.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 2.8799999999999999 109.683 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.8 mt -109.05 145.79 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.517 -0.739 . . . . 1.3600000000000001 109.349 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 147' ' ' ILE . 11.7 mm -76.34 119.46 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 1.9299999999999999 108.625 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.7 OUTLIER -94.79 87.03 4.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.255 -0.903 . . . . 1.54 109.918 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.9 mt -81.6 -10.33 59.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 1.3400000000000001 109.14 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.1 p -80.65 -12.18 59.53 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.273 -0.892 . . . . 1.98 109.461 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -103.56 49.95 0.82 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.473 -0.767 . . . . 1.3799999999999999 110.53 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.8 mm -71.2 164.12 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.812 -1.18 . . . . 1.3999999999999999 108.71 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -132.88 -33.1 1.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.351 -0.843 . . . . 2.7400000000000002 109.768 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -115.0 145.52 42.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.5 -0.75 . . . . 1.4099999999999999 109.614 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -66.95 126.66 29.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.415 -0.803 . . . . 1.3 109.232 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.4 m -148.97 172.38 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.154 -0.966 . . . . 1.28 109.668 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 53.5 mt -90.66 163.59 2.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.609 -1.256 . . . . 1.1499999999999999 107.609 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.7 tp -111.89 123.83 51.09 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.589 -0.694 . . . . 1.2 109.404 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.8 t -123.46 129.7 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.148 -0.686 . . . . 1.1599999999999999 109.148 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.29 146.14 11.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 1.2 109.671 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.94 -27.25 66.63 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.601 -1.312 . . . . 1.3200000000000001 107.468 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -175.47 157.94 2.2 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.64 -0.663 . . . . 2.3399999999999999 109.215 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 22.6 mt -129.88 131.03 45.92 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.439 -0.788 . . . . 1.26 109.321 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 p -94.59 153.28 40.28 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.285 -0.884 . . . . 1.3600000000000001 109.409 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -35.68 -41.78 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.541 2.16 . . . . 0.63 112.354 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.9 m -62.2 -56.29 20.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.162 -0.961 . . . . 1.0700000000000001 109.112 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -53.73 -31.19 47.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 1.25 109.526 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 28.3 p -82.49 -31.54 29.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 1.1799999999999999 109.539 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.82 -23.92 58.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 1.1399999999999999 109.966 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -105.26 -6.0 20.11 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.145 -0.972 . . . . 1.71 109.414 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.08 156.0 5.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.226 -1.027 . . . . 1.22 108.226 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 174' ' ' LYS . 52.2 t-20 -97.9 97.19 8.74 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.136 -0.978 . . . . 2.5499999999999998 109.564 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.544 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.6 mm? -82.05 26.23 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 1.96 109.193 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 172' ' ' ASN . 77.2 mttt -112.44 -18.13 12.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.421 -0.799 . . . . 2.46 109.103 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -131.26 -1.32 4.01 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.47 -0.769 . . . . 2.4199999999999999 110.133 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 39.3 t -78.95 151.54 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.874 -1.141 . . . . 1.1599999999999999 109.543 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.3 tp -121.33 -9.01 9.12 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.8 -0.562 . . . . 1.95 110.269 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.44 176.5 41.22 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.561 -1.304 . . . . 0.41999999999999998 110.069 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.82 130.35 35.94 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.517 -0.99 . . . . 0.52000000000000002 110.086 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.1 mt -129.56 120.05 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.01 -1.107 . . . . 1.1599999999999999 108.01 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 203' ' ' VAL . 64.1 p -141.67 152.45 43.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.213 -0.929 . . . . 1.22 110.868 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 21.4 p30 -89.45 43.83 1.17 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.088 -1.008 . . . . 2.2400000000000002 110.715 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.497 1.922 0 O-C-N 120.878 -1.139 . . . . 1.6499999999999999 108.799 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.3 t60 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.385 0.612 . . . . 1.0600000000000001 109.671 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -44.15 21.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 2.0899999999999999 109.987 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 38.6 t -59.71 -37.43 78.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.01 . . . . 1.8799999999999999 110.34 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 31.4 mm -60.43 -34.36 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.098 -1.001 . . . . 2.0099999999999998 110.397 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.2 mtp -71.67 -52.05 19.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.902 -1.124 . . . . 1.27 108.288 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.19 -30.99 51.67 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.722 -0.672 . . . . 1.1799999999999999 110.277 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -81.26 -47.76 12.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.066 -1.021 . . . . 3.5800000000000001 110.416 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.9 m -67.57 -37.1 82.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.933 -1.104 . . . . 1.1399999999999999 110.112 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 199' ' ' LEU . 15.9 mt -86.18 -0.13 54.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.981 -1.074 . . . . 1.28 109.105 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 56.81 0.37 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.396 -0.815 . . . . 1.49 112.015 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.1 mt -67.42 170.77 6.03 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.472 -1.393 . . . . 1.28 108.897 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -90.97 142.78 3.2 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.513 2.142 . . . . 0.69999999999999996 111.199 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.1 -178.19 5.88 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.562 -1.337 . . . . 1.1899999999999999 110.857 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.9 mt -149.69 158.48 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.962 -1.496 . . . . 1.25 106.962 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.525 ' O ' ' O ' ' A' ' 181' ' ' THR . 19.5 m -137.93 -32.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.989 -1.069 . . . . 1.29 111.434 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.34 42.54 3.16 Favored Glycine 0 N--CA 1.496 2.653 0 O-C-N 120.579 -1.326 . . . . 0.92000000000000004 110.727 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.8 p -71.39 -21.15 62.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.602 -1.528 . . . . 1.3100000000000001 109.297 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.452 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 71.75 -97.43 0.72 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.843 -1.17 . . . . 1.0 111.814 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 66.7 m -115.42 45.86 1.59 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.969 -1.312 . . . . 1.9199999999999999 112.743 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 17.7 t -79.93 -27.19 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.601 -1.312 . . . . 1.27 107.636 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.4 p -73.67 -11.21 60.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 1.3400000000000001 109.7 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 13.8 p -101.53 6.4 42.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.36 -0.837 . . . . 2.0699999999999998 109.405 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -130.47 -3.58 4.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.399 -0.813 . . . . 2.8599999999999999 109.203 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.0 t -125.81 152.59 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.055 -0.72 . . . . 1.3 109.055 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -118.68 -173.79 2.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.852 -1.536 . . . . 2.48 106.852 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 22.7 t-20 -80.03 145.42 32.51 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.818 -1.176 . . . . 2.6200000000000001 111.202 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.46 -7.4 1.46 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.839 -0.538 . . . . 2.3999999999999999 110.843 178.531 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.29 138.05 55.28 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.875 -1.141 . . . . 1.99 108.446 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -86.38 115.98 24.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.038 -1.039 . . . . 1.54 108.655 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.6 mt -117.99 179.1 4.19 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.374 1.083 . . . . 1.25 110.806 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.8 mt -146.93 107.92 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.387 -1.338 . . . . 1.26 107.387 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 tp -83.21 128.4 34.46 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.32 -0.993 . . . . 1.1799999999999999 108.32 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -52.6 4.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 2.2200000000000002 109.82 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.433 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 57.54 22.74 8.44 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.339 -0.85 . . . . 1.2 108.77 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.06 -49.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 107.295 -1.372 . . . . 1.48 107.295 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -106.95 12.14 29.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.936 -1.135 . . . . 2.8199999999999998 107.936 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 4' ' ' GLY . 59.0 t30 58.35 58.21 3.54 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.056 -0.72 . . . . 2.1099999999999999 109.056 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.43 ' NE2' ' H3 ' ' A' ' 1' ' ' MET . 17.4 tt0 -153.75 146.99 24.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.926 . . . . 2.6499999999999999 109.918 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.63 136.62 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.67 -0.644 . . . . 1.29 109.386 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -105.03 127.38 52.84 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.384 -0.822 . . . . 1.4199999999999999 109.2 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.58 127.89 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.516 -0.74 . . . . 1.26 109.864 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 49.05 69.96 2.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.857 . . . . 2.1499999999999999 109.989 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.5 153.44 13.73 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.78 2.32 . . . . 0.81999999999999995 111.64 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.5 p -73.93 169.59 17.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.979 . . . . 2.1099999999999999 109.98 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.53 -27.76 65.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.852 . . . . 3.1699999999999999 109.579 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.13 -38.65 91.33 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.418 -0.801 . . . . 3.0600000000000001 109.537 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.09 -46.31 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 1.6499999999999999 109.341 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.7 mt -52.05 -55.84 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 1.47 109.356 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -54.91 -44.83 74.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 2.54 109.972 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -67.54 -37.75 83.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 3.0 110.144 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 51.9 mtp -80.16 -25.92 39.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 1.6299999999999999 109.706 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.442 ' CA ' ' HE ' ' A' ' 240' ' ' ARG . 0.0 OUTLIER -60.16 -51.86 67.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.179 -0.951 . . . . 3.1600000000000001 109.853 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.71 -54.94 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 2.0899999999999999 109.771 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 84.5 t -49.03 -53.02 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 2.5699999999999998 109.511 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -55.29 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.249 -0.907 . . . . 3.5899999999999999 109.981 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 . . . . . 0 C--N 1.299 -1.6 0 O-C-N 121.122 -0.986 . . . . 1.76 110.499 -178.772 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.451 -0.574 . . . . 4.0700000000000003 109.451 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.3 mt -60.67 98.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.872 . . . . 1.5 109.475 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.0 m -93.37 114.67 27.15 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 1.8 109.619 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.72 -163.15 19.53 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.784 -1.726 . . . . 0.92000000000000004 108.784 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.4 mt -96.48 -9.46 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.039 -1.271 . . . . 1.5 108.789 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.2 tp 59.42 110.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.416 -0.803 . . . . 1.3999999999999999 109.151 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.77 -49.66 6.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.081 -1.081 . . . . 1.26 108.081 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -150.43 152.15 32.41 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.371 -0.83 . . . . 1.95 109.383 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.08 155.89 29.92 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.585 2.19 . . . . 0.93999999999999995 112.504 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 144.26 121.84 1.55 Allowed Glycine 0 N--CA 1.504 3.169 0 N-CA-C 110.232 -1.147 . . . . 0.78000000000000003 110.232 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.49 139.48 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.094 -1.239 . . . . 1.29 110.22 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.61 159.86 41.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.324 -0.86 . . . . 1.1499999999999999 109.68 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.595 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -130.39 135.79 48.4 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.107 -1.072 . . . . 0.71999999999999997 108.107 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 166.6 37.14 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 118.601 -1.762 . . . . 0.5 111.723 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -79.61 149.78 31.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.739 -0.859 . . . . 2.3599999999999999 110.392 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -76.37 125.02 28.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.39 -0.819 . . . . 1.1599999999999999 110.992 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.1 tp -110.79 93.15 4.34 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.174 -1.417 . . . . 1.24 107.174 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -81.79 126.83 32.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.04 -1.037 . . . . 1.3100000000000001 110.996 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.3 mt -101.94 94.44 5.79 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.609 -0.723 . . . . 1.3100000000000001 110.316 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -94.62 158.54 15.48 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.358 -0.979 . . . . 2.3500000000000001 108.358 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -130.18 125.4 34.89 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.384 -0.823 . . . . 2.5800000000000001 109.506 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 6.5 p-10 -80.27 130.2 35.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.32 -0.862 . . . . 2.1400000000000001 109.008 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.64 148.87 50.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 1.9299999999999999 109.235 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.5 136.73 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 1.28 109.145 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -103.11 121.05 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.369 -0.832 . . . . 1.3700000000000001 109.047 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.7 mt -87.14 132.98 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.386 -0.821 . . . . 1.3300000000000001 109.729 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -91.5 122.46 34.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 1.3700000000000001 108.724 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.486 ' HG2' HH11 ' A' ' 28' ' ' ARG . 0.4 OUTLIER -98.36 27.41 4.73 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.241 -0.912 . . . . 3.1899999999999999 109.887 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -81.01 143.33 32.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 2.8100000000000001 109.277 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -86.37 126.27 34.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.146 -0.971 . . . . 2.8300000000000001 109.416 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 pt -85.24 176.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 1.3400000000000001 109.6 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.9 p -95.58 173.96 7.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.79 . . . . 1.3500000000000001 109.478 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.29 -25.89 63.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 1.6100000000000001 109.551 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 3.3 m-20 -79.97 2.57 23.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 2.4700000000000002 108.617 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -116.75 -17.02 10.6 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.507 -0.924 . . . . 2.0699999999999998 108.507 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.9 t -66.61 -46.45 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.46 -0.775 . . . . 1.3300000000000001 109.382 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.2 -35.65 67.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.887 . . . . 1.46 109.626 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -69.07 -33.5 73.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.389 -0.819 . . . . 2.9399999999999999 110.267 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.2 -37.9 89.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.959 -1.088 . . . . 1.3 109.362 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.9 -47.31 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.359 -0.838 . . . . 1.3300000000000001 110.058 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.31 -41.29 85.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.136 -0.977 . . . . 1.5 109.086 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -60.44 -34.27 73.73 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.244 -0.91 . . . . 3.1499999999999999 109.092 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 28.1 t80 -86.83 -55.3 3.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.138 -0.976 . . . . 0.92000000000000004 109.407 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.39 -63.8 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 1.4099999999999999 110.081 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 t -66.48 -37.91 86.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 1.22 108.856 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.95 -52.63 47.7 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.672 -2.171 . . . . 0.58999999999999997 107.672 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -53.7 -22.55 9.31 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.648 -0.913 . . . . 3.3900000000000001 109.431 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.08 90.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.101 -0.999 . . . . 1.26 108.648 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' HG3' ' H ' ' A' ' 50' ' ' ALA . 28.7 pttt -78.41 -51.84 9.45 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.352 -0.939 . . . . 2.9900000000000002 109.296 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' H ' ' HG3' ' A' ' 49' ' ' LYS . . . -50.76 -41.1 56.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.561 -1.337 . . . . 1.1399999999999999 109.325 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t -62.43 -33.56 75.05 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.613 -1.254 . . . . 1.8400000000000001 107.613 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.88 -28.31 62.42 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.037 -0.727 . . . . 1.22 109.037 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -73.6 -62.97 1.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.372 -0.83 . . . . 2.0 109.093 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -49.71 -38.04 31.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.995 -1.066 . . . . 1.99 108.297 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.35 -41.64 98.87 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.326 -0.991 . . . . 1.27 108.326 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 m -62.97 -39.28 94.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.455 -0.778 . . . . 1.24 109.007 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.08 -39.6 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.574 -0.899 . . . . 1.21 108.574 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -49.2 -42.04 38.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.785 . . . . 1.53 109.571 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -71.27 -38.76 71.84 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.066 -1.022 . . . . 1.24 109.796 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' O ' ' OG1' ' A' ' 64' ' ' THR . 56.2 mttm -69.88 -14.9 62.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.866 -1.134 . . . . 2.3199999999999998 107.999 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.91 -36.03 21.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.51 -0.922 . . . . 1.1699999999999999 108.51 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.08 -27.86 29.95 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.199 -1.16 . . . . 0.57999999999999996 110.199 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -85.86 -15.59 41.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.008 -1.29 . . . . 1.3899999999999999 109.38 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 99.7 m -94.49 -48.22 6.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.176 -0.952 . . . . 1.3600000000000001 110.325 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -106.37 -17.54 14.25 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.164 -0.96 . . . . 1.1399999999999999 110.537 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.93 143.84 6.83 Favored Glycine 0 N--CA 1.502 3.042 0 N-CA-C 109.706 -1.357 . . . . 0.59999999999999998 109.706 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -51.26 -8.6 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -1.058 . . . . 2.5899999999999999 110.572 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 66' ' ' GLY . 97.7 mt-10 -65.69 -24.17 66.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.955 -1.091 . . . . 2.2000000000000002 110.474 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -91.45 -13.75 31.73 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.926 -1.109 . . . . 2.3599999999999999 110.739 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -62.92 -18.71 63.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.92 -1.113 . . . . 1.54 110.815 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.12 -37.16 85.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.913 -1.117 . . . . 1.24 110.04 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.446 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 27.3 mt -73.14 -38.79 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.965 . . . . 1.24 109.91 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -78.41 -22.34 47.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.80000000000000004 109.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -64.48 -48.27 75.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.201 -0.937 . . . . 1.23 109.111 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.07 -32.01 76.03 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.425 -1.47 . . . . 0.56000000000000005 109.425 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.446 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 32.5 m170 -61.69 -23.31 66.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -1.15 . . . . 2.0600000000000001 110.004 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.1 mt -85.28 -39.02 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.901 -1.125 . . . . 1.24 108.825 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.4 ttt -59.04 -46.7 87.57 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.578 -0.897 . . . . 2.4500000000000002 108.578 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tp -58.71 -40.03 82.5 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.545 -0.722 . . . . 1.21 109.062 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -67.03 -45.92 76.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.271 -0.893 . . . . 1.1200000000000001 109.395 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -84.57 9.04 14.68 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.874 . . . . 1.24 110.546 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -51.83 120.98 5.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.955 -1.091 . . . . 1.3100000000000001 109.231 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.74 -21.76 65.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -0.95 . . . . 1.3500000000000001 108.947 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.35 -47.44 23.44 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.327 -0.858 . . . . 2.1600000000000001 109.185 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.06 -18.83 64.75 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.223 -0.991 . . . . 1.24 108.93 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -81.79 -41.32 21.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.388 -0.82 . . . . 1.28 109.725 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -63.06 -33.32 75.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 1.79 109.469 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -74.07 -42.57 59.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 1.29 109.004 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.2 mt -59.57 -58.82 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.219 -1.03 . . . . 1.1399999999999999 108.219 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.4 mt -42.86 -64.36 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.758 -0.589 . . . . 1.3200000000000001 110.164 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.0 -49.78 15.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 1.3700000000000001 110.135 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 mt -56.4 -57.14 13.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -0.842 . . . . 1.3999999999999999 109.328 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.3 -38.39 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.071 -1.018 . . . . 1.23 110.169 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -86.53 -37.62 18.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.096 -1.002 . . . . 2.5099999999999998 112.105 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -82.1 -38.72 24.42 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.79 -1.194 . . . . 1.5900000000000001 111.691 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 97' ' ' HIS . 60.5 mmtt -105.45 14.1 29.2 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.806 -1.184 . . . . 2.3799999999999999 109.612 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 96' ' ' LYS . 77.4 m80 44.55 44.5 7.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.377 -0.827 . . . . 1.6200000000000001 109.365 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.3 mtt -95.59 153.04 17.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.472 -0.768 . . . . 1.8899999999999999 109.195 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.547 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 11.2 p -77.17 142.34 39.69 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.565 -0.71 . . . . 1.27 109.595 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.47 -26.85 2.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.401 -0.812 . . . . 1.1599999999999999 109.68 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.428 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 0.4 OUTLIER -76.0 -43.67 43.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.118 -0.989 . . . . 2.0 108.376 178.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.547 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -71.74 -55.36 7.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.731 -0.606 . . . . 1.25 110.407 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.57 -50.02 71.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.983 . . . . 1.1299999999999999 110.057 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.89 -30.8 62.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -0.937 . . . . 1.0800000000000001 109.797 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -69.98 -25.62 63.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.011 -1.056 . . . . 2.02 109.364 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -68.67 -60.7 2.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -0.922 . . . . 1.26 109.86 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -51.91 -48.16 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.929 -1.107 . . . . 1.1799999999999999 109.407 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.9 mm -63.42 -21.94 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 1.1899999999999999 109.694 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -69.26 -34.64 75.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.976 -1.078 . . . . 2.2000000000000002 109.543 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.27 -23.54 40.18 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.559 -1.305 . . . . 0.85999999999999999 112.293 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -68.3 -42.94 78.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.52 -1.576 . . . . 2.0 108.854 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.93 -49.18 14.65 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.214 -0.661 . . . . 1.3200000000000001 109.214 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.6 t -60.46 -45.89 92.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.404 -0.81 . . . . 2.1400000000000001 109.785 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.6 78.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 1.3799999999999999 110.344 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 mt -68.43 -28.85 67.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.864 -1.147 . . . . 1.3500000000000001 109.186 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -70.38 -17.6 63.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.189 -0.945 . . . . 1.95 109.404 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -80.97 -6.19 58.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 1.71 109.437 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.3 mt -84.01 142.86 30.16 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.277 -1.009 . . . . 1.71 108.277 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -94.34 57.62 2.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 2.8300000000000001 108.55 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -148.61 116.41 6.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 1.5800000000000001 109.267 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.92 -11.33 7.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 2.7999999999999998 109.725 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -78.85 -64.11 1.26 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -0.877 . . . . 1.27 109.286 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.3 mt -63.17 -23.43 67.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.009 -1.057 . . . . 1.5800000000000001 109.26 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 127' ' ' ALA . 40.6 tttm -66.78 -50.59 62.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.094 -1.004 . . . . 2.9199999999999999 108.36 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -55.1 -22.99 18.43 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.442 -0.947 . . . . 2.2000000000000002 108.442 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -72.74 -27.09 61.82 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.867 -1.531 . . . . 2.5299999999999998 106.867 177.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.53 -41.81 86.37 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.561 -0.903 . . . . 1.45 108.561 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.66 -43.8 75.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.508 -0.745 . . . . 1.5 109.83 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.74 -21.19 66.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 1.3500000000000001 109.528 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 t -78.07 -48.7 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.185 -0.947 . . . . 1.23 108.562 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -54.8 -34.99 63.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.05 -1.031 . . . . 3.73 108.587 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.57 -46.74 88.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.421 -0.799 . . . . 1.3200000000000001 110.224 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.05 -30.56 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.924 -1.11 . . . . 1.2 108.966 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.68 -48.4 7.96 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.821 -1.712 . . . . 0.48999999999999999 108.821 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -56.03 -49.82 72.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.444 -1.033 . . . . 3.1099999999999999 109.466 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.484 ' O ' ' ND2' ' A' ' 140' ' ' ASN . 9.8 mtt-85 -63.6 -49.93 71.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.231 -1.026 . . . . 2.9500000000000002 108.231 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 40.2 tp -48.0 -35.15 10.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 1.73 109.267 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.04 -48.19 58.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.157 -0.965 . . . . 1.22 109.55 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -53.99 -18.99 4.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 2.7799999999999998 110.71 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 29.4 m-80 -84.72 -38.87 19.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.868 -1.145 . . . . 2.0299999999999998 109.121 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 141' ' ' ILE . 94.9 mt -67.82 -35.29 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 1.2 109.05 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.21 -1.7 57.21 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.876 -0.787 . . . . 1.28 108.876 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.33 25.75 60.77 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.263 -1.935 . . . . 0.68999999999999995 108.263 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.35 133.79 47.28 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.533 -0.98 . . . . 1.3100000000000001 109.499 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.68 141.96 57.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 2.8799999999999999 109.028 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 92.0 mt -104.02 163.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.602 -0.888 . . . . 1.3600000000000001 108.602 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 mp -77.93 128.53 38.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.026 -1.046 . . . . 1.9299999999999999 108.984 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -97.09 84.82 3.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.327 -0.858 . . . . 1.54 109.584 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -82.57 -20.12 37.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.885 . . . . 1.3400000000000001 109.206 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -79.66 7.01 9.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.019 . . . . 1.98 109.304 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -118.82 23.39 11.46 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.556 -0.715 . . . . 1.3799999999999999 109.369 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.87 144.57 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 1.3999999999999999 109.725 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -137.63 8.14 2.82 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.91 -0.774 . . . . 2.7400000000000002 108.91 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -123.64 119.5 30.02 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.76 -0.83 . . . . 1.4099999999999999 108.76 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.67 121.05 13.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.283 -0.886 . . . . 1.3 109.488 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.2 m -150.05 177.45 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 1.28 108.952 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.2 mt -88.56 151.3 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.176 -1.046 . . . . 1.1499999999999999 108.176 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.76 117.87 35.25 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.533 0.682 . . . . 1.2 109.414 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.5 t -124.06 132.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.718 -0.845 . . . . 1.1599999999999999 108.718 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.56 153.08 14.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.803 . . . . 1.2 109.801 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.53 86.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.641 -1.287 . . . . 1.3200000000000001 107.915 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -174.42 156.88 2.58 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.463 -0.773 . . . . 2.3399999999999999 109.758 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 27.3 mt -130.84 137.7 49.51 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.538 -0.726 . . . . 1.26 109.499 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.9 p -93.72 153.57 41.1 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.227 -0.921 . . . . 1.3600000000000001 109.178 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -34.3 -46.82 0.52 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.735 2.29 . . . . 0.63 112.938 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 169' ' ' ALA . 69.1 m -50.77 -65.76 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.012 . . . . 1.0700000000000001 109.262 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -48.36 -37.4 16.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.341 -0.849 . . . . 1.25 109.737 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.606 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 12.3 p -75.87 -21.71 56.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 1.1799999999999999 109.484 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 166' ' ' SER . . . -80.81 -21.14 41.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 1.1399999999999999 110.153 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -107.14 -19.83 13.49 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.318 -0.864 . . . . 1.71 109.859 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.31 149.99 27.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 1.22 109.112 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -97.01 158.01 15.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.976 . . . . 2.5499999999999998 108.525 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 9.3 mp -96.37 -40.58 9.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.161 -0.962 . . . . 1.96 110.782 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -80.13 -13.64 59.11 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.706 -1.246 . . . . 2.46 111.603 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -94.01 -5.11 48.29 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.605 -1.309 . . . . 2.4199999999999999 108.469 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 42.9 t -102.14 155.27 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.045 -0.724 . . . . 1.1599999999999999 109.045 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.7 tp -113.75 -18.43 11.85 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.967 -0.753 . . . . 1.95 108.967 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.53 171.29 40.08 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.947 -1.661 . . . . 0.41999999999999998 108.947 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 4.2 m-85 -126.94 124.11 38.75 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.507 -0.996 . . . . 0.52000000000000002 109.623 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.2 mt -125.75 117.35 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.367 -1.346 . . . . 1.1599999999999999 107.367 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 203' ' ' VAL . 17.4 p -140.78 151.84 44.75 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.229 -0.919 . . . . 1.22 112.388 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.513 ' O ' ' CG ' ' A' ' 182' ' ' ASP . 6.7 t0 -82.03 40.78 0.63 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.517 0.675 . . . . 2.2400000000000002 109.621 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.118 0 O-C-N 120.29 -1.506 . . . . 1.6499999999999999 110.9 -178.069 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.606 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 43.7 t60 . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 108.034 -1.098 . . . . 1.0600000000000001 108.034 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.8 m -61.59 -43.75 98.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.053 -0.721 . . . . 2.0899999999999999 109.053 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.1 p -57.44 -32.2 66.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 1.8799999999999999 109.315 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.7 mm -71.19 -31.84 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 2.0099999999999998 109.754 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.7 mtp -71.84 -56.86 4.96 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.776 -1.194 . . . . 1.27 107.776 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.89 -38.72 73.19 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.641 -0.709 . . . . 1.1799999999999999 110.408 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -70.17 -50.81 36.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.08 -1.012 . . . . 3.5800000000000001 110.176 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.6 m -69.25 -36.87 77.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.266 -0.896 . . . . 1.1399999999999999 109.794 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 199' ' ' LEU . 14.9 mt -92.86 2.55 56.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.264 -0.898 . . . . 1.28 109.319 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 48.92 11.81 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.344 -0.847 . . . . 1.49 110.829 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 197' ' ' LEU . 84.2 mt -66.72 145.93 99.0 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.777 -1.202 . . . . 1.28 109.083 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.03 133.43 53.29 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.73 1.62 . . . . 0.69999999999999996 111.099 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.79 171.84 16.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.421 -1.424 . . . . 1.1899999999999999 111.4 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 65.9 mt -146.95 156.87 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.434 -1.691 . . . . 1.25 106.434 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.545 ' O ' ' O ' ' A' ' 181' ' ' THR . 29.9 m -140.66 -34.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 120.794 -1.191 . . . . 1.29 110.735 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.1 39.92 1.43 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.326 -1.91 . . . . 0.92000000000000004 108.326 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.497 ' H ' ' C ' ' A' ' 203' ' ' VAL . 16.6 p -68.53 -6.14 23.62 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.415 -1.05 . . . . 1.3100000000000001 109.46 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 49.74 -103.11 0.07 OUTLIER Glycine 0 N--CA 1.483 1.768 0 C-N-CA 119.709 -1.234 . . . . 1.0 110.149 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 12.3 p -115.81 51.17 0.96 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.197 -1.178 . . . . 1.9199999999999999 112.152 -176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.0 t -72.44 -25.72 23.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.145 -1.428 . . . . 1.27 107.145 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.6 p -70.51 -10.99 60.62 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.617 -0.882 . . . . 1.3400000000000001 108.617 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.3 t -104.2 12.27 34.0 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.445 -0.946 . . . . 2.0699999999999998 108.445 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -133.83 -27.27 1.49 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.689 -0.632 . . . . 2.8599999999999999 109.598 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 70.2 t -111.54 154.43 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.516 -0.74 . . . . 1.3 109.506 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.496 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 25.2 mmtp -123.8 -178.88 4.18 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.559 -1.645 . . . . 2.48 106.559 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.5 p-10 -79.97 149.38 30.82 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.73 -1.231 . . . . 2.6200000000000001 110.234 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 t70 81.49 -14.99 0.76 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.889 -0.507 . . . . 2.3999999999999999 110.664 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 73.7 m-20 -59.65 142.78 52.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.787 -1.196 . . . . 1.99 108.997 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -90.08 109.13 20.2 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.08 -1.012 . . . . 1.54 109.218 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.39 172.23 6.96 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.927 0.87 . . . . 1.25 109.714 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.9 mt -143.71 116.6 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.559 -1.274 . . . . 1.26 107.559 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.3 tp -84.79 127.06 33.94 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.161 -0.962 . . . . 1.1799999999999999 108.737 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 4.8 p-10 -89.22 -36.16 15.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.087 -1.008 . . . . 2.2200000000000002 109.119 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.539 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 44.58 21.57 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.542 -0.724 . . . . 1.2 110.142 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 221' ' ' ASP . 28.2 t -122.62 -61.4 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.754 -1.202 . . . . 1.48 107.754 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -91.99 17.07 9.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.396 -0.964 . . . . 2.8199999999999998 108.396 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 53.91 56.32 7.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.67 -0.644 . . . . 2.1099999999999999 109.928 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.445 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 69.2 mt-30 -152.96 144.32 23.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.191 -0.943 . . . . 2.6499999999999999 110.351 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 92.7 t -99.48 151.56 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.994 -1.113 . . . . 1.29 107.994 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -122.41 120.85 35.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.378 -0.826 . . . . 1.4199999999999999 109.216 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.3 t -104.93 120.32 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.455 -0.778 . . . . 1.26 109.642 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 48.29 65.55 6.9 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 2.1499999999999999 109.915 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.89 165.16 24.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.782 2.322 . . . . 0.81999999999999995 111.976 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.8 p -75.43 142.46 43.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 2.1099999999999999 109.388 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -54.41 -14.85 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 3.1699999999999999 109.243 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -72.84 -38.18 67.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -0.794 . . . . 3.0600000000000001 109.463 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.01 -41.25 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 1.6499999999999999 109.005 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.1 mt -55.85 -55.48 17.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.403 -0.81 . . . . 1.47 109.593 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -53.1 -40.02 63.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 2.54 109.849 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -66.91 -37.66 84.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.293 -0.879 . . . . 3.0 110.119 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 46.7 mtp -82.82 -25.26 32.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.154 -0.966 . . . . 1.6299999999999999 110.028 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 12.3 mmm-85 -59.91 -45.91 91.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.134 -0.979 . . . . 3.1600000000000001 109.74 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.79 -48.97 22.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 2.0899999999999999 110.178 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.79 -55.3 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.072 -1.017 . . . . 2.5699999999999998 110.027 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -44.93 -57.27 3.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 3.5899999999999999 110.148 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--N 1.297 -1.674 0 O-C-N 121.487 -0.758 . . . . 1.76 110.142 -179.174 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.518 ' O ' ' N ' ' A' ' 3' ' ' SER . 49.1 mtm . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.589 -0.523 . . . . 4.0700000000000003 109.589 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.445 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 53.3 mt -53.44 89.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 1.5 108.915 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 1' ' ' MET . 70.1 m -95.94 119.34 34.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.327 -0.858 . . . . 1.8 109.955 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.34 -158.53 12.41 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.446 -1.861 . . . . 0.92000000000000004 108.446 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.513 ' O ' ' O ' ' A' ' 6' ' ' LEU . 56.4 mt -97.77 -11.41 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.155 -1.203 . . . . 1.5 108.24 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.4 tp 50.87 109.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.591 0.71 . . . . 1.3999999999999999 109.376 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.36 -50.12 8.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.717 -1.239 . . . . 1.26 109.543 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.88 150.26 45.56 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.266 -0.896 . . . . 1.95 109.431 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.48 152.84 30.31 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.383 2.056 . . . . 0.93999999999999995 113.52 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 153.9 121.4 0.81 Allowed Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.319 -1.112 . . . . 0.78000000000000003 110.319 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.2 mt -88.55 133.14 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.079 -1.248 . . . . 1.29 109.818 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.07 161.51 36.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.561 -0.712 . . . . 1.1499999999999999 109.89 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.7 m-85 -130.48 135.92 48.46 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.517 -0.92 . . . . 0.71999999999999997 108.517 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.45 165.26 31.27 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 118.419 -1.848 . . . . 0.5 111.54 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -81.06 150.01 28.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.696 -0.885 . . . . 2.3599999999999999 109.916 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.81 128.78 33.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 1.1599999999999999 111.279 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.9 tp -107.38 95.38 5.66 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.204 -1.406 . . . . 1.24 107.204 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 tp -81.37 122.5 27.55 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.099 -1.001 . . . . 1.3100000000000001 110.844 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.3 98.33 9.89 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.015 -0.538 . . . . 1.3100000000000001 109.644 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -92.23 159.87 15.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 2.3500000000000001 108.798 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.484 ' OE2' ' N ' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -130.13 130.03 44.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.447 -0.783 . . . . 2.5800000000000001 109.083 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.484 ' N ' ' OE2' ' A' ' 21' ' ' GLU . 5.4 m-20 -80.22 131.96 35.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.268 -0.895 . . . . 2.1400000000000001 109.198 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -64.66 146.94 53.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 1.9299999999999999 109.274 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.65 135.35 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 1.28 109.72 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.39 114.49 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.85 -0.796 . . . . 1.3700000000000001 108.85 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.3 mt -90.29 139.61 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 1.3300000000000001 109.778 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -93.19 122.39 35.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.197 -0.939 . . . . 1.3700000000000001 110.029 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -96.31 19.15 12.4 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.283 -0.886 . . . . 3.1899999999999999 109.703 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -80.26 156.36 26.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.97 -1.081 . . . . 2.8100000000000001 109.906 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -90.67 127.69 36.38 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.159 -0.682 . . . . 2.8300000000000001 109.159 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.4 pt -78.87 171.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.006 . . . . 1.3400000000000001 109.58 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.2 p -101.04 163.82 12.1 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.946 -0.761 . . . . 1.3500000000000001 108.946 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.88 -25.92 63.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 1.6100000000000001 109.726 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.85 -12.8 59.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.127 -0.983 . . . . 2.4700000000000002 108.702 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -102.29 -12.31 18.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.639 -0.874 . . . . 2.0699999999999998 108.639 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -67.68 -49.71 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 1.3300000000000001 108.746 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 1.2 m-20 -57.96 -39.89 79.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 1.46 109.919 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -67.54 -36.6 81.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 2.9399999999999999 110.56 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -65.89 -33.23 75.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.972 -1.08 . . . . 1.3 109.528 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.6 t -62.25 -45.13 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 1.3300000000000001 109.276 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -64.29 -32.58 74.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.104 -0.997 . . . . 1.5 108.387 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.491 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 8.2 mtt-85 -66.18 -37.32 85.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.481 -0.762 . . . . 3.1499999999999999 109.083 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 34.6 t80 -86.21 -54.15 4.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.185 -0.947 . . . . 0.92000000000000004 108.903 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 tp -48.78 -66.99 0.31 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.333 -0.854 . . . . 1.4099999999999999 109.091 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 t -64.41 -28.38 69.64 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.784 -0.821 . . . . 1.22 108.784 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -59.93 -54.77 34.68 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 107.527 -2.229 . . . . 0.58999999999999997 107.527 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.45 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.0 OUTLIER -47.39 -30.64 3.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.647 -0.914 . . . . 3.3900000000000001 108.698 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.81 -34.88 76.72 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.211 -1.033 . . . . 1.26 108.211 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' GLY . 31.2 mtpt -82.14 -60.62 2.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.692 -0.63 . . . . 2.9900000000000002 109.646 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.25 -38.55 27.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 1.1399999999999999 109.975 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -65.35 -39.04 91.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.024 -1.047 . . . . 1.8400000000000001 108.922 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.61 64.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.753 -0.592 . . . . 1.22 110.584 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -63.62 -47.79 79.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 2.0 109.965 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.35 -46.42 64.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.922 -1.112 . . . . 1.99 109.455 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -48.15 -52.37 20.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.384 -0.822 . . . . 1.27 109.752 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -60.84 -34.0 73.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 1.24 109.849 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -72.3 -27.98 27.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.186 -0.946 . . . . 1.21 108.899 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -63.51 -42.39 98.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 1.53 109.898 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -72.72 -28.83 62.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.168 -0.957 . . . . 1.24 109.844 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.424 ' O ' ' OG1' ' A' ' 64' ' ' THR . 64.0 mttm -72.45 -25.31 61.4 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.657 -1.238 . . . . 2.3199999999999998 107.657 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.79 -29.95 56.26 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.948 -1.131 . . . . 1.1699999999999999 107.948 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.2 -29.84 24.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.895 -1.282 . . . . 0.57999999999999996 109.895 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -86.34 -16.21 38.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.864 -1.374 . . . . 1.3899999999999999 109.076 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 88.9 m -93.37 -48.89 6.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.89 . . . . 1.3600000000000001 110.065 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -106.93 -16.35 14.48 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.26 -0.9 . . . . 1.1399999999999999 110.793 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.557 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 119.44 142.92 6.89 Favored Glycine 0 N--CA 1.503 3.111 0 N-CA-C 109.486 -1.445 . . . . 0.59999999999999998 109.486 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -49.99 -5.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.397 -1.061 . . . . 2.5899999999999999 110.62 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.557 ' H ' ' C ' ' A' ' 66' ' ' GLY . 34.3 mt-10 -64.02 -24.09 67.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.937 -1.102 . . . . 2.2000000000000002 109.874 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -90.58 -9.44 47.1 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.076 -1.015 . . . . 2.3599999999999999 110.264 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -64.1 -29.63 70.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.003 -1.061 . . . . 1.54 110.893 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -35.96 82.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.826 -1.171 . . . . 1.24 110.105 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.6 mt -73.2 -45.78 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.999 -1.063 . . . . 1.24 109.658 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.62 -23.9 53.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.91 . . . . 0.80000000000000004 109.747 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -64.75 -44.67 89.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.931 -1.105 . . . . 1.23 109.152 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.36 -34.49 80.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.442 -1.463 . . . . 0.56000000000000005 109.442 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -62.65 -20.94 65.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -1.159 . . . . 2.0600000000000001 110.172 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.401 HD11 HG22 ' A' ' 77' ' ' ILE . 80.3 mt -85.29 -38.7 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.762 -1.211 . . . . 1.24 108.337 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.7 ttt -58.65 -39.45 80.61 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.491 -0.929 . . . . 2.4500000000000002 108.491 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tp -64.21 -41.9 96.84 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.867 -0.79 . . . . 1.21 108.867 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.3 tp -68.25 -44.76 74.92 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.759 -0.777 . . . . 1.1200000000000001 109.193 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.16 8.33 21.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.933 . . . . 1.24 110.117 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -47.57 123.55 5.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.822 -1.174 . . . . 1.3100000000000001 109.989 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.38 -26.07 67.09 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.788 -0.819 . . . . 1.3500000000000001 108.788 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.58 -50.47 17.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.346 -0.846 . . . . 2.1600000000000001 109.309 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.94 -16.83 63.79 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.187 -1.005 . . . . 1.24 109.282 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.82 -51.0 12.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 1.28 110.507 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -62.16 -29.92 70.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.139 -0.976 . . . . 1.79 110.232 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -74.14 -44.56 53.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 1.29 109.649 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.95 -57.35 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.09 -1.078 . . . . 1.1399999999999999 108.09 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.7 mt -46.31 -63.57 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.684 -0.635 . . . . 1.3200000000000001 109.786 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.34 -53.74 8.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.245 -0.909 . . . . 1.3700000000000001 110.103 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 57.7 mt -50.03 -54.7 18.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 1.3999999999999999 109.252 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.7 mt -53.53 -42.48 49.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.331 -0.856 . . . . 1.23 110.4 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -85.88 -36.82 19.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.99 -1.069 . . . . 2.5099999999999998 111.563 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -83.25 -38.16 22.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.943 -1.098 . . . . 1.5900000000000001 111.76 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -104.25 9.82 35.89 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.758 -1.214 . . . . 2.3799999999999999 109.804 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.4 m80 49.6 42.34 22.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.922 -1.111 . . . . 1.6200000000000001 109.188 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.5 mtt -97.49 150.78 20.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.082 -0.71 . . . . 1.8899999999999999 109.082 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.449 ' H ' ' HG1' ' A' ' 99' ' ' THR . 11.9 p -75.02 145.64 42.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.494 -0.754 . . . . 1.27 109.767 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.7 -26.27 8.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.218 -0.926 . . . . 1.1599999999999999 108.821 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -75.15 -50.0 17.73 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.589 -0.893 . . . . 2.0 108.589 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.27 -50.94 34.41 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.283 0.563 . . . . 1.25 110.066 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.57 -56.52 20.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 1.1299999999999999 109.888 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.44 62.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.199 -0.938 . . . . 1.0800000000000001 109.271 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -69.37 -21.21 63.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 2.02 109.024 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -70.57 -50.36 38.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.496 -0.752 . . . . 1.26 109.905 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.97 -40.66 89.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.862 -1.149 . . . . 1.1799999999999999 109.299 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.79 -19.48 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.243 -0.91 . . . . 1.1899999999999999 108.942 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -76.88 -34.78 57.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 2.2000000000000002 109.739 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.72 -23.36 46.67 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.104 -1.522 . . . . 0.85999999999999999 111.591 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -69.65 -42.87 73.67 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.822 -1.399 . . . . 2.0 108.638 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.73 -53.68 9.81 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.436 -0.79 . . . . 1.3200000000000001 109.824 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 t -60.55 -28.66 68.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.137 -0.977 . . . . 2.1400000000000001 109.788 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.01 -44.57 79.98 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.966 -1.084 . . . . 1.3799999999999999 110.345 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.9 -24.75 66.91 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.88 -1.138 . . . . 1.3500000000000001 109.003 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.73 -19.78 65.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 1.95 109.485 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -82.48 -7.03 59.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.196 -0.94 . . . . 1.71 109.513 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.1 mt -86.42 156.91 19.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.323 -0.861 . . . . 1.71 108.824 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -104.79 58.72 0.69 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.842 -0.799 . . . . 2.8300000000000001 108.842 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -150.31 118.77 6.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.25 -0.906 . . . . 1.5800000000000001 109.384 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -64.26 -9.59 18.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 2.7999999999999998 110.057 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -77.05 -61.22 2.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.184 -0.948 . . . . 1.27 109.444 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.4 mt -66.48 -26.64 67.27 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.276 -0.89 . . . . 1.5800000000000001 109.629 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 127' ' ' ALA . 47.7 tttp -67.2 -53.46 30.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 2.9199999999999999 108.582 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -55.97 -25.14 42.53 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.611 -0.885 . . . . 2.2000000000000002 108.611 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -72.94 -24.73 60.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.774 -1.565 . . . . 2.5299999999999998 106.774 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.88 -41.34 95.77 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.643 -0.873 . . . . 1.45 108.643 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.44 -38.12 86.67 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.423 -0.954 . . . . 1.5 108.423 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -71.51 -25.81 62.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 1.3500000000000001 109.286 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.44 -47.5 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.329 -0.857 . . . . 1.23 108.908 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -55.39 -36.49 66.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.876 -1.14 . . . . 3.73 108.283 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.13 -37.13 83.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.595 -0.69 . . . . 1.3200000000000001 110.718 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.5 mt -67.5 -25.08 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.981 -1.074 . . . . 1.2 109.655 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.56 -46.64 9.62 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.025 -1.63 . . . . 0.48999999999999999 109.025 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -48.58 -42.46 33.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.484 -1.009 . . . . 3.1099999999999999 109.677 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.431 ' HG2' HH11 ' A' ' 136' ' ' ARG . 24.4 mtt-85 -63.54 -52.32 61.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.095 -1.003 . . . . 2.9500000000000002 108.553 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.9 tp -51.2 -41.36 60.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.748 -0.595 . . . . 1.73 109.854 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 140' ' ' ASN . 11.2 mt -66.9 -61.31 2.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 1.22 110.008 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -43.95 -19.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.403 -0.811 . . . . 2.7799999999999998 110.858 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.491 ' ND2' ' N ' ' A' ' 140' ' ' ASN . 1.8 m120 -85.46 -34.1 21.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.04 -1.038 . . . . 2.0299999999999998 109.925 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.2 mt -73.45 -33.3 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.043 -1.036 . . . . 1.2 108.805 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 55.8 mt -86.73 3.08 46.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.334 -0.854 . . . . 1.28 109.344 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.06 27.73 23.36 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.433 -1.867 . . . . 0.68999999999999995 108.433 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.64 148.51 28.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.526 -0.985 . . . . 1.3100000000000001 109.443 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -66.56 132.81 49.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 2.8799999999999999 109.403 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 76.6 mt -102.13 134.59 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.383 -0.823 . . . . 1.3600000000000001 109.027 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.93 133.32 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 1.9299999999999999 110.09 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -98.53 88.46 4.11 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.614 -0.884 . . . . 1.54 108.614 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.0 mt -78.75 -30.08 45.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.318 -0.864 . . . . 1.3400000000000001 110.011 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 m -81.85 30.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 1.98 109.57 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.23 32.38 2.13 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.243 -0.91 . . . . 1.3799999999999999 109.129 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.43 152.56 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.369 -0.832 . . . . 1.3999999999999999 110.13 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -129.22 -10.19 4.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.538 -0.912 . . . . 2.7400000000000002 108.538 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 154' ' ' ASP . 0.7 OUTLIER -120.1 127.37 52.47 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.424 -0.798 . . . . 1.4099999999999999 109.17 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.92 124.09 20.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 1.3 109.614 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.83 175.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.194 -0.941 . . . . 1.28 109.411 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.8 mt -88.11 153.68 3.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.605 -1.257 . . . . 1.1499999999999999 107.605 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.5 tp -104.49 117.29 33.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.443 -0.786 . . . . 1.2 109.041 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 35.6 t -120.57 133.11 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.603 -0.888 . . . . 1.1599999999999999 108.603 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.58 143.21 11.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.373 -0.829 . . . . 1.2 109.039 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.42 -27.05 67.17 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.614 -1.304 . . . . 1.3200000000000001 107.909 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 20.2 t0 -172.27 145.45 1.71 Allowed 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.69 -0.631 . . . . 2.3399999999999999 109.59 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.527 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 25.3 mt -119.74 130.34 54.94 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.557 -0.905 . . . . 1.26 108.557 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.6 p -93.34 148.3 35.32 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.976 -1.078 . . . . 1.3600000000000001 109.677 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 169' ' ' ALA . 78.3 Cg_exo -36.96 -49.16 1.52 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.594 2.196 . . . . 0.63 112.327 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.8 m -51.41 -59.81 3.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 1.0700000000000001 109.228 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -53.57 -41.33 66.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -0.876 . . . . 1.25 109.432 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 19.4 p -73.59 -22.57 60.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 1.1799999999999999 110.013 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -76.61 -26.87 55.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.115 -0.991 . . . . 1.1399999999999999 110.066 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -105.15 -10.89 16.83 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.15 -0.969 . . . . 1.71 109.944 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.36 156.02 10.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.153 -0.967 . . . . 1.22 109.169 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -98.51 132.34 44.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.012 -1.055 . . . . 2.5499999999999998 108.233 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 9.4 mp -82.17 -44.67 16.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 1.96 111.238 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -83.44 -8.72 59.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.826 -1.171 . . . . 2.46 112.111 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -98.65 -8.54 26.1 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.612 -1.305 . . . . 2.4199999999999999 108.77 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.0 t -98.2 161.19 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.211 -1.033 . . . . 1.1599999999999999 108.211 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.3 tp -108.61 -23.97 11.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.313 -0.867 . . . . 1.95 109.907 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -178.33 174.41 46.68 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.942 -1.663 . . . . 0.41999999999999998 108.942 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -129.43 122.44 29.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.588 -0.948 . . . . 0.52000000000000002 108.992 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 12.9 mt -128.43 128.11 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.377 -0.971 . . . . 1.1599999999999999 108.377 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 203' ' ' VAL . 47.7 p -141.3 146.52 36.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.483 -0.761 . . . . 1.22 111.467 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.499 ' CG ' ' HG1' ' A' ' 209' ' ' THR . 2.8 m-20 -85.73 41.99 0.94 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -0.782 . . . . 2.2400000000000002 109.501 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.017 0 O-C-N 121.387 -0.821 . . . . 1.6499999999999999 109.727 -179.44 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.3 t60 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.034 -0.728 . . . . 1.0600000000000001 109.034 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -36.24 68.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.23 -0.919 . . . . 2.0899999999999999 108.937 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.5 t -75.0 -37.71 61.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.869 . . . . 1.8799999999999999 109.079 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 88.6 mt -50.51 -32.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.159 -0.963 . . . . 2.0099999999999998 108.647 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.5 mtm -71.78 -51.51 22.29 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 106.947 -1.501 . . . . 1.27 106.947 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.44 -39.01 66.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.071 -0.714 . . . . 1.1799999999999999 109.071 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -69.18 -51.69 35.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 3.5800000000000001 109.351 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.8 m -68.88 -36.62 78.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 1.1399999999999999 109.344 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 199' ' ' LEU . 39.5 mt -86.83 3.69 44.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.179 -0.95 . . . . 1.28 108.667 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 52.75 2.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 1.49 110.873 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.532 ' H ' ' C ' ' A' ' 197' ' ' LEU . 21.9 mt -64.74 169.37 5.35 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.654 -1.279 . . . . 1.28 107.751 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -90.38 143.94 3.87 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.16 1.907 . . . . 0.69999999999999996 111.684 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.62 175.86 10.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.706 -1.246 . . . . 1.1899999999999999 111.491 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 10.8 mt -150.78 155.01 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.786 -1.561 . . . . 1.25 106.786 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.6 m -143.51 -29.08 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 120.689 -1.257 . . . . 1.29 111.273 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.15 30.95 3.85 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.993 -1.243 . . . . 0.92000000000000004 109.993 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 207' ' ' SER . 3.2 p -61.61 -38.84 89.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.726 -1.455 . . . . 1.3100000000000001 107.806 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 57.36 -33.43 0.02 OUTLIER Glycine 0 N--CA 1.498 2.769 0 CA-C-O 119.684 -0.509 . . . . 1.0 113.851 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 205' ' ' THR . 95.2 p -124.83 1.14 8.09 Favored 'General case' 0 N--CA 1.512 2.646 0 CA-C-N 119.613 1.706 . . . . 1.9199999999999999 112.652 -177.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 t -65.44 -48.39 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.144 -1.597 . . . . 1.27 109.753 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.499 ' HG1' ' CG ' ' A' ' 182' ' ' ASP . 12.4 p -54.64 -16.1 2.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.884 -1.135 . . . . 1.3400000000000001 110.045 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.1 t -104.13 11.72 34.77 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.316 -0.865 . . . . 2.0699999999999998 109.65 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -142.25 -3.82 1.05 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.288 -0.882 . . . . 2.8599999999999999 110.411 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.75 145.18 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.433 -0.792 . . . . 1.3 108.936 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -120.55 172.98 7.46 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.515 -1.661 . . . . 2.48 106.515 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -74.25 141.13 45.38 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.722 -1.236 . . . . 2.6200000000000001 109.801 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.33 -10.12 1.22 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.807 -0.558 . . . . 2.3999999999999999 110.359 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -56.86 141.32 45.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.675 -1.265 . . . . 1.99 107.994 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -87.18 111.64 21.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.954 -1.091 . . . . 1.54 109.19 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 20.7 mt -121.41 168.32 11.81 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.992 0.901 . . . . 1.25 110.52 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.9 mt -140.46 123.56 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.192 -1.04 . . . . 1.26 108.192 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.72 128.6 36.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.925 . . . . 1.1799999999999999 109.169 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.27 -38.16 11.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.108 -0.995 . . . . 2.2200000000000002 108.923 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.431 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 44.78 25.0 0.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.63 -0.669 . . . . 1.2 110.53 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.15 -62.24 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 106.981 -1.488 . . . . 1.48 106.981 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -87.59 14.46 8.31 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.95 -1.13 . . . . 2.8199999999999998 107.95 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.64 57.66 3.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.68 -0.638 . . . . 2.1099999999999999 109.677 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -156.76 151.8 26.17 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.024 -1.048 . . . . 2.6499999999999999 110.833 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.55 137.54 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.901 -0.777 . . . . 1.29 108.901 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -107.14 131.72 53.82 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.21 -0.931 . . . . 1.4199999999999999 109.273 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.6 t -103.79 118.19 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 1.26 109.802 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 50.87 69.62 2.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 2.1499999999999999 109.989 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.96 157.97 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.66 2.24 . . . . 0.81999999999999995 111.347 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 80.3 p -72.76 144.9 47.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 2.1099999999999999 109.883 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.636 ' N ' HD21 ' A' ' 233' ' ' ASN . 0.8 OUTLIER -53.02 -27.72 20.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.43 -0.794 . . . . 3.1699999999999999 109.742 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -64.54 -37.3 87.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 3.0600000000000001 109.734 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 80.1 t -77.81 -36.16 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.243 -0.91 . . . . 1.6499999999999999 109.137 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.37 -58.74 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 1.47 109.438 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 233' ' ' ASN . 2.5 m-20 -53.33 -36.53 61.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 2.54 109.51 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -67.24 -36.9 82.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 3.0 108.97 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 62.0 mtp -80.18 -34.6 37.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.409 -0.807 . . . . 1.6299999999999999 109.463 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -54.87 -38.76 67.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 3.1600000000000001 109.459 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.97 -57.21 4.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 2.0899999999999999 109.689 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 73.9 t -58.74 -50.79 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.422 -0.799 . . . . 2.5699999999999998 110.275 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.37 -58.41 7.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.943 -1.098 . . . . 3.5899999999999999 110.148 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 C--N 1.298 -1.663 0 O-C-N 121.288 -0.882 . . . . 1.76 110.275 -179.038 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.518 -0.549 . . . . 4.0700000000000003 109.518 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.07 103.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 1.5 109.361 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -93.08 120.22 33.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.329 -0.857 . . . . 1.8 110.033 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.67 -160.19 11.6 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 108.41 -1.876 . . . . 0.92000000000000004 108.41 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.0 mt -93.55 -9.96 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.995 -1.297 . . . . 1.5 109.029 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' ILE . 14.2 tp 56.94 107.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 1.3999999999999999 109.306 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.52 -53.61 4.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.081 -1.012 . . . . 1.26 108.318 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.95 146.16 25.0 Favored Pre-proline 0 N--CA 1.494 1.741 0 N-CA-C 108.582 -0.896 . . . . 1.95 108.582 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.3 153.37 31.37 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.069 1.846 . . . . 0.93999999999999995 113.148 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 151.68 124.1 1.1 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.051 -1.22 . . . . 0.78000000000000003 110.051 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 11' ' ' ILE . 72.7 mt -89.36 129.01 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.132 -1.216 . . . . 1.29 109.566 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.16 149.22 49.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.383 -0.823 . . . . 1.1499999999999999 109.572 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.9 m-85 -117.87 140.06 50.24 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.626 -0.879 . . . . 0.71999999999999997 108.626 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.65 163.47 29.96 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.725 -1.702 . . . . 0.5 111.24 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -78.57 151.71 32.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.991 . . . . 2.3599999999999999 109.902 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.21 129.32 34.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 1.1599999999999999 111.114 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -111.82 90.84 3.45 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.193 -1.41 . . . . 1.24 107.193 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.38 128.72 34.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.059 -1.025 . . . . 1.3100000000000001 110.687 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.2 mt -96.88 93.99 6.97 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.454 0.645 . . . . 1.3100000000000001 109.854 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -93.07 156.35 16.93 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.54 -0.911 . . . . 2.3500000000000001 108.54 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.02 131.3 44.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.247 -0.908 . . . . 2.5800000000000001 109.036 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.92 138.63 38.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.148 -0.97 . . . . 2.1400000000000001 108.924 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.23 140.68 58.9 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.45 -0.781 . . . . 1.9299999999999999 109.282 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mt -91.69 132.96 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.215 -0.928 . . . . 1.28 109.917 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.8 t -106.61 111.98 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.637 -0.875 . . . . 1.3700000000000001 108.637 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.2 mt -85.07 152.2 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.941 . . . . 1.3300000000000001 109.586 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -90.89 107.54 19.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.497 -0.752 . . . . 1.3700000000000001 109.927 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.478 ' NH1' ' CB ' ' A' ' 102' ' ' ALA . 20.4 mmm180 -95.46 24.57 5.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.277 -0.889 . . . . 3.1899999999999999 108.754 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -85.85 144.04 27.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.371 -0.831 . . . . 2.8100000000000001 109.79 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -86.72 123.97 32.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.213 -0.929 . . . . 2.8300000000000001 108.824 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.2 pt -87.22 174.89 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.16 -0.962 . . . . 1.3400000000000001 110.599 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 34' ' ' ASP . 52.2 p -100.84 156.41 17.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.842 -0.799 . . . . 1.3500000000000001 108.842 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.9 -8.44 0.99 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 1.6100000000000001 109.47 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 32' ' ' SER . 6.7 m-20 -83.95 -21.28 31.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 2.4700000000000002 109.898 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -105.9 -1.36 24.22 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.329 -0.857 . . . . 2.0699999999999998 109.327 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -64.95 -44.85 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.975 . . . . 1.3300000000000001 108.742 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -52.34 -36.46 53.57 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.262 -0.899 . . . . 1.46 109.19 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -69.46 -34.3 74.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.476 -0.765 . . . . 2.9399999999999999 110.152 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.433 ' OE2' ' NH2' ' A' ' 42' ' ' ARG . 80.4 mm-40 -62.55 -43.34 99.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.999 -1.063 . . . . 1.3 109.715 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 44' ' ' LEU . 82.2 t -59.84 -48.58 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 1.3300000000000001 110.035 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -66.55 -44.77 81.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.012 -1.055 . . . . 1.5 108.991 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.433 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 72.1 mtm180 -61.36 -33.97 74.53 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.108 -0.995 . . . . 3.1499999999999999 108.895 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -86.35 -54.43 4.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.92000000000000004 108.945 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 40' ' ' VAL . 57.3 tp -51.01 -66.77 0.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.469 -0.77 . . . . 1.4099999999999999 109.493 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 t -63.19 -30.15 71.35 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.952 -1.093 . . . . 1.22 108.154 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.85 -8.01 51.34 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 107.347 -2.301 . . . . 0.58999999999999997 107.347 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.2 OUTLIER -85.02 -29.02 25.31 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.126 -1.805 . . . . 3.3900000000000001 106.126 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.36 64.17 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.941 -1.133 . . . . 1.26 107.941 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -84.91 -64.22 1.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.919 -0.771 . . . . 2.9900000000000002 108.919 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.32 -41.89 51.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.978 . . . . 1.1399999999999999 109.514 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.9 m -63.36 -37.93 89.18 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.011 -1.107 . . . . 1.8400000000000001 108.011 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.36 -21.51 60.51 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.401 -0.592 . . . . 1.22 109.401 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.649 HE22 ' ND2' ' A' ' 140' ' ' ASN . 74.0 mt-30 -73.45 -68.35 0.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 2.0 109.471 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 58' ' ' LYS . 13.7 mt -48.93 -42.52 37.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.064 -1.022 . . . . 1.99 108.839 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -50.55 -48.76 57.3 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.448 -0.945 . . . . 1.27 108.448 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -61.96 -40.37 95.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 1.24 109.053 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.6 mt -74.71 -25.14 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 1.21 108.879 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.589 ' HZ1' ' CG ' ' A' ' 70' ' ' GLU . 13.3 ttpp -64.31 -52.52 58.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.564 -0.71 . . . . 1.53 110.219 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.33 -25.45 63.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.968 -1.083 . . . . 1.24 109.794 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -71.63 -24.12 61.81 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.904 -1.122 . . . . 2.3199999999999998 108.029 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.74 -32.87 60.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.367 -0.975 . . . . 1.1699999999999999 108.367 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.73 -28.77 28.35 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.842 -1.303 . . . . 0.57999999999999996 109.842 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -86.42 -14.99 41.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.28 . . . . 1.3899999999999999 108.784 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.2 m -92.84 -51.4 5.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 1.3600000000000001 110.054 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -106.85 -21.77 12.91 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.305 -0.872 . . . . 1.1399999999999999 110.44 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.87 153.6 9.1 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 109.77 -1.332 . . . . 0.59999999999999998 109.77 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -48.87 -8.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.508 -0.995 . . . . 2.5899999999999999 110.464 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 66' ' ' GLY . 39.8 tt0 -63.91 -42.61 97.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 2.2000000000000002 110.377 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -90.81 -10.01 44.37 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.014 -1.054 . . . . 2.3599999999999999 110.494 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.589 ' CG ' ' HZ1' ' A' ' 58' ' ' LYS . 34.1 tt0 -67.04 -31.04 71.29 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.942 -1.099 . . . . 1.54 110.809 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.91 68.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.097 -1.002 . . . . 1.24 110.41 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.482 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 39.7 mt -72.04 -42.56 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.036 -1.04 . . . . 1.24 109.771 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -76.71 -19.21 57.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.097 -1.002 . . . . 0.80000000000000004 109.307 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.07 -49.32 72.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.26 -0.9 . . . . 1.23 108.704 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.38 82.17 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.312 -1.515 . . . . 0.56000000000000005 109.312 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.482 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 23.5 m170 -60.57 -24.39 65.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -1.204 . . . . 2.0600000000000001 110.036 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.5 mt -81.15 -36.18 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.727 -1.233 . . . . 1.24 108.546 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.9 ttp -58.02 -43.84 86.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.537 -0.912 . . . . 2.4500000000000002 108.537 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -57.31 -42.52 81.98 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.757 -0.831 . . . . 1.21 108.757 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.12 -41.48 77.32 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.352 -0.842 . . . . 1.1200000000000001 109.258 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -85.4 8.39 19.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.414 -0.803 . . . . 1.24 110.225 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 59.5 t0 -50.05 123.44 8.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.947 -1.096 . . . . 1.3100000000000001 109.484 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.55 -22.67 65.39 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.301 -0.875 . . . . 1.3500000000000001 108.911 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.403 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 45.3 mm-40 -76.76 -49.52 15.75 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.393 -0.817 . . . . 2.1600000000000001 109.318 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.9 mt -64.28 -15.32 59.95 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.292 -0.963 . . . . 1.24 109.242 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -82.9 -46.4 13.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 1.28 110.458 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -62.41 -30.19 71.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.13 -0.981 . . . . 1.79 109.906 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -73.29 -43.57 60.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.023 -1.048 . . . . 1.29 109.01 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.06 -56.96 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.492 -0.929 . . . . 1.1399999999999999 108.492 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.0 mt -48.9 -66.17 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.696 -0.627 . . . . 1.3200000000000001 110.417 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -43.1 -58.9 2.26 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.44 -0.788 . . . . 1.3700000000000001 110.876 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.0 mt -45.87 -54.35 8.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.317 -0.864 . . . . 1.3999999999999999 110.024 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.1 mt -50.86 -41.2 21.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.07 -1.019 . . . . 1.23 109.757 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -85.76 -38.53 18.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.277 -0.889 . . . . 2.5099999999999998 111.594 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -82.22 -40.25 21.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.901 -1.124 . . . . 1.5900000000000001 111.912 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -108.03 16.54 23.29 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.721 -1.237 . . . . 2.3799999999999999 110.162 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.9 m80 44.85 48.76 9.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.205 -0.935 . . . . 1.6200000000000001 109.525 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.7 mtt -100.72 147.47 25.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 1.8899999999999999 109.261 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.1 p -75.68 143.75 41.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.313 -0.867 . . . . 1.27 109.164 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.12 -25.62 2.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 1.1599999999999999 108.887 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.55 -48.97 23.71 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.534 -0.913 . . . . 2.0 108.534 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.478 ' CB ' ' NH1' ' A' ' 28' ' ' ARG . . . -70.51 -53.61 15.53 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.779 -0.575 . . . . 1.25 110.013 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.68 -46.7 77.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 1.1299999999999999 109.411 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.89 66.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 1.0800000000000001 109.478 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -69.75 -36.47 75.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 2.02 109.567 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -53.67 -50.54 65.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.832 . . . . 1.26 110.314 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.16 -49.02 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.975 -1.078 . . . . 1.1799999999999999 109.601 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -63.12 -19.27 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.429 -0.794 . . . . 1.1899999999999999 109.046 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -73.85 -37.53 64.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.992 . . . . 2.2000000000000002 109.952 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.02 -26.57 31.0 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.524 -1.322 . . . . 0.85999999999999999 112.619 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -67.68 -47.05 70.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.528 -1.572 . . . . 2.0 108.948 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.04 -50.38 23.36 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.604 -0.685 . . . . 1.3200000000000001 109.218 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -59.27 -42.28 90.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.78 . . . . 2.1400000000000001 110.039 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.3 86.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.125 -0.984 . . . . 1.3799999999999999 110.905 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.3 -29.59 68.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.735 -1.228 . . . . 1.3500000000000001 109.426 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -67.54 -15.87 63.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.935 . . . . 1.95 109.627 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.43 -9.06 59.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.94 . . . . 1.71 109.278 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.36 146.54 25.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 1.71 108.636 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 20.5 p-10 -100.6 62.71 1.05 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.45 -0.781 . . . . 2.8300000000000001 109.311 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 122' ' ' TYR . 44.7 t0 -150.08 113.5 4.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 1.5800000000000001 109.522 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -53.6 -12.28 0.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 2.7999999999999998 109.607 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.411 ' H ' ' C ' ' A' ' 120' ' ' ASP . 1.1 t80 -79.74 -62.19 1.76 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.933 . . . . 1.27 109.072 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.6 mt -71.01 -27.47 63.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.88 . . . . 1.5800000000000001 109.599 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -68.08 -52.52 34.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.061 -1.024 . . . . 2.9199999999999999 108.831 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.28 -20.9 58.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.423 -0.954 . . . . 2.2000000000000002 108.423 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.555 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -72.55 -26.96 61.93 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.485 -1.672 . . . . 2.5299999999999998 106.485 178.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.24 -44.09 92.35 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.284 -1.006 . . . . 1.45 108.284 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.09 80.82 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.818 -0.808 . . . . 1.5 108.818 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -70.07 -32.17 70.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.42 -0.8 . . . . 1.3500000000000001 109.371 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.2 t -77.83 -45.99 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 1.23 108.37 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -57.48 -39.97 77.58 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.263 -1.014 . . . . 3.73 108.263 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.51 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 14.5 t70 -56.27 -39.32 72.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.563 -0.71 . . . . 1.3200000000000001 109.637 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.47 -20.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.163 -0.96 . . . . 1.2 108.881 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.69 -53.53 4.27 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.943 -1.263 . . . . 0.48999999999999999 109.943 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -49.04 -39.48 27.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.012 -1.287 . . . . 3.1099999999999999 108.832 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' A' ' 136' ' ' ARG . 3.1 mtt-85 -65.16 -45.97 82.78 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.282 -1.007 . . . . 2.9500000000000002 108.282 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.5 tp -53.61 -45.13 69.98 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.042 -0.725 . . . . 1.73 109.042 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 140' ' ' ASN . 18.2 mt -60.41 -60.2 4.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 1.22 109.435 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -43.97 -20.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 2.7799999999999998 110.324 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.649 ' ND2' HE22 ' A' ' 53' ' ' GLN . 1.8 m120 -85.4 -49.92 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 2.0299999999999998 109.665 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -61.91 -35.43 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 1.2 109.541 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.6 mt -88.49 -4.45 58.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.871 . . . . 1.28 109.17 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.67 22.54 46.94 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.466 -1.854 . . . . 0.68999999999999995 108.466 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.02 162.46 14.03 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.538 -0.977 . . . . 1.3100000000000001 109.318 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -65.06 151.21 46.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 2.8799999999999999 109.528 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.3 mt -107.62 144.36 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 109.166 -0.679 . . . . 1.3600000000000001 109.166 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.1 mm -76.77 100.54 2.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.236 -0.915 . . . . 1.9299999999999999 109.138 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.71 92.7 6.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.407 -0.808 . . . . 1.54 109.591 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.484 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 34.2 mt -79.56 -11.8 59.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 1.3400000000000001 108.924 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.8 p -86.37 47.16 1.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 1.98 108.768 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.08 16.6 3.25 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.382 -0.823 . . . . 1.3799999999999999 110.199 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.484 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 2.4 mp -69.04 151.79 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.856 -1.152 . . . . 1.3999999999999999 108.884 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -133.28 -22.32 1.99 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.05 -0.722 . . . . 2.7400000000000002 109.05 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.97 151.36 36.88 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.68 -0.859 . . . . 1.4099999999999999 108.68 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.61 124.73 24.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 1.3 109.835 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.2 m -148.27 167.71 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.199 -0.938 . . . . 1.28 109.339 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.6 mt -89.5 156.99 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.789 -1.189 . . . . 1.1499999999999999 107.789 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.6 tp -107.23 121.67 45.0 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.732 0.777 . . . . 1.2 109.69 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.16 128.6 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.659 -0.867 . . . . 1.1599999999999999 108.659 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.74 152.29 13.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 1.2 109.9 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.77 -43.1 94.49 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.374 -1.453 . . . . 1.3200000000000001 107.949 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -172.34 153.27 2.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 2.3399999999999999 109.458 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.1 mt -125.69 133.89 52.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.571 -0.706 . . . . 1.26 109.399 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.4 p -93.04 154.39 41.71 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.822 . . . . 1.3600000000000001 109.084 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -33.9 -51.33 0.56 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.808 2.339 . . . . 0.63 112.948 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.7 m -50.03 -50.35 47.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.099 -1.001 . . . . 1.0700000000000001 109.289 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.99 -42.28 98.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.855 . . . . 1.25 109.846 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.4 p -70.49 -31.34 68.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 1.1799999999999999 109.563 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.62 -29.74 68.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 1.1399999999999999 110.011 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -103.53 -4.31 24.11 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.25 -0.906 . . . . 1.71 110.15 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 tp -57.71 153.14 14.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.91 -1.118 . . . . 1.22 108.275 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.682 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.2 OUTLIER -99.5 90.55 4.55 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.147 -0.971 . . . . 2.5499999999999998 110.3 -178.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.56 32.18 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 1.96 108.674 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 172' ' ' ASN . 67.6 mttm -111.12 -24.55 10.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.63 -0.669 . . . . 2.46 109.811 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -132.13 6.64 4.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.473 -0.767 . . . . 2.4199999999999999 109.796 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 39.4 t -79.27 154.78 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.087 -1.008 . . . . 1.1599999999999999 109.031 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.38 -28.21 8.31 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.714 -0.616 . . . . 1.95 110.154 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -176.91 177.96 48.16 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.91 -1.276 . . . . 0.41999999999999998 109.91 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -129.36 125.53 36.85 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.519 -0.989 . . . . 0.52000000000000002 110.022 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 16.8 mt -128.15 118.99 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.635 -1.246 . . . . 1.1599999999999999 107.635 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 203' ' ' VAL . 20.8 p -141.83 152.53 43.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.54 -0.725 . . . . 1.22 111.169 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 26.5 p30 -87.66 45.06 1.24 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.991 -1.068 . . . . 2.2400000000000002 110.823 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -95.92 103.4 15.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.961 -1.087 . . . . 1.6499999999999999 109.326 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.89 39.4 1.79 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.848 -1.301 . . . . 2.1000000000000001 109.848 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -96.87 116.43 5.48 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.029 -1.229 . . . . 1.8400000000000001 110.029 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -52.72 -17.03 1.13 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.223 -1.163 . . . . 5.7800000000000002 108.305 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 58.7 p -140.26 59.12 1.57 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.544 -0.722 . . . . 3.2400000000000002 109.172 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.1 t -80.17 142.99 34.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.884 . . . . 2.1099999999999999 108.958 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -45.91 -55.36 6.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.19 -0.944 . . . . 1.0600000000000001 110.044 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.7 t -46.91 -25.87 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 2.0899999999999999 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.0 p -78.92 -45.88 19.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 1.8799999999999999 109.884 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.5 mt -52.49 -32.58 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 2.0099999999999998 109.674 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.9 mtp -71.46 -51.91 21.28 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.363 -1.347 . . . . 1.27 107.363 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.71 58.82 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.628 -0.714 . . . . 1.1799999999999999 109.573 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.468 ' HG2' HH11 ' A' ' 195' ' ' ARG . 17.3 mtt-85 -76.95 -50.87 12.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 3.5800000000000001 109.904 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 61.1 m -68.7 -35.33 77.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 1.1399999999999999 109.738 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' A' ' 199' ' ' LEU . 27.2 mt -87.13 1.49 52.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.265 -0.897 . . . . 1.28 109.092 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 49.19 3.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.559 -0.713 . . . . 1.49 111.631 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 197' ' ' LEU . 40.7 mt -66.01 169.82 6.24 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.491 -1.381 . . . . 1.28 108.382 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -89.86 141.7 3.79 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.249 1.966 . . . . 0.69999999999999996 111.054 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.08 179.74 7.29 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.468 -1.293 . . . . 1.1899999999999999 110.65 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 203' ' ' VAL . 70.6 mt -147.66 160.93 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 106.82 -1.548 . . . . 1.25 106.82 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 183' ' ' ALA . 18.1 m -141.58 -28.17 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.873 -1.142 . . . . 1.29 110.918 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.36 38.5 3.18 Favored Glycine 0 N--CA 1.496 2.667 0 O-C-N 120.888 -1.132 . . . . 0.92000000000000004 110.987 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 20.1 p -67.2 -29.11 68.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.67 -1.488 . . . . 1.3100000000000001 108.77 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 76.7 -98.69 1.3 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.788 -1.196 . . . . 1.0 111.238 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.9 p -113.27 43.47 1.73 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.001 -1.294 . . . . 1.9199999999999999 112.395 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.8 -28.51 15.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.651 -1.281 . . . . 1.27 107.65 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.4 p -64.71 -12.98 52.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.287 -0.883 . . . . 1.3400000000000001 108.917 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.1 p -108.51 17.1 22.41 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.662 -0.866 . . . . 2.0699999999999998 108.662 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -131.55 -16.19 3.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.668 -0.645 . . . . 2.8599999999999999 109.668 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 71.1 t -120.38 164.07 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.457 -0.777 . . . . 1.3 109.597 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.465 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 0.5 OUTLIER -126.58 174.21 8.86 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.841 -1.54 . . . . 2.48 106.841 178.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 214' ' ' ASN . 1.4 p-10 -75.02 145.74 42.18 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.786 -1.197 . . . . 2.6200000000000001 109.824 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.6 OUTLIER 80.38 -12.12 1.07 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.803 -0.561 . . . . 2.3999999999999999 110.249 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -57.25 150.95 16.78 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.002 -1.061 . . . . 1.99 108.429 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -87.29 110.71 20.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.91 -1.119 . . . . 1.54 108.887 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 16.2 mt -106.22 160.92 14.97 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.89 0.853 . . . . 1.25 109.65 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.2 mt -141.94 107.75 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.725 -1.213 . . . . 1.26 107.725 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.5 tp -86.49 126.44 34.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.79 -0.818 . . . . 1.1799999999999999 108.79 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.0 -53.64 4.18 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.541 -0.911 . . . . 2.2200000000000002 108.541 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.422 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 58.51 22.87 10.14 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.413 -0.804 . . . . 1.2 109.24 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.0 t -117.83 -56.14 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.11 -1.441 . . . . 1.48 107.11 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -96.41 13.25 28.46 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.539 -1.282 . . . . 2.8199999999999998 107.539 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 59.81 60.19 2.26 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.074 0.464 . . . . 2.1099999999999999 109.916 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -157.08 147.62 21.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 2.6499999999999999 110.52 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.8 t -109.72 131.17 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.678 -0.86 . . . . 1.29 108.678 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -103.66 131.31 50.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.203 -0.936 . . . . 1.4199999999999999 109.344 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.5 t -102.97 114.8 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.446 -0.784 . . . . 1.26 109.716 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 36.8 t30 45.24 60.88 12.82 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.424 -0.798 . . . . 2.1499999999999999 110.571 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.35 165.06 32.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.283 1.989 . . . . 0.81999999999999995 111.415 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.9 m -72.27 158.04 36.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 2.1099999999999999 109.804 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -64.48 -22.35 66.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 3.1699999999999999 109.031 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 234' ' ' GLU . 0.8 OUTLIER -66.91 -36.8 83.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.434 -0.791 . . . . 3.0600000000000001 109.129 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 68.7 t -79.01 -48.94 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.248 -0.908 . . . . 1.6499999999999999 108.704 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.93 -59.09 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.408 -0.807 . . . . 1.47 109.651 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -52.12 -41.3 62.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 2.54 109.961 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -66.84 -37.65 84.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 3.0 109.739 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.504 ' O ' ' N ' ' A' ' 243' ' ' GLN . 28.5 mtm -81.94 -32.96 30.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.908 . . . . 1.6299999999999999 109.676 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -53.81 -40.03 66.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 3.1600000000000001 109.087 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.48 -51.65 12.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 2.0899999999999999 109.421 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.4 -47.11 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 2.5699999999999998 109.527 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 239' ' ' MET . 3.1 tm0? -47.56 -57.45 5.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 3.5899999999999999 109.818 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.26 -28.7 70.2 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.439 -0.788 . . . . 1.76 110.732 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -66.35 -21.9 66.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.68 -1.263 . . . . 3.21 107.849 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 95.8 t -77.51 -36.51 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.226 -1.027 . . . . 2.3500000000000001 108.226 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.6 -35.39 60.82 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.28 -1.007 . . . . 2.3999999999999999 108.28 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.0 t -75.55 -29.28 59.35 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.925 -0.768 . . . . 3.0299999999999998 108.925 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 . . . . . 0 N--CA 1.486 1.353 0 N-CA-C 107.432 -1.321 . . . . 3.4100000000000001 107.432 178.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.569 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.9 mpt? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.56 -0.533 . . . . 4.0700000000000003 109.56 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.23 94.18 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.584 -0.895 . . . . 1.5 108.584 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.7 m -96.16 115.86 28.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.31 -0.869 . . . . 1.8 109.894 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.8 -163.5 21.41 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.332 -1.907 . . . . 0.92000000000000004 108.332 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.472 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 51.1 mt -95.88 -6.15 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -1.171 . . . . 1.5 108.427 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 tp 60.21 107.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.419 -0.801 . . . . 1.3999999999999999 108.915 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.63 -55.58 3.92 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.982 -1.118 . . . . 1.26 107.982 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.23 150.27 37.44 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.32 -0.993 . . . . 1.95 108.32 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.47 154.18 21.07 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.087 1.858 . . . . 0.93999999999999995 113.954 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.08 -176.07 37.69 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.666 -1.373 . . . . 0.78000000000000003 109.666 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.7 mt -146.18 121.72 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.726 -1.455 . . . . 1.29 109.171 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.72 162.54 34.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.267 -0.896 . . . . 1.1499999999999999 109.733 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.9 m-85 -129.34 140.25 51.45 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.196 -1.039 . . . . 0.71999999999999997 108.196 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.18 159.76 28.15 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 118.612 -1.756 . . . . 0.5 111.319 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -78.47 150.81 32.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.615 -0.933 . . . . 2.3599999999999999 109.724 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.42 127.95 34.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.284 -0.885 . . . . 1.1599999999999999 110.913 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.6 85.35 2.18 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.472 -1.307 . . . . 1.24 107.472 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 15.6 tp -82.01 132.23 35.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.055 -1.028 . . . . 1.3100000000000001 110.617 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.3 mt -94.92 94.35 7.97 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.551 0.691 . . . . 1.3100000000000001 109.931 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' CB ' ' HZ1' ' A' ' 20' ' ' LYS . 6.3 mtmp? -94.23 142.04 27.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.782 -0.821 . . . . 2.3500000000000001 108.782 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -128.74 135.37 49.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 2.5800000000000001 108.729 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -78.03 136.7 37.98 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.168 -0.958 . . . . 2.1400000000000001 109.007 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -60.79 143.88 53.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 1.9299999999999999 109.109 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.54 133.97 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.43 -0.793 . . . . 1.28 109.906 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.4 t -106.78 113.72 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 1.3700000000000001 109.183 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.4 mt -87.69 134.83 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 1.3300000000000001 109.045 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -89.23 113.28 24.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 1.3700000000000001 109.638 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.424 HH11 ' HG3' ' A' ' 28' ' ' ARG . 14.1 mmm-85 -96.06 26.25 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 3.1899999999999999 108.845 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -83.56 146.03 28.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -0.814 . . . . 2.8100000000000001 109.748 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -85.08 118.41 24.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.394 -0.965 . . . . 2.8300000000000001 108.394 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 pt -81.54 173.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 1.3400000000000001 109.977 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.8 p -97.87 161.15 13.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.031 -0.729 . . . . 1.3500000000000001 109.031 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.0 -16.67 32.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.112 -0.993 . . . . 1.6100000000000001 109.283 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.16 -7.43 59.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 2.4700000000000002 109.265 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -114.96 -13.52 11.91 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.849 -0.797 . . . . 2.0699999999999998 108.849 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.9 t -65.66 -45.38 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 1.3300000000000001 109.402 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -54.94 -33.28 62.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 1.46 109.293 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -69.92 -33.99 72.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 2.9399999999999999 110.26 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -62.8 -43.57 98.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 1.3 109.688 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 44' ' ' LEU . 96.1 t -60.1 -46.94 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.41 -0.806 . . . . 1.3300000000000001 109.828 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.91 -43.39 88.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 1.5 108.883 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -65.18 -30.99 71.94 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.813 -0.81 . . . . 3.1499999999999999 108.813 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -86.39 -58.33 2.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.92000000000000004 109.266 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 40' ' ' VAL . 14.5 tp -52.48 -58.94 5.14 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.289 -0.882 . . . . 1.4099999999999999 109.287 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 t -63.76 -30.5 71.59 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.334 -0.987 . . . . 1.22 108.334 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.81 -54.6 35.41 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 107.977 -2.049 . . . . 0.58999999999999997 107.977 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 29.8 ttm-85 -49.47 -30.52 8.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.535 -0.98 . . . . 3.3900000000000001 109.074 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.99 -40.59 81.08 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.551 -0.907 . . . . 1.26 108.551 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -80.96 -59.34 2.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.667 -0.646 . . . . 2.9900000000000002 109.302 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.85 -40.83 57.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.032 . . . . 1.1399999999999999 110.205 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.459 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 29.2 t -62.32 -37.46 85.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.956 -1.09 . . . . 1.8400000000000001 108.183 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.58 -31.31 63.53 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.158 0.504 . . . . 1.22 109.732 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -75.86 -65.95 0.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 2.0 109.589 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 54' ' ' LEU . 9.7 mp -50.12 -27.02 5.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 1.99 109.332 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 51' ' ' SER . 4.1 mm-40 -71.76 -42.22 67.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 1.27 108.646 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 m -61.64 -37.16 83.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 1.24 109.435 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.32 -25.79 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 1.21 109.117 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.471 ' NZ ' ' OE1' ' A' ' 70' ' ' GLU . 9.9 ttpp -61.17 -46.88 88.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 1.53 110.2 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.18 -30.81 68.03 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.128 -0.983 . . . . 1.24 109.844 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.423 ' O ' ' OG1' ' A' ' 64' ' ' THR . 37.8 mttp -70.43 -18.89 63.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.695 -1.253 . . . . 2.3199999999999998 108.123 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.79 -33.42 30.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.567 -0.901 . . . . 1.1699999999999999 108.567 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.88 -28.42 28.92 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.192 -1.163 . . . . 0.57999999999999996 110.192 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.14 -15.09 42.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.016 -1.285 . . . . 1.3899999999999999 109.0 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 90.8 m -95.37 -48.37 5.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.24 -0.912 . . . . 1.3600000000000001 110.179 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -106.33 -21.73 13.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.339 -0.851 . . . . 1.1399999999999999 110.124 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 121.5 147.12 7.58 Favored Glycine 0 N--CA 1.503 3.13 0 N-CA-C 110.082 -1.207 . . . . 0.59999999999999998 110.082 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -48.49 -11.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.606 -0.938 . . . . 2.5899999999999999 110.197 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 66' ' ' GLY . 63.0 mt-10 -63.99 -29.61 70.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.089 -1.007 . . . . 2.2000000000000002 110.802 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -91.82 -7.65 48.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.8 -1.188 . . . . 2.3599999999999999 111.087 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.471 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 56.3 mt-10 -63.85 -24.52 67.78 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.732 -1.23 . . . . 1.54 110.598 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.67 -28.36 69.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.02 -1.05 . . . . 1.24 110.508 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.37 -44.25 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.011 -1.055 . . . . 1.24 110.064 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.55 -21.47 45.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.088 -1.007 . . . . 0.80000000000000004 109.845 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -64.93 -44.16 90.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 1.23 109.571 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.35 -37.22 59.1 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.66 -1.376 . . . . 0.56000000000000005 109.66 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -61.37 -20.55 63.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.294 -1.121 . . . . 2.0600000000000001 110.455 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.0 mt -85.79 -37.04 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.592 -1.317 . . . . 1.24 108.393 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.8 ttt -58.78 -42.25 88.56 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.224 -1.028 . . . . 2.4500000000000002 108.224 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.12 -37.23 84.34 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.358 -0.978 . . . . 1.21 108.358 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 23.8 tp -69.55 -43.97 71.86 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.649 -0.821 . . . . 1.1200000000000001 109.151 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -85.41 7.12 23.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 1.24 110.222 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.419 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 57.3 t0 -47.06 122.55 4.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.012 -1.055 . . . . 1.3100000000000001 109.695 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.66 -24.81 66.33 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.726 -0.842 . . . . 1.3500000000000001 108.726 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 18.7 mp0 -76.14 -49.53 17.06 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.783 -0.767 . . . . 2.1600000000000001 109.205 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.2 mt -63.75 -13.96 48.27 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.823 -1.151 . . . . 1.24 108.715 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -79.2 -56.18 4.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.508 -0.745 . . . . 1.28 109.836 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -63.33 -26.27 68.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 1.79 109.977 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.42 -44.05 62.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.101 -0.999 . . . . 1.29 108.673 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.1 mt -60.7 -56.49 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.097 -1.075 . . . . 1.1399999999999999 108.097 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -47.16 -53.0 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.635 -0.666 . . . . 1.3200000000000001 109.543 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.69 -44.41 93.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 1.3700000000000001 109.227 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.8 mt -57.97 -56.85 16.64 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.168 -1.049 . . . . 1.3999999999999999 108.168 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.6 mt -51.2 -39.84 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 1.23 110.073 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -85.34 -36.4 20.8 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.086 -1.008 . . . . 2.5099999999999998 111.681 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 91' ' ' ALA . 22.1 t70 -82.75 -43.55 16.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.798 -1.189 . . . . 1.5900000000000001 111.486 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -102.07 12.2 37.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.768 -1.208 . . . . 2.3799999999999999 109.538 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 45.59 48.57 11.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.371 -0.831 . . . . 1.6200000000000001 109.368 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtp -101.41 152.19 21.03 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.092 -0.706 . . . . 1.8899999999999999 109.092 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 p -76.31 145.05 39.84 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.436 -0.79 . . . . 1.27 109.462 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.44 29.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.166 -0.959 . . . . 1.1599999999999999 108.797 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -72.71 -45.99 55.95 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.28 -1.007 . . . . 2.0 108.28 179.049 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.1 -51.42 21.57 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.391 0.615 . . . . 1.25 109.973 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.34 -50.92 71.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 1.1299999999999999 109.647 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.37 -34.15 64.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.194 -0.941 . . . . 1.0800000000000001 109.799 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -69.03 -31.48 70.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 2.02 109.229 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.5 tt0 -71.59 -57.63 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 1.26 109.892 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 t -55.2 -49.9 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 1.1799999999999999 109.811 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.1 mm -64.68 -70.16 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 1.1899999999999999 109.613 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.46 ' OE2' ' NE ' ' A' ' 131' ' ' ARG . 18.1 tp10 -50.55 -45.3 56.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.826 -1.171 . . . . 2.2000000000000002 108.992 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -45.04 -40.07 6.92 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.11 -1.596 . . . . 0.85999999999999999 109.11 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -69.17 -59.41 3.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.343 -1.092 . . . . 2.0 108.29 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.74 -43.5 37.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.809 -0.812 . . . . 1.3200000000000001 108.809 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.8 m -59.99 -37.04 78.5 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.305 -0.872 . . . . 2.1400000000000001 109.186 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.54 84.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 1.3799999999999999 109.878 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.81 -29.48 67.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.929 -1.107 . . . . 1.3500000000000001 108.677 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.54 -17.13 62.48 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.455 -0.943 . . . . 1.95 108.455 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -82.42 -1.01 48.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.567 -0.708 . . . . 1.71 109.481 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -83.77 158.72 21.63 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.136 -0.978 . . . . 1.71 109.209 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -100.5 50.56 0.89 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.891 -0.781 . . . . 2.8300000000000001 108.891 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -146.56 119.21 8.56 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.222 -0.924 . . . . 1.5800000000000001 109.612 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.71 -19.3 58.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.372 -0.83 . . . . 2.7999999999999998 109.501 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.22 -65.21 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 1.27 109.275 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.8 mt -47.58 -31.29 4.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.09 -1.006 . . . . 1.5800000000000001 109.624 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 127' ' ' ALA . 1.9 ttmp? -65.52 -39.97 92.43 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.918 -1.113 . . . . 2.9199999999999999 108.319 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -58.13 -23.41 55.03 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.392 -0.966 . . . . 2.2000000000000002 108.392 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -72.99 -27.26 61.69 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.537 -1.653 . . . . 2.5299999999999998 106.537 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -57.67 -39.83 77.96 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.098 -1.075 . . . . 1.45 108.098 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.07 -36.42 81.98 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.793 -0.817 . . . . 1.5 108.793 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.45 -36.94 77.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.348 -0.845 . . . . 1.3500000000000001 109.254 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.4 t -76.65 -44.24 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.04 -1.096 . . . . 1.23 108.04 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.46 ' NE ' ' OE2' ' A' ' 109' ' ' GLU . 42.4 ttm180 -60.55 -34.7 74.53 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.925 -1.139 . . . . 3.73 107.925 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -58.94 -35.55 73.32 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.502 -0.749 . . . . 1.3200000000000001 109.17 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.19 -26.51 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 1.2 108.528 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.29 -42.64 14.6 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.145 -1.582 . . . . 0.48999999999999999 109.145 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -55.42 -54.09 48.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.545 -0.973 . . . . 3.1099999999999999 109.986 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.523 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 34.4 mtm180 -63.56 -38.79 92.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.176 -0.952 . . . . 2.9500000000000002 108.697 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 41.5 tp -61.83 -40.34 94.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.437 -0.79 . . . . 1.73 109.719 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.8 mt -67.54 -54.8 16.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.05 -1.031 . . . . 1.22 109.335 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -49.16 -19.0 0.39 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 2.7799999999999998 109.529 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -84.24 -39.9 18.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 2.0299999999999998 109.586 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.14 -40.3 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.005 . . . . 1.2 109.693 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.9 mt -88.72 2.11 53.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.158 -0.964 . . . . 1.28 109.272 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.64 29.23 48.27 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.422 -1.871 . . . . 0.68999999999999995 108.422 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.9 tp -58.52 148.14 29.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.595 -0.944 . . . . 1.3100000000000001 109.542 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.31 132.64 47.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.942 . . . . 2.8799999999999999 109.786 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.4 mt -110.47 144.12 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 109.172 -0.677 . . . . 1.3600000000000001 109.172 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.499 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.2 mp -78.54 133.21 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.072 -1.017 . . . . 1.9299999999999999 109.768 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.96 87.85 3.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.502 -0.749 . . . . 1.54 109.408 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.45 -22.22 44.44 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.241 -0.912 . . . . 1.3400000000000001 109.586 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.437 ' HG ' HD22 ' A' ' 172' ' ' ASN . 7.5 t -80.8 17.81 1.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.151 -0.968 . . . . 1.98 109.446 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.08 29.19 2.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.389 -0.819 . . . . 1.3799999999999999 109.416 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.59 153.14 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.293 -0.879 . . . . 1.3999999999999999 108.985 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -132.96 -2.1 3.26 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.394 -0.816 . . . . 2.7400000000000002 109.245 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -129.8 125.74 36.47 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.821 -0.807 . . . . 1.4099999999999999 108.821 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.68 129.19 38.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 1.3 109.714 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.32 175.79 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 1.28 108.806 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.8 mt -89.31 149.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.891 -1.151 . . . . 1.1499999999999999 107.891 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.3 tp -104.73 119.85 39.97 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.534 -0.729 . . . . 1.2 109.612 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.0 125.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.99 -0.744 . . . . 1.1599999999999999 108.99 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.5 147.06 12.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 1.2 109.816 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.38 -38.15 71.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.745 -1.222 . . . . 1.3200000000000001 108.131 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -173.97 147.66 1.32 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.428 -0.795 . . . . 2.3399999999999999 109.651 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.2 mt -117.68 136.53 53.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.634 -0.667 . . . . 1.26 109.383 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.6 p -94.06 152.19 40.24 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.222 -0.924 . . . . 1.3600000000000001 109.296 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -36.21 -39.38 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.442 2.095 . . . . 0.63 112.567 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.523 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 1.4 m -56.83 -57.23 13.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.138 -0.976 . . . . 1.0700000000000001 109.13 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -60.01 -41.99 93.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.474 -0.767 . . . . 1.25 109.79 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.0 p -71.17 -19.78 62.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.052 -1.03 . . . . 1.1799999999999999 109.409 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.3 -25.48 33.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 1.1399999999999999 109.745 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -103.47 -18.9 14.6 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.26 -0.9 . . . . 1.71 109.209 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.78 144.51 48.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.121 -1.066 . . . . 1.22 108.121 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.528 ' OD1' ' NZ ' ' A' ' 175' ' ' LYS . 1.7 m120 -95.64 134.79 38.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.0 -1.062 . . . . 2.5499999999999998 108.587 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.1 mt -78.66 -42.95 27.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.391 -0.818 . . . . 1.96 111.654 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -80.0 -8.82 59.56 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.672 -1.267 . . . . 2.46 111.767 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.528 ' NZ ' ' OD1' ' A' ' 172' ' ' ASN . 58.6 mttp -99.98 -7.3 25.28 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.694 -1.253 . . . . 2.4199999999999999 108.721 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.423 ' CG1' ' N ' ' A' ' 177' ' ' LEU . 54.3 t -98.32 162.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.488 -0.757 . . . . 1.1599999999999999 109.057 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.423 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 8.5 tp -115.2 -20.09 10.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.555 -0.716 . . . . 1.95 109.954 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.9 174.58 42.57 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.406 -1.478 . . . . 0.41999999999999998 109.406 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 1.3 m-85 -128.07 124.16 36.36 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.346 -1.091 . . . . 0.52000000000000002 110.156 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.8 mt -121.19 109.96 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 106.92 -1.511 . . . . 1.1599999999999999 106.92 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.604 ' O ' ' O ' ' A' ' 203' ' ' VAL . 31.2 p -140.58 154.99 46.7 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.119 -0.988 . . . . 1.22 112.578 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 182' ' ' ASP . 42.6 t0 -80.18 40.94 0.5 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.823 -0.626 . . . . 2.2400000000000002 110.831 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.567 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -100.85 95.59 6.73 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.229 -1.544 . . . . 1.6499999999999999 110.544 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.472 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -39.48 -21.15 0.02 OUTLIER Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.264 -0.898 . . . . 2.1000000000000001 111.104 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 114.84 -28.93 7.77 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 109.83 -1.308 . . . . 1.8400000000000001 109.83 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.554 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.2 OUTLIER -54.27 118.26 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.136 -1.214 . . . . 5.7800000000000002 109.335 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 26.6 p 48.66 32.77 3.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.434 -0.791 . . . . 3.2400000000000002 110.142 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.1 m -86.47 116.88 24.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.109 -0.995 . . . . 2.1099999999999999 109.554 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -72.02 -41.28 67.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 1.0600000000000001 108.972 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.8 p -50.54 -36.99 36.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 2.0899999999999999 109.147 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.1 m -62.01 -41.31 97.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.337 -0.852 . . . . 1.8799999999999999 109.35 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.5 mt -58.01 -24.76 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 2.0099999999999998 109.478 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.3 mtp -71.81 -58.83 3.13 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.689 -1.226 . . . . 1.27 107.689 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.22 -41.71 62.97 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.325 0.583 . . . . 1.1799999999999999 109.722 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 20.5 mtt-85 -69.02 -50.67 46.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 3.5800000000000001 109.882 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.5 m -69.12 -38.44 78.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.051 -1.031 . . . . 1.1399999999999999 109.906 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 199' ' ' LEU . 22.3 mt -87.81 3.39 48.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.106 -0.996 . . . . 1.28 108.858 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 44.02 11.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.741 -0.6 . . . . 1.49 112.019 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 197' ' ' LEU . 17.1 mt -68.98 169.51 11.16 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.372 -1.455 . . . . 1.28 108.495 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.88 139.64 3.86 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.345 2.03 . . . . 0.69999999999999996 110.907 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.37 -172.96 2.64 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.19 -1.404 . . . . 1.1899999999999999 111.595 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.2 mt -149.12 153.1 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.248 -1.39 . . . . 1.25 107.248 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.604 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.7 m -138.22 -39.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.874 -1.141 . . . . 1.29 111.113 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -71.45 39.96 0.61 Allowed Glycine 0 C--N 1.285 -2.276 0 N-CA-C 108.599 -1.8 . . . . 0.92000000000000004 108.599 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 203' ' ' VAL . 47.1 p -67.38 -18.29 65.07 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.106 -1.232 . . . . 1.3100000000000001 109.531 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.419 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 62.64 -101.08 0.36 Allowed Glycine 0 N--CA 1.484 1.859 0 C-N-CA 119.392 -1.385 . . . . 1.0 110.121 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.2 m -117.55 45.61 1.89 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.301 -1.117 . . . . 1.9199999999999999 112.331 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 62.6 t -74.82 -26.73 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.454 -1.403 . . . . 1.27 107.786 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.7 p -68.28 -12.75 61.54 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.738 . . . . 1.3400000000000001 109.599 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.9 m -102.4 9.34 39.79 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.416 -0.802 . . . . 2.0699999999999998 109.049 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -131.17 -5.78 3.86 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.569 -0.707 . . . . 2.8599999999999999 109.195 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 23.3 t -122.64 148.57 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.649 -0.871 . . . . 1.3 108.649 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -121.54 -174.29 2.83 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.619 -1.623 . . . . 2.48 106.619 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.6 m120 -79.51 150.52 31.15 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.776 -1.202 . . . . 2.6200000000000001 109.839 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.7 m-20 81.07 -14.42 0.83 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.052 -0.405 . . . . 2.3999999999999999 110.94 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.64 128.2 35.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.755 -1.215 . . . . 1.99 108.355 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -86.62 119.11 26.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.868 -1.145 . . . . 1.54 108.883 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.7 mt -119.62 163.29 17.58 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.666 0.746 . . . . 1.25 110.124 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 219' ' ' ILE . 71.1 mt -128.68 118.96 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.742 -1.207 . . . . 1.26 107.742 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.6 tp -87.18 120.61 28.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.425 -0.954 . . . . 1.1799999999999999 108.425 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.4 t0 -95.97 -31.07 13.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.212 -0.93 . . . . 2.2200000000000002 108.838 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 38.17 28.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.456 0.645 . . . . 1.2 110.248 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.6 t -123.9 -67.36 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.821 -1.548 . . . . 1.48 106.821 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 224' ' ' ASN . 19.9 t-20 -84.12 10.95 8.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.218 -1.401 . . . . 2.8199999999999998 107.218 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 58.22 61.99 2.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.906 -0.496 . . . . 2.1099999999999999 110.092 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -156.8 147.89 22.01 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.122 -0.986 . . . . 2.6499999999999999 110.673 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.47 141.5 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.663 -0.866 . . . . 1.29 108.663 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -104.62 127.77 52.46 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.177 -0.952 . . . . 1.4199999999999999 109.408 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.42 120.59 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.48 -0.762 . . . . 1.26 110.358 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 43.5 t30 55.55 74.37 0.72 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 2.1499999999999999 110.314 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -87.05 149.16 8.14 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.018 2.479 . . . . 0.81999999999999995 112.148 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.2 m -72.14 160.99 31.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.258 -0.901 . . . . 2.1099999999999999 109.966 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -64.37 -30.67 71.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -0.799 . . . . 3.1699999999999999 109.758 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -67.11 -37.61 84.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 3.0600000000000001 109.165 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.65 -32.59 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 1.6499999999999999 108.941 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt -72.88 -61.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 1.47 109.209 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -53.61 -41.49 66.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.498 -0.751 . . . . 2.54 110.106 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -66.34 -34.86 78.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.09 -1.006 . . . . 3.0 109.439 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 57.1 mtp -81.68 -39.37 24.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.89 . . . . 1.6299999999999999 109.437 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.404 ' O ' ' OE1' ' A' ' 244' ' ' GLU . 16.6 mmt180 -49.35 -47.25 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.139 -0.976 . . . . 3.1600000000000001 109.546 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.03 -64.11 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -0.963 . . . . 2.0899999999999999 110.671 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 24.4 t -59.68 -52.7 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 2.5699999999999998 111.201 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' A' ' 239' ' ' MET . 41.4 tp60 -54.78 -41.08 70.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.672 -1.267 . . . . 3.5899999999999999 109.925 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.404 ' OE1' ' O ' ' A' ' 240' ' ' ARG . 62.0 mt-10 -64.88 -27.36 68.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.623 -1.298 . . . . 1.76 109.881 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -67.62 -23.55 65.37 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.773 -1.205 . . . . 3.21 107.934 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.5 t -69.42 -40.41 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.399 -0.963 . . . . 2.3500000000000001 108.399 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.57 92.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.524 -0.735 . . . . 2.3999999999999999 109.804 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.7 m -78.11 -31.81 50.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 3.0299999999999998 110.207 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.032 -1.042 . . . . 3.4100000000000001 109.848 -179.452 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.372 -0.603 . . . . 4.0700000000000003 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.6 mt -129.95 91.54 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.809 -0.811 . . . . 1.5 108.809 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m -91.68 117.03 29.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.185 -0.947 . . . . 1.8 110.049 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.95 -159.54 11.98 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 108.149 -1.98 . . . . 0.92000000000000004 108.149 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.1 mt -97.63 -10.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.133 -1.216 . . . . 1.5 109.04 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 tp 60.3 103.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.343 -0.848 . . . . 1.3999999999999999 108.901 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.97 -48.43 7.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.997 -1.064 . . . . 1.26 108.974 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.98 145.8 26.15 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.411 -0.805 . . . . 1.95 108.975 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.47 153.48 23.79 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.32 2.014 . . . . 0.93999999999999995 113.748 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.75 177.12 32.55 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.959 -1.256 . . . . 0.78000000000000003 109.959 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mt -143.86 120.74 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.974 -1.309 . . . . 1.29 109.776 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.23 140.55 30.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.124 -0.985 . . . . 1.1499999999999999 109.399 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.7 m-85 -105.87 151.37 24.62 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.689 -0.856 . . . . 0.71999999999999997 108.689 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.58 166.38 31.05 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 118.66 -1.733 . . . . 0.5 111.467 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -81.92 153.34 26.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.653 -0.91 . . . . 2.3599999999999999 110.377 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.06 126.22 30.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.774 . . . . 1.1599999999999999 111.642 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.7 tp -108.13 89.26 2.94 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 107.52 -1.289 . . . . 1.24 107.52 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.0 tp -81.26 129.39 34.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.011 -1.055 . . . . 1.3100000000000001 110.206 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.9 mt -96.39 94.41 7.41 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.413 0.625 . . . . 1.3100000000000001 110.433 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.56 ' CB ' ' HZ1' ' A' ' 20' ' ' LYS . 8.0 mtpm? -97.16 157.68 15.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.726 -0.842 . . . . 2.3500000000000001 108.726 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -130.77 134.26 46.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.25 -0.906 . . . . 2.5800000000000001 108.87 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -79.31 137.76 37.47 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.173 -0.955 . . . . 2.1400000000000001 109.368 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.74 141.67 58.7 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.541 -0.724 . . . . 1.9299999999999999 109.136 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 24' ' ' ILE . 68.1 mt -89.36 138.32 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 1.28 109.586 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.04 114.83 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.505 -0.747 . . . . 1.3700000000000001 109.179 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.1 mt -87.43 133.88 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.912 . . . . 1.3300000000000001 109.611 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.78 120.41 31.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.462 -0.774 . . . . 1.3700000000000001 108.998 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -99.92 32.02 3.07 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.229 -0.92 . . . . 3.1899999999999999 109.444 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -83.31 138.53 33.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.044 -1.035 . . . . 2.8100000000000001 110.284 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -84.77 134.69 34.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.309 -0.997 . . . . 2.8300000000000001 108.309 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.9 pt -97.74 176.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.159 -0.963 . . . . 1.3400000000000001 110.841 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 34' ' ' ASP . 36.3 p -98.37 153.26 18.68 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.394 -0.965 . . . . 1.3500000000000001 108.394 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.34 -7.75 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 1.6100000000000001 110.139 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 32' ' ' SER . 17.7 t70 -84.78 -21.76 29.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.905 -1.122 . . . . 2.4700000000000002 110.323 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -106.41 -3.81 20.61 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.193 -0.942 . . . . 2.0699999999999998 109.531 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.7 -43.69 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 1.3300000000000001 109.237 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -53.79 -34.59 59.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.284 -0.885 . . . . 1.46 109.184 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -69.47 -33.3 72.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 2.9399999999999999 109.698 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -61.65 -46.64 88.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.007 -1.058 . . . . 1.3 109.68 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.78 -45.41 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 1.3300000000000001 109.693 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.28 -39.62 92.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.108 -0.995 . . . . 1.5 108.334 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -65.11 -32.75 74.61 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.949 -0.76 . . . . 3.1499999999999999 108.949 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -86.62 -57.68 2.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.144 -0.973 . . . . 0.92000000000000004 108.476 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -49.32 -61.93 1.82 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.73 -0.841 . . . . 1.4099999999999999 108.73 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 t -65.2 -33.82 76.91 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.312 -0.995 . . . . 1.22 108.312 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.27 -54.46 35.61 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 107.927 -2.069 . . . . 0.58999999999999997 107.927 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -48.63 -30.11 5.07 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.384 -1.068 . . . . 3.3900000000000001 108.561 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.43 70.21 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.897 -1.149 . . . . 1.26 107.897 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 mttt -79.17 -58.61 3.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.805 -0.813 . . . . 2.9900000000000002 108.805 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.35 -40.52 62.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 1.1399999999999999 109.937 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 t -62.23 -38.25 88.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.952 -1.093 . . . . 1.8400000000000001 108.498 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.82 -36.33 67.48 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.378 -0.601 . . . . 1.22 109.378 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -65.57 -62.76 1.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.351 -0.843 . . . . 2.0 109.535 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.08 -38.89 62.92 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.304 -0.873 . . . . 1.99 109.161 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -59.92 -46.88 87.97 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.591 -0.892 . . . . 1.27 108.591 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.5 m -61.99 -37.7 85.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.485 -0.759 . . . . 1.24 109.332 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.2 mt -73.3 -29.3 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.821 . . . . 1.21 109.151 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -63.94 -43.32 96.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -0.819 . . . . 1.53 109.03 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.2 m -72.34 -26.99 62.14 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.365 -0.834 . . . . 1.24 109.538 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.407 ' O ' ' OG1' ' A' ' 64' ' ' THR . 62.7 mttm -72.82 -30.04 63.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.638 -1.245 . . . . 2.3199999999999998 107.638 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.28 63.68 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.111 -1.07 . . . . 1.1699999999999999 108.111 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.12 -28.21 28.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.608 -1.397 . . . . 0.57999999999999996 109.608 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -86.54 -16.06 38.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.812 -1.404 . . . . 1.3899999999999999 108.462 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 99.2 m -94.44 -49.27 5.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 1.3600000000000001 110.36 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.508 ' C ' ' H ' ' A' ' 67' ' ' GLU . 53.0 m-85 -107.11 -33.21 7.52 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.156 -0.965 . . . . 1.1399999999999999 110.241 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.48 -29.92 0.71 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.179 -1.168 . . . . 0.59999999999999998 110.179 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 69' ' ' LYS . 38.4 mt-10 -52.85 179.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -1.157 . . . . 2.5899999999999999 110.3 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -68.36 40.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.518 -0.738 . . . . 2.2000000000000002 109.532 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' A' ' 67' ' ' GLU . 35.1 mmtt -85.03 -17.26 38.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.639 -0.874 . . . . 2.3599999999999999 108.639 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.78 -34.8 77.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.614 -0.679 . . . . 1.54 110.517 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.79 -27.15 67.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 1.24 110.817 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.9 mt -71.79 -46.73 59.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.849 -1.157 . . . . 1.24 109.782 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -74.98 -21.66 59.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.085 -1.009 . . . . 0.80000000000000004 109.757 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.6 -41.62 92.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.146 -0.971 . . . . 1.23 109.383 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.25 -37.47 63.3 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.483 -1.447 . . . . 0.56000000000000005 109.483 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -58.89 -21.37 57.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -1.15 . . . . 2.0600000000000001 109.3 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -85.15 -34.39 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.064 -1.022 . . . . 1.24 108.473 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.3 ttt -60.61 -44.93 95.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -0.972 . . . . 2.4500000000000002 108.511 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.79 -40.38 83.87 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.215 -1.032 . . . . 1.21 108.215 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.5 tp -65.87 -43.99 86.7 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.672 -0.811 . . . . 1.1200000000000001 108.858 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -85.84 9.48 16.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.191 -0.943 . . . . 1.24 110.363 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -50.47 119.92 4.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.77 -1.206 . . . . 1.3100000000000001 109.264 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.06 -22.97 67.05 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.245 -0.909 . . . . 1.3500000000000001 108.838 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.14 -51.87 12.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.412 -0.805 . . . . 2.1600000000000001 109.392 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.78 -12.28 45.91 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.208 -0.997 . . . . 1.24 109.224 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -79.7 -50.24 10.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.431 -0.793 . . . . 1.28 110.365 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -62.37 -31.96 72.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.128 -0.982 . . . . 1.79 110.099 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.02 -44.64 68.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 1.29 109.291 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.04 -58.53 6.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.576 -0.898 . . . . 1.1399999999999999 108.576 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 90' ' ' ILE . 70.7 mt -48.75 -61.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.686 -0.634 . . . . 1.3200000000000001 110.576 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -53.19 -45.31 68.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.024 -1.048 . . . . 1.3700000000000001 110.403 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 mt -56.23 -56.13 24.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.127 -0.983 . . . . 1.3999999999999999 108.663 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.8 mt -54.73 -47.54 73.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.187 -0.946 . . . . 1.23 110.57 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -78.32 -36.62 46.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.058 -1.026 . . . . 2.5099999999999998 111.302 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' ALA . 9.4 t70 -82.09 -40.51 21.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.901 -1.125 . . . . 1.5900000000000001 112.055 -176.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -109.84 21.29 17.06 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.752 -1.218 . . . . 2.3799999999999999 110.689 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.522 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 0.3 OUTLIER 42.73 55.19 4.38 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.299 -0.875 . . . . 1.6200000000000001 110.473 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.8 mtt -103.91 147.38 27.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.601 -0.889 . . . . 1.8899999999999999 108.601 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.2 p -77.68 150.5 34.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 1.27 109.87 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.42 -31.67 6.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 1.1599999999999999 108.892 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -77.08 -43.15 35.39 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.777 -0.823 . . . . 2.0 108.777 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.62 9.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.572 -0.705 . . . . 1.25 109.871 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.06 -48.28 78.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.859 . . . . 1.1299999999999999 109.466 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.5 64.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 1.0800000000000001 109.858 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.495 ' O ' ' N ' ' A' ' 109' ' ' GLU . 76.4 t60 -67.93 -51.09 51.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.999 -1.063 . . . . 2.02 109.727 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.11 -62.21 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.338 -0.851 . . . . 1.26 110.502 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 43.7 t -52.75 -54.18 17.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.804 -1.185 . . . . 1.1799999999999999 109.302 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.36 -23.19 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 1.1899999999999999 109.664 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 105' ' ' HIS . 45.8 tp10 -73.08 -30.45 63.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.025 -1.047 . . . . 2.2000000000000002 110.069 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.26 -27.97 29.12 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.114 -1.517 . . . . 0.85999999999999999 111.985 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -67.06 -45.35 77.61 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.425 -1.633 . . . . 2.0 108.035 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.16 -55.72 5.45 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.917 -0.489 . . . . 1.3200000000000001 110.698 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.9 p -56.97 -41.25 78.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 2.1400000000000001 110.215 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.97 81.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.085 -1.009 . . . . 1.3799999999999999 110.277 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.71 -30.38 70.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.761 -1.212 . . . . 1.3500000000000001 109.319 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.58 -18.94 65.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.095 . . . . 1.95 109.726 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -82.93 -9.24 59.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 1.71 109.385 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.8 138.45 31.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.264 -1.013 . . . . 1.71 108.264 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 22.8 p-10 -96.02 63.41 2.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 2.8300000000000001 109.154 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -148.79 108.7 4.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.317 -0.864 . . . . 1.5800000000000001 109.48 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -50.35 -15.85 0.28 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.569 -0.707 . . . . 2.7999999999999998 110.009 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -78.3 -60.92 2.18 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.242 -0.911 . . . . 1.27 109.353 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 mt -67.19 -31.52 71.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.262 -0.899 . . . . 1.5800000000000001 109.254 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -68.24 -49.54 59.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.991 . . . . 2.9199999999999999 109.234 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -61.14 -18.68 59.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.277 -1.008 . . . . 2.2000000000000002 108.277 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.422 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 26.1 ttt-85 -75.46 -28.24 59.21 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.093 -1.447 . . . . 2.5299999999999998 107.093 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.82 97.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.698 -0.853 . . . . 1.45 108.698 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.9 -35.08 79.98 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.247 -1.02 . . . . 1.5 108.247 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 2.8 m-20 -71.97 -32.2 67.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 1.3500000000000001 109.122 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.422 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 42.8 t -77.03 -45.6 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 1.23 108.95 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -60.19 -36.92 78.72 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.117 -0.989 . . . . 3.73 108.37 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.49 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 30.7 t70 -58.92 -36.5 74.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.5 -0.75 . . . . 1.3200000000000001 109.486 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.07 -26.08 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.058 -1.026 . . . . 1.2 108.803 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.34 -47.39 5.75 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.26 -1.536 . . . . 0.48999999999999999 109.26 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -51.58 -43.91 62.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -1.173 . . . . 3.1099999999999999 109.119 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.508 ' CG ' HH11 ' A' ' 136' ' ' ARG . 6.2 mtt-85 -65.51 -42.7 91.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.206 -1.035 . . . . 2.9500000000000002 108.206 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.77 -51.3 70.57 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.474 -0.565 . . . . 1.73 109.474 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.6 mt -53.13 -58.06 8.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 1.22 109.279 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -51.01 -21.4 1.77 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.882 . . . . 2.7799999999999998 109.673 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 136' ' ' ARG . 5.1 m120 -85.84 -42.05 14.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.03 . . . . 2.0299999999999998 109.111 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.89 -47.49 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.081 -1.012 . . . . 1.2 108.294 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 58.8 mt -90.76 -7.81 51.45 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.777 -0.823 . . . . 1.28 108.777 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 144' ' ' LEU . . . 60.99 26.08 65.09 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.239 -1.944 . . . . 0.68999999999999995 108.239 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.44 ' HG ' ' H ' ' A' ' 145' ' ' LYS . 3.1 tp -52.84 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.605 -0.938 . . . . 1.3100000000000001 109.095 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.44 ' H ' ' HG ' ' A' ' 144' ' ' LEU . 47.5 tttp -69.0 137.5 53.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.127 -0.983 . . . . 2.8799999999999999 110.429 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 75.1 mt -106.49 137.49 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.491 -0.929 . . . . 1.3600000000000001 108.491 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mm -75.79 116.65 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.073 -1.017 . . . . 1.9299999999999999 108.877 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -98.58 82.88 2.91 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.263 -0.898 . . . . 1.54 109.89 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.3 mt -84.51 -14.08 50.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 1.3400000000000001 109.103 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.7 p -84.3 -13.8 51.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 1.98 109.891 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.96 42.8 1.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.27 -0.894 . . . . 1.3799999999999999 110.862 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.6 mm -73.49 149.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.658 -1.276 . . . . 1.3999999999999999 108.738 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -136.78 -2.29 2.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.389 -0.819 . . . . 2.7400000000000002 109.466 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -125.45 127.93 47.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.512 -0.742 . . . . 1.4099999999999999 109.495 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.49 118.56 8.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.308 -0.87 . . . . 1.3 108.9 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -151.26 176.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 1.28 108.765 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 mt -89.5 156.49 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.136 -1.061 . . . . 1.1499999999999999 108.136 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 18.6 tp -108.89 123.01 48.4 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.512 0.672 . . . . 1.2 109.693 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.83 133.01 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.213 -0.662 . . . . 1.1599999999999999 109.213 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.99 145.67 10.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.073 -1.017 . . . . 1.2 109.918 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.19 -34.56 75.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.343 -1.473 . . . . 1.3200000000000001 108.039 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -173.19 154.06 2.62 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.296 -0.631 . . . . 2.3399999999999999 109.296 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.4 mt -128.37 130.65 48.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.484 -0.76 . . . . 1.26 109.126 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.5 p -89.74 152.49 46.88 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 1.3600000000000001 109.259 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -34.26 -41.8 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.713 2.276 . . . . 0.63 113.235 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 m -57.4 -60.31 3.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.819 -1.175 . . . . 1.0700000000000001 109.45 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -55.61 -36.27 66.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.472 -0.768 . . . . 1.25 110.352 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.8 p -73.73 -32.6 63.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.124 -0.985 . . . . 1.1799999999999999 110.055 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.33 -31.53 64.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.952 . . . . 1.1399999999999999 110.794 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -101.63 1.61 37.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.103 -0.998 . . . . 1.71 109.901 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.2 tp -54.28 160.96 1.47 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.089 -1.007 . . . . 1.22 109.054 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.563 ' C ' ' H ' ' A' ' 174' ' ' LYS . 15.6 t30 -100.73 79.7 2.1 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.39 -0.819 . . . . 2.5499999999999998 109.928 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 14.9 mt -74.81 28.65 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 1.96 108.642 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 172' ' ' ASN . 31.7 mtpt -106.71 -30.7 8.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 2.46 110.187 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.495 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 27.1 mtmm -133.2 14.32 4.2 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.232 -0.918 . . . . 2.4199999999999999 110.028 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 177' ' ' LEU . 14.7 t -79.02 161.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 1.1599999999999999 109.098 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.437 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 7.7 tp -112.98 -25.37 9.01 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.62 -0.675 . . . . 1.95 110.058 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.57 -179.43 45.9 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.64 -1.384 . . . . 0.41999999999999998 109.64 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.82 126.84 35.31 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.399 -1.06 . . . . 0.52000000000000002 110.199 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.84 123.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.993 -1.114 . . . . 1.1599999999999999 107.993 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 203' ' ' VAL . 59.0 p -141.75 148.29 38.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.184 -0.948 . . . . 1.22 111.352 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.423 ' OD2' ' CG2' ' A' ' 209' ' ' THR . 1.6 p30 -100.53 50.37 0.89 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.367 -0.975 . . . . 2.2400000000000002 108.367 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.29 -140.58 0.3 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.457 -0.777 . . . . 1.6499999999999999 110.077 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.44 -105.84 1.43 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.934 -1.266 . . . . 2.1000000000000001 109.934 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.05 -27.19 1.27 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.407 -1.477 . . . . 1.8400000000000001 109.407 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.443 ' O ' ' OG1' ' A' ' 187' ' ' THR . 28.2 mtm-85 -63.49 94.42 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -1.192 . . . . 5.7800000000000002 109.116 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 11.3 p 54.33 48.29 21.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 3.2400000000000002 109.395 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.1 t -85.62 136.07 33.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.278 -0.888 . . . . 2.1099999999999999 109.462 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -48.12 -49.06 33.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.09 -1.006 . . . . 1.0600000000000001 109.523 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 70.5 p -46.95 -44.76 20.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 2.0899999999999999 109.657 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.4 t -64.83 -43.66 92.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.467 -0.771 . . . . 1.8799999999999999 110.248 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 64.7 mt -46.36 -35.8 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.971 -1.08 . . . . 2.0099999999999998 109.999 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.5 mtm -74.14 -58.5 3.26 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.898 -1.149 . . . . 1.27 107.898 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.23 -31.19 19.82 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.612 -0.68 . . . . 1.1799999999999999 110.223 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -81.17 -46.54 14.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.045 -1.034 . . . . 3.5800000000000001 110.187 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 38.2 m -70.75 -36.34 73.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.927 -1.108 . . . . 1.1399999999999999 110.383 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.512 ' C ' ' H ' ' A' ' 199' ' ' LEU . 18.6 mt -84.83 -0.43 53.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.949 -1.094 . . . . 1.28 109.119 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 53.5 1.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 1.49 111.419 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 197' ' ' LEU . 55.6 mt -64.37 171.34 2.78 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.434 -1.416 . . . . 1.28 107.606 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -88.43 141.32 4.78 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.305 2.003 . . . . 0.69999999999999996 111.469 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.21 176.58 9.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.675 -1.266 . . . . 1.1899999999999999 111.513 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.6 mt -150.52 159.22 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.06 -1.459 . . . . 1.25 107.06 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.4 m -141.23 -28.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.697 -1.252 . . . . 1.29 111.186 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.61 29.49 6.23 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.139 -0.976 . . . . 0.92000000000000004 111.664 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 11.8 p -55.03 -37.79 67.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.319 -1.695 . . . . 1.3100000000000001 108.18 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.32 -37.01 0.26 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.751 -0.738 . . . . 1.0 113.481 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 40.4 p -131.06 -6.71 3.9 Favored 'General case' 0 N--CA 1.516 2.854 0 CA-C-N 119.657 1.728 . . . . 1.9199999999999999 113.332 -177.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 5.4 t -48.51 -57.15 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.156 -1.59 . . . . 1.27 110.593 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.423 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 26.8 p -53.06 -16.75 1.2 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.562 -1.336 . . . . 1.3400000000000001 110.4 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.1 t -103.92 11.09 35.95 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.191 -0.943 . . . . 2.0699999999999998 109.27 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -138.93 -13.51 1.22 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.392 -0.818 . . . . 2.8599999999999999 110.243 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.49 154.66 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.324 -0.86 . . . . 1.3 109.417 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -126.08 172.42 10.01 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.882 -1.525 . . . . 2.48 106.882 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 21.9 t-20 -72.71 144.87 47.51 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.864 -1.148 . . . . 2.6200000000000001 110.141 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.9 t70 80.61 -11.6 1.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.881 -0.512 . . . . 2.3999999999999999 110.875 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.25 147.63 34.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.773 -1.204 . . . . 1.99 108.843 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -88.35 123.1 32.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.043 -1.035 . . . . 1.54 108.517 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.7 mt -118.74 168.37 10.8 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.993 0.901 . . . . 1.25 110.608 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 mt -143.6 103.21 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.031 -1.1 . . . . 1.26 108.031 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.1 tp -86.2 123.81 31.9 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.773 -0.825 . . . . 1.1799999999999999 108.773 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 223' ' ' VAL . 50.1 t0 -100.12 -28.44 13.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.43 -0.794 . . . . 2.2200000000000002 109.127 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 38.21 28.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.272 0.558 . . . . 1.2 110.599 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.7 t -120.63 -62.24 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.969 -1.493 . . . . 1.48 106.969 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -83.36 10.36 8.84 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.349 -1.352 . . . . 2.8199999999999998 107.349 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 60.01 54.01 4.38 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.35 -0.611 . . . . 2.1099999999999999 109.35 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -154.42 144.1 21.59 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.849 0.833 . . . . 2.6499999999999999 110.23 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 19.5 t -116.08 132.01 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.924 -1.139 . . . . 1.29 107.924 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 228' ' ' TYR . 48.4 m-85 -100.48 130.89 46.61 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.115 -0.991 . . . . 1.4199999999999999 110.067 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.7 t -107.65 127.46 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.579 -0.7 . . . . 1.26 109.924 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 51.3 t30 47.87 60.6 15.11 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.849 . . . . 2.1499999999999999 110.297 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.56 154.81 35.57 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.381 2.054 . . . . 0.81999999999999995 111.474 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 8.4 m -72.83 157.08 38.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.977 -1.077 . . . . 2.1099999999999999 109.805 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -60.41 -27.32 67.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.427 -0.796 . . . . 3.1699999999999999 109.779 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.36 -39.13 91.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 3.0600000000000001 109.537 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.55 -42.18 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.928 . . . . 1.6499999999999999 109.071 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.68 -58.59 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 1.47 109.113 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.5 -40.65 72.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.547 -0.72 . . . . 2.54 110.389 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -67.12 -38.16 85.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.036 -1.04 . . . . 3.0 110.146 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.442 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 85.9 mtp -79.43 -32.59 42.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 1.6299999999999999 109.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -54.11 -44.26 71.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.068 -1.02 . . . . 3.1600000000000001 110.108 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.98 -58.69 3.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.018 -1.051 . . . . 2.0899999999999999 110.887 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.2 t -64.33 -53.47 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.128 -0.983 . . . . 2.5699999999999998 110.721 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.442 ' CB ' ' O ' ' A' ' 239' ' ' MET . 39.6 tp60 -52.95 -52.75 56.99 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.0 -1.063 . . . . 3.5899999999999999 109.711 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -60.18 -22.15 62.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.657 -1.277 . . . . 1.76 108.761 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -67.33 -25.12 65.85 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.292 -1.373 . . . . 3.21 107.292 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.3 -44.02 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.436 -1.32 . . . . 2.3500000000000001 107.436 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.46 81.0 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.445 -0.946 . . . . 2.3999999999999999 108.445 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 78.6 p -76.77 -23.16 52.94 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.506 -0.746 . . . . 3.0299999999999998 109.113 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 108.446 -0.946 . . . . 3.4100000000000001 108.446 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.245 0.545 . . . . 4.0700000000000003 109.565 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.0 mt -84.68 106.21 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.954 . . . . 1.5 109.628 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 m -99.48 110.6 23.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.382 -0.824 . . . . 1.8 109.706 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.89 -169.9 31.07 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.011 -1.636 . . . . 0.92000000000000004 109.011 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' LEU . 56.7 mt -93.08 -7.42 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.043 -1.269 . . . . 1.5 108.614 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.8 tp 54.34 104.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.495 -0.753 . . . . 1.3999999999999999 109.385 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.54 -41.17 12.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.903 -1.123 . . . . 1.26 108.609 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -150.06 148.96 26.2 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.29 -0.881 . . . . 1.95 108.769 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.15 148.22 16.77 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.564 2.176 . . . . 0.93999999999999995 114.092 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.82 176.29 31.73 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.894 -1.282 . . . . 0.78000000000000003 109.894 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 11' ' ' ILE . 97.1 mt -140.13 128.95 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.15 -1.206 . . . . 1.29 109.257 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.88 153.2 49.58 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.281 -0.887 . . . . 1.1499999999999999 109.722 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -123.93 132.86 53.79 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.191 -1.04 . . . . 0.71999999999999997 108.191 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.6 164.94 34.33 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 118.537 -1.792 . . . . 0.5 111.314 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -76.99 149.25 35.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.625 -0.926 . . . . 2.3599999999999999 109.383 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -77.3 132.27 38.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.398 -0.814 . . . . 1.1599999999999999 110.839 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 tp -115.23 89.62 3.14 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.459 -1.312 . . . . 1.24 107.459 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 tp -80.74 122.41 27.1 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.201 1.001 . . . . 1.3100000000000001 110.646 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.0 mt -92.53 98.06 11.22 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.011 -0.736 . . . . 1.3100000000000001 109.011 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -92.26 159.89 15.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 2.3500000000000001 109.665 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -111.71 133.37 54.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.858 -0.793 . . . . 2.5800000000000001 108.858 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' OE1' ' A' ' 21' ' ' GLU . 12.7 m-20 -80.52 124.99 29.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 2.1400000000000001 110.493 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.07 126.47 28.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.431 -0.793 . . . . 1.9299999999999999 109.1 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 80.7 mt -91.09 140.07 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.936 . . . . 1.28 109.502 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.74 115.61 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.486 -0.759 . . . . 1.3700000000000001 108.984 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.0 mt -88.06 133.54 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 1.3300000000000001 109.88 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -91.63 123.33 34.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 1.3700000000000001 109.375 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -96.65 25.16 5.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.173 -0.955 . . . . 3.1899999999999999 109.005 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -86.87 150.71 23.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 2.8100000000000001 110.38 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -93.22 123.05 36.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.923 -0.769 . . . . 2.8300000000000001 108.923 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -83.67 175.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.961 -1.087 . . . . 1.3400000000000001 109.368 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 34' ' ' ASP . 45.3 p -97.24 149.48 21.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.464 -0.772 . . . . 1.3500000000000001 109.121 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.97 -7.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 1.6100000000000001 109.667 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 32' ' ' SER . 29.9 t70 -84.14 -24.21 30.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 2.4700000000000002 109.968 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -103.44 -9.84 19.06 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.134 -0.979 . . . . 2.0699999999999998 109.536 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.15 -41.4 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.092 -1.005 . . . . 1.3300000000000001 109.071 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -54.92 -35.43 64.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.366 -0.834 . . . . 1.46 109.392 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -70.01 -37.82 75.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 2.9399999999999999 110.355 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -58.97 -39.1 80.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 1.3 109.481 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.44 -43.76 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.394 -0.816 . . . . 1.3300000000000001 109.48 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -63.39 -41.86 98.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.189 -0.945 . . . . 1.5 108.461 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.18 -30.25 71.43 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.364 -0.835 . . . . 3.1499999999999999 108.811 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -86.7 -51.81 5.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.854 . . . . 0.92000000000000004 109.49 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 tp -58.12 -63.21 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 1.4099999999999999 109.834 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 t -65.12 -35.6 81.63 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.822 -1.174 . . . . 1.22 109.14 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.36 -9.79 38.64 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.254 -1.938 . . . . 0.58999999999999997 108.254 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -85.72 -28.65 24.49 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.902 -1.518 . . . . 3.3900000000000001 106.902 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.9 -26.65 67.72 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.291 -1.003 . . . . 1.26 108.291 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -85.27 -62.88 1.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.281 -0.637 . . . . 2.9900000000000002 109.281 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.07 -38.07 49.42 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.094 -1.004 . . . . 1.1399999999999999 109.311 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 66.4 m -64.82 -38.56 91.38 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.45 -0.944 . . . . 1.8400000000000001 108.45 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.04 -39.77 65.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.292 0.567 . . . . 1.22 109.863 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -55.47 -74.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 2.0 109.541 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 58' ' ' LYS . 17.8 mt -46.64 -52.42 13.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.158 -0.964 . . . . 1.99 109.508 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 51' ' ' SER . 25.8 mm-40 -47.63 -53.4 14.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.454 -0.779 . . . . 1.27 109.639 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 m -62.34 -37.97 87.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 1.24 109.319 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.6 mt -72.62 -31.1 36.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.301 -0.874 . . . . 1.21 108.787 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 54' ' ' LEU . 15.8 ttpt -55.06 -44.23 74.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.414 -0.804 . . . . 1.53 109.28 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.45 -32.47 70.05 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.255 -0.903 . . . . 1.24 109.47 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.441 ' O ' ' OG1' ' A' ' 64' ' ' THR . 67.9 mttm -70.71 -17.67 62.82 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.906 -1.122 . . . . 2.3199999999999998 108.081 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.6 -34.53 21.39 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.867 -0.79 . . . . 1.1699999999999999 108.867 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.89 -27.69 30.95 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.061 -1.066 . . . . 0.57999999999999996 110.64 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -86.43 -17.66 33.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.688 -1.478 . . . . 1.3899999999999999 109.414 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 23.8 m -94.66 -45.25 7.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.078 -1.014 . . . . 1.3600000000000001 110.396 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -106.11 -18.85 13.89 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.208 -0.933 . . . . 1.1399999999999999 110.38 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 121.26 139.26 5.65 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 109.58 -1.408 . . . . 0.59999999999999998 109.58 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -48.93 -8.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.955 . . . . 2.5899999999999999 110.728 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 66' ' ' GLY . 2.5 pt-20 -66.57 -23.49 66.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.813 -1.179 . . . . 2.2000000000000002 110.298 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -88.81 -10.05 49.51 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.884 -1.135 . . . . 2.3599999999999999 110.074 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -63.55 -23.85 67.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.918 -1.114 . . . . 1.54 110.595 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.22 83.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.081 -1.012 . . . . 1.24 110.274 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.3 mt -70.33 -42.21 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 1.24 109.449 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -76.1 -20.82 57.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.152 -0.967 . . . . 0.80000000000000004 109.622 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -65.4 -38.86 91.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.977 -1.077 . . . . 1.23 108.95 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.74 -36.97 61.58 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.247 -1.541 . . . . 0.56000000000000005 109.247 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -62.42 -21.85 65.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.312 -1.11 . . . . 2.0600000000000001 110.768 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.2 mt -85.37 -39.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.559 -1.338 . . . . 1.24 108.99 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.4 ttt -59.31 -42.23 90.88 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.364 -0.976 . . . . 2.4500000000000002 108.364 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.5 -40.49 82.99 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.45 -0.945 . . . . 1.21 108.45 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.4 tp -65.96 -50.33 64.72 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.439 -0.788 . . . . 1.1200000000000001 109.674 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -85.55 10.48 13.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.162 -0.961 . . . . 1.24 110.976 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -48.46 122.8 5.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.738 -1.226 . . . . 1.3100000000000001 109.376 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -66.29 -25.9 67.07 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.406 -0.809 . . . . 1.3500000000000001 108.959 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -76.45 -49.75 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.458 -0.777 . . . . 2.1600000000000001 109.514 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.0 mt -64.95 -20.71 66.61 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.888 -1.125 . . . . 1.24 108.928 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -70.43 -47.57 60.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.381 -0.824 . . . . 1.28 109.476 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -64.89 -32.18 73.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.522 -0.736 . . . . 1.79 109.815 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -73.09 -48.77 32.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -0.951 . . . . 1.29 109.015 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.18 -57.71 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.75 -0.833 . . . . 1.1399999999999999 108.75 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 91' ' ' ALA . 77.3 mt -53.05 -61.88 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.714 -0.616 . . . . 1.3200000000000001 110.662 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 90' ' ' ILE . . . -40.93 -62.51 0.8 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.388 -0.82 . . . . 1.3700000000000001 110.748 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.4 mt -45.12 -51.11 10.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.376 -0.828 . . . . 1.3999999999999999 110.011 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.5 -41.35 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.929 -1.107 . . . . 1.23 110.011 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -85.16 -42.74 14.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.211 -0.93 . . . . 2.5099999999999998 111.808 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -83.64 -34.06 25.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.669 -1.269 . . . . 1.5900000000000001 111.74 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -104.16 10.7 35.71 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.836 -1.165 . . . . 2.3799999999999999 109.361 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.8 m80 43.77 47.7 6.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.703 . . . . 1.6200000000000001 109.691 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.5 mtp -99.33 154.88 17.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.77 -0.826 . . . . 1.8899999999999999 108.77 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.433 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 3.1 p -75.52 141.29 43.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.273 -0.892 . . . . 1.27 109.163 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.07 -25.98 2.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.155 -0.965 . . . . 1.1599999999999999 109.347 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.83 -45.34 51.85 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.277 -1.009 . . . . 2.0 108.277 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -70.91 -54.4 11.54 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.733 -0.604 . . . . 1.25 109.873 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -52.62 63.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.261 -0.9 . . . . 1.1299999999999999 109.478 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.09 -35.42 64.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.958 . . . . 1.0800000000000001 109.283 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -71.99 -32.41 67.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.853 . . . . 2.02 109.545 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.86 -61.9 2.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 1.26 110.035 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.8 t -53.66 -47.32 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 1.1799999999999999 110.038 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.49 -20.66 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 1.1899999999999999 109.681 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -74.14 -38.26 63.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.022 . . . . 2.2000000000000002 110.161 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.38 -21.84 46.76 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.525 -1.321 . . . . 0.85999999999999999 111.994 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -68.95 -53.48 20.58 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.735 -1.45 . . . . 2.0 108.691 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.66 67.28 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.656 -0.652 . . . . 1.3200000000000001 109.485 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 t -60.69 -43.6 97.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 2.1400000000000001 110.192 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.3 -33.08 75.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.042 . . . . 1.3799999999999999 110.449 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.1 mt -69.38 -27.9 65.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.729 -1.232 . . . . 1.3500000000000001 109.338 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.56 -16.09 64.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 1.95 109.224 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -80.37 -9.06 59.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.374 -0.829 . . . . 1.71 109.004 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.71 141.05 28.9 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.528 -0.915 . . . . 1.71 108.528 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -99.65 65.11 1.33 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.309 -0.869 . . . . 2.8300000000000001 109.186 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -147.18 111.87 5.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 1.5800000000000001 109.354 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -51.49 -17.02 0.69 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.537 -0.727 . . . . 2.7999999999999998 109.815 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -81.21 -63.87 1.31 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 1.27 109.272 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.4 mt -61.76 -31.27 71.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.264 -0.898 . . . . 1.5800000000000001 110.139 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -66.65 -46.43 75.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.856 -1.152 . . . . 2.9199999999999999 109.112 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -61.39 -18.75 60.21 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.512 -0.875 . . . . 2.2000000000000002 108.831 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -74.72 -27.69 60.48 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.678 -1.601 . . . . 2.5299999999999998 106.678 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.71 94.56 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.126 -0.694 . . . . 1.45 109.126 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.99 87.24 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.289 -0.882 . . . . 1.5 109.472 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.8 OUTLIER -70.52 -30.4 67.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.834 . . . . 1.3500000000000001 110.028 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.12 -39.68 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.958 -1.089 . . . . 1.23 108.45 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -61.69 -37.94 85.97 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.216 -1.031 . . . . 3.73 108.216 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.08 -36.37 77.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.535 -0.728 . . . . 1.3200000000000001 109.699 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.03 -27.72 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 1.2 109.771 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.33 -46.67 7.35 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.678 -1.369 . . . . 0.48999999999999999 109.678 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -49.6 -47.75 49.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -1.099 . . . . 3.1099999999999999 109.144 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.484 ' HG2' HH11 ' A' ' 136' ' ' ARG . 12.8 mtt-85 -64.77 -43.42 93.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.143 -0.973 . . . . 2.9500000000000002 108.713 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.6 tp -52.38 -39.99 61.51 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.968 -0.753 . . . . 1.73 108.968 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.41 -59.08 2.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 1.22 109.96 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.405 ' HG2' HH11 ' A' ' 139' ' ' ARG . 30.4 mtt-85 -47.67 -18.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 2.7799999999999998 110.841 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -84.6 -39.83 18.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.837 -1.164 . . . . 2.0299999999999998 108.965 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.61 -38.31 81.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.4 -0.812 . . . . 1.2 109.063 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.9 mt -91.19 -7.3 51.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.345 -0.847 . . . . 1.28 109.016 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.95 20.83 69.09 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.389 -1.884 . . . . 0.68999999999999995 108.389 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tp -57.82 168.29 0.96 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.689 -0.889 . . . . 1.3100000000000001 109.601 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -66.06 143.57 57.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 2.8799999999999999 109.375 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -102.13 147.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.625 -0.88 . . . . 1.3600000000000001 108.625 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.7 mp -79.08 94.02 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.168 -0.957 . . . . 1.9299999999999999 109.193 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -101.0 92.07 4.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.461 -0.774 . . . . 1.54 110.046 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.1 mt -82.56 -17.52 44.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.145 -0.972 . . . . 1.3400000000000001 108.917 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 170' ' ' GLN . 0.8 OUTLIER -82.99 35.34 0.47 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.763 . . . . 1.98 109.608 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.1 24.27 2.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 1.3799999999999999 109.024 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 79.4 mt -73.16 139.84 18.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.483 -0.761 . . . . 1.3999999999999999 109.449 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -118.34 -18.0 9.33 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.519 -0.919 . . . . 2.7400000000000002 108.519 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -117.62 127.73 54.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.982 -0.747 . . . . 1.4099999999999999 108.982 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -61.91 127.71 32.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.814 . . . . 1.3 109.889 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -149.99 176.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.393 -0.817 . . . . 1.28 108.888 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.1 mt -87.9 147.14 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.442 -0.948 . . . . 1.1499999999999999 108.442 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 tp -101.74 117.76 35.54 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.654 -0.869 . . . . 1.2 108.654 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.67 131.96 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.713 -0.847 . . . . 1.1599999999999999 108.713 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.33 149.17 15.29 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.78 -0.768 . . . . 1.2 109.644 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.76 78.46 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 120.682 -1.261 . . . . 1.3200000000000001 107.946 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -173.14 148.33 1.68 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.585 -0.697 . . . . 2.3399999999999999 109.134 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.4 mt -119.59 138.73 53.03 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.383 -0.823 . . . . 1.26 109.619 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.4 p -94.41 153.53 40.41 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 1.3600000000000001 109.243 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 169' ' ' ALA . 69.6 Cg_exo -37.36 -50.55 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.379 2.053 . . . . 0.63 112.482 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 m -49.78 -55.44 14.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 1.0700000000000001 109.281 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.19 -47.52 81.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.907 . . . . 1.25 109.543 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.4 p -67.95 -19.86 65.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 1.1799999999999999 109.778 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -80.09 -29.5 39.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.163 -0.961 . . . . 1.1399999999999999 110.113 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.432 ' O ' ' OG ' ' A' ' 150' ' ' SER . 20.9 pt20 -101.5 -11.66 19.13 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.154 -0.966 . . . . 1.71 109.117 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.89 151.72 21.04 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.538 -0.912 . . . . 1.22 108.538 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -99.57 139.35 35.35 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.407 -0.96 . . . . 2.5499999999999998 108.407 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.3 mm? -88.37 -41.21 12.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 1.96 109.978 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -82.49 -10.72 58.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.019 -1.05 . . . . 2.46 111.667 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -99.9 -17.03 17.79 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.621 -1.3 . . . . 2.4199999999999999 108.763 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 56.6 t -89.7 156.38 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.592 -0.892 . . . . 1.1599999999999999 108.592 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.8 tp -106.08 -20.46 13.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.364 -0.835 . . . . 1.95 109.609 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.4 173.0 41.64 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.095 -1.602 . . . . 0.41999999999999998 109.095 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -128.36 124.33 36.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -1.035 . . . . 0.52000000000000002 109.081 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.0 mt -130.2 131.68 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.017 -1.105 . . . . 1.1599999999999999 108.017 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 23.4 p -139.22 147.41 41.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.36 -0.837 . . . . 1.22 111.336 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 182' ' ' ASP . 7.1 p-10 -84.78 37.32 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.702 -0.624 . . . . 2.2400000000000002 110.09 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 203' ' ' VAL . . . -112.69 120.07 40.28 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.377 -0.827 . . . . 1.6499999999999999 110.034 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.03 65.94 2.53 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.613 -1.395 . . . . 2.1000000000000001 109.613 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -100.29 128.23 9.5 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.038 -1.225 . . . . 1.8400000000000001 110.038 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.478 ' O ' ' OG1' ' A' ' 187' ' ' THR . 16.7 ttm-85 -53.09 92.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.283 -1.377 . . . . 5.7800000000000002 107.283 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 185' ' ' GLY . 4.9 p 65.12 68.21 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.3 -1.0 . . . . 3.2400000000000002 108.3 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.0 t -72.11 165.01 25.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 2.1099999999999999 109.442 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -43.65 -47.49 7.66 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.522 -0.736 . . . . 1.0600000000000001 110.427 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.0 m -50.08 -31.04 12.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 2.0899999999999999 109.599 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.9 t -76.47 -39.41 53.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.194 -0.941 . . . . 1.8799999999999999 109.859 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 192' ' ' ILE . 1.5 mp -53.48 -36.43 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.956 . . . . 2.0099999999999998 108.758 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 33.3 mtp -71.13 -52.11 21.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.255 -1.387 . . . . 1.27 107.255 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.33 -46.05 86.96 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.528 -0.76 . . . . 1.1799999999999999 110.243 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -63.89 -48.76 75.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.064 -1.023 . . . . 3.5800000000000001 110.056 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.8 m -68.92 -36.43 77.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.125 -0.984 . . . . 1.1399999999999999 109.5 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 199' ' ' LEU . 21.3 mt -89.37 1.81 55.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.977 . . . . 1.28 109.018 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 194' ' ' ALA . 32.1 mt-10 54.71 2.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.466 -0.771 . . . . 1.49 111.261 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 197' ' ' LEU . 25.2 mt -66.61 168.47 10.11 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.622 -1.299 . . . . 1.28 108.54 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -85.71 144.0 8.59 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.21 1.94 . . . . 0.69999999999999996 111.081 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.36 172.6 17.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.653 -1.279 . . . . 1.1899999999999999 110.965 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.2 mt -150.95 156.0 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.365 -1.717 . . . . 1.25 106.365 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.8 m -143.04 -33.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.812 -1.18 . . . . 1.29 111.703 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -85.89 38.96 3.03 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 120.523 -1.36 . . . . 0.92000000000000004 110.202 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 206' ' ' GLY . 27.5 p -71.21 42.83 0.07 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.831 -1.394 . . . . 1.3100000000000001 109.199 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 39.18 -102.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.272 -1.131 . . . . 1.0 110.272 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.4 m -131.14 42.37 3.23 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.811 -0.817 . . . . 1.9199999999999999 110.039 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.3 t -54.56 -33.57 27.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.868 -1.145 . . . . 1.27 108.438 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.2 p -55.39 -16.48 3.64 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.047 -1.033 . . . . 1.3400000000000001 108.678 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 49.9 m -103.95 12.21 34.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.541 -0.724 . . . . 2.0699999999999998 109.322 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -135.74 -17.3 1.7 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.32 -0.862 . . . . 2.8599999999999999 109.968 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 5.8 t -112.55 141.91 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.637 -0.875 . . . . 1.3 108.637 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -177.92 3.26 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.764 -1.569 . . . . 2.48 106.764 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.3 p-10 -81.06 144.81 31.47 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.033 -1.042 . . . . 2.6200000000000001 110.04 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.8 m-20 81.04 -13.46 0.92 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.074 -0.392 . . . . 2.3999999999999999 110.857 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.51 136.37 56.71 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.854 -1.154 . . . . 1.99 108.416 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -86.7 117.21 25.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.926 -1.109 . . . . 1.54 108.952 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.3 mt -129.38 175.16 8.98 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.654 0.74 . . . . 1.25 109.585 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.6 mt -140.89 126.25 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.755 -0.831 . . . . 1.26 108.755 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.16 126.32 35.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 1.1799999999999999 108.725 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 223' ' ' VAL . 4.1 m-20 -95.38 -34.56 12.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.07 -1.019 . . . . 2.2200000000000002 109.486 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 40.51 21.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.675 -0.641 . . . . 1.2 110.142 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.3 t -115.12 -59.84 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 106.465 -1.68 . . . . 1.48 106.465 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -89.21 11.39 18.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.242 -1.392 . . . . 2.8199999999999998 107.242 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 64.3 t30 57.39 58.26 3.94 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.414 -0.588 . . . . 2.1099999999999999 109.414 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -156.1 151.76 27.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.054 -1.028 . . . . 2.6499999999999999 110.517 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 32.8 t -109.78 139.33 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.721 -0.844 . . . . 1.29 108.721 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -108.88 129.94 55.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.406 -0.809 . . . . 1.4199999999999999 109.555 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 11.3 t -103.18 113.81 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.401 -0.812 . . . . 1.26 109.362 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.1 t30 52.02 63.42 9.18 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.943 . . . . 2.1499999999999999 110.54 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.81 161.6 44.54 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.509 2.14 . . . . 0.81999999999999995 112.019 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.6 p -74.0 160.4 31.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.358 -0.839 . . . . 2.1099999999999999 109.464 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -68.01 -26.68 66.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 3.1699999999999999 109.137 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 234' ' ' GLU . 0.7 OUTLIER -62.05 -37.65 85.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.803 . . . . 3.0600000000000001 109.623 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.58 -45.28 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.007 -1.058 . . . . 1.6499999999999999 109.157 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 236' ' ' ILE . 97.5 mt -54.57 -57.96 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.323 -0.861 . . . . 1.47 109.67 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -53.72 -40.37 66.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.28 -0.887 . . . . 2.54 110.417 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -65.91 -40.23 91.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 3.0 110.279 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 28.9 mtm -80.7 -26.04 37.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.999 -1.063 . . . . 1.6299999999999999 109.911 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.4 ' HG3' ' NH1' ' A' ' 240' ' ' ARG . 15.1 mmm-85 -58.29 -42.16 85.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 3.1600000000000001 109.898 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.24 -52.28 11.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 2.0899999999999999 110.133 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 35.4 t -62.79 -50.23 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.101 -0.999 . . . . 2.5699999999999998 109.862 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -51.71 -59.12 4.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.197 -0.94 . . . . 3.5899999999999999 110.378 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.95 -23.75 66.57 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.271 -0.893 . . . . 1.76 110.625 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -67.09 -22.76 65.81 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.905 -1.146 . . . . 3.21 107.905 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.7 t -78.55 -39.15 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.756 -0.831 . . . . 2.3500000000000001 108.756 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.3 -28.26 69.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.488 -0.757 . . . . 2.3999999999999999 109.757 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.5 p -76.84 -32.51 57.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.139 -0.975 . . . . 3.0299999999999998 109.698 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 3.4100000000000001 109.217 179.793 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' N ' ' A' ' 3' ' ' SER . 21.1 mmt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.255 -0.646 . . . . 4.0700000000000003 109.255 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.59 85.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.092 -1.005 . . . . 1.5 108.649 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 1' ' ' MET . 6.9 m -88.54 114.15 24.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 1.8 109.253 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.55 -163.16 20.7 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 108.859 -1.696 . . . . 0.92000000000000004 108.859 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 65.1 mt -94.84 -6.44 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -1.174 . . . . 1.5 108.553 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 36.5 tp 54.17 104.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.106 -0.702 . . . . 1.3999999999999999 109.106 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.14 -56.0 4.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.064 -1.022 . . . . 1.26 108.345 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.64 145.61 26.3 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.144 -1.058 . . . . 1.95 108.144 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.58 154.19 35.0 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.986 1.79 . . . . 0.93999999999999995 113.499 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.51 133.2 1.81 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.721 -1.351 . . . . 0.78000000000000003 109.721 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.0 mt -94.85 135.65 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.955 -1.321 . . . . 1.29 109.795 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.6 155.42 44.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.216 -0.927 . . . . 1.1499999999999999 109.726 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.577 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -125.38 141.78 51.87 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.338 -0.986 . . . . 0.71999999999999997 108.338 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.24 163.02 28.08 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.127 -1.511 . . . . 0.5 110.887 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -78.51 150.97 32.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.488 -1.007 . . . . 2.3599999999999999 109.559 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.13 127.9 33.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 1.1599999999999999 111.012 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -109.71 91.94 3.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.436 -1.32 . . . . 1.24 107.436 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.61 ' H ' ' ND2' ' A' ' 214' ' ' ASN . 8.6 tp -81.65 126.3 31.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.021 -1.049 . . . . 1.3100000000000001 110.58 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.6 mt -96.43 93.5 6.87 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.905 -0.589 . . . . 1.3100000000000001 110.075 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -92.82 158.22 15.98 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.598 -0.89 . . . . 2.3500000000000001 108.598 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -130.62 135.93 48.36 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.351 -0.843 . . . . 2.5800000000000001 109.322 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.11 133.55 36.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -0.854 . . . . 2.1400000000000001 108.856 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.58 147.69 48.37 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.293 -0.88 . . . . 1.9299999999999999 109.135 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mt -89.27 129.76 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.298 -0.876 . . . . 1.28 109.417 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.4 112.59 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.605 -0.887 . . . . 1.3700000000000001 108.605 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.6 mt -86.56 131.78 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 1.3300000000000001 109.65 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -90.1 114.69 26.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.397 -0.814 . . . . 1.3700000000000001 109.374 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' ' 28' ' ' ARG . 19.9 mmm-85 -95.63 26.16 4.13 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.206 -0.934 . . . . 3.1899999999999999 108.857 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' CB ' ' HZ1' ' A' ' 29' ' ' LYS . 9.5 mtmp? -79.21 143.26 35.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 2.8100000000000001 109.384 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -84.76 123.63 30.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 2.8300000000000001 109.573 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -90.92 173.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.277 -0.889 . . . . 1.3400000000000001 109.987 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -105.53 172.9 6.55 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.776 -0.578 . . . . 1.3500000000000001 109.603 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.18 -8.55 32.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.815 . . . . 1.6100000000000001 109.722 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -82.84 -16.42 47.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.048 -1.032 . . . . 2.4700000000000002 109.814 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -110.78 -8.27 14.56 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.395 -0.815 . . . . 2.0699999999999998 109.263 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.49 -45.1 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 1.3300000000000001 108.587 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -53.9 -36.09 62.35 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.419 -0.8 . . . . 1.46 109.067 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -70.44 -42.06 72.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.497 -0.752 . . . . 2.9399999999999999 110.51 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -58.66 -45.6 89.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 1.3 109.535 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 44' ' ' LEU . 85.6 t -61.81 -44.21 98.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.192 -0.943 . . . . 1.3300000000000001 109.053 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -65.72 -42.49 90.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.28 -0.887 . . . . 1.5 109.083 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -63.62 -34.89 78.84 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.176 -0.952 . . . . 3.1499999999999999 108.92 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -86.39 -53.09 5.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.394 -0.816 . . . . 0.92000000000000004 109.059 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' VAL . 10.0 tp -53.79 -67.1 0.29 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.731 . . . . 1.4099999999999999 109.731 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.1 t -63.75 -35.07 79.38 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.192 -0.943 . . . . 1.22 108.935 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.55 -53.35 39.25 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.372 -2.291 . . . . 0.58999999999999997 107.372 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -46.74 -32.33 3.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.603 -0.939 . . . . 3.3900000000000001 108.775 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.86 -32.92 69.88 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.869 -1.159 . . . . 1.26 107.869 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 46' ' ' GLY . 16.5 ttmm -83.89 -61.05 1.92 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.021 -0.733 . . . . 2.9900000000000002 109.021 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.09 -45.03 64.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 1.1399999999999999 110.069 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.4 t -63.35 -38.14 89.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.06 -1.025 . . . . 1.8400000000000001 108.409 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 -31.2 65.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.089 -0.708 . . . . 1.22 109.089 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -69.25 -58.68 3.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.801 . . . . 2.0 109.099 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 58' ' ' LYS . 39.4 mt -55.85 -45.38 78.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 1.99 108.718 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -55.27 -48.66 73.7 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.981 -0.748 . . . . 1.27 108.981 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.1 m -63.13 -41.08 99.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 1.24 109.22 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.4 mt -71.53 -37.49 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.375 -0.972 . . . . 1.21 108.375 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 54' ' ' LEU . 11.7 ttpt -49.84 -45.58 50.4 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.57 -0.706 . . . . 1.53 109.408 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -70.95 -27.78 64.0 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.256 -0.902 . . . . 1.24 109.941 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.417 ' O ' ' OG1' ' A' ' 64' ' ' THR . 39.5 mtpt -71.79 -25.37 61.98 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.805 -1.184 . . . . 2.3199999999999998 108.475 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.58 -29.07 33.53 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.647 -0.872 . . . . 1.1699999999999999 108.647 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.21 -32.13 17.85 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.969 -1.11 . . . . 0.57999999999999996 110.653 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -85.88 -15.44 41.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.899 -1.353 . . . . 1.3899999999999999 109.107 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 71.8 m -95.49 -48.81 5.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.332 -0.855 . . . . 1.3600000000000001 110.498 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -106.64 -14.48 15.02 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.13 -0.981 . . . . 1.1399999999999999 110.67 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.81 136.86 5.2 Favored Glycine 0 N--CA 1.502 3.087 0 N-CA-C 109.733 -1.347 . . . . 0.59999999999999998 109.733 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -48.29 -9.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.536 -0.979 . . . . 2.5899999999999999 110.744 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 66' ' ' GLY . 13.6 pt-20 -66.51 -21.86 66.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.952 -1.093 . . . . 2.2000000000000002 110.586 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -87.93 -16.32 34.19 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.92 -1.113 . . . . 2.3599999999999999 109.781 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.15 -20.34 66.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.2 -0.937 . . . . 1.54 110.686 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.75 92.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.852 -1.155 . . . . 1.24 109.531 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.6 mt -71.73 -39.85 69.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.218 -0.926 . . . . 1.24 109.465 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -78.06 -23.53 48.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -0.958 . . . . 0.80000000000000004 108.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -64.7 -33.28 75.59 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.493 -0.928 . . . . 1.23 108.493 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.47 -35.9 35.6 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.048 -1.621 . . . . 0.56000000000000005 109.048 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -60.95 -21.1 63.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.352 -1.087 . . . . 2.0600000000000001 109.829 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 77' ' ' ILE . 91.2 mt -86.42 -42.4 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.9 -1.125 . . . . 1.24 108.76 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.3 ttm -59.88 -41.38 91.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.022 -0.733 . . . . 2.4500000000000002 109.022 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -63.93 -39.31 93.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 1.21 109.127 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -71.83 -42.58 66.81 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.534 -0.866 . . . . 1.1200000000000001 109.431 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -86.24 5.43 34.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 1.24 110.41 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -48.36 122.75 5.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 1.3100000000000001 109.753 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -67.42 -24.32 65.64 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.643 -0.873 . . . . 1.3500000000000001 108.643 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -76.14 -53.39 8.36 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.469 -0.769 . . . . 2.1600000000000001 109.055 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.06 -12.61 52.55 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.972 -1.091 . . . . 1.24 108.707 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -78.16 -53.75 7.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.434 -0.792 . . . . 1.28 109.897 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -62.5 -25.69 68.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 1.79 109.701 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -73.19 -47.04 47.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -0.99 . . . . 1.29 108.812 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 89' ' ' ILE . 79.4 mt -59.61 -56.32 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.441 -0.948 . . . . 1.1399999999999999 108.441 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.401 HD11 HG22 ' A' ' 90' ' ' ILE . 96.9 mt -48.34 -56.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.603 -0.686 . . . . 1.3200000000000001 110.055 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -47.79 -61.96 1.69 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 1.3700000000000001 110.308 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.5 mt -47.8 -52.14 19.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 1.3999999999999999 109.402 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.0 mt -52.2 -46.24 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.077 -1.014 . . . . 1.23 110.193 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -84.85 -35.51 22.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.094 -1.004 . . . . 2.5099999999999998 111.88 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.25 -37.98 22.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.536 -1.352 . . . . 1.5900000000000001 111.732 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -105.23 14.62 28.73 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.729 -1.232 . . . . 2.3799999999999999 109.48 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.8 m80 45.16 42.53 6.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.379 -0.826 . . . . 1.6200000000000001 109.597 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.7 mtt -95.36 149.54 21.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.936 -0.765 . . . . 1.8899999999999999 108.936 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 p -76.62 143.59 40.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.33 -0.856 . . . . 1.27 109.283 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.04 -27.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 1.1599999999999999 109.804 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 1.3 p30 -76.14 -43.85 41.06 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.293 -0.879 . . . . 2.0 108.717 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -70.52 -56.9 5.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.622 -0.674 . . . . 1.25 110.277 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.25 -49.68 68.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 1.1299999999999999 109.758 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.89 -30.94 59.31 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.247 -0.908 . . . . 1.0800000000000001 109.525 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -69.47 -34.63 74.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.991 -1.068 . . . . 2.02 109.873 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -63.78 -45.89 87.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.989 -1.07 . . . . 1.26 109.791 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.51 -47.82 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.825 -1.172 . . . . 1.1799999999999999 108.669 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.74 -18.19 22.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.493 -0.754 . . . . 1.1899999999999999 109.057 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.8 -42.87 73.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 2.2000000000000002 109.572 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.32 -29.32 22.53 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.617 -1.278 . . . . 0.85999999999999999 112.336 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -65.15 -39.45 93.01 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.414 -1.639 . . . . 2.0 108.797 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.67 -51.36 7.8 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.567 -0.708 . . . . 1.3200000000000001 109.178 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -60.34 -44.52 95.44 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.452 -0.78 . . . . 2.1400000000000001 110.149 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -63.89 -37.62 88.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.05 -1.031 . . . . 1.3799999999999999 111.235 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.41 -25.99 66.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.507 -1.371 . . . . 1.3500000000000001 109.216 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -71.63 -21.33 61.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.971 -1.08 . . . . 1.95 109.828 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -81.83 -7.02 59.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.214 -0.929 . . . . 1.71 108.921 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.89 136.86 33.12 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.255 -1.017 . . . . 1.71 108.255 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -94.07 63.43 3.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 2.8300000000000001 108.722 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -146.61 114.27 6.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.81 . . . . 1.5800000000000001 109.28 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.83 -16.01 4.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 2.7999999999999998 109.755 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -81.12 -63.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 1.27 109.368 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 mt -66.55 -31.32 71.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.236 -0.915 . . . . 1.5800000000000001 109.833 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 127' ' ' ALA . 27.6 ttpt -66.69 -50.05 64.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.942 -1.099 . . . . 2.9199999999999999 109.321 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.27 -25.73 49.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.091 -1.006 . . . . 2.2000000000000002 108.702 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -72.56 -23.57 60.99 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.542 -1.651 . . . . 2.5299999999999998 106.542 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.38 -47.83 82.59 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.233 -1.025 . . . . 1.45 108.233 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.41 -35.84 76.13 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.674 -0.641 . . . . 1.5 109.48 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.9 m-20 -68.69 -30.63 69.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.422 -0.799 . . . . 1.3500000000000001 109.733 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.4 t -77.48 -39.48 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.01 -1.056 . . . . 1.23 108.679 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -56.35 -40.93 75.31 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.107 -1.071 . . . . 3.73 108.107 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.61 -38.36 81.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.603 -0.686 . . . . 1.3200000000000001 109.665 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.52 -21.77 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 1.2 109.449 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.09 -58.36 2.99 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.0 -1.095 . . . . 0.48999999999999999 110.496 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -52.67 -42.67 64.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.007 -1.29 . . . . 3.1099999999999999 109.849 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 140' ' ' ASN . 23.2 mtt-85 -65.43 -45.91 82.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.957 -1.089 . . . . 2.9500000000000002 108.423 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.2 tp -55.68 -43.41 76.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.585 -0.697 . . . . 1.73 109.386 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.2 -47.9 75.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 1.22 110.268 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -52.96 -22.35 5.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.061 -1.024 . . . . 2.7799999999999998 110.8 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 70.4 m-80 -83.37 -45.55 13.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.915 -1.116 . . . . 2.0299999999999998 109.091 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.5 mt -53.93 -38.48 36.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.197 -0.94 . . . . 1.2 108.934 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.2 mt -88.15 3.59 48.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.245 -0.909 . . . . 1.28 109.101 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.2 30.88 55.83 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.744 -1.742 . . . . 0.68999999999999995 108.744 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.57 142.35 52.9 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.357 -1.084 . . . . 1.3100000000000001 109.462 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -67.5 136.01 53.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 2.8799999999999999 109.708 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 80.4 mt -106.54 144.6 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.898 -0.779 . . . . 1.3600000000000001 108.898 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.471 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.1 mp -77.92 138.98 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 1.9299999999999999 109.616 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -96.67 86.59 4.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.426 -0.796 . . . . 1.54 109.486 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.412 ' C ' ' H ' ' A' ' 151' ' ' ALA . 64.1 mt -80.17 -29.69 38.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.412 -0.805 . . . . 1.3400000000000001 109.651 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.8 p -79.98 20.64 0.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.933 . . . . 1.98 109.486 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -142.32 35.11 1.49 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.347 -0.845 . . . . 1.3799999999999999 109.714 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 57.7 mt -72.3 158.83 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 1.3999999999999999 109.148 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -134.43 -4.21 2.65 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.293 -0.879 . . . . 2.7400000000000002 109.601 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -125.2 128.34 48.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.533 -0.729 . . . . 1.4099999999999999 109.297 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.52 122.99 18.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 1.3 109.292 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.4 m -148.12 172.97 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.321 -0.862 . . . . 1.28 109.314 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.4 mt -88.85 152.91 3.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.809 -1.182 . . . . 1.1499999999999999 107.809 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.6 tp -105.98 118.76 37.44 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.619 0.724 . . . . 1.2 109.273 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 26.2 t -121.46 128.62 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.815 -0.809 . . . . 1.1599999999999999 108.815 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.67 146.59 11.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.313 -0.867 . . . . 1.2 109.539 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.5 71.72 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.677 -1.265 . . . . 1.3200000000000001 108.015 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -173.21 157.33 3.38 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.598 -0.689 . . . . 2.3399999999999999 109.48 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.7 mt -126.82 137.47 53.2 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.531 -0.731 . . . . 1.26 109.118 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.6 p -92.33 152.74 42.64 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.24 -0.913 . . . . 1.3600000000000001 109.195 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 169' ' ' ALA . 66.0 Cg_exo -35.92 -51.9 1.03 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.561 2.174 . . . . 0.63 112.663 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.5 m -47.92 -54.72 11.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 1.0700000000000001 109.473 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -59.04 -48.07 82.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 1.25 109.811 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.455 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 5.4 p -69.49 -24.33 63.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 1.1799999999999999 109.902 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -77.9 -24.62 48.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 1.1399999999999999 110.086 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -106.95 -15.39 14.71 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.316 -0.865 . . . . 1.71 109.681 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.1 tp -58.81 149.91 25.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.019 -1.051 . . . . 1.22 108.831 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.561 ' ND2' ' H ' ' A' ' 173' ' ' LEU . 2.6 t-20 -99.02 152.57 19.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 2.5499999999999998 108.702 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.561 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 11.8 mt -95.32 -40.84 9.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.177 -0.952 . . . . 1.96 110.938 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -81.79 -14.68 56.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.846 -1.159 . . . . 2.46 112.125 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -95.0 -11.11 29.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.433 -1.417 . . . . 2.4199999999999999 107.869 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.95 163.6 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.799 -1.186 . . . . 1.1599999999999999 107.799 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.404 ' CD1' ' O ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -112.18 -26.62 8.71 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.638 -0.875 . . . . 1.95 108.638 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.85 176.28 47.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.156 -1.578 . . . . 0.41999999999999998 109.156 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -128.39 123.45 33.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.438 -1.036 . . . . 0.52000000000000002 109.91 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.6 mt -128.25 129.92 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.492 -1.299 . . . . 1.1599999999999999 107.492 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.2 p -140.24 148.14 41.05 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.235 1.017 . . . . 1.22 111.785 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 1.1 t70 -87.78 38.72 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.77 -0.581 . . . . 2.2400000000000002 109.843 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.575 ' C ' ' H ' ' A' ' 185' ' ' GLY . . . -105.84 121.67 44.52 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.174 -0.954 . . . . 1.6499999999999999 110.287 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.05 4.82 0.01 OUTLIER Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.395 -0.816 . . . . 2.1000000000000001 111.971 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 183' ' ' ALA . . . 88.3 -13.18 62.52 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 120.314 -1.697 . . . . 1.8400000000000001 109.917 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -54.95 -33.37 62.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -1.176 . . . . 5.7800000000000002 109.262 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 p -146.9 40.87 1.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 3.2400000000000002 109.42 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.7 m -91.03 91.74 8.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.104 -0.998 . . . . 2.1099999999999999 109.79 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.455 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 13.5 t60 -60.7 -22.68 64.2 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.977 -1.12 . . . . 1.0600000000000001 107.977 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 95.1 m -63.11 -39.73 95.55 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.621 -0.881 . . . . 2.0899999999999999 108.621 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.3 t -57.09 -33.16 67.02 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 1.8799999999999999 109.051 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.87 -37.66 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.293 -0.879 . . . . 2.0099999999999998 110.444 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.7 mtm -71.94 -51.42 22.12 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.785 -1.197 . . . . 1.27 108.238 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.83 -32.33 31.24 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.147 0.498 . . . . 1.1799999999999999 109.705 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -75.52 -46.04 34.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.057 -1.027 . . . . 3.5800000000000001 109.376 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.3 m -70.77 -35.7 72.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.257 -0.902 . . . . 1.1399999999999999 109.63 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.5 mt -89.49 -2.37 58.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 1.28 109.139 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 51.17 10.12 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.562 -0.711 . . . . 1.49 111.783 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.9 mt -68.17 168.41 13.64 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.557 -1.339 . . . . 1.28 108.507 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.14 131.8 5.96 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.121 1.881 . . . . 0.69999999999999996 111.578 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.37 176.39 9.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.794 -1.191 . . . . 1.1899999999999999 111.177 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 11.4 mt -149.64 161.51 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.653 -1.61 . . . . 1.25 106.653 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 181' ' ' THR . 17.1 m -144.63 -31.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.725 -1.234 . . . . 1.29 111.413 -178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.18 31.2 5.5 Favored Glycine 0 N--CA 1.491 2.364 0 O-C-N 120.807 -1.183 . . . . 0.92000000000000004 110.486 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 10.1 p -56.02 -37.27 68.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.787 -1.419 . . . . 1.3100000000000001 108.514 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.43 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 64.94 -35.2 0.1 Allowed Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.923 -0.656 . . . . 1.0 113.522 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.6 m -121.66 16.43 11.13 Favored 'General case' 0 N--CA 1.513 2.704 0 CA-C-N 119.812 1.806 . . . . 1.9199999999999999 112.839 -177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 5.7 t -78.23 -52.54 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.221 -1.549 . . . . 1.27 109.888 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.3 p -53.62 -19.61 4.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.697 -1.252 . . . . 1.3400000000000001 109.961 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.8 m -105.72 14.45 28.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.341 -0.85 . . . . 2.0699999999999998 109.474 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -143.54 -5.6 0.83 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.235 -0.916 . . . . 2.8599999999999999 110.891 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 37.2 t -119.45 157.58 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.16 -0.963 . . . . 1.3 109.957 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 16.0 mmmt -134.34 171.38 14.35 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.813 -1.551 . . . . 2.48 106.813 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.61 ' ND2' ' H ' ' A' ' 18' ' ' LEU . 11.5 t-20 -76.17 143.06 41.36 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.876 -1.14 . . . . 2.6200000000000001 110.539 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.0 t70 80.12 -10.77 1.24 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.712 -0.617 . . . . 2.3999999999999999 110.867 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -57.85 143.62 41.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.772 -1.205 . . . . 1.99 108.657 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -86.08 110.95 19.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.011 -1.055 . . . . 1.54 108.555 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 13.4 mt -123.8 165.4 17.38 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.67 0.747 . . . . 1.25 109.946 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 219' ' ' ILE . 40.6 mt -138.71 125.22 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.833 -1.173 . . . . 1.26 107.833 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.4 tp -86.89 127.35 35.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.2 -0.938 . . . . 1.1799999999999999 108.735 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.7 -46.17 6.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.244 -0.91 . . . . 2.2200000000000002 109.433 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 44.51 23.87 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.513 -0.742 . . . . 1.2 110.165 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 t -115.96 -41.11 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 106.634 -1.617 . . . . 1.48 106.634 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -108.22 13.08 26.08 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.825 -1.546 . . . . 2.8199999999999998 106.825 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 60.66 52.63 4.36 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.964 -0.562 . . . . 2.1099999999999999 109.908 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -157.87 154.92 28.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.972 -1.08 . . . . 2.6499999999999999 110.712 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 87.6 t -107.19 163.21 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.843 -0.799 . . . . 1.29 108.843 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -122.07 116.27 23.96 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.358 -0.839 . . . . 1.4199999999999999 109.147 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.7 t -102.16 120.1 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.406 -0.809 . . . . 1.26 109.871 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 31.8 t30 65.68 74.98 0.36 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.685 -0.634 . . . . 2.1499999999999999 110.452 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -91.56 143.76 3.02 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 123.334 2.689 . . . . 0.81999999999999995 111.929 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 14.5 p -73.34 167.19 21.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 2.1099999999999999 109.714 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -72.4 -34.47 67.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 3.1699999999999999 108.958 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -66.25 -34.3 77.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.504 -0.747 . . . . 3.0600000000000001 109.473 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.1 t -76.03 -30.1 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 1.6499999999999999 109.151 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 69.5 mt -70.88 -56.37 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.311 -0.868 . . . . 1.47 109.074 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.85 -40.22 69.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 2.54 110.228 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -66.98 -40.27 87.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.119 -0.988 . . . . 3.0 110.197 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.8 mtp -81.07 -23.11 38.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.069 -1.019 . . . . 1.6299999999999999 109.692 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -60.02 -44.09 94.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 3.1600000000000001 109.385 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.65 -56.81 4.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 2.0899999999999999 110.019 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 94.0 t -48.81 -61.44 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.256 -0.902 . . . . 2.5699999999999998 110.091 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -49.29 -57.29 7.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.276 -0.89 . . . . 3.5899999999999999 110.223 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.0 -25.41 66.86 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.854 -1.153 . . . . 1.76 109.931 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -68.55 -28.73 67.22 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.628 -1.249 . . . . 3.21 107.628 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.03 -45.66 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.824 -0.806 . . . . 2.3500000000000001 108.824 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.13 -42.87 81.76 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.719 -0.792 . . . . 2.3999999999999999 109.585 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.4 t -80.36 -31.18 37.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.333 -0.854 . . . . 3.0299999999999998 110.746 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.026 -1.047 . . . . 3.4100000000000001 109.396 -179.357 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 3' ' ' SER . 66.6 mtt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.5 -0.555 . . . . 4.0700000000000003 109.5 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 2' ' ' ILE . 77.2 mt -60.78 83.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 1.5 109.556 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 1' ' ' MET . 50.8 m -94.59 112.12 23.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.963 -1.086 . . . . 1.8 108.696 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.76 -165.04 21.6 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 109.872 -1.291 . . . . 0.92000000000000004 109.872 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' ' 6' ' ' LEU . 58.2 mt -93.07 -6.18 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.249 -1.148 . . . . 1.5 108.595 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' ILE . 18.3 tp 57.16 110.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.538 -0.726 . . . . 1.3999999999999999 109.418 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.55 -45.87 9.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 1.26 109.23 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.51 150.53 31.33 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.241 -0.912 . . . . 1.95 109.384 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -83.01 148.29 13.4 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.478 2.118 . . . . 0.93999999999999995 113.733 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.56 -177.06 34.53 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.421 -1.472 . . . . 0.78000000000000003 109.421 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 mt -147.7 126.89 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.872 -1.37 . . . . 1.29 110.186 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.17 161.49 36.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.34 -0.85 . . . . 1.1499999999999999 109.48 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.474 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 8.1 m-85 -126.9 128.27 46.21 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.656 -0.868 . . . . 0.71999999999999997 108.656 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.77 165.95 38.47 Favored Glycine 0 N--CA 1.502 3.064 0 C-N-CA 118.48 -1.819 . . . . 0.5 111.836 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -82.12 151.45 26.98 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.46 -1.024 . . . . 2.3599999999999999 110.66 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.54 130.76 37.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.448 -0.782 . . . . 1.1599999999999999 111.878 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 tp -111.05 99.86 8.65 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.182 -1.414 . . . . 1.24 107.182 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 tp -85.51 122.55 29.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.785 -1.197 . . . . 1.3100000000000001 110.872 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.48 98.72 11.38 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.791 -0.818 . . . . 1.3100000000000001 108.791 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -89.85 142.52 27.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.433 -0.792 . . . . 2.3500000000000001 109.265 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -110.11 129.68 55.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.487 -0.758 . . . . 2.5800000000000001 109.681 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -78.13 122.26 25.4 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.17 -1.048 . . . . 2.1400000000000001 108.17 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -65.6 134.96 54.41 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.098 -1.001 . . . . 1.9299999999999999 109.765 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.0 mt -91.3 134.47 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.543 -0.723 . . . . 1.28 109.503 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.84 119.52 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.87 -0.789 . . . . 1.3700000000000001 108.87 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.5 mt -90.62 131.51 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.968 -1.082 . . . . 1.3300000000000001 109.41 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -89.69 123.79 34.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.135 -0.978 . . . . 1.3700000000000001 109.508 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -97.11 28.39 3.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.172 -0.955 . . . . 3.1899999999999999 109.185 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -85.72 141.32 29.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 2.8100000000000001 109.691 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -84.87 130.21 34.69 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.487 -0.931 . . . . 2.8300000000000001 108.487 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.3 pt -88.18 172.76 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 1.3400000000000001 110.25 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 34' ' ' ASP . 88.5 p -99.01 161.1 13.81 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.586 -0.894 . . . . 1.3500000000000001 108.586 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.82 -7.06 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.855 -1.153 . . . . 1.6100000000000001 109.893 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 32' ' ' SER . 38.2 m-20 -83.38 -15.01 51.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.978 -1.076 . . . . 2.4700000000000002 110.517 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -117.55 0.46 12.11 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.366 -0.834 . . . . 2.0699999999999998 109.758 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 t -68.64 -49.36 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.937 -1.102 . . . . 1.3300000000000001 109.593 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -59.67 -30.61 68.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.2 -0.937 . . . . 1.46 108.477 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.487 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 1.5 mp0 -70.67 -39.09 73.76 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.254 0.549 . . . . 2.9399999999999999 110.023 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -64.45 -37.13 86.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.105 -0.997 . . . . 1.3 109.5 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.33 -45.55 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.804 . . . . 1.3300000000000001 109.401 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.85 -37.95 89.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 1.5 108.543 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.576 ' CG ' HH11 ' A' ' 42' ' ' ARG . 4.6 mtt-85 -67.05 -41.08 87.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.048 -0.723 . . . . 3.1499999999999999 109.048 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -81.82 -41.93 20.38 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.372 -0.83 . . . . 0.92000000000000004 109.537 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 tp -64.6 -61.34 2.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.166 -0.959 . . . . 1.4099999999999999 108.569 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.0 t -65.4 -36.19 83.2 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.444 -0.785 . . . . 1.22 108.992 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -50.84 -56.97 11.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.302 -1.919 . . . . 0.58999999999999997 108.302 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.423 ' HB3' HH11 ' A' ' 47' ' ' ARG . 1.7 ttt-85 -47.04 -32.42 3.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.565 -0.962 . . . . 3.3900000000000001 108.735 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.21 -32.54 64.5 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.028 -1.101 . . . . 1.26 108.028 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 46' ' ' GLY . 93.5 mttt -81.33 -58.99 2.79 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.026 -0.731 . . . . 2.9900000000000002 109.026 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.93 -44.71 64.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.095 -1.003 . . . . 1.1399999999999999 110.148 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 65.5 p -61.43 -37.62 84.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.159 -0.963 . . . . 1.8400000000000001 108.67 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.455 ' N ' ' HG ' ' A' ' 51' ' ' SER . . . -73.68 -42.12 61.72 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.394 0.616 . . . . 1.22 109.401 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -67.29 -58.49 4.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.813 . . . . 2.0 109.585 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.9 mt -52.35 -47.11 66.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.119 -0.988 . . . . 1.99 108.875 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 51' ' ' SER . 6.2 mm-40 -52.25 -47.27 65.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.555 -0.715 . . . . 1.27 109.196 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m -58.6 -38.12 77.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 1.24 108.83 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.1 mt -75.12 -31.94 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 1.21 108.813 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -54.89 -50.11 69.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.439 -0.788 . . . . 1.53 109.85 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -70.22 -29.92 66.87 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.333 -0.854 . . . . 1.24 110.58 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.453 ' O ' ' OG1' ' A' ' 64' ' ' THR . 91.8 mttt -69.8 -14.92 63.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.712 -1.242 . . . . 2.3199999999999998 108.211 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.48 -36.92 21.94 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.699 -0.852 . . . . 1.1699999999999999 108.699 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.39 -26.64 42.57 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.68 -1.248 . . . . 0.57999999999999996 109.984 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.82 -17.1 34.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.075 -1.25 . . . . 1.3899999999999999 109.413 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 70.9 m -96.3 -47.58 5.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.284 -0.885 . . . . 1.3600000000000001 110.168 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -106.24 -15.57 14.81 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.071 -1.018 . . . . 1.1399999999999999 110.702 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 118.37 140.83 6.51 Favored Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.057 -1.617 . . . . 0.59999999999999998 109.057 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -47.45 -11.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -1.155 . . . . 2.5899999999999999 110.542 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 66' ' ' GLY . 55.0 tt0 -61.27 -30.91 70.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.581 -1.324 . . . . 2.2000000000000002 109.905 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -92.01 -10.47 39.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.891 -1.131 . . . . 2.3599999999999999 110.171 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -66.85 -35.12 79.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.042 -1.036 . . . . 1.54 110.187 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.06 -30.04 70.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 1.24 110.382 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -69.01 -42.76 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.941 -1.099 . . . . 1.24 108.725 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -77.8 -21.68 51.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.888 . . . . 0.80000000000000004 109.53 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.52 -38.05 89.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.12 -0.987 . . . . 1.23 108.662 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.19 -35.76 52.38 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.046 -1.621 . . . . 0.56000000000000005 109.046 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.24 -20.9 64.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -1.117 . . . . 2.0600000000000001 110.339 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.6 mt -84.09 -38.28 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.763 -1.21 . . . . 1.24 108.384 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.4 ttt -59.68 -36.39 76.37 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.272 -0.892 . . . . 2.4500000000000002 108.776 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.3 tp -65.13 -38.82 91.87 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.812 -1.181 . . . . 1.21 107.812 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.0 tp -73.25 -44.08 60.06 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.771 -0.772 . . . . 1.1200000000000001 109.466 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -85.75 5.72 31.06 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.218 -0.927 . . . . 1.24 110.195 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -47.14 123.16 5.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.944 -1.097 . . . . 1.3100000000000001 110.046 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -66.94 -26.07 66.66 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.894 -0.78 . . . . 1.3500000000000001 108.894 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -74.87 -51.09 14.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.427 -0.796 . . . . 2.1600000000000001 109.11 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.68 -17.72 64.81 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.975 -1.09 . . . . 1.24 109.12 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -74.17 -55.7 5.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.089 -1.007 . . . . 1.28 110.399 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -62.25 -29.89 70.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.393 -0.817 . . . . 1.79 110.215 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -72.21 -42.87 65.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 1.29 108.763 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.1 mt -59.85 -59.41 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.36 -1.348 . . . . 1.1399999999999999 107.36 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.1 mt -47.85 -62.77 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.902 -0.498 . . . . 1.3200000000000001 110.193 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -42.7 -63.28 0.81 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.291 -0.881 . . . . 1.3700000000000001 109.932 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.5 mt -46.58 -51.93 14.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 1.3999999999999999 109.688 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 79.5 mt -52.94 -41.93 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 1.23 109.309 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -85.68 -37.18 19.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 2.5099999999999998 111.734 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -86.2 -33.36 20.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.781 -1.199 . . . . 1.5900000000000001 112.416 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 97' ' ' HIS . 53.3 mmtt -109.7 20.06 18.5 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.453 -1.405 . . . . 2.3799999999999999 110.058 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 96' ' ' LYS . 46.9 m80 42.45 46.02 3.98 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.371 -0.831 . . . . 1.6200000000000001 110.158 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 34.8 mtt -98.28 144.77 27.35 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.726 -0.842 . . . . 1.8899999999999999 108.726 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.3 p -75.51 148.3 39.08 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.47 -0.769 . . . . 1.27 110.086 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.29 -31.5 21.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 1.1599999999999999 109.338 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -74.19 -42.2 60.22 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.016 -1.105 . . . . 2.0 108.016 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.26 -55.13 7.69 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.313 -0.555 . . . . 1.25 109.909 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.68 76.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 1.1299999999999999 109.685 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.01 -38.93 73.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 1.0800000000000001 109.623 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' GLU . 49.4 t-80 -67.77 -41.11 83.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.943 . . . . 2.02 109.753 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -48.14 -53.8 15.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 1.26 110.026 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.0 t -57.79 -54.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.047 -1.033 . . . . 1.1799999999999999 109.222 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.8 mm -61.62 -20.31 22.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.355 -0.841 . . . . 1.1899999999999999 109.047 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 105' ' ' HIS . 48.8 tt0 -66.23 -40.69 90.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 2.2000000000000002 110.243 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -86.53 -21.43 51.27 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.38 -1.39 . . . . 0.85999999999999999 111.941 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -67.01 -59.36 3.54 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.526 -1.573 . . . . 2.0 108.208 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.93 -52.03 65.7 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 120.072 -0.651 . . . . 1.3200000000000001 109.473 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.1 m -59.77 -46.4 89.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.122 -0.986 . . . . 2.1400000000000001 110.954 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -62.21 -31.93 72.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.768 -1.208 . . . . 1.3799999999999999 110.632 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 mt -70.11 -28.61 65.53 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.545 -1.262 . . . . 1.3500000000000001 109.512 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -68.74 -20.0 64.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.734 -1.229 . . . . 1.95 109.215 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -81.44 -7.64 59.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 1.71 108.873 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mt -88.91 140.17 29.71 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.217 -1.031 . . . . 1.71 108.217 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -97.18 64.84 1.96 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.332 -0.988 . . . . 2.8300000000000001 108.332 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -146.17 113.72 6.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.351 -0.843 . . . . 1.5800000000000001 110.069 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.555 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 18.7 mp0 -57.23 -16.18 7.67 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.787 -0.82 . . . . 2.7999999999999998 108.787 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -80.23 -63.28 1.44 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.336 -0.853 . . . . 1.27 109.244 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.9 mt -63.6 -23.88 67.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 1.5800000000000001 109.14 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -68.4 -51.13 47.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.053 -1.029 . . . . 2.9199999999999999 108.762 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -58.76 -18.78 34.77 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.27 -0.894 . . . . 2.2000000000000002 108.892 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -74.57 -27.89 60.7 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.638 -1.616 . . . . 2.5299999999999998 106.638 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.02 98.0 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.398 0.618 . . . . 1.45 109.41 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.09 73.97 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.278 -0.889 . . . . 1.5 109.649 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.2 -36.75 66.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 1.3500000000000001 109.375 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.1 t -72.64 -40.82 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.411 -0.806 . . . . 1.23 109.062 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.477 HH12 ' CE ' ' A' ' 135' ' ' LYS . 15.5 ttt-85 -54.38 -40.8 68.51 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.265 -0.897 . . . . 3.73 109.046 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.94 -32.56 73.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.595 -0.691 . . . . 1.3200000000000001 110.245 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 65.0 mt -69.29 -26.51 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.952 -1.093 . . . . 1.2 110.343 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.07 -49.14 6.51 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.438 -1.465 . . . . 0.48999999999999999 109.438 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.477 ' CE ' HH12 ' A' ' 131' ' ' ARG . 1.5 mptp? -51.98 -46.66 64.93 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.519 -0.989 . . . . 3.1099999999999999 109.387 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.453 ' HG2' HH11 ' A' ' 136' ' ' ARG . 6.8 mtt-85 -62.19 -52.31 64.32 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.988 -1.116 . . . . 2.9500000000000002 107.988 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.28 -40.38 34.37 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.794 -0.566 . . . . 1.73 109.609 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 140' ' ' ASN . 23.0 mt -69.08 -58.94 3.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 1.22 110.005 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 144' ' ' LEU . 89.9 mtt180 -44.52 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 2.7799999999999998 110.875 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 138' ' ' LEU . 30.9 m-20 -85.34 -51.15 6.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.815 -1.178 . . . . 2.0299999999999998 109.173 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.5 mt -55.88 -38.13 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 1.2 108.94 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 35.1 mt -86.21 1.29 51.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.486 -0.759 . . . . 1.28 109.006 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.69 30.95 60.12 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.204 -1.958 . . . . 0.68999999999999995 108.204 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 139' ' ' ARG . 4.7 tp -73.78 145.3 45.16 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.559 -0.965 . . . . 1.3100000000000001 109.755 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -67.48 139.52 57.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -0.784 . . . . 2.8799999999999999 110.12 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 mt -109.44 142.79 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.579 -0.897 . . . . 1.3600000000000001 108.579 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.2 mp -75.73 119.94 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 1.9299999999999999 109.773 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.6 OUTLIER -95.85 91.86 6.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.81 . . . . 1.54 109.446 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 151' ' ' ALA . 21.4 mt -79.77 -18.14 51.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.598 -0.689 . . . . 1.3400000000000001 109.276 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.6 p -79.46 23.4 0.4 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.945 . . . . 1.98 109.66 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -139.99 25.9 2.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.053 -1.03 . . . . 1.3799999999999999 110.017 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 74.4 mt -71.75 152.7 8.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.085 -1.009 . . . . 1.3999999999999999 109.351 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -141.11 9.57 2.11 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.594 -0.891 . . . . 2.7400000000000002 108.594 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -123.17 124.88 44.04 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.759 -0.83 . . . . 1.4099999999999999 108.759 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.61 115.35 5.12 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.141 -0.974 . . . . 1.3 108.932 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.8 m -148.31 174.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.169 -0.957 . . . . 1.28 109.431 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 13.9 mt -93.35 160.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.851 -1.166 . . . . 1.1499999999999999 107.851 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.3 tp -108.27 122.86 47.82 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.472 -0.767 . . . . 1.2 109.873 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.89 129.76 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.398 0.618 . . . . 1.1599999999999999 109.713 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -165.99 159.33 15.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 1.2 110.376 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.92 -42.7 94.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.63 -1.294 . . . . 1.3200000000000001 108.1 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 48.1 t0 -171.45 157.94 5.05 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.525 -0.735 . . . . 2.3399999999999999 109.39 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.417 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 27.6 mt -124.43 136.15 53.82 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.547 -0.721 . . . . 1.26 109.539 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.2 p -95.4 152.33 39.23 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.254 -0.904 . . . . 1.3600000000000001 109.661 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -32.83 -54.2 0.38 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.984 2.456 . . . . 0.63 113.219 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.444 ' H ' ' HG ' ' A' ' 166' ' ' SER . 3.7 m -51.06 -57.1 9.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -0.97 . . . . 1.0700000000000001 109.445 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -54.52 -38.22 66.29 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 1.25 109.536 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 33.7 p -76.46 -20.19 57.28 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.317 -0.864 . . . . 1.1799999999999999 109.751 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.46 -23.74 34.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 1.1399999999999999 109.664 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -104.52 -10.23 17.78 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.322 -0.861 . . . . 1.71 110.349 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.7 tp -64.02 144.37 57.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.954 -1.091 . . . . 1.22 108.615 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -95.46 140.71 29.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.876 -1.14 . . . . 2.5499999999999998 108.969 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 9.9 mp -85.65 -41.13 15.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 1.96 111.025 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -77.99 -12.06 59.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.712 -1.243 . . . . 2.46 111.807 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -101.27 -5.83 24.97 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.678 -1.263 . . . . 2.4199999999999999 108.86 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 177' ' ' LEU . 74.1 t -100.52 163.43 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.407 -0.808 . . . . 1.1599999999999999 109.059 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.436 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 4.8 tp -120.38 -17.25 8.24 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.466 -0.771 . . . . 1.95 109.715 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.27 172.71 42.98 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.271 -1.531 . . . . 0.41999999999999998 109.271 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -125.52 121.9 35.04 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.42 -1.047 . . . . 0.52000000000000002 108.962 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.73 125.56 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.313 -1.365 . . . . 1.1599999999999999 107.313 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 203' ' ' VAL . 2.2 p -135.08 141.35 46.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.356 0.598 . . . . 1.22 109.7 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -89.79 37.01 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.505 -0.747 . . . . 2.2400000000000002 109.004 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -105.53 121.42 43.91 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.467 -0.771 . . . . 1.6499999999999999 109.542 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -86.14 69.21 3.21 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.359 -1.096 . . . . 2.1000000000000001 110.359 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.438 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -110.72 108.87 2.49 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.11 -1.596 . . . . 1.8400000000000001 109.11 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -47.06 -22.32 0.33 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.083 -1.245 . . . . 5.7800000000000002 108.666 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.438 ' N ' ' C ' ' A' ' 185' ' ' GLY . 7.0 p -141.71 66.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.05 -1.093 . . . . 3.2400000000000002 108.05 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 191' ' ' SER . 13.5 t -78.16 140.64 38.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.428 -0.795 . . . . 2.1099999999999999 109.76 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -44.01 -51.86 7.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 1.0600000000000001 110.025 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 47.1 m -54.8 -31.19 58.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.188 -0.945 . . . . 2.0899999999999999 109.616 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 188' ' ' SER . 4.1 t -68.73 -35.94 77.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.351 -0.843 . . . . 1.8799999999999999 109.224 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.0 mm -60.31 -37.82 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 2.0099999999999998 109.856 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.5 mtm -70.59 -46.56 63.21 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.78 -1.193 . . . . 1.27 107.78 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.0 74.38 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.673 -0.642 . . . . 1.1799999999999999 110.005 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -67.81 -43.54 79.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 3.5800000000000001 109.804 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.2 m -71.44 -37.33 71.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.933 . . . . 1.1399999999999999 109.967 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.559 ' C ' ' H ' ' A' ' 199' ' ' LEU . 23.8 mt -88.03 3.36 49.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.872 . . . . 1.28 109.111 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 50.54 2.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.494 -0.754 . . . . 1.49 110.902 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.559 ' H ' ' C ' ' A' ' 197' ' ' LEU . 79.4 mt -65.88 167.62 11.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.015 -1.476 . . . . 1.28 107.015 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -90.93 145.59 3.65 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 C-N-CA 122.069 1.846 . . . . 0.69999999999999996 111.646 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.57 179.98 6.85 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.579 -1.248 . . . . 1.1899999999999999 111.16 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.401 HG21 ' N ' ' A' ' 203' ' ' VAL . 34.0 mt -149.38 155.6 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.008 -1.849 . . . . 1.25 106.008 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 181' ' ' THR . 15.8 m -137.28 -34.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.023 -1.048 . . . . 1.29 111.915 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.41 45.09 3.1 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 120.469 -1.395 . . . . 0.92000000000000004 111.248 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.6 p -72.56 1.0 8.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.334 -1.686 . . . . 1.3100000000000001 109.76 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.3 -98.78 0.84 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.828 -1.309 . . . . 1.0 109.828 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.7 p -131.19 35.6 3.9 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.422 -1.046 . . . . 1.9199999999999999 111.815 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.0 t -50.47 -28.95 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.356 -1.465 . . . . 1.27 109.077 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 182' ' ' ASP . 5.2 p -65.23 -11.95 46.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.923 -1.11 . . . . 1.3400000000000001 108.775 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -104.67 11.65 33.81 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.892 -0.781 . . . . 2.0699999999999998 108.892 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -128.53 -31.66 2.23 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.477 -0.764 . . . . 2.8599999999999999 110.278 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.4 t -115.39 155.85 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.324 -0.86 . . . . 1.3 110.008 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -114.8 -171.24 1.9 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.27 -1.382 . . . . 2.48 107.27 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.429 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -81.11 149.72 29.05 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.097 -1.002 . . . . 2.6200000000000001 110.648 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.3 m-20 80.91 -12.81 0.98 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 116.067 -0.515 . . . . 2.3999999999999999 110.982 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -56.89 145.76 28.81 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.711 -1.243 . . . . 1.99 107.774 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -88.3 121.29 30.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.869 -1.144 . . . . 1.54 109.636 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.2 mt -123.81 161.9 24.33 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.82 0.819 . . . . 1.25 109.911 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.4 mt -134.86 118.8 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.747 -1.205 . . . . 1.26 107.747 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 8.9 tp -90.08 120.31 31.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.42 -0.8 . . . . 1.1799999999999999 109.528 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 53.6 t0 -94.42 -27.76 15.86 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.224 -1.028 . . . . 2.2200000000000002 108.224 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 37.87 24.25 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.131 0.491 . . . . 1.2 110.709 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 10.5 t -117.14 -62.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 106.733 -1.58 . . . . 1.48 106.733 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -87.35 15.76 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.991 -1.114 . . . . 2.8199999999999998 107.991 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 55.86 54.17 8.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.625 -0.672 . . . . 2.1099999999999999 109.343 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -150.04 144.38 25.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.355 -0.84 . . . . 2.6499999999999999 110.29 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.54 153.39 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.289 -1.004 . . . . 1.29 108.289 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -110.64 126.07 54.1 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.354 -0.841 . . . . 1.4199999999999999 108.882 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.11 118.02 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.509 -0.744 . . . . 1.26 109.939 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 55.14 70.9 1.43 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 2.1499999999999999 110.249 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -90.09 149.51 4.7 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.308 2.672 . . . . 0.81999999999999995 111.986 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.5 m -75.19 163.23 27.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 2.1099999999999999 109.86 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -67.11 -32.22 73.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.343 -0.848 . . . . 3.1699999999999999 110.121 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.48 -35.53 77.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.225 -0.922 . . . . 3.0600000000000001 109.282 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.68 -38.86 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.865 . . . . 1.6499999999999999 109.3 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.548 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 79.4 mt -64.2 -58.57 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -0.902 . . . . 1.47 110.074 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -42.21 75.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 2.54 109.886 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -65.22 -36.09 83.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.946 . . . . 3.0 109.096 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 243' ' ' GLN . 54.4 mtp -79.08 -33.71 44.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 1.6299999999999999 109.041 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -50.07 -43.46 51.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.745 -1.222 . . . . 3.1600000000000001 109.438 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.47 -55.61 6.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 2.0899999999999999 110.156 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.8 t -66.32 -46.94 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 2.5699999999999998 109.77 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 239' ' ' MET . 0.9 OUTLIER -55.14 -57.92 9.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 3.5899999999999999 110.192 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -61.63 -22.89 65.64 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.879 -1.138 . . . . 1.76 109.705 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -68.36 -24.83 64.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.796 -1.187 . . . . 3.21 107.796 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 74.1 t -74.83 -39.9 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.41 -0.959 . . . . 2.3500000000000001 108.41 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.0 -32.8 66.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.388 -0.82 . . . . 2.3999999999999999 108.92 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -80.69 -30.03 36.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 3.0299999999999998 109.416 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 108.537 -0.912 . . . . 3.4100000000000001 108.537 179.797 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.582 ' SD ' ' NE2' ' A' ' 226' ' ' GLN . 14.4 mmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.636 -0.505 . . . . 4.0700000000000003 109.636 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.6 mt -67.15 98.39 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.052 -1.03 . . . . 1.5 108.782 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.3 m -98.42 121.86 40.89 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.353 -0.842 . . . . 1.8 109.609 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.705 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -119.89 -160.13 11.13 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.315 -1.514 . . . . 0.92000000000000004 109.315 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.3 mt -95.67 -9.92 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.332 -1.099 . . . . 1.5 108.799 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 tp 60.67 111.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.417 -0.802 . . . . 1.3999999999999999 109.413 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.68 -52.91 5.25 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.325 -0.991 . . . . 1.26 108.325 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.63 146.4 22.22 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 108.5 -0.926 . . . . 1.95 108.5 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.94 149.26 32.78 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.42 2.08 . . . . 0.93999999999999995 114.262 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 159.8 179.77 34.82 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.135 -1.586 . . . . 0.78000000000000003 109.135 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 mt -139.0 130.43 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.13 -1.218 . . . . 1.29 109.495 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.47 151.08 41.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.364 -0.835 . . . . 1.1499999999999999 109.74 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.2 m-85 -122.44 138.24 54.61 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.07 -1.085 . . . . 0.71999999999999997 108.07 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.89 168.46 38.66 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 118.769 -1.681 . . . . 0.5 111.564 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -80.71 147.48 30.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.683 -0.892 . . . . 2.3599999999999999 110.083 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.81 127.58 32.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 1.1599999999999999 111.322 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -105.49 96.99 6.89 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.08 -1.452 . . . . 1.24 107.08 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.672 ' H ' ' ND2' ' A' ' 214' ' ' ASN . 11.9 tp -80.4 120.04 23.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.956 -1.09 . . . . 1.3100000000000001 110.666 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.69 98.57 9.4 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.836 -0.62 . . . . 1.3100000000000001 109.406 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -93.23 159.24 15.36 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.66 -0.867 . . . . 2.3500000000000001 108.66 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -130.45 122.16 27.21 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.243 -0.911 . . . . 2.5800000000000001 109.467 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -81.62 131.76 35.28 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.35 -0.844 . . . . 2.1400000000000001 109.262 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -63.98 147.2 52.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 1.9299999999999999 109.638 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.7 mt -91.87 136.38 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.22 -0.925 . . . . 1.28 109.709 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 t -107.64 121.74 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.394 -0.816 . . . . 1.3700000000000001 109.397 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.3 mt -88.85 145.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 1.3300000000000001 109.94 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.68 120.55 35.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.321 -0.862 . . . . 1.3700000000000001 109.748 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -102.01 29.04 5.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.192 -0.943 . . . . 3.1899999999999999 109.58 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -75.36 147.34 40.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.995 . . . . 2.8100000000000001 110.0 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -87.49 116.18 25.42 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.22 -1.029 . . . . 2.8300000000000001 108.22 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.7 pt -84.18 171.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.897 -1.127 . . . . 1.3400000000000001 110.617 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -98.09 168.48 10.24 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.193 -0.669 . . . . 1.3500000000000001 109.193 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.31 -22.3 66.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 1.6100000000000001 109.581 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.14 -7.39 58.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 2.4700000000000002 108.609 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -107.77 -9.21 15.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.53 -0.915 . . . . 2.0699999999999998 108.53 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -67.93 -47.04 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 1.3300000000000001 108.979 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -51.46 -36.07 42.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 1.46 109.11 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.61 -32.61 71.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 2.9399999999999999 109.928 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -61.8 -47.02 87.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.99 -1.069 . . . . 1.3 109.51 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 44' ' ' LEU . 85.6 t -61.51 -47.19 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.355 -0.84 . . . . 1.3300000000000001 110.016 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.28 -40.65 97.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.058 -1.026 . . . . 1.5 108.367 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -65.86 -32.35 73.81 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.81 -0.811 . . . . 3.1499999999999999 108.81 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -86.37 -56.68 3.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.92000000000000004 108.972 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 40' ' ' VAL . 29.3 tp -51.54 -63.38 1.15 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.821 -0.807 . . . . 1.4099999999999999 108.821 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 t -61.73 -30.27 70.66 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.077 -1.082 . . . . 1.22 108.077 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -58.65 -52.9 50.31 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.422 -2.271 . . . . 0.58999999999999997 107.422 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -48.5 -30.0 4.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.75 -0.853 . . . . 3.3900000000000001 108.76 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.4 85.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.235 -1.024 . . . . 1.26 108.235 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 46' ' ' GLY . 52.3 mttm -81.73 -59.31 2.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.344 -0.613 . . . . 2.9900000000000002 109.344 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.7 -40.29 59.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.11 -0.994 . . . . 1.1399999999999999 109.832 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.7 t -62.75 -37.4 86.46 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.998 -1.064 . . . . 1.8400000000000001 108.221 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.76 -28.23 62.49 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.442 -0.577 . . . . 1.22 109.442 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.601 ' NE2' HD22 ' A' ' 140' ' ' ASN . 26.4 mt-30 -72.07 -62.84 1.28 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.19 -0.944 . . . . 2.0 109.109 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.3 mp -51.93 -48.96 63.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 1.99 108.466 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -49.81 -50.42 45.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.809 . . . . 1.27 109.218 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -63.13 -41.42 99.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 1.24 109.655 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.4 mt -70.63 -34.85 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 1.21 108.994 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -53.9 -45.1 71.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.284 -0.885 . . . . 1.53 109.197 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 m -71.46 -24.26 61.97 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.266 -0.896 . . . . 1.24 109.941 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.43 ' O ' ' OG1' ' A' ' 64' ' ' THR . 29.3 mttp -71.28 -33.11 69.45 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.748 -1.205 . . . . 2.3199999999999998 107.748 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.25 -34.11 76.75 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.793 -0.818 . . . . 1.1699999999999999 108.793 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.17 -30.23 25.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.678 -1.369 . . . . 0.57999999999999996 109.678 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -86.64 -12.3 48.88 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.823 -1.398 . . . . 1.3899999999999999 109.137 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 88.1 m -94.91 -46.96 6.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.2 -0.937 . . . . 1.3600000000000001 110.579 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -107.06 -34.71 7.08 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.111 -0.993 . . . . 1.1399999999999999 110.157 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 80.07 -41.29 2.4 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.969 -1.253 . . . . 0.59999999999999998 109.969 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 69' ' ' LYS . 67.3 mt-10 -50.51 178.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.241 . . . . 2.5899999999999999 109.573 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.62 43.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 2.2000000000000002 109.709 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 67' ' ' GLU . 15.9 mmmt -89.67 -17.91 27.48 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.557 -0.905 . . . . 2.3599999999999999 108.557 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.65 -35.06 74.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.472 -0.767 . . . . 1.54 110.688 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.28 -22.24 66.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -0.978 . . . . 1.24 110.412 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.48 -40.38 55.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.95 -1.094 . . . . 1.24 109.508 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -76.6 -28.33 56.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.925 . . . . 0.80000000000000004 109.616 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.66 -38.42 91.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.941 -1.099 . . . . 1.23 108.61 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.83 -32.38 61.24 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.578 -1.809 . . . . 0.56000000000000005 108.578 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -61.38 -18.79 60.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -1.07 . . . . 2.0600000000000001 109.172 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.5 mt -85.67 -39.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.246 -1.02 . . . . 1.24 108.246 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.3 ttt -58.8 -38.73 79.23 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.992 -0.744 . . . . 2.4500000000000002 108.992 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.9 tp -69.56 -43.76 72.26 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.852 -0.795 . . . . 1.21 108.852 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.0 tp -64.72 -48.01 76.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.44 -0.788 . . . . 1.1200000000000001 109.483 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -84.4 13.14 5.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.836 . . . . 1.24 110.467 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -49.1 125.2 10.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.998 -1.064 . . . . 1.3100000000000001 109.695 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -67.69 -25.03 65.48 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.339 -0.851 . . . . 1.3500000000000001 108.756 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.62 -52.34 9.87 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.436 -0.79 . . . . 2.1600000000000001 109.528 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.7 mt -64.61 -15.65 61.49 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.036 -1.066 . . . . 1.24 109.04 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -77.35 -43.4 33.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 1.28 109.801 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.03 -33.35 75.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -0.91 . . . . 1.79 110.405 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -72.77 -43.88 62.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 1.29 109.654 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.0 mt -57.36 -39.85 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.551 -0.907 . . . . 1.1399999999999999 108.551 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -67.5 -62.43 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.715 -0.615 . . . . 1.3200000000000001 110.27 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -50.07 -38.48 38.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.149 -0.969 . . . . 1.3700000000000001 109.834 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.6 -59.87 4.7 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.268 -0.895 . . . . 1.3999999999999999 108.676 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.7 mt -47.02 -44.26 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 1.23 110.171 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -82.67 -31.44 28.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.161 -0.962 . . . . 2.5099999999999998 111.029 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 91' ' ' ALA . 66.9 t0 -79.25 -48.44 14.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.859 -1.15 . . . . 1.5900000000000001 111.778 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -106.71 21.06 18.09 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.82 -1.175 . . . . 2.3799999999999999 110.046 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 44.07 48.22 7.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -0.905 . . . . 1.6200000000000001 109.927 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtt -102.72 151.04 22.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.485 -0.759 . . . . 1.8899999999999999 109.051 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.7 p -75.28 148.15 39.63 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.567 -0.708 . . . . 1.27 109.354 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.31 18.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.243 -0.911 . . . . 1.1599999999999999 109.167 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.31 -44.54 58.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.041 -1.096 . . . . 2.0 108.041 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.86 -52.92 15.0 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.647 -0.658 . . . . 1.25 109.886 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.15 -49.46 76.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 1.1299999999999999 109.67 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.72 -33.98 61.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 1.0800000000000001 109.893 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -68.97 -36.87 78.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.954 -1.091 . . . . 2.02 109.525 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -58.76 -52.68 64.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.985 . . . . 1.26 109.674 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.1 t -56.41 -49.14 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.105 -0.997 . . . . 1.1799999999999999 109.299 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.41 -17.62 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 1.1899999999999999 109.18 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -73.58 -35.18 65.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.082 -1.011 . . . . 2.2000000000000002 109.976 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.25 -27.13 28.83 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.318 -1.42 . . . . 0.85999999999999999 112.338 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -67.25 -40.24 86.23 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.598 -1.531 . . . . 2.0 109.209 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.22 -52.18 8.49 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.393 -0.817 . . . . 1.3200000000000001 109.632 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.7 p -60.52 -42.13 95.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 2.1400000000000001 110.245 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.54 -35.69 81.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.032 -1.042 . . . . 1.3799999999999999 110.334 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.89 -27.55 65.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.854 -1.154 . . . . 1.3500000000000001 109.599 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -69.14 -18.04 63.9 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.921 -1.112 . . . . 1.95 109.367 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -80.97 -4.81 56.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 1.71 109.348 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.5 mt -83.22 145.61 29.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 1.71 108.487 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -96.68 56.23 1.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.751 -0.833 . . . . 2.8300000000000001 108.751 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -146.25 117.27 7.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.303 -0.873 . . . . 1.5800000000000001 109.23 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.75 -16.77 18.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 2.7999999999999998 109.971 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.96 -65.6 0.95 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.935 . . . . 1.27 109.212 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.2 mt -61.1 -19.42 61.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 1.5800000000000001 109.116 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -67.79 -48.2 66.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.101 -0.999 . . . . 2.9199999999999999 108.36 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 50.3 mt-10 -61.85 -20.27 63.5 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.66 -0.867 . . . . 2.2000000000000002 108.66 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.516 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.5 OUTLIER -71.35 -29.53 65.08 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.6 -1.63 . . . . 2.5299999999999998 106.6 178.029 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.78 -50.66 72.96 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.957 -0.757 . . . . 1.45 108.957 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.68 -37.48 76.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 1.5 110.004 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 -68.18 -29.89 68.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.01 . . . . 1.3500000000000001 109.602 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.94 -40.49 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.221 -1.029 . . . . 1.23 108.221 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -56.0 -38.81 70.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.078 -1.082 . . . . 3.73 108.078 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -61.51 -36.49 80.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.635 -0.666 . . . . 1.3200000000000001 109.93 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.6 mt -68.21 -30.81 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.036 -1.04 . . . . 1.2 109.492 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.49 -46.13 72.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.257 -1.937 . . . . 0.48999999999999999 108.257 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -51.04 -44.61 61.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.78 -0.835 . . . . 3.1099999999999999 109.253 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.568 ' NH2' ' HG ' ' A' ' 166' ' ' SER . 69.4 mtt180 -62.57 -46.93 86.07 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.841 -1.17 . . . . 2.9500000000000002 107.841 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 tt -52.28 -54.29 33.27 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.878 -0.786 . . . . 1.73 108.878 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.93 -56.46 19.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 1.22 109.586 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -44.74 -22.55 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 2.7799999999999998 111.068 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.601 HD22 ' NE2' ' A' ' 53' ' ' GLN . 61.6 m-80 -85.18 -42.48 14.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.801 -1.187 . . . . 2.0299999999999998 110.074 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.35 -34.59 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.04 -1.038 . . . . 1.2 109.496 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.8 mt -90.98 -3.82 56.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.219 -0.926 . . . . 1.28 109.395 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.32 29.99 63.94 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.16 -1.976 . . . . 0.68999999999999995 108.16 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.76 148.83 45.94 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.527 -0.984 . . . . 1.3100000000000001 109.686 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -68.84 147.69 51.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 2.8799999999999999 109.317 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 146' ' ' ILE . 78.0 mt -102.67 157.75 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 1.3600000000000001 108.724 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.6 mm -76.85 104.06 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.057 -1.027 . . . . 1.9299999999999999 109.444 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -102.18 90.3 3.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.564 -0.71 . . . . 1.54 110.276 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.2 mt -80.03 -7.15 58.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 1.3400000000000001 108.703 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.9 t -83.97 40.69 0.77 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -0.792 . . . . 1.98 109.905 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.61 19.09 2.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.218 -0.926 . . . . 1.3799999999999999 109.006 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 60.1 mt -73.76 150.34 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.547 -0.721 . . . . 1.3999999999999999 109.593 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.3 2.36 1.67 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.339 -0.85 . . . . 2.7400000000000002 109.153 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -127.59 132.39 49.83 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.089 -0.708 . . . . 1.4099999999999999 109.089 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -63.04 120.51 11.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.915 . . . . 1.3 109.794 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.0 m -150.3 175.81 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.24 -0.912 . . . . 1.28 109.421 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.2 mt -90.8 157.56 2.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.948 -1.131 . . . . 1.1499999999999999 107.948 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.7 tp -107.64 122.2 46.22 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.547 -0.721 . . . . 1.2 109.212 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.7 t -123.75 132.59 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.311 0.577 . . . . 1.1599999999999999 109.504 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.44 144.84 12.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 1.2 109.491 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.53 -32.82 71.84 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.464 -1.397 . . . . 1.3200000000000001 107.846 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -172.64 155.95 3.44 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.585 -0.697 . . . . 2.3399999999999999 109.413 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.0 mt -130.73 132.08 45.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.553 -0.717 . . . . 1.26 109.319 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 p -92.33 152.89 42.77 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.262 -0.899 . . . . 1.3600000000000001 109.119 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.407 ' O ' ' OG1' ' A' ' 168' ' ' THR . 78.3 Cg_exo -36.36 -43.71 0.83 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.322 2.014 . . . . 0.63 112.189 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.568 ' HG ' ' NH2' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -54.16 -63.7 1.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 1.0700000000000001 108.938 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -48.46 -40.27 25.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 1.25 109.362 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 21.2 p -71.04 -23.52 62.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 1.1799999999999999 109.792 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.55 -29.36 46.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.912 . . . . 1.1399999999999999 110.285 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -104.54 -7.63 19.61 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.275 -0.891 . . . . 1.71 110.077 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.1 tp -57.36 135.67 56.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.822 -1.174 . . . . 1.22 108.08 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -99.89 120.7 40.19 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.221 -0.925 . . . . 2.5499999999999998 110.048 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 7.9 mp -93.58 45.99 1.18 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.843 . . . . 1.96 108.741 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -109.54 -27.47 9.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.404 -0.81 . . . . 2.46 109.02 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -131.2 11.86 5.04 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.439 -0.788 . . . . 2.4199999999999999 109.643 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 66.7 t -82.85 154.29 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.112 -0.993 . . . . 1.1599999999999999 109.494 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.0 tp -117.47 -12.2 10.43 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.719 -0.613 . . . . 1.95 109.547 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 163.99 179.84 38.49 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.61 -1.396 . . . . 0.41999999999999998 109.61 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -130.44 124.95 33.23 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.557 -0.966 . . . . 0.52000000000000002 109.635 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.8 mt -128.54 126.6 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.887 -1.153 . . . . 1.1599999999999999 107.887 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.501 ' O ' ' O ' ' A' ' 203' ' ' VAL . 40.7 p -142.01 149.36 39.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 1.22 110.549 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.436 ' OD2' ' OG1' ' A' ' 209' ' ' THR . 4.6 p30 -100.28 43.69 1.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.323 -0.861 . . . . 2.2400000000000002 109.268 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -133.88 29.96 3.74 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.424 -0.797 . . . . 1.6499999999999999 110.323 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -47.71 148.84 3.43 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 120.584 -1.322 . . . . 2.1000000000000001 111.029 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -154.4 173.31 32.91 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.26 -1.536 . . . . 1.8400000000000001 109.26 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.462 ' O ' ' OG1' ' A' ' 187' ' ' THR . 42.9 mtm-85 -55.7 87.6 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.102 -1.073 . . . . 5.7800000000000002 108.102 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.559 ' N ' ' O ' ' A' ' 185' ' ' GLY . 20.4 p 54.96 62.79 2.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.552 -0.717 . . . . 3.2400000000000002 109.418 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 m -75.3 160.21 30.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.08 -1.012 . . . . 2.1099999999999999 109.483 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -45.8 -43.76 13.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -0.891 . . . . 1.0600000000000001 109.95 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.2 p -52.95 -45.43 67.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 2.0899999999999999 109.924 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.5 t -68.31 -39.28 82.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 1.8799999999999999 110.041 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.5 mm -50.44 -38.52 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 2.0099999999999998 110.34 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 mtp -72.05 -59.57 2.67 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.7 -1.222 . . . . 1.27 107.7 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.69 -31.09 35.59 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.761 -0.654 . . . . 1.1799999999999999 109.847 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -78.95 -47.37 16.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 3.5800000000000001 109.898 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.8 m -69.51 -36.17 76.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.031 -1.043 . . . . 1.1399999999999999 109.755 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 199' ' ' LEU . 29.0 mt -86.53 0.06 55.09 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 1.28 108.927 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 47.81 10.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 1.49 111.051 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 197' ' ' LEU . 22.0 mt -66.79 161.01 65.14 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.801 -1.187 . . . . 1.28 108.597 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -79.38 127.88 7.67 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.188 1.259 . . . . 0.69999999999999996 111.172 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.87 179.04 7.32 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.844 -1.142 . . . . 1.1899999999999999 110.871 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.6 mt -146.35 162.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.001 -1.481 . . . . 1.25 107.001 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 184' ' ' GLY . 15.6 m -147.84 -28.2 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.718 -1.239 . . . . 1.29 111.408 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.9 26.94 14.18 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 120.901 -1.125 . . . . 0.92000000000000004 110.328 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 30.8 p -52.61 -41.06 63.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.833 -1.392 . . . . 1.3100000000000001 108.738 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 76.92 -38.1 1.51 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 120.781 -0.724 . . . . 1.0 113.837 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 83.8 p -130.19 27.28 5.11 Favored 'General case' 0 N--CA 1.514 2.773 0 CA-C-N 119.939 1.869 . . . . 1.9199999999999999 113.256 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.3 -41.94 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.133 -1.604 . . . . 1.27 110.323 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.436 ' OG1' ' OD2' ' A' ' 182' ' ' ASP . 10.2 p -64.65 -12.89 50.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.668 -1.27 . . . . 1.3400000000000001 110.137 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.8 p -106.17 11.84 30.84 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 2.0699999999999998 109.407 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -144.23 4.63 1.24 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.243 -0.91 . . . . 2.8599999999999999 110.588 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.5 t -126.93 151.37 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.305 -0.872 . . . . 1.3 109.524 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.506 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 42.6 mmtt -129.25 166.85 18.61 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.048 -1.464 . . . . 2.48 107.048 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.672 ' ND2' ' H ' ' A' ' 18' ' ' LEU . 28.3 m120 -64.14 143.47 57.85 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.8 -1.187 . . . . 2.6200000000000001 110.616 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 73.9 -2.44 2.78 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.797 -0.564 . . . . 2.3999999999999999 110.623 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.506 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 44.1 m-20 -57.51 142.26 44.9 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.914 -1.116 . . . . 1.99 108.673 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -86.52 107.22 18.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.44 -0.948 . . . . 1.54 108.44 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 40.8 mt -122.51 154.01 38.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.548 -0.72 . . . . 1.25 110.139 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 49.8 mt -126.04 122.82 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.501 -0.926 . . . . 1.26 108.501 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.5 tp -90.59 120.38 31.62 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.524 -0.917 . . . . 1.1799999999999999 108.524 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.3 m-20 -97.19 -29.79 13.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.215 -0.928 . . . . 2.2200000000000002 109.546 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 39.5 21.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.912 -0.492 . . . . 1.2 110.422 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -115.96 -51.66 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 106.967 -1.494 . . . . 1.48 106.967 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -96.46 10.85 37.0 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.112 -1.44 . . . . 2.8199999999999998 107.112 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.705 HD22 ' H ' ' A' ' 4' ' ' GLY . 34.8 t30 56.23 54.72 7.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.972 -0.751 . . . . 2.1099999999999999 108.972 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.582 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 65.9 tt0 -153.99 150.59 28.44 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.917 0.865 . . . . 2.6499999999999999 110.171 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 78.2 t -115.11 152.22 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.308 -0.997 . . . . 1.29 108.308 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -108.54 121.32 44.74 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.217 -0.927 . . . . 1.4199999999999999 109.45 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.69 114.98 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.574 -0.704 . . . . 1.26 109.518 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 69.02 67.5 0.47 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.659 -0.651 . . . . 2.1499999999999999 109.671 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -86.33 130.42 3.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 123.057 2.505 . . . . 0.81999999999999995 112.498 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.3 p -74.02 162.27 29.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 2.1099999999999999 109.594 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -64.06 -44.03 93.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 3.1699999999999999 109.828 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -53.27 -36.69 61.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.394 -0.816 . . . . 3.0600000000000001 109.384 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.2 t -76.74 -37.1 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.678 -0.86 . . . . 1.6499999999999999 108.678 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 75.3 mt -71.62 -57.4 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 1.47 109.344 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -51.07 -44.89 61.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -0.781 . . . . 2.54 110.014 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -65.33 -32.32 73.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 3.0 108.93 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 243' ' ' GLN . 77.1 mtp -81.94 -42.46 19.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.404 -0.81 . . . . 1.6299999999999999 109.555 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -47.45 -39.28 15.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.035 -1.04 . . . . 3.1600000000000001 109.82 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.36 -63.35 1.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.109 -0.995 . . . . 2.0899999999999999 110.394 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.8 t -66.08 -51.4 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.103 -0.998 . . . . 2.5699999999999998 110.198 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 239' ' ' MET . 45.8 tt0 -47.92 -47.44 32.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.078 -1.014 . . . . 3.5899999999999999 109.635 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.23 -29.14 70.26 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.828 -1.17 . . . . 1.76 108.939 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -67.92 -21.29 65.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.965 -1.124 . . . . 3.21 107.965 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 41.9 t -72.88 -31.84 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.338 -1.356 . . . . 2.3500000000000001 107.338 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.22 84.18 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.054 -0.721 . . . . 2.3999999999999999 109.054 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.9 m -77.49 -30.74 53.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.394 -0.816 . . . . 3.0299999999999998 109.734 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 120.963 -1.086 . . . . 3.4100000000000001 108.331 179.354 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 3' ' ' SER . 80.4 mtp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.338 0.59 . . . . 4.0700000000000003 109.494 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.42 81.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 1.5 109.604 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 1' ' ' MET . 1.5 m -98.22 113.79 25.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.259 -0.901 . . . . 1.8 109.725 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.95 -163.62 20.39 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 108.665 -1.774 . . . . 0.92000000000000004 108.665 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 6' ' ' LEU . 59.9 mt -96.96 -6.59 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.033 -1.275 . . . . 1.5 108.918 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.1 tp 53.46 104.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.515 -0.74 . . . . 1.3999999999999999 109.206 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.78 -51.46 6.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.996 . . . . 1.26 109.342 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -144.97 149.48 42.57 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.318 -0.864 . . . . 1.95 109.019 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -80.14 154.78 22.34 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.372 2.048 . . . . 0.93999999999999995 113.732 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.99 138.32 2.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.597 -1.401 . . . . 0.78000000000000003 109.597 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 11' ' ' ILE . 97.2 mt -96.73 132.49 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.186 -1.185 . . . . 1.29 109.388 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.35 157.37 46.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.33 -0.856 . . . . 1.1499999999999999 110.344 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.585 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -130.69 134.73 47.17 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.25 -1.019 . . . . 0.71999999999999997 108.25 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.96 164.66 34.24 Favored Glycine 0 N--CA 1.503 3.102 0 C-N-CA 118.204 -1.95 . . . . 0.5 111.813 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -77.62 146.55 36.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.576 -0.955 . . . . 2.3599999999999999 109.753 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.92 122.36 25.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.709 . . . . 1.1599999999999999 110.981 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 tp -100.82 94.67 6.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.845 -1.168 . . . . 1.24 107.845 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.6 tp -81.97 112.74 19.34 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.01 -1.056 . . . . 1.3100000000000001 109.759 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.89 93.95 6.62 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.661 -0.7 . . . . 1.3100000000000001 109.783 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -92.62 159.16 15.59 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.598 -0.89 . . . . 2.3500000000000001 108.598 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -118.3 131.79 56.32 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.438 -0.789 . . . . 2.5800000000000001 109.678 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.5 127.04 31.64 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.488 -0.93 . . . . 2.1400000000000001 108.488 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -62.74 136.94 58.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 1.9299999999999999 109.292 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.4 mt -90.82 131.33 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.26 -0.9 . . . . 1.28 110.194 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.33 122.77 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.655 -0.868 . . . . 1.3700000000000001 108.655 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -89.6 140.66 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.164 -0.96 . . . . 1.3300000000000001 110.028 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -90.66 128.95 36.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.22 -0.925 . . . . 1.3700000000000001 109.324 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -105.25 30.52 5.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.414 -0.803 . . . . 3.1899999999999999 109.959 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -76.24 144.03 40.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.117 -0.989 . . . . 2.8100000000000001 109.788 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -86.99 124.01 32.72 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.702 -0.851 . . . . 2.8300000000000001 108.702 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -90.64 170.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.102 -0.999 . . . . 1.3400000000000001 110.477 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.3 p -97.24 169.13 9.99 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.486 -0.561 . . . . 1.3500000000000001 109.486 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.25 -25.62 68.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 1.6100000000000001 109.433 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -80.22 -5.11 55.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 2.4700000000000002 109.239 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -109.96 -15.9 13.96 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.019 -1.104 . . . . 2.0699999999999998 108.019 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.29 -42.88 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.102 -0.703 . . . . 1.3300000000000001 109.102 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -53.42 -36.17 61.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 1.46 109.374 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -69.62 -32.69 71.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 2.9399999999999999 109.755 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -63.42 -41.92 98.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.152 -0.967 . . . . 1.3 109.267 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 44' ' ' LEU . 76.5 t -62.48 -49.01 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.412 -0.805 . . . . 1.3300000000000001 110.032 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -65.27 -45.02 86.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.04 . . . . 1.5 108.838 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -64.99 -31.75 73.15 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.704 -0.798 . . . . 3.1499999999999999 109.045 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -86.47 -59.36 2.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.078 -1.014 . . . . 0.92000000000000004 108.733 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 40' ' ' VAL . 30.8 tp -47.94 -65.18 0.61 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.36 0.6 . . . . 1.4099999999999999 109.695 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.1 t -64.28 -37.72 88.49 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.518 -0.919 . . . . 1.22 108.518 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.01 -52.41 49.25 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.355 -2.298 . . . . 0.58999999999999997 107.355 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.403 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.2 ttt-85 -51.41 -26.18 7.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.684 -0.892 . . . . 3.3900000000000001 109.033 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.73 -28.53 61.75 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.987 -1.116 . . . . 1.26 107.987 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 46' ' ' GLY . 33.3 ttmt -75.48 -56.67 4.47 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.082 -0.711 . . . . 2.9900000000000002 109.082 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.42 -30.75 30.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.086 -1.009 . . . . 1.1399999999999999 109.566 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 10.1 p -65.07 -38.67 91.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 1.8400000000000001 108.906 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.87 -28.28 65.52 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.478 0.656 . . . . 1.22 109.336 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -71.81 -67.66 0.51 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.764 . . . . 2.0 109.602 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 54' ' ' LEU . 9.3 mp -51.04 -34.73 30.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 1.99 108.819 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 51' ' ' SER . 9.5 mm-40 -63.88 -51.47 64.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.471 -0.768 . . . . 1.27 109.08 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -60.98 -34.56 74.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 1.24 108.592 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.28 -25.29 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.574 -0.899 . . . . 1.21 108.574 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -65.46 -44.47 87.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.559 -0.713 . . . . 1.53 109.588 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -71.79 -27.15 62.74 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.3 -0.875 . . . . 1.24 109.144 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -72.27 -29.68 64.12 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.769 -1.197 . . . . 2.3199999999999998 107.769 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.81 61.91 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.091 -1.077 . . . . 1.1699999999999999 108.091 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.7 -29.76 28.56 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.433 -1.467 . . . . 0.57999999999999996 109.433 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -86.55 -20.24 28.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -1.202 . . . . 1.3899999999999999 108.595 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -94.36 -46.89 6.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 1.3600000000000001 110.357 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -107.92 -27.16 10.35 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.111 -0.993 . . . . 1.1399999999999999 111.297 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.97 152.98 8.94 Favored Glycine 0 N--CA 1.506 3.337 0 N-CA-C 109.647 -1.381 . . . . 0.59999999999999998 109.647 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -50.2 -12.54 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -1.124 . . . . 2.5899999999999999 110.583 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 66' ' ' GLY . 27.7 tt0 -63.66 -31.22 72.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.988 . . . . 2.2000000000000002 110.454 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -91.08 -17.46 26.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.927 -1.108 . . . . 2.3599999999999999 110.28 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -62.53 -28.87 70.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.986 -1.071 . . . . 1.54 109.941 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.22 -30.36 69.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.179 -0.951 . . . . 1.24 109.604 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.38 -44.05 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -0.876 . . . . 1.24 109.105 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -77.27 -24.49 51.05 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.465 -0.772 . . . . 0.80000000000000004 109.664 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -63.9 -42.36 97.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.965 -1.084 . . . . 1.23 108.9 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.04 -36.24 80.49 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.928 -1.669 . . . . 0.56000000000000005 108.928 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.07 -18.56 61.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.445 -1.032 . . . . 2.0600000000000001 110.661 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.3 mt -85.03 -46.36 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.618 -1.301 . . . . 1.24 108.94 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 42.5 ttp -55.22 -49.16 72.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.36 -0.837 . . . . 2.4500000000000002 108.967 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tp -54.88 -43.44 73.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.407 -0.808 . . . . 1.21 109.171 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.31 -44.1 80.03 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.383 -0.823 . . . . 1.1200000000000001 109.417 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -85.37 8.42 18.88 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.416 -0.803 . . . . 1.24 110.161 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -49.14 121.53 4.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.974 -1.079 . . . . 1.3100000000000001 109.666 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -66.84 -24.26 66.13 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.542 -0.91 . . . . 1.3500000000000001 108.542 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -75.57 -48.89 20.38 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.334 -0.854 . . . . 2.1600000000000001 109.249 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.7 mt -63.68 -15.09 57.46 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.032 -1.067 . . . . 1.24 108.979 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -79.54 -45.64 18.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.438 -0.789 . . . . 1.28 110.041 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -64.56 -28.87 69.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.254 -0.904 . . . . 1.79 110.022 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.21 -46.25 35.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.196 -0.94 . . . . 1.29 109.889 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.7 mt -58.38 -55.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.06 -1.089 . . . . 1.1399999999999999 108.06 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.0 mt -45.14 -58.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.623 -0.673 . . . . 1.3200000000000001 109.872 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -49.04 -57.05 7.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.423 -0.798 . . . . 1.3700000000000001 110.418 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.2 mt -50.54 -56.49 11.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.426 -0.796 . . . . 1.3999999999999999 109.266 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.0 mt -47.4 -41.63 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 1.23 109.784 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -86.19 -33.72 20.71 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.116 -0.99 . . . . 2.5099999999999998 111.974 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -79.34 -44.29 21.86 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.536 -1.353 . . . . 1.5900000000000001 111.757 -176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -105.76 15.47 26.73 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.722 -1.236 . . . . 2.3799999999999999 109.23 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.505 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 1.5 m80 45.41 55.47 6.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.391 -0.818 . . . . 1.6200000000000001 109.54 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 74.1 mtp -102.51 153.65 19.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.571 -0.706 . . . . 1.8899999999999999 109.259 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.7 p -76.16 171.45 14.48 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.486 -0.759 . . . . 1.27 109.389 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.31 -28.47 62.1 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.758 . . . . 1.1599999999999999 109.668 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.13 -45.4 41.21 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.064 -1.087 . . . . 2.0 108.064 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.55 -52.33 22.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.714 -0.616 . . . . 1.25 110.201 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.34 -48.75 80.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 1.1299999999999999 109.754 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.21 -35.25 67.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 1.0800000000000001 109.606 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -68.77 -34.64 75.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.968 -1.082 . . . . 2.02 109.641 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -53.43 -60.94 2.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.375 -0.828 . . . . 1.26 110.118 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.0 t -50.93 -48.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.953 -1.092 . . . . 1.1799999999999999 109.682 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.453 HG22 HD11 ' A' ' 108' ' ' ILE . 49.5 mm -61.73 -20.62 23.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.39 -0.819 . . . . 1.1899999999999999 108.967 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.37 -37.86 74.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.089 -1.007 . . . . 2.2000000000000002 109.779 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.2 -23.95 38.91 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.491 -1.338 . . . . 0.85999999999999999 112.843 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -67.1 -52.82 37.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.343 -1.681 . . . . 2.0 108.746 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.14 -52.44 59.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.563 -0.71 . . . . 1.3200000000000001 109.816 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.8 m -61.63 -32.58 72.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.128 -0.982 . . . . 2.1400000000000001 109.992 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -63.04 -43.65 98.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.825 -1.172 . . . . 1.3799999999999999 110.064 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 mt -67.23 -22.66 65.68 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.541 -1.263 . . . . 1.3500000000000001 109.249 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.82 -23.65 64.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.779 -1.2 . . . . 1.95 109.165 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -82.99 -8.87 59.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -0.847 . . . . 1.71 109.032 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 mt -84.34 148.02 26.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.418 -0.956 . . . . 1.71 108.418 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -98.66 61.3 1.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.751 . . . . 2.8300000000000001 109.927 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -152.09 118.69 5.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.016 -1.053 . . . . 1.5800000000000001 110.11 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -62.27 -13.78 31.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 2.7999999999999998 109.238 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -78.03 -61.15 2.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.499 -0.75 . . . . 1.27 109.251 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.92 -29.33 70.7 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.265 -0.897 . . . . 1.5800000000000001 109.92 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 127' ' ' ALA . 71.5 tttt -66.4 -47.51 73.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.838 -1.164 . . . . 2.9199999999999999 108.162 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -57.67 -24.48 56.88 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.159 -1.052 . . . . 2.2000000000000002 108.159 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.552 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -73.17 -23.79 60.47 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.571 -1.64 . . . . 2.5299999999999998 106.571 178.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -61.0 -45.3 95.39 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.858 -0.793 . . . . 1.45 108.858 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.41 -35.83 80.06 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.863 -0.735 . . . . 1.5 109.025 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.5 m-20 -69.01 -36.3 77.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.418 -0.801 . . . . 1.3500000000000001 109.095 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.87 -42.98 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.995 -1.113 . . . . 1.23 107.995 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.471 ' CG ' ' NH1' ' A' ' 131' ' ' ARG . 1.4 ttt-85 -54.77 -39.15 68.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.608 -0.886 . . . . 3.73 108.608 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -60.18 -35.3 75.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.438 -0.789 . . . . 1.3200000000000001 109.497 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.1 mt -65.81 -26.14 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 1.2 109.053 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.94 -50.62 7.62 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.455 -1.458 . . . . 0.48999999999999999 109.455 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -50.4 -47.36 56.45 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.444 -1.033 . . . . 3.1099999999999999 109.994 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 58.9 mtt-85 -65.21 -46.29 81.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.947 -1.096 . . . . 2.9500000000000002 108.776 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.6 tp -54.19 -33.19 57.59 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.727 -0.608 . . . . 1.73 109.705 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 140' ' ' ASN . 16.8 mt -76.79 -56.6 4.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.819 -1.176 . . . . 1.22 109.687 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -46.24 -17.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.933 . . . . 2.7799999999999998 110.093 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.514 ' ND2' ' N ' ' A' ' 140' ' ' ASN . 1.7 m120 -85.93 -37.14 19.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.978 . . . . 2.0299999999999998 109.633 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.3 mt -72.84 -40.64 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 1.2 109.727 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.5 mt -86.67 1.93 50.25 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.668 -0.864 . . . . 1.28 108.668 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.06 20.39 8.74 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.096 -2.002 . . . . 0.68999999999999995 108.096 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.5 tp -54.84 163.54 0.96 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.645 -0.915 . . . . 1.3100000000000001 109.146 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -68.18 143.62 55.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 2.8799999999999999 110.103 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.3 mt -111.39 137.55 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.508 -0.745 . . . . 1.3600000000000001 109.141 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 mp -77.71 99.48 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 1.9299999999999999 109.085 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -99.38 92.29 5.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.413 -0.805 . . . . 1.54 109.64 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 151' ' ' ALA . 22.0 mt -79.24 -9.71 59.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 1.3400000000000001 109.104 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.2 t -79.77 35.27 0.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 1.98 108.979 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -142.67 18.29 2.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.399 -0.813 . . . . 1.3799999999999999 109.424 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.24 150.97 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 1.3999999999999999 110.13 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -145.86 11.89 1.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.293 -1.002 . . . . 2.7400000000000002 108.293 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -125.36 125.37 43.33 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.336 -0.987 . . . . 1.4099999999999999 108.336 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.82 115.27 4.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.359 -0.838 . . . . 1.3 109.29 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.29 178.62 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 1.28 109.675 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 26.8 mt -93.8 153.14 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.834 -1.173 . . . . 1.1499999999999999 107.834 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 25.4 tp -101.13 115.59 30.84 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.775 -0.824 . . . . 1.2 108.775 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.9 t -121.84 128.96 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.93 -0.767 . . . . 1.1599999999999999 108.93 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.86 149.96 11.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.483 -0.761 . . . . 1.2 109.098 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.09 -35.79 67.42 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.651 -1.281 . . . . 1.3200000000000001 107.928 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -174.9 156.5 2.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.653 -0.654 . . . . 2.3399999999999999 109.243 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.0 mt -123.83 133.73 53.74 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.547 -0.721 . . . . 1.26 109.581 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.8 p -93.57 152.52 40.94 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.921 -0.77 . . . . 1.3600000000000001 108.921 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -34.88 -51.98 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.459 2.106 . . . . 0.63 112.526 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.7 m -51.79 -50.26 61.08 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.179 -0.95 . . . . 1.0700000000000001 108.861 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.03 -35.73 77.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.596 -0.69 . . . . 1.25 109.819 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.7 p -79.94 -28.77 39.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.111 -0.993 . . . . 1.1799999999999999 109.411 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.21 -18.19 59.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.852 . . . . 1.1399999999999999 109.98 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -106.93 -14.52 14.94 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.218 -0.926 . . . . 1.71 109.336 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.2 tp -55.29 134.92 50.23 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.021 -1.103 . . . . 1.22 108.021 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 174' ' ' LYS . 3.3 t-20 -98.49 97.44 8.76 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.209 -0.932 . . . . 2.5499999999999998 109.586 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.6 mp -75.9 44.69 0.31 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.5 -0.75 . . . . 1.96 109.317 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 172' ' ' ASN . 95.4 mttt -106.5 -24.8 12.09 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.572 -0.899 . . . . 2.46 108.572 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -132.28 4.09 4.01 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.757 -0.59 . . . . 2.4199999999999999 110.03 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.1 153.91 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.971 -1.081 . . . . 1.1599999999999999 109.09 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.03 -37.53 5.34 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.659 -0.651 . . . . 1.95 110.003 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.41 -177.95 37.47 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.152 -1.579 . . . . 0.41999999999999998 109.152 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -132.46 127.88 36.25 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.465 -1.021 . . . . 0.52000000000000002 110.008 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.9 mt -127.03 118.55 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.981 -1.488 . . . . 1.1599999999999999 106.981 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 32.0 p -141.03 151.99 44.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.411 -0.805 . . . . 1.22 111.67 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -90.84 42.48 1.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.548 -0.72 . . . . 2.2400000000000002 109.224 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -91.87 -153.58 0.34 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.989 -1.069 . . . . 1.6499999999999999 110.474 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.425 ' N ' ' OG ' ' A' ' 188' ' ' SER . . . -91.75 -114.42 1.97 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.147 -1.181 . . . . 2.1000000000000001 110.147 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.45 -37.49 0.4 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.388 -1.885 . . . . 1.8400000000000001 108.388 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -69.7 -39.88 76.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -1.088 . . . . 5.7800000000000002 109.007 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 47.8 p -137.5 26.49 2.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.474 -0.766 . . . . 3.2400000000000002 109.093 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 184' ' ' GLY . 15.0 m -84.58 129.95 34.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.334 -0.854 . . . . 2.1099999999999999 109.619 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -57.22 -48.05 79.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.396 -0.815 . . . . 1.0600000000000001 110.12 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.1 m -46.33 -39.39 10.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.993 -1.067 . . . . 2.0899999999999999 109.571 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.0 p -61.04 -45.59 94.17 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.289 -0.882 . . . . 1.8799999999999999 109.003 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 74.1 mt -49.72 -33.05 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.931 . . . . 2.0099999999999998 109.29 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 74.4 mtp -73.62 -65.52 0.81 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.641 -1.244 . . . . 1.27 107.641 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.19 -28.54 7.66 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.679 -0.692 . . . . 1.1799999999999999 110.04 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 31.8 mtt-85 -80.61 -52.32 7.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.869 -1.145 . . . . 3.5800000000000001 110.512 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.6 m -71.14 -33.95 70.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.897 -1.127 . . . . 1.1399999999999999 109.687 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 199' ' ' LEU . 22.3 mt -90.4 -0.44 57.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.23 -0.919 . . . . 1.28 109.126 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 46.34 11.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.345 -0.847 . . . . 1.49 111.284 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 197' ' ' LEU . 17.8 mt -68.31 145.22 97.29 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.815 -1.178 . . . . 1.28 109.45 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -56.63 131.92 48.59 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.091 1.861 . . . . 0.69999999999999996 110.803 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.44 173.04 11.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.597 -1.314 . . . . 1.1899999999999999 111.33 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 202' ' ' ILE . 68.9 mt -143.9 159.45 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.78 -1.563 . . . . 1.25 106.78 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.1 m -143.11 -33.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 120.577 -1.327 . . . . 1.29 111.337 -178.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.76 36.67 2.98 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.075 -1.21 . . . . 0.92000000000000004 110.075 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.9 p -65.94 -31.47 72.41 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.866 -1.373 . . . . 1.3100000000000001 108.604 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.23 -91.04 0.37 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.068 -1.063 . . . . 1.0 111.713 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 10.9 m -111.29 40.51 2.06 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.196 -1.179 . . . . 1.9199999999999999 112.945 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.3 t -76.93 -28.68 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.383 -1.448 . . . . 1.27 107.418 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 29.9 p -66.76 -9.64 38.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.391 -0.818 . . . . 1.3400000000000001 109.179 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 41.3 m -104.85 9.19 34.88 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.302 -0.999 . . . . 2.0699999999999998 108.302 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -134.74 2.25 3.14 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.532 -0.914 . . . . 2.8599999999999999 108.532 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.53 151.87 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.152 -0.684 . . . . 1.3 109.152 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -131.81 162.44 30.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.608 -1.627 . . . . 2.48 106.608 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 60.4 m-80 -63.71 146.86 53.03 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.786 -1.196 . . . . 2.6200000000000001 110.461 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.3 t70 79.4 -20.89 0.36 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.722 -0.611 . . . . 2.3999999999999999 110.431 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.38 126.1 25.78 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.771 -1.206 . . . . 1.99 108.155 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.479 ' HH ' ' CG ' ' A' ' 230' ' ' ASN . 13.4 p90 -87.5 118.97 27.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.787 -1.196 . . . . 1.54 109.723 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.5 mt -113.62 137.35 51.72 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.492 -0.929 . . . . 1.25 108.492 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.31 115.64 47.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.825 -1.176 . . . . 1.26 107.825 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 30.9 tp -83.2 129.77 35.04 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.296 -1.002 . . . . 1.1799999999999999 108.296 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.8 t0 -97.55 -40.0 8.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.408 -0.807 . . . . 2.2200000000000002 109.036 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 39.59 27.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.61 0.719 . . . . 1.2 110.078 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 221' ' ' ASP . 7.8 t -119.47 -45.05 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.419 -1.697 . . . . 1.48 106.419 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -105.27 17.13 24.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.178 -1.416 . . . . 2.8199999999999998 107.178 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 55.8 53.44 9.4 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.597 -0.89 . . . . 2.1099999999999999 108.597 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -155.0 145.63 22.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 2.6499999999999999 110.584 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.0 t -105.39 163.43 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.384 -0.969 . . . . 1.29 108.384 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -129.55 122.74 29.8 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.329 -0.857 . . . . 1.4199999999999999 109.23 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.76 115.46 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.421 -0.799 . . . . 1.26 110.552 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.479 ' CG ' ' HH ' ' A' ' 217' ' ' TYR . 47.2 t-20 53.96 51.33 8.11 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.379 -0.826 . . . . 2.1499999999999999 111.098 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.8 Cg_endo -64.46 158.76 47.71 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.378 2.052 . . . . 0.81999999999999995 111.472 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 78.5 p -71.03 139.51 50.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.094 -1.004 . . . . 2.1099999999999999 109.165 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -53.38 -17.11 1.66 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.197 -0.939 . . . . 3.1699999999999999 109.587 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -68.15 -39.44 82.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 3.0600000000000001 108.755 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.2 t -79.49 -34.27 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 1.6499999999999999 109.011 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 21.4 mt -64.55 -55.23 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.83 . . . . 1.47 109.313 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -53.14 -40.5 64.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -0.795 . . . . 2.54 109.622 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -67.07 -41.18 86.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 3.0 110.084 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 44.0 mtp -79.53 -26.72 41.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.084 -1.01 . . . . 1.6299999999999999 109.708 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.427 ' NH1' ' OE2' ' A' ' 244' ' ' GLU . 13.4 mmm180 -59.47 -41.11 89.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.038 . . . . 3.1600000000000001 109.593 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 245' ' ' GLN . . . -74.07 -60.24 2.35 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.278 -0.889 . . . . 2.0899999999999999 110.226 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.2 t -46.8 -62.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 2.5699999999999998 110.668 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.4 HE21 HD13 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -45.98 -59.19 2.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.027 -1.046 . . . . 3.5899999999999999 109.531 -179.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.427 ' OE2' ' NH1' ' A' ' 240' ' ' ARG . 64.2 mt-10 -63.61 -22.66 67.02 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.338 -0.851 . . . . 1.76 109.776 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 241' ' ' ALA . 43.3 tt0 -68.98 -27.91 66.13 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.531 -1.285 . . . . 3.21 107.531 178.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.78 -46.08 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.535 -0.728 . . . . 2.3500000000000001 109.244 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.56 -37.25 79.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 2.3999999999999999 109.194 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.1 p -78.99 -29.54 43.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -0.849 . . . . 3.0299999999999998 110.541 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.035 . . . . 3.4100000000000001 109.618 -179.107 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 mmt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.321 0.581 . . . . 4.0700000000000003 109.502 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.2 mt 46.58 84.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.374 -0.828 . . . . 1.5 109.961 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m -95.11 113.39 25.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.208 -0.933 . . . . 1.8 109.093 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.24 -161.97 20.74 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.036 -1.626 . . . . 0.92000000000000004 109.036 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mt -95.77 -8.15 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.385 -1.068 . . . . 1.5 109.218 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tp 60.61 106.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -0.999 . . . . 1.3999999999999999 108.843 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.61 -46.02 9.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.779 -1.2 . . . . 1.26 108.444 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.54 142.57 15.66 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.428 -0.795 . . . . 1.95 108.934 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.02 155.63 30.02 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.029 1.82 . . . . 0.93999999999999995 113.814 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 160.78 -173.9 37.35 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.296 -1.522 . . . . 0.78000000000000003 109.296 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.4 mt -148.03 122.15 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.605 -1.527 . . . . 1.29 109.358 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.43 154.27 43.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.161 -0.962 . . . . 1.1499999999999999 110.406 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.495 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 8.7 m-85 -119.23 145.56 45.96 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.351 -0.981 . . . . 0.71999999999999997 108.351 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.4 159.9 22.75 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 118.885 -1.626 . . . . 0.5 111.248 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -78.57 153.45 31.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.99 . . . . 2.3599999999999999 109.638 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.15 121.89 25.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 1.1599999999999999 110.622 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.4 tp -101.73 92.76 4.99 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.518 -1.29 . . . . 1.24 107.518 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.49 127.2 33.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.966 -1.084 . . . . 1.3100000000000001 111.194 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.3 mt -95.26 93.31 7.21 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.511 -0.768 . . . . 1.3100000000000001 109.255 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -92.82 158.06 16.07 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.291 -0.88 . . . . 2.3500000000000001 109.624 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -130.39 135.6 48.19 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.609 -0.886 . . . . 2.5800000000000001 108.609 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.55 135.97 36.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.127 -0.983 . . . . 2.1400000000000001 109.542 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -65.45 132.53 49.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.597 -0.689 . . . . 1.9299999999999999 109.456 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.24 135.46 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.31 -0.869 . . . . 1.28 109.959 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.52 117.85 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.546 -0.721 . . . . 1.3700000000000001 109.364 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 26' ' ' ILE . 65.2 mt -87.01 132.65 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 1.3300000000000001 109.289 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.3 123.28 33.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.252 -0.905 . . . . 1.3700000000000001 109.655 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HG2' HH11 ' A' ' 28' ' ' ARG . 2.8 mmt-85 -96.25 26.05 4.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.248 -0.907 . . . . 3.1899999999999999 108.819 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -90.24 142.73 27.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.463 -0.773 . . . . 2.8100000000000001 110.384 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -88.34 129.16 35.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.252 -0.905 . . . . 2.8300000000000001 108.649 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 31' ' ' ILE . 14.7 pt -92.68 172.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.943 -1.098 . . . . 1.3400000000000001 110.426 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 34' ' ' ASP . 7.9 p -99.18 160.08 14.53 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.621 -0.881 . . . . 1.3500000000000001 108.621 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.3 -7.53 0.89 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.033 -1.042 . . . . 1.6100000000000001 109.373 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 32' ' ' SER . 3.9 m-20 -82.57 -10.03 59.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 2.4700000000000002 110.446 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -120.02 -17.0 8.52 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.158 -0.964 . . . . 2.0699999999999998 109.73 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.6 t -53.89 -36.35 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 1.3300000000000001 109.697 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -54.25 -40.46 67.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 1.46 110.152 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -69.93 -41.54 74.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.219 -0.926 . . . . 2.9399999999999999 110.575 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -59.73 -45.82 91.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.061 . . . . 1.3 109.864 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.1 t -59.27 -45.08 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 1.3300000000000001 109.3 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -60.66 -37.64 82.24 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.505 -0.924 . . . . 1.5 108.505 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -68.83 -31.57 70.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.531 -0.731 . . . . 3.1499999999999999 109.352 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -85.36 -51.26 6.68 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.28 -0.888 . . . . 0.92000000000000004 109.216 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.35 -59.74 4.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.886 . . . . 1.4099999999999999 109.085 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 t -62.78 -38.09 89.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 1.22 108.629 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -55.31 -54.1 36.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 107.325 -2.31 . . . . 0.58999999999999997 107.325 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -45.65 -32.25 2.3 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.341 -0.985 . . . . 3.3900000000000001 108.341 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.13 -34.93 74.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.34 -0.985 . . . . 1.26 108.34 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' GLY . 24.2 ttmt -85.12 -58.43 2.69 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.246 -0.65 . . . . 2.9900000000000002 109.246 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.07 -39.23 63.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.967 . . . . 1.1399999999999999 109.872 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -66.31 -40.01 89.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.102 -0.999 . . . . 1.8400000000000001 108.622 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.08 -35.32 64.21 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.867 -0.52 . . . . 1.22 109.83 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -65.22 -67.27 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 2.0 110.162 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -50.16 -33.96 20.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.865 -1.147 . . . . 1.99 108.899 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.48 -46.22 80.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.401 -0.812 . . . . 1.27 108.919 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -62.53 -37.39 85.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.293 -0.879 . . . . 1.24 109.785 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.42 -33.73 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.962 -1.086 . . . . 1.21 108.854 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -53.78 -44.66 70.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 1.53 109.836 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -71.22 -35.27 71.45 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.199 -0.938 . . . . 1.24 109.741 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.432 ' O ' ' OG1' ' A' ' 64' ' ' THR . 61.4 mttm -69.45 -26.18 64.47 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.563 -1.255 . . . . 2.3199999999999998 107.686 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.51 -33.76 67.13 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.354 -0.98 . . . . 1.1699999999999999 108.354 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -28.83 28.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.792 -1.323 . . . . 0.57999999999999996 109.792 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -86.2 -11.65 51.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.1 -1.235 . . . . 1.3899999999999999 108.764 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 99.3 m -99.16 -51.02 3.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.497 -0.752 . . . . 1.3600000000000001 110.353 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -106.25 -16.29 14.62 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.213 -0.93 . . . . 1.1399999999999999 110.711 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.53 143.79 6.9 Favored Glycine 0 N--CA 1.504 3.214 0 N-CA-C 110.274 -1.13 . . . . 0.59999999999999998 110.274 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -48.77 -9.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.365 -1.079 . . . . 2.5899999999999999 110.166 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 66' ' ' GLY . 35.4 mt-10 -63.72 -31.56 72.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.953 . . . . 2.2000000000000002 110.466 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -88.86 -6.32 57.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.943 -1.098 . . . . 2.3599999999999999 110.624 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.81 -31.33 72.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.642 -1.287 . . . . 1.54 109.983 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.86 -29.57 70.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 1.24 109.586 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.0 mt -73.36 -45.09 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 1.24 109.557 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -76.96 -21.24 55.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.80000000000000004 109.433 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.19 -40.59 94.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.134 -0.979 . . . . 1.23 108.869 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.9 -31.45 64.58 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.699 -1.76 . . . . 0.56000000000000005 108.699 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -62.29 -23.2 66.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.556 -0.967 . . . . 2.0600000000000001 110.162 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.1 mt -84.9 -35.33 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.776 -1.203 . . . . 1.24 108.773 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.8 ttt -57.27 -39.74 76.29 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.353 -0.98 . . . . 2.4500000000000002 108.353 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.99 -39.07 90.01 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.574 -0.899 . . . . 1.21 108.574 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.31 -43.04 53.13 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.617 -0.833 . . . . 1.1200000000000001 109.179 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -85.49 2.89 42.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.2 -0.938 . . . . 1.24 110.419 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -45.34 114.4 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.07 -1.018 . . . . 1.3100000000000001 109.261 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -64.04 -23.51 67.36 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -0.854 . . . . 1.3500000000000001 109.169 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -75.88 -46.78 28.32 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.344 -0.848 . . . . 2.1600000000000001 109.194 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.08 -20.43 66.16 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.935 -1.103 . . . . 1.24 109.554 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.43 -53.47 9.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.361 -0.837 . . . . 1.28 110.736 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -61.88 -29.97 70.55 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.25 -0.906 . . . . 1.79 110.469 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.11 -41.63 61.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.98 -1.075 . . . . 1.29 109.077 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.0 mt -60.55 -57.72 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.868 -1.16 . . . . 1.1399999999999999 107.868 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.9 mt -49.42 -53.63 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.666 -0.646 . . . . 1.3200000000000001 110.05 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.85 -63.3 1.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 1.3700000000000001 110.125 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.1 mt -45.19 -48.48 12.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.541 -0.725 . . . . 1.3999999999999999 110.008 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.3 mt -55.21 -40.84 57.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.157 -0.965 . . . . 1.23 110.004 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -85.61 -39.5 17.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.027 -1.046 . . . . 2.5099999999999998 111.313 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.31 -36.8 26.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.827 -1.171 . . . . 1.5900000000000001 111.54 -176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.65 12.19 33.24 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.919 -1.113 . . . . 2.3799999999999999 109.164 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.3 m80 45.12 44.26 8.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.486 -0.759 . . . . 1.6200000000000001 109.295 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.0 mtp -93.43 154.0 18.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.398 -0.814 . . . . 1.8899999999999999 109.302 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.9 p -79.25 142.47 36.17 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.317 -0.864 . . . . 1.27 109.262 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.16 -26.46 1.91 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 1.1599999999999999 109.646 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -76.19 -42.63 45.67 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.276 -0.89 . . . . 2.0 108.916 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.49 -58.58 3.27 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.726 -0.609 . . . . 1.25 111.175 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.41 -48.68 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.956 -1.09 . . . . 1.1299999999999999 109.804 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.07 -33.8 65.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.199 -0.938 . . . . 1.0800000000000001 109.333 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.478 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 85.5 t60 -70.75 -35.32 72.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 2.02 109.598 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.25 -64.25 0.92 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.363 -0.836 . . . . 1.26 110.47 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -48.54 -47.17 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.985 -1.072 . . . . 1.1799999999999999 109.55 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.58 -21.22 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.482 -0.761 . . . . 1.1899999999999999 109.734 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.478 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 11.9 tp10 -72.95 -38.88 66.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.166 -0.959 . . . . 2.2000000000000002 111.247 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.15 -21.12 55.99 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 118.828 -1.653 . . . . 0.85999999999999999 112.102 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -69.83 -59.41 2.95 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.606 -1.526 . . . . 2.0 108.171 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.71 -49.83 73.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.717 -0.614 . . . . 1.3200000000000001 109.533 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 109' ' ' GLU . 23.8 m -58.93 -35.81 73.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.263 -0.898 . . . . 2.1400000000000001 109.586 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.27 97.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.071 -1.018 . . . . 1.3799999999999999 110.116 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.8 mt -66.64 -27.77 67.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.879 -1.138 . . . . 1.3500000000000001 109.288 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -67.32 -18.29 65.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.113 -0.992 . . . . 1.95 110.011 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.38 -9.85 59.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.063 -1.023 . . . . 1.71 109.282 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mt -89.1 152.23 21.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.627 -0.879 . . . . 1.71 108.627 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -100.8 59.64 0.94 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -0.846 . . . . 2.8300000000000001 108.814 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -143.91 119.1 10.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.284 -0.885 . . . . 1.5800000000000001 109.375 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.481 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.4 pm0 -63.42 -9.28 11.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 2.7999999999999998 109.237 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -76.42 -62.61 1.56 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.35 -0.843 . . . . 1.27 109.938 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.57 -17.12 62.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.738 -1.226 . . . . 1.5800000000000001 109.36 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -69.37 -55.6 9.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.137 -0.977 . . . . 2.9199999999999999 108.778 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -60.48 -21.45 62.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.257 -0.902 . . . . 2.2000000000000002 108.938 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -71.75 -27.24 62.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.631 -1.618 . . . . 2.5299999999999998 106.631 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.27 92.95 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.226 -1.027 . . . . 1.45 108.226 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.09 79.87 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.527 -0.916 . . . . 1.5 108.527 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -32.54 71.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 1.3500000000000001 108.834 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.2 t -80.37 -47.02 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.436 -0.79 . . . . 1.23 108.891 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -64.42 -35.64 81.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.154 -0.966 . . . . 3.73 108.721 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.503 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 13.5 t0 -58.52 -43.52 89.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 1.3200000000000001 109.298 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 133' ' ' ILE . 90.0 mt -67.47 -25.57 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 1.2 108.402 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.08 -52.24 4.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.446 -1.461 . . . . 0.48999999999999999 109.446 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -52.82 -37.32 59.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -1.158 . . . . 3.1099999999999999 109.329 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.503 ' NH2' ' OD1' ' A' ' 132' ' ' ASP . 6.7 mtt-85 -63.46 -42.52 98.63 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.15 -1.055 . . . . 2.9500000000000002 108.15 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.6 tp -59.21 -48.92 79.83 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.57 -0.706 . . . . 1.73 109.291 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.2 mt -52.21 -53.16 46.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 1.22 109.787 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -54.39 -22.96 13.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.097 -1.002 . . . . 2.7799999999999998 110.0 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.415 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 2.6 m120 -83.96 -31.41 25.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 2.0299999999999998 109.047 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.0 mt -66.26 -43.78 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 1.2 108.842 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.6 mt -90.43 -7.14 53.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.211 -0.931 . . . . 1.28 109.397 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 68.73 27.55 73.77 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.578 -1.809 . . . . 0.68999999999999995 108.578 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tp -51.28 166.2 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.529 -0.983 . . . . 1.3100000000000001 109.609 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -67.06 141.25 57.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 2.8799999999999999 109.867 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -109.21 138.78 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.447 -0.783 . . . . 1.3600000000000001 109.135 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.5 mp -78.71 128.68 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.025 -1.047 . . . . 1.9299999999999999 110.03 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -98.13 86.32 3.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.494 -0.754 . . . . 1.54 109.246 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.5 mt -82.41 -33.84 28.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.235 -0.916 . . . . 1.3400000000000001 109.953 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.5 m -82.06 28.49 0.43 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.115 -0.991 . . . . 1.98 109.977 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.18 28.52 2.28 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.073 -1.017 . . . . 1.3799999999999999 109.671 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.9 152.96 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 1.3999999999999999 109.483 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -129.44 -16.02 3.97 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.353 -0.842 . . . . 2.7400000000000002 109.238 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -114.95 126.96 55.38 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.892 -0.781 . . . . 1.4099999999999999 108.892 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.16 124.97 23.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.046 -1.033 . . . . 1.3 109.288 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.3 m -149.33 175.9 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 1.28 108.94 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.2 mt -88.39 156.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.268 -1.012 . . . . 1.1499999999999999 108.268 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tp -107.55 124.92 50.63 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.103 -0.702 . . . . 1.2 109.103 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -124.71 129.27 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.062 -0.718 . . . . 1.1599999999999999 109.062 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.29 146.3 13.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 1.2 109.765 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.52 -34.84 67.41 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.746 -1.221 . . . . 1.3200000000000001 107.847 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -173.49 151.95 2.05 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.164 -0.68 . . . . 2.3399999999999999 109.164 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.2 mt -119.89 130.67 54.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.682 -0.859 . . . . 1.26 108.682 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.2 p -91.12 150.97 42.6 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.133 -0.98 . . . . 1.3600000000000001 109.076 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 169' ' ' ALA . 68.6 Cg_exo -35.41 -51.73 0.86 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 122.527 2.151 . . . . 0.63 112.379 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.8 m -48.0 -54.28 13.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.319 -0.863 . . . . 1.0700000000000001 109.28 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.75 -45.8 88.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.4 -0.813 . . . . 1.25 109.654 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 24.1 p -68.12 -26.06 65.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 1.1799999999999999 109.714 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -74.06 -30.77 62.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.114 -0.991 . . . . 1.1399999999999999 110.148 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -101.41 -14.21 17.66 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.188 -0.945 . . . . 1.71 109.818 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.0 tp -60.51 145.28 49.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.799 -1.188 . . . . 1.22 108.296 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 174' ' ' LYS . 11.7 t-20 -96.51 142.06 29.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.11 -0.994 . . . . 2.5499999999999998 108.497 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.413 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 37.0 mt -90.15 -39.97 12.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 1.96 111.04 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 35.1 mttm -79.94 -11.06 59.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.83 -1.168 . . . . 2.46 111.628 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -101.83 -13.22 17.77 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.857 -1.152 . . . . 2.4199999999999999 109.074 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.5 t -95.88 161.37 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.229 -0.919 . . . . 1.1599999999999999 108.646 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 53.8 tp -111.52 -28.54 8.12 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.25 -0.907 . . . . 1.95 110.119 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -174.32 177.53 46.47 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.714 -1.355 . . . . 0.41999999999999998 109.714 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.53 127.43 33.17 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.405 -1.056 . . . . 0.52000000000000002 109.853 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.6 mt -127.91 122.91 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.762 -1.57 . . . . 1.1599999999999999 106.762 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 38.0 p -140.77 156.23 46.22 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.331 1.063 . . . . 1.22 112.461 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 1.5 m-20 -87.07 37.55 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.692 -0.685 . . . . 2.2400000000000002 109.56 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -88.65 -167.41 1.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.081 -1.012 . . . . 1.6499999999999999 110.416 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.45 -106.35 1.45 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.488 -1.445 . . . . 2.1000000000000001 109.488 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 171.12 -36.59 0.17 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.388 -1.485 . . . . 1.8400000000000001 109.388 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.427 ' O ' ' OG1' ' A' ' 187' ' ' THR . 61.9 ttt180 -56.38 98.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -1.103 . . . . 5.7800000000000002 109.528 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 73.5 p 47.61 50.76 14.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.475 -0.766 . . . . 3.2400000000000002 110.039 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.1 t -86.64 140.6 29.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.209 -0.932 . . . . 2.1099999999999999 109.393 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -49.21 -52.09 28.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 1.0600000000000001 109.89 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 39.0 p -54.08 -45.97 71.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 2.0899999999999999 110.232 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 98.9 p -63.67 -46.4 85.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 1.8799999999999999 110.762 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -50.91 -28.68 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.903 -1.123 . . . . 2.0099999999999998 109.721 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.5 mtp -71.37 -57.0 4.87 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.789 -1.189 . . . . 1.27 107.789 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.83 -43.11 65.75 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.78 -0.645 . . . . 1.1799999999999999 110.076 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -68.1 -46.3 71.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 3.5800000000000001 109.779 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.3 m -70.24 -35.82 74.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 1.1399999999999999 109.727 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 199' ' ' LEU . 28.8 mt -89.76 -1.95 58.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.152 -0.967 . . . . 1.28 109.403 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 56.26 2.23 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 1.49 111.681 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 197' ' ' LEU . 18.2 mt -67.1 169.51 8.23 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.45 -1.406 . . . . 1.28 108.631 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.28 141.84 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.694 2.263 . . . . 0.69999999999999996 111.312 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.26 -178.63 5.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.448 -1.408 . . . . 1.1899999999999999 111.341 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 28.5 mt -148.76 157.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.452 -1.314 . . . . 1.25 107.452 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.0 m -138.35 -39.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.968 -1.083 . . . . 1.29 110.713 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -75.97 41.2 1.48 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.679 -1.368 . . . . 0.92000000000000004 109.679 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 203' ' ' VAL . 20.2 p -68.21 3.57 1.61 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.058 -1.26 . . . . 1.3100000000000001 109.042 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 55.83 -102.22 0.16 Allowed Glycine 0 N--CA 1.483 1.833 0 N-CA-C 109.83 -1.308 . . . . 1.0 109.83 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.5 p -125.49 43.38 3.07 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.403 -1.057 . . . . 1.9199999999999999 111.323 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 26.2 t -62.96 -32.06 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.521 -1.362 . . . . 1.27 107.825 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 p -60.25 -16.28 32.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 1.3400000000000001 109.094 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.7 m -105.67 15.36 27.0 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.876 -0.787 . . . . 2.0699999999999998 108.876 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -133.68 -15.28 2.41 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.554 -0.716 . . . . 2.8599999999999999 109.934 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 51.3 t -123.34 150.57 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.331 -0.856 . . . . 1.3 109.308 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -113.8 -174.74 2.53 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.593 -1.262 . . . . 2.48 107.593 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.46 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 9.6 t30 -80.26 145.41 32.2 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.14 -0.975 . . . . 2.6200000000000001 110.057 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 82.29 -11.77 0.98 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.036 -0.415 . . . . 2.3999999999999999 111.229 178.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -55.46 143.32 29.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.636 -1.29 . . . . 1.99 108.446 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -87.78 125.58 34.52 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.956 -1.09 . . . . 1.54 108.813 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.4 mt -123.7 162.98 22.01 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.841 0.829 . . . . 1.25 110.585 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.7 mt -136.69 107.87 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.775 -1.194 . . . . 1.26 107.775 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.5 tp -87.51 122.04 30.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -0.905 . . . . 1.1799999999999999 109.234 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.8 OUTLIER -101.05 -28.41 12.73 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.33 -0.856 . . . . 2.2200000000000002 109.014 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 37.57 27.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.891 -0.505 . . . . 1.2 111.246 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.2 t -118.25 -58.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 106.602 -1.629 . . . . 1.48 106.602 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -92.02 9.1 34.68 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.643 -1.614 . . . . 2.8199999999999998 106.643 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 60.13 64.63 1.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.211 -0.663 . . . . 2.1099999999999999 109.211 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -153.01 136.1 15.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 2.6499999999999999 110.698 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.3 t -115.18 126.6 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.887 -1.153 . . . . 1.29 107.887 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -96.4 130.71 43.47 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 1.4199999999999999 109.748 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.46 130.54 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.415 -0.587 . . . . 1.26 109.415 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 20.0 t30 55.24 71.62 1.24 Allowed Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.376 -0.828 . . . . 2.1499999999999999 110.229 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.36 146.08 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 123.321 2.681 . . . . 0.81999999999999995 112.06 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.5 p -72.21 177.89 4.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.804 . . . . 2.1099999999999999 109.776 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -76.86 -39.55 50.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 3.1699999999999999 109.553 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.514 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 13.3 mp0 -53.76 -39.12 65.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 3.0600000000000001 109.403 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.46 -39.41 54.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.089 -1.007 . . . . 1.6499999999999999 108.833 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.0 mt -65.94 -64.25 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 1.47 109.305 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -53.77 -44.09 69.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 2.54 110.606 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -65.73 -33.04 74.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.06 -1.025 . . . . 3.0 109.813 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.456 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 50.8 mtp -80.83 -38.73 27.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.981 -1.075 . . . . 1.6299999999999999 109.467 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -49.07 -50.17 37.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.046 -1.034 . . . . 3.1600000000000001 110.166 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.91 -61.8 1.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.06 -1.025 . . . . 2.0899999999999999 110.96 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.9 t -62.83 -52.44 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.951 -1.093 . . . . 2.5699999999999998 111.167 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 239' ' ' MET . 2.2 tp-100 -54.39 -41.28 69.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.712 -1.242 . . . . 3.5899999999999999 109.72 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.0 -25.7 67.79 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.567 -1.333 . . . . 1.76 108.659 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -70.19 -22.3 62.95 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.898 -1.149 . . . . 3.21 107.898 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.79 -55.25 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.328 -0.858 . . . . 2.3500000000000001 108.904 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.01 -34.65 43.81 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.54 -0.725 . . . . 2.3999999999999999 109.452 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -31.81 56.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -0.874 . . . . 3.0299999999999998 109.314 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 3.4100000000000001 109.067 179.623 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.936 -0.764 . . . . 4.0700000000000003 108.936 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.01 97.24 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 1.5 110.007 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.4 m -99.75 110.81 23.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.461 -0.774 . . . . 1.8 109.959 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.564 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -109.45 -162.45 19.62 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.755 -1.738 . . . . 0.92000000000000004 108.755 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' ' 6' ' ' LEU . 89.3 mt -94.82 -6.98 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.052 -1.264 . . . . 1.5 109.096 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' ILE . 5.4 tp 55.39 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.374 -0.829 . . . . 1.3999999999999999 108.878 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.45 -55.1 4.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.097 -1.002 . . . . 1.26 108.606 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.57 144.23 32.63 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.695 -0.854 . . . . 1.95 108.695 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.42 156.05 28.66 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.918 1.745 . . . . 0.93999999999999995 112.634 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.4 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 153.82 129.61 1.36 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.057 -1.217 . . . . 0.78000000000000003 110.057 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 11' ' ' ILE . 56.9 mt -99.6 131.48 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.202 -1.175 . . . . 1.29 110.724 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.26 143.65 29.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 1.1499999999999999 109.16 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.546 ' CZ ' ' OE1' ' A' ' 243' ' ' GLN . 4.2 m-85 -100.69 140.74 34.54 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.493 -1.299 . . . . 0.71999999999999997 107.493 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.56 156.25 19.49 Favored Glycine 0 N--CA 1.5 2.902 0 C-N-CA 118.49 -1.814 . . . . 0.5 111.881 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -78.75 152.09 31.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.846 -0.797 . . . . 2.3599999999999999 110.464 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.18 126.36 30.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.541 -0.724 . . . . 1.1599999999999999 111.119 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 tp -111.15 93.29 4.4 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.86 -1.533 . . . . 1.24 106.86 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.8 tp -80.6 127.51 32.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.782 -1.198 . . . . 1.3100000000000001 111.293 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.7 mt -97.16 94.61 7.23 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.438 0.637 . . . . 1.3100000000000001 109.957 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -92.68 156.89 16.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.412 -0.805 . . . . 2.3500000000000001 109.164 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.84 130.41 53.93 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.646 -0.872 . . . . 2.5800000000000001 108.646 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -76.77 132.77 39.43 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.185 -0.947 . . . . 2.1400000000000001 108.978 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.99 137.88 56.83 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.533 -0.729 . . . . 1.9299999999999999 109.442 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.34 136.08 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.23 -0.919 . . . . 1.28 110.159 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.2 t -102.66 117.53 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 1.3700000000000001 108.93 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.6 mt -90.96 129.73 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.248 -0.907 . . . . 1.3300000000000001 109.119 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -90.68 120.27 31.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 1.3700000000000001 109.922 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -96.11 29.64 2.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.384 -0.822 . . . . 3.1899999999999999 109.444 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -86.56 144.94 26.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.121 -0.987 . . . . 2.8100000000000001 109.442 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -85.84 125.97 33.69 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.984 -1.073 . . . . 2.8300000000000001 109.018 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -82.76 179.15 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.285 -0.884 . . . . 1.3400000000000001 109.535 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.439 ' H ' HE21 ' A' ' 35' ' ' GLN . 60.7 p -98.82 160.62 14.14 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.396 -0.815 . . . . 1.3500000000000001 109.332 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.1 -20.22 51.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 1.6100000000000001 109.307 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -82.53 -12.06 58.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.853 . . . . 2.4700000000000002 109.43 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.439 HE21 ' H ' ' A' ' 32' ' ' SER . 3.2 mt-30 -105.35 -10.13 17.17 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.941 -1.133 . . . . 2.0699999999999998 107.941 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.97 -48.36 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.682 -0.636 . . . . 1.3300000000000001 109.523 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -56.6 -30.04 62.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.085 -1.01 . . . . 1.46 108.942 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -70.37 -35.03 73.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.453 -0.779 . . . . 2.9399999999999999 110.16 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -64.43 -44.31 91.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.105 -0.997 . . . . 1.3 109.589 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 44' ' ' LEU . 83.6 t -58.15 -46.58 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.169 -0.957 . . . . 1.3300000000000001 109.328 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.85 -43.6 87.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.139 -0.976 . . . . 1.5 108.905 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -66.04 -32.09 73.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.568 -0.708 . . . . 3.1499999999999999 109.186 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -86.45 -57.66 2.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.133 -0.98 . . . . 0.92000000000000004 108.739 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 40' ' ' VAL . 34.0 tp -51.92 -60.69 2.89 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.425 -0.797 . . . . 1.4099999999999999 109.235 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 t -66.4 -31.34 72.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -0.891 . . . . 1.22 108.801 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.38 53.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.298 -1.921 . . . . 0.58999999999999997 108.298 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.53 HH22 ' CD ' ' A' ' 86' ' ' GLU . 27.6 ttp180 -60.44 -21.39 62.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -1.116 . . . . 3.3900000000000001 109.505 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.69 -45.59 78.33 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.345 -0.983 . . . . 1.26 108.345 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 52' ' ' ALA . 12.6 ptmt -78.4 -52.93 7.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.483 -0.932 . . . . 2.9900000000000002 108.483 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.74 -33.36 15.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.353 -1.467 . . . . 1.1399999999999999 108.789 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 m -66.54 -36.77 83.49 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.034 -1.098 . . . . 1.8400000000000001 108.034 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -70.46 -19.76 62.93 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.697 -0.853 . . . . 1.22 108.697 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -76.17 -66.06 0.84 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.4 -0.812 . . . . 2.0 109.645 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.9 mt -51.18 -35.6 36.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 1.99 108.867 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -60.74 -51.11 70.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.517 -0.739 . . . . 1.27 109.268 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 m -63.46 -38.25 90.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.157 -0.965 . . . . 1.24 109.088 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.5 mt -69.62 -27.75 34.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.295 -0.878 . . . . 1.21 108.984 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -63.3 -41.57 98.97 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.306 -0.871 . . . . 1.53 109.526 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -71.66 -24.78 61.9 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.51 -0.744 . . . . 1.24 109.264 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.427 ' O ' ' OG1' ' A' ' 64' ' ' THR . 97.0 mttt -72.59 -25.58 61.39 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.738 -1.208 . . . . 2.3199999999999998 107.738 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.98 -32.12 61.6 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.932 -1.136 . . . . 1.1699999999999999 107.932 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.96 -29.12 29.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.915 -1.674 . . . . 0.57999999999999996 108.915 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -86.64 -22.37 26.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.095 -1.238 . . . . 1.3899999999999999 108.638 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 56.5 m -94.67 -45.09 7.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.254 -0.904 . . . . 1.3600000000000001 110.56 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.573 ' C ' ' H ' ' A' ' 67' ' ' GLU . 52.4 m-85 -107.78 -34.17 7.04 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.191 -0.943 . . . . 1.1399999999999999 109.965 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 67.37 -30.21 0.21 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.366 -1.094 . . . . 0.59999999999999998 110.366 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.573 ' H ' ' C ' ' A' ' 65' ' ' PHE . 35.3 mt-10 -51.01 -179.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.03 -1.277 . . . . 2.5899999999999999 110.102 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.15 36.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.56 -0.712 . . . . 2.2000000000000002 109.821 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.556 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.8 mmtp -83.18 -10.48 58.6 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.406 -0.809 . . . . 2.3599999999999999 109.308 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -69.01 -35.96 77.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.246 -0.909 . . . . 1.54 110.292 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.41 68.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 1.24 110.398 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.499 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 11.2 mt -71.52 -46.19 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.079 -1.013 . . . . 1.24 109.821 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -76.19 -26.71 56.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.80000000000000004 109.571 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.84 -59.33 4.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.052 -1.03 . . . . 1.23 109.026 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.92 -33.73 64.22 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.76 -1.336 . . . . 0.56000000000000005 109.76 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.499 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 14.8 m170 -62.1 -22.2 65.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.019 -1.283 . . . . 2.0600000000000001 109.768 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.4 mt -84.81 -36.79 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.976 -1.077 . . . . 1.24 108.365 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.4 ttt -60.84 -44.51 96.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.172 -1.047 . . . . 2.4500000000000002 108.172 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.3 tp -57.59 -40.87 79.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.231 -1.026 . . . . 1.21 108.231 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.5 tp -69.62 -42.75 73.94 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.403 -0.81 . . . . 1.1200000000000001 109.519 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -84.9 9.57 14.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.306 -0.871 . . . . 1.24 110.262 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -49.43 121.78 5.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.015 -1.053 . . . . 1.3100000000000001 110.2 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -67.14 -24.62 65.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.242 -0.911 . . . . 1.3500000000000001 108.986 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -74.2 -49.93 21.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.328 -0.949 . . . . 2.1600000000000001 108.685 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.6 mt -64.17 -15.04 59.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.63 -1.228 . . . . 1.24 108.603 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.53 ' CD ' HH22 ' A' ' 47' ' ' ARG . 28.2 tt0 -77.29 -54.33 6.61 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.806 -1.184 . . . . 1.28 110.136 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.18 -30.79 69.58 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.674 -1.267 . . . . 1.79 110.003 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -71.88 -47.89 49.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.062 -1.024 . . . . 1.29 109.039 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.7 mt -59.5 -53.72 44.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.887 -0.783 . . . . 1.1399999999999999 108.887 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 91' ' ' ALA . 95.9 mt -51.25 -71.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.746 . . . . 1.3200000000000001 110.348 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -40.25 -48.31 2.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.383 -0.823 . . . . 1.3700000000000001 110.631 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.8 mt -55.36 -55.69 28.69 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.652 -0.87 . . . . 1.3999999999999999 108.652 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.1 mt -54.11 -41.89 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.829 . . . . 1.23 110.831 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -85.84 -35.11 20.84 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.03 -1.044 . . . . 2.5099999999999998 111.7 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 91' ' ' ALA . 37.8 t70 -81.94 -38.63 24.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.756 -1.215 . . . . 1.5900000000000001 111.48 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -105.97 12.6 30.35 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.899 -1.126 . . . . 2.3799999999999999 109.462 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.2 m170 46.05 46.35 12.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 1.6200000000000001 109.49 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.0 mtt -96.23 152.41 18.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.481 -0.762 . . . . 1.8899999999999999 109.207 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.8 p -78.53 142.93 37.01 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.61 -0.681 . . . . 1.27 110.183 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.87 -25.44 3.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.189 -0.944 . . . . 1.1599999999999999 108.736 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -75.21 -50.72 15.3 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.316 -0.994 . . . . 2.0 108.316 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.65 -50.1 33.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.64 -0.663 . . . . 1.25 109.813 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.73 -60.28 3.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 1.1299999999999999 109.657 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.5 -33.29 30.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 1.0800000000000001 109.8 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -68.16 -35.01 77.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.915 -1.116 . . . . 2.02 110.055 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.97 -45.05 91.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.121 -0.987 . . . . 1.26 110.814 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -66.72 -48.66 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.051 . . . . 1.1799999999999999 109.412 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -60.87 -23.77 30.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.737 -0.602 . . . . 1.1899999999999999 109.824 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -73.06 -37.39 66.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.104 -0.998 . . . . 2.2000000000000002 110.098 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.68 -22.1 48.06 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.372 -1.395 . . . . 0.85999999999999999 112.406 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.68 -53.37 15.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.711 -1.464 . . . . 2.0 108.79 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.15 71.78 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.652 -0.655 . . . . 1.3200000000000001 109.627 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 m -60.82 -37.43 81.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.444 -0.785 . . . . 2.1400000000000001 110.076 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.39 96.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.299 -0.876 . . . . 1.3799999999999999 111.15 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.8 mt -70.84 -26.58 63.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.451 -1.3 . . . . 1.3500000000000001 108.539 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -67.71 -19.5 65.16 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.606 -0.684 . . . . 1.95 110.41 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -82.5 -6.03 59.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.922 -1.111 . . . . 1.71 109.749 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 31.8 mt -84.32 166.99 16.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.057 -1.027 . . . . 1.71 109.528 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -107.84 47.71 0.88 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.736 -0.603 . . . . 2.8300000000000001 109.906 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -142.82 120.61 11.92 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.017 -1.052 . . . . 1.5800000000000001 109.531 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.69 -8.64 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.601 0.715 . . . . 2.7999999999999998 109.72 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -76.67 -62.03 1.77 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.4 -0.812 . . . . 1.27 109.989 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.5 mt -68.83 -24.7 64.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.024 -1.048 . . . . 1.5800000000000001 109.239 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -66.88 -50.87 61.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -0.879 . . . . 2.9199999999999999 109.083 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.19 -20.95 63.35 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.306 -0.998 . . . . 2.2000000000000002 108.306 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -72.88 -27.77 62.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.745 -1.576 . . . . 2.5299999999999998 106.745 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.09 -42.64 90.93 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.107 -1.071 . . . . 1.45 108.107 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.92 -39.04 79.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.413 -0.804 . . . . 1.5 109.784 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -70.67 -25.96 63.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 1.3500000000000001 109.616 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.62 -47.48 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 1.23 108.705 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -53.21 -39.02 63.39 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.062 -1.024 . . . . 3.73 108.405 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 22.1 t70 -59.4 -40.4 86.47 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -0.897 . . . . 1.3200000000000001 109.633 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.4 mt -66.05 -34.01 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.149 -0.969 . . . . 1.2 109.25 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.32 -44.88 16.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.515 -1.434 . . . . 0.48999999999999999 109.515 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -49.58 -45.9 48.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.411 -1.052 . . . . 3.1099999999999999 109.631 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HG2' HH11 ' A' ' 136' ' ' ARG . 11.0 mtt-85 -65.18 -42.92 93.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.08 . . . . 2.9500000000000002 108.491 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 tt -52.38 -35.88 52.51 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.082 -1.081 . . . . 1.73 108.082 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.64 -58.74 3.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.396 -0.815 . . . . 1.22 110.23 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -46.21 -20.13 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.146 -0.971 . . . . 2.7799999999999998 111.114 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -83.43 -49.73 9.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.88 -1.138 . . . . 2.0299999999999998 109.012 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.0 mt -57.56 -34.1 46.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.067 -1.021 . . . . 1.2 109.116 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 49.4 mt -87.22 0.08 55.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.062 -1.024 . . . . 1.28 108.536 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.23 25.86 12.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.449 -1.861 . . . . 0.68999999999999995 108.449 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.5 tp -57.57 153.5 12.96 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.779 -0.836 . . . . 1.3100000000000001 110.14 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -67.18 146.76 53.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.02 -1.05 . . . . 2.8799999999999999 109.747 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.85 140.13 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.449 -0.782 . . . . 1.3600000000000001 109.449 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.0 mp -78.03 120.15 28.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.225 -0.922 . . . . 1.9299999999999999 109.095 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -93.51 88.17 5.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 1.54 109.912 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 151' ' ' ALA . 27.9 mt -82.0 -24.05 35.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.877 . . . . 1.3400000000000001 108.798 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.0 t -80.44 26.14 0.39 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.457 -0.777 . . . . 1.98 108.945 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -138.5 28.38 2.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 1.3799999999999999 110.125 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 51.2 mt -74.59 152.35 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.869 . . . . 1.3999999999999999 109.127 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -131.76 -6.51 3.61 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.664 -0.865 . . . . 2.7400000000000002 108.664 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -121.82 136.06 54.92 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.954 -0.758 . . . . 1.4099999999999999 108.954 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.54 124.91 25.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 1.3 109.353 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.0 m -147.25 172.54 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.676 -0.861 . . . . 1.28 108.676 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.5 mt -90.19 157.96 2.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.828 -1.175 . . . . 1.1499999999999999 107.828 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.8 tp -108.98 121.36 44.96 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.675 0.75 . . . . 1.2 109.47 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.77 128.09 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.099 -0.704 . . . . 1.1599999999999999 109.099 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.84 151.47 14.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.442 -0.786 . . . . 1.2 109.918 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.35 -41.58 84.98 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.495 -1.378 . . . . 1.3200000000000001 107.895 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -172.94 152.8 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 2.3399999999999999 109.031 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.3 mt -116.06 141.22 48.42 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.365 -0.834 . . . . 1.26 109.867 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 26.2 p -94.97 151.1 38.66 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.315 -0.866 . . . . 1.3600000000000001 108.944 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.415 ' O ' ' OG1' ' A' ' 168' ' ' THR . 47.3 Cg_exo -35.78 -43.75 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.435 2.09 . . . . 0.63 112.243 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.3 m -53.9 -65.37 0.58 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.214 -0.929 . . . . 1.0700000000000001 109.258 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -47.67 -36.78 11.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.3 -0.875 . . . . 1.25 109.773 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 21.3 p -74.14 -20.11 60.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 1.1799999999999999 110.029 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.17 -19.8 27.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.093 -1.004 . . . . 1.1399999999999999 110.102 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -109.81 -16.57 13.86 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.443 -0.786 . . . . 1.71 110.109 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.06 147.86 45.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.908 -1.12 . . . . 1.22 108.556 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 174' ' ' LYS . 12.2 t-20 -96.02 155.35 16.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.973 -1.079 . . . . 2.5499999999999998 108.804 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 9.3 mp -94.53 -42.75 8.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.244 -0.91 . . . . 1.96 110.644 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 53.1 mtpt -79.67 -12.46 59.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.018 -1.051 . . . . 2.46 111.502 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -96.59 -6.16 37.45 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.675 -1.265 . . . . 2.4199999999999999 108.762 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 40.4 t -103.27 155.91 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.804 -0.813 . . . . 1.1599999999999999 108.804 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.5 tp -111.22 -18.09 13.04 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.928 -0.768 . . . . 1.95 108.928 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.46 177.14 42.47 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.073 -1.611 . . . . 0.41999999999999998 109.073 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -130.26 126.3 36.96 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.483 -1.01 . . . . 0.52000000000000002 108.852 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.4 mt -129.17 117.42 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.808 -1.182 . . . . 1.1599999999999999 107.808 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 203' ' ' VAL . 66.0 p -142.74 157.57 44.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.282 -0.886 . . . . 1.22 111.13 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 23.4 p30 -98.01 47.72 1.01 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.675 -0.81 . . . . 2.2400000000000002 110.179 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -94.23 -148.35 0.27 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.869 -1.144 . . . . 1.6499999999999999 110.116 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.11 -115.25 2.12 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.236 -1.146 . . . . 2.1000000000000001 110.236 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 164.28 -23.88 0.17 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.383 -1.887 . . . . 1.8400000000000001 108.383 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.464 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.3 OUTLIER -65.56 100.22 0.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.552 -0.969 . . . . 5.7800000000000002 109.455 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 186' ' ' ARG . 47.7 p 41.72 42.04 1.97 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.471 -0.768 . . . . 3.2400000000000002 109.797 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.4 t -82.24 151.16 26.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.21 -0.931 . . . . 2.1099999999999999 109.875 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -51.63 -57.58 8.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.457 -0.777 . . . . 1.0600000000000001 109.662 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.5 p -51.65 -38.69 55.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.523 -0.736 . . . . 2.0899999999999999 110.454 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 44.0 p -69.09 -42.83 75.64 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.745 -1.222 . . . . 1.8799999999999999 110.031 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 192' ' ' ILE . 96.7 mt -55.48 -29.82 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.052 -1.03 . . . . 2.0099999999999998 109.977 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.7 mtp -70.28 -56.22 7.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.322 -1.362 . . . . 1.27 107.322 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.99 83.77 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.477 -0.783 . . . . 1.1799999999999999 109.417 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -65.76 -47.71 74.3 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.259 -0.901 . . . . 3.5800000000000001 109.659 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.0 m -69.48 -38.06 77.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.923 -1.11 . . . . 1.1399999999999999 110.204 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 199' ' ' LEU . 14.4 mt -91.42 4.26 52.92 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.862 -1.149 . . . . 1.28 109.432 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 47.48 10.77 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 1.49 110.395 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 197' ' ' LEU . 27.3 mt -67.75 150.59 97.74 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.052 -1.03 . . . . 1.28 109.156 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.57 134.92 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.323 1.348 . . . . 0.69999999999999996 110.88 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.96 174.78 11.9 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.353 -1.339 . . . . 1.1899999999999999 111.037 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.3 mt -148.7 158.32 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 106.353 -1.721 . . . . 1.25 106.353 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.9 m -138.9 -32.67 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.01 -1.056 . . . . 1.29 110.776 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.79 40.01 2.97 Favored Glycine 0 N--CA 1.496 2.671 0 O-C-N 121.056 -1.028 . . . . 0.92000000000000004 110.99 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 29.9 p -69.23 -22.67 63.85 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.872 -1.37 . . . . 1.3100000000000001 108.924 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 73.34 -97.18 0.85 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.905 -1.141 . . . . 1.0 111.119 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 51.7 p -119.85 46.37 1.95 Allowed 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.979 -1.307 . . . . 1.9199999999999999 112.263 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 28.4 t -75.33 -28.9 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.639 -1.288 . . . . 1.27 107.879 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.8 p -67.75 -10.47 52.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.424 -0.798 . . . . 1.3400000000000001 109.032 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.9 p -106.76 14.54 26.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.101 -0.703 . . . . 2.0699999999999998 109.101 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -131.61 -25.1 2.16 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.427 -0.796 . . . . 2.8599999999999999 109.33 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.452 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 74.3 t -117.52 164.33 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.558 -0.714 . . . . 1.3 109.115 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.452 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 13.7 mmmt -127.17 -171.87 2.52 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.023 -1.473 . . . . 2.48 107.023 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.533 ' C ' HD21 ' A' ' 214' ' ' ASN . 0.4 OUTLIER -81.68 149.16 28.64 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.469 -1.394 . . . . 2.6200000000000001 110.107 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.2 t0 81.38 -11.61 1.07 Allowed 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.879 -0.513 . . . . 2.3999999999999999 111.495 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 0.8 OUTLIER -57.08 145.22 31.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.664 -1.272 . . . . 1.99 108.432 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -87.28 120.56 28.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.865 -1.147 . . . . 1.54 108.448 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 28.0 mt -123.65 170.19 10.71 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.253 1.025 . . . . 1.25 110.685 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.9 mt -144.74 106.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 106.423 -1.695 . . . . 1.26 106.423 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.4 tp -82.96 127.03 33.16 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.501 -0.926 . . . . 1.1799999999999999 108.501 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 223' ' ' VAL . 17.8 m-20 -97.15 -31.86 12.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.352 -0.843 . . . . 2.2200000000000002 109.453 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 39.62 25.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.428 0.632 . . . . 1.2 110.163 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.5 t -122.41 -51.88 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 106.486 -1.672 . . . . 1.48 106.486 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -97.58 16.04 21.58 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.257 -1.386 . . . . 2.8199999999999998 107.257 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.564 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 49.89 57.96 5.97 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.98 -0.748 . . . . 2.1099999999999999 108.98 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -154.67 143.76 21.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 2.6499999999999999 110.043 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.51 138.17 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.969 -0.752 . . . . 1.29 108.969 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -103.26 129.91 50.36 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.163 -0.961 . . . . 1.4199999999999999 109.511 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.9 t -108.91 122.88 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.775 -0.578 . . . . 1.26 110.198 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 50.31 58.25 17.3 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.903 . . . . 2.1499999999999999 109.607 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.47 159.51 50.17 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.7 2.267 . . . . 0.81999999999999995 112.431 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.8 m -76.28 157.72 32.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 2.1099999999999999 109.875 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -62.16 -25.54 67.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.069 -1.019 . . . . 3.1699999999999999 109.585 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -72.66 -35.73 67.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.305 -0.872 . . . . 3.0600000000000001 110.259 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.56 -45.88 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.892 . . . . 1.6499999999999999 109.808 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.8 mt -48.95 -60.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.218 -0.926 . . . . 1.47 109.005 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.63 -41.94 70.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.686 -0.633 . . . . 2.54 110.066 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -66.99 -35.1 79.19 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.993 -1.067 . . . . 3.0 109.953 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.4 mtp -80.97 -24.88 37.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.953 . . . . 1.6299999999999999 109.631 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -61.65 -45.65 93.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.104 -0.997 . . . . 3.1600000000000001 109.653 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 242' ' ' VAL . . . -74.9 -58.68 3.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.978 -1.076 . . . . 2.0899999999999999 109.011 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 241' ' ' ALA . 80.4 t -42.97 -59.12 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.471 -0.768 . . . . 2.5699999999999998 110.156 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 13' ' ' PHE . 24.8 tt0 -47.07 -62.62 1.33 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.013 -1.055 . . . . 3.5899999999999999 109.911 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -56.13 -29.21 60.39 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.124 -0.985 . . . . 1.76 110.875 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -68.08 -22.73 64.9 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.35 -1.34 . . . . 3.21 107.935 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.0 t -71.15 -51.97 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.603 -0.839 . . . . 2.3500000000000001 108.868 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -49.58 -36.86 25.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 2.3999999999999999 109.121 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.2 t -77.92 -17.58 57.1 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.552 -0.718 . . . . 3.0299999999999998 109.926 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.048 -1.033 . . . . 3.4100000000000001 109.671 -179.708 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.595 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.357 0.599 . . . . 4.0700000000000003 109.466 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -86.05 97.46 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.935 . . . . 1.5 109.476 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -94.65 108.66 20.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.244 -0.91 . . . . 1.8 109.138 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.17 -170.38 30.8 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.616 -1.394 . . . . 0.92000000000000004 109.616 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.467 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 71.5 mt -96.17 -10.04 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.396 -1.061 . . . . 1.5 109.037 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 tp 64.97 106.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.877 -0.786 . . . . 1.3999999999999999 108.877 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.57 -45.21 11.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.041 -1.096 . . . . 1.26 108.041 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -151.39 149.35 24.24 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.573 -0.899 . . . . 1.95 108.573 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.47 147.89 20.37 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.495 2.13 . . . . 0.93999999999999995 113.454 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.401 ' N ' ' HB2' ' A' ' 222' ' ' ALA . . . 154.3 -177.78 31.5 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.691 -1.363 . . . . 0.78000000000000003 109.691 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.6 mt -141.45 133.38 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.09 -1.241 . . . . 1.29 109.35 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.72 158.04 44.05 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.338 -0.851 . . . . 1.1499999999999999 110.223 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.1 m-85 -128.64 136.17 50.3 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 107.98 -1.119 . . . . 0.71999999999999997 107.98 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.98 163.11 31.74 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 118.784 -1.675 . . . . 0.5 111.003 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -79.88 148.28 31.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.634 -0.921 . . . . 2.3599999999999999 110.29 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.69 123.64 25.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.558 -0.714 . . . . 1.1599999999999999 111.278 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.0 tp -105.16 91.25 3.71 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.38 -1.341 . . . . 1.24 107.38 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 tp -82.78 136.43 34.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 1.3100000000000001 110.034 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.26 94.4 7.08 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.46 0.647 . . . . 1.3100000000000001 110.444 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -98.94 149.98 22.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.438 -0.789 . . . . 2.3500000000000001 109.184 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -130.42 141.42 50.54 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.259 -0.901 . . . . 2.5800000000000001 109.088 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.83 136.75 36.15 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.108 -0.995 . . . . 2.1400000000000001 109.377 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -67.13 130.84 44.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.462 -0.774 . . . . 1.9299999999999999 109.08 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.2 mt -91.88 137.73 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.238 -0.914 . . . . 1.28 109.544 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.9 t -105.06 117.73 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.515 -0.74 . . . . 1.3700000000000001 109.368 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 26' ' ' ILE . 80.5 mt -88.86 142.57 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.199 -0.938 . . . . 1.3300000000000001 109.266 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -91.06 124.02 34.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.159 -0.963 . . . . 1.3700000000000001 109.935 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -100.48 28.89 4.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.39 -0.819 . . . . 3.1899999999999999 109.206 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.63 144.6 29.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 2.8100000000000001 109.882 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -85.13 124.0 31.29 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.342 -0.984 . . . . 2.8300000000000001 108.342 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.9 pt -88.39 171.2 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.996 . . . . 1.3400000000000001 110.518 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 34' ' ' ASP . 21.3 p -101.35 155.0 18.31 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.94 -0.763 . . . . 1.3500000000000001 108.94 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.96 -5.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 1.6100000000000001 110.167 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 32' ' ' SER . 31.8 t0 -83.94 -28.39 27.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.02 -1.05 . . . . 2.4700000000000002 110.325 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -102.1 -2.98 28.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.144 -0.972 . . . . 2.0699999999999998 109.783 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.49 -44.02 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.087 -1.008 . . . . 1.3300000000000001 108.908 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -51.42 -37.11 46.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.892 . . . . 1.46 109.194 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -69.22 -34.3 74.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 2.9399999999999999 109.892 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -61.42 -46.63 89.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.09 -1.006 . . . . 1.3 109.442 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 44' ' ' LEU . 87.0 t -60.97 -48.4 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 1.3300000000000001 109.534 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -64.06 -39.67 94.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 1.5 108.543 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -64.75 -33.66 76.5 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.621 -0.881 . . . . 3.1499999999999999 108.621 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -86.81 -57.32 3.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.92000000000000004 108.969 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 40' ' ' VAL . 14.9 tp -49.16 -65.21 0.61 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.407 -0.808 . . . . 1.4099999999999999 109.378 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.0 t -64.24 -32.27 73.79 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.788 -0.819 . . . . 1.22 108.788 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -59.1 -54.21 39.91 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 107.612 -2.195 . . . . 0.58999999999999997 107.612 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -50.31 -27.83 6.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.597 -0.943 . . . . 3.3900000000000001 108.904 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.84 76.54 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.021 -1.103 . . . . 1.26 108.021 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 46' ' ' GLY . 24.6 mtpp -80.5 -58.04 3.3 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.843 -0.799 . . . . 2.9900000000000002 108.843 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.94 -36.16 62.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.091 -1.006 . . . . 1.1399999999999999 109.322 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.6 t -63.54 -37.11 86.04 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.35 -0.981 . . . . 1.8400000000000001 108.35 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.15 -32.65 63.23 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.296 -0.631 . . . . 1.22 109.296 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.453 HE22 ' ND2' ' A' ' 140' ' ' ASN . 55.8 mt-30 -68.96 -65.14 0.74 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.57 -0.706 . . . . 2.0 109.541 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 54' ' ' LEU . 9.3 mp -51.9 -27.94 14.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 1.99 109.078 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -73.09 -49.46 28.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 1.27 109.104 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.2 m -58.32 -31.77 67.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.115 -0.991 . . . . 1.24 109.198 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -73.28 -31.19 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.075 -1.016 . . . . 1.21 108.556 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -56.51 -45.4 81.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.504 -0.747 . . . . 1.53 109.319 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -70.71 -27.04 63.69 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.203 -0.935 . . . . 1.24 109.672 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.419 ' O ' ' OG1' ' A' ' 64' ' ' THR . 64.2 mttm -71.23 -34.66 71.0 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.872 -1.143 . . . . 2.3199999999999998 107.95 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.29 -29.05 63.5 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.033 -0.728 . . . . 1.1699999999999999 109.033 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.33 -34.3 12.52 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.917 -1.135 . . . . 0.57999999999999996 110.995 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -85.73 -12.2 51.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.586 -1.538 . . . . 1.3899999999999999 108.849 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 93.1 m -94.22 -52.92 4.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 1.3600000000000001 109.66 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.543 ' C ' ' H ' ' A' ' 67' ' ' GLU . 70.8 m-85 -107.91 -35.91 6.51 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.293 -0.88 . . . . 1.1399999999999999 109.778 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.77 -24.9 0.64 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.896 -1.282 . . . . 0.59999999999999998 109.896 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 69' ' ' LYS . 80.6 mt-10 -53.02 -172.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.252 . . . . 2.5899999999999999 110.323 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.56 34.61 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.468 -0.77 . . . . 2.2000000000000002 109.991 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' A' ' 67' ' ' GLU . 4.4 mmmm -85.12 -17.18 38.08 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.251 -0.906 . . . . 2.3599999999999999 109.305 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.16 -32.11 72.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 1.54 110.285 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.2 -21.38 65.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.197 -0.939 . . . . 1.24 110.597 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.1 mt -69.47 -46.39 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.984 -1.073 . . . . 1.24 109.539 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -76.82 -20.12 56.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.80000000000000004 109.801 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.88 -35.9 82.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 1.23 108.618 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.75 -34.64 24.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.631 -1.387 . . . . 0.56000000000000005 109.631 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -59.78 -20.96 59.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.08 -1.247 . . . . 2.0600000000000001 109.413 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.3 mt -86.44 -42.57 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.124 -1.065 . . . . 1.24 108.124 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.3 ttt -59.41 -43.01 93.09 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.769 -0.826 . . . . 2.4500000000000002 108.769 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -64.57 -45.22 87.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.734 -0.839 . . . . 1.21 108.734 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.1 tp -66.78 -46.91 73.81 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.536 -0.728 . . . . 1.1200000000000001 109.566 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -85.78 9.83 15.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.298 -0.876 . . . . 1.24 110.082 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -47.91 127.36 11.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.959 -1.088 . . . . 1.3100000000000001 109.274 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -65.73 -25.37 67.26 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.732 -0.84 . . . . 1.3500000000000001 108.732 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -77.91 -52.44 8.84 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.333 -0.854 . . . . 2.1600000000000001 109.724 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.74 -18.67 64.28 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.002 -1.061 . . . . 1.24 109.269 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.76 -54.68 6.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 1.28 109.478 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -64.26 -29.63 70.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 1.79 110.022 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.61 -47.58 46.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.094 -1.004 . . . . 1.29 109.005 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.2 mt -58.84 -59.92 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.328 -0.99 . . . . 1.1399999999999999 108.328 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.5 mt -45.29 -39.63 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.574 -0.704 . . . . 1.3200000000000001 109.855 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.35 -60.99 2.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 1.3700000000000001 109.759 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.9 mt -47.83 -50.77 25.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 1.3999999999999999 109.38 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.0 mt -54.45 -49.91 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.905 . . . . 1.23 110.679 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -85.24 -36.78 20.71 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.832 -1.168 . . . . 2.5099999999999998 111.754 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -84.44 -37.51 21.33 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.735 -1.228 . . . . 1.5900000000000001 111.693 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -103.69 14.88 30.13 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.777 -1.202 . . . . 2.3799999999999999 109.432 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.4 m170 44.3 49.17 7.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.412 -0.805 . . . . 1.6200000000000001 110.359 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 31.8 mtt -103.78 150.46 24.07 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.734 -0.839 . . . . 1.8899999999999999 108.734 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.8 p -76.89 148.91 36.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 1.27 109.811 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.25 -31.33 42.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.219 -0.926 . . . . 1.1599999999999999 109.202 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.25 -44.07 54.46 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.755 -0.832 . . . . 2.0 108.755 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.88 -54.2 12.34 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.736 -0.602 . . . . 1.25 110.422 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.7 -50.64 72.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 1.1299999999999999 109.48 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.91 -35.22 61.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.441 -0.787 . . . . 1.0800000000000001 109.73 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.25 -30.05 68.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.932 -1.105 . . . . 2.02 109.727 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 109' ' ' GLU . 79.0 tt0 -66.0 -62.67 1.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 1.26 110.274 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 t -49.95 -47.11 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.059 -1.026 . . . . 1.1799999999999999 109.546 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.32 -16.14 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.447 -0.945 . . . . 1.1899999999999999 108.447 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . 9.5 tp10 -73.46 -35.42 65.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 2.2000000000000002 109.159 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.65 -28.42 24.25 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.573 -1.299 . . . . 0.85999999999999999 112.194 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -65.03 -36.87 85.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.697 -1.472 . . . . 2.0 109.094 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.54 -54.37 5.96 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.975 -0.75 . . . . 1.3200000000000001 108.975 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.9 m -59.41 -37.53 78.25 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.427 -0.796 . . . . 2.1400000000000001 109.853 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -63.76 -41.46 97.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.343 -0.848 . . . . 1.3799999999999999 110.85 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.0 mt -67.02 -28.4 68.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.772 -1.205 . . . . 1.3500000000000001 109.208 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -67.34 -17.5 64.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.948 . . . . 1.95 109.97 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -82.76 -9.02 59.54 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.127 -0.983 . . . . 1.71 109.572 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mt -86.61 145.11 26.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.347 -0.846 . . . . 1.71 108.847 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.88 61.26 2.16 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.435 -0.95 . . . . 2.8300000000000001 108.435 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -149.38 120.46 7.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.783 . . . . 1.5800000000000001 109.763 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.46 -13.36 58.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 2.7999999999999998 109.196 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.61 -65.16 1.0 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.249 -0.907 . . . . 1.27 109.219 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.3 mt -64.04 -32.14 73.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 1.5800000000000001 109.324 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 127' ' ' ALA . 46.4 tttp -66.51 -53.27 36.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.041 . . . . 2.9199999999999999 109.117 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -56.1 -19.45 13.19 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.158 -1.053 . . . . 2.2000000000000002 108.158 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -73.76 -26.83 60.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.104 -1.813 . . . . 2.5299999999999998 106.104 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -57.29 -44.05 83.73 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.056 -1.09 . . . . 1.45 108.056 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.66 88.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.212 -1.033 . . . . 1.5 108.212 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -70.72 -27.59 64.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.479 -0.763 . . . . 1.3500000000000001 109.324 179.222 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.55 -44.41 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.13 -1.063 . . . . 1.23 108.13 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -52.72 -41.25 63.79 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.188 -1.042 . . . . 3.73 108.188 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -62.69 -33.81 75.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.575 -0.703 . . . . 1.3200000000000001 109.479 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.5 -36.01 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.918 -1.114 . . . . 1.2 108.966 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.51 -46.12 16.04 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.937 -1.665 . . . . 0.48999999999999999 108.937 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -55.3 -46.99 76.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.542 -0.975 . . . . 3.1099999999999999 109.538 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.476 ' HG2' HH11 ' A' ' 136' ' ' ARG . 14.4 mtt-85 -65.32 -43.99 89.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 2.9500000000000002 108.993 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.1 tp -54.36 -37.74 65.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 1.73 109.049 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.78 -58.3 7.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 1.22 109.626 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -50.56 -16.54 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.333 -0.854 . . . . 2.7799999999999998 110.195 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.453 ' ND2' HE22 ' A' ' 53' ' ' GLN . 3.0 m120 -84.65 -45.9 12.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.125 -0.984 . . . . 2.0299999999999998 109.425 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.31 -37.71 78.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.198 -0.939 . . . . 1.2 108.854 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 mt -90.67 -1.73 57.86 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 1.28 109.0 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 50.49 22.39 5.38 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.619 -1.793 . . . . 0.68999999999999995 108.619 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.56 166.04 0.34 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.665 -0.903 . . . . 1.3100000000000001 109.494 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -64.65 134.59 54.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.034 -1.041 . . . . 2.8799999999999999 108.647 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 mt -101.56 142.53 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.192 -0.942 . . . . 1.3600000000000001 108.872 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.4 mm -78.32 124.84 37.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.295 -0.878 . . . . 1.9299999999999999 110.05 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -99.18 85.9 3.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.357 -0.839 . . . . 1.54 109.368 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.0 mt -80.09 -7.77 59.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.341 -0.849 . . . . 1.3400000000000001 109.346 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.8 p -89.3 -11.45 43.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.226 -0.921 . . . . 1.98 109.927 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.71 44.56 1.01 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.168 -0.957 . . . . 1.3799999999999999 112.485 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 152' ' ' ILE . 1.5 mp -70.2 154.4 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.489 -1.382 . . . . 1.3999999999999999 107.558 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -130.74 -22.5 2.65 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.324 -0.86 . . . . 2.7400000000000002 109.714 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -122.38 137.48 54.85 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.485 -0.759 . . . . 1.4099999999999999 109.234 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -62.41 129.81 42.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 1.3 109.912 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.7 m -151.05 175.5 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.745 . . . . 1.28 109.251 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 22.9 mt -89.88 158.17 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 107.811 -1.181 . . . . 1.1499999999999999 107.811 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.1 tp -106.87 118.86 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.916 -0.772 . . . . 1.2 108.916 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.2 t -123.55 129.95 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 121.37 0.605 . . . . 1.1599999999999999 109.713 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.82 147.49 10.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 1.2 109.265 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.79 73.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.686 -1.259 . . . . 1.3200000000000001 107.983 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 66.1 t0 -173.63 145.74 1.23 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.482 -0.933 . . . . 2.3399999999999999 108.482 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.506 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.7 mt -117.74 137.47 52.68 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.155 -0.683 . . . . 1.26 109.155 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.6 p -89.36 150.04 43.9 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.353 -0.842 . . . . 1.3600000000000001 108.889 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 169' ' ' ALA . 76.6 Cg_exo -35.51 -46.54 0.82 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.393 2.062 . . . . 0.63 111.898 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 169' ' ' ALA . 38.2 m -52.86 -65.71 0.51 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.409 -0.96 . . . . 1.0700000000000001 108.409 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -44.82 -44.19 9.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.622 -0.674 . . . . 1.25 109.93 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.461 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 6.3 p -71.85 -25.4 61.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.107 -0.995 . . . . 1.1799999999999999 109.564 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 166' ' ' SER . . . -78.69 -29.71 45.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.963 . . . . 1.1399999999999999 110.165 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -100.13 -4.26 30.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.271 -0.893 . . . . 1.71 109.371 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 tp -58.18 147.45 30.16 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.276 -1.009 . . . . 1.22 108.276 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -99.02 106.65 18.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.133 -0.979 . . . . 2.5499999999999998 109.64 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -87.02 37.2 0.75 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -0.856 . . . . 1.96 109.177 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -109.34 -24.47 11.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.537 -0.727 . . . . 2.46 109.436 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -132.82 10.99 4.32 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 2.4199999999999999 110.248 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.9 t -79.28 154.45 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.928 -1.108 . . . . 1.1599999999999999 109.161 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.402 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 13.5 tp -114.9 -19.45 10.97 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.704 -0.623 . . . . 1.95 110.189 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.46 175.1 42.6 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.857 -1.297 . . . . 0.41999999999999998 109.857 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -126.77 122.3 34.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.481 -1.011 . . . . 0.52000000000000002 109.275 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.0 mt -130.33 124.39 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.501 -0.926 . . . . 1.1599999999999999 108.501 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 203' ' ' VAL . 40.6 p -142.68 151.76 41.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 1.22 111.202 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.403 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 1.6 m-20 -87.3 43.77 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 2.2400000000000002 108.996 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -109.11 123.52 49.31 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.413 -0.805 . . . . 1.6499999999999999 110.214 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 186' ' ' ARG . . . -42.96 -15.4 0.02 OUTLIER Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.459 -0.776 . . . . 2.1000000000000001 111.229 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 70.05 -8.85 3.33 Favored Glycine 0 N--CA 1.49 2.255 0 O-C-N 120.388 -1.654 . . . . 1.8400000000000001 109.89 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.531 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.8 OUTLIER -46.92 -35.24 6.24 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -1.135 . . . . 5.7800000000000002 109.177 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 76.2 p -152.68 31.57 0.51 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.694 -0.629 . . . . 3.2400000000000002 109.31 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.2 t -83.84 135.45 34.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.124 -0.985 . . . . 2.1099999999999999 109.56 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.461 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 27.9 t60 -70.06 -29.0 65.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 1.0600000000000001 108.683 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.3 p -55.54 -41.86 73.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.391 -0.818 . . . . 2.0899999999999999 109.42 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.2 t -62.48 -31.43 72.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 1.8799999999999999 109.557 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 192' ' ' ILE . 42.0 mm -68.33 -34.77 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.186 -0.946 . . . . 2.0099999999999998 110.143 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.3 mtm -71.41 -54.1 11.81 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.692 -1.225 . . . . 1.27 107.692 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.86 -44.19 70.17 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.392 -0.596 . . . . 1.1799999999999999 109.392 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -66.35 -46.63 76.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.15 -0.969 . . . . 3.5800000000000001 109.498 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.2 m -70.0 -37.13 75.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 1.1399999999999999 110.116 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.519 ' C ' ' H ' ' A' ' 199' ' ' LEU . 26.1 mt -86.61 -0.17 55.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.042 -1.036 . . . . 1.28 109.483 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 51.05 5.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.268 -0.895 . . . . 1.49 110.79 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.519 ' H ' ' C ' ' A' ' 197' ' ' LEU . 66.7 mt -66.76 139.68 95.92 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.747 -1.221 . . . . 1.28 108.65 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.08 131.64 44.65 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.711 1.607 . . . . 0.69999999999999996 111.508 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.52 -179.21 6.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.706 -1.246 . . . . 1.1899999999999999 110.787 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.7 mt -150.45 158.71 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.166 -1.42 . . . . 1.25 107.166 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.1 m -142.84 -25.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 120.771 -1.206 . . . . 1.29 110.703 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.44 27.99 5.48 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.934 -1.266 . . . . 0.92000000000000004 109.934 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 207' ' ' SER . 2.9 p -57.02 -37.27 71.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.678 -1.483 . . . . 1.3100000000000001 108.122 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 60.02 -35.68 0.04 OUTLIER Glycine 0 N--CA 1.492 2.402 0 C-N-CA 121.031 -0.604 . . . . 1.0 113.664 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 205' ' ' THR . 7.0 m -128.88 16.55 6.29 Favored 'General case' 0 N--CA 1.513 2.718 0 CA-C-N 119.749 1.774 . . . . 1.9199999999999999 113.209 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.17 -34.76 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.072 -1.643 . . . . 1.27 110.224 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.2 p -71.53 -21.26 61.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.827 -1.171 . . . . 1.3400000000000001 109.974 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.9 m -104.54 17.17 24.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.415 -0.803 . . . . 2.0699999999999998 109.137 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -139.32 -17.87 1.01 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.364 -0.835 . . . . 2.8599999999999999 110.835 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 55.1 t -119.82 162.47 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.255 -0.903 . . . . 1.3 109.691 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.462 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 13.5 mmtp -126.54 -176.83 3.79 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.165 -1.42 . . . . 2.48 107.165 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.466 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 10.8 p30 -77.01 149.57 35.87 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.74 -1.225 . . . . 2.6200000000000001 110.357 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.7 t70 81.03 -12.89 0.97 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.151 -0.343 . . . . 2.3999999999999999 110.667 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -57.76 140.68 50.98 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.794 -1.192 . . . . 1.99 108.358 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -90.66 109.97 21.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.939 -1.101 . . . . 1.54 108.91 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 7.3 mt -113.11 161.37 17.19 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.193 -0.669 . . . . 1.25 109.193 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 67.5 mt -133.39 120.1 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.617 -1.253 . . . . 1.26 107.617 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.78 127.65 35.32 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.022 -0.732 . . . . 1.1799999999999999 109.022 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 19.5 p-10 -98.01 -30.24 12.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.267 -0.895 . . . . 2.2200000000000002 109.034 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.537 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.76 24.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.387 0.613 . . . . 1.2 110.349 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.7 t -118.04 -59.0 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 106.695 -1.594 . . . . 1.48 106.695 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -94.35 13.17 24.48 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.51 -1.292 . . . . 2.8199999999999998 107.51 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 55.53 62.11 2.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.154 -0.684 . . . . 2.1099999999999999 109.154 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.446 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 53.7 tt0 -155.62 145.82 21.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.14 -0.975 . . . . 2.6499999999999999 110.769 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 76.6 t -106.52 159.98 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.074 -0.713 . . . . 1.29 109.074 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -124.88 114.53 19.31 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.52 -0.919 . . . . 1.4199999999999999 108.52 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.1 123.8 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 1.26 109.942 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.4 t30 69.73 67.84 0.43 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.564 -0.71 . . . . 2.1499999999999999 109.697 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -88.73 134.8 2.8 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 123.355 2.704 . . . . 0.81999999999999995 112.267 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 38.5 p -73.51 156.95 37.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 2.1099999999999999 109.393 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -65.69 -30.84 71.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 3.1699999999999999 109.375 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -56.86 -43.2 80.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.564 -0.71 . . . . 3.0600000000000001 109.724 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.4 t -72.93 -49.31 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 1.6499999999999999 109.608 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 236' ' ' ILE . 84.7 mt -50.57 -59.65 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.287 -0.883 . . . . 1.47 109.381 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -55.46 -36.23 66.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 2.54 110.284 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -64.76 -51.42 62.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 3.0 110.747 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 243' ' ' GLN . 9.1 mtm -79.49 -27.16 41.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.954 -1.091 . . . . 1.6299999999999999 110.339 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.421 HH11 ' HG3' ' A' ' 240' ' ' ARG . 9.9 mmm-85 -53.2 -41.56 65.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.811 -1.181 . . . . 3.1600000000000001 108.785 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.1 -52.44 10.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 2.0899999999999999 110.025 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.3 t -69.81 -51.06 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 2.5699999999999998 110.496 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 239' ' ' MET . 1.5 tm0? -55.56 -53.2 59.4 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.841 -1.162 . . . . 3.5899999999999999 110.321 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.418 ' OE1' ' O ' ' A' ' 240' ' ' ARG . 52.9 mt-10 -60.32 -20.89 61.05 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.981 -1.075 . . . . 1.76 109.397 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -65.45 -26.81 68.12 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.871 -1.529 . . . . 3.21 106.871 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.09 -43.42 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.686 -0.857 . . . . 2.3500000000000001 108.686 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.59 -36.29 80.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.577 -0.702 . . . . 2.3999999999999999 109.628 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -73.78 -33.31 64.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 3.0299999999999998 109.002 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 . . . . . 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 3.4100000000000001 108.85 179.375 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' H3 ' ' NE2' ' A' ' 226' ' ' GLN . 12.6 mmt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.315 -0.624 . . . . 4.0700000000000003 109.315 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.54 94.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 1.5 109.537 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 m -93.96 118.06 30.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.292 -0.88 . . . . 1.8 109.69 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' N ' HD22 ' A' ' 225' ' ' ASN . . . -113.49 -161.12 14.3 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 108.934 -1.666 . . . . 0.92000000000000004 108.934 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' LEU . 79.5 mt -92.89 -9.79 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.044 -1.268 . . . . 1.5 109.218 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.9 tp 57.54 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.971 . . . . 1.3999999999999999 109.469 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.05 -55.66 3.73 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.208 -1.034 . . . . 1.26 108.208 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.82 148.11 34.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 108.694 -0.854 . . . . 1.95 108.694 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.03 150.36 29.64 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.357 2.038 . . . . 0.93999999999999995 113.337 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 152.02 124.48 1.1 Allowed Glycine 0 N--CA 1.499 2.881 0 N-CA-C 110.17 -1.172 . . . . 0.78000000000000003 110.17 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.19 135.03 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.094 -1.239 . . . . 1.29 110.066 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.5 145.52 35.29 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.397 -0.814 . . . . 1.1499999999999999 110.224 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.8 m-85 -112.7 142.16 45.64 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.837 -1.172 . . . . 0.71999999999999997 107.837 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.22 164.8 30.44 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.424 -1.846 . . . . 0.5 111.732 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -79.33 146.76 32.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.594 -0.945 . . . . 2.3599999999999999 110.338 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.41 120.69 24.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 1.1599999999999999 110.613 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 tp -102.07 91.38 4.3 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.589 -1.263 . . . . 1.24 107.589 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.99 136.81 35.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.116 -0.99 . . . . 1.3100000000000001 110.166 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 mt -94.91 93.4 7.41 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.466 0.651 . . . . 1.3100000000000001 110.617 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -96.83 152.01 19.11 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.533 -0.914 . . . . 2.3500000000000001 108.533 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.88 145.05 51.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.196 -0.94 . . . . 2.5800000000000001 109.587 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.59 134.27 35.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 2.1400000000000001 109.407 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.57 136.45 55.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 1.9299999999999999 109.382 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.5 mt -92.99 135.67 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 1.28 109.457 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.9 t -102.38 119.12 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.336 -0.853 . . . . 1.3700000000000001 108.801 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.7 mt -88.74 137.92 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.809 . . . . 1.3300000000000001 110.115 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -91.23 115.67 28.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.356 -0.84 . . . . 1.3700000000000001 109.429 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 28' ' ' ARG . 14.2 mmm-85 -97.91 27.7 4.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.22 -0.925 . . . . 3.1899999999999999 109.259 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -82.87 147.85 28.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 2.8100000000000001 109.851 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -86.74 136.68 32.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.203 -0.935 . . . . 2.8300000000000001 108.747 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.9 pt -95.84 177.46 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.012 -1.055 . . . . 1.3400000000000001 110.303 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 34' ' ' ASP . 98.8 p -98.97 154.68 17.89 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.66 -0.867 . . . . 1.3500000000000001 108.66 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.11 -8.45 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.064 -1.022 . . . . 1.6100000000000001 109.984 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 32' ' ' SER . 9.6 t70 -82.86 -14.61 53.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 2.4700000000000002 110.078 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -112.86 -2.99 14.22 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.32 -0.862 . . . . 2.0699999999999998 109.688 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.67 -45.09 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.974 -1.079 . . . . 1.3300000000000001 108.728 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -56.66 -35.12 68.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 1.46 109.121 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -69.1 -36.53 77.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 2.9399999999999999 110.212 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -62.63 -45.43 92.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 1.3 109.485 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.31 -46.24 97.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.438 -0.789 . . . . 1.3300000000000001 109.732 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.82 -42.33 81.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 1.5 108.882 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -62.86 -31.7 72.78 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.701 -0.852 . . . . 3.1499999999999999 108.701 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -86.09 -55.79 3.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.92000000000000004 108.692 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.7 tp -51.81 -56.54 13.34 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.135 -1.061 . . . . 1.4099999999999999 108.135 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 t -66.46 -35.94 81.53 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.826 -1.175 . . . . 1.22 107.826 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -55.85 -54.76 32.88 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 107.609 -2.196 . . . . 0.58999999999999997 107.609 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -47.66 -30.82 4.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.407 -1.054 . . . . 3.3900000000000001 108.763 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.26 -32.97 70.48 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.498 -1.297 . . . . 1.26 107.498 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 46' ' ' GLY . 95.7 mttt -81.23 -62.86 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.64 -0.874 . . . . 2.9900000000000002 108.64 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.4 -40.56 26.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.899 . . . . 1.1399999999999999 109.598 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.4 p -62.35 -35.01 77.8 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.745 -1.205 . . . . 1.8400000000000001 107.745 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.82 -21.28 60.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.589 -0.523 . . . . 1.22 109.589 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -76.51 -67.34 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 2.0 109.488 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.59 -39.92 51.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.117 -0.989 . . . . 1.99 108.436 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.99 -48.12 83.02 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.948 -0.76 . . . . 1.27 108.948 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 52' ' ' ALA . 27.0 m -63.06 -38.86 92.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 1.24 108.898 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.36 -37.56 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.921 . . . . 1.21 108.546 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -51.06 -45.82 61.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.624 -0.673 . . . . 1.53 109.715 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -75.19 -23.99 57.74 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.148 -0.97 . . . . 1.24 110.427 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.445 ' O ' ' OG1' ' A' ' 64' ' ' THR . 21.5 mtpp -72.31 -32.63 66.74 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.779 -1.201 . . . . 2.3199999999999998 108.385 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.11 -26.62 42.9 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.507 -0.745 . . . . 1.1699999999999999 109.241 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.27 14.35 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.707 -1.235 . . . . 0.57999999999999996 110.509 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -86.22 -14.9 42.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.827 -1.396 . . . . 1.3899999999999999 109.204 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 68.4 m -96.18 -49.0 5.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.269 -0.894 . . . . 1.3600000000000001 110.654 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -106.37 -18.19 14.06 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.148 -0.97 . . . . 1.1399999999999999 110.38 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.86 143.86 6.85 Favored Glycine 0 N--CA 1.502 3.086 0 N-CA-C 109.686 -1.365 . . . . 0.59999999999999998 109.686 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -49.73 -7.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.469 -1.018 . . . . 2.5899999999999999 110.826 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 66' ' ' GLY . 52.9 tt0 -65.78 -27.89 68.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.872 -1.143 . . . . 2.2000000000000002 111.0 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -90.12 -12.24 38.87 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.799 -1.188 . . . . 2.3599999999999999 110.413 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -62.8 -21.28 65.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.091 -1.005 . . . . 1.54 110.709 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.92 70.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.851 -1.156 . . . . 1.24 110.081 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.2 mt -72.52 -43.81 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.076 -1.015 . . . . 1.24 109.636 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -77.05 -26.47 53.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.851 . . . . 0.80000000000000004 110.325 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.08 -44.19 93.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.903 -1.123 . . . . 1.23 109.262 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.39 -35.84 88.01 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.915 -1.674 . . . . 0.56000000000000005 108.915 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -19.08 63.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.413 -1.051 . . . . 2.0600000000000001 110.215 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.427 HD11 HG22 ' A' ' 77' ' ' ILE . 83.5 mt -83.84 -37.06 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.711 -1.243 . . . . 1.24 108.589 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.4 ttt -58.9 -53.35 59.38 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.769 -0.826 . . . . 2.4500000000000002 108.769 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -52.01 -41.52 62.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.44 -0.788 . . . . 1.21 108.905 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.8 tp -68.65 -44.32 74.39 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 1.1200000000000001 109.675 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -85.92 8.85 18.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.261 -0.899 . . . . 1.24 110.476 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -48.59 121.17 4.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.852 -1.155 . . . . 1.3100000000000001 109.328 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.74 -25.69 66.63 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.286 -0.884 . . . . 1.3500000000000001 108.808 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -76.99 -48.9 16.71 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.324 -0.86 . . . . 2.1600000000000001 109.625 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.64 -16.69 63.16 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.575 -1.25 . . . . 1.24 108.657 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.8 -50.16 18.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.4 -0.812 . . . . 1.28 109.591 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.57 -29.31 70.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 1.79 109.134 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -74.07 -48.15 31.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 1.29 109.104 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 89' ' ' ILE . 59.2 mt -57.31 -43.41 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.379 -0.971 . . . . 1.1399999999999999 108.379 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 90' ' ' ILE . 82.6 mt -62.11 -61.65 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 1.3200000000000001 110.195 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -45.23 -51.19 11.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 1.3700000000000001 110.275 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 49.9 mt -54.1 -55.0 31.75 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.452 -0.899 . . . . 1.3999999999999999 108.941 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.3 mt -51.02 -47.22 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.965 . . . . 1.23 110.377 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -81.94 -33.29 30.4 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.987 -1.071 . . . . 2.5099999999999998 111.441 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.4 t70 -81.31 -45.96 15.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.769 -1.207 . . . . 1.5900000000000001 111.735 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -103.91 17.85 23.24 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.628 -1.295 . . . . 2.3799999999999999 109.866 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.6 m80 45.3 50.91 9.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.177 -0.952 . . . . 1.6200000000000001 109.469 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.6 mtt -99.73 149.01 23.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.52 -0.738 . . . . 1.8899999999999999 109.114 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.3 p -76.15 146.78 38.97 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.399 -0.813 . . . . 1.27 109.21 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.67 -29.1 10.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 1.1599999999999999 108.702 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.37 -44.62 51.45 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.286 -1.005 . . . . 2.0 108.286 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.42 -54.45 12.34 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.313 0.577 . . . . 1.25 110.074 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.29 -50.47 72.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 1.1299999999999999 109.365 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.08 -37.35 69.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 1.0800000000000001 109.73 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -69.59 -35.07 75.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.046 -1.034 . . . . 2.02 109.491 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 109' ' ' GLU . 33.4 tt0 -62.28 -58.35 8.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 1.26 109.612 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.3 t -50.28 -47.11 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.977 -1.077 . . . . 1.1799999999999999 109.221 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.3 mm -65.13 -15.65 18.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.376 -0.828 . . . . 1.1899999999999999 109.007 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 106' ' ' GLU . 24.7 tt0 -75.28 -37.0 61.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 2.2000000000000002 109.706 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.56 -26.5 29.85 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.491 -1.338 . . . . 0.85999999999999999 112.174 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -67.58 -37.91 83.27 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.614 -1.521 . . . . 2.0 108.952 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.34 -51.36 7.03 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.671 -0.643 . . . . 1.3200000000000001 109.581 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.0 p -60.47 -42.79 96.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.317 -0.865 . . . . 2.1400000000000001 110.141 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.0 -38.41 90.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.976 -1.078 . . . . 1.3799999999999999 110.339 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.2 mt -67.72 -26.86 66.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.852 -1.155 . . . . 1.3500000000000001 109.438 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -69.48 -20.45 63.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.035 -1.04 . . . . 1.95 109.607 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -81.36 -6.85 59.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 1.71 109.183 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 mt -85.7 143.18 28.51 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.244 -1.021 . . . . 1.71 108.244 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -96.66 62.04 1.94 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.271 -0.893 . . . . 2.8300000000000001 109.024 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -148.96 115.22 5.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.221 -0.924 . . . . 1.5800000000000001 109.621 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.82 -13.08 3.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 2.7999999999999998 109.433 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.504 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 1.0 OUTLIER -79.92 -63.79 1.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 1.27 109.375 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.6 mt -68.09 -30.81 70.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.215 -0.928 . . . . 1.5800000000000001 109.444 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 127' ' ' ALA . 68.5 tttt -67.01 -51.64 52.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.956 . . . . 2.9199999999999999 109.337 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -57.86 -23.11 51.48 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.195 -0.94 . . . . 2.2000000000000002 108.995 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.504 ' NH2' ' OH ' ' A' ' 122' ' ' TYR . 18.6 ttm180 -73.41 -24.71 60.31 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.408 -1.701 . . . . 2.5299999999999998 106.408 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.08 -42.86 91.42 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.629 -0.878 . . . . 1.45 108.629 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.71 80.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.436 -0.79 . . . . 1.5 109.876 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.13 -25.32 65.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 1.3500000000000001 109.529 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.2 t -76.61 -42.62 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.163 -0.961 . . . . 1.23 108.444 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.419 HH11 ' HG3' ' A' ' 131' ' ' ARG . 16.6 ttm-85 -57.0 -37.69 72.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.223 -0.923 . . . . 3.73 108.68 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -61.06 -38.37 85.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.508 -0.745 . . . . 1.3200000000000001 110.319 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.8 mt -67.97 -26.83 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.018 -1.051 . . . . 1.2 109.975 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.5 -44.08 8.87 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.632 -1.387 . . . . 0.48999999999999999 109.632 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -50.92 -51.68 49.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.371 -1.076 . . . . 3.1099999999999999 109.642 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.532 ' CG ' HH11 ' A' ' 136' ' ' ARG . 4.5 mtt-85 -63.9 -46.21 85.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.109 -0.994 . . . . 2.9500000000000002 108.361 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.9 tp -49.83 -38.38 34.66 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.054 -0.721 . . . . 1.73 109.054 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.8 mt -70.5 -55.01 9.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 1.22 109.495 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -53.49 -17.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 2.7799999999999998 110.293 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 140' ' ' ASN . 2.4 m120 -85.02 -47.4 10.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.992 -1.067 . . . . 2.0299999999999998 109.204 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.27 -37.88 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.899 . . . . 1.2 109.118 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.83 -3.11 58.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 1.28 108.693 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.32 22.62 15.53 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.303 -1.919 . . . . 0.68999999999999995 108.303 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.6 tp -55.58 154.3 6.78 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.625 -0.927 . . . . 1.3100000000000001 109.297 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -66.76 147.55 53.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 2.8799999999999999 109.683 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.8 mt -109.05 145.79 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.517 -0.739 . . . . 1.3600000000000001 109.349 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 147' ' ' ILE . 11.7 mm -76.34 119.46 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 1.9299999999999999 108.625 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.7 OUTLIER -94.79 87.03 4.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.255 -0.903 . . . . 1.54 109.918 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.9 mt -81.6 -10.33 59.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 1.3400000000000001 109.14 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.1 p -80.65 -12.18 59.53 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.273 -0.892 . . . . 1.98 109.461 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -103.56 49.95 0.82 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.473 -0.767 . . . . 1.3799999999999999 110.53 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.8 mm -71.2 164.12 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.812 -1.18 . . . . 1.3999999999999999 108.71 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -132.88 -33.1 1.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.351 -0.843 . . . . 2.7400000000000002 109.768 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -115.0 145.52 42.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.5 -0.75 . . . . 1.4099999999999999 109.614 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -66.95 126.66 29.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.415 -0.803 . . . . 1.3 109.232 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.4 m -148.97 172.38 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.154 -0.966 . . . . 1.28 109.668 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 53.5 mt -90.66 163.59 2.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.609 -1.256 . . . . 1.1499999999999999 107.609 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.7 tp -111.89 123.83 51.09 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.589 -0.694 . . . . 1.2 109.404 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.8 t -123.46 129.7 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.148 -0.686 . . . . 1.1599999999999999 109.148 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.29 146.14 11.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 1.2 109.671 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.94 -27.25 66.63 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.601 -1.312 . . . . 1.3200000000000001 107.468 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -175.47 157.94 2.2 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.64 -0.663 . . . . 2.3399999999999999 109.215 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 22.6 mt -129.88 131.03 45.92 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.439 -0.788 . . . . 1.26 109.321 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 p -94.59 153.28 40.28 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.285 -0.884 . . . . 1.3600000000000001 109.409 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -35.68 -41.78 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.541 2.16 . . . . 0.63 112.354 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.9 m -62.2 -56.29 20.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.162 -0.961 . . . . 1.0700000000000001 109.112 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -53.73 -31.19 47.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 1.25 109.526 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 28.3 p -82.49 -31.54 29.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 1.1799999999999999 109.539 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.82 -23.92 58.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 1.1399999999999999 109.966 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -105.26 -6.0 20.11 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.145 -0.972 . . . . 1.71 109.414 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.08 156.0 5.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.226 -1.027 . . . . 1.22 108.226 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 174' ' ' LYS . 52.2 t-20 -97.9 97.19 8.74 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.136 -0.978 . . . . 2.5499999999999998 109.564 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.544 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.6 mm? -82.05 26.23 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 1.96 109.193 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 172' ' ' ASN . 77.2 mttt -112.44 -18.13 12.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.421 -0.799 . . . . 2.46 109.103 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -131.26 -1.32 4.01 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.47 -0.769 . . . . 2.4199999999999999 110.133 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 39.3 t -78.95 151.54 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.874 -1.141 . . . . 1.1599999999999999 109.543 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.3 tp -121.33 -9.01 9.12 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.8 -0.562 . . . . 1.95 110.269 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.44 176.5 41.22 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.561 -1.304 . . . . 0.41999999999999998 110.069 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.82 130.35 35.94 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.517 -0.99 . . . . 0.52000000000000002 110.086 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.1 mt -129.56 120.05 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.01 -1.107 . . . . 1.1599999999999999 108.01 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 203' ' ' VAL . 64.1 p -141.67 152.45 43.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.213 -0.929 . . . . 1.22 110.868 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 21.4 p30 -89.45 43.83 1.17 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.088 -1.008 . . . . 2.2400000000000002 110.715 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -94.5 103.63 15.59 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.878 -1.139 . . . . 1.6499999999999999 108.799 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.19 43.06 2.43 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.843 -1.17 . . . . 2.1000000000000001 110.414 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -108.39 109.21 2.82 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.805 -1.318 . . . . 1.8400000000000001 109.805 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -52.19 -23.8 6.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.105 -1.232 . . . . 5.7800000000000002 108.169 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.2 p -116.52 45.16 1.86 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.748 -0.834 . . . . 3.2400000000000002 108.748 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 40.7 p -81.23 142.25 33.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 2.1099999999999999 109.31 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -47.56 -53.06 15.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 1.0600000000000001 109.671 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -44.15 21.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 2.0899999999999999 109.987 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 38.6 t -59.71 -37.43 78.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.01 . . . . 1.8799999999999999 110.34 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 31.4 mm -60.43 -34.36 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.098 -1.001 . . . . 2.0099999999999998 110.397 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.2 mtp -71.67 -52.05 19.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.902 -1.124 . . . . 1.27 108.288 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.19 -30.99 51.67 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.722 -0.672 . . . . 1.1799999999999999 110.277 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -81.26 -47.76 12.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.066 -1.021 . . . . 3.5800000000000001 110.416 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.9 m -67.57 -37.1 82.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.933 -1.104 . . . . 1.1399999999999999 110.112 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 199' ' ' LEU . 15.9 mt -86.18 -0.13 54.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.981 -1.074 . . . . 1.28 109.105 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 56.81 0.37 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.396 -0.815 . . . . 1.49 112.015 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.1 mt -67.42 170.77 6.03 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.472 -1.393 . . . . 1.28 108.897 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -90.97 142.78 3.2 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.513 2.142 . . . . 0.69999999999999996 111.199 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.1 -178.19 5.88 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.562 -1.337 . . . . 1.1899999999999999 110.857 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.9 mt -149.69 158.48 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.962 -1.496 . . . . 1.25 106.962 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.525 ' O ' ' O ' ' A' ' 181' ' ' THR . 19.5 m -137.93 -32.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.989 -1.069 . . . . 1.29 111.434 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.34 42.54 3.16 Favored Glycine 0 N--CA 1.496 2.653 0 O-C-N 120.579 -1.326 . . . . 0.92000000000000004 110.727 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.8 p -71.39 -21.15 62.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.602 -1.528 . . . . 1.3100000000000001 109.297 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.452 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 71.75 -97.43 0.72 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.843 -1.17 . . . . 1.0 111.814 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 66.7 m -115.42 45.86 1.59 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.969 -1.312 . . . . 1.9199999999999999 112.743 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 17.7 t -79.93 -27.19 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.601 -1.312 . . . . 1.27 107.636 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.4 p -73.67 -11.21 60.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 1.3400000000000001 109.7 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 13.8 p -101.53 6.4 42.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.36 -0.837 . . . . 2.0699999999999998 109.405 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -130.47 -3.58 4.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.399 -0.813 . . . . 2.8599999999999999 109.203 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.0 t -125.81 152.59 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.055 -0.72 . . . . 1.3 109.055 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -118.68 -173.79 2.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.852 -1.536 . . . . 2.48 106.852 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 22.7 t-20 -80.03 145.42 32.51 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.818 -1.176 . . . . 2.6200000000000001 111.202 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.46 -7.4 1.46 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.839 -0.538 . . . . 2.3999999999999999 110.843 178.531 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.29 138.05 55.28 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.875 -1.141 . . . . 1.99 108.446 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -86.38 115.98 24.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.038 -1.039 . . . . 1.54 108.655 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.6 mt -117.99 179.1 4.19 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.374 1.083 . . . . 1.25 110.806 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.8 mt -146.93 107.92 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.387 -1.338 . . . . 1.26 107.387 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 tp -83.21 128.4 34.46 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.32 -0.993 . . . . 1.1799999999999999 108.32 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -52.6 4.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 2.2200000000000002 109.82 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.433 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 57.54 22.74 8.44 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.339 -0.85 . . . . 1.2 108.77 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.06 -49.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 107.295 -1.372 . . . . 1.48 107.295 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -106.95 12.14 29.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.936 -1.135 . . . . 2.8199999999999998 107.936 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 4' ' ' GLY . 59.0 t30 58.35 58.21 3.54 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.056 -0.72 . . . . 2.1099999999999999 109.056 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.43 ' NE2' ' H3 ' ' A' ' 1' ' ' MET . 17.4 tt0 -153.75 146.99 24.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.926 . . . . 2.6499999999999999 109.918 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.63 136.62 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.67 -0.644 . . . . 1.29 109.386 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -105.03 127.38 52.84 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.384 -0.822 . . . . 1.4199999999999999 109.2 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.58 127.89 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.516 -0.74 . . . . 1.26 109.864 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 49.05 69.96 2.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.857 . . . . 2.1499999999999999 109.989 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.5 153.44 13.73 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.78 2.32 . . . . 0.81999999999999995 111.64 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.5 p -73.93 169.59 17.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.979 . . . . 2.1099999999999999 109.98 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.53 -27.76 65.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.852 . . . . 3.1699999999999999 109.579 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.13 -38.65 91.33 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.418 -0.801 . . . . 3.0600000000000001 109.537 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.09 -46.31 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 1.6499999999999999 109.341 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.7 mt -52.05 -55.84 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 1.47 109.356 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -54.91 -44.83 74.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 2.54 109.972 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -67.54 -37.75 83.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 3.0 110.144 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 51.9 mtp -80.16 -25.92 39.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 1.6299999999999999 109.706 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.442 ' CA ' ' HE ' ' A' ' 240' ' ' ARG . 0.0 OUTLIER -60.16 -51.86 67.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.179 -0.951 . . . . 3.1600000000000001 109.853 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.71 -54.94 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 2.0899999999999999 109.771 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 84.5 t -49.03 -53.02 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 2.5699999999999998 109.511 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -55.29 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.249 -0.907 . . . . 3.5899999999999999 109.981 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -63.21 -35.62 80.92 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.122 -0.986 . . . . 1.76 110.499 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -68.91 -20.15 64.23 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.968 -1.082 . . . . 3.21 108.408 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.5 t -83.5 -31.44 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.679 -0.86 . . . . 2.3500000000000001 108.679 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.8 -36.16 77.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.441 -0.787 . . . . 2.3999999999999999 109.17 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.6 t -78.31 -29.37 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.335 -0.853 . . . . 3.0299999999999998 109.314 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.306 -0.871 . . . . 3.4100000000000001 109.555 -179.827 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.451 -0.574 . . . . 4.0700000000000003 109.451 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 74.3 mt -60.67 98.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.872 . . . . 1.5 109.475 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.0 m -93.37 114.67 27.15 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 1.8 109.619 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.72 -163.15 19.53 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.784 -1.726 . . . . 0.92000000000000004 108.784 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.4 mt -96.48 -9.46 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.039 -1.271 . . . . 1.5 108.789 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.2 tp 59.42 110.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.416 -0.803 . . . . 1.3999999999999999 109.151 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.77 -49.66 6.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.081 -1.081 . . . . 1.26 108.081 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -150.43 152.15 32.41 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.371 -0.83 . . . . 1.95 109.383 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.08 155.89 29.92 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.585 2.19 . . . . 0.93999999999999995 112.504 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 144.26 121.84 1.55 Allowed Glycine 0 N--CA 1.504 3.169 0 N-CA-C 110.232 -1.147 . . . . 0.78000000000000003 110.232 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.49 139.48 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.094 -1.239 . . . . 1.29 110.22 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.61 159.86 41.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.324 -0.86 . . . . 1.1499999999999999 109.68 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.595 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -130.39 135.79 48.4 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.107 -1.072 . . . . 0.71999999999999997 108.107 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 166.6 37.14 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 118.601 -1.762 . . . . 0.5 111.723 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -79.61 149.78 31.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.739 -0.859 . . . . 2.3599999999999999 110.392 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -76.37 125.02 28.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.39 -0.819 . . . . 1.1599999999999999 110.992 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.1 tp -110.79 93.15 4.34 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.174 -1.417 . . . . 1.24 107.174 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -81.79 126.83 32.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.04 -1.037 . . . . 1.3100000000000001 110.996 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.3 mt -101.94 94.44 5.79 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.609 -0.723 . . . . 1.3100000000000001 110.316 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -94.62 158.54 15.48 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.358 -0.979 . . . . 2.3500000000000001 108.358 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -130.18 125.4 34.89 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.384 -0.823 . . . . 2.5800000000000001 109.506 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 6.5 p-10 -80.27 130.2 35.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.32 -0.862 . . . . 2.1400000000000001 109.008 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.64 148.87 50.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 1.9299999999999999 109.235 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.5 136.73 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 1.28 109.145 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -103.11 121.05 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.369 -0.832 . . . . 1.3700000000000001 109.047 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.7 mt -87.14 132.98 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.386 -0.821 . . . . 1.3300000000000001 109.729 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -91.5 122.46 34.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 1.3700000000000001 108.724 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.486 ' HG2' HH11 ' A' ' 28' ' ' ARG . 0.4 OUTLIER -98.36 27.41 4.73 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.241 -0.912 . . . . 3.1899999999999999 109.887 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -81.01 143.33 32.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 2.8100000000000001 109.277 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -86.37 126.27 34.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.146 -0.971 . . . . 2.8300000000000001 109.416 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 pt -85.24 176.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 1.3400000000000001 109.6 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.9 p -95.58 173.96 7.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.79 . . . . 1.3500000000000001 109.478 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.29 -25.89 63.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 1.6100000000000001 109.551 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 3.3 m-20 -79.97 2.57 23.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 2.4700000000000002 108.617 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -116.75 -17.02 10.6 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.507 -0.924 . . . . 2.0699999999999998 108.507 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.9 t -66.61 -46.45 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.46 -0.775 . . . . 1.3300000000000001 109.382 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.2 -35.65 67.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.887 . . . . 1.46 109.626 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -69.07 -33.5 73.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.389 -0.819 . . . . 2.9399999999999999 110.267 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.2 -37.9 89.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.959 -1.088 . . . . 1.3 109.362 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.9 -47.31 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.359 -0.838 . . . . 1.3300000000000001 110.058 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.31 -41.29 85.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.136 -0.977 . . . . 1.5 109.086 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -60.44 -34.27 73.73 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.244 -0.91 . . . . 3.1499999999999999 109.092 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 28.1 t80 -86.83 -55.3 3.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.138 -0.976 . . . . 0.92000000000000004 109.407 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.39 -63.8 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 1.4099999999999999 110.081 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 t -66.48 -37.91 86.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 1.22 108.856 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.95 -52.63 47.7 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.672 -2.171 . . . . 0.58999999999999997 107.672 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -53.7 -22.55 9.31 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.648 -0.913 . . . . 3.3900000000000001 109.431 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.08 90.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.101 -0.999 . . . . 1.26 108.648 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' HG3' ' H ' ' A' ' 50' ' ' ALA . 28.7 pttt -78.41 -51.84 9.45 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.352 -0.939 . . . . 2.9900000000000002 109.296 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' H ' ' HG3' ' A' ' 49' ' ' LYS . . . -50.76 -41.1 56.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.561 -1.337 . . . . 1.1399999999999999 109.325 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t -62.43 -33.56 75.05 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.613 -1.254 . . . . 1.8400000000000001 107.613 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.88 -28.31 62.42 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.037 -0.727 . . . . 1.22 109.037 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -73.6 -62.97 1.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.372 -0.83 . . . . 2.0 109.093 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -49.71 -38.04 31.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.995 -1.066 . . . . 1.99 108.297 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.35 -41.64 98.87 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.326 -0.991 . . . . 1.27 108.326 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 m -62.97 -39.28 94.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.455 -0.778 . . . . 1.24 109.007 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.08 -39.6 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.574 -0.899 . . . . 1.21 108.574 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -49.2 -42.04 38.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.785 . . . . 1.53 109.571 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -71.27 -38.76 71.84 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.066 -1.022 . . . . 1.24 109.796 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' O ' ' OG1' ' A' ' 64' ' ' THR . 56.2 mttm -69.88 -14.9 62.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.866 -1.134 . . . . 2.3199999999999998 107.999 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.91 -36.03 21.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.51 -0.922 . . . . 1.1699999999999999 108.51 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.08 -27.86 29.95 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.199 -1.16 . . . . 0.57999999999999996 110.199 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -85.86 -15.59 41.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.008 -1.29 . . . . 1.3899999999999999 109.38 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 99.7 m -94.49 -48.22 6.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.176 -0.952 . . . . 1.3600000000000001 110.325 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -106.37 -17.54 14.25 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.164 -0.96 . . . . 1.1399999999999999 110.537 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.93 143.84 6.83 Favored Glycine 0 N--CA 1.502 3.042 0 N-CA-C 109.706 -1.357 . . . . 0.59999999999999998 109.706 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -51.26 -8.6 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -1.058 . . . . 2.5899999999999999 110.572 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 66' ' ' GLY . 97.7 mt-10 -65.69 -24.17 66.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.955 -1.091 . . . . 2.2000000000000002 110.474 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -91.45 -13.75 31.73 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.926 -1.109 . . . . 2.3599999999999999 110.739 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -62.92 -18.71 63.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.92 -1.113 . . . . 1.54 110.815 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.12 -37.16 85.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.913 -1.117 . . . . 1.24 110.04 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.446 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 27.3 mt -73.14 -38.79 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.965 . . . . 1.24 109.91 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -78.41 -22.34 47.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.80000000000000004 109.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -64.48 -48.27 75.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.201 -0.937 . . . . 1.23 109.111 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.07 -32.01 76.03 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.425 -1.47 . . . . 0.56000000000000005 109.425 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.446 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 32.5 m170 -61.69 -23.31 66.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -1.15 . . . . 2.0600000000000001 110.004 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.1 mt -85.28 -39.02 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.901 -1.125 . . . . 1.24 108.825 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.4 ttt -59.04 -46.7 87.57 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.578 -0.897 . . . . 2.4500000000000002 108.578 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tp -58.71 -40.03 82.5 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.545 -0.722 . . . . 1.21 109.062 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -67.03 -45.92 76.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.271 -0.893 . . . . 1.1200000000000001 109.395 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -84.57 9.04 14.68 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.874 . . . . 1.24 110.546 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -51.83 120.98 5.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.955 -1.091 . . . . 1.3100000000000001 109.231 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.74 -21.76 65.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -0.95 . . . . 1.3500000000000001 108.947 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.35 -47.44 23.44 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.327 -0.858 . . . . 2.1600000000000001 109.185 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.06 -18.83 64.75 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.223 -0.991 . . . . 1.24 108.93 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -81.79 -41.32 21.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.388 -0.82 . . . . 1.28 109.725 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -63.06 -33.32 75.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 1.79 109.469 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -74.07 -42.57 59.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 1.29 109.004 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.2 mt -59.57 -58.82 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.219 -1.03 . . . . 1.1399999999999999 108.219 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.4 mt -42.86 -64.36 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.758 -0.589 . . . . 1.3200000000000001 110.164 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.0 -49.78 15.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 1.3700000000000001 110.135 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 mt -56.4 -57.14 13.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -0.842 . . . . 1.3999999999999999 109.328 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.3 -38.39 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.071 -1.018 . . . . 1.23 110.169 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -86.53 -37.62 18.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.096 -1.002 . . . . 2.5099999999999998 112.105 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -82.1 -38.72 24.42 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.79 -1.194 . . . . 1.5900000000000001 111.691 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 97' ' ' HIS . 60.5 mmtt -105.45 14.1 29.2 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.806 -1.184 . . . . 2.3799999999999999 109.612 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 96' ' ' LYS . 77.4 m80 44.55 44.5 7.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.377 -0.827 . . . . 1.6200000000000001 109.365 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.3 mtt -95.59 153.04 17.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.472 -0.768 . . . . 1.8899999999999999 109.195 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.547 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 11.2 p -77.17 142.34 39.69 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.565 -0.71 . . . . 1.27 109.595 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.47 -26.85 2.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.401 -0.812 . . . . 1.1599999999999999 109.68 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.428 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 0.4 OUTLIER -76.0 -43.67 43.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.118 -0.989 . . . . 2.0 108.376 178.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.547 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -71.74 -55.36 7.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.731 -0.606 . . . . 1.25 110.407 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.57 -50.02 71.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.983 . . . . 1.1299999999999999 110.057 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.89 -30.8 62.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -0.937 . . . . 1.0800000000000001 109.797 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -69.98 -25.62 63.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.011 -1.056 . . . . 2.02 109.364 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -68.67 -60.7 2.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -0.922 . . . . 1.26 109.86 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -51.91 -48.16 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.929 -1.107 . . . . 1.1799999999999999 109.407 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.9 mm -63.42 -21.94 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 1.1899999999999999 109.694 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -69.26 -34.64 75.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.976 -1.078 . . . . 2.2000000000000002 109.543 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.27 -23.54 40.18 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.559 -1.305 . . . . 0.85999999999999999 112.293 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -68.3 -42.94 78.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.52 -1.576 . . . . 2.0 108.854 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.93 -49.18 14.65 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.214 -0.661 . . . . 1.3200000000000001 109.214 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.6 t -60.46 -45.89 92.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.404 -0.81 . . . . 2.1400000000000001 109.785 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.6 78.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 1.3799999999999999 110.344 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 mt -68.43 -28.85 67.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.864 -1.147 . . . . 1.3500000000000001 109.186 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -70.38 -17.6 63.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.189 -0.945 . . . . 1.95 109.404 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -80.97 -6.19 58.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 1.71 109.437 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.3 mt -84.01 142.86 30.16 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.277 -1.009 . . . . 1.71 108.277 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -94.34 57.62 2.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 2.8300000000000001 108.55 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -148.61 116.41 6.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 1.5800000000000001 109.267 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.92 -11.33 7.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 2.7999999999999998 109.725 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -78.85 -64.11 1.26 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -0.877 . . . . 1.27 109.286 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.3 mt -63.17 -23.43 67.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.009 -1.057 . . . . 1.5800000000000001 109.26 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 127' ' ' ALA . 40.6 tttm -66.78 -50.59 62.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.094 -1.004 . . . . 2.9199999999999999 108.36 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -55.1 -22.99 18.43 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.442 -0.947 . . . . 2.2000000000000002 108.442 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -72.74 -27.09 61.82 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.867 -1.531 . . . . 2.5299999999999998 106.867 177.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.53 -41.81 86.37 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.561 -0.903 . . . . 1.45 108.561 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.66 -43.8 75.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.508 -0.745 . . . . 1.5 109.83 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.74 -21.19 66.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 1.3500000000000001 109.528 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 t -78.07 -48.7 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.185 -0.947 . . . . 1.23 108.562 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -54.8 -34.99 63.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.05 -1.031 . . . . 3.73 108.587 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.57 -46.74 88.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.421 -0.799 . . . . 1.3200000000000001 110.224 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.05 -30.56 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.924 -1.11 . . . . 1.2 108.966 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.68 -48.4 7.96 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.821 -1.712 . . . . 0.48999999999999999 108.821 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -56.03 -49.82 72.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.444 -1.033 . . . . 3.1099999999999999 109.466 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.484 ' O ' ' ND2' ' A' ' 140' ' ' ASN . 9.8 mtt-85 -63.6 -49.93 71.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.231 -1.026 . . . . 2.9500000000000002 108.231 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 40.2 tp -48.0 -35.15 10.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 1.73 109.267 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.04 -48.19 58.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.157 -0.965 . . . . 1.22 109.55 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -53.99 -18.99 4.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 2.7799999999999998 110.71 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 29.4 m-80 -84.72 -38.87 19.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.868 -1.145 . . . . 2.0299999999999998 109.121 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 141' ' ' ILE . 94.9 mt -67.82 -35.29 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 1.2 109.05 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.21 -1.7 57.21 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.876 -0.787 . . . . 1.28 108.876 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.33 25.75 60.77 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.263 -1.935 . . . . 0.68999999999999995 108.263 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.35 133.79 47.28 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.533 -0.98 . . . . 1.3100000000000001 109.499 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.68 141.96 57.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 2.8799999999999999 109.028 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 92.0 mt -104.02 163.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.602 -0.888 . . . . 1.3600000000000001 108.602 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 mp -77.93 128.53 38.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.026 -1.046 . . . . 1.9299999999999999 108.984 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -97.09 84.82 3.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.327 -0.858 . . . . 1.54 109.584 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -82.57 -20.12 37.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.885 . . . . 1.3400000000000001 109.206 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -79.66 7.01 9.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.019 . . . . 1.98 109.304 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -118.82 23.39 11.46 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.556 -0.715 . . . . 1.3799999999999999 109.369 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.87 144.57 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 1.3999999999999999 109.725 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -137.63 8.14 2.82 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.91 -0.774 . . . . 2.7400000000000002 108.91 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -123.64 119.5 30.02 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.76 -0.83 . . . . 1.4099999999999999 108.76 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.67 121.05 13.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.283 -0.886 . . . . 1.3 109.488 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.2 m -150.05 177.45 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 1.28 108.952 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.2 mt -88.56 151.3 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.176 -1.046 . . . . 1.1499999999999999 108.176 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.76 117.87 35.25 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.533 0.682 . . . . 1.2 109.414 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.5 t -124.06 132.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.718 -0.845 . . . . 1.1599999999999999 108.718 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.56 153.08 14.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.803 . . . . 1.2 109.801 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.53 86.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.641 -1.287 . . . . 1.3200000000000001 107.915 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -174.42 156.88 2.58 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.463 -0.773 . . . . 2.3399999999999999 109.758 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 27.3 mt -130.84 137.7 49.51 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.538 -0.726 . . . . 1.26 109.499 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.9 p -93.72 153.57 41.1 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.227 -0.921 . . . . 1.3600000000000001 109.178 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -34.3 -46.82 0.52 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.735 2.29 . . . . 0.63 112.938 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 169' ' ' ALA . 69.1 m -50.77 -65.76 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.012 . . . . 1.0700000000000001 109.262 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -48.36 -37.4 16.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.341 -0.849 . . . . 1.25 109.737 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.606 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 12.3 p -75.87 -21.71 56.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 1.1799999999999999 109.484 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 166' ' ' SER . . . -80.81 -21.14 41.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 1.1399999999999999 110.153 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -107.14 -19.83 13.49 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.318 -0.864 . . . . 1.71 109.859 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.31 149.99 27.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 1.22 109.112 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -97.01 158.01 15.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.976 . . . . 2.5499999999999998 108.525 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 9.3 mp -96.37 -40.58 9.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.161 -0.962 . . . . 1.96 110.782 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -80.13 -13.64 59.11 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.706 -1.246 . . . . 2.46 111.603 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -94.01 -5.11 48.29 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.605 -1.309 . . . . 2.4199999999999999 108.469 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 42.9 t -102.14 155.27 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.045 -0.724 . . . . 1.1599999999999999 109.045 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.7 tp -113.75 -18.43 11.85 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.967 -0.753 . . . . 1.95 108.967 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.53 171.29 40.08 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.947 -1.661 . . . . 0.41999999999999998 108.947 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 4.2 m-85 -126.94 124.11 38.75 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.507 -0.996 . . . . 0.52000000000000002 109.623 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.2 mt -125.75 117.35 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.367 -1.346 . . . . 1.1599999999999999 107.367 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 203' ' ' VAL . 17.4 p -140.78 151.84 44.75 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.229 -0.919 . . . . 1.22 112.388 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.513 ' O ' ' CG ' ' A' ' 182' ' ' ASP . 6.7 t0 -82.03 40.78 0.63 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.517 0.675 . . . . 2.2400000000000002 109.621 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -100.65 102.41 13.54 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.29 -1.506 . . . . 1.6499999999999999 110.9 -178.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -40.73 -20.0 0.03 OUTLIER Glycine 0 N--CA 1.498 2.772 0 O-C-N 121.208 -0.932 . . . . 2.1000000000000001 110.917 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 106.69 -11.66 42.16 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 121.138 -1.213 . . . . 1.8400000000000001 110.348 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.401 HH11 ' HG3' ' A' ' 186' ' ' ARG . 24.6 ttm-85 -48.08 -47.18 34.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.932 -1.334 . . . . 5.7800000000000002 109.343 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 21.4 p -144.49 48.53 1.35 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.529 -0.915 . . . . 3.2400000000000002 108.529 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.2 t -87.41 105.26 17.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.479 -0.763 . . . . 2.1099999999999999 110.7 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.606 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 43.7 t60 -62.6 -24.71 67.71 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.034 -1.098 . . . . 1.0600000000000001 108.034 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.8 m -61.59 -43.75 98.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.053 -0.721 . . . . 2.0899999999999999 109.053 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.1 p -57.44 -32.2 66.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 1.8799999999999999 109.315 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.7 mm -71.19 -31.84 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 2.0099999999999998 109.754 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.7 mtp -71.84 -56.86 4.96 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.776 -1.194 . . . . 1.27 107.776 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.89 -38.72 73.19 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.641 -0.709 . . . . 1.1799999999999999 110.408 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -70.17 -50.81 36.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.08 -1.012 . . . . 3.5800000000000001 110.176 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.6 m -69.25 -36.87 77.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.266 -0.896 . . . . 1.1399999999999999 109.794 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 199' ' ' LEU . 14.9 mt -92.86 2.55 56.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.264 -0.898 . . . . 1.28 109.319 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 48.92 11.81 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.344 -0.847 . . . . 1.49 110.829 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 197' ' ' LEU . 84.2 mt -66.72 145.93 99.0 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.777 -1.202 . . . . 1.28 109.083 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.03 133.43 53.29 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.73 1.62 . . . . 0.69999999999999996 111.099 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.79 171.84 16.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.421 -1.424 . . . . 1.1899999999999999 111.4 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 65.9 mt -146.95 156.87 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.434 -1.691 . . . . 1.25 106.434 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.545 ' O ' ' O ' ' A' ' 181' ' ' THR . 29.9 m -140.66 -34.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 120.794 -1.191 . . . . 1.29 110.735 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.1 39.92 1.43 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.326 -1.91 . . . . 0.92000000000000004 108.326 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.497 ' H ' ' C ' ' A' ' 203' ' ' VAL . 16.6 p -68.53 -6.14 23.62 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.415 -1.05 . . . . 1.3100000000000001 109.46 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 49.74 -103.11 0.07 OUTLIER Glycine 0 N--CA 1.483 1.768 0 C-N-CA 119.709 -1.234 . . . . 1.0 110.149 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 12.3 p -115.81 51.17 0.96 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.197 -1.178 . . . . 1.9199999999999999 112.152 -176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.0 t -72.44 -25.72 23.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.145 -1.428 . . . . 1.27 107.145 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.6 p -70.51 -10.99 60.62 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.617 -0.882 . . . . 1.3400000000000001 108.617 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.3 t -104.2 12.27 34.0 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.445 -0.946 . . . . 2.0699999999999998 108.445 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -133.83 -27.27 1.49 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.689 -0.632 . . . . 2.8599999999999999 109.598 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 70.2 t -111.54 154.43 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.516 -0.74 . . . . 1.3 109.506 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.496 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 25.2 mmtp -123.8 -178.88 4.18 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.559 -1.645 . . . . 2.48 106.559 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.5 p-10 -79.97 149.38 30.82 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.73 -1.231 . . . . 2.6200000000000001 110.234 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 t70 81.49 -14.99 0.76 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.889 -0.507 . . . . 2.3999999999999999 110.664 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 73.7 m-20 -59.65 142.78 52.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.787 -1.196 . . . . 1.99 108.997 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -90.08 109.13 20.2 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.08 -1.012 . . . . 1.54 109.218 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.39 172.23 6.96 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.927 0.87 . . . . 1.25 109.714 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.9 mt -143.71 116.6 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.559 -1.274 . . . . 1.26 107.559 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.3 tp -84.79 127.06 33.94 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.161 -0.962 . . . . 1.1799999999999999 108.737 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 4.8 p-10 -89.22 -36.16 15.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.087 -1.008 . . . . 2.2200000000000002 109.119 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.539 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 44.58 21.57 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.542 -0.724 . . . . 1.2 110.142 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 221' ' ' ASP . 28.2 t -122.62 -61.4 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.754 -1.202 . . . . 1.48 107.754 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -91.99 17.07 9.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.396 -0.964 . . . . 2.8199999999999998 108.396 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 53.91 56.32 7.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.67 -0.644 . . . . 2.1099999999999999 109.928 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.445 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 69.2 mt-30 -152.96 144.32 23.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.191 -0.943 . . . . 2.6499999999999999 110.351 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 92.7 t -99.48 151.56 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.994 -1.113 . . . . 1.29 107.994 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -122.41 120.85 35.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.378 -0.826 . . . . 1.4199999999999999 109.216 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.3 t -104.93 120.32 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.455 -0.778 . . . . 1.26 109.642 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 48.29 65.55 6.9 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 2.1499999999999999 109.915 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.89 165.16 24.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.782 2.322 . . . . 0.81999999999999995 111.976 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.8 p -75.43 142.46 43.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 2.1099999999999999 109.388 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -54.41 -14.85 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 3.1699999999999999 109.243 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -72.84 -38.18 67.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -0.794 . . . . 3.0600000000000001 109.463 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.01 -41.25 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 1.6499999999999999 109.005 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.1 mt -55.85 -55.48 17.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.403 -0.81 . . . . 1.47 109.593 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -53.1 -40.02 63.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 2.54 109.849 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -66.91 -37.66 84.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.293 -0.879 . . . . 3.0 110.119 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 46.7 mtp -82.82 -25.26 32.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.154 -0.966 . . . . 1.6299999999999999 110.028 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 12.3 mmm-85 -59.91 -45.91 91.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.134 -0.979 . . . . 3.1600000000000001 109.74 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.79 -48.97 22.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 2.0899999999999999 110.178 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.79 -55.3 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.072 -1.017 . . . . 2.5699999999999998 110.027 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -44.93 -57.27 3.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 3.5899999999999999 110.148 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.76 -24.72 67.88 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.487 -0.758 . . . . 1.76 110.142 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -67.59 -22.83 65.35 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.484 -1.302 . . . . 3.21 107.484 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.2 t -75.25 -42.64 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.593 -0.891 . . . . 2.3500000000000001 108.593 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.78 -27.54 68.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.728 -0.842 . . . . 2.3999999999999999 108.728 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 7.9 t -76.37 -26.51 55.74 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.518 -0.739 . . . . 3.0299999999999998 109.169 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 3.4100000000000001 109.341 179.842 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.518 ' O ' ' N ' ' A' ' 3' ' ' SER . 49.1 mtm . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.589 -0.523 . . . . 4.0700000000000003 109.589 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.445 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 53.3 mt -53.44 89.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 1.5 108.915 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 1' ' ' MET . 70.1 m -95.94 119.34 34.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.327 -0.858 . . . . 1.8 109.955 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.34 -158.53 12.41 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.446 -1.861 . . . . 0.92000000000000004 108.446 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.513 ' O ' ' O ' ' A' ' 6' ' ' LEU . 56.4 mt -97.77 -11.41 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.155 -1.203 . . . . 1.5 108.24 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.4 tp 50.87 109.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.591 0.71 . . . . 1.3999999999999999 109.376 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.36 -50.12 8.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.717 -1.239 . . . . 1.26 109.543 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.88 150.26 45.56 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.266 -0.896 . . . . 1.95 109.431 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.48 152.84 30.31 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.383 2.056 . . . . 0.93999999999999995 113.52 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 153.9 121.4 0.81 Allowed Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.319 -1.112 . . . . 0.78000000000000003 110.319 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.2 mt -88.55 133.14 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.079 -1.248 . . . . 1.29 109.818 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.07 161.51 36.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.561 -0.712 . . . . 1.1499999999999999 109.89 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.7 m-85 -130.48 135.92 48.46 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.517 -0.92 . . . . 0.71999999999999997 108.517 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.45 165.26 31.27 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 118.419 -1.848 . . . . 0.5 111.54 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -81.06 150.01 28.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.696 -0.885 . . . . 2.3599999999999999 109.916 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.81 128.78 33.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 1.1599999999999999 111.279 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.9 tp -107.38 95.38 5.66 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.204 -1.406 . . . . 1.24 107.204 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 tp -81.37 122.5 27.55 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.099 -1.001 . . . . 1.3100000000000001 110.844 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.3 98.33 9.89 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.015 -0.538 . . . . 1.3100000000000001 109.644 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -92.23 159.87 15.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 2.3500000000000001 108.798 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.484 ' OE2' ' N ' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -130.13 130.03 44.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.447 -0.783 . . . . 2.5800000000000001 109.083 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.484 ' N ' ' OE2' ' A' ' 21' ' ' GLU . 5.4 m-20 -80.22 131.96 35.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.268 -0.895 . . . . 2.1400000000000001 109.198 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -64.66 146.94 53.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 1.9299999999999999 109.274 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.65 135.35 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 1.28 109.72 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.39 114.49 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.85 -0.796 . . . . 1.3700000000000001 108.85 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.3 mt -90.29 139.61 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 1.3300000000000001 109.778 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -93.19 122.39 35.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.197 -0.939 . . . . 1.3700000000000001 110.029 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -96.31 19.15 12.4 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.283 -0.886 . . . . 3.1899999999999999 109.703 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -80.26 156.36 26.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.97 -1.081 . . . . 2.8100000000000001 109.906 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -90.67 127.69 36.38 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.159 -0.682 . . . . 2.8300000000000001 109.159 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.4 pt -78.87 171.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.006 . . . . 1.3400000000000001 109.58 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.2 p -101.04 163.82 12.1 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.946 -0.761 . . . . 1.3500000000000001 108.946 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.88 -25.92 63.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 1.6100000000000001 109.726 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.85 -12.8 59.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.127 -0.983 . . . . 2.4700000000000002 108.702 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -102.29 -12.31 18.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.639 -0.874 . . . . 2.0699999999999998 108.639 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -67.68 -49.71 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 1.3300000000000001 108.746 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 1.2 m-20 -57.96 -39.89 79.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 1.46 109.919 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -67.54 -36.6 81.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 2.9399999999999999 110.56 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -65.89 -33.23 75.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.972 -1.08 . . . . 1.3 109.528 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.6 t -62.25 -45.13 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 1.3300000000000001 109.276 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -64.29 -32.58 74.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.104 -0.997 . . . . 1.5 108.387 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.491 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 8.2 mtt-85 -66.18 -37.32 85.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.481 -0.762 . . . . 3.1499999999999999 109.083 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 34.6 t80 -86.21 -54.15 4.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.185 -0.947 . . . . 0.92000000000000004 108.903 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 tp -48.78 -66.99 0.31 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.333 -0.854 . . . . 1.4099999999999999 109.091 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 t -64.41 -28.38 69.64 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.784 -0.821 . . . . 1.22 108.784 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -59.93 -54.77 34.68 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 107.527 -2.229 . . . . 0.58999999999999997 107.527 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.45 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.0 OUTLIER -47.39 -30.64 3.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.647 -0.914 . . . . 3.3900000000000001 108.698 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.81 -34.88 76.72 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.211 -1.033 . . . . 1.26 108.211 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' GLY . 31.2 mtpt -82.14 -60.62 2.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.692 -0.63 . . . . 2.9900000000000002 109.646 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.25 -38.55 27.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 1.1399999999999999 109.975 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -65.35 -39.04 91.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.024 -1.047 . . . . 1.8400000000000001 108.922 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.61 64.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.753 -0.592 . . . . 1.22 110.584 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -63.62 -47.79 79.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 2.0 109.965 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.35 -46.42 64.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.922 -1.112 . . . . 1.99 109.455 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -48.15 -52.37 20.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.384 -0.822 . . . . 1.27 109.752 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -60.84 -34.0 73.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 1.24 109.849 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -72.3 -27.98 27.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.186 -0.946 . . . . 1.21 108.899 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -63.51 -42.39 98.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 1.53 109.898 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -72.72 -28.83 62.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.168 -0.957 . . . . 1.24 109.844 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.424 ' O ' ' OG1' ' A' ' 64' ' ' THR . 64.0 mttm -72.45 -25.31 61.4 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.657 -1.238 . . . . 2.3199999999999998 107.657 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.79 -29.95 56.26 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.948 -1.131 . . . . 1.1699999999999999 107.948 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.2 -29.84 24.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.895 -1.282 . . . . 0.57999999999999996 109.895 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -86.34 -16.21 38.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.864 -1.374 . . . . 1.3899999999999999 109.076 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 88.9 m -93.37 -48.89 6.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.89 . . . . 1.3600000000000001 110.065 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -106.93 -16.35 14.48 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.26 -0.9 . . . . 1.1399999999999999 110.793 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.557 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 119.44 142.92 6.89 Favored Glycine 0 N--CA 1.503 3.111 0 N-CA-C 109.486 -1.445 . . . . 0.59999999999999998 109.486 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -49.99 -5.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.397 -1.061 . . . . 2.5899999999999999 110.62 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.557 ' H ' ' C ' ' A' ' 66' ' ' GLY . 34.3 mt-10 -64.02 -24.09 67.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.937 -1.102 . . . . 2.2000000000000002 109.874 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -90.58 -9.44 47.1 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.076 -1.015 . . . . 2.3599999999999999 110.264 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -64.1 -29.63 70.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.003 -1.061 . . . . 1.54 110.893 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -35.96 82.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.826 -1.171 . . . . 1.24 110.105 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.6 mt -73.2 -45.78 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.999 -1.063 . . . . 1.24 109.658 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.62 -23.9 53.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.91 . . . . 0.80000000000000004 109.747 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -64.75 -44.67 89.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.931 -1.105 . . . . 1.23 109.152 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.36 -34.49 80.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.442 -1.463 . . . . 0.56000000000000005 109.442 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -62.65 -20.94 65.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -1.159 . . . . 2.0600000000000001 110.172 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.401 HD11 HG22 ' A' ' 77' ' ' ILE . 80.3 mt -85.29 -38.7 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.762 -1.211 . . . . 1.24 108.337 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.7 ttt -58.65 -39.45 80.61 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.491 -0.929 . . . . 2.4500000000000002 108.491 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tp -64.21 -41.9 96.84 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.867 -0.79 . . . . 1.21 108.867 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.3 tp -68.25 -44.76 74.92 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.759 -0.777 . . . . 1.1200000000000001 109.193 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.16 8.33 21.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.933 . . . . 1.24 110.117 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -47.57 123.55 5.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.822 -1.174 . . . . 1.3100000000000001 109.989 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.38 -26.07 67.09 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.788 -0.819 . . . . 1.3500000000000001 108.788 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.58 -50.47 17.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.346 -0.846 . . . . 2.1600000000000001 109.309 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.94 -16.83 63.79 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.187 -1.005 . . . . 1.24 109.282 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.82 -51.0 12.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 1.28 110.507 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -62.16 -29.92 70.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.139 -0.976 . . . . 1.79 110.232 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -74.14 -44.56 53.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 1.29 109.649 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.95 -57.35 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.09 -1.078 . . . . 1.1399999999999999 108.09 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.7 mt -46.31 -63.57 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.684 -0.635 . . . . 1.3200000000000001 109.786 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.34 -53.74 8.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.245 -0.909 . . . . 1.3700000000000001 110.103 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 57.7 mt -50.03 -54.7 18.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 1.3999999999999999 109.252 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.7 mt -53.53 -42.48 49.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.331 -0.856 . . . . 1.23 110.4 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -85.88 -36.82 19.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.99 -1.069 . . . . 2.5099999999999998 111.563 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -83.25 -38.16 22.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.943 -1.098 . . . . 1.5900000000000001 111.76 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -104.25 9.82 35.89 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.758 -1.214 . . . . 2.3799999999999999 109.804 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.4 m80 49.6 42.34 22.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.922 -1.111 . . . . 1.6200000000000001 109.188 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.5 mtt -97.49 150.78 20.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.082 -0.71 . . . . 1.8899999999999999 109.082 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.449 ' H ' ' HG1' ' A' ' 99' ' ' THR . 11.9 p -75.02 145.64 42.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.494 -0.754 . . . . 1.27 109.767 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.7 -26.27 8.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.218 -0.926 . . . . 1.1599999999999999 108.821 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -75.15 -50.0 17.73 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.589 -0.893 . . . . 2.0 108.589 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.27 -50.94 34.41 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.283 0.563 . . . . 1.25 110.066 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.57 -56.52 20.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 1.1299999999999999 109.888 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.44 62.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.199 -0.938 . . . . 1.0800000000000001 109.271 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -69.37 -21.21 63.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 2.02 109.024 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -70.57 -50.36 38.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.496 -0.752 . . . . 1.26 109.905 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.97 -40.66 89.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.862 -1.149 . . . . 1.1799999999999999 109.299 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.79 -19.48 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.243 -0.91 . . . . 1.1899999999999999 108.942 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -76.88 -34.78 57.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 2.2000000000000002 109.739 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.72 -23.36 46.67 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.104 -1.522 . . . . 0.85999999999999999 111.591 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -69.65 -42.87 73.67 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.822 -1.399 . . . . 2.0 108.638 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.73 -53.68 9.81 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.436 -0.79 . . . . 1.3200000000000001 109.824 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 t -60.55 -28.66 68.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.137 -0.977 . . . . 2.1400000000000001 109.788 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.01 -44.57 79.98 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.966 -1.084 . . . . 1.3799999999999999 110.345 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.9 -24.75 66.91 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.88 -1.138 . . . . 1.3500000000000001 109.003 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.73 -19.78 65.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 1.95 109.485 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -82.48 -7.03 59.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.196 -0.94 . . . . 1.71 109.513 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.1 mt -86.42 156.91 19.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.323 -0.861 . . . . 1.71 108.824 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -104.79 58.72 0.69 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.842 -0.799 . . . . 2.8300000000000001 108.842 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -150.31 118.77 6.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.25 -0.906 . . . . 1.5800000000000001 109.384 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -64.26 -9.59 18.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 2.7999999999999998 110.057 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -77.05 -61.22 2.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.184 -0.948 . . . . 1.27 109.444 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.4 mt -66.48 -26.64 67.27 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.276 -0.89 . . . . 1.5800000000000001 109.629 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 127' ' ' ALA . 47.7 tttp -67.2 -53.46 30.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 2.9199999999999999 108.582 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -55.97 -25.14 42.53 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.611 -0.885 . . . . 2.2000000000000002 108.611 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -72.94 -24.73 60.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.774 -1.565 . . . . 2.5299999999999998 106.774 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.88 -41.34 95.77 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.643 -0.873 . . . . 1.45 108.643 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.44 -38.12 86.67 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.423 -0.954 . . . . 1.5 108.423 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -71.51 -25.81 62.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 1.3500000000000001 109.286 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.44 -47.5 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.329 -0.857 . . . . 1.23 108.908 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -55.39 -36.49 66.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.876 -1.14 . . . . 3.73 108.283 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.13 -37.13 83.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.595 -0.69 . . . . 1.3200000000000001 110.718 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.5 mt -67.5 -25.08 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.981 -1.074 . . . . 1.2 109.655 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.56 -46.64 9.62 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.025 -1.63 . . . . 0.48999999999999999 109.025 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -48.58 -42.46 33.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.484 -1.009 . . . . 3.1099999999999999 109.677 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.431 ' HG2' HH11 ' A' ' 136' ' ' ARG . 24.4 mtt-85 -63.54 -52.32 61.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.095 -1.003 . . . . 2.9500000000000002 108.553 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.9 tp -51.2 -41.36 60.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.748 -0.595 . . . . 1.73 109.854 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 140' ' ' ASN . 11.2 mt -66.9 -61.31 2.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 1.22 110.008 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -43.95 -19.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.403 -0.811 . . . . 2.7799999999999998 110.858 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.491 ' ND2' ' N ' ' A' ' 140' ' ' ASN . 1.8 m120 -85.46 -34.1 21.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.04 -1.038 . . . . 2.0299999999999998 109.925 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.2 mt -73.45 -33.3 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.043 -1.036 . . . . 1.2 108.805 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 55.8 mt -86.73 3.08 46.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.334 -0.854 . . . . 1.28 109.344 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.06 27.73 23.36 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.433 -1.867 . . . . 0.68999999999999995 108.433 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.64 148.51 28.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.526 -0.985 . . . . 1.3100000000000001 109.443 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -66.56 132.81 49.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 2.8799999999999999 109.403 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 76.6 mt -102.13 134.59 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.383 -0.823 . . . . 1.3600000000000001 109.027 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.93 133.32 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 1.9299999999999999 110.09 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -98.53 88.46 4.11 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.614 -0.884 . . . . 1.54 108.614 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.0 mt -78.75 -30.08 45.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.318 -0.864 . . . . 1.3400000000000001 110.011 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 m -81.85 30.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 1.98 109.57 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.23 32.38 2.13 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.243 -0.91 . . . . 1.3799999999999999 109.129 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.43 152.56 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.369 -0.832 . . . . 1.3999999999999999 110.13 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -129.22 -10.19 4.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.538 -0.912 . . . . 2.7400000000000002 108.538 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 154' ' ' ASP . 0.7 OUTLIER -120.1 127.37 52.47 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.424 -0.798 . . . . 1.4099999999999999 109.17 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.92 124.09 20.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 1.3 109.614 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.83 175.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.194 -0.941 . . . . 1.28 109.411 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.8 mt -88.11 153.68 3.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.605 -1.257 . . . . 1.1499999999999999 107.605 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.5 tp -104.49 117.29 33.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.443 -0.786 . . . . 1.2 109.041 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 35.6 t -120.57 133.11 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.603 -0.888 . . . . 1.1599999999999999 108.603 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.58 143.21 11.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.373 -0.829 . . . . 1.2 109.039 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.42 -27.05 67.17 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.614 -1.304 . . . . 1.3200000000000001 107.909 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 20.2 t0 -172.27 145.45 1.71 Allowed 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.69 -0.631 . . . . 2.3399999999999999 109.59 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.527 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 25.3 mt -119.74 130.34 54.94 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.557 -0.905 . . . . 1.26 108.557 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.6 p -93.34 148.3 35.32 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.976 -1.078 . . . . 1.3600000000000001 109.677 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 169' ' ' ALA . 78.3 Cg_exo -36.96 -49.16 1.52 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.594 2.196 . . . . 0.63 112.327 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.8 m -51.41 -59.81 3.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 1.0700000000000001 109.228 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -53.57 -41.33 66.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -0.876 . . . . 1.25 109.432 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 19.4 p -73.59 -22.57 60.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 1.1799999999999999 110.013 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -76.61 -26.87 55.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.115 -0.991 . . . . 1.1399999999999999 110.066 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -105.15 -10.89 16.83 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.15 -0.969 . . . . 1.71 109.944 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.36 156.02 10.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.153 -0.967 . . . . 1.22 109.169 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -98.51 132.34 44.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.012 -1.055 . . . . 2.5499999999999998 108.233 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 9.4 mp -82.17 -44.67 16.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 1.96 111.238 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -83.44 -8.72 59.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.826 -1.171 . . . . 2.46 112.111 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -98.65 -8.54 26.1 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.612 -1.305 . . . . 2.4199999999999999 108.77 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.0 t -98.2 161.19 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.211 -1.033 . . . . 1.1599999999999999 108.211 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.3 tp -108.61 -23.97 11.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.313 -0.867 . . . . 1.95 109.907 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -178.33 174.41 46.68 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.942 -1.663 . . . . 0.41999999999999998 108.942 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -129.43 122.44 29.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.588 -0.948 . . . . 0.52000000000000002 108.992 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 12.9 mt -128.43 128.11 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.377 -0.971 . . . . 1.1599999999999999 108.377 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 203' ' ' VAL . 47.7 p -141.3 146.52 36.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.483 -0.761 . . . . 1.22 111.467 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.499 ' CG ' ' HG1' ' A' ' 209' ' ' THR . 2.8 m-20 -85.73 41.99 0.94 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -0.782 . . . . 2.2400000000000002 109.501 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.54 116.04 31.24 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.387 -0.821 . . . . 1.6499999999999999 109.727 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -87.63 65.01 3.63 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.797 -1.321 . . . . 2.1000000000000001 109.797 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 88.5 -25.04 9.9 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.142 -1.183 . . . . 1.8400000000000001 110.142 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.96 -34.09 3.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -1.199 . . . . 5.7800000000000002 109.607 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.402 ' OG1' ' OD2' ' A' ' 162' ' ' ASP . 20.8 p -152.06 75.92 1.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.549 -0.908 . . . . 3.2400000000000002 108.549 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.9 p -80.04 5.1 15.07 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.331 -0.856 . . . . 2.1099999999999999 109.813 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -51.3 -44.59 61.94 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.765 -1.209 . . . . 1.0600000000000001 109.034 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -36.24 68.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.23 -0.919 . . . . 2.0899999999999999 108.937 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.5 t -75.0 -37.71 61.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.869 . . . . 1.8799999999999999 109.079 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 88.6 mt -50.51 -32.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.159 -0.963 . . . . 2.0099999999999998 108.647 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.5 mtm -71.78 -51.51 22.29 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 106.947 -1.501 . . . . 1.27 106.947 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.44 -39.01 66.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.071 -0.714 . . . . 1.1799999999999999 109.071 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -69.18 -51.69 35.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 3.5800000000000001 109.351 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.8 m -68.88 -36.62 78.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 1.1399999999999999 109.344 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 199' ' ' LEU . 39.5 mt -86.83 3.69 44.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.179 -0.95 . . . . 1.28 108.667 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 52.75 2.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 1.49 110.873 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.532 ' H ' ' C ' ' A' ' 197' ' ' LEU . 21.9 mt -64.74 169.37 5.35 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.654 -1.279 . . . . 1.28 107.751 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -90.38 143.94 3.87 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.16 1.907 . . . . 0.69999999999999996 111.684 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.62 175.86 10.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.706 -1.246 . . . . 1.1899999999999999 111.491 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 10.8 mt -150.78 155.01 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.786 -1.561 . . . . 1.25 106.786 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.6 m -143.51 -29.08 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 120.689 -1.257 . . . . 1.29 111.273 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.15 30.95 3.85 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.993 -1.243 . . . . 0.92000000000000004 109.993 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 207' ' ' SER . 3.2 p -61.61 -38.84 89.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.726 -1.455 . . . . 1.3100000000000001 107.806 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 57.36 -33.43 0.02 OUTLIER Glycine 0 N--CA 1.498 2.769 0 CA-C-O 119.684 -0.509 . . . . 1.0 113.851 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 205' ' ' THR . 95.2 p -124.83 1.14 8.09 Favored 'General case' 0 N--CA 1.512 2.646 0 CA-C-N 119.613 1.706 . . . . 1.9199999999999999 112.652 -177.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 t -65.44 -48.39 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.144 -1.597 . . . . 1.27 109.753 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.499 ' HG1' ' CG ' ' A' ' 182' ' ' ASP . 12.4 p -54.64 -16.1 2.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.884 -1.135 . . . . 1.3400000000000001 110.045 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.1 t -104.13 11.72 34.77 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.316 -0.865 . . . . 2.0699999999999998 109.65 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -142.25 -3.82 1.05 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.288 -0.882 . . . . 2.8599999999999999 110.411 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.75 145.18 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.433 -0.792 . . . . 1.3 108.936 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -120.55 172.98 7.46 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.515 -1.661 . . . . 2.48 106.515 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -74.25 141.13 45.38 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.722 -1.236 . . . . 2.6200000000000001 109.801 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.33 -10.12 1.22 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.807 -0.558 . . . . 2.3999999999999999 110.359 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -56.86 141.32 45.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.675 -1.265 . . . . 1.99 107.994 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -87.18 111.64 21.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.954 -1.091 . . . . 1.54 109.19 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 20.7 mt -121.41 168.32 11.81 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.992 0.901 . . . . 1.25 110.52 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.9 mt -140.46 123.56 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.192 -1.04 . . . . 1.26 108.192 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.72 128.6 36.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.925 . . . . 1.1799999999999999 109.169 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.27 -38.16 11.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.108 -0.995 . . . . 2.2200000000000002 108.923 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.431 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 44.78 25.0 0.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.63 -0.669 . . . . 1.2 110.53 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.15 -62.24 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 106.981 -1.488 . . . . 1.48 106.981 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -87.59 14.46 8.31 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.95 -1.13 . . . . 2.8199999999999998 107.95 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.64 57.66 3.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.68 -0.638 . . . . 2.1099999999999999 109.677 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -156.76 151.8 26.17 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.024 -1.048 . . . . 2.6499999999999999 110.833 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.55 137.54 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.901 -0.777 . . . . 1.29 108.901 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -107.14 131.72 53.82 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.21 -0.931 . . . . 1.4199999999999999 109.273 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.6 t -103.79 118.19 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 1.26 109.802 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 50.87 69.62 2.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 2.1499999999999999 109.989 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.96 157.97 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.66 2.24 . . . . 0.81999999999999995 111.347 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 80.3 p -72.76 144.9 47.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 2.1099999999999999 109.883 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.636 ' N ' HD21 ' A' ' 233' ' ' ASN . 0.8 OUTLIER -53.02 -27.72 20.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.43 -0.794 . . . . 3.1699999999999999 109.742 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -64.54 -37.3 87.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 3.0600000000000001 109.734 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 80.1 t -77.81 -36.16 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.243 -0.91 . . . . 1.6499999999999999 109.137 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.37 -58.74 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 1.47 109.438 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 233' ' ' ASN . 2.5 m-20 -53.33 -36.53 61.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 2.54 109.51 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -67.24 -36.9 82.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 3.0 108.97 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 62.0 mtp -80.18 -34.6 37.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.409 -0.807 . . . . 1.6299999999999999 109.463 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -54.87 -38.76 67.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 3.1600000000000001 109.459 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.97 -57.21 4.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 2.0899999999999999 109.689 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 73.9 t -58.74 -50.79 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.422 -0.799 . . . . 2.5699999999999998 110.275 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.37 -58.41 7.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.943 -1.098 . . . . 3.5899999999999999 110.148 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.27 -22.14 66.68 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.288 -0.882 . . . . 1.76 110.275 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -64.15 -26.58 68.6 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.182 -1.414 . . . . 3.21 107.182 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.1 t -72.1 -54.79 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.109 . . . . 2.3500000000000001 108.004 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.62 -26.93 62.27 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.504 -0.924 . . . . 2.3999999999999999 108.504 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 p -77.32 -22.94 51.13 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.072 -0.714 . . . . 3.0299999999999998 109.072 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 108.757 -0.831 . . . . 3.4100000000000001 108.757 179.664 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.518 -0.549 . . . . 3.6600000000000001 109.518 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.07 103.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 1.1200000000000001 109.361 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -93.08 120.22 33.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.329 -0.857 . . . . 1.45 110.033 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.67 -160.19 11.6 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 108.41 -1.876 . . . . 0.92000000000000004 108.41 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.0 mt -93.55 -9.96 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.995 -1.297 . . . . 1.05 109.029 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' ILE . 14.2 tp 56.94 107.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 0.88 109.306 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.52 -53.61 4.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.081 -1.012 . . . . 0.78000000000000003 108.318 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.95 146.16 25.0 Favored Pre-proline 0 N--CA 1.494 1.741 0 N-CA-C 108.582 -0.896 . . . . 1.5 108.582 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.3 153.37 31.37 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.069 1.846 . . . . 0.85999999999999999 113.148 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.68 124.1 1.1 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.051 -1.22 . . . . 0.78000000000000003 110.051 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.574 HD12 ' HG2' ' A' ' 243' ' ' GLN . 72.7 mt -89.36 129.01 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.132 -1.216 . . . . 0.73999999999999999 109.566 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.16 149.22 49.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.383 -0.823 . . . . 0.45000000000000001 109.572 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.9 m-85 -117.87 140.06 50.24 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.626 -0.879 . . . . 0.64000000000000001 108.626 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.65 163.47 29.96 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.725 -1.702 . . . . 0.45000000000000001 111.24 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -78.57 151.71 32.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.991 . . . . 1.8799999999999999 109.902 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.21 129.32 34.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.58999999999999997 111.114 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -111.82 90.84 3.45 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.193 -1.41 . . . . 0.64000000000000001 107.193 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 18' ' ' LEU . 11.7 tp -81.38 128.72 34.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.059 -1.025 . . . . 0.73999999999999999 110.687 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' A' ' 160' ' ' ALA . 32.2 mt -96.88 93.99 6.97 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.454 0.645 . . . . 0.73999999999999999 109.854 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -93.07 156.35 16.93 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.54 -0.911 . . . . 1.8700000000000001 108.54 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.02 131.3 44.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.247 -0.908 . . . . 2.5800000000000001 109.036 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.92 138.63 38.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.148 -0.97 . . . . 2.1400000000000001 108.924 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.23 140.68 58.9 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.45 -0.781 . . . . 1.9299999999999999 109.282 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mt -91.69 132.96 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.215 -0.928 . . . . 0.68000000000000005 109.917 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.8 t -106.61 111.98 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.637 -0.875 . . . . 0.83999999999999997 108.637 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.2 mt -85.07 152.2 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.941 . . . . 0.79000000000000004 109.586 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -90.89 107.54 19.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.497 -0.752 . . . . 1.3700000000000001 109.927 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.524 ' NH1' ' HB1' ' A' ' 102' ' ' ALA . 20.4 mmm180 -95.46 24.57 5.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.277 -0.889 . . . . 2.6200000000000001 108.754 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -85.85 144.04 27.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.371 -0.831 . . . . 2.3500000000000001 109.79 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -86.72 123.97 32.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.213 -0.929 . . . . 2.3500000000000001 108.824 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.2 pt -87.22 174.89 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.16 -0.962 . . . . 0.78000000000000003 110.599 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.2 p -100.84 156.41 17.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.842 -0.799 . . . . 1.04 108.842 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.9 -8.44 0.99 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 1.05 109.47 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.95 -21.28 31.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 2.4700000000000002 109.898 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -105.9 -1.36 24.22 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.329 -0.857 . . . . 1.46 109.327 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -64.95 -44.85 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.975 . . . . 0.77000000000000002 108.742 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -52.34 -36.46 53.57 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.262 -0.899 . . . . 1.46 109.19 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -69.46 -34.3 74.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.476 -0.765 . . . . 2.29 110.152 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.433 ' OE2' ' NH2' ' A' ' 42' ' ' ARG . 80.4 mm-40 -62.55 -43.34 99.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.999 -1.063 . . . . 1.3 109.715 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 44' ' ' LEU . 82.2 t -59.84 -48.58 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.76000000000000001 110.035 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -66.55 -44.77 81.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.012 -1.055 . . . . 1.5 108.991 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.433 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 72.1 mtm180 -61.36 -33.97 74.53 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.108 -0.995 . . . . 2.6600000000000001 108.895 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -86.35 -54.43 4.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.75 108.945 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 40' ' ' VAL . 57.3 tp -51.01 -66.77 0.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.469 -0.77 . . . . 0.82999999999999996 109.493 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 t -63.19 -30.15 71.35 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.952 -1.093 . . . . 0.78000000000000003 108.154 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.85 -8.01 51.34 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 107.347 -2.301 . . . . 0.56999999999999995 107.347 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.2 OUTLIER -85.02 -29.02 25.31 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.126 -1.805 . . . . 2.8300000000000001 106.126 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.36 64.17 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.941 -1.133 . . . . 0.65000000000000002 107.941 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -84.91 -64.22 1.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.919 -0.771 . . . . 2.5699999999999998 108.919 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.931 ' HB2' HD21 ' A' ' 140' ' ' ASN . . . -50.32 -41.89 51.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.978 . . . . 0.51000000000000001 109.514 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.9 m -63.36 -37.93 89.18 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.011 -1.107 . . . . 1.3600000000000001 108.011 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.36 -21.51 60.51 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.401 -0.592 . . . . 0.59999999999999998 109.401 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -73.45 -68.35 0.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 1.3600000000000001 109.471 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 58' ' ' LYS . 13.7 mt -48.93 -42.52 37.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.064 -1.022 . . . . 1.3799999999999999 108.839 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -50.55 -48.76 57.3 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.448 -0.945 . . . . 1.27 108.448 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -61.96 -40.37 95.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.59999999999999998 109.053 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.6 mt -74.71 -25.14 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.53000000000000003 108.879 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.584 ' HZ1' ' CD ' ' A' ' 70' ' ' GLU . 13.3 ttpp -64.31 -52.52 58.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.564 -0.71 . . . . 0.98999999999999999 110.219 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.33 -25.45 63.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.968 -1.083 . . . . 0.58999999999999997 109.794 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -71.63 -24.12 61.81 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.904 -1.122 . . . . 1.8100000000000001 108.029 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.74 -32.87 60.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.367 -0.975 . . . . 0.47999999999999998 108.367 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.73 -28.77 28.35 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.842 -1.303 . . . . 0.57999999999999996 109.842 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -86.42 -14.99 41.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.28 . . . . 1.3899999999999999 108.784 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.2 m -92.84 -51.4 5.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.81999999999999995 110.054 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -106.85 -21.77 12.91 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.305 -0.872 . . . . 0.98999999999999999 110.44 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.87 153.6 9.1 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 109.77 -1.332 . . . . 0.55000000000000004 109.77 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -48.87 -8.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.508 -0.995 . . . . 2.5899999999999999 110.464 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 66' ' ' GLY . 39.8 tt0 -63.91 -42.61 97.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 2.2000000000000002 110.377 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -90.81 -10.01 44.37 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.014 -1.054 . . . . 1.79 110.494 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.584 ' CD ' ' HZ1' ' A' ' 58' ' ' LYS . 34.1 tt0 -67.04 -31.04 71.29 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.942 -1.099 . . . . 1.54 110.809 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.91 68.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.097 -1.002 . . . . 0.64000000000000001 110.41 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.7 mt -72.04 -42.56 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.036 -1.04 . . . . 0.57999999999999996 109.771 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -76.71 -19.21 57.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.097 -1.002 . . . . 0.62 109.307 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.07 -49.32 72.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.26 -0.9 . . . . 1.23 108.704 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.38 82.17 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.312 -1.515 . . . . 0.52000000000000002 109.312 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.57 -24.39 65.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -1.204 . . . . 1.29 110.036 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.5 mt -81.15 -36.18 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.727 -1.233 . . . . 0.55000000000000004 108.546 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.9 ttp -58.02 -43.84 86.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.537 -0.912 . . . . 1.8899999999999999 108.537 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -57.31 -42.52 81.98 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.757 -0.831 . . . . 0.53000000000000003 108.757 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.12 -41.48 77.32 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.352 -0.842 . . . . 0.42999999999999999 109.258 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -85.4 8.39 19.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.414 -0.803 . . . . 1.24 110.225 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -50.05 123.44 8.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.947 -1.096 . . . . 1.3100000000000001 109.484 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.55 -22.67 65.39 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.301 -0.875 . . . . 1.3500000000000001 108.911 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -76.76 -49.52 15.75 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.393 -0.817 . . . . 2.1600000000000001 109.318 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.9 mt -64.28 -15.32 59.95 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.292 -0.963 . . . . 0.59999999999999998 109.242 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -82.9 -46.4 13.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 1.28 110.458 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -62.41 -30.19 71.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.13 -0.981 . . . . 1.28 109.906 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -73.29 -43.57 60.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.023 -1.048 . . . . 1.29 109.01 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.06 -56.96 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.492 -0.929 . . . . 0.57999999999999996 108.492 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.0 mt -48.9 -66.17 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.696 -0.627 . . . . 0.78000000000000003 110.417 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -43.1 -58.9 2.26 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.44 -0.788 . . . . 0.85999999999999999 110.876 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.0 mt -45.87 -54.35 8.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.317 -0.864 . . . . 0.79000000000000004 110.024 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.1 mt -50.86 -41.2 21.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.07 -1.019 . . . . 0.70999999999999996 109.757 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -85.76 -38.53 18.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.277 -0.889 . . . . 2.0499999999999998 111.594 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -82.22 -40.25 21.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.901 -1.124 . . . . 1.5900000000000001 111.912 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -108.03 16.54 23.29 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.721 -1.237 . . . . 1.8899999999999999 110.162 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.9 m80 44.85 48.76 9.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.205 -0.935 . . . . 1.3100000000000001 109.525 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.7 mtt -100.72 147.47 25.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 1.28 109.261 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.1 p -75.68 143.75 41.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.313 -0.867 . . . . 0.62 109.164 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.12 -25.62 2.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.46999999999999997 108.887 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.55 -48.97 23.71 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.534 -0.913 . . . . 2.0 108.534 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.524 ' HB1' ' NH1' ' A' ' 28' ' ' ARG . . . -70.51 -53.61 15.53 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.779 -0.575 . . . . 0.56000000000000005 110.013 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.68 -46.7 77.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.47999999999999998 109.411 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.89 66.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.44 109.478 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -69.75 -36.47 75.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 1.4199999999999999 109.567 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -53.67 -50.54 65.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.832 . . . . 1.26 110.314 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.16 -49.02 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.975 -1.078 . . . . 0.60999999999999999 109.601 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -63.12 -19.27 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.429 -0.794 . . . . 0.64000000000000001 109.046 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -73.85 -37.53 64.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.992 . . . . 2.2000000000000002 109.952 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.02 -26.57 31.0 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.524 -1.322 . . . . 0.81999999999999995 112.619 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -67.68 -47.05 70.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.528 -1.572 . . . . 1.27 108.948 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.04 -50.38 23.36 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.604 -0.685 . . . . 0.91000000000000003 109.218 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -59.27 -42.28 90.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.78 . . . . 1.73 110.039 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.3 86.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.125 -0.984 . . . . 1.04 110.905 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.3 -29.59 68.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.735 -1.228 . . . . 1.03 109.426 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -67.54 -15.87 63.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.935 . . . . 1.95 109.627 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.43 -9.06 59.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.94 . . . . 1.71 109.278 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 123' ' ' LEU . 2.2 mt -87.36 146.54 25.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 1.26 108.636 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 20.5 p-10 -100.6 62.71 1.05 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.45 -0.781 . . . . 2.8300000000000001 109.311 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -150.08 113.5 4.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 1.5800000000000001 109.522 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -53.6 -12.28 0.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 2.7999999999999998 109.607 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.74 -62.19 1.76 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.933 . . . . 1.02 109.072 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 118' ' ' LEU . 56.6 mt -71.01 -27.47 63.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.88 . . . . 1.0600000000000001 109.599 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -68.08 -52.52 34.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.061 -1.024 . . . . 2.3900000000000001 108.831 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.28 -20.9 58.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.423 -0.954 . . . . 2.2000000000000002 108.423 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.572 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -72.55 -26.96 61.93 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.485 -1.672 . . . . 2.0899999999999999 106.485 178.114 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.24 -44.09 92.35 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.284 -1.006 . . . . 0.85999999999999999 108.284 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.09 80.82 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.818 -0.808 . . . . 0.90000000000000002 108.818 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -70.07 -32.17 70.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.42 -0.8 . . . . 1.3500000000000001 109.371 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.2 t -77.83 -45.99 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 0.57999999999999996 108.37 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -57.48 -39.97 77.58 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.263 -1.014 . . . . 3.2200000000000002 108.263 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.51 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 14.5 t70 -56.27 -39.32 72.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.563 -0.71 . . . . 1.3200000000000001 109.637 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.47 -20.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.163 -0.96 . . . . 0.5 108.881 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.69 -53.53 4.27 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.943 -1.263 . . . . 0.44 109.943 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -49.04 -39.48 27.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.012 -1.287 . . . . 2.71 108.832 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' A' ' 136' ' ' ARG . 3.1 mtt-85 -65.16 -45.97 82.78 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.282 -1.007 . . . . 2.2000000000000002 108.282 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.5 tp -53.61 -45.13 69.98 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.042 -0.725 . . . . 1.1299999999999999 109.042 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 140' ' ' ASN . 18.2 mt -60.41 -60.2 4.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.54000000000000004 109.435 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -43.97 -20.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 2.3199999999999998 110.324 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.931 HD21 ' HB2' ' A' ' 50' ' ' ALA . 8.2 m-20 -85.4 -49.92 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 1.26 109.665 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -61.91 -35.43 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.62 109.541 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.6 mt -88.49 -4.45 58.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.871 . . . . 0.67000000000000004 109.17 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.67 22.54 46.94 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.466 -1.854 . . . . 0.68000000000000005 108.466 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.02 162.46 14.03 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.538 -0.977 . . . . 0.77000000000000002 109.318 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -65.06 151.21 46.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 2.3999999999999999 109.528 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.3 mt -107.62 144.36 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 109.166 -0.679 . . . . 0.87 109.166 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.1 mm -76.77 100.54 2.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.236 -0.915 . . . . 1.3200000000000001 109.138 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.71 92.7 6.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.407 -0.808 . . . . 1.54 109.591 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.484 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 34.2 mt -79.56 -11.8 59.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.77000000000000002 108.924 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.8 p -86.37 47.16 1.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 1.5700000000000001 108.768 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.08 16.6 3.25 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.382 -0.823 . . . . 0.81999999999999995 110.199 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 152' ' ' ILE . 2.4 mp -69.04 151.79 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.856 -1.152 . . . . 0.81999999999999995 108.884 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -133.28 -22.32 1.99 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.05 -0.722 . . . . 2.1099999999999999 109.05 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.97 151.36 36.88 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.68 -0.859 . . . . 1.4099999999999999 108.68 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.61 124.73 24.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 1.3 109.835 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.2 m -148.27 167.71 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.199 -0.938 . . . . 0.56999999999999995 109.339 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.6 mt -89.5 156.99 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.789 -1.189 . . . . 0.42999999999999999 107.789 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.6 tp -107.23 121.67 45.0 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.732 0.777 . . . . 0.56000000000000005 109.69 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.16 128.6 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.659 -0.867 . . . . 0.54000000000000004 108.659 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -163.74 152.29 13.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 0.62 109.9 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.77 -43.1 94.49 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.374 -1.453 . . . . 0.80000000000000004 107.949 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -172.34 153.27 2.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 2.3399999999999999 109.458 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.1 mt -125.69 133.89 52.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.571 -0.706 . . . . 0.65000000000000002 109.399 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.4 p -93.04 154.39 41.71 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.822 . . . . 0.73999999999999999 109.084 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -33.9 -51.33 0.56 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.808 2.339 . . . . 0.59999999999999998 112.948 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.7 m -50.03 -50.35 47.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.099 -1.001 . . . . 0.63 109.289 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.99 -42.28 98.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.855 . . . . 1.25 109.846 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.4 p -70.49 -31.34 68.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.5 109.563 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.62 -29.74 68.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.51000000000000001 110.011 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -103.53 -4.31 24.11 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.25 -0.906 . . . . 1.1699999999999999 110.15 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 tp -57.71 153.14 14.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.91 -1.118 . . . . 0.60999999999999999 108.275 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 174' ' ' LYS . 9.2 p-10 -99.5 90.55 4.55 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.147 -0.971 . . . . 2.1200000000000001 110.3 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.56 32.18 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 1.3400000000000001 108.674 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 172' ' ' ASN . 67.6 mttm -111.12 -24.55 10.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.63 -0.669 . . . . 1.97 109.811 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -132.13 6.64 4.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.473 -0.767 . . . . 1.8999999999999999 109.796 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 172' ' ' ASN . 39.4 t -79.27 154.78 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.087 -1.008 . . . . 0.47999999999999998 109.031 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.38 -28.21 8.31 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.714 -0.616 . . . . 1.3899999999999999 110.154 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -176.91 177.96 48.16 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.91 -1.276 . . . . 0.38 109.91 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -129.36 125.53 36.85 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.519 -0.989 . . . . 0.46000000000000002 110.022 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.557 ' CG2' HG21 ' A' ' 205' ' ' THR . 16.8 mt -128.15 118.99 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.635 -1.246 . . . . 0.58999999999999997 107.635 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 203' ' ' VAL . 20.8 p -141.83 152.53 43.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.54 -0.725 . . . . 0.67000000000000004 111.169 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 26.5 p30 -87.66 45.06 1.24 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.991 -1.068 . . . . 2.2400000000000002 110.823 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.95 0 O-C-N 120.961 -1.087 . . . . 1.1100000000000001 109.326 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 12.9 t60 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.182 0.515 . . . . 0.92000000000000004 110.044 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.7 t -46.91 -25.87 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 1.5900000000000001 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.0 p -78.92 -45.88 19.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 1.4199999999999999 109.884 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.5 mt -52.49 -32.58 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 1.4099999999999999 109.674 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.9 mtp -71.46 -51.91 21.28 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.363 -1.347 . . . . 0.85999999999999999 107.363 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.71 58.82 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.628 -0.714 . . . . 0.58999999999999997 109.573 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.505 ' HG2' HH11 ' A' ' 195' ' ' ARG . 17.3 mtt-85 -76.95 -50.87 12.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 3.0600000000000001 109.904 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 61.1 m -68.7 -35.33 77.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.72999999999999998 109.738 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 199' ' ' LEU . 27.2 mt -87.13 1.49 52.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.265 -0.897 . . . . 0.67000000000000004 109.092 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 49.19 3.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.559 -0.713 . . . . 1.49 111.631 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 197' ' ' LEU . 40.7 mt -66.01 169.82 6.24 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.491 -1.381 . . . . 0.64000000000000001 108.382 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -89.86 141.7 3.79 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.249 1.966 . . . . 0.58999999999999997 111.054 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.08 179.74 7.29 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.468 -1.293 . . . . 0.55000000000000004 110.65 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 203' ' ' VAL . 70.6 mt -147.66 160.93 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 106.82 -1.548 . . . . 0.63 106.82 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 183' ' ' ALA . 18.1 m -141.58 -28.17 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.873 -1.142 . . . . 0.77000000000000002 110.918 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.36 38.5 3.18 Favored Glycine 0 N--CA 1.496 2.667 0 O-C-N 120.888 -1.132 . . . . 0.87 110.987 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.557 HG21 ' CG2' ' A' ' 180' ' ' ILE . 20.1 p -67.2 -29.11 68.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.67 -1.488 . . . . 0.89000000000000001 108.77 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 76.7 -98.69 1.3 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.788 -1.196 . . . . 0.93000000000000005 111.238 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.9 p -113.27 43.47 1.73 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.001 -1.294 . . . . 1.6000000000000001 112.395 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.8 -28.51 15.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.651 -1.281 . . . . 0.75 107.65 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.4 p -64.71 -12.98 52.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.287 -0.883 . . . . 0.83999999999999997 108.917 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.1 p -108.51 17.1 22.41 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.662 -0.866 . . . . 1.6100000000000001 108.662 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -131.55 -16.19 3.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.668 -0.645 . . . . 2.2999999999999998 109.668 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.586 HG12 ' N ' ' A' ' 213' ' ' LYS . 71.1 t -120.38 164.07 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.457 -0.777 . . . . 0.76000000000000001 109.597 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.586 ' N ' HG12 ' A' ' 212' ' ' VAL . 0.5 OUTLIER -126.58 174.21 8.86 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.841 -1.54 . . . . 2.0099999999999998 106.841 178.342 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 214' ' ' ASN . 1.4 p-10 -75.02 145.74 42.18 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.786 -1.197 . . . . 2.1899999999999999 109.824 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.6 OUTLIER 80.38 -12.12 1.07 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.803 -0.561 . . . . 2.3999999999999999 110.249 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -57.25 150.95 16.78 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.002 -1.061 . . . . 1.99 108.429 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -87.29 110.71 20.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.91 -1.119 . . . . 1.3 108.887 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 16.2 mt -106.22 160.92 14.97 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.89 0.853 . . . . 0.53000000000000003 109.65 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.509 HD12 ' CG ' ' A' ' 231' ' ' PRO . 3.2 mt -141.94 107.75 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.725 -1.213 . . . . 0.59999999999999998 107.725 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.5 tp -86.49 126.44 34.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.79 -0.818 . . . . 0.56999999999999995 108.79 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.0 -53.64 4.18 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.541 -0.911 . . . . 2.2200000000000002 108.541 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 58.51 22.87 10.14 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.413 -0.804 . . . . 0.75 109.24 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.0 t -117.83 -56.14 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.11 -1.441 . . . . 0.92000000000000004 107.11 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -96.41 13.25 28.46 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.539 -1.282 . . . . 2.3599999999999999 107.539 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 59.81 60.19 2.26 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.074 0.464 . . . . 1.4199999999999999 109.916 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -157.08 147.62 21.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 1.97 110.52 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.8 t -109.72 131.17 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.678 -0.86 . . . . 0.65000000000000002 108.678 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -103.66 131.31 50.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.203 -0.936 . . . . 0.96999999999999997 109.344 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.5 t -102.97 114.8 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.446 -0.784 . . . . 0.67000000000000004 109.716 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 36.8 t30 45.24 60.88 12.82 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.424 -0.798 . . . . 1.45 110.571 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.509 ' CG ' HD12 ' A' ' 219' ' ' ILE . 38.4 Cg_endo -70.35 165.06 32.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.283 1.989 . . . . 0.81999999999999995 111.415 179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.9 m -72.27 158.04 36.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 1.6200000000000001 109.804 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -64.48 -22.35 66.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 2.6000000000000001 109.031 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 234' ' ' GLU . 0.8 OUTLIER -66.91 -36.8 83.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.434 -0.791 . . . . 3.0600000000000001 109.129 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 68.7 t -79.01 -48.94 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.248 -0.908 . . . . 1.1399999999999999 108.704 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.93 -59.09 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.408 -0.807 . . . . 1.04 109.651 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -52.12 -41.3 62.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 2.54 109.961 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -66.84 -37.65 84.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 2.6000000000000001 109.739 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 243' ' ' GLN . 28.5 mtm -81.94 -32.96 30.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.908 . . . . 1.23 109.676 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -53.81 -40.03 66.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 2.6699999999999999 109.087 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.48 -51.65 12.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 1.6599999999999999 109.421 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.4 -47.11 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 2.2000000000000002 109.527 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.574 ' HG2' HD12 ' A' ' 11' ' ' ILE . 3.1 tm0? -47.56 -57.45 5.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 3.0 109.818 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--N 1.299 -1.614 0 O-C-N 121.439 -0.788 . . . . 1.76 110.732 -178.755 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.549 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.9 mpt? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.56 -0.533 . . . . 3.6600000000000001 109.56 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.23 94.18 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.584 -0.895 . . . . 1.1200000000000001 108.584 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.7 m -96.16 115.86 28.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.31 -0.869 . . . . 1.45 109.894 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.8 -163.5 21.41 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.332 -1.907 . . . . 0.92000000000000004 108.332 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 5' ' ' ILE . 51.1 mt -95.88 -6.15 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -1.171 . . . . 1.05 108.427 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 tp 60.21 107.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.419 -0.801 . . . . 0.88 108.915 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.63 -55.58 3.92 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.982 -1.118 . . . . 0.78000000000000003 107.982 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.23 150.27 37.44 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.32 -0.993 . . . . 1.5 108.32 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.47 154.18 21.07 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.087 1.858 . . . . 0.85999999999999999 113.954 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 161.08 -176.07 37.69 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.666 -1.373 . . . . 0.78000000000000003 109.666 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.7 mt -146.18 121.72 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.726 -1.455 . . . . 0.73999999999999999 109.171 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HB1' HD21 ' A' ' 177' ' ' LEU . . . -139.72 162.54 34.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.267 -0.896 . . . . 0.45000000000000001 109.733 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.9 m-85 -129.34 140.25 51.45 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.196 -1.039 . . . . 0.64000000000000001 108.196 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.18 159.76 28.15 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 118.612 -1.756 . . . . 0.45000000000000001 111.319 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -78.47 150.81 32.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.615 -0.933 . . . . 1.8799999999999999 109.724 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.42 127.95 34.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.284 -0.885 . . . . 0.58999999999999997 110.913 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.6 85.35 2.18 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.472 -1.307 . . . . 0.64000000000000001 107.472 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 18' ' ' LEU . 15.6 tp -82.01 132.23 35.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.055 -1.028 . . . . 0.73999999999999999 110.617 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 160' ' ' ALA . 14.3 mt -94.92 94.35 7.97 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.551 0.691 . . . . 0.73999999999999999 109.931 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -94.23 142.04 27.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.782 -0.821 . . . . 1.8700000000000001 108.782 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -128.74 135.37 49.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 2.5800000000000001 108.729 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -78.03 136.7 37.98 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.168 -0.958 . . . . 2.1400000000000001 109.007 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -60.79 143.88 53.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 1.9299999999999999 109.109 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.54 133.97 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.43 -0.793 . . . . 0.68000000000000005 109.906 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.4 t -106.78 113.72 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 0.83999999999999997 109.183 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.4 mt -87.69 134.83 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.79000000000000004 109.045 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -89.23 113.28 24.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 1.3700000000000001 109.638 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 28' ' ' ARG . 14.1 mmm-85 -96.06 26.25 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 2.6200000000000001 108.845 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -83.56 146.03 28.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -0.814 . . . . 2.3500000000000001 109.748 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -85.08 118.41 24.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.394 -0.965 . . . . 2.3500000000000001 108.394 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 pt -81.54 173.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.78000000000000003 109.977 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.8 p -97.87 161.15 13.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.031 -0.729 . . . . 1.04 109.031 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.0 -16.67 32.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.112 -0.993 . . . . 1.05 109.283 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.16 -7.43 59.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 2.4700000000000002 109.265 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -114.96 -13.52 11.91 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.849 -0.797 . . . . 1.46 108.849 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.9 t -65.66 -45.38 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 0.77000000000000002 109.402 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -54.94 -33.28 62.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 1.46 109.293 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -69.92 -33.99 72.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 2.29 110.26 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -62.8 -43.57 98.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 1.3 109.688 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -60.1 -46.94 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.41 -0.806 . . . . 0.76000000000000001 109.828 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.91 -43.39 88.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 1.5 108.883 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -65.18 -30.99 71.94 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.813 -0.81 . . . . 2.6600000000000001 108.813 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -86.39 -58.33 2.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.75 109.266 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.5 tp -52.48 -58.94 5.14 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.289 -0.882 . . . . 0.82999999999999996 109.287 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.6 t -63.76 -30.5 71.59 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.334 -0.987 . . . . 0.78000000000000003 108.334 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.81 -54.6 35.41 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 107.977 -2.049 . . . . 0.56999999999999995 107.977 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 29.8 ttm-85 -49.47 -30.52 8.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.535 -0.98 . . . . 2.8300000000000001 109.074 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.99 -40.59 81.08 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.551 -0.907 . . . . 0.65000000000000002 108.551 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -80.96 -59.34 2.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.667 -0.646 . . . . 2.5699999999999998 109.302 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.85 -40.83 57.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.032 . . . . 0.51000000000000001 110.205 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.459 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 29.2 t -62.32 -37.46 85.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.956 -1.09 . . . . 1.3600000000000001 108.183 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.58 -31.31 63.53 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.158 0.504 . . . . 0.59999999999999998 109.732 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -75.86 -65.95 0.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 1.3600000000000001 109.589 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 54' ' ' LEU . 9.7 mp -50.12 -27.02 5.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 1.3799999999999999 109.332 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 51' ' ' SER . 4.1 mm-40 -71.76 -42.22 67.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 1.27 108.646 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 m -61.64 -37.16 83.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.59999999999999998 109.435 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.32 -25.79 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 0.53000000000000003 109.117 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.471 ' NZ ' ' OE1' ' A' ' 70' ' ' GLU . 9.9 ttpp -61.17 -46.88 88.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.98999999999999999 110.2 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.18 -30.81 68.03 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.128 -0.983 . . . . 0.58999999999999997 109.844 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -70.43 -18.89 63.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.695 -1.253 . . . . 1.8100000000000001 108.123 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.79 -33.42 30.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.567 -0.901 . . . . 0.47999999999999998 108.567 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.88 -28.42 28.92 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.192 -1.163 . . . . 0.57999999999999996 110.192 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.14 -15.09 42.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.016 -1.285 . . . . 1.3899999999999999 109.0 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.8 m -95.37 -48.37 5.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.24 -0.912 . . . . 0.81999999999999995 110.179 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -106.33 -21.73 13.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.339 -0.851 . . . . 0.98999999999999999 110.124 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 121.5 147.12 7.58 Favored Glycine 0 N--CA 1.503 3.13 0 N-CA-C 110.082 -1.207 . . . . 0.55000000000000004 110.082 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -48.49 -11.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.606 -0.938 . . . . 2.5899999999999999 110.197 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 66' ' ' GLY . 63.0 mt-10 -63.99 -29.61 70.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.089 -1.007 . . . . 2.2000000000000002 110.802 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -91.82 -7.65 48.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.8 -1.188 . . . . 1.79 111.087 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.471 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 56.3 mt-10 -63.85 -24.52 67.78 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.732 -1.23 . . . . 1.54 110.598 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.67 -28.36 69.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.02 -1.05 . . . . 0.64000000000000001 110.508 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.37 -44.25 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.011 -1.055 . . . . 0.57999999999999996 110.064 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.55 -21.47 45.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.088 -1.007 . . . . 0.62 109.845 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -64.93 -44.16 90.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 1.23 109.571 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.35 -37.22 59.1 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.66 -1.376 . . . . 0.52000000000000002 109.66 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -61.37 -20.55 63.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.294 -1.121 . . . . 1.29 110.455 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.0 mt -85.79 -37.04 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.592 -1.317 . . . . 0.55000000000000004 108.393 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.8 ttt -58.78 -42.25 88.56 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.224 -1.028 . . . . 1.8899999999999999 108.224 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.12 -37.23 84.34 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.358 -0.978 . . . . 0.53000000000000003 108.358 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.452 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 23.8 tp -69.55 -43.97 71.86 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.649 -0.821 . . . . 0.42999999999999999 109.151 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -85.41 7.12 23.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 1.24 110.222 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.419 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 57.3 t0 -47.06 122.55 4.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.012 -1.055 . . . . 1.3100000000000001 109.695 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.66 -24.81 66.33 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.726 -0.842 . . . . 1.3500000000000001 108.726 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 18.7 mp0 -76.14 -49.53 17.06 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.783 -0.767 . . . . 2.1600000000000001 109.205 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.2 mt -63.75 -13.96 48.27 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.823 -1.151 . . . . 0.59999999999999998 108.715 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -79.2 -56.18 4.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.508 -0.745 . . . . 1.28 109.836 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -63.33 -26.27 68.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 1.28 109.977 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.42 -44.05 62.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.101 -0.999 . . . . 1.29 108.673 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.1 mt -60.7 -56.49 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.097 -1.075 . . . . 0.57999999999999996 108.097 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -47.16 -53.0 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.635 -0.666 . . . . 0.78000000000000003 109.543 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.69 -44.41 93.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 0.85999999999999999 109.227 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.8 mt -57.97 -56.85 16.64 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.168 -1.049 . . . . 0.79000000000000004 108.168 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.6 mt -51.2 -39.84 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.70999999999999996 110.073 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -85.34 -36.4 20.8 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.086 -1.008 . . . . 2.0499999999999998 111.681 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 91' ' ' ALA . 22.1 t70 -82.75 -43.55 16.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.798 -1.189 . . . . 1.5900000000000001 111.486 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -102.07 12.2 37.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.768 -1.208 . . . . 1.8899999999999999 109.538 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 45.59 48.57 11.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.371 -0.831 . . . . 1.3100000000000001 109.368 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtp -101.41 152.19 21.03 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.092 -0.706 . . . . 1.28 109.092 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 p -76.31 145.05 39.84 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.436 -0.79 . . . . 0.62 109.462 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.44 29.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.166 -0.959 . . . . 0.46999999999999997 108.797 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -72.71 -45.99 55.95 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.28 -1.007 . . . . 2.0 108.28 179.049 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.1 -51.42 21.57 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.391 0.615 . . . . 0.56000000000000005 109.973 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.34 -50.92 71.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.47999999999999998 109.647 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.37 -34.15 64.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.194 -0.941 . . . . 0.44 109.799 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -69.03 -31.48 70.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 1.4199999999999999 109.229 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.5 tt0 -71.59 -57.63 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 1.26 109.892 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.445 ' H ' HG23 ' A' ' 107' ' ' VAL . 7.7 t -55.2 -49.9 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.60999999999999999 109.811 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.572 HG21 ' HA3' ' A' ' 134' ' ' GLY . 28.1 mm -64.68 -70.16 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.64000000000000001 109.613 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.46 ' OE2' ' NE ' ' A' ' 131' ' ' ARG . 18.1 tp10 -50.55 -45.3 56.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.826 -1.171 . . . . 2.2000000000000002 108.992 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -45.04 -40.07 6.92 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.11 -1.596 . . . . 0.81999999999999995 109.11 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -69.17 -59.41 3.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.343 -1.092 . . . . 1.27 108.29 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.74 -43.5 37.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.809 -0.812 . . . . 0.91000000000000003 108.809 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.8 m -59.99 -37.04 78.5 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.305 -0.872 . . . . 1.73 109.186 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.54 84.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 1.04 109.878 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.81 -29.48 67.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.929 -1.107 . . . . 1.03 108.677 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.54 -17.13 62.48 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.455 -0.943 . . . . 1.95 108.455 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -82.42 -1.01 48.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.567 -0.708 . . . . 1.71 109.481 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.5 HD13 HD13 ' A' ' 123' ' ' LEU . 12.1 mt -83.77 158.72 21.63 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.136 -0.978 . . . . 1.26 109.209 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -100.5 50.56 0.89 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.891 -0.781 . . . . 2.8300000000000001 108.891 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -146.56 119.21 8.56 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.222 -0.924 . . . . 1.5800000000000001 109.612 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.71 -19.3 58.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.372 -0.83 . . . . 2.7999999999999998 109.501 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.22 -65.21 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 1.02 109.275 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.5 HD13 HD13 ' A' ' 118' ' ' LEU . 46.8 mt -47.58 -31.29 4.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.09 -1.006 . . . . 1.0600000000000001 109.624 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 1.9 ttmp? -65.52 -39.97 92.43 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.918 -1.113 . . . . 2.3900000000000001 108.319 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -58.13 -23.41 55.03 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.392 -0.966 . . . . 2.2000000000000002 108.392 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -72.99 -27.26 61.69 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.537 -1.653 . . . . 2.0899999999999999 106.537 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -57.67 -39.83 77.96 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.098 -1.075 . . . . 0.85999999999999999 108.098 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.07 -36.42 81.98 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.793 -0.817 . . . . 0.90000000000000002 108.793 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.45 -36.94 77.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.348 -0.845 . . . . 1.3500000000000001 109.254 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.4 t -76.65 -44.24 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.04 -1.096 . . . . 0.57999999999999996 108.04 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.46 ' NE ' ' OE2' ' A' ' 109' ' ' GLU . 42.4 ttm180 -60.55 -34.7 74.53 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.925 -1.139 . . . . 3.2200000000000002 107.925 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -58.94 -35.55 73.32 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.502 -0.749 . . . . 1.3200000000000001 109.17 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.19 -26.51 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.5 108.528 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.572 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -78.29 -42.64 14.6 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.145 -1.582 . . . . 0.44 109.145 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -55.42 -54.09 48.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.545 -0.973 . . . . 2.71 109.986 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.523 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 34.4 mtm180 -63.56 -38.79 92.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.176 -0.952 . . . . 2.2000000000000002 108.697 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 41.5 tp -61.83 -40.34 94.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.437 -0.79 . . . . 1.1299999999999999 109.719 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.8 mt -67.54 -54.8 16.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.05 -1.031 . . . . 0.54000000000000004 109.335 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -49.16 -19.0 0.39 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 2.3199999999999998 109.529 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -84.24 -39.9 18.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 1.26 109.586 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.14 -40.3 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.005 . . . . 0.62 109.693 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.9 mt -88.72 2.11 53.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.158 -0.964 . . . . 0.67000000000000004 109.272 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.64 29.23 48.27 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.422 -1.871 . . . . 0.68000000000000005 108.422 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.9 tp -58.52 148.14 29.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.595 -0.944 . . . . 0.77000000000000002 109.542 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.31 132.64 47.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.942 . . . . 2.3999999999999999 109.786 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.4 mt -110.47 144.12 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 109.172 -0.677 . . . . 0.87 109.172 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.76 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.2 mp -78.54 133.21 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.072 -1.017 . . . . 1.3200000000000001 109.768 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.96 87.85 3.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.502 -0.749 . . . . 1.54 109.408 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.45 -22.22 44.44 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.241 -0.912 . . . . 0.77000000000000002 109.586 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.5 t -80.8 17.81 1.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.151 -0.968 . . . . 1.5700000000000001 109.446 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.08 29.19 2.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.389 -0.819 . . . . 0.81999999999999995 109.416 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.59 153.14 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.293 -0.879 . . . . 0.81999999999999995 108.985 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -132.96 -2.1 3.26 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.394 -0.816 . . . . 2.1099999999999999 109.245 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -129.8 125.74 36.47 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.821 -0.807 . . . . 1.4099999999999999 108.821 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.68 129.19 38.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 1.3 109.714 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.32 175.79 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.56999999999999995 108.806 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.8 mt -89.31 149.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.891 -1.151 . . . . 0.42999999999999999 107.891 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.3 tp -104.73 119.85 39.97 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.534 -0.729 . . . . 0.56000000000000005 109.612 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.0 125.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.99 -0.744 . . . . 0.54000000000000004 108.99 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.444 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -162.5 147.06 12.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.62 109.816 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.38 -38.15 71.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.745 -1.222 . . . . 0.80000000000000004 108.131 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -173.97 147.66 1.32 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.428 -0.795 . . . . 2.3399999999999999 109.651 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.2 mt -117.68 136.53 53.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.634 -0.667 . . . . 0.65000000000000002 109.383 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.6 p -94.06 152.19 40.24 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.222 -0.924 . . . . 0.73999999999999999 109.296 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -36.21 -39.38 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.442 2.095 . . . . 0.59999999999999998 112.567 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.523 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 1.4 m -56.83 -57.23 13.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.138 -0.976 . . . . 0.63 109.13 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -60.01 -41.99 93.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.474 -0.767 . . . . 1.25 109.79 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.0 p -71.17 -19.78 62.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.052 -1.03 . . . . 0.5 109.409 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.3 -25.48 33.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.51000000000000001 109.745 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -103.47 -18.9 14.6 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.26 -0.9 . . . . 1.1699999999999999 109.209 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.78 144.51 48.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.121 -1.066 . . . . 0.60999999999999999 108.121 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 175' ' ' LYS . 1.7 m120 -95.64 134.79 38.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.0 -1.062 . . . . 2.1200000000000001 108.587 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.1 mt -78.66 -42.95 27.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.391 -0.818 . . . . 1.3400000000000001 111.654 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -80.0 -8.82 59.56 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.672 -1.267 . . . . 1.97 111.767 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 172' ' ' ASN . 58.6 mttp -99.98 -7.3 25.28 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.694 -1.253 . . . . 1.8999999999999999 108.721 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 177' ' ' LEU . 54.3 t -98.32 162.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.488 -0.757 . . . . 0.47999999999999998 109.057 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.567 HD21 ' HB1' ' A' ' 12' ' ' ALA . 8.5 tp -115.2 -20.09 10.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.555 -0.716 . . . . 1.3899999999999999 109.954 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.9 174.58 42.57 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.406 -1.478 . . . . 0.38 109.406 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 1.3 m-85 -128.07 124.16 36.36 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.346 -1.091 . . . . 0.46000000000000002 110.156 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 205' ' ' THR . 7.8 mt -121.19 109.96 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 106.92 -1.511 . . . . 0.58999999999999997 106.92 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.604 ' O ' ' O ' ' A' ' 203' ' ' VAL . 31.2 p -140.58 154.99 46.7 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.119 -0.988 . . . . 0.67000000000000004 112.578 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 182' ' ' ASP . 42.6 t0 -80.18 40.94 0.5 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.823 -0.626 . . . . 2.2400000000000002 110.831 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.305 0 O-C-N 120.229 -1.544 . . . . 1.1100000000000001 110.544 -178.819 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 75.4 t60 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.972 -0.751 . . . . 0.92000000000000004 108.972 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.8 p -50.54 -36.99 36.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 1.5900000000000001 109.147 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.1 m -62.01 -41.31 97.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.337 -0.852 . . . . 1.4199999999999999 109.35 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.5 mt -58.01 -24.76 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 1.4099999999999999 109.478 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.3 mtp -71.81 -58.83 3.13 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.689 -1.226 . . . . 0.85999999999999999 107.689 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.22 -41.71 62.97 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.325 0.583 . . . . 0.58999999999999997 109.722 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 20.5 mtt-85 -69.02 -50.67 46.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 3.0600000000000001 109.882 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.5 m -69.12 -38.44 78.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.051 -1.031 . . . . 0.72999999999999998 109.906 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 199' ' ' LEU . 22.3 mt -87.81 3.39 48.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.106 -0.996 . . . . 0.67000000000000004 108.858 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 44.02 11.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.741 -0.6 . . . . 1.49 112.019 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 197' ' ' LEU . 17.1 mt -68.98 169.51 11.16 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.372 -1.455 . . . . 0.64000000000000001 108.495 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.88 139.64 3.86 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.345 2.03 . . . . 0.58999999999999997 110.907 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.37 -172.96 2.64 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.19 -1.404 . . . . 0.55000000000000004 111.595 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.2 mt -149.12 153.1 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.248 -1.39 . . . . 0.63 107.248 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.604 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.7 m -138.22 -39.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.874 -1.141 . . . . 0.77000000000000002 111.113 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.501 ' N ' HG23 ' A' ' 203' ' ' VAL . . . -71.45 39.96 0.61 Allowed Glycine 0 C--N 1.285 -2.276 0 N-CA-C 108.599 -1.8 . . . . 0.87 108.599 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.508 HG21 HG23 ' A' ' 180' ' ' ILE . 47.1 p -67.38 -18.29 65.07 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.106 -1.232 . . . . 0.89000000000000001 109.531 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.419 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 62.64 -101.08 0.36 Allowed Glycine 0 N--CA 1.484 1.859 0 C-N-CA 119.392 -1.385 . . . . 0.93000000000000005 110.121 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.2 m -117.55 45.61 1.89 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.301 -1.117 . . . . 1.6000000000000001 112.331 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 62.6 t -74.82 -26.73 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.454 -1.403 . . . . 0.75 107.786 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.7 p -68.28 -12.75 61.54 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.738 . . . . 0.83999999999999997 109.599 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.9 m -102.4 9.34 39.79 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.416 -0.802 . . . . 1.6100000000000001 109.049 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -131.17 -5.78 3.86 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.569 -0.707 . . . . 2.2999999999999998 109.195 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 23.3 t -122.64 148.57 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.649 -0.871 . . . . 0.76000000000000001 108.649 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -121.54 -174.29 2.83 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.619 -1.623 . . . . 2.0099999999999998 106.619 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.6 m120 -79.51 150.52 31.15 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.776 -1.202 . . . . 2.1899999999999999 109.839 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.7 m-20 81.07 -14.42 0.83 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.052 -0.405 . . . . 2.3999999999999999 110.94 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.64 128.2 35.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.755 -1.215 . . . . 1.99 108.355 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -86.62 119.11 26.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.868 -1.145 . . . . 1.3 108.883 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.7 mt -119.62 163.29 17.58 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.666 0.746 . . . . 0.53000000000000003 110.124 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.1 mt -128.68 118.96 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.742 -1.207 . . . . 0.59999999999999998 107.742 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.6 tp -87.18 120.61 28.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.425 -0.954 . . . . 0.56999999999999995 108.425 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.4 t0 -95.97 -31.07 13.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.212 -0.93 . . . . 2.2200000000000002 108.838 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.17 28.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.456 0.645 . . . . 0.75 110.248 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.6 t -123.9 -67.36 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.821 -1.548 . . . . 0.92000000000000004 106.821 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 224' ' ' ASN . 19.9 t-20 -84.12 10.95 8.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.218 -1.401 . . . . 2.3599999999999999 107.218 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 58.22 61.99 2.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.906 -0.496 . . . . 1.4199999999999999 110.092 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -156.8 147.89 22.01 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.122 -0.986 . . . . 1.97 110.673 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.47 141.5 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.663 -0.866 . . . . 0.65000000000000002 108.663 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -104.62 127.77 52.46 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.177 -0.952 . . . . 0.96999999999999997 109.408 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.42 120.59 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.48 -0.762 . . . . 0.67000000000000004 110.358 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 43.5 t30 55.55 74.37 0.72 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 1.45 110.314 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -87.05 149.16 8.14 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.018 2.479 . . . . 0.81999999999999995 112.148 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.2 m -72.14 160.99 31.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.258 -0.901 . . . . 1.6200000000000001 109.966 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -64.37 -30.67 71.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -0.799 . . . . 2.6000000000000001 109.758 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -67.11 -37.61 84.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 3.0600000000000001 109.165 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.65 -32.59 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 1.1399999999999999 108.941 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt -72.88 -61.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 1.04 109.209 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -53.61 -41.49 66.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.498 -0.751 . . . . 2.54 110.106 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -66.34 -34.86 78.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.09 -1.006 . . . . 2.6000000000000001 109.439 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 57.1 mtp -81.68 -39.37 24.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.89 . . . . 1.23 109.437 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.404 ' O ' ' OE1' ' A' ' 244' ' ' GLU . 16.6 mmt180 -49.35 -47.25 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.139 -0.976 . . . . 2.6699999999999999 109.546 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.03 -64.11 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -0.963 . . . . 1.6599999999999999 110.671 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 24.4 t -59.68 -52.7 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 2.2000000000000002 111.201 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' A' ' 239' ' ' MET . 7.0 tp-100 -54.78 -41.08 70.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.672 -1.267 . . . . 3.0 109.925 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.404 ' OE1' ' O ' ' A' ' 240' ' ' ARG . 62.0 mt-10 . . . . . 0 C--N 1.302 -1.47 0 O-C-N 120.623 -1.298 . . . . 1.76 109.881 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.372 -0.603 . . . . 3.6600000000000001 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.6 mt -129.95 91.54 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.809 -0.811 . . . . 1.1200000000000001 108.809 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m -91.68 117.03 29.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.185 -0.947 . . . . 1.45 110.049 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.95 -159.54 11.98 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 108.149 -1.98 . . . . 0.92000000000000004 108.149 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.1 mt -97.63 -10.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.133 -1.216 . . . . 1.05 109.04 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 tp 60.3 103.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.343 -0.848 . . . . 0.88 108.901 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.97 -48.43 7.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.997 -1.064 . . . . 0.78000000000000003 108.974 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.98 145.8 26.15 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.411 -0.805 . . . . 1.5 108.975 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.47 153.48 23.79 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.32 2.014 . . . . 0.85999999999999999 113.748 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.75 177.12 32.55 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.959 -1.256 . . . . 0.78000000000000003 109.959 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mt -143.86 120.74 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.974 -1.309 . . . . 0.73999999999999999 109.776 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.588 ' HB1' HD21 ' A' ' 177' ' ' LEU . . . -143.23 140.55 30.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.124 -0.985 . . . . 0.45000000000000001 109.399 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.7 m-85 -105.87 151.37 24.62 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.689 -0.856 . . . . 0.64000000000000001 108.689 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.58 166.38 31.05 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 118.66 -1.733 . . . . 0.45000000000000001 111.467 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -81.92 153.34 26.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.653 -0.91 . . . . 1.8799999999999999 110.377 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.06 126.22 30.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.774 . . . . 0.58999999999999997 111.642 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.7 tp -108.13 89.26 2.94 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 107.52 -1.289 . . . . 0.64000000000000001 107.52 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.0 tp -81.26 129.39 34.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.011 -1.055 . . . . 0.73999999999999999 110.206 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.468 HD11 HD11 ' A' ' 158' ' ' LEU . 17.9 mt -96.39 94.41 7.41 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.413 0.625 . . . . 0.73999999999999999 110.433 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -97.16 157.68 15.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.726 -0.842 . . . . 1.8700000000000001 108.726 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -130.77 134.26 46.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.25 -0.906 . . . . 2.5800000000000001 108.87 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -79.31 137.76 37.47 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.173 -0.955 . . . . 2.1400000000000001 109.368 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.74 141.67 58.7 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.541 -0.724 . . . . 1.9299999999999999 109.136 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.1 mt -89.36 138.32 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 0.68000000000000005 109.586 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.04 114.83 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.505 -0.747 . . . . 0.83999999999999997 109.179 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.1 mt -87.43 133.88 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.912 . . . . 0.79000000000000004 109.611 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.78 120.41 31.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.462 -0.774 . . . . 1.3700000000000001 108.998 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -99.92 32.02 3.07 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.229 -0.92 . . . . 2.6200000000000001 109.444 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -83.31 138.53 33.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.044 -1.035 . . . . 2.3500000000000001 110.284 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -84.77 134.69 34.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.309 -0.997 . . . . 2.3500000000000001 108.309 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.9 pt -97.74 176.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.159 -0.963 . . . . 0.78000000000000003 110.841 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 34' ' ' ASP . 36.3 p -98.37 153.26 18.68 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.394 -0.965 . . . . 1.04 108.394 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.34 -7.75 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 1.05 110.139 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 32' ' ' SER . 17.7 t70 -84.78 -21.76 29.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.905 -1.122 . . . . 2.4700000000000002 110.323 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -106.41 -3.81 20.61 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.193 -0.942 . . . . 1.46 109.531 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.7 -43.69 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.77000000000000002 109.237 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -53.79 -34.59 59.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.284 -0.885 . . . . 1.46 109.184 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.47 -33.3 72.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 2.29 109.698 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -61.65 -46.64 88.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.007 -1.058 . . . . 1.3 109.68 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.78 -45.41 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.76000000000000001 109.693 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.28 -39.62 92.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.108 -0.995 . . . . 1.5 108.334 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -65.11 -32.75 74.61 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.949 -0.76 . . . . 2.6600000000000001 108.949 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -86.62 -57.68 2.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.144 -0.973 . . . . 0.75 108.476 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -49.32 -61.93 1.82 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.73 -0.841 . . . . 0.82999999999999996 108.73 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.67 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.7 t -65.2 -33.82 76.91 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.312 -0.995 . . . . 0.78000000000000003 108.312 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.27 -54.46 35.61 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 107.927 -2.069 . . . . 0.56999999999999995 107.927 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -48.63 -30.11 5.07 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.384 -1.068 . . . . 2.8300000000000001 108.561 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.12 -34.43 70.21 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.897 -1.149 . . . . 0.65000000000000002 107.897 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 mttt -79.17 -58.61 3.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.805 -0.813 . . . . 2.5699999999999998 108.805 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.35 -40.52 62.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.51000000000000001 109.937 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 t -62.23 -38.25 88.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.952 -1.093 . . . . 1.3600000000000001 108.498 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.82 -36.33 67.48 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.378 -0.601 . . . . 0.59999999999999998 109.378 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -65.57 -62.76 1.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.351 -0.843 . . . . 1.3600000000000001 109.535 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.08 -38.89 62.92 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.304 -0.873 . . . . 1.3799999999999999 109.161 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -59.92 -46.88 87.97 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.591 -0.892 . . . . 1.27 108.591 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.5 m -61.99 -37.7 85.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.485 -0.759 . . . . 0.59999999999999998 109.332 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.2 mt -73.3 -29.3 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.821 . . . . 0.53000000000000003 109.151 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -63.94 -43.32 96.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -0.819 . . . . 0.98999999999999999 109.03 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.2 m -72.34 -26.99 62.14 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.365 -0.834 . . . . 0.58999999999999997 109.538 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -72.82 -30.04 63.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.638 -1.245 . . . . 1.8100000000000001 107.638 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.28 63.68 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.111 -1.07 . . . . 0.47999999999999998 108.111 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.12 -28.21 28.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.608 -1.397 . . . . 0.57999999999999996 109.608 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -86.54 -16.06 38.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.812 -1.404 . . . . 1.3899999999999999 108.462 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.2 m -94.44 -49.27 5.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.81999999999999995 110.36 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.472 ' C ' ' H ' ' A' ' 67' ' ' GLU . 53.0 m-85 -107.11 -33.21 7.52 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.156 -0.965 . . . . 0.98999999999999999 110.241 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.48 -29.92 0.71 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.179 -1.168 . . . . 0.55000000000000004 110.179 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 69' ' ' LYS . 38.4 mt-10 -52.85 179.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -1.157 . . . . 2.5899999999999999 110.3 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -68.36 40.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.518 -0.738 . . . . 2.2000000000000002 109.532 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 67' ' ' GLU . 35.1 mmtt -85.03 -17.26 38.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.639 -0.874 . . . . 1.79 108.639 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.78 -34.8 77.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.614 -0.679 . . . . 1.54 110.517 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.79 -27.15 67.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 0.64000000000000001 110.817 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.9 mt -71.79 -46.73 59.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.849 -1.157 . . . . 0.57999999999999996 109.782 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -74.98 -21.66 59.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.085 -1.009 . . . . 0.62 109.757 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.6 -41.62 92.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.146 -0.971 . . . . 1.23 109.383 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.25 -37.47 63.3 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.483 -1.447 . . . . 0.52000000000000002 109.483 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -21.37 57.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -1.15 . . . . 1.29 109.3 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -85.15 -34.39 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.064 -1.022 . . . . 0.55000000000000004 108.473 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.3 ttt -60.61 -44.93 95.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -0.972 . . . . 1.8899999999999999 108.511 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.79 -40.38 83.87 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.215 -1.032 . . . . 0.53000000000000003 108.215 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.5 tp -65.87 -43.99 86.7 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.672 -0.811 . . . . 0.42999999999999999 108.858 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -85.84 9.48 16.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.191 -0.943 . . . . 1.24 110.363 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -50.47 119.92 4.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.77 -1.206 . . . . 1.3100000000000001 109.264 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.06 -22.97 67.05 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.245 -0.909 . . . . 1.3500000000000001 108.838 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.14 -51.87 12.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.412 -0.805 . . . . 2.1600000000000001 109.392 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.78 -12.28 45.91 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.208 -0.997 . . . . 0.59999999999999998 109.224 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -79.7 -50.24 10.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.431 -0.793 . . . . 1.28 110.365 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -62.37 -31.96 72.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.128 -0.982 . . . . 1.28 110.099 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.02 -44.64 68.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 1.29 109.291 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.04 -58.53 6.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.576 -0.898 . . . . 0.57999999999999996 108.576 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.7 mt -48.75 -61.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.686 -0.634 . . . . 0.78000000000000003 110.576 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -53.19 -45.31 68.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.024 -1.048 . . . . 0.85999999999999999 110.403 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 mt -56.23 -56.13 24.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.127 -0.983 . . . . 0.79000000000000004 108.663 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.8 mt -54.73 -47.54 73.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.187 -0.946 . . . . 0.70999999999999996 110.57 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -78.32 -36.62 46.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.058 -1.026 . . . . 2.0499999999999998 111.302 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' ALA . 9.4 t70 -82.09 -40.51 21.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.901 -1.125 . . . . 1.5900000000000001 112.055 -176.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -109.84 21.29 17.06 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.752 -1.218 . . . . 1.8899999999999999 110.689 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.522 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 0.3 OUTLIER 42.73 55.19 4.38 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.299 -0.875 . . . . 1.3100000000000001 110.473 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.8 mtt -103.91 147.38 27.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.601 -0.889 . . . . 1.28 108.601 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.2 p -77.68 150.5 34.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.62 109.87 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.42 -31.67 6.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.46999999999999997 108.892 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -77.08 -43.15 35.39 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.777 -0.823 . . . . 2.0 108.777 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.62 9.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.572 -0.705 . . . . 0.56000000000000005 109.871 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.06 -48.28 78.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.859 . . . . 0.47999999999999998 109.466 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.5 64.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.44 109.858 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 109' ' ' GLU . 76.4 t60 -67.93 -51.09 51.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.999 -1.063 . . . . 1.4199999999999999 109.727 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.11 -62.21 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.338 -0.851 . . . . 1.26 110.502 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 43.7 t -52.75 -54.18 17.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.804 -1.185 . . . . 0.60999999999999999 109.302 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.36 -23.19 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.64000000000000001 109.664 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 105' ' ' HIS . 45.8 tp10 -73.08 -30.45 63.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.025 -1.047 . . . . 2.2000000000000002 110.069 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.26 -27.97 29.12 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.114 -1.517 . . . . 0.81999999999999995 111.985 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -67.06 -45.35 77.61 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.425 -1.633 . . . . 1.27 108.035 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.16 -55.72 5.45 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.917 -0.489 . . . . 0.91000000000000003 110.698 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.9 p -56.97 -41.25 78.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 1.73 110.215 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.97 81.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.085 -1.009 . . . . 1.04 110.277 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.71 -30.38 70.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.761 -1.212 . . . . 1.03 109.319 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.58 -18.94 65.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.095 . . . . 1.95 109.726 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -82.93 -9.24 59.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 1.71 109.385 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.415 HD13 HD13 ' A' ' 123' ' ' LEU . 0.8 OUTLIER -86.8 138.45 31.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.264 -1.013 . . . . 1.26 108.264 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 22.8 p-10 -96.02 63.41 2.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 2.8300000000000001 109.154 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -148.79 108.7 4.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.317 -0.864 . . . . 1.5800000000000001 109.48 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -50.35 -15.85 0.28 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.569 -0.707 . . . . 2.7999999999999998 110.009 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -78.3 -60.92 2.18 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.242 -0.911 . . . . 1.02 109.353 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.415 HD13 HD13 ' A' ' 118' ' ' LEU . 7.9 mt -67.19 -31.52 71.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.262 -0.899 . . . . 1.0600000000000001 109.254 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -68.24 -49.54 59.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.991 . . . . 2.3900000000000001 109.234 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -61.14 -18.68 59.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.277 -1.008 . . . . 2.2000000000000002 108.277 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.422 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 26.1 ttt-85 -75.46 -28.24 59.21 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.093 -1.447 . . . . 2.0899999999999999 107.093 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.82 97.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.698 -0.853 . . . . 0.85999999999999999 108.698 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.9 -35.08 79.98 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.247 -1.02 . . . . 0.90000000000000002 108.247 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 2.8 m-20 -71.97 -32.2 67.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 1.3500000000000001 109.122 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.422 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 42.8 t -77.03 -45.6 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.57999999999999996 108.95 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -60.19 -36.92 78.72 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.117 -0.989 . . . . 3.2200000000000002 108.37 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.49 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 30.7 t70 -58.92 -36.5 74.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.5 -0.75 . . . . 1.3200000000000001 109.486 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.07 -26.08 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.058 -1.026 . . . . 0.5 108.803 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.34 -47.39 5.75 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.26 -1.536 . . . . 0.44 109.26 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.416 ' HZ2' ' HB3' ' A' ' 135' ' ' LYS . 15.3 mtpp -51.58 -43.91 62.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -1.173 . . . . 2.71 109.119 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.522 ' CG ' HH11 ' A' ' 136' ' ' ARG . 6.2 mtt-85 -65.51 -42.7 91.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.206 -1.035 . . . . 2.2000000000000002 108.206 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.77 -51.3 70.57 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.474 -0.565 . . . . 1.1299999999999999 109.474 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.6 mt -53.13 -58.06 8.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.54000000000000004 109.279 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -51.01 -21.4 1.77 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.882 . . . . 2.3199999999999998 109.673 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 136' ' ' ARG . 5.1 m120 -85.84 -42.05 14.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.03 . . . . 1.26 109.111 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.89 -47.49 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.081 -1.012 . . . . 0.62 108.294 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 58.8 mt -90.76 -7.81 51.45 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.777 -0.823 . . . . 0.67000000000000004 108.777 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 144' ' ' LEU . . . 60.99 26.08 65.09 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.239 -1.944 . . . . 0.68000000000000005 108.239 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 145' ' ' LYS . 3.1 tp -52.84 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.605 -0.938 . . . . 0.77000000000000002 109.095 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.431 ' H ' ' HG ' ' A' ' 144' ' ' LEU . 47.5 tttp -69.0 137.5 53.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.127 -0.983 . . . . 2.3999999999999999 110.429 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 75.1 mt -106.49 137.49 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.491 -0.929 . . . . 0.87 108.491 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mm -75.79 116.65 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.073 -1.017 . . . . 1.3200000000000001 108.877 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -98.58 82.88 2.91 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.263 -0.898 . . . . 1.54 109.89 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.3 mt -84.51 -14.08 50.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 0.77000000000000002 109.103 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.7 p -84.3 -13.8 51.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 1.5700000000000001 109.891 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.96 42.8 1.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.27 -0.894 . . . . 0.81999999999999995 110.862 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.6 mm -73.49 149.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.658 -1.276 . . . . 0.81999999999999995 108.738 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -136.78 -2.29 2.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.389 -0.819 . . . . 2.1099999999999999 109.466 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -125.45 127.93 47.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.512 -0.742 . . . . 1.4099999999999999 109.495 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.49 118.56 8.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.308 -0.87 . . . . 1.3 108.9 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -151.26 176.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.56999999999999995 108.765 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 218' ' ' LEU . 3.2 mt -89.5 156.49 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.136 -1.061 . . . . 0.42999999999999999 108.136 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.468 HD11 HD11 ' A' ' 19' ' ' LEU . 18.6 tp -108.89 123.01 48.4 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.512 0.672 . . . . 0.56000000000000005 109.693 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.83 133.01 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.213 -0.662 . . . . 0.54000000000000004 109.213 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.99 145.67 10.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.073 -1.017 . . . . 0.62 109.918 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.19 -34.56 75.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.343 -1.473 . . . . 0.80000000000000004 108.039 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -173.19 154.06 2.62 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.296 -0.631 . . . . 2.3399999999999999 109.296 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.4 mt -128.37 130.65 48.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.484 -0.76 . . . . 0.65000000000000002 109.126 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.5 p -89.74 152.49 46.88 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.73999999999999999 109.259 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -34.26 -41.8 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.713 2.276 . . . . 0.59999999999999998 113.235 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 m -57.4 -60.31 3.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.819 -1.175 . . . . 0.63 109.45 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -55.61 -36.27 66.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.472 -0.768 . . . . 1.25 110.352 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.8 p -73.73 -32.6 63.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.124 -0.985 . . . . 0.5 110.055 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.33 -31.53 64.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.952 . . . . 0.51000000000000001 110.794 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -101.63 1.61 37.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.103 -0.998 . . . . 1.1699999999999999 109.901 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.2 tp -54.28 160.96 1.47 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.089 -1.007 . . . . 0.60999999999999999 109.054 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 174' ' ' LYS . 27.5 t-20 -100.73 79.7 2.1 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.39 -0.819 . . . . 2.1200000000000001 109.928 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 14.9 mt -74.81 28.65 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 1.3400000000000001 108.642 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 172' ' ' ASN . 31.7 mtpt -106.71 -30.7 8.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 1.97 110.187 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -133.2 14.32 4.2 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.232 -0.918 . . . . 1.8999999999999999 110.028 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 172' ' ' ASN . 14.7 t -79.02 161.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.47999999999999998 109.098 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.588 HD21 ' HB1' ' A' ' 12' ' ' ALA . 7.7 tp -112.98 -25.37 9.01 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.62 -0.675 . . . . 1.3899999999999999 110.058 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.57 -179.43 45.9 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.64 -1.384 . . . . 0.38 109.64 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.82 126.84 35.31 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.399 -1.06 . . . . 0.46000000000000002 110.199 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.84 123.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.993 -1.114 . . . . 0.58999999999999997 107.993 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 203' ' ' VAL . 59.0 p -141.75 148.29 38.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.184 -0.948 . . . . 0.67000000000000004 111.352 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.423 ' OD2' ' CG2' ' A' ' 209' ' ' THR . 1.6 p30 -100.53 50.37 0.89 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.367 -0.975 . . . . 2.2400000000000002 108.367 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.457 -0.777 . . . . 1.1100000000000001 110.077 -178.98 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.411 ' HA ' HD12 ' A' ' 192' ' ' ILE . 12.6 t60 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.315 0.579 . . . . 0.92000000000000004 109.523 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 70.5 p -46.95 -44.76 20.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 1.5900000000000001 109.657 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.4 t -64.83 -43.66 92.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.467 -0.771 . . . . 1.4199999999999999 110.248 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 189' ' ' HIS . 64.7 mt -46.36 -35.8 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.971 -1.08 . . . . 1.4099999999999999 109.999 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.5 mtm -74.14 -58.5 3.26 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.898 -1.149 . . . . 0.85999999999999999 107.898 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.23 -31.19 19.82 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.612 -0.68 . . . . 0.58999999999999997 110.223 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -81.17 -46.54 14.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.045 -1.034 . . . . 3.0600000000000001 110.187 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 38.2 m -70.75 -36.34 73.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.927 -1.108 . . . . 0.72999999999999998 110.383 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 199' ' ' LEU . 18.6 mt -84.83 -0.43 53.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.949 -1.094 . . . . 0.67000000000000004 109.119 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 53.5 1.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 1.49 111.419 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 197' ' ' LEU . 55.6 mt -64.37 171.34 2.78 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.434 -1.416 . . . . 0.64000000000000001 107.606 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -88.43 141.32 4.78 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.305 2.003 . . . . 0.58999999999999997 111.469 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.21 176.58 9.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.675 -1.266 . . . . 0.55000000000000004 111.513 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.6 mt -150.52 159.22 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.06 -1.459 . . . . 0.63 107.06 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.4 m -141.23 -28.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.697 -1.252 . . . . 0.77000000000000002 111.186 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.61 29.49 6.23 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.139 -0.976 . . . . 0.87 111.664 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 11.8 p -55.03 -37.79 67.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.319 -1.695 . . . . 0.89000000000000001 108.18 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.32 -37.01 0.26 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.751 -0.738 . . . . 0.93000000000000005 113.481 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 40.4 p -131.06 -6.71 3.9 Favored 'General case' 0 N--CA 1.516 2.854 0 CA-C-N 119.657 1.728 . . . . 1.6000000000000001 113.332 -177.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 5.4 t -48.51 -57.15 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.156 -1.59 . . . . 0.75 110.593 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.423 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 26.8 p -53.06 -16.75 1.2 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.562 -1.336 . . . . 0.83999999999999997 110.4 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.1 t -103.92 11.09 35.95 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.191 -0.943 . . . . 1.6100000000000001 109.27 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -138.93 -13.51 1.22 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.392 -0.818 . . . . 2.2999999999999998 110.243 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.49 154.66 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.324 -0.86 . . . . 0.76000000000000001 109.417 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -126.08 172.42 10.01 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.882 -1.525 . . . . 2.0099999999999998 106.882 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 21.9 t-20 -72.71 144.87 47.51 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.864 -1.148 . . . . 2.1899999999999999 110.141 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.9 t70 80.61 -11.6 1.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.881 -0.512 . . . . 2.3999999999999999 110.875 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.25 147.63 34.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.773 -1.204 . . . . 1.99 108.843 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -88.35 123.1 32.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.043 -1.035 . . . . 1.3 108.517 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.406 ' HB2' HD12 ' A' ' 157' ' ' ILE . 43.7 mt -118.74 168.37 10.8 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.993 0.901 . . . . 0.53000000000000003 110.608 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 mt -143.6 103.21 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.031 -1.1 . . . . 0.59999999999999998 108.031 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.1 tp -86.2 123.81 31.9 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.773 -0.825 . . . . 0.56999999999999995 108.773 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 223' ' ' VAL . 50.1 t0 -100.12 -28.44 13.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.43 -0.794 . . . . 2.2200000000000002 109.127 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.21 28.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.272 0.558 . . . . 0.75 110.599 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.7 t -120.63 -62.24 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.969 -1.493 . . . . 0.92000000000000004 106.969 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -83.36 10.36 8.84 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.349 -1.352 . . . . 2.3599999999999999 107.349 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 60.01 54.01 4.38 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.35 -0.611 . . . . 1.4199999999999999 109.35 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -154.42 144.1 21.59 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.849 0.833 . . . . 1.97 110.23 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 19.5 t -116.08 132.01 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.924 -1.139 . . . . 0.65000000000000002 107.924 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 228' ' ' TYR . 48.4 m-85 -100.48 130.89 46.61 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.115 -0.991 . . . . 0.96999999999999997 110.067 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.7 t -107.65 127.46 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.579 -0.7 . . . . 0.67000000000000004 109.924 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 51.3 t30 47.87 60.6 15.11 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.849 . . . . 1.45 110.297 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.56 154.81 35.57 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.381 2.054 . . . . 0.81999999999999995 111.474 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 8.4 m -72.83 157.08 38.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.977 -1.077 . . . . 1.6200000000000001 109.805 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -60.41 -27.32 67.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.427 -0.796 . . . . 2.6000000000000001 109.779 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.36 -39.13 91.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 3.0600000000000001 109.537 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.55 -42.18 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.928 . . . . 1.1399999999999999 109.071 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.68 -58.59 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 1.04 109.113 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.5 -40.65 72.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.547 -0.72 . . . . 2.54 110.389 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -67.12 -38.16 85.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.036 -1.04 . . . . 2.6000000000000001 110.146 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' MET . . . . . 0.442 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 85.9 mtp -79.43 -32.59 42.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 1.23 109.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -54.11 -44.26 71.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.068 -1.02 . . . . 2.6699999999999999 110.108 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.98 -58.69 3.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.018 -1.051 . . . . 1.6599999999999999 110.887 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.2 t -64.33 -53.47 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.128 -0.983 . . . . 2.2000000000000002 110.721 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.442 ' CB ' ' O ' ' A' ' 239' ' ' MET . 39.6 tp60 -52.95 -52.75 56.99 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.0 -1.063 . . . . 3.0 109.711 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 . . . . . 0 C--N 1.299 -1.62 0 O-C-N 120.657 -1.277 . . . . 1.76 108.761 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.245 0.545 . . . . 3.6600000000000001 109.565 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.0 mt -84.68 106.21 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.954 . . . . 1.1200000000000001 109.628 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 m -99.48 110.6 23.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.382 -0.824 . . . . 1.45 109.706 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.89 -169.9 31.07 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.011 -1.636 . . . . 0.92000000000000004 109.011 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' LEU . 56.7 mt -93.08 -7.42 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.043 -1.269 . . . . 1.05 108.614 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.8 tp 54.34 104.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.495 -0.753 . . . . 0.88 109.385 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.54 -41.17 12.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.903 -1.123 . . . . 0.78000000000000003 108.609 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -150.06 148.96 26.2 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.29 -0.881 . . . . 1.5 108.769 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.15 148.22 16.77 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.564 2.176 . . . . 0.85999999999999999 114.092 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.82 176.29 31.73 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.894 -1.282 . . . . 0.78000000000000003 109.894 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.42 HD12 ' HG2' ' A' ' 243' ' ' GLN . 97.1 mt -140.13 128.95 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.15 -1.206 . . . . 0.73999999999999999 109.257 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.88 153.2 49.58 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.281 -0.887 . . . . 0.45000000000000001 109.722 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -123.93 132.86 53.79 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.191 -1.04 . . . . 0.64000000000000001 108.191 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.6 164.94 34.33 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 118.537 -1.792 . . . . 0.45000000000000001 111.314 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HZ2' ' HB3' ' A' ' 15' ' ' LYS . 15.3 mtpp -76.99 149.25 35.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.625 -0.926 . . . . 1.8799999999999999 109.383 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.3 132.27 38.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.398 -0.814 . . . . 0.58999999999999997 110.839 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 tp -115.23 89.62 3.14 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.459 -1.312 . . . . 0.64000000000000001 107.459 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 tp -80.74 122.41 27.1 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.201 1.001 . . . . 0.73999999999999999 110.646 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.0 mt -92.53 98.06 11.22 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.011 -0.736 . . . . 0.73999999999999999 109.011 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -92.26 159.89 15.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 1.8700000000000001 109.665 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -111.71 133.37 54.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.858 -0.793 . . . . 2.5800000000000001 108.858 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' OE1' ' A' ' 21' ' ' GLU . 12.7 m-20 -80.52 124.99 29.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 2.1400000000000001 110.493 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.07 126.47 28.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.431 -0.793 . . . . 1.9299999999999999 109.1 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 80.7 mt -91.09 140.07 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.936 . . . . 0.68000000000000005 109.502 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.74 115.61 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.486 -0.759 . . . . 0.83999999999999997 108.984 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.416 HD11 ' CD2' ' A' ' 105' ' ' HIS . 65.0 mt -88.06 133.54 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 0.79000000000000004 109.88 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -91.63 123.33 34.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 1.3700000000000001 109.375 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -96.65 25.16 5.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.173 -0.955 . . . . 2.6200000000000001 109.005 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -86.87 150.71 23.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 2.3500000000000001 110.38 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -93.22 123.05 36.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.923 -0.769 . . . . 2.3500000000000001 108.923 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -83.67 175.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.961 -1.087 . . . . 0.78000000000000003 109.368 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 34' ' ' ASP . 45.3 p -97.24 149.48 21.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.464 -0.772 . . . . 1.04 109.121 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.97 -7.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 1.05 109.667 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 32' ' ' SER . 29.9 t70 -84.14 -24.21 30.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 2.4700000000000002 109.968 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -103.44 -9.84 19.06 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.134 -0.979 . . . . 1.46 109.536 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.15 -41.4 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.092 -1.005 . . . . 0.77000000000000002 109.071 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -54.92 -35.43 64.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.366 -0.834 . . . . 1.46 109.392 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -70.01 -37.82 75.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 2.29 110.355 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -58.97 -39.1 80.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 1.3 109.481 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.44 -43.76 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.394 -0.816 . . . . 0.76000000000000001 109.48 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -63.39 -41.86 98.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.189 -0.945 . . . . 1.5 108.461 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.18 -30.25 71.43 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.364 -0.835 . . . . 2.6600000000000001 108.811 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -86.7 -51.81 5.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.854 . . . . 0.75 109.49 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 tp -58.12 -63.21 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.82999999999999996 109.834 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 t -65.12 -35.6 81.63 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.822 -1.174 . . . . 0.78000000000000003 109.14 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.36 -9.79 38.64 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.254 -1.938 . . . . 0.56999999999999995 108.254 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -85.72 -28.65 24.49 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.902 -1.518 . . . . 2.8300000000000001 106.902 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.9 -26.65 67.72 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.291 -1.003 . . . . 0.65000000000000002 108.291 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -85.27 -62.88 1.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.281 -0.637 . . . . 2.5699999999999998 109.281 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.07 -38.07 49.42 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.094 -1.004 . . . . 0.51000000000000001 109.311 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 66.4 m -64.82 -38.56 91.38 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.45 -0.944 . . . . 1.3600000000000001 108.45 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.04 -39.77 65.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.292 0.567 . . . . 0.59999999999999998 109.863 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -55.47 -74.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 1.3600000000000001 109.541 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 58' ' ' LYS . 17.8 mt -46.64 -52.42 13.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.158 -0.964 . . . . 1.3799999999999999 109.508 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 51' ' ' SER . 25.8 mm-40 -47.63 -53.4 14.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.454 -0.779 . . . . 1.27 109.639 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 m -62.34 -37.97 87.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.59999999999999998 109.319 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.6 mt -72.62 -31.1 36.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.301 -0.874 . . . . 0.53000000000000003 108.787 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 54' ' ' LEU . 15.8 ttpt -55.06 -44.23 74.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.414 -0.804 . . . . 0.98999999999999999 109.28 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.45 -32.47 70.05 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.255 -0.903 . . . . 0.58999999999999997 109.47 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.71 -17.67 62.82 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.906 -1.122 . . . . 1.8100000000000001 108.081 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.401 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -85.6 -34.53 21.39 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.867 -0.79 . . . . 0.47999999999999998 108.867 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.89 -27.69 30.95 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.061 -1.066 . . . . 0.57999999999999996 110.64 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -86.43 -17.66 33.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.688 -1.478 . . . . 1.3899999999999999 109.414 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.8 m -94.66 -45.25 7.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.078 -1.014 . . . . 0.81999999999999995 110.396 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -106.11 -18.85 13.89 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.208 -0.933 . . . . 0.98999999999999999 110.38 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 121.26 139.26 5.65 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 109.58 -1.408 . . . . 0.55000000000000004 109.58 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -48.93 -8.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.955 . . . . 2.5899999999999999 110.728 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 66' ' ' GLY . 2.5 pt-20 -66.57 -23.49 66.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.813 -1.179 . . . . 2.2000000000000002 110.298 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -88.81 -10.05 49.51 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.884 -1.135 . . . . 1.79 110.074 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -63.55 -23.85 67.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.918 -1.114 . . . . 1.54 110.595 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.22 83.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.081 -1.012 . . . . 0.64000000000000001 110.274 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.3 mt -70.33 -42.21 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.57999999999999996 109.449 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -76.1 -20.82 57.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.152 -0.967 . . . . 0.62 109.622 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -65.4 -38.86 91.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.977 -1.077 . . . . 1.23 108.95 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.74 -36.97 61.58 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.247 -1.541 . . . . 0.52000000000000002 109.247 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -62.42 -21.85 65.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.312 -1.11 . . . . 1.29 110.768 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.2 mt -85.37 -39.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.559 -1.338 . . . . 0.55000000000000004 108.99 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.4 ttt -59.31 -42.23 90.88 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.364 -0.976 . . . . 1.8899999999999999 108.364 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.5 -40.49 82.99 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.45 -0.945 . . . . 0.53000000000000003 108.45 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.4 tp -65.96 -50.33 64.72 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.439 -0.788 . . . . 0.42999999999999999 109.674 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -85.55 10.48 13.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.162 -0.961 . . . . 1.24 110.976 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -48.46 122.8 5.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.738 -1.226 . . . . 1.3100000000000001 109.376 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -66.29 -25.9 67.07 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.406 -0.809 . . . . 1.3500000000000001 108.959 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -76.45 -49.75 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.458 -0.777 . . . . 2.1600000000000001 109.514 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.0 mt -64.95 -20.71 66.61 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.888 -1.125 . . . . 0.59999999999999998 108.928 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -70.43 -47.57 60.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.381 -0.824 . . . . 1.28 109.476 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -64.89 -32.18 73.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.522 -0.736 . . . . 1.28 109.815 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -73.09 -48.77 32.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -0.951 . . . . 1.29 109.015 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.18 -57.71 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.75 -0.833 . . . . 0.57999999999999996 108.75 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 91' ' ' ALA . 77.3 mt -53.05 -61.88 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.714 -0.616 . . . . 0.78000000000000003 110.662 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 90' ' ' ILE . . . -40.93 -62.51 0.8 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.388 -0.82 . . . . 0.85999999999999999 110.748 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.4 mt -45.12 -51.11 10.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.376 -0.828 . . . . 0.79000000000000004 110.011 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.5 -41.35 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.929 -1.107 . . . . 0.70999999999999996 110.011 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -85.16 -42.74 14.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.211 -0.93 . . . . 2.0499999999999998 111.808 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -83.64 -34.06 25.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.669 -1.269 . . . . 1.5900000000000001 111.74 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -104.16 10.7 35.71 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.836 -1.165 . . . . 1.8899999999999999 109.361 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.8 m80 43.77 47.7 6.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.703 . . . . 1.3100000000000001 109.691 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.5 mtp -99.33 154.88 17.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.77 -0.826 . . . . 1.28 108.77 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.1 p -75.52 141.29 43.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.273 -0.892 . . . . 0.62 109.163 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.07 -25.98 2.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.155 -0.965 . . . . 0.46999999999999997 109.347 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.83 -45.34 51.85 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.277 -1.009 . . . . 2.0 108.277 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.91 -54.4 11.54 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.733 -0.604 . . . . 0.56000000000000005 109.873 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -52.62 63.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.261 -0.9 . . . . 0.47999999999999998 109.478 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.09 -35.42 64.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.958 . . . . 0.44 109.283 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.416 ' CD2' HD11 ' A' ' 26' ' ' ILE . 36.2 t-80 -71.99 -32.41 67.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.853 . . . . 1.4199999999999999 109.545 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.86 -61.9 2.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 1.26 110.035 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 107' ' ' VAL . 5.8 t -53.66 -47.32 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.60999999999999999 110.038 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.49 -20.66 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.64000000000000001 109.681 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -74.14 -38.26 63.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.022 . . . . 2.2000000000000002 110.161 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.38 -21.84 46.76 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.525 -1.321 . . . . 0.81999999999999995 111.994 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -68.95 -53.48 20.58 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.735 -1.45 . . . . 1.27 108.691 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.66 67.28 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.656 -0.652 . . . . 0.91000000000000003 109.485 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 t -60.69 -43.6 97.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 1.73 110.192 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.3 -33.08 75.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.042 . . . . 1.04 110.449 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.4 HD21 HH21 ' A' ' 126' ' ' ARG . 17.1 mt -69.38 -27.9 65.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.729 -1.232 . . . . 1.03 109.338 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.56 -16.09 64.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 1.95 109.224 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -80.37 -9.06 59.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.374 -0.829 . . . . 1.71 109.004 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.71 141.05 28.9 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.528 -0.915 . . . . 1.26 108.528 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -99.65 65.11 1.33 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.309 -0.869 . . . . 2.8300000000000001 109.186 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -147.18 111.87 5.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 1.5800000000000001 109.354 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -51.49 -17.02 0.69 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.537 -0.727 . . . . 2.7999999999999998 109.815 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -81.21 -63.87 1.31 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 1.02 109.272 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.4 mt -61.76 -31.27 71.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.264 -0.898 . . . . 1.0600000000000001 110.139 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -66.65 -46.43 75.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.856 -1.152 . . . . 2.3900000000000001 109.112 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -61.39 -18.75 60.21 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.512 -0.875 . . . . 2.2000000000000002 108.831 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.4 HH21 HD21 ' A' ' 115' ' ' LEU . 39.3 ttp180 -74.72 -27.69 60.48 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.678 -1.601 . . . . 2.0899999999999999 106.678 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.71 94.56 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.126 -0.694 . . . . 0.85999999999999999 109.126 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.99 87.24 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.289 -0.882 . . . . 0.90000000000000002 109.472 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.8 OUTLIER -70.52 -30.4 67.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.834 . . . . 1.3500000000000001 110.028 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.12 -39.68 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.958 -1.089 . . . . 0.57999999999999996 108.45 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -61.69 -37.94 85.97 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.216 -1.031 . . . . 3.2200000000000002 108.216 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.08 -36.37 77.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.535 -0.728 . . . . 1.3200000000000001 109.699 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.03 -27.72 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 0.5 109.771 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.33 -46.67 7.35 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.678 -1.369 . . . . 0.44 109.678 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -49.6 -47.75 49.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -1.099 . . . . 2.71 109.144 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.519 ' HG2' HH11 ' A' ' 136' ' ' ARG . 12.8 mtt-85 -64.77 -43.42 93.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.143 -0.973 . . . . 2.2000000000000002 108.713 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.6 tp -52.38 -39.99 61.51 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.968 -0.753 . . . . 1.1299999999999999 108.968 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.41 -59.08 2.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 0.54000000000000004 109.96 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.421 ' HG2' HH11 ' A' ' 139' ' ' ARG . 30.4 mtt-85 -47.67 -18.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 2.3199999999999998 110.841 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -84.6 -39.83 18.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.837 -1.164 . . . . 1.26 108.965 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.61 -38.31 81.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.4 -0.812 . . . . 0.62 109.063 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.9 mt -91.19 -7.3 51.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.345 -0.847 . . . . 0.67000000000000004 109.016 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.95 20.83 69.09 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.389 -1.884 . . . . 0.68000000000000005 108.389 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tp -57.82 168.29 0.96 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.689 -0.889 . . . . 0.77000000000000002 109.601 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -66.06 143.57 57.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 2.3999999999999999 109.375 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -102.13 147.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.625 -0.88 . . . . 0.87 108.625 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.742 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.7 mp -79.08 94.02 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.168 -0.957 . . . . 1.3200000000000001 109.193 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -101.0 92.07 4.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.461 -0.774 . . . . 1.54 110.046 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.539 HD21 ' CG2' ' A' ' 147' ' ' ILE . 10.1 mt -82.56 -17.52 44.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.145 -0.972 . . . . 0.77000000000000002 108.917 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 170' ' ' GLN . 0.8 OUTLIER -82.99 35.34 0.47 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.763 . . . . 1.5700000000000001 109.608 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.1 24.27 2.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 0.81999999999999995 109.024 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 79.4 mt -73.16 139.84 18.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.483 -0.761 . . . . 0.81999999999999995 109.449 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -118.34 -18.0 9.33 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.519 -0.919 . . . . 2.1099999999999999 108.519 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -117.62 127.73 54.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.982 -0.747 . . . . 1.4099999999999999 108.982 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -61.91 127.71 32.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.814 . . . . 1.3 109.889 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -149.99 176.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.393 -0.817 . . . . 0.56999999999999995 108.888 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.1 mt -87.9 147.14 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.442 -0.948 . . . . 0.42999999999999999 108.442 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 tp -101.74 117.76 35.54 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.654 -0.869 . . . . 0.56000000000000005 108.654 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.67 131.96 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.713 -0.847 . . . . 0.54000000000000004 108.713 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.33 149.17 15.29 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.78 -0.768 . . . . 0.62 109.644 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.76 78.46 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 120.682 -1.261 . . . . 0.80000000000000004 107.946 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -173.14 148.33 1.68 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.585 -0.697 . . . . 2.3399999999999999 109.134 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.4 mt -119.59 138.73 53.03 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.383 -0.823 . . . . 0.65000000000000002 109.619 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.4 p -94.41 153.53 40.41 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 0.73999999999999999 109.243 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 169' ' ' ALA . 69.6 Cg_exo -37.36 -50.55 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.379 2.053 . . . . 0.59999999999999998 112.482 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 m -49.78 -55.44 14.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.63 109.281 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.19 -47.52 81.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.907 . . . . 1.25 109.543 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.4 p -67.95 -19.86 65.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 0.5 109.778 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -80.09 -29.5 39.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.163 -0.961 . . . . 0.51000000000000001 110.113 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.413 ' O ' ' OG ' ' A' ' 150' ' ' SER . 20.9 pt20 -101.5 -11.66 19.13 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.154 -0.966 . . . . 1.1699999999999999 109.117 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.89 151.72 21.04 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.538 -0.912 . . . . 0.60999999999999999 108.538 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -99.57 139.35 35.35 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.407 -0.96 . . . . 2.1200000000000001 108.407 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.78 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.3 mm? -88.37 -41.21 12.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 1.3400000000000001 109.978 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -82.49 -10.72 58.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.019 -1.05 . . . . 1.97 111.667 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -99.9 -17.03 17.79 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.621 -1.3 . . . . 1.8999999999999999 108.763 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 178' ' ' GLY . 56.6 t -89.7 156.38 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.592 -0.892 . . . . 0.47999999999999998 108.592 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.8 tp -106.08 -20.46 13.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.364 -0.835 . . . . 1.3899999999999999 109.609 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.473 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.4 173.0 41.64 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.095 -1.602 . . . . 0.38 109.095 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -128.36 124.33 36.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -1.035 . . . . 0.46000000000000002 109.081 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.0 mt -130.2 131.68 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.017 -1.105 . . . . 0.58999999999999997 108.017 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 23.4 p -139.22 147.41 41.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.36 -0.837 . . . . 0.67000000000000004 111.336 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 182' ' ' ASP . 7.1 p-10 -84.78 37.32 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.702 -0.624 . . . . 2.2400000000000002 110.09 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.501 2.088 0 O-C-N 121.377 -0.827 . . . . 1.1100000000000001 110.034 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 28.8 t60 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.132 0.491 . . . . 0.92000000000000004 110.427 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.0 m -50.08 -31.04 12.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 1.5900000000000001 109.599 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.9 t -76.47 -39.41 53.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.194 -0.941 . . . . 1.4199999999999999 109.859 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.5 mp -53.48 -36.43 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.956 . . . . 1.4099999999999999 108.758 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 33.3 mtp -71.13 -52.11 21.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.255 -1.387 . . . . 0.85999999999999999 107.255 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.33 -46.05 86.96 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.528 -0.76 . . . . 0.58999999999999997 110.243 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -63.89 -48.76 75.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.064 -1.023 . . . . 3.0600000000000001 110.056 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.8 m -68.92 -36.43 77.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.125 -0.984 . . . . 0.72999999999999998 109.5 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 199' ' ' LEU . 21.3 mt -89.37 1.81 55.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.977 . . . . 0.67000000000000004 109.018 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 194' ' ' ALA . 32.1 mt-10 54.71 2.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.466 -0.771 . . . . 1.49 111.261 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 197' ' ' LEU . 25.2 mt -66.61 168.47 10.11 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.622 -1.299 . . . . 0.64000000000000001 108.54 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -85.71 144.0 8.59 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.21 1.94 . . . . 0.58999999999999997 111.081 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.36 172.6 17.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.653 -1.279 . . . . 0.55000000000000004 110.965 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.598 HD12 HD11 ' A' ' 220' ' ' LEU . 12.2 mt -150.95 156.0 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.365 -1.717 . . . . 0.63 106.365 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.8 m -143.04 -33.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.812 -1.18 . . . . 0.77000000000000002 111.703 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.527 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -85.89 38.96 3.03 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 120.523 -1.36 . . . . 0.87 110.202 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 206' ' ' GLY . 27.5 p -71.21 42.83 0.07 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.831 -1.394 . . . . 0.89000000000000001 109.199 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 39.18 -102.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.272 -1.131 . . . . 0.93000000000000005 110.272 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.4 m -131.14 42.37 3.23 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.811 -0.817 . . . . 1.6000000000000001 110.039 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.3 t -54.56 -33.57 27.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.868 -1.145 . . . . 0.75 108.438 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.2 p -55.39 -16.48 3.64 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.047 -1.033 . . . . 0.83999999999999997 108.678 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 49.9 m -103.95 12.21 34.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.541 -0.724 . . . . 1.6100000000000001 109.322 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -135.74 -17.3 1.7 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.32 -0.862 . . . . 2.2999999999999998 109.968 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 5.8 t -112.55 141.91 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.637 -0.875 . . . . 0.76000000000000001 108.637 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -177.92 3.26 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.764 -1.569 . . . . 2.0099999999999998 106.764 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.3 p-10 -81.06 144.81 31.47 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.033 -1.042 . . . . 2.1899999999999999 110.04 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.8 m-20 81.04 -13.46 0.92 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.074 -0.392 . . . . 2.3999999999999999 110.857 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.51 136.37 56.71 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.854 -1.154 . . . . 1.99 108.416 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -86.7 117.21 25.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.926 -1.109 . . . . 1.3 108.952 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.3 mt -129.38 175.16 8.98 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.654 0.74 . . . . 0.53000000000000003 109.585 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.6 mt -140.89 126.25 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.755 -0.831 . . . . 0.59999999999999998 108.755 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.598 HD11 HD12 ' A' ' 202' ' ' ILE . 24.0 tp -90.16 126.32 35.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.56999999999999995 108.725 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 223' ' ' VAL . 4.1 m-20 -95.38 -34.56 12.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.07 -1.019 . . . . 2.2200000000000002 109.486 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.51 21.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.675 -0.641 . . . . 0.75 110.142 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.3 t -115.12 -59.84 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 106.465 -1.68 . . . . 0.92000000000000004 106.465 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -89.21 11.39 18.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.242 -1.392 . . . . 2.3599999999999999 107.242 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 64.3 t30 57.39 58.26 3.94 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.414 -0.588 . . . . 1.4199999999999999 109.414 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -156.1 151.76 27.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.054 -1.028 . . . . 1.97 110.517 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 32.8 t -109.78 139.33 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.721 -0.844 . . . . 0.65000000000000002 108.721 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -108.88 129.94 55.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.406 -0.809 . . . . 0.96999999999999997 109.555 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 11.3 t -103.18 113.81 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.401 -0.812 . . . . 0.67000000000000004 109.362 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.1 t30 52.02 63.42 9.18 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.943 . . . . 1.45 110.54 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.81 161.6 44.54 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.509 2.14 . . . . 0.81999999999999995 112.019 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.6 p -74.0 160.4 31.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.358 -0.839 . . . . 1.6200000000000001 109.464 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -68.01 -26.68 66.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 2.6000000000000001 109.137 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 234' ' ' GLU . 0.7 OUTLIER -62.05 -37.65 85.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.803 . . . . 3.0600000000000001 109.623 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.58 -45.28 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.007 -1.058 . . . . 1.1399999999999999 109.157 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.57 -57.96 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.323 -0.861 . . . . 1.04 109.67 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -53.72 -40.37 66.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.28 -0.887 . . . . 2.54 110.417 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -65.91 -40.23 91.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 2.6000000000000001 110.279 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 28.9 mtm -80.7 -26.04 37.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.999 -1.063 . . . . 1.23 109.911 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.403 ' HG3' ' NH1' ' A' ' 240' ' ' ARG . 15.1 mmm-85 -58.29 -42.16 85.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 2.6699999999999999 109.898 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.24 -52.28 11.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 1.6599999999999999 110.133 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 35.4 t -62.79 -50.23 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.101 -0.999 . . . . 2.2000000000000002 109.862 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.42 ' HG2' HD12 ' A' ' 11' ' ' ILE . 7.4 tm0? -51.71 -59.12 4.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.197 -0.94 . . . . 3.0 110.378 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.3 -1.547 0 O-C-N 121.271 -0.893 . . . . 1.76 110.625 -178.388 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' N ' ' A' ' 3' ' ' SER . 21.1 mmt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.255 -0.646 . . . . 3.6600000000000001 109.255 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.59 85.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.092 -1.005 . . . . 1.1200000000000001 108.649 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 1' ' ' MET . 6.9 m -88.54 114.15 24.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 1.45 109.253 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.55 -163.16 20.7 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 108.859 -1.696 . . . . 0.92000000000000004 108.859 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 5' ' ' ILE . 65.1 mt -94.84 -6.44 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -1.174 . . . . 1.05 108.553 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 36.5 tp 54.17 104.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.106 -0.702 . . . . 0.88 109.106 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.14 -56.0 4.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.064 -1.022 . . . . 0.78000000000000003 108.345 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.64 145.61 26.3 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.144 -1.058 . . . . 1.5 108.144 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.58 154.19 35.0 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.986 1.79 . . . . 0.85999999999999999 113.499 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.51 133.2 1.81 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.721 -1.351 . . . . 0.78000000000000003 109.721 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.0 mt -94.85 135.65 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.955 -1.321 . . . . 0.73999999999999999 109.795 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.412 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -143.6 155.42 44.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.216 -0.927 . . . . 0.45000000000000001 109.726 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.577 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -125.38 141.78 51.87 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.338 -0.986 . . . . 0.64000000000000001 108.338 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.24 163.02 28.08 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.127 -1.511 . . . . 0.45000000000000001 110.887 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -78.51 150.97 32.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.488 -1.007 . . . . 1.8799999999999999 109.559 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.566 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -76.13 127.9 33.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.58999999999999997 111.012 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -109.71 91.94 3.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.436 -1.32 . . . . 0.64000000000000001 107.436 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 tp -81.65 126.3 31.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.021 -1.049 . . . . 0.73999999999999999 110.58 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.489 HD11 HD11 ' A' ' 158' ' ' LEU . 13.6 mt -96.43 93.5 6.87 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.905 -0.589 . . . . 0.73999999999999999 110.075 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -92.82 158.22 15.98 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.598 -0.89 . . . . 1.8700000000000001 108.598 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -130.62 135.93 48.36 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.351 -0.843 . . . . 2.5800000000000001 109.322 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.11 133.55 36.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -0.854 . . . . 2.1400000000000001 108.856 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.58 147.69 48.37 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.293 -0.88 . . . . 1.9299999999999999 109.135 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mt -89.27 129.76 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.298 -0.876 . . . . 0.68000000000000005 109.417 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.4 112.59 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.605 -0.887 . . . . 0.83999999999999997 108.605 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.6 mt -86.56 131.78 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.79000000000000004 109.65 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -90.1 114.69 26.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.397 -0.814 . . . . 1.3700000000000001 109.374 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.426 HH11 ' HG3' ' A' ' 28' ' ' ARG . 19.9 mmm-85 -95.63 26.16 4.13 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.206 -0.934 . . . . 2.6200000000000001 108.857 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -79.21 143.26 35.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 2.3500000000000001 109.384 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -84.76 123.63 30.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 2.3500000000000001 109.573 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -90.92 173.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.277 -0.889 . . . . 0.78000000000000003 109.987 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -105.53 172.9 6.55 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.776 -0.578 . . . . 1.04 109.603 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.18 -8.55 32.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.815 . . . . 1.05 109.722 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -82.84 -16.42 47.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.048 -1.032 . . . . 2.4700000000000002 109.814 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -110.78 -8.27 14.56 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.395 -0.815 . . . . 1.46 109.263 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.49 -45.1 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.77000000000000002 108.587 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -53.9 -36.09 62.35 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.419 -0.8 . . . . 1.46 109.067 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -70.44 -42.06 72.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.497 -0.752 . . . . 2.29 110.51 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -58.66 -45.6 89.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 1.3 109.535 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 44' ' ' LEU . 85.6 t -61.81 -44.21 98.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.192 -0.943 . . . . 0.76000000000000001 109.053 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -65.72 -42.49 90.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.28 -0.887 . . . . 1.5 109.083 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -63.62 -34.89 78.84 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.176 -0.952 . . . . 2.6600000000000001 108.92 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -86.39 -53.09 5.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.394 -0.816 . . . . 0.75 109.059 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' VAL . 10.0 tp -53.79 -67.1 0.29 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.731 . . . . 0.82999999999999996 109.731 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.619 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 45.1 t -63.75 -35.07 79.38 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.192 -0.943 . . . . 0.78000000000000003 108.935 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.55 -53.35 39.25 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.372 -2.291 . . . . 0.56999999999999995 107.372 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -46.74 -32.33 3.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.603 -0.939 . . . . 2.8300000000000001 108.775 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.86 -32.92 69.88 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.869 -1.159 . . . . 0.65000000000000002 107.869 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 46' ' ' GLY . 16.5 ttmm -83.89 -61.05 1.92 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.021 -0.733 . . . . 2.5699999999999998 109.021 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.09 -45.03 64.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.51000000000000001 110.069 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.4 t -63.35 -38.14 89.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.06 -1.025 . . . . 1.3600000000000001 108.409 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 -31.2 65.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.089 -0.708 . . . . 0.59999999999999998 109.089 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -69.25 -58.68 3.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.801 . . . . 1.3600000000000001 109.099 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.4 mt -55.85 -45.38 78.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 1.3799999999999999 108.718 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -55.27 -48.66 73.7 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.981 -0.748 . . . . 1.27 108.981 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.1 m -63.13 -41.08 99.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.59999999999999998 109.22 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.4 mt -71.53 -37.49 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.375 -0.972 . . . . 0.53000000000000003 108.375 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -49.84 -45.58 50.4 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.57 -0.706 . . . . 0.98999999999999999 109.408 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -70.95 -27.78 64.0 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.256 -0.902 . . . . 0.58999999999999997 109.941 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -71.79 -25.37 61.98 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.805 -1.184 . . . . 1.8100000000000001 108.475 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.45 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -81.58 -29.07 33.53 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.647 -0.872 . . . . 0.47999999999999998 108.647 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.21 -32.13 17.85 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.969 -1.11 . . . . 0.57999999999999996 110.653 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -85.88 -15.44 41.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.899 -1.353 . . . . 1.3899999999999999 109.107 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.8 m -95.49 -48.81 5.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.332 -0.855 . . . . 0.81999999999999995 110.498 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -106.64 -14.48 15.02 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.13 -0.981 . . . . 0.98999999999999999 110.67 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.81 136.86 5.2 Favored Glycine 0 N--CA 1.502 3.087 0 N-CA-C 109.733 -1.347 . . . . 0.55000000000000004 109.733 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -48.29 -9.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.536 -0.979 . . . . 2.5899999999999999 110.744 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 66' ' ' GLY . 13.6 pt-20 -66.51 -21.86 66.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.952 -1.093 . . . . 2.2000000000000002 110.586 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -87.93 -16.32 34.19 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.92 -1.113 . . . . 1.79 109.781 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.15 -20.34 66.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.2 -0.937 . . . . 1.54 110.686 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.75 92.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.852 -1.155 . . . . 0.64000000000000001 109.531 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.6 mt -71.73 -39.85 69.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.218 -0.926 . . . . 0.57999999999999996 109.465 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -78.06 -23.53 48.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -0.958 . . . . 0.62 108.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -64.7 -33.28 75.59 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.493 -0.928 . . . . 1.23 108.493 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.47 -35.9 35.6 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.048 -1.621 . . . . 0.52000000000000002 109.048 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.95 -21.1 63.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.352 -1.087 . . . . 1.29 109.829 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.2 mt -86.42 -42.4 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.9 -1.125 . . . . 0.55000000000000004 108.76 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.3 ttm -59.88 -41.38 91.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.022 -0.733 . . . . 1.8899999999999999 109.022 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -63.93 -39.31 93.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.53000000000000003 109.127 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -71.83 -42.58 66.81 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.534 -0.866 . . . . 0.42999999999999999 109.431 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -86.24 5.43 34.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 1.24 110.41 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -48.36 122.75 5.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 1.3100000000000001 109.753 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -67.42 -24.32 65.64 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.643 -0.873 . . . . 1.3500000000000001 108.643 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -76.14 -53.39 8.36 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.469 -0.769 . . . . 2.1600000000000001 109.055 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.06 -12.61 52.55 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.972 -1.091 . . . . 0.59999999999999998 108.707 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -78.16 -53.75 7.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.434 -0.792 . . . . 1.28 109.897 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -62.5 -25.69 68.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 1.28 109.701 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -73.19 -47.04 47.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -0.99 . . . . 1.29 108.812 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.61 -56.32 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.441 -0.948 . . . . 0.57999999999999996 108.441 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -48.34 -56.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.603 -0.686 . . . . 0.78000000000000003 110.055 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -47.79 -61.96 1.69 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.85999999999999999 110.308 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.5 mt -47.8 -52.14 19.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.79000000000000004 109.402 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.0 mt -52.2 -46.24 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.077 -1.014 . . . . 0.70999999999999996 110.193 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -84.85 -35.51 22.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.094 -1.004 . . . . 2.0499999999999998 111.88 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.25 -37.98 22.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.536 -1.352 . . . . 1.5900000000000001 111.732 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -105.23 14.62 28.73 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.729 -1.232 . . . . 1.8899999999999999 109.48 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.8 m80 45.16 42.53 6.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.379 -0.826 . . . . 1.3100000000000001 109.597 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.7 mtt -95.36 149.54 21.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.936 -0.765 . . . . 1.28 108.936 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 p -76.62 143.59 40.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.33 -0.856 . . . . 0.62 109.283 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.04 -27.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 0.46999999999999997 109.804 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 1.3 p30 -76.14 -43.85 41.06 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.293 -0.879 . . . . 2.0 108.717 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -70.52 -56.9 5.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.622 -0.674 . . . . 0.56000000000000005 110.277 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.25 -49.68 68.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.47999999999999998 109.758 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.89 -30.94 59.31 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.247 -0.908 . . . . 0.44 109.525 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -69.47 -34.63 74.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.991 -1.068 . . . . 1.4199999999999999 109.873 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -63.78 -45.89 87.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.989 -1.07 . . . . 1.26 109.791 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.51 -47.82 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.825 -1.172 . . . . 0.60999999999999999 108.669 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.74 -18.19 22.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.493 -0.754 . . . . 0.64000000000000001 109.057 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.8 -42.87 73.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 2.2000000000000002 109.572 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.32 -29.32 22.53 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.617 -1.278 . . . . 0.81999999999999995 112.336 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -65.15 -39.45 93.01 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.414 -1.639 . . . . 1.27 108.797 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.67 -51.36 7.8 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.567 -0.708 . . . . 0.91000000000000003 109.178 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -60.34 -44.52 95.44 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.452 -0.78 . . . . 1.73 110.149 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -63.89 -37.62 88.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.05 -1.031 . . . . 1.04 111.235 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.41 -25.99 66.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.507 -1.371 . . . . 1.03 109.216 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -71.63 -21.33 61.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.971 -1.08 . . . . 1.95 109.828 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -81.83 -7.02 59.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.214 -0.929 . . . . 1.71 108.921 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.89 136.86 33.12 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.255 -1.017 . . . . 1.26 108.255 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -94.07 63.43 3.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 2.8300000000000001 108.722 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -146.61 114.27 6.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.81 . . . . 1.5800000000000001 109.28 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.83 -16.01 4.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 2.7999999999999998 109.755 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -81.12 -63.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 1.02 109.368 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 mt -66.55 -31.32 71.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.236 -0.915 . . . . 1.0600000000000001 109.833 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 27.6 ttpt -66.69 -50.05 64.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.942 -1.099 . . . . 2.3900000000000001 109.321 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.27 -25.73 49.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.091 -1.006 . . . . 2.2000000000000002 108.702 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -72.56 -23.57 60.99 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.542 -1.651 . . . . 2.0899999999999999 106.542 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -58.38 -47.83 82.59 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.233 -1.025 . . . . 0.85999999999999999 108.233 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.41 -35.84 76.13 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.674 -0.641 . . . . 0.90000000000000002 109.48 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.9 m-20 -68.69 -30.63 69.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.422 -0.799 . . . . 1.3500000000000001 109.733 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.4 t -77.48 -39.48 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.01 -1.056 . . . . 0.57999999999999996 108.679 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -56.35 -40.93 75.31 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.107 -1.071 . . . . 3.2200000000000002 108.107 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.61 -38.36 81.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.603 -0.686 . . . . 1.3200000000000001 109.665 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.52 -21.77 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.5 109.449 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.09 -58.36 2.99 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.0 -1.095 . . . . 0.44 110.496 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -52.67 -42.67 64.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.007 -1.29 . . . . 2.71 109.849 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 140' ' ' ASN . 23.2 mtt-85 -65.43 -45.91 82.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.957 -1.089 . . . . 2.2000000000000002 108.423 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.2 tp -55.68 -43.41 76.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.585 -0.697 . . . . 1.1299999999999999 109.386 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.2 -47.9 75.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.54000000000000004 110.268 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -52.96 -22.35 5.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.061 -1.024 . . . . 2.3199999999999998 110.8 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 70.4 m-80 -83.37 -45.55 13.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.915 -1.116 . . . . 1.26 109.091 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.5 mt -53.93 -38.48 36.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.197 -0.94 . . . . 0.62 108.934 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.2 mt -88.15 3.59 48.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.245 -0.909 . . . . 0.67000000000000004 109.101 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.2 30.88 55.83 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.744 -1.742 . . . . 0.68000000000000005 108.744 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.57 142.35 52.9 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.357 -1.084 . . . . 0.77000000000000002 109.462 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -67.5 136.01 53.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 2.3999999999999999 109.708 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 80.4 mt -106.54 144.6 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.898 -0.779 . . . . 0.87 108.898 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.709 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -77.92 138.98 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 1.3200000000000001 109.616 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -96.67 86.59 4.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.426 -0.796 . . . . 1.54 109.486 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.1 mt -80.17 -29.69 38.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.412 -0.805 . . . . 0.77000000000000002 109.651 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.8 p -79.98 20.64 0.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.933 . . . . 1.5700000000000001 109.486 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -142.32 35.11 1.49 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.347 -0.845 . . . . 0.81999999999999995 109.714 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 153' ' ' GLN . 57.7 mt -72.3 158.83 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.81999999999999995 109.148 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 152' ' ' ILE . 12.1 pt20 -134.43 -4.21 2.65 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.293 -0.879 . . . . 2.1099999999999999 109.601 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -125.2 128.34 48.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.533 -0.729 . . . . 1.4099999999999999 109.297 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.52 122.99 18.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 1.3 109.292 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.4 m -148.12 172.97 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.321 -0.862 . . . . 0.56999999999999995 109.314 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.4 mt -88.85 152.91 3.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.809 -1.182 . . . . 0.42999999999999999 107.809 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.489 HD11 HD11 ' A' ' 19' ' ' LEU . 14.6 tp -105.98 118.76 37.44 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.619 0.724 . . . . 0.56000000000000005 109.273 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 26.2 t -121.46 128.62 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.815 -0.809 . . . . 0.54000000000000004 108.815 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.67 146.59 11.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.313 -0.867 . . . . 0.62 109.539 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.5 71.72 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.677 -1.265 . . . . 0.80000000000000004 108.015 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -173.21 157.33 3.38 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.598 -0.689 . . . . 2.3399999999999999 109.48 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.7 mt -126.82 137.47 53.2 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.531 -0.731 . . . . 0.65000000000000002 109.118 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.6 p -92.33 152.74 42.64 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.24 -0.913 . . . . 0.73999999999999999 109.195 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 169' ' ' ALA . 66.0 Cg_exo -35.92 -51.9 1.03 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.561 2.174 . . . . 0.59999999999999998 112.663 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.5 m -47.92 -54.72 11.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.63 109.473 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -59.04 -48.07 82.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 1.25 109.811 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 168' ' ' THR . 5.4 p -69.49 -24.33 63.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.5 109.902 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -77.9 -24.62 48.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.51000000000000001 110.086 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -106.95 -15.39 14.71 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.316 -0.865 . . . . 1.1699999999999999 109.681 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.1 tp -58.81 149.91 25.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.019 -1.051 . . . . 0.60999999999999999 108.831 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 173' ' ' LEU . 2.6 t-20 -99.02 152.57 19.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 2.1200000000000001 108.702 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.54 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 11.8 mt -95.32 -40.84 9.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.177 -0.952 . . . . 1.3400000000000001 110.938 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -81.79 -14.68 56.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.846 -1.159 . . . . 1.97 112.125 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -95.0 -11.11 29.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.433 -1.417 . . . . 1.8999999999999999 107.869 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 177' ' ' LEU . 95.8 t -96.95 163.6 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.799 -1.186 . . . . 0.47999999999999998 107.799 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.545 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -112.18 -26.62 8.71 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.638 -0.875 . . . . 1.3899999999999999 108.638 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.42 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.85 176.28 47.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.156 -1.578 . . . . 0.38 109.156 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.448 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 1.6 m-85 -128.39 123.45 33.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.438 -1.036 . . . . 0.46000000000000002 109.91 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.6 mt -128.25 129.92 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.492 -1.299 . . . . 0.58999999999999997 107.492 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.2 p -140.24 148.14 41.05 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.235 1.017 . . . . 0.67000000000000004 111.785 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 1.1 t70 -87.78 38.72 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.77 -0.581 . . . . 2.2400000000000002 109.843 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.503 2.183 0 O-C-N 121.174 -0.954 . . . . 1.1100000000000001 110.287 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 13.5 t60 . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 107.977 -1.12 . . . . 0.92000000000000004 107.977 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 95.1 m -63.11 -39.73 95.55 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.621 -0.881 . . . . 1.5900000000000001 108.621 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.3 t -57.09 -33.16 67.02 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 1.4199999999999999 109.051 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.87 -37.66 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.293 -0.879 . . . . 1.4099999999999999 110.444 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.7 mtm -71.94 -51.42 22.12 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.785 -1.197 . . . . 0.85999999999999999 108.238 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.83 -32.33 31.24 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.147 0.498 . . . . 0.58999999999999997 109.705 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -75.52 -46.04 34.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.057 -1.027 . . . . 3.0600000000000001 109.376 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.3 m -70.77 -35.7 72.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.257 -0.902 . . . . 0.72999999999999998 109.63 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.5 mt -89.49 -2.37 58.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.67000000000000004 109.139 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 51.17 10.12 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.562 -0.711 . . . . 1.49 111.783 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.9 mt -68.17 168.41 13.64 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.557 -1.339 . . . . 0.64000000000000001 108.507 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.14 131.8 5.96 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.121 1.881 . . . . 0.58999999999999997 111.578 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -163.37 176.39 9.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.794 -1.191 . . . . 0.55000000000000004 111.177 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.409 HG23 ' H ' ' A' ' 6' ' ' LEU . 11.4 mt -149.64 161.51 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.653 -1.61 . . . . 0.63 106.653 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 181' ' ' THR . 17.1 m -144.63 -31.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.725 -1.234 . . . . 0.77000000000000002 111.413 -178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.18 31.2 5.5 Favored Glycine 0 N--CA 1.491 2.364 0 O-C-N 120.807 -1.183 . . . . 0.87 110.486 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.434 ' HB ' HG23 ' A' ' 208' ' ' VAL . 10.1 p -56.02 -37.27 68.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.787 -1.419 . . . . 0.89000000000000001 108.514 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.43 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 64.94 -35.2 0.1 Allowed Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.923 -0.656 . . . . 0.93000000000000005 113.522 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.6 m -121.66 16.43 11.13 Favored 'General case' 0 N--CA 1.513 2.704 0 CA-C-N 119.812 1.806 . . . . 1.6000000000000001 112.839 -177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' A' ' 205' ' ' THR . 5.7 t -78.23 -52.54 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.221 -1.549 . . . . 0.75 109.888 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.3 p -53.62 -19.61 4.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.697 -1.252 . . . . 0.83999999999999997 109.961 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.8 m -105.72 14.45 28.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.341 -0.85 . . . . 1.6100000000000001 109.474 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -143.54 -5.6 0.83 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.235 -0.916 . . . . 2.2999999999999998 110.891 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 37.2 t -119.45 157.58 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.16 -0.963 . . . . 0.76000000000000001 109.957 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 16.0 mmmt -134.34 171.38 14.35 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.813 -1.551 . . . . 2.0099999999999998 106.813 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.2 t30 -76.17 143.06 41.36 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.876 -1.14 . . . . 2.1899999999999999 110.539 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.0 t70 80.12 -10.77 1.24 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.712 -0.617 . . . . 2.3999999999999999 110.867 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -57.85 143.62 41.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.772 -1.205 . . . . 1.99 108.657 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -86.08 110.95 19.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.011 -1.055 . . . . 1.3 108.555 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.566 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 13.4 mt -123.8 165.4 17.38 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.67 0.747 . . . . 0.53000000000000003 109.946 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 40.6 mt -138.71 125.22 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.833 -1.173 . . . . 0.59999999999999998 107.833 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.4 tp -86.89 127.35 35.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.2 -0.938 . . . . 0.56999999999999995 108.735 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.7 -46.17 6.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.244 -0.91 . . . . 2.2200000000000002 109.433 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 44.51 23.87 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.513 -0.742 . . . . 0.75 110.165 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 t -115.96 -41.11 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 106.634 -1.617 . . . . 0.92000000000000004 106.634 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -108.22 13.08 26.08 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.825 -1.546 . . . . 2.3599999999999999 106.825 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 60.66 52.63 4.36 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.964 -0.562 . . . . 1.4199999999999999 109.908 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -157.87 154.92 28.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.972 -1.08 . . . . 1.97 110.712 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 228' ' ' TYR . 87.6 t -107.19 163.21 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.843 -0.799 . . . . 0.65000000000000002 108.843 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.517 ' N ' HG12 ' A' ' 227' ' ' VAL . 48.2 m-85 -122.07 116.27 23.96 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.358 -0.839 . . . . 0.96999999999999997 109.147 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.7 t -102.16 120.1 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.406 -0.809 . . . . 0.67000000000000004 109.871 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 31.8 t30 65.68 74.98 0.36 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.685 -0.634 . . . . 1.45 110.452 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -91.56 143.76 3.02 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 123.334 2.689 . . . . 0.81999999999999995 111.929 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 14.5 p -73.34 167.19 21.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 1.6200000000000001 109.714 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -72.4 -34.47 67.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 2.6000000000000001 108.958 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -66.25 -34.3 77.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.504 -0.747 . . . . 3.0600000000000001 109.473 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.1 t -76.03 -30.1 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 1.1399999999999999 109.151 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 69.5 mt -70.88 -56.37 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.311 -0.868 . . . . 1.04 109.074 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.85 -40.22 69.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 2.54 110.228 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -66.98 -40.27 87.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.119 -0.988 . . . . 2.6000000000000001 110.197 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.8 mtp -81.07 -23.11 38.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.069 -1.019 . . . . 1.23 109.692 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -60.02 -44.09 94.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 2.6699999999999999 109.385 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.65 -56.81 4.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 1.6599999999999999 110.019 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 94.0 t -48.81 -61.44 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.256 -0.902 . . . . 2.2000000000000002 110.091 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -49.29 -57.29 7.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.276 -0.89 . . . . 3.0 110.223 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--N 1.297 -1.69 0 O-C-N 120.854 -1.153 . . . . 1.76 109.931 -178.725 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 3' ' ' SER . 66.6 mtt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.5 -0.555 . . . . 3.6600000000000001 109.5 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.78 83.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 1.1200000000000001 109.556 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 1' ' ' MET . 50.8 m -94.59 112.12 23.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.963 -1.086 . . . . 1.45 108.696 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.76 -165.04 21.6 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 109.872 -1.291 . . . . 0.92000000000000004 109.872 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 5' ' ' ILE . 58.2 mt -93.07 -6.18 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.249 -1.148 . . . . 1.05 108.595 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' ILE . 18.3 tp 57.16 110.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.538 -0.726 . . . . 0.88 109.418 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.55 -45.87 9.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.78000000000000003 109.23 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.51 150.53 31.33 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.241 -0.912 . . . . 1.5 109.384 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -83.01 148.29 13.4 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.478 2.118 . . . . 0.85999999999999999 113.733 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.735 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.56 -177.06 34.53 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.421 -1.472 . . . . 0.78000000000000003 109.421 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 mt -147.7 126.89 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.872 -1.37 . . . . 0.73999999999999999 110.186 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.17 161.49 36.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.34 -0.85 . . . . 0.45000000000000001 109.48 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.474 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 8.1 m-85 -126.9 128.27 46.21 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.656 -0.868 . . . . 0.64000000000000001 108.656 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.77 165.95 38.47 Favored Glycine 0 N--CA 1.502 3.064 0 C-N-CA 118.48 -1.819 . . . . 0.45000000000000001 111.836 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -82.12 151.45 26.98 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.46 -1.024 . . . . 1.8799999999999999 110.66 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.54 130.76 37.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.448 -0.782 . . . . 0.58999999999999997 111.878 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 tp -111.05 99.86 8.65 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.182 -1.414 . . . . 0.64000000000000001 107.182 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 tp -85.51 122.55 29.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.785 -1.197 . . . . 0.73999999999999999 110.872 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 158' ' ' LEU . 20.9 mt -93.48 98.72 11.38 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.791 -0.818 . . . . 0.73999999999999999 108.791 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -89.85 142.52 27.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.433 -0.792 . . . . 1.8700000000000001 109.265 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -110.11 129.68 55.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.487 -0.758 . . . . 2.5800000000000001 109.681 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -78.13 122.26 25.4 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.17 -1.048 . . . . 2.1400000000000001 108.17 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -65.6 134.96 54.41 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.098 -1.001 . . . . 1.9299999999999999 109.765 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.0 mt -91.3 134.47 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.543 -0.723 . . . . 0.68000000000000005 109.503 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.84 119.52 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.87 -0.789 . . . . 0.83999999999999997 108.87 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.5 mt -90.62 131.51 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.968 -1.082 . . . . 0.79000000000000004 109.41 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -89.69 123.79 34.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.135 -0.978 . . . . 1.3700000000000001 109.508 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -97.11 28.39 3.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.172 -0.955 . . . . 2.6200000000000001 109.185 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -85.72 141.32 29.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 2.3500000000000001 109.691 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -84.87 130.21 34.69 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.487 -0.931 . . . . 2.3500000000000001 108.487 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.3 pt -88.18 172.76 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.78000000000000003 110.25 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 34' ' ' ASP . 88.5 p -99.01 161.1 13.81 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.586 -0.894 . . . . 1.04 108.586 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.82 -7.06 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.855 -1.153 . . . . 1.05 109.893 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 32' ' ' SER . 38.2 m-20 -83.38 -15.01 51.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.978 -1.076 . . . . 2.4700000000000002 110.517 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -117.55 0.46 12.11 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.366 -0.834 . . . . 1.46 109.758 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 t -68.64 -49.36 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.937 -1.102 . . . . 0.77000000000000002 109.593 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -59.67 -30.61 68.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.2 -0.937 . . . . 1.46 108.477 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.487 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 1.5 mp0 -70.67 -39.09 73.76 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.254 0.549 . . . . 2.29 110.023 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -64.45 -37.13 86.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.105 -0.997 . . . . 1.3 109.5 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.33 -45.55 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.804 . . . . 0.76000000000000001 109.401 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.85 -37.95 89.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 1.5 108.543 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.602 ' HG2' HH11 ' A' ' 42' ' ' ARG . 4.6 mtt-85 -67.05 -41.08 87.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.048 -0.723 . . . . 2.6600000000000001 109.048 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -81.82 -41.93 20.38 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.372 -0.83 . . . . 0.75 109.537 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 tp -64.6 -61.34 2.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.166 -0.959 . . . . 0.82999999999999996 108.569 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.0 t -65.4 -36.19 83.2 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.444 -0.785 . . . . 0.78000000000000003 108.992 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -50.84 -56.97 11.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.302 -1.919 . . . . 0.56999999999999995 108.302 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HB3' HH11 ' A' ' 47' ' ' ARG . 1.7 ttt-85 -47.04 -32.42 3.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.565 -0.962 . . . . 2.8300000000000001 108.735 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.21 -32.54 64.5 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.028 -1.101 . . . . 0.65000000000000002 108.028 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 46' ' ' GLY . 93.5 mttt -81.33 -58.99 2.79 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.026 -0.731 . . . . 2.5699999999999998 109.026 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.93 -44.71 64.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.095 -1.003 . . . . 0.51000000000000001 110.148 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 65.5 p -61.43 -37.62 84.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.159 -0.963 . . . . 1.3600000000000001 108.67 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.68 -42.12 61.72 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.394 0.616 . . . . 0.59999999999999998 109.401 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -67.29 -58.49 4.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.813 . . . . 1.3600000000000001 109.585 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.9 mt -52.35 -47.11 66.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.119 -0.988 . . . . 1.3799999999999999 108.875 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 51' ' ' SER . 6.2 mm-40 -52.25 -47.27 65.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.555 -0.715 . . . . 1.27 109.196 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m -58.6 -38.12 77.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.59999999999999998 108.83 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.1 mt -75.12 -31.94 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 0.53000000000000003 108.813 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -54.89 -50.11 69.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.439 -0.788 . . . . 0.98999999999999999 109.85 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.401 HG22 ' OE1' ' A' ' 63' ' ' GLU . 3.0 m -70.22 -29.92 66.87 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.333 -0.854 . . . . 0.58999999999999997 110.58 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -69.8 -14.92 63.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.712 -1.242 . . . . 1.8100000000000001 108.211 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.48 -36.92 21.94 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.699 -0.852 . . . . 0.47999999999999998 108.699 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.39 -26.64 42.57 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.68 -1.248 . . . . 0.57999999999999996 109.984 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.401 ' OE1' HG22 ' A' ' 59' ' ' THR . 32.3 mt-10 -86.82 -17.1 34.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.075 -1.25 . . . . 1.3899999999999999 109.413 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.9 m -96.3 -47.58 5.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.284 -0.885 . . . . 0.81999999999999995 110.168 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -106.24 -15.57 14.81 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.071 -1.018 . . . . 0.98999999999999999 110.702 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 118.37 140.83 6.51 Favored Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.057 -1.617 . . . . 0.55000000000000004 109.057 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -47.45 -11.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -1.155 . . . . 2.5899999999999999 110.542 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 66' ' ' GLY . 55.0 tt0 -61.27 -30.91 70.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.581 -1.324 . . . . 2.2000000000000002 109.905 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -92.01 -10.47 39.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.891 -1.131 . . . . 1.79 110.171 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -66.85 -35.12 79.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.042 -1.036 . . . . 1.54 110.187 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.06 -30.04 70.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.64000000000000001 110.382 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -69.01 -42.76 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.941 -1.099 . . . . 0.57999999999999996 108.725 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -77.8 -21.68 51.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.888 . . . . 0.62 109.53 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.52 -38.05 89.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.12 -0.987 . . . . 1.23 108.662 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.19 -35.76 52.38 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.046 -1.621 . . . . 0.52000000000000002 109.046 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.24 -20.9 64.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -1.117 . . . . 1.29 110.339 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.6 mt -84.09 -38.28 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.763 -1.21 . . . . 0.55000000000000004 108.384 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.4 ttt -59.68 -36.39 76.37 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.272 -0.892 . . . . 1.8899999999999999 108.776 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.3 tp -65.13 -38.82 91.87 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.812 -1.181 . . . . 0.53000000000000003 107.812 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.0 tp -73.25 -44.08 60.06 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.771 -0.772 . . . . 0.42999999999999999 109.466 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -85.75 5.72 31.06 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.218 -0.927 . . . . 1.24 110.195 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -47.14 123.16 5.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.944 -1.097 . . . . 1.3100000000000001 110.046 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -66.94 -26.07 66.66 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.894 -0.78 . . . . 1.3500000000000001 108.894 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -74.87 -51.09 14.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.427 -0.796 . . . . 2.1600000000000001 109.11 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.68 -17.72 64.81 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.975 -1.09 . . . . 0.59999999999999998 109.12 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -74.17 -55.7 5.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.089 -1.007 . . . . 1.28 110.399 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -62.25 -29.89 70.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.393 -0.817 . . . . 1.28 110.215 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -72.21 -42.87 65.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 1.29 108.763 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.1 mt -59.85 -59.41 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.36 -1.348 . . . . 0.57999999999999996 107.36 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.1 mt -47.85 -62.77 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.902 -0.498 . . . . 0.78000000000000003 110.193 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -42.7 -63.28 0.81 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.291 -0.881 . . . . 0.85999999999999999 109.932 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.5 mt -46.58 -51.93 14.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 0.79000000000000004 109.688 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 79.5 mt -52.94 -41.93 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 0.70999999999999996 109.309 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -85.68 -37.18 19.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 2.0499999999999998 111.734 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -86.2 -33.36 20.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.781 -1.199 . . . . 1.5900000000000001 112.416 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 97' ' ' HIS . 53.3 mmtt -109.7 20.06 18.5 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.453 -1.405 . . . . 1.8899999999999999 110.058 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 96' ' ' LYS . 46.9 m80 42.45 46.02 3.98 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.371 -0.831 . . . . 1.3100000000000001 110.158 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 34.8 mtt -98.28 144.77 27.35 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.726 -0.842 . . . . 1.28 108.726 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.3 p -75.51 148.3 39.08 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.47 -0.769 . . . . 0.62 110.086 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.29 -31.5 21.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.46999999999999997 109.338 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -74.19 -42.2 60.22 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.016 -1.105 . . . . 2.0 108.016 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.26 -55.13 7.69 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.313 -0.555 . . . . 0.56000000000000005 109.909 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.68 76.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 0.47999999999999998 109.685 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.01 -38.93 73.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.44 109.623 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' GLU . 49.4 t-80 -67.77 -41.11 83.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.943 . . . . 1.4199999999999999 109.753 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -48.14 -53.8 15.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 1.26 110.026 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.0 t -57.79 -54.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.047 -1.033 . . . . 0.60999999999999999 109.222 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.8 mm -61.62 -20.31 22.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.355 -0.841 . . . . 0.64000000000000001 109.047 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 105' ' ' HIS . 48.8 tt0 -66.23 -40.69 90.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 2.2000000000000002 110.243 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -86.53 -21.43 51.27 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.38 -1.39 . . . . 0.81999999999999995 111.941 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -67.01 -59.36 3.54 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.526 -1.573 . . . . 1.27 108.208 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.93 -52.03 65.7 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 120.072 -0.651 . . . . 0.91000000000000003 109.473 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.1 m -59.77 -46.4 89.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.122 -0.986 . . . . 1.73 110.954 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -62.21 -31.93 72.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.768 -1.208 . . . . 1.04 110.632 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 mt -70.11 -28.61 65.53 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.545 -1.262 . . . . 1.03 109.512 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -68.74 -20.0 64.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.734 -1.229 . . . . 1.95 109.215 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -81.44 -7.64 59.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 1.71 108.873 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mt -88.91 140.17 29.71 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.217 -1.031 . . . . 1.26 108.217 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -97.18 64.84 1.96 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.332 -0.988 . . . . 2.8300000000000001 108.332 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -146.17 113.72 6.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.351 -0.843 . . . . 1.5800000000000001 110.069 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.637 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 18.7 mp0 -57.23 -16.18 7.67 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.787 -0.82 . . . . 2.7999999999999998 108.787 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -80.23 -63.28 1.44 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.336 -0.853 . . . . 1.02 109.244 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.9 mt -63.6 -23.88 67.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 1.0600000000000001 109.14 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -68.4 -51.13 47.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.053 -1.029 . . . . 2.3900000000000001 108.762 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -58.76 -18.78 34.77 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.27 -0.894 . . . . 2.2000000000000002 108.892 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -74.57 -27.89 60.7 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.638 -1.616 . . . . 2.0899999999999999 106.638 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.02 98.0 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.398 0.618 . . . . 0.85999999999999999 109.41 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.09 73.97 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.278 -0.889 . . . . 0.90000000000000002 109.649 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.2 -36.75 66.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 1.3500000000000001 109.375 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.1 t -72.64 -40.82 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.411 -0.806 . . . . 0.57999999999999996 109.062 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.494 HH12 ' CE ' ' A' ' 135' ' ' LYS . 15.5 ttt-85 -54.38 -40.8 68.51 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.265 -0.897 . . . . 3.2200000000000002 109.046 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.94 -32.56 73.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.595 -0.691 . . . . 1.3200000000000001 110.245 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 65.0 mt -69.29 -26.51 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.952 -1.093 . . . . 0.5 110.343 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.07 -49.14 6.51 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.438 -1.465 . . . . 0.44 109.438 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.494 ' CE ' HH12 ' A' ' 131' ' ' ARG . 1.5 mptp? -51.98 -46.66 64.93 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.519 -0.989 . . . . 2.71 109.387 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HG2' HH11 ' A' ' 136' ' ' ARG . 6.8 mtt-85 -62.19 -52.31 64.32 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.988 -1.116 . . . . 2.2000000000000002 107.988 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.28 -40.38 34.37 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.794 -0.566 . . . . 1.1299999999999999 109.609 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 140' ' ' ASN . 23.0 mt -69.08 -58.94 3.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 0.54000000000000004 110.005 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 144' ' ' LEU . 89.9 mtt180 -44.52 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 2.3199999999999998 110.875 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 138' ' ' LEU . 8.0 m120 -85.34 -51.15 6.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.815 -1.178 . . . . 1.26 109.173 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.5 mt -55.88 -38.13 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 0.62 108.94 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 35.1 mt -86.21 1.29 51.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.486 -0.759 . . . . 0.67000000000000004 109.006 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.69 30.95 60.12 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.204 -1.958 . . . . 0.68000000000000005 108.204 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 139' ' ' ARG . 4.7 tp -73.78 145.3 45.16 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.559 -0.965 . . . . 0.77000000000000002 109.755 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -67.48 139.52 57.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -0.784 . . . . 2.3999999999999999 110.12 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 mt -109.44 142.79 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.579 -0.897 . . . . 0.87 108.579 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.58 HD12 ' H ' ' A' ' 147' ' ' ILE . 5.2 mp -75.73 119.94 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 1.3200000000000001 109.773 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.6 OUTLIER -95.85 91.86 6.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.81 . . . . 1.54 109.446 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 mt -79.77 -18.14 51.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.598 -0.689 . . . . 0.77000000000000002 109.276 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.6 p -79.46 23.4 0.4 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.945 . . . . 1.5700000000000001 109.66 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.99 25.9 2.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.053 -1.03 . . . . 0.81999999999999995 110.017 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 74.4 mt -71.75 152.7 8.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.085 -1.009 . . . . 0.81999999999999995 109.351 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -141.11 9.57 2.11 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.594 -0.891 . . . . 2.1099999999999999 108.594 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -123.17 124.88 44.04 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.759 -0.83 . . . . 1.4099999999999999 108.759 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.61 115.35 5.12 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.141 -0.974 . . . . 1.3 108.932 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.8 m -148.31 174.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.169 -0.957 . . . . 0.56999999999999995 109.431 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 13.9 mt -93.35 160.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.851 -1.166 . . . . 0.42999999999999999 107.851 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 19' ' ' LEU . 14.3 tp -108.27 122.86 47.82 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.472 -0.767 . . . . 0.56000000000000005 109.873 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.89 129.76 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.398 0.618 . . . . 0.54000000000000004 109.713 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -165.99 159.33 15.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 0.62 110.376 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.92 -42.7 94.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.63 -1.294 . . . . 0.80000000000000004 108.1 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 48.1 t0 -171.45 157.94 5.05 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.525 -0.735 . . . . 2.3399999999999999 109.39 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.417 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 27.6 mt -124.43 136.15 53.82 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.547 -0.721 . . . . 0.65000000000000002 109.539 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.2 p -95.4 152.33 39.23 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.254 -0.904 . . . . 0.73999999999999999 109.661 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -32.83 -54.2 0.38 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.984 2.456 . . . . 0.59999999999999998 113.219 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.7 m -51.06 -57.1 9.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -0.97 . . . . 0.63 109.445 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -54.52 -38.22 66.29 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 1.25 109.536 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 33.7 p -76.46 -20.19 57.28 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.317 -0.864 . . . . 0.5 109.751 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.46 -23.74 34.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.51000000000000001 109.664 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -104.52 -10.23 17.78 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.322 -0.861 . . . . 1.1699999999999999 110.349 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.7 tp -64.02 144.37 57.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.954 -1.091 . . . . 0.60999999999999999 108.615 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -95.46 140.71 29.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.876 -1.14 . . . . 2.1200000000000001 108.969 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.9 mp -85.65 -41.13 15.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 1.3400000000000001 111.025 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -77.99 -12.06 59.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.712 -1.243 . . . . 1.97 111.807 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -101.27 -5.83 24.97 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.678 -1.263 . . . . 1.8999999999999999 108.86 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 177' ' ' LEU . 74.1 t -100.52 163.43 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.407 -0.808 . . . . 0.47999999999999998 109.059 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.531 ' N ' HG12 ' A' ' 176' ' ' VAL . 4.8 tp -120.38 -17.25 8.24 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.466 -0.771 . . . . 1.3899999999999999 109.715 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.27 172.71 42.98 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.271 -1.531 . . . . 0.38 109.271 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -125.52 121.9 35.04 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.42 -1.047 . . . . 0.46000000000000002 108.962 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.73 125.56 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.313 -1.365 . . . . 0.58999999999999997 107.313 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 203' ' ' VAL . 2.2 p -135.08 141.35 46.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.356 0.598 . . . . 0.67000000000000004 109.7 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -89.79 37.01 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.505 -0.747 . . . . 2.2400000000000002 109.004 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.501 2.075 0 O-C-N 121.467 -0.771 . . . . 1.1100000000000001 109.542 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.9 t60 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.118 0.485 . . . . 0.92000000000000004 110.025 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 47.1 m -54.8 -31.19 58.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.188 -0.945 . . . . 1.5900000000000001 109.616 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.1 t -68.73 -35.94 77.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.351 -0.843 . . . . 1.4199999999999999 109.224 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.0 mm -60.31 -37.82 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 1.4099999999999999 109.856 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.5 mtm -70.59 -46.56 63.21 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.78 -1.193 . . . . 0.85999999999999999 107.78 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.0 74.38 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.673 -0.642 . . . . 0.58999999999999997 110.005 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -67.81 -43.54 79.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 3.0600000000000001 109.804 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.2 m -71.44 -37.33 71.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.933 . . . . 0.72999999999999998 109.967 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 199' ' ' LEU . 23.8 mt -88.03 3.36 49.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.872 . . . . 0.67000000000000004 109.111 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 50.54 2.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.494 -0.754 . . . . 1.49 110.902 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 197' ' ' LEU . 79.4 mt -65.88 167.62 11.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.015 -1.476 . . . . 0.64000000000000001 107.015 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -90.93 145.59 3.65 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 C-N-CA 122.069 1.846 . . . . 0.58999999999999997 111.646 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.57 179.98 6.85 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.579 -1.248 . . . . 0.55000000000000004 111.16 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 34.0 mt -149.38 155.6 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.008 -1.849 . . . . 0.63 106.008 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 181' ' ' THR . 15.8 m -137.28 -34.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.023 -1.048 . . . . 0.77000000000000002 111.915 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.41 45.09 3.1 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 120.469 -1.395 . . . . 0.87 111.248 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.6 p -72.56 1.0 8.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.334 -1.686 . . . . 0.89000000000000001 109.76 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.3 -98.78 0.84 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.828 -1.309 . . . . 0.93000000000000005 109.828 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.7 p -131.19 35.6 3.9 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.422 -1.046 . . . . 1.6000000000000001 111.815 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.0 t -50.47 -28.95 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.356 -1.465 . . . . 0.75 109.077 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.414 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 5.2 p -65.23 -11.95 46.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.923 -1.11 . . . . 0.83999999999999997 108.775 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -104.67 11.65 33.81 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.892 -0.781 . . . . 1.6100000000000001 108.892 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -128.53 -31.66 2.23 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.477 -0.764 . . . . 2.2999999999999998 110.278 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 213' ' ' LYS . 53.4 t -115.39 155.85 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.324 -0.86 . . . . 0.76000000000000001 110.008 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.44 ' O ' HG12 ' A' ' 212' ' ' VAL . 16.2 mmmt -114.8 -171.24 1.9 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.27 -1.382 . . . . 2.0099999999999998 107.27 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.429 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 11.6 p30 -81.11 149.72 29.05 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.097 -1.002 . . . . 2.1899999999999999 110.648 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.3 m-20 80.91 -12.81 0.98 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 116.067 -0.515 . . . . 2.3999999999999999 110.982 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -56.89 145.76 28.81 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.711 -1.243 . . . . 1.99 107.774 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -88.3 121.29 30.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.869 -1.144 . . . . 1.3 109.636 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.2 mt -123.81 161.9 24.33 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.82 0.819 . . . . 0.53000000000000003 109.911 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.4 mt -134.86 118.8 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.747 -1.205 . . . . 0.59999999999999998 107.747 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 8.9 tp -90.08 120.31 31.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.42 -0.8 . . . . 0.56999999999999995 109.528 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 53.6 t0 -94.42 -27.76 15.86 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.224 -1.028 . . . . 2.2200000000000002 108.224 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.87 24.25 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.131 0.491 . . . . 0.75 110.709 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 10.5 t -117.14 -62.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 106.733 -1.58 . . . . 0.92000000000000004 106.733 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -87.35 15.76 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.991 -1.114 . . . . 2.3599999999999999 107.991 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.8 t30 55.86 54.17 8.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.625 -0.672 . . . . 1.4199999999999999 109.343 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -150.04 144.38 25.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.355 -0.84 . . . . 1.97 110.29 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.54 153.39 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.289 -1.004 . . . . 0.65000000000000002 108.289 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -110.64 126.07 54.1 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.354 -0.841 . . . . 0.96999999999999997 108.882 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.11 118.02 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.509 -0.744 . . . . 0.67000000000000004 109.939 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 55.14 70.9 1.43 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 1.45 110.249 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -90.09 149.51 4.7 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.308 2.672 . . . . 0.81999999999999995 111.986 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.5 m -75.19 163.23 27.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 1.6200000000000001 109.86 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -67.11 -32.22 73.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.343 -0.848 . . . . 2.6000000000000001 110.121 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.48 -35.53 77.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.225 -0.922 . . . . 3.0600000000000001 109.282 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.68 -38.86 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.865 . . . . 1.1399999999999999 109.3 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.548 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 79.4 mt -64.2 -58.57 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -0.902 . . . . 1.04 110.074 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -42.21 75.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 2.54 109.886 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -65.22 -36.09 83.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.946 . . . . 2.6000000000000001 109.096 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 243' ' ' GLN . 54.4 mtp -79.08 -33.71 44.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 1.23 109.041 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -50.07 -43.46 51.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.745 -1.222 . . . . 2.6699999999999999 109.438 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.47 -55.61 6.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 1.6599999999999999 110.156 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.8 t -66.32 -46.94 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 2.2000000000000002 109.77 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 239' ' ' MET . 0.9 OUTLIER -55.14 -57.92 9.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 3.0 110.192 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 . . . . . 0 C--N 1.303 -1.413 0 O-C-N 120.879 -1.138 . . . . 1.76 109.705 -179.166 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.582 ' SD ' ' NE2' ' A' ' 226' ' ' GLN . 14.4 mmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.636 -0.505 . . . . 3.6600000000000001 109.636 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.6 mt -67.15 98.39 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.052 -1.03 . . . . 1.1200000000000001 108.782 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.3 m -98.42 121.86 40.89 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.353 -0.842 . . . . 1.45 109.609 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.89 -160.13 11.13 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.315 -1.514 . . . . 0.92000000000000004 109.315 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.3 mt -95.67 -9.92 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.332 -1.099 . . . . 1.05 108.799 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.442 HD13 HD21 ' A' ' 225' ' ' ASN . 5.5 tp 60.67 111.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.417 -0.802 . . . . 0.88 109.413 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.68 -52.91 5.25 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.325 -0.991 . . . . 0.78000000000000003 108.325 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.63 146.4 22.22 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 108.5 -0.926 . . . . 1.5 108.5 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.94 149.26 32.78 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.42 2.08 . . . . 0.85999999999999999 114.262 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.75 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.8 179.77 34.82 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.135 -1.586 . . . . 0.78000000000000003 109.135 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.449 HG21 ' NE2' ' A' ' 243' ' ' GLN . 42.0 mt -139.0 130.43 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.13 -1.218 . . . . 0.73999999999999999 109.495 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.47 151.08 41.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.364 -0.835 . . . . 0.45000000000000001 109.74 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.2 m-85 -122.44 138.24 54.61 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.07 -1.085 . . . . 0.64000000000000001 108.07 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.89 168.46 38.66 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 118.769 -1.681 . . . . 0.45000000000000001 111.564 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -80.71 147.48 30.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.683 -0.892 . . . . 1.8799999999999999 110.083 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -80.81 127.58 32.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.58999999999999997 111.322 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -105.49 96.99 6.89 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.08 -1.452 . . . . 0.64000000000000001 107.08 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.456 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 11.9 tp -80.4 120.04 23.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.956 -1.09 . . . . 0.73999999999999999 110.666 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.69 98.57 9.4 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.836 -0.62 . . . . 0.73999999999999999 109.406 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -93.23 159.24 15.36 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.66 -0.867 . . . . 1.8700000000000001 108.66 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -130.45 122.16 27.21 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.243 -0.911 . . . . 2.5800000000000001 109.467 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -81.62 131.76 35.28 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.35 -0.844 . . . . 2.1400000000000001 109.262 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -63.98 147.2 52.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 1.9299999999999999 109.638 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.7 mt -91.87 136.38 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.22 -0.925 . . . . 0.68000000000000005 109.709 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 t -107.64 121.74 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.394 -0.816 . . . . 0.83999999999999997 109.397 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.3 mt -88.85 145.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.79000000000000004 109.94 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.68 120.55 35.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.321 -0.862 . . . . 1.3700000000000001 109.748 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -102.01 29.04 5.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.192 -0.943 . . . . 2.6200000000000001 109.58 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -75.36 147.34 40.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.995 . . . . 2.3500000000000001 110.0 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -87.49 116.18 25.42 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.22 -1.029 . . . . 2.3500000000000001 108.22 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.7 pt -84.18 171.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.897 -1.127 . . . . 0.78000000000000003 110.617 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -98.09 168.48 10.24 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.193 -0.669 . . . . 1.04 109.193 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.31 -22.3 66.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 1.05 109.581 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.14 -7.39 58.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 2.4700000000000002 108.609 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -107.77 -9.21 15.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.53 -0.915 . . . . 1.46 108.53 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -67.93 -47.04 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.77000000000000002 108.979 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -51.46 -36.07 42.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 1.46 109.11 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.61 -32.61 71.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 2.29 109.928 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -61.8 -47.02 87.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.99 -1.069 . . . . 1.3 109.51 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 44' ' ' LEU . 85.6 t -61.51 -47.19 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.355 -0.84 . . . . 0.76000000000000001 110.016 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.28 -40.65 97.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.058 -1.026 . . . . 1.5 108.367 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -65.86 -32.35 73.81 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.81 -0.811 . . . . 2.6600000000000001 108.81 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -86.37 -56.68 3.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.75 108.972 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 40' ' ' VAL . 29.3 tp -51.54 -63.38 1.15 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.821 -0.807 . . . . 0.82999999999999996 108.821 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.5 t -61.73 -30.27 70.66 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.077 -1.082 . . . . 0.78000000000000003 108.077 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.65 -52.9 50.31 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.422 -2.271 . . . . 0.56999999999999995 107.422 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -48.5 -30.0 4.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.75 -0.853 . . . . 2.8300000000000001 108.76 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -62.5 -37.4 85.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.235 -1.024 . . . . 0.65000000000000002 108.235 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -81.73 -59.31 2.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.344 -0.613 . . . . 2.5699999999999998 109.344 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.7 -40.29 59.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.11 -0.994 . . . . 0.51000000000000001 109.832 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.7 t -62.75 -37.4 86.46 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.998 -1.064 . . . . 1.3600000000000001 108.221 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.76 -28.23 62.49 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.442 -0.577 . . . . 0.59999999999999998 109.442 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.484 ' NE2' ' OD1' ' A' ' 140' ' ' ASN . 90.3 mt-30 -72.07 -62.84 1.28 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.19 -0.944 . . . . 1.3600000000000001 109.109 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 54' ' ' LEU . 10.3 mp -51.93 -48.96 63.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 1.3799999999999999 108.466 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -49.81 -50.42 45.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.809 . . . . 1.27 109.218 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -63.13 -41.42 99.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.59999999999999998 109.655 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.4 mt -70.63 -34.85 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.53000000000000003 108.994 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -53.9 -45.1 71.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.284 -0.885 . . . . 0.98999999999999999 109.197 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 m -71.46 -24.26 61.97 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.266 -0.896 . . . . 0.58999999999999997 109.941 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.42 ' O ' ' OG1' ' A' ' 64' ' ' THR . 29.3 mttp -71.28 -33.11 69.45 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.748 -1.205 . . . . 1.8100000000000001 107.748 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.25 -34.11 76.75 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.793 -0.818 . . . . 0.47999999999999998 108.793 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.17 -30.23 25.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.678 -1.369 . . . . 0.57999999999999996 109.678 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -86.64 -12.3 48.88 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.823 -1.398 . . . . 1.3899999999999999 109.137 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 88.1 m -94.91 -46.96 6.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.2 -0.937 . . . . 0.81999999999999995 110.579 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -107.06 -34.71 7.08 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.111 -0.993 . . . . 0.98999999999999999 110.157 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 80.07 -41.29 2.4 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.969 -1.253 . . . . 0.55000000000000004 109.969 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 69' ' ' LYS . 67.3 mt-10 -50.51 178.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.241 . . . . 2.5899999999999999 109.573 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.62 43.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 2.2000000000000002 109.709 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 67' ' ' GLU . 15.9 mmmt -89.67 -17.91 27.48 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.557 -0.905 . . . . 1.79 108.557 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.65 -35.06 74.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.472 -0.767 . . . . 1.54 110.688 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.28 -22.24 66.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -0.978 . . . . 0.64000000000000001 110.412 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.48 -40.38 55.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.95 -1.094 . . . . 0.57999999999999996 109.508 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -76.6 -28.33 56.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.925 . . . . 0.62 109.616 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.66 -38.42 91.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.941 -1.099 . . . . 1.23 108.61 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.83 -32.38 61.24 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.578 -1.809 . . . . 0.52000000000000002 108.578 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -61.38 -18.79 60.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -1.07 . . . . 1.29 109.172 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.5 mt -85.67 -39.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.246 -1.02 . . . . 0.55000000000000004 108.246 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.3 ttt -58.8 -38.73 79.23 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.992 -0.744 . . . . 1.8899999999999999 108.992 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.9 tp -69.56 -43.76 72.26 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.852 -0.795 . . . . 0.53000000000000003 108.852 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.0 tp -64.72 -48.01 76.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.44 -0.788 . . . . 0.42999999999999999 109.483 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -84.4 13.14 5.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.836 . . . . 1.24 110.467 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -49.1 125.2 10.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.998 -1.064 . . . . 1.3100000000000001 109.695 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -67.69 -25.03 65.48 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.339 -0.851 . . . . 1.3500000000000001 108.756 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.62 -52.34 9.87 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.436 -0.79 . . . . 2.1600000000000001 109.528 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.7 mt -64.61 -15.65 61.49 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.036 -1.066 . . . . 0.59999999999999998 109.04 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -77.35 -43.4 33.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 1.28 109.801 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.03 -33.35 75.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -0.91 . . . . 1.28 110.405 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -72.77 -43.88 62.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 1.29 109.654 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.0 mt -57.36 -39.85 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.551 -0.907 . . . . 0.57999999999999996 108.551 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -67.5 -62.43 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.715 -0.615 . . . . 0.78000000000000003 110.27 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -50.07 -38.48 38.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.149 -0.969 . . . . 0.85999999999999999 109.834 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.6 -59.87 4.7 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.268 -0.895 . . . . 0.79000000000000004 108.676 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.7 mt -47.02 -44.26 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.70999999999999996 110.171 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -82.67 -31.44 28.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.161 -0.962 . . . . 2.0499999999999998 111.029 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 91' ' ' ALA . 66.9 t0 -79.25 -48.44 14.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.859 -1.15 . . . . 1.5900000000000001 111.778 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -106.71 21.06 18.09 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.82 -1.175 . . . . 1.8899999999999999 110.046 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 44.07 48.22 7.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -0.905 . . . . 1.3100000000000001 109.927 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtt -102.72 151.04 22.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.485 -0.759 . . . . 1.28 109.051 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.7 p -75.28 148.15 39.63 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.567 -0.708 . . . . 0.62 109.354 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.31 18.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.243 -0.911 . . . . 0.46999999999999997 109.167 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.31 -44.54 58.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.041 -1.096 . . . . 2.0 108.041 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.86 -52.92 15.0 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.647 -0.658 . . . . 0.56000000000000005 109.886 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.15 -49.46 76.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.47999999999999998 109.67 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.72 -33.98 61.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.44 109.893 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -68.97 -36.87 78.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.954 -1.091 . . . . 1.4199999999999999 109.525 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -58.76 -52.68 64.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.985 . . . . 1.26 109.674 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.1 t -56.41 -49.14 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.105 -0.997 . . . . 0.60999999999999999 109.299 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.41 -17.62 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.64000000000000001 109.18 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -73.58 -35.18 65.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.082 -1.011 . . . . 2.2000000000000002 109.976 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.25 -27.13 28.83 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.318 -1.42 . . . . 0.81999999999999995 112.338 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -67.25 -40.24 86.23 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.598 -1.531 . . . . 1.27 109.209 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.22 -52.18 8.49 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.393 -0.817 . . . . 0.91000000000000003 109.632 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.7 p -60.52 -42.13 95.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 1.73 110.245 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.54 -35.69 81.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.032 -1.042 . . . . 1.04 110.334 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.89 -27.55 65.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.854 -1.154 . . . . 1.03 109.599 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -69.14 -18.04 63.9 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.921 -1.112 . . . . 1.95 109.367 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -80.97 -4.81 56.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 1.71 109.348 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.5 mt -83.22 145.61 29.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 1.26 108.487 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -96.68 56.23 1.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.751 -0.833 . . . . 2.8300000000000001 108.751 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -146.25 117.27 7.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.303 -0.873 . . . . 1.5800000000000001 109.23 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.75 -16.77 18.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 2.7999999999999998 109.971 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.96 -65.6 0.95 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.935 . . . . 1.02 109.212 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.2 mt -61.1 -19.42 61.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 1.0600000000000001 109.116 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -67.79 -48.2 66.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.101 -0.999 . . . . 2.3900000000000001 108.36 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 50.3 mt-10 -61.85 -20.27 63.5 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.66 -0.867 . . . . 2.2000000000000002 108.66 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.527 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.5 OUTLIER -71.35 -29.53 65.08 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.6 -1.63 . . . . 2.0899999999999999 106.6 178.029 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.78 -50.66 72.96 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.957 -0.757 . . . . 0.85999999999999999 108.957 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.68 -37.48 76.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.90000000000000002 110.004 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 -68.18 -29.89 68.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.01 . . . . 1.3500000000000001 109.602 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.94 -40.49 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.221 -1.029 . . . . 0.57999999999999996 108.221 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' ' 131' ' ' ARG . 22.1 ttm-85 -56.0 -38.81 70.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.078 -1.082 . . . . 3.2200000000000002 108.078 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -61.51 -36.49 80.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.635 -0.666 . . . . 1.3200000000000001 109.93 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.6 mt -68.21 -30.81 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.036 -1.04 . . . . 0.5 109.492 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.49 -46.13 72.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.257 -1.937 . . . . 0.44 108.257 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -51.04 -44.61 61.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.78 -0.835 . . . . 2.71 109.253 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.542 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 69.4 mtt180 -62.57 -46.93 86.07 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.841 -1.17 . . . . 2.2000000000000002 107.841 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 137' ' ' LEU . 3.4 tt -52.28 -54.29 33.27 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.878 -0.786 . . . . 1.1299999999999999 108.878 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.93 -56.46 19.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.54000000000000004 109.586 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -44.74 -22.55 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 2.3199999999999998 111.068 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 61.6 m-80 -85.18 -42.48 14.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.801 -1.187 . . . . 1.26 110.074 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.35 -34.59 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.04 -1.038 . . . . 0.62 109.496 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.8 mt -90.98 -3.82 56.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.219 -0.926 . . . . 0.67000000000000004 109.395 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.32 29.99 63.94 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.16 -1.976 . . . . 0.68000000000000005 108.16 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.76 148.83 45.94 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.527 -0.984 . . . . 0.77000000000000002 109.686 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -68.84 147.69 51.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 2.3999999999999999 109.317 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 147' ' ' ILE . 78.0 mt -102.67 157.75 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.87 108.724 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.424 ' N ' HG22 ' A' ' 146' ' ' ILE . 11.6 mm -76.85 104.06 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.057 -1.027 . . . . 1.3200000000000001 109.444 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -102.18 90.3 3.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.564 -0.71 . . . . 1.54 110.276 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.2 mt -80.03 -7.15 58.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.77000000000000002 108.703 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.9 t -83.97 40.69 0.77 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -0.792 . . . . 1.5700000000000001 109.905 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.61 19.09 2.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.218 -0.926 . . . . 0.81999999999999995 109.006 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 60.1 mt -73.76 150.34 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.547 -0.721 . . . . 0.81999999999999995 109.593 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -141.3 2.36 1.67 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.339 -0.85 . . . . 2.1099999999999999 109.153 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -127.59 132.39 49.83 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.089 -0.708 . . . . 1.4099999999999999 109.089 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -63.04 120.51 11.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.915 . . . . 1.3 109.794 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.0 m -150.3 175.81 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.24 -0.912 . . . . 0.56999999999999995 109.421 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.2 mt -90.8 157.56 2.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.948 -1.131 . . . . 0.42999999999999999 107.948 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.7 tp -107.64 122.2 46.22 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.547 -0.721 . . . . 0.56000000000000005 109.212 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.7 t -123.75 132.59 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.311 0.577 . . . . 0.54000000000000004 109.504 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.44 144.84 12.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.62 109.491 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 183' ' ' ALA . . . -60.53 -32.82 71.84 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.464 -1.397 . . . . 0.80000000000000004 107.846 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -172.64 155.95 3.44 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.585 -0.697 . . . . 2.3399999999999999 109.413 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.0 mt -130.73 132.08 45.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.553 -0.717 . . . . 0.65000000000000002 109.319 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 p -92.33 152.89 42.77 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.262 -0.899 . . . . 0.73999999999999999 109.119 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -36.36 -43.71 0.83 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.322 2.014 . . . . 0.59999999999999998 112.189 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.542 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -54.16 -63.7 1.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.63 108.938 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -48.46 -40.27 25.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 1.25 109.362 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.2 p -71.04 -23.52 62.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 0.5 109.792 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.55 -29.36 46.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.912 . . . . 0.51000000000000001 110.285 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -104.54 -7.63 19.61 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.275 -0.891 . . . . 1.1699999999999999 110.077 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.1 tp -57.36 135.67 56.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.822 -1.174 . . . . 0.60999999999999999 108.08 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.404 ' O ' HG23 ' A' ' 176' ' ' VAL . 38.2 t-20 -99.89 120.7 40.19 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.221 -0.925 . . . . 2.1200000000000001 110.048 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 173' ' ' LEU . 7.9 mp -93.58 45.99 1.18 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.843 . . . . 1.3400000000000001 108.741 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -109.54 -27.47 9.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.404 -0.81 . . . . 1.97 109.02 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -131.2 11.86 5.04 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.439 -0.788 . . . . 1.8999999999999999 109.643 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 172' ' ' ASN . 66.7 t -82.85 154.29 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.112 -0.993 . . . . 0.47999999999999998 109.494 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.0 tp -117.47 -12.2 10.43 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.719 -0.613 . . . . 1.3899999999999999 109.547 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 163.99 179.84 38.49 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.61 -1.396 . . . . 0.38 109.61 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.489 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 1.6 m-85 -130.44 124.95 33.23 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.557 -0.966 . . . . 0.46000000000000002 109.635 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.8 mt -128.54 126.6 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.887 -1.153 . . . . 0.58999999999999997 107.887 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.501 ' O ' ' O ' ' A' ' 203' ' ' VAL . 40.7 p -142.01 149.36 39.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 0.67000000000000004 110.549 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.44 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 4.6 p30 -100.28 43.69 1.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.323 -0.861 . . . . 2.2400000000000002 109.268 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 161' ' ' ALA . . . . . . . . 0 N--CA 1.503 2.211 0 O-C-N 121.424 -0.797 . . . . 1.1100000000000001 110.323 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 46.5 t60 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.252 0.549 . . . . 0.92000000000000004 109.95 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.2 p -52.95 -45.43 67.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 1.5900000000000001 109.924 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.5 t -68.31 -39.28 82.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 1.4199999999999999 110.041 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.5 mm -50.44 -38.52 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 1.4099999999999999 110.34 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 mtp -72.05 -59.57 2.67 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.7 -1.222 . . . . 0.85999999999999999 107.7 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.69 -31.09 35.59 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.761 -0.654 . . . . 0.58999999999999997 109.847 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -78.95 -47.37 16.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 3.0600000000000001 109.898 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.8 m -69.51 -36.17 76.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.031 -1.043 . . . . 0.72999999999999998 109.755 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 199' ' ' LEU . 29.0 mt -86.53 0.06 55.09 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 0.67000000000000004 108.927 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 47.81 10.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 1.49 111.051 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 197' ' ' LEU . 22.0 mt -66.79 161.01 65.14 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.801 -1.187 . . . . 0.64000000000000001 108.597 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -79.38 127.88 7.67 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.188 1.259 . . . . 0.58999999999999997 111.172 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -163.87 179.04 7.32 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.844 -1.142 . . . . 0.55000000000000004 110.871 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.6 mt -146.35 162.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.001 -1.481 . . . . 0.63 107.001 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 181' ' ' THR . 15.6 m -147.84 -28.2 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.718 -1.239 . . . . 0.77000000000000002 111.408 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.9 26.94 14.18 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 120.901 -1.125 . . . . 0.87 110.328 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.425 ' HB ' HG23 ' A' ' 208' ' ' VAL . 30.8 p -52.61 -41.06 63.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.833 -1.392 . . . . 0.89000000000000001 108.738 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.44 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 76.92 -38.1 1.51 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 120.781 -0.724 . . . . 0.93000000000000005 113.837 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 83.8 p -130.19 27.28 5.11 Favored 'General case' 0 N--CA 1.514 2.773 0 CA-C-N 119.939 1.869 . . . . 1.6000000000000001 113.256 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.425 HG23 ' HB ' ' A' ' 205' ' ' THR . 5.5 t -79.3 -41.94 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.133 -1.604 . . . . 0.75 110.323 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 p -64.65 -12.89 50.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.668 -1.27 . . . . 0.83999999999999997 110.137 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.8 p -106.17 11.84 30.84 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 1.6100000000000001 109.407 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -144.23 4.63 1.24 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.243 -0.91 . . . . 2.2999999999999998 110.588 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.5 t -126.93 151.37 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.305 -0.872 . . . . 0.76000000000000001 109.524 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.506 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 42.6 mmtt -129.25 166.85 18.61 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.048 -1.464 . . . . 2.0099999999999998 107.048 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 67.7 m-80 -64.14 143.47 57.85 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.8 -1.187 . . . . 2.1899999999999999 110.616 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 73.9 -2.44 2.78 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.797 -0.564 . . . . 2.3999999999999999 110.623 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.506 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 44.1 m-20 -57.51 142.26 44.9 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.914 -1.116 . . . . 1.99 108.673 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -86.52 107.22 18.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.44 -0.948 . . . . 1.3 108.44 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' A' ' 16' ' ' ALA . 40.8 mt -122.51 154.01 38.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.548 -0.72 . . . . 0.53000000000000003 110.139 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.419 HG23 ' CD2' ' A' ' 13' ' ' PHE . 49.8 mt -126.04 122.82 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.501 -0.926 . . . . 0.59999999999999998 108.501 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.5 tp -90.59 120.38 31.62 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.524 -0.917 . . . . 0.56999999999999995 108.524 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.3 m-20 -97.19 -29.79 13.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.215 -0.928 . . . . 2.2200000000000002 109.546 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.5 21.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.912 -0.492 . . . . 0.75 110.422 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -115.96 -51.66 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 106.967 -1.494 . . . . 0.92000000000000004 106.967 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -96.46 10.85 37.0 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.112 -1.44 . . . . 2.3599999999999999 107.112 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.442 HD21 HD13 ' A' ' 6' ' ' LEU . 20.1 t-20 56.23 54.72 7.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.972 -0.751 . . . . 1.4199999999999999 108.972 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.582 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 65.9 tt0 -153.99 150.59 28.44 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.917 0.865 . . . . 1.97 110.171 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 78.2 t -115.11 152.22 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.308 -0.997 . . . . 0.65000000000000002 108.308 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -108.54 121.32 44.74 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.217 -0.927 . . . . 0.96999999999999997 109.45 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.69 114.98 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.574 -0.704 . . . . 0.67000000000000004 109.518 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 69.02 67.5 0.47 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.659 -0.651 . . . . 1.45 109.671 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -86.33 130.42 3.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 123.057 2.505 . . . . 0.81999999999999995 112.498 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.3 p -74.02 162.27 29.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 1.6200000000000001 109.594 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -64.06 -44.03 93.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 2.6000000000000001 109.828 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -53.27 -36.69 61.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.394 -0.816 . . . . 3.0600000000000001 109.384 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.2 t -76.74 -37.1 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.678 -0.86 . . . . 1.1399999999999999 108.678 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 75.3 mt -71.62 -57.4 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 1.04 109.344 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -51.07 -44.89 61.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -0.781 . . . . 2.54 110.014 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -65.33 -32.32 73.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 2.6000000000000001 108.93 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 243' ' ' GLN . 77.1 mtp -81.94 -42.46 19.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.404 -0.81 . . . . 1.23 109.555 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -47.45 -39.28 15.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.035 -1.04 . . . . 2.6699999999999999 109.82 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.36 -63.35 1.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.109 -0.995 . . . . 1.6599999999999999 110.394 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.8 t -66.08 -51.4 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.103 -0.998 . . . . 2.2000000000000002 110.198 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 239' ' ' MET . 45.8 tt0 -47.92 -47.44 32.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.078 -1.014 . . . . 3.0 109.635 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 . . . . . 0 C--N 1.3 -1.564 0 O-C-N 120.828 -1.17 . . . . 1.76 108.939 179.703 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 3' ' ' SER . 80.4 mtp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.338 0.59 . . . . 3.6600000000000001 109.494 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.428 HG23 ' CG2' ' A' ' 208' ' ' VAL . 83.5 mt -58.42 81.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 1.1200000000000001 109.604 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 1' ' ' MET . 1.5 m -98.22 113.79 25.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.259 -0.901 . . . . 1.45 109.725 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.95 -163.62 20.39 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 108.665 -1.774 . . . . 0.92000000000000004 108.665 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 5' ' ' ILE . 59.9 mt -96.96 -6.59 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.033 -1.275 . . . . 1.05 108.918 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.1 tp 53.46 104.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.515 -0.74 . . . . 0.88 109.206 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.78 -51.46 6.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.996 . . . . 0.78000000000000003 109.342 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -144.97 149.48 42.57 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.318 -0.864 . . . . 1.5 109.019 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HA ' ' HB1' ' A' ' 222' ' ' ALA . 63.1 Cg_endo -80.14 154.78 22.34 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.372 2.048 . . . . 0.85999999999999999 113.732 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.99 138.32 2.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.597 -1.401 . . . . 0.78000000000000003 109.597 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.2 mt -96.73 132.49 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.186 -1.185 . . . . 0.73999999999999999 109.388 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.474 ' HB1' HD12 ' A' ' 177' ' ' LEU . . . -139.35 157.37 46.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.33 -0.856 . . . . 0.45000000000000001 110.344 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.585 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -130.69 134.73 47.17 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.25 -1.019 . . . . 0.64000000000000001 108.25 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.96 164.66 34.24 Favored Glycine 0 N--CA 1.503 3.102 0 C-N-CA 118.204 -1.95 . . . . 0.45000000000000001 111.813 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -77.62 146.55 36.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.576 -0.955 . . . . 1.8799999999999999 109.753 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.92 122.36 25.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.709 . . . . 0.58999999999999997 110.981 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 tp -100.82 94.67 6.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.845 -1.168 . . . . 0.64000000000000001 107.845 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.6 tp -81.97 112.74 19.34 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.01 -1.056 . . . . 0.73999999999999999 109.759 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 158' ' ' LEU . 93.7 mt -97.89 93.95 6.62 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.661 -0.7 . . . . 0.73999999999999999 109.783 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -92.62 159.16 15.59 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.598 -0.89 . . . . 1.8700000000000001 108.598 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -118.3 131.79 56.32 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.438 -0.789 . . . . 2.5800000000000001 109.678 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.5 127.04 31.64 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.488 -0.93 . . . . 2.1400000000000001 108.488 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -62.74 136.94 58.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 1.9299999999999999 109.292 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.4 mt -90.82 131.33 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.26 -0.9 . . . . 0.68000000000000005 110.194 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.33 122.77 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.655 -0.868 . . . . 0.83999999999999997 108.655 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -89.6 140.66 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.164 -0.96 . . . . 0.79000000000000004 110.028 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -90.66 128.95 36.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.22 -0.925 . . . . 1.3700000000000001 109.324 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -105.25 30.52 5.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.414 -0.803 . . . . 2.6200000000000001 109.959 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -76.24 144.03 40.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.117 -0.989 . . . . 2.3500000000000001 109.788 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -86.99 124.01 32.72 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.702 -0.851 . . . . 2.3500000000000001 108.702 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -90.64 170.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.102 -0.999 . . . . 0.78000000000000003 110.477 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.3 p -97.24 169.13 9.99 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.486 -0.561 . . . . 1.04 109.486 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.25 -25.62 68.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 1.05 109.433 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -80.22 -5.11 55.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 2.4700000000000002 109.239 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -109.96 -15.9 13.96 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.019 -1.104 . . . . 1.46 108.019 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.29 -42.88 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.102 -0.703 . . . . 0.77000000000000002 109.102 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -53.42 -36.17 61.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 1.46 109.374 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -69.62 -32.69 71.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 2.29 109.755 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -63.42 -41.92 98.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.152 -0.967 . . . . 1.3 109.267 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 44' ' ' LEU . 76.5 t -62.48 -49.01 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.412 -0.805 . . . . 0.76000000000000001 110.032 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -65.27 -45.02 86.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.04 . . . . 1.5 108.838 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -64.99 -31.75 73.15 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.704 -0.798 . . . . 2.6600000000000001 109.045 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -86.47 -59.36 2.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.078 -1.014 . . . . 0.75 108.733 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 40' ' ' VAL . 30.8 tp -47.94 -65.18 0.61 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.36 0.6 . . . . 0.82999999999999996 109.695 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.1 t -64.28 -37.72 88.49 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.518 -0.919 . . . . 0.78000000000000003 108.518 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.01 -52.41 49.25 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.355 -2.298 . . . . 0.56999999999999995 107.355 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.415 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.2 ttt-85 -51.41 -26.18 7.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.684 -0.892 . . . . 2.8300000000000001 109.033 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -73.73 -28.53 61.75 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.987 -1.116 . . . . 0.65000000000000002 107.987 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 46' ' ' GLY . 33.3 ttmt -75.48 -56.67 4.47 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.082 -0.711 . . . . 2.5699999999999998 109.082 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.42 -30.75 30.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.086 -1.009 . . . . 0.51000000000000001 109.566 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 10.1 p -65.07 -38.67 91.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 1.3600000000000001 108.906 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.87 -28.28 65.52 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.478 0.656 . . . . 0.59999999999999998 109.336 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -71.81 -67.66 0.51 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.764 . . . . 1.3600000000000001 109.602 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 54' ' ' LEU . 9.3 mp -51.04 -34.73 30.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 1.3799999999999999 108.819 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 51' ' ' SER . 9.5 mm-40 -63.88 -51.47 64.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.471 -0.768 . . . . 1.27 109.08 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -60.98 -34.56 74.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.59999999999999998 108.592 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.28 -25.29 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.574 -0.899 . . . . 0.53000000000000003 108.574 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -65.46 -44.47 87.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.559 -0.713 . . . . 0.98999999999999999 109.588 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -71.79 -27.15 62.74 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.3 -0.875 . . . . 0.58999999999999997 109.144 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -72.27 -29.68 64.12 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.769 -1.197 . . . . 1.8100000000000001 107.769 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.81 61.91 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.091 -1.077 . . . . 0.47999999999999998 108.091 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.7 -29.76 28.56 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.433 -1.467 . . . . 0.57999999999999996 109.433 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -86.55 -20.24 28.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -1.202 . . . . 1.3899999999999999 108.595 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -94.36 -46.89 6.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.81999999999999995 110.357 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -107.92 -27.16 10.35 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.111 -0.993 . . . . 0.98999999999999999 111.297 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.97 152.98 8.94 Favored Glycine 0 N--CA 1.506 3.337 0 N-CA-C 109.647 -1.381 . . . . 0.55000000000000004 109.647 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -50.2 -12.54 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -1.124 . . . . 2.5899999999999999 110.583 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 66' ' ' GLY . 27.7 tt0 -63.66 -31.22 72.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.988 . . . . 2.2000000000000002 110.454 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -91.08 -17.46 26.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.927 -1.108 . . . . 1.79 110.28 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -62.53 -28.87 70.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.986 -1.071 . . . . 1.54 109.941 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.22 -30.36 69.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.179 -0.951 . . . . 0.64000000000000001 109.604 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.38 -44.05 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -0.876 . . . . 0.57999999999999996 109.105 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -77.27 -24.49 51.05 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.465 -0.772 . . . . 0.62 109.664 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -63.9 -42.36 97.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.965 -1.084 . . . . 1.23 108.9 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.04 -36.24 80.49 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.928 -1.669 . . . . 0.52000000000000002 108.928 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.07 -18.56 61.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.445 -1.032 . . . . 1.29 110.661 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.3 mt -85.03 -46.36 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.618 -1.301 . . . . 0.55000000000000004 108.94 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 42.5 ttp -55.22 -49.16 72.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.36 -0.837 . . . . 1.8899999999999999 108.967 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tp -54.88 -43.44 73.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.407 -0.808 . . . . 0.53000000000000003 109.171 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.31 -44.1 80.03 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.383 -0.823 . . . . 0.42999999999999999 109.417 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -85.37 8.42 18.88 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.416 -0.803 . . . . 1.24 110.161 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -49.14 121.53 4.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.974 -1.079 . . . . 1.3100000000000001 109.666 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -66.84 -24.26 66.13 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.542 -0.91 . . . . 1.3500000000000001 108.542 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -75.57 -48.89 20.38 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.334 -0.854 . . . . 2.1600000000000001 109.249 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.7 mt -63.68 -15.09 57.46 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.032 -1.067 . . . . 0.59999999999999998 108.979 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -79.54 -45.64 18.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.438 -0.789 . . . . 1.28 110.041 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -64.56 -28.87 69.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.254 -0.904 . . . . 1.28 110.022 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.21 -46.25 35.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.196 -0.94 . . . . 1.29 109.889 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.7 mt -58.38 -55.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.06 -1.089 . . . . 0.57999999999999996 108.06 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.0 mt -45.14 -58.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.623 -0.673 . . . . 0.78000000000000003 109.872 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -49.04 -57.05 7.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.423 -0.798 . . . . 0.85999999999999999 110.418 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.2 mt -50.54 -56.49 11.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.426 -0.796 . . . . 0.79000000000000004 109.266 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.0 mt -47.4 -41.63 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.70999999999999996 109.784 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -86.19 -33.72 20.71 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.116 -0.99 . . . . 2.0499999999999998 111.974 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -79.34 -44.29 21.86 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.536 -1.353 . . . . 1.5900000000000001 111.757 -176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -105.76 15.47 26.73 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.722 -1.236 . . . . 1.8899999999999999 109.23 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.505 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 1.5 m80 45.41 55.47 6.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.391 -0.818 . . . . 1.3100000000000001 109.54 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 74.1 mtp -102.51 153.65 19.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.571 -0.706 . . . . 1.28 109.259 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.7 p -76.16 171.45 14.48 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.486 -0.759 . . . . 0.62 109.389 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.31 -28.47 62.1 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.758 . . . . 0.46999999999999997 109.668 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.13 -45.4 41.21 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.064 -1.087 . . . . 2.0 108.064 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.55 -52.33 22.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.714 -0.616 . . . . 0.56000000000000005 110.201 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.34 -48.75 80.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.47999999999999998 109.754 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.21 -35.25 67.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 0.44 109.606 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -68.77 -34.64 75.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.968 -1.082 . . . . 1.4199999999999999 109.641 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -53.43 -60.94 2.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.375 -0.828 . . . . 1.26 110.118 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.0 t -50.93 -48.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.953 -1.092 . . . . 0.60999999999999999 109.682 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -61.73 -20.62 23.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.39 -0.819 . . . . 0.64000000000000001 108.967 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.37 -37.86 74.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.089 -1.007 . . . . 2.2000000000000002 109.779 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 114' ' ' ALA . . . -87.2 -23.95 38.91 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.491 -1.338 . . . . 0.81999999999999995 112.843 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -67.1 -52.82 37.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.343 -1.681 . . . . 1.27 108.746 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.14 -52.44 59.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.563 -0.71 . . . . 0.91000000000000003 109.816 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.8 m -61.63 -32.58 72.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.128 -0.982 . . . . 1.73 109.992 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -63.04 -43.65 98.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.825 -1.172 . . . . 1.04 110.064 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 123' ' ' LEU . 12.2 mt -67.23 -22.66 65.68 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.541 -1.263 . . . . 1.03 109.249 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.82 -23.65 64.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.779 -1.2 . . . . 1.95 109.165 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -82.99 -8.87 59.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -0.847 . . . . 1.71 109.032 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 mt -84.34 148.02 26.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.418 -0.956 . . . . 1.26 108.418 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -98.66 61.3 1.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.751 . . . . 2.8300000000000001 109.927 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -152.09 118.69 5.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.016 -1.053 . . . . 1.5800000000000001 110.11 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -62.27 -13.78 31.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 2.7999999999999998 109.238 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -78.03 -61.15 2.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.499 -0.75 . . . . 1.02 109.251 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.472 ' O ' HD13 ' A' ' 115' ' ' LEU . 27.1 mt -62.92 -29.33 70.7 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.265 -0.897 . . . . 1.0600000000000001 109.92 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 71.5 tttt -66.4 -47.51 73.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.838 -1.164 . . . . 2.3900000000000001 108.162 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -57.67 -24.48 56.88 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.159 -1.052 . . . . 2.2000000000000002 108.159 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -73.17 -23.79 60.47 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.571 -1.64 . . . . 2.0899999999999999 106.571 178.037 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -61.0 -45.3 95.39 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.858 -0.793 . . . . 0.85999999999999999 108.858 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.41 -35.83 80.06 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.863 -0.735 . . . . 0.90000000000000002 109.025 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.5 m-20 -69.01 -36.3 77.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.418 -0.801 . . . . 1.3500000000000001 109.095 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.87 -42.98 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.995 -1.113 . . . . 0.57999999999999996 107.995 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.504 ' HG2' HH11 ' A' ' 131' ' ' ARG . 1.4 ttt-85 -54.77 -39.15 68.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.608 -0.886 . . . . 3.2200000000000002 108.608 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -60.18 -35.3 75.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.438 -0.789 . . . . 1.3200000000000001 109.497 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.1 mt -65.81 -26.14 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.5 109.053 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.94 -50.62 7.62 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.455 -1.458 . . . . 0.44 109.455 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -50.4 -47.36 56.45 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.444 -1.033 . . . . 2.71 109.994 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.408 ' NH1' ' HG2' ' A' ' 136' ' ' ARG . 58.9 mtt-85 -65.21 -46.29 81.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.947 -1.096 . . . . 2.2000000000000002 108.776 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.6 tp -54.19 -33.19 57.59 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.727 -0.608 . . . . 1.1299999999999999 109.705 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 140' ' ' ASN . 16.8 mt -76.79 -56.6 4.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.819 -1.176 . . . . 0.54000000000000004 109.687 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -46.24 -17.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.933 . . . . 2.3199999999999998 110.093 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.521 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.7 m120 -85.93 -37.14 19.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.978 . . . . 1.26 109.633 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.3 mt -72.84 -40.64 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.62 109.727 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.5 mt -86.67 1.93 50.25 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.668 -0.864 . . . . 0.67000000000000004 108.668 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.06 20.39 8.74 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.096 -2.002 . . . . 0.68000000000000005 108.096 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.5 tp -54.84 163.54 0.96 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.645 -0.915 . . . . 0.77000000000000002 109.146 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -68.18 143.62 55.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 2.3999999999999999 110.103 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.3 mt -111.39 137.55 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.508 -0.745 . . . . 0.87 109.141 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.447 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.9 mp -77.71 99.48 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 1.3200000000000001 109.085 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -99.38 92.29 5.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.413 -0.805 . . . . 1.54 109.64 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.417 HD21 ' CG2' ' A' ' 147' ' ' ILE . 22.0 mt -79.24 -9.71 59.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 0.77000000000000002 109.104 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.2 t -79.77 35.27 0.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 1.5700000000000001 108.979 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -142.67 18.29 2.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.399 -0.813 . . . . 0.81999999999999995 109.424 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.24 150.97 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 0.81999999999999995 110.13 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -145.86 11.89 1.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.293 -1.002 . . . . 2.1099999999999999 108.293 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -125.36 125.37 43.33 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.336 -0.987 . . . . 1.4099999999999999 108.336 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.82 115.27 4.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.359 -0.838 . . . . 1.3 109.29 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.29 178.62 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 0.56999999999999995 109.675 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 26.8 mt -93.8 153.14 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.834 -1.173 . . . . 0.42999999999999999 107.834 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 19' ' ' LEU . 25.4 tp -101.13 115.59 30.84 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.775 -0.824 . . . . 0.56000000000000005 108.775 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.9 t -121.84 128.96 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.93 -0.767 . . . . 0.54000000000000004 108.93 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.86 149.96 11.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.483 -0.761 . . . . 0.62 109.098 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.09 -35.79 67.42 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.651 -1.281 . . . . 0.80000000000000004 107.928 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -174.9 156.5 2.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.653 -0.654 . . . . 2.3399999999999999 109.243 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.0 mt -123.83 133.73 53.74 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.547 -0.721 . . . . 0.65000000000000002 109.581 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.8 p -93.57 152.52 40.94 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.921 -0.77 . . . . 0.73999999999999999 108.921 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -34.88 -51.98 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.459 2.106 . . . . 0.59999999999999998 112.526 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.7 m -51.79 -50.26 61.08 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.179 -0.95 . . . . 0.63 108.861 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.03 -35.73 77.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.596 -0.69 . . . . 1.25 109.819 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.7 p -79.94 -28.77 39.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.111 -0.993 . . . . 0.5 109.411 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.21 -18.19 59.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.852 . . . . 0.51000000000000001 109.98 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -106.93 -14.52 14.94 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.218 -0.926 . . . . 1.1699999999999999 109.336 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.2 tp -55.29 134.92 50.23 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.021 -1.103 . . . . 0.60999999999999999 108.021 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -98.49 97.44 8.76 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.209 -0.932 . . . . 2.1200000000000001 109.586 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 173' ' ' LEU . 6.6 mp -75.9 44.69 0.31 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.5 -0.75 . . . . 1.3400000000000001 109.317 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -106.5 -24.8 12.09 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.572 -0.899 . . . . 1.97 108.572 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -132.28 4.09 4.01 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.757 -0.59 . . . . 1.8999999999999999 110.03 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.1 153.91 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.971 -1.081 . . . . 0.47999999999999998 109.09 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -111.03 -37.53 5.34 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.659 -0.651 . . . . 1.3899999999999999 110.003 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.41 -177.95 37.47 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.152 -1.579 . . . . 0.38 109.152 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -132.46 127.88 36.25 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.465 -1.021 . . . . 0.46000000000000002 110.008 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.9 mt -127.03 118.55 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.981 -1.488 . . . . 0.58999999999999997 106.981 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 32.0 p -141.03 151.99 44.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.411 -0.805 . . . . 0.67000000000000004 111.67 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -90.84 42.48 1.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.548 -0.72 . . . . 2.2400000000000002 109.224 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.809 0 O-C-N 120.989 -1.069 . . . . 1.1100000000000001 110.474 -178.299 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.9 t60 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.992 0.425 . . . . 0.92000000000000004 110.12 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.1 m -46.33 -39.39 10.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.993 -1.067 . . . . 1.5900000000000001 109.571 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.0 p -61.04 -45.59 94.17 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.289 -0.882 . . . . 1.4199999999999999 109.003 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 74.1 mt -49.72 -33.05 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.931 . . . . 1.4099999999999999 109.29 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 74.4 mtp -73.62 -65.52 0.81 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.641 -1.244 . . . . 0.85999999999999999 107.641 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.19 -28.54 7.66 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.679 -0.692 . . . . 0.58999999999999997 110.04 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.419 ' HG2' HH11 ' A' ' 195' ' ' ARG . 31.8 mtt-85 -80.61 -52.32 7.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.869 -1.145 . . . . 3.0600000000000001 110.512 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.6 m -71.14 -33.95 70.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.897 -1.127 . . . . 0.72999999999999998 109.687 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 199' ' ' LEU . 22.3 mt -90.4 -0.44 57.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.23 -0.919 . . . . 0.67000000000000004 109.126 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 46.34 11.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.345 -0.847 . . . . 1.49 111.284 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 197' ' ' LEU . 17.8 mt -68.31 145.22 97.29 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.815 -1.178 . . . . 0.64000000000000001 109.45 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -56.63 131.92 48.59 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.091 1.861 . . . . 0.58999999999999997 110.803 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.44 173.04 11.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.597 -1.314 . . . . 0.55000000000000004 111.33 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 203' ' ' VAL . 68.9 mt -143.9 159.45 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.78 -1.563 . . . . 0.63 106.78 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.1 m -143.11 -33.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 120.577 -1.327 . . . . 0.77000000000000002 111.337 -178.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.76 36.67 2.98 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.075 -1.21 . . . . 0.87 110.075 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.9 p -65.94 -31.47 72.41 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.866 -1.373 . . . . 0.89000000000000001 108.604 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.23 -91.04 0.37 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.068 -1.063 . . . . 0.93000000000000005 111.713 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 10.9 m -111.29 40.51 2.06 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.196 -1.179 . . . . 1.6000000000000001 112.945 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.428 ' CG2' HG23 ' A' ' 2' ' ' ILE . 23.3 t -76.93 -28.68 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.383 -1.448 . . . . 0.75 107.418 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 29.9 p -66.76 -9.64 38.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.391 -0.818 . . . . 0.83999999999999997 109.179 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 41.3 m -104.85 9.19 34.88 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.302 -0.999 . . . . 1.6100000000000001 108.302 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -134.74 2.25 3.14 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.532 -0.914 . . . . 2.2999999999999998 108.532 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.53 151.87 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.152 -0.684 . . . . 0.76000000000000001 109.152 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -131.81 162.44 30.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.608 -1.627 . . . . 2.0099999999999998 106.608 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 60.4 m-80 -63.71 146.86 53.03 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.786 -1.196 . . . . 2.1899999999999999 110.461 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.3 t70 79.4 -20.89 0.36 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.722 -0.611 . . . . 2.3999999999999999 110.431 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.38 126.1 25.78 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.771 -1.206 . . . . 1.99 108.155 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -87.5 118.97 27.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.787 -1.196 . . . . 1.3 109.723 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.5 mt -113.62 137.35 51.72 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.492 -0.929 . . . . 0.53000000000000003 108.492 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.31 115.64 47.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.825 -1.176 . . . . 0.59999999999999998 107.825 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 30.9 tp -83.2 129.77 35.04 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.296 -1.002 . . . . 0.56999999999999995 108.296 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.8 t0 -97.55 -40.0 8.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.408 -0.807 . . . . 2.2200000000000002 109.036 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.59 27.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.61 0.719 . . . . 0.75 110.078 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 221' ' ' ASP . 7.8 t -119.47 -45.05 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.419 -1.697 . . . . 0.92000000000000004 106.419 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -105.27 17.13 24.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.178 -1.416 . . . . 2.3599999999999999 107.178 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 55.8 53.44 9.4 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.597 -0.89 . . . . 1.4199999999999999 108.597 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -155.0 145.63 22.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 1.97 110.584 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 228' ' ' TYR . 93.0 t -105.39 163.43 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.384 -0.969 . . . . 0.65000000000000002 108.384 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.49 ' N ' HG12 ' A' ' 227' ' ' VAL . 63.4 m-85 -129.55 122.74 29.8 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.329 -0.857 . . . . 0.96999999999999997 109.23 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.76 115.46 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.421 -0.799 . . . . 0.67000000000000004 110.552 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 47.2 t-20 53.96 51.33 8.11 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.379 -0.826 . . . . 1.45 111.098 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.8 Cg_endo -64.46 158.76 47.71 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.378 2.052 . . . . 0.81999999999999995 111.472 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 78.5 p -71.03 139.51 50.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.094 -1.004 . . . . 1.6200000000000001 109.165 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -53.38 -17.11 1.66 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.197 -0.939 . . . . 2.6000000000000001 109.587 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -68.15 -39.44 82.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 3.0600000000000001 108.755 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.2 t -79.49 -34.27 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 1.1399999999999999 109.011 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 21.4 mt -64.55 -55.23 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.83 . . . . 1.04 109.313 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -53.14 -40.5 64.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -0.795 . . . . 2.54 109.622 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -67.07 -41.18 86.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 2.6000000000000001 110.084 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 44.0 mtp -79.53 -26.72 41.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.084 -1.01 . . . . 1.23 109.708 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.427 ' NH1' ' OE2' ' A' ' 244' ' ' GLU . 13.4 mmm180 -59.47 -41.11 89.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.038 . . . . 2.6699999999999999 109.593 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.07 -60.24 2.35 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.278 -0.889 . . . . 1.6599999999999999 110.226 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.2 t -46.8 -62.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 2.2000000000000002 110.668 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -45.98 -59.19 2.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.027 -1.046 . . . . 3.0 109.531 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.427 ' OE2' ' NH1' ' A' ' 240' ' ' ARG . 64.2 mt-10 . . . . . 0 C--N 1.295 -1.789 0 O-C-N 121.338 -0.851 . . . . 1.76 109.776 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 mmt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.321 0.581 . . . . 3.6600000000000001 109.502 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.2 mt 46.58 84.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.374 -0.828 . . . . 1.1200000000000001 109.961 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m -95.11 113.39 25.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.208 -0.933 . . . . 1.45 109.093 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.24 -161.97 20.74 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.036 -1.626 . . . . 0.92000000000000004 109.036 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.432 ' O ' HG22 ' A' ' 5' ' ' ILE . 45.1 mt -95.77 -8.15 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.385 -1.068 . . . . 1.05 109.218 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tp 60.61 106.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -0.999 . . . . 0.88 108.843 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.61 -46.02 9.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.779 -1.2 . . . . 0.78000000000000003 108.444 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.54 142.57 15.66 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.428 -0.795 . . . . 1.5 108.934 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.02 155.63 30.02 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.029 1.82 . . . . 0.85999999999999999 113.814 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 160.78 -173.9 37.35 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.296 -1.522 . . . . 0.78000000000000003 109.296 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.4 mt -148.03 122.15 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.605 -1.527 . . . . 0.73999999999999999 109.358 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.43 154.27 43.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.161 -0.962 . . . . 0.45000000000000001 110.406 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.495 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 8.7 m-85 -119.23 145.56 45.96 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.351 -0.981 . . . . 0.64000000000000001 108.351 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.4 159.9 22.75 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 118.885 -1.626 . . . . 0.45000000000000001 111.248 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -78.57 153.45 31.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.99 . . . . 1.8799999999999999 109.638 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -79.15 121.89 25.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.58999999999999997 110.622 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.4 tp -101.73 92.76 4.99 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.518 -1.29 . . . . 0.64000000000000001 107.518 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.49 127.2 33.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.966 -1.084 . . . . 0.73999999999999999 111.194 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 160' ' ' ALA . 15.3 mt -95.26 93.31 7.21 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.511 -0.768 . . . . 0.73999999999999999 109.255 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -92.82 158.06 16.07 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.291 -0.88 . . . . 1.8700000000000001 109.624 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -130.39 135.6 48.19 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.609 -0.886 . . . . 2.5800000000000001 108.609 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.55 135.97 36.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.127 -0.983 . . . . 2.1400000000000001 109.542 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -65.45 132.53 49.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.597 -0.689 . . . . 1.9299999999999999 109.456 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.24 135.46 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.31 -0.869 . . . . 0.68000000000000005 109.959 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.52 117.85 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.546 -0.721 . . . . 0.83999999999999997 109.364 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.2 mt -87.01 132.65 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.79000000000000004 109.289 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.3 123.28 33.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.252 -0.905 . . . . 1.3700000000000001 109.655 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.457 ' HG2' HH11 ' A' ' 28' ' ' ARG . 2.8 mmt-85 -96.25 26.05 4.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.248 -0.907 . . . . 2.6200000000000001 108.819 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -90.24 142.73 27.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.463 -0.773 . . . . 2.3500000000000001 110.384 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -88.34 129.16 35.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.252 -0.905 . . . . 2.3500000000000001 108.649 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.7 pt -92.68 172.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.943 -1.098 . . . . 0.78000000000000003 110.426 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 34' ' ' ASP . 7.9 p -99.18 160.08 14.53 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.621 -0.881 . . . . 1.04 108.621 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.3 -7.53 0.89 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.033 -1.042 . . . . 1.05 109.373 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 32' ' ' SER . 3.9 m-20 -82.57 -10.03 59.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 2.4700000000000002 110.446 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -120.02 -17.0 8.52 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.158 -0.964 . . . . 1.46 109.73 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.6 t -53.89 -36.35 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 0.77000000000000002 109.697 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -54.25 -40.46 67.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 1.46 110.152 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -69.93 -41.54 74.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.219 -0.926 . . . . 2.29 110.575 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -59.73 -45.82 91.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.061 . . . . 1.3 109.864 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.1 t -59.27 -45.08 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.76000000000000001 109.3 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -60.66 -37.64 82.24 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.505 -0.924 . . . . 1.5 108.505 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -68.83 -31.57 70.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.531 -0.731 . . . . 2.6600000000000001 109.352 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -85.36 -51.26 6.68 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.28 -0.888 . . . . 0.75 109.216 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.35 -59.74 4.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.886 . . . . 0.82999999999999996 109.085 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.669 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -62.78 -38.09 89.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.78000000000000003 108.629 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -55.31 -54.1 36.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 107.325 -2.31 . . . . 0.56999999999999995 107.325 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.9 ttt-85 -45.65 -32.25 2.3 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.341 -0.985 . . . . 2.8300000000000001 108.341 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.13 -34.93 74.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.34 -0.985 . . . . 0.65000000000000002 108.34 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' GLY . 24.2 ttmt -85.12 -58.43 2.69 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.246 -0.65 . . . . 2.5699999999999998 109.246 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.07 -39.23 63.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.967 . . . . 0.51000000000000001 109.872 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -66.31 -40.01 89.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.102 -0.999 . . . . 1.3600000000000001 108.622 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.08 -35.32 64.21 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.867 -0.52 . . . . 0.59999999999999998 109.83 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -65.22 -67.27 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.3600000000000001 110.162 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 54' ' ' LEU . 4.5 mm? -50.16 -33.96 20.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.865 -1.147 . . . . 1.3799999999999999 108.899 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.48 -46.22 80.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.401 -0.812 . . . . 1.27 108.919 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -62.53 -37.39 85.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.293 -0.879 . . . . 0.59999999999999998 109.785 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.42 -33.73 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.962 -1.086 . . . . 0.53000000000000003 108.854 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -53.78 -44.66 70.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 0.98999999999999999 109.836 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -71.22 -35.27 71.45 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.199 -0.938 . . . . 0.58999999999999997 109.741 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -69.45 -26.18 64.47 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.563 -1.255 . . . . 1.8100000000000001 107.686 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.51 -33.76 67.13 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.354 -0.98 . . . . 0.47999999999999998 108.354 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -28.83 28.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.792 -1.323 . . . . 0.57999999999999996 109.792 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -86.2 -11.65 51.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.1 -1.235 . . . . 1.3899999999999999 108.764 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -99.16 -51.02 3.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.497 -0.752 . . . . 0.81999999999999995 110.353 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -106.25 -16.29 14.62 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.213 -0.93 . . . . 0.98999999999999999 110.711 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.53 143.79 6.9 Favored Glycine 0 N--CA 1.504 3.214 0 N-CA-C 110.274 -1.13 . . . . 0.55000000000000004 110.274 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -48.77 -9.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.365 -1.079 . . . . 2.5899999999999999 110.166 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' GLY . 35.4 mt-10 -63.72 -31.56 72.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.953 . . . . 2.2000000000000002 110.466 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -88.86 -6.32 57.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.943 -1.098 . . . . 1.79 110.624 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.81 -31.33 72.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.642 -1.287 . . . . 1.54 109.983 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.86 -29.57 70.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.64000000000000001 109.586 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.0 mt -73.36 -45.09 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.57999999999999996 109.557 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -76.96 -21.24 55.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.62 109.433 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.19 -40.59 94.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.134 -0.979 . . . . 1.23 108.869 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.9 -31.45 64.58 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.699 -1.76 . . . . 0.52000000000000002 108.699 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -23.2 66.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.556 -0.967 . . . . 1.29 110.162 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.1 mt -84.9 -35.33 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.776 -1.203 . . . . 0.55000000000000004 108.773 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.8 ttt -57.27 -39.74 76.29 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.353 -0.98 . . . . 1.8899999999999999 108.353 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.99 -39.07 90.01 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.574 -0.899 . . . . 0.53000000000000003 108.574 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.31 -43.04 53.13 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.617 -0.833 . . . . 0.42999999999999999 109.179 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -85.49 2.89 42.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.2 -0.938 . . . . 1.24 110.419 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -45.34 114.4 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.07 -1.018 . . . . 1.3100000000000001 109.261 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -64.04 -23.51 67.36 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -0.854 . . . . 1.3500000000000001 109.169 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -75.88 -46.78 28.32 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.344 -0.848 . . . . 2.1600000000000001 109.194 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.08 -20.43 66.16 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.935 -1.103 . . . . 0.59999999999999998 109.554 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.43 -53.47 9.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.361 -0.837 . . . . 1.28 110.736 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -61.88 -29.97 70.55 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.25 -0.906 . . . . 1.28 110.469 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.11 -41.63 61.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.98 -1.075 . . . . 1.29 109.077 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.0 mt -60.55 -57.72 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.868 -1.16 . . . . 0.57999999999999996 107.868 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.9 mt -49.42 -53.63 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.666 -0.646 . . . . 0.78000000000000003 110.05 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.85 -63.3 1.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.85999999999999999 110.125 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.1 mt -45.19 -48.48 12.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.541 -0.725 . . . . 0.79000000000000004 110.008 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.3 mt -55.21 -40.84 57.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.157 -0.965 . . . . 0.70999999999999996 110.004 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -85.61 -39.5 17.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.027 -1.046 . . . . 2.0499999999999998 111.313 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.31 -36.8 26.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.827 -1.171 . . . . 1.5900000000000001 111.54 -176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.65 12.19 33.24 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.919 -1.113 . . . . 1.8899999999999999 109.164 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.3 m80 45.12 44.26 8.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.486 -0.759 . . . . 1.3100000000000001 109.295 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.0 mtp -93.43 154.0 18.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.398 -0.814 . . . . 1.28 109.302 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.9 p -79.25 142.47 36.17 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.317 -0.864 . . . . 0.62 109.262 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.16 -26.46 1.91 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.46999999999999997 109.646 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -76.19 -42.63 45.67 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.276 -0.89 . . . . 2.0 108.916 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.49 -58.58 3.27 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.726 -0.609 . . . . 0.56000000000000005 111.175 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.41 -48.68 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.956 -1.09 . . . . 0.47999999999999998 109.804 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.07 -33.8 65.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.199 -0.938 . . . . 0.44 109.333 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.478 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 85.5 t60 -70.75 -35.32 72.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 1.4199999999999999 109.598 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.25 -64.25 0.92 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.363 -0.836 . . . . 1.26 110.47 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -48.54 -47.17 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.985 -1.072 . . . . 0.60999999999999999 109.55 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.58 -21.22 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.482 -0.761 . . . . 0.64000000000000001 109.734 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.478 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 11.9 tp10 -72.95 -38.88 66.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.166 -0.959 . . . . 2.2000000000000002 111.247 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 114' ' ' ALA . . . -85.15 -21.12 55.99 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 118.828 -1.653 . . . . 0.81999999999999995 112.102 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -69.83 -59.41 2.95 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.606 -1.526 . . . . 1.27 108.171 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.71 -49.83 73.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.717 -0.614 . . . . 0.91000000000000003 109.533 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.8 m -58.93 -35.81 73.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.263 -0.898 . . . . 1.73 109.586 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -61.91 -44.27 97.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.071 -1.018 . . . . 1.04 110.116 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.8 mt -66.64 -27.77 67.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.879 -1.138 . . . . 1.03 109.288 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -67.32 -18.29 65.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.113 -0.992 . . . . 1.95 110.011 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.38 -9.85 59.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.063 -1.023 . . . . 1.71 109.282 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mt -89.1 152.23 21.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.627 -0.879 . . . . 1.26 108.627 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -100.8 59.64 0.94 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -0.846 . . . . 2.8300000000000001 108.814 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -143.91 119.1 10.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.284 -0.885 . . . . 1.5800000000000001 109.375 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.57 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.4 pm0 -63.42 -9.28 11.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 2.7999999999999998 109.237 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -76.42 -62.61 1.56 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.35 -0.843 . . . . 1.02 109.938 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.57 -17.12 62.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.738 -1.226 . . . . 1.0600000000000001 109.36 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -69.37 -55.6 9.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.137 -0.977 . . . . 2.3900000000000001 108.778 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -60.48 -21.45 62.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.257 -0.902 . . . . 2.2000000000000002 108.938 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -71.75 -27.24 62.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.631 -1.618 . . . . 2.0899999999999999 106.631 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.27 92.95 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.226 -1.027 . . . . 0.85999999999999999 108.226 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.09 79.87 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.527 -0.916 . . . . 0.90000000000000002 108.527 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -32.54 71.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 1.3500000000000001 108.834 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.2 t -80.37 -47.02 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.436 -0.79 . . . . 0.57999999999999996 108.891 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -64.42 -35.64 81.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.154 -0.966 . . . . 3.2200000000000002 108.721 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.503 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 13.5 t0 -58.52 -43.52 89.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 1.3200000000000001 109.298 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.0 mt -67.47 -25.57 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.5 108.402 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.08 -52.24 4.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.446 -1.461 . . . . 0.44 109.446 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -52.82 -37.32 59.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -1.158 . . . . 2.71 109.329 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.503 ' NH2' ' OD1' ' A' ' 132' ' ' ASP . 6.7 mtt-85 -63.46 -42.52 98.63 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.15 -1.055 . . . . 2.2000000000000002 108.15 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.6 tp -59.21 -48.92 79.83 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.57 -0.706 . . . . 1.1299999999999999 109.291 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.2 mt -52.21 -53.16 46.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.54000000000000004 109.787 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -54.39 -22.96 13.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.097 -1.002 . . . . 2.3199999999999998 110.0 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.415 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 2.6 m120 -83.96 -31.41 25.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 1.26 109.047 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.0 mt -66.26 -43.78 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.62 108.842 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.6 mt -90.43 -7.14 53.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.211 -0.931 . . . . 0.67000000000000004 109.397 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 68.73 27.55 73.77 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.578 -1.809 . . . . 0.68000000000000005 108.578 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tp -51.28 166.2 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.529 -0.983 . . . . 0.77000000000000002 109.609 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -67.06 141.25 57.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 2.3999999999999999 109.867 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -109.21 138.78 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.447 -0.783 . . . . 0.87 109.135 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.525 HD12 ' H ' ' A' ' 147' ' ' ILE . 2.5 mp -78.71 128.68 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.025 -1.047 . . . . 1.3200000000000001 110.03 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -98.13 86.32 3.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.494 -0.754 . . . . 1.54 109.246 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.5 mt -82.41 -33.84 28.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.235 -0.916 . . . . 0.77000000000000002 109.953 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.5 m -82.06 28.49 0.43 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.115 -0.991 . . . . 1.5700000000000001 109.977 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.18 28.52 2.28 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.073 -1.017 . . . . 0.81999999999999995 109.671 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.9 152.96 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.81999999999999995 109.483 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -129.44 -16.02 3.97 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.353 -0.842 . . . . 2.1099999999999999 109.238 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -114.95 126.96 55.38 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.892 -0.781 . . . . 1.4099999999999999 108.892 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.16 124.97 23.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.046 -1.033 . . . . 1.3 109.288 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.3 m -149.33 175.9 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.56999999999999995 108.94 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.2 mt -88.39 156.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.268 -1.012 . . . . 0.42999999999999999 108.268 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tp -107.55 124.92 50.63 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.103 -0.702 . . . . 0.56000000000000005 109.103 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -124.71 129.27 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.062 -0.718 . . . . 0.54000000000000004 109.062 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.471 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.29 146.3 13.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.62 109.765 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.52 -34.84 67.41 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.746 -1.221 . . . . 0.80000000000000004 107.847 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -173.49 151.95 2.05 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.164 -0.68 . . . . 2.3399999999999999 109.164 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.2 mt -119.89 130.67 54.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.682 -0.859 . . . . 0.65000000000000002 108.682 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.2 p -91.12 150.97 42.6 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.133 -0.98 . . . . 0.73999999999999999 109.076 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 169' ' ' ALA . 68.6 Cg_exo -35.41 -51.73 0.86 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 122.527 2.151 . . . . 0.59999999999999998 112.379 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.8 m -48.0 -54.28 13.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.319 -0.863 . . . . 0.63 109.28 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.75 -45.8 88.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.4 -0.813 . . . . 1.25 109.654 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 24.1 p -68.12 -26.06 65.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.5 109.714 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -74.06 -30.77 62.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.114 -0.991 . . . . 0.51000000000000001 110.148 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -101.41 -14.21 17.66 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.188 -0.945 . . . . 1.1699999999999999 109.818 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.0 tp -60.51 145.28 49.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.799 -1.188 . . . . 0.60999999999999999 108.296 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 174' ' ' LYS . 11.7 t-20 -96.51 142.06 29.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.11 -0.994 . . . . 2.1200000000000001 108.497 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.413 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 37.0 mt -90.15 -39.97 12.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 1.3400000000000001 111.04 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 35.1 mttm -79.94 -11.06 59.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.83 -1.168 . . . . 1.97 111.628 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -101.83 -13.22 17.77 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.857 -1.152 . . . . 1.8999999999999999 109.074 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 177' ' ' LEU . 74.5 t -95.88 161.37 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.229 -0.919 . . . . 0.47999999999999998 108.646 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.51 ' N ' HG12 ' A' ' 176' ' ' VAL . 53.8 tp -111.52 -28.54 8.12 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.25 -0.907 . . . . 1.3899999999999999 110.119 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -174.32 177.53 46.47 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.714 -1.355 . . . . 0.38 109.714 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.53 127.43 33.17 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.405 -1.056 . . . . 0.46000000000000002 109.853 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.6 mt -127.91 122.91 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.762 -1.57 . . . . 0.58999999999999997 106.762 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 38.0 p -140.77 156.23 46.22 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.331 1.063 . . . . 0.67000000000000004 112.461 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 1.5 m-20 -87.07 37.55 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.692 -0.685 . . . . 2.2400000000000002 109.56 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.081 -1.012 . . . . 1.1100000000000001 110.416 -177.851 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 53.7 t60 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.45 0.643 . . . . 0.92000000000000004 109.89 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 39.0 p -54.08 -45.97 71.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 1.5900000000000001 110.232 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 98.9 p -63.67 -46.4 85.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 1.4199999999999999 110.762 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -50.91 -28.68 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.903 -1.123 . . . . 1.4099999999999999 109.721 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.5 mtp -71.37 -57.0 4.87 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.789 -1.189 . . . . 0.85999999999999999 107.789 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.83 -43.11 65.75 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.78 -0.645 . . . . 0.58999999999999997 110.076 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -68.1 -46.3 71.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 3.0600000000000001 109.779 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.3 m -70.24 -35.82 74.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.72999999999999998 109.727 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.8 mt -89.76 -1.95 58.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.152 -0.967 . . . . 0.67000000000000004 109.403 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 56.26 2.23 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 1.49 111.681 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.1 169.51 8.23 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.45 -1.406 . . . . 0.64000000000000001 108.631 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.28 141.84 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.694 2.263 . . . . 0.58999999999999997 111.312 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.26 -178.63 5.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.448 -1.408 . . . . 0.55000000000000004 111.341 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 28.5 mt -148.76 157.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.452 -1.314 . . . . 0.63 107.452 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.0 m -138.35 -39.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.968 -1.083 . . . . 0.77000000000000002 110.713 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -75.97 41.2 1.48 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.679 -1.368 . . . . 0.87 109.679 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 181' ' ' THR . 20.2 p -68.21 3.57 1.61 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.058 -1.26 . . . . 0.89000000000000001 109.042 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.431 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 55.83 -102.22 0.16 Allowed Glycine 0 N--CA 1.483 1.833 0 N-CA-C 109.83 -1.308 . . . . 0.93000000000000005 109.83 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.5 p -125.49 43.38 3.07 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.403 -1.057 . . . . 1.6000000000000001 111.323 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 26.2 t -62.96 -32.06 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.521 -1.362 . . . . 0.75 107.825 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 p -60.25 -16.28 32.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.83999999999999997 109.094 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.7 m -105.67 15.36 27.0 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.876 -0.787 . . . . 1.6100000000000001 108.876 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -133.68 -15.28 2.41 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.554 -0.716 . . . . 2.2999999999999998 109.934 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 51.3 t -123.34 150.57 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.331 -0.856 . . . . 0.76000000000000001 109.308 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -113.8 -174.74 2.53 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.593 -1.262 . . . . 2.0099999999999998 107.593 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.46 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 9.6 t30 -80.26 145.41 32.2 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.14 -0.975 . . . . 2.1899999999999999 110.057 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 82.29 -11.77 0.98 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.036 -0.415 . . . . 2.3999999999999999 111.229 178.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -55.46 143.32 29.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.636 -1.29 . . . . 1.99 108.446 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -87.78 125.58 34.52 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.956 -1.09 . . . . 1.3 108.813 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 16' ' ' ALA . 43.4 mt -123.7 162.98 22.01 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.841 0.829 . . . . 0.53000000000000003 110.585 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.7 mt -136.69 107.87 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.775 -1.194 . . . . 0.59999999999999998 107.775 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.5 tp -87.51 122.04 30.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -0.905 . . . . 0.56999999999999995 109.234 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.8 OUTLIER -101.05 -28.41 12.73 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.33 -0.856 . . . . 2.2200000000000002 109.014 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.57 27.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.891 -0.505 . . . . 0.75 111.246 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.2 t -118.25 -58.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 106.602 -1.629 . . . . 0.92000000000000004 106.602 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -92.02 9.1 34.68 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.643 -1.614 . . . . 2.3599999999999999 106.643 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 60.13 64.63 1.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.211 -0.663 . . . . 1.4199999999999999 109.211 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -153.01 136.1 15.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 1.97 110.698 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.3 t -115.18 126.6 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.887 -1.153 . . . . 0.65000000000000002 107.887 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -96.4 130.71 43.47 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 0.96999999999999997 109.748 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.46 130.54 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.415 -0.587 . . . . 0.67000000000000004 109.415 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 20.0 t30 55.24 71.62 1.24 Allowed Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.376 -0.828 . . . . 1.45 110.229 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.36 146.08 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 123.321 2.681 . . . . 0.81999999999999995 112.06 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.5 p -72.21 177.89 4.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.804 . . . . 1.6200000000000001 109.776 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -76.86 -39.55 50.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 2.6000000000000001 109.553 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.588 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 13.3 mp0 -53.76 -39.12 65.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 3.0600000000000001 109.403 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.46 -39.41 54.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.089 -1.007 . . . . 1.1399999999999999 108.833 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.0 mt -65.94 -64.25 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 1.04 109.305 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -53.77 -44.09 69.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 2.54 110.606 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -65.73 -33.04 74.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.06 -1.025 . . . . 2.6000000000000001 109.813 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' MET . . . . . 0.456 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 50.8 mtp -80.83 -38.73 27.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.981 -1.075 . . . . 1.23 109.467 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -49.07 -50.17 37.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.046 -1.034 . . . . 2.6699999999999999 110.166 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.91 -61.8 1.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.06 -1.025 . . . . 1.6599999999999999 110.96 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.9 t -62.83 -52.44 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.951 -1.093 . . . . 2.2000000000000002 111.167 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 239' ' ' MET . 2.2 tp-100 -54.39 -41.28 69.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.712 -1.242 . . . . 3.0 109.72 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 . . . . . 0 C--N 1.301 -1.52 0 O-C-N 120.567 -1.333 . . . . 1.76 108.659 179.833 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.936 -0.764 . . . . 3.6600000000000001 108.936 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.01 97.24 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 1.1200000000000001 110.007 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.4 m -99.75 110.81 23.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.461 -0.774 . . . . 1.45 109.959 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.45 -162.45 19.62 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.755 -1.738 . . . . 0.92000000000000004 108.755 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 5' ' ' ILE . 89.3 mt -94.82 -6.98 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.052 -1.264 . . . . 1.05 109.096 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' ILE . 5.4 tp 55.39 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.374 -0.829 . . . . 0.88 108.878 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.45 -55.1 4.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.097 -1.002 . . . . 0.78000000000000003 108.606 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.57 144.23 32.63 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.695 -0.854 . . . . 1.5 108.695 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.42 156.05 28.66 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.918 1.745 . . . . 0.85999999999999999 112.634 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.82 129.61 1.36 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.057 -1.217 . . . . 0.78000000000000003 110.057 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.9 mt -99.6 131.48 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.202 -1.175 . . . . 0.73999999999999999 110.724 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.52 ' HB1' HD21 ' A' ' 177' ' ' LEU . . . -146.26 143.65 29.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 0.45000000000000001 109.16 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.546 ' CZ ' ' OE1' ' A' ' 243' ' ' GLN . 4.2 m-85 -100.69 140.74 34.54 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.493 -1.299 . . . . 0.64000000000000001 107.493 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.56 156.25 19.49 Favored Glycine 0 N--CA 1.5 2.902 0 C-N-CA 118.49 -1.814 . . . . 0.45000000000000001 111.881 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -78.75 152.09 31.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.846 -0.797 . . . . 1.8799999999999999 110.464 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.618 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -79.18 126.36 30.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.541 -0.724 . . . . 0.58999999999999997 111.119 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 tp -111.15 93.29 4.4 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.86 -1.533 . . . . 0.64000000000000001 106.86 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.8 tp -80.6 127.51 32.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.782 -1.198 . . . . 0.73999999999999999 111.293 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.7 mt -97.16 94.61 7.23 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.438 0.637 . . . . 0.73999999999999999 109.957 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -92.68 156.89 16.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.412 -0.805 . . . . 1.8700000000000001 109.164 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.84 130.41 53.93 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.646 -0.872 . . . . 2.5800000000000001 108.646 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -76.77 132.77 39.43 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.185 -0.947 . . . . 2.1400000000000001 108.978 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.99 137.88 56.83 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.533 -0.729 . . . . 1.9299999999999999 109.442 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.34 136.08 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.23 -0.919 . . . . 0.68000000000000005 110.159 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.2 t -102.66 117.53 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 0.83999999999999997 108.93 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.6 mt -90.96 129.73 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.248 -0.907 . . . . 0.79000000000000004 109.119 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -90.68 120.27 31.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 1.3700000000000001 109.922 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -96.11 29.64 2.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.384 -0.822 . . . . 2.6200000000000001 109.444 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -86.56 144.94 26.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.121 -0.987 . . . . 2.3500000000000001 109.442 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -85.84 125.97 33.69 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.984 -1.073 . . . . 2.3500000000000001 109.018 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -82.76 179.15 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.285 -0.884 . . . . 0.78000000000000003 109.535 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -98.82 160.62 14.14 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.396 -0.815 . . . . 1.04 109.332 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.1 -20.22 51.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 1.05 109.307 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -82.53 -12.06 58.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.853 . . . . 2.4700000000000002 109.43 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -105.35 -10.13 17.17 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.941 -1.133 . . . . 1.46 107.941 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.97 -48.36 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.682 -0.636 . . . . 0.77000000000000002 109.523 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -56.6 -30.04 62.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.085 -1.01 . . . . 1.46 108.942 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -70.37 -35.03 73.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.453 -0.779 . . . . 2.29 110.16 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -64.43 -44.31 91.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.105 -0.997 . . . . 1.3 109.589 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 44' ' ' LEU . 83.6 t -58.15 -46.58 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.169 -0.957 . . . . 0.76000000000000001 109.328 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.85 -43.6 87.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.139 -0.976 . . . . 1.5 108.905 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -66.04 -32.09 73.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.568 -0.708 . . . . 2.6600000000000001 109.186 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -86.45 -57.66 2.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.133 -0.98 . . . . 0.75 108.739 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 40' ' ' VAL . 34.0 tp -51.92 -60.69 2.89 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.425 -0.797 . . . . 0.82999999999999996 109.235 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -66.4 -31.34 72.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -0.891 . . . . 0.78000000000000003 108.801 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.38 53.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.298 -1.921 . . . . 0.56999999999999995 108.298 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.546 HH22 ' CD ' ' A' ' 86' ' ' GLU . 27.6 ttp180 -60.44 -21.39 62.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -1.116 . . . . 2.8300000000000001 109.505 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -66.69 -45.59 78.33 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.345 -0.983 . . . . 0.65000000000000002 108.345 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.456 ' H ' ' HG2' ' A' ' 49' ' ' LYS . 12.6 ptmt -78.4 -52.93 7.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.483 -0.932 . . . . 2.5699999999999998 108.483 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.74 -33.36 15.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.353 -1.467 . . . . 0.51000000000000001 108.789 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 m -66.54 -36.77 83.49 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.034 -1.098 . . . . 1.3600000000000001 108.034 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -70.46 -19.76 62.93 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.697 -0.853 . . . . 0.59999999999999998 108.697 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -76.17 -66.06 0.84 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.4 -0.812 . . . . 1.3600000000000001 109.645 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.9 mt -51.18 -35.6 36.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 1.3799999999999999 108.867 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -60.74 -51.11 70.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.517 -0.739 . . . . 1.27 109.268 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 m -63.46 -38.25 90.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.157 -0.965 . . . . 0.59999999999999998 109.088 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.5 mt -69.62 -27.75 34.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.295 -0.878 . . . . 0.53000000000000003 108.984 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -63.3 -41.57 98.97 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.306 -0.871 . . . . 0.98999999999999999 109.526 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -71.66 -24.78 61.9 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.51 -0.744 . . . . 0.58999999999999997 109.264 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.422 ' O ' ' CB ' ' A' ' 64' ' ' THR . 97.0 mttt -72.59 -25.58 61.39 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.738 -1.208 . . . . 1.8100000000000001 107.738 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.98 -32.12 61.6 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.932 -1.136 . . . . 0.47999999999999998 107.932 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.96 -29.12 29.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.915 -1.674 . . . . 0.57999999999999996 108.915 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -86.64 -22.37 26.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.095 -1.238 . . . . 1.3899999999999999 108.638 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 56.5 m -94.67 -45.09 7.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.254 -0.904 . . . . 0.81999999999999995 110.56 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.54 ' C ' ' H ' ' A' ' 67' ' ' GLU . 52.4 m-85 -107.78 -34.17 7.04 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.191 -0.943 . . . . 0.98999999999999999 109.965 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 67.37 -30.21 0.21 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.366 -1.094 . . . . 0.55000000000000004 110.366 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 65' ' ' PHE . 35.3 mt-10 -51.01 -179.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.03 -1.277 . . . . 2.5899999999999999 110.102 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.15 36.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.56 -0.712 . . . . 2.2000000000000002 109.821 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.8 mmtp -83.18 -10.48 58.6 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.406 -0.809 . . . . 1.79 109.308 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -69.01 -35.96 77.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.246 -0.909 . . . . 1.54 110.292 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.41 68.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.64000000000000001 110.398 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.2 mt -71.52 -46.19 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.079 -1.013 . . . . 0.57999999999999996 109.821 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -76.19 -26.71 56.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.62 109.571 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.84 -59.33 4.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.052 -1.03 . . . . 1.23 109.026 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.92 -33.73 64.22 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.76 -1.336 . . . . 0.52000000000000002 109.76 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.1 -22.2 65.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.019 -1.283 . . . . 1.29 109.768 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.4 mt -84.81 -36.79 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.976 -1.077 . . . . 0.55000000000000004 108.365 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.4 ttt -60.84 -44.51 96.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.172 -1.047 . . . . 1.8899999999999999 108.172 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.3 tp -57.59 -40.87 79.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.231 -1.026 . . . . 0.53000000000000003 108.231 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.5 tp -69.62 -42.75 73.94 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.403 -0.81 . . . . 0.42999999999999999 109.519 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -84.9 9.57 14.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.306 -0.871 . . . . 1.24 110.262 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -49.43 121.78 5.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.015 -1.053 . . . . 1.3100000000000001 110.2 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -67.14 -24.62 65.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.242 -0.911 . . . . 1.3500000000000001 108.986 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -74.2 -49.93 21.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.328 -0.949 . . . . 2.1600000000000001 108.685 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.6 mt -64.17 -15.04 59.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.63 -1.228 . . . . 0.59999999999999998 108.603 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.546 ' CD ' HH22 ' A' ' 47' ' ' ARG . 28.2 tt0 -77.29 -54.33 6.61 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.806 -1.184 . . . . 1.28 110.136 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.18 -30.79 69.58 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.674 -1.267 . . . . 1.28 110.003 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -71.88 -47.89 49.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.062 -1.024 . . . . 1.29 109.039 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.7 mt -59.5 -53.72 44.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.887 -0.783 . . . . 0.57999999999999996 108.887 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 91' ' ' ALA . 95.9 mt -51.25 -71.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.746 . . . . 0.78000000000000003 110.348 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -40.25 -48.31 2.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.383 -0.823 . . . . 0.85999999999999999 110.631 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.8 mt -55.36 -55.69 28.69 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.652 -0.87 . . . . 0.79000000000000004 108.652 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.1 mt -54.11 -41.89 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.829 . . . . 0.70999999999999996 110.831 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -85.84 -35.11 20.84 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.03 -1.044 . . . . 2.0499999999999998 111.7 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 91' ' ' ALA . 37.8 t70 -81.94 -38.63 24.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.756 -1.215 . . . . 1.5900000000000001 111.48 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -105.97 12.6 30.35 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.899 -1.126 . . . . 1.8899999999999999 109.462 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.2 m170 46.05 46.35 12.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 1.3100000000000001 109.49 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.0 mtt -96.23 152.41 18.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.481 -0.762 . . . . 1.28 109.207 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.8 p -78.53 142.93 37.01 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.61 -0.681 . . . . 0.62 110.183 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.87 -25.44 3.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.189 -0.944 . . . . 0.46999999999999997 108.736 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -75.21 -50.72 15.3 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.316 -0.994 . . . . 2.0 108.316 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.65 -50.1 33.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.64 -0.663 . . . . 0.56000000000000005 109.813 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.73 -60.28 3.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 0.47999999999999998 109.657 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.5 -33.29 30.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.44 109.8 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -68.16 -35.01 77.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.915 -1.116 . . . . 1.4199999999999999 110.055 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.97 -45.05 91.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.121 -0.987 . . . . 1.26 110.814 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -66.72 -48.66 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.051 . . . . 0.60999999999999999 109.412 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -60.87 -23.77 30.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.737 -0.602 . . . . 0.64000000000000001 109.824 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -73.06 -37.39 66.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.104 -0.998 . . . . 2.2000000000000002 110.098 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.68 -22.1 48.06 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.372 -1.395 . . . . 0.81999999999999995 112.406 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.68 -53.37 15.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.711 -1.464 . . . . 1.27 108.79 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.15 71.78 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.652 -0.655 . . . . 0.91000000000000003 109.627 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 m -60.82 -37.43 81.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.444 -0.785 . . . . 1.73 110.076 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.39 96.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.299 -0.876 . . . . 1.04 111.15 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.8 mt -70.84 -26.58 63.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.451 -1.3 . . . . 1.03 108.539 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -67.71 -19.5 65.16 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.606 -0.684 . . . . 1.95 110.41 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -82.5 -6.03 59.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.922 -1.111 . . . . 1.71 109.749 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 31.8 mt -84.32 166.99 16.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.057 -1.027 . . . . 1.26 109.528 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -107.84 47.71 0.88 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.736 -0.603 . . . . 2.8300000000000001 109.906 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -142.82 120.61 11.92 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.017 -1.052 . . . . 1.5800000000000001 109.531 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.69 -8.64 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.601 0.715 . . . . 2.7999999999999998 109.72 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -76.67 -62.03 1.77 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.4 -0.812 . . . . 1.02 109.989 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.5 mt -68.83 -24.7 64.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.024 -1.048 . . . . 1.0600000000000001 109.239 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -66.88 -50.87 61.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -0.879 . . . . 2.3900000000000001 109.083 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.19 -20.95 63.35 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.306 -0.998 . . . . 2.2000000000000002 108.306 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -72.88 -27.77 62.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.745 -1.576 . . . . 2.0899999999999999 106.745 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.09 -42.64 90.93 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.107 -1.071 . . . . 0.85999999999999999 108.107 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.92 -39.04 79.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.413 -0.804 . . . . 0.90000000000000002 109.784 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -70.67 -25.96 63.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 1.3500000000000001 109.616 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.62 -47.48 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.57999999999999996 108.705 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -53.21 -39.02 63.39 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.062 -1.024 . . . . 3.2200000000000002 108.405 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 22.1 t70 -59.4 -40.4 86.47 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -0.897 . . . . 1.3200000000000001 109.633 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.4 mt -66.05 -34.01 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.149 -0.969 . . . . 0.5 109.25 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.32 -44.88 16.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.515 -1.434 . . . . 0.44 109.515 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -49.58 -45.9 48.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.411 -1.052 . . . . 2.71 109.631 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.53 ' HG2' HH11 ' A' ' 136' ' ' ARG . 11.0 mtt-85 -65.18 -42.92 93.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.08 . . . . 2.2000000000000002 108.491 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 137' ' ' LEU . 1.1 tt -52.38 -35.88 52.51 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.082 -1.081 . . . . 1.1299999999999999 108.082 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.64 -58.74 3.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.396 -0.815 . . . . 0.54000000000000004 110.23 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -46.21 -20.13 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.146 -0.971 . . . . 2.3199999999999998 111.114 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -83.43 -49.73 9.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.88 -1.138 . . . . 1.26 109.012 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.0 mt -57.56 -34.1 46.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.067 -1.021 . . . . 0.62 109.116 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 49.4 mt -87.22 0.08 55.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.062 -1.024 . . . . 0.67000000000000004 108.536 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.23 25.86 12.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.449 -1.861 . . . . 0.68000000000000005 108.449 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.5 tp -57.57 153.5 12.96 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.779 -0.836 . . . . 0.77000000000000002 110.14 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -67.18 146.76 53.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.02 -1.05 . . . . 2.3999999999999999 109.747 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.85 140.13 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.449 -0.782 . . . . 0.87 109.449 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.517 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.0 mp -78.03 120.15 28.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.225 -0.922 . . . . 1.3200000000000001 109.095 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -93.51 88.17 5.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 1.54 109.912 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.9 mt -82.0 -24.05 35.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.877 . . . . 0.77000000000000002 108.798 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.0 t -80.44 26.14 0.39 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.457 -0.777 . . . . 1.5700000000000001 108.945 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.5 28.38 2.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 0.81999999999999995 110.125 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 51.2 mt -74.59 152.35 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.869 . . . . 0.81999999999999995 109.127 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -131.76 -6.51 3.61 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.664 -0.865 . . . . 2.1099999999999999 108.664 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -121.82 136.06 54.92 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.954 -0.758 . . . . 1.4099999999999999 108.954 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.54 124.91 25.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 1.3 109.353 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.0 m -147.25 172.54 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.676 -0.861 . . . . 0.56999999999999995 108.676 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.5 mt -90.19 157.96 2.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.828 -1.175 . . . . 0.42999999999999999 107.828 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.8 tp -108.98 121.36 44.96 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.675 0.75 . . . . 0.56000000000000005 109.47 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.77 128.09 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.099 -0.704 . . . . 0.54000000000000004 109.099 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.84 151.47 14.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.442 -0.786 . . . . 0.62 109.918 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.35 -41.58 84.98 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.495 -1.378 . . . . 0.80000000000000004 107.895 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -172.94 152.8 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 2.3399999999999999 109.031 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.3 mt -116.06 141.22 48.42 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.365 -0.834 . . . . 0.65000000000000002 109.867 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 26.2 p -94.97 151.1 38.66 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.315 -0.866 . . . . 0.73999999999999999 108.944 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -35.78 -43.75 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.435 2.09 . . . . 0.59999999999999998 112.243 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.3 m -53.9 -65.37 0.58 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.214 -0.929 . . . . 0.63 109.258 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -47.67 -36.78 11.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.3 -0.875 . . . . 1.25 109.773 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.431 HG21 ' CD2' ' A' ' 189' ' ' HIS . 21.3 p -74.14 -20.11 60.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.5 110.029 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.17 -19.8 27.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.093 -1.004 . . . . 0.51000000000000001 110.102 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -109.81 -16.57 13.86 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.443 -0.786 . . . . 1.1699999999999999 110.109 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.06 147.86 45.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.908 -1.12 . . . . 0.60999999999999999 108.556 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 174' ' ' LYS . 12.2 t-20 -96.02 155.35 16.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.973 -1.079 . . . . 2.1200000000000001 108.804 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.3 mp -94.53 -42.75 8.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.244 -0.91 . . . . 1.3400000000000001 110.644 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 53.1 mtpt -79.67 -12.46 59.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.018 -1.051 . . . . 1.97 111.502 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -96.59 -6.16 37.45 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.675 -1.265 . . . . 1.8999999999999999 108.762 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.468 HG11 ' CE1' ' A' ' 179' ' ' PHE . 40.4 t -103.27 155.91 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.804 -0.813 . . . . 0.47999999999999998 108.804 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.52 HD21 ' HB1' ' A' ' 12' ' ' ALA . 11.5 tp -111.22 -18.09 13.04 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.928 -0.768 . . . . 1.3899999999999999 108.928 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.46 177.14 42.47 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.073 -1.611 . . . . 0.38 109.073 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.468 ' CE1' HG11 ' A' ' 176' ' ' VAL . 2.8 m-85 -130.26 126.3 36.96 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.483 -1.01 . . . . 0.46000000000000002 108.852 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.4 mt -129.17 117.42 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.808 -1.182 . . . . 0.58999999999999997 107.808 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 203' ' ' VAL . 66.0 p -142.74 157.57 44.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.282 -0.886 . . . . 0.67000000000000004 111.13 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 23.4 p30 -98.01 47.72 1.01 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.675 -0.81 . . . . 2.2400000000000002 110.179 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.973 0 O-C-N 120.869 -1.144 . . . . 1.1100000000000001 110.116 -179.002 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.431 ' CD2' HG21 ' A' ' 168' ' ' THR . 11.8 t60 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.565 0.698 . . . . 0.92000000000000004 109.662 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.5 p -51.65 -38.69 55.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.523 -0.736 . . . . 1.5900000000000001 110.454 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 44.0 p -69.09 -42.83 75.64 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.745 -1.222 . . . . 1.4199999999999999 110.031 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.7 mt -55.48 -29.82 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.052 -1.03 . . . . 1.4099999999999999 109.977 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.7 mtp -70.28 -56.22 7.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.322 -1.362 . . . . 0.85999999999999999 107.322 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.99 83.77 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.477 -0.783 . . . . 0.58999999999999997 109.417 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -65.76 -47.71 74.3 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.259 -0.901 . . . . 3.0600000000000001 109.659 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.0 m -69.48 -38.06 77.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.923 -1.11 . . . . 0.72999999999999998 110.204 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 199' ' ' LEU . 14.4 mt -91.42 4.26 52.92 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.862 -1.149 . . . . 0.67000000000000004 109.432 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 47.48 10.77 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 1.49 110.395 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 197' ' ' LEU . 27.3 mt -67.75 150.59 97.74 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.052 -1.03 . . . . 0.64000000000000001 109.156 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.57 134.92 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.323 1.348 . . . . 0.58999999999999997 110.88 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.96 174.78 11.9 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.353 -1.339 . . . . 0.55000000000000004 111.037 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.3 mt -148.7 158.32 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 106.353 -1.721 . . . . 0.63 106.353 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.9 m -138.9 -32.67 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.01 -1.056 . . . . 0.77000000000000002 110.776 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.79 40.01 2.97 Favored Glycine 0 N--CA 1.496 2.671 0 O-C-N 121.056 -1.028 . . . . 0.87 110.99 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 29.9 p -69.23 -22.67 63.85 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.872 -1.37 . . . . 0.89000000000000001 108.924 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 73.34 -97.18 0.85 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.905 -1.141 . . . . 0.93000000000000005 111.119 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 51.7 p -119.85 46.37 1.95 Allowed 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.979 -1.307 . . . . 1.6000000000000001 112.263 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 28.4 t -75.33 -28.9 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.639 -1.288 . . . . 0.75 107.879 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.8 p -67.75 -10.47 52.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.424 -0.798 . . . . 0.83999999999999997 109.032 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.9 p -106.76 14.54 26.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.101 -0.703 . . . . 1.6100000000000001 109.101 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -131.61 -25.1 2.16 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.427 -0.796 . . . . 2.2999999999999998 109.33 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 213' ' ' LYS . 74.3 t -117.52 164.33 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.558 -0.714 . . . . 0.76000000000000001 109.115 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.566 ' N ' HG12 ' A' ' 212' ' ' VAL . 13.7 mmmt -127.17 -171.87 2.52 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.023 -1.473 . . . . 2.0099999999999998 107.023 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.56 ' C ' HD22 ' A' ' 214' ' ' ASN . 0.4 OUTLIER -81.68 149.16 28.64 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.469 -1.394 . . . . 2.1899999999999999 110.107 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.2 t0 81.38 -11.61 1.07 Allowed 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.879 -0.513 . . . . 2.3999999999999999 111.495 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 0.8 OUTLIER -57.08 145.22 31.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.664 -1.272 . . . . 1.99 108.432 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -87.28 120.56 28.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.865 -1.147 . . . . 1.3 108.448 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 16' ' ' ALA . 28.0 mt -123.65 170.19 10.71 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.253 1.025 . . . . 0.53000000000000003 110.685 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.9 mt -144.74 106.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 106.423 -1.695 . . . . 0.59999999999999998 106.423 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.4 tp -82.96 127.03 33.16 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.501 -0.926 . . . . 0.56999999999999995 108.501 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 223' ' ' VAL . 17.8 m-20 -97.15 -31.86 12.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.352 -0.843 . . . . 2.2200000000000002 109.453 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.62 25.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.428 0.632 . . . . 0.75 110.163 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.5 t -122.41 -51.88 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 106.486 -1.672 . . . . 0.92000000000000004 106.486 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -97.58 16.04 21.58 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.257 -1.386 . . . . 2.3599999999999999 107.257 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 49.89 57.96 5.97 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.98 -0.748 . . . . 1.4199999999999999 108.98 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -154.67 143.76 21.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 1.97 110.043 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.51 138.17 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.969 -0.752 . . . . 0.65000000000000002 108.969 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -103.26 129.91 50.36 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.163 -0.961 . . . . 0.96999999999999997 109.511 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.9 t -108.91 122.88 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.775 -0.578 . . . . 0.67000000000000004 110.198 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 50.31 58.25 17.3 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.903 . . . . 1.45 109.607 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.47 159.51 50.17 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.7 2.267 . . . . 0.81999999999999995 112.431 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.8 m -76.28 157.72 32.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 1.6200000000000001 109.875 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -62.16 -25.54 67.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.069 -1.019 . . . . 2.6000000000000001 109.585 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -72.66 -35.73 67.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.305 -0.872 . . . . 3.0600000000000001 110.259 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.56 -45.88 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.892 . . . . 1.1399999999999999 109.808 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.8 mt -48.95 -60.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.218 -0.926 . . . . 1.04 109.005 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.63 -41.94 70.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.686 -0.633 . . . . 2.54 110.066 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -66.99 -35.1 79.19 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.993 -1.067 . . . . 2.6000000000000001 109.953 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.4 mtp -80.97 -24.88 37.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.953 . . . . 1.23 109.631 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -61.65 -45.65 93.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.104 -0.997 . . . . 2.6699999999999999 109.653 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 242' ' ' VAL . . . -74.9 -58.68 3.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.978 -1.076 . . . . 1.6599999999999999 109.011 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 241' ' ' ALA . 80.4 t -42.97 -59.12 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.471 -0.768 . . . . 2.2000000000000002 110.156 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 13' ' ' PHE . 24.8 tt0 -47.07 -62.62 1.33 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.013 -1.055 . . . . 3.0 109.911 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 . . . . . 0 C--N 1.297 -1.691 0 O-C-N 121.124 -0.985 . . . . 1.76 110.875 -178.127 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.469 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.357 0.599 . . . . 3.6600000000000001 109.466 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.463 HD13 HG22 ' A' ' 208' ' ' VAL . 89.7 mt -86.05 97.46 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.935 . . . . 1.1200000000000001 109.476 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -94.65 108.66 20.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.244 -0.91 . . . . 1.45 109.138 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.17 -170.38 30.8 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.616 -1.394 . . . . 0.92000000000000004 109.616 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 5' ' ' ILE . 71.5 mt -96.17 -10.04 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.396 -1.061 . . . . 1.05 109.037 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 tp 64.97 106.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.877 -0.786 . . . . 0.88 108.877 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.57 -45.21 11.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.041 -1.096 . . . . 0.78000000000000003 108.041 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -151.39 149.35 24.24 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.573 -0.899 . . . . 1.5 108.573 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.47 147.89 20.37 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.495 2.13 . . . . 0.85999999999999999 113.454 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.687 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.3 -177.78 31.5 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.691 -1.363 . . . . 0.78000000000000003 109.691 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.6 mt -141.45 133.38 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.09 -1.241 . . . . 0.73999999999999999 109.35 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.72 158.04 44.05 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.338 -0.851 . . . . 0.45000000000000001 110.223 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.1 m-85 -128.64 136.17 50.3 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 107.98 -1.119 . . . . 0.64000000000000001 107.98 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.98 163.11 31.74 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 118.784 -1.675 . . . . 0.45000000000000001 111.003 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -79.88 148.28 31.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.634 -0.921 . . . . 1.8799999999999999 110.29 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.69 123.64 25.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.558 -0.714 . . . . 0.58999999999999997 111.278 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.0 tp -105.16 91.25 3.71 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.38 -1.341 . . . . 0.64000000000000001 107.38 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 tp -82.78 136.43 34.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.73999999999999999 110.034 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.26 94.4 7.08 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.46 0.647 . . . . 0.73999999999999999 110.444 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -98.94 149.98 22.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.438 -0.789 . . . . 1.8700000000000001 109.184 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -130.42 141.42 50.54 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.259 -0.901 . . . . 2.5800000000000001 109.088 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.83 136.75 36.15 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.108 -0.995 . . . . 2.1400000000000001 109.377 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -67.13 130.84 44.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.462 -0.774 . . . . 1.9299999999999999 109.08 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.2 mt -91.88 137.73 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.238 -0.914 . . . . 0.68000000000000005 109.544 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.9 t -105.06 117.73 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.515 -0.74 . . . . 0.83999999999999997 109.368 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -88.86 142.57 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.199 -0.938 . . . . 0.79000000000000004 109.266 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -91.06 124.02 34.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.159 -0.963 . . . . 1.3700000000000001 109.935 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -100.48 28.89 4.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.39 -0.819 . . . . 2.6200000000000001 109.206 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.63 144.6 29.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 2.3500000000000001 109.882 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -85.13 124.0 31.29 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.342 -0.984 . . . . 2.3500000000000001 108.342 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.9 pt -88.39 171.2 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.996 . . . . 0.78000000000000003 110.518 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.513 ' C ' ' H ' ' A' ' 34' ' ' ASP . 21.3 p -101.35 155.0 18.31 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.94 -0.763 . . . . 1.04 108.94 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.96 -5.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 1.05 110.167 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 32' ' ' SER . 31.8 t0 -83.94 -28.39 27.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.02 -1.05 . . . . 2.4700000000000002 110.325 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -102.1 -2.98 28.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.144 -0.972 . . . . 1.46 109.783 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.49 -44.02 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.087 -1.008 . . . . 0.77000000000000002 108.908 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -51.42 -37.11 46.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.892 . . . . 1.46 109.194 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -69.22 -34.3 74.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 2.29 109.892 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -61.42 -46.63 89.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.09 -1.006 . . . . 1.3 109.442 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 44' ' ' LEU . 87.0 t -60.97 -48.4 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.76000000000000001 109.534 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -64.06 -39.67 94.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 1.5 108.543 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -64.75 -33.66 76.5 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.621 -0.881 . . . . 2.6600000000000001 108.621 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -86.81 -57.32 3.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.75 108.969 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 40' ' ' VAL . 14.9 tp -49.16 -65.21 0.61 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.407 -0.808 . . . . 0.82999999999999996 109.378 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.582 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.0 t -64.24 -32.27 73.79 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.788 -0.819 . . . . 0.78000000000000003 108.788 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -59.1 -54.21 39.91 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 107.612 -2.195 . . . . 0.56999999999999995 107.612 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -50.31 -27.83 6.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.597 -0.943 . . . . 2.8300000000000001 108.904 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -63.75 -33.84 76.54 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.021 -1.103 . . . . 0.65000000000000002 108.021 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 46' ' ' GLY . 24.6 mtpp -80.5 -58.04 3.3 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.843 -0.799 . . . . 2.5699999999999998 108.843 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -53.94 -36.16 62.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.091 -1.006 . . . . 0.51000000000000001 109.322 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.6 t -63.54 -37.11 86.04 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.35 -0.981 . . . . 1.3600000000000001 108.35 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.15 -32.65 63.23 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.296 -0.631 . . . . 0.59999999999999998 109.296 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -68.96 -65.14 0.74 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.57 -0.706 . . . . 1.3600000000000001 109.541 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 54' ' ' LEU . 9.3 mp -51.9 -27.94 14.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 1.3799999999999999 109.078 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -73.09 -49.46 28.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 1.27 109.104 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.2 m -58.32 -31.77 67.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.115 -0.991 . . . . 0.59999999999999998 109.198 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -73.28 -31.19 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.075 -1.016 . . . . 0.53000000000000003 108.556 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -56.51 -45.4 81.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.504 -0.747 . . . . 0.98999999999999999 109.319 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -70.71 -27.04 63.69 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.203 -0.935 . . . . 0.58999999999999997 109.672 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -71.23 -34.66 71.0 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.872 -1.143 . . . . 1.8100000000000001 107.95 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.29 -29.05 63.5 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.033 -0.728 . . . . 0.47999999999999998 109.033 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.33 -34.3 12.52 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.917 -1.135 . . . . 0.57999999999999996 110.995 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -85.73 -12.2 51.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.586 -1.538 . . . . 1.3899999999999999 108.849 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.1 m -94.22 -52.92 4.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.81999999999999995 109.66 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.503 ' C ' ' H ' ' A' ' 67' ' ' GLU . 70.8 m-85 -107.91 -35.91 6.51 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.293 -0.88 . . . . 0.98999999999999999 109.778 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.77 -24.9 0.64 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.896 -1.282 . . . . 0.55000000000000004 109.896 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 69' ' ' LYS . 80.6 mt-10 -53.02 -172.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.252 . . . . 2.5899999999999999 110.323 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.56 34.61 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.468 -0.77 . . . . 2.2000000000000002 109.991 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 67' ' ' GLU . 4.4 mmmm -85.12 -17.18 38.08 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.251 -0.906 . . . . 1.79 109.305 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.16 -32.11 72.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 1.54 110.285 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.2 -21.38 65.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.197 -0.939 . . . . 0.64000000000000001 110.597 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.1 mt -69.47 -46.39 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.984 -1.073 . . . . 0.57999999999999996 109.539 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -76.82 -20.12 56.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.62 109.801 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.88 -35.9 82.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 1.23 108.618 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.75 -34.64 24.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.631 -1.387 . . . . 0.52000000000000002 109.631 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.78 -20.96 59.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.08 -1.247 . . . . 1.29 109.413 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.3 mt -86.44 -42.57 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.124 -1.065 . . . . 0.55000000000000004 108.124 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.3 ttt -59.41 -43.01 93.09 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.769 -0.826 . . . . 1.8899999999999999 108.769 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -64.57 -45.22 87.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.734 -0.839 . . . . 0.53000000000000003 108.734 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.1 tp -66.78 -46.91 73.81 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.536 -0.728 . . . . 0.42999999999999999 109.566 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -85.78 9.83 15.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.298 -0.876 . . . . 1.24 110.082 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -47.91 127.36 11.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.959 -1.088 . . . . 1.3100000000000001 109.274 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -65.73 -25.37 67.26 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.732 -0.84 . . . . 1.3500000000000001 108.732 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -77.91 -52.44 8.84 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.333 -0.854 . . . . 2.1600000000000001 109.724 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.74 -18.67 64.28 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.002 -1.061 . . . . 0.59999999999999998 109.269 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.76 -54.68 6.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 1.28 109.478 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -64.26 -29.63 70.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 1.28 110.022 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.61 -47.58 46.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.094 -1.004 . . . . 1.29 109.005 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.2 mt -58.84 -59.92 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.328 -0.99 . . . . 0.57999999999999996 108.328 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.5 mt -45.29 -39.63 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.574 -0.704 . . . . 0.78000000000000003 109.855 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.35 -60.99 2.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.85999999999999999 109.759 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.9 mt -47.83 -50.77 25.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 0.79000000000000004 109.38 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.0 mt -54.45 -49.91 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.905 . . . . 0.70999999999999996 110.679 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -85.24 -36.78 20.71 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.832 -1.168 . . . . 2.0499999999999998 111.754 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -84.44 -37.51 21.33 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.735 -1.228 . . . . 1.5900000000000001 111.693 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -103.69 14.88 30.13 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.777 -1.202 . . . . 1.8899999999999999 109.432 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.4 m170 44.3 49.17 7.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.412 -0.805 . . . . 1.3100000000000001 110.359 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 31.8 mtt -103.78 150.46 24.07 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.734 -0.839 . . . . 1.28 108.734 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.8 p -76.89 148.91 36.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 0.62 109.811 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.25 -31.33 42.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.219 -0.926 . . . . 0.46999999999999997 109.202 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.25 -44.07 54.46 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.755 -0.832 . . . . 2.0 108.755 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.88 -54.2 12.34 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.736 -0.602 . . . . 0.56000000000000005 110.422 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.7 -50.64 72.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.47999999999999998 109.48 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.91 -35.22 61.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.441 -0.787 . . . . 0.44 109.73 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.25 -30.05 68.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.932 -1.105 . . . . 1.4199999999999999 109.727 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 109' ' ' GLU . 79.0 tt0 -66.0 -62.67 1.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 1.26 110.274 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 t -49.95 -47.11 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.059 -1.026 . . . . 0.60999999999999999 109.546 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.32 -16.14 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.447 -0.945 . . . . 0.64000000000000001 108.447 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . 9.5 tp10 -73.46 -35.42 65.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 2.2000000000000002 109.159 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.65 -28.42 24.25 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.573 -1.299 . . . . 0.81999999999999995 112.194 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -65.03 -36.87 85.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.697 -1.472 . . . . 1.27 109.094 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.54 -54.37 5.96 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.975 -0.75 . . . . 0.91000000000000003 108.975 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.9 m -59.41 -37.53 78.25 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.427 -0.796 . . . . 1.73 109.853 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -63.76 -41.46 97.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.343 -0.848 . . . . 1.04 110.85 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.0 mt -67.02 -28.4 68.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.772 -1.205 . . . . 1.03 109.208 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -67.34 -17.5 64.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.948 . . . . 1.95 109.97 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -82.76 -9.02 59.54 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.127 -0.983 . . . . 1.71 109.572 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mt -86.61 145.11 26.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.347 -0.846 . . . . 1.26 108.847 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.88 61.26 2.16 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.435 -0.95 . . . . 2.8300000000000001 108.435 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -149.38 120.46 7.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.783 . . . . 1.5800000000000001 109.763 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.46 -13.36 58.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 2.7999999999999998 109.196 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.61 -65.16 1.0 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.249 -0.907 . . . . 1.02 109.219 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.3 mt -64.04 -32.14 73.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 1.0600000000000001 109.324 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 127' ' ' ALA . 46.4 tttp -66.51 -53.27 36.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.041 . . . . 2.3900000000000001 109.117 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -56.1 -19.45 13.19 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.158 -1.053 . . . . 2.2000000000000002 108.158 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -73.76 -26.83 60.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.104 -1.813 . . . . 2.0899999999999999 106.104 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -57.29 -44.05 83.73 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.056 -1.09 . . . . 0.85999999999999999 108.056 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.66 88.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.212 -1.033 . . . . 0.90000000000000002 108.212 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -70.72 -27.59 64.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.479 -0.763 . . . . 1.3500000000000001 109.324 179.222 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.55 -44.41 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.13 -1.063 . . . . 0.57999999999999996 108.13 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -52.72 -41.25 63.79 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.188 -1.042 . . . . 3.2200000000000002 108.188 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -62.69 -33.81 75.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.575 -0.703 . . . . 1.3200000000000001 109.479 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.5 -36.01 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.918 -1.114 . . . . 0.5 108.966 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.51 -46.12 16.04 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.937 -1.665 . . . . 0.44 108.937 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -55.3 -46.99 76.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.542 -0.975 . . . . 2.71 109.538 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.517 ' HG2' HH11 ' A' ' 136' ' ' ARG . 14.4 mtt-85 -65.32 -43.99 89.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 2.2000000000000002 108.993 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.1 tp -54.36 -37.74 65.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 1.1299999999999999 109.049 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.78 -58.3 7.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.54000000000000004 109.626 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -50.56 -16.54 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.333 -0.854 . . . . 2.3199999999999998 110.195 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.441 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 3.0 m120 -84.65 -45.9 12.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.125 -0.984 . . . . 1.26 109.425 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.31 -37.71 78.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.198 -0.939 . . . . 0.62 108.854 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 mt -90.67 -1.73 57.86 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 0.67000000000000004 109.0 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 50.49 22.39 5.38 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.619 -1.793 . . . . 0.68000000000000005 108.619 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.56 166.04 0.34 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.665 -0.903 . . . . 0.77000000000000002 109.494 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -64.65 134.59 54.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.034 -1.041 . . . . 2.3999999999999999 108.647 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 mt -101.56 142.53 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.192 -0.942 . . . . 0.87 108.872 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.4 mm -78.32 124.84 37.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.295 -0.878 . . . . 1.3200000000000001 110.05 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -99.18 85.9 3.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.357 -0.839 . . . . 1.54 109.368 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.442 ' O ' HD13 ' A' ' 152' ' ' ILE . 35.0 mt -80.09 -7.77 59.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.341 -0.849 . . . . 0.77000000000000002 109.346 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.8 p -89.3 -11.45 43.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.226 -0.921 . . . . 1.5700000000000001 109.927 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.71 44.56 1.01 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.168 -0.957 . . . . 0.81999999999999995 112.485 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 152' ' ' ILE . 1.5 mp -70.2 154.4 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.489 -1.382 . . . . 0.81999999999999995 107.558 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -130.74 -22.5 2.65 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.324 -0.86 . . . . 2.1099999999999999 109.714 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -122.38 137.48 54.85 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.485 -0.759 . . . . 1.4099999999999999 109.234 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -62.41 129.81 42.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 1.3 109.912 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.7 m -151.05 175.5 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.745 . . . . 0.56999999999999995 109.251 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 22.9 mt -89.88 158.17 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 107.811 -1.181 . . . . 0.42999999999999999 107.811 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.1 tp -106.87 118.86 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.916 -0.772 . . . . 0.56000000000000005 108.916 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.2 t -123.55 129.95 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 121.37 0.605 . . . . 0.54000000000000004 109.713 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.82 147.49 10.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 0.62 109.265 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.79 73.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.686 -1.259 . . . . 0.80000000000000004 107.983 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 66.1 t0 -173.63 145.74 1.23 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.482 -0.933 . . . . 2.3399999999999999 108.482 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.506 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.7 mt -117.74 137.47 52.68 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.155 -0.683 . . . . 0.65000000000000002 109.155 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.6 p -89.36 150.04 43.9 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.353 -0.842 . . . . 0.73999999999999999 108.889 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 169' ' ' ALA . 76.6 Cg_exo -35.51 -46.54 0.82 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.393 2.062 . . . . 0.59999999999999998 111.898 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 169' ' ' ALA . 38.2 m -52.86 -65.71 0.51 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.409 -0.96 . . . . 0.63 108.409 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -44.82 -44.19 9.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.622 -0.674 . . . . 1.25 109.93 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.3 p -71.85 -25.4 61.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.107 -0.995 . . . . 0.5 109.564 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 166' ' ' SER . . . -78.69 -29.71 45.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.963 . . . . 0.51000000000000001 110.165 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -100.13 -4.26 30.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.271 -0.893 . . . . 1.1699999999999999 109.371 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 tp -58.18 147.45 30.16 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.276 -1.009 . . . . 0.60999999999999999 108.276 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.441 ' O ' HG23 ' A' ' 176' ' ' VAL . 54.8 t-20 -99.02 106.65 18.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.133 -0.979 . . . . 2.1200000000000001 109.64 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -87.02 37.2 0.75 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -0.856 . . . . 1.3400000000000001 109.177 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -109.34 -24.47 11.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.537 -0.727 . . . . 1.97 109.436 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -132.82 10.99 4.32 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 1.8999999999999999 110.248 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 172' ' ' ASN . 30.9 t -79.28 154.45 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.928 -1.108 . . . . 0.47999999999999998 109.161 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.402 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 13.5 tp -114.9 -19.45 10.97 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.704 -0.623 . . . . 1.3899999999999999 110.189 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.46 175.1 42.6 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.857 -1.297 . . . . 0.38 109.857 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.484 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 4.4 m-85 -126.77 122.3 34.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.481 -1.011 . . . . 0.46000000000000002 109.275 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.0 mt -130.33 124.39 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.501 -0.926 . . . . 0.58999999999999997 108.501 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 203' ' ' VAL . 40.6 p -142.68 151.76 41.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 0.67000000000000004 111.202 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.476 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 1.6 m-20 -87.3 43.77 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 2.2400000000000002 108.996 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.149 0 O-C-N 121.413 -0.805 . . . . 1.1100000000000001 110.214 -179.053 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 27.9 t60 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.683 -0.858 . . . . 0.92000000000000004 108.683 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.3 p -55.54 -41.86 73.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.391 -0.818 . . . . 1.5900000000000001 109.42 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.2 t -62.48 -31.43 72.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 1.4199999999999999 109.557 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.0 mm -68.33 -34.77 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.186 -0.946 . . . . 1.4099999999999999 110.143 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.3 mtm -71.41 -54.1 11.81 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.692 -1.225 . . . . 0.85999999999999999 107.692 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.86 -44.19 70.17 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.392 -0.596 . . . . 0.58999999999999997 109.392 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -66.35 -46.63 76.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.15 -0.969 . . . . 3.0600000000000001 109.498 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.2 m -70.0 -37.13 75.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 0.72999999999999998 110.116 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 199' ' ' LEU . 26.1 mt -86.61 -0.17 55.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.042 -1.036 . . . . 0.67000000000000004 109.483 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 51.05 5.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.268 -0.895 . . . . 1.49 110.79 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 197' ' ' LEU . 66.7 mt -66.76 139.68 95.92 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.747 -1.221 . . . . 0.64000000000000001 108.65 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.08 131.64 44.65 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.711 1.607 . . . . 0.58999999999999997 111.508 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -163.52 -179.21 6.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.706 -1.246 . . . . 0.55000000000000004 110.787 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.487 ' CD1' HD11 ' A' ' 220' ' ' LEU . 14.7 mt -150.45 158.71 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.166 -1.42 . . . . 0.63 107.166 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.1 m -142.84 -25.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 120.771 -1.206 . . . . 0.77000000000000002 110.703 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.44 27.99 5.48 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.934 -1.266 . . . . 0.87 109.934 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 207' ' ' SER . 2.9 p -57.02 -37.27 71.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.678 -1.483 . . . . 0.89000000000000001 108.122 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.476 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 60.02 -35.68 0.04 OUTLIER Glycine 0 N--CA 1.492 2.402 0 C-N-CA 121.031 -0.604 . . . . 0.93000000000000005 113.664 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 205' ' ' THR . 7.0 m -128.88 16.55 6.29 Favored 'General case' 0 N--CA 1.513 2.718 0 CA-C-N 119.749 1.774 . . . . 1.6000000000000001 113.209 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.463 HG22 HD13 ' A' ' 2' ' ' ILE . 20.2 t -80.17 -34.76 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.072 -1.643 . . . . 0.75 110.224 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.2 p -71.53 -21.26 61.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.827 -1.171 . . . . 0.83999999999999997 109.974 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.9 m -104.54 17.17 24.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.415 -0.803 . . . . 1.6100000000000001 109.137 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -139.32 -17.87 1.01 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.364 -0.835 . . . . 2.2999999999999998 110.835 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 213' ' ' LYS . 55.1 t -119.82 162.47 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.255 -0.903 . . . . 0.76000000000000001 109.691 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 212' ' ' VAL . 13.5 mmtp -126.54 -176.83 3.79 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.165 -1.42 . . . . 2.0099999999999998 107.165 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.466 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 10.8 p30 -77.01 149.57 35.87 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.74 -1.225 . . . . 2.1899999999999999 110.357 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.7 t70 81.03 -12.89 0.97 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.151 -0.343 . . . . 2.3999999999999999 110.667 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -57.76 140.68 50.98 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.794 -1.192 . . . . 1.99 108.358 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -90.66 109.97 21.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.939 -1.101 . . . . 1.3 108.91 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 7.3 mt -113.11 161.37 17.19 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.193 -0.669 . . . . 0.53000000000000003 109.193 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 67.5 mt -133.39 120.1 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.617 -1.253 . . . . 0.59999999999999998 107.617 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 202' ' ' ILE . 13.8 tp -87.78 127.65 35.32 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.022 -0.732 . . . . 0.56999999999999995 109.022 -178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 19.5 p-10 -98.01 -30.24 12.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.267 -0.895 . . . . 2.2200000000000002 109.034 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.76 24.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.387 0.613 . . . . 0.75 110.349 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.7 t -118.04 -59.0 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 106.695 -1.594 . . . . 0.92000000000000004 106.695 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -94.35 13.17 24.48 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.51 -1.292 . . . . 2.3599999999999999 107.51 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 55.53 62.11 2.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.154 -0.684 . . . . 1.4199999999999999 109.154 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.446 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 53.7 tt0 -155.62 145.82 21.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.14 -0.975 . . . . 1.97 110.769 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 228' ' ' TYR . 76.6 t -106.52 159.98 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.074 -0.713 . . . . 0.65000000000000002 109.074 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.478 ' N ' HG12 ' A' ' 227' ' ' VAL . 61.8 m-85 -124.88 114.53 19.31 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.52 -0.919 . . . . 0.96999999999999997 108.52 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.1 123.8 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 0.67000000000000004 109.942 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.4 t30 69.73 67.84 0.43 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.564 -0.71 . . . . 1.45 109.697 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -88.73 134.8 2.8 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 123.355 2.704 . . . . 0.81999999999999995 112.267 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 38.5 p -73.51 156.95 37.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 1.6200000000000001 109.393 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -65.69 -30.84 71.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 2.6000000000000001 109.375 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -56.86 -43.2 80.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.564 -0.71 . . . . 3.0600000000000001 109.724 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.4 t -72.93 -49.31 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 1.1399999999999999 109.608 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 84.7 mt -50.57 -59.65 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.287 -0.883 . . . . 1.04 109.381 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -55.46 -36.23 66.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 2.54 110.284 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -64.76 -51.42 62.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 2.6000000000000001 110.747 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 243' ' ' GLN . 9.1 mtm -79.49 -27.16 41.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.954 -1.091 . . . . 1.23 110.339 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 240' ' ' ARG . 9.9 mmm-85 -53.2 -41.56 65.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.811 -1.181 . . . . 2.6699999999999999 108.785 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.1 -52.44 10.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 1.6599999999999999 110.025 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.3 t -69.81 -51.06 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 2.2000000000000002 110.496 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 239' ' ' MET . 1.5 tm0? -55.56 -53.2 59.4 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.841 -1.162 . . . . 3.0 110.321 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.418 ' OE1' ' O ' ' A' ' 240' ' ' ARG . 52.9 mt-10 . . . . . 0 C--N 1.301 -1.504 0 O-C-N 120.981 -1.075 . . . . 1.76 109.397 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.535 ' H2 ' ' HG3' ' A' ' 226' ' ' GLN . 12.6 mmt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.315 -0.624 . . . . 3.6600000000000001 109.315 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.54 94.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 1.1200000000000001 109.537 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 m -93.96 118.06 30.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.292 -0.88 . . . . 1.45 109.69 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.444 ' N ' HD21 ' A' ' 225' ' ' ASN . . . -113.49 -161.12 14.3 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 108.934 -1.666 . . . . 0.92000000000000004 108.934 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' LEU . 79.5 mt -92.89 -9.79 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.044 -1.268 . . . . 1.05 109.218 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.9 tp 57.54 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.971 . . . . 0.88 109.469 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.05 -55.66 3.73 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.208 -1.034 . . . . 0.78000000000000003 108.208 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.82 148.11 34.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 108.694 -0.854 . . . . 1.5 108.694 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.03 150.36 29.64 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.357 2.038 . . . . 0.85999999999999999 113.337 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.02 124.48 1.1 Allowed Glycine 0 N--CA 1.499 2.881 0 N-CA-C 110.17 -1.172 . . . . 0.78000000000000003 110.17 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.19 135.03 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.094 -1.239 . . . . 0.73999999999999999 110.066 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.5 145.52 35.29 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.397 -0.814 . . . . 0.45000000000000001 110.224 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.8 m-85 -112.7 142.16 45.64 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.837 -1.172 . . . . 0.64000000000000001 107.837 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.22 164.8 30.44 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.424 -1.846 . . . . 0.45000000000000001 111.732 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -79.33 146.76 32.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.594 -0.945 . . . . 1.8799999999999999 110.338 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.41 120.69 24.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 0.58999999999999997 110.613 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 tp -102.07 91.38 4.3 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.589 -1.263 . . . . 0.64000000000000001 107.589 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.99 136.81 35.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.116 -0.99 . . . . 0.73999999999999999 110.166 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 mt -94.91 93.4 7.41 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.466 0.651 . . . . 0.73999999999999999 110.617 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -96.83 152.01 19.11 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.533 -0.914 . . . . 1.8700000000000001 108.533 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.88 145.05 51.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.196 -0.94 . . . . 2.5800000000000001 109.587 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.59 134.27 35.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 2.1400000000000001 109.407 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.57 136.45 55.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 1.9299999999999999 109.382 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.5 mt -92.99 135.67 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.68000000000000005 109.457 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.9 t -102.38 119.12 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.336 -0.853 . . . . 0.83999999999999997 108.801 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.7 mt -88.74 137.92 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.809 . . . . 0.79000000000000004 110.115 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -91.23 115.67 28.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.356 -0.84 . . . . 1.3700000000000001 109.429 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.432 HH11 ' HG3' ' A' ' 28' ' ' ARG . 14.2 mmm-85 -97.91 27.7 4.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.22 -0.925 . . . . 2.6200000000000001 109.259 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -82.87 147.85 28.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 2.3500000000000001 109.851 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -86.74 136.68 32.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.203 -0.935 . . . . 2.3500000000000001 108.747 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.9 pt -95.84 177.46 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.012 -1.055 . . . . 0.78000000000000003 110.303 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 98.8 p -98.97 154.68 17.89 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.66 -0.867 . . . . 1.04 108.66 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.11 -8.45 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.064 -1.022 . . . . 1.05 109.984 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -82.86 -14.61 53.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 2.4700000000000002 110.078 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -112.86 -2.99 14.22 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.32 -0.862 . . . . 1.46 109.688 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.67 -45.09 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.974 -1.079 . . . . 0.77000000000000002 108.728 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -56.66 -35.12 68.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 1.46 109.121 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -69.1 -36.53 77.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 2.29 110.212 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -62.63 -45.43 92.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 1.3 109.485 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.31 -46.24 97.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.438 -0.789 . . . . 0.76000000000000001 109.732 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.82 -42.33 81.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 1.5 108.882 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -62.86 -31.7 72.78 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.701 -0.852 . . . . 2.6600000000000001 108.701 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -86.09 -55.79 3.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.75 108.692 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.7 tp -51.81 -56.54 13.34 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.135 -1.061 . . . . 0.82999999999999996 108.135 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.64 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.8 t -66.46 -35.94 81.53 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.826 -1.175 . . . . 0.78000000000000003 107.826 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -55.85 -54.76 32.88 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 107.609 -2.196 . . . . 0.56999999999999995 107.609 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -47.66 -30.82 4.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.407 -1.054 . . . . 2.8300000000000001 108.763 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.26 -32.97 70.48 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.498 -1.297 . . . . 0.65000000000000002 107.498 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 46' ' ' GLY . 95.7 mttt -81.23 -62.86 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.64 -0.874 . . . . 2.5699999999999998 108.64 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.473 ' HB2' HD21 ' A' ' 140' ' ' ASN . . . -48.4 -40.56 26.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.899 . . . . 0.51000000000000001 109.598 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.4 p -62.35 -35.01 77.8 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.745 -1.205 . . . . 1.3600000000000001 107.745 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.82 -21.28 60.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.589 -0.523 . . . . 0.59999999999999998 109.589 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -76.51 -67.34 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 1.3600000000000001 109.488 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.59 -39.92 51.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.117 -0.989 . . . . 1.3799999999999999 108.436 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.99 -48.12 83.02 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.948 -0.76 . . . . 1.27 108.948 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.0 m -63.06 -38.86 92.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.59999999999999998 108.898 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.36 -37.56 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.921 . . . . 0.53000000000000003 108.546 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -51.06 -45.82 61.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.624 -0.673 . . . . 0.98999999999999999 109.715 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -75.19 -23.99 57.74 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.148 -0.97 . . . . 0.58999999999999997 110.427 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -72.31 -32.63 66.74 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.779 -1.201 . . . . 1.8100000000000001 108.385 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.11 -26.62 42.9 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.507 -0.745 . . . . 0.47999999999999998 109.241 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.27 14.35 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.707 -1.235 . . . . 0.57999999999999996 110.509 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -86.22 -14.9 42.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.827 -1.396 . . . . 1.3899999999999999 109.204 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.4 m -96.18 -49.0 5.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.269 -0.894 . . . . 0.81999999999999995 110.654 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -106.37 -18.19 14.06 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.148 -0.97 . . . . 0.98999999999999999 110.38 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.86 143.86 6.85 Favored Glycine 0 N--CA 1.502 3.086 0 N-CA-C 109.686 -1.365 . . . . 0.55000000000000004 109.686 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -49.73 -7.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.469 -1.018 . . . . 2.5899999999999999 110.826 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 66' ' ' GLY . 52.9 tt0 -65.78 -27.89 68.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.872 -1.143 . . . . 2.2000000000000002 111.0 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -90.12 -12.24 38.87 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.799 -1.188 . . . . 1.79 110.413 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -62.8 -21.28 65.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.091 -1.005 . . . . 1.54 110.709 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.92 70.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.851 -1.156 . . . . 0.64000000000000001 110.081 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.2 mt -72.52 -43.81 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.076 -1.015 . . . . 0.57999999999999996 109.636 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -77.05 -26.47 53.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.851 . . . . 0.62 110.325 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.08 -44.19 93.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.903 -1.123 . . . . 1.23 109.262 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.39 -35.84 88.01 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.915 -1.674 . . . . 0.52000000000000002 108.915 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -19.08 63.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.413 -1.051 . . . . 1.29 110.215 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.5 mt -83.84 -37.06 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.711 -1.243 . . . . 0.55000000000000004 108.589 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.4 ttt -58.9 -53.35 59.38 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.769 -0.826 . . . . 1.8899999999999999 108.769 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -52.01 -41.52 62.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.44 -0.788 . . . . 0.53000000000000003 108.905 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.8 tp -68.65 -44.32 74.39 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.42999999999999999 109.675 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -85.92 8.85 18.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.261 -0.899 . . . . 1.24 110.476 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -48.59 121.17 4.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.852 -1.155 . . . . 1.3100000000000001 109.328 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.74 -25.69 66.63 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.286 -0.884 . . . . 1.3500000000000001 108.808 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -76.99 -48.9 16.71 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.324 -0.86 . . . . 2.1600000000000001 109.625 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.64 -16.69 63.16 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.575 -1.25 . . . . 0.59999999999999998 108.657 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.8 -50.16 18.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.4 -0.812 . . . . 1.28 109.591 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.57 -29.31 70.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 1.28 109.134 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -74.07 -48.15 31.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 1.29 109.104 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.2 mt -57.31 -43.41 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.379 -0.971 . . . . 0.57999999999999996 108.379 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.11 -61.65 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.78000000000000003 110.195 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -45.23 -51.19 11.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.85999999999999999 110.275 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 49.9 mt -54.1 -55.0 31.75 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.452 -0.899 . . . . 0.79000000000000004 108.941 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.3 mt -51.02 -47.22 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.965 . . . . 0.70999999999999996 110.377 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -81.94 -33.29 30.4 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.987 -1.071 . . . . 2.0499999999999998 111.441 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.4 t70 -81.31 -45.96 15.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.769 -1.207 . . . . 1.5900000000000001 111.735 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -103.91 17.85 23.24 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.628 -1.295 . . . . 1.8899999999999999 109.866 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.6 m80 45.3 50.91 9.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.177 -0.952 . . . . 1.3100000000000001 109.469 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.6 mtt -99.73 149.01 23.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.52 -0.738 . . . . 1.28 109.114 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.3 p -76.15 146.78 38.97 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.399 -0.813 . . . . 0.62 109.21 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.67 -29.1 10.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.46999999999999997 108.702 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.37 -44.62 51.45 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.286 -1.005 . . . . 2.0 108.286 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.42 -54.45 12.34 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.313 0.577 . . . . 0.56000000000000005 110.074 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.29 -50.47 72.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.47999999999999998 109.365 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.08 -37.35 69.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.44 109.73 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -69.59 -35.07 75.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.046 -1.034 . . . . 1.4199999999999999 109.491 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 109' ' ' GLU . 33.4 tt0 -62.28 -58.35 8.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 1.26 109.612 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.3 t -50.28 -47.11 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.977 -1.077 . . . . 0.60999999999999999 109.221 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.3 mm -65.13 -15.65 18.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.376 -0.828 . . . . 0.64000000000000001 109.007 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 106' ' ' GLU . 24.7 tt0 -75.28 -37.0 61.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 2.2000000000000002 109.706 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.56 -26.5 29.85 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.491 -1.338 . . . . 0.81999999999999995 112.174 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -67.58 -37.91 83.27 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.614 -1.521 . . . . 1.27 108.952 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.34 -51.36 7.03 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.671 -0.643 . . . . 0.91000000000000003 109.581 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.0 p -60.47 -42.79 96.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.317 -0.865 . . . . 1.73 110.141 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.0 -38.41 90.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.976 -1.078 . . . . 1.04 110.339 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 115' ' ' LEU . 71.2 mt -67.72 -26.86 66.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.852 -1.155 . . . . 1.03 109.438 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -69.48 -20.45 63.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.035 -1.04 . . . . 1.95 109.607 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -81.36 -6.85 59.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 1.71 109.183 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 mt -85.7 143.18 28.51 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.244 -1.021 . . . . 1.26 108.244 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -96.66 62.04 1.94 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.271 -0.893 . . . . 2.8300000000000001 109.024 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -148.96 115.22 5.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.221 -0.924 . . . . 1.5800000000000001 109.621 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.82 -13.08 3.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 2.7999999999999998 109.433 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.504 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 1.0 OUTLIER -79.92 -63.79 1.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 1.02 109.375 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.6 mt -68.09 -30.81 70.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.215 -0.928 . . . . 1.0600000000000001 109.444 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 68.5 tttt -67.01 -51.64 52.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.956 . . . . 2.3900000000000001 109.337 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -57.86 -23.11 51.48 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.195 -0.94 . . . . 2.2000000000000002 108.995 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.504 ' NH2' ' OH ' ' A' ' 122' ' ' TYR . 18.6 ttm180 -73.41 -24.71 60.31 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.408 -1.701 . . . . 2.0899999999999999 106.408 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.08 -42.86 91.42 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.629 -0.878 . . . . 0.85999999999999999 108.629 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.71 80.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.436 -0.79 . . . . 0.90000000000000002 109.876 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.13 -25.32 65.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 1.3500000000000001 109.529 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.2 t -76.61 -42.62 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.163 -0.961 . . . . 0.57999999999999996 108.444 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 131' ' ' ARG . 16.6 ttm-85 -57.0 -37.69 72.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.223 -0.923 . . . . 3.2200000000000002 108.68 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -61.06 -38.37 85.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.508 -0.745 . . . . 1.3200000000000001 110.319 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.8 mt -67.97 -26.83 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.018 -1.051 . . . . 0.5 109.975 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.5 -44.08 8.87 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.632 -1.387 . . . . 0.44 109.632 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.419 ' HZ2' ' HD2' ' A' ' 139' ' ' ARG . 43.5 tttm -50.92 -51.68 49.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.371 -1.076 . . . . 2.71 109.642 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.544 ' CG ' HH11 ' A' ' 136' ' ' ARG . 4.5 mtt-85 -63.9 -46.21 85.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.109 -0.994 . . . . 2.2000000000000002 108.361 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.9 tp -49.83 -38.38 34.66 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.054 -0.721 . . . . 1.1299999999999999 109.054 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.8 mt -70.5 -55.01 9.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.54000000000000004 109.495 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.419 ' HD2' ' HZ2' ' A' ' 135' ' ' LYS . 47.2 mtp180 -53.49 -17.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 2.3199999999999998 110.293 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.473 HD21 ' HB2' ' A' ' 50' ' ' ALA . 10.2 m-20 -85.02 -47.4 10.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.992 -1.067 . . . . 1.26 109.204 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.27 -37.88 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.899 . . . . 0.62 109.118 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.83 -3.11 58.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.67000000000000004 108.693 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.32 22.62 15.53 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.303 -1.919 . . . . 0.68000000000000005 108.303 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.6 tp -55.58 154.3 6.78 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.625 -0.927 . . . . 0.77000000000000002 109.297 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -66.76 147.55 53.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 2.3999999999999999 109.683 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.8 mt -109.05 145.79 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.517 -0.739 . . . . 0.87 109.349 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.7 mm -76.34 119.46 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 1.3200000000000001 108.625 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.7 OUTLIER -94.79 87.03 4.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.255 -0.903 . . . . 1.54 109.918 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.9 mt -81.6 -10.33 59.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.77000000000000002 109.14 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.1 p -80.65 -12.18 59.53 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.273 -0.892 . . . . 1.5700000000000001 109.461 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -103.56 49.95 0.82 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.473 -0.767 . . . . 0.81999999999999995 110.53 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 153' ' ' GLN . 26.8 mm -71.2 164.12 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.812 -1.18 . . . . 0.81999999999999995 108.71 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.492 ' N ' HG22 ' A' ' 152' ' ' ILE . 46.0 mt-30 -132.88 -33.1 1.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.351 -0.843 . . . . 2.1099999999999999 109.768 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -115.0 145.52 42.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.5 -0.75 . . . . 1.4099999999999999 109.614 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -66.95 126.66 29.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.415 -0.803 . . . . 1.3 109.232 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.4 m -148.97 172.38 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.154 -0.966 . . . . 0.56999999999999995 109.668 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 158' ' ' LEU . 53.5 mt -90.66 163.59 2.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.609 -1.256 . . . . 0.42999999999999999 107.609 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.494 ' N ' HG22 ' A' ' 157' ' ' ILE . 12.7 tp -111.89 123.83 51.09 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.589 -0.694 . . . . 0.56000000000000005 109.404 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.8 t -123.46 129.7 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.148 -0.686 . . . . 0.54000000000000004 109.148 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.29 146.14 11.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.62 109.671 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.94 -27.25 66.63 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.601 -1.312 . . . . 0.80000000000000004 107.468 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -175.47 157.94 2.2 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.64 -0.663 . . . . 2.3399999999999999 109.215 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 22.6 mt -129.88 131.03 45.92 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.439 -0.788 . . . . 0.65000000000000002 109.321 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 p -94.59 153.28 40.28 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.285 -0.884 . . . . 0.73999999999999999 109.409 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -35.68 -41.78 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.541 2.16 . . . . 0.59999999999999998 112.354 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.9 m -62.2 -56.29 20.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.162 -0.961 . . . . 0.63 109.112 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -53.73 -31.19 47.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 1.25 109.526 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.5 HG21 ' CD2' ' A' ' 189' ' ' HIS . 28.3 p -82.49 -31.54 29.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.5 109.539 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.82 -23.92 58.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.51000000000000001 109.966 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -105.26 -6.0 20.11 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.145 -0.972 . . . . 1.1699999999999999 109.414 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.08 156.0 5.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.226 -1.027 . . . . 0.60999999999999999 108.226 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 176' ' ' VAL . 52.2 t-20 -97.9 97.19 8.74 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.136 -0.978 . . . . 2.1200000000000001 109.564 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.745 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.6 mm? -82.05 26.23 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 1.3400000000000001 109.193 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -112.44 -18.13 12.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.421 -0.799 . . . . 1.97 109.103 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -131.26 -1.32 4.01 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.47 -0.769 . . . . 1.8999999999999999 110.133 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 172' ' ' ASN . 39.3 t -78.95 151.54 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.874 -1.141 . . . . 0.47999999999999998 109.543 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.3 tp -121.33 -9.01 9.12 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.8 -0.562 . . . . 1.3899999999999999 110.269 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.44 176.5 41.22 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.561 -1.304 . . . . 0.38 110.069 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.82 130.35 35.94 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.517 -0.99 . . . . 0.46000000000000002 110.086 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.437 ' CG2' HG21 ' A' ' 205' ' ' THR . 8.1 mt -129.56 120.05 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.01 -1.107 . . . . 0.58999999999999997 108.01 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 203' ' ' VAL . 64.1 p -141.67 152.45 43.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.213 -0.929 . . . . 0.67000000000000004 110.868 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 21.4 p30 -89.45 43.83 1.17 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.088 -1.008 . . . . 2.2400000000000002 110.715 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.497 1.922 0 O-C-N 120.878 -1.139 . . . . 1.1100000000000001 108.799 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.5 ' CD2' HG21 ' A' ' 168' ' ' THR . 5.3 t60 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.385 0.612 . . . . 0.92000000000000004 109.671 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 190' ' ' THR . 0.1 OUTLIER -47.1 -44.15 21.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 1.5900000000000001 109.987 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 38.6 t -59.71 -37.43 78.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.01 . . . . 1.4199999999999999 110.34 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 31.4 mm -60.43 -34.36 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.098 -1.001 . . . . 1.4099999999999999 110.397 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.2 mtp -71.67 -52.05 19.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.902 -1.124 . . . . 0.85999999999999999 108.288 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.19 -30.99 51.67 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.722 -0.672 . . . . 0.58999999999999997 110.277 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -81.26 -47.76 12.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.066 -1.021 . . . . 3.0600000000000001 110.416 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.9 m -67.57 -37.1 82.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.933 -1.104 . . . . 0.72999999999999998 110.112 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 199' ' ' LEU . 15.9 mt -86.18 -0.13 54.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.981 -1.074 . . . . 0.67000000000000004 109.105 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 56.81 0.37 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.396 -0.815 . . . . 1.49 112.015 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.1 mt -67.42 170.77 6.03 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.472 -1.393 . . . . 0.64000000000000001 108.897 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -90.97 142.78 3.2 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.513 2.142 . . . . 0.58999999999999997 111.199 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.1 -178.19 5.88 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.562 -1.337 . . . . 0.55000000000000004 110.857 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.9 mt -149.69 158.48 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.962 -1.496 . . . . 0.63 106.962 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.525 ' O ' ' O ' ' A' ' 181' ' ' THR . 19.5 m -137.93 -32.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.989 -1.069 . . . . 0.77000000000000002 111.434 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.34 42.54 3.16 Favored Glycine 0 N--CA 1.496 2.653 0 O-C-N 120.579 -1.326 . . . . 0.87 110.727 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.437 HG21 ' CG2' ' A' ' 180' ' ' ILE . 60.8 p -71.39 -21.15 62.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.602 -1.528 . . . . 0.89000000000000001 109.297 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.452 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 71.75 -97.43 0.72 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.843 -1.17 . . . . 0.93000000000000005 111.814 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 66.7 m -115.42 45.86 1.59 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.969 -1.312 . . . . 1.6000000000000001 112.743 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 17.7 t -79.93 -27.19 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.601 -1.312 . . . . 0.75 107.636 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.433 ' H ' HG23 ' A' ' 209' ' ' THR . 1.4 p -73.67 -11.21 60.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.83999999999999997 109.7 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 13.8 p -101.53 6.4 42.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.36 -0.837 . . . . 1.6100000000000001 109.405 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -130.47 -3.58 4.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.399 -0.813 . . . . 2.2999999999999998 109.203 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.0 t -125.81 152.59 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.055 -0.72 . . . . 0.76000000000000001 109.055 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -118.68 -173.79 2.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.852 -1.536 . . . . 2.0099999999999998 106.852 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 22.7 t-20 -80.03 145.42 32.51 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.818 -1.176 . . . . 2.1899999999999999 111.202 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.46 -7.4 1.46 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.839 -0.538 . . . . 2.3999999999999999 110.843 178.531 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.29 138.05 55.28 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.875 -1.141 . . . . 1.99 108.446 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -86.38 115.98 24.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.038 -1.039 . . . . 1.3 108.655 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.6 mt -117.99 179.1 4.19 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.374 1.083 . . . . 0.53000000000000003 110.806 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.8 mt -146.93 107.92 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.387 -1.338 . . . . 0.59999999999999998 107.387 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 tp -83.21 128.4 34.46 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.32 -0.993 . . . . 0.56999999999999995 108.32 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -52.6 4.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 2.2200000000000002 109.82 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 57.54 22.74 8.44 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.339 -0.85 . . . . 0.75 108.77 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.06 -49.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 107.295 -1.372 . . . . 0.92000000000000004 107.295 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -106.95 12.14 29.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.936 -1.135 . . . . 2.3599999999999999 107.936 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.444 HD21 ' N ' ' A' ' 4' ' ' GLY . 59.0 t30 58.35 58.21 3.54 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.056 -0.72 . . . . 1.4199999999999999 109.056 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.535 ' HG3' ' H2 ' ' A' ' 1' ' ' MET . 17.4 tt0 -153.75 146.99 24.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.926 . . . . 1.97 109.918 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.63 136.62 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.67 -0.644 . . . . 0.65000000000000002 109.386 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -105.03 127.38 52.84 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.384 -0.822 . . . . 0.96999999999999997 109.2 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.58 127.89 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.516 -0.74 . . . . 0.67000000000000004 109.864 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 49.05 69.96 2.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.857 . . . . 1.45 109.989 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.5 153.44 13.73 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.78 2.32 . . . . 0.81999999999999995 111.64 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.5 p -73.93 169.59 17.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.979 . . . . 1.6200000000000001 109.98 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.53 -27.76 65.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.852 . . . . 2.6000000000000001 109.579 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.13 -38.65 91.33 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.418 -0.801 . . . . 3.0600000000000001 109.537 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.09 -46.31 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 1.1399999999999999 109.341 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.7 mt -52.05 -55.84 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 1.04 109.356 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -54.91 -44.83 74.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 2.54 109.972 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.45 ' O ' HG23 ' A' ' 242' ' ' VAL . 50.8 tttm -67.54 -37.75 83.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 2.6000000000000001 110.144 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 51.9 mtp -80.16 -25.92 39.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 1.23 109.706 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.469 ' CA ' ' HE ' ' A' ' 240' ' ' ARG . 0.0 OUTLIER -60.16 -51.86 67.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.179 -0.951 . . . . 2.6699999999999999 109.853 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.71 -54.94 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 1.6599999999999999 109.771 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 238' ' ' LYS . 84.5 t -49.03 -53.02 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 2.2000000000000002 109.511 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -55.29 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.249 -0.907 . . . . 3.0 109.981 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 . . . . . 0 C--N 1.299 -1.6 0 O-C-N 121.122 -0.986 . . . . 1.76 110.499 -178.772 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.451 -0.574 . . . . 3.6600000000000001 109.451 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 208' ' ' VAL . 74.3 mt -60.67 98.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.872 . . . . 1.1200000000000001 109.475 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.0 m -93.37 114.67 27.15 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 1.45 109.619 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.72 -163.15 19.53 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.784 -1.726 . . . . 0.92000000000000004 108.784 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 5' ' ' ILE . 63.4 mt -96.48 -9.46 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.039 -1.271 . . . . 1.05 108.789 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.2 tp 59.42 110.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.416 -0.803 . . . . 0.88 109.151 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -89.77 -49.66 6.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.081 -1.081 . . . . 0.78000000000000003 108.081 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -150.43 152.15 32.41 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.371 -0.83 . . . . 1.5 109.383 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.08 155.89 29.92 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.585 2.19 . . . . 0.85999999999999999 112.504 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 144.26 121.84 1.55 Allowed Glycine 0 N--CA 1.504 3.169 0 N-CA-C 110.232 -1.147 . . . . 0.78000000000000003 110.232 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.49 139.48 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.094 -1.239 . . . . 0.73999999999999999 110.22 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.61 159.86 41.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.324 -0.86 . . . . 0.45000000000000001 109.68 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.595 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -130.39 135.79 48.4 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.107 -1.072 . . . . 0.64000000000000001 108.107 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 166.6 37.14 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 118.601 -1.762 . . . . 0.45000000000000001 111.723 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -79.61 149.78 31.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.739 -0.859 . . . . 1.8799999999999999 110.392 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -76.37 125.02 28.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.39 -0.819 . . . . 0.58999999999999997 110.992 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.1 tp -110.79 93.15 4.34 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.174 -1.417 . . . . 0.64000000000000001 107.174 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -81.79 126.83 32.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.04 -1.037 . . . . 0.73999999999999999 110.996 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.3 mt -101.94 94.44 5.79 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.609 -0.723 . . . . 0.73999999999999999 110.316 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -94.62 158.54 15.48 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.358 -0.979 . . . . 1.8700000000000001 108.358 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -130.18 125.4 34.89 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.384 -0.823 . . . . 2.5800000000000001 109.506 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 6.5 p-10 -80.27 130.2 35.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.32 -0.862 . . . . 2.1400000000000001 109.008 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.64 148.87 50.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 1.9299999999999999 109.235 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.5 136.73 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 0.68000000000000005 109.145 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -103.11 121.05 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.369 -0.832 . . . . 0.83999999999999997 109.047 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.7 mt -87.14 132.98 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.386 -0.821 . . . . 0.79000000000000004 109.729 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -91.5 122.46 34.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 1.3700000000000001 108.724 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.527 ' HG2' HH11 ' A' ' 28' ' ' ARG . 0.4 OUTLIER -98.36 27.41 4.73 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.241 -0.912 . . . . 2.6200000000000001 109.887 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -81.01 143.33 32.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 2.3500000000000001 109.277 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -86.37 126.27 34.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.146 -0.971 . . . . 2.3500000000000001 109.416 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 pt -85.24 176.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 0.78000000000000003 109.6 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.9 p -95.58 173.96 7.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.79 . . . . 1.04 109.478 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.29 -25.89 63.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 1.05 109.551 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 3.3 m-20 -79.97 2.57 23.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 2.4700000000000002 108.617 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -116.75 -17.02 10.6 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.507 -0.924 . . . . 1.46 108.507 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.9 t -66.61 -46.45 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.46 -0.775 . . . . 0.77000000000000002 109.382 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.2 -35.65 67.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.887 . . . . 1.46 109.626 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -69.07 -33.5 73.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.389 -0.819 . . . . 2.29 110.267 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.2 -37.9 89.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.959 -1.088 . . . . 1.3 109.362 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.9 -47.31 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.359 -0.838 . . . . 0.76000000000000001 110.058 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.31 -41.29 85.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.136 -0.977 . . . . 1.5 109.086 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -60.44 -34.27 73.73 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.244 -0.91 . . . . 2.6600000000000001 109.092 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 28.1 t80 -86.83 -55.3 3.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.138 -0.976 . . . . 0.75 109.407 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.39 -63.8 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.82999999999999996 110.081 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 12.9 t -66.48 -37.91 86.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.78000000000000003 108.856 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.95 -52.63 47.7 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.672 -2.171 . . . . 0.56999999999999995 107.672 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -53.7 -22.55 9.31 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.648 -0.913 . . . . 2.8300000000000001 109.431 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -64.11 -45.08 90.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.101 -0.999 . . . . 0.65000000000000002 108.648 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 50' ' ' ALA . 28.7 pttt -78.41 -51.84 9.45 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.352 -0.939 . . . . 2.5699999999999998 109.296 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' H ' ' HG3' ' A' ' 49' ' ' LYS . . . -50.76 -41.1 56.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.561 -1.337 . . . . 0.51000000000000001 109.325 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t -62.43 -33.56 75.05 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.613 -1.254 . . . . 1.3600000000000001 107.613 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.88 -28.31 62.42 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.037 -0.727 . . . . 0.59999999999999998 109.037 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -73.6 -62.97 1.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.372 -0.83 . . . . 1.3600000000000001 109.093 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 54' ' ' LEU . 10.8 mp -49.71 -38.04 31.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.995 -1.066 . . . . 1.3799999999999999 108.297 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.35 -41.64 98.87 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.326 -0.991 . . . . 1.27 108.326 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 m -62.97 -39.28 94.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.455 -0.778 . . . . 0.59999999999999998 109.007 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.08 -39.6 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.574 -0.899 . . . . 0.53000000000000003 108.574 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -49.2 -42.04 38.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.785 . . . . 0.98999999999999999 109.571 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -71.27 -38.76 71.84 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.066 -1.022 . . . . 0.58999999999999997 109.796 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -69.88 -14.9 62.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.866 -1.134 . . . . 1.8100000000000001 107.999 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.91 -36.03 21.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.51 -0.922 . . . . 0.47999999999999998 108.51 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.08 -27.86 29.95 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.199 -1.16 . . . . 0.57999999999999996 110.199 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -85.86 -15.59 41.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.008 -1.29 . . . . 1.3899999999999999 109.38 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.7 m -94.49 -48.22 6.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.176 -0.952 . . . . 0.81999999999999995 110.325 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -106.37 -17.54 14.25 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.164 -0.96 . . . . 0.98999999999999999 110.537 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.93 143.84 6.83 Favored Glycine 0 N--CA 1.502 3.042 0 N-CA-C 109.706 -1.357 . . . . 0.55000000000000004 109.706 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -51.26 -8.6 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -1.058 . . . . 2.5899999999999999 110.572 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.461 ' H ' ' C ' ' A' ' 66' ' ' GLY . 97.7 mt-10 -65.69 -24.17 66.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.955 -1.091 . . . . 2.2000000000000002 110.474 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -91.45 -13.75 31.73 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.926 -1.109 . . . . 1.79 110.739 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -62.92 -18.71 63.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.92 -1.113 . . . . 1.54 110.815 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.12 -37.16 85.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.913 -1.117 . . . . 0.64000000000000001 110.04 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 72' ' ' ILE . 27.3 mt -73.14 -38.79 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.965 . . . . 0.57999999999999996 109.91 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -78.41 -22.34 47.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.62 109.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -64.48 -48.27 75.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.201 -0.937 . . . . 1.23 109.111 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.07 -32.01 76.03 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.425 -1.47 . . . . 0.52000000000000002 109.425 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -61.69 -23.31 66.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -1.15 . . . . 1.29 110.004 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.1 mt -85.28 -39.02 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.901 -1.125 . . . . 0.55000000000000004 108.825 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.4 ttt -59.04 -46.7 87.57 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.578 -0.897 . . . . 1.8899999999999999 108.578 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tp -58.71 -40.03 82.5 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.545 -0.722 . . . . 0.53000000000000003 109.062 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -67.03 -45.92 76.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.271 -0.893 . . . . 0.42999999999999999 109.395 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -84.57 9.04 14.68 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.874 . . . . 1.24 110.546 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -51.83 120.98 5.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.955 -1.091 . . . . 1.3100000000000001 109.231 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.74 -21.76 65.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -0.95 . . . . 1.3500000000000001 108.947 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.35 -47.44 23.44 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.327 -0.858 . . . . 2.1600000000000001 109.185 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.06 -18.83 64.75 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.223 -0.991 . . . . 0.59999999999999998 108.93 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -81.79 -41.32 21.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.388 -0.82 . . . . 1.28 109.725 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -63.06 -33.32 75.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 1.28 109.469 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -74.07 -42.57 59.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 1.29 109.004 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.2 mt -59.57 -58.82 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.219 -1.03 . . . . 0.57999999999999996 108.219 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.4 mt -42.86 -64.36 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.758 -0.589 . . . . 0.78000000000000003 110.164 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.0 -49.78 15.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 0.85999999999999999 110.135 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 mt -56.4 -57.14 13.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -0.842 . . . . 0.79000000000000004 109.328 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.3 -38.39 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.071 -1.018 . . . . 0.70999999999999996 110.169 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -86.53 -37.62 18.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.096 -1.002 . . . . 2.0499999999999998 112.105 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -82.1 -38.72 24.42 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.79 -1.194 . . . . 1.5900000000000001 111.691 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 97' ' ' HIS . 60.5 mmtt -105.45 14.1 29.2 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.806 -1.184 . . . . 1.8899999999999999 109.612 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 96' ' ' LYS . 77.4 m80 44.55 44.5 7.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.377 -0.827 . . . . 1.3100000000000001 109.365 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.3 mtt -95.59 153.04 17.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.472 -0.768 . . . . 1.28 109.195 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.2 p -77.17 142.34 39.69 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.565 -0.71 . . . . 0.62 109.595 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.47 -26.85 2.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.401 -0.812 . . . . 0.46999999999999997 109.68 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.0 -43.67 43.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.118 -0.989 . . . . 2.0 108.376 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.74 -55.36 7.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.731 -0.606 . . . . 0.56000000000000005 110.407 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.57 -50.02 71.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.983 . . . . 0.47999999999999998 110.057 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.89 -30.8 62.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -0.937 . . . . 0.44 109.797 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -69.98 -25.62 63.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.011 -1.056 . . . . 1.4199999999999999 109.364 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -68.67 -60.7 2.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -0.922 . . . . 1.26 109.86 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -51.91 -48.16 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.929 -1.107 . . . . 0.60999999999999999 109.407 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.9 mm -63.42 -21.94 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.64000000000000001 109.694 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -69.26 -34.64 75.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.976 -1.078 . . . . 2.2000000000000002 109.543 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.27 -23.54 40.18 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.559 -1.305 . . . . 0.81999999999999995 112.293 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -68.3 -42.94 78.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.52 -1.576 . . . . 1.27 108.854 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.93 -49.18 14.65 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.214 -0.661 . . . . 0.91000000000000003 109.214 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.6 t -60.46 -45.89 92.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.404 -0.81 . . . . 1.73 109.785 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.6 78.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 1.04 110.344 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 mt -68.43 -28.85 67.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.864 -1.147 . . . . 1.03 109.186 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -70.38 -17.6 63.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.189 -0.945 . . . . 1.95 109.404 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -80.97 -6.19 58.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 1.71 109.437 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 123' ' ' LEU . 3.3 mt -84.01 142.86 30.16 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.277 -1.009 . . . . 1.26 108.277 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -94.34 57.62 2.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 2.8300000000000001 108.55 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -148.61 116.41 6.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 1.5800000000000001 109.267 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.92 -11.33 7.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 2.7999999999999998 109.725 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -78.85 -64.11 1.26 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -0.877 . . . . 1.02 109.286 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 118' ' ' LEU . 26.3 mt -63.17 -23.43 67.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.009 -1.057 . . . . 1.0600000000000001 109.26 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 127' ' ' ALA . 40.6 tttm -66.78 -50.59 62.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.094 -1.004 . . . . 2.3900000000000001 108.36 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -55.1 -22.99 18.43 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.442 -0.947 . . . . 2.2000000000000002 108.442 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.602 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -72.74 -27.09 61.82 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.867 -1.531 . . . . 2.0899999999999999 106.867 177.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.53 -41.81 86.37 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.561 -0.903 . . . . 0.85999999999999999 108.561 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.66 -43.8 75.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.508 -0.745 . . . . 0.90000000000000002 109.83 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.74 -21.19 66.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 1.3500000000000001 109.528 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 t -78.07 -48.7 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.185 -0.947 . . . . 0.57999999999999996 108.562 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -54.8 -34.99 63.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.05 -1.031 . . . . 3.2200000000000002 108.587 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.57 -46.74 88.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.421 -0.799 . . . . 1.3200000000000001 110.224 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.05 -30.56 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.924 -1.11 . . . . 0.5 108.966 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.68 -48.4 7.96 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.821 -1.712 . . . . 0.44 108.821 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -56.03 -49.82 72.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.444 -1.033 . . . . 2.71 109.466 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.505 ' HG2' HH11 ' A' ' 136' ' ' ARG . 9.8 mtt-85 -63.6 -49.93 71.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.231 -1.026 . . . . 2.2000000000000002 108.231 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 40.2 tp -48.0 -35.15 10.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 1.1299999999999999 109.267 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.04 -48.19 58.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.157 -0.965 . . . . 0.54000000000000004 109.55 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -53.99 -18.99 4.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 2.3199999999999998 110.71 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 29.4 m-80 -84.72 -38.87 19.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.868 -1.145 . . . . 1.26 109.121 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.9 mt -67.82 -35.29 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.62 109.05 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.21 -1.7 57.21 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.876 -0.787 . . . . 0.67000000000000004 108.876 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.33 25.75 60.77 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.263 -1.935 . . . . 0.68000000000000005 108.263 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.35 133.79 47.28 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.533 -0.98 . . . . 0.77000000000000002 109.499 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.68 141.96 57.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 2.3999999999999999 109.028 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 147' ' ' ILE . 92.0 mt -104.02 163.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.602 -0.888 . . . . 0.87 108.602 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.516 ' N ' HG22 ' A' ' 146' ' ' ILE . 4.2 mp -77.93 128.53 38.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.026 -1.046 . . . . 1.3200000000000001 108.984 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -97.09 84.82 3.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.327 -0.858 . . . . 1.54 109.584 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -82.57 -20.12 37.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.885 . . . . 0.77000000000000002 109.206 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -79.66 7.01 9.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.019 . . . . 1.5700000000000001 109.304 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -118.82 23.39 11.46 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.556 -0.715 . . . . 0.81999999999999995 109.369 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.87 144.57 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.81999999999999995 109.725 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -137.63 8.14 2.82 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.91 -0.774 . . . . 2.1099999999999999 108.91 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -123.64 119.5 30.02 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.76 -0.83 . . . . 1.4099999999999999 108.76 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.67 121.05 13.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.283 -0.886 . . . . 1.3 109.488 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.2 m -150.05 177.45 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.56999999999999995 108.952 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.2 mt -88.56 151.3 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.176 -1.046 . . . . 0.42999999999999999 108.176 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.76 117.87 35.25 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.533 0.682 . . . . 0.56000000000000005 109.414 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.5 t -124.06 132.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.718 -0.845 . . . . 0.54000000000000004 108.718 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.56 153.08 14.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.803 . . . . 0.62 109.801 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.53 86.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.641 -1.287 . . . . 0.80000000000000004 107.915 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -174.42 156.88 2.58 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.463 -0.773 . . . . 2.3399999999999999 109.758 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 27.3 mt -130.84 137.7 49.51 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.538 -0.726 . . . . 0.65000000000000002 109.499 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.9 p -93.72 153.57 41.1 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.227 -0.921 . . . . 0.73999999999999999 109.178 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -34.3 -46.82 0.52 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.735 2.29 . . . . 0.59999999999999998 112.938 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 169' ' ' ALA . 69.1 m -50.77 -65.76 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.012 . . . . 0.63 109.262 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -48.36 -37.4 16.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.341 -0.849 . . . . 1.25 109.737 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 12.3 p -75.87 -21.71 56.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.5 109.484 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 166' ' ' SER . . . -80.81 -21.14 41.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.51000000000000001 110.153 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -107.14 -19.83 13.49 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.318 -0.864 . . . . 1.1699999999999999 109.859 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.31 149.99 27.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.60999999999999999 109.112 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -97.01 158.01 15.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.976 . . . . 2.1200000000000001 108.525 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.3 mp -96.37 -40.58 9.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.161 -0.962 . . . . 1.3400000000000001 110.782 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -80.13 -13.64 59.11 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.706 -1.246 . . . . 1.97 111.603 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -94.01 -5.11 48.29 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.605 -1.309 . . . . 1.8999999999999999 108.469 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 178' ' ' GLY . 42.9 t -102.14 155.27 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.045 -0.724 . . . . 0.47999999999999998 109.045 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.7 tp -113.75 -18.43 11.85 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.967 -0.753 . . . . 1.3899999999999999 108.967 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.482 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.53 171.29 40.08 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.947 -1.661 . . . . 0.38 108.947 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 4.2 m-85 -126.94 124.11 38.75 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.507 -0.996 . . . . 0.46000000000000002 109.623 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.2 mt -125.75 117.35 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.367 -1.346 . . . . 0.58999999999999997 107.367 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 203' ' ' VAL . 17.4 p -140.78 151.84 44.75 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.229 -0.919 . . . . 0.67000000000000004 112.388 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.513 ' O ' ' CG ' ' A' ' 182' ' ' ASP . 6.7 t0 -82.03 40.78 0.63 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.517 0.675 . . . . 2.2400000000000002 109.621 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.118 0 O-C-N 120.29 -1.506 . . . . 1.1100000000000001 110.9 -178.069 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 t60 . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 108.034 -1.098 . . . . 0.92000000000000004 108.034 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.8 m -61.59 -43.75 98.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.053 -0.721 . . . . 1.5900000000000001 109.053 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.1 p -57.44 -32.2 66.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 1.4199999999999999 109.315 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.7 mm -71.19 -31.84 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 1.4099999999999999 109.754 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.7 mtp -71.84 -56.86 4.96 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.776 -1.194 . . . . 0.85999999999999999 107.776 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.89 -38.72 73.19 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.641 -0.709 . . . . 0.58999999999999997 110.408 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -70.17 -50.81 36.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.08 -1.012 . . . . 3.0600000000000001 110.176 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.6 m -69.25 -36.87 77.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.266 -0.896 . . . . 0.72999999999999998 109.794 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 199' ' ' LEU . 14.9 mt -92.86 2.55 56.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.264 -0.898 . . . . 0.67000000000000004 109.319 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 48.92 11.81 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.344 -0.847 . . . . 1.49 110.829 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 197' ' ' LEU . 84.2 mt -66.72 145.93 99.0 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.777 -1.202 . . . . 0.64000000000000001 109.083 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.03 133.43 53.29 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.73 1.62 . . . . 0.58999999999999997 111.099 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -162.79 171.84 16.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.421 -1.424 . . . . 0.55000000000000004 111.4 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.418 ' CD1' HD11 ' A' ' 220' ' ' LEU . 65.9 mt -146.95 156.87 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.434 -1.691 . . . . 0.63 106.434 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.545 ' O ' ' O ' ' A' ' 181' ' ' THR . 29.9 m -140.66 -34.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 120.794 -1.191 . . . . 0.77000000000000002 110.735 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.1 39.92 1.43 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.326 -1.91 . . . . 0.87 108.326 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' ' 203' ' ' VAL . 16.6 p -68.53 -6.14 23.62 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.415 -1.05 . . . . 0.89000000000000001 109.46 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 49.74 -103.11 0.07 OUTLIER Glycine 0 N--CA 1.483 1.768 0 C-N-CA 119.709 -1.234 . . . . 0.93000000000000005 110.149 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 12.3 p -115.81 51.17 0.96 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.197 -1.178 . . . . 1.6000000000000001 112.152 -176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.407 HG22 HD13 ' A' ' 2' ' ' ILE . 12.0 t -72.44 -25.72 23.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.145 -1.428 . . . . 0.75 107.145 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.6 p -70.51 -10.99 60.62 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.617 -0.882 . . . . 0.83999999999999997 108.617 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.3 t -104.2 12.27 34.0 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.445 -0.946 . . . . 1.6100000000000001 108.445 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -133.83 -27.27 1.49 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.689 -0.632 . . . . 2.2999999999999998 109.598 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 213' ' ' LYS . 70.2 t -111.54 154.43 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.516 -0.74 . . . . 0.76000000000000001 109.506 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.496 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 25.2 mmtp -123.8 -178.88 4.18 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.559 -1.645 . . . . 2.0099999999999998 106.559 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.5 p-10 -79.97 149.38 30.82 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.73 -1.231 . . . . 2.1899999999999999 110.234 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 t70 81.49 -14.99 0.76 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.889 -0.507 . . . . 2.3999999999999999 110.664 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 73.7 m-20 -59.65 142.78 52.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.787 -1.196 . . . . 1.99 108.997 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -90.08 109.13 20.2 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.08 -1.012 . . . . 1.3 109.218 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.39 172.23 6.96 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.927 0.87 . . . . 0.53000000000000003 109.714 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.9 mt -143.71 116.6 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.559 -1.274 . . . . 0.59999999999999998 107.559 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.418 HD11 ' CD1' ' A' ' 202' ' ' ILE . 23.3 tp -84.79 127.06 33.94 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.161 -0.962 . . . . 0.56999999999999995 108.737 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 4.8 p-10 -89.22 -36.16 15.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.087 -1.008 . . . . 2.2200000000000002 109.119 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.539 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 44.58 21.57 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.542 -0.724 . . . . 0.75 110.142 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 221' ' ' ASP . 28.2 t -122.62 -61.4 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.754 -1.202 . . . . 0.92000000000000004 107.754 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -91.99 17.07 9.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.396 -0.964 . . . . 2.3599999999999999 108.396 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 28.6 t30 53.91 56.32 7.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.67 -0.644 . . . . 1.4199999999999999 109.928 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.445 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 69.2 mt-30 -152.96 144.32 23.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.191 -0.943 . . . . 1.97 110.351 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 92.7 t -99.48 151.56 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.994 -1.113 . . . . 0.65000000000000002 107.994 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -122.41 120.85 35.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.378 -0.826 . . . . 0.96999999999999997 109.216 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.3 t -104.93 120.32 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.455 -0.778 . . . . 0.67000000000000004 109.642 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 48.29 65.55 6.9 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 1.45 109.915 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.89 165.16 24.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.782 2.322 . . . . 0.81999999999999995 111.976 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.8 p -75.43 142.46 43.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 1.6200000000000001 109.388 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -54.41 -14.85 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 2.6000000000000001 109.243 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -72.84 -38.18 67.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -0.794 . . . . 3.0600000000000001 109.463 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.01 -41.25 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 1.1399999999999999 109.005 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.1 mt -55.85 -55.48 17.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.403 -0.81 . . . . 1.04 109.593 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -53.1 -40.02 63.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 2.54 109.849 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -66.91 -37.66 84.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.293 -0.879 . . . . 2.6000000000000001 110.119 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 46.7 mtp -82.82 -25.26 32.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.154 -0.966 . . . . 1.23 110.028 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 12.3 mmm-85 -59.91 -45.91 91.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.134 -0.979 . . . . 2.6699999999999999 109.74 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.79 -48.97 22.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 1.6599999999999999 110.178 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.79 -55.3 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.072 -1.017 . . . . 2.2000000000000002 110.027 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -44.93 -57.27 3.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 3.0 110.148 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--N 1.297 -1.674 0 O-C-N 121.487 -0.758 . . . . 1.76 110.142 -179.174 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.518 ' O ' ' N ' ' A' ' 3' ' ' SER . 49.1 mtm . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.589 -0.523 . . . . 3.6600000000000001 109.589 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 53.3 mt -53.44 89.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 1.1200000000000001 108.915 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 1' ' ' MET . 70.1 m -95.94 119.34 34.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.327 -0.858 . . . . 1.45 109.955 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.34 -158.53 12.41 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.446 -1.861 . . . . 0.92000000000000004 108.446 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.513 ' O ' ' O ' ' A' ' 6' ' ' LEU . 56.4 mt -97.77 -11.41 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.155 -1.203 . . . . 1.05 108.24 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.4 tp 50.87 109.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.591 0.71 . . . . 0.88 109.376 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.36 -50.12 8.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.717 -1.239 . . . . 0.78000000000000003 109.543 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.88 150.26 45.56 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.266 -0.896 . . . . 1.5 109.431 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.48 152.84 30.31 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.383 2.056 . . . . 0.85999999999999999 113.52 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.9 121.4 0.81 Allowed Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.319 -1.112 . . . . 0.78000000000000003 110.319 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.2 mt -88.55 133.14 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.079 -1.248 . . . . 0.73999999999999999 109.818 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.07 161.51 36.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.561 -0.712 . . . . 0.45000000000000001 109.89 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.7 m-85 -130.48 135.92 48.46 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.517 -0.92 . . . . 0.64000000000000001 108.517 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.45 165.26 31.27 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 118.419 -1.848 . . . . 0.45000000000000001 111.54 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -81.06 150.01 28.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.696 -0.885 . . . . 1.8799999999999999 109.916 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.461 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -79.81 128.78 33.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 0.58999999999999997 111.279 -178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 17' ' ' LEU . 35.9 tp -107.38 95.38 5.66 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.204 -1.406 . . . . 0.64000000000000001 107.204 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.6 tp -81.37 122.5 27.55 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.099 -1.001 . . . . 0.73999999999999999 110.844 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.3 98.33 9.89 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.015 -0.538 . . . . 0.73999999999999999 109.644 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -92.23 159.87 15.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 1.8700000000000001 108.798 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.484 ' OE2' ' N ' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -130.13 130.03 44.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.447 -0.783 . . . . 2.5800000000000001 109.083 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.484 ' N ' ' OE2' ' A' ' 21' ' ' GLU . 5.4 m-20 -80.22 131.96 35.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.268 -0.895 . . . . 2.1400000000000001 109.198 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -64.66 146.94 53.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 1.9299999999999999 109.274 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.65 135.35 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 0.68000000000000005 109.72 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.39 114.49 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.85 -0.796 . . . . 0.83999999999999997 108.85 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.3 mt -90.29 139.61 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.79000000000000004 109.778 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -93.19 122.39 35.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.197 -0.939 . . . . 1.3700000000000001 110.029 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -96.31 19.15 12.4 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.283 -0.886 . . . . 2.6200000000000001 109.703 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -80.26 156.36 26.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.97 -1.081 . . . . 2.3500000000000001 109.906 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -90.67 127.69 36.38 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.159 -0.682 . . . . 2.3500000000000001 109.159 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.419 HG12 ' H ' ' A' ' 31' ' ' ILE . 9.4 pt -78.87 171.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.006 . . . . 0.78000000000000003 109.58 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.2 p -101.04 163.82 12.1 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.946 -0.761 . . . . 1.04 108.946 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.88 -25.92 63.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 1.05 109.726 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.85 -12.8 59.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.127 -0.983 . . . . 2.4700000000000002 108.702 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -102.29 -12.31 18.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.639 -0.874 . . . . 1.46 108.639 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -67.68 -49.71 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.77000000000000002 108.746 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 1.2 m-20 -57.96 -39.89 79.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 1.46 109.919 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -67.54 -36.6 81.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 2.29 110.56 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -65.89 -33.23 75.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.972 -1.08 . . . . 1.3 109.528 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.6 t -62.25 -45.13 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.76000000000000001 109.276 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -64.29 -32.58 74.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.104 -0.997 . . . . 1.5 108.387 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.51 ' HG2' HH11 ' A' ' 42' ' ' ARG . 8.2 mtt-85 -66.18 -37.32 85.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.481 -0.762 . . . . 2.6600000000000001 109.083 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 34.6 t80 -86.21 -54.15 4.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.185 -0.947 . . . . 0.75 108.903 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 tp -48.78 -66.99 0.31 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.333 -0.854 . . . . 0.82999999999999996 109.091 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.8 t -64.41 -28.38 69.64 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.784 -0.821 . . . . 0.78000000000000003 108.784 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -59.93 -54.77 34.68 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 107.527 -2.229 . . . . 0.56999999999999995 107.527 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.456 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.0 OUTLIER -47.39 -30.64 3.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.647 -0.914 . . . . 2.8300000000000001 108.698 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -61.81 -34.88 76.72 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.211 -1.033 . . . . 0.65000000000000002 108.211 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' GLY . 31.2 mtpt -82.14 -60.62 2.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.692 -0.63 . . . . 2.5699999999999998 109.646 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.531 ' HB2' HD21 ' A' ' 140' ' ' ASN . . . -49.25 -38.55 27.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.51000000000000001 109.975 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -65.35 -39.04 91.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.024 -1.047 . . . . 1.3600000000000001 108.922 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.61 64.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.753 -0.592 . . . . 0.59999999999999998 110.584 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -63.62 -47.79 79.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 1.3600000000000001 109.965 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.35 -46.42 64.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.922 -1.112 . . . . 1.3799999999999999 109.455 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -48.15 -52.37 20.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.384 -0.822 . . . . 1.27 109.752 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -60.84 -34.0 73.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.59999999999999998 109.849 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -72.3 -27.98 27.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.186 -0.946 . . . . 0.53000000000000003 108.899 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -63.51 -42.39 98.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 0.98999999999999999 109.898 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -72.72 -28.83 62.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.168 -0.957 . . . . 0.58999999999999997 109.844 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -72.45 -25.31 61.4 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.657 -1.238 . . . . 1.8100000000000001 107.657 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.79 -29.95 56.26 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.948 -1.131 . . . . 0.47999999999999998 107.948 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.2 -29.84 24.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.895 -1.282 . . . . 0.57999999999999996 109.895 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -86.34 -16.21 38.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.864 -1.374 . . . . 1.3899999999999999 109.076 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -93.37 -48.89 6.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.89 . . . . 0.81999999999999995 110.065 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -106.93 -16.35 14.48 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.26 -0.9 . . . . 0.98999999999999999 110.793 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 119.44 142.92 6.89 Favored Glycine 0 N--CA 1.503 3.111 0 N-CA-C 109.486 -1.445 . . . . 0.55000000000000004 109.486 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -49.99 -5.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.397 -1.061 . . . . 2.5899999999999999 110.62 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' GLY . 34.3 mt-10 -64.02 -24.09 67.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.937 -1.102 . . . . 2.2000000000000002 109.874 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -90.58 -9.44 47.1 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.076 -1.015 . . . . 1.79 110.264 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -64.1 -29.63 70.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.003 -1.061 . . . . 1.54 110.893 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -35.96 82.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.826 -1.171 . . . . 0.64000000000000001 110.105 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.6 mt -73.2 -45.78 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.999 -1.063 . . . . 0.57999999999999996 109.658 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.62 -23.9 53.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.91 . . . . 0.62 109.747 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -64.75 -44.67 89.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.931 -1.105 . . . . 1.23 109.152 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.36 -34.49 80.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.442 -1.463 . . . . 0.52000000000000002 109.442 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -20.94 65.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -1.159 . . . . 1.29 110.172 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.3 mt -85.29 -38.7 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.762 -1.211 . . . . 0.55000000000000004 108.337 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.7 ttt -58.65 -39.45 80.61 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.491 -0.929 . . . . 1.8899999999999999 108.491 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tp -64.21 -41.9 96.84 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.867 -0.79 . . . . 0.53000000000000003 108.867 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.3 tp -68.25 -44.76 74.92 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.759 -0.777 . . . . 0.42999999999999999 109.193 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.16 8.33 21.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.933 . . . . 1.24 110.117 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -47.57 123.55 5.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.822 -1.174 . . . . 1.3100000000000001 109.989 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.38 -26.07 67.09 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.788 -0.819 . . . . 1.3500000000000001 108.788 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.58 -50.47 17.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.346 -0.846 . . . . 2.1600000000000001 109.309 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.94 -16.83 63.79 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.187 -1.005 . . . . 0.59999999999999998 109.282 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.82 -51.0 12.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 1.28 110.507 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -62.16 -29.92 70.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.139 -0.976 . . . . 1.28 110.232 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -74.14 -44.56 53.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 1.29 109.649 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.95 -57.35 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.09 -1.078 . . . . 0.57999999999999996 108.09 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.7 mt -46.31 -63.57 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.684 -0.635 . . . . 0.78000000000000003 109.786 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.34 -53.74 8.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.245 -0.909 . . . . 0.85999999999999999 110.103 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.543 HD13 ' OE1' ' A' ' 106' ' ' GLU . 57.7 mt -50.03 -54.7 18.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 0.79000000000000004 109.252 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.7 mt -53.53 -42.48 49.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.331 -0.856 . . . . 0.70999999999999996 110.4 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -85.88 -36.82 19.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.99 -1.069 . . . . 2.0499999999999998 111.563 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -83.25 -38.16 22.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.943 -1.098 . . . . 1.5900000000000001 111.76 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -104.25 9.82 35.89 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.758 -1.214 . . . . 1.8899999999999999 109.804 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.4 m80 49.6 42.34 22.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.922 -1.111 . . . . 1.3100000000000001 109.188 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.5 mtt -97.49 150.78 20.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.082 -0.71 . . . . 1.28 109.082 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.9 p -75.02 145.64 42.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.494 -0.754 . . . . 0.62 109.767 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.7 -26.27 8.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.218 -0.926 . . . . 0.46999999999999997 108.821 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -75.15 -50.0 17.73 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.589 -0.893 . . . . 2.0 108.589 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.27 -50.94 34.41 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.283 0.563 . . . . 0.56000000000000005 110.066 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.57 -56.52 20.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.47999999999999998 109.888 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.44 62.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.199 -0.938 . . . . 0.44 109.271 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -69.37 -21.21 63.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 1.4199999999999999 109.024 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.543 ' OE1' HD13 ' A' ' 92' ' ' LEU . 41.8 tt0 -70.57 -50.36 38.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.496 -0.752 . . . . 1.26 109.905 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.97 -40.66 89.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.862 -1.149 . . . . 0.60999999999999999 109.299 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.79 -19.48 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.243 -0.91 . . . . 0.64000000000000001 108.942 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -76.88 -34.78 57.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 2.2000000000000002 109.739 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 114' ' ' ALA . . . -85.72 -23.36 46.67 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.104 -1.522 . . . . 0.81999999999999995 111.591 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -69.65 -42.87 73.67 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.822 -1.399 . . . . 1.27 108.638 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.73 -53.68 9.81 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.436 -0.79 . . . . 0.91000000000000003 109.824 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 t -60.55 -28.66 68.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.137 -0.977 . . . . 1.73 109.788 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -67.01 -44.57 79.98 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.966 -1.084 . . . . 1.04 110.345 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.9 -24.75 66.91 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.88 -1.138 . . . . 1.03 109.003 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.73 -19.78 65.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 1.95 109.485 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -82.48 -7.03 59.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.196 -0.94 . . . . 1.71 109.513 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 123' ' ' LEU . 2.1 mt -86.42 156.91 19.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.323 -0.861 . . . . 1.26 108.824 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -104.79 58.72 0.69 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.842 -0.799 . . . . 2.8300000000000001 108.842 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -150.31 118.77 6.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.25 -0.906 . . . . 1.5800000000000001 109.384 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -64.26 -9.59 18.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 2.7999999999999998 110.057 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -77.05 -61.22 2.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.184 -0.948 . . . . 1.02 109.444 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 118' ' ' LEU . 10.4 mt -66.48 -26.64 67.27 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.276 -0.89 . . . . 1.0600000000000001 109.629 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 127' ' ' ALA . 47.7 tttp -67.2 -53.46 30.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 2.3900000000000001 108.582 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -55.97 -25.14 42.53 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.611 -0.885 . . . . 2.2000000000000002 108.611 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -72.94 -24.73 60.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.774 -1.565 . . . . 2.0899999999999999 106.774 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.88 -41.34 95.77 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.643 -0.873 . . . . 0.85999999999999999 108.643 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.44 -38.12 86.67 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.423 -0.954 . . . . 0.90000000000000002 108.423 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -71.51 -25.81 62.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 1.3500000000000001 109.286 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.44 -47.5 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.329 -0.857 . . . . 0.57999999999999996 108.908 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -55.39 -36.49 66.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.876 -1.14 . . . . 3.2200000000000002 108.283 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.13 -37.13 83.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.595 -0.69 . . . . 1.3200000000000001 110.718 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.5 mt -67.5 -25.08 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.981 -1.074 . . . . 0.5 109.655 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.56 -46.64 9.62 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.025 -1.63 . . . . 0.44 109.025 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -48.58 -42.46 33.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.484 -1.009 . . . . 2.71 109.677 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.458 ' HG2' HH11 ' A' ' 136' ' ' ARG . 24.4 mtt-85 -63.54 -52.32 61.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.095 -1.003 . . . . 2.2000000000000002 108.553 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.9 tp -51.2 -41.36 60.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.748 -0.595 . . . . 1.1299999999999999 109.854 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 140' ' ' ASN . 11.2 mt -66.9 -61.31 2.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.54000000000000004 110.008 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -43.95 -19.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.403 -0.811 . . . . 2.3199999999999998 110.858 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.531 HD21 ' HB2' ' A' ' 50' ' ' ALA . 5.8 m-20 -85.46 -34.1 21.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.04 -1.038 . . . . 1.26 109.925 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.2 mt -73.45 -33.3 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.043 -1.036 . . . . 0.62 108.805 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 55.8 mt -86.73 3.08 46.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.334 -0.854 . . . . 0.67000000000000004 109.344 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.06 27.73 23.36 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.433 -1.867 . . . . 0.68000000000000005 108.433 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.64 148.51 28.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.526 -0.985 . . . . 0.77000000000000002 109.443 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -66.56 132.81 49.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 2.3999999999999999 109.403 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 76.6 mt -102.13 134.59 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.383 -0.823 . . . . 0.87 109.027 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.794 HD12 ' H ' ' A' ' 147' ' ' ILE . 2.5 mp -77.93 133.32 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 1.3200000000000001 110.09 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -98.53 88.46 4.11 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.614 -0.884 . . . . 1.54 108.614 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.0 mt -78.75 -30.08 45.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.318 -0.864 . . . . 0.77000000000000002 110.011 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 m -81.85 30.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 1.5700000000000001 109.57 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.23 32.38 2.13 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.243 -0.91 . . . . 0.81999999999999995 109.129 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.43 152.56 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.369 -0.832 . . . . 0.81999999999999995 110.13 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -129.22 -10.19 4.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.538 -0.912 . . . . 2.1099999999999999 108.538 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 154' ' ' ASP . 0.7 OUTLIER -120.1 127.37 52.47 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.424 -0.798 . . . . 1.4099999999999999 109.17 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.92 124.09 20.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 1.3 109.614 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.83 175.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.194 -0.941 . . . . 0.56999999999999995 109.411 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.8 mt -88.11 153.68 3.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.605 -1.257 . . . . 0.42999999999999999 107.605 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.5 tp -104.49 117.29 33.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.443 -0.786 . . . . 0.56000000000000005 109.041 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 35.6 t -120.57 133.11 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.603 -0.888 . . . . 0.54000000000000004 108.603 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.58 143.21 11.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.373 -0.829 . . . . 0.62 109.039 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.42 -27.05 67.17 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.614 -1.304 . . . . 0.80000000000000004 107.909 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 20.2 t0 -172.27 145.45 1.71 Allowed 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.69 -0.631 . . . . 2.3399999999999999 109.59 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.527 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 25.3 mt -119.74 130.34 54.94 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.557 -0.905 . . . . 0.65000000000000002 108.557 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.6 p -93.34 148.3 35.32 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.976 -1.078 . . . . 0.73999999999999999 109.677 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 169' ' ' ALA . 78.3 Cg_exo -36.96 -49.16 1.52 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.594 2.196 . . . . 0.59999999999999998 112.327 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.8 m -51.41 -59.81 3.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.63 109.228 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -53.57 -41.33 66.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -0.876 . . . . 1.25 109.432 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 19.4 p -73.59 -22.57 60.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.5 110.013 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -76.61 -26.87 55.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.115 -0.991 . . . . 0.51000000000000001 110.066 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -105.15 -10.89 16.83 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.15 -0.969 . . . . 1.1699999999999999 109.944 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.36 156.02 10.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.153 -0.967 . . . . 0.60999999999999999 109.169 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -98.51 132.34 44.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.012 -1.055 . . . . 2.1200000000000001 108.233 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.4 mp -82.17 -44.67 16.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 1.3400000000000001 111.238 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -83.44 -8.72 59.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.826 -1.171 . . . . 1.97 112.111 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -98.65 -8.54 26.1 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.612 -1.305 . . . . 1.8999999999999999 108.77 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 177' ' ' LEU . 53.0 t -98.2 161.19 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.211 -1.033 . . . . 0.47999999999999998 108.211 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.478 ' N ' HG12 ' A' ' 176' ' ' VAL . 9.3 tp -108.61 -23.97 11.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.313 -0.867 . . . . 1.3899999999999999 109.907 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -178.33 174.41 46.68 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.942 -1.663 . . . . 0.38 108.942 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -129.43 122.44 29.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.588 -0.948 . . . . 0.46000000000000002 108.992 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 12.9 mt -128.43 128.11 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.377 -0.971 . . . . 0.58999999999999997 108.377 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 203' ' ' VAL . 47.7 p -141.3 146.52 36.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.483 -0.761 . . . . 0.67000000000000004 111.467 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.461 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 2.8 m-20 -85.73 41.99 0.94 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -0.782 . . . . 2.2400000000000002 109.501 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.017 0 O-C-N 121.387 -0.821 . . . . 1.1100000000000001 109.727 -179.44 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.629 ' HA ' HD12 ' A' ' 192' ' ' ILE . 82.3 t60 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.034 -0.728 . . . . 0.92000000000000004 109.034 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.406 ' H ' HG22 ' A' ' 190' ' ' THR . 0.1 OUTLIER -56.36 -36.24 68.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.23 -0.919 . . . . 1.5900000000000001 108.937 179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.5 t -75.0 -37.71 61.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.869 . . . . 1.4199999999999999 109.079 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 189' ' ' HIS . 88.6 mt -50.51 -32.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.159 -0.963 . . . . 1.4099999999999999 108.647 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.5 mtm -71.78 -51.51 22.29 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 106.947 -1.501 . . . . 0.85999999999999999 106.947 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.44 -39.01 66.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.071 -0.714 . . . . 0.58999999999999997 109.071 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -69.18 -51.69 35.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 3.0600000000000001 109.351 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.8 m -68.88 -36.62 78.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 0.72999999999999998 109.344 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 199' ' ' LEU . 39.5 mt -86.83 3.69 44.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.179 -0.95 . . . . 0.67000000000000004 108.667 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 52.75 2.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 1.49 110.873 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 197' ' ' LEU . 21.9 mt -64.74 169.37 5.35 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.654 -1.279 . . . . 0.64000000000000001 107.751 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -90.38 143.94 3.87 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.16 1.907 . . . . 0.58999999999999997 111.684 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.62 175.86 10.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.706 -1.246 . . . . 0.55000000000000004 111.491 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.453 ' CD1' HD11 ' A' ' 220' ' ' LEU . 10.8 mt -150.78 155.01 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.786 -1.561 . . . . 0.63 106.786 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.6 m -143.51 -29.08 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 120.689 -1.257 . . . . 0.77000000000000002 111.273 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.15 30.95 3.85 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.993 -1.243 . . . . 0.87 109.993 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 207' ' ' SER . 3.2 p -61.61 -38.84 89.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.726 -1.455 . . . . 0.89000000000000001 107.806 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.461 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 57.36 -33.43 0.02 OUTLIER Glycine 0 N--CA 1.498 2.769 0 CA-C-O 119.684 -0.509 . . . . 0.93000000000000005 113.851 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 205' ' ' THR . 95.2 p -124.83 1.14 8.09 Favored 'General case' 0 N--CA 1.512 2.646 0 CA-C-N 119.613 1.706 . . . . 1.6000000000000001 112.652 -177.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 t -65.44 -48.39 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.144 -1.597 . . . . 0.75 109.753 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 p -54.64 -16.1 2.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.884 -1.135 . . . . 0.83999999999999997 110.045 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.1 t -104.13 11.72 34.77 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.316 -0.865 . . . . 1.6100000000000001 109.65 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -142.25 -3.82 1.05 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.288 -0.882 . . . . 2.2999999999999998 110.411 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.75 145.18 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.433 -0.792 . . . . 0.76000000000000001 108.936 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -120.55 172.98 7.46 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.515 -1.661 . . . . 2.0099999999999998 106.515 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -74.25 141.13 45.38 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.722 -1.236 . . . . 2.1899999999999999 109.801 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.33 -10.12 1.22 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.807 -0.558 . . . . 2.3999999999999999 110.359 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -56.86 141.32 45.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.675 -1.265 . . . . 1.99 107.994 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -87.18 111.64 21.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.954 -1.091 . . . . 1.3 109.19 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 20.7 mt -121.41 168.32 11.81 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.992 0.901 . . . . 0.53000000000000003 110.52 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.9 mt -140.46 123.56 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.192 -1.04 . . . . 0.59999999999999998 108.192 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.453 HD11 ' CD1' ' A' ' 202' ' ' ILE . 15.1 tp -89.72 128.6 36.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.925 . . . . 0.56999999999999995 109.169 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.27 -38.16 11.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.108 -0.995 . . . . 2.2200000000000002 108.923 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 44.78 25.0 0.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.63 -0.669 . . . . 0.75 110.53 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.15 -62.24 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 106.981 -1.488 . . . . 0.92000000000000004 106.981 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -87.59 14.46 8.31 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.95 -1.13 . . . . 2.3599999999999999 107.95 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 58.64 57.66 3.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.68 -0.638 . . . . 1.4199999999999999 109.677 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -156.76 151.8 26.17 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.024 -1.048 . . . . 1.97 110.833 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.55 137.54 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.901 -0.777 . . . . 0.65000000000000002 108.901 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -107.14 131.72 53.82 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.21 -0.931 . . . . 0.96999999999999997 109.273 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.6 t -103.79 118.19 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 0.67000000000000004 109.802 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 230' ' ' ASN . 0.3 OUTLIER 50.87 69.62 2.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 1.45 109.989 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.96 157.97 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.66 2.24 . . . . 0.81999999999999995 111.347 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 80.3 p -72.76 144.9 47.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 1.6200000000000001 109.883 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 237' ' ' ASP . 2.6 m-20 -53.02 -27.72 20.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.43 -0.794 . . . . 2.6000000000000001 109.742 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -64.54 -37.3 87.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 3.0600000000000001 109.734 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 80.1 t -77.81 -36.16 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.243 -0.91 . . . . 1.1399999999999999 109.137 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.37 -58.74 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 1.04 109.438 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 233' ' ' ASN . 2.5 m-20 -53.33 -36.53 61.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 2.54 109.51 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -67.24 -36.9 82.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 2.6000000000000001 108.97 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 62.0 mtp -80.18 -34.6 37.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.409 -0.807 . . . . 1.23 109.463 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -54.87 -38.76 67.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 2.6699999999999999 109.459 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.97 -57.21 4.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 1.6599999999999999 109.689 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 73.9 t -58.74 -50.79 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.422 -0.799 . . . . 2.2000000000000002 110.275 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.37 -58.41 7.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.943 -1.098 . . . . 3.0 110.148 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 C--N 1.298 -1.663 0 O-C-N 121.288 -0.882 . . . . 1.76 110.275 -179.038 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.518 -0.549 . . . . 3.6600000000000001 109.518 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.07 103.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 1.1200000000000001 109.361 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -93.08 120.22 33.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.329 -0.857 . . . . 1.45 110.033 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.67 -160.19 11.6 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 108.41 -1.876 . . . . 0.92000000000000004 108.41 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.0 mt -93.55 -9.96 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.995 -1.297 . . . . 1.05 109.029 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' ILE . 14.2 tp 56.94 107.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 0.88 109.306 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.52 -53.61 4.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.081 -1.012 . . . . 0.78000000000000003 108.318 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.95 146.16 25.0 Favored Pre-proline 0 N--CA 1.494 1.741 0 N-CA-C 108.582 -0.896 . . . . 1.5 108.582 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.3 153.37 31.37 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.069 1.846 . . . . 0.85999999999999999 113.148 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.68 124.1 1.1 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.051 -1.22 . . . . 0.78000000000000003 110.051 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.574 HD12 ' HG2' ' A' ' 243' ' ' GLN . 72.7 mt -89.36 129.01 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.132 -1.216 . . . . 0.73999999999999999 109.566 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.16 149.22 49.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.383 -0.823 . . . . 0.45000000000000001 109.572 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.9 m-85 -117.87 140.06 50.24 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.626 -0.879 . . . . 0.64000000000000001 108.626 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.65 163.47 29.96 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.725 -1.702 . . . . 0.45000000000000001 111.24 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -78.57 151.71 32.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.991 . . . . 1.8799999999999999 109.902 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.21 129.32 34.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.58999999999999997 111.114 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -111.82 90.84 3.45 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.193 -1.41 . . . . 0.64000000000000001 107.193 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 18' ' ' LEU . 11.7 tp -81.38 128.72 34.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.059 -1.025 . . . . 0.73999999999999999 110.687 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' A' ' 160' ' ' ALA . 32.2 mt -96.88 93.99 6.97 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.454 0.645 . . . . 0.73999999999999999 109.854 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -93.07 156.35 16.93 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.54 -0.911 . . . . 1.8700000000000001 108.54 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.02 131.3 44.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.247 -0.908 . . . . 2.5800000000000001 109.036 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.92 138.63 38.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.148 -0.97 . . . . 2.1400000000000001 108.924 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.23 140.68 58.9 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.45 -0.781 . . . . 1.9299999999999999 109.282 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mt -91.69 132.96 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.215 -0.928 . . . . 0.68000000000000005 109.917 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.8 t -106.61 111.98 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.637 -0.875 . . . . 0.83999999999999997 108.637 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.2 mt -85.07 152.2 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.941 . . . . 0.79000000000000004 109.586 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -90.89 107.54 19.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.497 -0.752 . . . . 1.3700000000000001 109.927 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' NH1' ' HB1' ' A' ' 102' ' ' ALA . 20.4 mmm180 -95.46 24.57 5.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.277 -0.889 . . . . 2.6200000000000001 108.754 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -85.85 144.04 27.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.371 -0.831 . . . . 2.3500000000000001 109.79 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -86.72 123.97 32.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.213 -0.929 . . . . 2.3500000000000001 108.824 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.2 pt -87.22 174.89 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.16 -0.962 . . . . 0.78000000000000003 110.599 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.2 p -100.84 156.41 17.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.842 -0.799 . . . . 1.04 108.842 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.9 -8.44 0.99 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 1.05 109.47 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.95 -21.28 31.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 2.4700000000000002 109.898 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -105.9 -1.36 24.22 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.329 -0.857 . . . . 1.46 109.327 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -64.95 -44.85 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.975 . . . . 0.77000000000000002 108.742 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -52.34 -36.46 53.57 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.262 -0.899 . . . . 1.46 109.19 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -69.46 -34.3 74.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.476 -0.765 . . . . 2.29 110.152 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.433 ' OE2' ' NH2' ' A' ' 42' ' ' ARG . 80.4 mm-40 -62.55 -43.34 99.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.999 -1.063 . . . . 1.3 109.715 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 44' ' ' LEU . 82.2 t -59.84 -48.58 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.76000000000000001 110.035 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -66.55 -44.77 81.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.012 -1.055 . . . . 1.5 108.991 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.433 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 72.1 mtm180 -61.36 -33.97 74.53 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.108 -0.995 . . . . 2.6600000000000001 108.895 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -86.35 -54.43 4.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.75 108.945 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 40' ' ' VAL . 57.3 tp -51.01 -66.77 0.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.469 -0.77 . . . . 0.82999999999999996 109.493 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 t -63.19 -30.15 71.35 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.952 -1.093 . . . . 0.78000000000000003 108.154 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.85 -8.01 51.34 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 107.347 -2.301 . . . . 0.56999999999999995 107.347 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.2 OUTLIER -85.02 -29.02 25.31 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.126 -1.805 . . . . 2.8300000000000001 106.126 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.36 64.17 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.941 -1.133 . . . . 0.65000000000000002 107.941 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -84.91 -64.22 1.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.919 -0.771 . . . . 2.5699999999999998 108.919 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.931 ' HB2' HD21 ' A' ' 140' ' ' ASN . . . -50.32 -41.89 51.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.978 . . . . 0.51000000000000001 109.514 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.9 m -63.36 -37.93 89.18 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.011 -1.107 . . . . 1.3600000000000001 108.011 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.36 -21.51 60.51 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.401 -0.592 . . . . 0.59999999999999998 109.401 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -73.45 -68.35 0.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 1.3600000000000001 109.471 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 58' ' ' LYS . 13.7 mt -48.93 -42.52 37.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.064 -1.022 . . . . 1.3799999999999999 108.839 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -50.55 -48.76 57.3 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.448 -0.945 . . . . 1.27 108.448 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -61.96 -40.37 95.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.59999999999999998 109.053 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.6 mt -74.71 -25.14 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.53000000000000003 108.879 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.584 ' HZ1' ' CD ' ' A' ' 70' ' ' GLU . 13.3 ttpp -64.31 -52.52 58.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.564 -0.71 . . . . 0.98999999999999999 110.219 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.33 -25.45 63.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.968 -1.083 . . . . 0.58999999999999997 109.794 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -71.63 -24.12 61.81 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.904 -1.122 . . . . 1.8100000000000001 108.029 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.74 -32.87 60.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.367 -0.975 . . . . 0.47999999999999998 108.367 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.73 -28.77 28.35 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.842 -1.303 . . . . 0.57999999999999996 109.842 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -86.42 -14.99 41.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.28 . . . . 1.3899999999999999 108.784 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.2 m -92.84 -51.4 5.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.81999999999999995 110.054 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -106.85 -21.77 12.91 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.305 -0.872 . . . . 0.98999999999999999 110.44 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.87 153.6 9.1 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 109.77 -1.332 . . . . 0.55000000000000004 109.77 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -48.87 -8.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.508 -0.995 . . . . 2.5899999999999999 110.464 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 66' ' ' GLY . 39.8 tt0 -63.91 -42.61 97.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 2.2000000000000002 110.377 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -90.81 -10.01 44.37 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.014 -1.054 . . . . 1.79 110.494 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.584 ' CD ' ' HZ1' ' A' ' 58' ' ' LYS . 34.1 tt0 -67.04 -31.04 71.29 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.942 -1.099 . . . . 1.54 110.809 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.91 68.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.097 -1.002 . . . . 0.64000000000000001 110.41 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.7 mt -72.04 -42.56 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.036 -1.04 . . . . 0.57999999999999996 109.771 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -76.71 -19.21 57.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.097 -1.002 . . . . 0.62 109.307 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.07 -49.32 72.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.26 -0.9 . . . . 1.23 108.704 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.38 82.17 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.312 -1.515 . . . . 0.52000000000000002 109.312 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.57 -24.39 65.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -1.204 . . . . 1.29 110.036 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.5 mt -81.15 -36.18 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.727 -1.233 . . . . 0.55000000000000004 108.546 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.9 ttp -58.02 -43.84 86.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.537 -0.912 . . . . 1.8899999999999999 108.537 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -57.31 -42.52 81.98 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.757 -0.831 . . . . 0.53000000000000003 108.757 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.12 -41.48 77.32 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.352 -0.842 . . . . 0.42999999999999999 109.258 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -85.4 8.39 19.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.414 -0.803 . . . . 1.24 110.225 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -50.05 123.44 8.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.947 -1.096 . . . . 1.3100000000000001 109.484 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.55 -22.67 65.39 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.301 -0.875 . . . . 1.3500000000000001 108.911 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -76.76 -49.52 15.75 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.393 -0.817 . . . . 2.1600000000000001 109.318 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.9 mt -64.28 -15.32 59.95 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.292 -0.963 . . . . 0.59999999999999998 109.242 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -82.9 -46.4 13.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 1.28 110.458 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -62.41 -30.19 71.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.13 -0.981 . . . . 1.28 109.906 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -73.29 -43.57 60.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.023 -1.048 . . . . 1.29 109.01 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.06 -56.96 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.492 -0.929 . . . . 0.57999999999999996 108.492 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.0 mt -48.9 -66.17 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.696 -0.627 . . . . 0.78000000000000003 110.417 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -43.1 -58.9 2.26 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.44 -0.788 . . . . 0.85999999999999999 110.876 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.0 mt -45.87 -54.35 8.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.317 -0.864 . . . . 0.79000000000000004 110.024 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.1 mt -50.86 -41.2 21.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.07 -1.019 . . . . 0.70999999999999996 109.757 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -85.76 -38.53 18.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.277 -0.889 . . . . 2.0499999999999998 111.594 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -82.22 -40.25 21.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.901 -1.124 . . . . 1.5900000000000001 111.912 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -108.03 16.54 23.29 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.721 -1.237 . . . . 1.8899999999999999 110.162 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.9 m80 44.85 48.76 9.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.205 -0.935 . . . . 1.3100000000000001 109.525 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.7 mtt -100.72 147.47 25.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 1.28 109.261 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.1 p -75.68 143.75 41.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.313 -0.867 . . . . 0.62 109.164 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.12 -25.62 2.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.46999999999999997 108.887 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.55 -48.97 23.71 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.534 -0.913 . . . . 2.0 108.534 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.524 ' HB1' ' NH1' ' A' ' 28' ' ' ARG . . . -70.51 -53.61 15.53 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.779 -0.575 . . . . 0.56000000000000005 110.013 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.68 -46.7 77.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.47999999999999998 109.411 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.89 66.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.44 109.478 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -69.75 -36.47 75.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 1.4199999999999999 109.567 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -53.67 -50.54 65.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.832 . . . . 1.26 110.314 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.16 -49.02 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.975 -1.078 . . . . 0.60999999999999999 109.601 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -63.12 -19.27 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.429 -0.794 . . . . 0.64000000000000001 109.046 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -73.85 -37.53 64.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.992 . . . . 2.2000000000000002 109.952 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.02 -26.57 31.0 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.524 -1.322 . . . . 0.81999999999999995 112.619 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -67.68 -47.05 70.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.528 -1.572 . . . . 1.27 108.948 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.04 -50.38 23.36 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.604 -0.685 . . . . 0.91000000000000003 109.218 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -59.27 -42.28 90.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.78 . . . . 1.73 110.039 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.3 86.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.125 -0.984 . . . . 1.04 110.905 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.3 -29.59 68.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.735 -1.228 . . . . 1.03 109.426 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -67.54 -15.87 63.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.935 . . . . 1.95 109.627 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.43 -9.06 59.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.94 . . . . 1.71 109.278 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 123' ' ' LEU . 2.2 mt -87.36 146.54 25.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 1.26 108.636 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 20.5 p-10 -100.6 62.71 1.05 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.45 -0.781 . . . . 2.8300000000000001 109.311 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -150.08 113.5 4.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 1.5800000000000001 109.522 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -53.6 -12.28 0.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 2.7999999999999998 109.607 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.74 -62.19 1.76 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.933 . . . . 1.02 109.072 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 118' ' ' LEU . 56.6 mt -71.01 -27.47 63.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.88 . . . . 1.0600000000000001 109.599 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -68.08 -52.52 34.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.061 -1.024 . . . . 2.3900000000000001 108.831 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.28 -20.9 58.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.423 -0.954 . . . . 2.2000000000000002 108.423 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.572 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -72.55 -26.96 61.93 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.485 -1.672 . . . . 2.0899999999999999 106.485 178.114 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.24 -44.09 92.35 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.284 -1.006 . . . . 0.85999999999999999 108.284 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.09 80.82 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.818 -0.808 . . . . 0.90000000000000002 108.818 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -70.07 -32.17 70.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.42 -0.8 . . . . 1.3500000000000001 109.371 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.2 t -77.83 -45.99 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 0.57999999999999996 108.37 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -57.48 -39.97 77.58 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.263 -1.014 . . . . 3.2200000000000002 108.263 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.51 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 14.5 t70 -56.27 -39.32 72.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.563 -0.71 . . . . 1.3200000000000001 109.637 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.47 -20.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.163 -0.96 . . . . 0.5 108.881 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.69 -53.53 4.27 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.943 -1.263 . . . . 0.44 109.943 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -49.04 -39.48 27.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.012 -1.287 . . . . 2.71 108.832 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' A' ' 136' ' ' ARG . 3.1 mtt-85 -65.16 -45.97 82.78 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.282 -1.007 . . . . 2.2000000000000002 108.282 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.5 tp -53.61 -45.13 69.98 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.042 -0.725 . . . . 1.1299999999999999 109.042 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 140' ' ' ASN . 18.2 mt -60.41 -60.2 4.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.54000000000000004 109.435 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -43.97 -20.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 2.3199999999999998 110.324 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.931 HD21 ' HB2' ' A' ' 50' ' ' ALA . 8.2 m-20 -85.4 -49.92 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 1.26 109.665 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -61.91 -35.43 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.62 109.541 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.6 mt -88.49 -4.45 58.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.871 . . . . 0.67000000000000004 109.17 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.67 22.54 46.94 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.466 -1.854 . . . . 0.68000000000000005 108.466 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.02 162.46 14.03 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.538 -0.977 . . . . 0.77000000000000002 109.318 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -65.06 151.21 46.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 2.3999999999999999 109.528 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.3 mt -107.62 144.36 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 109.166 -0.679 . . . . 0.87 109.166 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.1 mm -76.77 100.54 2.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.236 -0.915 . . . . 1.3200000000000001 109.138 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.71 92.7 6.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.407 -0.808 . . . . 1.54 109.591 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.484 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 34.2 mt -79.56 -11.8 59.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.77000000000000002 108.924 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.8 p -86.37 47.16 1.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 1.5700000000000001 108.768 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.08 16.6 3.25 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.382 -0.823 . . . . 0.81999999999999995 110.199 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 152' ' ' ILE . 2.4 mp -69.04 151.79 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.856 -1.152 . . . . 0.81999999999999995 108.884 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -133.28 -22.32 1.99 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.05 -0.722 . . . . 2.1099999999999999 109.05 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.97 151.36 36.88 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.68 -0.859 . . . . 1.4099999999999999 108.68 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.61 124.73 24.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 1.3 109.835 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.2 m -148.27 167.71 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.199 -0.938 . . . . 0.56999999999999995 109.339 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.6 mt -89.5 156.99 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.789 -1.189 . . . . 0.42999999999999999 107.789 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.6 tp -107.23 121.67 45.0 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.732 0.777 . . . . 0.56000000000000005 109.69 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.16 128.6 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.659 -0.867 . . . . 0.54000000000000004 108.659 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -163.74 152.29 13.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 0.62 109.9 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.77 -43.1 94.49 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.374 -1.453 . . . . 0.80000000000000004 107.949 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -172.34 153.27 2.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 2.3399999999999999 109.458 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.1 mt -125.69 133.89 52.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.571 -0.706 . . . . 0.65000000000000002 109.399 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.4 p -93.04 154.39 41.71 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.822 . . . . 0.73999999999999999 109.084 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -33.9 -51.33 0.56 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.808 2.339 . . . . 0.59999999999999998 112.948 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.7 m -50.03 -50.35 47.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.099 -1.001 . . . . 0.63 109.289 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.99 -42.28 98.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.855 . . . . 1.25 109.846 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.4 p -70.49 -31.34 68.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.5 109.563 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.62 -29.74 68.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.51000000000000001 110.011 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -103.53 -4.31 24.11 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.25 -0.906 . . . . 1.1699999999999999 110.15 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 tp -57.71 153.14 14.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.91 -1.118 . . . . 0.60999999999999999 108.275 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 174' ' ' LYS . 9.2 p-10 -99.5 90.55 4.55 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.147 -0.971 . . . . 2.1200000000000001 110.3 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.56 32.18 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 1.3400000000000001 108.674 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 172' ' ' ASN . 67.6 mttm -111.12 -24.55 10.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.63 -0.669 . . . . 1.97 109.811 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -132.13 6.64 4.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.473 -0.767 . . . . 1.8999999999999999 109.796 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 172' ' ' ASN . 39.4 t -79.27 154.78 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.087 -1.008 . . . . 0.47999999999999998 109.031 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.38 -28.21 8.31 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.714 -0.616 . . . . 1.3899999999999999 110.154 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -176.91 177.96 48.16 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.91 -1.276 . . . . 0.38 109.91 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -129.36 125.53 36.85 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.519 -0.989 . . . . 0.46000000000000002 110.022 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.557 ' CG2' HG21 ' A' ' 205' ' ' THR . 16.8 mt -128.15 118.99 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.635 -1.246 . . . . 0.58999999999999997 107.635 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 203' ' ' VAL . 20.8 p -141.83 152.53 43.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.54 -0.725 . . . . 0.67000000000000004 111.169 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 26.5 p30 -87.66 45.06 1.24 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.991 -1.068 . . . . 2.2400000000000002 110.823 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -95.92 103.4 15.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.961 -1.087 . . . . 1.1100000000000001 109.326 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.89 39.4 1.79 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.848 -1.301 . . . . 1.6299999999999999 109.848 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -96.87 116.43 5.48 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.029 -1.229 . . . . 1.47 110.029 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -52.72 -17.03 1.13 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.223 -1.163 . . . . 5.2400000000000002 108.305 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 58.7 p -140.26 59.12 1.57 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.544 -0.722 . . . . 2.9199999999999999 109.172 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.1 t -80.17 142.99 34.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.884 . . . . 1.6000000000000001 108.958 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -45.91 -55.36 6.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.19 -0.944 . . . . 0.92000000000000004 110.044 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.7 t -46.91 -25.87 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 1.5900000000000001 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.0 p -78.92 -45.88 19.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 1.4199999999999999 109.884 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.5 mt -52.49 -32.58 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 1.4099999999999999 109.674 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.9 mtp -71.46 -51.91 21.28 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.363 -1.347 . . . . 0.85999999999999999 107.363 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.71 58.82 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.628 -0.714 . . . . 0.58999999999999997 109.573 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.505 ' HG2' HH11 ' A' ' 195' ' ' ARG . 17.3 mtt-85 -76.95 -50.87 12.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 3.0600000000000001 109.904 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 61.1 m -68.7 -35.33 77.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.72999999999999998 109.738 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 199' ' ' LEU . 27.2 mt -87.13 1.49 52.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.265 -0.897 . . . . 0.67000000000000004 109.092 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 49.19 3.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.559 -0.713 . . . . 1.49 111.631 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 197' ' ' LEU . 40.7 mt -66.01 169.82 6.24 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.491 -1.381 . . . . 0.64000000000000001 108.382 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -89.86 141.7 3.79 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.249 1.966 . . . . 0.58999999999999997 111.054 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.08 179.74 7.29 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.468 -1.293 . . . . 0.55000000000000004 110.65 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 203' ' ' VAL . 70.6 mt -147.66 160.93 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 106.82 -1.548 . . . . 0.63 106.82 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 183' ' ' ALA . 18.1 m -141.58 -28.17 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.873 -1.142 . . . . 0.77000000000000002 110.918 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.36 38.5 3.18 Favored Glycine 0 N--CA 1.496 2.667 0 O-C-N 120.888 -1.132 . . . . 0.87 110.987 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.557 HG21 ' CG2' ' A' ' 180' ' ' ILE . 20.1 p -67.2 -29.11 68.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.67 -1.488 . . . . 0.89000000000000001 108.77 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 76.7 -98.69 1.3 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.788 -1.196 . . . . 0.93000000000000005 111.238 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.9 p -113.27 43.47 1.73 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.001 -1.294 . . . . 1.6000000000000001 112.395 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.8 -28.51 15.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.651 -1.281 . . . . 0.75 107.65 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.4 p -64.71 -12.98 52.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.287 -0.883 . . . . 0.83999999999999997 108.917 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.1 p -108.51 17.1 22.41 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.662 -0.866 . . . . 1.6100000000000001 108.662 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -131.55 -16.19 3.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.668 -0.645 . . . . 2.2999999999999998 109.668 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.586 HG12 ' N ' ' A' ' 213' ' ' LYS . 71.1 t -120.38 164.07 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.457 -0.777 . . . . 0.76000000000000001 109.597 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.586 ' N ' HG12 ' A' ' 212' ' ' VAL . 0.5 OUTLIER -126.58 174.21 8.86 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.841 -1.54 . . . . 2.0099999999999998 106.841 178.342 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 214' ' ' ASN . 1.4 p-10 -75.02 145.74 42.18 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.786 -1.197 . . . . 2.1899999999999999 109.824 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.6 OUTLIER 80.38 -12.12 1.07 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.803 -0.561 . . . . 2.3999999999999999 110.249 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -57.25 150.95 16.78 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.002 -1.061 . . . . 1.99 108.429 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -87.29 110.71 20.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.91 -1.119 . . . . 1.3 108.887 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 16.2 mt -106.22 160.92 14.97 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.89 0.853 . . . . 0.53000000000000003 109.65 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.509 HD12 ' CG ' ' A' ' 231' ' ' PRO . 3.2 mt -141.94 107.75 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.725 -1.213 . . . . 0.59999999999999998 107.725 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.5 tp -86.49 126.44 34.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.79 -0.818 . . . . 0.56999999999999995 108.79 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.0 -53.64 4.18 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.541 -0.911 . . . . 2.2200000000000002 108.541 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 58.51 22.87 10.14 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.413 -0.804 . . . . 0.75 109.24 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.0 t -117.83 -56.14 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.11 -1.441 . . . . 0.92000000000000004 107.11 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -96.41 13.25 28.46 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.539 -1.282 . . . . 2.3599999999999999 107.539 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 59.81 60.19 2.26 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.074 0.464 . . . . 1.4199999999999999 109.916 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -157.08 147.62 21.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 1.97 110.52 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.8 t -109.72 131.17 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.678 -0.86 . . . . 0.65000000000000002 108.678 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -103.66 131.31 50.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.203 -0.936 . . . . 0.96999999999999997 109.344 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.5 t -102.97 114.8 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.446 -0.784 . . . . 0.67000000000000004 109.716 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 36.8 t30 45.24 60.88 12.82 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.424 -0.798 . . . . 1.45 110.571 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.509 ' CG ' HD12 ' A' ' 219' ' ' ILE . 38.4 Cg_endo -70.35 165.06 32.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.283 1.989 . . . . 0.81999999999999995 111.415 179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.9 m -72.27 158.04 36.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 1.6200000000000001 109.804 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -64.48 -22.35 66.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 2.6000000000000001 109.031 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 234' ' ' GLU . 0.8 OUTLIER -66.91 -36.8 83.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.434 -0.791 . . . . 3.0600000000000001 109.129 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 68.7 t -79.01 -48.94 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.248 -0.908 . . . . 1.1399999999999999 108.704 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.93 -59.09 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.408 -0.807 . . . . 1.04 109.651 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -52.12 -41.3 62.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 2.54 109.961 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -66.84 -37.65 84.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 2.6000000000000001 109.739 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 243' ' ' GLN . 28.5 mtm -81.94 -32.96 30.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.908 . . . . 1.23 109.676 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -53.81 -40.03 66.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 2.6699999999999999 109.087 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.48 -51.65 12.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 1.6599999999999999 109.421 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.4 -47.11 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 2.2000000000000002 109.527 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.574 ' HG2' HD12 ' A' ' 11' ' ' ILE . 3.1 tm0? -47.56 -57.45 5.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 3.0 109.818 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.26 -28.7 70.2 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.439 -0.788 . . . . 1.76 110.732 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -66.35 -21.9 66.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.68 -1.263 . . . . 2.7799999999999998 107.849 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 95.8 t -77.51 -36.51 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.226 -1.027 . . . . 2.0600000000000001 108.226 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.6 -35.39 60.82 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.28 -1.007 . . . . 2.3999999999999999 108.28 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.0 t -75.55 -29.28 59.35 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.925 -0.768 . . . . 2.8700000000000001 108.925 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 . . . . . 0 N--CA 1.486 1.353 0 N-CA-C 107.432 -1.321 . . . . 3.4100000000000001 107.432 178.824 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.549 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.9 mpt? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.56 -0.533 . . . . 3.6600000000000001 109.56 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.23 94.18 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.584 -0.895 . . . . 1.1200000000000001 108.584 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.7 m -96.16 115.86 28.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.31 -0.869 . . . . 1.45 109.894 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.8 -163.5 21.41 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.332 -1.907 . . . . 0.92000000000000004 108.332 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 5' ' ' ILE . 51.1 mt -95.88 -6.15 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -1.171 . . . . 1.05 108.427 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 tp 60.21 107.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.419 -0.801 . . . . 0.88 108.915 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.63 -55.58 3.92 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.982 -1.118 . . . . 0.78000000000000003 107.982 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.23 150.27 37.44 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.32 -0.993 . . . . 1.5 108.32 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.47 154.18 21.07 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.087 1.858 . . . . 0.85999999999999999 113.954 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 161.08 -176.07 37.69 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.666 -1.373 . . . . 0.78000000000000003 109.666 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.7 mt -146.18 121.72 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.726 -1.455 . . . . 0.73999999999999999 109.171 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HB1' HD21 ' A' ' 177' ' ' LEU . . . -139.72 162.54 34.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.267 -0.896 . . . . 0.45000000000000001 109.733 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.9 m-85 -129.34 140.25 51.45 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.196 -1.039 . . . . 0.64000000000000001 108.196 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.18 159.76 28.15 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 118.612 -1.756 . . . . 0.45000000000000001 111.319 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -78.47 150.81 32.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.615 -0.933 . . . . 1.8799999999999999 109.724 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.42 127.95 34.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.284 -0.885 . . . . 0.58999999999999997 110.913 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.6 85.35 2.18 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.472 -1.307 . . . . 0.64000000000000001 107.472 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 18' ' ' LEU . 15.6 tp -82.01 132.23 35.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.055 -1.028 . . . . 0.73999999999999999 110.617 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 160' ' ' ALA . 14.3 mt -94.92 94.35 7.97 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.551 0.691 . . . . 0.73999999999999999 109.931 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -94.23 142.04 27.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.782 -0.821 . . . . 1.8700000000000001 108.782 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -128.74 135.37 49.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 2.5800000000000001 108.729 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -78.03 136.7 37.98 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.168 -0.958 . . . . 2.1400000000000001 109.007 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -60.79 143.88 53.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 1.9299999999999999 109.109 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.54 133.97 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.43 -0.793 . . . . 0.68000000000000005 109.906 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.4 t -106.78 113.72 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 0.83999999999999997 109.183 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.4 mt -87.69 134.83 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.79000000000000004 109.045 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -89.23 113.28 24.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 1.3700000000000001 109.638 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 28' ' ' ARG . 14.1 mmm-85 -96.06 26.25 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 2.6200000000000001 108.845 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -83.56 146.03 28.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -0.814 . . . . 2.3500000000000001 109.748 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -85.08 118.41 24.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.394 -0.965 . . . . 2.3500000000000001 108.394 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 pt -81.54 173.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.78000000000000003 109.977 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.8 p -97.87 161.15 13.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.031 -0.729 . . . . 1.04 109.031 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.0 -16.67 32.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.112 -0.993 . . . . 1.05 109.283 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.16 -7.43 59.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 2.4700000000000002 109.265 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -114.96 -13.52 11.91 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.849 -0.797 . . . . 1.46 108.849 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.9 t -65.66 -45.38 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 0.77000000000000002 109.402 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -54.94 -33.28 62.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 1.46 109.293 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -69.92 -33.99 72.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 2.29 110.26 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -62.8 -43.57 98.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 1.3 109.688 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -60.1 -46.94 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.41 -0.806 . . . . 0.76000000000000001 109.828 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.91 -43.39 88.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 1.5 108.883 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -65.18 -30.99 71.94 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.813 -0.81 . . . . 2.6600000000000001 108.813 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -86.39 -58.33 2.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.75 109.266 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.5 tp -52.48 -58.94 5.14 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.289 -0.882 . . . . 0.82999999999999996 109.287 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.6 t -63.76 -30.5 71.59 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.334 -0.987 . . . . 0.78000000000000003 108.334 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.81 -54.6 35.41 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 107.977 -2.049 . . . . 0.56999999999999995 107.977 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 29.8 ttm-85 -49.47 -30.52 8.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.535 -0.98 . . . . 2.8300000000000001 109.074 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.99 -40.59 81.08 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.551 -0.907 . . . . 0.65000000000000002 108.551 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -80.96 -59.34 2.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.667 -0.646 . . . . 2.5699999999999998 109.302 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.85 -40.83 57.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.032 . . . . 0.51000000000000001 110.205 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.459 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 29.2 t -62.32 -37.46 85.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.956 -1.09 . . . . 1.3600000000000001 108.183 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.58 -31.31 63.53 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.158 0.504 . . . . 0.59999999999999998 109.732 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -75.86 -65.95 0.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 1.3600000000000001 109.589 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 54' ' ' LEU . 9.7 mp -50.12 -27.02 5.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 1.3799999999999999 109.332 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 51' ' ' SER . 4.1 mm-40 -71.76 -42.22 67.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 1.27 108.646 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 m -61.64 -37.16 83.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.59999999999999998 109.435 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.32 -25.79 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 0.53000000000000003 109.117 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.471 ' NZ ' ' OE1' ' A' ' 70' ' ' GLU . 9.9 ttpp -61.17 -46.88 88.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.98999999999999999 110.2 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.18 -30.81 68.03 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.128 -0.983 . . . . 0.58999999999999997 109.844 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -70.43 -18.89 63.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.695 -1.253 . . . . 1.8100000000000001 108.123 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.79 -33.42 30.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.567 -0.901 . . . . 0.47999999999999998 108.567 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.88 -28.42 28.92 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.192 -1.163 . . . . 0.57999999999999996 110.192 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.14 -15.09 42.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.016 -1.285 . . . . 1.3899999999999999 109.0 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.8 m -95.37 -48.37 5.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.24 -0.912 . . . . 0.81999999999999995 110.179 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -106.33 -21.73 13.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.339 -0.851 . . . . 0.98999999999999999 110.124 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 121.5 147.12 7.58 Favored Glycine 0 N--CA 1.503 3.13 0 N-CA-C 110.082 -1.207 . . . . 0.55000000000000004 110.082 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -48.49 -11.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.606 -0.938 . . . . 2.5899999999999999 110.197 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 66' ' ' GLY . 63.0 mt-10 -63.99 -29.61 70.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.089 -1.007 . . . . 2.2000000000000002 110.802 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -91.82 -7.65 48.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.8 -1.188 . . . . 1.79 111.087 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.471 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 56.3 mt-10 -63.85 -24.52 67.78 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.732 -1.23 . . . . 1.54 110.598 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.67 -28.36 69.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.02 -1.05 . . . . 0.64000000000000001 110.508 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.37 -44.25 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.011 -1.055 . . . . 0.57999999999999996 110.064 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.55 -21.47 45.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.088 -1.007 . . . . 0.62 109.845 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -64.93 -44.16 90.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 1.23 109.571 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.35 -37.22 59.1 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.66 -1.376 . . . . 0.52000000000000002 109.66 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -61.37 -20.55 63.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.294 -1.121 . . . . 1.29 110.455 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.0 mt -85.79 -37.04 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.592 -1.317 . . . . 0.55000000000000004 108.393 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.8 ttt -58.78 -42.25 88.56 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.224 -1.028 . . . . 1.8899999999999999 108.224 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.12 -37.23 84.34 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.358 -0.978 . . . . 0.53000000000000003 108.358 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 23.8 tp -69.55 -43.97 71.86 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.649 -0.821 . . . . 0.42999999999999999 109.151 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -85.41 7.12 23.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 1.24 110.222 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.419 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 57.3 t0 -47.06 122.55 4.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.012 -1.055 . . . . 1.3100000000000001 109.695 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.66 -24.81 66.33 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.726 -0.842 . . . . 1.3500000000000001 108.726 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 18.7 mp0 -76.14 -49.53 17.06 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.783 -0.767 . . . . 2.1600000000000001 109.205 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.2 mt -63.75 -13.96 48.27 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.823 -1.151 . . . . 0.59999999999999998 108.715 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -79.2 -56.18 4.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.508 -0.745 . . . . 1.28 109.836 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -63.33 -26.27 68.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 1.28 109.977 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.42 -44.05 62.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.101 -0.999 . . . . 1.29 108.673 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.1 mt -60.7 -56.49 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.097 -1.075 . . . . 0.57999999999999996 108.097 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -47.16 -53.0 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.635 -0.666 . . . . 0.78000000000000003 109.543 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.69 -44.41 93.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 0.85999999999999999 109.227 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.8 mt -57.97 -56.85 16.64 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.168 -1.049 . . . . 0.79000000000000004 108.168 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.6 mt -51.2 -39.84 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.70999999999999996 110.073 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -85.34 -36.4 20.8 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.086 -1.008 . . . . 2.0499999999999998 111.681 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 91' ' ' ALA . 22.1 t70 -82.75 -43.55 16.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.798 -1.189 . . . . 1.5900000000000001 111.486 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -102.07 12.2 37.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.768 -1.208 . . . . 1.8899999999999999 109.538 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 45.59 48.57 11.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.371 -0.831 . . . . 1.3100000000000001 109.368 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtp -101.41 152.19 21.03 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.092 -0.706 . . . . 1.28 109.092 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 p -76.31 145.05 39.84 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.436 -0.79 . . . . 0.62 109.462 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.44 29.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.166 -0.959 . . . . 0.46999999999999997 108.797 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -72.71 -45.99 55.95 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.28 -1.007 . . . . 2.0 108.28 179.049 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.1 -51.42 21.57 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.391 0.615 . . . . 0.56000000000000005 109.973 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.34 -50.92 71.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.47999999999999998 109.647 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.37 -34.15 64.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.194 -0.941 . . . . 0.44 109.799 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -69.03 -31.48 70.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 1.4199999999999999 109.229 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.5 tt0 -71.59 -57.63 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 1.26 109.892 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.445 ' H ' HG23 ' A' ' 107' ' ' VAL . 7.7 t -55.2 -49.9 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.60999999999999999 109.811 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.572 HG21 ' HA3' ' A' ' 134' ' ' GLY . 28.1 mm -64.68 -70.16 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.64000000000000001 109.613 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.46 ' OE2' ' NE ' ' A' ' 131' ' ' ARG . 18.1 tp10 -50.55 -45.3 56.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.826 -1.171 . . . . 2.2000000000000002 108.992 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -45.04 -40.07 6.92 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.11 -1.596 . . . . 0.81999999999999995 109.11 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -69.17 -59.41 3.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.343 -1.092 . . . . 1.27 108.29 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.74 -43.5 37.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.809 -0.812 . . . . 0.91000000000000003 108.809 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.8 m -59.99 -37.04 78.5 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.305 -0.872 . . . . 1.73 109.186 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.54 84.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 1.04 109.878 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.81 -29.48 67.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.929 -1.107 . . . . 1.03 108.677 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.54 -17.13 62.48 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.455 -0.943 . . . . 1.95 108.455 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -82.42 -1.01 48.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.567 -0.708 . . . . 1.71 109.481 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.5 HD13 HD13 ' A' ' 123' ' ' LEU . 12.1 mt -83.77 158.72 21.63 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.136 -0.978 . . . . 1.26 109.209 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -100.5 50.56 0.89 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.891 -0.781 . . . . 2.8300000000000001 108.891 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -146.56 119.21 8.56 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.222 -0.924 . . . . 1.5800000000000001 109.612 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.71 -19.3 58.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.372 -0.83 . . . . 2.7999999999999998 109.501 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.22 -65.21 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 1.02 109.275 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.5 HD13 HD13 ' A' ' 118' ' ' LEU . 46.8 mt -47.58 -31.29 4.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.09 -1.006 . . . . 1.0600000000000001 109.624 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 1.9 ttmp? -65.52 -39.97 92.43 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.918 -1.113 . . . . 2.3900000000000001 108.319 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -58.13 -23.41 55.03 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.392 -0.966 . . . . 2.2000000000000002 108.392 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -72.99 -27.26 61.69 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.537 -1.653 . . . . 2.0899999999999999 106.537 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -57.67 -39.83 77.96 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.098 -1.075 . . . . 0.85999999999999999 108.098 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.07 -36.42 81.98 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.793 -0.817 . . . . 0.90000000000000002 108.793 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.45 -36.94 77.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.348 -0.845 . . . . 1.3500000000000001 109.254 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.4 t -76.65 -44.24 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.04 -1.096 . . . . 0.57999999999999996 108.04 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.46 ' NE ' ' OE2' ' A' ' 109' ' ' GLU . 42.4 ttm180 -60.55 -34.7 74.53 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.925 -1.139 . . . . 3.2200000000000002 107.925 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -58.94 -35.55 73.32 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.502 -0.749 . . . . 1.3200000000000001 109.17 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.19 -26.51 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.5 108.528 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.572 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -78.29 -42.64 14.6 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.145 -1.582 . . . . 0.44 109.145 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -55.42 -54.09 48.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.545 -0.973 . . . . 2.71 109.986 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.523 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 34.4 mtm180 -63.56 -38.79 92.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.176 -0.952 . . . . 2.2000000000000002 108.697 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 41.5 tp -61.83 -40.34 94.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.437 -0.79 . . . . 1.1299999999999999 109.719 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.8 mt -67.54 -54.8 16.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.05 -1.031 . . . . 0.54000000000000004 109.335 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -49.16 -19.0 0.39 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 2.3199999999999998 109.529 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -84.24 -39.9 18.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 1.26 109.586 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.14 -40.3 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.005 . . . . 0.62 109.693 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.9 mt -88.72 2.11 53.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.158 -0.964 . . . . 0.67000000000000004 109.272 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.64 29.23 48.27 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.422 -1.871 . . . . 0.68000000000000005 108.422 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.9 tp -58.52 148.14 29.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.595 -0.944 . . . . 0.77000000000000002 109.542 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.31 132.64 47.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.942 . . . . 2.3999999999999999 109.786 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.4 mt -110.47 144.12 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 109.172 -0.677 . . . . 0.87 109.172 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.76 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.2 mp -78.54 133.21 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.072 -1.017 . . . . 1.3200000000000001 109.768 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.96 87.85 3.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.502 -0.749 . . . . 1.54 109.408 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.45 -22.22 44.44 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.241 -0.912 . . . . 0.77000000000000002 109.586 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.5 t -80.8 17.81 1.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.151 -0.968 . . . . 1.5700000000000001 109.446 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.08 29.19 2.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.389 -0.819 . . . . 0.81999999999999995 109.416 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.59 153.14 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.293 -0.879 . . . . 0.81999999999999995 108.985 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -132.96 -2.1 3.26 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.394 -0.816 . . . . 2.1099999999999999 109.245 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -129.8 125.74 36.47 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.821 -0.807 . . . . 1.4099999999999999 108.821 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.68 129.19 38.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 1.3 109.714 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.32 175.79 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.56999999999999995 108.806 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.8 mt -89.31 149.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.891 -1.151 . . . . 0.42999999999999999 107.891 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.3 tp -104.73 119.85 39.97 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.534 -0.729 . . . . 0.56000000000000005 109.612 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.0 125.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.99 -0.744 . . . . 0.54000000000000004 108.99 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.444 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -162.5 147.06 12.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.62 109.816 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.38 -38.15 71.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.745 -1.222 . . . . 0.80000000000000004 108.131 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -173.97 147.66 1.32 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.428 -0.795 . . . . 2.3399999999999999 109.651 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.2 mt -117.68 136.53 53.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.634 -0.667 . . . . 0.65000000000000002 109.383 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.6 p -94.06 152.19 40.24 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.222 -0.924 . . . . 0.73999999999999999 109.296 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -36.21 -39.38 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.442 2.095 . . . . 0.59999999999999998 112.567 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.523 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 1.4 m -56.83 -57.23 13.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.138 -0.976 . . . . 0.63 109.13 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -60.01 -41.99 93.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.474 -0.767 . . . . 1.25 109.79 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.0 p -71.17 -19.78 62.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.052 -1.03 . . . . 0.5 109.409 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.3 -25.48 33.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.51000000000000001 109.745 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -103.47 -18.9 14.6 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.26 -0.9 . . . . 1.1699999999999999 109.209 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.78 144.51 48.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.121 -1.066 . . . . 0.60999999999999999 108.121 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 175' ' ' LYS . 1.7 m120 -95.64 134.79 38.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.0 -1.062 . . . . 2.1200000000000001 108.587 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.1 mt -78.66 -42.95 27.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.391 -0.818 . . . . 1.3400000000000001 111.654 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -80.0 -8.82 59.56 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.672 -1.267 . . . . 1.97 111.767 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 172' ' ' ASN . 58.6 mttp -99.98 -7.3 25.28 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.694 -1.253 . . . . 1.8999999999999999 108.721 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 177' ' ' LEU . 54.3 t -98.32 162.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.488 -0.757 . . . . 0.47999999999999998 109.057 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.567 HD21 ' HB1' ' A' ' 12' ' ' ALA . 8.5 tp -115.2 -20.09 10.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.555 -0.716 . . . . 1.3899999999999999 109.954 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.9 174.58 42.57 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.406 -1.478 . . . . 0.38 109.406 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 1.3 m-85 -128.07 124.16 36.36 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.346 -1.091 . . . . 0.46000000000000002 110.156 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 205' ' ' THR . 7.8 mt -121.19 109.96 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 106.92 -1.511 . . . . 0.58999999999999997 106.92 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.604 ' O ' ' O ' ' A' ' 203' ' ' VAL . 31.2 p -140.58 154.99 46.7 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.119 -0.988 . . . . 0.67000000000000004 112.578 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 182' ' ' ASP . 42.6 t0 -80.18 40.94 0.5 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.823 -0.626 . . . . 2.2400000000000002 110.831 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.567 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -100.85 95.59 6.73 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.229 -1.544 . . . . 1.1100000000000001 110.544 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.472 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -39.48 -21.15 0.02 OUTLIER Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.264 -0.898 . . . . 1.6299999999999999 111.104 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 114.84 -28.93 7.77 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 109.83 -1.308 . . . . 1.47 109.83 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.565 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.2 OUTLIER -54.27 118.26 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.136 -1.214 . . . . 5.2400000000000002 109.335 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 26.6 p 48.66 32.77 3.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.434 -0.791 . . . . 2.9199999999999999 110.142 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.1 m -86.47 116.88 24.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.109 -0.995 . . . . 1.6000000000000001 109.554 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -72.02 -41.28 67.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 0.92000000000000004 108.972 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.8 p -50.54 -36.99 36.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 1.5900000000000001 109.147 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.1 m -62.01 -41.31 97.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.337 -0.852 . . . . 1.4199999999999999 109.35 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.5 mt -58.01 -24.76 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 1.4099999999999999 109.478 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.3 mtp -71.81 -58.83 3.13 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.689 -1.226 . . . . 0.85999999999999999 107.689 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.22 -41.71 62.97 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.325 0.583 . . . . 0.58999999999999997 109.722 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 20.5 mtt-85 -69.02 -50.67 46.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 3.0600000000000001 109.882 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.5 m -69.12 -38.44 78.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.051 -1.031 . . . . 0.72999999999999998 109.906 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 199' ' ' LEU . 22.3 mt -87.81 3.39 48.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.106 -0.996 . . . . 0.67000000000000004 108.858 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 44.02 11.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.741 -0.6 . . . . 1.49 112.019 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 197' ' ' LEU . 17.1 mt -68.98 169.51 11.16 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.372 -1.455 . . . . 0.64000000000000001 108.495 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.88 139.64 3.86 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.345 2.03 . . . . 0.58999999999999997 110.907 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.37 -172.96 2.64 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.19 -1.404 . . . . 0.55000000000000004 111.595 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.2 mt -149.12 153.1 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.248 -1.39 . . . . 0.63 107.248 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.604 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.7 m -138.22 -39.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.874 -1.141 . . . . 0.77000000000000002 111.113 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.501 ' N ' HG23 ' A' ' 203' ' ' VAL . . . -71.45 39.96 0.61 Allowed Glycine 0 C--N 1.285 -2.276 0 N-CA-C 108.599 -1.8 . . . . 0.87 108.599 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.508 HG21 HG23 ' A' ' 180' ' ' ILE . 47.1 p -67.38 -18.29 65.07 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.106 -1.232 . . . . 0.89000000000000001 109.531 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.419 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 62.64 -101.08 0.36 Allowed Glycine 0 N--CA 1.484 1.859 0 C-N-CA 119.392 -1.385 . . . . 0.93000000000000005 110.121 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.2 m -117.55 45.61 1.89 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.301 -1.117 . . . . 1.6000000000000001 112.331 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 62.6 t -74.82 -26.73 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.454 -1.403 . . . . 0.75 107.786 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.7 p -68.28 -12.75 61.54 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.738 . . . . 0.83999999999999997 109.599 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.9 m -102.4 9.34 39.79 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.416 -0.802 . . . . 1.6100000000000001 109.049 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -131.17 -5.78 3.86 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.569 -0.707 . . . . 2.2999999999999998 109.195 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 23.3 t -122.64 148.57 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.649 -0.871 . . . . 0.76000000000000001 108.649 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -121.54 -174.29 2.83 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.619 -1.623 . . . . 2.0099999999999998 106.619 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.6 m120 -79.51 150.52 31.15 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.776 -1.202 . . . . 2.1899999999999999 109.839 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.7 m-20 81.07 -14.42 0.83 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.052 -0.405 . . . . 2.3999999999999999 110.94 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.64 128.2 35.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.755 -1.215 . . . . 1.99 108.355 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -86.62 119.11 26.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.868 -1.145 . . . . 1.3 108.883 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.7 mt -119.62 163.29 17.58 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.666 0.746 . . . . 0.53000000000000003 110.124 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.1 mt -128.68 118.96 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.742 -1.207 . . . . 0.59999999999999998 107.742 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.6 tp -87.18 120.61 28.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.425 -0.954 . . . . 0.56999999999999995 108.425 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.4 t0 -95.97 -31.07 13.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.212 -0.93 . . . . 2.2200000000000002 108.838 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.17 28.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.456 0.645 . . . . 0.75 110.248 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.6 t -123.9 -67.36 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.821 -1.548 . . . . 0.92000000000000004 106.821 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 224' ' ' ASN . 19.9 t-20 -84.12 10.95 8.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.218 -1.401 . . . . 2.3599999999999999 107.218 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 58.22 61.99 2.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.906 -0.496 . . . . 1.4199999999999999 110.092 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -156.8 147.89 22.01 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.122 -0.986 . . . . 1.97 110.673 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.47 141.5 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.663 -0.866 . . . . 0.65000000000000002 108.663 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -104.62 127.77 52.46 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.177 -0.952 . . . . 0.96999999999999997 109.408 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.42 120.59 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.48 -0.762 . . . . 0.67000000000000004 110.358 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 43.5 t30 55.55 74.37 0.72 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 1.45 110.314 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -87.05 149.16 8.14 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.018 2.479 . . . . 0.81999999999999995 112.148 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.2 m -72.14 160.99 31.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.258 -0.901 . . . . 1.6200000000000001 109.966 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -64.37 -30.67 71.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -0.799 . . . . 2.6000000000000001 109.758 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -67.11 -37.61 84.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 3.0600000000000001 109.165 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.65 -32.59 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 1.1399999999999999 108.941 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt -72.88 -61.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 1.04 109.209 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -53.61 -41.49 66.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.498 -0.751 . . . . 2.54 110.106 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -66.34 -34.86 78.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.09 -1.006 . . . . 2.6000000000000001 109.439 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 57.1 mtp -81.68 -39.37 24.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.89 . . . . 1.23 109.437 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.404 ' O ' ' OE1' ' A' ' 244' ' ' GLU . 16.6 mmt180 -49.35 -47.25 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.139 -0.976 . . . . 2.6699999999999999 109.546 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.03 -64.11 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -0.963 . . . . 1.6599999999999999 110.671 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 24.4 t -59.68 -52.7 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 2.2000000000000002 111.201 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' A' ' 239' ' ' MET . 7.0 tp-100 -54.78 -41.08 70.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.672 -1.267 . . . . 3.0 109.925 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.404 ' OE1' ' O ' ' A' ' 240' ' ' ARG . 62.0 mt-10 -64.88 -27.36 68.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.623 -1.298 . . . . 1.76 109.881 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -67.62 -23.55 65.37 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.773 -1.205 . . . . 2.7799999999999998 107.934 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.5 t -69.42 -40.41 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.399 -0.963 . . . . 2.0600000000000001 108.399 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.57 92.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.524 -0.735 . . . . 2.3999999999999999 109.804 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.7 m -78.11 -31.81 50.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 2.8700000000000001 110.207 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.032 -1.042 . . . . 3.4100000000000001 109.848 -179.452 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.372 -0.603 . . . . 3.6600000000000001 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.6 mt -129.95 91.54 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.809 -0.811 . . . . 1.1200000000000001 108.809 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m -91.68 117.03 29.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.185 -0.947 . . . . 1.45 110.049 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.95 -159.54 11.98 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 108.149 -1.98 . . . . 0.92000000000000004 108.149 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.1 mt -97.63 -10.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.133 -1.216 . . . . 1.05 109.04 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 tp 60.3 103.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.343 -0.848 . . . . 0.88 108.901 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.97 -48.43 7.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.997 -1.064 . . . . 0.78000000000000003 108.974 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.98 145.8 26.15 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.411 -0.805 . . . . 1.5 108.975 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.47 153.48 23.79 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.32 2.014 . . . . 0.85999999999999999 113.748 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.75 177.12 32.55 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.959 -1.256 . . . . 0.78000000000000003 109.959 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mt -143.86 120.74 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.974 -1.309 . . . . 0.73999999999999999 109.776 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.588 ' HB1' HD21 ' A' ' 177' ' ' LEU . . . -143.23 140.55 30.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.124 -0.985 . . . . 0.45000000000000001 109.399 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.7 m-85 -105.87 151.37 24.62 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.689 -0.856 . . . . 0.64000000000000001 108.689 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.58 166.38 31.05 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 118.66 -1.733 . . . . 0.45000000000000001 111.467 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -81.92 153.34 26.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.653 -0.91 . . . . 1.8799999999999999 110.377 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.06 126.22 30.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.774 . . . . 0.58999999999999997 111.642 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.7 tp -108.13 89.26 2.94 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 107.52 -1.289 . . . . 0.64000000000000001 107.52 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.0 tp -81.26 129.39 34.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.011 -1.055 . . . . 0.73999999999999999 110.206 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.468 HD11 HD11 ' A' ' 158' ' ' LEU . 17.9 mt -96.39 94.41 7.41 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.413 0.625 . . . . 0.73999999999999999 110.433 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -97.16 157.68 15.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.726 -0.842 . . . . 1.8700000000000001 108.726 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -130.77 134.26 46.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.25 -0.906 . . . . 2.5800000000000001 108.87 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -79.31 137.76 37.47 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.173 -0.955 . . . . 2.1400000000000001 109.368 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.74 141.67 58.7 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.541 -0.724 . . . . 1.9299999999999999 109.136 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.1 mt -89.36 138.32 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 0.68000000000000005 109.586 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.04 114.83 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.505 -0.747 . . . . 0.83999999999999997 109.179 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.1 mt -87.43 133.88 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.912 . . . . 0.79000000000000004 109.611 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.78 120.41 31.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.462 -0.774 . . . . 1.3700000000000001 108.998 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -99.92 32.02 3.07 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.229 -0.92 . . . . 2.6200000000000001 109.444 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -83.31 138.53 33.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.044 -1.035 . . . . 2.3500000000000001 110.284 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -84.77 134.69 34.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.309 -0.997 . . . . 2.3500000000000001 108.309 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.9 pt -97.74 176.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.159 -0.963 . . . . 0.78000000000000003 110.841 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 34' ' ' ASP . 36.3 p -98.37 153.26 18.68 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.394 -0.965 . . . . 1.04 108.394 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.34 -7.75 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 1.05 110.139 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 32' ' ' SER . 17.7 t70 -84.78 -21.76 29.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.905 -1.122 . . . . 2.4700000000000002 110.323 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -106.41 -3.81 20.61 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.193 -0.942 . . . . 1.46 109.531 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.7 -43.69 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.77000000000000002 109.237 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -53.79 -34.59 59.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.284 -0.885 . . . . 1.46 109.184 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.47 -33.3 72.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 2.29 109.698 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -61.65 -46.64 88.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.007 -1.058 . . . . 1.3 109.68 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.78 -45.41 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.76000000000000001 109.693 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.28 -39.62 92.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.108 -0.995 . . . . 1.5 108.334 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -65.11 -32.75 74.61 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.949 -0.76 . . . . 2.6600000000000001 108.949 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -86.62 -57.68 2.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.144 -0.973 . . . . 0.75 108.476 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -49.32 -61.93 1.82 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.73 -0.841 . . . . 0.82999999999999996 108.73 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.67 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.7 t -65.2 -33.82 76.91 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.312 -0.995 . . . . 0.78000000000000003 108.312 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.27 -54.46 35.61 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 107.927 -2.069 . . . . 0.56999999999999995 107.927 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -48.63 -30.11 5.07 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.384 -1.068 . . . . 2.8300000000000001 108.561 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.12 -34.43 70.21 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.897 -1.149 . . . . 0.65000000000000002 107.897 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 mttt -79.17 -58.61 3.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.805 -0.813 . . . . 2.5699999999999998 108.805 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.35 -40.52 62.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.51000000000000001 109.937 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 t -62.23 -38.25 88.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.952 -1.093 . . . . 1.3600000000000001 108.498 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.82 -36.33 67.48 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.378 -0.601 . . . . 0.59999999999999998 109.378 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -65.57 -62.76 1.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.351 -0.843 . . . . 1.3600000000000001 109.535 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.08 -38.89 62.92 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.304 -0.873 . . . . 1.3799999999999999 109.161 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -59.92 -46.88 87.97 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.591 -0.892 . . . . 1.27 108.591 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.5 m -61.99 -37.7 85.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.485 -0.759 . . . . 0.59999999999999998 109.332 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.2 mt -73.3 -29.3 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.821 . . . . 0.53000000000000003 109.151 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -63.94 -43.32 96.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -0.819 . . . . 0.98999999999999999 109.03 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.2 m -72.34 -26.99 62.14 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.365 -0.834 . . . . 0.58999999999999997 109.538 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -72.82 -30.04 63.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.638 -1.245 . . . . 1.8100000000000001 107.638 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.28 63.68 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.111 -1.07 . . . . 0.47999999999999998 108.111 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.12 -28.21 28.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.608 -1.397 . . . . 0.57999999999999996 109.608 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -86.54 -16.06 38.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.812 -1.404 . . . . 1.3899999999999999 108.462 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.2 m -94.44 -49.27 5.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.81999999999999995 110.36 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.472 ' C ' ' H ' ' A' ' 67' ' ' GLU . 53.0 m-85 -107.11 -33.21 7.52 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.156 -0.965 . . . . 0.98999999999999999 110.241 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.48 -29.92 0.71 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.179 -1.168 . . . . 0.55000000000000004 110.179 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 69' ' ' LYS . 38.4 mt-10 -52.85 179.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -1.157 . . . . 2.5899999999999999 110.3 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -68.36 40.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.518 -0.738 . . . . 2.2000000000000002 109.532 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 67' ' ' GLU . 35.1 mmtt -85.03 -17.26 38.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.639 -0.874 . . . . 1.79 108.639 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.78 -34.8 77.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.614 -0.679 . . . . 1.54 110.517 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.79 -27.15 67.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 0.64000000000000001 110.817 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.9 mt -71.79 -46.73 59.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.849 -1.157 . . . . 0.57999999999999996 109.782 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -74.98 -21.66 59.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.085 -1.009 . . . . 0.62 109.757 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.6 -41.62 92.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.146 -0.971 . . . . 1.23 109.383 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.25 -37.47 63.3 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.483 -1.447 . . . . 0.52000000000000002 109.483 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -21.37 57.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -1.15 . . . . 1.29 109.3 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -85.15 -34.39 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.064 -1.022 . . . . 0.55000000000000004 108.473 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.3 ttt -60.61 -44.93 95.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -0.972 . . . . 1.8899999999999999 108.511 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.79 -40.38 83.87 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.215 -1.032 . . . . 0.53000000000000003 108.215 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.5 tp -65.87 -43.99 86.7 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.672 -0.811 . . . . 0.42999999999999999 108.858 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -85.84 9.48 16.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.191 -0.943 . . . . 1.24 110.363 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -50.47 119.92 4.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.77 -1.206 . . . . 1.3100000000000001 109.264 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.06 -22.97 67.05 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.245 -0.909 . . . . 1.3500000000000001 108.838 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.14 -51.87 12.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.412 -0.805 . . . . 2.1600000000000001 109.392 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.78 -12.28 45.91 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.208 -0.997 . . . . 0.59999999999999998 109.224 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -79.7 -50.24 10.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.431 -0.793 . . . . 1.28 110.365 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -62.37 -31.96 72.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.128 -0.982 . . . . 1.28 110.099 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.02 -44.64 68.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 1.29 109.291 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.04 -58.53 6.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.576 -0.898 . . . . 0.57999999999999996 108.576 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.7 mt -48.75 -61.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.686 -0.634 . . . . 0.78000000000000003 110.576 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -53.19 -45.31 68.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.024 -1.048 . . . . 0.85999999999999999 110.403 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 mt -56.23 -56.13 24.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.127 -0.983 . . . . 0.79000000000000004 108.663 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.8 mt -54.73 -47.54 73.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.187 -0.946 . . . . 0.70999999999999996 110.57 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -78.32 -36.62 46.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.058 -1.026 . . . . 2.0499999999999998 111.302 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' ALA . 9.4 t70 -82.09 -40.51 21.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.901 -1.125 . . . . 1.5900000000000001 112.055 -176.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -109.84 21.29 17.06 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.752 -1.218 . . . . 1.8899999999999999 110.689 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.522 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 0.3 OUTLIER 42.73 55.19 4.38 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.299 -0.875 . . . . 1.3100000000000001 110.473 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.8 mtt -103.91 147.38 27.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.601 -0.889 . . . . 1.28 108.601 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.2 p -77.68 150.5 34.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.62 109.87 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.42 -31.67 6.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.46999999999999997 108.892 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -77.08 -43.15 35.39 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.777 -0.823 . . . . 2.0 108.777 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.62 9.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.572 -0.705 . . . . 0.56000000000000005 109.871 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.06 -48.28 78.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.859 . . . . 0.47999999999999998 109.466 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.5 64.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.44 109.858 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 109' ' ' GLU . 76.4 t60 -67.93 -51.09 51.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.999 -1.063 . . . . 1.4199999999999999 109.727 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.11 -62.21 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.338 -0.851 . . . . 1.26 110.502 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 43.7 t -52.75 -54.18 17.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.804 -1.185 . . . . 0.60999999999999999 109.302 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.36 -23.19 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.64000000000000001 109.664 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 105' ' ' HIS . 45.8 tp10 -73.08 -30.45 63.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.025 -1.047 . . . . 2.2000000000000002 110.069 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.26 -27.97 29.12 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.114 -1.517 . . . . 0.81999999999999995 111.985 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -67.06 -45.35 77.61 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.425 -1.633 . . . . 1.27 108.035 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.16 -55.72 5.45 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.917 -0.489 . . . . 0.91000000000000003 110.698 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.9 p -56.97 -41.25 78.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 1.73 110.215 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.97 81.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.085 -1.009 . . . . 1.04 110.277 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.71 -30.38 70.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.761 -1.212 . . . . 1.03 109.319 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.58 -18.94 65.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.095 . . . . 1.95 109.726 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -82.93 -9.24 59.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 1.71 109.385 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.415 HD13 HD13 ' A' ' 123' ' ' LEU . 0.8 OUTLIER -86.8 138.45 31.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.264 -1.013 . . . . 1.26 108.264 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 22.8 p-10 -96.02 63.41 2.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 2.8300000000000001 109.154 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -148.79 108.7 4.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.317 -0.864 . . . . 1.5800000000000001 109.48 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -50.35 -15.85 0.28 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.569 -0.707 . . . . 2.7999999999999998 110.009 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -78.3 -60.92 2.18 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.242 -0.911 . . . . 1.02 109.353 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.415 HD13 HD13 ' A' ' 118' ' ' LEU . 7.9 mt -67.19 -31.52 71.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.262 -0.899 . . . . 1.0600000000000001 109.254 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -68.24 -49.54 59.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.991 . . . . 2.3900000000000001 109.234 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -61.14 -18.68 59.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.277 -1.008 . . . . 2.2000000000000002 108.277 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.422 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 26.1 ttt-85 -75.46 -28.24 59.21 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.093 -1.447 . . . . 2.0899999999999999 107.093 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.82 97.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.698 -0.853 . . . . 0.85999999999999999 108.698 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.9 -35.08 79.98 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.247 -1.02 . . . . 0.90000000000000002 108.247 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 2.8 m-20 -71.97 -32.2 67.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 1.3500000000000001 109.122 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.422 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 42.8 t -77.03 -45.6 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.57999999999999996 108.95 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -60.19 -36.92 78.72 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.117 -0.989 . . . . 3.2200000000000002 108.37 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.49 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 30.7 t70 -58.92 -36.5 74.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.5 -0.75 . . . . 1.3200000000000001 109.486 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.07 -26.08 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.058 -1.026 . . . . 0.5 108.803 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.34 -47.39 5.75 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.26 -1.536 . . . . 0.44 109.26 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.416 ' HZ2' ' HB3' ' A' ' 135' ' ' LYS . 15.3 mtpp -51.58 -43.91 62.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -1.173 . . . . 2.71 109.119 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.522 ' CG ' HH11 ' A' ' 136' ' ' ARG . 6.2 mtt-85 -65.51 -42.7 91.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.206 -1.035 . . . . 2.2000000000000002 108.206 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.77 -51.3 70.57 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.474 -0.565 . . . . 1.1299999999999999 109.474 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.6 mt -53.13 -58.06 8.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.54000000000000004 109.279 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -51.01 -21.4 1.77 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.882 . . . . 2.3199999999999998 109.673 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 136' ' ' ARG . 5.1 m120 -85.84 -42.05 14.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.03 . . . . 1.26 109.111 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.89 -47.49 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.081 -1.012 . . . . 0.62 108.294 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 58.8 mt -90.76 -7.81 51.45 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.777 -0.823 . . . . 0.67000000000000004 108.777 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 144' ' ' LEU . . . 60.99 26.08 65.09 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.239 -1.944 . . . . 0.68000000000000005 108.239 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 145' ' ' LYS . 3.1 tp -52.84 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.605 -0.938 . . . . 0.77000000000000002 109.095 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.431 ' H ' ' HG ' ' A' ' 144' ' ' LEU . 47.5 tttp -69.0 137.5 53.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.127 -0.983 . . . . 2.3999999999999999 110.429 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 75.1 mt -106.49 137.49 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.491 -0.929 . . . . 0.87 108.491 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mm -75.79 116.65 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.073 -1.017 . . . . 1.3200000000000001 108.877 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -98.58 82.88 2.91 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.263 -0.898 . . . . 1.54 109.89 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.3 mt -84.51 -14.08 50.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 0.77000000000000002 109.103 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.7 p -84.3 -13.8 51.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 1.5700000000000001 109.891 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.96 42.8 1.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.27 -0.894 . . . . 0.81999999999999995 110.862 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.6 mm -73.49 149.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.658 -1.276 . . . . 0.81999999999999995 108.738 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -136.78 -2.29 2.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.389 -0.819 . . . . 2.1099999999999999 109.466 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -125.45 127.93 47.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.512 -0.742 . . . . 1.4099999999999999 109.495 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.49 118.56 8.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.308 -0.87 . . . . 1.3 108.9 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -151.26 176.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.56999999999999995 108.765 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 218' ' ' LEU . 3.2 mt -89.5 156.49 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.136 -1.061 . . . . 0.42999999999999999 108.136 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.468 HD11 HD11 ' A' ' 19' ' ' LEU . 18.6 tp -108.89 123.01 48.4 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.512 0.672 . . . . 0.56000000000000005 109.693 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.83 133.01 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.213 -0.662 . . . . 0.54000000000000004 109.213 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.99 145.67 10.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.073 -1.017 . . . . 0.62 109.918 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.19 -34.56 75.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.343 -1.473 . . . . 0.80000000000000004 108.039 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -173.19 154.06 2.62 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.296 -0.631 . . . . 2.3399999999999999 109.296 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.4 mt -128.37 130.65 48.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.484 -0.76 . . . . 0.65000000000000002 109.126 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.5 p -89.74 152.49 46.88 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.73999999999999999 109.259 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -34.26 -41.8 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.713 2.276 . . . . 0.59999999999999998 113.235 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 m -57.4 -60.31 3.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.819 -1.175 . . . . 0.63 109.45 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -55.61 -36.27 66.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.472 -0.768 . . . . 1.25 110.352 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.8 p -73.73 -32.6 63.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.124 -0.985 . . . . 0.5 110.055 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.33 -31.53 64.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.952 . . . . 0.51000000000000001 110.794 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -101.63 1.61 37.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.103 -0.998 . . . . 1.1699999999999999 109.901 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.2 tp -54.28 160.96 1.47 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.089 -1.007 . . . . 0.60999999999999999 109.054 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 174' ' ' LYS . 27.5 t-20 -100.73 79.7 2.1 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.39 -0.819 . . . . 2.1200000000000001 109.928 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 14.9 mt -74.81 28.65 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 1.3400000000000001 108.642 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 172' ' ' ASN . 31.7 mtpt -106.71 -30.7 8.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 1.97 110.187 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -133.2 14.32 4.2 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.232 -0.918 . . . . 1.8999999999999999 110.028 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 172' ' ' ASN . 14.7 t -79.02 161.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.47999999999999998 109.098 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.588 HD21 ' HB1' ' A' ' 12' ' ' ALA . 7.7 tp -112.98 -25.37 9.01 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.62 -0.675 . . . . 1.3899999999999999 110.058 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.57 -179.43 45.9 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.64 -1.384 . . . . 0.38 109.64 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.82 126.84 35.31 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.399 -1.06 . . . . 0.46000000000000002 110.199 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.84 123.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.993 -1.114 . . . . 0.58999999999999997 107.993 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 203' ' ' VAL . 59.0 p -141.75 148.29 38.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.184 -0.948 . . . . 0.67000000000000004 111.352 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.423 ' OD2' ' CG2' ' A' ' 209' ' ' THR . 1.6 p30 -100.53 50.37 0.89 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.367 -0.975 . . . . 2.2400000000000002 108.367 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.29 -140.58 0.3 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.457 -0.777 . . . . 1.1100000000000001 110.077 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.44 -105.84 1.43 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.934 -1.266 . . . . 1.6299999999999999 109.934 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.05 -27.19 1.27 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.407 -1.477 . . . . 1.47 109.407 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.432 HH11 ' HG3' ' A' ' 186' ' ' ARG . 28.2 mtm-85 -63.49 94.42 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -1.192 . . . . 5.2400000000000002 109.116 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 11.3 p 54.33 48.29 21.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 2.9199999999999999 109.395 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.1 t -85.62 136.07 33.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.278 -0.888 . . . . 1.6000000000000001 109.462 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.411 ' HA ' HD12 ' A' ' 192' ' ' ILE . 12.6 t60 -48.12 -49.06 33.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.09 -1.006 . . . . 0.92000000000000004 109.523 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 70.5 p -46.95 -44.76 20.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 1.5900000000000001 109.657 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.4 t -64.83 -43.66 92.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.467 -0.771 . . . . 1.4199999999999999 110.248 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 189' ' ' HIS . 64.7 mt -46.36 -35.8 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.971 -1.08 . . . . 1.4099999999999999 109.999 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.5 mtm -74.14 -58.5 3.26 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.898 -1.149 . . . . 0.85999999999999999 107.898 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.23 -31.19 19.82 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.612 -0.68 . . . . 0.58999999999999997 110.223 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -81.17 -46.54 14.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.045 -1.034 . . . . 3.0600000000000001 110.187 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 38.2 m -70.75 -36.34 73.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.927 -1.108 . . . . 0.72999999999999998 110.383 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 199' ' ' LEU . 18.6 mt -84.83 -0.43 53.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.949 -1.094 . . . . 0.67000000000000004 109.119 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 53.5 1.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 1.49 111.419 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 197' ' ' LEU . 55.6 mt -64.37 171.34 2.78 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.434 -1.416 . . . . 0.64000000000000001 107.606 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -88.43 141.32 4.78 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.305 2.003 . . . . 0.58999999999999997 111.469 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.21 176.58 9.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.675 -1.266 . . . . 0.55000000000000004 111.513 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.6 mt -150.52 159.22 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.06 -1.459 . . . . 0.63 107.06 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.4 m -141.23 -28.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.697 -1.252 . . . . 0.77000000000000002 111.186 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.61 29.49 6.23 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.139 -0.976 . . . . 0.87 111.664 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 11.8 p -55.03 -37.79 67.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.319 -1.695 . . . . 0.89000000000000001 108.18 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.32 -37.01 0.26 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.751 -0.738 . . . . 0.93000000000000005 113.481 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 40.4 p -131.06 -6.71 3.9 Favored 'General case' 0 N--CA 1.516 2.854 0 CA-C-N 119.657 1.728 . . . . 1.6000000000000001 113.332 -177.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 5.4 t -48.51 -57.15 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.156 -1.59 . . . . 0.75 110.593 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.423 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 26.8 p -53.06 -16.75 1.2 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.562 -1.336 . . . . 0.83999999999999997 110.4 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.1 t -103.92 11.09 35.95 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.191 -0.943 . . . . 1.6100000000000001 109.27 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -138.93 -13.51 1.22 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.392 -0.818 . . . . 2.2999999999999998 110.243 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.49 154.66 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.324 -0.86 . . . . 0.76000000000000001 109.417 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -126.08 172.42 10.01 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.882 -1.525 . . . . 2.0099999999999998 106.882 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 21.9 t-20 -72.71 144.87 47.51 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.864 -1.148 . . . . 2.1899999999999999 110.141 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.9 t70 80.61 -11.6 1.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.881 -0.512 . . . . 2.3999999999999999 110.875 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.25 147.63 34.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.773 -1.204 . . . . 1.99 108.843 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -88.35 123.1 32.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.043 -1.035 . . . . 1.3 108.517 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.406 ' HB2' HD12 ' A' ' 157' ' ' ILE . 43.7 mt -118.74 168.37 10.8 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.993 0.901 . . . . 0.53000000000000003 110.608 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 mt -143.6 103.21 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.031 -1.1 . . . . 0.59999999999999998 108.031 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.1 tp -86.2 123.81 31.9 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.773 -0.825 . . . . 0.56999999999999995 108.773 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 223' ' ' VAL . 50.1 t0 -100.12 -28.44 13.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.43 -0.794 . . . . 2.2200000000000002 109.127 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.21 28.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.272 0.558 . . . . 0.75 110.599 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.7 t -120.63 -62.24 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.969 -1.493 . . . . 0.92000000000000004 106.969 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -83.36 10.36 8.84 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.349 -1.352 . . . . 2.3599999999999999 107.349 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 60.01 54.01 4.38 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.35 -0.611 . . . . 1.4199999999999999 109.35 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -154.42 144.1 21.59 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.849 0.833 . . . . 1.97 110.23 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 19.5 t -116.08 132.01 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.924 -1.139 . . . . 0.65000000000000002 107.924 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 228' ' ' TYR . 48.4 m-85 -100.48 130.89 46.61 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.115 -0.991 . . . . 0.96999999999999997 110.067 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.7 t -107.65 127.46 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.579 -0.7 . . . . 0.67000000000000004 109.924 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 51.3 t30 47.87 60.6 15.11 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.849 . . . . 1.45 110.297 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.56 154.81 35.57 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.381 2.054 . . . . 0.81999999999999995 111.474 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 8.4 m -72.83 157.08 38.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.977 -1.077 . . . . 1.6200000000000001 109.805 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -60.41 -27.32 67.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.427 -0.796 . . . . 2.6000000000000001 109.779 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.36 -39.13 91.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 3.0600000000000001 109.537 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.55 -42.18 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.928 . . . . 1.1399999999999999 109.071 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.68 -58.59 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 1.04 109.113 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.5 -40.65 72.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.547 -0.72 . . . . 2.54 110.389 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -67.12 -38.16 85.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.036 -1.04 . . . . 2.6000000000000001 110.146 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.442 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 85.9 mtp -79.43 -32.59 42.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 1.23 109.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -54.11 -44.26 71.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.068 -1.02 . . . . 2.6699999999999999 110.108 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.98 -58.69 3.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.018 -1.051 . . . . 1.6599999999999999 110.887 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.2 t -64.33 -53.47 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.128 -0.983 . . . . 2.2000000000000002 110.721 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.442 ' CB ' ' O ' ' A' ' 239' ' ' MET . 39.6 tp60 -52.95 -52.75 56.99 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.0 -1.063 . . . . 3.0 109.711 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -60.18 -22.15 62.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.657 -1.277 . . . . 1.76 108.761 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -67.33 -25.12 65.85 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.292 -1.373 . . . . 2.7799999999999998 107.292 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.3 -44.02 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.436 -1.32 . . . . 2.0600000000000001 107.436 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.46 81.0 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.445 -0.946 . . . . 2.3999999999999999 108.445 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 78.6 p -76.77 -23.16 52.94 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.506 -0.746 . . . . 2.8700000000000001 109.113 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 108.446 -0.946 . . . . 3.4100000000000001 108.446 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.245 0.545 . . . . 3.6600000000000001 109.565 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.0 mt -84.68 106.21 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.954 . . . . 1.1200000000000001 109.628 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 m -99.48 110.6 23.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.382 -0.824 . . . . 1.45 109.706 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.89 -169.9 31.07 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.011 -1.636 . . . . 0.92000000000000004 109.011 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' LEU . 56.7 mt -93.08 -7.42 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.043 -1.269 . . . . 1.05 108.614 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.8 tp 54.34 104.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.495 -0.753 . . . . 0.88 109.385 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.54 -41.17 12.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.903 -1.123 . . . . 0.78000000000000003 108.609 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -150.06 148.96 26.2 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.29 -0.881 . . . . 1.5 108.769 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.15 148.22 16.77 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.564 2.176 . . . . 0.85999999999999999 114.092 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.82 176.29 31.73 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.894 -1.282 . . . . 0.78000000000000003 109.894 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.42 HD12 ' HG2' ' A' ' 243' ' ' GLN . 97.1 mt -140.13 128.95 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.15 -1.206 . . . . 0.73999999999999999 109.257 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.88 153.2 49.58 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.281 -0.887 . . . . 0.45000000000000001 109.722 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -123.93 132.86 53.79 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.191 -1.04 . . . . 0.64000000000000001 108.191 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.6 164.94 34.33 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 118.537 -1.792 . . . . 0.45000000000000001 111.314 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HZ2' ' HB3' ' A' ' 15' ' ' LYS . 15.3 mtpp -76.99 149.25 35.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.625 -0.926 . . . . 1.8799999999999999 109.383 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.3 132.27 38.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.398 -0.814 . . . . 0.58999999999999997 110.839 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 tp -115.23 89.62 3.14 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.459 -1.312 . . . . 0.64000000000000001 107.459 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 tp -80.74 122.41 27.1 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.201 1.001 . . . . 0.73999999999999999 110.646 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.0 mt -92.53 98.06 11.22 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.011 -0.736 . . . . 0.73999999999999999 109.011 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -92.26 159.89 15.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 1.8700000000000001 109.665 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -111.71 133.37 54.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.858 -0.793 . . . . 2.5800000000000001 108.858 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' OE1' ' A' ' 21' ' ' GLU . 12.7 m-20 -80.52 124.99 29.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 2.1400000000000001 110.493 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.07 126.47 28.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.431 -0.793 . . . . 1.9299999999999999 109.1 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 80.7 mt -91.09 140.07 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.936 . . . . 0.68000000000000005 109.502 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.74 115.61 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.486 -0.759 . . . . 0.83999999999999997 108.984 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.416 HD11 ' CD2' ' A' ' 105' ' ' HIS . 65.0 mt -88.06 133.54 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 0.79000000000000004 109.88 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -91.63 123.33 34.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 1.3700000000000001 109.375 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -96.65 25.16 5.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.173 -0.955 . . . . 2.6200000000000001 109.005 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -86.87 150.71 23.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 2.3500000000000001 110.38 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -93.22 123.05 36.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.923 -0.769 . . . . 2.3500000000000001 108.923 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -83.67 175.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.961 -1.087 . . . . 0.78000000000000003 109.368 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 34' ' ' ASP . 45.3 p -97.24 149.48 21.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.464 -0.772 . . . . 1.04 109.121 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.97 -7.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 1.05 109.667 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 32' ' ' SER . 29.9 t70 -84.14 -24.21 30.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 2.4700000000000002 109.968 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -103.44 -9.84 19.06 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.134 -0.979 . . . . 1.46 109.536 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.15 -41.4 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.092 -1.005 . . . . 0.77000000000000002 109.071 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -54.92 -35.43 64.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.366 -0.834 . . . . 1.46 109.392 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -70.01 -37.82 75.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 2.29 110.355 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -58.97 -39.1 80.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 1.3 109.481 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.44 -43.76 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.394 -0.816 . . . . 0.76000000000000001 109.48 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -63.39 -41.86 98.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.189 -0.945 . . . . 1.5 108.461 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.18 -30.25 71.43 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.364 -0.835 . . . . 2.6600000000000001 108.811 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -86.7 -51.81 5.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.854 . . . . 0.75 109.49 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 tp -58.12 -63.21 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.82999999999999996 109.834 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 t -65.12 -35.6 81.63 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.822 -1.174 . . . . 0.78000000000000003 109.14 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.36 -9.79 38.64 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.254 -1.938 . . . . 0.56999999999999995 108.254 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -85.72 -28.65 24.49 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.902 -1.518 . . . . 2.8300000000000001 106.902 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.9 -26.65 67.72 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.291 -1.003 . . . . 0.65000000000000002 108.291 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -85.27 -62.88 1.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.281 -0.637 . . . . 2.5699999999999998 109.281 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.07 -38.07 49.42 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.094 -1.004 . . . . 0.51000000000000001 109.311 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 66.4 m -64.82 -38.56 91.38 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.45 -0.944 . . . . 1.3600000000000001 108.45 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.04 -39.77 65.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.292 0.567 . . . . 0.59999999999999998 109.863 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -55.47 -74.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 1.3600000000000001 109.541 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 58' ' ' LYS . 17.8 mt -46.64 -52.42 13.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.158 -0.964 . . . . 1.3799999999999999 109.508 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 51' ' ' SER . 25.8 mm-40 -47.63 -53.4 14.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.454 -0.779 . . . . 1.27 109.639 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 m -62.34 -37.97 87.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.59999999999999998 109.319 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.6 mt -72.62 -31.1 36.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.301 -0.874 . . . . 0.53000000000000003 108.787 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 54' ' ' LEU . 15.8 ttpt -55.06 -44.23 74.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.414 -0.804 . . . . 0.98999999999999999 109.28 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.45 -32.47 70.05 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.255 -0.903 . . . . 0.58999999999999997 109.47 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.71 -17.67 62.82 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.906 -1.122 . . . . 1.8100000000000001 108.081 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.401 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -85.6 -34.53 21.39 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.867 -0.79 . . . . 0.47999999999999998 108.867 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.89 -27.69 30.95 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.061 -1.066 . . . . 0.57999999999999996 110.64 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -86.43 -17.66 33.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.688 -1.478 . . . . 1.3899999999999999 109.414 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.8 m -94.66 -45.25 7.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.078 -1.014 . . . . 0.81999999999999995 110.396 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -106.11 -18.85 13.89 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.208 -0.933 . . . . 0.98999999999999999 110.38 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 121.26 139.26 5.65 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 109.58 -1.408 . . . . 0.55000000000000004 109.58 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -48.93 -8.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.955 . . . . 2.5899999999999999 110.728 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 66' ' ' GLY . 2.5 pt-20 -66.57 -23.49 66.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.813 -1.179 . . . . 2.2000000000000002 110.298 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -88.81 -10.05 49.51 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.884 -1.135 . . . . 1.79 110.074 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -63.55 -23.85 67.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.918 -1.114 . . . . 1.54 110.595 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.22 83.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.081 -1.012 . . . . 0.64000000000000001 110.274 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.3 mt -70.33 -42.21 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.57999999999999996 109.449 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -76.1 -20.82 57.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.152 -0.967 . . . . 0.62 109.622 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -65.4 -38.86 91.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.977 -1.077 . . . . 1.23 108.95 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.74 -36.97 61.58 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.247 -1.541 . . . . 0.52000000000000002 109.247 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -62.42 -21.85 65.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.312 -1.11 . . . . 1.29 110.768 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.2 mt -85.37 -39.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.559 -1.338 . . . . 0.55000000000000004 108.99 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.4 ttt -59.31 -42.23 90.88 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.364 -0.976 . . . . 1.8899999999999999 108.364 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.5 -40.49 82.99 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.45 -0.945 . . . . 0.53000000000000003 108.45 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.4 tp -65.96 -50.33 64.72 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.439 -0.788 . . . . 0.42999999999999999 109.674 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -85.55 10.48 13.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.162 -0.961 . . . . 1.24 110.976 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -48.46 122.8 5.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.738 -1.226 . . . . 1.3100000000000001 109.376 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -66.29 -25.9 67.07 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.406 -0.809 . . . . 1.3500000000000001 108.959 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -76.45 -49.75 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.458 -0.777 . . . . 2.1600000000000001 109.514 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.0 mt -64.95 -20.71 66.61 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.888 -1.125 . . . . 0.59999999999999998 108.928 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -70.43 -47.57 60.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.381 -0.824 . . . . 1.28 109.476 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -64.89 -32.18 73.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.522 -0.736 . . . . 1.28 109.815 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -73.09 -48.77 32.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -0.951 . . . . 1.29 109.015 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.18 -57.71 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.75 -0.833 . . . . 0.57999999999999996 108.75 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 91' ' ' ALA . 77.3 mt -53.05 -61.88 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.714 -0.616 . . . . 0.78000000000000003 110.662 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 90' ' ' ILE . . . -40.93 -62.51 0.8 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.388 -0.82 . . . . 0.85999999999999999 110.748 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.4 mt -45.12 -51.11 10.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.376 -0.828 . . . . 0.79000000000000004 110.011 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.5 -41.35 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.929 -1.107 . . . . 0.70999999999999996 110.011 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -85.16 -42.74 14.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.211 -0.93 . . . . 2.0499999999999998 111.808 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -83.64 -34.06 25.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.669 -1.269 . . . . 1.5900000000000001 111.74 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -104.16 10.7 35.71 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.836 -1.165 . . . . 1.8899999999999999 109.361 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.8 m80 43.77 47.7 6.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.703 . . . . 1.3100000000000001 109.691 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.5 mtp -99.33 154.88 17.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.77 -0.826 . . . . 1.28 108.77 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.1 p -75.52 141.29 43.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.273 -0.892 . . . . 0.62 109.163 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.07 -25.98 2.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.155 -0.965 . . . . 0.46999999999999997 109.347 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.83 -45.34 51.85 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.277 -1.009 . . . . 2.0 108.277 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.91 -54.4 11.54 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.733 -0.604 . . . . 0.56000000000000005 109.873 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -52.62 63.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.261 -0.9 . . . . 0.47999999999999998 109.478 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.09 -35.42 64.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.958 . . . . 0.44 109.283 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.416 ' CD2' HD11 ' A' ' 26' ' ' ILE . 36.2 t-80 -71.99 -32.41 67.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.853 . . . . 1.4199999999999999 109.545 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.86 -61.9 2.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 1.26 110.035 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 107' ' ' VAL . 5.8 t -53.66 -47.32 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.60999999999999999 110.038 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.49 -20.66 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.64000000000000001 109.681 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -74.14 -38.26 63.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.022 . . . . 2.2000000000000002 110.161 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.38 -21.84 46.76 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.525 -1.321 . . . . 0.81999999999999995 111.994 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -68.95 -53.48 20.58 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.735 -1.45 . . . . 1.27 108.691 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.66 67.28 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.656 -0.652 . . . . 0.91000000000000003 109.485 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 t -60.69 -43.6 97.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 1.73 110.192 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.3 -33.08 75.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.042 . . . . 1.04 110.449 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.4 HD21 HH21 ' A' ' 126' ' ' ARG . 17.1 mt -69.38 -27.9 65.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.729 -1.232 . . . . 1.03 109.338 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.56 -16.09 64.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 1.95 109.224 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -80.37 -9.06 59.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.374 -0.829 . . . . 1.71 109.004 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.71 141.05 28.9 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.528 -0.915 . . . . 1.26 108.528 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -99.65 65.11 1.33 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.309 -0.869 . . . . 2.8300000000000001 109.186 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -147.18 111.87 5.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 1.5800000000000001 109.354 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -51.49 -17.02 0.69 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.537 -0.727 . . . . 2.7999999999999998 109.815 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -81.21 -63.87 1.31 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 1.02 109.272 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.4 mt -61.76 -31.27 71.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.264 -0.898 . . . . 1.0600000000000001 110.139 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -66.65 -46.43 75.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.856 -1.152 . . . . 2.3900000000000001 109.112 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -61.39 -18.75 60.21 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.512 -0.875 . . . . 2.2000000000000002 108.831 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.4 HH21 HD21 ' A' ' 115' ' ' LEU . 39.3 ttp180 -74.72 -27.69 60.48 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.678 -1.601 . . . . 2.0899999999999999 106.678 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.71 94.56 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.126 -0.694 . . . . 0.85999999999999999 109.126 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.99 87.24 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.289 -0.882 . . . . 0.90000000000000002 109.472 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.8 OUTLIER -70.52 -30.4 67.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.834 . . . . 1.3500000000000001 110.028 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.12 -39.68 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.958 -1.089 . . . . 0.57999999999999996 108.45 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -61.69 -37.94 85.97 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.216 -1.031 . . . . 3.2200000000000002 108.216 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.08 -36.37 77.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.535 -0.728 . . . . 1.3200000000000001 109.699 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.03 -27.72 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 0.5 109.771 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.33 -46.67 7.35 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.678 -1.369 . . . . 0.44 109.678 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -49.6 -47.75 49.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -1.099 . . . . 2.71 109.144 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.519 ' HG2' HH11 ' A' ' 136' ' ' ARG . 12.8 mtt-85 -64.77 -43.42 93.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.143 -0.973 . . . . 2.2000000000000002 108.713 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.6 tp -52.38 -39.99 61.51 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.968 -0.753 . . . . 1.1299999999999999 108.968 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.41 -59.08 2.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 0.54000000000000004 109.96 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.421 ' HG2' HH11 ' A' ' 139' ' ' ARG . 30.4 mtt-85 -47.67 -18.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 2.3199999999999998 110.841 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -84.6 -39.83 18.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.837 -1.164 . . . . 1.26 108.965 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.61 -38.31 81.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.4 -0.812 . . . . 0.62 109.063 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.9 mt -91.19 -7.3 51.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.345 -0.847 . . . . 0.67000000000000004 109.016 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.95 20.83 69.09 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.389 -1.884 . . . . 0.68000000000000005 108.389 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tp -57.82 168.29 0.96 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.689 -0.889 . . . . 0.77000000000000002 109.601 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -66.06 143.57 57.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 2.3999999999999999 109.375 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -102.13 147.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.625 -0.88 . . . . 0.87 108.625 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.742 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.7 mp -79.08 94.02 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.168 -0.957 . . . . 1.3200000000000001 109.193 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -101.0 92.07 4.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.461 -0.774 . . . . 1.54 110.046 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.539 HD21 ' CG2' ' A' ' 147' ' ' ILE . 10.1 mt -82.56 -17.52 44.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.145 -0.972 . . . . 0.77000000000000002 108.917 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 170' ' ' GLN . 0.8 OUTLIER -82.99 35.34 0.47 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.763 . . . . 1.5700000000000001 109.608 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.1 24.27 2.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 0.81999999999999995 109.024 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 79.4 mt -73.16 139.84 18.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.483 -0.761 . . . . 0.81999999999999995 109.449 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -118.34 -18.0 9.33 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.519 -0.919 . . . . 2.1099999999999999 108.519 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -117.62 127.73 54.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.982 -0.747 . . . . 1.4099999999999999 108.982 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -61.91 127.71 32.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.814 . . . . 1.3 109.889 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -149.99 176.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.393 -0.817 . . . . 0.56999999999999995 108.888 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.1 mt -87.9 147.14 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.442 -0.948 . . . . 0.42999999999999999 108.442 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 tp -101.74 117.76 35.54 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.654 -0.869 . . . . 0.56000000000000005 108.654 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.67 131.96 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.713 -0.847 . . . . 0.54000000000000004 108.713 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.33 149.17 15.29 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.78 -0.768 . . . . 0.62 109.644 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.76 78.46 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 120.682 -1.261 . . . . 0.80000000000000004 107.946 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -173.14 148.33 1.68 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.585 -0.697 . . . . 2.3399999999999999 109.134 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.4 mt -119.59 138.73 53.03 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.383 -0.823 . . . . 0.65000000000000002 109.619 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.4 p -94.41 153.53 40.41 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 0.73999999999999999 109.243 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 169' ' ' ALA . 69.6 Cg_exo -37.36 -50.55 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.379 2.053 . . . . 0.59999999999999998 112.482 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 m -49.78 -55.44 14.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.63 109.281 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.19 -47.52 81.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.907 . . . . 1.25 109.543 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.4 p -67.95 -19.86 65.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 0.5 109.778 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -80.09 -29.5 39.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.163 -0.961 . . . . 0.51000000000000001 110.113 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.413 ' O ' ' OG ' ' A' ' 150' ' ' SER . 20.9 pt20 -101.5 -11.66 19.13 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.154 -0.966 . . . . 1.1699999999999999 109.117 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.89 151.72 21.04 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.538 -0.912 . . . . 0.60999999999999999 108.538 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -99.57 139.35 35.35 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.407 -0.96 . . . . 2.1200000000000001 108.407 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.78 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.3 mm? -88.37 -41.21 12.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 1.3400000000000001 109.978 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -82.49 -10.72 58.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.019 -1.05 . . . . 1.97 111.667 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -99.9 -17.03 17.79 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.621 -1.3 . . . . 1.8999999999999999 108.763 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 178' ' ' GLY . 56.6 t -89.7 156.38 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.592 -0.892 . . . . 0.47999999999999998 108.592 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.8 tp -106.08 -20.46 13.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.364 -0.835 . . . . 1.3899999999999999 109.609 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.473 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.4 173.0 41.64 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.095 -1.602 . . . . 0.38 109.095 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -128.36 124.33 36.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -1.035 . . . . 0.46000000000000002 109.081 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.0 mt -130.2 131.68 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.017 -1.105 . . . . 0.58999999999999997 108.017 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 23.4 p -139.22 147.41 41.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.36 -0.837 . . . . 0.67000000000000004 111.336 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 182' ' ' ASP . 7.1 p-10 -84.78 37.32 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.702 -0.624 . . . . 2.2400000000000002 110.09 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 203' ' ' VAL . . . -112.69 120.07 40.28 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.377 -0.827 . . . . 1.1100000000000001 110.034 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.03 65.94 2.53 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.613 -1.395 . . . . 1.6299999999999999 109.613 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -100.29 128.23 9.5 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.038 -1.225 . . . . 1.47 110.038 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.478 ' O ' ' OG1' ' A' ' 187' ' ' THR . 16.7 ttm-85 -53.09 92.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.283 -1.377 . . . . 5.2400000000000002 107.283 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 185' ' ' GLY . 4.9 p 65.12 68.21 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.3 -1.0 . . . . 2.9199999999999999 108.3 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.0 t -72.11 165.01 25.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 1.6000000000000001 109.442 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -43.65 -47.49 7.66 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.522 -0.736 . . . . 0.92000000000000004 110.427 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.0 m -50.08 -31.04 12.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 1.5900000000000001 109.599 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.9 t -76.47 -39.41 53.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.194 -0.941 . . . . 1.4199999999999999 109.859 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.5 mp -53.48 -36.43 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.956 . . . . 1.4099999999999999 108.758 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 33.3 mtp -71.13 -52.11 21.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.255 -1.387 . . . . 0.85999999999999999 107.255 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.33 -46.05 86.96 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.528 -0.76 . . . . 0.58999999999999997 110.243 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -63.89 -48.76 75.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.064 -1.023 . . . . 3.0600000000000001 110.056 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.8 m -68.92 -36.43 77.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.125 -0.984 . . . . 0.72999999999999998 109.5 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 199' ' ' LEU . 21.3 mt -89.37 1.81 55.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.977 . . . . 0.67000000000000004 109.018 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 194' ' ' ALA . 32.1 mt-10 54.71 2.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.466 -0.771 . . . . 1.49 111.261 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 197' ' ' LEU . 25.2 mt -66.61 168.47 10.11 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.622 -1.299 . . . . 0.64000000000000001 108.54 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -85.71 144.0 8.59 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.21 1.94 . . . . 0.58999999999999997 111.081 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.36 172.6 17.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.653 -1.279 . . . . 0.55000000000000004 110.965 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.598 HD12 HD11 ' A' ' 220' ' ' LEU . 12.2 mt -150.95 156.0 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.365 -1.717 . . . . 0.63 106.365 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.8 m -143.04 -33.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.812 -1.18 . . . . 0.77000000000000002 111.703 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.527 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -85.89 38.96 3.03 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 120.523 -1.36 . . . . 0.87 110.202 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 206' ' ' GLY . 27.5 p -71.21 42.83 0.07 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.831 -1.394 . . . . 0.89000000000000001 109.199 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 39.18 -102.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.272 -1.131 . . . . 0.93000000000000005 110.272 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.4 m -131.14 42.37 3.23 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.811 -0.817 . . . . 1.6000000000000001 110.039 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.3 t -54.56 -33.57 27.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.868 -1.145 . . . . 0.75 108.438 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.2 p -55.39 -16.48 3.64 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.047 -1.033 . . . . 0.83999999999999997 108.678 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 49.9 m -103.95 12.21 34.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.541 -0.724 . . . . 1.6100000000000001 109.322 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -135.74 -17.3 1.7 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.32 -0.862 . . . . 2.2999999999999998 109.968 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 5.8 t -112.55 141.91 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.637 -0.875 . . . . 0.76000000000000001 108.637 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -177.92 3.26 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.764 -1.569 . . . . 2.0099999999999998 106.764 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.3 p-10 -81.06 144.81 31.47 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.033 -1.042 . . . . 2.1899999999999999 110.04 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.8 m-20 81.04 -13.46 0.92 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.074 -0.392 . . . . 2.3999999999999999 110.857 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.51 136.37 56.71 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.854 -1.154 . . . . 1.99 108.416 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -86.7 117.21 25.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.926 -1.109 . . . . 1.3 108.952 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.3 mt -129.38 175.16 8.98 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.654 0.74 . . . . 0.53000000000000003 109.585 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.6 mt -140.89 126.25 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.755 -0.831 . . . . 0.59999999999999998 108.755 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.598 HD11 HD12 ' A' ' 202' ' ' ILE . 24.0 tp -90.16 126.32 35.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.56999999999999995 108.725 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 223' ' ' VAL . 4.1 m-20 -95.38 -34.56 12.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.07 -1.019 . . . . 2.2200000000000002 109.486 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.51 21.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.675 -0.641 . . . . 0.75 110.142 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.3 t -115.12 -59.84 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 106.465 -1.68 . . . . 0.92000000000000004 106.465 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -89.21 11.39 18.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.242 -1.392 . . . . 2.3599999999999999 107.242 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 64.3 t30 57.39 58.26 3.94 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.414 -0.588 . . . . 1.4199999999999999 109.414 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -156.1 151.76 27.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.054 -1.028 . . . . 1.97 110.517 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 32.8 t -109.78 139.33 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.721 -0.844 . . . . 0.65000000000000002 108.721 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -108.88 129.94 55.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.406 -0.809 . . . . 0.96999999999999997 109.555 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 11.3 t -103.18 113.81 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.401 -0.812 . . . . 0.67000000000000004 109.362 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.1 t30 52.02 63.42 9.18 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.943 . . . . 1.45 110.54 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.81 161.6 44.54 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.509 2.14 . . . . 0.81999999999999995 112.019 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.6 p -74.0 160.4 31.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.358 -0.839 . . . . 1.6200000000000001 109.464 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -68.01 -26.68 66.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 2.6000000000000001 109.137 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 234' ' ' GLU . 0.7 OUTLIER -62.05 -37.65 85.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.803 . . . . 3.0600000000000001 109.623 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.58 -45.28 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.007 -1.058 . . . . 1.1399999999999999 109.157 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.57 -57.96 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.323 -0.861 . . . . 1.04 109.67 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -53.72 -40.37 66.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.28 -0.887 . . . . 2.54 110.417 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -65.91 -40.23 91.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 2.6000000000000001 110.279 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 28.9 mtm -80.7 -26.04 37.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.999 -1.063 . . . . 1.23 109.911 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.403 ' HG3' ' NH1' ' A' ' 240' ' ' ARG . 15.1 mmm-85 -58.29 -42.16 85.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 2.6699999999999999 109.898 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.24 -52.28 11.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 1.6599999999999999 110.133 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 35.4 t -62.79 -50.23 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.101 -0.999 . . . . 2.2000000000000002 109.862 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.42 ' HG2' HD12 ' A' ' 11' ' ' ILE . 7.4 tm0? -51.71 -59.12 4.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.197 -0.94 . . . . 3.0 110.378 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.95 -23.75 66.57 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.271 -0.893 . . . . 1.76 110.625 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -67.09 -22.76 65.81 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.905 -1.146 . . . . 2.7799999999999998 107.905 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.7 t -78.55 -39.15 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.756 -0.831 . . . . 2.0600000000000001 108.756 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.3 -28.26 69.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.488 -0.757 . . . . 2.3999999999999999 109.757 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.5 p -76.84 -32.51 57.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.139 -0.975 . . . . 2.8700000000000001 109.698 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 3.4100000000000001 109.217 179.793 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' N ' ' A' ' 3' ' ' SER . 21.1 mmt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.255 -0.646 . . . . 3.6600000000000001 109.255 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.59 85.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.092 -1.005 . . . . 1.1200000000000001 108.649 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 1' ' ' MET . 6.9 m -88.54 114.15 24.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 1.45 109.253 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.55 -163.16 20.7 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 108.859 -1.696 . . . . 0.92000000000000004 108.859 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 5' ' ' ILE . 65.1 mt -94.84 -6.44 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -1.174 . . . . 1.05 108.553 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 36.5 tp 54.17 104.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.106 -0.702 . . . . 0.88 109.106 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.14 -56.0 4.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.064 -1.022 . . . . 0.78000000000000003 108.345 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.64 145.61 26.3 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.144 -1.058 . . . . 1.5 108.144 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.58 154.19 35.0 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.986 1.79 . . . . 0.85999999999999999 113.499 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.51 133.2 1.81 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.721 -1.351 . . . . 0.78000000000000003 109.721 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.0 mt -94.85 135.65 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.955 -1.321 . . . . 0.73999999999999999 109.795 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.412 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -143.6 155.42 44.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.216 -0.927 . . . . 0.45000000000000001 109.726 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.577 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -125.38 141.78 51.87 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.338 -0.986 . . . . 0.64000000000000001 108.338 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.24 163.02 28.08 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.127 -1.511 . . . . 0.45000000000000001 110.887 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -78.51 150.97 32.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.488 -1.007 . . . . 1.8799999999999999 109.559 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.566 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -76.13 127.9 33.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.58999999999999997 111.012 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -109.71 91.94 3.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.436 -1.32 . . . . 0.64000000000000001 107.436 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 tp -81.65 126.3 31.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.021 -1.049 . . . . 0.73999999999999999 110.58 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.489 HD11 HD11 ' A' ' 158' ' ' LEU . 13.6 mt -96.43 93.5 6.87 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.905 -0.589 . . . . 0.73999999999999999 110.075 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -92.82 158.22 15.98 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.598 -0.89 . . . . 1.8700000000000001 108.598 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -130.62 135.93 48.36 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.351 -0.843 . . . . 2.5800000000000001 109.322 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.11 133.55 36.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -0.854 . . . . 2.1400000000000001 108.856 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.58 147.69 48.37 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.293 -0.88 . . . . 1.9299999999999999 109.135 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mt -89.27 129.76 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.298 -0.876 . . . . 0.68000000000000005 109.417 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.4 112.59 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.605 -0.887 . . . . 0.83999999999999997 108.605 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.6 mt -86.56 131.78 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.79000000000000004 109.65 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -90.1 114.69 26.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.397 -0.814 . . . . 1.3700000000000001 109.374 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.426 HH11 ' HG3' ' A' ' 28' ' ' ARG . 19.9 mmm-85 -95.63 26.16 4.13 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.206 -0.934 . . . . 2.6200000000000001 108.857 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -79.21 143.26 35.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 2.3500000000000001 109.384 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -84.76 123.63 30.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 2.3500000000000001 109.573 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -90.92 173.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.277 -0.889 . . . . 0.78000000000000003 109.987 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -105.53 172.9 6.55 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.776 -0.578 . . . . 1.04 109.603 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.18 -8.55 32.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.815 . . . . 1.05 109.722 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -82.84 -16.42 47.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.048 -1.032 . . . . 2.4700000000000002 109.814 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -110.78 -8.27 14.56 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.395 -0.815 . . . . 1.46 109.263 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.49 -45.1 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.77000000000000002 108.587 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -53.9 -36.09 62.35 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.419 -0.8 . . . . 1.46 109.067 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -70.44 -42.06 72.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.497 -0.752 . . . . 2.29 110.51 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -58.66 -45.6 89.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 1.3 109.535 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 44' ' ' LEU . 85.6 t -61.81 -44.21 98.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.192 -0.943 . . . . 0.76000000000000001 109.053 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -65.72 -42.49 90.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.28 -0.887 . . . . 1.5 109.083 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -63.62 -34.89 78.84 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.176 -0.952 . . . . 2.6600000000000001 108.92 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -86.39 -53.09 5.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.394 -0.816 . . . . 0.75 109.059 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' VAL . 10.0 tp -53.79 -67.1 0.29 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.731 . . . . 0.82999999999999996 109.731 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.619 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 45.1 t -63.75 -35.07 79.38 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.192 -0.943 . . . . 0.78000000000000003 108.935 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.55 -53.35 39.25 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.372 -2.291 . . . . 0.56999999999999995 107.372 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -46.74 -32.33 3.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.603 -0.939 . . . . 2.8300000000000001 108.775 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.86 -32.92 69.88 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.869 -1.159 . . . . 0.65000000000000002 107.869 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 46' ' ' GLY . 16.5 ttmm -83.89 -61.05 1.92 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.021 -0.733 . . . . 2.5699999999999998 109.021 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.09 -45.03 64.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.51000000000000001 110.069 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.4 t -63.35 -38.14 89.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.06 -1.025 . . . . 1.3600000000000001 108.409 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 -31.2 65.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.089 -0.708 . . . . 0.59999999999999998 109.089 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -69.25 -58.68 3.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.801 . . . . 1.3600000000000001 109.099 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.4 mt -55.85 -45.38 78.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 1.3799999999999999 108.718 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -55.27 -48.66 73.7 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.981 -0.748 . . . . 1.27 108.981 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.1 m -63.13 -41.08 99.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.59999999999999998 109.22 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.4 mt -71.53 -37.49 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.375 -0.972 . . . . 0.53000000000000003 108.375 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -49.84 -45.58 50.4 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.57 -0.706 . . . . 0.98999999999999999 109.408 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -70.95 -27.78 64.0 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.256 -0.902 . . . . 0.58999999999999997 109.941 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -71.79 -25.37 61.98 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.805 -1.184 . . . . 1.8100000000000001 108.475 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.45 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -81.58 -29.07 33.53 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.647 -0.872 . . . . 0.47999999999999998 108.647 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.21 -32.13 17.85 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.969 -1.11 . . . . 0.57999999999999996 110.653 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -85.88 -15.44 41.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.899 -1.353 . . . . 1.3899999999999999 109.107 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.8 m -95.49 -48.81 5.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.332 -0.855 . . . . 0.81999999999999995 110.498 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -106.64 -14.48 15.02 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.13 -0.981 . . . . 0.98999999999999999 110.67 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.81 136.86 5.2 Favored Glycine 0 N--CA 1.502 3.087 0 N-CA-C 109.733 -1.347 . . . . 0.55000000000000004 109.733 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -48.29 -9.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.536 -0.979 . . . . 2.5899999999999999 110.744 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 66' ' ' GLY . 13.6 pt-20 -66.51 -21.86 66.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.952 -1.093 . . . . 2.2000000000000002 110.586 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -87.93 -16.32 34.19 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.92 -1.113 . . . . 1.79 109.781 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.15 -20.34 66.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.2 -0.937 . . . . 1.54 110.686 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.75 92.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.852 -1.155 . . . . 0.64000000000000001 109.531 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.6 mt -71.73 -39.85 69.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.218 -0.926 . . . . 0.57999999999999996 109.465 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -78.06 -23.53 48.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -0.958 . . . . 0.62 108.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -64.7 -33.28 75.59 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.493 -0.928 . . . . 1.23 108.493 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.47 -35.9 35.6 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.048 -1.621 . . . . 0.52000000000000002 109.048 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.95 -21.1 63.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.352 -1.087 . . . . 1.29 109.829 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.2 mt -86.42 -42.4 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.9 -1.125 . . . . 0.55000000000000004 108.76 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.3 ttm -59.88 -41.38 91.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.022 -0.733 . . . . 1.8899999999999999 109.022 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -63.93 -39.31 93.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.53000000000000003 109.127 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -71.83 -42.58 66.81 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.534 -0.866 . . . . 0.42999999999999999 109.431 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -86.24 5.43 34.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 1.24 110.41 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -48.36 122.75 5.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 1.3100000000000001 109.753 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -67.42 -24.32 65.64 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.643 -0.873 . . . . 1.3500000000000001 108.643 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -76.14 -53.39 8.36 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.469 -0.769 . . . . 2.1600000000000001 109.055 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.06 -12.61 52.55 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.972 -1.091 . . . . 0.59999999999999998 108.707 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -78.16 -53.75 7.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.434 -0.792 . . . . 1.28 109.897 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -62.5 -25.69 68.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 1.28 109.701 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -73.19 -47.04 47.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -0.99 . . . . 1.29 108.812 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.61 -56.32 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.441 -0.948 . . . . 0.57999999999999996 108.441 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -48.34 -56.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.603 -0.686 . . . . 0.78000000000000003 110.055 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -47.79 -61.96 1.69 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.85999999999999999 110.308 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.5 mt -47.8 -52.14 19.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.79000000000000004 109.402 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.0 mt -52.2 -46.24 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.077 -1.014 . . . . 0.70999999999999996 110.193 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -84.85 -35.51 22.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.094 -1.004 . . . . 2.0499999999999998 111.88 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.25 -37.98 22.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.536 -1.352 . . . . 1.5900000000000001 111.732 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -105.23 14.62 28.73 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.729 -1.232 . . . . 1.8899999999999999 109.48 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.8 m80 45.16 42.53 6.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.379 -0.826 . . . . 1.3100000000000001 109.597 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.7 mtt -95.36 149.54 21.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.936 -0.765 . . . . 1.28 108.936 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 p -76.62 143.59 40.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.33 -0.856 . . . . 0.62 109.283 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.04 -27.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 0.46999999999999997 109.804 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 1.3 p30 -76.14 -43.85 41.06 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.293 -0.879 . . . . 2.0 108.717 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -70.52 -56.9 5.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.622 -0.674 . . . . 0.56000000000000005 110.277 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.25 -49.68 68.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.47999999999999998 109.758 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.89 -30.94 59.31 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.247 -0.908 . . . . 0.44 109.525 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -69.47 -34.63 74.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.991 -1.068 . . . . 1.4199999999999999 109.873 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -63.78 -45.89 87.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.989 -1.07 . . . . 1.26 109.791 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.51 -47.82 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.825 -1.172 . . . . 0.60999999999999999 108.669 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.74 -18.19 22.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.493 -0.754 . . . . 0.64000000000000001 109.057 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.8 -42.87 73.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 2.2000000000000002 109.572 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.32 -29.32 22.53 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.617 -1.278 . . . . 0.81999999999999995 112.336 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -65.15 -39.45 93.01 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.414 -1.639 . . . . 1.27 108.797 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.67 -51.36 7.8 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.567 -0.708 . . . . 0.91000000000000003 109.178 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -60.34 -44.52 95.44 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.452 -0.78 . . . . 1.73 110.149 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -63.89 -37.62 88.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.05 -1.031 . . . . 1.04 111.235 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.41 -25.99 66.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.507 -1.371 . . . . 1.03 109.216 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -71.63 -21.33 61.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.971 -1.08 . . . . 1.95 109.828 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -81.83 -7.02 59.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.214 -0.929 . . . . 1.71 108.921 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.89 136.86 33.12 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.255 -1.017 . . . . 1.26 108.255 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -94.07 63.43 3.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 2.8300000000000001 108.722 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -146.61 114.27 6.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.81 . . . . 1.5800000000000001 109.28 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.83 -16.01 4.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 2.7999999999999998 109.755 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -81.12 -63.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 1.02 109.368 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 mt -66.55 -31.32 71.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.236 -0.915 . . . . 1.0600000000000001 109.833 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 27.6 ttpt -66.69 -50.05 64.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.942 -1.099 . . . . 2.3900000000000001 109.321 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.27 -25.73 49.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.091 -1.006 . . . . 2.2000000000000002 108.702 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -72.56 -23.57 60.99 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.542 -1.651 . . . . 2.0899999999999999 106.542 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -58.38 -47.83 82.59 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.233 -1.025 . . . . 0.85999999999999999 108.233 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.41 -35.84 76.13 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.674 -0.641 . . . . 0.90000000000000002 109.48 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.9 m-20 -68.69 -30.63 69.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.422 -0.799 . . . . 1.3500000000000001 109.733 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.4 t -77.48 -39.48 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.01 -1.056 . . . . 0.57999999999999996 108.679 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -56.35 -40.93 75.31 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.107 -1.071 . . . . 3.2200000000000002 108.107 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.61 -38.36 81.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.603 -0.686 . . . . 1.3200000000000001 109.665 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.52 -21.77 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.5 109.449 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.09 -58.36 2.99 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.0 -1.095 . . . . 0.44 110.496 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -52.67 -42.67 64.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.007 -1.29 . . . . 2.71 109.849 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 140' ' ' ASN . 23.2 mtt-85 -65.43 -45.91 82.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.957 -1.089 . . . . 2.2000000000000002 108.423 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.2 tp -55.68 -43.41 76.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.585 -0.697 . . . . 1.1299999999999999 109.386 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.2 -47.9 75.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.54000000000000004 110.268 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -52.96 -22.35 5.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.061 -1.024 . . . . 2.3199999999999998 110.8 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 70.4 m-80 -83.37 -45.55 13.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.915 -1.116 . . . . 1.26 109.091 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.5 mt -53.93 -38.48 36.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.197 -0.94 . . . . 0.62 108.934 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.2 mt -88.15 3.59 48.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.245 -0.909 . . . . 0.67000000000000004 109.101 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.2 30.88 55.83 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.744 -1.742 . . . . 0.68000000000000005 108.744 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.57 142.35 52.9 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.357 -1.084 . . . . 0.77000000000000002 109.462 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -67.5 136.01 53.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 2.3999999999999999 109.708 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 80.4 mt -106.54 144.6 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.898 -0.779 . . . . 0.87 108.898 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.709 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -77.92 138.98 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 1.3200000000000001 109.616 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -96.67 86.59 4.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.426 -0.796 . . . . 1.54 109.486 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.1 mt -80.17 -29.69 38.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.412 -0.805 . . . . 0.77000000000000002 109.651 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.8 p -79.98 20.64 0.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.933 . . . . 1.5700000000000001 109.486 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -142.32 35.11 1.49 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.347 -0.845 . . . . 0.81999999999999995 109.714 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 153' ' ' GLN . 57.7 mt -72.3 158.83 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.81999999999999995 109.148 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 152' ' ' ILE . 12.1 pt20 -134.43 -4.21 2.65 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.293 -0.879 . . . . 2.1099999999999999 109.601 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -125.2 128.34 48.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.533 -0.729 . . . . 1.4099999999999999 109.297 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.52 122.99 18.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 1.3 109.292 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.4 m -148.12 172.97 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.321 -0.862 . . . . 0.56999999999999995 109.314 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.4 mt -88.85 152.91 3.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.809 -1.182 . . . . 0.42999999999999999 107.809 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.489 HD11 HD11 ' A' ' 19' ' ' LEU . 14.6 tp -105.98 118.76 37.44 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.619 0.724 . . . . 0.56000000000000005 109.273 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 26.2 t -121.46 128.62 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.815 -0.809 . . . . 0.54000000000000004 108.815 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.67 146.59 11.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.313 -0.867 . . . . 0.62 109.539 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.5 71.72 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.677 -1.265 . . . . 0.80000000000000004 108.015 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -173.21 157.33 3.38 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.598 -0.689 . . . . 2.3399999999999999 109.48 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.7 mt -126.82 137.47 53.2 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.531 -0.731 . . . . 0.65000000000000002 109.118 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.6 p -92.33 152.74 42.64 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.24 -0.913 . . . . 0.73999999999999999 109.195 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 169' ' ' ALA . 66.0 Cg_exo -35.92 -51.9 1.03 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.561 2.174 . . . . 0.59999999999999998 112.663 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.5 m -47.92 -54.72 11.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.63 109.473 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -59.04 -48.07 82.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 1.25 109.811 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 168' ' ' THR . 5.4 p -69.49 -24.33 63.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.5 109.902 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -77.9 -24.62 48.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.51000000000000001 110.086 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -106.95 -15.39 14.71 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.316 -0.865 . . . . 1.1699999999999999 109.681 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.1 tp -58.81 149.91 25.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.019 -1.051 . . . . 0.60999999999999999 108.831 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 173' ' ' LEU . 2.6 t-20 -99.02 152.57 19.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 2.1200000000000001 108.702 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.54 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 11.8 mt -95.32 -40.84 9.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.177 -0.952 . . . . 1.3400000000000001 110.938 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -81.79 -14.68 56.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.846 -1.159 . . . . 1.97 112.125 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -95.0 -11.11 29.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.433 -1.417 . . . . 1.8999999999999999 107.869 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 177' ' ' LEU . 95.8 t -96.95 163.6 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.799 -1.186 . . . . 0.47999999999999998 107.799 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.545 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -112.18 -26.62 8.71 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.638 -0.875 . . . . 1.3899999999999999 108.638 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.42 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.85 176.28 47.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.156 -1.578 . . . . 0.38 109.156 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.448 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 1.6 m-85 -128.39 123.45 33.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.438 -1.036 . . . . 0.46000000000000002 109.91 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.6 mt -128.25 129.92 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.492 -1.299 . . . . 0.58999999999999997 107.492 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.2 p -140.24 148.14 41.05 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.235 1.017 . . . . 0.67000000000000004 111.785 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 1.1 t70 -87.78 38.72 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.77 -0.581 . . . . 2.2400000000000002 109.843 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.548 ' C ' ' H ' ' A' ' 185' ' ' GLY . . . -105.84 121.67 44.52 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.174 -0.954 . . . . 1.1100000000000001 110.287 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.05 4.82 0.01 OUTLIER Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.395 -0.816 . . . . 1.6299999999999999 111.971 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 183' ' ' ALA . . . 88.3 -13.18 62.52 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 120.314 -1.697 . . . . 1.47 109.917 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -54.95 -33.37 62.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -1.176 . . . . 5.2400000000000002 109.262 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 p -146.9 40.87 1.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 2.9199999999999999 109.42 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 183' ' ' ALA . 31.7 m -91.03 91.74 8.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.104 -0.998 . . . . 1.6000000000000001 109.79 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -60.7 -22.68 64.2 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.977 -1.12 . . . . 0.92000000000000004 107.977 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 95.1 m -63.11 -39.73 95.55 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.621 -0.881 . . . . 1.5900000000000001 108.621 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.3 t -57.09 -33.16 67.02 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 1.4199999999999999 109.051 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.87 -37.66 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.293 -0.879 . . . . 1.4099999999999999 110.444 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.7 mtm -71.94 -51.42 22.12 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.785 -1.197 . . . . 0.85999999999999999 108.238 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.83 -32.33 31.24 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.147 0.498 . . . . 0.58999999999999997 109.705 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -75.52 -46.04 34.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.057 -1.027 . . . . 3.0600000000000001 109.376 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.3 m -70.77 -35.7 72.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.257 -0.902 . . . . 0.72999999999999998 109.63 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.5 mt -89.49 -2.37 58.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.67000000000000004 109.139 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 51.17 10.12 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.562 -0.711 . . . . 1.49 111.783 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.9 mt -68.17 168.41 13.64 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.557 -1.339 . . . . 0.64000000000000001 108.507 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.14 131.8 5.96 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.121 1.881 . . . . 0.58999999999999997 111.578 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -163.37 176.39 9.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.794 -1.191 . . . . 0.55000000000000004 111.177 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.409 HG23 ' H ' ' A' ' 6' ' ' LEU . 11.4 mt -149.64 161.51 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.653 -1.61 . . . . 0.63 106.653 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 181' ' ' THR . 17.1 m -144.63 -31.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.725 -1.234 . . . . 0.77000000000000002 111.413 -178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.18 31.2 5.5 Favored Glycine 0 N--CA 1.491 2.364 0 O-C-N 120.807 -1.183 . . . . 0.87 110.486 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.434 ' HB ' HG23 ' A' ' 208' ' ' VAL . 10.1 p -56.02 -37.27 68.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.787 -1.419 . . . . 0.89000000000000001 108.514 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.43 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 64.94 -35.2 0.1 Allowed Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.923 -0.656 . . . . 0.93000000000000005 113.522 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.6 m -121.66 16.43 11.13 Favored 'General case' 0 N--CA 1.513 2.704 0 CA-C-N 119.812 1.806 . . . . 1.6000000000000001 112.839 -177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' A' ' 205' ' ' THR . 5.7 t -78.23 -52.54 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.221 -1.549 . . . . 0.75 109.888 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.3 p -53.62 -19.61 4.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.697 -1.252 . . . . 0.83999999999999997 109.961 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.8 m -105.72 14.45 28.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.341 -0.85 . . . . 1.6100000000000001 109.474 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -143.54 -5.6 0.83 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.235 -0.916 . . . . 2.2999999999999998 110.891 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 37.2 t -119.45 157.58 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.16 -0.963 . . . . 0.76000000000000001 109.957 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 16.0 mmmt -134.34 171.38 14.35 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.813 -1.551 . . . . 2.0099999999999998 106.813 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.2 t30 -76.17 143.06 41.36 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.876 -1.14 . . . . 2.1899999999999999 110.539 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.0 t70 80.12 -10.77 1.24 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.712 -0.617 . . . . 2.3999999999999999 110.867 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -57.85 143.62 41.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.772 -1.205 . . . . 1.99 108.657 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -86.08 110.95 19.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.011 -1.055 . . . . 1.3 108.555 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.566 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 13.4 mt -123.8 165.4 17.38 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.67 0.747 . . . . 0.53000000000000003 109.946 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 40.6 mt -138.71 125.22 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.833 -1.173 . . . . 0.59999999999999998 107.833 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.4 tp -86.89 127.35 35.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.2 -0.938 . . . . 0.56999999999999995 108.735 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.7 -46.17 6.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.244 -0.91 . . . . 2.2200000000000002 109.433 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 44.51 23.87 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.513 -0.742 . . . . 0.75 110.165 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 t -115.96 -41.11 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 106.634 -1.617 . . . . 0.92000000000000004 106.634 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -108.22 13.08 26.08 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.825 -1.546 . . . . 2.3599999999999999 106.825 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 60.66 52.63 4.36 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.964 -0.562 . . . . 1.4199999999999999 109.908 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -157.87 154.92 28.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.972 -1.08 . . . . 1.97 110.712 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 228' ' ' TYR . 87.6 t -107.19 163.21 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.843 -0.799 . . . . 0.65000000000000002 108.843 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.517 ' N ' HG12 ' A' ' 227' ' ' VAL . 48.2 m-85 -122.07 116.27 23.96 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.358 -0.839 . . . . 0.96999999999999997 109.147 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.7 t -102.16 120.1 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.406 -0.809 . . . . 0.67000000000000004 109.871 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 31.8 t30 65.68 74.98 0.36 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.685 -0.634 . . . . 1.45 110.452 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -91.56 143.76 3.02 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 123.334 2.689 . . . . 0.81999999999999995 111.929 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 14.5 p -73.34 167.19 21.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 1.6200000000000001 109.714 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -72.4 -34.47 67.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 2.6000000000000001 108.958 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -66.25 -34.3 77.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.504 -0.747 . . . . 3.0600000000000001 109.473 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.1 t -76.03 -30.1 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 1.1399999999999999 109.151 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 69.5 mt -70.88 -56.37 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.311 -0.868 . . . . 1.04 109.074 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.85 -40.22 69.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 2.54 110.228 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -66.98 -40.27 87.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.119 -0.988 . . . . 2.6000000000000001 110.197 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.8 mtp -81.07 -23.11 38.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.069 -1.019 . . . . 1.23 109.692 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -60.02 -44.09 94.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 2.6699999999999999 109.385 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.65 -56.81 4.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 1.6599999999999999 110.019 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 94.0 t -48.81 -61.44 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.256 -0.902 . . . . 2.2000000000000002 110.091 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -49.29 -57.29 7.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.276 -0.89 . . . . 3.0 110.223 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.0 -25.41 66.86 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.854 -1.153 . . . . 1.76 109.931 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -68.55 -28.73 67.22 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.628 -1.249 . . . . 2.7799999999999998 107.628 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.03 -45.66 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.824 -0.806 . . . . 2.0600000000000001 108.824 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.13 -42.87 81.76 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.719 -0.792 . . . . 2.3999999999999999 109.585 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.4 t -80.36 -31.18 37.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.333 -0.854 . . . . 2.8700000000000001 110.746 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.026 -1.047 . . . . 3.4100000000000001 109.396 -179.357 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 3' ' ' SER . 66.6 mtt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.5 -0.555 . . . . 3.6600000000000001 109.5 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.78 83.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 1.1200000000000001 109.556 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 1' ' ' MET . 50.8 m -94.59 112.12 23.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.963 -1.086 . . . . 1.45 108.696 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.76 -165.04 21.6 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 109.872 -1.291 . . . . 0.92000000000000004 109.872 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 5' ' ' ILE . 58.2 mt -93.07 -6.18 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.249 -1.148 . . . . 1.05 108.595 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' ILE . 18.3 tp 57.16 110.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.538 -0.726 . . . . 0.88 109.418 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.55 -45.87 9.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.78000000000000003 109.23 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.51 150.53 31.33 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.241 -0.912 . . . . 1.5 109.384 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -83.01 148.29 13.4 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.478 2.118 . . . . 0.85999999999999999 113.733 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.735 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.56 -177.06 34.53 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.421 -1.472 . . . . 0.78000000000000003 109.421 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 mt -147.7 126.89 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.872 -1.37 . . . . 0.73999999999999999 110.186 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.17 161.49 36.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.34 -0.85 . . . . 0.45000000000000001 109.48 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.474 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 8.1 m-85 -126.9 128.27 46.21 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.656 -0.868 . . . . 0.64000000000000001 108.656 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.77 165.95 38.47 Favored Glycine 0 N--CA 1.502 3.064 0 C-N-CA 118.48 -1.819 . . . . 0.45000000000000001 111.836 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -82.12 151.45 26.98 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.46 -1.024 . . . . 1.8799999999999999 110.66 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.54 130.76 37.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.448 -0.782 . . . . 0.58999999999999997 111.878 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 tp -111.05 99.86 8.65 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.182 -1.414 . . . . 0.64000000000000001 107.182 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 tp -85.51 122.55 29.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.785 -1.197 . . . . 0.73999999999999999 110.872 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 158' ' ' LEU . 20.9 mt -93.48 98.72 11.38 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.791 -0.818 . . . . 0.73999999999999999 108.791 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -89.85 142.52 27.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.433 -0.792 . . . . 1.8700000000000001 109.265 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -110.11 129.68 55.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.487 -0.758 . . . . 2.5800000000000001 109.681 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -78.13 122.26 25.4 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.17 -1.048 . . . . 2.1400000000000001 108.17 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -65.6 134.96 54.41 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.098 -1.001 . . . . 1.9299999999999999 109.765 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.0 mt -91.3 134.47 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.543 -0.723 . . . . 0.68000000000000005 109.503 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.84 119.52 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.87 -0.789 . . . . 0.83999999999999997 108.87 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.5 mt -90.62 131.51 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.968 -1.082 . . . . 0.79000000000000004 109.41 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -89.69 123.79 34.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.135 -0.978 . . . . 1.3700000000000001 109.508 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -97.11 28.39 3.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.172 -0.955 . . . . 2.6200000000000001 109.185 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -85.72 141.32 29.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 2.3500000000000001 109.691 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -84.87 130.21 34.69 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.487 -0.931 . . . . 2.3500000000000001 108.487 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.3 pt -88.18 172.76 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.78000000000000003 110.25 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 34' ' ' ASP . 88.5 p -99.01 161.1 13.81 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.586 -0.894 . . . . 1.04 108.586 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.82 -7.06 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.855 -1.153 . . . . 1.05 109.893 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 32' ' ' SER . 38.2 m-20 -83.38 -15.01 51.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.978 -1.076 . . . . 2.4700000000000002 110.517 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -117.55 0.46 12.11 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.366 -0.834 . . . . 1.46 109.758 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 t -68.64 -49.36 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.937 -1.102 . . . . 0.77000000000000002 109.593 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -59.67 -30.61 68.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.2 -0.937 . . . . 1.46 108.477 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.487 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 1.5 mp0 -70.67 -39.09 73.76 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.254 0.549 . . . . 2.29 110.023 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -64.45 -37.13 86.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.105 -0.997 . . . . 1.3 109.5 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.33 -45.55 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.804 . . . . 0.76000000000000001 109.401 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.85 -37.95 89.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 1.5 108.543 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.602 ' HG2' HH11 ' A' ' 42' ' ' ARG . 4.6 mtt-85 -67.05 -41.08 87.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.048 -0.723 . . . . 2.6600000000000001 109.048 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -81.82 -41.93 20.38 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.372 -0.83 . . . . 0.75 109.537 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 tp -64.6 -61.34 2.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.166 -0.959 . . . . 0.82999999999999996 108.569 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.0 t -65.4 -36.19 83.2 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.444 -0.785 . . . . 0.78000000000000003 108.992 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -50.84 -56.97 11.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.302 -1.919 . . . . 0.56999999999999995 108.302 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HB3' HH11 ' A' ' 47' ' ' ARG . 1.7 ttt-85 -47.04 -32.42 3.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.565 -0.962 . . . . 2.8300000000000001 108.735 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.21 -32.54 64.5 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.028 -1.101 . . . . 0.65000000000000002 108.028 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 46' ' ' GLY . 93.5 mttt -81.33 -58.99 2.79 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.026 -0.731 . . . . 2.5699999999999998 109.026 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.93 -44.71 64.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.095 -1.003 . . . . 0.51000000000000001 110.148 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 65.5 p -61.43 -37.62 84.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.159 -0.963 . . . . 1.3600000000000001 108.67 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.68 -42.12 61.72 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.394 0.616 . . . . 0.59999999999999998 109.401 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -67.29 -58.49 4.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.813 . . . . 1.3600000000000001 109.585 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.9 mt -52.35 -47.11 66.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.119 -0.988 . . . . 1.3799999999999999 108.875 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 51' ' ' SER . 6.2 mm-40 -52.25 -47.27 65.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.555 -0.715 . . . . 1.27 109.196 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m -58.6 -38.12 77.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.59999999999999998 108.83 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.1 mt -75.12 -31.94 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 0.53000000000000003 108.813 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -54.89 -50.11 69.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.439 -0.788 . . . . 0.98999999999999999 109.85 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.401 HG22 ' OE1' ' A' ' 63' ' ' GLU . 3.0 m -70.22 -29.92 66.87 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.333 -0.854 . . . . 0.58999999999999997 110.58 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -69.8 -14.92 63.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.712 -1.242 . . . . 1.8100000000000001 108.211 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.48 -36.92 21.94 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.699 -0.852 . . . . 0.47999999999999998 108.699 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.39 -26.64 42.57 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.68 -1.248 . . . . 0.57999999999999996 109.984 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.401 ' OE1' HG22 ' A' ' 59' ' ' THR . 32.3 mt-10 -86.82 -17.1 34.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.075 -1.25 . . . . 1.3899999999999999 109.413 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.9 m -96.3 -47.58 5.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.284 -0.885 . . . . 0.81999999999999995 110.168 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -106.24 -15.57 14.81 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.071 -1.018 . . . . 0.98999999999999999 110.702 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 118.37 140.83 6.51 Favored Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.057 -1.617 . . . . 0.55000000000000004 109.057 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -47.45 -11.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -1.155 . . . . 2.5899999999999999 110.542 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 66' ' ' GLY . 55.0 tt0 -61.27 -30.91 70.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.581 -1.324 . . . . 2.2000000000000002 109.905 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -92.01 -10.47 39.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.891 -1.131 . . . . 1.79 110.171 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -66.85 -35.12 79.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.042 -1.036 . . . . 1.54 110.187 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.06 -30.04 70.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.64000000000000001 110.382 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -69.01 -42.76 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.941 -1.099 . . . . 0.57999999999999996 108.725 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -77.8 -21.68 51.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.888 . . . . 0.62 109.53 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.52 -38.05 89.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.12 -0.987 . . . . 1.23 108.662 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.19 -35.76 52.38 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.046 -1.621 . . . . 0.52000000000000002 109.046 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.24 -20.9 64.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -1.117 . . . . 1.29 110.339 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.6 mt -84.09 -38.28 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.763 -1.21 . . . . 0.55000000000000004 108.384 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.4 ttt -59.68 -36.39 76.37 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.272 -0.892 . . . . 1.8899999999999999 108.776 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.3 tp -65.13 -38.82 91.87 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.812 -1.181 . . . . 0.53000000000000003 107.812 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.0 tp -73.25 -44.08 60.06 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.771 -0.772 . . . . 0.42999999999999999 109.466 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -85.75 5.72 31.06 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.218 -0.927 . . . . 1.24 110.195 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -47.14 123.16 5.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.944 -1.097 . . . . 1.3100000000000001 110.046 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -66.94 -26.07 66.66 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.894 -0.78 . . . . 1.3500000000000001 108.894 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -74.87 -51.09 14.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.427 -0.796 . . . . 2.1600000000000001 109.11 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.68 -17.72 64.81 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.975 -1.09 . . . . 0.59999999999999998 109.12 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -74.17 -55.7 5.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.089 -1.007 . . . . 1.28 110.399 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -62.25 -29.89 70.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.393 -0.817 . . . . 1.28 110.215 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -72.21 -42.87 65.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 1.29 108.763 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.1 mt -59.85 -59.41 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.36 -1.348 . . . . 0.57999999999999996 107.36 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.1 mt -47.85 -62.77 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.902 -0.498 . . . . 0.78000000000000003 110.193 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -42.7 -63.28 0.81 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.291 -0.881 . . . . 0.85999999999999999 109.932 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.5 mt -46.58 -51.93 14.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 0.79000000000000004 109.688 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 79.5 mt -52.94 -41.93 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 0.70999999999999996 109.309 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -85.68 -37.18 19.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 2.0499999999999998 111.734 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -86.2 -33.36 20.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.781 -1.199 . . . . 1.5900000000000001 112.416 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 97' ' ' HIS . 53.3 mmtt -109.7 20.06 18.5 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.453 -1.405 . . . . 1.8899999999999999 110.058 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 96' ' ' LYS . 46.9 m80 42.45 46.02 3.98 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.371 -0.831 . . . . 1.3100000000000001 110.158 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 34.8 mtt -98.28 144.77 27.35 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.726 -0.842 . . . . 1.28 108.726 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.3 p -75.51 148.3 39.08 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.47 -0.769 . . . . 0.62 110.086 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.29 -31.5 21.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.46999999999999997 109.338 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -74.19 -42.2 60.22 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.016 -1.105 . . . . 2.0 108.016 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.26 -55.13 7.69 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.313 -0.555 . . . . 0.56000000000000005 109.909 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.68 76.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 0.47999999999999998 109.685 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.01 -38.93 73.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.44 109.623 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' GLU . 49.4 t-80 -67.77 -41.11 83.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.943 . . . . 1.4199999999999999 109.753 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -48.14 -53.8 15.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 1.26 110.026 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.0 t -57.79 -54.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.047 -1.033 . . . . 0.60999999999999999 109.222 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.8 mm -61.62 -20.31 22.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.355 -0.841 . . . . 0.64000000000000001 109.047 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 105' ' ' HIS . 48.8 tt0 -66.23 -40.69 90.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 2.2000000000000002 110.243 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -86.53 -21.43 51.27 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.38 -1.39 . . . . 0.81999999999999995 111.941 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -67.01 -59.36 3.54 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.526 -1.573 . . . . 1.27 108.208 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.93 -52.03 65.7 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 120.072 -0.651 . . . . 0.91000000000000003 109.473 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.1 m -59.77 -46.4 89.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.122 -0.986 . . . . 1.73 110.954 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -62.21 -31.93 72.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.768 -1.208 . . . . 1.04 110.632 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 mt -70.11 -28.61 65.53 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.545 -1.262 . . . . 1.03 109.512 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -68.74 -20.0 64.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.734 -1.229 . . . . 1.95 109.215 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -81.44 -7.64 59.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 1.71 108.873 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mt -88.91 140.17 29.71 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.217 -1.031 . . . . 1.26 108.217 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -97.18 64.84 1.96 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.332 -0.988 . . . . 2.8300000000000001 108.332 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -146.17 113.72 6.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.351 -0.843 . . . . 1.5800000000000001 110.069 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.637 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 18.7 mp0 -57.23 -16.18 7.67 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.787 -0.82 . . . . 2.7999999999999998 108.787 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -80.23 -63.28 1.44 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.336 -0.853 . . . . 1.02 109.244 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.9 mt -63.6 -23.88 67.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 1.0600000000000001 109.14 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -68.4 -51.13 47.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.053 -1.029 . . . . 2.3900000000000001 108.762 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -58.76 -18.78 34.77 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.27 -0.894 . . . . 2.2000000000000002 108.892 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -74.57 -27.89 60.7 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.638 -1.616 . . . . 2.0899999999999999 106.638 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.02 98.0 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.398 0.618 . . . . 0.85999999999999999 109.41 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.09 73.97 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.278 -0.889 . . . . 0.90000000000000002 109.649 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.2 -36.75 66.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 1.3500000000000001 109.375 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.1 t -72.64 -40.82 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.411 -0.806 . . . . 0.57999999999999996 109.062 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.494 HH12 ' CE ' ' A' ' 135' ' ' LYS . 15.5 ttt-85 -54.38 -40.8 68.51 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.265 -0.897 . . . . 3.2200000000000002 109.046 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.94 -32.56 73.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.595 -0.691 . . . . 1.3200000000000001 110.245 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 65.0 mt -69.29 -26.51 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.952 -1.093 . . . . 0.5 110.343 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.07 -49.14 6.51 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.438 -1.465 . . . . 0.44 109.438 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.494 ' CE ' HH12 ' A' ' 131' ' ' ARG . 1.5 mptp? -51.98 -46.66 64.93 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.519 -0.989 . . . . 2.71 109.387 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HG2' HH11 ' A' ' 136' ' ' ARG . 6.8 mtt-85 -62.19 -52.31 64.32 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.988 -1.116 . . . . 2.2000000000000002 107.988 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.28 -40.38 34.37 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.794 -0.566 . . . . 1.1299999999999999 109.609 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 140' ' ' ASN . 23.0 mt -69.08 -58.94 3.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 0.54000000000000004 110.005 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 144' ' ' LEU . 89.9 mtt180 -44.52 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 2.3199999999999998 110.875 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 138' ' ' LEU . 8.0 m120 -85.34 -51.15 6.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.815 -1.178 . . . . 1.26 109.173 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.5 mt -55.88 -38.13 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 0.62 108.94 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 35.1 mt -86.21 1.29 51.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.486 -0.759 . . . . 0.67000000000000004 109.006 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.69 30.95 60.12 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.204 -1.958 . . . . 0.68000000000000005 108.204 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 139' ' ' ARG . 4.7 tp -73.78 145.3 45.16 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.559 -0.965 . . . . 0.77000000000000002 109.755 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -67.48 139.52 57.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -0.784 . . . . 2.3999999999999999 110.12 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 mt -109.44 142.79 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.579 -0.897 . . . . 0.87 108.579 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.58 HD12 ' H ' ' A' ' 147' ' ' ILE . 5.2 mp -75.73 119.94 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 1.3200000000000001 109.773 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.6 OUTLIER -95.85 91.86 6.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.81 . . . . 1.54 109.446 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 mt -79.77 -18.14 51.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.598 -0.689 . . . . 0.77000000000000002 109.276 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.6 p -79.46 23.4 0.4 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.945 . . . . 1.5700000000000001 109.66 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.99 25.9 2.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.053 -1.03 . . . . 0.81999999999999995 110.017 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 74.4 mt -71.75 152.7 8.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.085 -1.009 . . . . 0.81999999999999995 109.351 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -141.11 9.57 2.11 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.594 -0.891 . . . . 2.1099999999999999 108.594 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -123.17 124.88 44.04 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.759 -0.83 . . . . 1.4099999999999999 108.759 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.61 115.35 5.12 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.141 -0.974 . . . . 1.3 108.932 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.8 m -148.31 174.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.169 -0.957 . . . . 0.56999999999999995 109.431 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 13.9 mt -93.35 160.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.851 -1.166 . . . . 0.42999999999999999 107.851 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 19' ' ' LEU . 14.3 tp -108.27 122.86 47.82 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.472 -0.767 . . . . 0.56000000000000005 109.873 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.89 129.76 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.398 0.618 . . . . 0.54000000000000004 109.713 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -165.99 159.33 15.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 0.62 110.376 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.92 -42.7 94.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.63 -1.294 . . . . 0.80000000000000004 108.1 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 48.1 t0 -171.45 157.94 5.05 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.525 -0.735 . . . . 2.3399999999999999 109.39 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.417 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 27.6 mt -124.43 136.15 53.82 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.547 -0.721 . . . . 0.65000000000000002 109.539 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.2 p -95.4 152.33 39.23 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.254 -0.904 . . . . 0.73999999999999999 109.661 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -32.83 -54.2 0.38 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.984 2.456 . . . . 0.59999999999999998 113.219 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.7 m -51.06 -57.1 9.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -0.97 . . . . 0.63 109.445 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -54.52 -38.22 66.29 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 1.25 109.536 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 33.7 p -76.46 -20.19 57.28 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.317 -0.864 . . . . 0.5 109.751 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.46 -23.74 34.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.51000000000000001 109.664 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -104.52 -10.23 17.78 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.322 -0.861 . . . . 1.1699999999999999 110.349 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.7 tp -64.02 144.37 57.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.954 -1.091 . . . . 0.60999999999999999 108.615 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -95.46 140.71 29.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.876 -1.14 . . . . 2.1200000000000001 108.969 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.9 mp -85.65 -41.13 15.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 1.3400000000000001 111.025 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -77.99 -12.06 59.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.712 -1.243 . . . . 1.97 111.807 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -101.27 -5.83 24.97 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.678 -1.263 . . . . 1.8999999999999999 108.86 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 177' ' ' LEU . 74.1 t -100.52 163.43 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.407 -0.808 . . . . 0.47999999999999998 109.059 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.531 ' N ' HG12 ' A' ' 176' ' ' VAL . 4.8 tp -120.38 -17.25 8.24 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.466 -0.771 . . . . 1.3899999999999999 109.715 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.27 172.71 42.98 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.271 -1.531 . . . . 0.38 109.271 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -125.52 121.9 35.04 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.42 -1.047 . . . . 0.46000000000000002 108.962 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.73 125.56 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.313 -1.365 . . . . 0.58999999999999997 107.313 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 203' ' ' VAL . 2.2 p -135.08 141.35 46.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.356 0.598 . . . . 0.67000000000000004 109.7 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -89.79 37.01 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.505 -0.747 . . . . 2.2400000000000002 109.004 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -105.53 121.42 43.91 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.467 -0.771 . . . . 1.1100000000000001 109.542 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -86.14 69.21 3.21 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.359 -1.096 . . . . 1.6299999999999999 110.359 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.438 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -110.72 108.87 2.49 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.11 -1.596 . . . . 1.47 109.11 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -47.06 -22.32 0.33 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.083 -1.245 . . . . 5.2400000000000002 108.666 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.438 ' N ' ' C ' ' A' ' 185' ' ' GLY . 7.0 p -141.71 66.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.05 -1.093 . . . . 2.9199999999999999 108.05 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 191' ' ' SER . 13.5 t -78.16 140.64 38.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.428 -0.795 . . . . 1.6000000000000001 109.76 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -44.01 -51.86 7.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 0.92000000000000004 110.025 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 47.1 m -54.8 -31.19 58.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.188 -0.945 . . . . 1.5900000000000001 109.616 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 188' ' ' SER . 4.1 t -68.73 -35.94 77.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.351 -0.843 . . . . 1.4199999999999999 109.224 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.0 mm -60.31 -37.82 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 1.4099999999999999 109.856 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.5 mtm -70.59 -46.56 63.21 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.78 -1.193 . . . . 0.85999999999999999 107.78 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.0 74.38 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.673 -0.642 . . . . 0.58999999999999997 110.005 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -67.81 -43.54 79.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 3.0600000000000001 109.804 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.2 m -71.44 -37.33 71.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.933 . . . . 0.72999999999999998 109.967 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 199' ' ' LEU . 23.8 mt -88.03 3.36 49.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.872 . . . . 0.67000000000000004 109.111 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 50.54 2.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.494 -0.754 . . . . 1.49 110.902 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 197' ' ' LEU . 79.4 mt -65.88 167.62 11.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.015 -1.476 . . . . 0.64000000000000001 107.015 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -90.93 145.59 3.65 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 C-N-CA 122.069 1.846 . . . . 0.58999999999999997 111.646 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.57 179.98 6.85 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.579 -1.248 . . . . 0.55000000000000004 111.16 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 34.0 mt -149.38 155.6 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.008 -1.849 . . . . 0.63 106.008 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 181' ' ' THR . 15.8 m -137.28 -34.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.023 -1.048 . . . . 0.77000000000000002 111.915 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.41 45.09 3.1 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 120.469 -1.395 . . . . 0.87 111.248 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.6 p -72.56 1.0 8.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.334 -1.686 . . . . 0.89000000000000001 109.76 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.3 -98.78 0.84 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.828 -1.309 . . . . 0.93000000000000005 109.828 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.7 p -131.19 35.6 3.9 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.422 -1.046 . . . . 1.6000000000000001 111.815 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.0 t -50.47 -28.95 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.356 -1.465 . . . . 0.75 109.077 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.414 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 5.2 p -65.23 -11.95 46.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.923 -1.11 . . . . 0.83999999999999997 108.775 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -104.67 11.65 33.81 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.892 -0.781 . . . . 1.6100000000000001 108.892 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -128.53 -31.66 2.23 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.477 -0.764 . . . . 2.2999999999999998 110.278 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 213' ' ' LYS . 53.4 t -115.39 155.85 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.324 -0.86 . . . . 0.76000000000000001 110.008 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.44 ' O ' HG12 ' A' ' 212' ' ' VAL . 16.2 mmmt -114.8 -171.24 1.9 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.27 -1.382 . . . . 2.0099999999999998 107.27 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.429 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 11.6 p30 -81.11 149.72 29.05 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.097 -1.002 . . . . 2.1899999999999999 110.648 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.3 m-20 80.91 -12.81 0.98 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 116.067 -0.515 . . . . 2.3999999999999999 110.982 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -56.89 145.76 28.81 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.711 -1.243 . . . . 1.99 107.774 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -88.3 121.29 30.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.869 -1.144 . . . . 1.3 109.636 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.2 mt -123.81 161.9 24.33 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.82 0.819 . . . . 0.53000000000000003 109.911 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.4 mt -134.86 118.8 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.747 -1.205 . . . . 0.59999999999999998 107.747 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 8.9 tp -90.08 120.31 31.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.42 -0.8 . . . . 0.56999999999999995 109.528 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 53.6 t0 -94.42 -27.76 15.86 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.224 -1.028 . . . . 2.2200000000000002 108.224 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.87 24.25 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.131 0.491 . . . . 0.75 110.709 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 10.5 t -117.14 -62.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 106.733 -1.58 . . . . 0.92000000000000004 106.733 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -87.35 15.76 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.991 -1.114 . . . . 2.3599999999999999 107.991 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.8 t30 55.86 54.17 8.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.625 -0.672 . . . . 1.4199999999999999 109.343 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -150.04 144.38 25.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.355 -0.84 . . . . 1.97 110.29 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.54 153.39 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.289 -1.004 . . . . 0.65000000000000002 108.289 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -110.64 126.07 54.1 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.354 -0.841 . . . . 0.96999999999999997 108.882 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.11 118.02 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.509 -0.744 . . . . 0.67000000000000004 109.939 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 55.14 70.9 1.43 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 1.45 110.249 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -90.09 149.51 4.7 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.308 2.672 . . . . 0.81999999999999995 111.986 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.5 m -75.19 163.23 27.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 1.6200000000000001 109.86 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -67.11 -32.22 73.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.343 -0.848 . . . . 2.6000000000000001 110.121 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.48 -35.53 77.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.225 -0.922 . . . . 3.0600000000000001 109.282 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.68 -38.86 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.865 . . . . 1.1399999999999999 109.3 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.548 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 79.4 mt -64.2 -58.57 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -0.902 . . . . 1.04 110.074 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -42.21 75.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 2.54 109.886 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -65.22 -36.09 83.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.946 . . . . 2.6000000000000001 109.096 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 243' ' ' GLN . 54.4 mtp -79.08 -33.71 44.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 1.23 109.041 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -50.07 -43.46 51.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.745 -1.222 . . . . 2.6699999999999999 109.438 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.47 -55.61 6.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 1.6599999999999999 110.156 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.8 t -66.32 -46.94 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 2.2000000000000002 109.77 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 239' ' ' MET . 0.9 OUTLIER -55.14 -57.92 9.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 3.0 110.192 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -61.63 -22.89 65.64 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.879 -1.138 . . . . 1.76 109.705 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -68.36 -24.83 64.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.796 -1.187 . . . . 2.7799999999999998 107.796 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 74.1 t -74.83 -39.9 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.41 -0.959 . . . . 2.0600000000000001 108.41 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.0 -32.8 66.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.388 -0.82 . . . . 2.3999999999999999 108.92 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -80.69 -30.03 36.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 2.8700000000000001 109.416 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 108.537 -0.912 . . . . 3.4100000000000001 108.537 179.797 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.582 ' SD ' ' NE2' ' A' ' 226' ' ' GLN . 14.4 mmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.636 -0.505 . . . . 3.6600000000000001 109.636 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.6 mt -67.15 98.39 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.052 -1.03 . . . . 1.1200000000000001 108.782 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.3 m -98.42 121.86 40.89 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.353 -0.842 . . . . 1.45 109.609 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.89 -160.13 11.13 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.315 -1.514 . . . . 0.92000000000000004 109.315 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.3 mt -95.67 -9.92 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.332 -1.099 . . . . 1.05 108.799 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.442 HD13 HD21 ' A' ' 225' ' ' ASN . 5.5 tp 60.67 111.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.417 -0.802 . . . . 0.88 109.413 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.68 -52.91 5.25 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.325 -0.991 . . . . 0.78000000000000003 108.325 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.63 146.4 22.22 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 108.5 -0.926 . . . . 1.5 108.5 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.94 149.26 32.78 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.42 2.08 . . . . 0.85999999999999999 114.262 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.75 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.8 179.77 34.82 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.135 -1.586 . . . . 0.78000000000000003 109.135 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.449 HG21 ' NE2' ' A' ' 243' ' ' GLN . 42.0 mt -139.0 130.43 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.13 -1.218 . . . . 0.73999999999999999 109.495 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.47 151.08 41.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.364 -0.835 . . . . 0.45000000000000001 109.74 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.2 m-85 -122.44 138.24 54.61 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.07 -1.085 . . . . 0.64000000000000001 108.07 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.89 168.46 38.66 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 118.769 -1.681 . . . . 0.45000000000000001 111.564 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -80.71 147.48 30.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.683 -0.892 . . . . 1.8799999999999999 110.083 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -80.81 127.58 32.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.58999999999999997 111.322 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -105.49 96.99 6.89 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.08 -1.452 . . . . 0.64000000000000001 107.08 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.456 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 11.9 tp -80.4 120.04 23.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.956 -1.09 . . . . 0.73999999999999999 110.666 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.69 98.57 9.4 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.836 -0.62 . . . . 0.73999999999999999 109.406 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -93.23 159.24 15.36 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.66 -0.867 . . . . 1.8700000000000001 108.66 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -130.45 122.16 27.21 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.243 -0.911 . . . . 2.5800000000000001 109.467 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -81.62 131.76 35.28 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.35 -0.844 . . . . 2.1400000000000001 109.262 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -63.98 147.2 52.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 1.9299999999999999 109.638 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.7 mt -91.87 136.38 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.22 -0.925 . . . . 0.68000000000000005 109.709 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 t -107.64 121.74 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.394 -0.816 . . . . 0.83999999999999997 109.397 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.3 mt -88.85 145.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.79000000000000004 109.94 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.68 120.55 35.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.321 -0.862 . . . . 1.3700000000000001 109.748 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -102.01 29.04 5.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.192 -0.943 . . . . 2.6200000000000001 109.58 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -75.36 147.34 40.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.995 . . . . 2.3500000000000001 110.0 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -87.49 116.18 25.42 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.22 -1.029 . . . . 2.3500000000000001 108.22 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.7 pt -84.18 171.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.897 -1.127 . . . . 0.78000000000000003 110.617 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -98.09 168.48 10.24 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.193 -0.669 . . . . 1.04 109.193 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.31 -22.3 66.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 1.05 109.581 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.14 -7.39 58.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 2.4700000000000002 108.609 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -107.77 -9.21 15.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.53 -0.915 . . . . 1.46 108.53 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -67.93 -47.04 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.77000000000000002 108.979 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -51.46 -36.07 42.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 1.46 109.11 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.61 -32.61 71.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 2.29 109.928 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -61.8 -47.02 87.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.99 -1.069 . . . . 1.3 109.51 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 44' ' ' LEU . 85.6 t -61.51 -47.19 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.355 -0.84 . . . . 0.76000000000000001 110.016 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.28 -40.65 97.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.058 -1.026 . . . . 1.5 108.367 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -65.86 -32.35 73.81 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.81 -0.811 . . . . 2.6600000000000001 108.81 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -86.37 -56.68 3.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.75 108.972 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 40' ' ' VAL . 29.3 tp -51.54 -63.38 1.15 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.821 -0.807 . . . . 0.82999999999999996 108.821 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.5 t -61.73 -30.27 70.66 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.077 -1.082 . . . . 0.78000000000000003 108.077 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.65 -52.9 50.31 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.422 -2.271 . . . . 0.56999999999999995 107.422 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -48.5 -30.0 4.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.75 -0.853 . . . . 2.8300000000000001 108.76 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -62.5 -37.4 85.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.235 -1.024 . . . . 0.65000000000000002 108.235 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -81.73 -59.31 2.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.344 -0.613 . . . . 2.5699999999999998 109.344 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.7 -40.29 59.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.11 -0.994 . . . . 0.51000000000000001 109.832 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.7 t -62.75 -37.4 86.46 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.998 -1.064 . . . . 1.3600000000000001 108.221 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.76 -28.23 62.49 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.442 -0.577 . . . . 0.59999999999999998 109.442 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.484 ' NE2' ' OD1' ' A' ' 140' ' ' ASN . 90.3 mt-30 -72.07 -62.84 1.28 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.19 -0.944 . . . . 1.3600000000000001 109.109 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 54' ' ' LEU . 10.3 mp -51.93 -48.96 63.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 1.3799999999999999 108.466 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -49.81 -50.42 45.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.809 . . . . 1.27 109.218 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -63.13 -41.42 99.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.59999999999999998 109.655 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.4 mt -70.63 -34.85 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.53000000000000003 108.994 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -53.9 -45.1 71.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.284 -0.885 . . . . 0.98999999999999999 109.197 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 m -71.46 -24.26 61.97 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.266 -0.896 . . . . 0.58999999999999997 109.941 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.42 ' O ' ' OG1' ' A' ' 64' ' ' THR . 29.3 mttp -71.28 -33.11 69.45 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.748 -1.205 . . . . 1.8100000000000001 107.748 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.25 -34.11 76.75 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.793 -0.818 . . . . 0.47999999999999998 108.793 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.17 -30.23 25.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.678 -1.369 . . . . 0.57999999999999996 109.678 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -86.64 -12.3 48.88 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.823 -1.398 . . . . 1.3899999999999999 109.137 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 88.1 m -94.91 -46.96 6.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.2 -0.937 . . . . 0.81999999999999995 110.579 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -107.06 -34.71 7.08 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.111 -0.993 . . . . 0.98999999999999999 110.157 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 80.07 -41.29 2.4 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.969 -1.253 . . . . 0.55000000000000004 109.969 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 69' ' ' LYS . 67.3 mt-10 -50.51 178.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.241 . . . . 2.5899999999999999 109.573 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.62 43.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 2.2000000000000002 109.709 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 67' ' ' GLU . 15.9 mmmt -89.67 -17.91 27.48 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.557 -0.905 . . . . 1.79 108.557 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.65 -35.06 74.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.472 -0.767 . . . . 1.54 110.688 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.28 -22.24 66.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -0.978 . . . . 0.64000000000000001 110.412 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.48 -40.38 55.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.95 -1.094 . . . . 0.57999999999999996 109.508 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -76.6 -28.33 56.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.925 . . . . 0.62 109.616 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.66 -38.42 91.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.941 -1.099 . . . . 1.23 108.61 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.83 -32.38 61.24 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.578 -1.809 . . . . 0.52000000000000002 108.578 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -61.38 -18.79 60.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -1.07 . . . . 1.29 109.172 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.5 mt -85.67 -39.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.246 -1.02 . . . . 0.55000000000000004 108.246 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.3 ttt -58.8 -38.73 79.23 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.992 -0.744 . . . . 1.8899999999999999 108.992 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.9 tp -69.56 -43.76 72.26 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.852 -0.795 . . . . 0.53000000000000003 108.852 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.0 tp -64.72 -48.01 76.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.44 -0.788 . . . . 0.42999999999999999 109.483 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -84.4 13.14 5.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.836 . . . . 1.24 110.467 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -49.1 125.2 10.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.998 -1.064 . . . . 1.3100000000000001 109.695 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -67.69 -25.03 65.48 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.339 -0.851 . . . . 1.3500000000000001 108.756 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.62 -52.34 9.87 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.436 -0.79 . . . . 2.1600000000000001 109.528 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.7 mt -64.61 -15.65 61.49 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.036 -1.066 . . . . 0.59999999999999998 109.04 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -77.35 -43.4 33.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 1.28 109.801 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.03 -33.35 75.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -0.91 . . . . 1.28 110.405 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -72.77 -43.88 62.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 1.29 109.654 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.0 mt -57.36 -39.85 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.551 -0.907 . . . . 0.57999999999999996 108.551 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -67.5 -62.43 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.715 -0.615 . . . . 0.78000000000000003 110.27 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -50.07 -38.48 38.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.149 -0.969 . . . . 0.85999999999999999 109.834 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.6 -59.87 4.7 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.268 -0.895 . . . . 0.79000000000000004 108.676 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.7 mt -47.02 -44.26 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.70999999999999996 110.171 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -82.67 -31.44 28.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.161 -0.962 . . . . 2.0499999999999998 111.029 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 91' ' ' ALA . 66.9 t0 -79.25 -48.44 14.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.859 -1.15 . . . . 1.5900000000000001 111.778 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -106.71 21.06 18.09 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.82 -1.175 . . . . 1.8899999999999999 110.046 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 44.07 48.22 7.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -0.905 . . . . 1.3100000000000001 109.927 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtt -102.72 151.04 22.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.485 -0.759 . . . . 1.28 109.051 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.7 p -75.28 148.15 39.63 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.567 -0.708 . . . . 0.62 109.354 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.31 18.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.243 -0.911 . . . . 0.46999999999999997 109.167 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.31 -44.54 58.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.041 -1.096 . . . . 2.0 108.041 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.86 -52.92 15.0 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.647 -0.658 . . . . 0.56000000000000005 109.886 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.15 -49.46 76.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.47999999999999998 109.67 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.72 -33.98 61.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.44 109.893 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -68.97 -36.87 78.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.954 -1.091 . . . . 1.4199999999999999 109.525 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -58.76 -52.68 64.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.985 . . . . 1.26 109.674 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.1 t -56.41 -49.14 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.105 -0.997 . . . . 0.60999999999999999 109.299 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.41 -17.62 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.64000000000000001 109.18 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -73.58 -35.18 65.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.082 -1.011 . . . . 2.2000000000000002 109.976 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.25 -27.13 28.83 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.318 -1.42 . . . . 0.81999999999999995 112.338 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -67.25 -40.24 86.23 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.598 -1.531 . . . . 1.27 109.209 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.22 -52.18 8.49 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.393 -0.817 . . . . 0.91000000000000003 109.632 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.7 p -60.52 -42.13 95.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 1.73 110.245 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.54 -35.69 81.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.032 -1.042 . . . . 1.04 110.334 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.89 -27.55 65.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.854 -1.154 . . . . 1.03 109.599 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -69.14 -18.04 63.9 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.921 -1.112 . . . . 1.95 109.367 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -80.97 -4.81 56.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 1.71 109.348 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.5 mt -83.22 145.61 29.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 1.26 108.487 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -96.68 56.23 1.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.751 -0.833 . . . . 2.8300000000000001 108.751 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -146.25 117.27 7.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.303 -0.873 . . . . 1.5800000000000001 109.23 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.75 -16.77 18.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 2.7999999999999998 109.971 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.96 -65.6 0.95 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.935 . . . . 1.02 109.212 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.2 mt -61.1 -19.42 61.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 1.0600000000000001 109.116 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -67.79 -48.2 66.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.101 -0.999 . . . . 2.3900000000000001 108.36 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 50.3 mt-10 -61.85 -20.27 63.5 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.66 -0.867 . . . . 2.2000000000000002 108.66 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.527 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.5 OUTLIER -71.35 -29.53 65.08 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.6 -1.63 . . . . 2.0899999999999999 106.6 178.029 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.78 -50.66 72.96 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.957 -0.757 . . . . 0.85999999999999999 108.957 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.68 -37.48 76.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.90000000000000002 110.004 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 -68.18 -29.89 68.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.01 . . . . 1.3500000000000001 109.602 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.94 -40.49 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.221 -1.029 . . . . 0.57999999999999996 108.221 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' ' 131' ' ' ARG . 22.1 ttm-85 -56.0 -38.81 70.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.078 -1.082 . . . . 3.2200000000000002 108.078 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -61.51 -36.49 80.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.635 -0.666 . . . . 1.3200000000000001 109.93 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.6 mt -68.21 -30.81 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.036 -1.04 . . . . 0.5 109.492 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.49 -46.13 72.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.257 -1.937 . . . . 0.44 108.257 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -51.04 -44.61 61.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.78 -0.835 . . . . 2.71 109.253 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.542 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 69.4 mtt180 -62.57 -46.93 86.07 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.841 -1.17 . . . . 2.2000000000000002 107.841 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 137' ' ' LEU . 3.4 tt -52.28 -54.29 33.27 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.878 -0.786 . . . . 1.1299999999999999 108.878 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.93 -56.46 19.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.54000000000000004 109.586 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -44.74 -22.55 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 2.3199999999999998 111.068 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 61.6 m-80 -85.18 -42.48 14.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.801 -1.187 . . . . 1.26 110.074 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.35 -34.59 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.04 -1.038 . . . . 0.62 109.496 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.8 mt -90.98 -3.82 56.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.219 -0.926 . . . . 0.67000000000000004 109.395 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.32 29.99 63.94 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.16 -1.976 . . . . 0.68000000000000005 108.16 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.76 148.83 45.94 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.527 -0.984 . . . . 0.77000000000000002 109.686 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -68.84 147.69 51.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 2.3999999999999999 109.317 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 147' ' ' ILE . 78.0 mt -102.67 157.75 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.87 108.724 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.424 ' N ' HG22 ' A' ' 146' ' ' ILE . 11.6 mm -76.85 104.06 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.057 -1.027 . . . . 1.3200000000000001 109.444 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -102.18 90.3 3.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.564 -0.71 . . . . 1.54 110.276 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.2 mt -80.03 -7.15 58.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.77000000000000002 108.703 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.9 t -83.97 40.69 0.77 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -0.792 . . . . 1.5700000000000001 109.905 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.61 19.09 2.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.218 -0.926 . . . . 0.81999999999999995 109.006 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 60.1 mt -73.76 150.34 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.547 -0.721 . . . . 0.81999999999999995 109.593 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -141.3 2.36 1.67 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.339 -0.85 . . . . 2.1099999999999999 109.153 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -127.59 132.39 49.83 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.089 -0.708 . . . . 1.4099999999999999 109.089 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -63.04 120.51 11.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.915 . . . . 1.3 109.794 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.0 m -150.3 175.81 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.24 -0.912 . . . . 0.56999999999999995 109.421 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.2 mt -90.8 157.56 2.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.948 -1.131 . . . . 0.42999999999999999 107.948 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.7 tp -107.64 122.2 46.22 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.547 -0.721 . . . . 0.56000000000000005 109.212 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.7 t -123.75 132.59 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.311 0.577 . . . . 0.54000000000000004 109.504 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.44 144.84 12.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.62 109.491 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 183' ' ' ALA . . . -60.53 -32.82 71.84 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.464 -1.397 . . . . 0.80000000000000004 107.846 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -172.64 155.95 3.44 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.585 -0.697 . . . . 2.3399999999999999 109.413 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.0 mt -130.73 132.08 45.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.553 -0.717 . . . . 0.65000000000000002 109.319 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 p -92.33 152.89 42.77 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.262 -0.899 . . . . 0.73999999999999999 109.119 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -36.36 -43.71 0.83 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.322 2.014 . . . . 0.59999999999999998 112.189 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.542 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -54.16 -63.7 1.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.63 108.938 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -48.46 -40.27 25.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 1.25 109.362 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.2 p -71.04 -23.52 62.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 0.5 109.792 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.55 -29.36 46.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.912 . . . . 0.51000000000000001 110.285 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -104.54 -7.63 19.61 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.275 -0.891 . . . . 1.1699999999999999 110.077 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.1 tp -57.36 135.67 56.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.822 -1.174 . . . . 0.60999999999999999 108.08 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.404 ' O ' HG23 ' A' ' 176' ' ' VAL . 38.2 t-20 -99.89 120.7 40.19 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.221 -0.925 . . . . 2.1200000000000001 110.048 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 173' ' ' LEU . 7.9 mp -93.58 45.99 1.18 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.843 . . . . 1.3400000000000001 108.741 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -109.54 -27.47 9.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.404 -0.81 . . . . 1.97 109.02 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -131.2 11.86 5.04 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.439 -0.788 . . . . 1.8999999999999999 109.643 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 172' ' ' ASN . 66.7 t -82.85 154.29 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.112 -0.993 . . . . 0.47999999999999998 109.494 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.0 tp -117.47 -12.2 10.43 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.719 -0.613 . . . . 1.3899999999999999 109.547 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 163.99 179.84 38.49 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.61 -1.396 . . . . 0.38 109.61 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.489 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 1.6 m-85 -130.44 124.95 33.23 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.557 -0.966 . . . . 0.46000000000000002 109.635 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.8 mt -128.54 126.6 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.887 -1.153 . . . . 0.58999999999999997 107.887 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.501 ' O ' ' O ' ' A' ' 203' ' ' VAL . 40.7 p -142.01 149.36 39.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 0.67000000000000004 110.549 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.44 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 4.6 p30 -100.28 43.69 1.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.323 -0.861 . . . . 2.2400000000000002 109.268 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 161' ' ' ALA . . . -133.88 29.96 3.74 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.424 -0.797 . . . . 1.1100000000000001 110.323 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -47.71 148.84 3.43 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 120.584 -1.322 . . . . 1.6299999999999999 111.029 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -154.4 173.31 32.91 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.26 -1.536 . . . . 1.47 109.26 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.462 ' O ' ' OG1' ' A' ' 187' ' ' THR . 42.9 mtm-85 -55.7 87.6 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.102 -1.073 . . . . 5.2400000000000002 108.102 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.559 ' N ' ' O ' ' A' ' 185' ' ' GLY . 20.4 p 54.96 62.79 2.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.552 -0.717 . . . . 2.9199999999999999 109.418 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 m -75.3 160.21 30.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.08 -1.012 . . . . 1.6000000000000001 109.483 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -45.8 -43.76 13.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -0.891 . . . . 0.92000000000000004 109.95 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.2 p -52.95 -45.43 67.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 1.5900000000000001 109.924 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.5 t -68.31 -39.28 82.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 1.4199999999999999 110.041 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.5 mm -50.44 -38.52 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 1.4099999999999999 110.34 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 mtp -72.05 -59.57 2.67 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.7 -1.222 . . . . 0.85999999999999999 107.7 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.69 -31.09 35.59 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.761 -0.654 . . . . 0.58999999999999997 109.847 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -78.95 -47.37 16.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 3.0600000000000001 109.898 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.8 m -69.51 -36.17 76.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.031 -1.043 . . . . 0.72999999999999998 109.755 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 199' ' ' LEU . 29.0 mt -86.53 0.06 55.09 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 0.67000000000000004 108.927 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 47.81 10.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 1.49 111.051 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 197' ' ' LEU . 22.0 mt -66.79 161.01 65.14 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.801 -1.187 . . . . 0.64000000000000001 108.597 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -79.38 127.88 7.67 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.188 1.259 . . . . 0.58999999999999997 111.172 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -163.87 179.04 7.32 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.844 -1.142 . . . . 0.55000000000000004 110.871 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.6 mt -146.35 162.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.001 -1.481 . . . . 0.63 107.001 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 184' ' ' GLY . 15.6 m -147.84 -28.2 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.718 -1.239 . . . . 0.77000000000000002 111.408 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.447 ' HA2' ' H ' ' A' ' 184' ' ' GLY . . . -93.9 26.94 14.18 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 120.901 -1.125 . . . . 0.87 110.328 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.425 ' HB ' HG23 ' A' ' 208' ' ' VAL . 30.8 p -52.61 -41.06 63.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.833 -1.392 . . . . 0.89000000000000001 108.738 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.44 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 76.92 -38.1 1.51 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 120.781 -0.724 . . . . 0.93000000000000005 113.837 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 83.8 p -130.19 27.28 5.11 Favored 'General case' 0 N--CA 1.514 2.773 0 CA-C-N 119.939 1.869 . . . . 1.6000000000000001 113.256 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.425 HG23 ' HB ' ' A' ' 205' ' ' THR . 5.5 t -79.3 -41.94 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.133 -1.604 . . . . 0.75 110.323 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 p -64.65 -12.89 50.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.668 -1.27 . . . . 0.83999999999999997 110.137 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.8 p -106.17 11.84 30.84 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 1.6100000000000001 109.407 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -144.23 4.63 1.24 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.243 -0.91 . . . . 2.2999999999999998 110.588 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.5 t -126.93 151.37 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.305 -0.872 . . . . 0.76000000000000001 109.524 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.506 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 42.6 mmtt -129.25 166.85 18.61 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.048 -1.464 . . . . 2.0099999999999998 107.048 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 67.7 m-80 -64.14 143.47 57.85 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.8 -1.187 . . . . 2.1899999999999999 110.616 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 73.9 -2.44 2.78 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.797 -0.564 . . . . 2.3999999999999999 110.623 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.506 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 44.1 m-20 -57.51 142.26 44.9 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.914 -1.116 . . . . 1.99 108.673 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -86.52 107.22 18.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.44 -0.948 . . . . 1.3 108.44 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' A' ' 16' ' ' ALA . 40.8 mt -122.51 154.01 38.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.548 -0.72 . . . . 0.53000000000000003 110.139 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.419 HG23 ' CD2' ' A' ' 13' ' ' PHE . 49.8 mt -126.04 122.82 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.501 -0.926 . . . . 0.59999999999999998 108.501 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.5 tp -90.59 120.38 31.62 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.524 -0.917 . . . . 0.56999999999999995 108.524 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.3 m-20 -97.19 -29.79 13.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.215 -0.928 . . . . 2.2200000000000002 109.546 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.5 21.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.912 -0.492 . . . . 0.75 110.422 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -115.96 -51.66 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 106.967 -1.494 . . . . 0.92000000000000004 106.967 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -96.46 10.85 37.0 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.112 -1.44 . . . . 2.3599999999999999 107.112 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.442 HD21 HD13 ' A' ' 6' ' ' LEU . 20.1 t-20 56.23 54.72 7.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.972 -0.751 . . . . 1.4199999999999999 108.972 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.582 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 65.9 tt0 -153.99 150.59 28.44 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.917 0.865 . . . . 1.97 110.171 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 78.2 t -115.11 152.22 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.308 -0.997 . . . . 0.65000000000000002 108.308 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -108.54 121.32 44.74 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.217 -0.927 . . . . 0.96999999999999997 109.45 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.69 114.98 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.574 -0.704 . . . . 0.67000000000000004 109.518 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 69.02 67.5 0.47 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.659 -0.651 . . . . 1.45 109.671 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -86.33 130.42 3.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 123.057 2.505 . . . . 0.81999999999999995 112.498 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.3 p -74.02 162.27 29.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 1.6200000000000001 109.594 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -64.06 -44.03 93.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 2.6000000000000001 109.828 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -53.27 -36.69 61.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.394 -0.816 . . . . 3.0600000000000001 109.384 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.2 t -76.74 -37.1 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.678 -0.86 . . . . 1.1399999999999999 108.678 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 75.3 mt -71.62 -57.4 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 1.04 109.344 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -51.07 -44.89 61.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -0.781 . . . . 2.54 110.014 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -65.33 -32.32 73.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 2.6000000000000001 108.93 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 243' ' ' GLN . 77.1 mtp -81.94 -42.46 19.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.404 -0.81 . . . . 1.23 109.555 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -47.45 -39.28 15.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.035 -1.04 . . . . 2.6699999999999999 109.82 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.36 -63.35 1.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.109 -0.995 . . . . 1.6599999999999999 110.394 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.8 t -66.08 -51.4 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.103 -0.998 . . . . 2.2000000000000002 110.198 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 239' ' ' MET . 45.8 tt0 -47.92 -47.44 32.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.078 -1.014 . . . . 3.0 109.635 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.23 -29.14 70.26 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.828 -1.17 . . . . 1.76 108.939 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -67.92 -21.29 65.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.965 -1.124 . . . . 2.7799999999999998 107.965 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 41.9 t -72.88 -31.84 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.338 -1.356 . . . . 2.0600000000000001 107.338 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.22 84.18 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.054 -0.721 . . . . 2.3999999999999999 109.054 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.9 m -77.49 -30.74 53.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.394 -0.816 . . . . 2.8700000000000001 109.734 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 120.963 -1.086 . . . . 3.4100000000000001 108.331 179.354 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 3' ' ' SER . 80.4 mtp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.338 0.59 . . . . 3.6600000000000001 109.494 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.428 HG23 ' CG2' ' A' ' 208' ' ' VAL . 83.5 mt -58.42 81.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 1.1200000000000001 109.604 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 1' ' ' MET . 1.5 m -98.22 113.79 25.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.259 -0.901 . . . . 1.45 109.725 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.95 -163.62 20.39 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 108.665 -1.774 . . . . 0.92000000000000004 108.665 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 5' ' ' ILE . 59.9 mt -96.96 -6.59 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.033 -1.275 . . . . 1.05 108.918 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.1 tp 53.46 104.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.515 -0.74 . . . . 0.88 109.206 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.78 -51.46 6.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.996 . . . . 0.78000000000000003 109.342 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -144.97 149.48 42.57 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.318 -0.864 . . . . 1.5 109.019 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HA ' ' HB1' ' A' ' 222' ' ' ALA . 63.1 Cg_endo -80.14 154.78 22.34 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.372 2.048 . . . . 0.85999999999999999 113.732 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.99 138.32 2.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.597 -1.401 . . . . 0.78000000000000003 109.597 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.2 mt -96.73 132.49 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.186 -1.185 . . . . 0.73999999999999999 109.388 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.474 ' HB1' HD12 ' A' ' 177' ' ' LEU . . . -139.35 157.37 46.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.33 -0.856 . . . . 0.45000000000000001 110.344 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.585 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -130.69 134.73 47.17 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.25 -1.019 . . . . 0.64000000000000001 108.25 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.96 164.66 34.24 Favored Glycine 0 N--CA 1.503 3.102 0 C-N-CA 118.204 -1.95 . . . . 0.45000000000000001 111.813 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -77.62 146.55 36.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.576 -0.955 . . . . 1.8799999999999999 109.753 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.92 122.36 25.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.709 . . . . 0.58999999999999997 110.981 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 tp -100.82 94.67 6.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.845 -1.168 . . . . 0.64000000000000001 107.845 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.6 tp -81.97 112.74 19.34 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.01 -1.056 . . . . 0.73999999999999999 109.759 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 158' ' ' LEU . 93.7 mt -97.89 93.95 6.62 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.661 -0.7 . . . . 0.73999999999999999 109.783 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -92.62 159.16 15.59 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.598 -0.89 . . . . 1.8700000000000001 108.598 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -118.3 131.79 56.32 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.438 -0.789 . . . . 2.5800000000000001 109.678 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.5 127.04 31.64 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.488 -0.93 . . . . 2.1400000000000001 108.488 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -62.74 136.94 58.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 1.9299999999999999 109.292 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.4 mt -90.82 131.33 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.26 -0.9 . . . . 0.68000000000000005 110.194 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.33 122.77 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.655 -0.868 . . . . 0.83999999999999997 108.655 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -89.6 140.66 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.164 -0.96 . . . . 0.79000000000000004 110.028 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -90.66 128.95 36.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.22 -0.925 . . . . 1.3700000000000001 109.324 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -105.25 30.52 5.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.414 -0.803 . . . . 2.6200000000000001 109.959 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -76.24 144.03 40.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.117 -0.989 . . . . 2.3500000000000001 109.788 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -86.99 124.01 32.72 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.702 -0.851 . . . . 2.3500000000000001 108.702 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -90.64 170.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.102 -0.999 . . . . 0.78000000000000003 110.477 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.3 p -97.24 169.13 9.99 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.486 -0.561 . . . . 1.04 109.486 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.25 -25.62 68.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 1.05 109.433 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -80.22 -5.11 55.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 2.4700000000000002 109.239 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -109.96 -15.9 13.96 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.019 -1.104 . . . . 1.46 108.019 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.29 -42.88 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.102 -0.703 . . . . 0.77000000000000002 109.102 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -53.42 -36.17 61.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 1.46 109.374 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -69.62 -32.69 71.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 2.29 109.755 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -63.42 -41.92 98.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.152 -0.967 . . . . 1.3 109.267 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 44' ' ' LEU . 76.5 t -62.48 -49.01 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.412 -0.805 . . . . 0.76000000000000001 110.032 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -65.27 -45.02 86.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.04 . . . . 1.5 108.838 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -64.99 -31.75 73.15 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.704 -0.798 . . . . 2.6600000000000001 109.045 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -86.47 -59.36 2.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.078 -1.014 . . . . 0.75 108.733 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 40' ' ' VAL . 30.8 tp -47.94 -65.18 0.61 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.36 0.6 . . . . 0.82999999999999996 109.695 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.1 t -64.28 -37.72 88.49 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.518 -0.919 . . . . 0.78000000000000003 108.518 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.01 -52.41 49.25 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.355 -2.298 . . . . 0.56999999999999995 107.355 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.415 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.2 ttt-85 -51.41 -26.18 7.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.684 -0.892 . . . . 2.8300000000000001 109.033 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -73.73 -28.53 61.75 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.987 -1.116 . . . . 0.65000000000000002 107.987 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 46' ' ' GLY . 33.3 ttmt -75.48 -56.67 4.47 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.082 -0.711 . . . . 2.5699999999999998 109.082 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.42 -30.75 30.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.086 -1.009 . . . . 0.51000000000000001 109.566 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 10.1 p -65.07 -38.67 91.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 1.3600000000000001 108.906 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.87 -28.28 65.52 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.478 0.656 . . . . 0.59999999999999998 109.336 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -71.81 -67.66 0.51 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.764 . . . . 1.3600000000000001 109.602 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 54' ' ' LEU . 9.3 mp -51.04 -34.73 30.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 1.3799999999999999 108.819 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 51' ' ' SER . 9.5 mm-40 -63.88 -51.47 64.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.471 -0.768 . . . . 1.27 109.08 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -60.98 -34.56 74.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.59999999999999998 108.592 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.28 -25.29 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.574 -0.899 . . . . 0.53000000000000003 108.574 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -65.46 -44.47 87.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.559 -0.713 . . . . 0.98999999999999999 109.588 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -71.79 -27.15 62.74 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.3 -0.875 . . . . 0.58999999999999997 109.144 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -72.27 -29.68 64.12 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.769 -1.197 . . . . 1.8100000000000001 107.769 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.81 61.91 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.091 -1.077 . . . . 0.47999999999999998 108.091 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.7 -29.76 28.56 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.433 -1.467 . . . . 0.57999999999999996 109.433 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -86.55 -20.24 28.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -1.202 . . . . 1.3899999999999999 108.595 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -94.36 -46.89 6.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.81999999999999995 110.357 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -107.92 -27.16 10.35 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.111 -0.993 . . . . 0.98999999999999999 111.297 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.97 152.98 8.94 Favored Glycine 0 N--CA 1.506 3.337 0 N-CA-C 109.647 -1.381 . . . . 0.55000000000000004 109.647 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -50.2 -12.54 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -1.124 . . . . 2.5899999999999999 110.583 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 66' ' ' GLY . 27.7 tt0 -63.66 -31.22 72.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.988 . . . . 2.2000000000000002 110.454 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -91.08 -17.46 26.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.927 -1.108 . . . . 1.79 110.28 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -62.53 -28.87 70.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.986 -1.071 . . . . 1.54 109.941 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.22 -30.36 69.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.179 -0.951 . . . . 0.64000000000000001 109.604 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.38 -44.05 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -0.876 . . . . 0.57999999999999996 109.105 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -77.27 -24.49 51.05 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.465 -0.772 . . . . 0.62 109.664 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -63.9 -42.36 97.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.965 -1.084 . . . . 1.23 108.9 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.04 -36.24 80.49 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.928 -1.669 . . . . 0.52000000000000002 108.928 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.07 -18.56 61.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.445 -1.032 . . . . 1.29 110.661 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.3 mt -85.03 -46.36 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.618 -1.301 . . . . 0.55000000000000004 108.94 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 42.5 ttp -55.22 -49.16 72.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.36 -0.837 . . . . 1.8899999999999999 108.967 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tp -54.88 -43.44 73.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.407 -0.808 . . . . 0.53000000000000003 109.171 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.31 -44.1 80.03 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.383 -0.823 . . . . 0.42999999999999999 109.417 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -85.37 8.42 18.88 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.416 -0.803 . . . . 1.24 110.161 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -49.14 121.53 4.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.974 -1.079 . . . . 1.3100000000000001 109.666 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -66.84 -24.26 66.13 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.542 -0.91 . . . . 1.3500000000000001 108.542 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -75.57 -48.89 20.38 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.334 -0.854 . . . . 2.1600000000000001 109.249 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.7 mt -63.68 -15.09 57.46 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.032 -1.067 . . . . 0.59999999999999998 108.979 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -79.54 -45.64 18.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.438 -0.789 . . . . 1.28 110.041 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -64.56 -28.87 69.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.254 -0.904 . . . . 1.28 110.022 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.21 -46.25 35.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.196 -0.94 . . . . 1.29 109.889 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.7 mt -58.38 -55.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.06 -1.089 . . . . 0.57999999999999996 108.06 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.0 mt -45.14 -58.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.623 -0.673 . . . . 0.78000000000000003 109.872 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -49.04 -57.05 7.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.423 -0.798 . . . . 0.85999999999999999 110.418 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.2 mt -50.54 -56.49 11.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.426 -0.796 . . . . 0.79000000000000004 109.266 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.0 mt -47.4 -41.63 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.70999999999999996 109.784 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -86.19 -33.72 20.71 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.116 -0.99 . . . . 2.0499999999999998 111.974 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -79.34 -44.29 21.86 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.536 -1.353 . . . . 1.5900000000000001 111.757 -176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -105.76 15.47 26.73 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.722 -1.236 . . . . 1.8899999999999999 109.23 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.505 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 1.5 m80 45.41 55.47 6.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.391 -0.818 . . . . 1.3100000000000001 109.54 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 74.1 mtp -102.51 153.65 19.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.571 -0.706 . . . . 1.28 109.259 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.7 p -76.16 171.45 14.48 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.486 -0.759 . . . . 0.62 109.389 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.31 -28.47 62.1 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.758 . . . . 0.46999999999999997 109.668 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.13 -45.4 41.21 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.064 -1.087 . . . . 2.0 108.064 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.55 -52.33 22.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.714 -0.616 . . . . 0.56000000000000005 110.201 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.34 -48.75 80.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.47999999999999998 109.754 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.21 -35.25 67.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 0.44 109.606 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -68.77 -34.64 75.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.968 -1.082 . . . . 1.4199999999999999 109.641 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -53.43 -60.94 2.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.375 -0.828 . . . . 1.26 110.118 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.0 t -50.93 -48.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.953 -1.092 . . . . 0.60999999999999999 109.682 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -61.73 -20.62 23.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.39 -0.819 . . . . 0.64000000000000001 108.967 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.37 -37.86 74.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.089 -1.007 . . . . 2.2000000000000002 109.779 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 114' ' ' ALA . . . -87.2 -23.95 38.91 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.491 -1.338 . . . . 0.81999999999999995 112.843 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -67.1 -52.82 37.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.343 -1.681 . . . . 1.27 108.746 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.14 -52.44 59.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.563 -0.71 . . . . 0.91000000000000003 109.816 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.8 m -61.63 -32.58 72.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.128 -0.982 . . . . 1.73 109.992 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -63.04 -43.65 98.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.825 -1.172 . . . . 1.04 110.064 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 123' ' ' LEU . 12.2 mt -67.23 -22.66 65.68 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.541 -1.263 . . . . 1.03 109.249 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.82 -23.65 64.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.779 -1.2 . . . . 1.95 109.165 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -82.99 -8.87 59.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -0.847 . . . . 1.71 109.032 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 mt -84.34 148.02 26.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.418 -0.956 . . . . 1.26 108.418 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -98.66 61.3 1.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.751 . . . . 2.8300000000000001 109.927 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -152.09 118.69 5.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.016 -1.053 . . . . 1.5800000000000001 110.11 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -62.27 -13.78 31.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 2.7999999999999998 109.238 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -78.03 -61.15 2.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.499 -0.75 . . . . 1.02 109.251 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.472 ' O ' HD13 ' A' ' 115' ' ' LEU . 27.1 mt -62.92 -29.33 70.7 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.265 -0.897 . . . . 1.0600000000000001 109.92 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 71.5 tttt -66.4 -47.51 73.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.838 -1.164 . . . . 2.3900000000000001 108.162 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -57.67 -24.48 56.88 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.159 -1.052 . . . . 2.2000000000000002 108.159 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -73.17 -23.79 60.47 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.571 -1.64 . . . . 2.0899999999999999 106.571 178.037 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -61.0 -45.3 95.39 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.858 -0.793 . . . . 0.85999999999999999 108.858 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.41 -35.83 80.06 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.863 -0.735 . . . . 0.90000000000000002 109.025 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.5 m-20 -69.01 -36.3 77.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.418 -0.801 . . . . 1.3500000000000001 109.095 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.87 -42.98 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.995 -1.113 . . . . 0.57999999999999996 107.995 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.504 ' HG2' HH11 ' A' ' 131' ' ' ARG . 1.4 ttt-85 -54.77 -39.15 68.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.608 -0.886 . . . . 3.2200000000000002 108.608 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -60.18 -35.3 75.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.438 -0.789 . . . . 1.3200000000000001 109.497 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.1 mt -65.81 -26.14 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.5 109.053 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.94 -50.62 7.62 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.455 -1.458 . . . . 0.44 109.455 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -50.4 -47.36 56.45 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.444 -1.033 . . . . 2.71 109.994 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.408 ' NH1' ' HG2' ' A' ' 136' ' ' ARG . 58.9 mtt-85 -65.21 -46.29 81.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.947 -1.096 . . . . 2.2000000000000002 108.776 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.6 tp -54.19 -33.19 57.59 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.727 -0.608 . . . . 1.1299999999999999 109.705 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 140' ' ' ASN . 16.8 mt -76.79 -56.6 4.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.819 -1.176 . . . . 0.54000000000000004 109.687 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -46.24 -17.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.933 . . . . 2.3199999999999998 110.093 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.521 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.7 m120 -85.93 -37.14 19.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.978 . . . . 1.26 109.633 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.3 mt -72.84 -40.64 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.62 109.727 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.5 mt -86.67 1.93 50.25 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.668 -0.864 . . . . 0.67000000000000004 108.668 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.06 20.39 8.74 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.096 -2.002 . . . . 0.68000000000000005 108.096 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.5 tp -54.84 163.54 0.96 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.645 -0.915 . . . . 0.77000000000000002 109.146 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -68.18 143.62 55.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 2.3999999999999999 110.103 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.3 mt -111.39 137.55 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.508 -0.745 . . . . 0.87 109.141 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.447 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.9 mp -77.71 99.48 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 1.3200000000000001 109.085 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -99.38 92.29 5.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.413 -0.805 . . . . 1.54 109.64 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.417 HD21 ' CG2' ' A' ' 147' ' ' ILE . 22.0 mt -79.24 -9.71 59.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 0.77000000000000002 109.104 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.2 t -79.77 35.27 0.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 1.5700000000000001 108.979 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -142.67 18.29 2.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.399 -0.813 . . . . 0.81999999999999995 109.424 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.24 150.97 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 0.81999999999999995 110.13 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -145.86 11.89 1.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.293 -1.002 . . . . 2.1099999999999999 108.293 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -125.36 125.37 43.33 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.336 -0.987 . . . . 1.4099999999999999 108.336 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.82 115.27 4.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.359 -0.838 . . . . 1.3 109.29 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.29 178.62 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 0.56999999999999995 109.675 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 26.8 mt -93.8 153.14 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.834 -1.173 . . . . 0.42999999999999999 107.834 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 19' ' ' LEU . 25.4 tp -101.13 115.59 30.84 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.775 -0.824 . . . . 0.56000000000000005 108.775 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.9 t -121.84 128.96 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.93 -0.767 . . . . 0.54000000000000004 108.93 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.86 149.96 11.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.483 -0.761 . . . . 0.62 109.098 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.09 -35.79 67.42 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.651 -1.281 . . . . 0.80000000000000004 107.928 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -174.9 156.5 2.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.653 -0.654 . . . . 2.3399999999999999 109.243 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.0 mt -123.83 133.73 53.74 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.547 -0.721 . . . . 0.65000000000000002 109.581 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.8 p -93.57 152.52 40.94 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.921 -0.77 . . . . 0.73999999999999999 108.921 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -34.88 -51.98 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.459 2.106 . . . . 0.59999999999999998 112.526 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.7 m -51.79 -50.26 61.08 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.179 -0.95 . . . . 0.63 108.861 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.03 -35.73 77.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.596 -0.69 . . . . 1.25 109.819 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.7 p -79.94 -28.77 39.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.111 -0.993 . . . . 0.5 109.411 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.21 -18.19 59.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.852 . . . . 0.51000000000000001 109.98 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -106.93 -14.52 14.94 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.218 -0.926 . . . . 1.1699999999999999 109.336 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.2 tp -55.29 134.92 50.23 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.021 -1.103 . . . . 0.60999999999999999 108.021 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -98.49 97.44 8.76 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.209 -0.932 . . . . 2.1200000000000001 109.586 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 173' ' ' LEU . 6.6 mp -75.9 44.69 0.31 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.5 -0.75 . . . . 1.3400000000000001 109.317 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -106.5 -24.8 12.09 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.572 -0.899 . . . . 1.97 108.572 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -132.28 4.09 4.01 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.757 -0.59 . . . . 1.8999999999999999 110.03 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.1 153.91 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.971 -1.081 . . . . 0.47999999999999998 109.09 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -111.03 -37.53 5.34 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.659 -0.651 . . . . 1.3899999999999999 110.003 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.41 -177.95 37.47 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.152 -1.579 . . . . 0.38 109.152 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -132.46 127.88 36.25 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.465 -1.021 . . . . 0.46000000000000002 110.008 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.9 mt -127.03 118.55 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.981 -1.488 . . . . 0.58999999999999997 106.981 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 32.0 p -141.03 151.99 44.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.411 -0.805 . . . . 0.67000000000000004 111.67 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -90.84 42.48 1.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.548 -0.72 . . . . 2.2400000000000002 109.224 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -91.87 -153.58 0.34 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.989 -1.069 . . . . 1.1100000000000001 110.474 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.425 ' N ' ' OG ' ' A' ' 188' ' ' SER . . . -91.75 -114.42 1.97 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.147 -1.181 . . . . 1.6299999999999999 110.147 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.45 -37.49 0.4 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.388 -1.885 . . . . 1.47 108.388 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -69.7 -39.88 76.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -1.088 . . . . 5.2400000000000002 109.007 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 47.8 p -137.5 26.49 2.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.474 -0.766 . . . . 2.9199999999999999 109.093 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 184' ' ' GLY . 15.0 m -84.58 129.95 34.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.334 -0.854 . . . . 1.6000000000000001 109.619 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -57.22 -48.05 79.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.396 -0.815 . . . . 0.92000000000000004 110.12 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.1 m -46.33 -39.39 10.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.993 -1.067 . . . . 1.5900000000000001 109.571 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.0 p -61.04 -45.59 94.17 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.289 -0.882 . . . . 1.4199999999999999 109.003 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 74.1 mt -49.72 -33.05 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.931 . . . . 1.4099999999999999 109.29 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 74.4 mtp -73.62 -65.52 0.81 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.641 -1.244 . . . . 0.85999999999999999 107.641 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.19 -28.54 7.66 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.679 -0.692 . . . . 0.58999999999999997 110.04 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.419 ' HG2' HH11 ' A' ' 195' ' ' ARG . 31.8 mtt-85 -80.61 -52.32 7.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.869 -1.145 . . . . 3.0600000000000001 110.512 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.6 m -71.14 -33.95 70.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.897 -1.127 . . . . 0.72999999999999998 109.687 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 199' ' ' LEU . 22.3 mt -90.4 -0.44 57.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.23 -0.919 . . . . 0.67000000000000004 109.126 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 46.34 11.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.345 -0.847 . . . . 1.49 111.284 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 197' ' ' LEU . 17.8 mt -68.31 145.22 97.29 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.815 -1.178 . . . . 0.64000000000000001 109.45 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -56.63 131.92 48.59 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.091 1.861 . . . . 0.58999999999999997 110.803 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.44 173.04 11.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.597 -1.314 . . . . 0.55000000000000004 111.33 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 203' ' ' VAL . 68.9 mt -143.9 159.45 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.78 -1.563 . . . . 0.63 106.78 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.1 m -143.11 -33.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 120.577 -1.327 . . . . 0.77000000000000002 111.337 -178.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.76 36.67 2.98 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.075 -1.21 . . . . 0.87 110.075 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.9 p -65.94 -31.47 72.41 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.866 -1.373 . . . . 0.89000000000000001 108.604 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.23 -91.04 0.37 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.068 -1.063 . . . . 0.93000000000000005 111.713 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 10.9 m -111.29 40.51 2.06 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.196 -1.179 . . . . 1.6000000000000001 112.945 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.428 ' CG2' HG23 ' A' ' 2' ' ' ILE . 23.3 t -76.93 -28.68 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.383 -1.448 . . . . 0.75 107.418 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 29.9 p -66.76 -9.64 38.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.391 -0.818 . . . . 0.83999999999999997 109.179 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 41.3 m -104.85 9.19 34.88 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.302 -0.999 . . . . 1.6100000000000001 108.302 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -134.74 2.25 3.14 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.532 -0.914 . . . . 2.2999999999999998 108.532 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.53 151.87 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.152 -0.684 . . . . 0.76000000000000001 109.152 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -131.81 162.44 30.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.608 -1.627 . . . . 2.0099999999999998 106.608 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 60.4 m-80 -63.71 146.86 53.03 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.786 -1.196 . . . . 2.1899999999999999 110.461 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.3 t70 79.4 -20.89 0.36 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.722 -0.611 . . . . 2.3999999999999999 110.431 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.38 126.1 25.78 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.771 -1.206 . . . . 1.99 108.155 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -87.5 118.97 27.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.787 -1.196 . . . . 1.3 109.723 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.5 mt -113.62 137.35 51.72 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.492 -0.929 . . . . 0.53000000000000003 108.492 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.31 115.64 47.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.825 -1.176 . . . . 0.59999999999999998 107.825 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 30.9 tp -83.2 129.77 35.04 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.296 -1.002 . . . . 0.56999999999999995 108.296 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.8 t0 -97.55 -40.0 8.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.408 -0.807 . . . . 2.2200000000000002 109.036 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.59 27.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.61 0.719 . . . . 0.75 110.078 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 221' ' ' ASP . 7.8 t -119.47 -45.05 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.419 -1.697 . . . . 0.92000000000000004 106.419 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -105.27 17.13 24.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.178 -1.416 . . . . 2.3599999999999999 107.178 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 55.8 53.44 9.4 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.597 -0.89 . . . . 1.4199999999999999 108.597 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -155.0 145.63 22.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 1.97 110.584 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 228' ' ' TYR . 93.0 t -105.39 163.43 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.384 -0.969 . . . . 0.65000000000000002 108.384 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.49 ' N ' HG12 ' A' ' 227' ' ' VAL . 63.4 m-85 -129.55 122.74 29.8 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.329 -0.857 . . . . 0.96999999999999997 109.23 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.76 115.46 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.421 -0.799 . . . . 0.67000000000000004 110.552 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 47.2 t-20 53.96 51.33 8.11 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.379 -0.826 . . . . 1.45 111.098 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.8 Cg_endo -64.46 158.76 47.71 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.378 2.052 . . . . 0.81999999999999995 111.472 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 78.5 p -71.03 139.51 50.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.094 -1.004 . . . . 1.6200000000000001 109.165 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -53.38 -17.11 1.66 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.197 -0.939 . . . . 2.6000000000000001 109.587 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -68.15 -39.44 82.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 3.0600000000000001 108.755 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.2 t -79.49 -34.27 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 1.1399999999999999 109.011 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 21.4 mt -64.55 -55.23 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.83 . . . . 1.04 109.313 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -53.14 -40.5 64.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -0.795 . . . . 2.54 109.622 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -67.07 -41.18 86.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 2.6000000000000001 110.084 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 44.0 mtp -79.53 -26.72 41.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.084 -1.01 . . . . 1.23 109.708 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.427 ' NH1' ' OE2' ' A' ' 244' ' ' GLU . 13.4 mmm180 -59.47 -41.11 89.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.038 . . . . 2.6699999999999999 109.593 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.07 -60.24 2.35 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.278 -0.889 . . . . 1.6599999999999999 110.226 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.2 t -46.8 -62.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 2.2000000000000002 110.668 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -45.98 -59.19 2.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.027 -1.046 . . . . 3.0 109.531 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.427 ' OE2' ' NH1' ' A' ' 240' ' ' ARG . 64.2 mt-10 -63.61 -22.66 67.02 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.338 -0.851 . . . . 1.76 109.776 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -68.98 -27.91 66.13 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.531 -1.285 . . . . 2.7799999999999998 107.531 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.78 -46.08 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.535 -0.728 . . . . 2.0600000000000001 109.244 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.56 -37.25 79.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 2.3999999999999999 109.194 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.1 p -78.99 -29.54 43.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -0.849 . . . . 2.8700000000000001 110.541 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.035 . . . . 3.4100000000000001 109.618 -179.107 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 mmt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.321 0.581 . . . . 3.6600000000000001 109.502 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.2 mt 46.58 84.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.374 -0.828 . . . . 1.1200000000000001 109.961 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m -95.11 113.39 25.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.208 -0.933 . . . . 1.45 109.093 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.24 -161.97 20.74 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.036 -1.626 . . . . 0.92000000000000004 109.036 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.432 ' O ' HG22 ' A' ' 5' ' ' ILE . 45.1 mt -95.77 -8.15 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.385 -1.068 . . . . 1.05 109.218 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tp 60.61 106.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -0.999 . . . . 0.88 108.843 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.61 -46.02 9.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.779 -1.2 . . . . 0.78000000000000003 108.444 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.54 142.57 15.66 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.428 -0.795 . . . . 1.5 108.934 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.02 155.63 30.02 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.029 1.82 . . . . 0.85999999999999999 113.814 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 160.78 -173.9 37.35 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.296 -1.522 . . . . 0.78000000000000003 109.296 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.4 mt -148.03 122.15 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.605 -1.527 . . . . 0.73999999999999999 109.358 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.43 154.27 43.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.161 -0.962 . . . . 0.45000000000000001 110.406 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.495 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 8.7 m-85 -119.23 145.56 45.96 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.351 -0.981 . . . . 0.64000000000000001 108.351 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.4 159.9 22.75 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 118.885 -1.626 . . . . 0.45000000000000001 111.248 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -78.57 153.45 31.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.99 . . . . 1.8799999999999999 109.638 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -79.15 121.89 25.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.58999999999999997 110.622 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.4 tp -101.73 92.76 4.99 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.518 -1.29 . . . . 0.64000000000000001 107.518 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.49 127.2 33.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.966 -1.084 . . . . 0.73999999999999999 111.194 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 160' ' ' ALA . 15.3 mt -95.26 93.31 7.21 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.511 -0.768 . . . . 0.73999999999999999 109.255 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -92.82 158.06 16.07 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.291 -0.88 . . . . 1.8700000000000001 109.624 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -130.39 135.6 48.19 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.609 -0.886 . . . . 2.5800000000000001 108.609 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.55 135.97 36.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.127 -0.983 . . . . 2.1400000000000001 109.542 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -65.45 132.53 49.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.597 -0.689 . . . . 1.9299999999999999 109.456 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.24 135.46 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.31 -0.869 . . . . 0.68000000000000005 109.959 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.52 117.85 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.546 -0.721 . . . . 0.83999999999999997 109.364 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.2 mt -87.01 132.65 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.79000000000000004 109.289 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.3 123.28 33.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.252 -0.905 . . . . 1.3700000000000001 109.655 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.457 ' HG2' HH11 ' A' ' 28' ' ' ARG . 2.8 mmt-85 -96.25 26.05 4.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.248 -0.907 . . . . 2.6200000000000001 108.819 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -90.24 142.73 27.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.463 -0.773 . . . . 2.3500000000000001 110.384 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -88.34 129.16 35.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.252 -0.905 . . . . 2.3500000000000001 108.649 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.7 pt -92.68 172.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.943 -1.098 . . . . 0.78000000000000003 110.426 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 34' ' ' ASP . 7.9 p -99.18 160.08 14.53 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.621 -0.881 . . . . 1.04 108.621 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.3 -7.53 0.89 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.033 -1.042 . . . . 1.05 109.373 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 32' ' ' SER . 3.9 m-20 -82.57 -10.03 59.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 2.4700000000000002 110.446 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -120.02 -17.0 8.52 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.158 -0.964 . . . . 1.46 109.73 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.6 t -53.89 -36.35 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 0.77000000000000002 109.697 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -54.25 -40.46 67.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 1.46 110.152 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -69.93 -41.54 74.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.219 -0.926 . . . . 2.29 110.575 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -59.73 -45.82 91.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.061 . . . . 1.3 109.864 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.1 t -59.27 -45.08 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.76000000000000001 109.3 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -60.66 -37.64 82.24 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.505 -0.924 . . . . 1.5 108.505 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -68.83 -31.57 70.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.531 -0.731 . . . . 2.6600000000000001 109.352 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -85.36 -51.26 6.68 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.28 -0.888 . . . . 0.75 109.216 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.35 -59.74 4.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.886 . . . . 0.82999999999999996 109.085 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.669 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -62.78 -38.09 89.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.78000000000000003 108.629 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -55.31 -54.1 36.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 107.325 -2.31 . . . . 0.56999999999999995 107.325 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.9 ttt-85 -45.65 -32.25 2.3 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.341 -0.985 . . . . 2.8300000000000001 108.341 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.13 -34.93 74.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.34 -0.985 . . . . 0.65000000000000002 108.34 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' GLY . 24.2 ttmt -85.12 -58.43 2.69 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.246 -0.65 . . . . 2.5699999999999998 109.246 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.07 -39.23 63.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.967 . . . . 0.51000000000000001 109.872 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -66.31 -40.01 89.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.102 -0.999 . . . . 1.3600000000000001 108.622 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.08 -35.32 64.21 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.867 -0.52 . . . . 0.59999999999999998 109.83 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -65.22 -67.27 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.3600000000000001 110.162 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 54' ' ' LEU . 4.5 mm? -50.16 -33.96 20.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.865 -1.147 . . . . 1.3799999999999999 108.899 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.48 -46.22 80.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.401 -0.812 . . . . 1.27 108.919 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -62.53 -37.39 85.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.293 -0.879 . . . . 0.59999999999999998 109.785 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.42 -33.73 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.962 -1.086 . . . . 0.53000000000000003 108.854 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -53.78 -44.66 70.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 0.98999999999999999 109.836 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -71.22 -35.27 71.45 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.199 -0.938 . . . . 0.58999999999999997 109.741 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -69.45 -26.18 64.47 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.563 -1.255 . . . . 1.8100000000000001 107.686 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.51 -33.76 67.13 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.354 -0.98 . . . . 0.47999999999999998 108.354 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -28.83 28.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.792 -1.323 . . . . 0.57999999999999996 109.792 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -86.2 -11.65 51.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.1 -1.235 . . . . 1.3899999999999999 108.764 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -99.16 -51.02 3.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.497 -0.752 . . . . 0.81999999999999995 110.353 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -106.25 -16.29 14.62 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.213 -0.93 . . . . 0.98999999999999999 110.711 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.53 143.79 6.9 Favored Glycine 0 N--CA 1.504 3.214 0 N-CA-C 110.274 -1.13 . . . . 0.55000000000000004 110.274 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -48.77 -9.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.365 -1.079 . . . . 2.5899999999999999 110.166 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' GLY . 35.4 mt-10 -63.72 -31.56 72.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.953 . . . . 2.2000000000000002 110.466 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -88.86 -6.32 57.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.943 -1.098 . . . . 1.79 110.624 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.81 -31.33 72.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.642 -1.287 . . . . 1.54 109.983 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.86 -29.57 70.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.64000000000000001 109.586 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.0 mt -73.36 -45.09 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.57999999999999996 109.557 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -76.96 -21.24 55.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.62 109.433 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.19 -40.59 94.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.134 -0.979 . . . . 1.23 108.869 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.9 -31.45 64.58 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.699 -1.76 . . . . 0.52000000000000002 108.699 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -23.2 66.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.556 -0.967 . . . . 1.29 110.162 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.1 mt -84.9 -35.33 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.776 -1.203 . . . . 0.55000000000000004 108.773 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.8 ttt -57.27 -39.74 76.29 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.353 -0.98 . . . . 1.8899999999999999 108.353 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.99 -39.07 90.01 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.574 -0.899 . . . . 0.53000000000000003 108.574 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.31 -43.04 53.13 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.617 -0.833 . . . . 0.42999999999999999 109.179 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -85.49 2.89 42.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.2 -0.938 . . . . 1.24 110.419 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -45.34 114.4 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.07 -1.018 . . . . 1.3100000000000001 109.261 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -64.04 -23.51 67.36 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -0.854 . . . . 1.3500000000000001 109.169 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -75.88 -46.78 28.32 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.344 -0.848 . . . . 2.1600000000000001 109.194 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.08 -20.43 66.16 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.935 -1.103 . . . . 0.59999999999999998 109.554 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.43 -53.47 9.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.361 -0.837 . . . . 1.28 110.736 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -61.88 -29.97 70.55 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.25 -0.906 . . . . 1.28 110.469 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.11 -41.63 61.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.98 -1.075 . . . . 1.29 109.077 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.0 mt -60.55 -57.72 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.868 -1.16 . . . . 0.57999999999999996 107.868 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.9 mt -49.42 -53.63 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.666 -0.646 . . . . 0.78000000000000003 110.05 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.85 -63.3 1.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.85999999999999999 110.125 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.1 mt -45.19 -48.48 12.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.541 -0.725 . . . . 0.79000000000000004 110.008 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.3 mt -55.21 -40.84 57.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.157 -0.965 . . . . 0.70999999999999996 110.004 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -85.61 -39.5 17.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.027 -1.046 . . . . 2.0499999999999998 111.313 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.31 -36.8 26.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.827 -1.171 . . . . 1.5900000000000001 111.54 -176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.65 12.19 33.24 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.919 -1.113 . . . . 1.8899999999999999 109.164 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.3 m80 45.12 44.26 8.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.486 -0.759 . . . . 1.3100000000000001 109.295 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.0 mtp -93.43 154.0 18.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.398 -0.814 . . . . 1.28 109.302 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.9 p -79.25 142.47 36.17 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.317 -0.864 . . . . 0.62 109.262 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.16 -26.46 1.91 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.46999999999999997 109.646 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -76.19 -42.63 45.67 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.276 -0.89 . . . . 2.0 108.916 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.49 -58.58 3.27 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.726 -0.609 . . . . 0.56000000000000005 111.175 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.41 -48.68 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.956 -1.09 . . . . 0.47999999999999998 109.804 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.07 -33.8 65.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.199 -0.938 . . . . 0.44 109.333 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.478 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 85.5 t60 -70.75 -35.32 72.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 1.4199999999999999 109.598 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.25 -64.25 0.92 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.363 -0.836 . . . . 1.26 110.47 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -48.54 -47.17 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.985 -1.072 . . . . 0.60999999999999999 109.55 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.58 -21.22 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.482 -0.761 . . . . 0.64000000000000001 109.734 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.478 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 11.9 tp10 -72.95 -38.88 66.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.166 -0.959 . . . . 2.2000000000000002 111.247 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 114' ' ' ALA . . . -85.15 -21.12 55.99 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 118.828 -1.653 . . . . 0.81999999999999995 112.102 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -69.83 -59.41 2.95 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.606 -1.526 . . . . 1.27 108.171 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.71 -49.83 73.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.717 -0.614 . . . . 0.91000000000000003 109.533 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.8 m -58.93 -35.81 73.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.263 -0.898 . . . . 1.73 109.586 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -61.91 -44.27 97.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.071 -1.018 . . . . 1.04 110.116 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.8 mt -66.64 -27.77 67.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.879 -1.138 . . . . 1.03 109.288 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -67.32 -18.29 65.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.113 -0.992 . . . . 1.95 110.011 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.38 -9.85 59.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.063 -1.023 . . . . 1.71 109.282 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mt -89.1 152.23 21.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.627 -0.879 . . . . 1.26 108.627 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -100.8 59.64 0.94 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -0.846 . . . . 2.8300000000000001 108.814 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -143.91 119.1 10.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.284 -0.885 . . . . 1.5800000000000001 109.375 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.57 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.4 pm0 -63.42 -9.28 11.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 2.7999999999999998 109.237 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -76.42 -62.61 1.56 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.35 -0.843 . . . . 1.02 109.938 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.57 -17.12 62.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.738 -1.226 . . . . 1.0600000000000001 109.36 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -69.37 -55.6 9.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.137 -0.977 . . . . 2.3900000000000001 108.778 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -60.48 -21.45 62.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.257 -0.902 . . . . 2.2000000000000002 108.938 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -71.75 -27.24 62.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.631 -1.618 . . . . 2.0899999999999999 106.631 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.27 92.95 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.226 -1.027 . . . . 0.85999999999999999 108.226 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.09 79.87 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.527 -0.916 . . . . 0.90000000000000002 108.527 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -32.54 71.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 1.3500000000000001 108.834 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.2 t -80.37 -47.02 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.436 -0.79 . . . . 0.57999999999999996 108.891 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -64.42 -35.64 81.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.154 -0.966 . . . . 3.2200000000000002 108.721 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.503 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 13.5 t0 -58.52 -43.52 89.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 1.3200000000000001 109.298 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.0 mt -67.47 -25.57 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.5 108.402 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.08 -52.24 4.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.446 -1.461 . . . . 0.44 109.446 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -52.82 -37.32 59.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -1.158 . . . . 2.71 109.329 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.503 ' NH2' ' OD1' ' A' ' 132' ' ' ASP . 6.7 mtt-85 -63.46 -42.52 98.63 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.15 -1.055 . . . . 2.2000000000000002 108.15 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.6 tp -59.21 -48.92 79.83 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.57 -0.706 . . . . 1.1299999999999999 109.291 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.2 mt -52.21 -53.16 46.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.54000000000000004 109.787 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -54.39 -22.96 13.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.097 -1.002 . . . . 2.3199999999999998 110.0 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.415 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 2.6 m120 -83.96 -31.41 25.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 1.26 109.047 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.0 mt -66.26 -43.78 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.62 108.842 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.6 mt -90.43 -7.14 53.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.211 -0.931 . . . . 0.67000000000000004 109.397 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 68.73 27.55 73.77 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.578 -1.809 . . . . 0.68000000000000005 108.578 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tp -51.28 166.2 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.529 -0.983 . . . . 0.77000000000000002 109.609 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -67.06 141.25 57.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 2.3999999999999999 109.867 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -109.21 138.78 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.447 -0.783 . . . . 0.87 109.135 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.525 HD12 ' H ' ' A' ' 147' ' ' ILE . 2.5 mp -78.71 128.68 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.025 -1.047 . . . . 1.3200000000000001 110.03 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -98.13 86.32 3.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.494 -0.754 . . . . 1.54 109.246 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.5 mt -82.41 -33.84 28.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.235 -0.916 . . . . 0.77000000000000002 109.953 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.5 m -82.06 28.49 0.43 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.115 -0.991 . . . . 1.5700000000000001 109.977 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.18 28.52 2.28 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.073 -1.017 . . . . 0.81999999999999995 109.671 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.9 152.96 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.81999999999999995 109.483 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -129.44 -16.02 3.97 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.353 -0.842 . . . . 2.1099999999999999 109.238 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -114.95 126.96 55.38 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.892 -0.781 . . . . 1.4099999999999999 108.892 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.16 124.97 23.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.046 -1.033 . . . . 1.3 109.288 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.3 m -149.33 175.9 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.56999999999999995 108.94 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.2 mt -88.39 156.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.268 -1.012 . . . . 0.42999999999999999 108.268 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tp -107.55 124.92 50.63 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.103 -0.702 . . . . 0.56000000000000005 109.103 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -124.71 129.27 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.062 -0.718 . . . . 0.54000000000000004 109.062 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.471 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.29 146.3 13.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.62 109.765 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.52 -34.84 67.41 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.746 -1.221 . . . . 0.80000000000000004 107.847 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -173.49 151.95 2.05 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.164 -0.68 . . . . 2.3399999999999999 109.164 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.2 mt -119.89 130.67 54.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.682 -0.859 . . . . 0.65000000000000002 108.682 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.2 p -91.12 150.97 42.6 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.133 -0.98 . . . . 0.73999999999999999 109.076 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 169' ' ' ALA . 68.6 Cg_exo -35.41 -51.73 0.86 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 122.527 2.151 . . . . 0.59999999999999998 112.379 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.8 m -48.0 -54.28 13.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.319 -0.863 . . . . 0.63 109.28 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.75 -45.8 88.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.4 -0.813 . . . . 1.25 109.654 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 24.1 p -68.12 -26.06 65.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.5 109.714 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -74.06 -30.77 62.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.114 -0.991 . . . . 0.51000000000000001 110.148 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -101.41 -14.21 17.66 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.188 -0.945 . . . . 1.1699999999999999 109.818 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.0 tp -60.51 145.28 49.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.799 -1.188 . . . . 0.60999999999999999 108.296 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 174' ' ' LYS . 11.7 t-20 -96.51 142.06 29.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.11 -0.994 . . . . 2.1200000000000001 108.497 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.413 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 37.0 mt -90.15 -39.97 12.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 1.3400000000000001 111.04 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 35.1 mttm -79.94 -11.06 59.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.83 -1.168 . . . . 1.97 111.628 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -101.83 -13.22 17.77 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.857 -1.152 . . . . 1.8999999999999999 109.074 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 177' ' ' LEU . 74.5 t -95.88 161.37 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.229 -0.919 . . . . 0.47999999999999998 108.646 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.51 ' N ' HG12 ' A' ' 176' ' ' VAL . 53.8 tp -111.52 -28.54 8.12 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.25 -0.907 . . . . 1.3899999999999999 110.119 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -174.32 177.53 46.47 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.714 -1.355 . . . . 0.38 109.714 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.53 127.43 33.17 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.405 -1.056 . . . . 0.46000000000000002 109.853 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.6 mt -127.91 122.91 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.762 -1.57 . . . . 0.58999999999999997 106.762 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 38.0 p -140.77 156.23 46.22 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.331 1.063 . . . . 0.67000000000000004 112.461 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 1.5 m-20 -87.07 37.55 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.692 -0.685 . . . . 2.2400000000000002 109.56 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -88.65 -167.41 1.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.081 -1.012 . . . . 1.1100000000000001 110.416 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.45 -106.35 1.45 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.488 -1.445 . . . . 1.6299999999999999 109.488 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 171.12 -36.59 0.17 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.388 -1.485 . . . . 1.47 109.388 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -56.38 98.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -1.103 . . . . 5.2400000000000002 109.528 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.5 p 47.61 50.76 14.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.475 -0.766 . . . . 2.9199999999999999 110.039 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.1 t -86.64 140.6 29.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.209 -0.932 . . . . 1.6000000000000001 109.393 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -49.21 -52.09 28.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 0.92000000000000004 109.89 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 39.0 p -54.08 -45.97 71.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 1.5900000000000001 110.232 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 98.9 p -63.67 -46.4 85.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 1.4199999999999999 110.762 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -50.91 -28.68 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.903 -1.123 . . . . 1.4099999999999999 109.721 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.5 mtp -71.37 -57.0 4.87 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.789 -1.189 . . . . 0.85999999999999999 107.789 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.83 -43.11 65.75 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.78 -0.645 . . . . 0.58999999999999997 110.076 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -68.1 -46.3 71.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 3.0600000000000001 109.779 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.3 m -70.24 -35.82 74.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.72999999999999998 109.727 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.8 mt -89.76 -1.95 58.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.152 -0.967 . . . . 0.67000000000000004 109.403 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 56.26 2.23 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 1.49 111.681 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.1 169.51 8.23 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.45 -1.406 . . . . 0.64000000000000001 108.631 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.28 141.84 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.694 2.263 . . . . 0.58999999999999997 111.312 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.26 -178.63 5.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.448 -1.408 . . . . 0.55000000000000004 111.341 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 28.5 mt -148.76 157.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.452 -1.314 . . . . 0.63 107.452 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.0 m -138.35 -39.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.968 -1.083 . . . . 0.77000000000000002 110.713 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -75.97 41.2 1.48 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.679 -1.368 . . . . 0.87 109.679 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 181' ' ' THR . 20.2 p -68.21 3.57 1.61 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.058 -1.26 . . . . 0.89000000000000001 109.042 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.431 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 55.83 -102.22 0.16 Allowed Glycine 0 N--CA 1.483 1.833 0 N-CA-C 109.83 -1.308 . . . . 0.93000000000000005 109.83 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.5 p -125.49 43.38 3.07 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.403 -1.057 . . . . 1.6000000000000001 111.323 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 26.2 t -62.96 -32.06 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.521 -1.362 . . . . 0.75 107.825 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 p -60.25 -16.28 32.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.83999999999999997 109.094 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.7 m -105.67 15.36 27.0 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.876 -0.787 . . . . 1.6100000000000001 108.876 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -133.68 -15.28 2.41 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.554 -0.716 . . . . 2.2999999999999998 109.934 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 51.3 t -123.34 150.57 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.331 -0.856 . . . . 0.76000000000000001 109.308 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -113.8 -174.74 2.53 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.593 -1.262 . . . . 2.0099999999999998 107.593 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.46 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 9.6 t30 -80.26 145.41 32.2 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.14 -0.975 . . . . 2.1899999999999999 110.057 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 82.29 -11.77 0.98 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.036 -0.415 . . . . 2.3999999999999999 111.229 178.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -55.46 143.32 29.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.636 -1.29 . . . . 1.99 108.446 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -87.78 125.58 34.52 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.956 -1.09 . . . . 1.3 108.813 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 16' ' ' ALA . 43.4 mt -123.7 162.98 22.01 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.841 0.829 . . . . 0.53000000000000003 110.585 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.7 mt -136.69 107.87 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.775 -1.194 . . . . 0.59999999999999998 107.775 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.5 tp -87.51 122.04 30.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -0.905 . . . . 0.56999999999999995 109.234 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.8 OUTLIER -101.05 -28.41 12.73 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.33 -0.856 . . . . 2.2200000000000002 109.014 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.57 27.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.891 -0.505 . . . . 0.75 111.246 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.2 t -118.25 -58.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 106.602 -1.629 . . . . 0.92000000000000004 106.602 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -92.02 9.1 34.68 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.643 -1.614 . . . . 2.3599999999999999 106.643 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 60.13 64.63 1.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.211 -0.663 . . . . 1.4199999999999999 109.211 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -153.01 136.1 15.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 1.97 110.698 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.3 t -115.18 126.6 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.887 -1.153 . . . . 0.65000000000000002 107.887 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -96.4 130.71 43.47 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 0.96999999999999997 109.748 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.46 130.54 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.415 -0.587 . . . . 0.67000000000000004 109.415 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 20.0 t30 55.24 71.62 1.24 Allowed Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.376 -0.828 . . . . 1.45 110.229 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.36 146.08 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 123.321 2.681 . . . . 0.81999999999999995 112.06 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.5 p -72.21 177.89 4.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.804 . . . . 1.6200000000000001 109.776 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -76.86 -39.55 50.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 2.6000000000000001 109.553 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.588 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 13.3 mp0 -53.76 -39.12 65.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 3.0600000000000001 109.403 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.46 -39.41 54.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.089 -1.007 . . . . 1.1399999999999999 108.833 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.0 mt -65.94 -64.25 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 1.04 109.305 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -53.77 -44.09 69.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 2.54 110.606 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -65.73 -33.04 74.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.06 -1.025 . . . . 2.6000000000000001 109.813 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.456 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 50.8 mtp -80.83 -38.73 27.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.981 -1.075 . . . . 1.23 109.467 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -49.07 -50.17 37.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.046 -1.034 . . . . 2.6699999999999999 110.166 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.91 -61.8 1.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.06 -1.025 . . . . 1.6599999999999999 110.96 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.9 t -62.83 -52.44 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.951 -1.093 . . . . 2.2000000000000002 111.167 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 239' ' ' MET . 2.2 tp-100 -54.39 -41.28 69.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.712 -1.242 . . . . 3.0 109.72 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.0 -25.7 67.79 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.567 -1.333 . . . . 1.76 108.659 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -70.19 -22.3 62.95 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.898 -1.149 . . . . 2.7799999999999998 107.898 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.79 -55.25 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.328 -0.858 . . . . 2.0600000000000001 108.904 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.01 -34.65 43.81 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.54 -0.725 . . . . 2.3999999999999999 109.452 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -31.81 56.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -0.874 . . . . 2.8700000000000001 109.314 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 3.4100000000000001 109.067 179.623 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.936 -0.764 . . . . 3.6600000000000001 108.936 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.01 97.24 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 1.1200000000000001 110.007 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.4 m -99.75 110.81 23.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.461 -0.774 . . . . 1.45 109.959 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.45 -162.45 19.62 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.755 -1.738 . . . . 0.92000000000000004 108.755 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 5' ' ' ILE . 89.3 mt -94.82 -6.98 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.052 -1.264 . . . . 1.05 109.096 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' ILE . 5.4 tp 55.39 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.374 -0.829 . . . . 0.88 108.878 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.45 -55.1 4.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.097 -1.002 . . . . 0.78000000000000003 108.606 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.57 144.23 32.63 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.695 -0.854 . . . . 1.5 108.695 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.42 156.05 28.66 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.918 1.745 . . . . 0.85999999999999999 112.634 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.82 129.61 1.36 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.057 -1.217 . . . . 0.78000000000000003 110.057 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.9 mt -99.6 131.48 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.202 -1.175 . . . . 0.73999999999999999 110.724 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.52 ' HB1' HD21 ' A' ' 177' ' ' LEU . . . -146.26 143.65 29.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 0.45000000000000001 109.16 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.546 ' CZ ' ' OE1' ' A' ' 243' ' ' GLN . 4.2 m-85 -100.69 140.74 34.54 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.493 -1.299 . . . . 0.64000000000000001 107.493 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.56 156.25 19.49 Favored Glycine 0 N--CA 1.5 2.902 0 C-N-CA 118.49 -1.814 . . . . 0.45000000000000001 111.881 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -78.75 152.09 31.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.846 -0.797 . . . . 1.8799999999999999 110.464 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.618 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -79.18 126.36 30.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.541 -0.724 . . . . 0.58999999999999997 111.119 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 tp -111.15 93.29 4.4 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.86 -1.533 . . . . 0.64000000000000001 106.86 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.8 tp -80.6 127.51 32.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.782 -1.198 . . . . 0.73999999999999999 111.293 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.7 mt -97.16 94.61 7.23 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.438 0.637 . . . . 0.73999999999999999 109.957 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -92.68 156.89 16.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.412 -0.805 . . . . 1.8700000000000001 109.164 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.84 130.41 53.93 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.646 -0.872 . . . . 2.5800000000000001 108.646 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -76.77 132.77 39.43 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.185 -0.947 . . . . 2.1400000000000001 108.978 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.99 137.88 56.83 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.533 -0.729 . . . . 1.9299999999999999 109.442 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.34 136.08 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.23 -0.919 . . . . 0.68000000000000005 110.159 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.2 t -102.66 117.53 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 0.83999999999999997 108.93 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.6 mt -90.96 129.73 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.248 -0.907 . . . . 0.79000000000000004 109.119 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -90.68 120.27 31.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 1.3700000000000001 109.922 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -96.11 29.64 2.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.384 -0.822 . . . . 2.6200000000000001 109.444 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -86.56 144.94 26.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.121 -0.987 . . . . 2.3500000000000001 109.442 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -85.84 125.97 33.69 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.984 -1.073 . . . . 2.3500000000000001 109.018 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -82.76 179.15 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.285 -0.884 . . . . 0.78000000000000003 109.535 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -98.82 160.62 14.14 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.396 -0.815 . . . . 1.04 109.332 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.1 -20.22 51.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 1.05 109.307 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -82.53 -12.06 58.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.853 . . . . 2.4700000000000002 109.43 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -105.35 -10.13 17.17 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.941 -1.133 . . . . 1.46 107.941 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.97 -48.36 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.682 -0.636 . . . . 0.77000000000000002 109.523 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -56.6 -30.04 62.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.085 -1.01 . . . . 1.46 108.942 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -70.37 -35.03 73.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.453 -0.779 . . . . 2.29 110.16 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -64.43 -44.31 91.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.105 -0.997 . . . . 1.3 109.589 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 44' ' ' LEU . 83.6 t -58.15 -46.58 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.169 -0.957 . . . . 0.76000000000000001 109.328 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.85 -43.6 87.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.139 -0.976 . . . . 1.5 108.905 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -66.04 -32.09 73.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.568 -0.708 . . . . 2.6600000000000001 109.186 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -86.45 -57.66 2.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.133 -0.98 . . . . 0.75 108.739 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 40' ' ' VAL . 34.0 tp -51.92 -60.69 2.89 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.425 -0.797 . . . . 0.82999999999999996 109.235 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -66.4 -31.34 72.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -0.891 . . . . 0.78000000000000003 108.801 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.38 53.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.298 -1.921 . . . . 0.56999999999999995 108.298 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.546 HH22 ' CD ' ' A' ' 86' ' ' GLU . 27.6 ttp180 -60.44 -21.39 62.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -1.116 . . . . 2.8300000000000001 109.505 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -66.69 -45.59 78.33 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.345 -0.983 . . . . 0.65000000000000002 108.345 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.456 ' H ' ' HG2' ' A' ' 49' ' ' LYS . 12.6 ptmt -78.4 -52.93 7.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.483 -0.932 . . . . 2.5699999999999998 108.483 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.74 -33.36 15.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.353 -1.467 . . . . 0.51000000000000001 108.789 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 m -66.54 -36.77 83.49 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.034 -1.098 . . . . 1.3600000000000001 108.034 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -70.46 -19.76 62.93 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.697 -0.853 . . . . 0.59999999999999998 108.697 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -76.17 -66.06 0.84 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.4 -0.812 . . . . 1.3600000000000001 109.645 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.9 mt -51.18 -35.6 36.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 1.3799999999999999 108.867 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -60.74 -51.11 70.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.517 -0.739 . . . . 1.27 109.268 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 m -63.46 -38.25 90.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.157 -0.965 . . . . 0.59999999999999998 109.088 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.5 mt -69.62 -27.75 34.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.295 -0.878 . . . . 0.53000000000000003 108.984 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -63.3 -41.57 98.97 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.306 -0.871 . . . . 0.98999999999999999 109.526 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -71.66 -24.78 61.9 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.51 -0.744 . . . . 0.58999999999999997 109.264 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.422 ' O ' ' CB ' ' A' ' 64' ' ' THR . 97.0 mttt -72.59 -25.58 61.39 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.738 -1.208 . . . . 1.8100000000000001 107.738 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.98 -32.12 61.6 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.932 -1.136 . . . . 0.47999999999999998 107.932 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.96 -29.12 29.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.915 -1.674 . . . . 0.57999999999999996 108.915 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -86.64 -22.37 26.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.095 -1.238 . . . . 1.3899999999999999 108.638 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 56.5 m -94.67 -45.09 7.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.254 -0.904 . . . . 0.81999999999999995 110.56 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.54 ' C ' ' H ' ' A' ' 67' ' ' GLU . 52.4 m-85 -107.78 -34.17 7.04 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.191 -0.943 . . . . 0.98999999999999999 109.965 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 67.37 -30.21 0.21 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.366 -1.094 . . . . 0.55000000000000004 110.366 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 65' ' ' PHE . 35.3 mt-10 -51.01 -179.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.03 -1.277 . . . . 2.5899999999999999 110.102 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.15 36.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.56 -0.712 . . . . 2.2000000000000002 109.821 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.8 mmtp -83.18 -10.48 58.6 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.406 -0.809 . . . . 1.79 109.308 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -69.01 -35.96 77.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.246 -0.909 . . . . 1.54 110.292 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.41 68.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.64000000000000001 110.398 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.2 mt -71.52 -46.19 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.079 -1.013 . . . . 0.57999999999999996 109.821 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -76.19 -26.71 56.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.62 109.571 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.84 -59.33 4.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.052 -1.03 . . . . 1.23 109.026 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.92 -33.73 64.22 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.76 -1.336 . . . . 0.52000000000000002 109.76 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.1 -22.2 65.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.019 -1.283 . . . . 1.29 109.768 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.4 mt -84.81 -36.79 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.976 -1.077 . . . . 0.55000000000000004 108.365 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.4 ttt -60.84 -44.51 96.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.172 -1.047 . . . . 1.8899999999999999 108.172 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.3 tp -57.59 -40.87 79.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.231 -1.026 . . . . 0.53000000000000003 108.231 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.5 tp -69.62 -42.75 73.94 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.403 -0.81 . . . . 0.42999999999999999 109.519 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -84.9 9.57 14.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.306 -0.871 . . . . 1.24 110.262 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -49.43 121.78 5.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.015 -1.053 . . . . 1.3100000000000001 110.2 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -67.14 -24.62 65.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.242 -0.911 . . . . 1.3500000000000001 108.986 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -74.2 -49.93 21.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.328 -0.949 . . . . 2.1600000000000001 108.685 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.6 mt -64.17 -15.04 59.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.63 -1.228 . . . . 0.59999999999999998 108.603 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.546 ' CD ' HH22 ' A' ' 47' ' ' ARG . 28.2 tt0 -77.29 -54.33 6.61 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.806 -1.184 . . . . 1.28 110.136 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.18 -30.79 69.58 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.674 -1.267 . . . . 1.28 110.003 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -71.88 -47.89 49.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.062 -1.024 . . . . 1.29 109.039 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.7 mt -59.5 -53.72 44.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.887 -0.783 . . . . 0.57999999999999996 108.887 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 91' ' ' ALA . 95.9 mt -51.25 -71.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.746 . . . . 0.78000000000000003 110.348 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -40.25 -48.31 2.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.383 -0.823 . . . . 0.85999999999999999 110.631 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.8 mt -55.36 -55.69 28.69 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.652 -0.87 . . . . 0.79000000000000004 108.652 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.1 mt -54.11 -41.89 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.829 . . . . 0.70999999999999996 110.831 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -85.84 -35.11 20.84 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.03 -1.044 . . . . 2.0499999999999998 111.7 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 91' ' ' ALA . 37.8 t70 -81.94 -38.63 24.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.756 -1.215 . . . . 1.5900000000000001 111.48 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -105.97 12.6 30.35 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.899 -1.126 . . . . 1.8899999999999999 109.462 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.2 m170 46.05 46.35 12.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 1.3100000000000001 109.49 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.0 mtt -96.23 152.41 18.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.481 -0.762 . . . . 1.28 109.207 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.8 p -78.53 142.93 37.01 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.61 -0.681 . . . . 0.62 110.183 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.87 -25.44 3.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.189 -0.944 . . . . 0.46999999999999997 108.736 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -75.21 -50.72 15.3 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.316 -0.994 . . . . 2.0 108.316 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.65 -50.1 33.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.64 -0.663 . . . . 0.56000000000000005 109.813 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.73 -60.28 3.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 0.47999999999999998 109.657 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.5 -33.29 30.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.44 109.8 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -68.16 -35.01 77.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.915 -1.116 . . . . 1.4199999999999999 110.055 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.97 -45.05 91.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.121 -0.987 . . . . 1.26 110.814 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -66.72 -48.66 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.051 . . . . 0.60999999999999999 109.412 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -60.87 -23.77 30.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.737 -0.602 . . . . 0.64000000000000001 109.824 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -73.06 -37.39 66.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.104 -0.998 . . . . 2.2000000000000002 110.098 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.68 -22.1 48.06 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.372 -1.395 . . . . 0.81999999999999995 112.406 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.68 -53.37 15.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.711 -1.464 . . . . 1.27 108.79 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.15 71.78 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.652 -0.655 . . . . 0.91000000000000003 109.627 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 m -60.82 -37.43 81.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.444 -0.785 . . . . 1.73 110.076 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.39 96.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.299 -0.876 . . . . 1.04 111.15 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.8 mt -70.84 -26.58 63.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.451 -1.3 . . . . 1.03 108.539 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -67.71 -19.5 65.16 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.606 -0.684 . . . . 1.95 110.41 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -82.5 -6.03 59.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.922 -1.111 . . . . 1.71 109.749 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 31.8 mt -84.32 166.99 16.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.057 -1.027 . . . . 1.26 109.528 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -107.84 47.71 0.88 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.736 -0.603 . . . . 2.8300000000000001 109.906 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -142.82 120.61 11.92 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.017 -1.052 . . . . 1.5800000000000001 109.531 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.69 -8.64 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.601 0.715 . . . . 2.7999999999999998 109.72 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -76.67 -62.03 1.77 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.4 -0.812 . . . . 1.02 109.989 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.5 mt -68.83 -24.7 64.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.024 -1.048 . . . . 1.0600000000000001 109.239 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -66.88 -50.87 61.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -0.879 . . . . 2.3900000000000001 109.083 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.19 -20.95 63.35 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.306 -0.998 . . . . 2.2000000000000002 108.306 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -72.88 -27.77 62.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.745 -1.576 . . . . 2.0899999999999999 106.745 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.09 -42.64 90.93 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.107 -1.071 . . . . 0.85999999999999999 108.107 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.92 -39.04 79.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.413 -0.804 . . . . 0.90000000000000002 109.784 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -70.67 -25.96 63.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 1.3500000000000001 109.616 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.62 -47.48 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.57999999999999996 108.705 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -53.21 -39.02 63.39 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.062 -1.024 . . . . 3.2200000000000002 108.405 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 22.1 t70 -59.4 -40.4 86.47 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -0.897 . . . . 1.3200000000000001 109.633 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.4 mt -66.05 -34.01 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.149 -0.969 . . . . 0.5 109.25 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.32 -44.88 16.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.515 -1.434 . . . . 0.44 109.515 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -49.58 -45.9 48.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.411 -1.052 . . . . 2.71 109.631 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.53 ' HG2' HH11 ' A' ' 136' ' ' ARG . 11.0 mtt-85 -65.18 -42.92 93.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.08 . . . . 2.2000000000000002 108.491 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 137' ' ' LEU . 1.1 tt -52.38 -35.88 52.51 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.082 -1.081 . . . . 1.1299999999999999 108.082 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.64 -58.74 3.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.396 -0.815 . . . . 0.54000000000000004 110.23 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -46.21 -20.13 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.146 -0.971 . . . . 2.3199999999999998 111.114 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -83.43 -49.73 9.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.88 -1.138 . . . . 1.26 109.012 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.0 mt -57.56 -34.1 46.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.067 -1.021 . . . . 0.62 109.116 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 49.4 mt -87.22 0.08 55.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.062 -1.024 . . . . 0.67000000000000004 108.536 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.23 25.86 12.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.449 -1.861 . . . . 0.68000000000000005 108.449 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.5 tp -57.57 153.5 12.96 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.779 -0.836 . . . . 0.77000000000000002 110.14 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -67.18 146.76 53.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.02 -1.05 . . . . 2.3999999999999999 109.747 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.85 140.13 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.449 -0.782 . . . . 0.87 109.449 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.517 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.0 mp -78.03 120.15 28.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.225 -0.922 . . . . 1.3200000000000001 109.095 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -93.51 88.17 5.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 1.54 109.912 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.9 mt -82.0 -24.05 35.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.877 . . . . 0.77000000000000002 108.798 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.0 t -80.44 26.14 0.39 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.457 -0.777 . . . . 1.5700000000000001 108.945 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.5 28.38 2.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 0.81999999999999995 110.125 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 51.2 mt -74.59 152.35 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.869 . . . . 0.81999999999999995 109.127 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -131.76 -6.51 3.61 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.664 -0.865 . . . . 2.1099999999999999 108.664 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -121.82 136.06 54.92 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.954 -0.758 . . . . 1.4099999999999999 108.954 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.54 124.91 25.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 1.3 109.353 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.0 m -147.25 172.54 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.676 -0.861 . . . . 0.56999999999999995 108.676 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.5 mt -90.19 157.96 2.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.828 -1.175 . . . . 0.42999999999999999 107.828 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.8 tp -108.98 121.36 44.96 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.675 0.75 . . . . 0.56000000000000005 109.47 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.77 128.09 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.099 -0.704 . . . . 0.54000000000000004 109.099 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.84 151.47 14.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.442 -0.786 . . . . 0.62 109.918 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.35 -41.58 84.98 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.495 -1.378 . . . . 0.80000000000000004 107.895 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -172.94 152.8 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 2.3399999999999999 109.031 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.3 mt -116.06 141.22 48.42 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.365 -0.834 . . . . 0.65000000000000002 109.867 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 26.2 p -94.97 151.1 38.66 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.315 -0.866 . . . . 0.73999999999999999 108.944 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -35.78 -43.75 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.435 2.09 . . . . 0.59999999999999998 112.243 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.3 m -53.9 -65.37 0.58 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.214 -0.929 . . . . 0.63 109.258 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -47.67 -36.78 11.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.3 -0.875 . . . . 1.25 109.773 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.431 HG21 ' CD2' ' A' ' 189' ' ' HIS . 21.3 p -74.14 -20.11 60.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.5 110.029 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.17 -19.8 27.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.093 -1.004 . . . . 0.51000000000000001 110.102 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -109.81 -16.57 13.86 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.443 -0.786 . . . . 1.1699999999999999 110.109 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.06 147.86 45.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.908 -1.12 . . . . 0.60999999999999999 108.556 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 174' ' ' LYS . 12.2 t-20 -96.02 155.35 16.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.973 -1.079 . . . . 2.1200000000000001 108.804 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.3 mp -94.53 -42.75 8.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.244 -0.91 . . . . 1.3400000000000001 110.644 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 53.1 mtpt -79.67 -12.46 59.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.018 -1.051 . . . . 1.97 111.502 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -96.59 -6.16 37.45 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.675 -1.265 . . . . 1.8999999999999999 108.762 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.468 HG11 ' CE1' ' A' ' 179' ' ' PHE . 40.4 t -103.27 155.91 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.804 -0.813 . . . . 0.47999999999999998 108.804 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.52 HD21 ' HB1' ' A' ' 12' ' ' ALA . 11.5 tp -111.22 -18.09 13.04 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.928 -0.768 . . . . 1.3899999999999999 108.928 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.46 177.14 42.47 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.073 -1.611 . . . . 0.38 109.073 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.468 ' CE1' HG11 ' A' ' 176' ' ' VAL . 2.8 m-85 -130.26 126.3 36.96 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.483 -1.01 . . . . 0.46000000000000002 108.852 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.4 mt -129.17 117.42 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.808 -1.182 . . . . 0.58999999999999997 107.808 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 203' ' ' VAL . 66.0 p -142.74 157.57 44.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.282 -0.886 . . . . 0.67000000000000004 111.13 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 23.4 p30 -98.01 47.72 1.01 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.675 -0.81 . . . . 2.2400000000000002 110.179 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -94.23 -148.35 0.27 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.869 -1.144 . . . . 1.1100000000000001 110.116 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.11 -115.25 2.12 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.236 -1.146 . . . . 1.6299999999999999 110.236 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 164.28 -23.88 0.17 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.383 -1.887 . . . . 1.47 108.383 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.474 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.3 OUTLIER -65.56 100.22 0.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.552 -0.969 . . . . 5.2400000000000002 109.455 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 186' ' ' ARG . 47.7 p 41.72 42.04 1.97 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.471 -0.768 . . . . 2.9199999999999999 109.797 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.4 t -82.24 151.16 26.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.21 -0.931 . . . . 1.6000000000000001 109.875 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.431 ' CD2' HG21 ' A' ' 168' ' ' THR . 11.8 t60 -51.63 -57.58 8.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.457 -0.777 . . . . 0.92000000000000004 109.662 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.5 p -51.65 -38.69 55.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.523 -0.736 . . . . 1.5900000000000001 110.454 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 44.0 p -69.09 -42.83 75.64 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.745 -1.222 . . . . 1.4199999999999999 110.031 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.7 mt -55.48 -29.82 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.052 -1.03 . . . . 1.4099999999999999 109.977 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.7 mtp -70.28 -56.22 7.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.322 -1.362 . . . . 0.85999999999999999 107.322 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.99 83.77 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.477 -0.783 . . . . 0.58999999999999997 109.417 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -65.76 -47.71 74.3 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.259 -0.901 . . . . 3.0600000000000001 109.659 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.0 m -69.48 -38.06 77.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.923 -1.11 . . . . 0.72999999999999998 110.204 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 199' ' ' LEU . 14.4 mt -91.42 4.26 52.92 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.862 -1.149 . . . . 0.67000000000000004 109.432 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 47.48 10.77 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 1.49 110.395 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 197' ' ' LEU . 27.3 mt -67.75 150.59 97.74 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.052 -1.03 . . . . 0.64000000000000001 109.156 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.57 134.92 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.323 1.348 . . . . 0.58999999999999997 110.88 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.96 174.78 11.9 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.353 -1.339 . . . . 0.55000000000000004 111.037 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.3 mt -148.7 158.32 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 106.353 -1.721 . . . . 0.63 106.353 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.9 m -138.9 -32.67 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.01 -1.056 . . . . 0.77000000000000002 110.776 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.79 40.01 2.97 Favored Glycine 0 N--CA 1.496 2.671 0 O-C-N 121.056 -1.028 . . . . 0.87 110.99 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 29.9 p -69.23 -22.67 63.85 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.872 -1.37 . . . . 0.89000000000000001 108.924 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 73.34 -97.18 0.85 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.905 -1.141 . . . . 0.93000000000000005 111.119 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 51.7 p -119.85 46.37 1.95 Allowed 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.979 -1.307 . . . . 1.6000000000000001 112.263 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 28.4 t -75.33 -28.9 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.639 -1.288 . . . . 0.75 107.879 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.8 p -67.75 -10.47 52.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.424 -0.798 . . . . 0.83999999999999997 109.032 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.9 p -106.76 14.54 26.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.101 -0.703 . . . . 1.6100000000000001 109.101 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -131.61 -25.1 2.16 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.427 -0.796 . . . . 2.2999999999999998 109.33 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 213' ' ' LYS . 74.3 t -117.52 164.33 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.558 -0.714 . . . . 0.76000000000000001 109.115 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.566 ' N ' HG12 ' A' ' 212' ' ' VAL . 13.7 mmmt -127.17 -171.87 2.52 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.023 -1.473 . . . . 2.0099999999999998 107.023 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.56 ' C ' HD22 ' A' ' 214' ' ' ASN . 0.4 OUTLIER -81.68 149.16 28.64 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.469 -1.394 . . . . 2.1899999999999999 110.107 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.2 t0 81.38 -11.61 1.07 Allowed 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.879 -0.513 . . . . 2.3999999999999999 111.495 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 0.8 OUTLIER -57.08 145.22 31.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.664 -1.272 . . . . 1.99 108.432 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -87.28 120.56 28.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.865 -1.147 . . . . 1.3 108.448 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 16' ' ' ALA . 28.0 mt -123.65 170.19 10.71 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.253 1.025 . . . . 0.53000000000000003 110.685 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.9 mt -144.74 106.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 106.423 -1.695 . . . . 0.59999999999999998 106.423 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.4 tp -82.96 127.03 33.16 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.501 -0.926 . . . . 0.56999999999999995 108.501 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 223' ' ' VAL . 17.8 m-20 -97.15 -31.86 12.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.352 -0.843 . . . . 2.2200000000000002 109.453 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.62 25.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.428 0.632 . . . . 0.75 110.163 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.5 t -122.41 -51.88 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 106.486 -1.672 . . . . 0.92000000000000004 106.486 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -97.58 16.04 21.58 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.257 -1.386 . . . . 2.3599999999999999 107.257 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 49.89 57.96 5.97 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.98 -0.748 . . . . 1.4199999999999999 108.98 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -154.67 143.76 21.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 1.97 110.043 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.51 138.17 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.969 -0.752 . . . . 0.65000000000000002 108.969 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -103.26 129.91 50.36 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.163 -0.961 . . . . 0.96999999999999997 109.511 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.9 t -108.91 122.88 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.775 -0.578 . . . . 0.67000000000000004 110.198 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 50.31 58.25 17.3 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.903 . . . . 1.45 109.607 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.47 159.51 50.17 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.7 2.267 . . . . 0.81999999999999995 112.431 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.8 m -76.28 157.72 32.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 1.6200000000000001 109.875 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -62.16 -25.54 67.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.069 -1.019 . . . . 2.6000000000000001 109.585 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -72.66 -35.73 67.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.305 -0.872 . . . . 3.0600000000000001 110.259 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.56 -45.88 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.892 . . . . 1.1399999999999999 109.808 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.8 mt -48.95 -60.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.218 -0.926 . . . . 1.04 109.005 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.63 -41.94 70.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.686 -0.633 . . . . 2.54 110.066 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -66.99 -35.1 79.19 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.993 -1.067 . . . . 2.6000000000000001 109.953 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.4 mtp -80.97 -24.88 37.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.953 . . . . 1.23 109.631 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -61.65 -45.65 93.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.104 -0.997 . . . . 2.6699999999999999 109.653 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 242' ' ' VAL . . . -74.9 -58.68 3.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.978 -1.076 . . . . 1.6599999999999999 109.011 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 241' ' ' ALA . 80.4 t -42.97 -59.12 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.471 -0.768 . . . . 2.2000000000000002 110.156 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 13' ' ' PHE . 24.8 tt0 -47.07 -62.62 1.33 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.013 -1.055 . . . . 3.0 109.911 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -56.13 -29.21 60.39 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.124 -0.985 . . . . 1.76 110.875 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -68.08 -22.73 64.9 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.35 -1.34 . . . . 2.7799999999999998 107.935 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.0 t -71.15 -51.97 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.603 -0.839 . . . . 2.0600000000000001 108.868 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -49.58 -36.86 25.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 2.3999999999999999 109.121 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.2 t -77.92 -17.58 57.1 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.552 -0.718 . . . . 2.8700000000000001 109.926 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.048 -1.033 . . . . 3.4100000000000001 109.671 -179.708 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.469 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.357 0.599 . . . . 3.6600000000000001 109.466 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.463 HD13 HG22 ' A' ' 208' ' ' VAL . 89.7 mt -86.05 97.46 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.935 . . . . 1.1200000000000001 109.476 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -94.65 108.66 20.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.244 -0.91 . . . . 1.45 109.138 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.17 -170.38 30.8 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.616 -1.394 . . . . 0.92000000000000004 109.616 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.467 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 71.5 mt -96.17 -10.04 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.396 -1.061 . . . . 1.05 109.037 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 tp 64.97 106.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.877 -0.786 . . . . 0.88 108.877 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.57 -45.21 11.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.041 -1.096 . . . . 0.78000000000000003 108.041 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -151.39 149.35 24.24 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.573 -0.899 . . . . 1.5 108.573 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.47 147.89 20.37 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.495 2.13 . . . . 0.85999999999999999 113.454 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.687 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.3 -177.78 31.5 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.691 -1.363 . . . . 0.78000000000000003 109.691 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.6 mt -141.45 133.38 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.09 -1.241 . . . . 0.73999999999999999 109.35 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.72 158.04 44.05 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.338 -0.851 . . . . 0.45000000000000001 110.223 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.1 m-85 -128.64 136.17 50.3 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 107.98 -1.119 . . . . 0.64000000000000001 107.98 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.98 163.11 31.74 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 118.784 -1.675 . . . . 0.45000000000000001 111.003 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -79.88 148.28 31.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.634 -0.921 . . . . 1.8799999999999999 110.29 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.69 123.64 25.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.558 -0.714 . . . . 0.58999999999999997 111.278 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.0 tp -105.16 91.25 3.71 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.38 -1.341 . . . . 0.64000000000000001 107.38 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 tp -82.78 136.43 34.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.73999999999999999 110.034 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.26 94.4 7.08 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.46 0.647 . . . . 0.73999999999999999 110.444 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -98.94 149.98 22.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.438 -0.789 . . . . 1.8700000000000001 109.184 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -130.42 141.42 50.54 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.259 -0.901 . . . . 2.5800000000000001 109.088 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.83 136.75 36.15 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.108 -0.995 . . . . 2.1400000000000001 109.377 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -67.13 130.84 44.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.462 -0.774 . . . . 1.9299999999999999 109.08 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.2 mt -91.88 137.73 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.238 -0.914 . . . . 0.68000000000000005 109.544 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.9 t -105.06 117.73 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.515 -0.74 . . . . 0.83999999999999997 109.368 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -88.86 142.57 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.199 -0.938 . . . . 0.79000000000000004 109.266 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -91.06 124.02 34.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.159 -0.963 . . . . 1.3700000000000001 109.935 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -100.48 28.89 4.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.39 -0.819 . . . . 2.6200000000000001 109.206 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.63 144.6 29.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 2.3500000000000001 109.882 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -85.13 124.0 31.29 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.342 -0.984 . . . . 2.3500000000000001 108.342 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.9 pt -88.39 171.2 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.996 . . . . 0.78000000000000003 110.518 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.513 ' C ' ' H ' ' A' ' 34' ' ' ASP . 21.3 p -101.35 155.0 18.31 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.94 -0.763 . . . . 1.04 108.94 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.96 -5.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 1.05 110.167 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 32' ' ' SER . 31.8 t0 -83.94 -28.39 27.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.02 -1.05 . . . . 2.4700000000000002 110.325 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -102.1 -2.98 28.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.144 -0.972 . . . . 1.46 109.783 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.49 -44.02 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.087 -1.008 . . . . 0.77000000000000002 108.908 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -51.42 -37.11 46.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.892 . . . . 1.46 109.194 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -69.22 -34.3 74.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 2.29 109.892 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -61.42 -46.63 89.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.09 -1.006 . . . . 1.3 109.442 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 44' ' ' LEU . 87.0 t -60.97 -48.4 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.76000000000000001 109.534 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -64.06 -39.67 94.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 1.5 108.543 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -64.75 -33.66 76.5 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.621 -0.881 . . . . 2.6600000000000001 108.621 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -86.81 -57.32 3.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.75 108.969 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 40' ' ' VAL . 14.9 tp -49.16 -65.21 0.61 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.407 -0.808 . . . . 0.82999999999999996 109.378 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.582 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.0 t -64.24 -32.27 73.79 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.788 -0.819 . . . . 0.78000000000000003 108.788 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -59.1 -54.21 39.91 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 107.612 -2.195 . . . . 0.56999999999999995 107.612 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -50.31 -27.83 6.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.597 -0.943 . . . . 2.8300000000000001 108.904 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -63.75 -33.84 76.54 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.021 -1.103 . . . . 0.65000000000000002 108.021 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 46' ' ' GLY . 24.6 mtpp -80.5 -58.04 3.3 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.843 -0.799 . . . . 2.5699999999999998 108.843 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -53.94 -36.16 62.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.091 -1.006 . . . . 0.51000000000000001 109.322 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.6 t -63.54 -37.11 86.04 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.35 -0.981 . . . . 1.3600000000000001 108.35 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.15 -32.65 63.23 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.296 -0.631 . . . . 0.59999999999999998 109.296 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -68.96 -65.14 0.74 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.57 -0.706 . . . . 1.3600000000000001 109.541 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 54' ' ' LEU . 9.3 mp -51.9 -27.94 14.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 1.3799999999999999 109.078 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -73.09 -49.46 28.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 1.27 109.104 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.2 m -58.32 -31.77 67.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.115 -0.991 . . . . 0.59999999999999998 109.198 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -73.28 -31.19 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.075 -1.016 . . . . 0.53000000000000003 108.556 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -56.51 -45.4 81.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.504 -0.747 . . . . 0.98999999999999999 109.319 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -70.71 -27.04 63.69 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.203 -0.935 . . . . 0.58999999999999997 109.672 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -71.23 -34.66 71.0 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.872 -1.143 . . . . 1.8100000000000001 107.95 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.29 -29.05 63.5 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.033 -0.728 . . . . 0.47999999999999998 109.033 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.33 -34.3 12.52 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.917 -1.135 . . . . 0.57999999999999996 110.995 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -85.73 -12.2 51.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.586 -1.538 . . . . 1.3899999999999999 108.849 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.1 m -94.22 -52.92 4.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.81999999999999995 109.66 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.503 ' C ' ' H ' ' A' ' 67' ' ' GLU . 70.8 m-85 -107.91 -35.91 6.51 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.293 -0.88 . . . . 0.98999999999999999 109.778 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.77 -24.9 0.64 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.896 -1.282 . . . . 0.55000000000000004 109.896 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 69' ' ' LYS . 80.6 mt-10 -53.02 -172.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.252 . . . . 2.5899999999999999 110.323 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.56 34.61 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.468 -0.77 . . . . 2.2000000000000002 109.991 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 67' ' ' GLU . 4.4 mmmm -85.12 -17.18 38.08 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.251 -0.906 . . . . 1.79 109.305 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.16 -32.11 72.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 1.54 110.285 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.2 -21.38 65.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.197 -0.939 . . . . 0.64000000000000001 110.597 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.1 mt -69.47 -46.39 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.984 -1.073 . . . . 0.57999999999999996 109.539 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -76.82 -20.12 56.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.62 109.801 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.88 -35.9 82.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 1.23 108.618 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.75 -34.64 24.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.631 -1.387 . . . . 0.52000000000000002 109.631 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.78 -20.96 59.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.08 -1.247 . . . . 1.29 109.413 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.3 mt -86.44 -42.57 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.124 -1.065 . . . . 0.55000000000000004 108.124 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.3 ttt -59.41 -43.01 93.09 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.769 -0.826 . . . . 1.8899999999999999 108.769 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -64.57 -45.22 87.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.734 -0.839 . . . . 0.53000000000000003 108.734 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.1 tp -66.78 -46.91 73.81 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.536 -0.728 . . . . 0.42999999999999999 109.566 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -85.78 9.83 15.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.298 -0.876 . . . . 1.24 110.082 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -47.91 127.36 11.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.959 -1.088 . . . . 1.3100000000000001 109.274 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -65.73 -25.37 67.26 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.732 -0.84 . . . . 1.3500000000000001 108.732 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -77.91 -52.44 8.84 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.333 -0.854 . . . . 2.1600000000000001 109.724 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.74 -18.67 64.28 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.002 -1.061 . . . . 0.59999999999999998 109.269 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.76 -54.68 6.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 1.28 109.478 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -64.26 -29.63 70.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 1.28 110.022 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.61 -47.58 46.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.094 -1.004 . . . . 1.29 109.005 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.2 mt -58.84 -59.92 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.328 -0.99 . . . . 0.57999999999999996 108.328 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.5 mt -45.29 -39.63 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.574 -0.704 . . . . 0.78000000000000003 109.855 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.35 -60.99 2.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.85999999999999999 109.759 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.9 mt -47.83 -50.77 25.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 0.79000000000000004 109.38 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.0 mt -54.45 -49.91 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.905 . . . . 0.70999999999999996 110.679 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -85.24 -36.78 20.71 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.832 -1.168 . . . . 2.0499999999999998 111.754 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -84.44 -37.51 21.33 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.735 -1.228 . . . . 1.5900000000000001 111.693 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -103.69 14.88 30.13 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.777 -1.202 . . . . 1.8899999999999999 109.432 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.4 m170 44.3 49.17 7.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.412 -0.805 . . . . 1.3100000000000001 110.359 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 31.8 mtt -103.78 150.46 24.07 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.734 -0.839 . . . . 1.28 108.734 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.8 p -76.89 148.91 36.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 0.62 109.811 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.25 -31.33 42.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.219 -0.926 . . . . 0.46999999999999997 109.202 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.25 -44.07 54.46 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.755 -0.832 . . . . 2.0 108.755 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.88 -54.2 12.34 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.736 -0.602 . . . . 0.56000000000000005 110.422 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.7 -50.64 72.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.47999999999999998 109.48 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.91 -35.22 61.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.441 -0.787 . . . . 0.44 109.73 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.25 -30.05 68.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.932 -1.105 . . . . 1.4199999999999999 109.727 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 109' ' ' GLU . 79.0 tt0 -66.0 -62.67 1.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 1.26 110.274 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 t -49.95 -47.11 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.059 -1.026 . . . . 0.60999999999999999 109.546 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.32 -16.14 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.447 -0.945 . . . . 0.64000000000000001 108.447 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . 9.5 tp10 -73.46 -35.42 65.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 2.2000000000000002 109.159 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.65 -28.42 24.25 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.573 -1.299 . . . . 0.81999999999999995 112.194 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -65.03 -36.87 85.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.697 -1.472 . . . . 1.27 109.094 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.54 -54.37 5.96 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.975 -0.75 . . . . 0.91000000000000003 108.975 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.9 m -59.41 -37.53 78.25 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.427 -0.796 . . . . 1.73 109.853 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -63.76 -41.46 97.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.343 -0.848 . . . . 1.04 110.85 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.0 mt -67.02 -28.4 68.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.772 -1.205 . . . . 1.03 109.208 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -67.34 -17.5 64.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.948 . . . . 1.95 109.97 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -82.76 -9.02 59.54 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.127 -0.983 . . . . 1.71 109.572 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mt -86.61 145.11 26.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.347 -0.846 . . . . 1.26 108.847 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.88 61.26 2.16 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.435 -0.95 . . . . 2.8300000000000001 108.435 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -149.38 120.46 7.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.783 . . . . 1.5800000000000001 109.763 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.46 -13.36 58.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 2.7999999999999998 109.196 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.61 -65.16 1.0 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.249 -0.907 . . . . 1.02 109.219 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.3 mt -64.04 -32.14 73.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 1.0600000000000001 109.324 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 127' ' ' ALA . 46.4 tttp -66.51 -53.27 36.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.041 . . . . 2.3900000000000001 109.117 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -56.1 -19.45 13.19 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.158 -1.053 . . . . 2.2000000000000002 108.158 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -73.76 -26.83 60.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.104 -1.813 . . . . 2.0899999999999999 106.104 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -57.29 -44.05 83.73 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.056 -1.09 . . . . 0.85999999999999999 108.056 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.66 88.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.212 -1.033 . . . . 0.90000000000000002 108.212 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -70.72 -27.59 64.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.479 -0.763 . . . . 1.3500000000000001 109.324 179.222 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.55 -44.41 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.13 -1.063 . . . . 0.57999999999999996 108.13 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -52.72 -41.25 63.79 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.188 -1.042 . . . . 3.2200000000000002 108.188 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -62.69 -33.81 75.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.575 -0.703 . . . . 1.3200000000000001 109.479 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.5 -36.01 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.918 -1.114 . . . . 0.5 108.966 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.51 -46.12 16.04 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.937 -1.665 . . . . 0.44 108.937 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -55.3 -46.99 76.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.542 -0.975 . . . . 2.71 109.538 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.517 ' HG2' HH11 ' A' ' 136' ' ' ARG . 14.4 mtt-85 -65.32 -43.99 89.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 2.2000000000000002 108.993 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.1 tp -54.36 -37.74 65.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 1.1299999999999999 109.049 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.78 -58.3 7.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.54000000000000004 109.626 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -50.56 -16.54 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.333 -0.854 . . . . 2.3199999999999998 110.195 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.441 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 3.0 m120 -84.65 -45.9 12.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.125 -0.984 . . . . 1.26 109.425 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.31 -37.71 78.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.198 -0.939 . . . . 0.62 108.854 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 mt -90.67 -1.73 57.86 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 0.67000000000000004 109.0 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 50.49 22.39 5.38 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.619 -1.793 . . . . 0.68000000000000005 108.619 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.56 166.04 0.34 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.665 -0.903 . . . . 0.77000000000000002 109.494 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -64.65 134.59 54.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.034 -1.041 . . . . 2.3999999999999999 108.647 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 mt -101.56 142.53 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.192 -0.942 . . . . 0.87 108.872 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.4 mm -78.32 124.84 37.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.295 -0.878 . . . . 1.3200000000000001 110.05 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -99.18 85.9 3.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.357 -0.839 . . . . 1.54 109.368 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.442 ' O ' HD13 ' A' ' 152' ' ' ILE . 35.0 mt -80.09 -7.77 59.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.341 -0.849 . . . . 0.77000000000000002 109.346 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.8 p -89.3 -11.45 43.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.226 -0.921 . . . . 1.5700000000000001 109.927 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.71 44.56 1.01 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.168 -0.957 . . . . 0.81999999999999995 112.485 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 152' ' ' ILE . 1.5 mp -70.2 154.4 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.489 -1.382 . . . . 0.81999999999999995 107.558 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -130.74 -22.5 2.65 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.324 -0.86 . . . . 2.1099999999999999 109.714 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -122.38 137.48 54.85 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.485 -0.759 . . . . 1.4099999999999999 109.234 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -62.41 129.81 42.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 1.3 109.912 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.7 m -151.05 175.5 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.745 . . . . 0.56999999999999995 109.251 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 22.9 mt -89.88 158.17 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 107.811 -1.181 . . . . 0.42999999999999999 107.811 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.1 tp -106.87 118.86 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.916 -0.772 . . . . 0.56000000000000005 108.916 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.2 t -123.55 129.95 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 121.37 0.605 . . . . 0.54000000000000004 109.713 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.82 147.49 10.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 0.62 109.265 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.79 73.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.686 -1.259 . . . . 0.80000000000000004 107.983 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 66.1 t0 -173.63 145.74 1.23 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.482 -0.933 . . . . 2.3399999999999999 108.482 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.506 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.7 mt -117.74 137.47 52.68 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.155 -0.683 . . . . 0.65000000000000002 109.155 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.6 p -89.36 150.04 43.9 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.353 -0.842 . . . . 0.73999999999999999 108.889 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 169' ' ' ALA . 76.6 Cg_exo -35.51 -46.54 0.82 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.393 2.062 . . . . 0.59999999999999998 111.898 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 169' ' ' ALA . 38.2 m -52.86 -65.71 0.51 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.409 -0.96 . . . . 0.63 108.409 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -44.82 -44.19 9.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.622 -0.674 . . . . 1.25 109.93 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.3 p -71.85 -25.4 61.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.107 -0.995 . . . . 0.5 109.564 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 166' ' ' SER . . . -78.69 -29.71 45.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.963 . . . . 0.51000000000000001 110.165 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -100.13 -4.26 30.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.271 -0.893 . . . . 1.1699999999999999 109.371 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 tp -58.18 147.45 30.16 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.276 -1.009 . . . . 0.60999999999999999 108.276 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.441 ' O ' HG23 ' A' ' 176' ' ' VAL . 54.8 t-20 -99.02 106.65 18.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.133 -0.979 . . . . 2.1200000000000001 109.64 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -87.02 37.2 0.75 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -0.856 . . . . 1.3400000000000001 109.177 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -109.34 -24.47 11.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.537 -0.727 . . . . 1.97 109.436 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -132.82 10.99 4.32 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 1.8999999999999999 110.248 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 172' ' ' ASN . 30.9 t -79.28 154.45 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.928 -1.108 . . . . 0.47999999999999998 109.161 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.402 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 13.5 tp -114.9 -19.45 10.97 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.704 -0.623 . . . . 1.3899999999999999 110.189 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.46 175.1 42.6 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.857 -1.297 . . . . 0.38 109.857 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.484 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 4.4 m-85 -126.77 122.3 34.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.481 -1.011 . . . . 0.46000000000000002 109.275 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.0 mt -130.33 124.39 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.501 -0.926 . . . . 0.58999999999999997 108.501 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 203' ' ' VAL . 40.6 p -142.68 151.76 41.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 0.67000000000000004 111.202 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.476 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 1.6 m-20 -87.3 43.77 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 2.2400000000000002 108.996 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -109.11 123.52 49.31 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.413 -0.805 . . . . 1.1100000000000001 110.214 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.467 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -42.96 -15.4 0.02 OUTLIER Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.459 -0.776 . . . . 1.6299999999999999 111.229 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 70.05 -8.85 3.33 Favored Glycine 0 N--CA 1.49 2.255 0 O-C-N 120.388 -1.654 . . . . 1.47 109.89 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.546 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.8 OUTLIER -46.92 -35.24 6.24 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -1.135 . . . . 5.2400000000000002 109.177 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 76.2 p -152.68 31.57 0.51 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.694 -0.629 . . . . 2.9199999999999999 109.31 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.2 t -83.84 135.45 34.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.124 -0.985 . . . . 1.6000000000000001 109.56 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -70.06 -29.0 65.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.92000000000000004 108.683 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.3 p -55.54 -41.86 73.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.391 -0.818 . . . . 1.5900000000000001 109.42 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.2 t -62.48 -31.43 72.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 1.4199999999999999 109.557 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.0 mm -68.33 -34.77 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.186 -0.946 . . . . 1.4099999999999999 110.143 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.3 mtm -71.41 -54.1 11.81 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.692 -1.225 . . . . 0.85999999999999999 107.692 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.86 -44.19 70.17 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.392 -0.596 . . . . 0.58999999999999997 109.392 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -66.35 -46.63 76.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.15 -0.969 . . . . 3.0600000000000001 109.498 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.2 m -70.0 -37.13 75.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 0.72999999999999998 110.116 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 199' ' ' LEU . 26.1 mt -86.61 -0.17 55.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.042 -1.036 . . . . 0.67000000000000004 109.483 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 51.05 5.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.268 -0.895 . . . . 1.49 110.79 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 197' ' ' LEU . 66.7 mt -66.76 139.68 95.92 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.747 -1.221 . . . . 0.64000000000000001 108.65 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.08 131.64 44.65 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.711 1.607 . . . . 0.58999999999999997 111.508 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -163.52 -179.21 6.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.706 -1.246 . . . . 0.55000000000000004 110.787 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.487 ' CD1' HD11 ' A' ' 220' ' ' LEU . 14.7 mt -150.45 158.71 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.166 -1.42 . . . . 0.63 107.166 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.1 m -142.84 -25.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 120.771 -1.206 . . . . 0.77000000000000002 110.703 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.44 27.99 5.48 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.934 -1.266 . . . . 0.87 109.934 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 207' ' ' SER . 2.9 p -57.02 -37.27 71.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.678 -1.483 . . . . 0.89000000000000001 108.122 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.476 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 60.02 -35.68 0.04 OUTLIER Glycine 0 N--CA 1.492 2.402 0 C-N-CA 121.031 -0.604 . . . . 0.93000000000000005 113.664 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 205' ' ' THR . 7.0 m -128.88 16.55 6.29 Favored 'General case' 0 N--CA 1.513 2.718 0 CA-C-N 119.749 1.774 . . . . 1.6000000000000001 113.209 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.463 HG22 HD13 ' A' ' 2' ' ' ILE . 20.2 t -80.17 -34.76 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.072 -1.643 . . . . 0.75 110.224 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.2 p -71.53 -21.26 61.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.827 -1.171 . . . . 0.83999999999999997 109.974 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.9 m -104.54 17.17 24.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.415 -0.803 . . . . 1.6100000000000001 109.137 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -139.32 -17.87 1.01 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.364 -0.835 . . . . 2.2999999999999998 110.835 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 213' ' ' LYS . 55.1 t -119.82 162.47 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.255 -0.903 . . . . 0.76000000000000001 109.691 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 212' ' ' VAL . 13.5 mmtp -126.54 -176.83 3.79 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.165 -1.42 . . . . 2.0099999999999998 107.165 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.466 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 10.8 p30 -77.01 149.57 35.87 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.74 -1.225 . . . . 2.1899999999999999 110.357 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.7 t70 81.03 -12.89 0.97 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.151 -0.343 . . . . 2.3999999999999999 110.667 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -57.76 140.68 50.98 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.794 -1.192 . . . . 1.99 108.358 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -90.66 109.97 21.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.939 -1.101 . . . . 1.3 108.91 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 7.3 mt -113.11 161.37 17.19 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.193 -0.669 . . . . 0.53000000000000003 109.193 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 67.5 mt -133.39 120.1 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.617 -1.253 . . . . 0.59999999999999998 107.617 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 202' ' ' ILE . 13.8 tp -87.78 127.65 35.32 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.022 -0.732 . . . . 0.56999999999999995 109.022 -178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 19.5 p-10 -98.01 -30.24 12.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.267 -0.895 . . . . 2.2200000000000002 109.034 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.76 24.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.387 0.613 . . . . 0.75 110.349 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.7 t -118.04 -59.0 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 106.695 -1.594 . . . . 0.92000000000000004 106.695 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -94.35 13.17 24.48 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.51 -1.292 . . . . 2.3599999999999999 107.51 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 55.53 62.11 2.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.154 -0.684 . . . . 1.4199999999999999 109.154 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.446 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 53.7 tt0 -155.62 145.82 21.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.14 -0.975 . . . . 1.97 110.769 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 228' ' ' TYR . 76.6 t -106.52 159.98 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.074 -0.713 . . . . 0.65000000000000002 109.074 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.478 ' N ' HG12 ' A' ' 227' ' ' VAL . 61.8 m-85 -124.88 114.53 19.31 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.52 -0.919 . . . . 0.96999999999999997 108.52 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.1 123.8 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 0.67000000000000004 109.942 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.4 t30 69.73 67.84 0.43 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.564 -0.71 . . . . 1.45 109.697 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -88.73 134.8 2.8 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 123.355 2.704 . . . . 0.81999999999999995 112.267 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 38.5 p -73.51 156.95 37.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 1.6200000000000001 109.393 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -65.69 -30.84 71.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 2.6000000000000001 109.375 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -56.86 -43.2 80.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.564 -0.71 . . . . 3.0600000000000001 109.724 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.4 t -72.93 -49.31 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 1.1399999999999999 109.608 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 84.7 mt -50.57 -59.65 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.287 -0.883 . . . . 1.04 109.381 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -55.46 -36.23 66.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 2.54 110.284 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -64.76 -51.42 62.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 2.6000000000000001 110.747 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 243' ' ' GLN . 9.1 mtm -79.49 -27.16 41.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.954 -1.091 . . . . 1.23 110.339 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 240' ' ' ARG . 9.9 mmm-85 -53.2 -41.56 65.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.811 -1.181 . . . . 2.6699999999999999 108.785 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.1 -52.44 10.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 1.6599999999999999 110.025 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.3 t -69.81 -51.06 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 2.2000000000000002 110.496 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 239' ' ' MET . 1.5 tm0? -55.56 -53.2 59.4 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.841 -1.162 . . . . 3.0 110.321 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.418 ' OE1' ' O ' ' A' ' 240' ' ' ARG . 52.9 mt-10 -60.32 -20.89 61.05 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.981 -1.075 . . . . 1.76 109.397 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -65.45 -26.81 68.12 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.871 -1.529 . . . . 2.7799999999999998 106.871 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.09 -43.42 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.686 -0.857 . . . . 2.0600000000000001 108.686 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.59 -36.29 80.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.577 -0.702 . . . . 2.3999999999999999 109.628 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -73.78 -33.31 64.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 2.8700000000000001 109.002 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 . . . . . 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 3.4100000000000001 108.85 179.375 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.535 ' H2 ' ' HG3' ' A' ' 226' ' ' GLN . 12.6 mmt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.315 -0.624 . . . . 3.6600000000000001 109.315 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.54 94.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 1.1200000000000001 109.537 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 m -93.96 118.06 30.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.292 -0.88 . . . . 1.45 109.69 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.444 ' N ' HD21 ' A' ' 225' ' ' ASN . . . -113.49 -161.12 14.3 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 108.934 -1.666 . . . . 0.92000000000000004 108.934 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' LEU . 79.5 mt -92.89 -9.79 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.044 -1.268 . . . . 1.05 109.218 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.9 tp 57.54 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.971 . . . . 0.88 109.469 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.05 -55.66 3.73 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.208 -1.034 . . . . 0.78000000000000003 108.208 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.82 148.11 34.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 108.694 -0.854 . . . . 1.5 108.694 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.03 150.36 29.64 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.357 2.038 . . . . 0.85999999999999999 113.337 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.02 124.48 1.1 Allowed Glycine 0 N--CA 1.499 2.881 0 N-CA-C 110.17 -1.172 . . . . 0.78000000000000003 110.17 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.19 135.03 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.094 -1.239 . . . . 0.73999999999999999 110.066 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.5 145.52 35.29 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.397 -0.814 . . . . 0.45000000000000001 110.224 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.8 m-85 -112.7 142.16 45.64 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.837 -1.172 . . . . 0.64000000000000001 107.837 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.22 164.8 30.44 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.424 -1.846 . . . . 0.45000000000000001 111.732 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -79.33 146.76 32.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.594 -0.945 . . . . 1.8799999999999999 110.338 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.41 120.69 24.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 0.58999999999999997 110.613 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 tp -102.07 91.38 4.3 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.589 -1.263 . . . . 0.64000000000000001 107.589 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.99 136.81 35.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.116 -0.99 . . . . 0.73999999999999999 110.166 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 mt -94.91 93.4 7.41 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.466 0.651 . . . . 0.73999999999999999 110.617 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -96.83 152.01 19.11 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.533 -0.914 . . . . 1.8700000000000001 108.533 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.88 145.05 51.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.196 -0.94 . . . . 2.5800000000000001 109.587 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.59 134.27 35.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 2.1400000000000001 109.407 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.57 136.45 55.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 1.9299999999999999 109.382 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.5 mt -92.99 135.67 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.68000000000000005 109.457 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.9 t -102.38 119.12 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.336 -0.853 . . . . 0.83999999999999997 108.801 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.7 mt -88.74 137.92 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.809 . . . . 0.79000000000000004 110.115 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -91.23 115.67 28.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.356 -0.84 . . . . 1.3700000000000001 109.429 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.432 HH11 ' HG3' ' A' ' 28' ' ' ARG . 14.2 mmm-85 -97.91 27.7 4.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.22 -0.925 . . . . 2.6200000000000001 109.259 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -82.87 147.85 28.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 2.3500000000000001 109.851 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -86.74 136.68 32.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.203 -0.935 . . . . 2.3500000000000001 108.747 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.9 pt -95.84 177.46 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.012 -1.055 . . . . 0.78000000000000003 110.303 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 98.8 p -98.97 154.68 17.89 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.66 -0.867 . . . . 1.04 108.66 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.11 -8.45 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.064 -1.022 . . . . 1.05 109.984 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -82.86 -14.61 53.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 2.4700000000000002 110.078 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -112.86 -2.99 14.22 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.32 -0.862 . . . . 1.46 109.688 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.67 -45.09 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.974 -1.079 . . . . 0.77000000000000002 108.728 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -56.66 -35.12 68.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 1.46 109.121 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -69.1 -36.53 77.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 2.29 110.212 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -62.63 -45.43 92.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 1.3 109.485 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.31 -46.24 97.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.438 -0.789 . . . . 0.76000000000000001 109.732 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.82 -42.33 81.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 1.5 108.882 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -62.86 -31.7 72.78 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.701 -0.852 . . . . 2.6600000000000001 108.701 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -86.09 -55.79 3.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.75 108.692 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.7 tp -51.81 -56.54 13.34 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.135 -1.061 . . . . 0.82999999999999996 108.135 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.64 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.8 t -66.46 -35.94 81.53 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.826 -1.175 . . . . 0.78000000000000003 107.826 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -55.85 -54.76 32.88 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 107.609 -2.196 . . . . 0.56999999999999995 107.609 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -47.66 -30.82 4.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.407 -1.054 . . . . 2.8300000000000001 108.763 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.26 -32.97 70.48 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.498 -1.297 . . . . 0.65000000000000002 107.498 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 46' ' ' GLY . 95.7 mttt -81.23 -62.86 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.64 -0.874 . . . . 2.5699999999999998 108.64 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.473 ' HB2' HD21 ' A' ' 140' ' ' ASN . . . -48.4 -40.56 26.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.899 . . . . 0.51000000000000001 109.598 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.4 p -62.35 -35.01 77.8 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.745 -1.205 . . . . 1.3600000000000001 107.745 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.82 -21.28 60.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.589 -0.523 . . . . 0.59999999999999998 109.589 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -76.51 -67.34 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 1.3600000000000001 109.488 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.59 -39.92 51.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.117 -0.989 . . . . 1.3799999999999999 108.436 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.99 -48.12 83.02 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.948 -0.76 . . . . 1.27 108.948 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.0 m -63.06 -38.86 92.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.59999999999999998 108.898 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.36 -37.56 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.921 . . . . 0.53000000000000003 108.546 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -51.06 -45.82 61.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.624 -0.673 . . . . 0.98999999999999999 109.715 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -75.19 -23.99 57.74 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.148 -0.97 . . . . 0.58999999999999997 110.427 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -72.31 -32.63 66.74 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.779 -1.201 . . . . 1.8100000000000001 108.385 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.11 -26.62 42.9 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.507 -0.745 . . . . 0.47999999999999998 109.241 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.27 14.35 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.707 -1.235 . . . . 0.57999999999999996 110.509 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -86.22 -14.9 42.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.827 -1.396 . . . . 1.3899999999999999 109.204 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.4 m -96.18 -49.0 5.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.269 -0.894 . . . . 0.81999999999999995 110.654 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -106.37 -18.19 14.06 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.148 -0.97 . . . . 0.98999999999999999 110.38 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.86 143.86 6.85 Favored Glycine 0 N--CA 1.502 3.086 0 N-CA-C 109.686 -1.365 . . . . 0.55000000000000004 109.686 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -49.73 -7.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.469 -1.018 . . . . 2.5899999999999999 110.826 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 66' ' ' GLY . 52.9 tt0 -65.78 -27.89 68.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.872 -1.143 . . . . 2.2000000000000002 111.0 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -90.12 -12.24 38.87 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.799 -1.188 . . . . 1.79 110.413 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -62.8 -21.28 65.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.091 -1.005 . . . . 1.54 110.709 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.92 70.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.851 -1.156 . . . . 0.64000000000000001 110.081 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.2 mt -72.52 -43.81 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.076 -1.015 . . . . 0.57999999999999996 109.636 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -77.05 -26.47 53.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.851 . . . . 0.62 110.325 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.08 -44.19 93.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.903 -1.123 . . . . 1.23 109.262 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.39 -35.84 88.01 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.915 -1.674 . . . . 0.52000000000000002 108.915 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -19.08 63.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.413 -1.051 . . . . 1.29 110.215 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.5 mt -83.84 -37.06 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.711 -1.243 . . . . 0.55000000000000004 108.589 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.4 ttt -58.9 -53.35 59.38 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.769 -0.826 . . . . 1.8899999999999999 108.769 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -52.01 -41.52 62.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.44 -0.788 . . . . 0.53000000000000003 108.905 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.8 tp -68.65 -44.32 74.39 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.42999999999999999 109.675 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -85.92 8.85 18.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.261 -0.899 . . . . 1.24 110.476 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -48.59 121.17 4.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.852 -1.155 . . . . 1.3100000000000001 109.328 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.74 -25.69 66.63 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.286 -0.884 . . . . 1.3500000000000001 108.808 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -76.99 -48.9 16.71 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.324 -0.86 . . . . 2.1600000000000001 109.625 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.64 -16.69 63.16 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.575 -1.25 . . . . 0.59999999999999998 108.657 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.8 -50.16 18.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.4 -0.812 . . . . 1.28 109.591 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.57 -29.31 70.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 1.28 109.134 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -74.07 -48.15 31.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 1.29 109.104 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.2 mt -57.31 -43.41 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.379 -0.971 . . . . 0.57999999999999996 108.379 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.11 -61.65 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.78000000000000003 110.195 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -45.23 -51.19 11.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.85999999999999999 110.275 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 49.9 mt -54.1 -55.0 31.75 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.452 -0.899 . . . . 0.79000000000000004 108.941 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.3 mt -51.02 -47.22 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.965 . . . . 0.70999999999999996 110.377 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -81.94 -33.29 30.4 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.987 -1.071 . . . . 2.0499999999999998 111.441 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.4 t70 -81.31 -45.96 15.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.769 -1.207 . . . . 1.5900000000000001 111.735 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -103.91 17.85 23.24 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.628 -1.295 . . . . 1.8899999999999999 109.866 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.6 m80 45.3 50.91 9.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.177 -0.952 . . . . 1.3100000000000001 109.469 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.6 mtt -99.73 149.01 23.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.52 -0.738 . . . . 1.28 109.114 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.3 p -76.15 146.78 38.97 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.399 -0.813 . . . . 0.62 109.21 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.67 -29.1 10.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.46999999999999997 108.702 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.37 -44.62 51.45 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.286 -1.005 . . . . 2.0 108.286 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.42 -54.45 12.34 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.313 0.577 . . . . 0.56000000000000005 110.074 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.29 -50.47 72.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.47999999999999998 109.365 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.08 -37.35 69.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.44 109.73 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -69.59 -35.07 75.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.046 -1.034 . . . . 1.4199999999999999 109.491 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 109' ' ' GLU . 33.4 tt0 -62.28 -58.35 8.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 1.26 109.612 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.3 t -50.28 -47.11 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.977 -1.077 . . . . 0.60999999999999999 109.221 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.3 mm -65.13 -15.65 18.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.376 -0.828 . . . . 0.64000000000000001 109.007 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 106' ' ' GLU . 24.7 tt0 -75.28 -37.0 61.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 2.2000000000000002 109.706 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.56 -26.5 29.85 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.491 -1.338 . . . . 0.81999999999999995 112.174 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -67.58 -37.91 83.27 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.614 -1.521 . . . . 1.27 108.952 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.34 -51.36 7.03 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.671 -0.643 . . . . 0.91000000000000003 109.581 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.0 p -60.47 -42.79 96.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.317 -0.865 . . . . 1.73 110.141 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.0 -38.41 90.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.976 -1.078 . . . . 1.04 110.339 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 115' ' ' LEU . 71.2 mt -67.72 -26.86 66.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.852 -1.155 . . . . 1.03 109.438 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -69.48 -20.45 63.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.035 -1.04 . . . . 1.95 109.607 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -81.36 -6.85 59.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 1.71 109.183 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 mt -85.7 143.18 28.51 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.244 -1.021 . . . . 1.26 108.244 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -96.66 62.04 1.94 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.271 -0.893 . . . . 2.8300000000000001 109.024 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -148.96 115.22 5.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.221 -0.924 . . . . 1.5800000000000001 109.621 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.82 -13.08 3.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 2.7999999999999998 109.433 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.504 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 1.0 OUTLIER -79.92 -63.79 1.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 1.02 109.375 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.6 mt -68.09 -30.81 70.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.215 -0.928 . . . . 1.0600000000000001 109.444 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 68.5 tttt -67.01 -51.64 52.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.956 . . . . 2.3900000000000001 109.337 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -57.86 -23.11 51.48 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.195 -0.94 . . . . 2.2000000000000002 108.995 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.504 ' NH2' ' OH ' ' A' ' 122' ' ' TYR . 18.6 ttm180 -73.41 -24.71 60.31 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.408 -1.701 . . . . 2.0899999999999999 106.408 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.08 -42.86 91.42 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.629 -0.878 . . . . 0.85999999999999999 108.629 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.71 80.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.436 -0.79 . . . . 0.90000000000000002 109.876 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.13 -25.32 65.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 1.3500000000000001 109.529 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.2 t -76.61 -42.62 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.163 -0.961 . . . . 0.57999999999999996 108.444 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 131' ' ' ARG . 16.6 ttm-85 -57.0 -37.69 72.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.223 -0.923 . . . . 3.2200000000000002 108.68 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -61.06 -38.37 85.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.508 -0.745 . . . . 1.3200000000000001 110.319 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.8 mt -67.97 -26.83 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.018 -1.051 . . . . 0.5 109.975 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.5 -44.08 8.87 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.632 -1.387 . . . . 0.44 109.632 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.419 ' HZ2' ' HD2' ' A' ' 139' ' ' ARG . 43.5 tttm -50.92 -51.68 49.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.371 -1.076 . . . . 2.71 109.642 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.544 ' CG ' HH11 ' A' ' 136' ' ' ARG . 4.5 mtt-85 -63.9 -46.21 85.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.109 -0.994 . . . . 2.2000000000000002 108.361 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.9 tp -49.83 -38.38 34.66 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.054 -0.721 . . . . 1.1299999999999999 109.054 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.8 mt -70.5 -55.01 9.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.54000000000000004 109.495 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.419 ' HD2' ' HZ2' ' A' ' 135' ' ' LYS . 47.2 mtp180 -53.49 -17.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 2.3199999999999998 110.293 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.473 HD21 ' HB2' ' A' ' 50' ' ' ALA . 10.2 m-20 -85.02 -47.4 10.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.992 -1.067 . . . . 1.26 109.204 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.27 -37.88 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.899 . . . . 0.62 109.118 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.83 -3.11 58.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.67000000000000004 108.693 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.32 22.62 15.53 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.303 -1.919 . . . . 0.68000000000000005 108.303 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.6 tp -55.58 154.3 6.78 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.625 -0.927 . . . . 0.77000000000000002 109.297 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -66.76 147.55 53.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 2.3999999999999999 109.683 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.8 mt -109.05 145.79 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.517 -0.739 . . . . 0.87 109.349 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.7 mm -76.34 119.46 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 1.3200000000000001 108.625 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.7 OUTLIER -94.79 87.03 4.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.255 -0.903 . . . . 1.54 109.918 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.9 mt -81.6 -10.33 59.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.77000000000000002 109.14 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.1 p -80.65 -12.18 59.53 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.273 -0.892 . . . . 1.5700000000000001 109.461 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -103.56 49.95 0.82 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.473 -0.767 . . . . 0.81999999999999995 110.53 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 153' ' ' GLN . 26.8 mm -71.2 164.12 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.812 -1.18 . . . . 0.81999999999999995 108.71 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.492 ' N ' HG22 ' A' ' 152' ' ' ILE . 46.0 mt-30 -132.88 -33.1 1.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.351 -0.843 . . . . 2.1099999999999999 109.768 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -115.0 145.52 42.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.5 -0.75 . . . . 1.4099999999999999 109.614 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -66.95 126.66 29.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.415 -0.803 . . . . 1.3 109.232 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.4 m -148.97 172.38 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.154 -0.966 . . . . 0.56999999999999995 109.668 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 158' ' ' LEU . 53.5 mt -90.66 163.59 2.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.609 -1.256 . . . . 0.42999999999999999 107.609 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.494 ' N ' HG22 ' A' ' 157' ' ' ILE . 12.7 tp -111.89 123.83 51.09 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.589 -0.694 . . . . 0.56000000000000005 109.404 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.8 t -123.46 129.7 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.148 -0.686 . . . . 0.54000000000000004 109.148 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.29 146.14 11.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.62 109.671 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.94 -27.25 66.63 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.601 -1.312 . . . . 0.80000000000000004 107.468 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -175.47 157.94 2.2 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.64 -0.663 . . . . 2.3399999999999999 109.215 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 22.6 mt -129.88 131.03 45.92 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.439 -0.788 . . . . 0.65000000000000002 109.321 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 p -94.59 153.28 40.28 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.285 -0.884 . . . . 0.73999999999999999 109.409 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -35.68 -41.78 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.541 2.16 . . . . 0.59999999999999998 112.354 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.9 m -62.2 -56.29 20.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.162 -0.961 . . . . 0.63 109.112 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -53.73 -31.19 47.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 1.25 109.526 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.5 HG21 ' CD2' ' A' ' 189' ' ' HIS . 28.3 p -82.49 -31.54 29.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.5 109.539 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.82 -23.92 58.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.51000000000000001 109.966 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -105.26 -6.0 20.11 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.145 -0.972 . . . . 1.1699999999999999 109.414 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.08 156.0 5.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.226 -1.027 . . . . 0.60999999999999999 108.226 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 176' ' ' VAL . 52.2 t-20 -97.9 97.19 8.74 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.136 -0.978 . . . . 2.1200000000000001 109.564 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.745 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.6 mm? -82.05 26.23 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 1.3400000000000001 109.193 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -112.44 -18.13 12.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.421 -0.799 . . . . 1.97 109.103 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -131.26 -1.32 4.01 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.47 -0.769 . . . . 1.8999999999999999 110.133 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 172' ' ' ASN . 39.3 t -78.95 151.54 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.874 -1.141 . . . . 0.47999999999999998 109.543 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.3 tp -121.33 -9.01 9.12 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.8 -0.562 . . . . 1.3899999999999999 110.269 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.44 176.5 41.22 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.561 -1.304 . . . . 0.38 110.069 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.82 130.35 35.94 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.517 -0.99 . . . . 0.46000000000000002 110.086 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.437 ' CG2' HG21 ' A' ' 205' ' ' THR . 8.1 mt -129.56 120.05 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.01 -1.107 . . . . 0.58999999999999997 108.01 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 203' ' ' VAL . 64.1 p -141.67 152.45 43.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.213 -0.929 . . . . 0.67000000000000004 110.868 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 21.4 p30 -89.45 43.83 1.17 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.088 -1.008 . . . . 2.2400000000000002 110.715 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -94.5 103.63 15.59 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.878 -1.139 . . . . 1.1100000000000001 108.799 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.19 43.06 2.43 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.843 -1.17 . . . . 1.6299999999999999 110.414 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -108.39 109.21 2.82 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.805 -1.318 . . . . 1.47 109.805 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -52.19 -23.8 6.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.105 -1.232 . . . . 5.2400000000000002 108.169 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.2 p -116.52 45.16 1.86 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.748 -0.834 . . . . 2.9199999999999999 108.748 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 40.7 p -81.23 142.25 33.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 1.6000000000000001 109.31 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.5 ' CD2' HG21 ' A' ' 168' ' ' THR . 5.3 t60 -47.56 -53.06 15.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 0.92000000000000004 109.671 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 190' ' ' THR . 0.1 OUTLIER -47.1 -44.15 21.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 1.5900000000000001 109.987 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 38.6 t -59.71 -37.43 78.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.01 . . . . 1.4199999999999999 110.34 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 31.4 mm -60.43 -34.36 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.098 -1.001 . . . . 1.4099999999999999 110.397 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.2 mtp -71.67 -52.05 19.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.902 -1.124 . . . . 0.85999999999999999 108.288 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.19 -30.99 51.67 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.722 -0.672 . . . . 0.58999999999999997 110.277 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -81.26 -47.76 12.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.066 -1.021 . . . . 3.0600000000000001 110.416 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.9 m -67.57 -37.1 82.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.933 -1.104 . . . . 0.72999999999999998 110.112 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 199' ' ' LEU . 15.9 mt -86.18 -0.13 54.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.981 -1.074 . . . . 0.67000000000000004 109.105 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 56.81 0.37 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.396 -0.815 . . . . 1.49 112.015 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.1 mt -67.42 170.77 6.03 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.472 -1.393 . . . . 0.64000000000000001 108.897 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -90.97 142.78 3.2 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.513 2.142 . . . . 0.58999999999999997 111.199 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.1 -178.19 5.88 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.562 -1.337 . . . . 0.55000000000000004 110.857 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.9 mt -149.69 158.48 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.962 -1.496 . . . . 0.63 106.962 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.525 ' O ' ' O ' ' A' ' 181' ' ' THR . 19.5 m -137.93 -32.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.989 -1.069 . . . . 0.77000000000000002 111.434 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.34 42.54 3.16 Favored Glycine 0 N--CA 1.496 2.653 0 O-C-N 120.579 -1.326 . . . . 0.87 110.727 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.437 HG21 ' CG2' ' A' ' 180' ' ' ILE . 60.8 p -71.39 -21.15 62.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.602 -1.528 . . . . 0.89000000000000001 109.297 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.452 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 71.75 -97.43 0.72 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.843 -1.17 . . . . 0.93000000000000005 111.814 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 66.7 m -115.42 45.86 1.59 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.969 -1.312 . . . . 1.6000000000000001 112.743 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 17.7 t -79.93 -27.19 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.601 -1.312 . . . . 0.75 107.636 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.433 ' H ' HG23 ' A' ' 209' ' ' THR . 1.4 p -73.67 -11.21 60.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.83999999999999997 109.7 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 13.8 p -101.53 6.4 42.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.36 -0.837 . . . . 1.6100000000000001 109.405 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -130.47 -3.58 4.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.399 -0.813 . . . . 2.2999999999999998 109.203 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.0 t -125.81 152.59 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.055 -0.72 . . . . 0.76000000000000001 109.055 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -118.68 -173.79 2.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.852 -1.536 . . . . 2.0099999999999998 106.852 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 22.7 t-20 -80.03 145.42 32.51 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.818 -1.176 . . . . 2.1899999999999999 111.202 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.46 -7.4 1.46 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.839 -0.538 . . . . 2.3999999999999999 110.843 178.531 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.29 138.05 55.28 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.875 -1.141 . . . . 1.99 108.446 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -86.38 115.98 24.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.038 -1.039 . . . . 1.3 108.655 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.6 mt -117.99 179.1 4.19 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.374 1.083 . . . . 0.53000000000000003 110.806 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.8 mt -146.93 107.92 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.387 -1.338 . . . . 0.59999999999999998 107.387 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 tp -83.21 128.4 34.46 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.32 -0.993 . . . . 0.56999999999999995 108.32 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -52.6 4.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 2.2200000000000002 109.82 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 57.54 22.74 8.44 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.339 -0.85 . . . . 0.75 108.77 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.06 -49.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 107.295 -1.372 . . . . 0.92000000000000004 107.295 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -106.95 12.14 29.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.936 -1.135 . . . . 2.3599999999999999 107.936 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.444 HD21 ' N ' ' A' ' 4' ' ' GLY . 59.0 t30 58.35 58.21 3.54 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.056 -0.72 . . . . 1.4199999999999999 109.056 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.535 ' HG3' ' H2 ' ' A' ' 1' ' ' MET . 17.4 tt0 -153.75 146.99 24.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.926 . . . . 1.97 109.918 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.63 136.62 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.67 -0.644 . . . . 0.65000000000000002 109.386 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -105.03 127.38 52.84 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.384 -0.822 . . . . 0.96999999999999997 109.2 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.58 127.89 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.516 -0.74 . . . . 0.67000000000000004 109.864 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 49.05 69.96 2.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.857 . . . . 1.45 109.989 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.5 153.44 13.73 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.78 2.32 . . . . 0.81999999999999995 111.64 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.5 p -73.93 169.59 17.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.979 . . . . 1.6200000000000001 109.98 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.53 -27.76 65.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.852 . . . . 2.6000000000000001 109.579 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.13 -38.65 91.33 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.418 -0.801 . . . . 3.0600000000000001 109.537 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.09 -46.31 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 1.1399999999999999 109.341 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.7 mt -52.05 -55.84 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 1.04 109.356 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -54.91 -44.83 74.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 2.54 109.972 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.45 ' O ' HG23 ' A' ' 242' ' ' VAL . 50.8 tttm -67.54 -37.75 83.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 2.6000000000000001 110.144 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 51.9 mtp -80.16 -25.92 39.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 1.23 109.706 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.469 ' CA ' ' HE ' ' A' ' 240' ' ' ARG . 0.0 OUTLIER -60.16 -51.86 67.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.179 -0.951 . . . . 2.6699999999999999 109.853 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.71 -54.94 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 1.6599999999999999 109.771 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 238' ' ' LYS . 84.5 t -49.03 -53.02 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 2.2000000000000002 109.511 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -55.29 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.249 -0.907 . . . . 3.0 109.981 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -63.21 -35.62 80.92 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.122 -0.986 . . . . 1.76 110.499 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -68.91 -20.15 64.23 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.968 -1.082 . . . . 2.7799999999999998 108.408 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.5 t -83.5 -31.44 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.679 -0.86 . . . . 2.0600000000000001 108.679 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.8 -36.16 77.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.441 -0.787 . . . . 2.3999999999999999 109.17 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.6 t -78.31 -29.37 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.335 -0.853 . . . . 2.8700000000000001 109.314 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.306 -0.871 . . . . 3.4100000000000001 109.555 -179.827 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.451 -0.574 . . . . 3.6600000000000001 109.451 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 208' ' ' VAL . 74.3 mt -60.67 98.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.872 . . . . 1.1200000000000001 109.475 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.0 m -93.37 114.67 27.15 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 1.45 109.619 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.72 -163.15 19.53 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.784 -1.726 . . . . 0.92000000000000004 108.784 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 5' ' ' ILE . 63.4 mt -96.48 -9.46 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.039 -1.271 . . . . 1.05 108.789 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.2 tp 59.42 110.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.416 -0.803 . . . . 0.88 109.151 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -89.77 -49.66 6.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.081 -1.081 . . . . 0.78000000000000003 108.081 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -150.43 152.15 32.41 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.371 -0.83 . . . . 1.5 109.383 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.08 155.89 29.92 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.585 2.19 . . . . 0.85999999999999999 112.504 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 144.26 121.84 1.55 Allowed Glycine 0 N--CA 1.504 3.169 0 N-CA-C 110.232 -1.147 . . . . 0.78000000000000003 110.232 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.49 139.48 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.094 -1.239 . . . . 0.73999999999999999 110.22 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.61 159.86 41.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.324 -0.86 . . . . 0.45000000000000001 109.68 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.595 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -130.39 135.79 48.4 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.107 -1.072 . . . . 0.64000000000000001 108.107 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 166.6 37.14 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 118.601 -1.762 . . . . 0.45000000000000001 111.723 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -79.61 149.78 31.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.739 -0.859 . . . . 1.8799999999999999 110.392 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -76.37 125.02 28.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.39 -0.819 . . . . 0.58999999999999997 110.992 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.1 tp -110.79 93.15 4.34 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.174 -1.417 . . . . 0.64000000000000001 107.174 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -81.79 126.83 32.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.04 -1.037 . . . . 0.73999999999999999 110.996 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.3 mt -101.94 94.44 5.79 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.609 -0.723 . . . . 0.73999999999999999 110.316 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -94.62 158.54 15.48 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.358 -0.979 . . . . 1.8700000000000001 108.358 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -130.18 125.4 34.89 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.384 -0.823 . . . . 2.5800000000000001 109.506 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 6.5 p-10 -80.27 130.2 35.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.32 -0.862 . . . . 2.1400000000000001 109.008 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.64 148.87 50.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 1.9299999999999999 109.235 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.5 136.73 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 0.68000000000000005 109.145 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -103.11 121.05 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.369 -0.832 . . . . 0.83999999999999997 109.047 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.7 mt -87.14 132.98 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.386 -0.821 . . . . 0.79000000000000004 109.729 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -91.5 122.46 34.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 1.3700000000000001 108.724 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.527 ' HG2' HH11 ' A' ' 28' ' ' ARG . 0.4 OUTLIER -98.36 27.41 4.73 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.241 -0.912 . . . . 2.6200000000000001 109.887 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -81.01 143.33 32.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 2.3500000000000001 109.277 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -86.37 126.27 34.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.146 -0.971 . . . . 2.3500000000000001 109.416 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 pt -85.24 176.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 0.78000000000000003 109.6 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.9 p -95.58 173.96 7.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.79 . . . . 1.04 109.478 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.29 -25.89 63.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 1.05 109.551 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 3.3 m-20 -79.97 2.57 23.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 2.4700000000000002 108.617 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -116.75 -17.02 10.6 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.507 -0.924 . . . . 1.46 108.507 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.9 t -66.61 -46.45 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.46 -0.775 . . . . 0.77000000000000002 109.382 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.2 -35.65 67.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.887 . . . . 1.46 109.626 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -69.07 -33.5 73.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.389 -0.819 . . . . 2.29 110.267 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.2 -37.9 89.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.959 -1.088 . . . . 1.3 109.362 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.9 -47.31 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.359 -0.838 . . . . 0.76000000000000001 110.058 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.31 -41.29 85.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.136 -0.977 . . . . 1.5 109.086 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -60.44 -34.27 73.73 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.244 -0.91 . . . . 2.6600000000000001 109.092 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 28.1 t80 -86.83 -55.3 3.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.138 -0.976 . . . . 0.75 109.407 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.39 -63.8 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.82999999999999996 110.081 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 12.9 t -66.48 -37.91 86.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.78000000000000003 108.856 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.95 -52.63 47.7 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.672 -2.171 . . . . 0.56999999999999995 107.672 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -53.7 -22.55 9.31 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.648 -0.913 . . . . 2.8300000000000001 109.431 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -64.11 -45.08 90.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.101 -0.999 . . . . 0.65000000000000002 108.648 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 50' ' ' ALA . 28.7 pttt -78.41 -51.84 9.45 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.352 -0.939 . . . . 2.5699999999999998 109.296 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' H ' ' HG3' ' A' ' 49' ' ' LYS . . . -50.76 -41.1 56.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.561 -1.337 . . . . 0.51000000000000001 109.325 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t -62.43 -33.56 75.05 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.613 -1.254 . . . . 1.3600000000000001 107.613 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.88 -28.31 62.42 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.037 -0.727 . . . . 0.59999999999999998 109.037 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -73.6 -62.97 1.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.372 -0.83 . . . . 1.3600000000000001 109.093 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 54' ' ' LEU . 10.8 mp -49.71 -38.04 31.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.995 -1.066 . . . . 1.3799999999999999 108.297 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.35 -41.64 98.87 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.326 -0.991 . . . . 1.27 108.326 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 m -62.97 -39.28 94.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.455 -0.778 . . . . 0.59999999999999998 109.007 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.08 -39.6 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.574 -0.899 . . . . 0.53000000000000003 108.574 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -49.2 -42.04 38.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.785 . . . . 0.98999999999999999 109.571 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -71.27 -38.76 71.84 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.066 -1.022 . . . . 0.58999999999999997 109.796 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -69.88 -14.9 62.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.866 -1.134 . . . . 1.8100000000000001 107.999 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.91 -36.03 21.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.51 -0.922 . . . . 0.47999999999999998 108.51 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.08 -27.86 29.95 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.199 -1.16 . . . . 0.57999999999999996 110.199 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -85.86 -15.59 41.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.008 -1.29 . . . . 1.3899999999999999 109.38 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.7 m -94.49 -48.22 6.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.176 -0.952 . . . . 0.81999999999999995 110.325 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -106.37 -17.54 14.25 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.164 -0.96 . . . . 0.98999999999999999 110.537 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.93 143.84 6.83 Favored Glycine 0 N--CA 1.502 3.042 0 N-CA-C 109.706 -1.357 . . . . 0.55000000000000004 109.706 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -51.26 -8.6 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -1.058 . . . . 2.5899999999999999 110.572 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.461 ' H ' ' C ' ' A' ' 66' ' ' GLY . 97.7 mt-10 -65.69 -24.17 66.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.955 -1.091 . . . . 2.2000000000000002 110.474 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -91.45 -13.75 31.73 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.926 -1.109 . . . . 1.79 110.739 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -62.92 -18.71 63.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.92 -1.113 . . . . 1.54 110.815 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.12 -37.16 85.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.913 -1.117 . . . . 0.64000000000000001 110.04 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 72' ' ' ILE . 27.3 mt -73.14 -38.79 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.965 . . . . 0.57999999999999996 109.91 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -78.41 -22.34 47.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.62 109.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -64.48 -48.27 75.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.201 -0.937 . . . . 1.23 109.111 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.07 -32.01 76.03 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.425 -1.47 . . . . 0.52000000000000002 109.425 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -61.69 -23.31 66.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -1.15 . . . . 1.29 110.004 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.1 mt -85.28 -39.02 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.901 -1.125 . . . . 0.55000000000000004 108.825 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.4 ttt -59.04 -46.7 87.57 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.578 -0.897 . . . . 1.8899999999999999 108.578 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tp -58.71 -40.03 82.5 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.545 -0.722 . . . . 0.53000000000000003 109.062 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -67.03 -45.92 76.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.271 -0.893 . . . . 0.42999999999999999 109.395 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -84.57 9.04 14.68 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.874 . . . . 1.24 110.546 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -51.83 120.98 5.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.955 -1.091 . . . . 1.3100000000000001 109.231 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.74 -21.76 65.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -0.95 . . . . 1.3500000000000001 108.947 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.35 -47.44 23.44 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.327 -0.858 . . . . 2.1600000000000001 109.185 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.06 -18.83 64.75 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.223 -0.991 . . . . 0.59999999999999998 108.93 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -81.79 -41.32 21.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.388 -0.82 . . . . 1.28 109.725 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -63.06 -33.32 75.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 1.28 109.469 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -74.07 -42.57 59.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 1.29 109.004 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.2 mt -59.57 -58.82 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.219 -1.03 . . . . 0.57999999999999996 108.219 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.4 mt -42.86 -64.36 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.758 -0.589 . . . . 0.78000000000000003 110.164 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.0 -49.78 15.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 0.85999999999999999 110.135 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 mt -56.4 -57.14 13.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -0.842 . . . . 0.79000000000000004 109.328 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.3 -38.39 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.071 -1.018 . . . . 0.70999999999999996 110.169 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -86.53 -37.62 18.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.096 -1.002 . . . . 2.0499999999999998 112.105 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -82.1 -38.72 24.42 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.79 -1.194 . . . . 1.5900000000000001 111.691 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 97' ' ' HIS . 60.5 mmtt -105.45 14.1 29.2 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.806 -1.184 . . . . 1.8899999999999999 109.612 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 96' ' ' LYS . 77.4 m80 44.55 44.5 7.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.377 -0.827 . . . . 1.3100000000000001 109.365 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.3 mtt -95.59 153.04 17.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.472 -0.768 . . . . 1.28 109.195 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.2 p -77.17 142.34 39.69 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.565 -0.71 . . . . 0.62 109.595 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.47 -26.85 2.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.401 -0.812 . . . . 0.46999999999999997 109.68 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.0 -43.67 43.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.118 -0.989 . . . . 2.0 108.376 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.74 -55.36 7.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.731 -0.606 . . . . 0.56000000000000005 110.407 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.57 -50.02 71.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.983 . . . . 0.47999999999999998 110.057 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.89 -30.8 62.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -0.937 . . . . 0.44 109.797 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -69.98 -25.62 63.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.011 -1.056 . . . . 1.4199999999999999 109.364 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -68.67 -60.7 2.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -0.922 . . . . 1.26 109.86 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -51.91 -48.16 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.929 -1.107 . . . . 0.60999999999999999 109.407 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.9 mm -63.42 -21.94 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.64000000000000001 109.694 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -69.26 -34.64 75.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.976 -1.078 . . . . 2.2000000000000002 109.543 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.27 -23.54 40.18 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.559 -1.305 . . . . 0.81999999999999995 112.293 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -68.3 -42.94 78.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.52 -1.576 . . . . 1.27 108.854 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.93 -49.18 14.65 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.214 -0.661 . . . . 0.91000000000000003 109.214 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.6 t -60.46 -45.89 92.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.404 -0.81 . . . . 1.73 109.785 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.6 78.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 1.04 110.344 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 mt -68.43 -28.85 67.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.864 -1.147 . . . . 1.03 109.186 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -70.38 -17.6 63.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.189 -0.945 . . . . 1.95 109.404 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -80.97 -6.19 58.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 1.71 109.437 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 123' ' ' LEU . 3.3 mt -84.01 142.86 30.16 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.277 -1.009 . . . . 1.26 108.277 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -94.34 57.62 2.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 2.8300000000000001 108.55 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -148.61 116.41 6.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 1.5800000000000001 109.267 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.92 -11.33 7.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 2.7999999999999998 109.725 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -78.85 -64.11 1.26 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -0.877 . . . . 1.02 109.286 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 118' ' ' LEU . 26.3 mt -63.17 -23.43 67.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.009 -1.057 . . . . 1.0600000000000001 109.26 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 127' ' ' ALA . 40.6 tttm -66.78 -50.59 62.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.094 -1.004 . . . . 2.3900000000000001 108.36 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -55.1 -22.99 18.43 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.442 -0.947 . . . . 2.2000000000000002 108.442 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.602 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -72.74 -27.09 61.82 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.867 -1.531 . . . . 2.0899999999999999 106.867 177.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.53 -41.81 86.37 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.561 -0.903 . . . . 0.85999999999999999 108.561 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.66 -43.8 75.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.508 -0.745 . . . . 0.90000000000000002 109.83 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.74 -21.19 66.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 1.3500000000000001 109.528 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 t -78.07 -48.7 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.185 -0.947 . . . . 0.57999999999999996 108.562 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -54.8 -34.99 63.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.05 -1.031 . . . . 3.2200000000000002 108.587 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.57 -46.74 88.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.421 -0.799 . . . . 1.3200000000000001 110.224 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.05 -30.56 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.924 -1.11 . . . . 0.5 108.966 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.68 -48.4 7.96 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.821 -1.712 . . . . 0.44 108.821 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -56.03 -49.82 72.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.444 -1.033 . . . . 2.71 109.466 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.505 ' HG2' HH11 ' A' ' 136' ' ' ARG . 9.8 mtt-85 -63.6 -49.93 71.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.231 -1.026 . . . . 2.2000000000000002 108.231 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 40.2 tp -48.0 -35.15 10.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 1.1299999999999999 109.267 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.04 -48.19 58.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.157 -0.965 . . . . 0.54000000000000004 109.55 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -53.99 -18.99 4.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 2.3199999999999998 110.71 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 29.4 m-80 -84.72 -38.87 19.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.868 -1.145 . . . . 1.26 109.121 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.9 mt -67.82 -35.29 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.62 109.05 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.21 -1.7 57.21 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.876 -0.787 . . . . 0.67000000000000004 108.876 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.33 25.75 60.77 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.263 -1.935 . . . . 0.68000000000000005 108.263 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.35 133.79 47.28 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.533 -0.98 . . . . 0.77000000000000002 109.499 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.68 141.96 57.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 2.3999999999999999 109.028 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 147' ' ' ILE . 92.0 mt -104.02 163.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.602 -0.888 . . . . 0.87 108.602 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.516 ' N ' HG22 ' A' ' 146' ' ' ILE . 4.2 mp -77.93 128.53 38.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.026 -1.046 . . . . 1.3200000000000001 108.984 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -97.09 84.82 3.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.327 -0.858 . . . . 1.54 109.584 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -82.57 -20.12 37.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.885 . . . . 0.77000000000000002 109.206 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -79.66 7.01 9.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.019 . . . . 1.5700000000000001 109.304 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -118.82 23.39 11.46 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.556 -0.715 . . . . 0.81999999999999995 109.369 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.87 144.57 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.81999999999999995 109.725 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -137.63 8.14 2.82 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.91 -0.774 . . . . 2.1099999999999999 108.91 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -123.64 119.5 30.02 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.76 -0.83 . . . . 1.4099999999999999 108.76 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.67 121.05 13.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.283 -0.886 . . . . 1.3 109.488 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.2 m -150.05 177.45 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.56999999999999995 108.952 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.2 mt -88.56 151.3 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.176 -1.046 . . . . 0.42999999999999999 108.176 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.76 117.87 35.25 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.533 0.682 . . . . 0.56000000000000005 109.414 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.5 t -124.06 132.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.718 -0.845 . . . . 0.54000000000000004 108.718 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.56 153.08 14.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.803 . . . . 0.62 109.801 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.53 86.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.641 -1.287 . . . . 0.80000000000000004 107.915 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -174.42 156.88 2.58 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.463 -0.773 . . . . 2.3399999999999999 109.758 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 27.3 mt -130.84 137.7 49.51 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.538 -0.726 . . . . 0.65000000000000002 109.499 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.9 p -93.72 153.57 41.1 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.227 -0.921 . . . . 0.73999999999999999 109.178 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -34.3 -46.82 0.52 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.735 2.29 . . . . 0.59999999999999998 112.938 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 169' ' ' ALA . 69.1 m -50.77 -65.76 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.012 . . . . 0.63 109.262 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -48.36 -37.4 16.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.341 -0.849 . . . . 1.25 109.737 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 12.3 p -75.87 -21.71 56.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.5 109.484 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 166' ' ' SER . . . -80.81 -21.14 41.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.51000000000000001 110.153 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -107.14 -19.83 13.49 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.318 -0.864 . . . . 1.1699999999999999 109.859 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.31 149.99 27.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.60999999999999999 109.112 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -97.01 158.01 15.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.976 . . . . 2.1200000000000001 108.525 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.3 mp -96.37 -40.58 9.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.161 -0.962 . . . . 1.3400000000000001 110.782 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -80.13 -13.64 59.11 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.706 -1.246 . . . . 1.97 111.603 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -94.01 -5.11 48.29 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.605 -1.309 . . . . 1.8999999999999999 108.469 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 178' ' ' GLY . 42.9 t -102.14 155.27 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.045 -0.724 . . . . 0.47999999999999998 109.045 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.7 tp -113.75 -18.43 11.85 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.967 -0.753 . . . . 1.3899999999999999 108.967 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.482 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.53 171.29 40.08 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.947 -1.661 . . . . 0.38 108.947 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 4.2 m-85 -126.94 124.11 38.75 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.507 -0.996 . . . . 0.46000000000000002 109.623 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.2 mt -125.75 117.35 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.367 -1.346 . . . . 0.58999999999999997 107.367 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 203' ' ' VAL . 17.4 p -140.78 151.84 44.75 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.229 -0.919 . . . . 0.67000000000000004 112.388 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.513 ' O ' ' CG ' ' A' ' 182' ' ' ASP . 6.7 t0 -82.03 40.78 0.63 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.517 0.675 . . . . 2.2400000000000002 109.621 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -100.65 102.41 13.54 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.29 -1.506 . . . . 1.1100000000000001 110.9 -178.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -40.73 -20.0 0.03 OUTLIER Glycine 0 N--CA 1.498 2.772 0 O-C-N 121.208 -0.932 . . . . 1.6299999999999999 110.917 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 106.69 -11.66 42.16 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 121.138 -1.213 . . . . 1.47 110.348 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 186' ' ' ARG . 24.6 ttm-85 -48.08 -47.18 34.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.932 -1.334 . . . . 5.2400000000000002 109.343 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 21.4 p -144.49 48.53 1.35 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.529 -0.915 . . . . 2.9199999999999999 108.529 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.2 t -87.41 105.26 17.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.479 -0.763 . . . . 1.6000000000000001 110.7 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -62.6 -24.71 67.71 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.034 -1.098 . . . . 0.92000000000000004 108.034 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.8 m -61.59 -43.75 98.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.053 -0.721 . . . . 1.5900000000000001 109.053 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.1 p -57.44 -32.2 66.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 1.4199999999999999 109.315 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.7 mm -71.19 -31.84 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 1.4099999999999999 109.754 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.7 mtp -71.84 -56.86 4.96 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.776 -1.194 . . . . 0.85999999999999999 107.776 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.89 -38.72 73.19 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.641 -0.709 . . . . 0.58999999999999997 110.408 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -70.17 -50.81 36.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.08 -1.012 . . . . 3.0600000000000001 110.176 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.6 m -69.25 -36.87 77.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.266 -0.896 . . . . 0.72999999999999998 109.794 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 199' ' ' LEU . 14.9 mt -92.86 2.55 56.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.264 -0.898 . . . . 0.67000000000000004 109.319 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 48.92 11.81 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.344 -0.847 . . . . 1.49 110.829 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 197' ' ' LEU . 84.2 mt -66.72 145.93 99.0 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.777 -1.202 . . . . 0.64000000000000001 109.083 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.03 133.43 53.29 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.73 1.62 . . . . 0.58999999999999997 111.099 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -162.79 171.84 16.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.421 -1.424 . . . . 0.55000000000000004 111.4 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.418 ' CD1' HD11 ' A' ' 220' ' ' LEU . 65.9 mt -146.95 156.87 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.434 -1.691 . . . . 0.63 106.434 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.545 ' O ' ' O ' ' A' ' 181' ' ' THR . 29.9 m -140.66 -34.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 120.794 -1.191 . . . . 0.77000000000000002 110.735 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.1 39.92 1.43 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.326 -1.91 . . . . 0.87 108.326 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' ' 203' ' ' VAL . 16.6 p -68.53 -6.14 23.62 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.415 -1.05 . . . . 0.89000000000000001 109.46 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 49.74 -103.11 0.07 OUTLIER Glycine 0 N--CA 1.483 1.768 0 C-N-CA 119.709 -1.234 . . . . 0.93000000000000005 110.149 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 12.3 p -115.81 51.17 0.96 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.197 -1.178 . . . . 1.6000000000000001 112.152 -176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.407 HG22 HD13 ' A' ' 2' ' ' ILE . 12.0 t -72.44 -25.72 23.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.145 -1.428 . . . . 0.75 107.145 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.6 p -70.51 -10.99 60.62 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.617 -0.882 . . . . 0.83999999999999997 108.617 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.3 t -104.2 12.27 34.0 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.445 -0.946 . . . . 1.6100000000000001 108.445 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -133.83 -27.27 1.49 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.689 -0.632 . . . . 2.2999999999999998 109.598 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 213' ' ' LYS . 70.2 t -111.54 154.43 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.516 -0.74 . . . . 0.76000000000000001 109.506 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.496 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 25.2 mmtp -123.8 -178.88 4.18 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.559 -1.645 . . . . 2.0099999999999998 106.559 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.5 p-10 -79.97 149.38 30.82 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.73 -1.231 . . . . 2.1899999999999999 110.234 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 t70 81.49 -14.99 0.76 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.889 -0.507 . . . . 2.3999999999999999 110.664 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 73.7 m-20 -59.65 142.78 52.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.787 -1.196 . . . . 1.99 108.997 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -90.08 109.13 20.2 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.08 -1.012 . . . . 1.3 109.218 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.39 172.23 6.96 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.927 0.87 . . . . 0.53000000000000003 109.714 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.9 mt -143.71 116.6 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.559 -1.274 . . . . 0.59999999999999998 107.559 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.418 HD11 ' CD1' ' A' ' 202' ' ' ILE . 23.3 tp -84.79 127.06 33.94 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.161 -0.962 . . . . 0.56999999999999995 108.737 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 4.8 p-10 -89.22 -36.16 15.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.087 -1.008 . . . . 2.2200000000000002 109.119 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.539 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 44.58 21.57 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.542 -0.724 . . . . 0.75 110.142 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 221' ' ' ASP . 28.2 t -122.62 -61.4 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.754 -1.202 . . . . 0.92000000000000004 107.754 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -91.99 17.07 9.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.396 -0.964 . . . . 2.3599999999999999 108.396 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 28.6 t30 53.91 56.32 7.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.67 -0.644 . . . . 1.4199999999999999 109.928 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.445 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 69.2 mt-30 -152.96 144.32 23.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.191 -0.943 . . . . 1.97 110.351 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 92.7 t -99.48 151.56 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.994 -1.113 . . . . 0.65000000000000002 107.994 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -122.41 120.85 35.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.378 -0.826 . . . . 0.96999999999999997 109.216 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.3 t -104.93 120.32 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.455 -0.778 . . . . 0.67000000000000004 109.642 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 48.29 65.55 6.9 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 1.45 109.915 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.89 165.16 24.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.782 2.322 . . . . 0.81999999999999995 111.976 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.8 p -75.43 142.46 43.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 1.6200000000000001 109.388 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -54.41 -14.85 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 2.6000000000000001 109.243 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -72.84 -38.18 67.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -0.794 . . . . 3.0600000000000001 109.463 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.01 -41.25 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 1.1399999999999999 109.005 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.1 mt -55.85 -55.48 17.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.403 -0.81 . . . . 1.04 109.593 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -53.1 -40.02 63.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 2.54 109.849 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -66.91 -37.66 84.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.293 -0.879 . . . . 2.6000000000000001 110.119 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 46.7 mtp -82.82 -25.26 32.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.154 -0.966 . . . . 1.23 110.028 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 12.3 mmm-85 -59.91 -45.91 91.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.134 -0.979 . . . . 2.6699999999999999 109.74 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.79 -48.97 22.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 1.6599999999999999 110.178 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.79 -55.3 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.072 -1.017 . . . . 2.2000000000000002 110.027 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -44.93 -57.27 3.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 3.0 110.148 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.76 -24.72 67.88 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.487 -0.758 . . . . 1.76 110.142 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -67.59 -22.83 65.35 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.484 -1.302 . . . . 2.7799999999999998 107.484 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.2 t -75.25 -42.64 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.593 -0.891 . . . . 2.0600000000000001 108.593 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.78 -27.54 68.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.728 -0.842 . . . . 2.3999999999999999 108.728 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 7.9 t -76.37 -26.51 55.74 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.518 -0.739 . . . . 2.8700000000000001 109.169 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 3.4100000000000001 109.341 179.842 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.518 ' O ' ' N ' ' A' ' 3' ' ' SER . 49.1 mtm . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.589 -0.523 . . . . 3.6600000000000001 109.589 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 53.3 mt -53.44 89.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 1.1200000000000001 108.915 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 1' ' ' MET . 70.1 m -95.94 119.34 34.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.327 -0.858 . . . . 1.45 109.955 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.34 -158.53 12.41 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.446 -1.861 . . . . 0.92000000000000004 108.446 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.513 ' O ' ' O ' ' A' ' 6' ' ' LEU . 56.4 mt -97.77 -11.41 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.155 -1.203 . . . . 1.05 108.24 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.4 tp 50.87 109.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.591 0.71 . . . . 0.88 109.376 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.36 -50.12 8.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.717 -1.239 . . . . 0.78000000000000003 109.543 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.88 150.26 45.56 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.266 -0.896 . . . . 1.5 109.431 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.48 152.84 30.31 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.383 2.056 . . . . 0.85999999999999999 113.52 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.9 121.4 0.81 Allowed Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.319 -1.112 . . . . 0.78000000000000003 110.319 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.2 mt -88.55 133.14 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.079 -1.248 . . . . 0.73999999999999999 109.818 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.07 161.51 36.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.561 -0.712 . . . . 0.45000000000000001 109.89 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.7 m-85 -130.48 135.92 48.46 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.517 -0.92 . . . . 0.64000000000000001 108.517 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.45 165.26 31.27 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 118.419 -1.848 . . . . 0.45000000000000001 111.54 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -81.06 150.01 28.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.696 -0.885 . . . . 1.8799999999999999 109.916 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.461 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -79.81 128.78 33.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 0.58999999999999997 111.279 -178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 17' ' ' LEU . 35.9 tp -107.38 95.38 5.66 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.204 -1.406 . . . . 0.64000000000000001 107.204 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.6 tp -81.37 122.5 27.55 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.099 -1.001 . . . . 0.73999999999999999 110.844 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.3 98.33 9.89 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.015 -0.538 . . . . 0.73999999999999999 109.644 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -92.23 159.87 15.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 1.8700000000000001 108.798 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.484 ' OE2' ' N ' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -130.13 130.03 44.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.447 -0.783 . . . . 2.5800000000000001 109.083 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.484 ' N ' ' OE2' ' A' ' 21' ' ' GLU . 5.4 m-20 -80.22 131.96 35.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.268 -0.895 . . . . 2.1400000000000001 109.198 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -64.66 146.94 53.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 1.9299999999999999 109.274 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.65 135.35 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 0.68000000000000005 109.72 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.39 114.49 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.85 -0.796 . . . . 0.83999999999999997 108.85 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.3 mt -90.29 139.61 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.79000000000000004 109.778 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -93.19 122.39 35.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.197 -0.939 . . . . 1.3700000000000001 110.029 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -96.31 19.15 12.4 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.283 -0.886 . . . . 2.6200000000000001 109.703 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -80.26 156.36 26.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.97 -1.081 . . . . 2.3500000000000001 109.906 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -90.67 127.69 36.38 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.159 -0.682 . . . . 2.3500000000000001 109.159 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.419 HG12 ' H ' ' A' ' 31' ' ' ILE . 9.4 pt -78.87 171.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.006 . . . . 0.78000000000000003 109.58 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.2 p -101.04 163.82 12.1 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.946 -0.761 . . . . 1.04 108.946 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.88 -25.92 63.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 1.05 109.726 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.85 -12.8 59.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.127 -0.983 . . . . 2.4700000000000002 108.702 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -102.29 -12.31 18.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.639 -0.874 . . . . 1.46 108.639 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -67.68 -49.71 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.77000000000000002 108.746 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 1.2 m-20 -57.96 -39.89 79.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 1.46 109.919 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -67.54 -36.6 81.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 2.29 110.56 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -65.89 -33.23 75.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.972 -1.08 . . . . 1.3 109.528 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.6 t -62.25 -45.13 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.76000000000000001 109.276 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -64.29 -32.58 74.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.104 -0.997 . . . . 1.5 108.387 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.51 ' HG2' HH11 ' A' ' 42' ' ' ARG . 8.2 mtt-85 -66.18 -37.32 85.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.481 -0.762 . . . . 2.6600000000000001 109.083 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 34.6 t80 -86.21 -54.15 4.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.185 -0.947 . . . . 0.75 108.903 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 tp -48.78 -66.99 0.31 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.333 -0.854 . . . . 0.82999999999999996 109.091 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.8 t -64.41 -28.38 69.64 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.784 -0.821 . . . . 0.78000000000000003 108.784 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -59.93 -54.77 34.68 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 107.527 -2.229 . . . . 0.56999999999999995 107.527 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.456 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.0 OUTLIER -47.39 -30.64 3.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.647 -0.914 . . . . 2.8300000000000001 108.698 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -61.81 -34.88 76.72 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.211 -1.033 . . . . 0.65000000000000002 108.211 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' GLY . 31.2 mtpt -82.14 -60.62 2.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.692 -0.63 . . . . 2.5699999999999998 109.646 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.531 ' HB2' HD21 ' A' ' 140' ' ' ASN . . . -49.25 -38.55 27.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.51000000000000001 109.975 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -65.35 -39.04 91.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.024 -1.047 . . . . 1.3600000000000001 108.922 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.61 64.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.753 -0.592 . . . . 0.59999999999999998 110.584 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -63.62 -47.79 79.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 1.3600000000000001 109.965 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.35 -46.42 64.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.922 -1.112 . . . . 1.3799999999999999 109.455 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -48.15 -52.37 20.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.384 -0.822 . . . . 1.27 109.752 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -60.84 -34.0 73.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.59999999999999998 109.849 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -72.3 -27.98 27.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.186 -0.946 . . . . 0.53000000000000003 108.899 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -63.51 -42.39 98.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 0.98999999999999999 109.898 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -72.72 -28.83 62.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.168 -0.957 . . . . 0.58999999999999997 109.844 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -72.45 -25.31 61.4 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.657 -1.238 . . . . 1.8100000000000001 107.657 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.79 -29.95 56.26 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.948 -1.131 . . . . 0.47999999999999998 107.948 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.2 -29.84 24.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.895 -1.282 . . . . 0.57999999999999996 109.895 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -86.34 -16.21 38.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.864 -1.374 . . . . 1.3899999999999999 109.076 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -93.37 -48.89 6.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.89 . . . . 0.81999999999999995 110.065 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -106.93 -16.35 14.48 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.26 -0.9 . . . . 0.98999999999999999 110.793 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 119.44 142.92 6.89 Favored Glycine 0 N--CA 1.503 3.111 0 N-CA-C 109.486 -1.445 . . . . 0.55000000000000004 109.486 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -49.99 -5.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.397 -1.061 . . . . 2.5899999999999999 110.62 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' GLY . 34.3 mt-10 -64.02 -24.09 67.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.937 -1.102 . . . . 2.2000000000000002 109.874 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -90.58 -9.44 47.1 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.076 -1.015 . . . . 1.79 110.264 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -64.1 -29.63 70.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.003 -1.061 . . . . 1.54 110.893 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -35.96 82.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.826 -1.171 . . . . 0.64000000000000001 110.105 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.6 mt -73.2 -45.78 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.999 -1.063 . . . . 0.57999999999999996 109.658 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.62 -23.9 53.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.91 . . . . 0.62 109.747 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -64.75 -44.67 89.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.931 -1.105 . . . . 1.23 109.152 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.36 -34.49 80.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.442 -1.463 . . . . 0.52000000000000002 109.442 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -20.94 65.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -1.159 . . . . 1.29 110.172 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.3 mt -85.29 -38.7 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.762 -1.211 . . . . 0.55000000000000004 108.337 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.7 ttt -58.65 -39.45 80.61 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.491 -0.929 . . . . 1.8899999999999999 108.491 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tp -64.21 -41.9 96.84 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.867 -0.79 . . . . 0.53000000000000003 108.867 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.3 tp -68.25 -44.76 74.92 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.759 -0.777 . . . . 0.42999999999999999 109.193 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.16 8.33 21.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.933 . . . . 1.24 110.117 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -47.57 123.55 5.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.822 -1.174 . . . . 1.3100000000000001 109.989 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.38 -26.07 67.09 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.788 -0.819 . . . . 1.3500000000000001 108.788 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.58 -50.47 17.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.346 -0.846 . . . . 2.1600000000000001 109.309 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.94 -16.83 63.79 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.187 -1.005 . . . . 0.59999999999999998 109.282 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.82 -51.0 12.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 1.28 110.507 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -62.16 -29.92 70.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.139 -0.976 . . . . 1.28 110.232 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -74.14 -44.56 53.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 1.29 109.649 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.95 -57.35 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.09 -1.078 . . . . 0.57999999999999996 108.09 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.7 mt -46.31 -63.57 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.684 -0.635 . . . . 0.78000000000000003 109.786 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.34 -53.74 8.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.245 -0.909 . . . . 0.85999999999999999 110.103 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.543 HD13 ' OE1' ' A' ' 106' ' ' GLU . 57.7 mt -50.03 -54.7 18.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 0.79000000000000004 109.252 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.7 mt -53.53 -42.48 49.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.331 -0.856 . . . . 0.70999999999999996 110.4 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -85.88 -36.82 19.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.99 -1.069 . . . . 2.0499999999999998 111.563 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -83.25 -38.16 22.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.943 -1.098 . . . . 1.5900000000000001 111.76 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -104.25 9.82 35.89 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.758 -1.214 . . . . 1.8899999999999999 109.804 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.4 m80 49.6 42.34 22.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.922 -1.111 . . . . 1.3100000000000001 109.188 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.5 mtt -97.49 150.78 20.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.082 -0.71 . . . . 1.28 109.082 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.9 p -75.02 145.64 42.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.494 -0.754 . . . . 0.62 109.767 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.7 -26.27 8.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.218 -0.926 . . . . 0.46999999999999997 108.821 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -75.15 -50.0 17.73 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.589 -0.893 . . . . 2.0 108.589 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.27 -50.94 34.41 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.283 0.563 . . . . 0.56000000000000005 110.066 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.57 -56.52 20.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.47999999999999998 109.888 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.44 62.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.199 -0.938 . . . . 0.44 109.271 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -69.37 -21.21 63.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 1.4199999999999999 109.024 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.543 ' OE1' HD13 ' A' ' 92' ' ' LEU . 41.8 tt0 -70.57 -50.36 38.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.496 -0.752 . . . . 1.26 109.905 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.97 -40.66 89.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.862 -1.149 . . . . 0.60999999999999999 109.299 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.79 -19.48 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.243 -0.91 . . . . 0.64000000000000001 108.942 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -76.88 -34.78 57.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 2.2000000000000002 109.739 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 114' ' ' ALA . . . -85.72 -23.36 46.67 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.104 -1.522 . . . . 0.81999999999999995 111.591 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -69.65 -42.87 73.67 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.822 -1.399 . . . . 1.27 108.638 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.73 -53.68 9.81 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.436 -0.79 . . . . 0.91000000000000003 109.824 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 t -60.55 -28.66 68.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.137 -0.977 . . . . 1.73 109.788 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -67.01 -44.57 79.98 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.966 -1.084 . . . . 1.04 110.345 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.9 -24.75 66.91 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.88 -1.138 . . . . 1.03 109.003 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.73 -19.78 65.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 1.95 109.485 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -82.48 -7.03 59.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.196 -0.94 . . . . 1.71 109.513 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 123' ' ' LEU . 2.1 mt -86.42 156.91 19.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.323 -0.861 . . . . 1.26 108.824 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -104.79 58.72 0.69 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.842 -0.799 . . . . 2.8300000000000001 108.842 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -150.31 118.77 6.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.25 -0.906 . . . . 1.5800000000000001 109.384 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -64.26 -9.59 18.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 2.7999999999999998 110.057 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -77.05 -61.22 2.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.184 -0.948 . . . . 1.02 109.444 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 118' ' ' LEU . 10.4 mt -66.48 -26.64 67.27 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.276 -0.89 . . . . 1.0600000000000001 109.629 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 127' ' ' ALA . 47.7 tttp -67.2 -53.46 30.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 2.3900000000000001 108.582 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -55.97 -25.14 42.53 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.611 -0.885 . . . . 2.2000000000000002 108.611 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -72.94 -24.73 60.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.774 -1.565 . . . . 2.0899999999999999 106.774 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.88 -41.34 95.77 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.643 -0.873 . . . . 0.85999999999999999 108.643 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.44 -38.12 86.67 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.423 -0.954 . . . . 0.90000000000000002 108.423 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -71.51 -25.81 62.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 1.3500000000000001 109.286 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.44 -47.5 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.329 -0.857 . . . . 0.57999999999999996 108.908 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -55.39 -36.49 66.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.876 -1.14 . . . . 3.2200000000000002 108.283 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.13 -37.13 83.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.595 -0.69 . . . . 1.3200000000000001 110.718 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.5 mt -67.5 -25.08 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.981 -1.074 . . . . 0.5 109.655 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.56 -46.64 9.62 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.025 -1.63 . . . . 0.44 109.025 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -48.58 -42.46 33.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.484 -1.009 . . . . 2.71 109.677 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.458 ' HG2' HH11 ' A' ' 136' ' ' ARG . 24.4 mtt-85 -63.54 -52.32 61.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.095 -1.003 . . . . 2.2000000000000002 108.553 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.9 tp -51.2 -41.36 60.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.748 -0.595 . . . . 1.1299999999999999 109.854 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 140' ' ' ASN . 11.2 mt -66.9 -61.31 2.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.54000000000000004 110.008 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -43.95 -19.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.403 -0.811 . . . . 2.3199999999999998 110.858 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.531 HD21 ' HB2' ' A' ' 50' ' ' ALA . 5.8 m-20 -85.46 -34.1 21.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.04 -1.038 . . . . 1.26 109.925 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.2 mt -73.45 -33.3 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.043 -1.036 . . . . 0.62 108.805 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 55.8 mt -86.73 3.08 46.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.334 -0.854 . . . . 0.67000000000000004 109.344 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.06 27.73 23.36 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.433 -1.867 . . . . 0.68000000000000005 108.433 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.64 148.51 28.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.526 -0.985 . . . . 0.77000000000000002 109.443 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -66.56 132.81 49.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 2.3999999999999999 109.403 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 76.6 mt -102.13 134.59 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.383 -0.823 . . . . 0.87 109.027 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.794 HD12 ' H ' ' A' ' 147' ' ' ILE . 2.5 mp -77.93 133.32 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 1.3200000000000001 110.09 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -98.53 88.46 4.11 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.614 -0.884 . . . . 1.54 108.614 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.0 mt -78.75 -30.08 45.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.318 -0.864 . . . . 0.77000000000000002 110.011 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 m -81.85 30.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 1.5700000000000001 109.57 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.23 32.38 2.13 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.243 -0.91 . . . . 0.81999999999999995 109.129 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.43 152.56 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.369 -0.832 . . . . 0.81999999999999995 110.13 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -129.22 -10.19 4.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.538 -0.912 . . . . 2.1099999999999999 108.538 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 154' ' ' ASP . 0.7 OUTLIER -120.1 127.37 52.47 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.424 -0.798 . . . . 1.4099999999999999 109.17 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.92 124.09 20.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 1.3 109.614 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.83 175.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.194 -0.941 . . . . 0.56999999999999995 109.411 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.8 mt -88.11 153.68 3.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.605 -1.257 . . . . 0.42999999999999999 107.605 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.5 tp -104.49 117.29 33.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.443 -0.786 . . . . 0.56000000000000005 109.041 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 35.6 t -120.57 133.11 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.603 -0.888 . . . . 0.54000000000000004 108.603 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.58 143.21 11.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.373 -0.829 . . . . 0.62 109.039 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.42 -27.05 67.17 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.614 -1.304 . . . . 0.80000000000000004 107.909 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 20.2 t0 -172.27 145.45 1.71 Allowed 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.69 -0.631 . . . . 2.3399999999999999 109.59 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.527 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 25.3 mt -119.74 130.34 54.94 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.557 -0.905 . . . . 0.65000000000000002 108.557 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.6 p -93.34 148.3 35.32 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.976 -1.078 . . . . 0.73999999999999999 109.677 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 169' ' ' ALA . 78.3 Cg_exo -36.96 -49.16 1.52 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.594 2.196 . . . . 0.59999999999999998 112.327 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.8 m -51.41 -59.81 3.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.63 109.228 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -53.57 -41.33 66.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -0.876 . . . . 1.25 109.432 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 19.4 p -73.59 -22.57 60.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.5 110.013 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -76.61 -26.87 55.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.115 -0.991 . . . . 0.51000000000000001 110.066 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -105.15 -10.89 16.83 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.15 -0.969 . . . . 1.1699999999999999 109.944 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.36 156.02 10.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.153 -0.967 . . . . 0.60999999999999999 109.169 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -98.51 132.34 44.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.012 -1.055 . . . . 2.1200000000000001 108.233 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.4 mp -82.17 -44.67 16.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 1.3400000000000001 111.238 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -83.44 -8.72 59.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.826 -1.171 . . . . 1.97 112.111 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -98.65 -8.54 26.1 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.612 -1.305 . . . . 1.8999999999999999 108.77 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 177' ' ' LEU . 53.0 t -98.2 161.19 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.211 -1.033 . . . . 0.47999999999999998 108.211 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.478 ' N ' HG12 ' A' ' 176' ' ' VAL . 9.3 tp -108.61 -23.97 11.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.313 -0.867 . . . . 1.3899999999999999 109.907 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -178.33 174.41 46.68 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.942 -1.663 . . . . 0.38 108.942 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -129.43 122.44 29.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.588 -0.948 . . . . 0.46000000000000002 108.992 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 12.9 mt -128.43 128.11 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.377 -0.971 . . . . 0.58999999999999997 108.377 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 203' ' ' VAL . 47.7 p -141.3 146.52 36.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.483 -0.761 . . . . 0.67000000000000004 111.467 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.461 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 2.8 m-20 -85.73 41.99 0.94 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -0.782 . . . . 2.2400000000000002 109.501 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.54 116.04 31.24 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.387 -0.821 . . . . 1.1100000000000001 109.727 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -87.63 65.01 3.63 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.797 -1.321 . . . . 1.6299999999999999 109.797 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 88.5 -25.04 9.9 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.142 -1.183 . . . . 1.47 110.142 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.96 -34.09 3.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -1.199 . . . . 5.2400000000000002 109.607 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 20.8 p -152.06 75.92 1.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.549 -0.908 . . . . 2.9199999999999999 108.549 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.9 p -80.04 5.1 15.07 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.331 -0.856 . . . . 1.6000000000000001 109.813 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.629 ' HA ' HD12 ' A' ' 192' ' ' ILE . 82.3 t60 -51.3 -44.59 61.94 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.765 -1.209 . . . . 0.92000000000000004 109.034 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.406 ' H ' HG22 ' A' ' 190' ' ' THR . 0.1 OUTLIER -56.36 -36.24 68.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.23 -0.919 . . . . 1.5900000000000001 108.937 179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.5 t -75.0 -37.71 61.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.869 . . . . 1.4199999999999999 109.079 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 189' ' ' HIS . 88.6 mt -50.51 -32.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.159 -0.963 . . . . 1.4099999999999999 108.647 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.5 mtm -71.78 -51.51 22.29 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 106.947 -1.501 . . . . 0.85999999999999999 106.947 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.44 -39.01 66.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.071 -0.714 . . . . 0.58999999999999997 109.071 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -69.18 -51.69 35.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 3.0600000000000001 109.351 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.8 m -68.88 -36.62 78.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 0.72999999999999998 109.344 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 199' ' ' LEU . 39.5 mt -86.83 3.69 44.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.179 -0.95 . . . . 0.67000000000000004 108.667 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 52.75 2.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 1.49 110.873 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 197' ' ' LEU . 21.9 mt -64.74 169.37 5.35 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.654 -1.279 . . . . 0.64000000000000001 107.751 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -90.38 143.94 3.87 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.16 1.907 . . . . 0.58999999999999997 111.684 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.62 175.86 10.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.706 -1.246 . . . . 0.55000000000000004 111.491 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.453 ' CD1' HD11 ' A' ' 220' ' ' LEU . 10.8 mt -150.78 155.01 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.786 -1.561 . . . . 0.63 106.786 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.6 m -143.51 -29.08 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 120.689 -1.257 . . . . 0.77000000000000002 111.273 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.15 30.95 3.85 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.993 -1.243 . . . . 0.87 109.993 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 207' ' ' SER . 3.2 p -61.61 -38.84 89.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.726 -1.455 . . . . 0.89000000000000001 107.806 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.461 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 57.36 -33.43 0.02 OUTLIER Glycine 0 N--CA 1.498 2.769 0 CA-C-O 119.684 -0.509 . . . . 0.93000000000000005 113.851 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 205' ' ' THR . 95.2 p -124.83 1.14 8.09 Favored 'General case' 0 N--CA 1.512 2.646 0 CA-C-N 119.613 1.706 . . . . 1.6000000000000001 112.652 -177.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 t -65.44 -48.39 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.144 -1.597 . . . . 0.75 109.753 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 p -54.64 -16.1 2.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.884 -1.135 . . . . 0.83999999999999997 110.045 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.1 t -104.13 11.72 34.77 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.316 -0.865 . . . . 1.6100000000000001 109.65 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -142.25 -3.82 1.05 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.288 -0.882 . . . . 2.2999999999999998 110.411 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.75 145.18 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.433 -0.792 . . . . 0.76000000000000001 108.936 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -120.55 172.98 7.46 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.515 -1.661 . . . . 2.0099999999999998 106.515 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -74.25 141.13 45.38 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.722 -1.236 . . . . 2.1899999999999999 109.801 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.33 -10.12 1.22 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.807 -0.558 . . . . 2.3999999999999999 110.359 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -56.86 141.32 45.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.675 -1.265 . . . . 1.99 107.994 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -87.18 111.64 21.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.954 -1.091 . . . . 1.3 109.19 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 20.7 mt -121.41 168.32 11.81 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.992 0.901 . . . . 0.53000000000000003 110.52 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.9 mt -140.46 123.56 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.192 -1.04 . . . . 0.59999999999999998 108.192 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.453 HD11 ' CD1' ' A' ' 202' ' ' ILE . 15.1 tp -89.72 128.6 36.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.925 . . . . 0.56999999999999995 109.169 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.27 -38.16 11.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.108 -0.995 . . . . 2.2200000000000002 108.923 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 44.78 25.0 0.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.63 -0.669 . . . . 0.75 110.53 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.15 -62.24 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 106.981 -1.488 . . . . 0.92000000000000004 106.981 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -87.59 14.46 8.31 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.95 -1.13 . . . . 2.3599999999999999 107.95 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 58.64 57.66 3.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.68 -0.638 . . . . 1.4199999999999999 109.677 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -156.76 151.8 26.17 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.024 -1.048 . . . . 1.97 110.833 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.55 137.54 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.901 -0.777 . . . . 0.65000000000000002 108.901 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -107.14 131.72 53.82 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.21 -0.931 . . . . 0.96999999999999997 109.273 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.6 t -103.79 118.19 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 0.67000000000000004 109.802 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 230' ' ' ASN . 0.3 OUTLIER 50.87 69.62 2.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 1.45 109.989 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.96 157.97 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.66 2.24 . . . . 0.81999999999999995 111.347 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 80.3 p -72.76 144.9 47.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 1.6200000000000001 109.883 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 237' ' ' ASP . 2.6 m-20 -53.02 -27.72 20.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.43 -0.794 . . . . 2.6000000000000001 109.742 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -64.54 -37.3 87.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 3.0600000000000001 109.734 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 80.1 t -77.81 -36.16 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.243 -0.91 . . . . 1.1399999999999999 109.137 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.37 -58.74 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 1.04 109.438 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 233' ' ' ASN . 2.5 m-20 -53.33 -36.53 61.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 2.54 109.51 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -67.24 -36.9 82.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 2.6000000000000001 108.97 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 62.0 mtp -80.18 -34.6 37.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.409 -0.807 . . . . 1.23 109.463 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -54.87 -38.76 67.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 2.6699999999999999 109.459 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.97 -57.21 4.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 1.6599999999999999 109.689 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 73.9 t -58.74 -50.79 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.422 -0.799 . . . . 2.2000000000000002 110.275 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.37 -58.41 7.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.943 -1.098 . . . . 3.0 110.148 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.27 -22.14 66.68 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.288 -0.882 . . . . 1.76 110.275 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -64.15 -26.58 68.6 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.182 -1.414 . . . . 2.7799999999999998 107.182 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.1 t -72.1 -54.79 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.109 . . . . 2.0600000000000001 108.004 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.62 -26.93 62.27 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.504 -0.924 . . . . 2.3999999999999999 108.504 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 p -77.32 -22.94 51.13 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.072 -0.714 . . . . 2.8700000000000001 109.072 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 108.757 -0.831 . . . . 3.4100000000000001 108.757 179.664 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.518 -0.549 . . . . 3.66 109.518 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.07 103.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 1.12 109.361 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -93.08 120.22 33.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.329 -0.857 . . . . 1.45 110.033 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.67 -160.19 11.6 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 108.41 -1.876 . . . . 0.92 108.41 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.0 mt -93.55 -9.96 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.995 -1.297 . . . . 1.05 109.029 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' ILE . 14.2 tp 56.94 107.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 0.88 109.306 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.52 -53.61 4.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.081 -1.012 . . . . 0.78 108.318 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.95 146.16 25.0 Favored Pre-proline 0 N--CA 1.494 1.741 0 N-CA-C 108.582 -0.896 . . . . 1.5 108.582 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.3 153.37 31.37 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.069 1.846 . . . . 0.86 113.148 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.68 124.1 1.1 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.051 -1.22 . . . . 0.78 110.051 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.574 HD12 ' HG2' ' A' ' 243' ' ' GLN . 72.7 mt -89.36 129.01 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.132 -1.216 . . . . 0.74 109.566 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.16 149.22 49.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.383 -0.823 . . . . 0.45 109.572 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.9 m-85 -117.87 140.06 50.24 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.626 -0.879 . . . . 0.64 108.626 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.65 163.47 29.96 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.725 -1.702 . . . . 0.45 111.24 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -78.57 151.71 32.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.991 . . . . 1.88 109.902 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.21 129.32 34.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.59 111.114 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -111.82 90.84 3.45 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.193 -1.41 . . . . 0.64 107.193 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 18' ' ' LEU . 11.7 tp -81.38 128.72 34.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.059 -1.025 . . . . 0.74 110.687 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' A' ' 160' ' ' ALA . 32.2 mt -96.88 93.99 6.97 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.454 0.645 . . . . 0.74 109.854 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -93.07 156.35 16.93 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.54 -0.911 . . . . 1.87 108.54 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.02 131.3 44.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.247 -0.908 . . . . 2.58 109.036 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.92 138.63 38.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.148 -0.97 . . . . 2.14 108.924 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.23 140.68 58.9 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.45 -0.781 . . . . 1.93 109.282 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mt -91.69 132.96 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.215 -0.928 . . . . 0.68 109.917 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.8 t -106.61 111.98 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.637 -0.875 . . . . 0.84 108.637 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.2 mt -85.07 152.2 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.941 . . . . 0.79 109.586 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -90.89 107.54 19.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.497 -0.752 . . . . 1.37 109.927 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.524 ' NH1' ' HB1' ' A' ' 102' ' ' ALA . 20.4 mmm180 -95.46 24.57 5.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.277 -0.889 . . . . 2.62 108.754 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -85.85 144.04 27.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.371 -0.831 . . . . 2.35 109.79 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -86.72 123.97 32.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.213 -0.929 . . . . 2.35 108.824 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.2 pt -87.22 174.89 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.16 -0.962 . . . . 0.78 110.599 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.2 p -100.84 156.41 17.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.842 -0.799 . . . . 1.04 108.842 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.9 -8.44 0.99 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 1.05 109.47 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.95 -21.28 31.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 2.47 109.898 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -105.9 -1.36 24.22 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.329 -0.857 . . . . 1.46 109.327 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -64.95 -44.85 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.975 . . . . 0.77 108.742 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -52.34 -36.46 53.57 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.262 -0.899 . . . . 1.46 109.19 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -69.46 -34.3 74.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.476 -0.765 . . . . 2.29 110.152 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.433 ' OE2' ' NH2' ' A' ' 42' ' ' ARG . 80.4 mm-40 -62.55 -43.34 99.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.999 -1.063 . . . . 1.3 109.715 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 44' ' ' LEU . 82.2 t -59.84 -48.58 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.76 110.035 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -66.55 -44.77 81.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.012 -1.055 . . . . 1.5 108.991 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.433 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 72.1 mtm180 -61.36 -33.97 74.53 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.108 -0.995 . . . . 2.66 108.895 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -86.35 -54.43 4.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.75 108.945 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 40' ' ' VAL . 57.3 tp -51.01 -66.77 0.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.469 -0.77 . . . . 0.83 109.493 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 t -63.19 -30.15 71.35 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.952 -1.093 . . . . 0.78 108.154 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.85 -8.01 51.34 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 107.347 -2.301 . . . . 0.57 107.347 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.2 OUTLIER -85.02 -29.02 25.31 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.126 -1.805 . . . . 2.83 106.126 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.36 64.17 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.941 -1.133 . . . . 0.65 107.941 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -84.91 -64.22 1.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.919 -0.771 . . . . 2.57 108.919 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.32 -41.89 51.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.978 . . . . 0.51 109.514 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.9 m -63.36 -37.93 89.18 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.011 -1.107 . . . . 1.36 108.011 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.36 -21.51 60.51 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.401 -0.592 . . . . 0.6 109.401 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.683 HE22 ' ND2' ' A' ' 140' ' ' ASN . 74.0 mt-30 -73.45 -68.35 0.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 1.36 109.471 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 58' ' ' LYS . 13.7 mt -48.93 -42.52 37.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.064 -1.022 . . . . 1.38 108.839 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -50.55 -48.76 57.3 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.448 -0.945 . . . . 1.27 108.448 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -61.96 -40.37 95.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.6 109.053 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.6 mt -74.71 -25.14 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.53 108.879 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.584 ' HZ1' ' CD ' ' A' ' 70' ' ' GLU . 13.3 ttpp -64.31 -52.52 58.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.564 -0.71 . . . . 0.99 110.219 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.33 -25.45 63.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.968 -1.083 . . . . 0.59 109.794 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -71.63 -24.12 61.81 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.904 -1.122 . . . . 1.81 108.029 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.74 -32.87 60.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.367 -0.975 . . . . 0.48 108.367 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.73 -28.77 28.35 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.842 -1.303 . . . . 0.58 109.842 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -86.42 -14.99 41.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.28 . . . . 1.39 108.784 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.2 m -92.84 -51.4 5.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.82 110.054 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -106.85 -21.77 12.91 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.305 -0.872 . . . . 0.99 110.44 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.87 153.6 9.1 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 109.77 -1.332 . . . . 0.55 109.77 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -48.87 -8.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.508 -0.995 . . . . 2.59 110.464 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 66' ' ' GLY . 39.8 tt0 -63.91 -42.61 97.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 2.2 110.377 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -90.81 -10.01 44.37 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.014 -1.054 . . . . 1.79 110.494 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.584 ' CD ' ' HZ1' ' A' ' 58' ' ' LYS . 34.1 tt0 -67.04 -31.04 71.29 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.942 -1.099 . . . . 1.54 110.809 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.91 68.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.097 -1.002 . . . . 0.64 110.41 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.482 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 39.7 mt -72.04 -42.56 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.036 -1.04 . . . . 0.58 109.771 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -76.71 -19.21 57.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.097 -1.002 . . . . 0.62 109.307 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.07 -49.32 72.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.26 -0.9 . . . . 1.23 108.704 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.38 82.17 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.312 -1.515 . . . . 0.52 109.312 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.482 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 23.5 m170 -60.57 -24.39 65.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -1.204 . . . . 1.29 110.036 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.5 mt -81.15 -36.18 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.727 -1.233 . . . . 0.55 108.546 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.9 ttp -58.02 -43.84 86.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.537 -0.912 . . . . 1.89 108.537 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -57.31 -42.52 81.98 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.757 -0.831 . . . . 0.53 108.757 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.12 -41.48 77.32 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.352 -0.842 . . . . 0.43 109.258 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -85.4 8.39 19.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.414 -0.803 . . . . 1.24 110.225 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -50.05 123.44 8.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.947 -1.096 . . . . 1.31 109.484 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.55 -22.67 65.39 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.301 -0.875 . . . . 1.35 108.911 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -76.76 -49.52 15.75 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.393 -0.817 . . . . 2.16 109.318 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.9 mt -64.28 -15.32 59.95 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.292 -0.963 . . . . 0.6 109.242 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -82.9 -46.4 13.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 1.28 110.458 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -62.41 -30.19 71.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.13 -0.981 . . . . 1.28 109.906 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -73.29 -43.57 60.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.023 -1.048 . . . . 1.29 109.01 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.06 -56.96 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.492 -0.929 . . . . 0.58 108.492 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.0 mt -48.9 -66.17 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.696 -0.627 . . . . 0.78 110.417 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -43.1 -58.9 2.26 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.44 -0.788 . . . . 0.86 110.876 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.0 mt -45.87 -54.35 8.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.317 -0.864 . . . . 0.79 110.024 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.1 mt -50.86 -41.2 21.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.07 -1.019 . . . . 0.71 109.757 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -85.76 -38.53 18.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.277 -0.889 . . . . 2.05 111.594 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -82.22 -40.25 21.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.901 -1.124 . . . . 1.59 111.912 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -108.03 16.54 23.29 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.721 -1.237 . . . . 1.89 110.162 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.9 m80 44.85 48.76 9.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.205 -0.935 . . . . 1.31 109.525 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.7 mtt -100.72 147.47 25.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 1.28 109.261 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.1 p -75.68 143.75 41.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.313 -0.867 . . . . 0.62 109.164 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.12 -25.62 2.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.47 108.887 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.55 -48.97 23.71 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.534 -0.913 . . . . 2.0 108.534 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.524 ' HB1' ' NH1' ' A' ' 28' ' ' ARG . . . -70.51 -53.61 15.53 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.779 -0.575 . . . . 0.56 110.013 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.68 -46.7 77.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.48 109.411 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.89 66.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.44 109.478 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -69.75 -36.47 75.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 1.42 109.567 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -53.67 -50.54 65.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.832 . . . . 1.26 110.314 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.16 -49.02 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.975 -1.078 . . . . 0.61 109.601 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -63.12 -19.27 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.429 -0.794 . . . . 0.64 109.046 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -73.85 -37.53 64.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.992 . . . . 2.2 109.952 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.02 -26.57 31.0 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.524 -1.322 . . . . 0.82 112.619 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -67.68 -47.05 70.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.528 -1.572 . . . . 1.27 108.948 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.04 -50.38 23.36 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.604 -0.685 . . . . 0.91 109.218 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -59.27 -42.28 90.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.78 . . . . 1.73 110.039 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.3 86.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.125 -0.984 . . . . 1.04 110.905 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.3 -29.59 68.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.735 -1.228 . . . . 1.03 109.426 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -67.54 -15.87 63.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.935 . . . . 1.95 109.627 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.43 -9.06 59.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.94 . . . . 1.71 109.278 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 123' ' ' LEU . 2.2 mt -87.36 146.54 25.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 1.26 108.636 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 20.5 p-10 -100.6 62.71 1.05 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.45 -0.781 . . . . 2.83 109.311 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -150.08 113.5 4.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 1.58 109.522 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -53.6 -12.28 0.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 2.8 109.607 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.74 -62.19 1.76 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.933 . . . . 1.02 109.072 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 118' ' ' LEU . 56.6 mt -71.01 -27.47 63.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.88 . . . . 1.06 109.599 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -68.08 -52.52 34.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.061 -1.024 . . . . 2.39 108.831 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.28 -20.9 58.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.423 -0.954 . . . . 2.2 108.423 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.572 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -72.55 -26.96 61.93 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.485 -1.672 . . . . 2.09 106.485 178.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.24 -44.09 92.35 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.284 -1.006 . . . . 0.86 108.284 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.09 80.82 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.818 -0.808 . . . . 0.9 108.818 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -70.07 -32.17 70.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.42 -0.8 . . . . 1.35 109.371 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.2 t -77.83 -45.99 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 0.58 108.37 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -57.48 -39.97 77.58 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.263 -1.014 . . . . 3.22 108.263 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.51 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 14.5 t70 -56.27 -39.32 72.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.563 -0.71 . . . . 1.32 109.637 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.47 -20.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.163 -0.96 . . . . 0.5 108.881 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.69 -53.53 4.27 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.943 -1.263 . . . . 0.44 109.943 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -49.04 -39.48 27.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.012 -1.287 . . . . 2.71 108.832 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' A' ' 136' ' ' ARG . 3.1 mtt-85 -65.16 -45.97 82.78 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.282 -1.007 . . . . 2.2 108.282 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.5 tp -53.61 -45.13 69.98 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.042 -0.725 . . . . 1.13 109.042 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 140' ' ' ASN . 18.2 mt -60.41 -60.2 4.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.54 109.435 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -43.97 -20.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 2.32 110.324 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.683 ' ND2' HE22 ' A' ' 53' ' ' GLN . 1.8 m120 -85.4 -49.92 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 1.26 109.665 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -61.91 -35.43 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.62 109.541 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.6 mt -88.49 -4.45 58.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.871 . . . . 0.67 109.17 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.67 22.54 46.94 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.466 -1.854 . . . . 0.68 108.466 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.02 162.46 14.03 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.538 -0.977 . . . . 0.77 109.318 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -65.06 151.21 46.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 2.4 109.528 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.3 mt -107.62 144.36 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 109.166 -0.679 . . . . 0.87 109.166 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.1 mm -76.77 100.54 2.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.236 -0.915 . . . . 1.32 109.138 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.71 92.7 6.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.407 -0.808 . . . . 1.54 109.591 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.484 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 34.2 mt -79.56 -11.8 59.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.77 108.924 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.8 p -86.37 47.16 1.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 1.57 108.768 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.08 16.6 3.25 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.382 -0.823 . . . . 0.82 110.199 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 152' ' ' ILE . 2.4 mp -69.04 151.79 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.856 -1.152 . . . . 0.82 108.884 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -133.28 -22.32 1.99 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.05 -0.722 . . . . 2.11 109.05 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.97 151.36 36.88 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.68 -0.859 . . . . 1.41 108.68 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.61 124.73 24.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 1.3 109.835 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.2 m -148.27 167.71 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.199 -0.938 . . . . 0.57 109.339 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.6 mt -89.5 156.99 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.789 -1.189 . . . . 0.43 107.789 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.6 tp -107.23 121.67 45.0 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.732 0.777 . . . . 0.56 109.69 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.16 128.6 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.659 -0.867 . . . . 0.54 108.659 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -163.74 152.29 13.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 0.62 109.9 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.77 -43.1 94.49 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.374 -1.453 . . . . 0.8 107.949 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -172.34 153.27 2.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 2.34 109.458 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.1 mt -125.69 133.89 52.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.571 -0.706 . . . . 0.65 109.399 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.4 p -93.04 154.39 41.71 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.822 . . . . 0.74 109.084 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -33.9 -51.33 0.56 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.808 2.339 . . . . 0.6 112.948 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.7 m -50.03 -50.35 47.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.099 -1.001 . . . . 0.63 109.289 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.99 -42.28 98.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.855 . . . . 1.25 109.846 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.4 p -70.49 -31.34 68.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.5 109.563 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.62 -29.74 68.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.51 110.011 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -103.53 -4.31 24.11 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.25 -0.906 . . . . 1.17 110.15 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 tp -57.71 153.14 14.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.91 -1.118 . . . . 0.61 108.275 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.762 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.2 OUTLIER -99.5 90.55 4.55 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.147 -0.971 . . . . 2.12 110.3 -178.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.56 32.18 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 1.34 108.674 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 172' ' ' ASN . 67.6 mttm -111.12 -24.55 10.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.63 -0.669 . . . . 1.97 109.811 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -132.13 6.64 4.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.473 -0.767 . . . . 1.9 109.796 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 172' ' ' ASN . 39.4 t -79.27 154.78 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.087 -1.008 . . . . 0.48 109.031 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.38 -28.21 8.31 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.714 -0.616 . . . . 1.39 110.154 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -176.91 177.96 48.16 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.91 -1.276 . . . . 0.38 109.91 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -129.36 125.53 36.85 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.519 -0.989 . . . . 0.46 110.022 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.557 ' CG2' HG21 ' A' ' 205' ' ' THR . 16.8 mt -128.15 118.99 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.635 -1.246 . . . . 0.59 107.635 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 203' ' ' VAL . 20.8 p -141.83 152.53 43.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.54 -0.725 . . . . 0.67 111.169 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 26.5 p30 -87.66 45.06 1.24 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.991 -1.068 . . . . 2.24 110.823 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.95 0 O-C-N 120.961 -1.087 . . . . 1.11 109.326 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 12.9 t60 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.182 0.515 . . . . 0.92 110.044 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.7 t -46.91 -25.87 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 1.59 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.0 p -78.92 -45.88 19.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 1.42 109.884 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.5 mt -52.49 -32.58 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 1.41 109.674 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.9 mtp -71.46 -51.91 21.28 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.363 -1.347 . . . . 0.86 107.363 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.71 58.82 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.628 -0.714 . . . . 0.59 109.573 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.505 HH11 ' HG2' ' A' ' 195' ' ' ARG . 17.3 mtt-85 -76.95 -50.87 12.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 3.06 109.904 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 61.1 m -68.7 -35.33 77.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.73 109.738 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 199' ' ' LEU . 27.2 mt -87.13 1.49 52.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.265 -0.897 . . . . 0.67 109.092 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 49.19 3.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.559 -0.713 . . . . 1.49 111.631 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 197' ' ' LEU . 40.7 mt -66.01 169.82 6.24 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.491 -1.381 . . . . 0.64 108.382 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -89.86 141.7 3.79 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.249 1.966 . . . . 0.59 111.054 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.08 179.74 7.29 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.468 -1.293 . . . . 0.55 110.65 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 203' ' ' VAL . 70.6 mt -147.66 160.93 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 106.82 -1.548 . . . . 0.63 106.82 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 183' ' ' ALA . 18.1 m -141.58 -28.17 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.873 -1.142 . . . . 0.77 110.918 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.36 38.5 3.18 Favored Glycine 0 N--CA 1.496 2.667 0 O-C-N 120.888 -1.132 . . . . 0.87 110.987 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.557 HG21 ' CG2' ' A' ' 180' ' ' ILE . 20.1 p -67.2 -29.11 68.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.67 -1.488 . . . . 0.89 108.77 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 76.7 -98.69 1.3 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.788 -1.196 . . . . 0.93 111.238 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.9 p -113.27 43.47 1.73 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.001 -1.294 . . . . 1.6 112.395 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.8 -28.51 15.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.651 -1.281 . . . . 0.75 107.65 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.4 p -64.71 -12.98 52.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.287 -0.883 . . . . 0.84 108.917 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.1 p -108.51 17.1 22.41 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.662 -0.866 . . . . 1.61 108.662 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -131.55 -16.19 3.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.668 -0.645 . . . . 2.3 109.668 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.586 HG12 ' N ' ' A' ' 213' ' ' LYS . 71.1 t -120.38 164.07 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.457 -0.777 . . . . 0.76 109.597 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.586 ' N ' HG12 ' A' ' 212' ' ' VAL . 0.5 OUTLIER -126.58 174.21 8.86 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.841 -1.54 . . . . 2.01 106.841 178.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 214' ' ' ASN . 1.4 p-10 -75.02 145.74 42.18 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.786 -1.197 . . . . 2.19 109.824 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.6 OUTLIER 80.38 -12.12 1.07 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.803 -0.561 . . . . 2.4 110.249 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -57.25 150.95 16.78 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.002 -1.061 . . . . 1.99 108.429 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -87.29 110.71 20.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.91 -1.119 . . . . 1.3 108.887 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 16.2 mt -106.22 160.92 14.97 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.89 0.853 . . . . 0.53 109.65 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.509 HD12 ' CG ' ' A' ' 231' ' ' PRO . 3.2 mt -141.94 107.75 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.725 -1.213 . . . . 0.6 107.725 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.5 tp -86.49 126.44 34.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.79 -0.818 . . . . 0.57 108.79 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.0 -53.64 4.18 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.541 -0.911 . . . . 2.22 108.541 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 58.51 22.87 10.14 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.413 -0.804 . . . . 0.75 109.24 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.0 t -117.83 -56.14 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.11 -1.441 . . . . 0.92 107.11 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -96.41 13.25 28.46 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.539 -1.282 . . . . 2.36 107.539 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 59.81 60.19 2.26 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.074 0.464 . . . . 1.42 109.916 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -157.08 147.62 21.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 1.97 110.52 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.8 t -109.72 131.17 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.678 -0.86 . . . . 0.65 108.678 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -103.66 131.31 50.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.203 -0.936 . . . . 0.97 109.344 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.5 t -102.97 114.8 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.446 -0.784 . . . . 0.67 109.716 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 36.8 t30 45.24 60.88 12.82 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.424 -0.798 . . . . 1.45 110.571 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.509 ' CG ' HD12 ' A' ' 219' ' ' ILE . 38.4 Cg_endo -70.35 165.06 32.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.283 1.989 . . . . 0.82 111.415 179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.9 m -72.27 158.04 36.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 1.62 109.804 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -64.48 -22.35 66.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 2.6 109.031 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 234' ' ' GLU . 0.8 OUTLIER -66.91 -36.8 83.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.434 -0.791 . . . . 3.06 109.129 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 68.7 t -79.01 -48.94 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.248 -0.908 . . . . 1.14 108.704 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.93 -59.09 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.408 -0.807 . . . . 1.04 109.651 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -52.12 -41.3 62.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 2.54 109.961 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -66.84 -37.65 84.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 2.6 109.739 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 243' ' ' GLN . 28.5 mtm -81.94 -32.96 30.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.908 . . . . 1.23 109.676 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -53.81 -40.03 66.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 2.67 109.087 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.48 -51.65 12.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 1.66 109.421 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.4 -47.11 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 2.2 109.527 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.574 ' HG2' HD12 ' A' ' 11' ' ' ILE . 3.1 tm0? -47.56 -57.45 5.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 3.0 109.818 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--N 1.299 -1.614 0 O-C-N 121.439 -0.788 . . . . 1.76 110.732 -178.755 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.549 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.9 mpt? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.56 -0.533 . . . . 3.66 109.56 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.23 94.18 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.584 -0.895 . . . . 1.12 108.584 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.7 m -96.16 115.86 28.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.31 -0.869 . . . . 1.45 109.894 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.8 -163.5 21.41 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.332 -1.907 . . . . 0.92 108.332 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 5' ' ' ILE . 51.1 mt -95.88 -6.15 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -1.171 . . . . 1.05 108.427 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 tp 60.21 107.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.419 -0.801 . . . . 0.88 108.915 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.63 -55.58 3.92 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.982 -1.118 . . . . 0.78 107.982 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.23 150.27 37.44 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.32 -0.993 . . . . 1.5 108.32 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.47 154.18 21.07 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.087 1.858 . . . . 0.86 113.954 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 161.08 -176.07 37.69 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.666 -1.373 . . . . 0.78 109.666 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.402 ' CD1' HE21 ' A' ' 243' ' ' GLN . 36.7 mt -146.18 121.72 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.726 -1.455 . . . . 0.74 109.171 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HB1' HD21 ' A' ' 177' ' ' LEU . . . -139.72 162.54 34.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.267 -0.896 . . . . 0.45 109.733 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.9 m-85 -129.34 140.25 51.45 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.196 -1.039 . . . . 0.64 108.196 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.18 159.76 28.15 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 118.612 -1.756 . . . . 0.45 111.319 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -78.47 150.81 32.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.615 -0.933 . . . . 1.88 109.724 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.42 127.95 34.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.284 -0.885 . . . . 0.59 110.913 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.6 85.35 2.18 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.472 -1.307 . . . . 0.64 107.472 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 18' ' ' LEU . 15.6 tp -82.01 132.23 35.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.055 -1.028 . . . . 0.74 110.617 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 160' ' ' ALA . 14.3 mt -94.92 94.35 7.97 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.551 0.691 . . . . 0.74 109.931 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -94.23 142.04 27.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.782 -0.821 . . . . 1.87 108.782 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -128.74 135.37 49.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 2.58 108.729 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -78.03 136.7 37.98 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.168 -0.958 . . . . 2.14 109.007 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -60.79 143.88 53.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 1.93 109.109 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.54 133.97 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.43 -0.793 . . . . 0.68 109.906 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.4 t -106.78 113.72 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 0.84 109.183 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.4 mt -87.69 134.83 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.79 109.045 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -89.23 113.28 24.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 1.37 109.638 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 28' ' ' ARG . 14.1 mmm-85 -96.06 26.25 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 2.62 108.845 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -83.56 146.03 28.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -0.814 . . . . 2.35 109.748 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -85.08 118.41 24.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.394 -0.965 . . . . 2.35 108.394 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 pt -81.54 173.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.78 109.977 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.8 p -97.87 161.15 13.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.031 -0.729 . . . . 1.04 109.031 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.0 -16.67 32.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.112 -0.993 . . . . 1.05 109.283 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.16 -7.43 59.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 2.47 109.265 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -114.96 -13.52 11.91 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.849 -0.797 . . . . 1.46 108.849 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.9 t -65.66 -45.38 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 0.77 109.402 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -54.94 -33.28 62.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 1.46 109.293 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -69.92 -33.99 72.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 2.29 110.26 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -62.8 -43.57 98.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 1.3 109.688 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -60.1 -46.94 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.41 -0.806 . . . . 0.76 109.828 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.91 -43.39 88.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 1.5 108.883 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -65.18 -30.99 71.94 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.813 -0.81 . . . . 2.66 108.813 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -86.39 -58.33 2.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.75 109.266 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.5 tp -52.48 -58.94 5.14 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.289 -0.882 . . . . 0.83 109.287 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.6 t -63.76 -30.5 71.59 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.334 -0.987 . . . . 0.78 108.334 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.81 -54.6 35.41 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 107.977 -2.049 . . . . 0.57 107.977 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 29.8 ttm-85 -49.47 -30.52 8.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.535 -0.98 . . . . 2.83 109.074 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.99 -40.59 81.08 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.551 -0.907 . . . . 0.65 108.551 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -80.96 -59.34 2.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.667 -0.646 . . . . 2.57 109.302 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.85 -40.83 57.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.032 . . . . 0.51 110.205 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.459 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 29.2 t -62.32 -37.46 85.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.956 -1.09 . . . . 1.36 108.183 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.58 -31.31 63.53 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.158 0.504 . . . . 0.6 109.732 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -75.86 -65.95 0.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 1.36 109.589 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.502 HD12 ' N ' ' A' ' 54' ' ' LEU . 9.7 mp -50.12 -27.02 5.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 1.38 109.332 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 51' ' ' SER . 4.1 mm-40 -71.76 -42.22 67.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 1.27 108.646 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 m -61.64 -37.16 83.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.6 109.435 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.32 -25.79 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 0.53 109.117 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.471 ' NZ ' ' OE1' ' A' ' 70' ' ' GLU . 9.9 ttpp -61.17 -46.88 88.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.99 110.2 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.18 -30.81 68.03 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.128 -0.983 . . . . 0.59 109.844 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -70.43 -18.89 63.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.695 -1.253 . . . . 1.81 108.123 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.79 -33.42 30.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.567 -0.901 . . . . 0.48 108.567 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.88 -28.42 28.92 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.192 -1.163 . . . . 0.58 110.192 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.14 -15.09 42.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.016 -1.285 . . . . 1.39 109.0 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.8 m -95.37 -48.37 5.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.24 -0.912 . . . . 0.82 110.179 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -106.33 -21.73 13.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.339 -0.851 . . . . 0.99 110.124 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 121.5 147.12 7.58 Favored Glycine 0 N--CA 1.503 3.13 0 N-CA-C 110.082 -1.207 . . . . 0.55 110.082 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -48.49 -11.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.606 -0.938 . . . . 2.59 110.197 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 66' ' ' GLY . 63.0 mt-10 -63.99 -29.61 70.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.089 -1.007 . . . . 2.2 110.802 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -91.82 -7.65 48.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.8 -1.188 . . . . 1.79 111.087 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.471 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 56.3 mt-10 -63.85 -24.52 67.78 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.732 -1.23 . . . . 1.54 110.598 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.67 -28.36 69.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.02 -1.05 . . . . 0.64 110.508 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.37 -44.25 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.011 -1.055 . . . . 0.58 110.064 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.55 -21.47 45.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.088 -1.007 . . . . 0.62 109.845 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -64.93 -44.16 90.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 1.23 109.571 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.35 -37.22 59.1 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.66 -1.376 . . . . 0.52 109.66 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -61.37 -20.55 63.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.294 -1.121 . . . . 1.29 110.455 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.0 mt -85.79 -37.04 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.592 -1.317 . . . . 0.55 108.393 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.8 ttt -58.78 -42.25 88.56 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.224 -1.028 . . . . 1.89 108.224 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.12 -37.23 84.34 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.358 -0.978 . . . . 0.53 108.358 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.452 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 23.8 tp -69.55 -43.97 71.86 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.649 -0.821 . . . . 0.43 109.151 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -85.41 7.12 23.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 1.24 110.222 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.419 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 57.3 t0 -47.06 122.55 4.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.012 -1.055 . . . . 1.31 109.695 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.66 -24.81 66.33 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.726 -0.842 . . . . 1.35 108.726 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 18.7 mp0 -76.14 -49.53 17.06 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.783 -0.767 . . . . 2.16 109.205 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.2 mt -63.75 -13.96 48.27 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.823 -1.151 . . . . 0.6 108.715 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -79.2 -56.18 4.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.508 -0.745 . . . . 1.28 109.836 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -63.33 -26.27 68.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 1.28 109.977 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.42 -44.05 62.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.101 -0.999 . . . . 1.29 108.673 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.1 mt -60.7 -56.49 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.097 -1.075 . . . . 0.58 108.097 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -47.16 -53.0 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.635 -0.666 . . . . 0.78 109.543 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.69 -44.41 93.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 0.86 109.227 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.8 mt -57.97 -56.85 16.64 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.168 -1.049 . . . . 0.79 108.168 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.6 mt -51.2 -39.84 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.71 110.073 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -85.34 -36.4 20.8 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.086 -1.008 . . . . 2.05 111.681 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 91' ' ' ALA . 22.1 t70 -82.75 -43.55 16.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.798 -1.189 . . . . 1.59 111.486 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -102.07 12.2 37.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.768 -1.208 . . . . 1.89 109.538 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 45.59 48.57 11.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.371 -0.831 . . . . 1.31 109.368 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtp -101.41 152.19 21.03 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.092 -0.706 . . . . 1.28 109.092 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 p -76.31 145.05 39.84 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.436 -0.79 . . . . 0.62 109.462 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.44 29.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.166 -0.959 . . . . 0.47 108.797 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -72.71 -45.99 55.95 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.28 -1.007 . . . . 2.0 108.28 179.049 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.1 -51.42 21.57 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.391 0.615 . . . . 0.56 109.973 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.34 -50.92 71.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.48 109.647 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.37 -34.15 64.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.194 -0.941 . . . . 0.44 109.799 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -69.03 -31.48 70.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 1.42 109.229 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.5 tt0 -71.59 -57.63 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 1.26 109.892 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.445 ' H ' HG23 ' A' ' 107' ' ' VAL . 7.7 t -55.2 -49.9 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.61 109.811 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.572 HG21 ' HA3' ' A' ' 134' ' ' GLY . 28.1 mm -64.68 -70.16 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.64 109.613 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.46 ' OE2' ' NE ' ' A' ' 131' ' ' ARG . 18.1 tp10 -50.55 -45.3 56.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.826 -1.171 . . . . 2.2 108.992 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -45.04 -40.07 6.92 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.11 -1.596 . . . . 0.82 109.11 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -69.17 -59.41 3.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.343 -1.092 . . . . 1.27 108.29 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.74 -43.5 37.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.809 -0.812 . . . . 0.91 108.809 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.8 m -59.99 -37.04 78.5 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.305 -0.872 . . . . 1.73 109.186 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.54 84.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 1.04 109.878 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.81 -29.48 67.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.929 -1.107 . . . . 1.03 108.677 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.54 -17.13 62.48 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.455 -0.943 . . . . 1.95 108.455 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -82.42 -1.01 48.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.567 -0.708 . . . . 1.71 109.481 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.5 HD13 HD13 ' A' ' 123' ' ' LEU . 12.1 mt -83.77 158.72 21.63 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.136 -0.978 . . . . 1.26 109.209 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -100.5 50.56 0.89 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.891 -0.781 . . . . 2.83 108.891 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -146.56 119.21 8.56 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.222 -0.924 . . . . 1.58 109.612 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.71 -19.3 58.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.372 -0.83 . . . . 2.8 109.501 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.22 -65.21 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 1.02 109.275 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.5 HD13 HD13 ' A' ' 118' ' ' LEU . 46.8 mt -47.58 -31.29 4.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.09 -1.006 . . . . 1.06 109.624 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 1.9 ttmp? -65.52 -39.97 92.43 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.918 -1.113 . . . . 2.39 108.319 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -58.13 -23.41 55.03 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.392 -0.966 . . . . 2.2 108.392 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -72.99 -27.26 61.69 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.537 -1.653 . . . . 2.09 106.537 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -57.67 -39.83 77.96 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.098 -1.075 . . . . 0.86 108.098 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.07 -36.42 81.98 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.793 -0.817 . . . . 0.9 108.793 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.45 -36.94 77.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.348 -0.845 . . . . 1.35 109.254 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.4 t -76.65 -44.24 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.04 -1.096 . . . . 0.58 108.04 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.46 ' NE ' ' OE2' ' A' ' 109' ' ' GLU . 42.4 ttm180 -60.55 -34.7 74.53 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.925 -1.139 . . . . 3.22 107.925 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -58.94 -35.55 73.32 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.502 -0.749 . . . . 1.32 109.17 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.19 -26.51 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.5 108.528 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.572 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -78.29 -42.64 14.6 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.145 -1.582 . . . . 0.44 109.145 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -55.42 -54.09 48.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.545 -0.973 . . . . 2.71 109.986 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.523 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 34.4 mtm180 -63.56 -38.79 92.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.176 -0.952 . . . . 2.2 108.697 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 41.5 tp -61.83 -40.34 94.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.437 -0.79 . . . . 1.13 109.719 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.8 mt -67.54 -54.8 16.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.05 -1.031 . . . . 0.54 109.335 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -49.16 -19.0 0.39 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 2.32 109.529 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -84.24 -39.9 18.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 1.26 109.586 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.14 -40.3 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.005 . . . . 0.62 109.693 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.9 mt -88.72 2.11 53.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.158 -0.964 . . . . 0.67 109.272 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.64 29.23 48.27 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.422 -1.871 . . . . 0.68 108.422 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.9 tp -58.52 148.14 29.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.595 -0.944 . . . . 0.77 109.542 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.31 132.64 47.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.942 . . . . 2.4 109.786 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.4 mt -110.47 144.12 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 109.172 -0.677 . . . . 0.87 109.172 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.76 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.2 mp -78.54 133.21 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.072 -1.017 . . . . 1.32 109.768 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.96 87.85 3.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.502 -0.749 . . . . 1.54 109.408 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.45 -22.22 44.44 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.241 -0.912 . . . . 0.77 109.586 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.5 t -80.8 17.81 1.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.151 -0.968 . . . . 1.57 109.446 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.08 29.19 2.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.389 -0.819 . . . . 0.82 109.416 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.59 153.14 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.293 -0.879 . . . . 0.82 108.985 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -132.96 -2.1 3.26 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.394 -0.816 . . . . 2.11 109.245 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -129.8 125.74 36.47 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.821 -0.807 . . . . 1.41 108.821 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.68 129.19 38.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 1.3 109.714 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.32 175.79 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.57 108.806 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.8 mt -89.31 149.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.891 -1.151 . . . . 0.43 107.891 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.3 tp -104.73 119.85 39.97 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.534 -0.729 . . . . 0.56 109.612 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.0 125.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.99 -0.744 . . . . 0.54 108.99 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.444 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -162.5 147.06 12.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.62 109.816 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.38 -38.15 71.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.745 -1.222 . . . . 0.8 108.131 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -173.97 147.66 1.32 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.428 -0.795 . . . . 2.34 109.651 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.2 mt -117.68 136.53 53.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.634 -0.667 . . . . 0.65 109.383 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.6 p -94.06 152.19 40.24 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.222 -0.924 . . . . 0.74 109.296 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -36.21 -39.38 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.442 2.095 . . . . 0.6 112.567 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.523 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 1.4 m -56.83 -57.23 13.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.138 -0.976 . . . . 0.63 109.13 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -60.01 -41.99 93.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.474 -0.767 . . . . 1.25 109.79 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.0 p -71.17 -19.78 62.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.052 -1.03 . . . . 0.5 109.409 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.3 -25.48 33.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.51 109.745 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -103.47 -18.9 14.6 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.26 -0.9 . . . . 1.17 109.209 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.78 144.51 48.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.121 -1.066 . . . . 0.61 108.121 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 175' ' ' LYS . 1.7 m120 -95.64 134.79 38.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.0 -1.062 . . . . 2.12 108.587 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.1 mt -78.66 -42.95 27.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.391 -0.818 . . . . 1.34 111.654 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -80.0 -8.82 59.56 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.672 -1.267 . . . . 1.97 111.767 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 172' ' ' ASN . 58.6 mttp -99.98 -7.3 25.28 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.694 -1.253 . . . . 1.9 108.721 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 177' ' ' LEU . 54.3 t -98.32 162.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.488 -0.757 . . . . 0.48 109.057 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.567 HD21 ' HB1' ' A' ' 12' ' ' ALA . 8.5 tp -115.2 -20.09 10.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.555 -0.716 . . . . 1.39 109.954 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.9 174.58 42.57 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.406 -1.478 . . . . 0.38 109.406 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 1.3 m-85 -128.07 124.16 36.36 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.346 -1.091 . . . . 0.46 110.156 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 205' ' ' THR . 7.8 mt -121.19 109.96 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 106.92 -1.511 . . . . 0.59 106.92 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.604 ' O ' ' O ' ' A' ' 203' ' ' VAL . 31.2 p -140.58 154.99 46.7 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.119 -0.988 . . . . 0.67 112.578 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 42.6 t0 -80.18 40.94 0.5 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.823 -0.626 . . . . 2.24 110.831 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.305 0 O-C-N 120.229 -1.544 . . . . 1.11 110.544 -178.819 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 75.4 t60 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.972 -0.751 . . . . 0.92 108.972 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.8 p -50.54 -36.99 36.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 1.59 109.147 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.1 m -62.01 -41.31 97.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.337 -0.852 . . . . 1.42 109.35 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.5 mt -58.01 -24.76 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 1.41 109.478 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.3 mtp -71.81 -58.83 3.13 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.689 -1.226 . . . . 0.86 107.689 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.22 -41.71 62.97 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.325 0.583 . . . . 0.59 109.722 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 20.5 mtt-85 -69.02 -50.67 46.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 3.06 109.882 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.5 m -69.12 -38.44 78.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.051 -1.031 . . . . 0.73 109.906 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 199' ' ' LEU . 22.3 mt -87.81 3.39 48.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.106 -0.996 . . . . 0.67 108.858 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 44.02 11.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.741 -0.6 . . . . 1.49 112.019 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 197' ' ' LEU . 17.1 mt -68.98 169.51 11.16 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.372 -1.455 . . . . 0.64 108.495 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.88 139.64 3.86 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.345 2.03 . . . . 0.59 110.907 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.37 -172.96 2.64 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.19 -1.404 . . . . 0.55 111.595 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.2 mt -149.12 153.1 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.248 -1.39 . . . . 0.63 107.248 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.604 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.7 m -138.22 -39.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.874 -1.141 . . . . 0.77 111.113 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.501 ' N ' HG23 ' A' ' 203' ' ' VAL . . . -71.45 39.96 0.61 Allowed Glycine 0 C--N 1.285 -2.276 0 N-CA-C 108.599 -1.8 . . . . 0.87 108.599 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.508 HG21 HG23 ' A' ' 180' ' ' ILE . 47.1 p -67.38 -18.29 65.07 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.106 -1.232 . . . . 0.89 109.531 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.419 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 62.64 -101.08 0.36 Allowed Glycine 0 N--CA 1.484 1.859 0 C-N-CA 119.392 -1.385 . . . . 0.93 110.121 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.2 m -117.55 45.61 1.89 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.301 -1.117 . . . . 1.6 112.331 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 62.6 t -74.82 -26.73 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.454 -1.403 . . . . 0.75 107.786 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.7 p -68.28 -12.75 61.54 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.738 . . . . 0.84 109.599 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.9 m -102.4 9.34 39.79 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.416 -0.802 . . . . 1.61 109.049 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -131.17 -5.78 3.86 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.569 -0.707 . . . . 2.3 109.195 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 23.3 t -122.64 148.57 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.649 -0.871 . . . . 0.76 108.649 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -121.54 -174.29 2.83 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.619 -1.623 . . . . 2.01 106.619 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.6 m120 -79.51 150.52 31.15 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.776 -1.202 . . . . 2.19 109.839 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.7 m-20 81.07 -14.42 0.83 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.052 -0.405 . . . . 2.4 110.94 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.64 128.2 35.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.755 -1.215 . . . . 1.99 108.355 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -86.62 119.11 26.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.868 -1.145 . . . . 1.3 108.883 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.7 mt -119.62 163.29 17.58 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.666 0.746 . . . . 0.53 110.124 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.1 mt -128.68 118.96 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.742 -1.207 . . . . 0.6 107.742 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.6 tp -87.18 120.61 28.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.425 -0.954 . . . . 0.57 108.425 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.4 t0 -95.97 -31.07 13.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.212 -0.93 . . . . 2.22 108.838 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.17 28.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.456 0.645 . . . . 0.75 110.248 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.6 t -123.9 -67.36 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.821 -1.548 . . . . 0.92 106.821 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 224' ' ' ASN . 19.9 t-20 -84.12 10.95 8.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.218 -1.401 . . . . 2.36 107.218 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 58.22 61.99 2.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.906 -0.496 . . . . 1.42 110.092 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -156.8 147.89 22.01 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.122 -0.986 . . . . 1.97 110.673 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.47 141.5 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.663 -0.866 . . . . 0.65 108.663 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -104.62 127.77 52.46 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.177 -0.952 . . . . 0.97 109.408 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.42 120.59 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.48 -0.762 . . . . 0.67 110.358 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 43.5 t30 55.55 74.37 0.72 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 1.45 110.314 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -87.05 149.16 8.14 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.018 2.479 . . . . 0.82 112.148 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.2 m -72.14 160.99 31.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.258 -0.901 . . . . 1.62 109.966 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.484 ' H ' HD22 ' A' ' 233' ' ' ASN . 2.4 p30 -64.37 -30.67 71.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -0.799 . . . . 2.6 109.758 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -67.11 -37.61 84.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 3.06 109.165 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.65 -32.59 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 1.14 108.941 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt -72.88 -61.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 1.04 109.209 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -53.61 -41.49 66.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.498 -0.751 . . . . 2.54 110.106 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -66.34 -34.86 78.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.09 -1.006 . . . . 2.6 109.439 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 57.1 mtp -81.68 -39.37 24.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.89 . . . . 1.23 109.437 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.404 ' O ' ' OE1' ' A' ' 244' ' ' GLU . 16.6 mmt180 -49.35 -47.25 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.139 -0.976 . . . . 2.67 109.546 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.03 -64.11 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -0.963 . . . . 1.66 110.671 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 24.4 t -59.68 -52.7 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 2.2 111.201 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' A' ' 239' ' ' MET . 41.4 tp60 -54.78 -41.08 70.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.672 -1.267 . . . . 3.0 109.925 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.404 ' OE1' ' O ' ' A' ' 240' ' ' ARG . 62.0 mt-10 . . . . . 0 C--N 1.302 -1.47 0 O-C-N 120.623 -1.298 . . . . 1.76 109.881 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.372 -0.603 . . . . 3.66 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.6 mt -129.95 91.54 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.809 -0.811 . . . . 1.12 108.809 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m -91.68 117.03 29.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.185 -0.947 . . . . 1.45 110.049 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.95 -159.54 11.98 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 108.149 -1.98 . . . . 0.92 108.149 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.1 mt -97.63 -10.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.133 -1.216 . . . . 1.05 109.04 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 tp 60.3 103.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.343 -0.848 . . . . 0.88 108.901 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.97 -48.43 7.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.997 -1.064 . . . . 0.78 108.974 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.98 145.8 26.15 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.411 -0.805 . . . . 1.5 108.975 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.47 153.48 23.79 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.32 2.014 . . . . 0.86 113.748 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.75 177.12 32.55 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.959 -1.256 . . . . 0.78 109.959 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mt -143.86 120.74 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.974 -1.309 . . . . 0.74 109.776 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.588 ' HB1' HD21 ' A' ' 177' ' ' LEU . . . -143.23 140.55 30.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.124 -0.985 . . . . 0.45 109.399 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.7 m-85 -105.87 151.37 24.62 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.689 -0.856 . . . . 0.64 108.689 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.58 166.38 31.05 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 118.66 -1.733 . . . . 0.45 111.467 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -81.92 153.34 26.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.653 -0.91 . . . . 1.88 110.377 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.06 126.22 30.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.774 . . . . 0.59 111.642 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.7 tp -108.13 89.26 2.94 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 107.52 -1.289 . . . . 0.64 107.52 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.0 tp -81.26 129.39 34.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.011 -1.055 . . . . 0.74 110.206 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.468 HD11 HD11 ' A' ' 158' ' ' LEU . 17.9 mt -96.39 94.41 7.41 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.413 0.625 . . . . 0.74 110.433 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -97.16 157.68 15.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.726 -0.842 . . . . 1.87 108.726 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -130.77 134.26 46.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.25 -0.906 . . . . 2.58 108.87 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -79.31 137.76 37.47 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.173 -0.955 . . . . 2.14 109.368 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.74 141.67 58.7 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.541 -0.724 . . . . 1.93 109.136 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.1 mt -89.36 138.32 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 0.68 109.586 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.04 114.83 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.505 -0.747 . . . . 0.84 109.179 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.1 mt -87.43 133.88 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.912 . . . . 0.79 109.611 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.78 120.41 31.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.462 -0.774 . . . . 1.37 108.998 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -99.92 32.02 3.07 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.229 -0.92 . . . . 2.62 109.444 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -83.31 138.53 33.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.044 -1.035 . . . . 2.35 110.284 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -84.77 134.69 34.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.309 -0.997 . . . . 2.35 108.309 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.9 pt -97.74 176.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.159 -0.963 . . . . 0.78 110.841 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 34' ' ' ASP . 36.3 p -98.37 153.26 18.68 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.394 -0.965 . . . . 1.04 108.394 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.34 -7.75 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 1.05 110.139 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 32' ' ' SER . 17.7 t70 -84.78 -21.76 29.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.905 -1.122 . . . . 2.47 110.323 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -106.41 -3.81 20.61 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.193 -0.942 . . . . 1.46 109.531 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.7 -43.69 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.77 109.237 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -53.79 -34.59 59.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.284 -0.885 . . . . 1.46 109.184 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -69.47 -33.3 72.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 2.29 109.698 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -61.65 -46.64 88.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.007 -1.058 . . . . 1.3 109.68 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.78 -45.41 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.76 109.693 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.28 -39.62 92.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.108 -0.995 . . . . 1.5 108.334 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -65.11 -32.75 74.61 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.949 -0.76 . . . . 2.66 108.949 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -86.62 -57.68 2.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.144 -0.973 . . . . 0.75 108.476 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -49.32 -61.93 1.82 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.73 -0.841 . . . . 0.83 108.73 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.67 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.7 t -65.2 -33.82 76.91 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.312 -0.995 . . . . 0.78 108.312 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.27 -54.46 35.61 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 107.927 -2.069 . . . . 0.57 107.927 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -48.63 -30.11 5.07 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.384 -1.068 . . . . 2.83 108.561 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.12 -34.43 70.21 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.897 -1.149 . . . . 0.65 107.897 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 mttt -79.17 -58.61 3.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.805 -0.813 . . . . 2.57 108.805 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.35 -40.52 62.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.51 109.937 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 t -62.23 -38.25 88.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.952 -1.093 . . . . 1.36 108.498 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.82 -36.33 67.48 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.378 -0.601 . . . . 0.6 109.378 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -65.57 -62.76 1.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.351 -0.843 . . . . 1.36 109.535 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.08 -38.89 62.92 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.304 -0.873 . . . . 1.38 109.161 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -59.92 -46.88 87.97 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.591 -0.892 . . . . 1.27 108.591 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.5 m -61.99 -37.7 85.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.485 -0.759 . . . . 0.6 109.332 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.2 mt -73.3 -29.3 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.821 . . . . 0.53 109.151 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -63.94 -43.32 96.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -0.819 . . . . 0.99 109.03 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.2 m -72.34 -26.99 62.14 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.365 -0.834 . . . . 0.59 109.538 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -72.82 -30.04 63.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.638 -1.245 . . . . 1.81 107.638 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.28 63.68 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.111 -1.07 . . . . 0.48 108.111 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.12 -28.21 28.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.608 -1.397 . . . . 0.58 109.608 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -86.54 -16.06 38.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.812 -1.404 . . . . 1.39 108.462 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.2 m -94.44 -49.27 5.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.82 110.36 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.472 ' C ' ' H ' ' A' ' 67' ' ' GLU . 53.0 m-85 -107.11 -33.21 7.52 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.156 -0.965 . . . . 0.99 110.241 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.48 -29.92 0.71 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.179 -1.168 . . . . 0.55 110.179 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 69' ' ' LYS . 38.4 mt-10 -52.85 179.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -1.157 . . . . 2.59 110.3 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -68.36 40.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.518 -0.738 . . . . 2.2 109.532 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 67' ' ' GLU . 35.1 mmtt -85.03 -17.26 38.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.639 -0.874 . . . . 1.79 108.639 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.78 -34.8 77.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.614 -0.679 . . . . 1.54 110.517 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.79 -27.15 67.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 0.64 110.817 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.9 mt -71.79 -46.73 59.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.849 -1.157 . . . . 0.58 109.782 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -74.98 -21.66 59.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.085 -1.009 . . . . 0.62 109.757 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.6 -41.62 92.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.146 -0.971 . . . . 1.23 109.383 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.25 -37.47 63.3 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.483 -1.447 . . . . 0.52 109.483 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -58.89 -21.37 57.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -1.15 . . . . 1.29 109.3 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -85.15 -34.39 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.064 -1.022 . . . . 0.55 108.473 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.3 ttt -60.61 -44.93 95.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -0.972 . . . . 1.89 108.511 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.79 -40.38 83.87 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.215 -1.032 . . . . 0.53 108.215 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.5 tp -65.87 -43.99 86.7 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.672 -0.811 . . . . 0.43 108.858 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -85.84 9.48 16.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.191 -0.943 . . . . 1.24 110.363 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -50.47 119.92 4.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.77 -1.206 . . . . 1.31 109.264 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.06 -22.97 67.05 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.245 -0.909 . . . . 1.35 108.838 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.14 -51.87 12.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.412 -0.805 . . . . 2.16 109.392 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.78 -12.28 45.91 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.208 -0.997 . . . . 0.6 109.224 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -79.7 -50.24 10.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.431 -0.793 . . . . 1.28 110.365 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -62.37 -31.96 72.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.128 -0.982 . . . . 1.28 110.099 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.02 -44.64 68.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 1.29 109.291 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.04 -58.53 6.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.576 -0.898 . . . . 0.58 108.576 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.7 mt -48.75 -61.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.686 -0.634 . . . . 0.78 110.576 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -53.19 -45.31 68.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.024 -1.048 . . . . 0.86 110.403 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 mt -56.23 -56.13 24.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.127 -0.983 . . . . 0.79 108.663 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.8 mt -54.73 -47.54 73.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.187 -0.946 . . . . 0.71 110.57 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -78.32 -36.62 46.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.058 -1.026 . . . . 2.05 111.302 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' ALA . 9.4 t70 -82.09 -40.51 21.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.901 -1.125 . . . . 1.59 112.055 -176.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -109.84 21.29 17.06 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.752 -1.218 . . . . 1.89 110.689 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.522 ' ND1' ' N ' ' A' ' 97' ' ' HIS . 0.3 OUTLIER 42.73 55.19 4.38 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.299 -0.875 . . . . 1.31 110.473 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.8 mtt -103.91 147.38 27.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.601 -0.889 . . . . 1.28 108.601 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.2 p -77.68 150.5 34.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.62 109.87 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.42 -31.67 6.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.47 108.892 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -77.08 -43.15 35.39 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.777 -0.823 . . . . 2.0 108.777 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.62 9.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.572 -0.705 . . . . 0.56 109.871 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.06 -48.28 78.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.859 . . . . 0.48 109.466 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.5 64.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.44 109.858 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 109' ' ' GLU . 76.4 t60 -67.93 -51.09 51.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.999 -1.063 . . . . 1.42 109.727 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.11 -62.21 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.338 -0.851 . . . . 1.26 110.502 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 43.7 t -52.75 -54.18 17.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.804 -1.185 . . . . 0.61 109.302 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.36 -23.19 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.64 109.664 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 105' ' ' HIS . 45.8 tp10 -73.08 -30.45 63.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.025 -1.047 . . . . 2.2 110.069 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.26 -27.97 29.12 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.114 -1.517 . . . . 0.82 111.985 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -67.06 -45.35 77.61 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.425 -1.633 . . . . 1.27 108.035 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.16 -55.72 5.45 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.917 -0.489 . . . . 0.91 110.698 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.9 p -56.97 -41.25 78.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 1.73 110.215 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.97 81.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.085 -1.009 . . . . 1.04 110.277 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.71 -30.38 70.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.761 -1.212 . . . . 1.03 109.319 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.58 -18.94 65.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.095 . . . . 1.95 109.726 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -82.93 -9.24 59.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 1.71 109.385 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.415 HD13 HD13 ' A' ' 123' ' ' LEU . 0.8 OUTLIER -86.8 138.45 31.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.264 -1.013 . . . . 1.26 108.264 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 22.8 p-10 -96.02 63.41 2.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 2.83 109.154 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -148.79 108.7 4.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.317 -0.864 . . . . 1.58 109.48 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -50.35 -15.85 0.28 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.569 -0.707 . . . . 2.8 110.009 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -78.3 -60.92 2.18 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.242 -0.911 . . . . 1.02 109.353 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.415 HD13 HD13 ' A' ' 118' ' ' LEU . 7.9 mt -67.19 -31.52 71.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.262 -0.899 . . . . 1.06 109.254 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -68.24 -49.54 59.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.991 . . . . 2.39 109.234 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -61.14 -18.68 59.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.277 -1.008 . . . . 2.2 108.277 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.422 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 26.1 ttt-85 -75.46 -28.24 59.21 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.093 -1.447 . . . . 2.09 107.093 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.82 97.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.698 -0.853 . . . . 0.86 108.698 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.9 -35.08 79.98 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.247 -1.02 . . . . 0.9 108.247 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 2.8 m-20 -71.97 -32.2 67.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 1.35 109.122 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.422 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 42.8 t -77.03 -45.6 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.58 108.95 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -60.19 -36.92 78.72 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.117 -0.989 . . . . 3.22 108.37 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.49 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 30.7 t70 -58.92 -36.5 74.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.5 -0.75 . . . . 1.32 109.486 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.07 -26.08 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.058 -1.026 . . . . 0.5 108.803 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.34 -47.39 5.75 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.26 -1.536 . . . . 0.44 109.26 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.416 ' HZ2' ' HB3' ' A' ' 135' ' ' LYS . 15.3 mtpp -51.58 -43.91 62.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -1.173 . . . . 2.71 109.119 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.522 ' CG ' HH11 ' A' ' 136' ' ' ARG . 6.2 mtt-85 -65.51 -42.7 91.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.206 -1.035 . . . . 2.2 108.206 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.77 -51.3 70.57 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.474 -0.565 . . . . 1.13 109.474 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.6 mt -53.13 -58.06 8.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.54 109.279 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -51.01 -21.4 1.77 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.882 . . . . 2.32 109.673 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 136' ' ' ARG . 5.1 m120 -85.84 -42.05 14.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.03 . . . . 1.26 109.111 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.89 -47.49 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.081 -1.012 . . . . 0.62 108.294 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 58.8 mt -90.76 -7.81 51.45 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.777 -0.823 . . . . 0.67 108.777 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 144' ' ' LEU . . . 60.99 26.08 65.09 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.239 -1.944 . . . . 0.68 108.239 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 145' ' ' LYS . 3.1 tp -52.84 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.605 -0.938 . . . . 0.77 109.095 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.431 ' H ' ' HG ' ' A' ' 144' ' ' LEU . 47.5 tttp -69.0 137.5 53.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.127 -0.983 . . . . 2.4 110.429 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 75.1 mt -106.49 137.49 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.491 -0.929 . . . . 0.87 108.491 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mm -75.79 116.65 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.073 -1.017 . . . . 1.32 108.877 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -98.58 82.88 2.91 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.263 -0.898 . . . . 1.54 109.89 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.3 mt -84.51 -14.08 50.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 0.77 109.103 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.7 p -84.3 -13.8 51.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 1.57 109.891 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.96 42.8 1.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.27 -0.894 . . . . 0.82 110.862 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.6 mm -73.49 149.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.658 -1.276 . . . . 0.82 108.738 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -136.78 -2.29 2.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.389 -0.819 . . . . 2.11 109.466 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -125.45 127.93 47.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.512 -0.742 . . . . 1.41 109.495 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.49 118.56 8.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.308 -0.87 . . . . 1.3 108.9 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -151.26 176.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.57 108.765 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 218' ' ' LEU . 3.2 mt -89.5 156.49 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.136 -1.061 . . . . 0.43 108.136 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.468 HD11 HD11 ' A' ' 19' ' ' LEU . 18.6 tp -108.89 123.01 48.4 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.512 0.672 . . . . 0.56 109.693 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.83 133.01 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.213 -0.662 . . . . 0.54 109.213 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.99 145.67 10.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.073 -1.017 . . . . 0.62 109.918 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.19 -34.56 75.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.343 -1.473 . . . . 0.8 108.039 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -173.19 154.06 2.62 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.296 -0.631 . . . . 2.34 109.296 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.4 mt -128.37 130.65 48.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.484 -0.76 . . . . 0.65 109.126 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.5 p -89.74 152.49 46.88 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.74 109.259 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -34.26 -41.8 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.713 2.276 . . . . 0.6 113.235 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 m -57.4 -60.31 3.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.819 -1.175 . . . . 0.63 109.45 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -55.61 -36.27 66.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.472 -0.768 . . . . 1.25 110.352 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.8 p -73.73 -32.6 63.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.124 -0.985 . . . . 0.5 110.055 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.33 -31.53 64.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.952 . . . . 0.51 110.794 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -101.63 1.61 37.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.103 -0.998 . . . . 1.17 109.901 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.2 tp -54.28 160.96 1.47 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.089 -1.007 . . . . 0.61 109.054 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.528 ' ND2' ' H ' ' A' ' 175' ' ' LYS . 15.6 t30 -100.73 79.7 2.1 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.39 -0.819 . . . . 2.12 109.928 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 14.9 mt -74.81 28.65 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 1.34 108.642 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 172' ' ' ASN . 31.7 mtpt -106.71 -30.7 8.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 1.97 110.187 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.528 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 27.1 mtmm -133.2 14.32 4.2 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.232 -0.918 . . . . 1.9 110.028 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 172' ' ' ASN . 14.7 t -79.02 161.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.48 109.098 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.588 HD21 ' HB1' ' A' ' 12' ' ' ALA . 7.7 tp -112.98 -25.37 9.01 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.62 -0.675 . . . . 1.39 110.058 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.57 -179.43 45.9 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.64 -1.384 . . . . 0.38 109.64 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.82 126.84 35.31 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.399 -1.06 . . . . 0.46 110.199 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.84 123.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.993 -1.114 . . . . 0.59 107.993 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 203' ' ' VAL . 59.0 p -141.75 148.29 38.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.184 -0.948 . . . . 0.67 111.352 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.423 ' OD2' ' CG2' ' A' ' 209' ' ' THR . 1.6 p30 -100.53 50.37 0.89 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.367 -0.975 . . . . 2.24 108.367 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.457 -0.777 . . . . 1.11 110.077 -178.98 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.411 ' HA ' HD12 ' A' ' 192' ' ' ILE . 12.6 t60 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.315 0.579 . . . . 0.92 109.523 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 70.5 p -46.95 -44.76 20.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 1.59 109.657 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.4 t -64.83 -43.66 92.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.467 -0.771 . . . . 1.42 110.248 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 189' ' ' HIS . 64.7 mt -46.36 -35.8 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.971 -1.08 . . . . 1.41 109.999 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.5 mtm -74.14 -58.5 3.26 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.898 -1.149 . . . . 0.86 107.898 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.23 -31.19 19.82 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.612 -0.68 . . . . 0.59 110.223 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -81.17 -46.54 14.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.045 -1.034 . . . . 3.06 110.187 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 38.2 m -70.75 -36.34 73.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.927 -1.108 . . . . 0.73 110.383 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 199' ' ' LEU . 18.6 mt -84.83 -0.43 53.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.949 -1.094 . . . . 0.67 109.119 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 53.5 1.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 1.49 111.419 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 197' ' ' LEU . 55.6 mt -64.37 171.34 2.78 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.434 -1.416 . . . . 0.64 107.606 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -88.43 141.32 4.78 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.305 2.003 . . . . 0.59 111.469 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.21 176.58 9.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.675 -1.266 . . . . 0.55 111.513 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.6 mt -150.52 159.22 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.06 -1.459 . . . . 0.63 107.06 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.4 m -141.23 -28.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.697 -1.252 . . . . 0.77 111.186 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.61 29.49 6.23 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.139 -0.976 . . . . 0.87 111.664 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 11.8 p -55.03 -37.79 67.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.319 -1.695 . . . . 0.89 108.18 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.32 -37.01 0.26 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.751 -0.738 . . . . 0.93 113.481 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 40.4 p -131.06 -6.71 3.9 Favored 'General case' 0 N--CA 1.516 2.854 0 CA-C-N 119.657 1.728 . . . . 1.6 113.332 -177.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 5.4 t -48.51 -57.15 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.156 -1.59 . . . . 0.75 110.593 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.423 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 26.8 p -53.06 -16.75 1.2 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.562 -1.336 . . . . 0.84 110.4 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.1 t -103.92 11.09 35.95 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.191 -0.943 . . . . 1.61 109.27 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -138.93 -13.51 1.22 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.392 -0.818 . . . . 2.3 110.243 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.49 154.66 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.324 -0.86 . . . . 0.76 109.417 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -126.08 172.42 10.01 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.882 -1.525 . . . . 2.01 106.882 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 21.9 t-20 -72.71 144.87 47.51 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.864 -1.148 . . . . 2.19 110.141 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.9 t70 80.61 -11.6 1.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.881 -0.512 . . . . 2.4 110.875 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.25 147.63 34.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.773 -1.204 . . . . 1.99 108.843 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -88.35 123.1 32.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.043 -1.035 . . . . 1.3 108.517 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.406 ' HB2' HD12 ' A' ' 157' ' ' ILE . 43.7 mt -118.74 168.37 10.8 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.993 0.901 . . . . 0.53 110.608 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 mt -143.6 103.21 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.031 -1.1 . . . . 0.6 108.031 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.1 tp -86.2 123.81 31.9 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.773 -0.825 . . . . 0.57 108.773 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 223' ' ' VAL . 50.1 t0 -100.12 -28.44 13.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.43 -0.794 . . . . 2.22 109.127 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.21 28.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.272 0.558 . . . . 0.75 110.599 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.7 t -120.63 -62.24 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.969 -1.493 . . . . 0.92 106.969 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -83.36 10.36 8.84 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.349 -1.352 . . . . 2.36 107.349 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 60.01 54.01 4.38 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.35 -0.611 . . . . 1.42 109.35 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -154.42 144.1 21.59 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.849 0.833 . . . . 1.97 110.23 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 19.5 t -116.08 132.01 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.924 -1.139 . . . . 0.65 107.924 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 228' ' ' TYR . 48.4 m-85 -100.48 130.89 46.61 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.115 -0.991 . . . . 0.97 110.067 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.7 t -107.65 127.46 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.579 -0.7 . . . . 0.67 109.924 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 51.3 t30 47.87 60.6 15.11 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.849 . . . . 1.45 110.297 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.56 154.81 35.57 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.381 2.054 . . . . 0.82 111.474 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 8.4 m -72.83 157.08 38.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.977 -1.077 . . . . 1.62 109.805 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -60.41 -27.32 67.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.427 -0.796 . . . . 2.6 109.779 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.36 -39.13 91.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 3.06 109.537 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.55 -42.18 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.928 . . . . 1.14 109.071 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.68 -58.59 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 1.04 109.113 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.5 -40.65 72.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.547 -0.72 . . . . 2.54 110.389 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -67.12 -38.16 85.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.036 -1.04 . . . . 2.6 110.146 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . 0.442 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 85.9 mtp -79.43 -32.59 42.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 1.23 109.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -54.11 -44.26 71.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.068 -1.02 . . . . 2.67 110.108 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.98 -58.69 3.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.018 -1.051 . . . . 1.66 110.887 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.2 t -64.33 -53.47 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.128 -0.983 . . . . 2.2 110.721 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.442 ' CB ' ' O ' ' A' ' 239' ' ' MET . 39.6 tp60 -52.95 -52.75 56.99 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.0 -1.063 . . . . 3.0 109.711 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 . . . . . 0 C--N 1.299 -1.62 0 O-C-N 120.657 -1.277 . . . . 1.76 108.761 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.245 0.545 . . . . 3.66 109.565 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.0 mt -84.68 106.21 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.954 . . . . 1.12 109.628 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 m -99.48 110.6 23.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.382 -0.824 . . . . 1.45 109.706 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.89 -169.9 31.07 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.011 -1.636 . . . . 0.92 109.011 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' LEU . 56.7 mt -93.08 -7.42 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.043 -1.269 . . . . 1.05 108.614 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.8 tp 54.34 104.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.495 -0.753 . . . . 0.88 109.385 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.54 -41.17 12.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.903 -1.123 . . . . 0.78 108.609 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -150.06 148.96 26.2 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.29 -0.881 . . . . 1.5 108.769 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.15 148.22 16.77 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.564 2.176 . . . . 0.86 114.092 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.82 176.29 31.73 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.894 -1.282 . . . . 0.78 109.894 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.42 HD12 ' HG2' ' A' ' 243' ' ' GLN . 97.1 mt -140.13 128.95 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.15 -1.206 . . . . 0.74 109.257 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.88 153.2 49.58 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.281 -0.887 . . . . 0.45 109.722 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -123.93 132.86 53.79 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.191 -1.04 . . . . 0.64 108.191 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.6 164.94 34.33 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 118.537 -1.792 . . . . 0.45 111.314 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HZ2' ' HB3' ' A' ' 15' ' ' LYS . 15.3 mtpp -76.99 149.25 35.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.625 -0.926 . . . . 1.88 109.383 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.3 132.27 38.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.398 -0.814 . . . . 0.59 110.839 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 tp -115.23 89.62 3.14 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.459 -1.312 . . . . 0.64 107.459 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 tp -80.74 122.41 27.1 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.201 1.001 . . . . 0.74 110.646 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.0 mt -92.53 98.06 11.22 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.011 -0.736 . . . . 0.74 109.011 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -92.26 159.89 15.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 1.87 109.665 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -111.71 133.37 54.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.858 -0.793 . . . . 2.58 108.858 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' OE1' ' A' ' 21' ' ' GLU . 12.7 m-20 -80.52 124.99 29.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 2.14 110.493 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.07 126.47 28.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.431 -0.793 . . . . 1.93 109.1 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 80.7 mt -91.09 140.07 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.936 . . . . 0.68 109.502 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.74 115.61 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.486 -0.759 . . . . 0.84 108.984 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.416 HD11 ' CD2' ' A' ' 105' ' ' HIS . 65.0 mt -88.06 133.54 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 0.79 109.88 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -91.63 123.33 34.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 1.37 109.375 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -96.65 25.16 5.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.173 -0.955 . . . . 2.62 109.005 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -86.87 150.71 23.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 2.35 110.38 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -93.22 123.05 36.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.923 -0.769 . . . . 2.35 108.923 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -83.67 175.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.961 -1.087 . . . . 0.78 109.368 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 34' ' ' ASP . 45.3 p -97.24 149.48 21.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.464 -0.772 . . . . 1.04 109.121 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.97 -7.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 1.05 109.667 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 32' ' ' SER . 29.9 t70 -84.14 -24.21 30.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 2.47 109.968 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -103.44 -9.84 19.06 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.134 -0.979 . . . . 1.46 109.536 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.15 -41.4 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.092 -1.005 . . . . 0.77 109.071 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -54.92 -35.43 64.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.366 -0.834 . . . . 1.46 109.392 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -70.01 -37.82 75.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 2.29 110.355 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -58.97 -39.1 80.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 1.3 109.481 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.44 -43.76 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.394 -0.816 . . . . 0.76 109.48 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -63.39 -41.86 98.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.189 -0.945 . . . . 1.5 108.461 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.18 -30.25 71.43 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.364 -0.835 . . . . 2.66 108.811 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -86.7 -51.81 5.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.854 . . . . 0.75 109.49 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 tp -58.12 -63.21 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.83 109.834 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 t -65.12 -35.6 81.63 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.822 -1.174 . . . . 0.78 109.14 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.36 -9.79 38.64 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.254 -1.938 . . . . 0.57 108.254 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -85.72 -28.65 24.49 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.902 -1.518 . . . . 2.83 106.902 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.9 -26.65 67.72 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.291 -1.003 . . . . 0.65 108.291 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -85.27 -62.88 1.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.281 -0.637 . . . . 2.57 109.281 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.07 -38.07 49.42 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.094 -1.004 . . . . 0.51 109.311 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 66.4 m -64.82 -38.56 91.38 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.45 -0.944 . . . . 1.36 108.45 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.04 -39.77 65.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.292 0.567 . . . . 0.6 109.863 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -55.47 -74.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 1.36 109.541 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 58' ' ' LYS . 17.8 mt -46.64 -52.42 13.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.158 -0.964 . . . . 1.38 109.508 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 51' ' ' SER . 25.8 mm-40 -47.63 -53.4 14.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.454 -0.779 . . . . 1.27 109.639 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 m -62.34 -37.97 87.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.6 109.319 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.6 mt -72.62 -31.1 36.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.301 -0.874 . . . . 0.53 108.787 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 54' ' ' LEU . 15.8 ttpt -55.06 -44.23 74.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.414 -0.804 . . . . 0.99 109.28 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.45 -32.47 70.05 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.255 -0.903 . . . . 0.59 109.47 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.71 -17.67 62.82 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.906 -1.122 . . . . 1.81 108.081 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.401 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -85.6 -34.53 21.39 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.867 -0.79 . . . . 0.48 108.867 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.89 -27.69 30.95 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.061 -1.066 . . . . 0.58 110.64 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -86.43 -17.66 33.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.688 -1.478 . . . . 1.39 109.414 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.8 m -94.66 -45.25 7.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.078 -1.014 . . . . 0.82 110.396 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -106.11 -18.85 13.89 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.208 -0.933 . . . . 0.99 110.38 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 121.26 139.26 5.65 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 109.58 -1.408 . . . . 0.55 109.58 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -48.93 -8.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.955 . . . . 2.59 110.728 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 66' ' ' GLY . 2.5 pt-20 -66.57 -23.49 66.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.813 -1.179 . . . . 2.2 110.298 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -88.81 -10.05 49.51 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.884 -1.135 . . . . 1.79 110.074 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -63.55 -23.85 67.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.918 -1.114 . . . . 1.54 110.595 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.22 83.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.081 -1.012 . . . . 0.64 110.274 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.3 mt -70.33 -42.21 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.58 109.449 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -76.1 -20.82 57.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.152 -0.967 . . . . 0.62 109.622 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -65.4 -38.86 91.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.977 -1.077 . . . . 1.23 108.95 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.74 -36.97 61.58 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.247 -1.541 . . . . 0.52 109.247 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -62.42 -21.85 65.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.312 -1.11 . . . . 1.29 110.768 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.2 mt -85.37 -39.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.559 -1.338 . . . . 0.55 108.99 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.4 ttt -59.31 -42.23 90.88 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.364 -0.976 . . . . 1.89 108.364 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.5 -40.49 82.99 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.45 -0.945 . . . . 0.53 108.45 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.4 tp -65.96 -50.33 64.72 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.439 -0.788 . . . . 0.43 109.674 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -85.55 10.48 13.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.162 -0.961 . . . . 1.24 110.976 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -48.46 122.8 5.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.738 -1.226 . . . . 1.31 109.376 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -66.29 -25.9 67.07 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.406 -0.809 . . . . 1.35 108.959 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -76.45 -49.75 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.458 -0.777 . . . . 2.16 109.514 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.0 mt -64.95 -20.71 66.61 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.888 -1.125 . . . . 0.6 108.928 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -70.43 -47.57 60.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.381 -0.824 . . . . 1.28 109.476 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -64.89 -32.18 73.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.522 -0.736 . . . . 1.28 109.815 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -73.09 -48.77 32.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -0.951 . . . . 1.29 109.015 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.18 -57.71 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.75 -0.833 . . . . 0.58 108.75 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 91' ' ' ALA . 77.3 mt -53.05 -61.88 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.714 -0.616 . . . . 0.78 110.662 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 90' ' ' ILE . . . -40.93 -62.51 0.8 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.388 -0.82 . . . . 0.86 110.748 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.4 mt -45.12 -51.11 10.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.376 -0.828 . . . . 0.79 110.011 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.5 -41.35 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.929 -1.107 . . . . 0.71 110.011 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -85.16 -42.74 14.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.211 -0.93 . . . . 2.05 111.808 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -83.64 -34.06 25.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.669 -1.269 . . . . 1.59 111.74 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -104.16 10.7 35.71 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.836 -1.165 . . . . 1.89 109.361 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.8 m80 43.77 47.7 6.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.703 . . . . 1.31 109.691 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.5 mtp -99.33 154.88 17.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.77 -0.826 . . . . 1.28 108.77 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.1 p -75.52 141.29 43.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.273 -0.892 . . . . 0.62 109.163 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.07 -25.98 2.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.155 -0.965 . . . . 0.47 109.347 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.83 -45.34 51.85 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.277 -1.009 . . . . 2.0 108.277 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.91 -54.4 11.54 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.733 -0.604 . . . . 0.56 109.873 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -52.62 63.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.261 -0.9 . . . . 0.48 109.478 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.09 -35.42 64.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.958 . . . . 0.44 109.283 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.416 ' CD2' HD11 ' A' ' 26' ' ' ILE . 36.2 t-80 -71.99 -32.41 67.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.853 . . . . 1.42 109.545 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.86 -61.9 2.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 1.26 110.035 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 107' ' ' VAL . 5.8 t -53.66 -47.32 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.61 110.038 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.49 -20.66 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.64 109.681 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -74.14 -38.26 63.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.022 . . . . 2.2 110.161 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.38 -21.84 46.76 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.525 -1.321 . . . . 0.82 111.994 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -68.95 -53.48 20.58 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.735 -1.45 . . . . 1.27 108.691 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.66 67.28 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.656 -0.652 . . . . 0.91 109.485 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 t -60.69 -43.6 97.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 1.73 110.192 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.3 -33.08 75.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.042 . . . . 1.04 110.449 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.4 HD21 HH21 ' A' ' 126' ' ' ARG . 17.1 mt -69.38 -27.9 65.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.729 -1.232 . . . . 1.03 109.338 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.56 -16.09 64.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 1.95 109.224 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -80.37 -9.06 59.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.374 -0.829 . . . . 1.71 109.004 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.71 141.05 28.9 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.528 -0.915 . . . . 1.26 108.528 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -99.65 65.11 1.33 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.309 -0.869 . . . . 2.83 109.186 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -147.18 111.87 5.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 1.58 109.354 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -51.49 -17.02 0.69 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.537 -0.727 . . . . 2.8 109.815 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -81.21 -63.87 1.31 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 1.02 109.272 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.4 mt -61.76 -31.27 71.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.264 -0.898 . . . . 1.06 110.139 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -66.65 -46.43 75.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.856 -1.152 . . . . 2.39 109.112 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -61.39 -18.75 60.21 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.512 -0.875 . . . . 2.2 108.831 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.4 HH21 HD21 ' A' ' 115' ' ' LEU . 39.3 ttp180 -74.72 -27.69 60.48 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.678 -1.601 . . . . 2.09 106.678 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.71 94.56 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.126 -0.694 . . . . 0.86 109.126 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.99 87.24 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.289 -0.882 . . . . 0.9 109.472 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.8 OUTLIER -70.52 -30.4 67.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.834 . . . . 1.35 110.028 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.12 -39.68 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.958 -1.089 . . . . 0.58 108.45 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -61.69 -37.94 85.97 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.216 -1.031 . . . . 3.22 108.216 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.08 -36.37 77.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.535 -0.728 . . . . 1.32 109.699 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.03 -27.72 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 0.5 109.771 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.33 -46.67 7.35 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.678 -1.369 . . . . 0.44 109.678 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -49.6 -47.75 49.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -1.099 . . . . 2.71 109.144 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.519 HH11 ' HG2' ' A' ' 136' ' ' ARG . 12.8 mtt-85 -64.77 -43.42 93.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.143 -0.973 . . . . 2.2 108.713 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.6 tp -52.38 -39.99 61.51 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.968 -0.753 . . . . 1.13 108.968 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.41 -59.08 2.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 0.54 109.96 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 139' ' ' ARG . 30.4 mtt-85 -47.67 -18.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 2.32 110.841 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -84.6 -39.83 18.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.837 -1.164 . . . . 1.26 108.965 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.61 -38.31 81.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.4 -0.812 . . . . 0.62 109.063 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.9 mt -91.19 -7.3 51.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.345 -0.847 . . . . 0.67 109.016 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.95 20.83 69.09 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.389 -1.884 . . . . 0.68 108.389 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tp -57.82 168.29 0.96 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.689 -0.889 . . . . 0.77 109.601 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -66.06 143.57 57.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 2.4 109.375 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -102.13 147.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.625 -0.88 . . . . 0.87 108.625 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.742 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.7 mp -79.08 94.02 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.168 -0.957 . . . . 1.32 109.193 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -101.0 92.07 4.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.461 -0.774 . . . . 1.54 110.046 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.539 HD21 ' CG2' ' A' ' 147' ' ' ILE . 10.1 mt -82.56 -17.52 44.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.145 -0.972 . . . . 0.77 108.917 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 170' ' ' GLN . 0.8 OUTLIER -82.99 35.34 0.47 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.763 . . . . 1.57 109.608 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.1 24.27 2.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 0.82 109.024 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 79.4 mt -73.16 139.84 18.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.483 -0.761 . . . . 0.82 109.449 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -118.34 -18.0 9.33 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.519 -0.919 . . . . 2.11 108.519 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -117.62 127.73 54.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.982 -0.747 . . . . 1.41 108.982 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -61.91 127.71 32.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.814 . . . . 1.3 109.889 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -149.99 176.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.393 -0.817 . . . . 0.57 108.888 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.1 mt -87.9 147.14 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.442 -0.948 . . . . 0.43 108.442 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 tp -101.74 117.76 35.54 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.654 -0.869 . . . . 0.56 108.654 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.67 131.96 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.713 -0.847 . . . . 0.54 108.713 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.33 149.17 15.29 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.78 -0.768 . . . . 0.62 109.644 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.76 78.46 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 120.682 -1.261 . . . . 0.8 107.946 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -173.14 148.33 1.68 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.585 -0.697 . . . . 2.34 109.134 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.4 mt -119.59 138.73 53.03 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.383 -0.823 . . . . 0.65 109.619 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.4 p -94.41 153.53 40.41 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 0.74 109.243 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 169' ' ' ALA . 69.6 Cg_exo -37.36 -50.55 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.379 2.053 . . . . 0.6 112.482 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 m -49.78 -55.44 14.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.63 109.281 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.19 -47.52 81.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.907 . . . . 1.25 109.543 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.4 p -67.95 -19.86 65.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 0.5 109.778 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -80.09 -29.5 39.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.163 -0.961 . . . . 0.51 110.113 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.413 ' O ' ' OG ' ' A' ' 150' ' ' SER . 20.9 pt20 -101.5 -11.66 19.13 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.154 -0.966 . . . . 1.17 109.117 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.89 151.72 21.04 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.538 -0.912 . . . . 0.61 108.538 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -99.57 139.35 35.35 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.407 -0.96 . . . . 2.12 108.407 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.78 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.3 mm? -88.37 -41.21 12.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 1.34 109.978 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -82.49 -10.72 58.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.019 -1.05 . . . . 1.97 111.667 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -99.9 -17.03 17.79 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.621 -1.3 . . . . 1.9 108.763 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 178' ' ' GLY . 56.6 t -89.7 156.38 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.592 -0.892 . . . . 0.48 108.592 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.8 tp -106.08 -20.46 13.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.364 -0.835 . . . . 1.39 109.609 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.473 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.4 173.0 41.64 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.095 -1.602 . . . . 0.38 109.095 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -128.36 124.33 36.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -1.035 . . . . 0.46 109.081 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.0 mt -130.2 131.68 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.017 -1.105 . . . . 0.59 108.017 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 23.4 p -139.22 147.41 41.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.36 -0.837 . . . . 0.67 111.336 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.45 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 7.1 p-10 -84.78 37.32 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.702 -0.624 . . . . 2.24 110.09 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.501 2.088 0 O-C-N 121.377 -0.827 . . . . 1.11 110.034 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 28.8 t60 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.132 0.491 . . . . 0.92 110.427 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.0 m -50.08 -31.04 12.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 1.59 109.599 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.9 t -76.47 -39.41 53.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.194 -0.941 . . . . 1.42 109.859 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.518 HD12 ' N ' ' A' ' 192' ' ' ILE . 1.5 mp -53.48 -36.43 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.956 . . . . 1.41 108.758 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 33.3 mtp -71.13 -52.11 21.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.255 -1.387 . . . . 0.86 107.255 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.33 -46.05 86.96 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.528 -0.76 . . . . 0.59 110.243 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -63.89 -48.76 75.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.064 -1.023 . . . . 3.06 110.056 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.8 m -68.92 -36.43 77.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.125 -0.984 . . . . 0.73 109.5 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 199' ' ' LEU . 21.3 mt -89.37 1.81 55.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.977 . . . . 0.67 109.018 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 194' ' ' ALA . 32.1 mt-10 54.71 2.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.466 -0.771 . . . . 1.49 111.261 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 197' ' ' LEU . 25.2 mt -66.61 168.47 10.11 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.622 -1.299 . . . . 0.64 108.54 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -85.71 144.0 8.59 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.21 1.94 . . . . 0.59 111.081 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.36 172.6 17.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.653 -1.279 . . . . 0.55 110.965 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.598 HD12 HD11 ' A' ' 220' ' ' LEU . 12.2 mt -150.95 156.0 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.365 -1.717 . . . . 0.63 106.365 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.8 m -143.04 -33.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.812 -1.18 . . . . 0.77 111.703 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.527 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -85.89 38.96 3.03 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 120.523 -1.36 . . . . 0.87 110.202 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 206' ' ' GLY . 27.5 p -71.21 42.83 0.07 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.831 -1.394 . . . . 0.89 109.199 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 39.18 -102.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.272 -1.131 . . . . 0.93 110.272 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.4 m -131.14 42.37 3.23 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.811 -0.817 . . . . 1.6 110.039 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.3 t -54.56 -33.57 27.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.868 -1.145 . . . . 0.75 108.438 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.2 p -55.39 -16.48 3.64 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.047 -1.033 . . . . 0.84 108.678 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 49.9 m -103.95 12.21 34.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.541 -0.724 . . . . 1.61 109.322 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -135.74 -17.3 1.7 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.32 -0.862 . . . . 2.3 109.968 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 5.8 t -112.55 141.91 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.637 -0.875 . . . . 0.76 108.637 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -177.92 3.26 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.764 -1.569 . . . . 2.01 106.764 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.3 p-10 -81.06 144.81 31.47 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.033 -1.042 . . . . 2.19 110.04 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.8 m-20 81.04 -13.46 0.92 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.074 -0.392 . . . . 2.4 110.857 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.51 136.37 56.71 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.854 -1.154 . . . . 1.99 108.416 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -86.7 117.21 25.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.926 -1.109 . . . . 1.3 108.952 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.3 mt -129.38 175.16 8.98 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.654 0.74 . . . . 0.53 109.585 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.6 mt -140.89 126.25 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.755 -0.831 . . . . 0.6 108.755 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.598 HD11 HD12 ' A' ' 202' ' ' ILE . 24.0 tp -90.16 126.32 35.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.57 108.725 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 223' ' ' VAL . 4.1 m-20 -95.38 -34.56 12.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.07 -1.019 . . . . 2.22 109.486 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.51 21.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.675 -0.641 . . . . 0.75 110.142 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.3 t -115.12 -59.84 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 106.465 -1.68 . . . . 0.92 106.465 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -89.21 11.39 18.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.242 -1.392 . . . . 2.36 107.242 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 64.3 t30 57.39 58.26 3.94 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.414 -0.588 . . . . 1.42 109.414 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -156.1 151.76 27.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.054 -1.028 . . . . 1.97 110.517 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 32.8 t -109.78 139.33 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.721 -0.844 . . . . 0.65 108.721 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -108.88 129.94 55.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.406 -0.809 . . . . 0.97 109.555 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 11.3 t -103.18 113.81 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.401 -0.812 . . . . 0.67 109.362 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.1 t30 52.02 63.42 9.18 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.943 . . . . 1.45 110.54 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.81 161.6 44.54 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.509 2.14 . . . . 0.82 112.019 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.6 p -74.0 160.4 31.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.358 -0.839 . . . . 1.62 109.464 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -68.01 -26.68 66.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 2.6 109.137 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 234' ' ' GLU . 0.7 OUTLIER -62.05 -37.65 85.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.803 . . . . 3.06 109.623 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.58 -45.28 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.007 -1.058 . . . . 1.14 109.157 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.57 -57.96 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.323 -0.861 . . . . 1.04 109.67 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -53.72 -40.37 66.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.28 -0.887 . . . . 2.54 110.417 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -65.91 -40.23 91.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 2.6 110.279 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 28.9 mtm -80.7 -26.04 37.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.999 -1.063 . . . . 1.23 109.911 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.403 ' NH1' ' HG3' ' A' ' 240' ' ' ARG . 15.1 mmm-85 -58.29 -42.16 85.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 2.67 109.898 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.24 -52.28 11.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 1.66 110.133 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 35.4 t -62.79 -50.23 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.101 -0.999 . . . . 2.2 109.862 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.42 ' HG2' HD12 ' A' ' 11' ' ' ILE . 7.4 tm0? -51.71 -59.12 4.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.197 -0.94 . . . . 3.0 110.378 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.3 -1.547 0 O-C-N 121.271 -0.893 . . . . 1.76 110.625 -178.388 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' N ' ' A' ' 3' ' ' SER . 21.1 mmt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.255 -0.646 . . . . 3.66 109.255 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.59 85.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.092 -1.005 . . . . 1.12 108.649 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 1' ' ' MET . 6.9 m -88.54 114.15 24.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 1.45 109.253 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.55 -163.16 20.7 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 108.859 -1.696 . . . . 0.92 108.859 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 5' ' ' ILE . 65.1 mt -94.84 -6.44 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -1.174 . . . . 1.05 108.553 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 36.5 tp 54.17 104.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.106 -0.702 . . . . 0.88 109.106 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.14 -56.0 4.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.064 -1.022 . . . . 0.78 108.345 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.64 145.61 26.3 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.144 -1.058 . . . . 1.5 108.144 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.58 154.19 35.0 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.986 1.79 . . . . 0.86 113.499 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.51 133.2 1.81 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.721 -1.351 . . . . 0.78 109.721 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.0 mt -94.85 135.65 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.955 -1.321 . . . . 0.74 109.795 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.412 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -143.6 155.42 44.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.216 -0.927 . . . . 0.45 109.726 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -125.38 141.78 51.87 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.338 -0.986 . . . . 0.64 108.338 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.24 163.02 28.08 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.127 -1.511 . . . . 0.45 110.887 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -78.51 150.97 32.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.488 -1.007 . . . . 1.88 109.559 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.566 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -76.13 127.9 33.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.59 111.012 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -109.71 91.94 3.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.436 -1.32 . . . . 0.64 107.436 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.649 ' H ' ' ND2' ' A' ' 214' ' ' ASN . 8.6 tp -81.65 126.3 31.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.021 -1.049 . . . . 0.74 110.58 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.489 HD11 HD11 ' A' ' 158' ' ' LEU . 13.6 mt -96.43 93.5 6.87 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.905 -0.589 . . . . 0.74 110.075 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -92.82 158.22 15.98 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.598 -0.89 . . . . 1.87 108.598 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -130.62 135.93 48.36 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.351 -0.843 . . . . 2.58 109.322 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.11 133.55 36.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -0.854 . . . . 2.14 108.856 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.58 147.69 48.37 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.293 -0.88 . . . . 1.93 109.135 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mt -89.27 129.76 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.298 -0.876 . . . . 0.68 109.417 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.4 112.59 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.605 -0.887 . . . . 0.84 108.605 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.6 mt -86.56 131.78 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.79 109.65 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -90.1 114.69 26.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.397 -0.814 . . . . 1.37 109.374 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.426 HH11 ' HG3' ' A' ' 28' ' ' ARG . 19.9 mmm-85 -95.63 26.16 4.13 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.206 -0.934 . . . . 2.62 108.857 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -79.21 143.26 35.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 2.35 109.384 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -84.76 123.63 30.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 2.35 109.573 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -90.92 173.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.277 -0.889 . . . . 0.78 109.987 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -105.53 172.9 6.55 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.776 -0.578 . . . . 1.04 109.603 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.18 -8.55 32.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.815 . . . . 1.05 109.722 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -82.84 -16.42 47.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.048 -1.032 . . . . 2.47 109.814 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -110.78 -8.27 14.56 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.395 -0.815 . . . . 1.46 109.263 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.49 -45.1 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.77 108.587 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -53.9 -36.09 62.35 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.419 -0.8 . . . . 1.46 109.067 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -70.44 -42.06 72.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.497 -0.752 . . . . 2.29 110.51 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -58.66 -45.6 89.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 1.3 109.535 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 44' ' ' LEU . 85.6 t -61.81 -44.21 98.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.192 -0.943 . . . . 0.76 109.053 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -65.72 -42.49 90.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.28 -0.887 . . . . 1.5 109.083 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -63.62 -34.89 78.84 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.176 -0.952 . . . . 2.66 108.92 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -86.39 -53.09 5.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.394 -0.816 . . . . 0.75 109.059 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' VAL . 10.0 tp -53.79 -67.1 0.29 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.731 . . . . 0.83 109.731 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.619 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 45.1 t -63.75 -35.07 79.38 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.192 -0.943 . . . . 0.78 108.935 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.55 -53.35 39.25 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.372 -2.291 . . . . 0.57 107.372 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -46.74 -32.33 3.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.603 -0.939 . . . . 2.83 108.775 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.86 -32.92 69.88 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.869 -1.159 . . . . 0.65 107.869 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 46' ' ' GLY . 16.5 ttmm -83.89 -61.05 1.92 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.021 -0.733 . . . . 2.57 109.021 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.09 -45.03 64.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.51 110.069 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.4 t -63.35 -38.14 89.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.06 -1.025 . . . . 1.36 108.409 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 -31.2 65.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.089 -0.708 . . . . 0.6 109.089 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -69.25 -58.68 3.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.801 . . . . 1.36 109.099 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.4 mt -55.85 -45.38 78.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 1.38 108.718 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -55.27 -48.66 73.7 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.981 -0.748 . . . . 1.27 108.981 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.1 m -63.13 -41.08 99.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.6 109.22 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.4 mt -71.53 -37.49 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.375 -0.972 . . . . 0.53 108.375 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -49.84 -45.58 50.4 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.57 -0.706 . . . . 0.99 109.408 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -70.95 -27.78 64.0 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.256 -0.902 . . . . 0.59 109.941 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -71.79 -25.37 61.98 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.805 -1.184 . . . . 1.81 108.475 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.45 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -81.58 -29.07 33.53 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.647 -0.872 . . . . 0.48 108.647 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.21 -32.13 17.85 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.969 -1.11 . . . . 0.58 110.653 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -85.88 -15.44 41.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.899 -1.353 . . . . 1.39 109.107 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.8 m -95.49 -48.81 5.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.332 -0.855 . . . . 0.82 110.498 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -106.64 -14.48 15.02 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.13 -0.981 . . . . 0.99 110.67 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.81 136.86 5.2 Favored Glycine 0 N--CA 1.502 3.087 0 N-CA-C 109.733 -1.347 . . . . 0.55 109.733 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -48.29 -9.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.536 -0.979 . . . . 2.59 110.744 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 66' ' ' GLY . 13.6 pt-20 -66.51 -21.86 66.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.952 -1.093 . . . . 2.2 110.586 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -87.93 -16.32 34.19 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.92 -1.113 . . . . 1.79 109.781 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.15 -20.34 66.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.2 -0.937 . . . . 1.54 110.686 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.75 92.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.852 -1.155 . . . . 0.64 109.531 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.6 mt -71.73 -39.85 69.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.218 -0.926 . . . . 0.58 109.465 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -78.06 -23.53 48.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -0.958 . . . . 0.62 108.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -64.7 -33.28 75.59 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.493 -0.928 . . . . 1.23 108.493 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.47 -35.9 35.6 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.048 -1.621 . . . . 0.52 109.048 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -60.95 -21.1 63.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.352 -1.087 . . . . 1.29 109.829 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.2 mt -86.42 -42.4 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.9 -1.125 . . . . 0.55 108.76 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.3 ttm -59.88 -41.38 91.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.022 -0.733 . . . . 1.89 109.022 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -63.93 -39.31 93.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.53 109.127 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -71.83 -42.58 66.81 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.534 -0.866 . . . . 0.43 109.431 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -86.24 5.43 34.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 1.24 110.41 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -48.36 122.75 5.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 1.31 109.753 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -67.42 -24.32 65.64 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.643 -0.873 . . . . 1.35 108.643 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -76.14 -53.39 8.36 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.469 -0.769 . . . . 2.16 109.055 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.06 -12.61 52.55 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.972 -1.091 . . . . 0.6 108.707 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -78.16 -53.75 7.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.434 -0.792 . . . . 1.28 109.897 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -62.5 -25.69 68.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 1.28 109.701 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -73.19 -47.04 47.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -0.99 . . . . 1.29 108.812 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.61 -56.32 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.441 -0.948 . . . . 0.58 108.441 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -48.34 -56.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.603 -0.686 . . . . 0.78 110.055 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -47.79 -61.96 1.69 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.86 110.308 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.5 mt -47.8 -52.14 19.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.79 109.402 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.0 mt -52.2 -46.24 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.077 -1.014 . . . . 0.71 110.193 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -84.85 -35.51 22.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.094 -1.004 . . . . 2.05 111.88 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.25 -37.98 22.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.536 -1.352 . . . . 1.59 111.732 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -105.23 14.62 28.73 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.729 -1.232 . . . . 1.89 109.48 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.8 m80 45.16 42.53 6.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.379 -0.826 . . . . 1.31 109.597 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.7 mtt -95.36 149.54 21.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.936 -0.765 . . . . 1.28 108.936 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 p -76.62 143.59 40.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.33 -0.856 . . . . 0.62 109.283 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.04 -27.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 0.47 109.804 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 1.3 p30 -76.14 -43.85 41.06 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.293 -0.879 . . . . 2.0 108.717 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -70.52 -56.9 5.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.622 -0.674 . . . . 0.56 110.277 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.25 -49.68 68.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.48 109.758 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.89 -30.94 59.31 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.247 -0.908 . . . . 0.44 109.525 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -69.47 -34.63 74.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.991 -1.068 . . . . 1.42 109.873 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -63.78 -45.89 87.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.989 -1.07 . . . . 1.26 109.791 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.51 -47.82 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.825 -1.172 . . . . 0.61 108.669 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.74 -18.19 22.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.493 -0.754 . . . . 0.64 109.057 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.8 -42.87 73.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 2.2 109.572 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.32 -29.32 22.53 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.617 -1.278 . . . . 0.82 112.336 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -65.15 -39.45 93.01 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.414 -1.639 . . . . 1.27 108.797 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.67 -51.36 7.8 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.567 -0.708 . . . . 0.91 109.178 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -60.34 -44.52 95.44 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.452 -0.78 . . . . 1.73 110.149 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -63.89 -37.62 88.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.05 -1.031 . . . . 1.04 111.235 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.41 -25.99 66.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.507 -1.371 . . . . 1.03 109.216 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -71.63 -21.33 61.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.971 -1.08 . . . . 1.95 109.828 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -81.83 -7.02 59.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.214 -0.929 . . . . 1.71 108.921 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.89 136.86 33.12 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.255 -1.017 . . . . 1.26 108.255 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -94.07 63.43 3.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 2.83 108.722 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -146.61 114.27 6.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.81 . . . . 1.58 109.28 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.83 -16.01 4.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 2.8 109.755 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -81.12 -63.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 1.02 109.368 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 mt -66.55 -31.32 71.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.236 -0.915 . . . . 1.06 109.833 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 27.6 ttpt -66.69 -50.05 64.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.942 -1.099 . . . . 2.39 109.321 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.27 -25.73 49.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.091 -1.006 . . . . 2.2 108.702 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -72.56 -23.57 60.99 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.542 -1.651 . . . . 2.09 106.542 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -58.38 -47.83 82.59 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.233 -1.025 . . . . 0.86 108.233 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.41 -35.84 76.13 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.674 -0.641 . . . . 0.9 109.48 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 1.9 m-20 -68.69 -30.63 69.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.422 -0.799 . . . . 1.35 109.733 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.4 t -77.48 -39.48 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.01 -1.056 . . . . 0.58 108.679 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -56.35 -40.93 75.31 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.107 -1.071 . . . . 3.22 108.107 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.61 -38.36 81.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.603 -0.686 . . . . 1.32 109.665 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.52 -21.77 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.5 109.449 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.09 -58.36 2.99 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.0 -1.095 . . . . 0.44 110.496 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -52.67 -42.67 64.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.007 -1.29 . . . . 2.71 109.849 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 140' ' ' ASN . 23.2 mtt-85 -65.43 -45.91 82.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.957 -1.089 . . . . 2.2 108.423 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.2 tp -55.68 -43.41 76.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.585 -0.697 . . . . 1.13 109.386 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.2 -47.9 75.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.54 110.268 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -52.96 -22.35 5.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.061 -1.024 . . . . 2.32 110.8 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 70.4 m-80 -83.37 -45.55 13.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.915 -1.116 . . . . 1.26 109.091 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.5 mt -53.93 -38.48 36.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.197 -0.94 . . . . 0.62 108.934 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.2 mt -88.15 3.59 48.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.245 -0.909 . . . . 0.67 109.101 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.2 30.88 55.83 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.744 -1.742 . . . . 0.68 108.744 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.57 142.35 52.9 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.357 -1.084 . . . . 0.77 109.462 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -67.5 136.01 53.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 2.4 109.708 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 80.4 mt -106.54 144.6 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.898 -0.779 . . . . 0.87 108.898 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.709 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -77.92 138.98 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 1.32 109.616 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -96.67 86.59 4.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.426 -0.796 . . . . 1.54 109.486 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.1 mt -80.17 -29.69 38.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.412 -0.805 . . . . 0.77 109.651 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.8 p -79.98 20.64 0.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.933 . . . . 1.57 109.486 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -142.32 35.11 1.49 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.347 -0.845 . . . . 0.82 109.714 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 153' ' ' GLN . 57.7 mt -72.3 158.83 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.82 109.148 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 152' ' ' ILE . 1.2 pt20 -134.43 -4.21 2.65 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.293 -0.879 . . . . 2.11 109.601 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -125.2 128.34 48.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.533 -0.729 . . . . 1.41 109.297 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.52 122.99 18.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 1.3 109.292 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.4 m -148.12 172.97 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.321 -0.862 . . . . 0.57 109.314 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.4 mt -88.85 152.91 3.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.809 -1.182 . . . . 0.43 107.809 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.489 HD11 HD11 ' A' ' 19' ' ' LEU . 14.6 tp -105.98 118.76 37.44 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.619 0.724 . . . . 0.56 109.273 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 26.2 t -121.46 128.62 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.815 -0.809 . . . . 0.54 108.815 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.67 146.59 11.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.313 -0.867 . . . . 0.62 109.539 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.5 71.72 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.677 -1.265 . . . . 0.8 108.015 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -173.21 157.33 3.38 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.598 -0.689 . . . . 2.34 109.48 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.7 mt -126.82 137.47 53.2 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.531 -0.731 . . . . 0.65 109.118 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.6 p -92.33 152.74 42.64 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.24 -0.913 . . . . 0.74 109.195 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 169' ' ' ALA . 66.0 Cg_exo -35.92 -51.9 1.03 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.561 2.174 . . . . 0.6 112.663 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.5 m -47.92 -54.72 11.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.63 109.473 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -59.04 -48.07 82.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 1.25 109.811 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 168' ' ' THR . 5.4 p -69.49 -24.33 63.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.5 109.902 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -77.9 -24.62 48.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.51 110.086 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -106.95 -15.39 14.71 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.316 -0.865 . . . . 1.17 109.681 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.1 tp -58.81 149.91 25.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.019 -1.051 . . . . 0.61 108.831 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 173' ' ' LEU . 2.6 t-20 -99.02 152.57 19.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 2.12 108.702 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.54 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 11.8 mt -95.32 -40.84 9.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.177 -0.952 . . . . 1.34 110.938 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -81.79 -14.68 56.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.846 -1.159 . . . . 1.97 112.125 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -95.0 -11.11 29.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.433 -1.417 . . . . 1.9 107.869 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 177' ' ' LEU . 95.8 t -96.95 163.6 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.799 -1.186 . . . . 0.48 107.799 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.545 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -112.18 -26.62 8.71 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.638 -0.875 . . . . 1.39 108.638 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.42 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.85 176.28 47.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.156 -1.578 . . . . 0.38 109.156 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.448 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 1.6 m-85 -128.39 123.45 33.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.438 -1.036 . . . . 0.46 109.91 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.6 mt -128.25 129.92 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.492 -1.299 . . . . 0.59 107.492 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.2 p -140.24 148.14 41.05 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.235 1.017 . . . . 0.67 111.785 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 1.1 t70 -87.78 38.72 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.77 -0.581 . . . . 2.24 109.843 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.503 2.183 0 O-C-N 121.174 -0.954 . . . . 1.11 110.287 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 13.5 t60 . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 107.977 -1.12 . . . . 0.92 107.977 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 95.1 m -63.11 -39.73 95.55 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.621 -0.881 . . . . 1.59 108.621 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.3 t -57.09 -33.16 67.02 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 1.42 109.051 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.87 -37.66 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.293 -0.879 . . . . 1.41 110.444 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.7 mtm -71.94 -51.42 22.12 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.785 -1.197 . . . . 0.86 108.238 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.83 -32.33 31.24 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.147 0.498 . . . . 0.59 109.705 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -75.52 -46.04 34.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.057 -1.027 . . . . 3.06 109.376 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.3 m -70.77 -35.7 72.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.257 -0.902 . . . . 0.73 109.63 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.5 mt -89.49 -2.37 58.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.67 109.139 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 51.17 10.12 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.562 -0.711 . . . . 1.49 111.783 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.9 mt -68.17 168.41 13.64 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.557 -1.339 . . . . 0.64 108.507 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.14 131.8 5.96 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.121 1.881 . . . . 0.59 111.578 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -163.37 176.39 9.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.794 -1.191 . . . . 0.55 111.177 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.409 HG23 ' H ' ' A' ' 6' ' ' LEU . 11.4 mt -149.64 161.51 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.653 -1.61 . . . . 0.63 106.653 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 181' ' ' THR . 17.1 m -144.63 -31.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.725 -1.234 . . . . 0.77 111.413 -178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.18 31.2 5.5 Favored Glycine 0 N--CA 1.491 2.364 0 O-C-N 120.807 -1.183 . . . . 0.87 110.486 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.434 ' HB ' HG23 ' A' ' 208' ' ' VAL . 10.1 p -56.02 -37.27 68.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.787 -1.419 . . . . 0.89 108.514 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.43 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 64.94 -35.2 0.1 Allowed Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.923 -0.656 . . . . 0.93 113.522 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.6 m -121.66 16.43 11.13 Favored 'General case' 0 N--CA 1.513 2.704 0 CA-C-N 119.812 1.806 . . . . 1.6 112.839 -177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' A' ' 205' ' ' THR . 5.7 t -78.23 -52.54 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.221 -1.549 . . . . 0.75 109.888 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.3 p -53.62 -19.61 4.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.697 -1.252 . . . . 0.84 109.961 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.8 m -105.72 14.45 28.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.341 -0.85 . . . . 1.61 109.474 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -143.54 -5.6 0.83 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.235 -0.916 . . . . 2.3 110.891 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 37.2 t -119.45 157.58 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.16 -0.963 . . . . 0.76 109.957 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.426 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 16.0 mmmt -134.34 171.38 14.35 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.813 -1.551 . . . . 2.01 106.813 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.649 ' ND2' ' H ' ' A' ' 18' ' ' LEU . 11.5 t-20 -76.17 143.06 41.36 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.876 -1.14 . . . . 2.19 110.539 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.0 t70 80.12 -10.77 1.24 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.712 -0.617 . . . . 2.4 110.867 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -57.85 143.62 41.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.772 -1.205 . . . . 1.99 108.657 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -86.08 110.95 19.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.011 -1.055 . . . . 1.3 108.555 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.566 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 13.4 mt -123.8 165.4 17.38 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.67 0.747 . . . . 0.53 109.946 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 40.6 mt -138.71 125.22 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.833 -1.173 . . . . 0.6 107.833 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.4 tp -86.89 127.35 35.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.2 -0.938 . . . . 0.57 108.735 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.7 -46.17 6.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.244 -0.91 . . . . 2.22 109.433 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 44.51 23.87 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.513 -0.742 . . . . 0.75 110.165 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 t -115.96 -41.11 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 106.634 -1.617 . . . . 0.92 106.634 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -108.22 13.08 26.08 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.825 -1.546 . . . . 2.36 106.825 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 60.66 52.63 4.36 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.964 -0.562 . . . . 1.42 109.908 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -157.87 154.92 28.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.972 -1.08 . . . . 1.97 110.712 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 228' ' ' TYR . 87.6 t -107.19 163.21 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.843 -0.799 . . . . 0.65 108.843 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.517 ' N ' HG12 ' A' ' 227' ' ' VAL . 48.2 m-85 -122.07 116.27 23.96 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.358 -0.839 . . . . 0.97 109.147 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.7 t -102.16 120.1 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.406 -0.809 . . . . 0.67 109.871 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 31.8 t30 65.68 74.98 0.36 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.685 -0.634 . . . . 1.45 110.452 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -91.56 143.76 3.02 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 123.334 2.689 . . . . 0.82 111.929 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 14.5 p -73.34 167.19 21.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 1.62 109.714 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -72.4 -34.47 67.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 2.6 108.958 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -66.25 -34.3 77.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.504 -0.747 . . . . 3.06 109.473 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.1 t -76.03 -30.1 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 1.14 109.151 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 69.5 mt -70.88 -56.37 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.311 -0.868 . . . . 1.04 109.074 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.85 -40.22 69.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 2.54 110.228 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -66.98 -40.27 87.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.119 -0.988 . . . . 2.6 110.197 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.8 mtp -81.07 -23.11 38.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.069 -1.019 . . . . 1.23 109.692 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -60.02 -44.09 94.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 2.67 109.385 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.65 -56.81 4.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 1.66 110.019 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 94.0 t -48.81 -61.44 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.256 -0.902 . . . . 2.2 110.091 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -49.29 -57.29 7.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.276 -0.89 . . . . 3.0 110.223 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--N 1.297 -1.69 0 O-C-N 120.854 -1.153 . . . . 1.76 109.931 -178.725 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 3' ' ' SER . 66.6 mtt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.5 -0.555 . . . . 3.66 109.5 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.78 83.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 1.12 109.556 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 1' ' ' MET . 50.8 m -94.59 112.12 23.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.963 -1.086 . . . . 1.45 108.696 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.76 -165.04 21.6 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 109.872 -1.291 . . . . 0.92 109.872 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 5' ' ' ILE . 58.2 mt -93.07 -6.18 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.249 -1.148 . . . . 1.05 108.595 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' ILE . 18.3 tp 57.16 110.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.538 -0.726 . . . . 0.88 109.418 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.55 -45.87 9.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.78 109.23 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.51 150.53 31.33 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.241 -0.912 . . . . 1.5 109.384 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -83.01 148.29 13.4 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.478 2.118 . . . . 0.86 113.733 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.735 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.56 -177.06 34.53 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.421 -1.472 . . . . 0.78 109.421 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 mt -147.7 126.89 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.872 -1.37 . . . . 0.74 110.186 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.17 161.49 36.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.34 -0.85 . . . . 0.45 109.48 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 8.1 m-85 -126.9 128.27 46.21 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.656 -0.868 . . . . 0.64 108.656 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.77 165.95 38.47 Favored Glycine 0 N--CA 1.502 3.064 0 C-N-CA 118.48 -1.819 . . . . 0.45 111.836 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -82.12 151.45 26.98 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.46 -1.024 . . . . 1.88 110.66 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.54 130.76 37.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.448 -0.782 . . . . 0.59 111.878 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 tp -111.05 99.86 8.65 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.182 -1.414 . . . . 0.64 107.182 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 tp -85.51 122.55 29.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.785 -1.197 . . . . 0.74 110.872 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 158' ' ' LEU . 20.9 mt -93.48 98.72 11.38 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.791 -0.818 . . . . 0.74 108.791 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -89.85 142.52 27.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.433 -0.792 . . . . 1.87 109.265 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -110.11 129.68 55.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.487 -0.758 . . . . 2.58 109.681 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -78.13 122.26 25.4 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.17 -1.048 . . . . 2.14 108.17 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -65.6 134.96 54.41 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.098 -1.001 . . . . 1.93 109.765 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.0 mt -91.3 134.47 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.543 -0.723 . . . . 0.68 109.503 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.84 119.52 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.87 -0.789 . . . . 0.84 108.87 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.5 mt -90.62 131.51 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.968 -1.082 . . . . 0.79 109.41 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -89.69 123.79 34.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.135 -0.978 . . . . 1.37 109.508 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -97.11 28.39 3.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.172 -0.955 . . . . 2.62 109.185 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -85.72 141.32 29.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 2.35 109.691 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -84.87 130.21 34.69 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.487 -0.931 . . . . 2.35 108.487 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.3 pt -88.18 172.76 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.78 110.25 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 34' ' ' ASP . 88.5 p -99.01 161.1 13.81 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.586 -0.894 . . . . 1.04 108.586 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.82 -7.06 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.855 -1.153 . . . . 1.05 109.893 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 32' ' ' SER . 38.2 m-20 -83.38 -15.01 51.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.978 -1.076 . . . . 2.47 110.517 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -117.55 0.46 12.11 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.366 -0.834 . . . . 1.46 109.758 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 t -68.64 -49.36 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.937 -1.102 . . . . 0.77 109.593 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -59.67 -30.61 68.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.2 -0.937 . . . . 1.46 108.477 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.487 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 1.5 mp0 -70.67 -39.09 73.76 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.254 0.549 . . . . 2.29 110.023 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -64.45 -37.13 86.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.105 -0.997 . . . . 1.3 109.5 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.33 -45.55 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.804 . . . . 0.76 109.401 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.85 -37.95 89.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 1.5 108.543 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.602 HH11 ' HG2' ' A' ' 42' ' ' ARG . 4.6 mtt-85 -67.05 -41.08 87.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.048 -0.723 . . . . 2.66 109.048 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -81.82 -41.93 20.38 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.372 -0.83 . . . . 0.75 109.537 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 tp -64.6 -61.34 2.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.166 -0.959 . . . . 0.83 108.569 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.0 t -65.4 -36.19 83.2 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.444 -0.785 . . . . 0.78 108.992 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -50.84 -56.97 11.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.302 -1.919 . . . . 0.57 108.302 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.443 HH11 ' HB3' ' A' ' 47' ' ' ARG . 1.7 ttt-85 -47.04 -32.42 3.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.565 -0.962 . . . . 2.83 108.735 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.21 -32.54 64.5 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.028 -1.101 . . . . 0.65 108.028 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 46' ' ' GLY . 93.5 mttt -81.33 -58.99 2.79 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.026 -0.731 . . . . 2.57 109.026 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.93 -44.71 64.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.095 -1.003 . . . . 0.51 110.148 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 65.5 p -61.43 -37.62 84.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.159 -0.963 . . . . 1.36 108.67 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.68 -42.12 61.72 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.394 0.616 . . . . 0.6 109.401 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -67.29 -58.49 4.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.813 . . . . 1.36 109.585 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.9 mt -52.35 -47.11 66.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.119 -0.988 . . . . 1.38 108.875 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 51' ' ' SER . 6.2 mm-40 -52.25 -47.27 65.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.555 -0.715 . . . . 1.27 109.196 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m -58.6 -38.12 77.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.6 108.83 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.1 mt -75.12 -31.94 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 0.53 108.813 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -54.89 -50.11 69.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.439 -0.788 . . . . 0.99 109.85 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.401 HG22 ' OE1' ' A' ' 63' ' ' GLU . 3.0 m -70.22 -29.92 66.87 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.333 -0.854 . . . . 0.59 110.58 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -69.8 -14.92 63.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.712 -1.242 . . . . 1.81 108.211 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.48 -36.92 21.94 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.699 -0.852 . . . . 0.48 108.699 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.39 -26.64 42.57 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.68 -1.248 . . . . 0.58 109.984 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.401 ' OE1' HG22 ' A' ' 59' ' ' THR . 32.3 mt-10 -86.82 -17.1 34.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.075 -1.25 . . . . 1.39 109.413 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.9 m -96.3 -47.58 5.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.284 -0.885 . . . . 0.82 110.168 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -106.24 -15.57 14.81 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.071 -1.018 . . . . 0.99 110.702 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 118.37 140.83 6.51 Favored Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.057 -1.617 . . . . 0.55 109.057 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -47.45 -11.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -1.155 . . . . 2.59 110.542 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 66' ' ' GLY . 55.0 tt0 -61.27 -30.91 70.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.581 -1.324 . . . . 2.2 109.905 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -92.01 -10.47 39.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.891 -1.131 . . . . 1.79 110.171 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -66.85 -35.12 79.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.042 -1.036 . . . . 1.54 110.187 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.06 -30.04 70.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.64 110.382 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -69.01 -42.76 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.941 -1.099 . . . . 0.58 108.725 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -77.8 -21.68 51.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.888 . . . . 0.62 109.53 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.52 -38.05 89.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.12 -0.987 . . . . 1.23 108.662 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.19 -35.76 52.38 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.046 -1.621 . . . . 0.52 109.046 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.24 -20.9 64.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -1.117 . . . . 1.29 110.339 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.6 mt -84.09 -38.28 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.763 -1.21 . . . . 0.55 108.384 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.4 ttt -59.68 -36.39 76.37 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.272 -0.892 . . . . 1.89 108.776 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.3 tp -65.13 -38.82 91.87 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.812 -1.181 . . . . 0.53 107.812 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.0 tp -73.25 -44.08 60.06 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.771 -0.772 . . . . 0.43 109.466 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -85.75 5.72 31.06 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.218 -0.927 . . . . 1.24 110.195 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -47.14 123.16 5.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.944 -1.097 . . . . 1.31 110.046 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -66.94 -26.07 66.66 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.894 -0.78 . . . . 1.35 108.894 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -74.87 -51.09 14.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.427 -0.796 . . . . 2.16 109.11 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.68 -17.72 64.81 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.975 -1.09 . . . . 0.6 109.12 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -74.17 -55.7 5.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.089 -1.007 . . . . 1.28 110.399 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -62.25 -29.89 70.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.393 -0.817 . . . . 1.28 110.215 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -72.21 -42.87 65.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 1.29 108.763 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.1 mt -59.85 -59.41 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.36 -1.348 . . . . 0.58 107.36 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.1 mt -47.85 -62.77 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.902 -0.498 . . . . 0.78 110.193 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -42.7 -63.28 0.81 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.291 -0.881 . . . . 0.86 109.932 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.5 mt -46.58 -51.93 14.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 0.79 109.688 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 79.5 mt -52.94 -41.93 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 0.71 109.309 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -85.68 -37.18 19.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 2.05 111.734 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -86.2 -33.36 20.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.781 -1.199 . . . . 1.59 112.416 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 97' ' ' HIS . 53.3 mmtt -109.7 20.06 18.5 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.453 -1.405 . . . . 1.89 110.058 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 96' ' ' LYS . 46.9 m80 42.45 46.02 3.98 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.371 -0.831 . . . . 1.31 110.158 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 34.8 mtt -98.28 144.77 27.35 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.726 -0.842 . . . . 1.28 108.726 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.3 p -75.51 148.3 39.08 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.47 -0.769 . . . . 0.62 110.086 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.29 -31.5 21.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.47 109.338 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -74.19 -42.2 60.22 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.016 -1.105 . . . . 2.0 108.016 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.26 -55.13 7.69 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.313 -0.555 . . . . 0.56 109.909 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.68 76.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 0.48 109.685 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.01 -38.93 73.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.44 109.623 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' GLU . 49.4 t-80 -67.77 -41.11 83.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.943 . . . . 1.42 109.753 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -48.14 -53.8 15.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 1.26 110.026 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.0 t -57.79 -54.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.047 -1.033 . . . . 0.61 109.222 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.8 mm -61.62 -20.31 22.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.355 -0.841 . . . . 0.64 109.047 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 105' ' ' HIS . 48.8 tt0 -66.23 -40.69 90.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 2.2 110.243 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -86.53 -21.43 51.27 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.38 -1.39 . . . . 0.82 111.941 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -67.01 -59.36 3.54 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.526 -1.573 . . . . 1.27 108.208 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.93 -52.03 65.7 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 120.072 -0.651 . . . . 0.91 109.473 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.1 m -59.77 -46.4 89.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.122 -0.986 . . . . 1.73 110.954 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -62.21 -31.93 72.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.768 -1.208 . . . . 1.04 110.632 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 mt -70.11 -28.61 65.53 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.545 -1.262 . . . . 1.03 109.512 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -68.74 -20.0 64.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.734 -1.229 . . . . 1.95 109.215 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -81.44 -7.64 59.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 1.71 108.873 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mt -88.91 140.17 29.71 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.217 -1.031 . . . . 1.26 108.217 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -97.18 64.84 1.96 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.332 -0.988 . . . . 2.83 108.332 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -146.17 113.72 6.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.351 -0.843 . . . . 1.58 110.069 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 18.7 mp0 -57.23 -16.18 7.67 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.787 -0.82 . . . . 2.8 108.787 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -80.23 -63.28 1.44 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.336 -0.853 . . . . 1.02 109.244 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.9 mt -63.6 -23.88 67.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 1.06 109.14 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -68.4 -51.13 47.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.053 -1.029 . . . . 2.39 108.762 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -58.76 -18.78 34.77 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.27 -0.894 . . . . 2.2 108.892 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -74.57 -27.89 60.7 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.638 -1.616 . . . . 2.09 106.638 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.02 98.0 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.398 0.618 . . . . 0.86 109.41 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.09 73.97 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.278 -0.889 . . . . 0.9 109.649 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.2 -36.75 66.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 1.35 109.375 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.1 t -72.64 -40.82 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.411 -0.806 . . . . 0.58 109.062 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.494 HH12 ' CE ' ' A' ' 135' ' ' LYS . 15.5 ttt-85 -54.38 -40.8 68.51 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.265 -0.897 . . . . 3.22 109.046 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.94 -32.56 73.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.595 -0.691 . . . . 1.32 110.245 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 65.0 mt -69.29 -26.51 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.952 -1.093 . . . . 0.5 110.343 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.07 -49.14 6.51 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.438 -1.465 . . . . 0.44 109.438 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.494 ' CE ' HH12 ' A' ' 131' ' ' ARG . 1.5 mptp? -51.98 -46.66 64.93 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.519 -0.989 . . . . 2.71 109.387 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.488 HH11 ' HG2' ' A' ' 136' ' ' ARG . 6.8 mtt-85 -62.19 -52.31 64.32 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.988 -1.116 . . . . 2.2 107.988 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.28 -40.38 34.37 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.794 -0.566 . . . . 1.13 109.609 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 140' ' ' ASN . 23.0 mt -69.08 -58.94 3.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 0.54 110.005 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 144' ' ' LEU . 89.9 mtt180 -44.52 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 2.32 110.875 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 138' ' ' LEU . 30.9 m-20 -85.34 -51.15 6.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.815 -1.178 . . . . 1.26 109.173 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.5 mt -55.88 -38.13 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 0.62 108.94 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 35.1 mt -86.21 1.29 51.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.486 -0.759 . . . . 0.67 109.006 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.69 30.95 60.12 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.204 -1.958 . . . . 0.68 108.204 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 139' ' ' ARG . 4.7 tp -73.78 145.3 45.16 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.559 -0.965 . . . . 0.77 109.755 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -67.48 139.52 57.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -0.784 . . . . 2.4 110.12 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 mt -109.44 142.79 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.579 -0.897 . . . . 0.87 108.579 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.58 ' H ' HD12 ' A' ' 147' ' ' ILE . 5.2 mp -75.73 119.94 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 1.32 109.773 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.6 OUTLIER -95.85 91.86 6.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.81 . . . . 1.54 109.446 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 mt -79.77 -18.14 51.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.598 -0.689 . . . . 0.77 109.276 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.6 p -79.46 23.4 0.4 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.945 . . . . 1.57 109.66 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.99 25.9 2.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.053 -1.03 . . . . 0.82 110.017 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 74.4 mt -71.75 152.7 8.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.085 -1.009 . . . . 0.82 109.351 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -141.11 9.57 2.11 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.594 -0.891 . . . . 2.11 108.594 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -123.17 124.88 44.04 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.759 -0.83 . . . . 1.41 108.759 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.61 115.35 5.12 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.141 -0.974 . . . . 1.3 108.932 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.8 m -148.31 174.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.169 -0.957 . . . . 0.57 109.431 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 13.9 mt -93.35 160.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.851 -1.166 . . . . 0.43 107.851 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 19' ' ' LEU . 14.3 tp -108.27 122.86 47.82 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.472 -0.767 . . . . 0.56 109.873 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.89 129.76 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.398 0.618 . . . . 0.54 109.713 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -165.99 159.33 15.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 0.62 110.376 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.92 -42.7 94.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.63 -1.294 . . . . 0.8 108.1 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 48.1 t0 -171.45 157.94 5.05 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.525 -0.735 . . . . 2.34 109.39 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.417 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 27.6 mt -124.43 136.15 53.82 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.547 -0.721 . . . . 0.65 109.539 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.2 p -95.4 152.33 39.23 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.254 -0.904 . . . . 0.74 109.661 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -32.83 -54.2 0.38 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.984 2.456 . . . . 0.6 113.219 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.7 m -51.06 -57.1 9.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -0.97 . . . . 0.63 109.445 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -54.52 -38.22 66.29 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 1.25 109.536 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 33.7 p -76.46 -20.19 57.28 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.317 -0.864 . . . . 0.5 109.751 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.46 -23.74 34.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.51 109.664 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -104.52 -10.23 17.78 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.322 -0.861 . . . . 1.17 110.349 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.7 tp -64.02 144.37 57.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.954 -1.091 . . . . 0.61 108.615 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -95.46 140.71 29.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.876 -1.14 . . . . 2.12 108.969 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.9 mp -85.65 -41.13 15.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 1.34 111.025 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -77.99 -12.06 59.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.712 -1.243 . . . . 1.97 111.807 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -101.27 -5.83 24.97 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.678 -1.263 . . . . 1.9 108.86 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 177' ' ' LEU . 74.1 t -100.52 163.43 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.407 -0.808 . . . . 0.48 109.059 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.531 ' N ' HG12 ' A' ' 176' ' ' VAL . 4.8 tp -120.38 -17.25 8.24 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.466 -0.771 . . . . 1.39 109.715 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.27 172.71 42.98 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.271 -1.531 . . . . 0.38 109.271 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -125.52 121.9 35.04 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.42 -1.047 . . . . 0.46 108.962 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.73 125.56 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.313 -1.365 . . . . 0.59 107.313 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 203' ' ' VAL . 2.2 p -135.08 141.35 46.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.356 0.598 . . . . 0.67 109.7 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -89.79 37.01 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.505 -0.747 . . . . 2.24 109.004 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.501 2.075 0 O-C-N 121.467 -0.771 . . . . 1.11 109.542 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.9 t60 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.118 0.485 . . . . 0.92 110.025 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 47.1 m -54.8 -31.19 58.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.188 -0.945 . . . . 1.59 109.616 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.1 t -68.73 -35.94 77.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.351 -0.843 . . . . 1.42 109.224 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.0 mm -60.31 -37.82 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 1.41 109.856 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.5 mtm -70.59 -46.56 63.21 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.78 -1.193 . . . . 0.86 107.78 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.0 74.38 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.673 -0.642 . . . . 0.59 110.005 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -67.81 -43.54 79.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 3.06 109.804 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.2 m -71.44 -37.33 71.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.933 . . . . 0.73 109.967 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 199' ' ' LEU . 23.8 mt -88.03 3.36 49.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.872 . . . . 0.67 109.111 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 50.54 2.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.494 -0.754 . . . . 1.49 110.902 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 197' ' ' LEU . 79.4 mt -65.88 167.62 11.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.015 -1.476 . . . . 0.64 107.015 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -90.93 145.59 3.65 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 C-N-CA 122.069 1.846 . . . . 0.59 111.646 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.57 179.98 6.85 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.579 -1.248 . . . . 0.55 111.16 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 34.0 mt -149.38 155.6 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.008 -1.849 . . . . 0.63 106.008 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 181' ' ' THR . 15.8 m -137.28 -34.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.023 -1.048 . . . . 0.77 111.915 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.41 45.09 3.1 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 120.469 -1.395 . . . . 0.87 111.248 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.6 p -72.56 1.0 8.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.334 -1.686 . . . . 0.89 109.76 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.3 -98.78 0.84 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.828 -1.309 . . . . 0.93 109.828 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.7 p -131.19 35.6 3.9 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.422 -1.046 . . . . 1.6 111.815 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.0 t -50.47 -28.95 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.356 -1.465 . . . . 0.75 109.077 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.414 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 5.2 p -65.23 -11.95 46.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.923 -1.11 . . . . 0.84 108.775 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -104.67 11.65 33.81 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.892 -0.781 . . . . 1.61 108.892 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -128.53 -31.66 2.23 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.477 -0.764 . . . . 2.3 110.278 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 213' ' ' LYS . 53.4 t -115.39 155.85 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.324 -0.86 . . . . 0.76 110.008 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.44 ' O ' HG12 ' A' ' 212' ' ' VAL . 16.2 mmmt -114.8 -171.24 1.9 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.27 -1.382 . . . . 2.01 107.27 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.429 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -81.11 149.72 29.05 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.097 -1.002 . . . . 2.19 110.648 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.3 m-20 80.91 -12.81 0.98 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 116.067 -0.515 . . . . 2.4 110.982 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -56.89 145.76 28.81 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.711 -1.243 . . . . 1.99 107.774 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -88.3 121.29 30.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.869 -1.144 . . . . 1.3 109.636 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.2 mt -123.81 161.9 24.33 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.82 0.819 . . . . 0.53 109.911 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.4 mt -134.86 118.8 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.747 -1.205 . . . . 0.6 107.747 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 8.9 tp -90.08 120.31 31.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.42 -0.8 . . . . 0.57 109.528 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 53.6 t0 -94.42 -27.76 15.86 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.224 -1.028 . . . . 2.22 108.224 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.87 24.25 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.131 0.491 . . . . 0.75 110.709 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 10.5 t -117.14 -62.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 106.733 -1.58 . . . . 0.92 106.733 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -87.35 15.76 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.991 -1.114 . . . . 2.36 107.991 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 55.86 54.17 8.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.625 -0.672 . . . . 1.42 109.343 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -150.04 144.38 25.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.355 -0.84 . . . . 1.97 110.29 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.54 153.39 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.289 -1.004 . . . . 0.65 108.289 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -110.64 126.07 54.1 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.354 -0.841 . . . . 0.97 108.882 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.11 118.02 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.509 -0.744 . . . . 0.67 109.939 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 55.14 70.9 1.43 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 1.45 110.249 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -90.09 149.51 4.7 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.308 2.672 . . . . 0.82 111.986 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.5 m -75.19 163.23 27.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 1.62 109.86 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -67.11 -32.22 73.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.343 -0.848 . . . . 2.6 110.121 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.48 -35.53 77.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.225 -0.922 . . . . 3.06 109.282 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.68 -38.86 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.865 . . . . 1.14 109.3 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.548 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 79.4 mt -64.2 -58.57 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -0.902 . . . . 1.04 110.074 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -42.21 75.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 2.54 109.886 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -65.22 -36.09 83.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.946 . . . . 2.6 109.096 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 243' ' ' GLN . 54.4 mtp -79.08 -33.71 44.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 1.23 109.041 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -50.07 -43.46 51.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.745 -1.222 . . . . 2.67 109.438 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.47 -55.61 6.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 1.66 110.156 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.8 t -66.32 -46.94 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 2.2 109.77 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 239' ' ' MET . 0.9 OUTLIER -55.14 -57.92 9.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 3.0 110.192 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 . . . . . 0 C--N 1.303 -1.413 0 O-C-N 120.879 -1.138 . . . . 1.76 109.705 -179.166 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.582 ' SD ' ' NE2' ' A' ' 226' ' ' GLN . 14.4 mmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.636 -0.505 . . . . 3.66 109.636 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.6 mt -67.15 98.39 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.052 -1.03 . . . . 1.12 108.782 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.3 m -98.42 121.86 40.89 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.353 -0.842 . . . . 1.45 109.609 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.738 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -119.89 -160.13 11.13 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.315 -1.514 . . . . 0.92 109.315 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.3 mt -95.67 -9.92 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.332 -1.099 . . . . 1.05 108.799 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 tp 60.67 111.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.417 -0.802 . . . . 0.88 109.413 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.68 -52.91 5.25 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.325 -0.991 . . . . 0.78 108.325 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.63 146.4 22.22 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 108.5 -0.926 . . . . 1.5 108.5 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.94 149.26 32.78 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.42 2.08 . . . . 0.86 114.262 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.75 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.8 179.77 34.82 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.135 -1.586 . . . . 0.78 109.135 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.449 HG21 ' NE2' ' A' ' 243' ' ' GLN . 42.0 mt -139.0 130.43 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.13 -1.218 . . . . 0.74 109.495 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.47 151.08 41.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.364 -0.835 . . . . 0.45 109.74 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.55 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.2 m-85 -122.44 138.24 54.61 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.07 -1.085 . . . . 0.64 108.07 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.89 168.46 38.66 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 118.769 -1.681 . . . . 0.45 111.564 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -80.71 147.48 30.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.683 -0.892 . . . . 1.88 110.083 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -80.81 127.58 32.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.59 111.322 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -105.49 96.99 6.89 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.08 -1.452 . . . . 0.64 107.08 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.75 ' H ' ' ND2' ' A' ' 214' ' ' ASN . 11.9 tp -80.4 120.04 23.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.956 -1.09 . . . . 0.74 110.666 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.69 98.57 9.4 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.836 -0.62 . . . . 0.74 109.406 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -93.23 159.24 15.36 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.66 -0.867 . . . . 1.87 108.66 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -130.45 122.16 27.21 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.243 -0.911 . . . . 2.58 109.467 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -81.62 131.76 35.28 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.35 -0.844 . . . . 2.14 109.262 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -63.98 147.2 52.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 1.93 109.638 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.7 mt -91.87 136.38 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.22 -0.925 . . . . 0.68 109.709 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 t -107.64 121.74 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.394 -0.816 . . . . 0.84 109.397 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.3 mt -88.85 145.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.79 109.94 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.68 120.55 35.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.321 -0.862 . . . . 1.37 109.748 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -102.01 29.04 5.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.192 -0.943 . . . . 2.62 109.58 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -75.36 147.34 40.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.995 . . . . 2.35 110.0 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -87.49 116.18 25.42 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.22 -1.029 . . . . 2.35 108.22 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.7 pt -84.18 171.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.897 -1.127 . . . . 0.78 110.617 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -98.09 168.48 10.24 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.193 -0.669 . . . . 1.04 109.193 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.31 -22.3 66.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 1.05 109.581 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.14 -7.39 58.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 2.47 108.609 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -107.77 -9.21 15.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.53 -0.915 . . . . 1.46 108.53 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -67.93 -47.04 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.77 108.979 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -51.46 -36.07 42.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 1.46 109.11 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.61 -32.61 71.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 2.29 109.928 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -61.8 -47.02 87.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.99 -1.069 . . . . 1.3 109.51 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 44' ' ' LEU . 85.6 t -61.51 -47.19 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.355 -0.84 . . . . 0.76 110.016 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.28 -40.65 97.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.058 -1.026 . . . . 1.5 108.367 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -65.86 -32.35 73.81 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.81 -0.811 . . . . 2.66 108.81 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -86.37 -56.68 3.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.75 108.972 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 40' ' ' VAL . 29.3 tp -51.54 -63.38 1.15 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.821 -0.807 . . . . 0.83 108.821 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.5 t -61.73 -30.27 70.66 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.077 -1.082 . . . . 0.78 108.077 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.65 -52.9 50.31 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.422 -2.271 . . . . 0.57 107.422 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -48.5 -30.0 4.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.75 -0.853 . . . . 2.83 108.76 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -62.5 -37.4 85.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.235 -1.024 . . . . 0.65 108.235 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -81.73 -59.31 2.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.344 -0.613 . . . . 2.57 109.344 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.7 -40.29 59.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.11 -0.994 . . . . 0.51 109.832 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.7 t -62.75 -37.4 86.46 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.998 -1.064 . . . . 1.36 108.221 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.76 -28.23 62.49 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.442 -0.577 . . . . 0.6 109.442 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.628 ' NE2' HD21 ' A' ' 140' ' ' ASN . 26.4 mt-30 -72.07 -62.84 1.28 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.19 -0.944 . . . . 1.36 109.109 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 54' ' ' LEU . 10.3 mp -51.93 -48.96 63.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 1.38 108.466 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -49.81 -50.42 45.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.809 . . . . 1.27 109.218 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -63.13 -41.42 99.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.6 109.655 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.4 mt -70.63 -34.85 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.53 108.994 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -53.9 -45.1 71.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.284 -0.885 . . . . 0.99 109.197 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 m -71.46 -24.26 61.97 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.266 -0.896 . . . . 0.59 109.941 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.42 ' O ' ' OG1' ' A' ' 64' ' ' THR . 29.3 mttp -71.28 -33.11 69.45 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.748 -1.205 . . . . 1.81 107.748 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.25 -34.11 76.75 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.793 -0.818 . . . . 0.48 108.793 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.17 -30.23 25.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.678 -1.369 . . . . 0.58 109.678 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -86.64 -12.3 48.88 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.823 -1.398 . . . . 1.39 109.137 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 88.1 m -94.91 -46.96 6.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.2 -0.937 . . . . 0.82 110.579 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -107.06 -34.71 7.08 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.111 -0.993 . . . . 0.99 110.157 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 80.07 -41.29 2.4 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.969 -1.253 . . . . 0.55 109.969 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 69' ' ' LYS . 67.3 mt-10 -50.51 178.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.241 . . . . 2.59 109.573 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.62 43.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 2.2 109.709 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 67' ' ' GLU . 15.9 mmmt -89.67 -17.91 27.48 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.557 -0.905 . . . . 1.79 108.557 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.65 -35.06 74.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.472 -0.767 . . . . 1.54 110.688 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.28 -22.24 66.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -0.978 . . . . 0.64 110.412 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.48 -40.38 55.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.95 -1.094 . . . . 0.58 109.508 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -76.6 -28.33 56.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.925 . . . . 0.62 109.616 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.66 -38.42 91.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.941 -1.099 . . . . 1.23 108.61 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.83 -32.38 61.24 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.578 -1.809 . . . . 0.52 108.578 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -61.38 -18.79 60.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -1.07 . . . . 1.29 109.172 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.5 mt -85.67 -39.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.246 -1.02 . . . . 0.55 108.246 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.3 ttt -58.8 -38.73 79.23 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.992 -0.744 . . . . 1.89 108.992 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.9 tp -69.56 -43.76 72.26 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.852 -0.795 . . . . 0.53 108.852 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.0 tp -64.72 -48.01 76.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.44 -0.788 . . . . 0.43 109.483 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -84.4 13.14 5.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.836 . . . . 1.24 110.467 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -49.1 125.2 10.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.998 -1.064 . . . . 1.31 109.695 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -67.69 -25.03 65.48 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.339 -0.851 . . . . 1.35 108.756 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.62 -52.34 9.87 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.436 -0.79 . . . . 2.16 109.528 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.7 mt -64.61 -15.65 61.49 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.036 -1.066 . . . . 0.6 109.04 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -77.35 -43.4 33.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 1.28 109.801 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.03 -33.35 75.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -0.91 . . . . 1.28 110.405 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -72.77 -43.88 62.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 1.29 109.654 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.0 mt -57.36 -39.85 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.551 -0.907 . . . . 0.58 108.551 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -67.5 -62.43 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.715 -0.615 . . . . 0.78 110.27 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -50.07 -38.48 38.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.149 -0.969 . . . . 0.86 109.834 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.6 -59.87 4.7 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.268 -0.895 . . . . 0.79 108.676 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.7 mt -47.02 -44.26 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.71 110.171 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -82.67 -31.44 28.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.161 -0.962 . . . . 2.05 111.029 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 91' ' ' ALA . 66.9 t0 -79.25 -48.44 14.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.859 -1.15 . . . . 1.59 111.778 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -106.71 21.06 18.09 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.82 -1.175 . . . . 1.89 110.046 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 44.07 48.22 7.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -0.905 . . . . 1.31 109.927 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtt -102.72 151.04 22.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.485 -0.759 . . . . 1.28 109.051 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.7 p -75.28 148.15 39.63 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.567 -0.708 . . . . 0.62 109.354 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.31 18.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.243 -0.911 . . . . 0.47 109.167 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.31 -44.54 58.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.041 -1.096 . . . . 2.0 108.041 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.86 -52.92 15.0 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.647 -0.658 . . . . 0.56 109.886 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.15 -49.46 76.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.48 109.67 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.72 -33.98 61.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.44 109.893 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -68.97 -36.87 78.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.954 -1.091 . . . . 1.42 109.525 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -58.76 -52.68 64.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.985 . . . . 1.26 109.674 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.1 t -56.41 -49.14 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.105 -0.997 . . . . 0.61 109.299 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.41 -17.62 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.64 109.18 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -73.58 -35.18 65.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.082 -1.011 . . . . 2.2 109.976 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.25 -27.13 28.83 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.318 -1.42 . . . . 0.82 112.338 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -67.25 -40.24 86.23 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.598 -1.531 . . . . 1.27 109.209 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.22 -52.18 8.49 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.393 -0.817 . . . . 0.91 109.632 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.7 p -60.52 -42.13 95.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 1.73 110.245 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.54 -35.69 81.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.032 -1.042 . . . . 1.04 110.334 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.89 -27.55 65.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.854 -1.154 . . . . 1.03 109.599 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -69.14 -18.04 63.9 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.921 -1.112 . . . . 1.95 109.367 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -80.97 -4.81 56.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 1.71 109.348 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.5 mt -83.22 145.61 29.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 1.26 108.487 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -96.68 56.23 1.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.751 -0.833 . . . . 2.83 108.751 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -146.25 117.27 7.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.303 -0.873 . . . . 1.58 109.23 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.75 -16.77 18.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 2.8 109.971 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.96 -65.6 0.95 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.935 . . . . 1.02 109.212 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.2 mt -61.1 -19.42 61.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 1.06 109.116 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -67.79 -48.2 66.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.101 -0.999 . . . . 2.39 108.36 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 50.3 mt-10 -61.85 -20.27 63.5 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.66 -0.867 . . . . 2.2 108.66 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.527 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.5 OUTLIER -71.35 -29.53 65.08 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.6 -1.63 . . . . 2.09 106.6 178.029 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.78 -50.66 72.96 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.957 -0.757 . . . . 0.86 108.957 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.68 -37.48 76.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.9 110.004 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 -68.18 -29.89 68.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.01 . . . . 1.35 109.602 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.94 -40.49 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.221 -1.029 . . . . 0.58 108.221 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' ' 131' ' ' ARG . 22.1 ttm-85 -56.0 -38.81 70.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.078 -1.082 . . . . 3.22 108.078 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -61.51 -36.49 80.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.635 -0.666 . . . . 1.32 109.93 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.6 mt -68.21 -30.81 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.036 -1.04 . . . . 0.5 109.492 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.49 -46.13 72.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.257 -1.937 . . . . 0.44 108.257 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -51.04 -44.61 61.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.78 -0.835 . . . . 2.71 109.253 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.542 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 69.4 mtt180 -62.57 -46.93 86.07 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.841 -1.17 . . . . 2.2 107.841 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.4 tt -52.28 -54.29 33.27 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.878 -0.786 . . . . 1.13 108.878 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.93 -56.46 19.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.54 109.586 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -44.74 -22.55 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 2.32 111.068 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.628 HD21 ' NE2' ' A' ' 53' ' ' GLN . 61.6 m-80 -85.18 -42.48 14.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.801 -1.187 . . . . 1.26 110.074 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.35 -34.59 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.04 -1.038 . . . . 0.62 109.496 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.8 mt -90.98 -3.82 56.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.219 -0.926 . . . . 0.67 109.395 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.32 29.99 63.94 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.16 -1.976 . . . . 0.68 108.16 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.76 148.83 45.94 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.527 -0.984 . . . . 0.77 109.686 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -68.84 147.69 51.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 2.4 109.317 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 147' ' ' ILE . 78.0 mt -102.67 157.75 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.87 108.724 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.424 ' N ' HG22 ' A' ' 146' ' ' ILE . 11.6 mm -76.85 104.06 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.057 -1.027 . . . . 1.32 109.444 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -102.18 90.3 3.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.564 -0.71 . . . . 1.54 110.276 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.2 mt -80.03 -7.15 58.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.77 108.703 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.9 t -83.97 40.69 0.77 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -0.792 . . . . 1.57 109.905 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.61 19.09 2.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.218 -0.926 . . . . 0.82 109.006 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 60.1 mt -73.76 150.34 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.547 -0.721 . . . . 0.82 109.593 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.3 2.36 1.67 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.339 -0.85 . . . . 2.11 109.153 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -127.59 132.39 49.83 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.089 -0.708 . . . . 1.41 109.089 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -63.04 120.51 11.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.915 . . . . 1.3 109.794 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.0 m -150.3 175.81 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.24 -0.912 . . . . 0.57 109.421 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.2 mt -90.8 157.56 2.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.948 -1.131 . . . . 0.43 107.948 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.7 tp -107.64 122.2 46.22 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.547 -0.721 . . . . 0.56 109.212 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.7 t -123.75 132.59 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.311 0.577 . . . . 0.54 109.504 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.44 144.84 12.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.62 109.491 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 183' ' ' ALA . . . -60.53 -32.82 71.84 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.464 -1.397 . . . . 0.8 107.846 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -172.64 155.95 3.44 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.585 -0.697 . . . . 2.34 109.413 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.0 mt -130.73 132.08 45.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.553 -0.717 . . . . 0.65 109.319 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 p -92.33 152.89 42.77 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.262 -0.899 . . . . 0.74 109.119 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -36.36 -43.71 0.83 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.322 2.014 . . . . 0.6 112.189 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.542 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -54.16 -63.7 1.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.63 108.938 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -48.46 -40.27 25.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 1.25 109.362 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.2 p -71.04 -23.52 62.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 0.5 109.792 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.55 -29.36 46.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.912 . . . . 0.51 110.285 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -104.54 -7.63 19.61 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.275 -0.891 . . . . 1.17 110.077 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.1 tp -57.36 135.67 56.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.822 -1.174 . . . . 0.61 108.08 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.404 ' O ' HG23 ' A' ' 176' ' ' VAL . 38.2 t-20 -99.89 120.7 40.19 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.221 -0.925 . . . . 2.12 110.048 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 173' ' ' LEU . 7.9 mp -93.58 45.99 1.18 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.843 . . . . 1.34 108.741 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -109.54 -27.47 9.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.404 -0.81 . . . . 1.97 109.02 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -131.2 11.86 5.04 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.439 -0.788 . . . . 1.9 109.643 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 172' ' ' ASN . 66.7 t -82.85 154.29 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.112 -0.993 . . . . 0.48 109.494 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.0 tp -117.47 -12.2 10.43 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.719 -0.613 . . . . 1.39 109.547 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 163.99 179.84 38.49 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.61 -1.396 . . . . 0.38 109.61 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.489 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 1.6 m-85 -130.44 124.95 33.23 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.557 -0.966 . . . . 0.46 109.635 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.8 mt -128.54 126.6 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.887 -1.153 . . . . 0.59 107.887 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.501 ' O ' ' O ' ' A' ' 203' ' ' VAL . 40.7 p -142.01 149.36 39.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 0.67 110.549 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.44 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 4.6 p30 -100.28 43.69 1.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.323 -0.861 . . . . 2.24 109.268 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 161' ' ' ALA . . . . . . . . 0 N--CA 1.503 2.211 0 O-C-N 121.424 -0.797 . . . . 1.11 110.323 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 46.5 t60 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.252 0.549 . . . . 0.92 109.95 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.2 p -52.95 -45.43 67.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 1.59 109.924 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.5 t -68.31 -39.28 82.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 1.42 110.041 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.5 mm -50.44 -38.52 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 1.41 110.34 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 mtp -72.05 -59.57 2.67 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.7 -1.222 . . . . 0.86 107.7 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.69 -31.09 35.59 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.761 -0.654 . . . . 0.59 109.847 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -78.95 -47.37 16.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 3.06 109.898 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.8 m -69.51 -36.17 76.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.031 -1.043 . . . . 0.73 109.755 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 199' ' ' LEU . 29.0 mt -86.53 0.06 55.09 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 0.67 108.927 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 47.81 10.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 1.49 111.051 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 197' ' ' LEU . 22.0 mt -66.79 161.01 65.14 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.801 -1.187 . . . . 0.64 108.597 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -79.38 127.88 7.67 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.188 1.259 . . . . 0.59 111.172 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -163.87 179.04 7.32 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.844 -1.142 . . . . 0.55 110.871 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.6 mt -146.35 162.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.001 -1.481 . . . . 0.63 107.001 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 181' ' ' THR . 15.6 m -147.84 -28.2 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.718 -1.239 . . . . 0.77 111.408 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.9 26.94 14.18 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 120.901 -1.125 . . . . 0.87 110.328 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.425 ' HB ' HG23 ' A' ' 208' ' ' VAL . 30.8 p -52.61 -41.06 63.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.833 -1.392 . . . . 0.89 108.738 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.44 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 76.92 -38.1 1.51 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 120.781 -0.724 . . . . 0.93 113.837 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 83.8 p -130.19 27.28 5.11 Favored 'General case' 0 N--CA 1.514 2.773 0 CA-C-N 119.939 1.869 . . . . 1.6 113.256 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.425 HG23 ' HB ' ' A' ' 205' ' ' THR . 5.5 t -79.3 -41.94 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.133 -1.604 . . . . 0.75 110.323 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 p -64.65 -12.89 50.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.668 -1.27 . . . . 0.84 110.137 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.8 p -106.17 11.84 30.84 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 1.61 109.407 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -144.23 4.63 1.24 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.243 -0.91 . . . . 2.3 110.588 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.5 t -126.93 151.37 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.305 -0.872 . . . . 0.76 109.524 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.506 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 42.6 mmtt -129.25 166.85 18.61 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.048 -1.464 . . . . 2.01 107.048 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.75 ' ND2' ' H ' ' A' ' 18' ' ' LEU . 28.3 m120 -64.14 143.47 57.85 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.8 -1.187 . . . . 2.19 110.616 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 73.9 -2.44 2.78 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.797 -0.564 . . . . 2.4 110.623 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.506 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 44.1 m-20 -57.51 142.26 44.9 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.914 -1.116 . . . . 1.99 108.673 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -86.52 107.22 18.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.44 -0.948 . . . . 1.3 108.44 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' A' ' 16' ' ' ALA . 40.8 mt -122.51 154.01 38.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.548 -0.72 . . . . 0.53 110.139 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.419 HG23 ' CD2' ' A' ' 13' ' ' PHE . 49.8 mt -126.04 122.82 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.501 -0.926 . . . . 0.6 108.501 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.5 tp -90.59 120.38 31.62 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.524 -0.917 . . . . 0.57 108.524 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.3 m-20 -97.19 -29.79 13.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.215 -0.928 . . . . 2.22 109.546 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.5 21.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.912 -0.492 . . . . 0.75 110.422 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -115.96 -51.66 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 106.967 -1.494 . . . . 0.92 106.967 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -96.46 10.85 37.0 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.112 -1.44 . . . . 2.36 107.112 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.738 HD21 ' H ' ' A' ' 4' ' ' GLY . 34.8 t30 56.23 54.72 7.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.972 -0.751 . . . . 1.42 108.972 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.582 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 65.9 tt0 -153.99 150.59 28.44 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.917 0.865 . . . . 1.97 110.171 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 78.2 t -115.11 152.22 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.308 -0.997 . . . . 0.65 108.308 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -108.54 121.32 44.74 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.217 -0.927 . . . . 0.97 109.45 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.69 114.98 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.574 -0.704 . . . . 0.67 109.518 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 69.02 67.5 0.47 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.659 -0.651 . . . . 1.45 109.671 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -86.33 130.42 3.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 123.057 2.505 . . . . 0.82 112.498 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.3 p -74.02 162.27 29.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 1.62 109.594 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -64.06 -44.03 93.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 2.6 109.828 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -53.27 -36.69 61.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.394 -0.816 . . . . 3.06 109.384 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.2 t -76.74 -37.1 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.678 -0.86 . . . . 1.14 108.678 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 75.3 mt -71.62 -57.4 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 1.04 109.344 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -51.07 -44.89 61.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -0.781 . . . . 2.54 110.014 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -65.33 -32.32 73.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 2.6 108.93 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 243' ' ' GLN . 77.1 mtp -81.94 -42.46 19.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.404 -0.81 . . . . 1.23 109.555 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -47.45 -39.28 15.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.035 -1.04 . . . . 2.67 109.82 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.36 -63.35 1.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.109 -0.995 . . . . 1.66 110.394 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.8 t -66.08 -51.4 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.103 -0.998 . . . . 2.2 110.198 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 239' ' ' MET . 45.8 tt0 -47.92 -47.44 32.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.078 -1.014 . . . . 3.0 109.635 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 . . . . . 0 C--N 1.3 -1.564 0 O-C-N 120.828 -1.17 . . . . 1.76 108.939 179.703 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 3' ' ' SER . 80.4 mtp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.338 0.59 . . . . 3.66 109.494 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.428 HG23 ' CG2' ' A' ' 208' ' ' VAL . 83.5 mt -58.42 81.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 1.12 109.604 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 1' ' ' MET . 1.5 m -98.22 113.79 25.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.259 -0.901 . . . . 1.45 109.725 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.95 -163.62 20.39 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 108.665 -1.774 . . . . 0.92 108.665 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 5' ' ' ILE . 59.9 mt -96.96 -6.59 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.033 -1.275 . . . . 1.05 108.918 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.1 tp 53.46 104.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.515 -0.74 . . . . 0.88 109.206 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.78 -51.46 6.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.996 . . . . 0.78 109.342 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -144.97 149.48 42.57 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.318 -0.864 . . . . 1.5 109.019 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HA ' ' HB1' ' A' ' 222' ' ' ALA . 63.1 Cg_endo -80.14 154.78 22.34 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.372 2.048 . . . . 0.86 113.732 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.99 138.32 2.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.597 -1.401 . . . . 0.78 109.597 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.47 HD12 HE21 ' A' ' 243' ' ' GLN . 97.2 mt -96.73 132.49 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.186 -1.185 . . . . 0.74 109.388 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.474 ' HB1' HD12 ' A' ' 177' ' ' LEU . . . -139.35 157.37 46.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.33 -0.856 . . . . 0.45 110.344 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -130.69 134.73 47.17 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.25 -1.019 . . . . 0.64 108.25 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.96 164.66 34.24 Favored Glycine 0 N--CA 1.503 3.102 0 C-N-CA 118.204 -1.95 . . . . 0.45 111.813 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -77.62 146.55 36.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.576 -0.955 . . . . 1.88 109.753 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.92 122.36 25.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.709 . . . . 0.59 110.981 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 tp -100.82 94.67 6.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.845 -1.168 . . . . 0.64 107.845 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.6 tp -81.97 112.74 19.34 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.01 -1.056 . . . . 0.74 109.759 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 158' ' ' LEU . 93.7 mt -97.89 93.95 6.62 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.661 -0.7 . . . . 0.74 109.783 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -92.62 159.16 15.59 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.598 -0.89 . . . . 1.87 108.598 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -118.3 131.79 56.32 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.438 -0.789 . . . . 2.58 109.678 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.5 127.04 31.64 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.488 -0.93 . . . . 2.14 108.488 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -62.74 136.94 58.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 1.93 109.292 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.4 mt -90.82 131.33 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.26 -0.9 . . . . 0.68 110.194 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.33 122.77 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.655 -0.868 . . . . 0.84 108.655 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -89.6 140.66 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.164 -0.96 . . . . 0.79 110.028 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -90.66 128.95 36.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.22 -0.925 . . . . 1.37 109.324 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -105.25 30.52 5.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.414 -0.803 . . . . 2.62 109.959 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -76.24 144.03 40.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.117 -0.989 . . . . 2.35 109.788 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -86.99 124.01 32.72 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.702 -0.851 . . . . 2.35 108.702 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -90.64 170.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.102 -0.999 . . . . 0.78 110.477 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.3 p -97.24 169.13 9.99 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.486 -0.561 . . . . 1.04 109.486 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.25 -25.62 68.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 1.05 109.433 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -80.22 -5.11 55.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 2.47 109.239 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -109.96 -15.9 13.96 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.019 -1.104 . . . . 1.46 108.019 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.29 -42.88 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.102 -0.703 . . . . 0.77 109.102 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -53.42 -36.17 61.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 1.46 109.374 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -69.62 -32.69 71.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 2.29 109.755 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -63.42 -41.92 98.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.152 -0.967 . . . . 1.3 109.267 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 44' ' ' LEU . 76.5 t -62.48 -49.01 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.412 -0.805 . . . . 0.76 110.032 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -65.27 -45.02 86.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.04 . . . . 1.5 108.838 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -64.99 -31.75 73.15 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.704 -0.798 . . . . 2.66 109.045 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -86.47 -59.36 2.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.078 -1.014 . . . . 0.75 108.733 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 40' ' ' VAL . 30.8 tp -47.94 -65.18 0.61 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.36 0.6 . . . . 0.83 109.695 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.1 t -64.28 -37.72 88.49 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.518 -0.919 . . . . 0.78 108.518 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.01 -52.41 49.25 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.355 -2.298 . . . . 0.57 107.355 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.415 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.2 ttt-85 -51.41 -26.18 7.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.684 -0.892 . . . . 2.83 109.033 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -73.73 -28.53 61.75 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.987 -1.116 . . . . 0.65 107.987 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 46' ' ' GLY . 33.3 ttmt -75.48 -56.67 4.47 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.082 -0.711 . . . . 2.57 109.082 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.42 -30.75 30.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.086 -1.009 . . . . 0.51 109.566 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 10.1 p -65.07 -38.67 91.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 1.36 108.906 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.87 -28.28 65.52 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.478 0.656 . . . . 0.6 109.336 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -71.81 -67.66 0.51 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.764 . . . . 1.36 109.602 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 54' ' ' LEU . 9.3 mp -51.04 -34.73 30.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 1.38 108.819 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 51' ' ' SER . 9.5 mm-40 -63.88 -51.47 64.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.471 -0.768 . . . . 1.27 109.08 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -60.98 -34.56 74.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.6 108.592 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.28 -25.29 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.574 -0.899 . . . . 0.53 108.574 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -65.46 -44.47 87.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.559 -0.713 . . . . 0.99 109.588 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -71.79 -27.15 62.74 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.3 -0.875 . . . . 0.59 109.144 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -72.27 -29.68 64.12 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.769 -1.197 . . . . 1.81 107.769 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.81 61.91 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.091 -1.077 . . . . 0.48 108.091 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.7 -29.76 28.56 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.433 -1.467 . . . . 0.58 109.433 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -86.55 -20.24 28.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -1.202 . . . . 1.39 108.595 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -94.36 -46.89 6.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.82 110.357 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -107.92 -27.16 10.35 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.111 -0.993 . . . . 0.99 111.297 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.97 152.98 8.94 Favored Glycine 0 N--CA 1.506 3.337 0 N-CA-C 109.647 -1.381 . . . . 0.55 109.647 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -50.2 -12.54 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -1.124 . . . . 2.59 110.583 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 66' ' ' GLY . 27.7 tt0 -63.66 -31.22 72.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.988 . . . . 2.2 110.454 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -91.08 -17.46 26.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.927 -1.108 . . . . 1.79 110.28 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -62.53 -28.87 70.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.986 -1.071 . . . . 1.54 109.941 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.22 -30.36 69.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.179 -0.951 . . . . 0.64 109.604 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.38 -44.05 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -0.876 . . . . 0.58 109.105 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -77.27 -24.49 51.05 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.465 -0.772 . . . . 0.62 109.664 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -63.9 -42.36 97.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.965 -1.084 . . . . 1.23 108.9 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.04 -36.24 80.49 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.928 -1.669 . . . . 0.52 108.928 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.07 -18.56 61.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.445 -1.032 . . . . 1.29 110.661 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.3 mt -85.03 -46.36 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.618 -1.301 . . . . 0.55 108.94 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 42.5 ttp -55.22 -49.16 72.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.36 -0.837 . . . . 1.89 108.967 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tp -54.88 -43.44 73.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.407 -0.808 . . . . 0.53 109.171 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.31 -44.1 80.03 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.383 -0.823 . . . . 0.43 109.417 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -85.37 8.42 18.88 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.416 -0.803 . . . . 1.24 110.161 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -49.14 121.53 4.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.974 -1.079 . . . . 1.31 109.666 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -66.84 -24.26 66.13 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.542 -0.91 . . . . 1.35 108.542 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -75.57 -48.89 20.38 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.334 -0.854 . . . . 2.16 109.249 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.7 mt -63.68 -15.09 57.46 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.032 -1.067 . . . . 0.6 108.979 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -79.54 -45.64 18.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.438 -0.789 . . . . 1.28 110.041 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -64.56 -28.87 69.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.254 -0.904 . . . . 1.28 110.022 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.21 -46.25 35.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.196 -0.94 . . . . 1.29 109.889 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.7 mt -58.38 -55.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.06 -1.089 . . . . 0.58 108.06 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.0 mt -45.14 -58.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.623 -0.673 . . . . 0.78 109.872 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -49.04 -57.05 7.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.423 -0.798 . . . . 0.86 110.418 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.2 mt -50.54 -56.49 11.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.426 -0.796 . . . . 0.79 109.266 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.0 mt -47.4 -41.63 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.71 109.784 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -86.19 -33.72 20.71 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.116 -0.99 . . . . 2.05 111.974 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -79.34 -44.29 21.86 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.536 -1.353 . . . . 1.59 111.757 -176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -105.76 15.47 26.73 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.722 -1.236 . . . . 1.89 109.23 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.505 ' ND1' ' N ' ' A' ' 97' ' ' HIS . 1.5 m80 45.41 55.47 6.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.391 -0.818 . . . . 1.31 109.54 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 74.1 mtp -102.51 153.65 19.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.571 -0.706 . . . . 1.28 109.259 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.7 p -76.16 171.45 14.48 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.486 -0.759 . . . . 0.62 109.389 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.31 -28.47 62.1 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.758 . . . . 0.47 109.668 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.13 -45.4 41.21 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.064 -1.087 . . . . 2.0 108.064 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.55 -52.33 22.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.714 -0.616 . . . . 0.56 110.201 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.34 -48.75 80.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.48 109.754 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.21 -35.25 67.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 0.44 109.606 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -68.77 -34.64 75.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.968 -1.082 . . . . 1.42 109.641 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -53.43 -60.94 2.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.375 -0.828 . . . . 1.26 110.118 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.0 t -50.93 -48.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.953 -1.092 . . . . 0.61 109.682 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -61.73 -20.62 23.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.39 -0.819 . . . . 0.64 108.967 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.37 -37.86 74.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.089 -1.007 . . . . 2.2 109.779 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 114' ' ' ALA . . . -87.2 -23.95 38.91 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.491 -1.338 . . . . 0.82 112.843 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -67.1 -52.82 37.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.343 -1.681 . . . . 1.27 108.746 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.14 -52.44 59.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.563 -0.71 . . . . 0.91 109.816 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.8 m -61.63 -32.58 72.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.128 -0.982 . . . . 1.73 109.992 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -63.04 -43.65 98.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.825 -1.172 . . . . 1.04 110.064 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 123' ' ' LEU . 12.2 mt -67.23 -22.66 65.68 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.541 -1.263 . . . . 1.03 109.249 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.82 -23.65 64.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.779 -1.2 . . . . 1.95 109.165 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -82.99 -8.87 59.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -0.847 . . . . 1.71 109.032 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 mt -84.34 148.02 26.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.418 -0.956 . . . . 1.26 108.418 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -98.66 61.3 1.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.751 . . . . 2.83 109.927 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -152.09 118.69 5.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.016 -1.053 . . . . 1.58 110.11 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -62.27 -13.78 31.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 2.8 109.238 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -78.03 -61.15 2.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.499 -0.75 . . . . 1.02 109.251 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.472 ' O ' HD13 ' A' ' 115' ' ' LEU . 27.1 mt -62.92 -29.33 70.7 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.265 -0.897 . . . . 1.06 109.92 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 71.5 tttt -66.4 -47.51 73.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.838 -1.164 . . . . 2.39 108.162 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -57.67 -24.48 56.88 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.159 -1.052 . . . . 2.2 108.159 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -73.17 -23.79 60.47 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.571 -1.64 . . . . 2.09 106.571 178.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -61.0 -45.3 95.39 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.858 -0.793 . . . . 0.86 108.858 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.41 -35.83 80.06 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.863 -0.735 . . . . 0.9 109.025 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.5 m-20 -69.01 -36.3 77.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.418 -0.801 . . . . 1.35 109.095 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.87 -42.98 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.995 -1.113 . . . . 0.58 107.995 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.504 HH11 ' HG2' ' A' ' 131' ' ' ARG . 1.4 ttt-85 -54.77 -39.15 68.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.608 -0.886 . . . . 3.22 108.608 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -60.18 -35.3 75.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.438 -0.789 . . . . 1.32 109.497 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.1 mt -65.81 -26.14 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.5 109.053 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.94 -50.62 7.62 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.455 -1.458 . . . . 0.44 109.455 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -50.4 -47.36 56.45 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.444 -1.033 . . . . 2.71 109.994 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.408 ' HG2' ' NH1' ' A' ' 136' ' ' ARG . 58.9 mtt-85 -65.21 -46.29 81.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.947 -1.096 . . . . 2.2 108.776 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.6 tp -54.19 -33.19 57.59 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.727 -0.608 . . . . 1.13 109.705 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 140' ' ' ASN . 16.8 mt -76.79 -56.6 4.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.819 -1.176 . . . . 0.54 109.687 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -46.24 -17.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.933 . . . . 2.32 110.093 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.521 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.7 m120 -85.93 -37.14 19.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.978 . . . . 1.26 109.633 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.3 mt -72.84 -40.64 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.62 109.727 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.5 mt -86.67 1.93 50.25 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.668 -0.864 . . . . 0.67 108.668 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.06 20.39 8.74 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.096 -2.002 . . . . 0.68 108.096 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.5 tp -54.84 163.54 0.96 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.645 -0.915 . . . . 0.77 109.146 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -68.18 143.62 55.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 2.4 110.103 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.3 mt -111.39 137.55 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.508 -0.745 . . . . 0.87 109.141 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.9 mp -77.71 99.48 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 1.32 109.085 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -99.38 92.29 5.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.413 -0.805 . . . . 1.54 109.64 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.417 HD21 ' CG2' ' A' ' 147' ' ' ILE . 22.0 mt -79.24 -9.71 59.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 0.77 109.104 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.2 t -79.77 35.27 0.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 1.57 108.979 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -142.67 18.29 2.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.399 -0.813 . . . . 0.82 109.424 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.24 150.97 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 0.82 110.13 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -145.86 11.89 1.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.293 -1.002 . . . . 2.11 108.293 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -125.36 125.37 43.33 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.336 -0.987 . . . . 1.41 108.336 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.82 115.27 4.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.359 -0.838 . . . . 1.3 109.29 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.29 178.62 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 0.57 109.675 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 26.8 mt -93.8 153.14 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.834 -1.173 . . . . 0.43 107.834 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 19' ' ' LEU . 25.4 tp -101.13 115.59 30.84 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.775 -0.824 . . . . 0.56 108.775 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.9 t -121.84 128.96 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.93 -0.767 . . . . 0.54 108.93 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.86 149.96 11.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.483 -0.761 . . . . 0.62 109.098 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.09 -35.79 67.42 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.651 -1.281 . . . . 0.8 107.928 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -174.9 156.5 2.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.653 -0.654 . . . . 2.34 109.243 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.0 mt -123.83 133.73 53.74 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.547 -0.721 . . . . 0.65 109.581 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.8 p -93.57 152.52 40.94 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.921 -0.77 . . . . 0.74 108.921 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -34.88 -51.98 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.459 2.106 . . . . 0.6 112.526 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.7 m -51.79 -50.26 61.08 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.179 -0.95 . . . . 0.63 108.861 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.03 -35.73 77.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.596 -0.69 . . . . 1.25 109.819 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.7 p -79.94 -28.77 39.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.111 -0.993 . . . . 0.5 109.411 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.21 -18.19 59.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.852 . . . . 0.51 109.98 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -106.93 -14.52 14.94 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.218 -0.926 . . . . 1.17 109.336 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.2 tp -55.29 134.92 50.23 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.021 -1.103 . . . . 0.61 108.021 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -98.49 97.44 8.76 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.209 -0.932 . . . . 2.12 109.586 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 173' ' ' LEU . 6.6 mp -75.9 44.69 0.31 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.5 -0.75 . . . . 1.34 109.317 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -106.5 -24.8 12.09 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.572 -0.899 . . . . 1.97 108.572 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -132.28 4.09 4.01 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.757 -0.59 . . . . 1.9 110.03 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.1 153.91 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.971 -1.081 . . . . 0.48 109.09 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -111.03 -37.53 5.34 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.659 -0.651 . . . . 1.39 110.003 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.41 -177.95 37.47 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.152 -1.579 . . . . 0.38 109.152 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -132.46 127.88 36.25 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.465 -1.021 . . . . 0.46 110.008 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.9 mt -127.03 118.55 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.981 -1.488 . . . . 0.59 106.981 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 32.0 p -141.03 151.99 44.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.411 -0.805 . . . . 0.67 111.67 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -90.84 42.48 1.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.548 -0.72 . . . . 2.24 109.224 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.809 0 O-C-N 120.989 -1.069 . . . . 1.11 110.474 -178.299 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.9 t60 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.992 0.425 . . . . 0.92 110.12 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.1 m -46.33 -39.39 10.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.993 -1.067 . . . . 1.59 109.571 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.0 p -61.04 -45.59 94.17 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.289 -0.882 . . . . 1.42 109.003 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 74.1 mt -49.72 -33.05 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.931 . . . . 1.41 109.29 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 74.4 mtp -73.62 -65.52 0.81 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.641 -1.244 . . . . 0.86 107.641 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.19 -28.54 7.66 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.679 -0.692 . . . . 0.59 110.04 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.419 HH11 ' HG2' ' A' ' 195' ' ' ARG . 31.8 mtt-85 -80.61 -52.32 7.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.869 -1.145 . . . . 3.06 110.512 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.6 m -71.14 -33.95 70.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.897 -1.127 . . . . 0.73 109.687 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 199' ' ' LEU . 22.3 mt -90.4 -0.44 57.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.23 -0.919 . . . . 0.67 109.126 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 46.34 11.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.345 -0.847 . . . . 1.49 111.284 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 197' ' ' LEU . 17.8 mt -68.31 145.22 97.29 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.815 -1.178 . . . . 0.64 109.45 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -56.63 131.92 48.59 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.091 1.861 . . . . 0.59 110.803 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.44 173.04 11.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.597 -1.314 . . . . 0.55 111.33 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 203' ' ' VAL . 68.9 mt -143.9 159.45 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.78 -1.563 . . . . 0.63 106.78 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.1 m -143.11 -33.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 120.577 -1.327 . . . . 0.77 111.337 -178.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.76 36.67 2.98 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.075 -1.21 . . . . 0.87 110.075 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.9 p -65.94 -31.47 72.41 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.866 -1.373 . . . . 0.89 108.604 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.23 -91.04 0.37 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.068 -1.063 . . . . 0.93 111.713 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 10.9 m -111.29 40.51 2.06 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.196 -1.179 . . . . 1.6 112.945 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.428 ' CG2' HG23 ' A' ' 2' ' ' ILE . 23.3 t -76.93 -28.68 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.383 -1.448 . . . . 0.75 107.418 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 29.9 p -66.76 -9.64 38.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.391 -0.818 . . . . 0.84 109.179 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 41.3 m -104.85 9.19 34.88 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.302 -0.999 . . . . 1.61 108.302 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -134.74 2.25 3.14 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.532 -0.914 . . . . 2.3 108.532 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.53 151.87 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.152 -0.684 . . . . 0.76 109.152 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -131.81 162.44 30.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.608 -1.627 . . . . 2.01 106.608 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 60.4 m-80 -63.71 146.86 53.03 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.786 -1.196 . . . . 2.19 110.461 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.3 t70 79.4 -20.89 0.36 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.722 -0.611 . . . . 2.4 110.431 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.38 126.1 25.78 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.771 -1.206 . . . . 1.99 108.155 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -87.5 118.97 27.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.787 -1.196 . . . . 1.3 109.723 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.5 mt -113.62 137.35 51.72 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.492 -0.929 . . . . 0.53 108.492 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.31 115.64 47.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.825 -1.176 . . . . 0.6 107.825 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 30.9 tp -83.2 129.77 35.04 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.296 -1.002 . . . . 0.57 108.296 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.8 t0 -97.55 -40.0 8.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.408 -0.807 . . . . 2.22 109.036 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.59 27.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.61 0.719 . . . . 0.75 110.078 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 221' ' ' ASP . 7.8 t -119.47 -45.05 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.419 -1.697 . . . . 0.92 106.419 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -105.27 17.13 24.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.178 -1.416 . . . . 2.36 107.178 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 55.8 53.44 9.4 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.597 -0.89 . . . . 1.42 108.597 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -155.0 145.63 22.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 1.97 110.584 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 228' ' ' TYR . 93.0 t -105.39 163.43 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.384 -0.969 . . . . 0.65 108.384 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.49 ' N ' HG12 ' A' ' 227' ' ' VAL . 63.4 m-85 -129.55 122.74 29.8 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.329 -0.857 . . . . 0.97 109.23 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.76 115.46 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.421 -0.799 . . . . 0.67 110.552 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 47.2 t-20 53.96 51.33 8.11 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.379 -0.826 . . . . 1.45 111.098 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.8 Cg_endo -64.46 158.76 47.71 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.378 2.052 . . . . 0.82 111.472 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 78.5 p -71.03 139.51 50.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.094 -1.004 . . . . 1.62 109.165 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -53.38 -17.11 1.66 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.197 -0.939 . . . . 2.6 109.587 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -68.15 -39.44 82.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 3.06 108.755 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.2 t -79.49 -34.27 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 1.14 109.011 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 21.4 mt -64.55 -55.23 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.83 . . . . 1.04 109.313 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -53.14 -40.5 64.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -0.795 . . . . 2.54 109.622 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -67.07 -41.18 86.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 2.6 110.084 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 44.0 mtp -79.53 -26.72 41.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.084 -1.01 . . . . 1.23 109.708 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.427 ' NH1' ' OE2' ' A' ' 244' ' ' GLU . 13.4 mmm180 -59.47 -41.11 89.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.038 . . . . 2.67 109.593 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.07 -60.24 2.35 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.278 -0.889 . . . . 1.66 110.226 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.2 t -46.8 -62.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 2.2 110.668 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.47 HE21 HD12 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -45.98 -59.19 2.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.027 -1.046 . . . . 3.0 109.531 -179.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.427 ' OE2' ' NH1' ' A' ' 240' ' ' ARG . 64.2 mt-10 . . . . . 0 C--N 1.295 -1.789 0 O-C-N 121.338 -0.851 . . . . 1.76 109.776 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 mmt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.321 0.581 . . . . 3.66 109.502 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.2 mt 46.58 84.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.374 -0.828 . . . . 1.12 109.961 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m -95.11 113.39 25.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.208 -0.933 . . . . 1.45 109.093 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.24 -161.97 20.74 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.036 -1.626 . . . . 0.92 109.036 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.432 ' O ' HG22 ' A' ' 5' ' ' ILE . 45.1 mt -95.77 -8.15 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.385 -1.068 . . . . 1.05 109.218 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tp 60.61 106.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -0.999 . . . . 0.88 108.843 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.61 -46.02 9.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.779 -1.2 . . . . 0.78 108.444 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.54 142.57 15.66 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.428 -0.795 . . . . 1.5 108.934 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.02 155.63 30.02 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.029 1.82 . . . . 0.86 113.814 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 160.78 -173.9 37.35 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.296 -1.522 . . . . 0.78 109.296 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.4 mt -148.03 122.15 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.605 -1.527 . . . . 0.74 109.358 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.43 154.27 43.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.161 -0.962 . . . . 0.45 110.406 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.495 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 8.7 m-85 -119.23 145.56 45.96 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.351 -0.981 . . . . 0.64 108.351 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.4 159.9 22.75 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 118.885 -1.626 . . . . 0.45 111.248 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -78.57 153.45 31.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.99 . . . . 1.88 109.638 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -79.15 121.89 25.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.59 110.622 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.4 tp -101.73 92.76 4.99 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.518 -1.29 . . . . 0.64 107.518 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.49 127.2 33.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.966 -1.084 . . . . 0.74 111.194 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 160' ' ' ALA . 15.3 mt -95.26 93.31 7.21 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.511 -0.768 . . . . 0.74 109.255 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -92.82 158.06 16.07 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.291 -0.88 . . . . 1.87 109.624 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -130.39 135.6 48.19 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.609 -0.886 . . . . 2.58 108.609 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.55 135.97 36.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.127 -0.983 . . . . 2.14 109.542 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -65.45 132.53 49.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.597 -0.689 . . . . 1.93 109.456 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.24 135.46 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.31 -0.869 . . . . 0.68 109.959 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.52 117.85 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.546 -0.721 . . . . 0.84 109.364 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.2 mt -87.01 132.65 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.79 109.289 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.3 123.28 33.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.252 -0.905 . . . . 1.37 109.655 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.457 HH11 ' HG2' ' A' ' 28' ' ' ARG . 2.8 mmt-85 -96.25 26.05 4.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.248 -0.907 . . . . 2.62 108.819 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -90.24 142.73 27.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.463 -0.773 . . . . 2.35 110.384 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -88.34 129.16 35.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.252 -0.905 . . . . 2.35 108.649 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.7 pt -92.68 172.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.943 -1.098 . . . . 0.78 110.426 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 34' ' ' ASP . 7.9 p -99.18 160.08 14.53 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.621 -0.881 . . . . 1.04 108.621 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.3 -7.53 0.89 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.033 -1.042 . . . . 1.05 109.373 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 32' ' ' SER . 3.9 m-20 -82.57 -10.03 59.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 2.47 110.446 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -120.02 -17.0 8.52 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.158 -0.964 . . . . 1.46 109.73 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.6 t -53.89 -36.35 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 0.77 109.697 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -54.25 -40.46 67.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 1.46 110.152 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -69.93 -41.54 74.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.219 -0.926 . . . . 2.29 110.575 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -59.73 -45.82 91.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.061 . . . . 1.3 109.864 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.1 t -59.27 -45.08 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.76 109.3 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -60.66 -37.64 82.24 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.505 -0.924 . . . . 1.5 108.505 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -68.83 -31.57 70.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.531 -0.731 . . . . 2.66 109.352 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -85.36 -51.26 6.68 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.28 -0.888 . . . . 0.75 109.216 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.35 -59.74 4.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.886 . . . . 0.83 109.085 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.669 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -62.78 -38.09 89.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.78 108.629 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -55.31 -54.1 36.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 107.325 -2.31 . . . . 0.57 107.325 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.9 ttt-85 -45.65 -32.25 2.3 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.341 -0.985 . . . . 2.83 108.341 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.13 -34.93 74.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.34 -0.985 . . . . 0.65 108.34 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' GLY . 24.2 ttmt -85.12 -58.43 2.69 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.246 -0.65 . . . . 2.57 109.246 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.07 -39.23 63.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.967 . . . . 0.51 109.872 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -66.31 -40.01 89.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.102 -0.999 . . . . 1.36 108.622 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.08 -35.32 64.21 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.867 -0.52 . . . . 0.6 109.83 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -65.22 -67.27 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.36 110.162 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 54' ' ' LEU . 4.5 mm? -50.16 -33.96 20.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.865 -1.147 . . . . 1.38 108.899 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.48 -46.22 80.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.401 -0.812 . . . . 1.27 108.919 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -62.53 -37.39 85.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.293 -0.879 . . . . 0.6 109.785 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.42 -33.73 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.962 -1.086 . . . . 0.53 108.854 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -53.78 -44.66 70.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 0.99 109.836 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -71.22 -35.27 71.45 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.199 -0.938 . . . . 0.59 109.741 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -69.45 -26.18 64.47 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.563 -1.255 . . . . 1.81 107.686 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.51 -33.76 67.13 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.354 -0.98 . . . . 0.48 108.354 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -28.83 28.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.792 -1.323 . . . . 0.58 109.792 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -86.2 -11.65 51.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.1 -1.235 . . . . 1.39 108.764 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -99.16 -51.02 3.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.497 -0.752 . . . . 0.82 110.353 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -106.25 -16.29 14.62 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.213 -0.93 . . . . 0.99 110.711 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.53 143.79 6.9 Favored Glycine 0 N--CA 1.504 3.214 0 N-CA-C 110.274 -1.13 . . . . 0.55 110.274 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -48.77 -9.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.365 -1.079 . . . . 2.59 110.166 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' GLY . 35.4 mt-10 -63.72 -31.56 72.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.953 . . . . 2.2 110.466 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -88.86 -6.32 57.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.943 -1.098 . . . . 1.79 110.624 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.81 -31.33 72.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.642 -1.287 . . . . 1.54 109.983 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.86 -29.57 70.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.64 109.586 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.0 mt -73.36 -45.09 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.58 109.557 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -76.96 -21.24 55.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.62 109.433 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.19 -40.59 94.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.134 -0.979 . . . . 1.23 108.869 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.9 -31.45 64.58 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.699 -1.76 . . . . 0.52 108.699 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -62.29 -23.2 66.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.556 -0.967 . . . . 1.29 110.162 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.1 mt -84.9 -35.33 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.776 -1.203 . . . . 0.55 108.773 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.8 ttt -57.27 -39.74 76.29 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.353 -0.98 . . . . 1.89 108.353 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.99 -39.07 90.01 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.574 -0.899 . . . . 0.53 108.574 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.31 -43.04 53.13 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.617 -0.833 . . . . 0.43 109.179 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -85.49 2.89 42.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.2 -0.938 . . . . 1.24 110.419 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -45.34 114.4 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.07 -1.018 . . . . 1.31 109.261 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -64.04 -23.51 67.36 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -0.854 . . . . 1.35 109.169 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -75.88 -46.78 28.32 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.344 -0.848 . . . . 2.16 109.194 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.08 -20.43 66.16 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.935 -1.103 . . . . 0.6 109.554 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.43 -53.47 9.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.361 -0.837 . . . . 1.28 110.736 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -61.88 -29.97 70.55 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.25 -0.906 . . . . 1.28 110.469 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.11 -41.63 61.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.98 -1.075 . . . . 1.29 109.077 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.0 mt -60.55 -57.72 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.868 -1.16 . . . . 0.58 107.868 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.9 mt -49.42 -53.63 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.666 -0.646 . . . . 0.78 110.05 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.85 -63.3 1.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.86 110.125 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.1 mt -45.19 -48.48 12.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.541 -0.725 . . . . 0.79 110.008 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.3 mt -55.21 -40.84 57.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.157 -0.965 . . . . 0.71 110.004 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -85.61 -39.5 17.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.027 -1.046 . . . . 2.05 111.313 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.31 -36.8 26.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.827 -1.171 . . . . 1.59 111.54 -176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.65 12.19 33.24 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.919 -1.113 . . . . 1.89 109.164 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.3 m80 45.12 44.26 8.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.486 -0.759 . . . . 1.31 109.295 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.0 mtp -93.43 154.0 18.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.398 -0.814 . . . . 1.28 109.302 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.9 p -79.25 142.47 36.17 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.317 -0.864 . . . . 0.62 109.262 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.16 -26.46 1.91 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.47 109.646 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -76.19 -42.63 45.67 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.276 -0.89 . . . . 2.0 108.916 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.49 -58.58 3.27 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.726 -0.609 . . . . 0.56 111.175 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.41 -48.68 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.956 -1.09 . . . . 0.48 109.804 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.07 -33.8 65.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.199 -0.938 . . . . 0.44 109.333 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.478 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 85.5 t60 -70.75 -35.32 72.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 1.42 109.598 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.25 -64.25 0.92 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.363 -0.836 . . . . 1.26 110.47 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -48.54 -47.17 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.985 -1.072 . . . . 0.61 109.55 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.58 -21.22 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.482 -0.761 . . . . 0.64 109.734 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.478 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 11.9 tp10 -72.95 -38.88 66.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.166 -0.959 . . . . 2.2 111.247 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 114' ' ' ALA . . . -85.15 -21.12 55.99 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 118.828 -1.653 . . . . 0.82 112.102 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -69.83 -59.41 2.95 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.606 -1.526 . . . . 1.27 108.171 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.71 -49.83 73.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.717 -0.614 . . . . 0.91 109.533 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.8 m -58.93 -35.81 73.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.263 -0.898 . . . . 1.73 109.586 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -61.91 -44.27 97.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.071 -1.018 . . . . 1.04 110.116 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.8 mt -66.64 -27.77 67.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.879 -1.138 . . . . 1.03 109.288 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -67.32 -18.29 65.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.113 -0.992 . . . . 1.95 110.011 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.38 -9.85 59.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.063 -1.023 . . . . 1.71 109.282 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mt -89.1 152.23 21.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.627 -0.879 . . . . 1.26 108.627 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -100.8 59.64 0.94 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -0.846 . . . . 2.83 108.814 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -143.91 119.1 10.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.284 -0.885 . . . . 1.58 109.375 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.4 pm0 -63.42 -9.28 11.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 2.8 109.237 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -76.42 -62.61 1.56 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.35 -0.843 . . . . 1.02 109.938 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.57 -17.12 62.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.738 -1.226 . . . . 1.06 109.36 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -69.37 -55.6 9.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.137 -0.977 . . . . 2.39 108.778 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -60.48 -21.45 62.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.257 -0.902 . . . . 2.2 108.938 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -71.75 -27.24 62.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.631 -1.618 . . . . 2.09 106.631 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.27 92.95 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.226 -1.027 . . . . 0.86 108.226 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.09 79.87 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.527 -0.916 . . . . 0.9 108.527 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -32.54 71.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 1.35 108.834 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.2 t -80.37 -47.02 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.436 -0.79 . . . . 0.58 108.891 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -64.42 -35.64 81.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.154 -0.966 . . . . 3.22 108.721 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.503 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 13.5 t0 -58.52 -43.52 89.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 1.32 109.298 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.0 mt -67.47 -25.57 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.5 108.402 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.08 -52.24 4.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.446 -1.461 . . . . 0.44 109.446 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -52.82 -37.32 59.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -1.158 . . . . 2.71 109.329 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.503 ' NH2' ' OD1' ' A' ' 132' ' ' ASP . 6.7 mtt-85 -63.46 -42.52 98.63 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.15 -1.055 . . . . 2.2 108.15 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.6 tp -59.21 -48.92 79.83 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.57 -0.706 . . . . 1.13 109.291 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.2 mt -52.21 -53.16 46.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.54 109.787 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -54.39 -22.96 13.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.097 -1.002 . . . . 2.32 110.0 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.415 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 2.6 m120 -83.96 -31.41 25.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 1.26 109.047 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.0 mt -66.26 -43.78 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.62 108.842 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.6 mt -90.43 -7.14 53.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.211 -0.931 . . . . 0.67 109.397 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 68.73 27.55 73.77 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.578 -1.809 . . . . 0.68 108.578 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tp -51.28 166.2 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.529 -0.983 . . . . 0.77 109.609 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -67.06 141.25 57.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 2.4 109.867 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -109.21 138.78 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.447 -0.783 . . . . 0.87 109.135 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.525 ' H ' HD12 ' A' ' 147' ' ' ILE . 2.5 mp -78.71 128.68 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.025 -1.047 . . . . 1.32 110.03 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -98.13 86.32 3.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.494 -0.754 . . . . 1.54 109.246 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.5 mt -82.41 -33.84 28.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.235 -0.916 . . . . 0.77 109.953 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.5 m -82.06 28.49 0.43 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.115 -0.991 . . . . 1.57 109.977 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.18 28.52 2.28 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.073 -1.017 . . . . 0.82 109.671 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.9 152.96 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.82 109.483 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -129.44 -16.02 3.97 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.353 -0.842 . . . . 2.11 109.238 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -114.95 126.96 55.38 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.892 -0.781 . . . . 1.41 108.892 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.16 124.97 23.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.046 -1.033 . . . . 1.3 109.288 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.3 m -149.33 175.9 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.57 108.94 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.2 mt -88.39 156.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.268 -1.012 . . . . 0.43 108.268 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tp -107.55 124.92 50.63 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.103 -0.702 . . . . 0.56 109.103 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -124.71 129.27 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.062 -0.718 . . . . 0.54 109.062 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.471 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.29 146.3 13.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.62 109.765 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.52 -34.84 67.41 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.746 -1.221 . . . . 0.8 107.847 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -173.49 151.95 2.05 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.164 -0.68 . . . . 2.34 109.164 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.2 mt -119.89 130.67 54.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.682 -0.859 . . . . 0.65 108.682 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.2 p -91.12 150.97 42.6 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.133 -0.98 . . . . 0.74 109.076 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 169' ' ' ALA . 68.6 Cg_exo -35.41 -51.73 0.86 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 122.527 2.151 . . . . 0.6 112.379 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.8 m -48.0 -54.28 13.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.319 -0.863 . . . . 0.63 109.28 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.75 -45.8 88.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.4 -0.813 . . . . 1.25 109.654 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 24.1 p -68.12 -26.06 65.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.5 109.714 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -74.06 -30.77 62.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.114 -0.991 . . . . 0.51 110.148 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -101.41 -14.21 17.66 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.188 -0.945 . . . . 1.17 109.818 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.0 tp -60.51 145.28 49.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.799 -1.188 . . . . 0.61 108.296 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 174' ' ' LYS . 11.7 t-20 -96.51 142.06 29.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.11 -0.994 . . . . 2.12 108.497 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.413 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 37.0 mt -90.15 -39.97 12.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 1.34 111.04 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 35.1 mttm -79.94 -11.06 59.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.83 -1.168 . . . . 1.97 111.628 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -101.83 -13.22 17.77 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.857 -1.152 . . . . 1.9 109.074 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 177' ' ' LEU . 74.5 t -95.88 161.37 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.229 -0.919 . . . . 0.48 108.646 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.51 ' N ' HG12 ' A' ' 176' ' ' VAL . 53.8 tp -111.52 -28.54 8.12 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.25 -0.907 . . . . 1.39 110.119 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -174.32 177.53 46.47 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.714 -1.355 . . . . 0.38 109.714 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.53 127.43 33.17 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.405 -1.056 . . . . 0.46 109.853 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.6 mt -127.91 122.91 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.762 -1.57 . . . . 0.59 106.762 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 38.0 p -140.77 156.23 46.22 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.331 1.063 . . . . 0.67 112.461 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 1.5 m-20 -87.07 37.55 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.692 -0.685 . . . . 2.24 109.56 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.081 -1.012 . . . . 1.11 110.416 -177.851 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 53.7 t60 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.45 0.643 . . . . 0.92 109.89 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 39.0 p -54.08 -45.97 71.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 1.59 110.232 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 98.9 p -63.67 -46.4 85.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 1.42 110.762 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -50.91 -28.68 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.903 -1.123 . . . . 1.41 109.721 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.5 mtp -71.37 -57.0 4.87 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.789 -1.189 . . . . 0.86 107.789 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.83 -43.11 65.75 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.78 -0.645 . . . . 0.59 110.076 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -68.1 -46.3 71.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 3.06 109.779 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.3 m -70.24 -35.82 74.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.73 109.727 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.8 mt -89.76 -1.95 58.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.152 -0.967 . . . . 0.67 109.403 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 56.26 2.23 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 1.49 111.681 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.1 169.51 8.23 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.45 -1.406 . . . . 0.64 108.631 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.28 141.84 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.694 2.263 . . . . 0.59 111.312 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.26 -178.63 5.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.448 -1.408 . . . . 0.55 111.341 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 28.5 mt -148.76 157.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.452 -1.314 . . . . 0.63 107.452 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.0 m -138.35 -39.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.968 -1.083 . . . . 0.77 110.713 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -75.97 41.2 1.48 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.679 -1.368 . . . . 0.87 109.679 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 181' ' ' THR . 20.2 p -68.21 3.57 1.61 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.058 -1.26 . . . . 0.89 109.042 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 55.83 -102.22 0.16 Allowed Glycine 0 N--CA 1.483 1.833 0 N-CA-C 109.83 -1.308 . . . . 0.93 109.83 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.5 p -125.49 43.38 3.07 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.403 -1.057 . . . . 1.6 111.323 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 26.2 t -62.96 -32.06 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.521 -1.362 . . . . 0.75 107.825 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 p -60.25 -16.28 32.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.84 109.094 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.7 m -105.67 15.36 27.0 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.876 -0.787 . . . . 1.61 108.876 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -133.68 -15.28 2.41 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.554 -0.716 . . . . 2.3 109.934 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 51.3 t -123.34 150.57 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.331 -0.856 . . . . 0.76 109.308 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -113.8 -174.74 2.53 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.593 -1.262 . . . . 2.01 107.593 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.46 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 9.6 t30 -80.26 145.41 32.2 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.14 -0.975 . . . . 2.19 110.057 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 82.29 -11.77 0.98 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.036 -0.415 . . . . 2.4 111.229 178.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -55.46 143.32 29.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.636 -1.29 . . . . 1.99 108.446 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -87.78 125.58 34.52 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.956 -1.09 . . . . 1.3 108.813 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 16' ' ' ALA . 43.4 mt -123.7 162.98 22.01 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.841 0.829 . . . . 0.53 110.585 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.7 mt -136.69 107.87 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.775 -1.194 . . . . 0.6 107.775 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.5 tp -87.51 122.04 30.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -0.905 . . . . 0.57 109.234 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.8 OUTLIER -101.05 -28.41 12.73 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.33 -0.856 . . . . 2.22 109.014 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.57 27.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.891 -0.505 . . . . 0.75 111.246 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.2 t -118.25 -58.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 106.602 -1.629 . . . . 0.92 106.602 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -92.02 9.1 34.68 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.643 -1.614 . . . . 2.36 106.643 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 60.13 64.63 1.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.211 -0.663 . . . . 1.42 109.211 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -153.01 136.1 15.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 1.97 110.698 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.3 t -115.18 126.6 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.887 -1.153 . . . . 0.65 107.887 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -96.4 130.71 43.47 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 0.97 109.748 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.46 130.54 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.415 -0.587 . . . . 0.67 109.415 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 20.0 t30 55.24 71.62 1.24 Allowed Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.376 -0.828 . . . . 1.45 110.229 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.36 146.08 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 123.321 2.681 . . . . 0.82 112.06 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.5 p -72.21 177.89 4.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.804 . . . . 1.62 109.776 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -76.86 -39.55 50.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 2.6 109.553 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 234' ' ' GLU . 13.3 mp0 -53.76 -39.12 65.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 3.06 109.403 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.46 -39.41 54.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.089 -1.007 . . . . 1.14 108.833 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.0 mt -65.94 -64.25 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 1.04 109.305 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -53.77 -44.09 69.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 2.54 110.606 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -65.73 -33.04 74.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.06 -1.025 . . . . 2.6 109.813 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . 0.456 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 50.8 mtp -80.83 -38.73 27.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.981 -1.075 . . . . 1.23 109.467 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -49.07 -50.17 37.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.046 -1.034 . . . . 2.67 110.166 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.91 -61.8 1.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.06 -1.025 . . . . 1.66 110.96 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.9 t -62.83 -52.44 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.951 -1.093 . . . . 2.2 111.167 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 239' ' ' MET . 2.2 tp-100 -54.39 -41.28 69.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.712 -1.242 . . . . 3.0 109.72 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 . . . . . 0 C--N 1.301 -1.52 0 O-C-N 120.567 -1.333 . . . . 1.76 108.659 179.833 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.936 -0.764 . . . . 3.66 108.936 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.01 97.24 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 1.12 110.007 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.4 m -99.75 110.81 23.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.461 -0.774 . . . . 1.45 109.959 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.641 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -109.45 -162.45 19.62 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.755 -1.738 . . . . 0.92 108.755 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 5' ' ' ILE . 89.3 mt -94.82 -6.98 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.052 -1.264 . . . . 1.05 109.096 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' ILE . 5.4 tp 55.39 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.374 -0.829 . . . . 0.88 108.878 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.45 -55.1 4.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.097 -1.002 . . . . 0.78 108.606 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.57 144.23 32.63 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.695 -0.854 . . . . 1.5 108.695 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.42 156.05 28.66 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.918 1.745 . . . . 0.86 112.634 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.82 129.61 1.36 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.057 -1.217 . . . . 0.78 110.057 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.9 mt -99.6 131.48 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.202 -1.175 . . . . 0.74 110.724 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.52 ' HB1' HD21 ' A' ' 177' ' ' LEU . . . -146.26 143.65 29.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 0.45 109.16 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.546 ' CZ ' ' OE1' ' A' ' 243' ' ' GLN . 4.2 m-85 -100.69 140.74 34.54 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.493 -1.299 . . . . 0.64 107.493 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.56 156.25 19.49 Favored Glycine 0 N--CA 1.5 2.902 0 C-N-CA 118.49 -1.814 . . . . 0.45 111.881 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -78.75 152.09 31.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.846 -0.797 . . . . 1.88 110.464 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.618 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -79.18 126.36 30.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.541 -0.724 . . . . 0.59 111.119 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 tp -111.15 93.29 4.4 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.86 -1.533 . . . . 0.64 106.86 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.8 tp -80.6 127.51 32.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.782 -1.198 . . . . 0.74 111.293 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.7 mt -97.16 94.61 7.23 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.438 0.637 . . . . 0.74 109.957 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -92.68 156.89 16.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.412 -0.805 . . . . 1.87 109.164 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.84 130.41 53.93 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.646 -0.872 . . . . 2.58 108.646 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -76.77 132.77 39.43 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.185 -0.947 . . . . 2.14 108.978 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.99 137.88 56.83 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.533 -0.729 . . . . 1.93 109.442 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.34 136.08 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.23 -0.919 . . . . 0.68 110.159 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.2 t -102.66 117.53 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 0.84 108.93 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.6 mt -90.96 129.73 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.248 -0.907 . . . . 0.79 109.119 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -90.68 120.27 31.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 1.37 109.922 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -96.11 29.64 2.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.384 -0.822 . . . . 2.62 109.444 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -86.56 144.94 26.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.121 -0.987 . . . . 2.35 109.442 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -85.84 125.97 33.69 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.984 -1.073 . . . . 2.35 109.018 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -82.76 179.15 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.285 -0.884 . . . . 0.78 109.535 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.536 ' H ' HE21 ' A' ' 35' ' ' GLN . 60.7 p -98.82 160.62 14.14 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.396 -0.815 . . . . 1.04 109.332 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.1 -20.22 51.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 1.05 109.307 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -82.53 -12.06 58.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.853 . . . . 2.47 109.43 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.536 HE21 ' H ' ' A' ' 32' ' ' SER . 3.2 mt-30 -105.35 -10.13 17.17 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.941 -1.133 . . . . 1.46 107.941 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.97 -48.36 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.682 -0.636 . . . . 0.77 109.523 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -56.6 -30.04 62.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.085 -1.01 . . . . 1.46 108.942 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -70.37 -35.03 73.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.453 -0.779 . . . . 2.29 110.16 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -64.43 -44.31 91.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.105 -0.997 . . . . 1.3 109.589 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 44' ' ' LEU . 83.6 t -58.15 -46.58 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.169 -0.957 . . . . 0.76 109.328 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.85 -43.6 87.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.139 -0.976 . . . . 1.5 108.905 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -66.04 -32.09 73.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.568 -0.708 . . . . 2.66 109.186 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -86.45 -57.66 2.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.133 -0.98 . . . . 0.75 108.739 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 40' ' ' VAL . 34.0 tp -51.92 -60.69 2.89 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.425 -0.797 . . . . 0.83 109.235 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -66.4 -31.34 72.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -0.891 . . . . 0.78 108.801 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.38 53.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.298 -1.921 . . . . 0.57 108.298 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.546 HH22 ' CD ' ' A' ' 86' ' ' GLU . 27.6 ttp180 -60.44 -21.39 62.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -1.116 . . . . 2.83 109.505 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -66.69 -45.59 78.33 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.345 -0.983 . . . . 0.65 108.345 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.456 ' H ' ' HG2' ' A' ' 49' ' ' LYS . 12.6 ptmt -78.4 -52.93 7.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.483 -0.932 . . . . 2.57 108.483 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.74 -33.36 15.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.353 -1.467 . . . . 0.51 108.789 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 m -66.54 -36.77 83.49 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.034 -1.098 . . . . 1.36 108.034 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -70.46 -19.76 62.93 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.697 -0.853 . . . . 0.6 108.697 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -76.17 -66.06 0.84 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.4 -0.812 . . . . 1.36 109.645 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.9 mt -51.18 -35.6 36.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 1.38 108.867 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -60.74 -51.11 70.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.517 -0.739 . . . . 1.27 109.268 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 m -63.46 -38.25 90.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.157 -0.965 . . . . 0.6 109.088 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.5 mt -69.62 -27.75 34.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.295 -0.878 . . . . 0.53 108.984 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -63.3 -41.57 98.97 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.306 -0.871 . . . . 0.99 109.526 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -71.66 -24.78 61.9 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.51 -0.744 . . . . 0.59 109.264 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.422 ' O ' ' CB ' ' A' ' 64' ' ' THR . 97.0 mttt -72.59 -25.58 61.39 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.738 -1.208 . . . . 1.81 107.738 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.98 -32.12 61.6 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.932 -1.136 . . . . 0.48 107.932 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.96 -29.12 29.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.915 -1.674 . . . . 0.58 108.915 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -86.64 -22.37 26.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.095 -1.238 . . . . 1.39 108.638 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 56.5 m -94.67 -45.09 7.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.254 -0.904 . . . . 0.82 110.56 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.54 ' C ' ' H ' ' A' ' 67' ' ' GLU . 52.4 m-85 -107.78 -34.17 7.04 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.191 -0.943 . . . . 0.99 109.965 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 67.37 -30.21 0.21 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.366 -1.094 . . . . 0.55 110.366 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 65' ' ' PHE . 35.3 mt-10 -51.01 -179.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.03 -1.277 . . . . 2.59 110.102 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.15 36.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.56 -0.712 . . . . 2.2 109.821 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.8 mmtp -83.18 -10.48 58.6 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.406 -0.809 . . . . 1.79 109.308 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -69.01 -35.96 77.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.246 -0.909 . . . . 1.54 110.292 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.41 68.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.64 110.398 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.499 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 11.2 mt -71.52 -46.19 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.079 -1.013 . . . . 0.58 109.821 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -76.19 -26.71 56.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.62 109.571 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.84 -59.33 4.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.052 -1.03 . . . . 1.23 109.026 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.92 -33.73 64.22 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.76 -1.336 . . . . 0.52 109.76 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.499 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 14.8 m170 -62.1 -22.2 65.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.019 -1.283 . . . . 1.29 109.768 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.4 mt -84.81 -36.79 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.976 -1.077 . . . . 0.55 108.365 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.4 ttt -60.84 -44.51 96.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.172 -1.047 . . . . 1.89 108.172 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.3 tp -57.59 -40.87 79.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.231 -1.026 . . . . 0.53 108.231 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.5 tp -69.62 -42.75 73.94 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.403 -0.81 . . . . 0.43 109.519 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -84.9 9.57 14.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.306 -0.871 . . . . 1.24 110.262 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -49.43 121.78 5.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.015 -1.053 . . . . 1.31 110.2 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -67.14 -24.62 65.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.242 -0.911 . . . . 1.35 108.986 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -74.2 -49.93 21.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.328 -0.949 . . . . 2.16 108.685 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.6 mt -64.17 -15.04 59.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.63 -1.228 . . . . 0.6 108.603 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.546 ' CD ' HH22 ' A' ' 47' ' ' ARG . 28.2 tt0 -77.29 -54.33 6.61 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.806 -1.184 . . . . 1.28 110.136 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.18 -30.79 69.58 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.674 -1.267 . . . . 1.28 110.003 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -71.88 -47.89 49.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.062 -1.024 . . . . 1.29 109.039 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.7 mt -59.5 -53.72 44.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.887 -0.783 . . . . 0.58 108.887 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 91' ' ' ALA . 95.9 mt -51.25 -71.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.746 . . . . 0.78 110.348 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -40.25 -48.31 2.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.383 -0.823 . . . . 0.86 110.631 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.8 mt -55.36 -55.69 28.69 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.652 -0.87 . . . . 0.79 108.652 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.1 mt -54.11 -41.89 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.829 . . . . 0.71 110.831 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -85.84 -35.11 20.84 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.03 -1.044 . . . . 2.05 111.7 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 91' ' ' ALA . 37.8 t70 -81.94 -38.63 24.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.756 -1.215 . . . . 1.59 111.48 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -105.97 12.6 30.35 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.899 -1.126 . . . . 1.89 109.462 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.2 m170 46.05 46.35 12.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 1.31 109.49 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.0 mtt -96.23 152.41 18.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.481 -0.762 . . . . 1.28 109.207 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.8 p -78.53 142.93 37.01 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.61 -0.681 . . . . 0.62 110.183 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.87 -25.44 3.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.189 -0.944 . . . . 0.47 108.736 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -75.21 -50.72 15.3 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.316 -0.994 . . . . 2.0 108.316 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.65 -50.1 33.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.64 -0.663 . . . . 0.56 109.813 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.73 -60.28 3.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 0.48 109.657 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.5 -33.29 30.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.44 109.8 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -68.16 -35.01 77.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.915 -1.116 . . . . 1.42 110.055 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.97 -45.05 91.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.121 -0.987 . . . . 1.26 110.814 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -66.72 -48.66 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.051 . . . . 0.61 109.412 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -60.87 -23.77 30.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.737 -0.602 . . . . 0.64 109.824 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -73.06 -37.39 66.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.104 -0.998 . . . . 2.2 110.098 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.68 -22.1 48.06 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.372 -1.395 . . . . 0.82 112.406 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.68 -53.37 15.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.711 -1.464 . . . . 1.27 108.79 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.15 71.78 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.652 -0.655 . . . . 0.91 109.627 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 m -60.82 -37.43 81.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.444 -0.785 . . . . 1.73 110.076 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.39 96.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.299 -0.876 . . . . 1.04 111.15 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.8 mt -70.84 -26.58 63.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.451 -1.3 . . . . 1.03 108.539 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -67.71 -19.5 65.16 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.606 -0.684 . . . . 1.95 110.41 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -82.5 -6.03 59.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.922 -1.111 . . . . 1.71 109.749 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 31.8 mt -84.32 166.99 16.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.057 -1.027 . . . . 1.26 109.528 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -107.84 47.71 0.88 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.736 -0.603 . . . . 2.83 109.906 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -142.82 120.61 11.92 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.017 -1.052 . . . . 1.58 109.531 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.69 -8.64 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.601 0.715 . . . . 2.8 109.72 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -76.67 -62.03 1.77 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.4 -0.812 . . . . 1.02 109.989 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.5 mt -68.83 -24.7 64.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.024 -1.048 . . . . 1.06 109.239 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -66.88 -50.87 61.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -0.879 . . . . 2.39 109.083 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.19 -20.95 63.35 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.306 -0.998 . . . . 2.2 108.306 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -72.88 -27.77 62.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.745 -1.576 . . . . 2.09 106.745 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.09 -42.64 90.93 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.107 -1.071 . . . . 0.86 108.107 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.92 -39.04 79.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.413 -0.804 . . . . 0.9 109.784 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -70.67 -25.96 63.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 1.35 109.616 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.62 -47.48 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.58 108.705 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -53.21 -39.02 63.39 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.062 -1.024 . . . . 3.22 108.405 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 22.1 t70 -59.4 -40.4 86.47 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -0.897 . . . . 1.32 109.633 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.4 mt -66.05 -34.01 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.149 -0.969 . . . . 0.5 109.25 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.32 -44.88 16.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.515 -1.434 . . . . 0.44 109.515 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -49.58 -45.9 48.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.411 -1.052 . . . . 2.71 109.631 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.53 HH11 ' HG2' ' A' ' 136' ' ' ARG . 11.0 mtt-85 -65.18 -42.92 93.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.08 . . . . 2.2 108.491 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.567 ' O ' HD23 ' A' ' 137' ' ' LEU . 1.1 tt -52.38 -35.88 52.51 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.082 -1.081 . . . . 1.13 108.082 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.64 -58.74 3.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.396 -0.815 . . . . 0.54 110.23 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -46.21 -20.13 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.146 -0.971 . . . . 2.32 111.114 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -83.43 -49.73 9.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.88 -1.138 . . . . 1.26 109.012 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.0 mt -57.56 -34.1 46.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.067 -1.021 . . . . 0.62 109.116 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 49.4 mt -87.22 0.08 55.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.062 -1.024 . . . . 0.67 108.536 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.23 25.86 12.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.449 -1.861 . . . . 0.68 108.449 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.5 tp -57.57 153.5 12.96 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.779 -0.836 . . . . 0.77 110.14 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -67.18 146.76 53.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.02 -1.05 . . . . 2.4 109.747 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.85 140.13 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.449 -0.782 . . . . 0.87 109.449 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.517 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.0 mp -78.03 120.15 28.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.225 -0.922 . . . . 1.32 109.095 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -93.51 88.17 5.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 1.54 109.912 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.9 mt -82.0 -24.05 35.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.877 . . . . 0.77 108.798 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.0 t -80.44 26.14 0.39 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.457 -0.777 . . . . 1.57 108.945 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.5 28.38 2.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 0.82 110.125 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 51.2 mt -74.59 152.35 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.869 . . . . 0.82 109.127 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -131.76 -6.51 3.61 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.664 -0.865 . . . . 2.11 108.664 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -121.82 136.06 54.92 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.954 -0.758 . . . . 1.41 108.954 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.54 124.91 25.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 1.3 109.353 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.0 m -147.25 172.54 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.676 -0.861 . . . . 0.57 108.676 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.5 mt -90.19 157.96 2.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.828 -1.175 . . . . 0.43 107.828 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.8 tp -108.98 121.36 44.96 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.675 0.75 . . . . 0.56 109.47 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.77 128.09 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.099 -0.704 . . . . 0.54 109.099 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.84 151.47 14.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.442 -0.786 . . . . 0.62 109.918 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.35 -41.58 84.98 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.495 -1.378 . . . . 0.8 107.895 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -172.94 152.8 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 2.34 109.031 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.3 mt -116.06 141.22 48.42 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.365 -0.834 . . . . 0.65 109.867 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 26.2 p -94.97 151.1 38.66 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.315 -0.866 . . . . 0.74 108.944 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -35.78 -43.75 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.435 2.09 . . . . 0.6 112.243 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.3 m -53.9 -65.37 0.58 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.214 -0.929 . . . . 0.63 109.258 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -47.67 -36.78 11.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.3 -0.875 . . . . 1.25 109.773 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.431 HG21 ' CD2' ' A' ' 189' ' ' HIS . 21.3 p -74.14 -20.11 60.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.5 110.029 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.17 -19.8 27.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.093 -1.004 . . . . 0.51 110.102 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -109.81 -16.57 13.86 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.443 -0.786 . . . . 1.17 110.109 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.06 147.86 45.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.908 -1.12 . . . . 0.61 108.556 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 174' ' ' LYS . 12.2 t-20 -96.02 155.35 16.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.973 -1.079 . . . . 2.12 108.804 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.3 mp -94.53 -42.75 8.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.244 -0.91 . . . . 1.34 110.644 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 53.1 mtpt -79.67 -12.46 59.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.018 -1.051 . . . . 1.97 111.502 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -96.59 -6.16 37.45 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.675 -1.265 . . . . 1.9 108.762 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.468 HG11 ' CE1' ' A' ' 179' ' ' PHE . 40.4 t -103.27 155.91 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.804 -0.813 . . . . 0.48 108.804 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.52 HD21 ' HB1' ' A' ' 12' ' ' ALA . 11.5 tp -111.22 -18.09 13.04 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.928 -0.768 . . . . 1.39 108.928 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.46 177.14 42.47 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.073 -1.611 . . . . 0.38 109.073 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.468 ' CE1' HG11 ' A' ' 176' ' ' VAL . 2.8 m-85 -130.26 126.3 36.96 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.483 -1.01 . . . . 0.46 108.852 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.4 mt -129.17 117.42 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.808 -1.182 . . . . 0.59 107.808 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 203' ' ' VAL . 66.0 p -142.74 157.57 44.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.282 -0.886 . . . . 0.67 111.13 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 23.4 p30 -98.01 47.72 1.01 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.675 -0.81 . . . . 2.24 110.179 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.973 0 O-C-N 120.869 -1.144 . . . . 1.11 110.116 -179.002 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.431 ' CD2' HG21 ' A' ' 168' ' ' THR . 11.8 t60 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.565 0.698 . . . . 0.92 109.662 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.5 p -51.65 -38.69 55.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.523 -0.736 . . . . 1.59 110.454 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 44.0 p -69.09 -42.83 75.64 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.745 -1.222 . . . . 1.42 110.031 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.7 mt -55.48 -29.82 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.052 -1.03 . . . . 1.41 109.977 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.7 mtp -70.28 -56.22 7.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.322 -1.362 . . . . 0.86 107.322 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.99 83.77 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.477 -0.783 . . . . 0.59 109.417 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -65.76 -47.71 74.3 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.259 -0.901 . . . . 3.06 109.659 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.0 m -69.48 -38.06 77.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.923 -1.11 . . . . 0.73 110.204 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 199' ' ' LEU . 14.4 mt -91.42 4.26 52.92 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.862 -1.149 . . . . 0.67 109.432 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 47.48 10.77 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 1.49 110.395 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 197' ' ' LEU . 27.3 mt -67.75 150.59 97.74 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.052 -1.03 . . . . 0.64 109.156 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.57 134.92 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.323 1.348 . . . . 0.59 110.88 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.96 174.78 11.9 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.353 -1.339 . . . . 0.55 111.037 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.3 mt -148.7 158.32 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 106.353 -1.721 . . . . 0.63 106.353 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.9 m -138.9 -32.67 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.01 -1.056 . . . . 0.77 110.776 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.79 40.01 2.97 Favored Glycine 0 N--CA 1.496 2.671 0 O-C-N 121.056 -1.028 . . . . 0.87 110.99 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 29.9 p -69.23 -22.67 63.85 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.872 -1.37 . . . . 0.89 108.924 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 73.34 -97.18 0.85 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.905 -1.141 . . . . 0.93 111.119 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 51.7 p -119.85 46.37 1.95 Allowed 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.979 -1.307 . . . . 1.6 112.263 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 28.4 t -75.33 -28.9 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.639 -1.288 . . . . 0.75 107.879 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.8 p -67.75 -10.47 52.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.424 -0.798 . . . . 0.84 109.032 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.9 p -106.76 14.54 26.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.101 -0.703 . . . . 1.61 109.101 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -131.61 -25.1 2.16 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.427 -0.796 . . . . 2.3 109.33 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 213' ' ' LYS . 74.3 t -117.52 164.33 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.558 -0.714 . . . . 0.76 109.115 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.566 ' N ' HG12 ' A' ' 212' ' ' VAL . 13.7 mmmt -127.17 -171.87 2.52 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.023 -1.473 . . . . 2.01 107.023 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.56 HD22 ' C ' ' A' ' 214' ' ' ASN . 0.4 OUTLIER -81.68 149.16 28.64 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.469 -1.394 . . . . 2.19 110.107 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.2 t0 81.38 -11.61 1.07 Allowed 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.879 -0.513 . . . . 2.4 111.495 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 0.8 OUTLIER -57.08 145.22 31.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.664 -1.272 . . . . 1.99 108.432 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -87.28 120.56 28.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.865 -1.147 . . . . 1.3 108.448 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 16' ' ' ALA . 28.0 mt -123.65 170.19 10.71 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.253 1.025 . . . . 0.53 110.685 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.9 mt -144.74 106.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 106.423 -1.695 . . . . 0.6 106.423 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.4 tp -82.96 127.03 33.16 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.501 -0.926 . . . . 0.57 108.501 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 223' ' ' VAL . 17.8 m-20 -97.15 -31.86 12.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.352 -0.843 . . . . 2.22 109.453 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.62 25.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.428 0.632 . . . . 0.75 110.163 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.5 t -122.41 -51.88 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 106.486 -1.672 . . . . 0.92 106.486 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -97.58 16.04 21.58 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.257 -1.386 . . . . 2.36 107.257 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.641 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 49.89 57.96 5.97 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.98 -0.748 . . . . 1.42 108.98 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -154.67 143.76 21.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 1.97 110.043 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.51 138.17 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.969 -0.752 . . . . 0.65 108.969 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -103.26 129.91 50.36 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.163 -0.961 . . . . 0.97 109.511 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.9 t -108.91 122.88 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.775 -0.578 . . . . 0.67 110.198 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 50.31 58.25 17.3 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.903 . . . . 1.45 109.607 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.47 159.51 50.17 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.7 2.267 . . . . 0.82 112.431 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.8 m -76.28 157.72 32.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 1.62 109.875 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -62.16 -25.54 67.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.069 -1.019 . . . . 2.6 109.585 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -72.66 -35.73 67.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.305 -0.872 . . . . 3.06 110.259 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.56 -45.88 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.892 . . . . 1.14 109.808 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.8 mt -48.95 -60.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.218 -0.926 . . . . 1.04 109.005 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.63 -41.94 70.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.686 -0.633 . . . . 2.54 110.066 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -66.99 -35.1 79.19 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.993 -1.067 . . . . 2.6 109.953 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.4 mtp -80.97 -24.88 37.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.953 . . . . 1.23 109.631 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -61.65 -45.65 93.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.104 -0.997 . . . . 2.67 109.653 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 242' ' ' VAL . . . -74.9 -58.68 3.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.978 -1.076 . . . . 1.66 109.011 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 241' ' ' ALA . 80.4 t -42.97 -59.12 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.471 -0.768 . . . . 2.2 110.156 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 13' ' ' PHE . 24.8 tt0 -47.07 -62.62 1.33 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.013 -1.055 . . . . 3.0 109.911 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 . . . . . 0 C--N 1.297 -1.691 0 O-C-N 121.124 -0.985 . . . . 1.76 110.875 -178.127 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.469 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.357 0.599 . . . . 3.66 109.466 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.463 HD13 HG22 ' A' ' 208' ' ' VAL . 89.7 mt -86.05 97.46 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.935 . . . . 1.12 109.476 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -94.65 108.66 20.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.244 -0.91 . . . . 1.45 109.138 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.17 -170.38 30.8 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.616 -1.394 . . . . 0.92 109.616 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 5' ' ' ILE . 71.5 mt -96.17 -10.04 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.396 -1.061 . . . . 1.05 109.037 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 tp 64.97 106.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.877 -0.786 . . . . 0.88 108.877 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.57 -45.21 11.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.041 -1.096 . . . . 0.78 108.041 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -151.39 149.35 24.24 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.573 -0.899 . . . . 1.5 108.573 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.47 147.89 20.37 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.495 2.13 . . . . 0.86 113.454 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.687 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.3 -177.78 31.5 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.691 -1.363 . . . . 0.78 109.691 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.6 mt -141.45 133.38 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.09 -1.241 . . . . 0.74 109.35 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.72 158.04 44.05 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.338 -0.851 . . . . 0.45 110.223 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -128.64 136.17 50.3 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 107.98 -1.119 . . . . 0.64 107.98 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.98 163.11 31.74 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 118.784 -1.675 . . . . 0.45 111.003 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -79.88 148.28 31.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.634 -0.921 . . . . 1.88 110.29 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.69 123.64 25.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.558 -0.714 . . . . 0.59 111.278 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.0 tp -105.16 91.25 3.71 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.38 -1.341 . . . . 0.64 107.38 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 tp -82.78 136.43 34.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.74 110.034 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.26 94.4 7.08 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.46 0.647 . . . . 0.74 110.444 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -98.94 149.98 22.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.438 -0.789 . . . . 1.87 109.184 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -130.42 141.42 50.54 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.259 -0.901 . . . . 2.58 109.088 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.83 136.75 36.15 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.108 -0.995 . . . . 2.14 109.377 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -67.13 130.84 44.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.462 -0.774 . . . . 1.93 109.08 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.2 mt -91.88 137.73 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.238 -0.914 . . . . 0.68 109.544 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.9 t -105.06 117.73 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.515 -0.74 . . . . 0.84 109.368 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -88.86 142.57 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.199 -0.938 . . . . 0.79 109.266 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -91.06 124.02 34.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.159 -0.963 . . . . 1.37 109.935 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -100.48 28.89 4.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.39 -0.819 . . . . 2.62 109.206 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.63 144.6 29.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 2.35 109.882 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -85.13 124.0 31.29 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.342 -0.984 . . . . 2.35 108.342 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.9 pt -88.39 171.2 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.996 . . . . 0.78 110.518 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.513 ' C ' ' H ' ' A' ' 34' ' ' ASP . 21.3 p -101.35 155.0 18.31 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.94 -0.763 . . . . 1.04 108.94 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.96 -5.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 1.05 110.167 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 32' ' ' SER . 31.8 t0 -83.94 -28.39 27.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.02 -1.05 . . . . 2.47 110.325 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -102.1 -2.98 28.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.144 -0.972 . . . . 1.46 109.783 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.49 -44.02 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.087 -1.008 . . . . 0.77 108.908 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -51.42 -37.11 46.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.892 . . . . 1.46 109.194 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -69.22 -34.3 74.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 2.29 109.892 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -61.42 -46.63 89.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.09 -1.006 . . . . 1.3 109.442 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 44' ' ' LEU . 87.0 t -60.97 -48.4 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.76 109.534 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -64.06 -39.67 94.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 1.5 108.543 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -64.75 -33.66 76.5 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.621 -0.881 . . . . 2.66 108.621 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -86.81 -57.32 3.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.75 108.969 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 40' ' ' VAL . 14.9 tp -49.16 -65.21 0.61 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.407 -0.808 . . . . 0.83 109.378 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.582 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.0 t -64.24 -32.27 73.79 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.788 -0.819 . . . . 0.78 108.788 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -59.1 -54.21 39.91 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 107.612 -2.195 . . . . 0.57 107.612 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -50.31 -27.83 6.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.597 -0.943 . . . . 2.83 108.904 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -63.75 -33.84 76.54 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.021 -1.103 . . . . 0.65 108.021 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 46' ' ' GLY . 24.6 mtpp -80.5 -58.04 3.3 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.843 -0.799 . . . . 2.57 108.843 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -53.94 -36.16 62.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.091 -1.006 . . . . 0.51 109.322 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.6 t -63.54 -37.11 86.04 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.35 -0.981 . . . . 1.36 108.35 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.15 -32.65 63.23 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.296 -0.631 . . . . 0.6 109.296 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.492 HE22 ' ND2' ' A' ' 140' ' ' ASN . 55.8 mt-30 -68.96 -65.14 0.74 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.57 -0.706 . . . . 1.36 109.541 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 54' ' ' LEU . 9.3 mp -51.9 -27.94 14.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 1.38 109.078 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -73.09 -49.46 28.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 1.27 109.104 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.2 m -58.32 -31.77 67.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.115 -0.991 . . . . 0.6 109.198 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -73.28 -31.19 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.075 -1.016 . . . . 0.53 108.556 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -56.51 -45.4 81.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.504 -0.747 . . . . 0.99 109.319 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -70.71 -27.04 63.69 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.203 -0.935 . . . . 0.59 109.672 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -71.23 -34.66 71.0 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.872 -1.143 . . . . 1.81 107.95 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.29 -29.05 63.5 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.033 -0.728 . . . . 0.48 109.033 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.33 -34.3 12.52 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.917 -1.135 . . . . 0.58 110.995 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -85.73 -12.2 51.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.586 -1.538 . . . . 1.39 108.849 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.1 m -94.22 -52.92 4.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.82 109.66 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.503 ' C ' ' H ' ' A' ' 67' ' ' GLU . 70.8 m-85 -107.91 -35.91 6.51 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.293 -0.88 . . . . 0.99 109.778 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.77 -24.9 0.64 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.896 -1.282 . . . . 0.55 109.896 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 69' ' ' LYS . 80.6 mt-10 -53.02 -172.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.252 . . . . 2.59 110.323 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.56 34.61 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.468 -0.77 . . . . 2.2 109.991 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 67' ' ' GLU . 4.4 mmmm -85.12 -17.18 38.08 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.251 -0.906 . . . . 1.79 109.305 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.16 -32.11 72.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 1.54 110.285 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.2 -21.38 65.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.197 -0.939 . . . . 0.64 110.597 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.1 mt -69.47 -46.39 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.984 -1.073 . . . . 0.58 109.539 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -76.82 -20.12 56.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.62 109.801 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.88 -35.9 82.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 1.23 108.618 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.75 -34.64 24.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.631 -1.387 . . . . 0.52 109.631 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -59.78 -20.96 59.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.08 -1.247 . . . . 1.29 109.413 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.3 mt -86.44 -42.57 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.124 -1.065 . . . . 0.55 108.124 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.3 ttt -59.41 -43.01 93.09 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.769 -0.826 . . . . 1.89 108.769 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -64.57 -45.22 87.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.734 -0.839 . . . . 0.53 108.734 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.1 tp -66.78 -46.91 73.81 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.536 -0.728 . . . . 0.43 109.566 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -85.78 9.83 15.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.298 -0.876 . . . . 1.24 110.082 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -47.91 127.36 11.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.959 -1.088 . . . . 1.31 109.274 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -65.73 -25.37 67.26 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.732 -0.84 . . . . 1.35 108.732 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -77.91 -52.44 8.84 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.333 -0.854 . . . . 2.16 109.724 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.74 -18.67 64.28 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.002 -1.061 . . . . 0.6 109.269 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.76 -54.68 6.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 1.28 109.478 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -64.26 -29.63 70.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 1.28 110.022 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.61 -47.58 46.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.094 -1.004 . . . . 1.29 109.005 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.2 mt -58.84 -59.92 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.328 -0.99 . . . . 0.58 108.328 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.5 mt -45.29 -39.63 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.574 -0.704 . . . . 0.78 109.855 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.35 -60.99 2.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.86 109.759 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.9 mt -47.83 -50.77 25.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 0.79 109.38 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.0 mt -54.45 -49.91 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.905 . . . . 0.71 110.679 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -85.24 -36.78 20.71 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.832 -1.168 . . . . 2.05 111.754 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -84.44 -37.51 21.33 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.735 -1.228 . . . . 1.59 111.693 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -103.69 14.88 30.13 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.777 -1.202 . . . . 1.89 109.432 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.4 m170 44.3 49.17 7.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.412 -0.805 . . . . 1.31 110.359 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 31.8 mtt -103.78 150.46 24.07 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.734 -0.839 . . . . 1.28 108.734 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.8 p -76.89 148.91 36.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 0.62 109.811 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.25 -31.33 42.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.219 -0.926 . . . . 0.47 109.202 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.25 -44.07 54.46 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.755 -0.832 . . . . 2.0 108.755 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.88 -54.2 12.34 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.736 -0.602 . . . . 0.56 110.422 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.7 -50.64 72.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.48 109.48 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.91 -35.22 61.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.441 -0.787 . . . . 0.44 109.73 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.25 -30.05 68.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.932 -1.105 . . . . 1.42 109.727 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 109' ' ' GLU . 79.0 tt0 -66.0 -62.67 1.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 1.26 110.274 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 t -49.95 -47.11 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.059 -1.026 . . . . 0.61 109.546 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.32 -16.14 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.447 -0.945 . . . . 0.64 108.447 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . 9.5 tp10 -73.46 -35.42 65.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 2.2 109.159 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.65 -28.42 24.25 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.573 -1.299 . . . . 0.82 112.194 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -65.03 -36.87 85.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.697 -1.472 . . . . 1.27 109.094 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.54 -54.37 5.96 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.975 -0.75 . . . . 0.91 108.975 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.9 m -59.41 -37.53 78.25 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.427 -0.796 . . . . 1.73 109.853 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -63.76 -41.46 97.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.343 -0.848 . . . . 1.04 110.85 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.0 mt -67.02 -28.4 68.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.772 -1.205 . . . . 1.03 109.208 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -67.34 -17.5 64.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.948 . . . . 1.95 109.97 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -82.76 -9.02 59.54 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.127 -0.983 . . . . 1.71 109.572 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mt -86.61 145.11 26.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.347 -0.846 . . . . 1.26 108.847 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.88 61.26 2.16 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.435 -0.95 . . . . 2.83 108.435 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -149.38 120.46 7.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.783 . . . . 1.58 109.763 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.46 -13.36 58.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 2.8 109.196 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.61 -65.16 1.0 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.249 -0.907 . . . . 1.02 109.219 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.3 mt -64.04 -32.14 73.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 1.06 109.324 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 127' ' ' ALA . 46.4 tttp -66.51 -53.27 36.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.041 . . . . 2.39 109.117 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -56.1 -19.45 13.19 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.158 -1.053 . . . . 2.2 108.158 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -73.76 -26.83 60.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.104 -1.813 . . . . 2.09 106.104 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -57.29 -44.05 83.73 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.056 -1.09 . . . . 0.86 108.056 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.66 88.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.212 -1.033 . . . . 0.9 108.212 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -70.72 -27.59 64.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.479 -0.763 . . . . 1.35 109.324 179.222 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.55 -44.41 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.13 -1.063 . . . . 0.58 108.13 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -52.72 -41.25 63.79 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.188 -1.042 . . . . 3.22 108.188 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -62.69 -33.81 75.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.575 -0.703 . . . . 1.32 109.479 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.5 -36.01 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.918 -1.114 . . . . 0.5 108.966 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.51 -46.12 16.04 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.937 -1.665 . . . . 0.44 108.937 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -55.3 -46.99 76.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.542 -0.975 . . . . 2.71 109.538 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.517 HH11 ' HG2' ' A' ' 136' ' ' ARG . 14.4 mtt-85 -65.32 -43.99 89.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 2.2 108.993 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.1 tp -54.36 -37.74 65.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 1.13 109.049 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.78 -58.3 7.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.54 109.626 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -50.56 -16.54 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.333 -0.854 . . . . 2.32 110.195 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.492 ' ND2' HE22 ' A' ' 53' ' ' GLN . 3.0 m120 -84.65 -45.9 12.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.125 -0.984 . . . . 1.26 109.425 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.31 -37.71 78.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.198 -0.939 . . . . 0.62 108.854 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 mt -90.67 -1.73 57.86 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 0.67 109.0 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 50.49 22.39 5.38 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.619 -1.793 . . . . 0.68 108.619 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.56 166.04 0.34 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.665 -0.903 . . . . 0.77 109.494 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -64.65 134.59 54.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.034 -1.041 . . . . 2.4 108.647 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 mt -101.56 142.53 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.192 -0.942 . . . . 0.87 108.872 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.4 mm -78.32 124.84 37.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.295 -0.878 . . . . 1.32 110.05 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -99.18 85.9 3.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.357 -0.839 . . . . 1.54 109.368 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.442 ' O ' HD13 ' A' ' 152' ' ' ILE . 35.0 mt -80.09 -7.77 59.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.341 -0.849 . . . . 0.77 109.346 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.8 p -89.3 -11.45 43.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.226 -0.921 . . . . 1.57 109.927 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.71 44.56 1.01 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.168 -0.957 . . . . 0.82 112.485 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.539 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.5 mp -70.2 154.4 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.489 -1.382 . . . . 0.82 107.558 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -130.74 -22.5 2.65 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.324 -0.86 . . . . 2.11 109.714 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -122.38 137.48 54.85 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.485 -0.759 . . . . 1.41 109.234 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -62.41 129.81 42.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 1.3 109.912 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.7 m -151.05 175.5 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.745 . . . . 0.57 109.251 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 22.9 mt -89.88 158.17 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 107.811 -1.181 . . . . 0.43 107.811 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.1 tp -106.87 118.86 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.916 -0.772 . . . . 0.56 108.916 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.2 t -123.55 129.95 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 121.37 0.605 . . . . 0.54 109.713 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.82 147.49 10.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 0.62 109.265 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.79 73.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.686 -1.259 . . . . 0.8 107.983 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 66.1 t0 -173.63 145.74 1.23 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.482 -0.933 . . . . 2.34 108.482 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.506 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.7 mt -117.74 137.47 52.68 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.155 -0.683 . . . . 0.65 109.155 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.6 p -89.36 150.04 43.9 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.353 -0.842 . . . . 0.74 108.889 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 169' ' ' ALA . 76.6 Cg_exo -35.51 -46.54 0.82 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.393 2.062 . . . . 0.6 111.898 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 169' ' ' ALA . 38.2 m -52.86 -65.71 0.51 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.409 -0.96 . . . . 0.63 108.409 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -44.82 -44.19 9.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.622 -0.674 . . . . 1.25 109.93 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.3 p -71.85 -25.4 61.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.107 -0.995 . . . . 0.5 109.564 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 166' ' ' SER . . . -78.69 -29.71 45.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.963 . . . . 0.51 110.165 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -100.13 -4.26 30.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.271 -0.893 . . . . 1.17 109.371 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 tp -58.18 147.45 30.16 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.276 -1.009 . . . . 0.61 108.276 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.441 ' O ' HG23 ' A' ' 176' ' ' VAL . 54.8 t-20 -99.02 106.65 18.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.133 -0.979 . . . . 2.12 109.64 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -87.02 37.2 0.75 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -0.856 . . . . 1.34 109.177 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -109.34 -24.47 11.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.537 -0.727 . . . . 1.97 109.436 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -132.82 10.99 4.32 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 1.9 110.248 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 172' ' ' ASN . 30.9 t -79.28 154.45 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.928 -1.108 . . . . 0.48 109.161 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.402 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 13.5 tp -114.9 -19.45 10.97 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.704 -0.623 . . . . 1.39 110.189 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.46 175.1 42.6 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.857 -1.297 . . . . 0.38 109.857 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.484 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 4.4 m-85 -126.77 122.3 34.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.481 -1.011 . . . . 0.46 109.275 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.0 mt -130.33 124.39 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.501 -0.926 . . . . 0.59 108.501 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 203' ' ' VAL . 40.6 p -142.68 151.76 41.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 0.67 111.202 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.476 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 1.6 m-20 -87.3 43.77 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 2.24 108.996 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.149 0 O-C-N 121.413 -0.805 . . . . 1.11 110.214 -179.053 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 27.9 t60 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.683 -0.858 . . . . 0.92 108.683 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.3 p -55.54 -41.86 73.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.391 -0.818 . . . . 1.59 109.42 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.2 t -62.48 -31.43 72.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 1.42 109.557 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.0 mm -68.33 -34.77 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.186 -0.946 . . . . 1.41 110.143 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.3 mtm -71.41 -54.1 11.81 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.692 -1.225 . . . . 0.86 107.692 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.86 -44.19 70.17 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.392 -0.596 . . . . 0.59 109.392 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -66.35 -46.63 76.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.15 -0.969 . . . . 3.06 109.498 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.2 m -70.0 -37.13 75.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 0.73 110.116 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 199' ' ' LEU . 26.1 mt -86.61 -0.17 55.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.042 -1.036 . . . . 0.67 109.483 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 51.05 5.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.268 -0.895 . . . . 1.49 110.79 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 197' ' ' LEU . 66.7 mt -66.76 139.68 95.92 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.747 -1.221 . . . . 0.64 108.65 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.08 131.64 44.65 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.711 1.607 . . . . 0.59 111.508 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -163.52 -179.21 6.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.706 -1.246 . . . . 0.55 110.787 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.487 ' CD1' HD11 ' A' ' 220' ' ' LEU . 14.7 mt -150.45 158.71 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.166 -1.42 . . . . 0.63 107.166 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.1 m -142.84 -25.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 120.771 -1.206 . . . . 0.77 110.703 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.44 27.99 5.48 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.934 -1.266 . . . . 0.87 109.934 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 207' ' ' SER . 2.9 p -57.02 -37.27 71.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.678 -1.483 . . . . 0.89 108.122 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.476 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 60.02 -35.68 0.04 OUTLIER Glycine 0 N--CA 1.492 2.402 0 C-N-CA 121.031 -0.604 . . . . 0.93 113.664 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 205' ' ' THR . 7.0 m -128.88 16.55 6.29 Favored 'General case' 0 N--CA 1.513 2.718 0 CA-C-N 119.749 1.774 . . . . 1.6 113.209 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.463 HG22 HD13 ' A' ' 2' ' ' ILE . 20.2 t -80.17 -34.76 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.072 -1.643 . . . . 0.75 110.224 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.2 p -71.53 -21.26 61.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.827 -1.171 . . . . 0.84 109.974 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.9 m -104.54 17.17 24.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.415 -0.803 . . . . 1.61 109.137 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -139.32 -17.87 1.01 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.364 -0.835 . . . . 2.3 110.835 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 213' ' ' LYS . 55.1 t -119.82 162.47 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.255 -0.903 . . . . 0.76 109.691 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 212' ' ' VAL . 13.5 mmtp -126.54 -176.83 3.79 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.165 -1.42 . . . . 2.01 107.165 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.466 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 10.8 p30 -77.01 149.57 35.87 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.74 -1.225 . . . . 2.19 110.357 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.7 t70 81.03 -12.89 0.97 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.151 -0.343 . . . . 2.4 110.667 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -57.76 140.68 50.98 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.794 -1.192 . . . . 1.99 108.358 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -90.66 109.97 21.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.939 -1.101 . . . . 1.3 108.91 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 7.3 mt -113.11 161.37 17.19 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.193 -0.669 . . . . 0.53 109.193 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 67.5 mt -133.39 120.1 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.617 -1.253 . . . . 0.6 107.617 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 202' ' ' ILE . 13.8 tp -87.78 127.65 35.32 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.022 -0.732 . . . . 0.57 109.022 -178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 19.5 p-10 -98.01 -30.24 12.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.267 -0.895 . . . . 2.22 109.034 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.76 24.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.387 0.613 . . . . 0.75 110.349 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.7 t -118.04 -59.0 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 106.695 -1.594 . . . . 0.92 106.695 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -94.35 13.17 24.48 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.51 -1.292 . . . . 2.36 107.51 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 55.53 62.11 2.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.154 -0.684 . . . . 1.42 109.154 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.446 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 53.7 tt0 -155.62 145.82 21.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.14 -0.975 . . . . 1.97 110.769 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 228' ' ' TYR . 76.6 t -106.52 159.98 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.074 -0.713 . . . . 0.65 109.074 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.478 ' N ' HG12 ' A' ' 227' ' ' VAL . 61.8 m-85 -124.88 114.53 19.31 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.52 -0.919 . . . . 0.97 108.52 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.1 123.8 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 0.67 109.942 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.4 t30 69.73 67.84 0.43 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.564 -0.71 . . . . 1.45 109.697 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -88.73 134.8 2.8 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 123.355 2.704 . . . . 0.82 112.267 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 38.5 p -73.51 156.95 37.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 1.62 109.393 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -65.69 -30.84 71.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 2.6 109.375 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -56.86 -43.2 80.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.564 -0.71 . . . . 3.06 109.724 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.4 t -72.93 -49.31 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 1.14 109.608 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 84.7 mt -50.57 -59.65 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.287 -0.883 . . . . 1.04 109.381 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -55.46 -36.23 66.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 2.54 110.284 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -64.76 -51.42 62.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 2.6 110.747 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 243' ' ' GLN . 9.1 mtm -79.49 -27.16 41.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.954 -1.091 . . . . 1.23 110.339 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 240' ' ' ARG . 9.9 mmm-85 -53.2 -41.56 65.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.811 -1.181 . . . . 2.67 108.785 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.1 -52.44 10.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 1.66 110.025 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.3 t -69.81 -51.06 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 2.2 110.496 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 239' ' ' MET . 1.5 tm0? -55.56 -53.2 59.4 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.841 -1.162 . . . . 3.0 110.321 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.418 ' OE1' ' O ' ' A' ' 240' ' ' ARG . 52.9 mt-10 . . . . . 0 C--N 1.301 -1.504 0 O-C-N 120.981 -1.075 . . . . 1.76 109.397 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.535 ' H2 ' ' HG3' ' A' ' 226' ' ' GLN . 12.6 mmt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.315 -0.624 . . . . 3.66 109.315 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.54 94.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 1.12 109.537 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 m -93.96 118.06 30.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.292 -0.88 . . . . 1.45 109.69 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.444 ' N ' HD21 ' A' ' 225' ' ' ASN . . . -113.49 -161.12 14.3 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 108.934 -1.666 . . . . 0.92 108.934 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' LEU . 79.5 mt -92.89 -9.79 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.044 -1.268 . . . . 1.05 109.218 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.9 tp 57.54 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.971 . . . . 0.88 109.469 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.05 -55.66 3.73 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.208 -1.034 . . . . 0.78 108.208 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.82 148.11 34.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 108.694 -0.854 . . . . 1.5 108.694 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.03 150.36 29.64 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.357 2.038 . . . . 0.86 113.337 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.02 124.48 1.1 Allowed Glycine 0 N--CA 1.499 2.881 0 N-CA-C 110.17 -1.172 . . . . 0.78 110.17 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.19 135.03 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.094 -1.239 . . . . 0.74 110.066 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.5 145.52 35.29 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.397 -0.814 . . . . 0.45 110.224 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.8 m-85 -112.7 142.16 45.64 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.837 -1.172 . . . . 0.64 107.837 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.22 164.8 30.44 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.424 -1.846 . . . . 0.45 111.732 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -79.33 146.76 32.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.594 -0.945 . . . . 1.88 110.338 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.41 120.69 24.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 0.59 110.613 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 tp -102.07 91.38 4.3 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.589 -1.263 . . . . 0.64 107.589 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.99 136.81 35.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.116 -0.99 . . . . 0.74 110.166 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 mt -94.91 93.4 7.41 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.466 0.651 . . . . 0.74 110.617 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -96.83 152.01 19.11 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.533 -0.914 . . . . 1.87 108.533 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.88 145.05 51.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.196 -0.94 . . . . 2.58 109.587 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.59 134.27 35.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 2.14 109.407 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.57 136.45 55.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 1.93 109.382 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.5 mt -92.99 135.67 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.68 109.457 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.9 t -102.38 119.12 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.336 -0.853 . . . . 0.84 108.801 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.7 mt -88.74 137.92 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.809 . . . . 0.79 110.115 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -91.23 115.67 28.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.356 -0.84 . . . . 1.37 109.429 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.432 HH11 ' HG3' ' A' ' 28' ' ' ARG . 14.2 mmm-85 -97.91 27.7 4.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.22 -0.925 . . . . 2.62 109.259 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -82.87 147.85 28.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 2.35 109.851 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -86.74 136.68 32.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.203 -0.935 . . . . 2.35 108.747 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.9 pt -95.84 177.46 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.012 -1.055 . . . . 0.78 110.303 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 98.8 p -98.97 154.68 17.89 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.66 -0.867 . . . . 1.04 108.66 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.11 -8.45 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.064 -1.022 . . . . 1.05 109.984 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -82.86 -14.61 53.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 2.47 110.078 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -112.86 -2.99 14.22 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.32 -0.862 . . . . 1.46 109.688 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.67 -45.09 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.974 -1.079 . . . . 0.77 108.728 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -56.66 -35.12 68.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 1.46 109.121 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -69.1 -36.53 77.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 2.29 110.212 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -62.63 -45.43 92.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 1.3 109.485 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.31 -46.24 97.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.438 -0.789 . . . . 0.76 109.732 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.82 -42.33 81.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 1.5 108.882 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -62.86 -31.7 72.78 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.701 -0.852 . . . . 2.66 108.701 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -86.09 -55.79 3.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.75 108.692 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.7 tp -51.81 -56.54 13.34 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.135 -1.061 . . . . 0.83 108.135 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.64 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.8 t -66.46 -35.94 81.53 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.826 -1.175 . . . . 0.78 107.826 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -55.85 -54.76 32.88 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 107.609 -2.196 . . . . 0.57 107.609 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -47.66 -30.82 4.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.407 -1.054 . . . . 2.83 108.763 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.26 -32.97 70.48 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.498 -1.297 . . . . 0.65 107.498 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 46' ' ' GLY . 95.7 mttt -81.23 -62.86 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.64 -0.874 . . . . 2.57 108.64 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.4 -40.56 26.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.899 . . . . 0.51 109.598 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.4 p -62.35 -35.01 77.8 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.745 -1.205 . . . . 1.36 107.745 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.82 -21.28 60.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.589 -0.523 . . . . 0.6 109.589 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.426 HE22 HD21 ' A' ' 140' ' ' ASN . 22.8 mt-30 -76.51 -67.34 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 1.36 109.488 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.59 -39.92 51.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.117 -0.989 . . . . 1.38 108.436 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.99 -48.12 83.02 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.948 -0.76 . . . . 1.27 108.948 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.0 m -63.06 -38.86 92.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.6 108.898 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.36 -37.56 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.921 . . . . 0.53 108.546 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -51.06 -45.82 61.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.624 -0.673 . . . . 0.99 109.715 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -75.19 -23.99 57.74 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.148 -0.97 . . . . 0.59 110.427 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -72.31 -32.63 66.74 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.779 -1.201 . . . . 1.81 108.385 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.11 -26.62 42.9 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.507 -0.745 . . . . 0.48 109.241 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.27 14.35 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.707 -1.235 . . . . 0.58 110.509 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -86.22 -14.9 42.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.827 -1.396 . . . . 1.39 109.204 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.4 m -96.18 -49.0 5.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.269 -0.894 . . . . 0.82 110.654 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -106.37 -18.19 14.06 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.148 -0.97 . . . . 0.99 110.38 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.86 143.86 6.85 Favored Glycine 0 N--CA 1.502 3.086 0 N-CA-C 109.686 -1.365 . . . . 0.55 109.686 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -49.73 -7.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.469 -1.018 . . . . 2.59 110.826 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 66' ' ' GLY . 52.9 tt0 -65.78 -27.89 68.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.872 -1.143 . . . . 2.2 111.0 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -90.12 -12.24 38.87 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.799 -1.188 . . . . 1.79 110.413 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -62.8 -21.28 65.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.091 -1.005 . . . . 1.54 110.709 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.92 70.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.851 -1.156 . . . . 0.64 110.081 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.2 mt -72.52 -43.81 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.076 -1.015 . . . . 0.58 109.636 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -77.05 -26.47 53.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.851 . . . . 0.62 110.325 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.08 -44.19 93.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.903 -1.123 . . . . 1.23 109.262 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.39 -35.84 88.01 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.915 -1.674 . . . . 0.52 108.915 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -19.08 63.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.413 -1.051 . . . . 1.29 110.215 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.5 mt -83.84 -37.06 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.711 -1.243 . . . . 0.55 108.589 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.4 ttt -58.9 -53.35 59.38 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.769 -0.826 . . . . 1.89 108.769 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -52.01 -41.52 62.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.44 -0.788 . . . . 0.53 108.905 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.8 tp -68.65 -44.32 74.39 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.43 109.675 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -85.92 8.85 18.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.261 -0.899 . . . . 1.24 110.476 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -48.59 121.17 4.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.852 -1.155 . . . . 1.31 109.328 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.74 -25.69 66.63 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.286 -0.884 . . . . 1.35 108.808 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -76.99 -48.9 16.71 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.324 -0.86 . . . . 2.16 109.625 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.64 -16.69 63.16 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.575 -1.25 . . . . 0.6 108.657 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.8 -50.16 18.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.4 -0.812 . . . . 1.28 109.591 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.57 -29.31 70.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 1.28 109.134 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -74.07 -48.15 31.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 1.29 109.104 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.2 mt -57.31 -43.41 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.379 -0.971 . . . . 0.58 108.379 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.11 -61.65 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.78 110.195 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -45.23 -51.19 11.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.86 110.275 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 49.9 mt -54.1 -55.0 31.75 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.452 -0.899 . . . . 0.79 108.941 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.3 mt -51.02 -47.22 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.965 . . . . 0.71 110.377 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -81.94 -33.29 30.4 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.987 -1.071 . . . . 2.05 111.441 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.4 t70 -81.31 -45.96 15.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.769 -1.207 . . . . 1.59 111.735 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -103.91 17.85 23.24 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.628 -1.295 . . . . 1.89 109.866 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.6 m80 45.3 50.91 9.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.177 -0.952 . . . . 1.31 109.469 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.6 mtt -99.73 149.01 23.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.52 -0.738 . . . . 1.28 109.114 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.3 p -76.15 146.78 38.97 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.399 -0.813 . . . . 0.62 109.21 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.67 -29.1 10.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.47 108.702 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.37 -44.62 51.45 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.286 -1.005 . . . . 2.0 108.286 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.42 -54.45 12.34 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.313 0.577 . . . . 0.56 110.074 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.29 -50.47 72.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.48 109.365 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.08 -37.35 69.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.44 109.73 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -69.59 -35.07 75.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.046 -1.034 . . . . 1.42 109.491 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 109' ' ' GLU . 33.4 tt0 -62.28 -58.35 8.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 1.26 109.612 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.3 t -50.28 -47.11 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.977 -1.077 . . . . 0.61 109.221 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.3 mm -65.13 -15.65 18.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.376 -0.828 . . . . 0.64 109.007 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 106' ' ' GLU . 24.7 tt0 -75.28 -37.0 61.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 2.2 109.706 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.56 -26.5 29.85 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.491 -1.338 . . . . 0.82 112.174 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -67.58 -37.91 83.27 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.614 -1.521 . . . . 1.27 108.952 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.34 -51.36 7.03 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.671 -0.643 . . . . 0.91 109.581 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.0 p -60.47 -42.79 96.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.317 -0.865 . . . . 1.73 110.141 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.0 -38.41 90.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.976 -1.078 . . . . 1.04 110.339 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 115' ' ' LEU . 71.2 mt -67.72 -26.86 66.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.852 -1.155 . . . . 1.03 109.438 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -69.48 -20.45 63.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.035 -1.04 . . . . 1.95 109.607 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -81.36 -6.85 59.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 1.71 109.183 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 mt -85.7 143.18 28.51 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.244 -1.021 . . . . 1.26 108.244 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -96.66 62.04 1.94 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.271 -0.893 . . . . 2.83 109.024 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -148.96 115.22 5.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.221 -0.924 . . . . 1.58 109.621 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.82 -13.08 3.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 2.8 109.433 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.504 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 1.0 OUTLIER -79.92 -63.79 1.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 1.02 109.375 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.6 mt -68.09 -30.81 70.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.215 -0.928 . . . . 1.06 109.444 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 68.5 tttt -67.01 -51.64 52.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.956 . . . . 2.39 109.337 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -57.86 -23.11 51.48 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.195 -0.94 . . . . 2.2 108.995 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.504 ' NH2' ' OH ' ' A' ' 122' ' ' TYR . 18.6 ttm180 -73.41 -24.71 60.31 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.408 -1.701 . . . . 2.09 106.408 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.08 -42.86 91.42 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.629 -0.878 . . . . 0.86 108.629 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.71 80.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.436 -0.79 . . . . 0.9 109.876 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.13 -25.32 65.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 1.35 109.529 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.2 t -76.61 -42.62 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.163 -0.961 . . . . 0.58 108.444 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' A' ' 131' ' ' ARG . 16.6 ttm-85 -57.0 -37.69 72.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.223 -0.923 . . . . 3.22 108.68 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -61.06 -38.37 85.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.508 -0.745 . . . . 1.32 110.319 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.8 mt -67.97 -26.83 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.018 -1.051 . . . . 0.5 109.975 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.5 -44.08 8.87 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.632 -1.387 . . . . 0.44 109.632 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.419 ' HZ2' ' HD2' ' A' ' 139' ' ' ARG . 43.5 tttm -50.92 -51.68 49.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.371 -1.076 . . . . 2.71 109.642 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.544 ' CG ' HH11 ' A' ' 136' ' ' ARG . 4.5 mtt-85 -63.9 -46.21 85.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.109 -0.994 . . . . 2.2 108.361 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.9 tp -49.83 -38.38 34.66 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.054 -0.721 . . . . 1.13 109.054 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.8 mt -70.5 -55.01 9.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.54 109.495 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.419 ' HD2' ' HZ2' ' A' ' 135' ' ' LYS . 47.2 mtp180 -53.49 -17.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 2.32 110.293 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.464 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 2.4 m120 -85.02 -47.4 10.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.992 -1.067 . . . . 1.26 109.204 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.27 -37.88 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.899 . . . . 0.62 109.118 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.83 -3.11 58.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.67 108.693 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.32 22.62 15.53 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.303 -1.919 . . . . 0.68 108.303 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.6 tp -55.58 154.3 6.78 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.625 -0.927 . . . . 0.77 109.297 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -66.76 147.55 53.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 2.4 109.683 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.8 mt -109.05 145.79 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.517 -0.739 . . . . 0.87 109.349 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.7 mm -76.34 119.46 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 1.32 108.625 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.7 OUTLIER -94.79 87.03 4.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.255 -0.903 . . . . 1.54 109.918 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.9 mt -81.6 -10.33 59.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.77 109.14 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.1 p -80.65 -12.18 59.53 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.273 -0.892 . . . . 1.57 109.461 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -103.56 49.95 0.82 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.473 -0.767 . . . . 0.82 110.53 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 153' ' ' GLN . 26.8 mm -71.2 164.12 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.812 -1.18 . . . . 0.82 108.71 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.492 ' N ' HG22 ' A' ' 152' ' ' ILE . 10.9 mt-30 -132.88 -33.1 1.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.351 -0.843 . . . . 2.11 109.768 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -115.0 145.52 42.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.5 -0.75 . . . . 1.41 109.614 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -66.95 126.66 29.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.415 -0.803 . . . . 1.3 109.232 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.4 m -148.97 172.38 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.154 -0.966 . . . . 0.57 109.668 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 158' ' ' LEU . 53.5 mt -90.66 163.59 2.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.609 -1.256 . . . . 0.43 107.609 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.494 ' N ' HG22 ' A' ' 157' ' ' ILE . 12.7 tp -111.89 123.83 51.09 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.589 -0.694 . . . . 0.56 109.404 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.8 t -123.46 129.7 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.148 -0.686 . . . . 0.54 109.148 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.29 146.14 11.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.62 109.671 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.94 -27.25 66.63 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.601 -1.312 . . . . 0.8 107.468 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -175.47 157.94 2.2 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.64 -0.663 . . . . 2.34 109.215 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 22.6 mt -129.88 131.03 45.92 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.439 -0.788 . . . . 0.65 109.321 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 p -94.59 153.28 40.28 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.285 -0.884 . . . . 0.74 109.409 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -35.68 -41.78 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.541 2.16 . . . . 0.6 112.354 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.9 m -62.2 -56.29 20.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.162 -0.961 . . . . 0.63 109.112 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -53.73 -31.19 47.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 1.25 109.526 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.5 HG21 ' CD2' ' A' ' 189' ' ' HIS . 28.3 p -82.49 -31.54 29.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.5 109.539 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.82 -23.92 58.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.51 109.966 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -105.26 -6.0 20.11 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.145 -0.972 . . . . 1.17 109.414 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.08 156.0 5.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.226 -1.027 . . . . 0.61 108.226 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 176' ' ' VAL . 52.2 t-20 -97.9 97.19 8.74 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.136 -0.978 . . . . 2.12 109.564 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.745 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.6 mm? -82.05 26.23 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 1.34 109.193 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -112.44 -18.13 12.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.421 -0.799 . . . . 1.97 109.103 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -131.26 -1.32 4.01 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.47 -0.769 . . . . 1.9 110.133 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 172' ' ' ASN . 39.3 t -78.95 151.54 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.874 -1.141 . . . . 0.48 109.543 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.3 tp -121.33 -9.01 9.12 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.8 -0.562 . . . . 1.39 110.269 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.44 176.5 41.22 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.561 -1.304 . . . . 0.38 110.069 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.82 130.35 35.94 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.517 -0.99 . . . . 0.46 110.086 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.437 ' CG2' HG21 ' A' ' 205' ' ' THR . 8.1 mt -129.56 120.05 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.01 -1.107 . . . . 0.59 108.01 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 203' ' ' VAL . 64.1 p -141.67 152.45 43.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.213 -0.929 . . . . 0.67 110.868 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 21.4 p30 -89.45 43.83 1.17 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.088 -1.008 . . . . 2.24 110.715 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . . . . . . 0 N--CA 1.497 1.922 0 O-C-N 120.878 -1.139 . . . . 1.11 108.799 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.5 ' CD2' HG21 ' A' ' 168' ' ' THR . 5.3 t60 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.385 0.612 . . . . 0.92 109.671 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 190' ' ' THR . 0.1 OUTLIER -47.1 -44.15 21.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 1.59 109.987 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 38.6 t -59.71 -37.43 78.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.01 . . . . 1.42 110.34 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 31.4 mm -60.43 -34.36 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.098 -1.001 . . . . 1.41 110.397 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.2 mtp -71.67 -52.05 19.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.902 -1.124 . . . . 0.86 108.288 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.19 -30.99 51.67 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.722 -0.672 . . . . 0.59 110.277 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -81.26 -47.76 12.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.066 -1.021 . . . . 3.06 110.416 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.9 m -67.57 -37.1 82.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.933 -1.104 . . . . 0.73 110.112 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 199' ' ' LEU . 15.9 mt -86.18 -0.13 54.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.981 -1.074 . . . . 0.67 109.105 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 56.81 0.37 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.396 -0.815 . . . . 1.49 112.015 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.1 mt -67.42 170.77 6.03 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.472 -1.393 . . . . 0.64 108.897 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -90.97 142.78 3.2 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.513 2.142 . . . . 0.59 111.199 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.1 -178.19 5.88 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.562 -1.337 . . . . 0.55 110.857 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.9 mt -149.69 158.48 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.962 -1.496 . . . . 0.63 106.962 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.525 ' O ' ' O ' ' A' ' 181' ' ' THR . 19.5 m -137.93 -32.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.989 -1.069 . . . . 0.77 111.434 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.34 42.54 3.16 Favored Glycine 0 N--CA 1.496 2.653 0 O-C-N 120.579 -1.326 . . . . 0.87 110.727 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.437 HG21 ' CG2' ' A' ' 180' ' ' ILE . 60.8 p -71.39 -21.15 62.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.602 -1.528 . . . . 0.89 109.297 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.452 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 71.75 -97.43 0.72 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.843 -1.17 . . . . 0.93 111.814 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 66.7 m -115.42 45.86 1.59 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.969 -1.312 . . . . 1.6 112.743 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 17.7 t -79.93 -27.19 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.601 -1.312 . . . . 0.75 107.636 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.433 ' H ' HG23 ' A' ' 209' ' ' THR . 1.4 p -73.67 -11.21 60.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.84 109.7 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 13.8 p -101.53 6.4 42.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.36 -0.837 . . . . 1.61 109.405 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -130.47 -3.58 4.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.399 -0.813 . . . . 2.3 109.203 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.0 t -125.81 152.59 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.055 -0.72 . . . . 0.76 109.055 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -118.68 -173.79 2.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.852 -1.536 . . . . 2.01 106.852 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 22.7 t-20 -80.03 145.42 32.51 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.818 -1.176 . . . . 2.19 111.202 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.46 -7.4 1.46 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.839 -0.538 . . . . 2.4 110.843 178.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.29 138.05 55.28 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.875 -1.141 . . . . 1.99 108.446 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -86.38 115.98 24.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.038 -1.039 . . . . 1.3 108.655 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.6 mt -117.99 179.1 4.19 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.374 1.083 . . . . 0.53 110.806 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.8 mt -146.93 107.92 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.387 -1.338 . . . . 0.6 107.387 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 tp -83.21 128.4 34.46 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.32 -0.993 . . . . 0.57 108.32 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -52.6 4.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 2.22 109.82 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 57.54 22.74 8.44 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.339 -0.85 . . . . 0.75 108.77 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.06 -49.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 107.295 -1.372 . . . . 0.92 107.295 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -106.95 12.14 29.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.936 -1.135 . . . . 2.36 107.936 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.444 HD21 ' N ' ' A' ' 4' ' ' GLY . 59.0 t30 58.35 58.21 3.54 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.056 -0.72 . . . . 1.42 109.056 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.535 ' HG3' ' H2 ' ' A' ' 1' ' ' MET . 17.4 tt0 -153.75 146.99 24.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.926 . . . . 1.97 109.918 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.63 136.62 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.67 -0.644 . . . . 0.65 109.386 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -105.03 127.38 52.84 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.384 -0.822 . . . . 0.97 109.2 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.58 127.89 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.516 -0.74 . . . . 0.67 109.864 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 49.05 69.96 2.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.857 . . . . 1.45 109.989 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.5 153.44 13.73 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.78 2.32 . . . . 0.82 111.64 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.5 p -73.93 169.59 17.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.979 . . . . 1.62 109.98 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.53 -27.76 65.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.852 . . . . 2.6 109.579 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.13 -38.65 91.33 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.418 -0.801 . . . . 3.06 109.537 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.09 -46.31 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 1.14 109.341 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.7 mt -52.05 -55.84 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 1.04 109.356 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -54.91 -44.83 74.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 2.54 109.972 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.45 ' O ' HG23 ' A' ' 242' ' ' VAL . 50.8 tttm -67.54 -37.75 83.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 2.6 110.144 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 51.9 mtp -80.16 -25.92 39.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 1.23 109.706 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.469 ' HE ' ' CA ' ' A' ' 240' ' ' ARG . 0.0 OUTLIER -60.16 -51.86 67.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.179 -0.951 . . . . 2.67 109.853 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.71 -54.94 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 1.66 109.771 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 238' ' ' LYS . 84.5 t -49.03 -53.02 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 2.2 109.511 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -55.29 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.249 -0.907 . . . . 3.0 109.981 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 . . . . . 0 C--N 1.299 -1.6 0 O-C-N 121.122 -0.986 . . . . 1.76 110.499 -178.772 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.451 -0.574 . . . . 3.66 109.451 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 208' ' ' VAL . 74.3 mt -60.67 98.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.872 . . . . 1.12 109.475 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.0 m -93.37 114.67 27.15 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 1.45 109.619 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.72 -163.15 19.53 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.784 -1.726 . . . . 0.92 108.784 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 5' ' ' ILE . 63.4 mt -96.48 -9.46 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.039 -1.271 . . . . 1.05 108.789 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.2 tp 59.42 110.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.416 -0.803 . . . . 0.88 109.151 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -89.77 -49.66 6.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.081 -1.081 . . . . 0.78 108.081 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -150.43 152.15 32.41 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.371 -0.83 . . . . 1.5 109.383 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.08 155.89 29.92 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.585 2.19 . . . . 0.86 112.504 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 144.26 121.84 1.55 Allowed Glycine 0 N--CA 1.504 3.169 0 N-CA-C 110.232 -1.147 . . . . 0.78 110.232 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.49 139.48 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.094 -1.239 . . . . 0.74 110.22 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.61 159.86 41.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.324 -0.86 . . . . 0.45 109.68 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.595 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -130.39 135.79 48.4 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.107 -1.072 . . . . 0.64 108.107 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 166.6 37.14 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 118.601 -1.762 . . . . 0.45 111.723 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -79.61 149.78 31.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.739 -0.859 . . . . 1.88 110.392 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -76.37 125.02 28.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.39 -0.819 . . . . 0.59 110.992 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.1 tp -110.79 93.15 4.34 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.174 -1.417 . . . . 0.64 107.174 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -81.79 126.83 32.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.04 -1.037 . . . . 0.74 110.996 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.3 mt -101.94 94.44 5.79 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.609 -0.723 . . . . 0.74 110.316 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -94.62 158.54 15.48 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.358 -0.979 . . . . 1.87 108.358 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -130.18 125.4 34.89 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.384 -0.823 . . . . 2.58 109.506 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 6.5 p-10 -80.27 130.2 35.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.32 -0.862 . . . . 2.14 109.008 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.64 148.87 50.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 1.93 109.235 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.5 136.73 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 0.68 109.145 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -103.11 121.05 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.369 -0.832 . . . . 0.84 109.047 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.7 mt -87.14 132.98 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.386 -0.821 . . . . 0.79 109.729 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -91.5 122.46 34.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 1.37 108.724 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.527 HH11 ' HG2' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -98.36 27.41 4.73 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.241 -0.912 . . . . 2.62 109.887 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -81.01 143.33 32.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 2.35 109.277 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -86.37 126.27 34.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.146 -0.971 . . . . 2.35 109.416 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 pt -85.24 176.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 0.78 109.6 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.9 p -95.58 173.96 7.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.79 . . . . 1.04 109.478 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.29 -25.89 63.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 1.05 109.551 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 3.3 m-20 -79.97 2.57 23.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 2.47 108.617 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -116.75 -17.02 10.6 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.507 -0.924 . . . . 1.46 108.507 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.9 t -66.61 -46.45 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.46 -0.775 . . . . 0.77 109.382 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.2 -35.65 67.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.887 . . . . 1.46 109.626 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -69.07 -33.5 73.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.389 -0.819 . . . . 2.29 110.267 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.2 -37.9 89.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.959 -1.088 . . . . 1.3 109.362 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.9 -47.31 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.359 -0.838 . . . . 0.76 110.058 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.31 -41.29 85.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.136 -0.977 . . . . 1.5 109.086 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -60.44 -34.27 73.73 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.244 -0.91 . . . . 2.66 109.092 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 28.1 t80 -86.83 -55.3 3.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.138 -0.976 . . . . 0.75 109.407 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.39 -63.8 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.83 110.081 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 12.9 t -66.48 -37.91 86.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.78 108.856 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.95 -52.63 47.7 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.672 -2.171 . . . . 0.57 107.672 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -53.7 -22.55 9.31 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.648 -0.913 . . . . 2.83 109.431 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -64.11 -45.08 90.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.101 -0.999 . . . . 0.65 108.648 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 50' ' ' ALA . 28.7 pttt -78.41 -51.84 9.45 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.352 -0.939 . . . . 2.57 109.296 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' H ' ' HG3' ' A' ' 49' ' ' LYS . . . -50.76 -41.1 56.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.561 -1.337 . . . . 0.51 109.325 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t -62.43 -33.56 75.05 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.613 -1.254 . . . . 1.36 107.613 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.88 -28.31 62.42 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.037 -0.727 . . . . 0.6 109.037 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -73.6 -62.97 1.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.372 -0.83 . . . . 1.36 109.093 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 54' ' ' LEU . 10.8 mp -49.71 -38.04 31.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.995 -1.066 . . . . 1.38 108.297 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.35 -41.64 98.87 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.326 -0.991 . . . . 1.27 108.326 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 m -62.97 -39.28 94.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.455 -0.778 . . . . 0.6 109.007 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.08 -39.6 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.574 -0.899 . . . . 0.53 108.574 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -49.2 -42.04 38.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.785 . . . . 0.99 109.571 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -71.27 -38.76 71.84 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.066 -1.022 . . . . 0.59 109.796 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -69.88 -14.9 62.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.866 -1.134 . . . . 1.81 107.999 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.91 -36.03 21.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.51 -0.922 . . . . 0.48 108.51 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.08 -27.86 29.95 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.199 -1.16 . . . . 0.58 110.199 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -85.86 -15.59 41.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.008 -1.29 . . . . 1.39 109.38 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.7 m -94.49 -48.22 6.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.176 -0.952 . . . . 0.82 110.325 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -106.37 -17.54 14.25 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.164 -0.96 . . . . 0.99 110.537 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.93 143.84 6.83 Favored Glycine 0 N--CA 1.502 3.042 0 N-CA-C 109.706 -1.357 . . . . 0.55 109.706 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -51.26 -8.6 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -1.058 . . . . 2.59 110.572 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.461 ' H ' ' C ' ' A' ' 66' ' ' GLY . 97.7 mt-10 -65.69 -24.17 66.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.955 -1.091 . . . . 2.2 110.474 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -91.45 -13.75 31.73 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.926 -1.109 . . . . 1.79 110.739 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -62.92 -18.71 63.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.92 -1.113 . . . . 1.54 110.815 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.12 -37.16 85.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.913 -1.117 . . . . 0.64 110.04 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.446 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 27.3 mt -73.14 -38.79 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.965 . . . . 0.58 109.91 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -78.41 -22.34 47.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.62 109.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -64.48 -48.27 75.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.201 -0.937 . . . . 1.23 109.111 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.07 -32.01 76.03 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.425 -1.47 . . . . 0.52 109.425 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.446 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 32.5 m170 -61.69 -23.31 66.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -1.15 . . . . 1.29 110.004 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.1 mt -85.28 -39.02 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.901 -1.125 . . . . 0.55 108.825 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.4 ttt -59.04 -46.7 87.57 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.578 -0.897 . . . . 1.89 108.578 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tp -58.71 -40.03 82.5 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.545 -0.722 . . . . 0.53 109.062 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -67.03 -45.92 76.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.271 -0.893 . . . . 0.43 109.395 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -84.57 9.04 14.68 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.874 . . . . 1.24 110.546 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -51.83 120.98 5.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.955 -1.091 . . . . 1.31 109.231 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.74 -21.76 65.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -0.95 . . . . 1.35 108.947 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.35 -47.44 23.44 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.327 -0.858 . . . . 2.16 109.185 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.06 -18.83 64.75 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.223 -0.991 . . . . 0.6 108.93 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -81.79 -41.32 21.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.388 -0.82 . . . . 1.28 109.725 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -63.06 -33.32 75.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 1.28 109.469 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -74.07 -42.57 59.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 1.29 109.004 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.2 mt -59.57 -58.82 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.219 -1.03 . . . . 0.58 108.219 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.4 mt -42.86 -64.36 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.758 -0.589 . . . . 0.78 110.164 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.0 -49.78 15.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 0.86 110.135 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 mt -56.4 -57.14 13.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -0.842 . . . . 0.79 109.328 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.3 -38.39 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.071 -1.018 . . . . 0.71 110.169 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -86.53 -37.62 18.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.096 -1.002 . . . . 2.05 112.105 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -82.1 -38.72 24.42 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.79 -1.194 . . . . 1.59 111.691 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 97' ' ' HIS . 60.5 mmtt -105.45 14.1 29.2 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.806 -1.184 . . . . 1.89 109.612 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 96' ' ' LYS . 77.4 m80 44.55 44.5 7.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.377 -0.827 . . . . 1.31 109.365 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.3 mtt -95.59 153.04 17.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.472 -0.768 . . . . 1.28 109.195 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.2 p -77.17 142.34 39.69 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.565 -0.71 . . . . 0.62 109.595 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.47 -26.85 2.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.401 -0.812 . . . . 0.47 109.68 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.0 -43.67 43.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.118 -0.989 . . . . 2.0 108.376 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.74 -55.36 7.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.731 -0.606 . . . . 0.56 110.407 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.57 -50.02 71.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.983 . . . . 0.48 110.057 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.89 -30.8 62.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -0.937 . . . . 0.44 109.797 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -69.98 -25.62 63.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.011 -1.056 . . . . 1.42 109.364 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -68.67 -60.7 2.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -0.922 . . . . 1.26 109.86 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -51.91 -48.16 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.929 -1.107 . . . . 0.61 109.407 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.9 mm -63.42 -21.94 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.64 109.694 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -69.26 -34.64 75.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.976 -1.078 . . . . 2.2 109.543 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.27 -23.54 40.18 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.559 -1.305 . . . . 0.82 112.293 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -68.3 -42.94 78.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.52 -1.576 . . . . 1.27 108.854 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.93 -49.18 14.65 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.214 -0.661 . . . . 0.91 109.214 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.6 t -60.46 -45.89 92.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.404 -0.81 . . . . 1.73 109.785 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.6 78.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 1.04 110.344 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 mt -68.43 -28.85 67.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.864 -1.147 . . . . 1.03 109.186 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -70.38 -17.6 63.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.189 -0.945 . . . . 1.95 109.404 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -80.97 -6.19 58.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 1.71 109.437 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 123' ' ' LEU . 3.3 mt -84.01 142.86 30.16 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.277 -1.009 . . . . 1.26 108.277 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -94.34 57.62 2.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 2.83 108.55 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -148.61 116.41 6.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 1.58 109.267 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.92 -11.33 7.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 2.8 109.725 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -78.85 -64.11 1.26 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -0.877 . . . . 1.02 109.286 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 118' ' ' LEU . 26.3 mt -63.17 -23.43 67.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.009 -1.057 . . . . 1.06 109.26 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 127' ' ' ALA . 40.6 tttm -66.78 -50.59 62.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.094 -1.004 . . . . 2.39 108.36 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -55.1 -22.99 18.43 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.442 -0.947 . . . . 2.2 108.442 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.602 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -72.74 -27.09 61.82 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.867 -1.531 . . . . 2.09 106.867 177.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.53 -41.81 86.37 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.561 -0.903 . . . . 0.86 108.561 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.66 -43.8 75.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.508 -0.745 . . . . 0.9 109.83 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.74 -21.19 66.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 1.35 109.528 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 t -78.07 -48.7 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.185 -0.947 . . . . 0.58 108.562 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -54.8 -34.99 63.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.05 -1.031 . . . . 3.22 108.587 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.57 -46.74 88.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.421 -0.799 . . . . 1.32 110.224 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.05 -30.56 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.924 -1.11 . . . . 0.5 108.966 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.68 -48.4 7.96 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.821 -1.712 . . . . 0.44 108.821 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -56.03 -49.82 72.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.444 -1.033 . . . . 2.71 109.466 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.505 HH11 ' HG2' ' A' ' 136' ' ' ARG . 9.8 mtt-85 -63.6 -49.93 71.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.231 -1.026 . . . . 2.2 108.231 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 40.2 tp -48.0 -35.15 10.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 1.13 109.267 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.04 -48.19 58.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.157 -0.965 . . . . 0.54 109.55 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -53.99 -18.99 4.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 2.32 110.71 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 29.4 m-80 -84.72 -38.87 19.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.868 -1.145 . . . . 1.26 109.121 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.9 mt -67.82 -35.29 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.62 109.05 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.21 -1.7 57.21 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.876 -0.787 . . . . 0.67 108.876 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.33 25.75 60.77 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.263 -1.935 . . . . 0.68 108.263 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.35 133.79 47.28 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.533 -0.98 . . . . 0.77 109.499 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.68 141.96 57.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 2.4 109.028 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 147' ' ' ILE . 92.0 mt -104.02 163.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.602 -0.888 . . . . 0.87 108.602 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.516 ' N ' HG22 ' A' ' 146' ' ' ILE . 4.2 mp -77.93 128.53 38.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.026 -1.046 . . . . 1.32 108.984 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -97.09 84.82 3.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.327 -0.858 . . . . 1.54 109.584 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -82.57 -20.12 37.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.885 . . . . 0.77 109.206 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -79.66 7.01 9.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.019 . . . . 1.57 109.304 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -118.82 23.39 11.46 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.556 -0.715 . . . . 0.82 109.369 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.87 144.57 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.82 109.725 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -137.63 8.14 2.82 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.91 -0.774 . . . . 2.11 108.91 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -123.64 119.5 30.02 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.76 -0.83 . . . . 1.41 108.76 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.67 121.05 13.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.283 -0.886 . . . . 1.3 109.488 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.2 m -150.05 177.45 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.57 108.952 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.2 mt -88.56 151.3 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.176 -1.046 . . . . 0.43 108.176 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.76 117.87 35.25 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.533 0.682 . . . . 0.56 109.414 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.5 t -124.06 132.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.718 -0.845 . . . . 0.54 108.718 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.56 153.08 14.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.803 . . . . 0.62 109.801 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.53 86.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.641 -1.287 . . . . 0.8 107.915 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -174.42 156.88 2.58 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.463 -0.773 . . . . 2.34 109.758 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 27.3 mt -130.84 137.7 49.51 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.538 -0.726 . . . . 0.65 109.499 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.9 p -93.72 153.57 41.1 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.227 -0.921 . . . . 0.74 109.178 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -34.3 -46.82 0.52 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.735 2.29 . . . . 0.6 112.938 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 169' ' ' ALA . 69.1 m -50.77 -65.76 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.012 . . . . 0.63 109.262 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -48.36 -37.4 16.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.341 -0.849 . . . . 1.25 109.737 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 12.3 p -75.87 -21.71 56.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.5 109.484 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 166' ' ' SER . . . -80.81 -21.14 41.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.51 110.153 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -107.14 -19.83 13.49 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.318 -0.864 . . . . 1.17 109.859 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.31 149.99 27.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.61 109.112 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -97.01 158.01 15.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.976 . . . . 2.12 108.525 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.3 mp -96.37 -40.58 9.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.161 -0.962 . . . . 1.34 110.782 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -80.13 -13.64 59.11 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.706 -1.246 . . . . 1.97 111.603 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -94.01 -5.11 48.29 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.605 -1.309 . . . . 1.9 108.469 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 178' ' ' GLY . 42.9 t -102.14 155.27 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.045 -0.724 . . . . 0.48 109.045 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.7 tp -113.75 -18.43 11.85 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.967 -0.753 . . . . 1.39 108.967 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.482 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.53 171.29 40.08 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.947 -1.661 . . . . 0.38 108.947 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 4.2 m-85 -126.94 124.11 38.75 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.507 -0.996 . . . . 0.46 109.623 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.2 mt -125.75 117.35 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.367 -1.346 . . . . 0.59 107.367 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 203' ' ' VAL . 17.4 p -140.78 151.84 44.75 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.229 -0.919 . . . . 0.67 112.388 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.513 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 6.7 t0 -82.03 40.78 0.63 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.517 0.675 . . . . 2.24 109.621 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.118 0 O-C-N 120.29 -1.506 . . . . 1.11 110.9 -178.069 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 t60 . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 108.034 -1.098 . . . . 0.92 108.034 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.8 m -61.59 -43.75 98.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.053 -0.721 . . . . 1.59 109.053 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.1 p -57.44 -32.2 66.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 1.42 109.315 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.7 mm -71.19 -31.84 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 1.41 109.754 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.7 mtp -71.84 -56.86 4.96 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.776 -1.194 . . . . 0.86 107.776 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.89 -38.72 73.19 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.641 -0.709 . . . . 0.59 110.408 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -70.17 -50.81 36.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.08 -1.012 . . . . 3.06 110.176 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.6 m -69.25 -36.87 77.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.266 -0.896 . . . . 0.73 109.794 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 199' ' ' LEU . 14.9 mt -92.86 2.55 56.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.264 -0.898 . . . . 0.67 109.319 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 48.92 11.81 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.344 -0.847 . . . . 1.49 110.829 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 197' ' ' LEU . 84.2 mt -66.72 145.93 99.0 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.777 -1.202 . . . . 0.64 109.083 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.03 133.43 53.29 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.73 1.62 . . . . 0.59 111.099 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -162.79 171.84 16.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.421 -1.424 . . . . 0.55 111.4 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.418 ' CD1' HD11 ' A' ' 220' ' ' LEU . 65.9 mt -146.95 156.87 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.434 -1.691 . . . . 0.63 106.434 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.545 ' O ' ' O ' ' A' ' 181' ' ' THR . 29.9 m -140.66 -34.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 120.794 -1.191 . . . . 0.77 110.735 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.1 39.92 1.43 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.326 -1.91 . . . . 0.87 108.326 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' ' 203' ' ' VAL . 16.6 p -68.53 -6.14 23.62 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.415 -1.05 . . . . 0.89 109.46 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 49.74 -103.11 0.07 OUTLIER Glycine 0 N--CA 1.483 1.768 0 C-N-CA 119.709 -1.234 . . . . 0.93 110.149 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 12.3 p -115.81 51.17 0.96 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.197 -1.178 . . . . 1.6 112.152 -176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.407 HG22 HD13 ' A' ' 2' ' ' ILE . 12.0 t -72.44 -25.72 23.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.145 -1.428 . . . . 0.75 107.145 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.6 p -70.51 -10.99 60.62 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.617 -0.882 . . . . 0.84 108.617 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.3 t -104.2 12.27 34.0 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.445 -0.946 . . . . 1.61 108.445 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -133.83 -27.27 1.49 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.689 -0.632 . . . . 2.3 109.598 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 213' ' ' LYS . 70.2 t -111.54 154.43 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.516 -0.74 . . . . 0.76 109.506 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.496 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 25.2 mmtp -123.8 -178.88 4.18 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.559 -1.645 . . . . 2.01 106.559 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.5 p-10 -79.97 149.38 30.82 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.73 -1.231 . . . . 2.19 110.234 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 t70 81.49 -14.99 0.76 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.889 -0.507 . . . . 2.4 110.664 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 73.7 m-20 -59.65 142.78 52.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.787 -1.196 . . . . 1.99 108.997 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -90.08 109.13 20.2 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.08 -1.012 . . . . 1.3 109.218 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.39 172.23 6.96 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.927 0.87 . . . . 0.53 109.714 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.9 mt -143.71 116.6 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.559 -1.274 . . . . 0.6 107.559 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.418 HD11 ' CD1' ' A' ' 202' ' ' ILE . 23.3 tp -84.79 127.06 33.94 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.161 -0.962 . . . . 0.57 108.737 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 4.8 p-10 -89.22 -36.16 15.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.087 -1.008 . . . . 2.22 109.119 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.539 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 44.58 21.57 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.542 -0.724 . . . . 0.75 110.142 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 221' ' ' ASP . 28.2 t -122.62 -61.4 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.754 -1.202 . . . . 0.92 107.754 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -91.99 17.07 9.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.396 -0.964 . . . . 2.36 108.396 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 53.91 56.32 7.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.67 -0.644 . . . . 1.42 109.928 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.445 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 69.2 mt-30 -152.96 144.32 23.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.191 -0.943 . . . . 1.97 110.351 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 92.7 t -99.48 151.56 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.994 -1.113 . . . . 0.65 107.994 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -122.41 120.85 35.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.378 -0.826 . . . . 0.97 109.216 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.3 t -104.93 120.32 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.455 -0.778 . . . . 0.67 109.642 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 48.29 65.55 6.9 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 1.45 109.915 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.89 165.16 24.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.782 2.322 . . . . 0.82 111.976 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.8 p -75.43 142.46 43.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 1.62 109.388 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -54.41 -14.85 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 2.6 109.243 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -72.84 -38.18 67.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -0.794 . . . . 3.06 109.463 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.01 -41.25 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 1.14 109.005 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.1 mt -55.85 -55.48 17.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.403 -0.81 . . . . 1.04 109.593 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -53.1 -40.02 63.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 2.54 109.849 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -66.91 -37.66 84.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.293 -0.879 . . . . 2.6 110.119 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 46.7 mtp -82.82 -25.26 32.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.154 -0.966 . . . . 1.23 110.028 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 12.3 mmm-85 -59.91 -45.91 91.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.134 -0.979 . . . . 2.67 109.74 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.79 -48.97 22.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 1.66 110.178 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.79 -55.3 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.072 -1.017 . . . . 2.2 110.027 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -44.93 -57.27 3.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 3.0 110.148 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--N 1.297 -1.674 0 O-C-N 121.487 -0.758 . . . . 1.76 110.142 -179.174 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.518 ' O ' ' N ' ' A' ' 3' ' ' SER . 49.1 mtm . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.589 -0.523 . . . . 3.66 109.589 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 53.3 mt -53.44 89.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 1.12 108.915 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 1' ' ' MET . 70.1 m -95.94 119.34 34.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.327 -0.858 . . . . 1.45 109.955 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.34 -158.53 12.41 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.446 -1.861 . . . . 0.92 108.446 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.513 ' O ' ' O ' ' A' ' 6' ' ' LEU . 56.4 mt -97.77 -11.41 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.155 -1.203 . . . . 1.05 108.24 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.4 tp 50.87 109.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.591 0.71 . . . . 0.88 109.376 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.36 -50.12 8.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.717 -1.239 . . . . 0.78 109.543 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.88 150.26 45.56 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.266 -0.896 . . . . 1.5 109.431 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.48 152.84 30.31 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.383 2.056 . . . . 0.86 113.52 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.9 121.4 0.81 Allowed Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.319 -1.112 . . . . 0.78 110.319 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.2 mt -88.55 133.14 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.079 -1.248 . . . . 0.74 109.818 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.07 161.51 36.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.561 -0.712 . . . . 0.45 109.89 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.7 m-85 -130.48 135.92 48.46 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.517 -0.92 . . . . 0.64 108.517 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.45 165.26 31.27 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 118.419 -1.848 . . . . 0.45 111.54 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -81.06 150.01 28.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.696 -0.885 . . . . 1.88 109.916 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.461 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -79.81 128.78 33.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 0.59 111.279 -178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 17' ' ' LEU . 35.9 tp -107.38 95.38 5.66 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.204 -1.406 . . . . 0.64 107.204 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.6 tp -81.37 122.5 27.55 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.099 -1.001 . . . . 0.74 110.844 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.3 98.33 9.89 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.015 -0.538 . . . . 0.74 109.644 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -92.23 159.87 15.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 1.87 108.798 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.484 ' OE2' ' N ' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -130.13 130.03 44.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.447 -0.783 . . . . 2.58 109.083 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.484 ' N ' ' OE2' ' A' ' 21' ' ' GLU . 5.4 m-20 -80.22 131.96 35.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.268 -0.895 . . . . 2.14 109.198 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -64.66 146.94 53.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 1.93 109.274 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.65 135.35 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 0.68 109.72 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.39 114.49 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.85 -0.796 . . . . 0.84 108.85 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.3 mt -90.29 139.61 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.79 109.778 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -93.19 122.39 35.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.197 -0.939 . . . . 1.37 110.029 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -96.31 19.15 12.4 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.283 -0.886 . . . . 2.62 109.703 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -80.26 156.36 26.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.97 -1.081 . . . . 2.35 109.906 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -90.67 127.69 36.38 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.159 -0.682 . . . . 2.35 109.159 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.419 HG12 ' H ' ' A' ' 31' ' ' ILE . 9.4 pt -78.87 171.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.006 . . . . 0.78 109.58 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.476 ' HG ' ' CG ' ' A' ' 34' ' ' ASP . 72.2 p -101.04 163.82 12.1 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.946 -0.761 . . . . 1.04 108.946 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.88 -25.92 63.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 1.05 109.726 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.476 ' CG ' ' HG ' ' A' ' 32' ' ' SER . 1.4 p-10 -79.85 -12.8 59.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.127 -0.983 . . . . 2.47 108.702 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.403 ' NE2' ' H ' ' A' ' 32' ' ' SER . 9.3 mt-30 -102.29 -12.31 18.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.639 -0.874 . . . . 1.46 108.639 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -67.68 -49.71 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.77 108.746 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 1.2 m-20 -57.96 -39.89 79.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 1.46 109.919 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -67.54 -36.6 81.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 2.29 110.56 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -65.89 -33.23 75.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.972 -1.08 . . . . 1.3 109.528 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.6 t -62.25 -45.13 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.76 109.276 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -64.29 -32.58 74.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.104 -0.997 . . . . 1.5 108.387 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' A' ' 42' ' ' ARG . 8.2 mtt-85 -66.18 -37.32 85.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.481 -0.762 . . . . 2.66 109.083 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 34.6 t80 -86.21 -54.15 4.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.185 -0.947 . . . . 0.75 108.903 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 tp -48.78 -66.99 0.31 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.333 -0.854 . . . . 0.83 109.091 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.8 t -64.41 -28.38 69.64 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.784 -0.821 . . . . 0.78 108.784 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -59.93 -54.77 34.68 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 107.527 -2.229 . . . . 0.57 107.527 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.456 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.0 OUTLIER -47.39 -30.64 3.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.647 -0.914 . . . . 2.83 108.698 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -61.81 -34.88 76.72 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.211 -1.033 . . . . 0.65 108.211 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' GLY . 31.2 mtpt -82.14 -60.62 2.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.692 -0.63 . . . . 2.57 109.646 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.25 -38.55 27.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.51 109.975 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -65.35 -39.04 91.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.024 -1.047 . . . . 1.36 108.922 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.61 64.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.753 -0.592 . . . . 0.6 110.584 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -63.62 -47.79 79.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 1.36 109.965 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.35 -46.42 64.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.922 -1.112 . . . . 1.38 109.455 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -48.15 -52.37 20.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.384 -0.822 . . . . 1.27 109.752 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -60.84 -34.0 73.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.6 109.849 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -72.3 -27.98 27.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.186 -0.946 . . . . 0.53 108.899 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -63.51 -42.39 98.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 0.99 109.898 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -72.72 -28.83 62.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.168 -0.957 . . . . 0.59 109.844 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -72.45 -25.31 61.4 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.657 -1.238 . . . . 1.81 107.657 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.79 -29.95 56.26 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.948 -1.131 . . . . 0.48 107.948 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.2 -29.84 24.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.895 -1.282 . . . . 0.58 109.895 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -86.34 -16.21 38.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.864 -1.374 . . . . 1.39 109.076 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -93.37 -48.89 6.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.89 . . . . 0.82 110.065 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -106.93 -16.35 14.48 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.26 -0.9 . . . . 0.99 110.793 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 119.44 142.92 6.89 Favored Glycine 0 N--CA 1.503 3.111 0 N-CA-C 109.486 -1.445 . . . . 0.55 109.486 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -49.99 -5.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.397 -1.061 . . . . 2.59 110.62 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' GLY . 34.3 mt-10 -64.02 -24.09 67.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.937 -1.102 . . . . 2.2 109.874 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -90.58 -9.44 47.1 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.076 -1.015 . . . . 1.79 110.264 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -64.1 -29.63 70.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.003 -1.061 . . . . 1.54 110.893 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -35.96 82.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.826 -1.171 . . . . 0.64 110.105 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.6 mt -73.2 -45.78 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.999 -1.063 . . . . 0.58 109.658 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.62 -23.9 53.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.91 . . . . 0.62 109.747 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -64.75 -44.67 89.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.931 -1.105 . . . . 1.23 109.152 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.36 -34.49 80.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.442 -1.463 . . . . 0.52 109.442 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -62.65 -20.94 65.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -1.159 . . . . 1.29 110.172 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.3 mt -85.29 -38.7 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.762 -1.211 . . . . 0.55 108.337 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.7 ttt -58.65 -39.45 80.61 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.491 -0.929 . . . . 1.89 108.491 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tp -64.21 -41.9 96.84 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.867 -0.79 . . . . 0.53 108.867 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.3 tp -68.25 -44.76 74.92 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.759 -0.777 . . . . 0.43 109.193 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.16 8.33 21.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.933 . . . . 1.24 110.117 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -47.57 123.55 5.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.822 -1.174 . . . . 1.31 109.989 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.38 -26.07 67.09 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.788 -0.819 . . . . 1.35 108.788 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.58 -50.47 17.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.346 -0.846 . . . . 2.16 109.309 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.94 -16.83 63.79 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.187 -1.005 . . . . 0.6 109.282 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.82 -51.0 12.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 1.28 110.507 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -62.16 -29.92 70.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.139 -0.976 . . . . 1.28 110.232 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -74.14 -44.56 53.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 1.29 109.649 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.95 -57.35 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.09 -1.078 . . . . 0.58 108.09 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.7 mt -46.31 -63.57 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.684 -0.635 . . . . 0.78 109.786 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.34 -53.74 8.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.245 -0.909 . . . . 0.86 110.103 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.543 HD13 ' OE1' ' A' ' 106' ' ' GLU . 57.7 mt -50.03 -54.7 18.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 0.79 109.252 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.7 mt -53.53 -42.48 49.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.331 -0.856 . . . . 0.71 110.4 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -85.88 -36.82 19.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.99 -1.069 . . . . 2.05 111.563 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -83.25 -38.16 22.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.943 -1.098 . . . . 1.59 111.76 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -104.25 9.82 35.89 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.758 -1.214 . . . . 1.89 109.804 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.4 m80 49.6 42.34 22.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.922 -1.111 . . . . 1.31 109.188 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.5 mtt -97.49 150.78 20.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.082 -0.71 . . . . 1.28 109.082 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.9 p -75.02 145.64 42.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.494 -0.754 . . . . 0.62 109.767 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.7 -26.27 8.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.218 -0.926 . . . . 0.47 108.821 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -75.15 -50.0 17.73 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.589 -0.893 . . . . 2.0 108.589 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.27 -50.94 34.41 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.283 0.563 . . . . 0.56 110.066 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.57 -56.52 20.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.48 109.888 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.44 62.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.199 -0.938 . . . . 0.44 109.271 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -69.37 -21.21 63.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 1.42 109.024 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.543 ' OE1' HD13 ' A' ' 92' ' ' LEU . 41.8 tt0 -70.57 -50.36 38.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.496 -0.752 . . . . 1.26 109.905 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.97 -40.66 89.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.862 -1.149 . . . . 0.61 109.299 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.79 -19.48 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.243 -0.91 . . . . 0.64 108.942 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -76.88 -34.78 57.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 2.2 109.739 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 114' ' ' ALA . . . -85.72 -23.36 46.67 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.104 -1.522 . . . . 0.82 111.591 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -69.65 -42.87 73.67 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.822 -1.399 . . . . 1.27 108.638 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.73 -53.68 9.81 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.436 -0.79 . . . . 0.91 109.824 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 t -60.55 -28.66 68.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.137 -0.977 . . . . 1.73 109.788 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -67.01 -44.57 79.98 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.966 -1.084 . . . . 1.04 110.345 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.9 -24.75 66.91 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.88 -1.138 . . . . 1.03 109.003 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.73 -19.78 65.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 1.95 109.485 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -82.48 -7.03 59.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.196 -0.94 . . . . 1.71 109.513 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 123' ' ' LEU . 2.1 mt -86.42 156.91 19.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.323 -0.861 . . . . 1.26 108.824 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -104.79 58.72 0.69 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.842 -0.799 . . . . 2.83 108.842 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -150.31 118.77 6.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.25 -0.906 . . . . 1.58 109.384 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -64.26 -9.59 18.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 2.8 110.057 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -77.05 -61.22 2.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.184 -0.948 . . . . 1.02 109.444 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 118' ' ' LEU . 10.4 mt -66.48 -26.64 67.27 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.276 -0.89 . . . . 1.06 109.629 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 127' ' ' ALA . 47.7 tttp -67.2 -53.46 30.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 2.39 108.582 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -55.97 -25.14 42.53 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.611 -0.885 . . . . 2.2 108.611 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -72.94 -24.73 60.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.774 -1.565 . . . . 2.09 106.774 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.88 -41.34 95.77 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.643 -0.873 . . . . 0.86 108.643 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.44 -38.12 86.67 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.423 -0.954 . . . . 0.9 108.423 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -71.51 -25.81 62.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 1.35 109.286 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.44 -47.5 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.329 -0.857 . . . . 0.58 108.908 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -55.39 -36.49 66.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.876 -1.14 . . . . 3.22 108.283 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.13 -37.13 83.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.595 -0.69 . . . . 1.32 110.718 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.5 mt -67.5 -25.08 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.981 -1.074 . . . . 0.5 109.655 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.56 -46.64 9.62 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.025 -1.63 . . . . 0.44 109.025 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -48.58 -42.46 33.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.484 -1.009 . . . . 2.71 109.677 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 136' ' ' ARG . 24.4 mtt-85 -63.54 -52.32 61.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.095 -1.003 . . . . 2.2 108.553 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.9 tp -51.2 -41.36 60.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.748 -0.595 . . . . 1.13 109.854 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 140' ' ' ASN . 11.2 mt -66.9 -61.31 2.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.54 110.008 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -43.95 -19.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.403 -0.811 . . . . 2.32 110.858 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.491 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 1.8 m120 -85.46 -34.1 21.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.04 -1.038 . . . . 1.26 109.925 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.2 mt -73.45 -33.3 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.043 -1.036 . . . . 0.62 108.805 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 55.8 mt -86.73 3.08 46.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.334 -0.854 . . . . 0.67 109.344 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.06 27.73 23.36 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.433 -1.867 . . . . 0.68 108.433 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.64 148.51 28.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.526 -0.985 . . . . 0.77 109.443 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -66.56 132.81 49.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 2.4 109.403 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 76.6 mt -102.13 134.59 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.383 -0.823 . . . . 0.87 109.027 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.794 ' H ' HD12 ' A' ' 147' ' ' ILE . 2.5 mp -77.93 133.32 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 1.32 110.09 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -98.53 88.46 4.11 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.614 -0.884 . . . . 1.54 108.614 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.0 mt -78.75 -30.08 45.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.318 -0.864 . . . . 0.77 110.011 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 m -81.85 30.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 1.57 109.57 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.23 32.38 2.13 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.243 -0.91 . . . . 0.82 109.129 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.43 152.56 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.369 -0.832 . . . . 0.82 110.13 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -129.22 -10.19 4.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.538 -0.912 . . . . 2.11 108.538 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 154' ' ' ASP . 0.7 OUTLIER -120.1 127.37 52.47 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.424 -0.798 . . . . 1.41 109.17 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.92 124.09 20.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 1.3 109.614 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.83 175.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.194 -0.941 . . . . 0.57 109.411 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.8 mt -88.11 153.68 3.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.605 -1.257 . . . . 0.43 107.605 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.5 tp -104.49 117.29 33.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.443 -0.786 . . . . 0.56 109.041 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 35.6 t -120.57 133.11 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.603 -0.888 . . . . 0.54 108.603 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.58 143.21 11.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.373 -0.829 . . . . 0.62 109.039 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.42 -27.05 67.17 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.614 -1.304 . . . . 0.8 107.909 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 20.2 t0 -172.27 145.45 1.71 Allowed 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.69 -0.631 . . . . 2.34 109.59 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.527 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 25.3 mt -119.74 130.34 54.94 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.557 -0.905 . . . . 0.65 108.557 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.6 p -93.34 148.3 35.32 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.976 -1.078 . . . . 0.74 109.677 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 169' ' ' ALA . 78.3 Cg_exo -36.96 -49.16 1.52 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.594 2.196 . . . . 0.6 112.327 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.8 m -51.41 -59.81 3.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.63 109.228 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -53.57 -41.33 66.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -0.876 . . . . 1.25 109.432 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 19.4 p -73.59 -22.57 60.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.5 110.013 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -76.61 -26.87 55.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.115 -0.991 . . . . 0.51 110.066 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -105.15 -10.89 16.83 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.15 -0.969 . . . . 1.17 109.944 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.36 156.02 10.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.153 -0.967 . . . . 0.61 109.169 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -98.51 132.34 44.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.012 -1.055 . . . . 2.12 108.233 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.4 mp -82.17 -44.67 16.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 1.34 111.238 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -83.44 -8.72 59.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.826 -1.171 . . . . 1.97 112.111 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -98.65 -8.54 26.1 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.612 -1.305 . . . . 1.9 108.77 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 177' ' ' LEU . 53.0 t -98.2 161.19 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.211 -1.033 . . . . 0.48 108.211 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.478 ' N ' HG12 ' A' ' 176' ' ' VAL . 9.3 tp -108.61 -23.97 11.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.313 -0.867 . . . . 1.39 109.907 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -178.33 174.41 46.68 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.942 -1.663 . . . . 0.38 108.942 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -129.43 122.44 29.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.588 -0.948 . . . . 0.46 108.992 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 12.9 mt -128.43 128.11 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.377 -0.971 . . . . 0.59 108.377 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 203' ' ' VAL . 47.7 p -141.3 146.52 36.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.483 -0.761 . . . . 0.67 111.467 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.461 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 2.8 m-20 -85.73 41.99 0.94 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -0.782 . . . . 2.24 109.501 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.017 0 O-C-N 121.387 -0.821 . . . . 1.11 109.727 -179.44 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.629 ' HA ' HD12 ' A' ' 192' ' ' ILE . 82.3 t60 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.034 -0.728 . . . . 0.92 109.034 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.406 ' H ' HG22 ' A' ' 190' ' ' THR . 0.1 OUTLIER -56.36 -36.24 68.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.23 -0.919 . . . . 1.59 108.937 179.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.5 t -75.0 -37.71 61.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.869 . . . . 1.42 109.079 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 189' ' ' HIS . 88.6 mt -50.51 -32.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.159 -0.963 . . . . 1.41 108.647 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.5 mtm -71.78 -51.51 22.29 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 106.947 -1.501 . . . . 0.86 106.947 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.44 -39.01 66.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.071 -0.714 . . . . 0.59 109.071 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -69.18 -51.69 35.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 3.06 109.351 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.8 m -68.88 -36.62 78.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 0.73 109.344 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 199' ' ' LEU . 39.5 mt -86.83 3.69 44.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.179 -0.95 . . . . 0.67 108.667 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 52.75 2.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 1.49 110.873 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 197' ' ' LEU . 21.9 mt -64.74 169.37 5.35 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.654 -1.279 . . . . 0.64 107.751 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -90.38 143.94 3.87 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.16 1.907 . . . . 0.59 111.684 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.62 175.86 10.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.706 -1.246 . . . . 0.55 111.491 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.453 ' CD1' HD11 ' A' ' 220' ' ' LEU . 10.8 mt -150.78 155.01 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.786 -1.561 . . . . 0.63 106.786 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.6 m -143.51 -29.08 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 120.689 -1.257 . . . . 0.77 111.273 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.15 30.95 3.85 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.993 -1.243 . . . . 0.87 109.993 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 207' ' ' SER . 3.2 p -61.61 -38.84 89.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.726 -1.455 . . . . 0.89 107.806 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.461 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 57.36 -33.43 0.02 OUTLIER Glycine 0 N--CA 1.498 2.769 0 CA-C-O 119.684 -0.509 . . . . 0.93 113.851 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 205' ' ' THR . 95.2 p -124.83 1.14 8.09 Favored 'General case' 0 N--CA 1.512 2.646 0 CA-C-N 119.613 1.706 . . . . 1.6 112.652 -177.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 t -65.44 -48.39 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.144 -1.597 . . . . 0.75 109.753 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 p -54.64 -16.1 2.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.884 -1.135 . . . . 0.84 110.045 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.1 t -104.13 11.72 34.77 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.316 -0.865 . . . . 1.61 109.65 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -142.25 -3.82 1.05 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.288 -0.882 . . . . 2.3 110.411 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.75 145.18 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.433 -0.792 . . . . 0.76 108.936 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -120.55 172.98 7.46 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.515 -1.661 . . . . 2.01 106.515 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -74.25 141.13 45.38 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.722 -1.236 . . . . 2.19 109.801 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.33 -10.12 1.22 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.807 -0.558 . . . . 2.4 110.359 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -56.86 141.32 45.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.675 -1.265 . . . . 1.99 107.994 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -87.18 111.64 21.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.954 -1.091 . . . . 1.3 109.19 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 20.7 mt -121.41 168.32 11.81 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.992 0.901 . . . . 0.53 110.52 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.9 mt -140.46 123.56 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.192 -1.04 . . . . 0.6 108.192 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.453 HD11 ' CD1' ' A' ' 202' ' ' ILE . 15.1 tp -89.72 128.6 36.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.925 . . . . 0.57 109.169 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.27 -38.16 11.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.108 -0.995 . . . . 2.22 108.923 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 44.78 25.0 0.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.63 -0.669 . . . . 0.75 110.53 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.15 -62.24 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 106.981 -1.488 . . . . 0.92 106.981 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -87.59 14.46 8.31 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.95 -1.13 . . . . 2.36 107.95 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.64 57.66 3.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.68 -0.638 . . . . 1.42 109.677 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -156.76 151.8 26.17 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.024 -1.048 . . . . 1.97 110.833 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.55 137.54 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.901 -0.777 . . . . 0.65 108.901 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -107.14 131.72 53.82 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.21 -0.931 . . . . 0.97 109.273 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.6 t -103.79 118.19 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 0.67 109.802 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 50.87 69.62 2.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 1.45 109.989 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.96 157.97 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.66 2.24 . . . . 0.82 111.347 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 80.3 p -72.76 144.9 47.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 1.62 109.883 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.664 ' N ' HD22 ' A' ' 233' ' ' ASN . 0.8 OUTLIER -53.02 -27.72 20.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.43 -0.794 . . . . 2.6 109.742 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -64.54 -37.3 87.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 3.06 109.734 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 80.1 t -77.81 -36.16 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.243 -0.91 . . . . 1.14 109.137 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.37 -58.74 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 1.04 109.438 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 233' ' ' ASN . 2.5 m-20 -53.33 -36.53 61.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 2.54 109.51 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -67.24 -36.9 82.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 2.6 108.97 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 62.0 mtp -80.18 -34.6 37.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.409 -0.807 . . . . 1.23 109.463 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -54.87 -38.76 67.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 2.67 109.459 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.97 -57.21 4.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 1.66 109.689 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 73.9 t -58.74 -50.79 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.422 -0.799 . . . . 2.2 110.275 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.37 -58.41 7.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.943 -1.098 . . . . 3.0 110.148 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 C--N 1.298 -1.663 0 O-C-N 121.288 -0.882 . . . . 1.76 110.275 -179.038 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.518 -0.549 . . . . 3.66 109.518 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.07 103.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 1.12 109.361 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -93.08 120.22 33.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.329 -0.857 . . . . 1.45 110.033 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.67 -160.19 11.6 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 108.41 -1.876 . . . . 0.92 108.41 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.0 mt -93.55 -9.96 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.995 -1.297 . . . . 1.05 109.029 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' ILE . 14.2 tp 56.94 107.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 0.88 109.306 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.52 -53.61 4.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.081 -1.012 . . . . 0.78 108.318 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.95 146.16 25.0 Favored Pre-proline 0 N--CA 1.494 1.741 0 N-CA-C 108.582 -0.896 . . . . 1.5 108.582 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.3 153.37 31.37 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.069 1.846 . . . . 0.86 113.148 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.68 124.1 1.1 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.051 -1.22 . . . . 0.78 110.051 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.574 HD12 ' HG2' ' A' ' 243' ' ' GLN . 72.7 mt -89.36 129.01 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.132 -1.216 . . . . 0.74 109.566 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.16 149.22 49.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.383 -0.823 . . . . 0.45 109.572 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.9 m-85 -117.87 140.06 50.24 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.626 -0.879 . . . . 0.64 108.626 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.65 163.47 29.96 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.725 -1.702 . . . . 0.45 111.24 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -78.57 151.71 32.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.991 . . . . 1.88 109.902 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.21 129.32 34.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.59 111.114 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -111.82 90.84 3.45 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.193 -1.41 . . . . 0.64 107.193 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 18' ' ' LEU . 11.7 tp -81.38 128.72 34.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.059 -1.025 . . . . 0.74 110.687 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' A' ' 160' ' ' ALA . 32.2 mt -96.88 93.99 6.97 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.454 0.645 . . . . 0.74 109.854 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -93.07 156.35 16.93 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.54 -0.911 . . . . 1.87 108.54 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.02 131.3 44.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.247 -0.908 . . . . 2.58 109.036 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.92 138.63 38.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.148 -0.97 . . . . 2.14 108.924 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.23 140.68 58.9 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.45 -0.781 . . . . 1.93 109.282 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mt -91.69 132.96 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.215 -0.928 . . . . 0.68 109.917 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.8 t -106.61 111.98 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.637 -0.875 . . . . 0.84 108.637 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.2 mt -85.07 152.2 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.941 . . . . 0.79 109.586 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -90.89 107.54 19.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.497 -0.752 . . . . 1.37 109.927 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' NH1' ' HB1' ' A' ' 102' ' ' ALA . 20.4 mmm180 -95.46 24.57 5.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.277 -0.889 . . . . 2.62 108.754 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -85.85 144.04 27.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.371 -0.831 . . . . 2.35 109.79 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -86.72 123.97 32.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.213 -0.929 . . . . 2.35 108.824 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.2 pt -87.22 174.89 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.16 -0.962 . . . . 0.78 110.599 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.2 p -100.84 156.41 17.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.842 -0.799 . . . . 1.04 108.842 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.9 -8.44 0.99 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 1.05 109.47 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.95 -21.28 31.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 2.47 109.898 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -105.9 -1.36 24.22 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.329 -0.857 . . . . 1.46 109.327 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -64.95 -44.85 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.975 . . . . 0.77 108.742 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -52.34 -36.46 53.57 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.262 -0.899 . . . . 1.46 109.19 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -69.46 -34.3 74.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.476 -0.765 . . . . 2.29 110.152 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.433 ' OE2' ' NH2' ' A' ' 42' ' ' ARG . 80.4 mm-40 -62.55 -43.34 99.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.999 -1.063 . . . . 1.3 109.715 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 44' ' ' LEU . 82.2 t -59.84 -48.58 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.76 110.035 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -66.55 -44.77 81.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.012 -1.055 . . . . 1.5 108.991 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.433 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 72.1 mtm180 -61.36 -33.97 74.53 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.108 -0.995 . . . . 2.66 108.895 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -86.35 -54.43 4.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.75 108.945 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 40' ' ' VAL . 57.3 tp -51.01 -66.77 0.33 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.469 -0.77 . . . . 0.83 109.493 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 t -63.19 -30.15 71.35 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.952 -1.093 . . . . 0.78 108.154 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.85 -8.01 51.34 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 107.347 -2.301 . . . . 0.57 107.347 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.2 OUTLIER -85.02 -29.02 25.31 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.126 -1.805 . . . . 2.83 106.126 177.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.36 64.17 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.941 -1.133 . . . . 0.65 107.941 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -84.91 -64.22 1.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.919 -0.771 . . . . 2.57 108.919 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.32 -41.89 51.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.978 . . . . 0.51 109.514 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.9 m -63.36 -37.93 89.18 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.011 -1.107 . . . . 1.36 108.011 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.36 -21.51 60.51 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.401 -0.592 . . . . 0.6 109.401 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.683 HE22 ' ND2' ' A' ' 140' ' ' ASN . 74.0 mt-30 -73.45 -68.35 0.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 1.36 109.471 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 58' ' ' LYS . 13.7 mt -48.93 -42.52 37.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.064 -1.022 . . . . 1.38 108.839 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -50.55 -48.76 57.3 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.448 -0.945 . . . . 1.27 108.448 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -61.96 -40.37 95.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.6 109.053 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.6 mt -74.71 -25.14 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.53 108.879 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.584 ' HZ1' ' CD ' ' A' ' 70' ' ' GLU . 13.3 ttpp -64.31 -52.52 58.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.564 -0.71 . . . . 0.99 110.219 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.33 -25.45 63.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.968 -1.083 . . . . 0.59 109.794 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -71.63 -24.12 61.81 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.904 -1.122 . . . . 1.81 108.029 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.74 -32.87 60.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.367 -0.975 . . . . 0.48 108.367 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.73 -28.77 28.35 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.842 -1.303 . . . . 0.58 109.842 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -86.42 -14.99 41.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.28 . . . . 1.39 108.784 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.2 m -92.84 -51.4 5.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.82 110.054 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -106.85 -21.77 12.91 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.305 -0.872 . . . . 0.99 110.44 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.87 153.6 9.1 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 109.77 -1.332 . . . . 0.55 109.77 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -48.87 -8.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.508 -0.995 . . . . 2.59 110.464 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 66' ' ' GLY . 39.8 tt0 -63.91 -42.61 97.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 2.2 110.377 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -90.81 -10.01 44.37 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.014 -1.054 . . . . 1.79 110.494 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.584 ' CD ' ' HZ1' ' A' ' 58' ' ' LYS . 34.1 tt0 -67.04 -31.04 71.29 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.942 -1.099 . . . . 1.54 110.809 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.91 68.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.097 -1.002 . . . . 0.64 110.41 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.482 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 39.7 mt -72.04 -42.56 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.036 -1.04 . . . . 0.58 109.771 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -76.71 -19.21 57.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.097 -1.002 . . . . 0.62 109.307 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.07 -49.32 72.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.26 -0.9 . . . . 1.23 108.704 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.38 82.17 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.312 -1.515 . . . . 0.52 109.312 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.482 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 23.5 m170 -60.57 -24.39 65.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -1.204 . . . . 1.29 110.036 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.5 mt -81.15 -36.18 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.727 -1.233 . . . . 0.55 108.546 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.9 ttp -58.02 -43.84 86.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.537 -0.912 . . . . 1.89 108.537 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -57.31 -42.52 81.98 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.757 -0.831 . . . . 0.53 108.757 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.12 -41.48 77.32 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.352 -0.842 . . . . 0.43 109.258 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -85.4 8.39 19.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.414 -0.803 . . . . 1.24 110.225 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -50.05 123.44 8.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.947 -1.096 . . . . 1.31 109.484 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.55 -22.67 65.39 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.301 -0.875 . . . . 1.35 108.911 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -76.76 -49.52 15.75 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.393 -0.817 . . . . 2.16 109.318 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.9 mt -64.28 -15.32 59.95 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.292 -0.963 . . . . 0.6 109.242 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -82.9 -46.4 13.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 1.28 110.458 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -62.41 -30.19 71.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.13 -0.981 . . . . 1.28 109.906 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -73.29 -43.57 60.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.023 -1.048 . . . . 1.29 109.01 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.06 -56.96 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.492 -0.929 . . . . 0.58 108.492 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.0 mt -48.9 -66.17 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.696 -0.627 . . . . 0.78 110.417 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -43.1 -58.9 2.26 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.44 -0.788 . . . . 0.86 110.876 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.0 mt -45.87 -54.35 8.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.317 -0.864 . . . . 0.79 110.024 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.1 mt -50.86 -41.2 21.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.07 -1.019 . . . . 0.71 109.757 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -85.76 -38.53 18.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.277 -0.889 . . . . 2.05 111.594 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -82.22 -40.25 21.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.901 -1.124 . . . . 1.59 111.912 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -108.03 16.54 23.29 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.721 -1.237 . . . . 1.89 110.162 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.9 m80 44.85 48.76 9.14 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.205 -0.935 . . . . 1.31 109.525 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.7 mtt -100.72 147.47 25.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 1.28 109.261 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.1 p -75.68 143.75 41.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.313 -0.867 . . . . 0.62 109.164 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.12 -25.62 2.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.47 108.887 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.55 -48.97 23.71 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.534 -0.913 . . . . 2.0 108.534 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.524 ' HB1' ' NH1' ' A' ' 28' ' ' ARG . . . -70.51 -53.61 15.53 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.779 -0.575 . . . . 0.56 110.013 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.68 -46.7 77.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.48 109.411 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.89 66.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.44 109.478 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -69.75 -36.47 75.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 1.42 109.567 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -53.67 -50.54 65.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.832 . . . . 1.26 110.314 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.16 -49.02 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.975 -1.078 . . . . 0.61 109.601 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -63.12 -19.27 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.429 -0.794 . . . . 0.64 109.046 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -73.85 -37.53 64.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.992 . . . . 2.2 109.952 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.02 -26.57 31.0 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.524 -1.322 . . . . 0.82 112.619 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -67.68 -47.05 70.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.528 -1.572 . . . . 1.27 108.948 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.04 -50.38 23.36 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.604 -0.685 . . . . 0.91 109.218 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -59.27 -42.28 90.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.78 . . . . 1.73 110.039 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.07 -37.3 86.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.125 -0.984 . . . . 1.04 110.905 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.3 -29.59 68.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.735 -1.228 . . . . 1.03 109.426 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -67.54 -15.87 63.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.935 . . . . 1.95 109.627 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.43 -9.06 59.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.197 -0.94 . . . . 1.71 109.278 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 123' ' ' LEU . 2.2 mt -87.36 146.54 25.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 1.26 108.636 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 20.5 p-10 -100.6 62.71 1.05 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.45 -0.781 . . . . 2.83 109.311 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -150.08 113.5 4.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 1.58 109.522 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -53.6 -12.28 0.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 2.8 109.607 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.74 -62.19 1.76 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.933 . . . . 1.02 109.072 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 118' ' ' LEU . 56.6 mt -71.01 -27.47 63.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.88 . . . . 1.06 109.599 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -68.08 -52.52 34.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.061 -1.024 . . . . 2.39 108.831 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.28 -20.9 58.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.423 -0.954 . . . . 2.2 108.423 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.572 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -72.55 -26.96 61.93 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.485 -1.672 . . . . 2.09 106.485 178.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.24 -44.09 92.35 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.284 -1.006 . . . . 0.86 108.284 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.09 80.82 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.818 -0.808 . . . . 0.9 108.818 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -70.07 -32.17 70.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.42 -0.8 . . . . 1.35 109.371 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.2 t -77.83 -45.99 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.128 -0.983 . . . . 0.58 108.37 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -57.48 -39.97 77.58 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.263 -1.014 . . . . 3.22 108.263 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.51 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 14.5 t70 -56.27 -39.32 72.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.563 -0.71 . . . . 1.32 109.637 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.47 -20.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.163 -0.96 . . . . 0.5 108.881 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.69 -53.53 4.27 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.943 -1.263 . . . . 0.44 109.943 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -49.04 -39.48 27.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.012 -1.287 . . . . 2.71 108.832 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' A' ' 136' ' ' ARG . 3.1 mtt-85 -65.16 -45.97 82.78 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.282 -1.007 . . . . 2.2 108.282 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.5 tp -53.61 -45.13 69.98 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.042 -0.725 . . . . 1.13 109.042 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 140' ' ' ASN . 18.2 mt -60.41 -60.2 4.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.54 109.435 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -43.97 -20.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 2.32 110.324 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.683 ' ND2' HE22 ' A' ' 53' ' ' GLN . 1.8 m120 -85.4 -49.92 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 1.26 109.665 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -61.91 -35.43 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.62 109.541 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.6 mt -88.49 -4.45 58.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.307 -0.871 . . . . 0.67 109.17 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.67 22.54 46.94 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.466 -1.854 . . . . 0.68 108.466 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.02 162.46 14.03 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.538 -0.977 . . . . 0.77 109.318 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -65.06 151.21 46.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 2.4 109.528 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.3 mt -107.62 144.36 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 109.166 -0.679 . . . . 0.87 109.166 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.1 mm -76.77 100.54 2.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.236 -0.915 . . . . 1.32 109.138 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.71 92.7 6.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.407 -0.808 . . . . 1.54 109.591 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.484 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 34.2 mt -79.56 -11.8 59.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.77 108.924 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.8 p -86.37 47.16 1.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 1.57 108.768 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.08 16.6 3.25 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.382 -0.823 . . . . 0.82 110.199 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 152' ' ' ILE . 2.4 mp -69.04 151.79 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.856 -1.152 . . . . 0.82 108.884 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -133.28 -22.32 1.99 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.05 -0.722 . . . . 2.11 109.05 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.97 151.36 36.88 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.68 -0.859 . . . . 1.41 108.68 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.61 124.73 24.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 1.3 109.835 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.2 m -148.27 167.71 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.199 -0.938 . . . . 0.57 109.339 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.6 mt -89.5 156.99 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.789 -1.189 . . . . 0.43 107.789 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.6 tp -107.23 121.67 45.0 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.732 0.777 . . . . 0.56 109.69 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.16 128.6 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.659 -0.867 . . . . 0.54 108.659 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -163.74 152.29 13.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 0.62 109.9 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.77 -43.1 94.49 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.374 -1.453 . . . . 0.8 107.949 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -172.34 153.27 2.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.372 -0.83 . . . . 2.34 109.458 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.1 mt -125.69 133.89 52.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.571 -0.706 . . . . 0.65 109.399 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.4 p -93.04 154.39 41.71 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.822 . . . . 0.74 109.084 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -33.9 -51.33 0.56 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.808 2.339 . . . . 0.6 112.948 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.7 m -50.03 -50.35 47.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.099 -1.001 . . . . 0.63 109.289 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.99 -42.28 98.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.333 -0.855 . . . . 1.25 109.846 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.4 p -70.49 -31.34 68.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.5 109.563 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.62 -29.74 68.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.51 110.011 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -103.53 -4.31 24.11 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.25 -0.906 . . . . 1.17 110.15 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 tp -57.71 153.14 14.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.91 -1.118 . . . . 0.61 108.275 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.762 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.2 OUTLIER -99.5 90.55 4.55 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.147 -0.971 . . . . 2.12 110.3 -178.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.56 32.18 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 1.34 108.674 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 172' ' ' ASN . 67.6 mttm -111.12 -24.55 10.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.63 -0.669 . . . . 1.97 109.811 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -132.13 6.64 4.23 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.473 -0.767 . . . . 1.9 109.796 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 172' ' ' ASN . 39.4 t -79.27 154.78 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.087 -1.008 . . . . 0.48 109.031 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.38 -28.21 8.31 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.714 -0.616 . . . . 1.39 110.154 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -176.91 177.96 48.16 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.91 -1.276 . . . . 0.38 109.91 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -129.36 125.53 36.85 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.519 -0.989 . . . . 0.46 110.022 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.557 ' CG2' HG21 ' A' ' 205' ' ' THR . 16.8 mt -128.15 118.99 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.635 -1.246 . . . . 0.59 107.635 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 203' ' ' VAL . 20.8 p -141.83 152.53 43.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.54 -0.725 . . . . 0.67 111.169 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 26.5 p30 -87.66 45.06 1.24 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.991 -1.068 . . . . 2.24 110.823 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -95.92 103.4 15.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.961 -1.087 . . . . 1.11 109.326 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.89 39.4 1.79 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.848 -1.301 . . . . 1.63 109.848 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -96.87 116.43 5.48 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.029 -1.229 . . . . 1.47 110.029 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -52.72 -17.03 1.13 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.223 -1.163 . . . . 5.24 108.305 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 58.7 p -140.26 59.12 1.57 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.544 -0.722 . . . . 2.92 109.172 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.1 t -80.17 142.99 34.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -0.884 . . . . 1.6 108.958 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -45.91 -55.36 6.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.19 -0.944 . . . . 0.92 110.044 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.7 t -46.91 -25.87 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 1.59 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.0 p -78.92 -45.88 19.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 1.42 109.884 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.5 mt -52.49 -32.58 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 1.41 109.674 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.9 mtp -71.46 -51.91 21.28 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.363 -1.347 . . . . 0.86 107.363 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.71 58.82 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.628 -0.714 . . . . 0.59 109.573 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.505 HH11 ' HG2' ' A' ' 195' ' ' ARG . 17.3 mtt-85 -76.95 -50.87 12.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 3.06 109.904 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 61.1 m -68.7 -35.33 77.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.73 109.738 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 199' ' ' LEU . 27.2 mt -87.13 1.49 52.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.265 -0.897 . . . . 0.67 109.092 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 49.19 3.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.559 -0.713 . . . . 1.49 111.631 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 197' ' ' LEU . 40.7 mt -66.01 169.82 6.24 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.491 -1.381 . . . . 0.64 108.382 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -89.86 141.7 3.79 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 122.249 1.966 . . . . 0.59 111.054 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.08 179.74 7.29 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.468 -1.293 . . . . 0.55 110.65 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 203' ' ' VAL . 70.6 mt -147.66 160.93 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 106.82 -1.548 . . . . 0.63 106.82 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 183' ' ' ALA . 18.1 m -141.58 -28.17 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.873 -1.142 . . . . 0.77 110.918 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.36 38.5 3.18 Favored Glycine 0 N--CA 1.496 2.667 0 O-C-N 120.888 -1.132 . . . . 0.87 110.987 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.557 HG21 ' CG2' ' A' ' 180' ' ' ILE . 20.1 p -67.2 -29.11 68.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.67 -1.488 . . . . 0.89 108.77 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 76.7 -98.69 1.3 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.788 -1.196 . . . . 0.93 111.238 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.9 p -113.27 43.47 1.73 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.001 -1.294 . . . . 1.6 112.395 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.8 -28.51 15.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.651 -1.281 . . . . 0.75 107.65 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 18.4 p -64.71 -12.98 52.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.287 -0.883 . . . . 0.84 108.917 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.1 p -108.51 17.1 22.41 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.662 -0.866 . . . . 1.61 108.662 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -131.55 -16.19 3.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.668 -0.645 . . . . 2.3 109.668 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.586 HG12 ' N ' ' A' ' 213' ' ' LYS . 71.1 t -120.38 164.07 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.457 -0.777 . . . . 0.76 109.597 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.586 ' N ' HG12 ' A' ' 212' ' ' VAL . 0.5 OUTLIER -126.58 174.21 8.86 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.841 -1.54 . . . . 2.01 106.841 178.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 214' ' ' ASN . 1.4 p-10 -75.02 145.74 42.18 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.786 -1.197 . . . . 2.19 109.824 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.6 OUTLIER 80.38 -12.12 1.07 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.803 -0.561 . . . . 2.4 110.249 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -57.25 150.95 16.78 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.002 -1.061 . . . . 1.99 108.429 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -87.29 110.71 20.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.91 -1.119 . . . . 1.3 108.887 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 16.2 mt -106.22 160.92 14.97 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.89 0.853 . . . . 0.53 109.65 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.509 HD12 ' CG ' ' A' ' 231' ' ' PRO . 3.2 mt -141.94 107.75 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.725 -1.213 . . . . 0.6 107.725 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.5 tp -86.49 126.44 34.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.79 -0.818 . . . . 0.57 108.79 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.0 -53.64 4.18 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.541 -0.911 . . . . 2.22 108.541 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 58.51 22.87 10.14 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.413 -0.804 . . . . 0.75 109.24 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.0 t -117.83 -56.14 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.11 -1.441 . . . . 0.92 107.11 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -96.41 13.25 28.46 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.539 -1.282 . . . . 2.36 107.539 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 59.81 60.19 2.26 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.074 0.464 . . . . 1.42 109.916 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -157.08 147.62 21.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 1.97 110.52 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.8 t -109.72 131.17 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.678 -0.86 . . . . 0.65 108.678 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -103.66 131.31 50.94 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.203 -0.936 . . . . 0.97 109.344 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.5 t -102.97 114.8 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.446 -0.784 . . . . 0.67 109.716 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 36.8 t30 45.24 60.88 12.82 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.424 -0.798 . . . . 1.45 110.571 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.509 ' CG ' HD12 ' A' ' 219' ' ' ILE . 38.4 Cg_endo -70.35 165.06 32.9 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.283 1.989 . . . . 0.82 111.415 179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.9 m -72.27 158.04 36.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 1.62 109.804 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -64.48 -22.35 66.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 2.6 109.031 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 234' ' ' GLU . 0.8 OUTLIER -66.91 -36.8 83.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.434 -0.791 . . . . 3.06 109.129 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 68.7 t -79.01 -48.94 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.248 -0.908 . . . . 1.14 108.704 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.93 -59.09 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.408 -0.807 . . . . 1.04 109.651 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -52.12 -41.3 62.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 2.54 109.961 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -66.84 -37.65 84.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 2.6 109.739 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 243' ' ' GLN . 28.5 mtm -81.94 -32.96 30.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.908 . . . . 1.23 109.676 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -53.81 -40.03 66.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 2.67 109.087 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.48 -51.65 12.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 1.66 109.421 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.4 -47.11 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 2.2 109.527 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.574 ' HG2' HD12 ' A' ' 11' ' ' ILE . 3.1 tm0? -47.56 -57.45 5.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 3.0 109.818 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.26 -28.7 70.2 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.439 -0.788 . . . . 1.76 110.732 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -66.35 -21.9 66.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.68 -1.263 . . . . 2.78 107.849 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 95.8 t -77.51 -36.51 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.226 -1.027 . . . . 2.06 108.226 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.6 -35.39 60.82 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.28 -1.007 . . . . 2.4 108.28 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.0 t -75.55 -29.28 59.35 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.925 -0.768 . . . . 2.87 108.925 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 . . . . . 0 N--CA 1.486 1.353 0 N-CA-C 107.432 -1.321 . . . . 3.41 107.432 178.824 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.549 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.9 mpt? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.56 -0.533 . . . . 3.66 109.56 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.23 94.18 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.584 -0.895 . . . . 1.12 108.584 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.7 m -96.16 115.86 28.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.31 -0.869 . . . . 1.45 109.894 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.8 -163.5 21.41 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.332 -1.907 . . . . 0.92 108.332 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 5' ' ' ILE . 51.1 mt -95.88 -6.15 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -1.171 . . . . 1.05 108.427 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 tp 60.21 107.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.419 -0.801 . . . . 0.88 108.915 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.63 -55.58 3.92 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.982 -1.118 . . . . 0.78 107.982 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.23 150.27 37.44 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.32 -0.993 . . . . 1.5 108.32 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.47 154.18 21.07 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.087 1.858 . . . . 0.86 113.954 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 161.08 -176.07 37.69 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.666 -1.373 . . . . 0.78 109.666 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.402 ' CD1' HE21 ' A' ' 243' ' ' GLN . 36.7 mt -146.18 121.72 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.726 -1.455 . . . . 0.74 109.171 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HB1' HD21 ' A' ' 177' ' ' LEU . . . -139.72 162.54 34.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.267 -0.896 . . . . 0.45 109.733 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.9 m-85 -129.34 140.25 51.45 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.196 -1.039 . . . . 0.64 108.196 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.18 159.76 28.15 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 118.612 -1.756 . . . . 0.45 111.319 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -78.47 150.81 32.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.615 -0.933 . . . . 1.88 109.724 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.42 127.95 34.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.284 -0.885 . . . . 0.59 110.913 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.6 85.35 2.18 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.472 -1.307 . . . . 0.64 107.472 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 18' ' ' LEU . 15.6 tp -82.01 132.23 35.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.055 -1.028 . . . . 0.74 110.617 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 160' ' ' ALA . 14.3 mt -94.92 94.35 7.97 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.551 0.691 . . . . 0.74 109.931 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -94.23 142.04 27.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.782 -0.821 . . . . 1.87 108.782 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -128.74 135.37 49.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 2.58 108.729 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -78.03 136.7 37.98 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.168 -0.958 . . . . 2.14 109.007 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -60.79 143.88 53.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 1.93 109.109 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.54 133.97 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.43 -0.793 . . . . 0.68 109.906 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.4 t -106.78 113.72 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 0.84 109.183 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.4 mt -87.69 134.83 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.322 -0.861 . . . . 0.79 109.045 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -89.23 113.28 24.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 1.37 109.638 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 28' ' ' ARG . 14.1 mmm-85 -96.06 26.25 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 2.62 108.845 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -83.56 146.03 28.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.398 -0.814 . . . . 2.35 109.748 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -85.08 118.41 24.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.394 -0.965 . . . . 2.35 108.394 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 pt -81.54 173.51 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.78 109.977 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.8 p -97.87 161.15 13.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.031 -0.729 . . . . 1.04 109.031 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.0 -16.67 32.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.112 -0.993 . . . . 1.05 109.283 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.16 -7.43 59.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 2.47 109.265 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -114.96 -13.52 11.91 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.849 -0.797 . . . . 1.46 108.849 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.9 t -65.66 -45.38 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 0.77 109.402 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -54.94 -33.28 62.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 1.46 109.293 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -69.92 -33.99 72.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 2.29 110.26 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -62.8 -43.57 98.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 1.3 109.688 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -60.1 -46.94 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.41 -0.806 . . . . 0.76 109.828 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.91 -43.39 88.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 1.5 108.883 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -65.18 -30.99 71.94 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.813 -0.81 . . . . 2.66 108.813 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -86.39 -58.33 2.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.75 109.266 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.5 tp -52.48 -58.94 5.14 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.289 -0.882 . . . . 0.83 109.287 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.6 t -63.76 -30.5 71.59 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.334 -0.987 . . . . 0.78 108.334 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.81 -54.6 35.41 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 107.977 -2.049 . . . . 0.57 107.977 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 80' ' ' LEU . 29.8 ttm-85 -49.47 -30.52 8.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.535 -0.98 . . . . 2.83 109.074 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.99 -40.59 81.08 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.551 -0.907 . . . . 0.65 108.551 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -80.96 -59.34 2.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.667 -0.646 . . . . 2.57 109.302 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.85 -40.83 57.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.032 . . . . 0.51 110.205 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.459 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 29.2 t -62.32 -37.46 85.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.956 -1.09 . . . . 1.36 108.183 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.58 -31.31 63.53 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.158 0.504 . . . . 0.6 109.732 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -75.86 -65.95 0.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 1.36 109.589 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.502 HD12 ' N ' ' A' ' 54' ' ' LEU . 9.7 mp -50.12 -27.02 5.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 1.38 109.332 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 51' ' ' SER . 4.1 mm-40 -71.76 -42.22 67.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 1.27 108.646 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 m -61.64 -37.16 83.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.6 109.435 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.32 -25.79 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 0.53 109.117 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.471 ' NZ ' ' OE1' ' A' ' 70' ' ' GLU . 9.9 ttpp -61.17 -46.88 88.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.99 110.2 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -70.18 -30.81 68.03 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.128 -0.983 . . . . 0.59 109.844 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -70.43 -18.89 63.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.695 -1.253 . . . . 1.81 108.123 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.79 -33.42 30.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.567 -0.901 . . . . 0.48 108.567 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.88 -28.42 28.92 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.192 -1.163 . . . . 0.58 110.192 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.14 -15.09 42.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.016 -1.285 . . . . 1.39 109.0 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.8 m -95.37 -48.37 5.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.24 -0.912 . . . . 0.82 110.179 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -106.33 -21.73 13.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.339 -0.851 . . . . 0.99 110.124 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 121.5 147.12 7.58 Favored Glycine 0 N--CA 1.503 3.13 0 N-CA-C 110.082 -1.207 . . . . 0.55 110.082 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -48.49 -11.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.606 -0.938 . . . . 2.59 110.197 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 66' ' ' GLY . 63.0 mt-10 -63.99 -29.61 70.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.089 -1.007 . . . . 2.2 110.802 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -91.82 -7.65 48.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.8 -1.188 . . . . 1.79 111.087 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.471 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 56.3 mt-10 -63.85 -24.52 67.78 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.732 -1.23 . . . . 1.54 110.598 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.67 -28.36 69.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.02 -1.05 . . . . 0.64 110.508 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.37 -44.25 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.011 -1.055 . . . . 0.58 110.064 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.55 -21.47 45.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.088 -1.007 . . . . 0.62 109.845 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -64.93 -44.16 90.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 1.23 109.571 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.35 -37.22 59.1 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.66 -1.376 . . . . 0.52 109.66 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -61.37 -20.55 63.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.294 -1.121 . . . . 1.29 110.455 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.0 mt -85.79 -37.04 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.592 -1.317 . . . . 0.55 108.393 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.8 ttt -58.78 -42.25 88.56 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.224 -1.028 . . . . 1.89 108.224 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.12 -37.23 84.34 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.358 -0.978 . . . . 0.53 108.358 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' O ' ' NH1' ' A' ' 47' ' ' ARG . 23.8 tp -69.55 -43.97 71.86 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.649 -0.821 . . . . 0.43 109.151 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -85.41 7.12 23.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 1.24 110.222 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.419 ' OD1' ' OE1' ' A' ' 84' ' ' GLU . 57.3 t0 -47.06 122.55 4.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.012 -1.055 . . . . 1.31 109.695 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.66 -24.81 66.33 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.726 -0.842 . . . . 1.35 108.726 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 18.7 mp0 -76.14 -49.53 17.06 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.783 -0.767 . . . . 2.16 109.205 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.2 mt -63.75 -13.96 48.27 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.823 -1.151 . . . . 0.6 108.715 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -79.2 -56.18 4.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.508 -0.745 . . . . 1.28 109.836 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -63.33 -26.27 68.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 1.28 109.977 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.42 -44.05 62.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.101 -0.999 . . . . 1.29 108.673 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.1 mt -60.7 -56.49 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.097 -1.075 . . . . 0.58 108.097 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -47.16 -53.0 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.635 -0.666 . . . . 0.78 109.543 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.69 -44.41 93.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 0.86 109.227 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.8 mt -57.97 -56.85 16.64 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.168 -1.049 . . . . 0.79 108.168 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.6 mt -51.2 -39.84 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.71 110.073 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -85.34 -36.4 20.8 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.086 -1.008 . . . . 2.05 111.681 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 91' ' ' ALA . 22.1 t70 -82.75 -43.55 16.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.798 -1.189 . . . . 1.59 111.486 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -102.07 12.2 37.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.768 -1.208 . . . . 1.89 109.538 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 45.59 48.57 11.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.371 -0.831 . . . . 1.31 109.368 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtp -101.41 152.19 21.03 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.092 -0.706 . . . . 1.28 109.092 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.4 p -76.31 145.05 39.84 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.436 -0.79 . . . . 0.62 109.462 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.44 29.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.166 -0.959 . . . . 0.47 108.797 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.4 OUTLIER -72.71 -45.99 55.95 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.28 -1.007 . . . . 2.0 108.28 179.049 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.1 -51.42 21.57 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.391 0.615 . . . . 0.56 109.973 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.34 -50.92 71.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.48 109.647 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.37 -34.15 64.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.194 -0.941 . . . . 0.44 109.799 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -69.03 -31.48 70.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 1.42 109.229 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.5 tt0 -71.59 -57.63 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 1.26 109.892 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.445 ' H ' HG23 ' A' ' 107' ' ' VAL . 7.7 t -55.2 -49.9 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.61 109.811 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.572 HG21 ' HA3' ' A' ' 134' ' ' GLY . 28.1 mm -64.68 -70.16 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.64 109.613 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.46 ' OE2' ' NE ' ' A' ' 131' ' ' ARG . 18.1 tp10 -50.55 -45.3 56.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.826 -1.171 . . . . 2.2 108.992 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -45.04 -40.07 6.92 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.11 -1.596 . . . . 0.82 109.11 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -69.17 -59.41 3.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.343 -1.092 . . . . 1.27 108.29 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.74 -43.5 37.61 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.809 -0.812 . . . . 0.91 108.809 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.8 m -59.99 -37.04 78.5 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.305 -0.872 . . . . 1.73 109.186 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.54 84.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 1.04 109.878 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.81 -29.48 67.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.929 -1.107 . . . . 1.03 108.677 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.54 -17.13 62.48 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.455 -0.943 . . . . 1.95 108.455 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -82.42 -1.01 48.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.567 -0.708 . . . . 1.71 109.481 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.5 HD13 HD13 ' A' ' 123' ' ' LEU . 12.1 mt -83.77 158.72 21.63 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.136 -0.978 . . . . 1.26 109.209 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -100.5 50.56 0.89 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.891 -0.781 . . . . 2.83 108.891 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -146.56 119.21 8.56 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.222 -0.924 . . . . 1.58 109.612 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.71 -19.3 58.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.372 -0.83 . . . . 2.8 109.501 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.22 -65.21 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 1.02 109.275 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.5 HD13 HD13 ' A' ' 118' ' ' LEU . 46.8 mt -47.58 -31.29 4.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.09 -1.006 . . . . 1.06 109.624 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 1.9 ttmp? -65.52 -39.97 92.43 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.918 -1.113 . . . . 2.39 108.319 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -58.13 -23.41 55.03 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.392 -0.966 . . . . 2.2 108.392 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -72.99 -27.26 61.69 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.537 -1.653 . . . . 2.09 106.537 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -57.67 -39.83 77.96 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.098 -1.075 . . . . 0.86 108.098 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.07 -36.42 81.98 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.793 -0.817 . . . . 0.9 108.793 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.45 -36.94 77.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.348 -0.845 . . . . 1.35 109.254 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.4 t -76.65 -44.24 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.04 -1.096 . . . . 0.58 108.04 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.46 ' NE ' ' OE2' ' A' ' 109' ' ' GLU . 42.4 ttm180 -60.55 -34.7 74.53 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.925 -1.139 . . . . 3.22 107.925 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -58.94 -35.55 73.32 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.502 -0.749 . . . . 1.32 109.17 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.19 -26.51 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.5 108.528 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.572 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -78.29 -42.64 14.6 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.145 -1.582 . . . . 0.44 109.145 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -55.42 -54.09 48.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.545 -0.973 . . . . 2.71 109.986 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.523 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 34.4 mtm180 -63.56 -38.79 92.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.176 -0.952 . . . . 2.2 108.697 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 41.5 tp -61.83 -40.34 94.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.437 -0.79 . . . . 1.13 109.719 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.8 mt -67.54 -54.8 16.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.05 -1.031 . . . . 0.54 109.335 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -49.16 -19.0 0.39 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 2.32 109.529 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -84.24 -39.9 18.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 1.26 109.586 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.14 -40.3 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.005 . . . . 0.62 109.693 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.9 mt -88.72 2.11 53.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.158 -0.964 . . . . 0.67 109.272 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.64 29.23 48.27 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.422 -1.871 . . . . 0.68 108.422 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.9 tp -58.52 148.14 29.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.595 -0.944 . . . . 0.77 109.542 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.31 132.64 47.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.942 . . . . 2.4 109.786 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.4 mt -110.47 144.12 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 109.172 -0.677 . . . . 0.87 109.172 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.76 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.2 mp -78.54 133.21 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.072 -1.017 . . . . 1.32 109.768 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.96 87.85 3.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.502 -0.749 . . . . 1.54 109.408 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.45 -22.22 44.44 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.241 -0.912 . . . . 0.77 109.586 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.5 t -80.8 17.81 1.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.151 -0.968 . . . . 1.57 109.446 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.08 29.19 2.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.389 -0.819 . . . . 0.82 109.416 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.59 153.14 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.293 -0.879 . . . . 0.82 108.985 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -132.96 -2.1 3.26 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.394 -0.816 . . . . 2.11 109.245 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -129.8 125.74 36.47 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.821 -0.807 . . . . 1.41 108.821 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.68 129.19 38.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 1.3 109.714 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.32 175.79 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.57 108.806 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.8 mt -89.31 149.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.891 -1.151 . . . . 0.43 107.891 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.3 tp -104.73 119.85 39.97 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.534 -0.729 . . . . 0.56 109.612 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.0 125.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.99 -0.744 . . . . 0.54 108.99 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.444 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -162.5 147.06 12.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.62 109.816 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.38 -38.15 71.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.745 -1.222 . . . . 0.8 108.131 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -173.97 147.66 1.32 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.428 -0.795 . . . . 2.34 109.651 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.2 mt -117.68 136.53 53.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.634 -0.667 . . . . 0.65 109.383 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.6 p -94.06 152.19 40.24 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.222 -0.924 . . . . 0.74 109.296 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -36.21 -39.38 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.442 2.095 . . . . 0.6 112.567 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.523 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 1.4 m -56.83 -57.23 13.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.138 -0.976 . . . . 0.63 109.13 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -60.01 -41.99 93.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.474 -0.767 . . . . 1.25 109.79 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.0 p -71.17 -19.78 62.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.052 -1.03 . . . . 0.5 109.409 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.3 -25.48 33.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.51 109.745 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -103.47 -18.9 14.6 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.26 -0.9 . . . . 1.17 109.209 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.78 144.51 48.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.121 -1.066 . . . . 0.61 108.121 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 175' ' ' LYS . 1.7 m120 -95.64 134.79 38.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.0 -1.062 . . . . 2.12 108.587 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.1 mt -78.66 -42.95 27.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.391 -0.818 . . . . 1.34 111.654 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -80.0 -8.82 59.56 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.672 -1.267 . . . . 1.97 111.767 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 172' ' ' ASN . 58.6 mttp -99.98 -7.3 25.28 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.694 -1.253 . . . . 1.9 108.721 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 177' ' ' LEU . 54.3 t -98.32 162.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.488 -0.757 . . . . 0.48 109.057 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.567 HD21 ' HB1' ' A' ' 12' ' ' ALA . 8.5 tp -115.2 -20.09 10.54 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.555 -0.716 . . . . 1.39 109.954 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.9 174.58 42.57 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.406 -1.478 . . . . 0.38 109.406 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 1.3 m-85 -128.07 124.16 36.36 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.346 -1.091 . . . . 0.46 110.156 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 205' ' ' THR . 7.8 mt -121.19 109.96 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 106.92 -1.511 . . . . 0.59 106.92 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.604 ' O ' ' O ' ' A' ' 203' ' ' VAL . 31.2 p -140.58 154.99 46.7 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.119 -0.988 . . . . 0.67 112.578 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 42.6 t0 -80.18 40.94 0.5 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.823 -0.626 . . . . 2.24 110.831 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.567 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -100.85 95.59 6.73 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.229 -1.544 . . . . 1.11 110.544 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.472 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -39.48 -21.15 0.02 OUTLIER Glycine 0 N--CA 1.5 2.909 0 O-C-N 121.264 -0.898 . . . . 1.63 111.104 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 114.84 -28.93 7.77 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 109.83 -1.308 . . . . 1.47 109.83 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.565 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.2 OUTLIER -54.27 118.26 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.136 -1.214 . . . . 5.24 109.335 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 26.6 p 48.66 32.77 3.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.434 -0.791 . . . . 2.92 110.142 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.1 m -86.47 116.88 24.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.109 -0.995 . . . . 1.6 109.554 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -72.02 -41.28 67.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 0.92 108.972 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.8 p -50.54 -36.99 36.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 1.59 109.147 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 73.1 m -62.01 -41.31 97.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.337 -0.852 . . . . 1.42 109.35 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.5 mt -58.01 -24.76 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 1.41 109.478 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.3 mtp -71.81 -58.83 3.13 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.689 -1.226 . . . . 0.86 107.689 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.22 -41.71 62.97 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.325 0.583 . . . . 0.59 109.722 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 20.5 mtt-85 -69.02 -50.67 46.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 3.06 109.882 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.5 m -69.12 -38.44 78.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.051 -1.031 . . . . 0.73 109.906 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 199' ' ' LEU . 22.3 mt -87.81 3.39 48.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.106 -0.996 . . . . 0.67 108.858 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 44.02 11.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.741 -0.6 . . . . 1.49 112.019 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 197' ' ' LEU . 17.1 mt -68.98 169.51 11.16 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.372 -1.455 . . . . 0.64 108.495 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -88.88 139.64 3.86 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.345 2.03 . . . . 0.59 110.907 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.37 -172.96 2.64 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.19 -1.404 . . . . 0.55 111.595 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.2 mt -149.12 153.1 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.248 -1.39 . . . . 0.63 107.248 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.604 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.7 m -138.22 -39.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.874 -1.141 . . . . 0.77 111.113 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.501 ' N ' HG23 ' A' ' 203' ' ' VAL . . . -71.45 39.96 0.61 Allowed Glycine 0 C--N 1.285 -2.276 0 N-CA-C 108.599 -1.8 . . . . 0.87 108.599 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.508 HG21 HG23 ' A' ' 180' ' ' ILE . 47.1 p -67.38 -18.29 65.07 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.106 -1.232 . . . . 0.89 109.531 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.419 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 62.64 -101.08 0.36 Allowed Glycine 0 N--CA 1.484 1.859 0 C-N-CA 119.392 -1.385 . . . . 0.93 110.121 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.2 m -117.55 45.61 1.89 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.301 -1.117 . . . . 1.6 112.331 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 62.6 t -74.82 -26.73 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.454 -1.403 . . . . 0.75 107.786 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.7 p -68.28 -12.75 61.54 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.738 . . . . 0.84 109.599 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.9 m -102.4 9.34 39.79 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.416 -0.802 . . . . 1.61 109.049 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -131.17 -5.78 3.86 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.569 -0.707 . . . . 2.3 109.195 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 23.3 t -122.64 148.57 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.649 -0.871 . . . . 0.76 108.649 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -121.54 -174.29 2.83 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.619 -1.623 . . . . 2.01 106.619 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.6 m120 -79.51 150.52 31.15 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.776 -1.202 . . . . 2.19 109.839 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.7 m-20 81.07 -14.42 0.83 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.052 -0.405 . . . . 2.4 110.94 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.64 128.2 35.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.755 -1.215 . . . . 1.99 108.355 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -86.62 119.11 26.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.868 -1.145 . . . . 1.3 108.883 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.7 mt -119.62 163.29 17.58 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.666 0.746 . . . . 0.53 110.124 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.1 mt -128.68 118.96 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.742 -1.207 . . . . 0.6 107.742 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.6 tp -87.18 120.61 28.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.425 -0.954 . . . . 0.57 108.425 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.4 t0 -95.97 -31.07 13.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.212 -0.93 . . . . 2.22 108.838 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.17 28.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.456 0.645 . . . . 0.75 110.248 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.6 t -123.9 -67.36 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.821 -1.548 . . . . 0.92 106.821 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 224' ' ' ASN . 19.9 t-20 -84.12 10.95 8.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.218 -1.401 . . . . 2.36 107.218 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 58.22 61.99 2.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.906 -0.496 . . . . 1.42 110.092 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -156.8 147.89 22.01 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.122 -0.986 . . . . 1.97 110.673 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.47 141.5 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.663 -0.866 . . . . 0.65 108.663 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -104.62 127.77 52.46 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.177 -0.952 . . . . 0.97 109.408 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.42 120.59 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.48 -0.762 . . . . 0.67 110.358 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 43.5 t30 55.55 74.37 0.72 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 1.45 110.314 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -87.05 149.16 8.14 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.018 2.479 . . . . 0.82 112.148 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.2 m -72.14 160.99 31.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.258 -0.901 . . . . 1.62 109.966 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.484 ' H ' HD22 ' A' ' 233' ' ' ASN . 2.4 p30 -64.37 -30.67 71.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -0.799 . . . . 2.6 109.758 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -67.11 -37.61 84.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 3.06 109.165 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.65 -32.59 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 1.14 108.941 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt -72.88 -61.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 1.04 109.209 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -53.61 -41.49 66.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.498 -0.751 . . . . 2.54 110.106 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -66.34 -34.86 78.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.09 -1.006 . . . . 2.6 109.439 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 57.1 mtp -81.68 -39.37 24.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.89 . . . . 1.23 109.437 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.404 ' O ' ' OE1' ' A' ' 244' ' ' GLU . 16.6 mmt180 -49.35 -47.25 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.139 -0.976 . . . . 2.67 109.546 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.03 -64.11 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -0.963 . . . . 1.66 110.671 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 24.4 t -59.68 -52.7 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 2.2 111.201 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' A' ' 239' ' ' MET . 41.4 tp60 -54.78 -41.08 70.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.672 -1.267 . . . . 3.0 109.925 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.404 ' OE1' ' O ' ' A' ' 240' ' ' ARG . 62.0 mt-10 -64.88 -27.36 68.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.623 -1.298 . . . . 1.76 109.881 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -67.62 -23.55 65.37 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.773 -1.205 . . . . 2.78 107.934 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.5 t -69.42 -40.41 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.399 -0.963 . . . . 2.06 108.399 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.57 92.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.524 -0.735 . . . . 2.4 109.804 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.7 m -78.11 -31.81 50.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 2.87 110.207 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.032 -1.042 . . . . 3.41 109.848 -179.452 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.372 -0.603 . . . . 3.66 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.6 mt -129.95 91.54 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.809 -0.811 . . . . 1.12 108.809 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m -91.68 117.03 29.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.185 -0.947 . . . . 1.45 110.049 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.95 -159.54 11.98 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 108.149 -1.98 . . . . 0.92 108.149 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 5' ' ' ILE . 90.1 mt -97.63 -10.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.133 -1.216 . . . . 1.05 109.04 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 tp 60.3 103.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.343 -0.848 . . . . 0.88 108.901 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.97 -48.43 7.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.997 -1.064 . . . . 0.78 108.974 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.98 145.8 26.15 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.411 -0.805 . . . . 1.5 108.975 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.47 153.48 23.79 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.32 2.014 . . . . 0.86 113.748 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.75 177.12 32.55 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.959 -1.256 . . . . 0.78 109.959 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 51.2 mt -143.86 120.74 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.974 -1.309 . . . . 0.74 109.776 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.588 ' HB1' HD21 ' A' ' 177' ' ' LEU . . . -143.23 140.55 30.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.124 -0.985 . . . . 0.45 109.399 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.7 m-85 -105.87 151.37 24.62 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.689 -0.856 . . . . 0.64 108.689 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.58 166.38 31.05 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 118.66 -1.733 . . . . 0.45 111.467 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -81.92 153.34 26.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.653 -0.91 . . . . 1.88 110.377 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.06 126.22 30.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.774 . . . . 0.59 111.642 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.7 tp -108.13 89.26 2.94 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 107.52 -1.289 . . . . 0.64 107.52 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.0 tp -81.26 129.39 34.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.011 -1.055 . . . . 0.74 110.206 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.468 HD11 HD11 ' A' ' 158' ' ' LEU . 17.9 mt -96.39 94.41 7.41 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.413 0.625 . . . . 0.74 110.433 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -97.16 157.68 15.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.726 -0.842 . . . . 1.87 108.726 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -130.77 134.26 46.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.25 -0.906 . . . . 2.58 108.87 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -79.31 137.76 37.47 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.173 -0.955 . . . . 2.14 109.368 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.74 141.67 58.7 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.541 -0.724 . . . . 1.93 109.136 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.1 mt -89.36 138.32 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 0.68 109.586 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.04 114.83 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.505 -0.747 . . . . 0.84 109.179 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.1 mt -87.43 133.88 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.912 . . . . 0.79 109.611 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.78 120.41 31.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.462 -0.774 . . . . 1.37 108.998 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -99.92 32.02 3.07 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.229 -0.92 . . . . 2.62 109.444 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -83.31 138.53 33.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.044 -1.035 . . . . 2.35 110.284 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -84.77 134.69 34.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.309 -0.997 . . . . 2.35 108.309 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.9 pt -97.74 176.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.159 -0.963 . . . . 0.78 110.841 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 34' ' ' ASP . 36.3 p -98.37 153.26 18.68 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.394 -0.965 . . . . 1.04 108.394 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.34 -7.75 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 1.05 110.139 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 32' ' ' SER . 17.7 t70 -84.78 -21.76 29.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.905 -1.122 . . . . 2.47 110.323 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -106.41 -3.81 20.61 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.193 -0.942 . . . . 1.46 109.531 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.7 -43.69 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.77 109.237 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -53.79 -34.59 59.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.284 -0.885 . . . . 1.46 109.184 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -69.47 -33.3 72.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 2.29 109.698 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -61.65 -46.64 88.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.007 -1.058 . . . . 1.3 109.68 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.78 -45.41 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.76 109.693 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.28 -39.62 92.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.108 -0.995 . . . . 1.5 108.334 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -65.11 -32.75 74.61 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.949 -0.76 . . . . 2.66 108.949 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -86.62 -57.68 2.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.144 -0.973 . . . . 0.75 108.476 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -49.32 -61.93 1.82 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.73 -0.841 . . . . 0.83 108.73 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.67 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.7 t -65.2 -33.82 76.91 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.312 -0.995 . . . . 0.78 108.312 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.27 -54.46 35.61 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 107.927 -2.069 . . . . 0.57 107.927 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -48.63 -30.11 5.07 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.384 -1.068 . . . . 2.83 108.561 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.12 -34.43 70.21 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.897 -1.149 . . . . 0.65 107.897 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 mttt -79.17 -58.61 3.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.805 -0.813 . . . . 2.57 108.805 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.35 -40.52 62.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.51 109.937 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 t -62.23 -38.25 88.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.952 -1.093 . . . . 1.36 108.498 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.82 -36.33 67.48 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.378 -0.601 . . . . 0.6 109.378 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -65.57 -62.76 1.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.351 -0.843 . . . . 1.36 109.535 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.08 -38.89 62.92 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.304 -0.873 . . . . 1.38 109.161 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -59.92 -46.88 87.97 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.591 -0.892 . . . . 1.27 108.591 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.5 m -61.99 -37.7 85.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.485 -0.759 . . . . 0.6 109.332 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.2 mt -73.3 -29.3 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.821 . . . . 0.53 109.151 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -63.94 -43.32 96.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -0.819 . . . . 0.99 109.03 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.2 m -72.34 -26.99 62.14 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.365 -0.834 . . . . 0.59 109.538 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -72.82 -30.04 63.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.638 -1.245 . . . . 1.81 107.638 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.48 -31.28 63.68 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.111 -1.07 . . . . 0.48 108.111 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.12 -28.21 28.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.608 -1.397 . . . . 0.58 109.608 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -86.54 -16.06 38.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.812 -1.404 . . . . 1.39 108.462 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.2 m -94.44 -49.27 5.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.82 110.36 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.472 ' C ' ' H ' ' A' ' 67' ' ' GLU . 53.0 m-85 -107.11 -33.21 7.52 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.156 -0.965 . . . . 0.99 110.241 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.48 -29.92 0.71 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.179 -1.168 . . . . 0.55 110.179 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 69' ' ' LYS . 38.4 mt-10 -52.85 179.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -1.157 . . . . 2.59 110.3 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -68.36 40.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.518 -0.738 . . . . 2.2 109.532 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 67' ' ' GLU . 35.1 mmtt -85.03 -17.26 38.07 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.639 -0.874 . . . . 1.79 108.639 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.78 -34.8 77.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.614 -0.679 . . . . 1.54 110.517 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.79 -27.15 67.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 0.64 110.817 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.9 mt -71.79 -46.73 59.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.849 -1.157 . . . . 0.58 109.782 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -74.98 -21.66 59.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.085 -1.009 . . . . 0.62 109.757 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.6 -41.62 92.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.146 -0.971 . . . . 1.23 109.383 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.25 -37.47 63.3 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.483 -1.447 . . . . 0.52 109.483 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -58.89 -21.37 57.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -1.15 . . . . 1.29 109.3 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.8 mt -85.15 -34.39 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.064 -1.022 . . . . 0.55 108.473 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.3 ttt -60.61 -44.93 95.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -0.972 . . . . 1.89 108.511 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.79 -40.38 83.87 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.215 -1.032 . . . . 0.53 108.215 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.5 tp -65.87 -43.99 86.7 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.672 -0.811 . . . . 0.43 108.858 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -85.84 9.48 16.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.191 -0.943 . . . . 1.24 110.363 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -50.47 119.92 4.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.77 -1.206 . . . . 1.31 109.264 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.06 -22.97 67.05 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.245 -0.909 . . . . 1.35 108.838 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.14 -51.87 12.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.412 -0.805 . . . . 2.16 109.392 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.78 -12.28 45.91 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.208 -0.997 . . . . 0.6 109.224 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -79.7 -50.24 10.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.431 -0.793 . . . . 1.28 110.365 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -62.37 -31.96 72.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.128 -0.982 . . . . 1.28 110.099 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.02 -44.64 68.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 1.29 109.291 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.04 -58.53 6.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.576 -0.898 . . . . 0.58 108.576 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.7 mt -48.75 -61.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.686 -0.634 . . . . 0.78 110.576 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -53.19 -45.31 68.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.024 -1.048 . . . . 0.86 110.403 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 mt -56.23 -56.13 24.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.127 -0.983 . . . . 0.79 108.663 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.8 mt -54.73 -47.54 73.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.187 -0.946 . . . . 0.71 110.57 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -78.32 -36.62 46.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.058 -1.026 . . . . 2.05 111.302 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' ALA . 9.4 t70 -82.09 -40.51 21.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.901 -1.125 . . . . 1.59 112.055 -176.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -109.84 21.29 17.06 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.752 -1.218 . . . . 1.89 110.689 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.522 ' ND1' ' N ' ' A' ' 97' ' ' HIS . 0.3 OUTLIER 42.73 55.19 4.38 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.299 -0.875 . . . . 1.31 110.473 179.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.8 mtt -103.91 147.38 27.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.601 -0.889 . . . . 1.28 108.601 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.2 p -77.68 150.5 34.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.62 109.87 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.42 -31.67 6.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.47 108.892 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -77.08 -43.15 35.39 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.777 -0.823 . . . . 2.0 108.777 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.62 9.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.572 -0.705 . . . . 0.56 109.871 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.06 -48.28 78.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.859 . . . . 0.48 109.466 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.5 64.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.44 109.858 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 109' ' ' GLU . 76.4 t60 -67.93 -51.09 51.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.999 -1.063 . . . . 1.42 109.727 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -46.11 -62.21 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.338 -0.851 . . . . 1.26 110.502 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 43.7 t -52.75 -54.18 17.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.804 -1.185 . . . . 0.61 109.302 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.36 -23.19 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.64 109.664 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 105' ' ' HIS . 45.8 tp10 -73.08 -30.45 63.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.025 -1.047 . . . . 2.2 110.069 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.26 -27.97 29.12 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.114 -1.517 . . . . 0.82 111.985 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -67.06 -45.35 77.61 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.425 -1.633 . . . . 1.27 108.035 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.16 -55.72 5.45 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.917 -0.489 . . . . 0.91 110.698 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.9 p -56.97 -41.25 78.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 1.73 110.215 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.97 81.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.085 -1.009 . . . . 1.04 110.277 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.71 -30.38 70.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.761 -1.212 . . . . 1.03 109.319 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.58 -18.94 65.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.095 . . . . 1.95 109.726 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -82.93 -9.24 59.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 1.71 109.385 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.415 HD13 HD13 ' A' ' 123' ' ' LEU . 0.8 OUTLIER -86.8 138.45 31.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.264 -1.013 . . . . 1.26 108.264 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 22.8 p-10 -96.02 63.41 2.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 2.83 109.154 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -148.79 108.7 4.05 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.317 -0.864 . . . . 1.58 109.48 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -50.35 -15.85 0.28 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.569 -0.707 . . . . 2.8 110.009 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -78.3 -60.92 2.18 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.242 -0.911 . . . . 1.02 109.353 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.415 HD13 HD13 ' A' ' 118' ' ' LEU . 7.9 mt -67.19 -31.52 71.97 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.262 -0.899 . . . . 1.06 109.254 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -68.24 -49.54 59.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.991 . . . . 2.39 109.234 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -61.14 -18.68 59.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.277 -1.008 . . . . 2.2 108.277 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.422 ' NH1' ' CG2' ' A' ' 130' ' ' VAL . 26.1 ttt-85 -75.46 -28.24 59.21 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.093 -1.447 . . . . 2.09 107.093 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.82 97.83 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.698 -0.853 . . . . 0.86 108.698 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.9 -35.08 79.98 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.247 -1.02 . . . . 0.9 108.247 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 2.8 m-20 -71.97 -32.2 67.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 1.35 109.122 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.422 ' CG2' ' NH1' ' A' ' 126' ' ' ARG . 42.8 t -77.03 -45.6 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.58 108.95 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -60.19 -36.92 78.72 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.117 -0.989 . . . . 3.22 108.37 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.49 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 30.7 t70 -58.92 -36.5 74.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.5 -0.75 . . . . 1.32 109.486 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.07 -26.08 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.058 -1.026 . . . . 0.5 108.803 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.34 -47.39 5.75 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.26 -1.536 . . . . 0.44 109.26 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.416 ' HZ2' ' HB3' ' A' ' 135' ' ' LYS . 15.3 mtpp -51.58 -43.91 62.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -1.173 . . . . 2.71 109.119 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.522 ' CG ' HH11 ' A' ' 136' ' ' ARG . 6.2 mtt-85 -65.51 -42.7 91.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.206 -1.035 . . . . 2.2 108.206 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.77 -51.3 70.57 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.474 -0.565 . . . . 1.13 109.474 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.6 mt -53.13 -58.06 8.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.54 109.279 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -51.01 -21.4 1.77 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.882 . . . . 2.32 109.673 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 136' ' ' ARG . 5.1 m120 -85.84 -42.05 14.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.03 . . . . 1.26 109.111 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.89 -47.49 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.081 -1.012 . . . . 0.62 108.294 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 58.8 mt -90.76 -7.81 51.45 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.777 -0.823 . . . . 0.67 108.777 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 144' ' ' LEU . . . 60.99 26.08 65.09 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.239 -1.944 . . . . 0.68 108.239 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 145' ' ' LYS . 3.1 tp -52.84 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.605 -0.938 . . . . 0.77 109.095 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.431 ' H ' ' HG ' ' A' ' 144' ' ' LEU . 47.5 tttp -69.0 137.5 53.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.127 -0.983 . . . . 2.4 110.429 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 75.1 mt -106.49 137.49 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.491 -0.929 . . . . 0.87 108.491 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mm -75.79 116.65 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.073 -1.017 . . . . 1.32 108.877 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -98.58 82.88 2.91 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.263 -0.898 . . . . 1.54 109.89 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.3 mt -84.51 -14.08 50.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 0.77 109.103 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.7 p -84.3 -13.8 51.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 1.57 109.891 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.96 42.8 1.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.27 -0.894 . . . . 0.82 110.862 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.6 mm -73.49 149.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.658 -1.276 . . . . 0.82 108.738 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -136.78 -2.29 2.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.389 -0.819 . . . . 2.11 109.466 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -125.45 127.93 47.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.512 -0.742 . . . . 1.41 109.495 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.49 118.56 8.97 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.308 -0.87 . . . . 1.3 108.9 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -151.26 176.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.57 108.765 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 218' ' ' LEU . 3.2 mt -89.5 156.49 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.136 -1.061 . . . . 0.43 108.136 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.468 HD11 HD11 ' A' ' 19' ' ' LEU . 18.6 tp -108.89 123.01 48.4 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.512 0.672 . . . . 0.56 109.693 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.83 133.01 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 109.213 -0.662 . . . . 0.54 109.213 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.99 145.67 10.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.073 -1.017 . . . . 0.62 109.918 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.19 -34.56 75.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.343 -1.473 . . . . 0.8 108.039 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -173.19 154.06 2.62 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 109.296 -0.631 . . . . 2.34 109.296 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.4 mt -128.37 130.65 48.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.484 -0.76 . . . . 0.65 109.126 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.5 p -89.74 152.49 46.88 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.74 109.259 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -34.26 -41.8 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.713 2.276 . . . . 0.6 113.235 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 m -57.4 -60.31 3.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.819 -1.175 . . . . 0.63 109.45 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -55.61 -36.27 66.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.472 -0.768 . . . . 1.25 110.352 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.8 p -73.73 -32.6 63.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.124 -0.985 . . . . 0.5 110.055 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.33 -31.53 64.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.952 . . . . 0.51 110.794 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -101.63 1.61 37.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.103 -0.998 . . . . 1.17 109.901 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.2 tp -54.28 160.96 1.47 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.089 -1.007 . . . . 0.61 109.054 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.528 ' ND2' ' H ' ' A' ' 175' ' ' LYS . 15.6 t30 -100.73 79.7 2.1 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.39 -0.819 . . . . 2.12 109.928 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 14.9 mt -74.81 28.65 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 1.34 108.642 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 172' ' ' ASN . 31.7 mtpt -106.71 -30.7 8.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 1.97 110.187 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.528 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 27.1 mtmm -133.2 14.32 4.2 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.232 -0.918 . . . . 1.9 110.028 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 172' ' ' ASN . 14.7 t -79.02 161.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.48 109.098 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.588 HD21 ' HB1' ' A' ' 12' ' ' ALA . 7.7 tp -112.98 -25.37 9.01 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.62 -0.675 . . . . 1.39 110.058 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.57 -179.43 45.9 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.64 -1.384 . . . . 0.38 109.64 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.82 126.84 35.31 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.399 -1.06 . . . . 0.46 110.199 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.84 123.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.993 -1.114 . . . . 0.59 107.993 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 203' ' ' VAL . 59.0 p -141.75 148.29 38.73 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.184 -0.948 . . . . 0.67 111.352 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.423 ' OD2' ' CG2' ' A' ' 209' ' ' THR . 1.6 p30 -100.53 50.37 0.89 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.367 -0.975 . . . . 2.24 108.367 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.29 -140.58 0.3 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.457 -0.777 . . . . 1.11 110.077 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.44 -105.84 1.43 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.934 -1.266 . . . . 1.63 109.934 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.05 -27.19 1.27 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.407 -1.477 . . . . 1.47 109.407 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.432 ' HG3' HH11 ' A' ' 186' ' ' ARG . 28.2 mtm-85 -63.49 94.42 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -1.192 . . . . 5.24 109.116 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 11.3 p 54.33 48.29 21.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 2.92 109.395 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.1 t -85.62 136.07 33.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.278 -0.888 . . . . 1.6 109.462 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.411 ' HA ' HD12 ' A' ' 192' ' ' ILE . 12.6 t60 -48.12 -49.06 33.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.09 -1.006 . . . . 0.92 109.523 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 70.5 p -46.95 -44.76 20.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 1.59 109.657 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.4 t -64.83 -43.66 92.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.467 -0.771 . . . . 1.42 110.248 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 189' ' ' HIS . 64.7 mt -46.36 -35.8 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.971 -1.08 . . . . 1.41 109.999 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.5 mtm -74.14 -58.5 3.26 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.898 -1.149 . . . . 0.86 107.898 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.23 -31.19 19.82 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.612 -0.68 . . . . 0.59 110.223 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -81.17 -46.54 14.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.045 -1.034 . . . . 3.06 110.187 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 38.2 m -70.75 -36.34 73.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.927 -1.108 . . . . 0.73 110.383 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 199' ' ' LEU . 18.6 mt -84.83 -0.43 53.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.949 -1.094 . . . . 0.67 109.119 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 53.5 1.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 1.49 111.419 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 197' ' ' LEU . 55.6 mt -64.37 171.34 2.78 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.434 -1.416 . . . . 0.64 107.606 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -88.43 141.32 4.78 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.305 2.003 . . . . 0.59 111.469 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.21 176.58 9.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.675 -1.266 . . . . 0.55 111.513 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.6 mt -150.52 159.22 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.06 -1.459 . . . . 0.63 107.06 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.4 m -141.23 -28.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.697 -1.252 . . . . 0.77 111.186 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.61 29.49 6.23 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.139 -0.976 . . . . 0.87 111.664 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 11.8 p -55.03 -37.79 67.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.319 -1.695 . . . . 0.89 108.18 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.32 -37.01 0.26 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.751 -0.738 . . . . 0.93 113.481 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 40.4 p -131.06 -6.71 3.9 Favored 'General case' 0 N--CA 1.516 2.854 0 CA-C-N 119.657 1.728 . . . . 1.6 113.332 -177.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 5.4 t -48.51 -57.15 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 120.156 -1.59 . . . . 0.75 110.593 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.423 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 26.8 p -53.06 -16.75 1.2 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.562 -1.336 . . . . 0.84 110.4 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.1 t -103.92 11.09 35.95 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.191 -0.943 . . . . 1.61 109.27 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -138.93 -13.51 1.22 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.392 -0.818 . . . . 2.3 110.243 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.49 154.66 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.324 -0.86 . . . . 0.76 109.417 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -126.08 172.42 10.01 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.882 -1.525 . . . . 2.01 106.882 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 21.9 t-20 -72.71 144.87 47.51 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.864 -1.148 . . . . 2.19 110.141 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.9 t70 80.61 -11.6 1.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.881 -0.512 . . . . 2.4 110.875 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.25 147.63 34.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.773 -1.204 . . . . 1.99 108.843 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -88.35 123.1 32.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.043 -1.035 . . . . 1.3 108.517 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.406 ' HB2' HD12 ' A' ' 157' ' ' ILE . 43.7 mt -118.74 168.37 10.8 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.993 0.901 . . . . 0.53 110.608 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 mt -143.6 103.21 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.031 -1.1 . . . . 0.6 108.031 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.1 tp -86.2 123.81 31.9 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.773 -0.825 . . . . 0.57 108.773 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 223' ' ' VAL . 50.1 t0 -100.12 -28.44 13.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.43 -0.794 . . . . 2.22 109.127 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.21 28.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.272 0.558 . . . . 0.75 110.599 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.7 t -120.63 -62.24 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.969 -1.493 . . . . 0.92 106.969 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -83.36 10.36 8.84 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.349 -1.352 . . . . 2.36 107.349 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 60.01 54.01 4.38 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.35 -0.611 . . . . 1.42 109.35 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -154.42 144.1 21.59 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.849 0.833 . . . . 1.97 110.23 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 19.5 t -116.08 132.01 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.924 -1.139 . . . . 0.65 107.924 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 228' ' ' TYR . 48.4 m-85 -100.48 130.89 46.61 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.115 -0.991 . . . . 0.97 110.067 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.7 t -107.65 127.46 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.579 -0.7 . . . . 0.67 109.924 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 51.3 t30 47.87 60.6 15.11 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.849 . . . . 1.45 110.297 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.56 154.81 35.57 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.381 2.054 . . . . 0.82 111.474 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 8.4 m -72.83 157.08 38.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.977 -1.077 . . . . 1.62 109.805 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -60.41 -27.32 67.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.427 -0.796 . . . . 2.6 109.779 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.36 -39.13 91.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 3.06 109.537 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.55 -42.18 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.928 . . . . 1.14 109.071 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.6 mt -60.68 -58.59 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 1.04 109.113 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.5 -40.65 72.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.547 -0.72 . . . . 2.54 110.389 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -67.12 -38.16 85.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.036 -1.04 . . . . 2.6 110.146 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.442 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 85.9 mtp -79.43 -32.59 42.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 1.23 109.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -54.11 -44.26 71.14 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.068 -1.02 . . . . 2.67 110.108 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.98 -58.69 3.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.018 -1.051 . . . . 1.66 110.887 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.2 t -64.33 -53.47 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.128 -0.983 . . . . 2.2 110.721 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.442 ' CB ' ' O ' ' A' ' 239' ' ' MET . 39.6 tp60 -52.95 -52.75 56.99 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.0 -1.063 . . . . 3.0 109.711 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -60.18 -22.15 62.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.657 -1.277 . . . . 1.76 108.761 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -67.33 -25.12 65.85 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.292 -1.373 . . . . 2.78 107.292 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.3 -44.02 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.436 -1.32 . . . . 2.06 107.436 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.46 81.0 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.445 -0.946 . . . . 2.4 108.445 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 78.6 p -76.77 -23.16 52.94 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.506 -0.746 . . . . 2.87 109.113 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 108.446 -0.946 . . . . 3.41 108.446 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.245 0.545 . . . . 3.66 109.565 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.0 mt -84.68 106.21 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.954 . . . . 1.12 109.628 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 m -99.48 110.6 23.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.382 -0.824 . . . . 1.45 109.706 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.89 -169.9 31.07 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.011 -1.636 . . . . 0.92 109.011 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' LEU . 56.7 mt -93.08 -7.42 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.043 -1.269 . . . . 1.05 108.614 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.8 tp 54.34 104.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.495 -0.753 . . . . 0.88 109.385 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -88.54 -41.17 12.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.903 -1.123 . . . . 0.78 108.609 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -150.06 148.96 26.2 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.29 -0.881 . . . . 1.5 108.769 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.15 148.22 16.77 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.564 2.176 . . . . 0.86 114.092 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.82 176.29 31.73 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.894 -1.282 . . . . 0.78 109.894 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.42 HD12 ' HG2' ' A' ' 243' ' ' GLN . 97.1 mt -140.13 128.95 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.15 -1.206 . . . . 0.74 109.257 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.88 153.2 49.58 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.281 -0.887 . . . . 0.45 109.722 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -123.93 132.86 53.79 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.191 -1.04 . . . . 0.64 108.191 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.6 164.94 34.33 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 118.537 -1.792 . . . . 0.45 111.314 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HZ2' ' HB3' ' A' ' 15' ' ' LYS . 15.3 mtpp -76.99 149.25 35.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.625 -0.926 . . . . 1.88 109.383 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.3 132.27 38.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.398 -0.814 . . . . 0.59 110.839 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 tp -115.23 89.62 3.14 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.459 -1.312 . . . . 0.64 107.459 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 tp -80.74 122.41 27.1 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.201 1.001 . . . . 0.74 110.646 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.0 mt -92.53 98.06 11.22 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.011 -0.736 . . . . 0.74 109.011 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -92.26 159.89 15.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 1.87 109.665 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -111.71 133.37 54.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.858 -0.793 . . . . 2.58 108.858 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' OE1' ' A' ' 21' ' ' GLU . 12.7 m-20 -80.52 124.99 29.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 2.14 110.493 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.07 126.47 28.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.431 -0.793 . . . . 1.93 109.1 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 80.7 mt -91.09 140.07 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.936 . . . . 0.68 109.502 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.74 115.61 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.486 -0.759 . . . . 0.84 108.984 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.416 HD11 ' CD2' ' A' ' 105' ' ' HIS . 65.0 mt -88.06 133.54 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 0.79 109.88 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -91.63 123.33 34.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 1.37 109.375 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -96.65 25.16 5.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.173 -0.955 . . . . 2.62 109.005 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -86.87 150.71 23.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 2.35 110.38 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -93.22 123.05 36.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.923 -0.769 . . . . 2.35 108.923 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -83.67 175.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.961 -1.087 . . . . 0.78 109.368 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 34' ' ' ASP . 45.3 p -97.24 149.48 21.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.464 -0.772 . . . . 1.04 109.121 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.97 -7.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 1.05 109.667 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 32' ' ' SER . 29.9 t70 -84.14 -24.21 30.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 2.47 109.968 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -103.44 -9.84 19.06 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.134 -0.979 . . . . 1.46 109.536 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.15 -41.4 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.092 -1.005 . . . . 0.77 109.071 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -54.92 -35.43 64.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.366 -0.834 . . . . 1.46 109.392 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -70.01 -37.82 75.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -0.849 . . . . 2.29 110.355 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -58.97 -39.1 80.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 1.3 109.481 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.44 -43.76 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.394 -0.816 . . . . 0.76 109.48 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -63.39 -41.86 98.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.189 -0.945 . . . . 1.5 108.461 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.18 -30.25 71.43 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.364 -0.835 . . . . 2.66 108.811 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -86.7 -51.81 5.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.854 . . . . 0.75 109.49 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 tp -58.12 -63.21 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.83 109.834 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 t -65.12 -35.6 81.63 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.822 -1.174 . . . . 0.78 109.14 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.36 -9.79 38.64 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.254 -1.938 . . . . 0.57 108.254 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -85.72 -28.65 24.49 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.902 -1.518 . . . . 2.83 106.902 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.9 -26.65 67.72 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.291 -1.003 . . . . 0.65 108.291 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -85.27 -62.88 1.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.281 -0.637 . . . . 2.57 109.281 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.07 -38.07 49.42 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.094 -1.004 . . . . 0.51 109.311 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 66.4 m -64.82 -38.56 91.38 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.45 -0.944 . . . . 1.36 108.45 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.04 -39.77 65.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.292 0.567 . . . . 0.6 109.863 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -55.47 -74.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 1.36 109.541 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 58' ' ' LYS . 17.8 mt -46.64 -52.42 13.74 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.158 -0.964 . . . . 1.38 109.508 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 51' ' ' SER . 25.8 mm-40 -47.63 -53.4 14.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.454 -0.779 . . . . 1.27 109.639 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 m -62.34 -37.97 87.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.6 109.319 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.6 mt -72.62 -31.1 36.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.301 -0.874 . . . . 0.53 108.787 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 54' ' ' LEU . 15.8 ttpt -55.06 -44.23 74.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.414 -0.804 . . . . 0.99 109.28 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.45 -32.47 70.05 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.255 -0.903 . . . . 0.59 109.47 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.71 -17.67 62.82 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.906 -1.122 . . . . 1.81 108.081 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.401 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -85.6 -34.53 21.39 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.867 -0.79 . . . . 0.48 108.867 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.89 -27.69 30.95 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.061 -1.066 . . . . 0.58 110.64 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -86.43 -17.66 33.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.688 -1.478 . . . . 1.39 109.414 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.8 m -94.66 -45.25 7.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.078 -1.014 . . . . 0.82 110.396 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -106.11 -18.85 13.89 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.208 -0.933 . . . . 0.99 110.38 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 121.26 139.26 5.65 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 109.58 -1.408 . . . . 0.55 109.58 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -48.93 -8.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.955 . . . . 2.59 110.728 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 66' ' ' GLY . 2.5 pt-20 -66.57 -23.49 66.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.813 -1.179 . . . . 2.2 110.298 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -88.81 -10.05 49.51 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.884 -1.135 . . . . 1.79 110.074 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -63.55 -23.85 67.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.918 -1.114 . . . . 1.54 110.595 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.22 83.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.081 -1.012 . . . . 0.64 110.274 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.3 mt -70.33 -42.21 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.58 109.449 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -76.1 -20.82 57.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.152 -0.967 . . . . 0.62 109.622 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -65.4 -38.86 91.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.977 -1.077 . . . . 1.23 108.95 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.74 -36.97 61.58 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.247 -1.541 . . . . 0.52 109.247 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -62.42 -21.85 65.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.312 -1.11 . . . . 1.29 110.768 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.2 mt -85.37 -39.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.559 -1.338 . . . . 0.55 108.99 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.4 ttt -59.31 -42.23 90.88 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.364 -0.976 . . . . 1.89 108.364 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.5 -40.49 82.99 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.45 -0.945 . . . . 0.53 108.45 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.4 tp -65.96 -50.33 64.72 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.439 -0.788 . . . . 0.43 109.674 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -85.55 10.48 13.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.162 -0.961 . . . . 1.24 110.976 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -48.46 122.8 5.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.738 -1.226 . . . . 1.31 109.376 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -66.29 -25.9 67.07 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.406 -0.809 . . . . 1.35 108.959 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -76.45 -49.75 15.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.458 -0.777 . . . . 2.16 109.514 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.0 mt -64.95 -20.71 66.61 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.888 -1.125 . . . . 0.6 108.928 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -70.43 -47.57 60.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.381 -0.824 . . . . 1.28 109.476 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -64.89 -32.18 73.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.522 -0.736 . . . . 1.28 109.815 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -73.09 -48.77 32.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -0.951 . . . . 1.29 109.015 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.18 -57.71 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.75 -0.833 . . . . 0.58 108.75 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 91' ' ' ALA . 77.3 mt -53.05 -61.88 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.714 -0.616 . . . . 0.78 110.662 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 90' ' ' ILE . . . -40.93 -62.51 0.8 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.388 -0.82 . . . . 0.86 110.748 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.4 mt -45.12 -51.11 10.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.376 -0.828 . . . . 0.79 110.011 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.5 -41.35 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.929 -1.107 . . . . 0.71 110.011 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -85.16 -42.74 14.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.211 -0.93 . . . . 2.05 111.808 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -83.64 -34.06 25.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.669 -1.269 . . . . 1.59 111.74 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -104.16 10.7 35.71 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.836 -1.165 . . . . 1.89 109.361 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.8 m80 43.77 47.7 6.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.703 . . . . 1.31 109.691 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.5 mtp -99.33 154.88 17.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.77 -0.826 . . . . 1.28 108.77 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.1 p -75.52 141.29 43.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.273 -0.892 . . . . 0.62 109.163 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.07 -25.98 2.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.155 -0.965 . . . . 0.47 109.347 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.83 -45.34 51.85 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.277 -1.009 . . . . 2.0 108.277 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.91 -54.4 11.54 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.733 -0.604 . . . . 0.56 109.873 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -52.62 63.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.261 -0.9 . . . . 0.48 109.478 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.09 -35.42 64.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.958 . . . . 0.44 109.283 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.416 ' CD2' HD11 ' A' ' 26' ' ' ILE . 36.2 t-80 -71.99 -32.41 67.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.853 . . . . 1.42 109.545 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.86 -61.9 2.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 1.26 110.035 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 107' ' ' VAL . 5.8 t -53.66 -47.32 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.015 -1.053 . . . . 0.61 110.038 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.49 -20.66 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.64 109.681 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -74.14 -38.26 63.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.022 . . . . 2.2 110.161 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.38 -21.84 46.76 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.525 -1.321 . . . . 0.82 111.994 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -68.95 -53.48 20.58 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.735 -1.45 . . . . 1.27 108.691 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.66 67.28 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.656 -0.652 . . . . 0.91 109.485 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.9 t -60.69 -43.6 97.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 1.73 110.192 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.3 -33.08 75.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.042 . . . . 1.04 110.449 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.4 HD21 HH21 ' A' ' 126' ' ' ARG . 17.1 mt -69.38 -27.9 65.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.729 -1.232 . . . . 1.03 109.338 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.56 -16.09 64.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 1.95 109.224 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -80.37 -9.06 59.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.374 -0.829 . . . . 1.71 109.004 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.71 141.05 28.9 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.528 -0.915 . . . . 1.26 108.528 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -99.65 65.11 1.33 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.309 -0.869 . . . . 2.83 109.186 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -147.18 111.87 5.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.252 -0.905 . . . . 1.58 109.354 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -51.49 -17.02 0.69 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.537 -0.727 . . . . 2.8 109.815 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -81.21 -63.87 1.31 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 1.02 109.272 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.4 mt -61.76 -31.27 71.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.264 -0.898 . . . . 1.06 110.139 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -66.65 -46.43 75.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.856 -1.152 . . . . 2.39 109.112 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -61.39 -18.75 60.21 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.512 -0.875 . . . . 2.2 108.831 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.4 HH21 HD21 ' A' ' 115' ' ' LEU . 39.3 ttp180 -74.72 -27.69 60.48 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.678 -1.601 . . . . 2.09 106.678 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.71 94.56 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.126 -0.694 . . . . 0.86 109.126 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.99 87.24 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.289 -0.882 . . . . 0.9 109.472 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.8 OUTLIER -70.52 -30.4 67.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.834 . . . . 1.35 110.028 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.12 -39.68 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.958 -1.089 . . . . 0.58 108.45 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -61.69 -37.94 85.97 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.216 -1.031 . . . . 3.22 108.216 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.08 -36.37 77.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.535 -0.728 . . . . 1.32 109.699 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.03 -27.72 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 0.5 109.771 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.33 -46.67 7.35 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.678 -1.369 . . . . 0.44 109.678 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -49.6 -47.75 49.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -1.099 . . . . 2.71 109.144 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.519 HH11 ' HG2' ' A' ' 136' ' ' ARG . 12.8 mtt-85 -64.77 -43.42 93.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.143 -0.973 . . . . 2.2 108.713 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.6 tp -52.38 -39.99 61.51 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.968 -0.753 . . . . 1.13 108.968 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.41 -59.08 2.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 0.54 109.96 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 139' ' ' ARG . 30.4 mtt-85 -47.67 -18.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 2.32 110.841 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -84.6 -39.83 18.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.837 -1.164 . . . . 1.26 108.965 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.61 -38.31 81.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.4 -0.812 . . . . 0.62 109.063 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.9 mt -91.19 -7.3 51.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.345 -0.847 . . . . 0.67 109.016 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.95 20.83 69.09 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.389 -1.884 . . . . 0.68 108.389 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tp -57.82 168.29 0.96 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.689 -0.889 . . . . 0.77 109.601 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -66.06 143.57 57.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 2.4 109.375 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -102.13 147.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.625 -0.88 . . . . 0.87 108.625 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.742 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.7 mp -79.08 94.02 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.168 -0.957 . . . . 1.32 109.193 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -101.0 92.07 4.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.461 -0.774 . . . . 1.54 110.046 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.539 HD21 ' CG2' ' A' ' 147' ' ' ILE . 10.1 mt -82.56 -17.52 44.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.145 -0.972 . . . . 0.77 108.917 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 170' ' ' GLN . 0.8 OUTLIER -82.99 35.34 0.47 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.763 . . . . 1.57 109.608 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.1 24.27 2.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 0.82 109.024 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 79.4 mt -73.16 139.84 18.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.483 -0.761 . . . . 0.82 109.449 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -118.34 -18.0 9.33 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.519 -0.919 . . . . 2.11 108.519 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -117.62 127.73 54.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.982 -0.747 . . . . 1.41 108.982 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -61.91 127.71 32.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.814 . . . . 1.3 109.889 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -149.99 176.86 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.393 -0.817 . . . . 0.57 108.888 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 16.1 mt -87.9 147.14 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.442 -0.948 . . . . 0.43 108.442 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 tp -101.74 117.76 35.54 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.654 -0.869 . . . . 0.56 108.654 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.67 131.96 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.713 -0.847 . . . . 0.54 108.713 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.33 149.17 15.29 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.78 -0.768 . . . . 0.62 109.644 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.76 78.46 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 120.682 -1.261 . . . . 0.8 107.946 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -173.14 148.33 1.68 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.585 -0.697 . . . . 2.34 109.134 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.4 mt -119.59 138.73 53.03 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.383 -0.823 . . . . 0.65 109.619 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.4 p -94.41 153.53 40.41 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 0.74 109.243 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 169' ' ' ALA . 69.6 Cg_exo -37.36 -50.55 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.379 2.053 . . . . 0.6 112.482 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 m -49.78 -55.44 14.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.63 109.281 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.19 -47.52 81.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.907 . . . . 1.25 109.543 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.4 p -67.95 -19.86 65.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 0.5 109.778 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -80.09 -29.5 39.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.163 -0.961 . . . . 0.51 110.113 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.413 ' O ' ' OG ' ' A' ' 150' ' ' SER . 20.9 pt20 -101.5 -11.66 19.13 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.154 -0.966 . . . . 1.17 109.117 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.89 151.72 21.04 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.538 -0.912 . . . . 0.61 108.538 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -99.57 139.35 35.35 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.407 -0.96 . . . . 2.12 108.407 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.78 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.3 mm? -88.37 -41.21 12.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 1.34 109.978 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -82.49 -10.72 58.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.019 -1.05 . . . . 1.97 111.667 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -99.9 -17.03 17.79 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.621 -1.3 . . . . 1.9 108.763 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 178' ' ' GLY . 56.6 t -89.7 156.38 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.592 -0.892 . . . . 0.48 108.592 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.8 tp -106.08 -20.46 13.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.364 -0.835 . . . . 1.39 109.609 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.473 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.4 173.0 41.64 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.095 -1.602 . . . . 0.38 109.095 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -128.36 124.33 36.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -1.035 . . . . 0.46 109.081 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.0 mt -130.2 131.68 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.017 -1.105 . . . . 0.59 108.017 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 23.4 p -139.22 147.41 41.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.36 -0.837 . . . . 0.67 111.336 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.45 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 7.1 p-10 -84.78 37.32 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.702 -0.624 . . . . 2.24 110.09 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 203' ' ' VAL . . . -112.69 120.07 40.28 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.377 -0.827 . . . . 1.11 110.034 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.03 65.94 2.53 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.613 -1.395 . . . . 1.63 109.613 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -100.29 128.23 9.5 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.038 -1.225 . . . . 1.47 110.038 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.478 ' O ' ' OG1' ' A' ' 187' ' ' THR . 16.7 ttm-85 -53.09 92.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.283 -1.377 . . . . 5.24 107.283 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 185' ' ' GLY . 4.9 p 65.12 68.21 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.3 -1.0 . . . . 2.92 108.3 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.0 t -72.11 165.01 25.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 1.6 109.442 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -43.65 -47.49 7.66 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.522 -0.736 . . . . 0.92 110.427 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.0 m -50.08 -31.04 12.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 1.59 109.599 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.9 t -76.47 -39.41 53.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.194 -0.941 . . . . 1.42 109.859 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.518 HD12 ' N ' ' A' ' 192' ' ' ILE . 1.5 mp -53.48 -36.43 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.956 . . . . 1.41 108.758 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 33.3 mtp -71.13 -52.11 21.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.255 -1.387 . . . . 0.86 107.255 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -58.33 -46.05 86.96 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.528 -0.76 . . . . 0.59 110.243 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -63.89 -48.76 75.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.064 -1.023 . . . . 3.06 110.056 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.8 m -68.92 -36.43 77.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.125 -0.984 . . . . 0.73 109.5 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 199' ' ' LEU . 21.3 mt -89.37 1.81 55.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.977 . . . . 0.67 109.018 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 194' ' ' ALA . 32.1 mt-10 54.71 2.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.466 -0.771 . . . . 1.49 111.261 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 197' ' ' LEU . 25.2 mt -66.61 168.47 10.11 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.622 -1.299 . . . . 0.64 108.54 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -85.71 144.0 8.59 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.21 1.94 . . . . 0.59 111.081 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -160.36 172.6 17.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.653 -1.279 . . . . 0.55 110.965 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.598 HD12 HD11 ' A' ' 220' ' ' LEU . 12.2 mt -150.95 156.0 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.365 -1.717 . . . . 0.63 106.365 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 181' ' ' THR . 12.8 m -143.04 -33.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.812 -1.18 . . . . 0.77 111.703 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.527 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -85.89 38.96 3.03 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 120.523 -1.36 . . . . 0.87 110.202 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 206' ' ' GLY . 27.5 p -71.21 42.83 0.07 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.831 -1.394 . . . . 0.89 109.199 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 39.18 -102.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.272 -1.131 . . . . 0.93 110.272 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.4 m -131.14 42.37 3.23 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.811 -0.817 . . . . 1.6 110.039 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.3 t -54.56 -33.57 27.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.868 -1.145 . . . . 0.75 108.438 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 5.2 p -55.39 -16.48 3.64 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.047 -1.033 . . . . 0.84 108.678 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 49.9 m -103.95 12.21 34.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.541 -0.724 . . . . 1.61 109.322 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -135.74 -17.3 1.7 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.32 -0.862 . . . . 2.3 109.968 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 5.8 t -112.55 141.91 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.637 -0.875 . . . . 0.76 108.637 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -177.92 3.26 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.764 -1.569 . . . . 2.01 106.764 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.3 p-10 -81.06 144.81 31.47 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.033 -1.042 . . . . 2.19 110.04 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.8 m-20 81.04 -13.46 0.92 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.074 -0.392 . . . . 2.4 110.857 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.51 136.37 56.71 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.854 -1.154 . . . . 1.99 108.416 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -86.7 117.21 25.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.926 -1.109 . . . . 1.3 108.952 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.3 mt -129.38 175.16 8.98 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.654 0.74 . . . . 0.53 109.585 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.6 mt -140.89 126.25 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.755 -0.831 . . . . 0.6 108.755 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.598 HD11 HD12 ' A' ' 202' ' ' ILE . 24.0 tp -90.16 126.32 35.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.57 108.725 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 223' ' ' VAL . 4.1 m-20 -95.38 -34.56 12.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.07 -1.019 . . . . 2.22 109.486 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.51 21.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.675 -0.641 . . . . 0.75 110.142 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.3 t -115.12 -59.84 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 106.465 -1.68 . . . . 0.92 106.465 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -89.21 11.39 18.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.242 -1.392 . . . . 2.36 107.242 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 64.3 t30 57.39 58.26 3.94 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.414 -0.588 . . . . 1.42 109.414 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -156.1 151.76 27.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.054 -1.028 . . . . 1.97 110.517 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 32.8 t -109.78 139.33 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.721 -0.844 . . . . 0.65 108.721 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -108.88 129.94 55.42 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.406 -0.809 . . . . 0.97 109.555 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 11.3 t -103.18 113.81 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.401 -0.812 . . . . 0.67 109.362 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.1 t30 52.02 63.42 9.18 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.943 . . . . 1.45 110.54 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.81 161.6 44.54 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.509 2.14 . . . . 0.82 112.019 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.6 p -74.0 160.4 31.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.358 -0.839 . . . . 1.62 109.464 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -68.01 -26.68 66.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 2.6 109.137 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 234' ' ' GLU . 0.7 OUTLIER -62.05 -37.65 85.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.414 -0.803 . . . . 3.06 109.623 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.58 -45.28 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.007 -1.058 . . . . 1.14 109.157 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.57 -57.96 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.323 -0.861 . . . . 1.04 109.67 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -53.72 -40.37 66.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.28 -0.887 . . . . 2.54 110.417 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -65.91 -40.23 91.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 2.6 110.279 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 28.9 mtm -80.7 -26.04 37.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.999 -1.063 . . . . 1.23 109.911 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.403 ' NH1' ' HG3' ' A' ' 240' ' ' ARG . 15.1 mmm-85 -58.29 -42.16 85.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 2.67 109.898 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.24 -52.28 11.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 1.66 110.133 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 35.4 t -62.79 -50.23 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.101 -0.999 . . . . 2.2 109.862 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.42 ' HG2' HD12 ' A' ' 11' ' ' ILE . 7.4 tm0? -51.71 -59.12 4.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.197 -0.94 . . . . 3.0 110.378 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.95 -23.75 66.57 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.271 -0.893 . . . . 1.76 110.625 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -67.09 -22.76 65.81 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.905 -1.146 . . . . 2.78 107.905 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 88.7 t -78.55 -39.15 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.756 -0.831 . . . . 2.06 108.756 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.3 -28.26 69.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.488 -0.757 . . . . 2.4 109.757 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.5 p -76.84 -32.51 57.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.139 -0.975 . . . . 2.87 109.698 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 3.41 109.217 179.793 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' N ' ' A' ' 3' ' ' SER . 21.1 mmt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.255 -0.646 . . . . 3.66 109.255 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.59 85.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.092 -1.005 . . . . 1.12 108.649 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 1' ' ' MET . 6.9 m -88.54 114.15 24.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 1.45 109.253 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.55 -163.16 20.7 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 108.859 -1.696 . . . . 0.92 108.859 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 5' ' ' ILE . 65.1 mt -94.84 -6.44 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -1.174 . . . . 1.05 108.553 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 36.5 tp 54.17 104.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.106 -0.702 . . . . 0.88 109.106 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.14 -56.0 4.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.064 -1.022 . . . . 0.78 108.345 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.64 145.61 26.3 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.144 -1.058 . . . . 1.5 108.144 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.58 154.19 35.0 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.986 1.79 . . . . 0.86 113.499 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.51 133.2 1.81 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.721 -1.351 . . . . 0.78 109.721 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.0 mt -94.85 135.65 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.955 -1.321 . . . . 0.74 109.795 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.412 ' HB1' HD22 ' A' ' 177' ' ' LEU . . . -143.6 155.42 44.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.216 -0.927 . . . . 0.45 109.726 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -125.38 141.78 51.87 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.338 -0.986 . . . . 0.64 108.338 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.24 163.02 28.08 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.127 -1.511 . . . . 0.45 110.887 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -78.51 150.97 32.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.488 -1.007 . . . . 1.88 109.559 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.566 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -76.13 127.9 33.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.59 111.012 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -109.71 91.94 3.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.436 -1.32 . . . . 0.64 107.436 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.649 ' H ' ' ND2' ' A' ' 214' ' ' ASN . 8.6 tp -81.65 126.3 31.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.021 -1.049 . . . . 0.74 110.58 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.489 HD11 HD11 ' A' ' 158' ' ' LEU . 13.6 mt -96.43 93.5 6.87 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.905 -0.589 . . . . 0.74 110.075 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -92.82 158.22 15.98 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.598 -0.89 . . . . 1.87 108.598 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -130.62 135.93 48.36 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.351 -0.843 . . . . 2.58 109.322 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.11 133.55 36.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -0.854 . . . . 2.14 108.856 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.58 147.69 48.37 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.293 -0.88 . . . . 1.93 109.135 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.0 mt -89.27 129.76 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.298 -0.876 . . . . 0.68 109.417 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.4 112.59 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.605 -0.887 . . . . 0.84 108.605 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.6 mt -86.56 131.78 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.79 109.65 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -90.1 114.69 26.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.397 -0.814 . . . . 1.37 109.374 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.426 HH11 ' HG3' ' A' ' 28' ' ' ARG . 19.9 mmm-85 -95.63 26.16 4.13 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.206 -0.934 . . . . 2.62 108.857 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -79.21 143.26 35.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 2.35 109.384 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -84.76 123.63 30.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 2.35 109.573 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -90.92 173.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.277 -0.889 . . . . 0.78 109.987 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -105.53 172.9 6.55 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.776 -0.578 . . . . 1.04 109.603 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.18 -8.55 32.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.815 . . . . 1.05 109.722 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -82.84 -16.42 47.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.048 -1.032 . . . . 2.47 109.814 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -110.78 -8.27 14.56 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.395 -0.815 . . . . 1.46 109.263 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.49 -45.1 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.77 108.587 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -53.9 -36.09 62.35 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.419 -0.8 . . . . 1.46 109.067 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -70.44 -42.06 72.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.497 -0.752 . . . . 2.29 110.51 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -58.66 -45.6 89.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 1.3 109.535 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 44' ' ' LEU . 85.6 t -61.81 -44.21 98.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.192 -0.943 . . . . 0.76 109.053 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -65.72 -42.49 90.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.28 -0.887 . . . . 1.5 109.083 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -63.62 -34.89 78.84 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.176 -0.952 . . . . 2.66 108.92 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -86.39 -53.09 5.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.394 -0.816 . . . . 0.75 109.059 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' VAL . 10.0 tp -53.79 -67.1 0.29 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.731 . . . . 0.83 109.731 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.619 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 45.1 t -63.75 -35.07 79.38 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.192 -0.943 . . . . 0.78 108.935 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.55 -53.35 39.25 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.372 -2.291 . . . . 0.57 107.372 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -46.74 -32.33 3.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.603 -0.939 . . . . 2.83 108.775 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.86 -32.92 69.88 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.869 -1.159 . . . . 0.65 107.869 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 46' ' ' GLY . 16.5 ttmm -83.89 -61.05 1.92 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.021 -0.733 . . . . 2.57 109.021 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.09 -45.03 64.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.51 110.069 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.4 t -63.35 -38.14 89.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.06 -1.025 . . . . 1.36 108.409 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 -31.2 65.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.089 -0.708 . . . . 0.6 109.089 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -69.25 -58.68 3.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.801 . . . . 1.36 109.099 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.4 mt -55.85 -45.38 78.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 1.38 108.718 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -55.27 -48.66 73.7 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.981 -0.748 . . . . 1.27 108.981 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.1 m -63.13 -41.08 99.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.6 109.22 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.4 mt -71.53 -37.49 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.375 -0.972 . . . . 0.53 108.375 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -49.84 -45.58 50.4 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.57 -0.706 . . . . 0.99 109.408 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -70.95 -27.78 64.0 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.256 -0.902 . . . . 0.59 109.941 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -71.79 -25.37 61.98 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.805 -1.184 . . . . 1.81 108.475 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.45 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -81.58 -29.07 33.53 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.647 -0.872 . . . . 0.48 108.647 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.21 -32.13 17.85 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.969 -1.11 . . . . 0.58 110.653 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -85.88 -15.44 41.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.899 -1.353 . . . . 1.39 109.107 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.8 m -95.49 -48.81 5.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.332 -0.855 . . . . 0.82 110.498 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -106.64 -14.48 15.02 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.13 -0.981 . . . . 0.99 110.67 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.81 136.86 5.2 Favored Glycine 0 N--CA 1.502 3.087 0 N-CA-C 109.733 -1.347 . . . . 0.55 109.733 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -48.29 -9.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.536 -0.979 . . . . 2.59 110.744 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 66' ' ' GLY . 13.6 pt-20 -66.51 -21.86 66.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.952 -1.093 . . . . 2.2 110.586 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -87.93 -16.32 34.19 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.92 -1.113 . . . . 1.79 109.781 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.15 -20.34 66.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.2 -0.937 . . . . 1.54 110.686 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.75 92.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.852 -1.155 . . . . 0.64 109.531 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.6 mt -71.73 -39.85 69.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.218 -0.926 . . . . 0.58 109.465 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -78.06 -23.53 48.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -0.958 . . . . 0.62 108.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -64.7 -33.28 75.59 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.493 -0.928 . . . . 1.23 108.493 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.47 -35.9 35.6 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.048 -1.621 . . . . 0.52 109.048 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -60.95 -21.1 63.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.352 -1.087 . . . . 1.29 109.829 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.2 mt -86.42 -42.4 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.9 -1.125 . . . . 0.55 108.76 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.3 ttm -59.88 -41.38 91.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.022 -0.733 . . . . 1.89 109.022 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -63.93 -39.31 93.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.53 109.127 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -71.83 -42.58 66.81 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.534 -0.866 . . . . 0.43 109.431 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -86.24 5.43 34.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 1.24 110.41 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -48.36 122.75 5.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.884 -1.135 . . . . 1.31 109.753 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -67.42 -24.32 65.64 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.643 -0.873 . . . . 1.35 108.643 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -76.14 -53.39 8.36 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.469 -0.769 . . . . 2.16 109.055 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.06 -12.61 52.55 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.972 -1.091 . . . . 0.6 108.707 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -78.16 -53.75 7.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.434 -0.792 . . . . 1.28 109.897 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -62.5 -25.69 68.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 1.28 109.701 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -73.19 -47.04 47.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -0.99 . . . . 1.29 108.812 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.61 -56.32 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.441 -0.948 . . . . 0.58 108.441 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -48.34 -56.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.603 -0.686 . . . . 0.78 110.055 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -47.79 -61.96 1.69 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.86 110.308 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.5 mt -47.8 -52.14 19.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.79 109.402 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.0 mt -52.2 -46.24 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.077 -1.014 . . . . 0.71 110.193 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -84.85 -35.51 22.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.094 -1.004 . . . . 2.05 111.88 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.25 -37.98 22.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.536 -1.352 . . . . 1.59 111.732 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -105.23 14.62 28.73 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.729 -1.232 . . . . 1.89 109.48 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.8 m80 45.16 42.53 6.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.379 -0.826 . . . . 1.31 109.597 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.7 mtt -95.36 149.54 21.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.936 -0.765 . . . . 1.28 108.936 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 p -76.62 143.59 40.09 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.33 -0.856 . . . . 0.62 109.283 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.04 -27.94 1.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 0.47 109.804 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 1.3 p30 -76.14 -43.85 41.06 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.293 -0.879 . . . . 2.0 108.717 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -70.52 -56.9 5.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.622 -0.674 . . . . 0.56 110.277 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.25 -49.68 68.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.48 109.758 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.89 -30.94 59.31 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.247 -0.908 . . . . 0.44 109.525 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -69.47 -34.63 74.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.991 -1.068 . . . . 1.42 109.873 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -63.78 -45.89 87.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.989 -1.07 . . . . 1.26 109.791 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.51 -47.82 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.825 -1.172 . . . . 0.61 108.669 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.74 -18.19 22.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.493 -0.754 . . . . 0.64 109.057 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.8 -42.87 73.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 2.2 109.572 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.32 -29.32 22.53 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.617 -1.278 . . . . 0.82 112.336 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -65.15 -39.45 93.01 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.414 -1.639 . . . . 1.27 108.797 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.67 -51.36 7.8 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.567 -0.708 . . . . 0.91 109.178 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.9 t -60.34 -44.52 95.44 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.452 -0.78 . . . . 1.73 110.149 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -63.89 -37.62 88.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.05 -1.031 . . . . 1.04 111.235 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.41 -25.99 66.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.507 -1.371 . . . . 1.03 109.216 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -71.63 -21.33 61.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.971 -1.08 . . . . 1.95 109.828 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -81.83 -7.02 59.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.214 -0.929 . . . . 1.71 108.921 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.89 136.86 33.12 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.255 -1.017 . . . . 1.26 108.255 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -94.07 63.43 3.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 2.83 108.722 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -146.61 114.27 6.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.81 . . . . 1.58 109.28 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.83 -16.01 4.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 2.8 109.755 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -81.12 -63.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 1.02 109.368 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 mt -66.55 -31.32 71.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.236 -0.915 . . . . 1.06 109.833 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 27.6 ttpt -66.69 -50.05 64.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.942 -1.099 . . . . 2.39 109.321 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.27 -25.73 49.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.091 -1.006 . . . . 2.2 108.702 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -72.56 -23.57 60.99 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.542 -1.651 . . . . 2.09 106.542 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -58.38 -47.83 82.59 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.233 -1.025 . . . . 0.86 108.233 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.41 -35.84 76.13 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.674 -0.641 . . . . 0.9 109.48 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 1.9 m-20 -68.69 -30.63 69.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.422 -0.799 . . . . 1.35 109.733 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.4 t -77.48 -39.48 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.01 -1.056 . . . . 0.58 108.679 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -56.35 -40.93 75.31 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.107 -1.071 . . . . 3.22 108.107 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.61 -38.36 81.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.603 -0.686 . . . . 1.32 109.665 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.5 mt -69.52 -21.77 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.5 109.449 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.09 -58.36 2.99 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.0 -1.095 . . . . 0.44 110.496 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -52.67 -42.67 64.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.007 -1.29 . . . . 2.71 109.849 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 140' ' ' ASN . 23.2 mtt-85 -65.43 -45.91 82.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.957 -1.089 . . . . 2.2 108.423 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.2 tp -55.68 -43.41 76.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.585 -0.697 . . . . 1.13 109.386 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.2 -47.9 75.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.54 110.268 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -52.96 -22.35 5.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.061 -1.024 . . . . 2.32 110.8 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 70.4 m-80 -83.37 -45.55 13.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.915 -1.116 . . . . 1.26 109.091 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.5 mt -53.93 -38.48 36.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.197 -0.94 . . . . 0.62 108.934 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.2 mt -88.15 3.59 48.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.245 -0.909 . . . . 0.67 109.101 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.2 30.88 55.83 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.744 -1.742 . . . . 0.68 108.744 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.57 142.35 52.9 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.357 -1.084 . . . . 0.77 109.462 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -67.5 136.01 53.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 2.4 109.708 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 80.4 mt -106.54 144.6 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.898 -0.779 . . . . 0.87 108.898 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.709 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.1 mp -77.92 138.98 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 1.32 109.616 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -96.67 86.59 4.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.426 -0.796 . . . . 1.54 109.486 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.1 mt -80.17 -29.69 38.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.412 -0.805 . . . . 0.77 109.651 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.8 p -79.98 20.64 0.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.933 . . . . 1.57 109.486 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -142.32 35.11 1.49 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.347 -0.845 . . . . 0.82 109.714 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 153' ' ' GLN . 57.7 mt -72.3 158.83 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.82 109.148 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 152' ' ' ILE . 1.2 pt20 -134.43 -4.21 2.65 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.293 -0.879 . . . . 2.11 109.601 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -125.2 128.34 48.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.533 -0.729 . . . . 1.41 109.297 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.52 122.99 18.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 1.3 109.292 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.4 m -148.12 172.97 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.321 -0.862 . . . . 0.57 109.314 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.4 mt -88.85 152.91 3.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.809 -1.182 . . . . 0.43 107.809 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.489 HD11 HD11 ' A' ' 19' ' ' LEU . 14.6 tp -105.98 118.76 37.44 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.619 0.724 . . . . 0.56 109.273 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 26.2 t -121.46 128.62 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.815 -0.809 . . . . 0.54 108.815 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.67 146.59 11.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.313 -0.867 . . . . 0.62 109.539 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.5 71.72 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.677 -1.265 . . . . 0.8 108.015 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -173.21 157.33 3.38 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.598 -0.689 . . . . 2.34 109.48 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.7 mt -126.82 137.47 53.2 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.531 -0.731 . . . . 0.65 109.118 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.6 p -92.33 152.74 42.64 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.24 -0.913 . . . . 0.74 109.195 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 169' ' ' ALA . 66.0 Cg_exo -35.92 -51.9 1.03 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.561 2.174 . . . . 0.6 112.663 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.5 m -47.92 -54.72 11.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.63 109.473 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -59.04 -48.07 82.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 1.25 109.811 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 168' ' ' THR . 5.4 p -69.49 -24.33 63.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.5 109.902 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -77.9 -24.62 48.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.51 110.086 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -106.95 -15.39 14.71 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.316 -0.865 . . . . 1.17 109.681 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.1 tp -58.81 149.91 25.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.019 -1.051 . . . . 0.61 108.831 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.54 ' ND2' ' H ' ' A' ' 173' ' ' LEU . 2.6 t-20 -99.02 152.57 19.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 2.12 108.702 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.54 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 11.8 mt -95.32 -40.84 9.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.177 -0.952 . . . . 1.34 110.938 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -81.79 -14.68 56.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.846 -1.159 . . . . 1.97 112.125 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -95.0 -11.11 29.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.433 -1.417 . . . . 1.9 107.869 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 177' ' ' LEU . 95.8 t -96.95 163.6 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.799 -1.186 . . . . 0.48 107.799 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.545 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -112.18 -26.62 8.71 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.638 -0.875 . . . . 1.39 108.638 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.42 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.85 176.28 47.37 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.156 -1.578 . . . . 0.38 109.156 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.448 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 1.6 m-85 -128.39 123.45 33.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.438 -1.036 . . . . 0.46 109.91 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.6 mt -128.25 129.92 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.492 -1.299 . . . . 0.59 107.492 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.2 p -140.24 148.14 41.05 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.235 1.017 . . . . 0.67 111.785 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 1.1 t70 -87.78 38.72 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.77 -0.581 . . . . 2.24 109.843 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.548 ' C ' ' H ' ' A' ' 185' ' ' GLY . . . -105.84 121.67 44.52 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.174 -0.954 . . . . 1.11 110.287 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.05 4.82 0.01 OUTLIER Glycine 0 N--CA 1.496 2.69 0 O-C-N 121.395 -0.816 . . . . 1.63 111.971 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 183' ' ' ALA . . . 88.3 -13.18 62.52 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 120.314 -1.697 . . . . 1.47 109.917 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -54.95 -33.37 62.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -1.176 . . . . 5.24 109.262 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 p -146.9 40.87 1.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 2.92 109.42 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 183' ' ' ALA . 31.7 m -91.03 91.74 8.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.104 -0.998 . . . . 1.6 109.79 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -60.7 -22.68 64.2 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.977 -1.12 . . . . 0.92 107.977 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 95.1 m -63.11 -39.73 95.55 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.621 -0.881 . . . . 1.59 108.621 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.3 t -57.09 -33.16 67.02 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 1.42 109.051 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.87 -37.66 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.293 -0.879 . . . . 1.41 110.444 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 21.7 mtm -71.94 -51.42 22.12 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.785 -1.197 . . . . 0.86 108.238 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.83 -32.33 31.24 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.147 0.498 . . . . 0.59 109.705 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -75.52 -46.04 34.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.057 -1.027 . . . . 3.06 109.376 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.3 m -70.77 -35.7 72.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.257 -0.902 . . . . 0.73 109.63 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.5 mt -89.49 -2.37 58.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.67 109.139 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 51.17 10.12 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.562 -0.711 . . . . 1.49 111.783 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 14.9 mt -68.17 168.41 13.64 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.557 -1.339 . . . . 0.64 108.507 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.14 131.8 5.96 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.121 1.881 . . . . 0.59 111.578 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -163.37 176.39 9.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.794 -1.191 . . . . 0.55 111.177 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.409 HG23 ' H ' ' A' ' 6' ' ' LEU . 11.4 mt -149.64 161.51 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.653 -1.61 . . . . 0.63 106.653 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 181' ' ' THR . 17.1 m -144.63 -31.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.725 -1.234 . . . . 0.77 111.413 -178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.18 31.2 5.5 Favored Glycine 0 N--CA 1.491 2.364 0 O-C-N 120.807 -1.183 . . . . 0.87 110.486 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.434 ' HB ' HG23 ' A' ' 208' ' ' VAL . 10.1 p -56.02 -37.27 68.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.787 -1.419 . . . . 0.89 108.514 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.43 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 64.94 -35.2 0.1 Allowed Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.923 -0.656 . . . . 0.93 113.522 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.6 m -121.66 16.43 11.13 Favored 'General case' 0 N--CA 1.513 2.704 0 CA-C-N 119.812 1.806 . . . . 1.6 112.839 -177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' A' ' 205' ' ' THR . 5.7 t -78.23 -52.54 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.221 -1.549 . . . . 0.75 109.888 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.3 p -53.62 -19.61 4.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.697 -1.252 . . . . 0.84 109.961 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.8 m -105.72 14.45 28.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.341 -0.85 . . . . 1.61 109.474 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -143.54 -5.6 0.83 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.235 -0.916 . . . . 2.3 110.891 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 37.2 t -119.45 157.58 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.16 -0.963 . . . . 0.76 109.957 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.426 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 16.0 mmmt -134.34 171.38 14.35 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.813 -1.551 . . . . 2.01 106.813 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.649 ' ND2' ' H ' ' A' ' 18' ' ' LEU . 11.5 t-20 -76.17 143.06 41.36 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.876 -1.14 . . . . 2.19 110.539 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.0 t70 80.12 -10.77 1.24 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.712 -0.617 . . . . 2.4 110.867 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -57.85 143.62 41.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.772 -1.205 . . . . 1.99 108.657 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -86.08 110.95 19.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.011 -1.055 . . . . 1.3 108.555 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.566 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 13.4 mt -123.8 165.4 17.38 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.67 0.747 . . . . 0.53 109.946 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 40.6 mt -138.71 125.22 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.833 -1.173 . . . . 0.6 107.833 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.4 tp -86.89 127.35 35.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.2 -0.938 . . . . 0.57 108.735 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.7 -46.17 6.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.244 -0.91 . . . . 2.22 109.433 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 44.51 23.87 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.513 -0.742 . . . . 0.75 110.165 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 t -115.96 -41.11 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 106.634 -1.617 . . . . 0.92 106.634 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -108.22 13.08 26.08 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.825 -1.546 . . . . 2.36 106.825 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 60.66 52.63 4.36 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.964 -0.562 . . . . 1.42 109.908 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -157.87 154.92 28.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.972 -1.08 . . . . 1.97 110.712 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 228' ' ' TYR . 87.6 t -107.19 163.21 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.843 -0.799 . . . . 0.65 108.843 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.517 ' N ' HG12 ' A' ' 227' ' ' VAL . 48.2 m-85 -122.07 116.27 23.96 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.358 -0.839 . . . . 0.97 109.147 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.7 t -102.16 120.1 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.406 -0.809 . . . . 0.67 109.871 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 31.8 t30 65.68 74.98 0.36 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.685 -0.634 . . . . 1.45 110.452 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -91.56 143.76 3.02 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 123.334 2.689 . . . . 0.82 111.929 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 14.5 p -73.34 167.19 21.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 1.62 109.714 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -72.4 -34.47 67.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 2.6 108.958 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -66.25 -34.3 77.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.504 -0.747 . . . . 3.06 109.473 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.1 t -76.03 -30.1 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 1.14 109.151 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 69.5 mt -70.88 -56.37 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.311 -0.868 . . . . 1.04 109.074 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -54.85 -40.22 69.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 2.54 110.228 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -66.98 -40.27 87.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.119 -0.988 . . . . 2.6 110.197 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.8 mtp -81.07 -23.11 38.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.069 -1.019 . . . . 1.23 109.692 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -60.02 -44.09 94.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 2.67 109.385 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.65 -56.81 4.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 1.66 110.019 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 94.0 t -48.81 -61.44 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.256 -0.902 . . . . 2.2 110.091 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -49.29 -57.29 7.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.276 -0.89 . . . . 3.0 110.223 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.0 -25.41 66.86 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.854 -1.153 . . . . 1.76 109.931 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -68.55 -28.73 67.22 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.628 -1.249 . . . . 2.78 107.628 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.03 -45.66 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.824 -0.806 . . . . 2.06 108.824 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.13 -42.87 81.76 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.719 -0.792 . . . . 2.4 109.585 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.4 t -80.36 -31.18 37.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.333 -0.854 . . . . 2.87 110.746 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.026 -1.047 . . . . 3.41 109.396 -179.357 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 3' ' ' SER . 66.6 mtt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.5 -0.555 . . . . 3.66 109.5 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.78 83.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 1.12 109.556 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 1' ' ' MET . 50.8 m -94.59 112.12 23.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.963 -1.086 . . . . 1.45 108.696 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.76 -165.04 21.6 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 109.872 -1.291 . . . . 0.92 109.872 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 5' ' ' ILE . 58.2 mt -93.07 -6.18 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.249 -1.148 . . . . 1.05 108.595 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' ILE . 18.3 tp 57.16 110.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.538 -0.726 . . . . 0.88 109.418 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.55 -45.87 9.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.78 109.23 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.51 150.53 31.33 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.241 -0.912 . . . . 1.5 109.384 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -83.01 148.29 13.4 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.478 2.118 . . . . 0.86 113.733 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.735 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.56 -177.06 34.53 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.421 -1.472 . . . . 0.78 109.421 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 mt -147.7 126.89 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.872 -1.37 . . . . 0.74 110.186 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.17 161.49 36.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.34 -0.85 . . . . 0.45 109.48 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 8.1 m-85 -126.9 128.27 46.21 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.656 -0.868 . . . . 0.64 108.656 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.77 165.95 38.47 Favored Glycine 0 N--CA 1.502 3.064 0 C-N-CA 118.48 -1.819 . . . . 0.45 111.836 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -82.12 151.45 26.98 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.46 -1.024 . . . . 1.88 110.66 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.54 130.76 37.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.448 -0.782 . . . . 0.59 111.878 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 tp -111.05 99.86 8.65 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.182 -1.414 . . . . 0.64 107.182 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 tp -85.51 122.55 29.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.785 -1.197 . . . . 0.74 110.872 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 158' ' ' LEU . 20.9 mt -93.48 98.72 11.38 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.791 -0.818 . . . . 0.74 108.791 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -89.85 142.52 27.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.433 -0.792 . . . . 1.87 109.265 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -110.11 129.68 55.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.487 -0.758 . . . . 2.58 109.681 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -78.13 122.26 25.4 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.17 -1.048 . . . . 2.14 108.17 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -65.6 134.96 54.41 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.098 -1.001 . . . . 1.93 109.765 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.0 mt -91.3 134.47 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.543 -0.723 . . . . 0.68 109.503 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.84 119.52 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.87 -0.789 . . . . 0.84 108.87 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.5 mt -90.62 131.51 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.968 -1.082 . . . . 0.79 109.41 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -89.69 123.79 34.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.135 -0.978 . . . . 1.37 109.508 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -97.11 28.39 3.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.172 -0.955 . . . . 2.62 109.185 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -85.72 141.32 29.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 2.35 109.691 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -84.87 130.21 34.69 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.487 -0.931 . . . . 2.35 108.487 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.3 pt -88.18 172.76 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.78 110.25 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 34' ' ' ASP . 88.5 p -99.01 161.1 13.81 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.586 -0.894 . . . . 1.04 108.586 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.82 -7.06 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.855 -1.153 . . . . 1.05 109.893 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 32' ' ' SER . 38.2 m-20 -83.38 -15.01 51.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.978 -1.076 . . . . 2.47 110.517 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -117.55 0.46 12.11 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.366 -0.834 . . . . 1.46 109.758 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 t -68.64 -49.36 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.937 -1.102 . . . . 0.77 109.593 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -59.67 -30.61 68.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.2 -0.937 . . . . 1.46 108.477 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.487 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 1.5 mp0 -70.67 -39.09 73.76 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.254 0.549 . . . . 2.29 110.023 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -64.45 -37.13 86.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.105 -0.997 . . . . 1.3 109.5 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -60.33 -45.55 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.804 . . . . 0.76 109.401 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.85 -37.95 89.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 1.5 108.543 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.602 HH11 ' HG2' ' A' ' 42' ' ' ARG . 4.6 mtt-85 -67.05 -41.08 87.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.048 -0.723 . . . . 2.66 109.048 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -81.82 -41.93 20.38 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.372 -0.83 . . . . 0.75 109.537 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 tp -64.6 -61.34 2.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.166 -0.959 . . . . 0.83 108.569 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.0 t -65.4 -36.19 83.2 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.444 -0.785 . . . . 0.78 108.992 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -50.84 -56.97 11.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.302 -1.919 . . . . 0.57 108.302 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.443 HH11 ' HB3' ' A' ' 47' ' ' ARG . 1.7 ttt-85 -47.04 -32.42 3.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.565 -0.962 . . . . 2.83 108.735 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.21 -32.54 64.5 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.028 -1.101 . . . . 0.65 108.028 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 46' ' ' GLY . 93.5 mttt -81.33 -58.99 2.79 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.026 -0.731 . . . . 2.57 109.026 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.93 -44.71 64.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.095 -1.003 . . . . 0.51 110.148 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 65.5 p -61.43 -37.62 84.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.159 -0.963 . . . . 1.36 108.67 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.68 -42.12 61.72 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.394 0.616 . . . . 0.6 109.401 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -67.29 -58.49 4.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.813 . . . . 1.36 109.585 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.9 mt -52.35 -47.11 66.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.119 -0.988 . . . . 1.38 108.875 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 51' ' ' SER . 6.2 mm-40 -52.25 -47.27 65.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.555 -0.715 . . . . 1.27 109.196 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m -58.6 -38.12 77.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.6 108.83 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.1 mt -75.12 -31.94 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 0.53 108.813 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -54.89 -50.11 69.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.439 -0.788 . . . . 0.99 109.85 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.401 HG22 ' OE1' ' A' ' 63' ' ' GLU . 3.0 m -70.22 -29.92 66.87 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.333 -0.854 . . . . 0.59 110.58 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -69.8 -14.92 63.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.712 -1.242 . . . . 1.81 108.211 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.48 -36.92 21.94 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.699 -0.852 . . . . 0.48 108.699 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.39 -26.64 42.57 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.68 -1.248 . . . . 0.58 109.984 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.401 ' OE1' HG22 ' A' ' 59' ' ' THR . 32.3 mt-10 -86.82 -17.1 34.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.075 -1.25 . . . . 1.39 109.413 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.9 m -96.3 -47.58 5.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.284 -0.885 . . . . 0.82 110.168 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -106.24 -15.57 14.81 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.071 -1.018 . . . . 0.99 110.702 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 118.37 140.83 6.51 Favored Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.057 -1.617 . . . . 0.55 109.057 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -47.45 -11.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -1.155 . . . . 2.59 110.542 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 66' ' ' GLY . 55.0 tt0 -61.27 -30.91 70.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.581 -1.324 . . . . 2.2 109.905 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -92.01 -10.47 39.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.891 -1.131 . . . . 1.79 110.171 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -66.85 -35.12 79.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.042 -1.036 . . . . 1.54 110.187 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.06 -30.04 70.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.64 110.382 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.7 mt -69.01 -42.76 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.941 -1.099 . . . . 0.58 108.725 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -77.8 -21.68 51.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.888 . . . . 0.62 109.53 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.52 -38.05 89.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.12 -0.987 . . . . 1.23 108.662 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.19 -35.76 52.38 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.046 -1.621 . . . . 0.52 109.046 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.24 -20.9 64.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -1.117 . . . . 1.29 110.339 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.6 mt -84.09 -38.28 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.763 -1.21 . . . . 0.55 108.384 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.4 ttt -59.68 -36.39 76.37 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.272 -0.892 . . . . 1.89 108.776 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.3 tp -65.13 -38.82 91.87 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.812 -1.181 . . . . 0.53 107.812 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.0 tp -73.25 -44.08 60.06 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.771 -0.772 . . . . 0.43 109.466 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -85.75 5.72 31.06 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.218 -0.927 . . . . 1.24 110.195 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -47.14 123.16 5.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.944 -1.097 . . . . 1.31 110.046 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -66.94 -26.07 66.66 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.894 -0.78 . . . . 1.35 108.894 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -74.87 -51.09 14.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.427 -0.796 . . . . 2.16 109.11 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.68 -17.72 64.81 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.975 -1.09 . . . . 0.6 109.12 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -74.17 -55.7 5.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.089 -1.007 . . . . 1.28 110.399 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -62.25 -29.89 70.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.393 -0.817 . . . . 1.28 110.215 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -72.21 -42.87 65.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 1.29 108.763 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.1 mt -59.85 -59.41 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.36 -1.348 . . . . 0.58 107.36 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.1 mt -47.85 -62.77 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.902 -0.498 . . . . 0.78 110.193 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -42.7 -63.28 0.81 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.291 -0.881 . . . . 0.86 109.932 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.5 mt -46.58 -51.93 14.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.281 -0.887 . . . . 0.79 109.688 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 79.5 mt -52.94 -41.93 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 0.71 109.309 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -85.68 -37.18 19.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 2.05 111.734 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -86.2 -33.36 20.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.781 -1.199 . . . . 1.59 112.416 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 97' ' ' HIS . 53.3 mmtt -109.7 20.06 18.5 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.453 -1.405 . . . . 1.89 110.058 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 96' ' ' LYS . 46.9 m80 42.45 46.02 3.98 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.371 -0.831 . . . . 1.31 110.158 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 34.8 mtt -98.28 144.77 27.35 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.726 -0.842 . . . . 1.28 108.726 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.3 p -75.51 148.3 39.08 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.47 -0.769 . . . . 0.62 110.086 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.29 -31.5 21.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.47 109.338 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -74.19 -42.2 60.22 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.016 -1.105 . . . . 2.0 108.016 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.26 -55.13 7.69 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.313 -0.555 . . . . 0.56 109.909 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.68 76.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 0.48 109.685 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.01 -38.93 73.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.44 109.623 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' GLU . 49.4 t-80 -67.77 -41.11 83.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.943 . . . . 1.42 109.753 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -48.14 -53.8 15.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 1.26 110.026 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.0 t -57.79 -54.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.047 -1.033 . . . . 0.61 109.222 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.8 mm -61.62 -20.31 22.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.355 -0.841 . . . . 0.64 109.047 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 105' ' ' HIS . 48.8 tt0 -66.23 -40.69 90.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 2.2 110.243 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -86.53 -21.43 51.27 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.38 -1.39 . . . . 0.82 111.941 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -67.01 -59.36 3.54 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.526 -1.573 . . . . 1.27 108.208 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.93 -52.03 65.7 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 120.072 -0.651 . . . . 0.91 109.473 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.1 m -59.77 -46.4 89.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.122 -0.986 . . . . 1.73 110.954 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -62.21 -31.93 72.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.768 -1.208 . . . . 1.04 110.632 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 mt -70.11 -28.61 65.53 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.545 -1.262 . . . . 1.03 109.512 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -68.74 -20.0 64.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.734 -1.229 . . . . 1.95 109.215 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -81.44 -7.64 59.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 1.71 108.873 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mt -88.91 140.17 29.71 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.217 -1.031 . . . . 1.26 108.217 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -97.18 64.84 1.96 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.332 -0.988 . . . . 2.83 108.332 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -146.17 113.72 6.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.351 -0.843 . . . . 1.58 110.069 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 18.7 mp0 -57.23 -16.18 7.67 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.787 -0.82 . . . . 2.8 108.787 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -80.23 -63.28 1.44 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.336 -0.853 . . . . 1.02 109.244 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.9 mt -63.6 -23.88 67.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 1.06 109.14 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -68.4 -51.13 47.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.053 -1.029 . . . . 2.39 108.762 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -58.76 -18.78 34.77 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.27 -0.894 . . . . 2.2 108.892 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -74.57 -27.89 60.7 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.638 -1.616 . . . . 2.09 106.638 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.02 98.0 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.398 0.618 . . . . 0.86 109.41 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.09 73.97 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.278 -0.889 . . . . 0.9 109.649 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.2 -36.75 66.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 1.35 109.375 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.1 t -72.64 -40.82 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.411 -0.806 . . . . 0.58 109.062 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.494 HH12 ' CE ' ' A' ' 135' ' ' LYS . 15.5 ttt-85 -54.38 -40.8 68.51 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.265 -0.897 . . . . 3.22 109.046 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.94 -32.56 73.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.595 -0.691 . . . . 1.32 110.245 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 65.0 mt -69.29 -26.51 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.952 -1.093 . . . . 0.5 110.343 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -79.07 -49.14 6.51 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.438 -1.465 . . . . 0.44 109.438 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.494 ' CE ' HH12 ' A' ' 131' ' ' ARG . 1.5 mptp? -51.98 -46.66 64.93 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.519 -0.989 . . . . 2.71 109.387 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.488 HH11 ' HG2' ' A' ' 136' ' ' ARG . 6.8 mtt-85 -62.19 -52.31 64.32 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.988 -1.116 . . . . 2.2 107.988 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.28 -40.38 34.37 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.794 -0.566 . . . . 1.13 109.609 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 140' ' ' ASN . 23.0 mt -69.08 -58.94 3.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 0.54 110.005 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 144' ' ' LEU . 89.9 mtt180 -44.52 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 2.32 110.875 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 138' ' ' LEU . 30.9 m-20 -85.34 -51.15 6.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.815 -1.178 . . . . 1.26 109.173 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.5 mt -55.88 -38.13 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 0.62 108.94 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 35.1 mt -86.21 1.29 51.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.486 -0.759 . . . . 0.67 109.006 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.69 30.95 60.12 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.204 -1.958 . . . . 0.68 108.204 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 139' ' ' ARG . 4.7 tp -73.78 145.3 45.16 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.559 -0.965 . . . . 0.77 109.755 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -67.48 139.52 57.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -0.784 . . . . 2.4 110.12 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 mt -109.44 142.79 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.579 -0.897 . . . . 0.87 108.579 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.58 ' H ' HD12 ' A' ' 147' ' ' ILE . 5.2 mp -75.73 119.94 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 1.32 109.773 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.6 OUTLIER -95.85 91.86 6.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.81 . . . . 1.54 109.446 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 mt -79.77 -18.14 51.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.598 -0.689 . . . . 0.77 109.276 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.6 p -79.46 23.4 0.4 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.189 -0.945 . . . . 1.57 109.66 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.99 25.9 2.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.053 -1.03 . . . . 0.82 110.017 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 74.4 mt -71.75 152.7 8.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.085 -1.009 . . . . 0.82 109.351 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -141.11 9.57 2.11 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.594 -0.891 . . . . 2.11 108.594 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -123.17 124.88 44.04 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.759 -0.83 . . . . 1.41 108.759 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.61 115.35 5.12 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.141 -0.974 . . . . 1.3 108.932 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.8 m -148.31 174.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.169 -0.957 . . . . 0.57 109.431 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 13.9 mt -93.35 160.6 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.851 -1.166 . . . . 0.43 107.851 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.633 HD11 HD11 ' A' ' 19' ' ' LEU . 14.3 tp -108.27 122.86 47.82 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.472 -0.767 . . . . 0.56 109.873 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.89 129.76 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.398 0.618 . . . . 0.54 109.713 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -165.99 159.33 15.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 0.62 110.376 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.92 -42.7 94.5 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.63 -1.294 . . . . 0.8 108.1 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 48.1 t0 -171.45 157.94 5.05 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.525 -0.735 . . . . 2.34 109.39 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.417 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 27.6 mt -124.43 136.15 53.82 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.547 -0.721 . . . . 0.65 109.539 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.2 p -95.4 152.33 39.23 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.254 -0.904 . . . . 0.74 109.661 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -32.83 -54.2 0.38 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.984 2.456 . . . . 0.6 113.219 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.7 m -51.06 -57.1 9.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -0.97 . . . . 0.63 109.445 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -54.52 -38.22 66.29 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 1.25 109.536 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 33.7 p -76.46 -20.19 57.28 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.317 -0.864 . . . . 0.5 109.751 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.46 -23.74 34.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.51 109.664 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -104.52 -10.23 17.78 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.322 -0.861 . . . . 1.17 110.349 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.7 tp -64.02 144.37 57.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.954 -1.091 . . . . 0.61 108.615 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -95.46 140.71 29.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.876 -1.14 . . . . 2.12 108.969 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.9 mp -85.65 -41.13 15.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 1.34 111.025 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -77.99 -12.06 59.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.712 -1.243 . . . . 1.97 111.807 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -101.27 -5.83 24.97 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.678 -1.263 . . . . 1.9 108.86 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 177' ' ' LEU . 74.1 t -100.52 163.43 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.407 -0.808 . . . . 0.48 109.059 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.531 ' N ' HG12 ' A' ' 176' ' ' VAL . 4.8 tp -120.38 -17.25 8.24 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.466 -0.771 . . . . 1.39 109.715 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.27 172.71 42.98 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.271 -1.531 . . . . 0.38 109.271 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -125.52 121.9 35.04 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.42 -1.047 . . . . 0.46 108.962 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.73 125.56 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.313 -1.365 . . . . 0.59 107.313 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 203' ' ' VAL . 2.2 p -135.08 141.35 46.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.356 0.598 . . . . 0.67 109.7 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -89.79 37.01 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.505 -0.747 . . . . 2.24 109.004 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -105.53 121.42 43.91 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.467 -0.771 . . . . 1.11 109.542 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -86.14 69.21 3.21 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.359 -1.096 . . . . 1.63 110.359 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.438 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -110.72 108.87 2.49 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.11 -1.596 . . . . 1.47 109.11 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -47.06 -22.32 0.33 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.083 -1.245 . . . . 5.24 108.666 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.438 ' N ' ' C ' ' A' ' 185' ' ' GLY . 7.0 p -141.71 66.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.05 -1.093 . . . . 2.92 108.05 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 191' ' ' SER . 13.5 t -78.16 140.64 38.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.428 -0.795 . . . . 1.6 109.76 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -44.01 -51.86 7.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 0.92 110.025 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 47.1 m -54.8 -31.19 58.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.188 -0.945 . . . . 1.59 109.616 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 188' ' ' SER . 4.1 t -68.73 -35.94 77.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.351 -0.843 . . . . 1.42 109.224 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.0 mm -60.31 -37.82 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 1.41 109.856 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.5 mtm -70.59 -46.56 63.21 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.78 -1.193 . . . . 0.86 107.78 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.06 -44.0 74.38 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.673 -0.642 . . . . 0.59 110.005 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -67.81 -43.54 79.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 3.06 109.804 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.2 m -71.44 -37.33 71.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.933 . . . . 0.73 109.967 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 199' ' ' LEU . 23.8 mt -88.03 3.36 49.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -0.872 . . . . 0.67 109.111 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 50.54 2.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.494 -0.754 . . . . 1.49 110.902 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 197' ' ' LEU . 79.4 mt -65.88 167.62 11.1 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 107.015 -1.476 . . . . 0.64 107.015 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -90.93 145.59 3.65 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 C-N-CA 122.069 1.846 . . . . 0.59 111.646 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.57 179.98 6.85 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.579 -1.248 . . . . 0.55 111.16 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 34.0 mt -149.38 155.6 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.008 -1.849 . . . . 0.63 106.008 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 181' ' ' THR . 15.8 m -137.28 -34.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.023 -1.048 . . . . 0.77 111.915 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.41 45.09 3.1 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 120.469 -1.395 . . . . 0.87 111.248 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.6 p -72.56 1.0 8.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.334 -1.686 . . . . 0.89 109.76 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.3 -98.78 0.84 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.828 -1.309 . . . . 0.93 109.828 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.7 p -131.19 35.6 3.9 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.422 -1.046 . . . . 1.6 111.815 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.0 t -50.47 -28.95 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.356 -1.465 . . . . 0.75 109.077 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.414 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 5.2 p -65.23 -11.95 46.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.923 -1.11 . . . . 0.84 108.775 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -104.67 11.65 33.81 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.892 -0.781 . . . . 1.61 108.892 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -128.53 -31.66 2.23 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.477 -0.764 . . . . 2.3 110.278 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 213' ' ' LYS . 53.4 t -115.39 155.85 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 121.324 -0.86 . . . . 0.76 110.008 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.44 ' O ' HG12 ' A' ' 212' ' ' VAL . 16.2 mmmt -114.8 -171.24 1.9 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.27 -1.382 . . . . 2.01 107.27 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.429 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -81.11 149.72 29.05 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.097 -1.002 . . . . 2.19 110.648 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.3 m-20 80.91 -12.81 0.98 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 116.067 -0.515 . . . . 2.4 110.982 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -56.89 145.76 28.81 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.711 -1.243 . . . . 1.99 107.774 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -88.3 121.29 30.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.869 -1.144 . . . . 1.3 109.636 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.2 mt -123.81 161.9 24.33 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.82 0.819 . . . . 0.53 109.911 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.4 mt -134.86 118.8 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.747 -1.205 . . . . 0.6 107.747 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 8.9 tp -90.08 120.31 31.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.42 -0.8 . . . . 0.57 109.528 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 53.6 t0 -94.42 -27.76 15.86 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.224 -1.028 . . . . 2.22 108.224 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.87 24.25 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.131 0.491 . . . . 0.75 110.709 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 10.5 t -117.14 -62.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 106.733 -1.58 . . . . 0.92 106.733 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -87.35 15.76 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.991 -1.114 . . . . 2.36 107.991 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 55.86 54.17 8.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.625 -0.672 . . . . 1.42 109.343 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -150.04 144.38 25.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.355 -0.84 . . . . 1.97 110.29 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.54 153.39 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.289 -1.004 . . . . 0.65 108.289 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -110.64 126.07 54.1 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.354 -0.841 . . . . 0.97 108.882 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.11 118.02 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.509 -0.744 . . . . 0.67 109.939 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 55.14 70.9 1.43 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 1.45 110.249 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -90.09 149.51 4.7 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.308 2.672 . . . . 0.82 111.986 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.5 m -75.19 163.23 27.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.022 -1.049 . . . . 1.62 109.86 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -67.11 -32.22 73.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.343 -0.848 . . . . 2.6 110.121 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.48 -35.53 77.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.225 -0.922 . . . . 3.06 109.282 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.68 -38.86 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.865 . . . . 1.14 109.3 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.548 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 79.4 mt -64.2 -58.57 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -0.902 . . . . 1.04 110.074 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.79 -42.21 75.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 2.54 109.886 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -65.22 -36.09 83.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.946 . . . . 2.6 109.096 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 243' ' ' GLN . 54.4 mtp -79.08 -33.71 44.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 1.23 109.041 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -50.07 -43.46 51.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.745 -1.222 . . . . 2.67 109.438 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.47 -55.61 6.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 1.66 110.156 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.8 t -66.32 -46.94 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 2.2 109.77 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 239' ' ' MET . 0.9 OUTLIER -55.14 -57.92 9.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 3.0 110.192 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -61.63 -22.89 65.64 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.879 -1.138 . . . . 1.76 109.705 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -68.36 -24.83 64.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.796 -1.187 . . . . 2.78 107.796 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 74.1 t -74.83 -39.9 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.41 -0.959 . . . . 2.06 108.41 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.0 -32.8 66.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.388 -0.82 . . . . 2.4 108.92 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -80.69 -30.03 36.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.041 -1.037 . . . . 2.87 109.416 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 108.537 -0.912 . . . . 3.41 108.537 179.797 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.582 ' SD ' ' NE2' ' A' ' 226' ' ' GLN . 14.4 mmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.636 -0.505 . . . . 3.66 109.636 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.6 mt -67.15 98.39 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.052 -1.03 . . . . 1.12 108.782 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.3 m -98.42 121.86 40.89 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.353 -0.842 . . . . 1.45 109.609 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.738 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -119.89 -160.13 11.13 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 109.315 -1.514 . . . . 0.92 109.315 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.3 mt -95.67 -9.92 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.332 -1.099 . . . . 1.05 108.799 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 tp 60.67 111.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.417 -0.802 . . . . 0.88 109.413 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.68 -52.91 5.25 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.325 -0.991 . . . . 0.78 108.325 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.63 146.4 22.22 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 108.5 -0.926 . . . . 1.5 108.5 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.94 149.26 32.78 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.42 2.08 . . . . 0.86 114.262 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.75 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.8 179.77 34.82 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.135 -1.586 . . . . 0.78 109.135 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.449 HG21 ' NE2' ' A' ' 243' ' ' GLN . 42.0 mt -139.0 130.43 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.13 -1.218 . . . . 0.74 109.495 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.47 151.08 41.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.364 -0.835 . . . . 0.45 109.74 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.55 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.2 m-85 -122.44 138.24 54.61 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.07 -1.085 . . . . 0.64 108.07 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.89 168.46 38.66 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 118.769 -1.681 . . . . 0.45 111.564 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -80.71 147.48 30.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.683 -0.892 . . . . 1.88 110.083 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -80.81 127.58 32.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.59 111.322 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -105.49 96.99 6.89 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.08 -1.452 . . . . 0.64 107.08 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.75 ' H ' ' ND2' ' A' ' 214' ' ' ASN . 11.9 tp -80.4 120.04 23.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.956 -1.09 . . . . 0.74 110.666 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.69 98.57 9.4 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.836 -0.62 . . . . 0.74 109.406 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -93.23 159.24 15.36 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.66 -0.867 . . . . 1.87 108.66 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -130.45 122.16 27.21 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.243 -0.911 . . . . 2.58 109.467 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -81.62 131.76 35.28 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.35 -0.844 . . . . 2.14 109.262 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -63.98 147.2 52.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 1.93 109.638 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.7 mt -91.87 136.38 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.22 -0.925 . . . . 0.68 109.709 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 t -107.64 121.74 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.394 -0.816 . . . . 0.84 109.397 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.3 mt -88.85 145.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.23 -0.919 . . . . 0.79 109.94 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -94.68 120.55 35.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.321 -0.862 . . . . 1.37 109.748 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -102.01 29.04 5.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.192 -0.943 . . . . 2.62 109.58 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -75.36 147.34 40.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.995 . . . . 2.35 110.0 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -87.49 116.18 25.42 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.22 -1.029 . . . . 2.35 108.22 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.7 pt -84.18 171.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.897 -1.127 . . . . 0.78 110.617 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -98.09 168.48 10.24 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.193 -0.669 . . . . 1.04 109.193 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.31 -22.3 66.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 1.05 109.581 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.14 -7.39 58.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 2.47 108.609 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -107.77 -9.21 15.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.53 -0.915 . . . . 1.46 108.53 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -67.93 -47.04 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.77 108.979 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -51.46 -36.07 42.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 1.46 109.11 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.61 -32.61 71.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 2.29 109.928 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -61.8 -47.02 87.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.99 -1.069 . . . . 1.3 109.51 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 44' ' ' LEU . 85.6 t -61.51 -47.19 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.355 -0.84 . . . . 0.76 110.016 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.28 -40.65 97.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.058 -1.026 . . . . 1.5 108.367 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -65.86 -32.35 73.81 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.81 -0.811 . . . . 2.66 108.81 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -86.37 -56.68 3.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.75 108.972 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 40' ' ' VAL . 29.3 tp -51.54 -63.38 1.15 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.821 -0.807 . . . . 0.83 108.821 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.5 t -61.73 -30.27 70.66 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.077 -1.082 . . . . 0.78 108.077 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.65 -52.9 50.31 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.422 -2.271 . . . . 0.57 107.422 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -48.5 -30.0 4.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.75 -0.853 . . . . 2.83 108.76 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -62.5 -37.4 85.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.235 -1.024 . . . . 0.65 108.235 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -81.73 -59.31 2.64 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.344 -0.613 . . . . 2.57 109.344 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.7 -40.29 59.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.11 -0.994 . . . . 0.51 109.832 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.7 t -62.75 -37.4 86.46 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.998 -1.064 . . . . 1.36 108.221 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.76 -28.23 62.49 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.442 -0.577 . . . . 0.6 109.442 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.628 ' NE2' HD21 ' A' ' 140' ' ' ASN . 26.4 mt-30 -72.07 -62.84 1.28 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.19 -0.944 . . . . 1.36 109.109 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 54' ' ' LEU . 10.3 mp -51.93 -48.96 63.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 1.38 108.466 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -49.81 -50.42 45.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.405 -0.809 . . . . 1.27 109.218 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -63.13 -41.42 99.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.6 109.655 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.4 mt -70.63 -34.85 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.53 108.994 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -53.9 -45.1 71.0 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.284 -0.885 . . . . 0.99 109.197 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 m -71.46 -24.26 61.97 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.266 -0.896 . . . . 0.59 109.941 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.42 ' O ' ' OG1' ' A' ' 64' ' ' THR . 29.3 mttp -71.28 -33.11 69.45 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.748 -1.205 . . . . 1.81 107.748 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.25 -34.11 76.75 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.793 -0.818 . . . . 0.48 108.793 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.17 -30.23 25.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.678 -1.369 . . . . 0.58 109.678 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -86.64 -12.3 48.88 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.823 -1.398 . . . . 1.39 109.137 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 88.1 m -94.91 -46.96 6.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.2 -0.937 . . . . 0.82 110.579 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -107.06 -34.71 7.08 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.111 -0.993 . . . . 0.99 110.157 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 80.07 -41.29 2.4 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.969 -1.253 . . . . 0.55 109.969 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 69' ' ' LYS . 67.3 mt-10 -50.51 178.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.241 . . . . 2.59 109.573 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.62 43.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 2.2 109.709 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 67' ' ' GLU . 15.9 mmmt -89.67 -17.91 27.48 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.557 -0.905 . . . . 1.79 108.557 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.65 -35.06 74.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.472 -0.767 . . . . 1.54 110.688 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.28 -22.24 66.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -0.978 . . . . 0.64 110.412 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.48 -40.38 55.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.95 -1.094 . . . . 0.58 109.508 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -76.6 -28.33 56.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.925 . . . . 0.62 109.616 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.66 -38.42 91.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.941 -1.099 . . . . 1.23 108.61 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.83 -32.38 61.24 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.578 -1.809 . . . . 0.52 108.578 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -61.38 -18.79 60.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -1.07 . . . . 1.29 109.172 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.5 mt -85.67 -39.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.246 -1.02 . . . . 0.55 108.246 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.3 ttt -58.8 -38.73 79.23 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.992 -0.744 . . . . 1.89 108.992 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.9 tp -69.56 -43.76 72.26 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.852 -0.795 . . . . 0.53 108.852 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.0 tp -64.72 -48.01 76.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.44 -0.788 . . . . 0.43 109.483 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -84.4 13.14 5.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.836 . . . . 1.24 110.467 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -49.1 125.2 10.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.998 -1.064 . . . . 1.31 109.695 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -67.69 -25.03 65.48 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.339 -0.851 . . . . 1.35 108.756 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.62 -52.34 9.87 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.436 -0.79 . . . . 2.16 109.528 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.7 mt -64.61 -15.65 61.49 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.036 -1.066 . . . . 0.6 109.04 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -77.35 -43.4 33.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 1.28 109.801 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.03 -33.35 75.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -0.91 . . . . 1.28 110.405 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -72.77 -43.88 62.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 1.29 109.654 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.0 mt -57.36 -39.85 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.551 -0.907 . . . . 0.58 108.551 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -67.5 -62.43 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.715 -0.615 . . . . 0.78 110.27 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -50.07 -38.48 38.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.149 -0.969 . . . . 0.86 109.834 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.6 -59.87 4.7 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.268 -0.895 . . . . 0.79 108.676 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.7 mt -47.02 -44.26 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.71 110.171 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -82.67 -31.44 28.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.161 -0.962 . . . . 2.05 111.029 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 91' ' ' ALA . 66.9 t0 -79.25 -48.44 14.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.859 -1.15 . . . . 1.59 111.778 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -106.71 21.06 18.09 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.82 -1.175 . . . . 1.89 110.046 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 44.07 48.22 7.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -0.905 . . . . 1.31 109.927 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.7 mtt -102.72 151.04 22.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.485 -0.759 . . . . 1.28 109.051 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.7 p -75.28 148.15 39.63 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.567 -0.708 . . . . 0.62 109.354 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.31 18.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.243 -0.911 . . . . 0.47 109.167 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.31 -44.54 58.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.041 -1.096 . . . . 2.0 108.041 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.86 -52.92 15.0 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.647 -0.658 . . . . 0.56 109.886 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.15 -49.46 76.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.48 109.67 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.72 -33.98 61.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.44 109.893 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -68.97 -36.87 78.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.954 -1.091 . . . . 1.42 109.525 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -58.76 -52.68 64.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.985 . . . . 1.26 109.674 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.1 t -56.41 -49.14 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.105 -0.997 . . . . 0.61 109.299 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.41 -17.62 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.64 109.18 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -73.58 -35.18 65.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.082 -1.011 . . . . 2.2 109.976 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.25 -27.13 28.83 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.318 -1.42 . . . . 0.82 112.338 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -67.25 -40.24 86.23 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.598 -1.531 . . . . 1.27 109.209 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.22 -52.18 8.49 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.393 -0.817 . . . . 0.91 109.632 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.7 p -60.52 -42.13 95.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 1.73 110.245 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.54 -35.69 81.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.032 -1.042 . . . . 1.04 110.334 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.89 -27.55 65.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.854 -1.154 . . . . 1.03 109.599 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -69.14 -18.04 63.9 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.921 -1.112 . . . . 1.95 109.367 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -80.97 -4.81 56.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 1.71 109.348 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.5 mt -83.22 145.61 29.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 1.26 108.487 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -96.68 56.23 1.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.751 -0.833 . . . . 2.83 108.751 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -146.25 117.27 7.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.303 -0.873 . . . . 1.58 109.23 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.75 -16.77 18.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 2.8 109.971 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -77.96 -65.6 0.95 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.935 . . . . 1.02 109.212 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.2 mt -61.1 -19.42 61.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 1.06 109.116 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -67.79 -48.2 66.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.101 -0.999 . . . . 2.39 108.36 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 50.3 mt-10 -61.85 -20.27 63.5 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.66 -0.867 . . . . 2.2 108.66 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.527 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.5 OUTLIER -71.35 -29.53 65.08 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.6 -1.63 . . . . 2.09 106.6 178.029 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.78 -50.66 72.96 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.957 -0.757 . . . . 0.86 108.957 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.68 -37.48 76.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.9 110.004 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 -68.18 -29.89 68.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.084 -1.01 . . . . 1.35 109.602 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.94 -40.49 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.221 -1.029 . . . . 0.58 108.221 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' ' 131' ' ' ARG . 22.1 ttm-85 -56.0 -38.81 70.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.078 -1.082 . . . . 3.22 108.078 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -61.51 -36.49 80.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.635 -0.666 . . . . 1.32 109.93 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.6 mt -68.21 -30.81 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.036 -1.04 . . . . 0.5 109.492 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.49 -46.13 72.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.257 -1.937 . . . . 0.44 108.257 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -51.04 -44.61 61.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.78 -0.835 . . . . 2.71 109.253 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.542 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 69.4 mtt180 -62.57 -46.93 86.07 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.841 -1.17 . . . . 2.2 107.841 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 137' ' ' LEU . 3.4 tt -52.28 -54.29 33.27 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.878 -0.786 . . . . 1.13 108.878 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.93 -56.46 19.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.54 109.586 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -44.74 -22.55 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 2.32 111.068 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.628 HD21 ' NE2' ' A' ' 53' ' ' GLN . 61.6 m-80 -85.18 -42.48 14.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.801 -1.187 . . . . 1.26 110.074 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.35 -34.59 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.04 -1.038 . . . . 0.62 109.496 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.8 mt -90.98 -3.82 56.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.219 -0.926 . . . . 0.67 109.395 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.32 29.99 63.94 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.16 -1.976 . . . . 0.68 108.16 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.76 148.83 45.94 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.527 -0.984 . . . . 0.77 109.686 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -68.84 147.69 51.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 2.4 109.317 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 147' ' ' ILE . 78.0 mt -102.67 157.75 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.87 108.724 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.424 ' N ' HG22 ' A' ' 146' ' ' ILE . 11.6 mm -76.85 104.06 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.057 -1.027 . . . . 1.32 109.444 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -102.18 90.3 3.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.564 -0.71 . . . . 1.54 110.276 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.2 mt -80.03 -7.15 58.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.77 108.703 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.9 t -83.97 40.69 0.77 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -0.792 . . . . 1.57 109.905 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.61 19.09 2.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.218 -0.926 . . . . 0.82 109.006 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 60.1 mt -73.76 150.34 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.547 -0.721 . . . . 0.82 109.593 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -141.3 2.36 1.67 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.339 -0.85 . . . . 2.11 109.153 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -127.59 132.39 49.83 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.089 -0.708 . . . . 1.41 109.089 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -63.04 120.51 11.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.915 . . . . 1.3 109.794 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.0 m -150.3 175.81 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.24 -0.912 . . . . 0.57 109.421 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.2 mt -90.8 157.56 2.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.948 -1.131 . . . . 0.43 107.948 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.7 tp -107.64 122.2 46.22 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.547 -0.721 . . . . 0.56 109.212 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.7 t -123.75 132.59 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.311 0.577 . . . . 0.54 109.504 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.44 144.84 12.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.62 109.491 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 183' ' ' ALA . . . -60.53 -32.82 71.84 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.464 -1.397 . . . . 0.8 107.846 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -172.64 155.95 3.44 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.585 -0.697 . . . . 2.34 109.413 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.0 mt -130.73 132.08 45.13 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.553 -0.717 . . . . 0.65 109.319 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 p -92.33 152.89 42.77 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.262 -0.899 . . . . 0.74 109.119 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -36.36 -43.71 0.83 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.322 2.014 . . . . 0.6 112.189 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.542 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -54.16 -63.7 1.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.63 108.938 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -48.46 -40.27 25.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 1.25 109.362 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.2 p -71.04 -23.52 62.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 0.5 109.792 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.55 -29.36 46.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.912 . . . . 0.51 110.285 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -104.54 -7.63 19.61 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.275 -0.891 . . . . 1.17 110.077 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 36.1 tp -57.36 135.67 56.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.822 -1.174 . . . . 0.61 108.08 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.404 ' O ' HG23 ' A' ' 176' ' ' VAL . 38.2 t-20 -99.89 120.7 40.19 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.221 -0.925 . . . . 2.12 110.048 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 173' ' ' LEU . 7.9 mp -93.58 45.99 1.18 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.843 . . . . 1.34 108.741 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -109.54 -27.47 9.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.404 -0.81 . . . . 1.97 109.02 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -131.2 11.86 5.04 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.439 -0.788 . . . . 1.9 109.643 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 172' ' ' ASN . 66.7 t -82.85 154.29 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.112 -0.993 . . . . 0.48 109.494 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.0 tp -117.47 -12.2 10.43 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.719 -0.613 . . . . 1.39 109.547 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 163.99 179.84 38.49 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.61 -1.396 . . . . 0.38 109.61 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.489 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 1.6 m-85 -130.44 124.95 33.23 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.557 -0.966 . . . . 0.46 109.635 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.8 mt -128.54 126.6 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.887 -1.153 . . . . 0.59 107.887 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.501 ' O ' ' O ' ' A' ' 203' ' ' VAL . 40.7 p -142.01 149.36 39.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 0.67 110.549 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.44 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 4.6 p30 -100.28 43.69 1.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.323 -0.861 . . . . 2.24 109.268 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 161' ' ' ALA . . . -133.88 29.96 3.74 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.424 -0.797 . . . . 1.11 110.323 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -47.71 148.84 3.43 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 120.584 -1.322 . . . . 1.63 111.029 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 187' ' ' THR . . . -154.4 173.31 32.91 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.26 -1.536 . . . . 1.47 109.26 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.462 ' O ' ' OG1' ' A' ' 187' ' ' THR . 42.9 mtm-85 -55.7 87.6 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.102 -1.073 . . . . 5.24 108.102 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.559 ' N ' ' O ' ' A' ' 185' ' ' GLY . 20.4 p 54.96 62.79 2.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.552 -0.717 . . . . 2.92 109.418 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 m -75.3 160.21 30.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.08 -1.012 . . . . 1.6 109.483 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -45.8 -43.76 13.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -0.891 . . . . 0.92 109.95 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.2 p -52.95 -45.43 67.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 1.59 109.924 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.5 t -68.31 -39.28 82.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 1.42 110.041 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.5 mm -50.44 -38.52 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 1.41 110.34 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 mtp -72.05 -59.57 2.67 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.7 -1.222 . . . . 0.86 107.7 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.69 -31.09 35.59 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.761 -0.654 . . . . 0.59 109.847 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -78.95 -47.37 16.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.991 . . . . 3.06 109.898 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.8 m -69.51 -36.17 76.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.031 -1.043 . . . . 0.73 109.755 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 199' ' ' LEU . 29.0 mt -86.53 0.06 55.09 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.1 -1.0 . . . . 0.67 108.927 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 47.81 10.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 1.49 111.051 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 197' ' ' LEU . 22.0 mt -66.79 161.01 65.14 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.801 -1.187 . . . . 0.64 108.597 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -79.38 127.88 7.67 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.188 1.259 . . . . 0.59 111.172 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -163.87 179.04 7.32 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.844 -1.142 . . . . 0.55 110.871 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.6 mt -146.35 162.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.001 -1.481 . . . . 0.63 107.001 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 184' ' ' GLY . 15.6 m -147.84 -28.2 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 120.718 -1.239 . . . . 0.77 111.408 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.447 ' HA2' ' H ' ' A' ' 184' ' ' GLY . . . -93.9 26.94 14.18 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 120.901 -1.125 . . . . 0.87 110.328 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.425 ' HB ' HG23 ' A' ' 208' ' ' VAL . 30.8 p -52.61 -41.06 63.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.833 -1.392 . . . . 0.89 108.738 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.44 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 76.92 -38.1 1.51 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 120.781 -0.724 . . . . 0.93 113.837 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 83.8 p -130.19 27.28 5.11 Favored 'General case' 0 N--CA 1.514 2.773 0 CA-C-N 119.939 1.869 . . . . 1.6 113.256 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.425 HG23 ' HB ' ' A' ' 205' ' ' THR . 5.5 t -79.3 -41.94 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.133 -1.604 . . . . 0.75 110.323 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 p -64.65 -12.89 50.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.668 -1.27 . . . . 0.84 110.137 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.8 p -106.17 11.84 30.84 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 1.61 109.407 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -144.23 4.63 1.24 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.243 -0.91 . . . . 2.3 110.588 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.5 t -126.93 151.37 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.305 -0.872 . . . . 0.76 109.524 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.506 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 42.6 mmtt -129.25 166.85 18.61 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.048 -1.464 . . . . 2.01 107.048 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.75 ' ND2' ' H ' ' A' ' 18' ' ' LEU . 28.3 m120 -64.14 143.47 57.85 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.8 -1.187 . . . . 2.19 110.616 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 73.9 -2.44 2.78 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.797 -0.564 . . . . 2.4 110.623 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.506 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 44.1 m-20 -57.51 142.26 44.9 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.914 -1.116 . . . . 1.99 108.673 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -86.52 107.22 18.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.44 -0.948 . . . . 1.3 108.44 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' A' ' 16' ' ' ALA . 40.8 mt -122.51 154.01 38.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.548 -0.72 . . . . 0.53 110.139 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.419 HG23 ' CD2' ' A' ' 13' ' ' PHE . 49.8 mt -126.04 122.82 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.501 -0.926 . . . . 0.6 108.501 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.5 tp -90.59 120.38 31.62 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.524 -0.917 . . . . 0.57 108.524 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.3 m-20 -97.19 -29.79 13.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.215 -0.928 . . . . 2.22 109.546 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.5 21.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.912 -0.492 . . . . 0.75 110.422 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -115.96 -51.66 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 106.967 -1.494 . . . . 0.92 106.967 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -96.46 10.85 37.0 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.112 -1.44 . . . . 2.36 107.112 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.738 HD21 ' H ' ' A' ' 4' ' ' GLY . 34.8 t30 56.23 54.72 7.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.972 -0.751 . . . . 1.42 108.972 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.582 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 65.9 tt0 -153.99 150.59 28.44 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.917 0.865 . . . . 1.97 110.171 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 78.2 t -115.11 152.22 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.308 -0.997 . . . . 0.65 108.308 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -108.54 121.32 44.74 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.217 -0.927 . . . . 0.97 109.45 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.69 114.98 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.574 -0.704 . . . . 0.67 109.518 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 69.02 67.5 0.47 Allowed Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.659 -0.651 . . . . 1.45 109.671 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -86.33 130.42 3.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 123.057 2.505 . . . . 0.82 112.498 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.3 p -74.02 162.27 29.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 1.62 109.594 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -64.06 -44.03 93.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 2.6 109.828 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -53.27 -36.69 61.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.394 -0.816 . . . . 3.06 109.384 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.2 t -76.74 -37.1 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.678 -0.86 . . . . 1.14 108.678 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 75.3 mt -71.62 -57.4 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 1.04 109.344 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -51.07 -44.89 61.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -0.781 . . . . 2.54 110.014 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -65.33 -32.32 73.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 2.6 108.93 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 243' ' ' GLN . 77.1 mtp -81.94 -42.46 19.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.404 -0.81 . . . . 1.23 109.555 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -47.45 -39.28 15.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.035 -1.04 . . . . 2.67 109.82 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.36 -63.35 1.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.109 -0.995 . . . . 1.66 110.394 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.8 t -66.08 -51.4 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.103 -0.998 . . . . 2.2 110.198 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 239' ' ' MET . 45.8 tt0 -47.92 -47.44 32.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.078 -1.014 . . . . 3.0 109.635 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.23 -29.14 70.26 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.828 -1.17 . . . . 1.76 108.939 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -67.92 -21.29 65.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.965 -1.124 . . . . 2.78 107.965 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 41.9 t -72.88 -31.84 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.338 -1.356 . . . . 2.06 107.338 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.22 84.18 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.054 -0.721 . . . . 2.4 109.054 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.9 m -77.49 -30.74 53.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.394 -0.816 . . . . 2.87 109.734 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 120.963 -1.086 . . . . 3.41 108.331 179.354 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 3' ' ' SER . 80.4 mtp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.338 0.59 . . . . 3.66 109.494 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.428 HG23 ' CG2' ' A' ' 208' ' ' VAL . 83.5 mt -58.42 81.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 1.12 109.604 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 1' ' ' MET . 1.5 m -98.22 113.79 25.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.259 -0.901 . . . . 1.45 109.725 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.95 -163.62 20.39 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 108.665 -1.774 . . . . 0.92 108.665 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 5' ' ' ILE . 59.9 mt -96.96 -6.59 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.033 -1.275 . . . . 1.05 108.918 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.1 tp 53.46 104.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.515 -0.74 . . . . 0.88 109.206 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.78 -51.46 6.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.996 . . . . 0.78 109.342 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -144.97 149.48 42.57 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.318 -0.864 . . . . 1.5 109.019 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HA ' ' HB1' ' A' ' 222' ' ' ALA . 63.1 Cg_endo -80.14 154.78 22.34 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.372 2.048 . . . . 0.86 113.732 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.99 138.32 2.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.597 -1.401 . . . . 0.78 109.597 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.47 HD12 HE21 ' A' ' 243' ' ' GLN . 97.2 mt -96.73 132.49 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.186 -1.185 . . . . 0.74 109.388 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.474 ' HB1' HD12 ' A' ' 177' ' ' LEU . . . -139.35 157.37 46.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.33 -0.856 . . . . 0.45 110.344 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -130.69 134.73 47.17 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.25 -1.019 . . . . 0.64 108.25 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.96 164.66 34.24 Favored Glycine 0 N--CA 1.503 3.102 0 C-N-CA 118.204 -1.95 . . . . 0.45 111.813 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -77.62 146.55 36.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.576 -0.955 . . . . 1.88 109.753 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.92 122.36 25.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.709 . . . . 0.59 110.981 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 tp -100.82 94.67 6.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.845 -1.168 . . . . 0.64 107.845 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.6 tp -81.97 112.74 19.34 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.01 -1.056 . . . . 0.74 109.759 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 158' ' ' LEU . 93.7 mt -97.89 93.95 6.62 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.661 -0.7 . . . . 0.74 109.783 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -92.62 159.16 15.59 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.598 -0.89 . . . . 1.87 108.598 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -118.3 131.79 56.32 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.438 -0.789 . . . . 2.58 109.678 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.5 127.04 31.64 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.488 -0.93 . . . . 2.14 108.488 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -62.74 136.94 58.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 1.93 109.292 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.4 mt -90.82 131.33 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.26 -0.9 . . . . 0.68 110.194 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.3 t -108.33 122.77 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.655 -0.868 . . . . 0.84 108.655 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -89.6 140.66 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.164 -0.96 . . . . 0.79 110.028 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -90.66 128.95 36.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.22 -0.925 . . . . 1.37 109.324 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -105.25 30.52 5.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.414 -0.803 . . . . 2.62 109.959 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -76.24 144.03 40.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.117 -0.989 . . . . 2.35 109.788 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.6 OUTLIER -86.99 124.01 32.72 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.702 -0.851 . . . . 2.35 108.702 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -90.64 170.61 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.102 -0.999 . . . . 0.78 110.477 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.3 p -97.24 169.13 9.99 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.486 -0.561 . . . . 1.04 109.486 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.25 -25.62 68.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 1.05 109.433 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -80.22 -5.11 55.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 2.47 109.239 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -109.96 -15.9 13.96 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.019 -1.104 . . . . 1.46 108.019 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.29 -42.88 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.102 -0.703 . . . . 0.77 109.102 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -53.42 -36.17 61.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 1.46 109.374 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -69.62 -32.69 71.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 2.29 109.755 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -63.42 -41.92 98.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.152 -0.967 . . . . 1.3 109.267 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 44' ' ' LEU . 76.5 t -62.48 -49.01 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.412 -0.805 . . . . 0.76 110.032 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -65.27 -45.02 86.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.04 . . . . 1.5 108.838 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -64.99 -31.75 73.15 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.704 -0.798 . . . . 2.66 109.045 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -86.47 -59.36 2.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.078 -1.014 . . . . 0.75 108.733 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 40' ' ' VAL . 30.8 tp -47.94 -65.18 0.61 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.36 0.6 . . . . 0.83 109.695 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.1 t -64.28 -37.72 88.49 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.518 -0.919 . . . . 0.78 108.518 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.01 -52.41 49.25 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.355 -2.298 . . . . 0.57 107.355 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.415 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.2 ttt-85 -51.41 -26.18 7.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.684 -0.892 . . . . 2.83 109.033 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -73.73 -28.53 61.75 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.987 -1.116 . . . . 0.65 107.987 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 46' ' ' GLY . 33.3 ttmt -75.48 -56.67 4.47 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.082 -0.711 . . . . 2.57 109.082 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.42 -30.75 30.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.086 -1.009 . . . . 0.51 109.566 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 10.1 p -65.07 -38.67 91.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 1.36 108.906 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.87 -28.28 65.52 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.478 0.656 . . . . 0.6 109.336 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -71.81 -67.66 0.51 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.764 . . . . 1.36 109.602 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 54' ' ' LEU . 9.3 mp -51.04 -34.73 30.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 1.38 108.819 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 51' ' ' SER . 9.5 mm-40 -63.88 -51.47 64.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.471 -0.768 . . . . 1.27 109.08 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -60.98 -34.56 74.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.6 108.592 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.28 -25.29 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.574 -0.899 . . . . 0.53 108.574 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -65.46 -44.47 87.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.559 -0.713 . . . . 0.99 109.588 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -71.79 -27.15 62.74 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.3 -0.875 . . . . 0.59 109.144 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -72.27 -29.68 64.12 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.769 -1.197 . . . . 1.81 107.769 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.81 61.91 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.091 -1.077 . . . . 0.48 108.091 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.7 -29.76 28.56 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.433 -1.467 . . . . 0.58 109.433 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -86.55 -20.24 28.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -1.202 . . . . 1.39 108.595 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -94.36 -46.89 6.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.82 110.357 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -107.92 -27.16 10.35 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.111 -0.993 . . . . 0.99 111.297 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.97 152.98 8.94 Favored Glycine 0 N--CA 1.506 3.337 0 N-CA-C 109.647 -1.381 . . . . 0.55 109.647 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -50.2 -12.54 0.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -1.124 . . . . 2.59 110.583 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 66' ' ' GLY . 27.7 tt0 -63.66 -31.22 72.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.988 . . . . 2.2 110.454 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -91.08 -17.46 26.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.927 -1.108 . . . . 1.79 110.28 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -62.53 -28.87 70.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.986 -1.071 . . . . 1.54 109.941 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.22 -30.36 69.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.179 -0.951 . . . . 0.64 109.604 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.38 -44.05 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -0.876 . . . . 0.58 109.105 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -77.27 -24.49 51.05 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.465 -0.772 . . . . 0.62 109.664 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -63.9 -42.36 97.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.965 -1.084 . . . . 1.23 108.9 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.04 -36.24 80.49 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.928 -1.669 . . . . 0.52 108.928 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.07 -18.56 61.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.445 -1.032 . . . . 1.29 110.661 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.3 mt -85.03 -46.36 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.618 -1.301 . . . . 0.55 108.94 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 42.5 ttp -55.22 -49.16 72.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.36 -0.837 . . . . 1.89 108.967 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tp -54.88 -43.44 73.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.407 -0.808 . . . . 0.53 109.171 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.31 -44.1 80.03 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.383 -0.823 . . . . 0.43 109.417 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -85.37 8.42 18.88 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.416 -0.803 . . . . 1.24 110.161 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -49.14 121.53 4.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.974 -1.079 . . . . 1.31 109.666 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -66.84 -24.26 66.13 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.542 -0.91 . . . . 1.35 108.542 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -75.57 -48.89 20.38 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.334 -0.854 . . . . 2.16 109.249 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.7 mt -63.68 -15.09 57.46 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.032 -1.067 . . . . 0.6 108.979 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -79.54 -45.64 18.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.438 -0.789 . . . . 1.28 110.041 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -64.56 -28.87 69.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.254 -0.904 . . . . 1.28 110.022 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -75.21 -46.25 35.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.196 -0.94 . . . . 1.29 109.889 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.7 mt -58.38 -55.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.06 -1.089 . . . . 0.58 108.06 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.0 mt -45.14 -58.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.623 -0.673 . . . . 0.78 109.872 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -49.04 -57.05 7.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.423 -0.798 . . . . 0.86 110.418 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.2 mt -50.54 -56.49 11.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.426 -0.796 . . . . 0.79 109.266 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.0 mt -47.4 -41.63 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.71 109.784 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -86.19 -33.72 20.71 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.116 -0.99 . . . . 2.05 111.974 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -79.34 -44.29 21.86 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.536 -1.353 . . . . 1.59 111.757 -176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -105.76 15.47 26.73 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.722 -1.236 . . . . 1.89 109.23 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.505 ' ND1' ' N ' ' A' ' 97' ' ' HIS . 1.5 m80 45.41 55.47 6.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.391 -0.818 . . . . 1.31 109.54 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 74.1 mtp -102.51 153.65 19.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.571 -0.706 . . . . 1.28 109.259 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.7 p -76.16 171.45 14.48 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.486 -0.759 . . . . 0.62 109.389 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.31 -28.47 62.1 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.758 . . . . 0.47 109.668 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.13 -45.4 41.21 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.064 -1.087 . . . . 2.0 108.064 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.55 -52.33 22.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.714 -0.616 . . . . 0.56 110.201 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.34 -48.75 80.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.48 109.754 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.21 -35.25 67.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 0.44 109.606 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -68.77 -34.64 75.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.968 -1.082 . . . . 1.42 109.641 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -53.43 -60.94 2.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.375 -0.828 . . . . 1.26 110.118 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.0 t -50.93 -48.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.953 -1.092 . . . . 0.61 109.682 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -61.73 -20.62 23.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.39 -0.819 . . . . 0.64 108.967 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.37 -37.86 74.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.089 -1.007 . . . . 2.2 109.779 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 114' ' ' ALA . . . -87.2 -23.95 38.91 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.491 -1.338 . . . . 0.82 112.843 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 -67.1 -52.82 37.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.343 -1.681 . . . . 1.27 108.746 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.14 -52.44 59.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.563 -0.71 . . . . 0.91 109.816 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.8 m -61.63 -32.58 72.73 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.128 -0.982 . . . . 1.73 109.992 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -63.04 -43.65 98.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.825 -1.172 . . . . 1.04 110.064 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 123' ' ' LEU . 12.2 mt -67.23 -22.66 65.68 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.541 -1.263 . . . . 1.03 109.249 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.82 -23.65 64.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.779 -1.2 . . . . 1.95 109.165 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -82.99 -8.87 59.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -0.847 . . . . 1.71 109.032 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 mt -84.34 148.02 26.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.418 -0.956 . . . . 1.26 108.418 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -98.66 61.3 1.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.751 . . . . 2.83 109.927 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -152.09 118.69 5.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.016 -1.053 . . . . 1.58 110.11 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -62.27 -13.78 31.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 2.8 109.238 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -78.03 -61.15 2.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.499 -0.75 . . . . 1.02 109.251 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.472 ' O ' HD13 ' A' ' 115' ' ' LEU . 27.1 mt -62.92 -29.33 70.7 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.265 -0.897 . . . . 1.06 109.92 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 71.5 tttt -66.4 -47.51 73.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.838 -1.164 . . . . 2.39 108.162 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -57.67 -24.48 56.88 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.159 -1.052 . . . . 2.2 108.159 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -73.17 -23.79 60.47 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.571 -1.64 . . . . 2.09 106.571 178.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -61.0 -45.3 95.39 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.858 -0.793 . . . . 0.86 108.858 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.41 -35.83 80.06 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.863 -0.735 . . . . 0.9 109.025 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.5 m-20 -69.01 -36.3 77.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.418 -0.801 . . . . 1.35 109.095 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.87 -42.98 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.995 -1.113 . . . . 0.58 107.995 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.504 HH11 ' HG2' ' A' ' 131' ' ' ARG . 1.4 ttt-85 -54.77 -39.15 68.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.608 -0.886 . . . . 3.22 108.608 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -60.18 -35.3 75.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.438 -0.789 . . . . 1.32 109.497 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.1 mt -65.81 -26.14 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.5 109.053 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.94 -50.62 7.62 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.455 -1.458 . . . . 0.44 109.455 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -50.4 -47.36 56.45 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.444 -1.033 . . . . 2.71 109.994 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.408 ' HG2' ' NH1' ' A' ' 136' ' ' ARG . 58.9 mtt-85 -65.21 -46.29 81.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.947 -1.096 . . . . 2.2 108.776 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.6 tp -54.19 -33.19 57.59 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.727 -0.608 . . . . 1.13 109.705 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 140' ' ' ASN . 16.8 mt -76.79 -56.6 4.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.819 -1.176 . . . . 0.54 109.687 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -46.24 -17.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.933 . . . . 2.32 110.093 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.521 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.7 m120 -85.93 -37.14 19.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.978 . . . . 1.26 109.633 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.3 mt -72.84 -40.64 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.62 109.727 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.5 mt -86.67 1.93 50.25 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.668 -0.864 . . . . 0.67 108.668 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.06 20.39 8.74 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.096 -2.002 . . . . 0.68 108.096 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.5 tp -54.84 163.54 0.96 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.645 -0.915 . . . . 0.77 109.146 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -68.18 143.62 55.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 2.4 110.103 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.3 mt -111.39 137.55 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.508 -0.745 . . . . 0.87 109.141 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.9 mp -77.71 99.48 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 1.32 109.085 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -99.38 92.29 5.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.413 -0.805 . . . . 1.54 109.64 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.417 HD21 ' CG2' ' A' ' 147' ' ' ILE . 22.0 mt -79.24 -9.71 59.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 0.77 109.104 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.2 t -79.77 35.27 0.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 1.57 108.979 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -142.67 18.29 2.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.399 -0.813 . . . . 0.82 109.424 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.24 150.97 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 0.82 110.13 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -145.86 11.89 1.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.293 -1.002 . . . . 2.11 108.293 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -125.36 125.37 43.33 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.336 -0.987 . . . . 1.41 108.336 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.82 115.27 4.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.359 -0.838 . . . . 1.3 109.29 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.29 178.62 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 0.57 109.675 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 26.8 mt -93.8 153.14 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.834 -1.173 . . . . 0.43 107.834 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 19' ' ' LEU . 25.4 tp -101.13 115.59 30.84 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.775 -0.824 . . . . 0.56 108.775 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.9 t -121.84 128.96 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.93 -0.767 . . . . 0.54 108.93 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.86 149.96 11.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.483 -0.761 . . . . 0.62 109.098 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.09 -35.79 67.42 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.651 -1.281 . . . . 0.8 107.928 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -174.9 156.5 2.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.653 -0.654 . . . . 2.34 109.243 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.0 mt -123.83 133.73 53.74 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.547 -0.721 . . . . 0.65 109.581 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.8 p -93.57 152.52 40.94 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.921 -0.77 . . . . 0.74 108.921 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -34.88 -51.98 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.459 2.106 . . . . 0.6 112.526 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.7 m -51.79 -50.26 61.08 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.179 -0.95 . . . . 0.63 108.861 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.03 -35.73 77.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.596 -0.69 . . . . 1.25 109.819 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.7 p -79.94 -28.77 39.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.111 -0.993 . . . . 0.5 109.411 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.21 -18.19 59.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.852 . . . . 0.51 109.98 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -106.93 -14.52 14.94 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.218 -0.926 . . . . 1.17 109.336 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.2 tp -55.29 134.92 50.23 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.021 -1.103 . . . . 0.61 108.021 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -98.49 97.44 8.76 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.209 -0.932 . . . . 2.12 109.586 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 173' ' ' LEU . 6.6 mp -75.9 44.69 0.31 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.5 -0.75 . . . . 1.34 109.317 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -106.5 -24.8 12.09 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.572 -0.899 . . . . 1.97 108.572 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -132.28 4.09 4.01 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.757 -0.59 . . . . 1.9 110.03 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.1 153.91 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.971 -1.081 . . . . 0.48 109.09 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -111.03 -37.53 5.34 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.659 -0.651 . . . . 1.39 110.003 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.41 -177.95 37.47 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.152 -1.579 . . . . 0.38 109.152 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -132.46 127.88 36.25 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.465 -1.021 . . . . 0.46 110.008 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.9 mt -127.03 118.55 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.981 -1.488 . . . . 0.59 106.981 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 32.0 p -141.03 151.99 44.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.411 -0.805 . . . . 0.67 111.67 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -90.84 42.48 1.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.548 -0.72 . . . . 2.24 109.224 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -91.87 -153.58 0.34 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.989 -1.069 . . . . 1.11 110.474 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.425 ' N ' ' OG ' ' A' ' 188' ' ' SER . . . -91.75 -114.42 1.97 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.147 -1.181 . . . . 1.63 110.147 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.45 -37.49 0.4 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.388 -1.885 . . . . 1.47 108.388 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -69.7 -39.88 76.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -1.088 . . . . 5.24 109.007 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 47.8 p -137.5 26.49 2.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.474 -0.766 . . . . 2.92 109.093 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 184' ' ' GLY . 15.0 m -84.58 129.95 34.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.334 -0.854 . . . . 1.6 109.619 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -57.22 -48.05 79.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.396 -0.815 . . . . 0.92 110.12 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.1 m -46.33 -39.39 10.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.993 -1.067 . . . . 1.59 109.571 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.0 p -61.04 -45.59 94.17 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.289 -0.882 . . . . 1.42 109.003 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 74.1 mt -49.72 -33.05 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.931 . . . . 1.41 109.29 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 74.4 mtp -73.62 -65.52 0.81 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.641 -1.244 . . . . 0.86 107.641 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.19 -28.54 7.66 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.679 -0.692 . . . . 0.59 110.04 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.419 HH11 ' HG2' ' A' ' 195' ' ' ARG . 31.8 mtt-85 -80.61 -52.32 7.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.869 -1.145 . . . . 3.06 110.512 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 49.6 m -71.14 -33.95 70.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.897 -1.127 . . . . 0.73 109.687 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 199' ' ' LEU . 22.3 mt -90.4 -0.44 57.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.23 -0.919 . . . . 0.67 109.126 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 46.34 11.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.345 -0.847 . . . . 1.49 111.284 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 197' ' ' LEU . 17.8 mt -68.31 145.22 97.29 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.815 -1.178 . . . . 0.64 109.45 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -56.63 131.92 48.59 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.091 1.861 . . . . 0.59 110.803 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.44 173.04 11.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.597 -1.314 . . . . 0.55 111.33 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 203' ' ' VAL . 68.9 mt -143.9 159.45 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.78 -1.563 . . . . 0.63 106.78 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.1 m -143.11 -33.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 120.577 -1.327 . . . . 0.77 111.337 -178.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.76 36.67 2.98 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.075 -1.21 . . . . 0.87 110.075 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.9 p -65.94 -31.47 72.41 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.866 -1.373 . . . . 0.89 108.604 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.23 -91.04 0.37 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.068 -1.063 . . . . 0.93 111.713 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 10.9 m -111.29 40.51 2.06 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.196 -1.179 . . . . 1.6 112.945 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.428 ' CG2' HG23 ' A' ' 2' ' ' ILE . 23.3 t -76.93 -28.68 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.383 -1.448 . . . . 0.75 107.418 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 29.9 p -66.76 -9.64 38.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.391 -0.818 . . . . 0.84 109.179 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 41.3 m -104.85 9.19 34.88 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.302 -0.999 . . . . 1.61 108.302 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -134.74 2.25 3.14 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.532 -0.914 . . . . 2.3 108.532 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.53 151.87 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.152 -0.684 . . . . 0.76 109.152 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -131.81 162.44 30.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.608 -1.627 . . . . 2.01 106.608 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 60.4 m-80 -63.71 146.86 53.03 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.786 -1.196 . . . . 2.19 110.461 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.3 t70 79.4 -20.89 0.36 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.722 -0.611 . . . . 2.4 110.431 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.38 126.1 25.78 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.771 -1.206 . . . . 1.99 108.155 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -87.5 118.97 27.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.787 -1.196 . . . . 1.3 109.723 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.5 mt -113.62 137.35 51.72 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.492 -0.929 . . . . 0.53 108.492 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.31 115.64 47.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.825 -1.176 . . . . 0.6 107.825 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 30.9 tp -83.2 129.77 35.04 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.296 -1.002 . . . . 0.57 108.296 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 223' ' ' VAL . 42.8 t0 -97.55 -40.0 8.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.408 -0.807 . . . . 2.22 109.036 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.59 27.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.61 0.719 . . . . 0.75 110.078 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 221' ' ' ASP . 7.8 t -119.47 -45.05 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.419 -1.697 . . . . 0.92 106.419 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -105.27 17.13 24.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.178 -1.416 . . . . 2.36 107.178 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 55.8 53.44 9.4 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.597 -0.89 . . . . 1.42 108.597 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -155.0 145.63 22.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 1.97 110.584 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 228' ' ' TYR . 93.0 t -105.39 163.43 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.384 -0.969 . . . . 0.65 108.384 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.49 ' N ' HG12 ' A' ' 227' ' ' VAL . 63.4 m-85 -129.55 122.74 29.8 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.329 -0.857 . . . . 0.97 109.23 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.76 115.46 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.421 -0.799 . . . . 0.67 110.552 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 47.2 t-20 53.96 51.33 8.11 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.379 -0.826 . . . . 1.45 111.098 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 31.8 Cg_endo -64.46 158.76 47.71 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.378 2.052 . . . . 0.82 111.472 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 78.5 p -71.03 139.51 50.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.094 -1.004 . . . . 1.62 109.165 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -53.38 -17.11 1.66 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.197 -0.939 . . . . 2.6 109.587 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -68.15 -39.44 82.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 3.06 108.755 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.2 t -79.49 -34.27 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.848 . . . . 1.14 109.011 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 21.4 mt -64.55 -55.23 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.83 . . . . 1.04 109.313 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -53.14 -40.5 64.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -0.795 . . . . 2.54 109.622 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -67.07 -41.18 86.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 2.6 110.084 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 44.0 mtp -79.53 -26.72 41.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.084 -1.01 . . . . 1.23 109.708 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.427 ' NH1' ' OE2' ' A' ' 244' ' ' GLU . 13.4 mmm180 -59.47 -41.11 89.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.039 -1.038 . . . . 2.67 109.593 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.07 -60.24 2.35 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.278 -0.889 . . . . 1.66 110.226 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.2 t -46.8 -62.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 2.2 110.668 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.47 HE21 HD12 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -45.98 -59.19 2.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.027 -1.046 . . . . 3.0 109.531 -179.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.427 ' OE2' ' NH1' ' A' ' 240' ' ' ARG . 64.2 mt-10 -63.61 -22.66 67.02 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.338 -0.851 . . . . 1.76 109.776 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -68.98 -27.91 66.13 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.531 -1.285 . . . . 2.78 107.531 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.78 -46.08 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.535 -0.728 . . . . 2.06 109.244 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.56 -37.25 79.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 2.4 109.194 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.1 p -78.99 -29.54 43.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -0.849 . . . . 2.87 110.541 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.035 . . . . 3.41 109.618 -179.107 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 mmt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.321 0.581 . . . . 3.66 109.502 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.2 mt 46.58 84.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.374 -0.828 . . . . 1.12 109.961 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m -95.11 113.39 25.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.208 -0.933 . . . . 1.45 109.093 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.24 -161.97 20.74 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.036 -1.626 . . . . 0.92 109.036 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.432 ' O ' HG22 ' A' ' 5' ' ' ILE . 45.1 mt -95.77 -8.15 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.385 -1.068 . . . . 1.05 109.218 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tp 60.61 106.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -0.999 . . . . 0.88 108.843 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.61 -46.02 9.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.779 -1.2 . . . . 0.78 108.444 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.54 142.57 15.66 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.428 -0.795 . . . . 1.5 108.934 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.02 155.63 30.02 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.029 1.82 . . . . 0.86 113.814 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 160.78 -173.9 37.35 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.296 -1.522 . . . . 0.78 109.296 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.4 mt -148.03 122.15 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.605 -1.527 . . . . 0.74 109.358 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.43 154.27 43.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.161 -0.962 . . . . 0.45 110.406 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.495 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 8.7 m-85 -119.23 145.56 45.96 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.351 -0.981 . . . . 0.64 108.351 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.4 159.9 22.75 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 118.885 -1.626 . . . . 0.45 111.248 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -78.57 153.45 31.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.99 . . . . 1.88 109.638 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -79.15 121.89 25.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.59 110.622 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.4 tp -101.73 92.76 4.99 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.518 -1.29 . . . . 0.64 107.518 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.49 127.2 33.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.966 -1.084 . . . . 0.74 111.194 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 160' ' ' ALA . 15.3 mt -95.26 93.31 7.21 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.511 -0.768 . . . . 0.74 109.255 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -92.82 158.06 16.07 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.291 -0.88 . . . . 1.87 109.624 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -130.39 135.6 48.19 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.609 -0.886 . . . . 2.58 108.609 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.55 135.97 36.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.127 -0.983 . . . . 2.14 109.542 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -65.45 132.53 49.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.597 -0.689 . . . . 1.93 109.456 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.24 135.46 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.31 -0.869 . . . . 0.68 109.959 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.52 117.85 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.546 -0.721 . . . . 0.84 109.364 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.2 mt -87.01 132.65 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.79 109.289 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.3 123.28 33.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.252 -0.905 . . . . 1.37 109.655 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.457 HH11 ' HG2' ' A' ' 28' ' ' ARG . 2.8 mmt-85 -96.25 26.05 4.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.248 -0.907 . . . . 2.62 108.819 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -90.24 142.73 27.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.463 -0.773 . . . . 2.35 110.384 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -88.34 129.16 35.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.252 -0.905 . . . . 2.35 108.649 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.7 pt -92.68 172.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.943 -1.098 . . . . 0.78 110.426 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 34' ' ' ASP . 7.9 p -99.18 160.08 14.53 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.621 -0.881 . . . . 1.04 108.621 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.3 -7.53 0.89 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.033 -1.042 . . . . 1.05 109.373 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 32' ' ' SER . 3.9 m-20 -82.57 -10.03 59.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 2.47 110.446 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -120.02 -17.0 8.52 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.158 -0.964 . . . . 1.46 109.73 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.6 t -53.89 -36.35 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 0.77 109.697 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -54.25 -40.46 67.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 1.46 110.152 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -69.93 -41.54 74.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.219 -0.926 . . . . 2.29 110.575 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -59.73 -45.82 91.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.002 -1.061 . . . . 1.3 109.864 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.1 t -59.27 -45.08 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.76 109.3 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -60.66 -37.64 82.24 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.505 -0.924 . . . . 1.5 108.505 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -68.83 -31.57 70.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.531 -0.731 . . . . 2.66 109.352 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -85.36 -51.26 6.68 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.28 -0.888 . . . . 0.75 109.216 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.35 -59.74 4.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.886 . . . . 0.83 109.085 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.669 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -62.78 -38.09 89.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.78 108.629 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -55.31 -54.1 36.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 107.325 -2.31 . . . . 0.57 107.325 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.9 ttt-85 -45.65 -32.25 2.3 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.341 -0.985 . . . . 2.83 108.341 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.13 -34.93 74.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.34 -0.985 . . . . 0.65 108.34 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' GLY . 24.2 ttmt -85.12 -58.43 2.69 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.246 -0.65 . . . . 2.57 109.246 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.07 -39.23 63.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.967 . . . . 0.51 109.872 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 t -66.31 -40.01 89.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.102 -0.999 . . . . 1.36 108.622 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.08 -35.32 64.21 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.867 -0.52 . . . . 0.6 109.83 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -65.22 -67.27 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.36 110.162 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 54' ' ' LEU . 4.5 mm? -50.16 -33.96 20.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.865 -1.147 . . . . 1.38 108.899 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.48 -46.22 80.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.401 -0.812 . . . . 1.27 108.919 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.9 m -62.53 -37.39 85.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.293 -0.879 . . . . 0.6 109.785 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.42 -33.73 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.962 -1.086 . . . . 0.53 108.854 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -53.78 -44.66 70.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 0.99 109.836 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -71.22 -35.27 71.45 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.199 -0.938 . . . . 0.59 109.741 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -69.45 -26.18 64.47 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.563 -1.255 . . . . 1.81 107.686 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.51 -33.76 67.13 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.354 -0.98 . . . . 0.48 108.354 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -28.83 28.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.792 -1.323 . . . . 0.58 109.792 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -86.2 -11.65 51.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.1 -1.235 . . . . 1.39 108.764 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -99.16 -51.02 3.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.497 -0.752 . . . . 0.82 110.353 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -106.25 -16.29 14.62 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.213 -0.93 . . . . 0.99 110.711 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 120.53 143.79 6.9 Favored Glycine 0 N--CA 1.504 3.214 0 N-CA-C 110.274 -1.13 . . . . 0.55 110.274 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -48.77 -9.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.365 -1.079 . . . . 2.59 110.166 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' GLY . 35.4 mt-10 -63.72 -31.56 72.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.953 . . . . 2.2 110.466 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -88.86 -6.32 57.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.943 -1.098 . . . . 1.79 110.624 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.81 -31.33 72.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.642 -1.287 . . . . 1.54 109.983 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.86 -29.57 70.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.64 109.586 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.0 mt -73.36 -45.09 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.88 . . . . 0.58 109.557 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -76.96 -21.24 55.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.62 109.433 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.19 -40.59 94.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.134 -0.979 . . . . 1.23 108.869 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.9 -31.45 64.58 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.699 -1.76 . . . . 0.52 108.699 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -62.29 -23.2 66.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.556 -0.967 . . . . 1.29 110.162 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.1 mt -84.9 -35.33 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.776 -1.203 . . . . 0.55 108.773 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.8 ttt -57.27 -39.74 76.29 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.353 -0.98 . . . . 1.89 108.353 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.99 -39.07 90.01 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.574 -0.899 . . . . 0.53 108.574 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.31 -43.04 53.13 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.617 -0.833 . . . . 0.43 109.179 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -85.49 2.89 42.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.2 -0.938 . . . . 1.24 110.419 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -45.34 114.4 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.07 -1.018 . . . . 1.31 109.261 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -64.04 -23.51 67.36 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -0.854 . . . . 1.35 109.169 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -75.88 -46.78 28.32 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.344 -0.848 . . . . 2.16 109.194 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.08 -20.43 66.16 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.935 -1.103 . . . . 0.6 109.554 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.43 -53.47 9.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.361 -0.837 . . . . 1.28 110.736 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -61.88 -29.97 70.55 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.25 -0.906 . . . . 1.28 110.469 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.11 -41.63 61.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.98 -1.075 . . . . 1.29 109.077 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.0 mt -60.55 -57.72 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.868 -1.16 . . . . 0.58 107.868 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.9 mt -49.42 -53.63 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.666 -0.646 . . . . 0.78 110.05 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.85 -63.3 1.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.86 110.125 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.1 mt -45.19 -48.48 12.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.541 -0.725 . . . . 0.79 110.008 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.3 mt -55.21 -40.84 57.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.157 -0.965 . . . . 0.71 110.004 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -85.61 -39.5 17.26 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.027 -1.046 . . . . 2.05 111.313 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.31 -36.8 26.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.827 -1.171 . . . . 1.59 111.54 -176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -104.65 12.19 33.24 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.919 -1.113 . . . . 1.89 109.164 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.3 m80 45.12 44.26 8.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.486 -0.759 . . . . 1.31 109.295 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.0 mtp -93.43 154.0 18.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.398 -0.814 . . . . 1.28 109.302 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.9 p -79.25 142.47 36.17 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.317 -0.864 . . . . 0.62 109.262 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.16 -26.46 1.91 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.47 109.646 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -76.19 -42.63 45.67 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.276 -0.89 . . . . 2.0 108.916 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.49 -58.58 3.27 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.726 -0.609 . . . . 0.56 111.175 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.41 -48.68 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.956 -1.09 . . . . 0.48 109.804 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.07 -33.8 65.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.199 -0.938 . . . . 0.44 109.333 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.478 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 85.5 t60 -70.75 -35.32 72.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 1.42 109.598 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.25 -64.25 0.92 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.363 -0.836 . . . . 1.26 110.47 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.6 t -48.54 -47.17 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.985 -1.072 . . . . 0.61 109.55 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.58 -21.22 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.482 -0.761 . . . . 0.64 109.734 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.478 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 11.9 tp10 -72.95 -38.88 66.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.166 -0.959 . . . . 2.2 111.247 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 114' ' ' ALA . . . -85.15 -21.12 55.99 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 118.828 -1.653 . . . . 0.82 112.102 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -69.83 -59.41 2.95 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.606 -1.526 . . . . 1.27 108.171 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.71 -49.83 73.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.717 -0.614 . . . . 0.91 109.533 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.8 m -58.93 -35.81 73.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.263 -0.898 . . . . 1.73 109.586 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -61.91 -44.27 97.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.071 -1.018 . . . . 1.04 110.116 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.8 mt -66.64 -27.77 67.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.879 -1.138 . . . . 1.03 109.288 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -67.32 -18.29 65.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.113 -0.992 . . . . 1.95 110.011 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.38 -9.85 59.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.063 -1.023 . . . . 1.71 109.282 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mt -89.1 152.23 21.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.627 -0.879 . . . . 1.26 108.627 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -100.8 59.64 0.94 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -0.846 . . . . 2.83 108.814 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -143.91 119.1 10.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.284 -0.885 . . . . 1.58 109.375 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.4 pm0 -63.42 -9.28 11.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 2.8 109.237 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -76.42 -62.61 1.56 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.35 -0.843 . . . . 1.02 109.938 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.57 -17.12 62.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.738 -1.226 . . . . 1.06 109.36 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -69.37 -55.6 9.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.137 -0.977 . . . . 2.39 108.778 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -60.48 -21.45 62.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.257 -0.902 . . . . 2.2 108.938 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -71.75 -27.24 62.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.631 -1.618 . . . . 2.09 106.631 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.27 92.95 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.226 -1.027 . . . . 0.86 108.226 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.09 79.87 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.527 -0.916 . . . . 0.9 108.527 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -32.54 71.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 1.35 108.834 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.2 t -80.37 -47.02 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.436 -0.79 . . . . 0.58 108.891 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -64.42 -35.64 81.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.154 -0.966 . . . . 3.22 108.721 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.503 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 13.5 t0 -58.52 -43.52 89.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 1.32 109.298 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.0 mt -67.47 -25.57 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.072 -1.017 . . . . 0.5 108.402 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.08 -52.24 4.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.446 -1.461 . . . . 0.44 109.446 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -52.82 -37.32 59.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -1.158 . . . . 2.71 109.329 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.503 ' NH2' ' OD1' ' A' ' 132' ' ' ASP . 6.7 mtt-85 -63.46 -42.52 98.63 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.15 -1.055 . . . . 2.2 108.15 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.6 tp -59.21 -48.92 79.83 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.57 -0.706 . . . . 1.13 109.291 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.2 mt -52.21 -53.16 46.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.54 109.787 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -54.39 -22.96 13.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.097 -1.002 . . . . 2.32 110.0 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.415 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 2.6 m120 -83.96 -31.41 25.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.119 -0.988 . . . . 1.26 109.047 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.0 mt -66.26 -43.78 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.62 108.842 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.6 mt -90.43 -7.14 53.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.211 -0.931 . . . . 0.67 109.397 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 68.73 27.55 73.77 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.578 -1.809 . . . . 0.68 108.578 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tp -51.28 166.2 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.529 -0.983 . . . . 0.77 109.609 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -67.06 141.25 57.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 2.4 109.867 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -109.21 138.78 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.447 -0.783 . . . . 0.87 109.135 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.525 ' H ' HD12 ' A' ' 147' ' ' ILE . 2.5 mp -78.71 128.68 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.025 -1.047 . . . . 1.32 110.03 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -98.13 86.32 3.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.494 -0.754 . . . . 1.54 109.246 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.5 mt -82.41 -33.84 28.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.235 -0.916 . . . . 0.77 109.953 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.5 m -82.06 28.49 0.43 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.115 -0.991 . . . . 1.57 109.977 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.18 28.52 2.28 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.073 -1.017 . . . . 0.82 109.671 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.9 152.96 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.223 -0.923 . . . . 0.82 109.483 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -129.44 -16.02 3.97 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.353 -0.842 . . . . 2.11 109.238 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -114.95 126.96 55.38 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.892 -0.781 . . . . 1.41 108.892 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.16 124.97 23.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.046 -1.033 . . . . 1.3 109.288 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.3 m -149.33 175.9 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.57 108.94 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.2 mt -88.39 156.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.268 -1.012 . . . . 0.43 108.268 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.2 tp -107.55 124.92 50.63 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.103 -0.702 . . . . 0.56 109.103 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -124.71 129.27 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 109.062 -0.718 . . . . 0.54 109.062 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.471 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.29 146.3 13.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.62 109.765 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.52 -34.84 67.41 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.746 -1.221 . . . . 0.8 107.847 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -173.49 151.95 2.05 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.164 -0.68 . . . . 2.34 109.164 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.2 mt -119.89 130.67 54.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.682 -0.859 . . . . 0.65 108.682 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.2 p -91.12 150.97 42.6 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.133 -0.98 . . . . 0.74 109.076 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 169' ' ' ALA . 68.6 Cg_exo -35.41 -51.73 0.86 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 122.527 2.151 . . . . 0.6 112.379 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.8 m -48.0 -54.28 13.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.319 -0.863 . . . . 0.63 109.28 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.75 -45.8 88.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.4 -0.813 . . . . 1.25 109.654 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 24.1 p -68.12 -26.06 65.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.5 109.714 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -74.06 -30.77 62.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.114 -0.991 . . . . 0.51 110.148 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -101.41 -14.21 17.66 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.188 -0.945 . . . . 1.17 109.818 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.0 tp -60.51 145.28 49.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.799 -1.188 . . . . 0.61 108.296 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 174' ' ' LYS . 11.7 t-20 -96.51 142.06 29.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.11 -0.994 . . . . 2.12 108.497 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.413 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 37.0 mt -90.15 -39.97 12.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 1.34 111.04 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 35.1 mttm -79.94 -11.06 59.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.83 -1.168 . . . . 1.97 111.628 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -101.83 -13.22 17.77 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.857 -1.152 . . . . 1.9 109.074 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 177' ' ' LEU . 74.5 t -95.88 161.37 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.229 -0.919 . . . . 0.48 108.646 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.51 ' N ' HG12 ' A' ' 176' ' ' VAL . 53.8 tp -111.52 -28.54 8.12 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.25 -0.907 . . . . 1.39 110.119 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -174.32 177.53 46.47 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.714 -1.355 . . . . 0.38 109.714 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.53 127.43 33.17 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.405 -1.056 . . . . 0.46 109.853 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.6 mt -127.91 122.91 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.762 -1.57 . . . . 0.59 106.762 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 38.0 p -140.77 156.23 46.22 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.331 1.063 . . . . 0.67 112.461 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 1.5 m-20 -87.07 37.55 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.692 -0.685 . . . . 2.24 109.56 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -88.65 -167.41 1.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.081 -1.012 . . . . 1.11 110.416 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.45 -106.35 1.45 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.488 -1.445 . . . . 1.63 109.488 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 171.12 -36.59 0.17 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.388 -1.485 . . . . 1.47 109.388 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -56.38 98.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -1.103 . . . . 5.24 109.528 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.5 p 47.61 50.76 14.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.475 -0.766 . . . . 2.92 110.039 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.1 t -86.64 140.6 29.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.209 -0.932 . . . . 1.6 109.393 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -49.21 -52.09 28.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 0.92 109.89 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 39.0 p -54.08 -45.97 71.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 1.59 110.232 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 98.9 p -63.67 -46.4 85.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 1.42 110.762 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -50.91 -28.68 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.903 -1.123 . . . . 1.41 109.721 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.5 mtp -71.37 -57.0 4.87 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.789 -1.189 . . . . 0.86 107.789 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.83 -43.11 65.75 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.78 -0.645 . . . . 0.59 110.076 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -68.1 -46.3 71.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 3.06 109.779 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.3 m -70.24 -35.82 74.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.73 109.727 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.8 mt -89.76 -1.95 58.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.152 -0.967 . . . . 0.67 109.403 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 56.26 2.23 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 1.49 111.681 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.1 169.51 8.23 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.45 -1.406 . . . . 0.64 108.631 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.28 141.84 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.694 2.263 . . . . 0.59 111.312 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.26 -178.63 5.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.448 -1.408 . . . . 0.55 111.341 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 28.5 mt -148.76 157.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.452 -1.314 . . . . 0.63 107.452 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.0 m -138.35 -39.2 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.968 -1.083 . . . . 0.77 110.713 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -75.97 41.2 1.48 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.679 -1.368 . . . . 0.87 109.679 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 181' ' ' THR . 20.2 p -68.21 3.57 1.61 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.058 -1.26 . . . . 0.89 109.042 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 55.83 -102.22 0.16 Allowed Glycine 0 N--CA 1.483 1.833 0 N-CA-C 109.83 -1.308 . . . . 0.93 109.83 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.5 p -125.49 43.38 3.07 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.403 -1.057 . . . . 1.6 111.323 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 26.2 t -62.96 -32.06 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.521 -1.362 . . . . 0.75 107.825 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 p -60.25 -16.28 32.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.84 109.094 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.7 m -105.67 15.36 27.0 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.876 -0.787 . . . . 1.61 108.876 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -133.68 -15.28 2.41 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.554 -0.716 . . . . 2.3 109.934 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 51.3 t -123.34 150.57 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.331 -0.856 . . . . 0.76 109.308 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -113.8 -174.74 2.53 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.593 -1.262 . . . . 2.01 107.593 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.46 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 9.6 t30 -80.26 145.41 32.2 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.14 -0.975 . . . . 2.19 110.057 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 82.29 -11.77 0.98 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.036 -0.415 . . . . 2.4 111.229 178.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -55.46 143.32 29.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.636 -1.29 . . . . 1.99 108.446 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -87.78 125.58 34.52 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.956 -1.09 . . . . 1.3 108.813 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 16' ' ' ALA . 43.4 mt -123.7 162.98 22.01 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.841 0.829 . . . . 0.53 110.585 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.7 mt -136.69 107.87 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.775 -1.194 . . . . 0.6 107.775 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.5 tp -87.51 122.04 30.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -0.905 . . . . 0.57 109.234 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.8 OUTLIER -101.05 -28.41 12.73 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.33 -0.856 . . . . 2.22 109.014 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 37.57 27.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.891 -0.505 . . . . 0.75 111.246 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.483 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.2 t -118.25 -58.85 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 106.602 -1.629 . . . . 0.92 106.602 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -92.02 9.1 34.68 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.643 -1.614 . . . . 2.36 106.643 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 60.13 64.63 1.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.211 -0.663 . . . . 1.42 109.211 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -153.01 136.1 15.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 1.97 110.698 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.3 t -115.18 126.6 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.887 -1.153 . . . . 0.65 107.887 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -96.4 130.71 43.47 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 0.97 109.748 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.46 130.54 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.415 -0.587 . . . . 0.67 109.415 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 20.0 t30 55.24 71.62 1.24 Allowed Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.376 -0.828 . . . . 1.45 110.229 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.36 146.08 2.25 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 123.321 2.681 . . . . 0.82 112.06 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.5 p -72.21 177.89 4.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.413 -0.804 . . . . 1.62 109.776 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -76.86 -39.55 50.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 2.6 109.553 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 234' ' ' GLU . 13.3 mp0 -53.76 -39.12 65.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 3.06 109.403 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.46 -39.41 54.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.089 -1.007 . . . . 1.14 108.833 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.0 mt -65.94 -64.25 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 1.04 109.305 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -53.77 -44.09 69.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 2.54 110.606 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -65.73 -33.04 74.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.06 -1.025 . . . . 2.6 109.813 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.456 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 50.8 mtp -80.83 -38.73 27.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.981 -1.075 . . . . 1.23 109.467 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -49.07 -50.17 37.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.046 -1.034 . . . . 2.67 110.166 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.91 -61.8 1.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.06 -1.025 . . . . 1.66 110.96 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.9 t -62.83 -52.44 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.951 -1.093 . . . . 2.2 111.167 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 239' ' ' MET . 2.2 tp-100 -54.39 -41.28 69.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.712 -1.242 . . . . 3.0 109.72 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.0 -25.7 67.79 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.567 -1.333 . . . . 1.76 108.659 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -70.19 -22.3 62.95 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.898 -1.149 . . . . 2.78 107.898 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.79 -55.25 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.328 -0.858 . . . . 2.06 108.904 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.01 -34.65 43.81 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.54 -0.725 . . . . 2.4 109.452 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.03 -31.81 56.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -0.874 . . . . 2.87 109.314 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 3.41 109.067 179.623 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.936 -0.764 . . . . 3.66 108.936 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.01 97.24 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 1.12 110.007 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.4 m -99.75 110.81 23.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.461 -0.774 . . . . 1.45 109.959 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.641 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -109.45 -162.45 19.62 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.755 -1.738 . . . . 0.92 108.755 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 5' ' ' ILE . 89.3 mt -94.82 -6.98 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.052 -1.264 . . . . 1.05 109.096 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 5' ' ' ILE . 5.4 tp 55.39 102.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.374 -0.829 . . . . 0.88 108.878 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.45 -55.1 4.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.097 -1.002 . . . . 0.78 108.606 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.57 144.23 32.63 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.695 -0.854 . . . . 1.5 108.695 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.42 156.05 28.66 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.918 1.745 . . . . 0.86 112.634 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.82 129.61 1.36 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.057 -1.217 . . . . 0.78 110.057 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.9 mt -99.6 131.48 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.202 -1.175 . . . . 0.74 110.724 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.52 ' HB1' HD21 ' A' ' 177' ' ' LEU . . . -146.26 143.65 29.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 0.45 109.16 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.546 ' CZ ' ' OE1' ' A' ' 243' ' ' GLN . 4.2 m-85 -100.69 140.74 34.54 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.493 -1.299 . . . . 0.64 107.493 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.56 156.25 19.49 Favored Glycine 0 N--CA 1.5 2.902 0 C-N-CA 118.49 -1.814 . . . . 0.45 111.881 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -78.75 152.09 31.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.846 -0.797 . . . . 1.88 110.464 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.618 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -79.18 126.36 30.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.541 -0.724 . . . . 0.59 111.119 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 tp -111.15 93.29 4.4 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.86 -1.533 . . . . 0.64 106.86 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.8 tp -80.6 127.51 32.54 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.782 -1.198 . . . . 0.74 111.293 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.7 mt -97.16 94.61 7.23 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.438 0.637 . . . . 0.74 109.957 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -92.68 156.89 16.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.412 -0.805 . . . . 1.87 109.164 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.84 130.41 53.93 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.646 -0.872 . . . . 2.58 108.646 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -76.77 132.77 39.43 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.185 -0.947 . . . . 2.14 108.978 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.99 137.88 56.83 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.533 -0.729 . . . . 1.93 109.442 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.34 136.08 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.23 -0.919 . . . . 0.68 110.159 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.2 t -102.66 117.53 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.44 -0.787 . . . . 0.84 108.93 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.6 mt -90.96 129.73 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.248 -0.907 . . . . 0.79 109.119 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -90.68 120.27 31.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 1.37 109.922 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -96.11 29.64 2.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.384 -0.822 . . . . 2.62 109.444 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -86.56 144.94 26.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.121 -0.987 . . . . 2.35 109.442 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -85.84 125.97 33.69 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.984 -1.073 . . . . 2.35 109.018 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -82.76 179.15 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.285 -0.884 . . . . 0.78 109.535 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.536 ' H ' HE21 ' A' ' 35' ' ' GLN . 60.7 p -98.82 160.62 14.14 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.396 -0.815 . . . . 1.04 109.332 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.1 -20.22 51.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 1.05 109.307 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -82.53 -12.06 58.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.853 . . . . 2.47 109.43 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.536 HE21 ' H ' ' A' ' 32' ' ' SER . 3.2 mt-30 -105.35 -10.13 17.17 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.941 -1.133 . . . . 1.46 107.941 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.97 -48.36 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.682 -0.636 . . . . 0.77 109.523 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -56.6 -30.04 62.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.085 -1.01 . . . . 1.46 108.942 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -70.37 -35.03 73.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.453 -0.779 . . . . 2.29 110.16 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -64.43 -44.31 91.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.105 -0.997 . . . . 1.3 109.589 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 44' ' ' LEU . 83.6 t -58.15 -46.58 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.169 -0.957 . . . . 0.76 109.328 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.85 -43.6 87.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.139 -0.976 . . . . 1.5 108.905 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -66.04 -32.09 73.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.568 -0.708 . . . . 2.66 109.186 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -86.45 -57.66 2.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.133 -0.98 . . . . 0.75 108.739 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 40' ' ' VAL . 34.0 tp -51.92 -60.69 2.89 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.425 -0.797 . . . . 0.83 109.235 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.1 t -66.4 -31.34 72.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.274 -0.891 . . . . 0.78 108.801 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.38 53.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.298 -1.921 . . . . 0.57 108.298 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.546 HH22 ' CD ' ' A' ' 86' ' ' GLU . 27.6 ttp180 -60.44 -21.39 62.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -1.116 . . . . 2.83 109.505 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -66.69 -45.59 78.33 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.345 -0.983 . . . . 0.65 108.345 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.456 ' H ' ' HG2' ' A' ' 49' ' ' LYS . 12.6 ptmt -78.4 -52.93 7.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.483 -0.932 . . . . 2.57 108.483 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.74 -33.36 15.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.353 -1.467 . . . . 0.51 108.789 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 m -66.54 -36.77 83.49 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.034 -1.098 . . . . 1.36 108.034 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -70.46 -19.76 62.93 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.697 -0.853 . . . . 0.6 108.697 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -76.17 -66.06 0.84 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.4 -0.812 . . . . 1.36 109.645 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.9 mt -51.18 -35.6 36.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 1.38 108.867 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -60.74 -51.11 70.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.517 -0.739 . . . . 1.27 109.268 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 m -63.46 -38.25 90.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.157 -0.965 . . . . 0.6 109.088 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.5 mt -69.62 -27.75 34.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.295 -0.878 . . . . 0.53 108.984 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -63.3 -41.57 98.97 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.306 -0.871 . . . . 0.99 109.526 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -71.66 -24.78 61.9 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.51 -0.744 . . . . 0.59 109.264 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.422 ' O ' ' CB ' ' A' ' 64' ' ' THR . 97.0 mttt -72.59 -25.58 61.39 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.738 -1.208 . . . . 1.81 107.738 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.98 -32.12 61.6 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.932 -1.136 . . . . 0.48 107.932 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.96 -29.12 29.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.915 -1.674 . . . . 0.58 108.915 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -86.64 -22.37 26.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.095 -1.238 . . . . 1.39 108.638 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 56.5 m -94.67 -45.09 7.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.254 -0.904 . . . . 0.82 110.56 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.54 ' C ' ' H ' ' A' ' 67' ' ' GLU . 52.4 m-85 -107.78 -34.17 7.04 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.191 -0.943 . . . . 0.99 109.965 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 67.37 -30.21 0.21 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.366 -1.094 . . . . 0.55 110.366 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 65' ' ' PHE . 35.3 mt-10 -51.01 -179.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.03 -1.277 . . . . 2.59 110.102 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.15 36.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.56 -0.712 . . . . 2.2 109.821 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.8 mmtp -83.18 -10.48 58.6 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.406 -0.809 . . . . 1.79 109.308 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -69.01 -35.96 77.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.246 -0.909 . . . . 1.54 110.292 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.17 -28.41 68.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.64 110.398 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.499 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 11.2 mt -71.52 -46.19 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.079 -1.013 . . . . 0.58 109.821 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -76.19 -26.71 56.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.62 109.571 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.84 -59.33 4.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.052 -1.03 . . . . 1.23 109.026 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.92 -33.73 64.22 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.76 -1.336 . . . . 0.52 109.76 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.499 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 14.8 m170 -62.1 -22.2 65.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.019 -1.283 . . . . 1.29 109.768 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.4 mt -84.81 -36.79 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.976 -1.077 . . . . 0.55 108.365 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.4 ttt -60.84 -44.51 96.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.172 -1.047 . . . . 1.89 108.172 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.3 tp -57.59 -40.87 79.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.231 -1.026 . . . . 0.53 108.231 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.5 tp -69.62 -42.75 73.94 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.403 -0.81 . . . . 0.43 109.519 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -84.9 9.57 14.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.306 -0.871 . . . . 1.24 110.262 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -49.43 121.78 5.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.015 -1.053 . . . . 1.31 110.2 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -67.14 -24.62 65.92 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.242 -0.911 . . . . 1.35 108.986 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -74.2 -49.93 21.35 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.328 -0.949 . . . . 2.16 108.685 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.6 mt -64.17 -15.04 59.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.63 -1.228 . . . . 0.6 108.603 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.546 ' CD ' HH22 ' A' ' 47' ' ' ARG . 28.2 tt0 -77.29 -54.33 6.61 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.806 -1.184 . . . . 1.28 110.136 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -60.18 -30.79 69.58 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.674 -1.267 . . . . 1.28 110.003 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -71.88 -47.89 49.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.062 -1.024 . . . . 1.29 109.039 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.7 mt -59.5 -53.72 44.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.887 -0.783 . . . . 0.58 108.887 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 91' ' ' ALA . 95.9 mt -51.25 -71.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.746 . . . . 0.78 110.348 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -40.25 -48.31 2.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.383 -0.823 . . . . 0.86 110.631 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.8 mt -55.36 -55.69 28.69 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.652 -0.87 . . . . 0.79 108.652 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.1 mt -54.11 -41.89 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.829 . . . . 0.71 110.831 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -85.84 -35.11 20.84 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.03 -1.044 . . . . 2.05 111.7 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 91' ' ' ALA . 37.8 t70 -81.94 -38.63 24.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.756 -1.215 . . . . 1.59 111.48 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -105.97 12.6 30.35 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.899 -1.126 . . . . 1.89 109.462 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.2 m170 46.05 46.35 12.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 1.31 109.49 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.0 mtt -96.23 152.41 18.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.481 -0.762 . . . . 1.28 109.207 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.8 p -78.53 142.93 37.01 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.61 -0.681 . . . . 0.62 110.183 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.87 -25.44 3.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.189 -0.944 . . . . 0.47 108.736 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -75.21 -50.72 15.3 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.316 -0.994 . . . . 2.0 108.316 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.65 -50.1 33.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.64 -0.663 . . . . 0.56 109.813 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.73 -60.28 3.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.941 . . . . 0.48 109.657 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.5 -33.29 30.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.44 109.8 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -68.16 -35.01 77.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.915 -1.116 . . . . 1.42 110.055 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.97 -45.05 91.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.121 -0.987 . . . . 1.26 110.814 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -66.72 -48.66 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.051 . . . . 0.61 109.412 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -60.87 -23.77 30.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.737 -0.602 . . . . 0.64 109.824 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -73.06 -37.39 66.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.104 -0.998 . . . . 2.2 110.098 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.68 -22.1 48.06 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.372 -1.395 . . . . 0.82 112.406 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.68 -53.37 15.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.711 -1.464 . . . . 1.27 108.79 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.15 71.78 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.652 -0.655 . . . . 0.91 109.627 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 m -60.82 -37.43 81.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.444 -0.785 . . . . 1.73 110.076 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.39 96.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.299 -0.876 . . . . 1.04 111.15 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.8 mt -70.84 -26.58 63.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.451 -1.3 . . . . 1.03 108.539 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -67.71 -19.5 65.16 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.606 -0.684 . . . . 1.95 110.41 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -82.5 -6.03 59.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.922 -1.111 . . . . 1.71 109.749 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 31.8 mt -84.32 166.99 16.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.057 -1.027 . . . . 1.26 109.528 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -107.84 47.71 0.88 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.736 -0.603 . . . . 2.83 109.906 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -142.82 120.61 11.92 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.017 -1.052 . . . . 1.58 109.531 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.69 -8.64 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.601 0.715 . . . . 2.8 109.72 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -76.67 -62.03 1.77 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.4 -0.812 . . . . 1.02 109.989 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.5 mt -68.83 -24.7 64.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.024 -1.048 . . . . 1.06 109.239 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -66.88 -50.87 61.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -0.879 . . . . 2.39 109.083 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.19 -20.95 63.35 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.306 -0.998 . . . . 2.2 108.306 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -72.88 -27.77 62.1 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.745 -1.576 . . . . 2.09 106.745 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.09 -42.64 90.93 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.107 -1.071 . . . . 0.86 108.107 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.92 -39.04 79.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.413 -0.804 . . . . 0.9 109.784 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -70.67 -25.96 63.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 1.35 109.616 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.62 -47.48 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.58 108.705 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -53.21 -39.02 63.39 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.062 -1.024 . . . . 3.22 108.405 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 22.1 t70 -59.4 -40.4 86.47 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -0.897 . . . . 1.32 109.633 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.4 mt -66.05 -34.01 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.149 -0.969 . . . . 0.5 109.25 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.32 -44.88 16.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.515 -1.434 . . . . 0.44 109.515 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -49.58 -45.9 48.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.411 -1.052 . . . . 2.71 109.631 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.53 HH11 ' HG2' ' A' ' 136' ' ' ARG . 11.0 mtt-85 -65.18 -42.92 93.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.08 . . . . 2.2 108.491 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.567 ' O ' HD23 ' A' ' 137' ' ' LEU . 1.1 tt -52.38 -35.88 52.51 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.082 -1.081 . . . . 1.13 108.082 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.64 -58.74 3.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.396 -0.815 . . . . 0.54 110.23 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -46.21 -20.13 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.146 -0.971 . . . . 2.32 111.114 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -83.43 -49.73 9.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.88 -1.138 . . . . 1.26 109.012 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.0 mt -57.56 -34.1 46.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.067 -1.021 . . . . 0.62 109.116 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 49.4 mt -87.22 0.08 55.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.062 -1.024 . . . . 0.67 108.536 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.23 25.86 12.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.449 -1.861 . . . . 0.68 108.449 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.5 tp -57.57 153.5 12.96 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.779 -0.836 . . . . 0.77 110.14 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -67.18 146.76 53.89 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.02 -1.05 . . . . 2.4 109.747 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.85 140.13 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.449 -0.782 . . . . 0.87 109.449 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.517 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.0 mp -78.03 120.15 28.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.225 -0.922 . . . . 1.32 109.095 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -93.51 88.17 5.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 1.54 109.912 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.9 mt -82.0 -24.05 35.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.877 . . . . 0.77 108.798 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.0 t -80.44 26.14 0.39 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.457 -0.777 . . . . 1.57 108.945 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.5 28.38 2.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 0.82 110.125 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 51.2 mt -74.59 152.35 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.869 . . . . 0.82 109.127 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -131.76 -6.51 3.61 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.664 -0.865 . . . . 2.11 108.664 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -121.82 136.06 54.92 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.954 -0.758 . . . . 1.41 108.954 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.54 124.91 25.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 1.3 109.353 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.0 m -147.25 172.54 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.676 -0.861 . . . . 0.57 108.676 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.5 mt -90.19 157.96 2.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.828 -1.175 . . . . 0.43 107.828 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.8 tp -108.98 121.36 44.96 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.675 0.75 . . . . 0.56 109.47 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.77 128.09 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.099 -0.704 . . . . 0.54 109.099 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.84 151.47 14.52 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.442 -0.786 . . . . 0.62 109.918 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.35 -41.58 84.98 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.495 -1.378 . . . . 0.8 107.895 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -172.94 152.8 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 2.34 109.031 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.3 mt -116.06 141.22 48.42 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.365 -0.834 . . . . 0.65 109.867 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 26.2 p -94.97 151.1 38.66 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.315 -0.866 . . . . 0.74 108.944 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -35.78 -43.75 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.435 2.09 . . . . 0.6 112.243 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.3 m -53.9 -65.37 0.58 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.214 -0.929 . . . . 0.63 109.258 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -47.67 -36.78 11.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.3 -0.875 . . . . 1.25 109.773 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.431 HG21 ' CD2' ' A' ' 189' ' ' HIS . 21.3 p -74.14 -20.11 60.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.5 110.029 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.17 -19.8 27.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.093 -1.004 . . . . 0.51 110.102 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -109.81 -16.57 13.86 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.443 -0.786 . . . . 1.17 110.109 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.06 147.86 45.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.908 -1.12 . . . . 0.61 108.556 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 174' ' ' LYS . 12.2 t-20 -96.02 155.35 16.79 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.973 -1.079 . . . . 2.12 108.804 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.3 mp -94.53 -42.75 8.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.244 -0.91 . . . . 1.34 110.644 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 53.1 mtpt -79.67 -12.46 59.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.018 -1.051 . . . . 1.97 111.502 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -96.59 -6.16 37.45 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.675 -1.265 . . . . 1.9 108.762 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.468 HG11 ' CE1' ' A' ' 179' ' ' PHE . 40.4 t -103.27 155.91 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.804 -0.813 . . . . 0.48 108.804 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.52 HD21 ' HB1' ' A' ' 12' ' ' ALA . 11.5 tp -111.22 -18.09 13.04 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.928 -0.768 . . . . 1.39 108.928 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.46 177.14 42.47 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.073 -1.611 . . . . 0.38 109.073 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.468 ' CE1' HG11 ' A' ' 176' ' ' VAL . 2.8 m-85 -130.26 126.3 36.96 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.483 -1.01 . . . . 0.46 108.852 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.4 mt -129.17 117.42 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.808 -1.182 . . . . 0.59 107.808 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 203' ' ' VAL . 66.0 p -142.74 157.57 44.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.282 -0.886 . . . . 0.67 111.13 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 23.4 p30 -98.01 47.72 1.01 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.675 -0.81 . . . . 2.24 110.179 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -94.23 -148.35 0.27 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.869 -1.144 . . . . 1.11 110.116 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.11 -115.25 2.12 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.236 -1.146 . . . . 1.63 110.236 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 164.28 -23.88 0.17 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.383 -1.887 . . . . 1.47 108.383 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.474 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.3 OUTLIER -65.56 100.22 0.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.552 -0.969 . . . . 5.24 109.455 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 186' ' ' ARG . 47.7 p 41.72 42.04 1.97 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.471 -0.768 . . . . 2.92 109.797 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.4 t -82.24 151.16 26.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.21 -0.931 . . . . 1.6 109.875 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.431 ' CD2' HG21 ' A' ' 168' ' ' THR . 11.8 t60 -51.63 -57.58 8.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.457 -0.777 . . . . 0.92 109.662 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.5 p -51.65 -38.69 55.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.523 -0.736 . . . . 1.59 110.454 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 44.0 p -69.09 -42.83 75.64 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.745 -1.222 . . . . 1.42 110.031 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.7 mt -55.48 -29.82 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.052 -1.03 . . . . 1.41 109.977 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.7 mtp -70.28 -56.22 7.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.322 -1.362 . . . . 0.86 107.322 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.99 83.77 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.477 -0.783 . . . . 0.59 109.417 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -65.76 -47.71 74.3 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.259 -0.901 . . . . 3.06 109.659 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.0 m -69.48 -38.06 77.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.923 -1.11 . . . . 0.73 110.204 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 199' ' ' LEU . 14.4 mt -91.42 4.26 52.92 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.862 -1.149 . . . . 0.67 109.432 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 47.48 10.77 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 1.49 110.395 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 197' ' ' LEU . 27.3 mt -67.75 150.59 97.74 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.052 -1.03 . . . . 0.64 109.156 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.57 134.92 31.93 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.323 1.348 . . . . 0.59 110.88 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.96 174.78 11.9 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.353 -1.339 . . . . 0.55 111.037 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.3 mt -148.7 158.32 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 106.353 -1.721 . . . . 0.63 106.353 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 181' ' ' THR . 4.9 m -138.9 -32.67 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.01 -1.056 . . . . 0.77 110.776 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.79 40.01 2.97 Favored Glycine 0 N--CA 1.496 2.671 0 O-C-N 121.056 -1.028 . . . . 0.87 110.99 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 29.9 p -69.23 -22.67 63.85 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.872 -1.37 . . . . 0.89 108.924 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 73.34 -97.18 0.85 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.905 -1.141 . . . . 0.93 111.119 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 51.7 p -119.85 46.37 1.95 Allowed 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.979 -1.307 . . . . 1.6 112.263 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 28.4 t -75.33 -28.9 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.639 -1.288 . . . . 0.75 107.879 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.8 p -67.75 -10.47 52.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.424 -0.798 . . . . 0.84 109.032 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.9 p -106.76 14.54 26.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.101 -0.703 . . . . 1.61 109.101 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -131.61 -25.1 2.16 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.427 -0.796 . . . . 2.3 109.33 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 213' ' ' LYS . 74.3 t -117.52 164.33 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.558 -0.714 . . . . 0.76 109.115 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.566 ' N ' HG12 ' A' ' 212' ' ' VAL . 13.7 mmmt -127.17 -171.87 2.52 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.023 -1.473 . . . . 2.01 107.023 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.56 HD22 ' C ' ' A' ' 214' ' ' ASN . 0.4 OUTLIER -81.68 149.16 28.64 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.469 -1.394 . . . . 2.19 110.107 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.2 t0 81.38 -11.61 1.07 Allowed 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.879 -0.513 . . . . 2.4 111.495 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 0.8 OUTLIER -57.08 145.22 31.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.664 -1.272 . . . . 1.99 108.432 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -87.28 120.56 28.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.865 -1.147 . . . . 1.3 108.448 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 16' ' ' ALA . 28.0 mt -123.65 170.19 10.71 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.253 1.025 . . . . 0.53 110.685 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.9 mt -144.74 106.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 106.423 -1.695 . . . . 0.6 106.423 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 59.4 tp -82.96 127.03 33.16 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.501 -0.926 . . . . 0.57 108.501 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 223' ' ' VAL . 17.8 m-20 -97.15 -31.86 12.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.352 -0.843 . . . . 2.22 109.453 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.62 25.46 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.428 0.632 . . . . 0.75 110.163 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.5 t -122.41 -51.88 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 106.486 -1.672 . . . . 0.92 106.486 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -97.58 16.04 21.58 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.257 -1.386 . . . . 2.36 107.257 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.641 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 49.89 57.96 5.97 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.98 -0.748 . . . . 1.42 108.98 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -154.67 143.76 21.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 1.97 110.043 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.51 138.17 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.969 -0.752 . . . . 0.65 108.969 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -103.26 129.91 50.36 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.163 -0.961 . . . . 0.97 109.511 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.9 t -108.91 122.88 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.775 -0.578 . . . . 0.67 110.198 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 50.31 58.25 17.3 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.903 . . . . 1.45 109.607 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.47 159.51 50.17 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.7 2.267 . . . . 0.82 112.431 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.8 m -76.28 157.72 32.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 1.62 109.875 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -62.16 -25.54 67.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.069 -1.019 . . . . 2.6 109.585 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -72.66 -35.73 67.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.305 -0.872 . . . . 3.06 110.259 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.56 -45.88 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.892 . . . . 1.14 109.808 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.8 mt -48.95 -60.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.218 -0.926 . . . . 1.04 109.005 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.63 -41.94 70.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.686 -0.633 . . . . 2.54 110.066 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -66.99 -35.1 79.19 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.993 -1.067 . . . . 2.6 109.953 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.4 mtp -80.97 -24.88 37.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.953 . . . . 1.23 109.631 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -61.65 -45.65 93.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.104 -0.997 . . . . 2.67 109.653 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 242' ' ' VAL . . . -74.9 -58.68 3.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.978 -1.076 . . . . 1.66 109.011 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 241' ' ' ALA . 80.4 t -42.97 -59.12 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.471 -0.768 . . . . 2.2 110.156 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 13' ' ' PHE . 24.8 tt0 -47.07 -62.62 1.33 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.013 -1.055 . . . . 3.0 109.911 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -56.13 -29.21 60.39 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.124 -0.985 . . . . 1.76 110.875 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -68.08 -22.73 64.9 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.35 -1.34 . . . . 2.78 107.935 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.0 t -71.15 -51.97 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.603 -0.839 . . . . 2.06 108.868 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -49.58 -36.86 25.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 2.4 109.121 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.2 t -77.92 -17.58 57.1 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.552 -0.718 . . . . 2.87 109.926 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.048 -1.033 . . . . 3.41 109.671 -179.708 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.469 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.357 0.599 . . . . 3.66 109.466 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.463 HD13 HG22 ' A' ' 208' ' ' VAL . 89.7 mt -86.05 97.46 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.935 . . . . 1.12 109.476 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -94.65 108.66 20.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.244 -0.91 . . . . 1.45 109.138 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.17 -170.38 30.8 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.616 -1.394 . . . . 0.92 109.616 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.467 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 71.5 mt -96.17 -10.04 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.396 -1.061 . . . . 1.05 109.037 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 tp 64.97 106.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.877 -0.786 . . . . 0.88 108.877 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.57 -45.21 11.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.041 -1.096 . . . . 0.78 108.041 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -151.39 149.35 24.24 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.573 -0.899 . . . . 1.5 108.573 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.47 147.89 20.37 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.495 2.13 . . . . 0.86 113.454 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.687 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.3 -177.78 31.5 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.691 -1.363 . . . . 0.78 109.691 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.6 mt -141.45 133.38 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.09 -1.241 . . . . 0.74 109.35 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.72 158.04 44.05 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.338 -0.851 . . . . 0.45 110.223 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -128.64 136.17 50.3 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 107.98 -1.119 . . . . 0.64 107.98 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.98 163.11 31.74 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 118.784 -1.675 . . . . 0.45 111.003 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -79.88 148.28 31.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.634 -0.921 . . . . 1.88 110.29 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.69 123.64 25.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.558 -0.714 . . . . 0.59 111.278 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.0 tp -105.16 91.25 3.71 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.38 -1.341 . . . . 0.64 107.38 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 tp -82.78 136.43 34.67 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.74 110.034 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.26 94.4 7.08 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.46 0.647 . . . . 0.74 110.444 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -98.94 149.98 22.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.438 -0.789 . . . . 1.87 109.184 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -130.42 141.42 50.54 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.259 -0.901 . . . . 2.58 109.088 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.83 136.75 36.15 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.108 -0.995 . . . . 2.14 109.377 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -67.13 130.84 44.41 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.462 -0.774 . . . . 1.93 109.08 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.2 mt -91.88 137.73 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.238 -0.914 . . . . 0.68 109.544 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.9 t -105.06 117.73 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.515 -0.74 . . . . 0.84 109.368 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.5 mt -88.86 142.57 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.199 -0.938 . . . . 0.79 109.266 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -91.06 124.02 34.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.159 -0.963 . . . . 1.37 109.935 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -100.48 28.89 4.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.39 -0.819 . . . . 2.62 109.206 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.63 144.6 29.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 2.35 109.882 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -85.13 124.0 31.29 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.342 -0.984 . . . . 2.35 108.342 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.9 pt -88.39 171.2 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.996 . . . . 0.78 110.518 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.513 ' C ' ' H ' ' A' ' 34' ' ' ASP . 21.3 p -101.35 155.0 18.31 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.94 -0.763 . . . . 1.04 108.94 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.96 -5.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 1.05 110.167 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 32' ' ' SER . 31.8 t0 -83.94 -28.39 27.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.02 -1.05 . . . . 2.47 110.325 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -102.1 -2.98 28.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.144 -0.972 . . . . 1.46 109.783 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.49 -44.02 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.087 -1.008 . . . . 0.77 108.908 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -51.42 -37.11 46.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.892 . . . . 1.46 109.194 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -69.22 -34.3 74.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 2.29 109.892 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -61.42 -46.63 89.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.09 -1.006 . . . . 1.3 109.442 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 44' ' ' LEU . 87.0 t -60.97 -48.4 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.76 109.534 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -64.06 -39.67 94.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 1.5 108.543 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -64.75 -33.66 76.5 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.621 -0.881 . . . . 2.66 108.621 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -86.81 -57.32 3.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.75 108.969 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 40' ' ' VAL . 14.9 tp -49.16 -65.21 0.61 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.407 -0.808 . . . . 0.83 109.378 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.582 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.0 t -64.24 -32.27 73.79 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.788 -0.819 . . . . 0.78 108.788 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -59.1 -54.21 39.91 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 107.612 -2.195 . . . . 0.57 107.612 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -50.31 -27.83 6.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.597 -0.943 . . . . 2.83 108.904 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -63.75 -33.84 76.54 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.021 -1.103 . . . . 0.65 108.021 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 46' ' ' GLY . 24.6 mtpp -80.5 -58.04 3.3 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.843 -0.799 . . . . 2.57 108.843 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -53.94 -36.16 62.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.091 -1.006 . . . . 0.51 109.322 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.6 t -63.54 -37.11 86.04 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.35 -0.981 . . . . 1.36 108.35 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.15 -32.65 63.23 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.296 -0.631 . . . . 0.6 109.296 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.492 HE22 ' ND2' ' A' ' 140' ' ' ASN . 55.8 mt-30 -68.96 -65.14 0.74 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.57 -0.706 . . . . 1.36 109.541 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 54' ' ' LEU . 9.3 mp -51.9 -27.94 14.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 1.38 109.078 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -73.09 -49.46 28.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 1.27 109.104 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.2 m -58.32 -31.77 67.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.115 -0.991 . . . . 0.6 109.198 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -73.28 -31.19 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.075 -1.016 . . . . 0.53 108.556 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -56.51 -45.4 81.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.504 -0.747 . . . . 0.99 109.319 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -70.71 -27.04 63.69 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.203 -0.935 . . . . 0.59 109.672 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -71.23 -34.66 71.0 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.872 -1.143 . . . . 1.81 107.95 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.29 -29.05 63.5 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.033 -0.728 . . . . 0.48 109.033 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.33 -34.3 12.52 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.917 -1.135 . . . . 0.58 110.995 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -85.73 -12.2 51.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.586 -1.538 . . . . 1.39 108.849 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.1 m -94.22 -52.92 4.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.82 109.66 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.503 ' C ' ' H ' ' A' ' 67' ' ' GLU . 70.8 m-85 -107.91 -35.91 6.51 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.293 -0.88 . . . . 0.99 109.778 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.77 -24.9 0.64 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.896 -1.282 . . . . 0.55 109.896 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 69' ' ' LYS . 80.6 mt-10 -53.02 -172.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.252 . . . . 2.59 110.323 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.56 34.61 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.468 -0.77 . . . . 2.2 109.991 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 67' ' ' GLU . 4.4 mmmm -85.12 -17.18 38.08 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.251 -0.906 . . . . 1.79 109.305 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.16 -32.11 72.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 1.54 110.285 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.2 -21.38 65.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.197 -0.939 . . . . 0.64 110.597 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.1 mt -69.47 -46.39 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.984 -1.073 . . . . 0.58 109.539 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -76.82 -20.12 56.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.62 109.801 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.88 -35.9 82.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 1.23 108.618 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.75 -34.64 24.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.631 -1.387 . . . . 0.52 109.631 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -59.78 -20.96 59.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.08 -1.247 . . . . 1.29 109.413 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.3 mt -86.44 -42.57 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.124 -1.065 . . . . 0.55 108.124 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 17.3 ttt -59.41 -43.01 93.09 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.769 -0.826 . . . . 1.89 108.769 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -64.57 -45.22 87.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.734 -0.839 . . . . 0.53 108.734 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.1 tp -66.78 -46.91 73.81 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.536 -0.728 . . . . 0.43 109.566 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -85.78 9.83 15.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.298 -0.876 . . . . 1.24 110.082 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -47.91 127.36 11.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.959 -1.088 . . . . 1.31 109.274 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -65.73 -25.37 67.26 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.732 -0.84 . . . . 1.35 108.732 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -77.91 -52.44 8.84 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.333 -0.854 . . . . 2.16 109.724 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.74 -18.67 64.28 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.002 -1.061 . . . . 0.6 109.269 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.76 -54.68 6.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 1.28 109.478 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -64.26 -29.63 70.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 1.28 110.022 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.61 -47.58 46.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.094 -1.004 . . . . 1.29 109.005 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.2 mt -58.84 -59.92 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.328 -0.99 . . . . 0.58 108.328 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 80.5 mt -45.29 -39.63 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.574 -0.704 . . . . 0.78 109.855 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.35 -60.99 2.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.86 109.759 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.9 mt -47.83 -50.77 25.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 0.79 109.38 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 98.0 mt -54.45 -49.91 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.905 . . . . 0.71 110.679 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -85.24 -36.78 20.71 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.832 -1.168 . . . . 2.05 111.754 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -84.44 -37.51 21.33 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.735 -1.228 . . . . 1.59 111.693 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -103.69 14.88 30.13 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.777 -1.202 . . . . 1.89 109.432 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 27.4 m170 44.3 49.17 7.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.412 -0.805 . . . . 1.31 110.359 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 31.8 mtt -103.78 150.46 24.07 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.734 -0.839 . . . . 1.28 108.734 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.8 p -76.89 148.91 36.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 0.62 109.811 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.25 -31.33 42.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.219 -0.926 . . . . 0.47 109.202 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.25 -44.07 54.46 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.755 -0.832 . . . . 2.0 108.755 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.88 -54.2 12.34 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.736 -0.602 . . . . 0.56 110.422 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.7 -50.64 72.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.48 109.48 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.91 -35.22 61.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.441 -0.787 . . . . 0.44 109.73 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.25 -30.05 68.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.932 -1.105 . . . . 1.42 109.727 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 109' ' ' GLU . 79.0 tt0 -66.0 -62.67 1.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 1.26 110.274 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 t -49.95 -47.11 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.059 -1.026 . . . . 0.61 109.546 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.32 -16.14 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.447 -0.945 . . . . 0.64 108.447 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . 9.5 tp10 -73.46 -35.42 65.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 2.2 109.159 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.65 -28.42 24.25 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.573 -1.299 . . . . 0.82 112.194 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -65.03 -36.87 85.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.697 -1.472 . . . . 1.27 109.094 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.54 -54.37 5.96 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.975 -0.75 . . . . 0.91 108.975 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.9 m -59.41 -37.53 78.25 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.427 -0.796 . . . . 1.73 109.853 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -63.76 -41.46 97.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.343 -0.848 . . . . 1.04 110.85 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.0 mt -67.02 -28.4 68.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.772 -1.205 . . . . 1.03 109.208 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -67.34 -17.5 64.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.948 . . . . 1.95 109.97 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -82.76 -9.02 59.54 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.127 -0.983 . . . . 1.71 109.572 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mt -86.61 145.11 26.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.347 -0.846 . . . . 1.26 108.847 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.88 61.26 2.16 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.435 -0.95 . . . . 2.83 108.435 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -149.38 120.46 7.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.783 . . . . 1.58 109.763 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -65.46 -13.36 58.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 2.8 109.196 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.61 -65.16 1.0 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.249 -0.907 . . . . 1.02 109.219 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.3 mt -64.04 -32.14 73.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 1.06 109.324 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 127' ' ' ALA . 46.4 tttp -66.51 -53.27 36.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.041 . . . . 2.39 109.117 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -56.1 -19.45 13.19 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.158 -1.053 . . . . 2.2 108.158 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -73.76 -26.83 60.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.104 -1.813 . . . . 2.09 106.104 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -57.29 -44.05 83.73 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.056 -1.09 . . . . 0.86 108.056 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.66 88.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.212 -1.033 . . . . 0.9 108.212 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -70.72 -27.59 64.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.479 -0.763 . . . . 1.35 109.324 179.222 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.9 t -77.55 -44.41 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.13 -1.063 . . . . 0.58 108.13 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -52.72 -41.25 63.79 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.188 -1.042 . . . . 3.22 108.188 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -62.69 -33.81 75.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.575 -0.703 . . . . 1.32 109.479 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.5 -36.01 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.918 -1.114 . . . . 0.5 108.966 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.51 -46.12 16.04 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.937 -1.665 . . . . 0.44 108.937 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -55.3 -46.99 76.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.542 -0.975 . . . . 2.71 109.538 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.517 HH11 ' HG2' ' A' ' 136' ' ' ARG . 14.4 mtt-85 -65.32 -43.99 89.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 2.2 108.993 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.1 tp -54.36 -37.74 65.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 1.13 109.049 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.78 -58.3 7.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 0.54 109.626 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -50.56 -16.54 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.333 -0.854 . . . . 2.32 110.195 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.492 ' ND2' HE22 ' A' ' 53' ' ' GLN . 3.0 m120 -84.65 -45.9 12.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.125 -0.984 . . . . 1.26 109.425 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.31 -37.71 78.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.198 -0.939 . . . . 0.62 108.854 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 mt -90.67 -1.73 57.86 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 0.67 109.0 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 50.49 22.39 5.38 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.619 -1.793 . . . . 0.68 108.619 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.1 tp -53.56 166.04 0.34 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.665 -0.903 . . . . 0.77 109.494 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -64.65 134.59 54.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.034 -1.041 . . . . 2.4 108.647 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 mt -101.56 142.53 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.192 -0.942 . . . . 0.87 108.872 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.4 mm -78.32 124.84 37.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.295 -0.878 . . . . 1.32 110.05 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -99.18 85.9 3.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.357 -0.839 . . . . 1.54 109.368 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.442 ' O ' HD13 ' A' ' 152' ' ' ILE . 35.0 mt -80.09 -7.77 59.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.341 -0.849 . . . . 0.77 109.346 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.8 p -89.3 -11.45 43.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.226 -0.921 . . . . 1.57 109.927 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.71 44.56 1.01 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.168 -0.957 . . . . 0.82 112.485 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.539 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.5 mp -70.2 154.4 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.489 -1.382 . . . . 0.82 107.558 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -130.74 -22.5 2.65 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.324 -0.86 . . . . 2.11 109.714 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -122.38 137.48 54.85 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.485 -0.759 . . . . 1.41 109.234 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -62.41 129.81 42.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 1.3 109.912 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.7 m -151.05 175.5 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.745 . . . . 0.57 109.251 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 22.9 mt -89.88 158.17 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 107.811 -1.181 . . . . 0.43 107.811 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.1 tp -106.87 118.86 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.916 -0.772 . . . . 0.56 108.916 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.2 t -123.55 129.95 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 121.37 0.605 . . . . 0.54 109.713 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.82 147.49 10.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 0.62 109.265 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.79 73.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.686 -1.259 . . . . 0.8 107.983 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 66.1 t0 -173.63 145.74 1.23 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.482 -0.933 . . . . 2.34 108.482 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.506 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.7 mt -117.74 137.47 52.68 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.155 -0.683 . . . . 0.65 109.155 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.6 p -89.36 150.04 43.9 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.353 -0.842 . . . . 0.74 108.889 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 169' ' ' ALA . 76.6 Cg_exo -35.51 -46.54 0.82 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.393 2.062 . . . . 0.6 111.898 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 169' ' ' ALA . 38.2 m -52.86 -65.71 0.51 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.409 -0.96 . . . . 0.63 108.409 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -44.82 -44.19 9.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.622 -0.674 . . . . 1.25 109.93 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.3 p -71.85 -25.4 61.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.107 -0.995 . . . . 0.5 109.564 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 166' ' ' SER . . . -78.69 -29.71 45.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.963 . . . . 0.51 110.165 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -100.13 -4.26 30.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.271 -0.893 . . . . 1.17 109.371 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 tp -58.18 147.45 30.16 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.276 -1.009 . . . . 0.61 108.276 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.441 ' O ' HG23 ' A' ' 176' ' ' VAL . 54.8 t-20 -99.02 106.65 18.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.133 -0.979 . . . . 2.12 109.64 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.4 mm? -87.02 37.2 0.75 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -0.856 . . . . 1.34 109.177 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -109.34 -24.47 11.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.537 -0.727 . . . . 1.97 109.436 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -132.82 10.99 4.32 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 1.9 110.248 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 172' ' ' ASN . 30.9 t -79.28 154.45 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.928 -1.108 . . . . 0.48 109.161 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.402 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 13.5 tp -114.9 -19.45 10.97 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.704 -0.623 . . . . 1.39 110.189 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.46 175.1 42.6 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.857 -1.297 . . . . 0.38 109.857 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.484 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 4.4 m-85 -126.77 122.3 34.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.481 -1.011 . . . . 0.46 109.275 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.0 mt -130.33 124.39 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.501 -0.926 . . . . 0.59 108.501 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 203' ' ' VAL . 40.6 p -142.68 151.76 41.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 0.67 111.202 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.476 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 1.6 m-20 -87.3 43.77 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 2.24 108.996 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -109.11 123.52 49.31 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.413 -0.805 . . . . 1.11 110.214 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.467 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -42.96 -15.4 0.02 OUTLIER Glycine 0 N--CA 1.492 2.383 0 O-C-N 121.459 -0.776 . . . . 1.63 111.229 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 70.05 -8.85 3.33 Favored Glycine 0 N--CA 1.49 2.255 0 O-C-N 120.388 -1.654 . . . . 1.47 109.89 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.546 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.8 OUTLIER -46.92 -35.24 6.24 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -1.135 . . . . 5.24 109.177 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 76.2 p -152.68 31.57 0.51 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.694 -0.629 . . . . 2.92 109.31 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.2 t -83.84 135.45 34.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.124 -0.985 . . . . 1.6 109.56 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -70.06 -29.0 65.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.92 108.683 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 50.3 p -55.54 -41.86 73.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.391 -0.818 . . . . 1.59 109.42 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.2 t -62.48 -31.43 72.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.237 -0.914 . . . . 1.42 109.557 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.0 mm -68.33 -34.77 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.186 -0.946 . . . . 1.41 110.143 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 12.3 mtm -71.41 -54.1 11.81 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.692 -1.225 . . . . 0.86 107.692 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.86 -44.19 70.17 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.392 -0.596 . . . . 0.59 109.392 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -66.35 -46.63 76.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.15 -0.969 . . . . 3.06 109.498 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.2 m -70.0 -37.13 75.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 0.73 110.116 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 199' ' ' LEU . 26.1 mt -86.61 -0.17 55.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.042 -1.036 . . . . 0.67 109.483 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 51.05 5.19 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.268 -0.895 . . . . 1.49 110.79 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 197' ' ' LEU . 66.7 mt -66.76 139.68 95.92 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.747 -1.221 . . . . 0.64 108.65 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.08 131.64 44.65 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.711 1.607 . . . . 0.59 111.508 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -163.52 -179.21 6.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.706 -1.246 . . . . 0.55 110.787 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.487 ' CD1' HD11 ' A' ' 220' ' ' LEU . 14.7 mt -150.45 158.71 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.166 -1.42 . . . . 0.63 107.166 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.1 m -142.84 -25.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 120.771 -1.206 . . . . 0.77 110.703 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.44 27.99 5.48 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.934 -1.266 . . . . 0.87 109.934 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 207' ' ' SER . 2.9 p -57.02 -37.27 71.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.678 -1.483 . . . . 0.89 108.122 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.476 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 60.02 -35.68 0.04 OUTLIER Glycine 0 N--CA 1.492 2.402 0 C-N-CA 121.031 -0.604 . . . . 0.93 113.664 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 205' ' ' THR . 7.0 m -128.88 16.55 6.29 Favored 'General case' 0 N--CA 1.513 2.718 0 CA-C-N 119.749 1.774 . . . . 1.6 113.209 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.463 HG22 HD13 ' A' ' 2' ' ' ILE . 20.2 t -80.17 -34.76 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.072 -1.643 . . . . 0.75 110.224 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 17.2 p -71.53 -21.26 61.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.827 -1.171 . . . . 0.84 109.974 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.9 m -104.54 17.17 24.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.415 -0.803 . . . . 1.61 109.137 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -139.32 -17.87 1.01 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.364 -0.835 . . . . 2.3 110.835 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 213' ' ' LYS . 55.1 t -119.82 162.47 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.255 -0.903 . . . . 0.76 109.691 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 212' ' ' VAL . 13.5 mmtp -126.54 -176.83 3.79 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.165 -1.42 . . . . 2.01 107.165 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.466 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 10.8 p30 -77.01 149.57 35.87 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.74 -1.225 . . . . 2.19 110.357 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.7 t70 81.03 -12.89 0.97 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.151 -0.343 . . . . 2.4 110.667 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -57.76 140.68 50.98 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.794 -1.192 . . . . 1.99 108.358 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -90.66 109.97 21.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.939 -1.101 . . . . 1.3 108.91 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 7.3 mt -113.11 161.37 17.19 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.193 -0.669 . . . . 0.53 109.193 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 67.5 mt -133.39 120.1 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.617 -1.253 . . . . 0.6 107.617 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 202' ' ' ILE . 13.8 tp -87.78 127.65 35.32 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.022 -0.732 . . . . 0.57 109.022 -178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 19.5 p-10 -98.01 -30.24 12.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.267 -0.895 . . . . 2.22 109.034 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.76 24.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.387 0.613 . . . . 0.75 110.349 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.7 t -118.04 -59.0 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 106.695 -1.594 . . . . 0.92 106.695 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -94.35 13.17 24.48 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.51 -1.292 . . . . 2.36 107.51 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 55.53 62.11 2.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.154 -0.684 . . . . 1.42 109.154 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.446 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 53.7 tt0 -155.62 145.82 21.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.14 -0.975 . . . . 1.97 110.769 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 228' ' ' TYR . 76.6 t -106.52 159.98 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.074 -0.713 . . . . 0.65 109.074 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.478 ' N ' HG12 ' A' ' 227' ' ' VAL . 61.8 m-85 -124.88 114.53 19.31 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.52 -0.919 . . . . 0.97 108.52 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.1 123.8 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 0.67 109.942 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.4 t30 69.73 67.84 0.43 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.564 -0.71 . . . . 1.45 109.697 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -88.73 134.8 2.8 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 123.355 2.704 . . . . 0.82 112.267 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 38.5 p -73.51 156.95 37.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 1.62 109.393 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -65.69 -30.84 71.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 2.6 109.375 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -56.86 -43.2 80.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.564 -0.71 . . . . 3.06 109.724 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.4 t -72.93 -49.31 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 1.14 109.608 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 84.7 mt -50.57 -59.65 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.287 -0.883 . . . . 1.04 109.381 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -55.46 -36.23 66.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 2.54 110.284 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -64.76 -51.42 62.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 2.6 110.747 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 243' ' ' GLN . 9.1 mtm -79.49 -27.16 41.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.954 -1.091 . . . . 1.23 110.339 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 240' ' ' ARG . 9.9 mmm-85 -53.2 -41.56 65.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.811 -1.181 . . . . 2.67 108.785 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.1 -52.44 10.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 1.66 110.025 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.3 t -69.81 -51.06 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 2.2 110.496 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 239' ' ' MET . 1.5 tm0? -55.56 -53.2 59.4 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.841 -1.162 . . . . 3.0 110.321 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.418 ' OE1' ' O ' ' A' ' 240' ' ' ARG . 52.9 mt-10 -60.32 -20.89 61.05 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.981 -1.075 . . . . 1.76 109.397 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -65.45 -26.81 68.12 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.871 -1.529 . . . . 2.78 106.871 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.09 -43.42 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.686 -0.857 . . . . 2.06 108.686 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.59 -36.29 80.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.577 -0.702 . . . . 2.4 109.628 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -73.78 -33.31 64.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 2.87 109.002 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 . . . . . 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 3.41 108.85 179.375 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.535 ' H2 ' ' HG3' ' A' ' 226' ' ' GLN . 12.6 mmt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.315 -0.624 . . . . 3.66 109.315 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.54 94.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 1.12 109.537 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 m -93.96 118.06 30.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.292 -0.88 . . . . 1.45 109.69 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.444 ' N ' HD21 ' A' ' 225' ' ' ASN . . . -113.49 -161.12 14.3 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 108.934 -1.666 . . . . 0.92 108.934 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' LEU . 79.5 mt -92.89 -9.79 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.044 -1.268 . . . . 1.05 109.218 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.9 tp 57.54 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.971 . . . . 0.88 109.469 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.05 -55.66 3.73 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.208 -1.034 . . . . 0.78 108.208 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.82 148.11 34.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 108.694 -0.854 . . . . 1.5 108.694 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.03 150.36 29.64 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.357 2.038 . . . . 0.86 113.337 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.02 124.48 1.1 Allowed Glycine 0 N--CA 1.499 2.881 0 N-CA-C 110.17 -1.172 . . . . 0.78 110.17 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.19 135.03 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.094 -1.239 . . . . 0.74 110.066 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.5 145.52 35.29 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.397 -0.814 . . . . 0.45 110.224 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.8 m-85 -112.7 142.16 45.64 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.837 -1.172 . . . . 0.64 107.837 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.22 164.8 30.44 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.424 -1.846 . . . . 0.45 111.732 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -79.33 146.76 32.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.594 -0.945 . . . . 1.88 110.338 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.41 120.69 24.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 0.59 110.613 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 tp -102.07 91.38 4.3 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.589 -1.263 . . . . 0.64 107.589 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.99 136.81 35.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.116 -0.99 . . . . 0.74 110.166 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 mt -94.91 93.4 7.41 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.466 0.651 . . . . 0.74 110.617 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -96.83 152.01 19.11 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.533 -0.914 . . . . 1.87 108.533 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.88 145.05 51.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.196 -0.94 . . . . 2.58 109.587 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.59 134.27 35.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 2.14 109.407 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.57 136.45 55.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 1.93 109.382 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.5 mt -92.99 135.67 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.68 109.457 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.9 t -102.38 119.12 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.336 -0.853 . . . . 0.84 108.801 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.7 mt -88.74 137.92 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.809 . . . . 0.79 110.115 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -91.23 115.67 28.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.356 -0.84 . . . . 1.37 109.429 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.432 HH11 ' HG3' ' A' ' 28' ' ' ARG . 14.2 mmm-85 -97.91 27.7 4.34 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.22 -0.925 . . . . 2.62 109.259 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -82.87 147.85 28.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 2.35 109.851 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -86.74 136.68 32.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.203 -0.935 . . . . 2.35 108.747 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.9 pt -95.84 177.46 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.012 -1.055 . . . . 0.78 110.303 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 98.8 p -98.97 154.68 17.89 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.66 -0.867 . . . . 1.04 108.66 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.11 -8.45 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.064 -1.022 . . . . 1.05 109.984 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -82.86 -14.61 53.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 2.47 110.078 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -112.86 -2.99 14.22 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.32 -0.862 . . . . 1.46 109.688 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.67 -45.09 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.974 -1.079 . . . . 0.77 108.728 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -56.66 -35.12 68.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 1.46 109.121 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -69.1 -36.53 77.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 2.29 110.212 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -62.63 -45.43 92.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 1.3 109.485 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.31 -46.24 97.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.438 -0.789 . . . . 0.76 109.732 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -67.82 -42.33 81.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 1.5 108.882 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -62.86 -31.7 72.78 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.701 -0.852 . . . . 2.66 108.701 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -86.09 -55.79 3.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.75 108.692 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.7 tp -51.81 -56.54 13.34 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.135 -1.061 . . . . 0.83 108.135 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.64 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.8 t -66.46 -35.94 81.53 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.826 -1.175 . . . . 0.78 107.826 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -55.85 -54.76 32.88 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 107.609 -2.196 . . . . 0.57 107.609 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -47.66 -30.82 4.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.407 -1.054 . . . . 2.83 108.763 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.26 -32.97 70.48 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.498 -1.297 . . . . 0.65 107.498 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 46' ' ' GLY . 95.7 mttt -81.23 -62.86 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.64 -0.874 . . . . 2.57 108.64 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.4 -40.56 26.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.899 . . . . 0.51 109.598 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.4 p -62.35 -35.01 77.8 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.745 -1.205 . . . . 1.36 107.745 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.82 -21.28 60.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.589 -0.523 . . . . 0.6 109.589 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.426 HE22 HD21 ' A' ' 140' ' ' ASN . 22.8 mt-30 -76.51 -67.34 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 1.36 109.488 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.59 -39.92 51.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.117 -0.989 . . . . 1.38 108.436 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.99 -48.12 83.02 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.948 -0.76 . . . . 1.27 108.948 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.0 m -63.06 -38.86 92.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.6 108.898 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.36 -37.56 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.921 . . . . 0.53 108.546 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -51.06 -45.82 61.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.624 -0.673 . . . . 0.99 109.715 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -75.19 -23.99 57.74 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.148 -0.97 . . . . 0.59 110.427 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -72.31 -32.63 66.74 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.779 -1.201 . . . . 1.81 108.385 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.11 -26.62 42.9 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.507 -0.745 . . . . 0.48 109.241 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.27 14.35 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.707 -1.235 . . . . 0.58 110.509 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -86.22 -14.9 42.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.827 -1.396 . . . . 1.39 109.204 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.4 m -96.18 -49.0 5.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.269 -0.894 . . . . 0.82 110.654 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -106.37 -18.19 14.06 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.148 -0.97 . . . . 0.99 110.38 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.86 143.86 6.85 Favored Glycine 0 N--CA 1.502 3.086 0 N-CA-C 109.686 -1.365 . . . . 0.55 109.686 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -49.73 -7.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.469 -1.018 . . . . 2.59 110.826 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 66' ' ' GLY . 52.9 tt0 -65.78 -27.89 68.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.872 -1.143 . . . . 2.2 111.0 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -90.12 -12.24 38.87 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.799 -1.188 . . . . 1.79 110.413 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -62.8 -21.28 65.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.091 -1.005 . . . . 1.54 110.709 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.92 70.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.851 -1.156 . . . . 0.64 110.081 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.2 mt -72.52 -43.81 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.076 -1.015 . . . . 0.58 109.636 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -77.05 -26.47 53.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.851 . . . . 0.62 110.325 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.08 -44.19 93.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.903 -1.123 . . . . 1.23 109.262 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.39 -35.84 88.01 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.915 -1.674 . . . . 0.52 108.915 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -19.08 63.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.413 -1.051 . . . . 1.29 110.215 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.5 mt -83.84 -37.06 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.711 -1.243 . . . . 0.55 108.589 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.4 ttt -58.9 -53.35 59.38 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.769 -0.826 . . . . 1.89 108.769 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -52.01 -41.52 62.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.44 -0.788 . . . . 0.53 108.905 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.8 tp -68.65 -44.32 74.39 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.43 109.675 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -85.92 8.85 18.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.261 -0.899 . . . . 1.24 110.476 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -48.59 121.17 4.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.852 -1.155 . . . . 1.31 109.328 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.74 -25.69 66.63 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.286 -0.884 . . . . 1.35 108.808 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -76.99 -48.9 16.71 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.324 -0.86 . . . . 2.16 109.625 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.64 -16.69 63.16 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.575 -1.25 . . . . 0.6 108.657 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.8 -50.16 18.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.4 -0.812 . . . . 1.28 109.591 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.57 -29.31 70.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 1.28 109.134 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -74.07 -48.15 31.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 1.29 109.104 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.2 mt -57.31 -43.41 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.379 -0.971 . . . . 0.58 108.379 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.11 -61.65 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.78 110.195 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -45.23 -51.19 11.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.86 110.275 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 49.9 mt -54.1 -55.0 31.75 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.452 -0.899 . . . . 0.79 108.941 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.3 mt -51.02 -47.22 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.965 . . . . 0.71 110.377 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -81.94 -33.29 30.4 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.987 -1.071 . . . . 2.05 111.441 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.4 t70 -81.31 -45.96 15.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.769 -1.207 . . . . 1.59 111.735 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -103.91 17.85 23.24 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.628 -1.295 . . . . 1.89 109.866 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.6 m80 45.3 50.91 9.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.177 -0.952 . . . . 1.31 109.469 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.6 mtt -99.73 149.01 23.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.52 -0.738 . . . . 1.28 109.114 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.3 p -76.15 146.78 38.97 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.399 -0.813 . . . . 0.62 109.21 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.67 -29.1 10.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.47 108.702 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.37 -44.62 51.45 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.286 -1.005 . . . . 2.0 108.286 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.42 -54.45 12.34 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.313 0.577 . . . . 0.56 110.074 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.29 -50.47 72.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.48 109.365 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.08 -37.35 69.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.44 109.73 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -69.59 -35.07 75.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.046 -1.034 . . . . 1.42 109.491 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 109' ' ' GLU . 33.4 tt0 -62.28 -58.35 8.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 1.26 109.612 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.3 t -50.28 -47.11 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.977 -1.077 . . . . 0.61 109.221 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.3 mm -65.13 -15.65 18.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.376 -0.828 . . . . 0.64 109.007 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 106' ' ' GLU . 24.7 tt0 -75.28 -37.0 61.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 2.2 109.706 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.56 -26.5 29.85 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.491 -1.338 . . . . 0.82 112.174 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -67.58 -37.91 83.27 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.614 -1.521 . . . . 1.27 108.952 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.34 -51.36 7.03 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.671 -0.643 . . . . 0.91 109.581 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.0 p -60.47 -42.79 96.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.317 -0.865 . . . . 1.73 110.141 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.0 -38.41 90.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.976 -1.078 . . . . 1.04 110.339 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 115' ' ' LEU . 71.2 mt -67.72 -26.86 66.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.852 -1.155 . . . . 1.03 109.438 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -69.48 -20.45 63.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.035 -1.04 . . . . 1.95 109.607 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -81.36 -6.85 59.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 1.71 109.183 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 mt -85.7 143.18 28.51 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.244 -1.021 . . . . 1.26 108.244 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -96.66 62.04 1.94 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.271 -0.893 . . . . 2.83 109.024 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -148.96 115.22 5.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.221 -0.924 . . . . 1.58 109.621 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.82 -13.08 3.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 2.8 109.433 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.504 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 1.0 OUTLIER -79.92 -63.79 1.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 1.02 109.375 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.6 mt -68.09 -30.81 70.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.215 -0.928 . . . . 1.06 109.444 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 68.5 tttt -67.01 -51.64 52.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.956 . . . . 2.39 109.337 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -57.86 -23.11 51.48 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.195 -0.94 . . . . 2.2 108.995 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.504 ' NH2' ' OH ' ' A' ' 122' ' ' TYR . 18.6 ttm180 -73.41 -24.71 60.31 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.408 -1.701 . . . . 2.09 106.408 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.08 -42.86 91.42 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.629 -0.878 . . . . 0.86 108.629 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.71 80.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.436 -0.79 . . . . 0.9 109.876 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.13 -25.32 65.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 1.35 109.529 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.2 t -76.61 -42.62 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.163 -0.961 . . . . 0.58 108.444 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' A' ' 131' ' ' ARG . 16.6 ttm-85 -57.0 -37.69 72.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.223 -0.923 . . . . 3.22 108.68 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -61.06 -38.37 85.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.508 -0.745 . . . . 1.32 110.319 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.8 mt -67.97 -26.83 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.018 -1.051 . . . . 0.5 109.975 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.5 -44.08 8.87 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.632 -1.387 . . . . 0.44 109.632 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.419 ' HZ2' ' HD2' ' A' ' 139' ' ' ARG . 43.5 tttm -50.92 -51.68 49.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.371 -1.076 . . . . 2.71 109.642 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.544 ' CG ' HH11 ' A' ' 136' ' ' ARG . 4.5 mtt-85 -63.9 -46.21 85.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.109 -0.994 . . . . 2.2 108.361 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 36.9 tp -49.83 -38.38 34.66 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.054 -0.721 . . . . 1.13 109.054 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.8 mt -70.5 -55.01 9.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.54 109.495 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.419 ' HD2' ' HZ2' ' A' ' 135' ' ' LYS . 47.2 mtp180 -53.49 -17.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 2.32 110.293 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.464 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 2.4 m120 -85.02 -47.4 10.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.992 -1.067 . . . . 1.26 109.204 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.27 -37.88 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.899 . . . . 0.62 109.118 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.83 -3.11 58.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.67 108.693 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.32 22.62 15.53 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.303 -1.919 . . . . 0.68 108.303 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 31.6 tp -55.58 154.3 6.78 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.625 -0.927 . . . . 0.77 109.297 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -66.76 147.55 53.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 2.4 109.683 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.8 mt -109.05 145.79 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.517 -0.739 . . . . 0.87 109.349 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.7 mm -76.34 119.46 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 1.32 108.625 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 0.7 OUTLIER -94.79 87.03 4.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.255 -0.903 . . . . 1.54 109.918 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.9 mt -81.6 -10.33 59.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.77 109.14 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.1 p -80.65 -12.18 59.53 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.273 -0.892 . . . . 1.57 109.461 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -103.56 49.95 0.82 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.473 -0.767 . . . . 0.82 110.53 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 153' ' ' GLN . 26.8 mm -71.2 164.12 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.812 -1.18 . . . . 0.82 108.71 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.492 ' N ' HG22 ' A' ' 152' ' ' ILE . 10.9 mt-30 -132.88 -33.1 1.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.351 -0.843 . . . . 2.11 109.768 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -115.0 145.52 42.18 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.5 -0.75 . . . . 1.41 109.614 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -66.95 126.66 29.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.415 -0.803 . . . . 1.3 109.232 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.4 m -148.97 172.38 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.154 -0.966 . . . . 0.57 109.668 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 158' ' ' LEU . 53.5 mt -90.66 163.59 2.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.609 -1.256 . . . . 0.43 107.609 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.494 ' N ' HG22 ' A' ' 157' ' ' ILE . 12.7 tp -111.89 123.83 51.09 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.589 -0.694 . . . . 0.56 109.404 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.8 t -123.46 129.7 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.148 -0.686 . . . . 0.54 109.148 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.29 146.14 11.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.62 109.671 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.436 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.94 -27.25 66.63 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.601 -1.312 . . . . 0.8 107.468 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -175.47 157.94 2.2 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.64 -0.663 . . . . 2.34 109.215 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 22.6 mt -129.88 131.03 45.92 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.439 -0.788 . . . . 0.65 109.321 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.0 p -94.59 153.28 40.28 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.285 -0.884 . . . . 0.74 109.409 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -35.68 -41.78 0.46 Allowed 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.541 2.16 . . . . 0.6 112.354 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.9 m -62.2 -56.29 20.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.162 -0.961 . . . . 0.63 109.112 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -53.73 -31.19 47.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.427 -0.796 . . . . 1.25 109.526 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.5 HG21 ' CD2' ' A' ' 189' ' ' HIS . 28.3 p -82.49 -31.54 29.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.5 109.539 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.82 -23.92 58.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.51 109.966 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -105.26 -6.0 20.11 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.145 -0.972 . . . . 1.17 109.414 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.08 156.0 5.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.226 -1.027 . . . . 0.61 108.226 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 176' ' ' VAL . 52.2 t-20 -97.9 97.19 8.74 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.136 -0.978 . . . . 2.12 109.564 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.745 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.6 mm? -82.05 26.23 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 1.34 109.193 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -112.44 -18.13 12.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.421 -0.799 . . . . 1.97 109.103 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -131.26 -1.32 4.01 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.47 -0.769 . . . . 1.9 110.133 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 172' ' ' ASN . 39.3 t -78.95 151.54 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.874 -1.141 . . . . 0.48 109.543 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.3 tp -121.33 -9.01 9.12 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.8 -0.562 . . . . 1.39 110.269 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.44 176.5 41.22 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.561 -1.304 . . . . 0.38 110.069 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.82 130.35 35.94 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.517 -0.99 . . . . 0.46 110.086 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.437 ' CG2' HG21 ' A' ' 205' ' ' THR . 8.1 mt -129.56 120.05 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.01 -1.107 . . . . 0.59 108.01 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 203' ' ' VAL . 64.1 p -141.67 152.45 43.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.213 -0.929 . . . . 0.67 110.868 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 21.4 p30 -89.45 43.83 1.17 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.088 -1.008 . . . . 2.24 110.715 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -94.5 103.63 15.59 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.878 -1.139 . . . . 1.11 108.799 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.19 43.06 2.43 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.843 -1.17 . . . . 1.63 110.414 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -108.39 109.21 2.82 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.805 -1.318 . . . . 1.47 109.805 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -52.19 -23.8 6.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.105 -1.232 . . . . 5.24 108.169 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.2 p -116.52 45.16 1.86 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.748 -0.834 . . . . 2.92 108.748 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 40.7 p -81.23 142.25 33.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 1.6 109.31 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.5 ' CD2' HG21 ' A' ' 168' ' ' THR . 5.3 t60 -47.56 -53.06 15.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 0.92 109.671 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 190' ' ' THR . 0.1 OUTLIER -47.1 -44.15 21.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 1.59 109.987 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 38.6 t -59.71 -37.43 78.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.01 . . . . 1.42 110.34 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 31.4 mm -60.43 -34.36 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.098 -1.001 . . . . 1.41 110.397 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.2 mtp -71.67 -52.05 19.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.902 -1.124 . . . . 0.86 108.288 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.19 -30.99 51.67 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.722 -0.672 . . . . 0.59 110.277 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -81.26 -47.76 12.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.066 -1.021 . . . . 3.06 110.416 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.9 m -67.57 -37.1 82.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.933 -1.104 . . . . 0.73 110.112 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 199' ' ' LEU . 15.9 mt -86.18 -0.13 54.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.981 -1.074 . . . . 0.67 109.105 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 56.81 0.37 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.396 -0.815 . . . . 1.49 112.015 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.1 mt -67.42 170.77 6.03 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.472 -1.393 . . . . 0.64 108.897 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -90.97 142.78 3.2 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.513 2.142 . . . . 0.59 111.199 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.1 -178.19 5.88 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.562 -1.337 . . . . 0.55 110.857 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.9 mt -149.69 158.48 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.962 -1.496 . . . . 0.63 106.962 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.525 ' O ' ' O ' ' A' ' 181' ' ' THR . 19.5 m -137.93 -32.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.989 -1.069 . . . . 0.77 111.434 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.34 42.54 3.16 Favored Glycine 0 N--CA 1.496 2.653 0 O-C-N 120.579 -1.326 . . . . 0.87 110.727 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.437 HG21 ' CG2' ' A' ' 180' ' ' ILE . 60.8 p -71.39 -21.15 62.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.602 -1.528 . . . . 0.89 109.297 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.452 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 71.75 -97.43 0.72 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.843 -1.17 . . . . 0.93 111.814 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 66.7 m -115.42 45.86 1.59 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.969 -1.312 . . . . 1.6 112.743 -175.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 17.7 t -79.93 -27.19 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.601 -1.312 . . . . 0.75 107.636 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.433 ' H ' HG23 ' A' ' 209' ' ' THR . 1.4 p -73.67 -11.21 60.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.367 -0.833 . . . . 0.84 109.7 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 13.8 p -101.53 6.4 42.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.36 -0.837 . . . . 1.61 109.405 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -130.47 -3.58 4.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.399 -0.813 . . . . 2.3 109.203 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.0 t -125.81 152.59 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.055 -0.72 . . . . 0.76 109.055 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -118.68 -173.79 2.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.852 -1.536 . . . . 2.01 106.852 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 22.7 t-20 -80.03 145.42 32.51 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.818 -1.176 . . . . 2.19 111.202 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.46 -7.4 1.46 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.839 -0.538 . . . . 2.4 110.843 178.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.29 138.05 55.28 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.875 -1.141 . . . . 1.99 108.446 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -86.38 115.98 24.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.038 -1.039 . . . . 1.3 108.655 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.6 mt -117.99 179.1 4.19 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.374 1.083 . . . . 0.53 110.806 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.8 mt -146.93 107.92 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.387 -1.338 . . . . 0.6 107.387 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 tp -83.21 128.4 34.46 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.32 -0.993 . . . . 0.57 108.32 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -52.6 4.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 2.22 109.82 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 57.54 22.74 8.44 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.339 -0.85 . . . . 0.75 108.77 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.06 -49.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 107.295 -1.372 . . . . 0.92 107.295 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -106.95 12.14 29.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.936 -1.135 . . . . 2.36 107.936 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.444 HD21 ' N ' ' A' ' 4' ' ' GLY . 59.0 t30 58.35 58.21 3.54 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.056 -0.72 . . . . 1.42 109.056 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.535 ' HG3' ' H2 ' ' A' ' 1' ' ' MET . 17.4 tt0 -153.75 146.99 24.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.926 . . . . 1.97 109.918 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.63 136.62 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.67 -0.644 . . . . 0.65 109.386 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -105.03 127.38 52.84 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.384 -0.822 . . . . 0.97 109.2 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.58 127.89 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.516 -0.74 . . . . 0.67 109.864 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 49.05 69.96 2.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.857 . . . . 1.45 109.989 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.5 153.44 13.73 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.78 2.32 . . . . 0.82 111.64 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.5 p -73.93 169.59 17.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.979 . . . . 1.62 109.98 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.53 -27.76 65.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.852 . . . . 2.6 109.579 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.13 -38.65 91.33 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.418 -0.801 . . . . 3.06 109.537 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.09 -46.31 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 1.14 109.341 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.7 mt -52.05 -55.84 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 1.04 109.356 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -54.91 -44.83 74.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 2.54 109.972 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.45 ' O ' HG23 ' A' ' 242' ' ' VAL . 50.8 tttm -67.54 -37.75 83.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 2.6 110.144 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 51.9 mtp -80.16 -25.92 39.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 1.23 109.706 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.469 ' HE ' ' CA ' ' A' ' 240' ' ' ARG . 0.0 OUTLIER -60.16 -51.86 67.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.179 -0.951 . . . . 2.67 109.853 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.71 -54.94 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 1.66 109.771 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 238' ' ' LYS . 84.5 t -49.03 -53.02 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 2.2 109.511 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -55.29 6.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.249 -0.907 . . . . 3.0 109.981 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -63.21 -35.62 80.92 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.122 -0.986 . . . . 1.76 110.499 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -68.91 -20.15 64.23 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.968 -1.082 . . . . 2.78 108.408 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.5 t -83.5 -31.44 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.679 -0.86 . . . . 2.06 108.679 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.8 -36.16 77.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.441 -0.787 . . . . 2.4 109.17 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.6 t -78.31 -29.37 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.335 -0.853 . . . . 2.87 109.314 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.306 -0.871 . . . . 3.41 109.555 -179.827 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.451 -0.574 . . . . 3.66 109.451 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 208' ' ' VAL . 74.3 mt -60.67 98.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.872 . . . . 1.12 109.475 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.0 m -93.37 114.67 27.15 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 1.45 109.619 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.72 -163.15 19.53 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.784 -1.726 . . . . 0.92 108.784 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 5' ' ' ILE . 63.4 mt -96.48 -9.46 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.039 -1.271 . . . . 1.05 108.789 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.2 tp 59.42 110.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.416 -0.803 . . . . 0.88 109.151 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -89.77 -49.66 6.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.081 -1.081 . . . . 0.78 108.081 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -150.43 152.15 32.41 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.371 -0.83 . . . . 1.5 109.383 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.08 155.89 29.92 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.585 2.19 . . . . 0.86 112.504 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 144.26 121.84 1.55 Allowed Glycine 0 N--CA 1.504 3.169 0 N-CA-C 110.232 -1.147 . . . . 0.78 110.232 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.49 139.48 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.094 -1.239 . . . . 0.74 110.22 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.61 159.86 41.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.324 -0.86 . . . . 0.45 109.68 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.595 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -130.39 135.79 48.4 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.107 -1.072 . . . . 0.64 108.107 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 166.6 37.14 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 118.601 -1.762 . . . . 0.45 111.723 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -79.61 149.78 31.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.739 -0.859 . . . . 1.88 110.392 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -76.37 125.02 28.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.39 -0.819 . . . . 0.59 110.992 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.1 tp -110.79 93.15 4.34 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.174 -1.417 . . . . 0.64 107.174 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -81.79 126.83 32.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.04 -1.037 . . . . 0.74 110.996 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.3 mt -101.94 94.44 5.79 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.609 -0.723 . . . . 0.74 110.316 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -94.62 158.54 15.48 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.358 -0.979 . . . . 1.87 108.358 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -130.18 125.4 34.89 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.384 -0.823 . . . . 2.58 109.506 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 6.5 p-10 -80.27 130.2 35.03 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.32 -0.862 . . . . 2.14 109.008 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.64 148.87 50.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 1.93 109.235 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.5 136.73 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 0.68 109.145 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -103.11 121.05 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.369 -0.832 . . . . 0.84 109.047 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.7 mt -87.14 132.98 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.386 -0.821 . . . . 0.79 109.729 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -91.5 122.46 34.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 1.37 108.724 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.527 HH11 ' HG2' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -98.36 27.41 4.73 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.241 -0.912 . . . . 2.62 109.887 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -81.01 143.33 32.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 2.35 109.277 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -86.37 126.27 34.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.146 -0.971 . . . . 2.35 109.416 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 pt -85.24 176.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 0.78 109.6 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.9 p -95.58 173.96 7.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.79 . . . . 1.04 109.478 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.29 -25.89 63.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -0.959 . . . . 1.05 109.551 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 3.3 m-20 -79.97 2.57 23.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 2.47 108.617 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -116.75 -17.02 10.6 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.507 -0.924 . . . . 1.46 108.507 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.9 t -66.61 -46.45 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.46 -0.775 . . . . 0.77 109.382 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.2 -35.65 67.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.887 . . . . 1.46 109.626 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -69.07 -33.5 73.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.389 -0.819 . . . . 2.29 110.267 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.2 -37.9 89.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.959 -1.088 . . . . 1.3 109.362 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -62.9 -47.31 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.359 -0.838 . . . . 0.76 110.058 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.31 -41.29 85.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.136 -0.977 . . . . 1.5 109.086 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -60.44 -34.27 73.73 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.244 -0.91 . . . . 2.66 109.092 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 28.1 t80 -86.83 -55.3 3.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.138 -0.976 . . . . 0.75 109.407 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.39 -63.8 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.83 110.081 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 12.9 t -66.48 -37.91 86.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.78 108.856 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.95 -52.63 47.7 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.672 -2.171 . . . . 0.57 107.672 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -53.7 -22.55 9.31 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.648 -0.913 . . . . 2.83 109.431 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -64.11 -45.08 90.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.101 -0.999 . . . . 0.65 108.648 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 50' ' ' ALA . 28.7 pttt -78.41 -51.84 9.45 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.352 -0.939 . . . . 2.57 109.296 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' H ' ' HG3' ' A' ' 49' ' ' LYS . . . -50.76 -41.1 56.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.561 -1.337 . . . . 0.51 109.325 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t -62.43 -33.56 75.05 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.613 -1.254 . . . . 1.36 107.613 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.88 -28.31 62.42 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.037 -0.727 . . . . 0.6 109.037 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -73.6 -62.97 1.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.372 -0.83 . . . . 1.36 109.093 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 54' ' ' LEU . 10.8 mp -49.71 -38.04 31.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.995 -1.066 . . . . 1.38 108.297 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.35 -41.64 98.87 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.326 -0.991 . . . . 1.27 108.326 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 m -62.97 -39.28 94.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.455 -0.778 . . . . 0.6 109.007 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.08 -39.6 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.574 -0.899 . . . . 0.53 108.574 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -49.2 -42.04 38.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -0.785 . . . . 0.99 109.571 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -71.27 -38.76 71.84 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.066 -1.022 . . . . 0.59 109.796 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -69.88 -14.9 62.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.866 -1.134 . . . . 1.81 107.999 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.91 -36.03 21.73 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.51 -0.922 . . . . 0.48 108.51 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.08 -27.86 29.95 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.199 -1.16 . . . . 0.58 110.199 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -85.86 -15.59 41.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.008 -1.29 . . . . 1.39 109.38 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.7 m -94.49 -48.22 6.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.176 -0.952 . . . . 0.82 110.325 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -106.37 -17.54 14.25 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.164 -0.96 . . . . 0.99 110.537 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.93 143.84 6.83 Favored Glycine 0 N--CA 1.502 3.042 0 N-CA-C 109.706 -1.357 . . . . 0.55 109.706 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -51.26 -8.6 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -1.058 . . . . 2.59 110.572 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.461 ' H ' ' C ' ' A' ' 66' ' ' GLY . 97.7 mt-10 -65.69 -24.17 66.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.955 -1.091 . . . . 2.2 110.474 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -91.45 -13.75 31.73 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.926 -1.109 . . . . 1.79 110.739 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -62.92 -18.71 63.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.92 -1.113 . . . . 1.54 110.815 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.12 -37.16 85.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.913 -1.117 . . . . 0.64 110.04 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.446 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 27.3 mt -73.14 -38.79 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.965 . . . . 0.58 109.91 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -78.41 -22.34 47.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.62 109.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -64.48 -48.27 75.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.201 -0.937 . . . . 1.23 109.111 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.07 -32.01 76.03 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.425 -1.47 . . . . 0.52 109.425 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.446 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 32.5 m170 -61.69 -23.31 66.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -1.15 . . . . 1.29 110.004 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.1 mt -85.28 -39.02 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.901 -1.125 . . . . 0.55 108.825 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.4 ttt -59.04 -46.7 87.57 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.578 -0.897 . . . . 1.89 108.578 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tp -58.71 -40.03 82.5 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.545 -0.722 . . . . 0.53 109.062 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -67.03 -45.92 76.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.271 -0.893 . . . . 0.43 109.395 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -84.57 9.04 14.68 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.302 -0.874 . . . . 1.24 110.546 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -51.83 120.98 5.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.955 -1.091 . . . . 1.31 109.231 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -67.74 -21.76 65.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -0.95 . . . . 1.35 108.947 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.35 -47.44 23.44 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.327 -0.858 . . . . 2.16 109.185 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.1 mt -64.06 -18.83 64.75 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.223 -0.991 . . . . 0.6 108.93 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -81.79 -41.32 21.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.388 -0.82 . . . . 1.28 109.725 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -63.06 -33.32 75.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 1.28 109.469 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -74.07 -42.57 59.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 1.29 109.004 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.2 mt -59.57 -58.82 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.219 -1.03 . . . . 0.58 108.219 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.4 mt -42.86 -64.36 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.758 -0.589 . . . . 0.78 110.164 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.0 -49.78 15.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 0.86 110.135 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 mt -56.4 -57.14 13.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -0.842 . . . . 0.79 109.328 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.3 -38.39 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.071 -1.018 . . . . 0.71 110.169 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -86.53 -37.62 18.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.096 -1.002 . . . . 2.05 112.105 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -82.1 -38.72 24.42 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.79 -1.194 . . . . 1.59 111.691 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 97' ' ' HIS . 60.5 mmtt -105.45 14.1 29.2 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.806 -1.184 . . . . 1.89 109.612 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 96' ' ' LYS . 77.4 m80 44.55 44.5 7.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.377 -0.827 . . . . 1.31 109.365 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.3 mtt -95.59 153.04 17.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.472 -0.768 . . . . 1.28 109.195 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.2 p -77.17 142.34 39.69 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.565 -0.71 . . . . 0.62 109.595 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.47 -26.85 2.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.401 -0.812 . . . . 0.47 109.68 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.0 -43.67 43.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.118 -0.989 . . . . 2.0 108.376 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.74 -55.36 7.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.731 -0.606 . . . . 0.56 110.407 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.57 -50.02 71.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.983 . . . . 0.48 110.057 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.89 -30.8 62.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -0.937 . . . . 0.44 109.797 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -69.98 -25.62 63.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.011 -1.056 . . . . 1.42 109.364 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -68.67 -60.7 2.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -0.922 . . . . 1.26 109.86 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -51.91 -48.16 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.929 -1.107 . . . . 0.61 109.407 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.9 mm -63.42 -21.94 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.64 109.694 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -69.26 -34.64 75.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.976 -1.078 . . . . 2.2 109.543 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.27 -23.54 40.18 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.559 -1.305 . . . . 0.82 112.293 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -68.3 -42.94 78.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.52 -1.576 . . . . 1.27 108.854 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.93 -49.18 14.65 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.214 -0.661 . . . . 0.91 109.214 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.6 t -60.46 -45.89 92.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.404 -0.81 . . . . 1.73 109.785 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.6 78.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -1.0 . . . . 1.04 110.344 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 mt -68.43 -28.85 67.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.864 -1.147 . . . . 1.03 109.186 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -70.38 -17.6 63.04 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.189 -0.945 . . . . 1.95 109.404 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -80.97 -6.19 58.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 1.71 109.437 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 123' ' ' LEU . 3.3 mt -84.01 142.86 30.16 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.277 -1.009 . . . . 1.26 108.277 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -94.34 57.62 2.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 2.83 108.55 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -148.61 116.41 6.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 1.58 109.267 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.92 -11.33 7.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 2.8 109.725 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -78.85 -64.11 1.26 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.296 -0.877 . . . . 1.02 109.286 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 118' ' ' LEU . 26.3 mt -63.17 -23.43 67.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.009 -1.057 . . . . 1.06 109.26 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 127' ' ' ALA . 40.6 tttm -66.78 -50.59 62.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.094 -1.004 . . . . 2.39 108.36 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -55.1 -22.99 18.43 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.442 -0.947 . . . . 2.2 108.442 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.602 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -72.74 -27.09 61.82 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.867 -1.531 . . . . 2.09 106.867 177.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.53 -41.81 86.37 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.561 -0.903 . . . . 0.86 108.561 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.66 -43.8 75.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.508 -0.745 . . . . 0.9 109.83 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.74 -21.19 66.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 1.35 109.528 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 t -78.07 -48.7 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.185 -0.947 . . . . 0.58 108.562 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -54.8 -34.99 63.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.05 -1.031 . . . . 3.22 108.587 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.57 -46.74 88.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.421 -0.799 . . . . 1.32 110.224 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.05 -30.56 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.924 -1.11 . . . . 0.5 108.966 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.68 -48.4 7.96 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.821 -1.712 . . . . 0.44 108.821 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -56.03 -49.82 72.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.444 -1.033 . . . . 2.71 109.466 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.505 HH11 ' HG2' ' A' ' 136' ' ' ARG . 9.8 mtt-85 -63.6 -49.93 71.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.231 -1.026 . . . . 2.2 108.231 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 40.2 tp -48.0 -35.15 10.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 1.13 109.267 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.04 -48.19 58.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.157 -0.965 . . . . 0.54 109.55 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -53.99 -18.99 4.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 2.32 110.71 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 29.4 m-80 -84.72 -38.87 19.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.868 -1.145 . . . . 1.26 109.121 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.9 mt -67.82 -35.29 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.62 109.05 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.21 -1.7 57.21 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.876 -0.787 . . . . 0.67 108.876 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.33 25.75 60.77 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.263 -1.935 . . . . 0.68 108.263 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.35 133.79 47.28 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.533 -0.98 . . . . 0.77 109.499 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.68 141.96 57.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 2.4 109.028 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 147' ' ' ILE . 92.0 mt -104.02 163.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.602 -0.888 . . . . 0.87 108.602 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.516 ' N ' HG22 ' A' ' 146' ' ' ILE . 4.2 mp -77.93 128.53 38.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.026 -1.046 . . . . 1.32 108.984 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -97.09 84.82 3.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.327 -0.858 . . . . 1.54 109.584 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.3 mt -82.57 -20.12 37.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.885 . . . . 0.77 109.206 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -79.66 7.01 9.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.069 -1.019 . . . . 1.57 109.304 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -118.82 23.39 11.46 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.556 -0.715 . . . . 0.82 109.369 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.87 144.57 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.82 109.725 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -137.63 8.14 2.82 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.91 -0.774 . . . . 2.11 108.91 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -123.64 119.5 30.02 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.76 -0.83 . . . . 1.41 108.76 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.67 121.05 13.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.283 -0.886 . . . . 1.3 109.488 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.2 m -150.05 177.45 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.57 108.952 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.2 mt -88.56 151.3 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.176 -1.046 . . . . 0.43 108.176 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.76 117.87 35.25 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.533 0.682 . . . . 0.56 109.414 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.5 t -124.06 132.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.718 -0.845 . . . . 0.54 108.718 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.56 153.08 14.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.803 . . . . 0.62 109.801 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.53 86.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.641 -1.287 . . . . 0.8 107.915 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -174.42 156.88 2.58 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.463 -0.773 . . . . 2.34 109.758 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 27.3 mt -130.84 137.7 49.51 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.538 -0.726 . . . . 0.65 109.499 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.9 p -93.72 153.57 41.1 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.227 -0.921 . . . . 0.74 109.178 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -34.3 -46.82 0.52 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.735 2.29 . . . . 0.6 112.938 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 169' ' ' ALA . 69.1 m -50.77 -65.76 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.012 . . . . 0.63 109.262 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -48.36 -37.4 16.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.341 -0.849 . . . . 1.25 109.737 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 12.3 p -75.87 -21.71 56.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.5 109.484 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 166' ' ' SER . . . -80.81 -21.14 41.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.51 110.153 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -107.14 -19.83 13.49 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.318 -0.864 . . . . 1.17 109.859 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.31 149.99 27.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.61 109.112 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -97.01 158.01 15.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.976 . . . . 2.12 108.525 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.3 mp -96.37 -40.58 9.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.161 -0.962 . . . . 1.34 110.782 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -80.13 -13.64 59.11 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.706 -1.246 . . . . 1.97 111.603 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -94.01 -5.11 48.29 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.605 -1.309 . . . . 1.9 108.469 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 178' ' ' GLY . 42.9 t -102.14 155.27 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.045 -0.724 . . . . 0.48 109.045 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.7 tp -113.75 -18.43 11.85 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.967 -0.753 . . . . 1.39 108.967 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.482 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.53 171.29 40.08 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.947 -1.661 . . . . 0.38 108.947 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 4.2 m-85 -126.94 124.11 38.75 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.507 -0.996 . . . . 0.46 109.623 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.2 mt -125.75 117.35 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.367 -1.346 . . . . 0.59 107.367 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 203' ' ' VAL . 17.4 p -140.78 151.84 44.75 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.229 -0.919 . . . . 0.67 112.388 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.513 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 6.7 t0 -82.03 40.78 0.63 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.517 0.675 . . . . 2.24 109.621 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -100.65 102.41 13.54 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.29 -1.506 . . . . 1.11 110.9 -178.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -40.73 -20.0 0.03 OUTLIER Glycine 0 N--CA 1.498 2.772 0 O-C-N 121.208 -0.932 . . . . 1.63 110.917 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 106.69 -11.66 42.16 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 121.138 -1.213 . . . . 1.47 110.348 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.417 ' HG3' HH11 ' A' ' 186' ' ' ARG . 24.6 ttm-85 -48.08 -47.18 34.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.932 -1.334 . . . . 5.24 109.343 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 21.4 p -144.49 48.53 1.35 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.529 -0.915 . . . . 2.92 108.529 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.2 t -87.41 105.26 17.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.479 -0.763 . . . . 1.6 110.7 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -62.6 -24.71 67.71 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.034 -1.098 . . . . 0.92 108.034 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.8 m -61.59 -43.75 98.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.053 -0.721 . . . . 1.59 109.053 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.1 p -57.44 -32.2 66.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 1.42 109.315 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.7 mm -71.19 -31.84 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 1.41 109.754 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.7 mtp -71.84 -56.86 4.96 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.776 -1.194 . . . . 0.86 107.776 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.89 -38.72 73.19 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.641 -0.709 . . . . 0.59 110.408 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -70.17 -50.81 36.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.08 -1.012 . . . . 3.06 110.176 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.6 m -69.25 -36.87 77.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.266 -0.896 . . . . 0.73 109.794 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 199' ' ' LEU . 14.9 mt -92.86 2.55 56.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.264 -0.898 . . . . 0.67 109.319 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 48.92 11.81 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.344 -0.847 . . . . 1.49 110.829 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 197' ' ' LEU . 84.2 mt -66.72 145.93 99.0 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.777 -1.202 . . . . 0.64 109.083 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.03 133.43 53.29 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.73 1.62 . . . . 0.59 111.099 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -162.79 171.84 16.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.421 -1.424 . . . . 0.55 111.4 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.418 ' CD1' HD11 ' A' ' 220' ' ' LEU . 65.9 mt -146.95 156.87 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.434 -1.691 . . . . 0.63 106.434 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.545 ' O ' ' O ' ' A' ' 181' ' ' THR . 29.9 m -140.66 -34.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 120.794 -1.191 . . . . 0.77 110.735 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.1 39.92 1.43 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.326 -1.91 . . . . 0.87 108.326 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' ' 203' ' ' VAL . 16.6 p -68.53 -6.14 23.62 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.415 -1.05 . . . . 0.89 109.46 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 49.74 -103.11 0.07 OUTLIER Glycine 0 N--CA 1.483 1.768 0 C-N-CA 119.709 -1.234 . . . . 0.93 110.149 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 12.3 p -115.81 51.17 0.96 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.197 -1.178 . . . . 1.6 112.152 -176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.407 HG22 HD13 ' A' ' 2' ' ' ILE . 12.0 t -72.44 -25.72 23.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.145 -1.428 . . . . 0.75 107.145 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.6 p -70.51 -10.99 60.62 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.617 -0.882 . . . . 0.84 108.617 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.3 t -104.2 12.27 34.0 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.445 -0.946 . . . . 1.61 108.445 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -133.83 -27.27 1.49 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.689 -0.632 . . . . 2.3 109.598 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 213' ' ' LYS . 70.2 t -111.54 154.43 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.516 -0.74 . . . . 0.76 109.506 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.496 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 25.2 mmtp -123.8 -178.88 4.18 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.559 -1.645 . . . . 2.01 106.559 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.488 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.5 p-10 -79.97 149.38 30.82 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.73 -1.231 . . . . 2.19 110.234 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 t70 81.49 -14.99 0.76 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.889 -0.507 . . . . 2.4 110.664 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 73.7 m-20 -59.65 142.78 52.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.787 -1.196 . . . . 1.99 108.997 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -90.08 109.13 20.2 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.08 -1.012 . . . . 1.3 109.218 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 2.2 mt -108.39 172.23 6.96 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.927 0.87 . . . . 0.53 109.714 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.9 mt -143.71 116.6 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.559 -1.274 . . . . 0.6 107.559 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.418 HD11 ' CD1' ' A' ' 202' ' ' ILE . 23.3 tp -84.79 127.06 33.94 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.161 -0.962 . . . . 0.57 108.737 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 4.8 p-10 -89.22 -36.16 15.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.087 -1.008 . . . . 2.22 109.119 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.539 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 44.58 21.57 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.542 -0.724 . . . . 0.75 110.142 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 221' ' ' ASP . 28.2 t -122.62 -61.4 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.754 -1.202 . . . . 0.92 107.754 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -91.99 17.07 9.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.396 -0.964 . . . . 2.36 108.396 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 53.91 56.32 7.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.67 -0.644 . . . . 1.42 109.928 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.445 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 69.2 mt-30 -152.96 144.32 23.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.191 -0.943 . . . . 1.97 110.351 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 92.7 t -99.48 151.56 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.994 -1.113 . . . . 0.65 107.994 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -122.41 120.85 35.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.378 -0.826 . . . . 0.97 109.216 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.3 t -104.93 120.32 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.455 -0.778 . . . . 0.67 109.642 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 48.29 65.55 6.9 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 1.45 109.915 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.89 165.16 24.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.782 2.322 . . . . 0.82 111.976 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.8 p -75.43 142.46 43.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 1.62 109.388 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -54.41 -14.85 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 2.6 109.243 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -72.84 -38.18 67.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -0.794 . . . . 3.06 109.463 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.01 -41.25 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 1.14 109.005 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.1 mt -55.85 -55.48 17.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.403 -0.81 . . . . 1.04 109.593 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -53.1 -40.02 63.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 2.54 109.849 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -66.91 -37.66 84.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.293 -0.879 . . . . 2.6 110.119 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 46.7 mtp -82.82 -25.26 32.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.154 -0.966 . . . . 1.23 110.028 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 12.3 mmm-85 -59.91 -45.91 91.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.134 -0.979 . . . . 2.67 109.74 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.79 -48.97 22.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 1.66 110.178 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.79 -55.3 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.072 -1.017 . . . . 2.2 110.027 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -44.93 -57.27 3.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 3.0 110.148 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.76 -24.72 67.88 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.487 -0.758 . . . . 1.76 110.142 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -67.59 -22.83 65.35 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.484 -1.302 . . . . 2.78 107.484 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.2 t -75.25 -42.64 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.593 -0.891 . . . . 2.06 108.593 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.78 -27.54 68.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.728 -0.842 . . . . 2.4 108.728 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 7.9 t -76.37 -26.51 55.74 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.518 -0.739 . . . . 2.87 109.169 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 3.41 109.341 179.842 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.518 ' O ' ' N ' ' A' ' 3' ' ' SER . 49.1 mtm . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.589 -0.523 . . . . 3.66 109.589 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 53.3 mt -53.44 89.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 1.12 108.915 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 1' ' ' MET . 70.1 m -95.94 119.34 34.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.327 -0.858 . . . . 1.45 109.955 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.34 -158.53 12.41 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.446 -1.861 . . . . 0.92 108.446 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.513 ' O ' ' O ' ' A' ' 6' ' ' LEU . 56.4 mt -97.77 -11.41 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.155 -1.203 . . . . 1.05 108.24 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' A' ' 5' ' ' ILE . 13.4 tp 50.87 109.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.591 0.71 . . . . 0.88 109.376 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.36 -50.12 8.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.717 -1.239 . . . . 0.78 109.543 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.88 150.26 45.56 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.266 -0.896 . . . . 1.5 109.431 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.48 152.84 30.31 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.383 2.056 . . . . 0.86 113.52 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 153.9 121.4 0.81 Allowed Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.319 -1.112 . . . . 0.78 110.319 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.2 mt -88.55 133.14 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.079 -1.248 . . . . 0.74 109.818 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.07 161.51 36.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.561 -0.712 . . . . 0.45 109.89 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.7 m-85 -130.48 135.92 48.46 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.517 -0.92 . . . . 0.64 108.517 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.45 165.26 31.27 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 118.419 -1.848 . . . . 0.45 111.54 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -81.06 150.01 28.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.696 -0.885 . . . . 1.88 109.916 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.461 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -79.81 128.78 33.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 0.59 111.279 -178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 17' ' ' LEU . 35.9 tp -107.38 95.38 5.66 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.204 -1.406 . . . . 0.64 107.204 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.6 tp -81.37 122.5 27.55 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.099 -1.001 . . . . 0.74 110.844 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.3 98.33 9.89 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.015 -0.538 . . . . 0.74 109.644 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -92.23 159.87 15.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 1.87 108.798 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.484 ' OE2' ' N ' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -130.13 130.03 44.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.447 -0.783 . . . . 2.58 109.083 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.484 ' N ' ' OE2' ' A' ' 21' ' ' GLU . 5.4 m-20 -80.22 131.96 35.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.268 -0.895 . . . . 2.14 109.198 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -64.66 146.94 53.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 1.93 109.274 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.65 135.35 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 0.68 109.72 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.39 114.49 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.85 -0.796 . . . . 0.84 108.85 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.3 mt -90.29 139.61 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.79 109.778 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -93.19 122.39 35.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.197 -0.939 . . . . 1.37 110.029 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -96.31 19.15 12.4 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.283 -0.886 . . . . 2.62 109.703 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -80.26 156.36 26.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.97 -1.081 . . . . 2.35 109.906 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -90.67 127.69 36.38 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.159 -0.682 . . . . 2.35 109.159 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.419 HG12 ' H ' ' A' ' 31' ' ' ILE . 9.4 pt -78.87 171.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.091 -1.006 . . . . 0.78 109.58 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.476 ' HG ' ' CG ' ' A' ' 34' ' ' ASP . 72.2 p -101.04 163.82 12.1 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.946 -0.761 . . . . 1.04 108.946 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.88 -25.92 63.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 1.05 109.726 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.476 ' CG ' ' HG ' ' A' ' 32' ' ' SER . 1.4 p-10 -79.85 -12.8 59.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.127 -0.983 . . . . 2.47 108.702 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.403 ' NE2' ' H ' ' A' ' 32' ' ' SER . 9.3 mt-30 -102.29 -12.31 18.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.639 -0.874 . . . . 1.46 108.639 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -67.68 -49.71 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.77 108.746 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 1.2 m-20 -57.96 -39.89 79.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 1.46 109.919 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -67.54 -36.6 81.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 2.29 110.56 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -65.89 -33.23 75.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.972 -1.08 . . . . 1.3 109.528 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.6 t -62.25 -45.13 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.76 109.276 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -64.29 -32.58 74.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.104 -0.997 . . . . 1.5 108.387 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' A' ' 42' ' ' ARG . 8.2 mtt-85 -66.18 -37.32 85.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.481 -0.762 . . . . 2.66 109.083 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 34.6 t80 -86.21 -54.15 4.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.185 -0.947 . . . . 0.75 108.903 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 tp -48.78 -66.99 0.31 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.333 -0.854 . . . . 0.83 109.091 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.8 t -64.41 -28.38 69.64 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.784 -0.821 . . . . 0.78 108.784 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -59.93 -54.77 34.68 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 107.527 -2.229 . . . . 0.57 107.527 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.456 ' CG ' HH11 ' A' ' 47' ' ' ARG . 1.0 OUTLIER -47.39 -30.64 3.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.647 -0.914 . . . . 2.83 108.698 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -61.81 -34.88 76.72 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.211 -1.033 . . . . 0.65 108.211 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' GLY . 31.2 mtpt -82.14 -60.62 2.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.692 -0.63 . . . . 2.57 109.646 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.25 -38.55 27.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.51 109.975 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -65.35 -39.04 91.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.024 -1.047 . . . . 1.36 108.922 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.61 64.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.753 -0.592 . . . . 0.6 110.584 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -63.62 -47.79 79.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 1.36 109.965 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.35 -46.42 64.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.922 -1.112 . . . . 1.38 109.455 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -48.15 -52.37 20.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.384 -0.822 . . . . 1.27 109.752 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -60.84 -34.0 73.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 0.6 109.849 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -72.3 -27.98 27.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.186 -0.946 . . . . 0.53 108.899 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -63.51 -42.39 98.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 0.99 109.898 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -72.72 -28.83 62.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.168 -0.957 . . . . 0.59 109.844 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -72.45 -25.31 61.4 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.657 -1.238 . . . . 1.81 107.657 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.79 -29.95 56.26 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.948 -1.131 . . . . 0.48 107.948 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.2 -29.84 24.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.895 -1.282 . . . . 0.58 109.895 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -86.34 -16.21 38.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.864 -1.374 . . . . 1.39 109.076 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -93.37 -48.89 6.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.89 . . . . 0.82 110.065 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -106.93 -16.35 14.48 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.26 -0.9 . . . . 0.99 110.793 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 119.44 142.92 6.89 Favored Glycine 0 N--CA 1.503 3.111 0 N-CA-C 109.486 -1.445 . . . . 0.55 109.486 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -49.99 -5.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.397 -1.061 . . . . 2.59 110.62 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' GLY . 34.3 mt-10 -64.02 -24.09 67.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.937 -1.102 . . . . 2.2 109.874 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -90.58 -9.44 47.1 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.076 -1.015 . . . . 1.79 110.264 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -64.1 -29.63 70.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.003 -1.061 . . . . 1.54 110.893 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -35.96 82.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.826 -1.171 . . . . 0.64 110.105 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.6 mt -73.2 -45.78 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.999 -1.063 . . . . 0.58 109.658 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -76.62 -23.9 53.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.91 . . . . 0.62 109.747 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -64.75 -44.67 89.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.931 -1.105 . . . . 1.23 109.152 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.36 -34.49 80.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.442 -1.463 . . . . 0.52 109.442 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -62.65 -20.94 65.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -1.159 . . . . 1.29 110.172 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.3 mt -85.29 -38.7 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.762 -1.211 . . . . 0.55 108.337 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.7 ttt -58.65 -39.45 80.61 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.491 -0.929 . . . . 1.89 108.491 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tp -64.21 -41.9 96.84 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.867 -0.79 . . . . 0.53 108.867 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.3 tp -68.25 -44.76 74.92 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.759 -0.777 . . . . 0.43 109.193 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.16 8.33 21.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.933 . . . . 1.24 110.117 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -47.57 123.55 5.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.822 -1.174 . . . . 1.31 109.989 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.38 -26.07 67.09 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.788 -0.819 . . . . 1.35 108.788 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.58 -50.47 17.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.346 -0.846 . . . . 2.16 109.309 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.5 mt -64.94 -16.83 63.79 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.187 -1.005 . . . . 0.6 109.282 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.82 -51.0 12.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 1.28 110.507 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -62.16 -29.92 70.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.139 -0.976 . . . . 1.28 110.232 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -74.14 -44.56 53.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 1.29 109.649 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.95 -57.35 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.09 -1.078 . . . . 0.58 108.09 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.7 mt -46.31 -63.57 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.684 -0.635 . . . . 0.78 109.786 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.34 -53.74 8.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.245 -0.909 . . . . 0.86 110.103 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.543 HD13 ' OE1' ' A' ' 106' ' ' GLU . 57.7 mt -50.03 -54.7 18.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.244 -0.91 . . . . 0.79 109.252 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.7 mt -53.53 -42.48 49.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.331 -0.856 . . . . 0.71 110.4 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -85.88 -36.82 19.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.99 -1.069 . . . . 2.05 111.563 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -83.25 -38.16 22.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.943 -1.098 . . . . 1.59 111.76 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -104.25 9.82 35.89 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.758 -1.214 . . . . 1.89 109.804 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.4 m80 49.6 42.34 22.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.922 -1.111 . . . . 1.31 109.188 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.5 mtt -97.49 150.78 20.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.082 -0.71 . . . . 1.28 109.082 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.9 p -75.02 145.64 42.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.494 -0.754 . . . . 0.62 109.767 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.7 -26.27 8.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.218 -0.926 . . . . 0.47 108.821 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -75.15 -50.0 17.73 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.589 -0.893 . . . . 2.0 108.589 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.27 -50.94 34.41 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.283 0.563 . . . . 0.56 110.066 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.57 -56.52 20.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.48 109.888 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.44 62.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.199 -0.938 . . . . 0.44 109.271 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -69.37 -21.21 63.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 1.42 109.024 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.543 ' OE1' HD13 ' A' ' 92' ' ' LEU . 41.8 tt0 -70.57 -50.36 38.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.496 -0.752 . . . . 1.26 109.905 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.97 -40.66 89.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.862 -1.149 . . . . 0.61 109.299 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.79 -19.48 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.243 -0.91 . . . . 0.64 108.942 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -76.88 -34.78 57.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 2.2 109.739 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 114' ' ' ALA . . . -85.72 -23.36 46.67 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.104 -1.522 . . . . 0.82 111.591 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -69.65 -42.87 73.67 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.822 -1.399 . . . . 1.27 108.638 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.73 -53.68 9.81 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.436 -0.79 . . . . 0.91 109.824 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 t -60.55 -28.66 68.6 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.137 -0.977 . . . . 1.73 109.788 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -67.01 -44.57 79.98 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.966 -1.084 . . . . 1.04 110.345 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.9 -24.75 66.91 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.88 -1.138 . . . . 1.03 109.003 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.73 -19.78 65.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 1.95 109.485 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -82.48 -7.03 59.65 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.196 -0.94 . . . . 1.71 109.513 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 123' ' ' LEU . 2.1 mt -86.42 156.91 19.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.323 -0.861 . . . . 1.26 108.824 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -104.79 58.72 0.69 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.842 -0.799 . . . . 2.83 108.842 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -150.31 118.77 6.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.25 -0.906 . . . . 1.58 109.384 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -64.26 -9.59 18.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 2.8 110.057 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -77.05 -61.22 2.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.184 -0.948 . . . . 1.02 109.444 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 118' ' ' LEU . 10.4 mt -66.48 -26.64 67.27 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.276 -0.89 . . . . 1.06 109.629 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 127' ' ' ALA . 47.7 tttp -67.2 -53.46 30.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.975 -1.078 . . . . 2.39 108.582 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -55.97 -25.14 42.53 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.611 -0.885 . . . . 2.2 108.611 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -72.94 -24.73 60.84 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.774 -1.565 . . . . 2.09 106.774 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.88 -41.34 95.77 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.643 -0.873 . . . . 0.86 108.643 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.44 -38.12 86.67 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.423 -0.954 . . . . 0.9 108.423 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -71.51 -25.81 62.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 1.35 109.286 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.44 -47.5 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.329 -0.857 . . . . 0.58 108.908 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -55.39 -36.49 66.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.876 -1.14 . . . . 3.22 108.283 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.13 -37.13 83.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.595 -0.69 . . . . 1.32 110.718 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.5 mt -67.5 -25.08 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.981 -1.074 . . . . 0.5 109.655 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.56 -46.64 9.62 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.025 -1.63 . . . . 0.44 109.025 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -48.58 -42.46 33.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.484 -1.009 . . . . 2.71 109.677 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 136' ' ' ARG . 24.4 mtt-85 -63.54 -52.32 61.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.095 -1.003 . . . . 2.2 108.553 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.9 tp -51.2 -41.36 60.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.748 -0.595 . . . . 1.13 109.854 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 140' ' ' ASN . 11.2 mt -66.9 -61.31 2.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.54 110.008 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -43.95 -19.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.403 -0.811 . . . . 2.32 110.858 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.491 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 1.8 m120 -85.46 -34.1 21.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.04 -1.038 . . . . 1.26 109.925 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.2 mt -73.45 -33.3 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.043 -1.036 . . . . 0.62 108.805 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 55.8 mt -86.73 3.08 46.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.334 -0.854 . . . . 0.67 109.344 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.06 27.73 23.36 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.433 -1.867 . . . . 0.68 108.433 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.64 148.51 28.83 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.526 -0.985 . . . . 0.77 109.443 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -66.56 132.81 49.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 2.4 109.403 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 76.6 mt -102.13 134.59 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.383 -0.823 . . . . 0.87 109.027 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.794 ' H ' HD12 ' A' ' 147' ' ' ILE . 2.5 mp -77.93 133.32 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 1.32 110.09 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -98.53 88.46 4.11 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.614 -0.884 . . . . 1.54 108.614 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.0 mt -78.75 -30.08 45.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.318 -0.864 . . . . 0.77 110.011 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 m -81.85 30.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 1.57 109.57 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.23 32.38 2.13 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.243 -0.91 . . . . 0.82 109.129 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.43 152.56 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.369 -0.832 . . . . 0.82 110.13 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -129.22 -10.19 4.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.538 -0.912 . . . . 2.11 108.538 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 154' ' ' ASP . 0.7 OUTLIER -120.1 127.37 52.47 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.424 -0.798 . . . . 1.41 109.17 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.92 124.09 20.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 1.3 109.614 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.83 175.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.194 -0.941 . . . . 0.57 109.411 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.8 mt -88.11 153.68 3.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.605 -1.257 . . . . 0.43 107.605 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.5 tp -104.49 117.29 33.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.443 -0.786 . . . . 0.56 109.041 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 35.6 t -120.57 133.11 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.603 -0.888 . . . . 0.54 108.603 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.58 143.21 11.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.373 -0.829 . . . . 0.62 109.039 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.42 -27.05 67.17 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.614 -1.304 . . . . 0.8 107.909 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 20.2 t0 -172.27 145.45 1.71 Allowed 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.69 -0.631 . . . . 2.34 109.59 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.527 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 25.3 mt -119.74 130.34 54.94 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.557 -0.905 . . . . 0.65 108.557 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.6 p -93.34 148.3 35.32 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.976 -1.078 . . . . 0.74 109.677 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 169' ' ' ALA . 78.3 Cg_exo -36.96 -49.16 1.52 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.594 2.196 . . . . 0.6 112.327 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.8 m -51.41 -59.81 3.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.63 109.228 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -53.57 -41.33 66.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.298 -0.876 . . . . 1.25 109.432 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 19.4 p -73.59 -22.57 60.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.5 110.013 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -76.61 -26.87 55.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.115 -0.991 . . . . 0.51 110.066 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -105.15 -10.89 16.83 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.15 -0.969 . . . . 1.17 109.944 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.36 156.02 10.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.153 -0.967 . . . . 0.61 109.169 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -98.51 132.34 44.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.012 -1.055 . . . . 2.12 108.233 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.4 mp -82.17 -44.67 16.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 1.34 111.238 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -83.44 -8.72 59.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.826 -1.171 . . . . 1.97 112.111 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -98.65 -8.54 26.1 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.612 -1.305 . . . . 1.9 108.77 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 177' ' ' LEU . 53.0 t -98.2 161.19 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.211 -1.033 . . . . 0.48 108.211 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.478 ' N ' HG12 ' A' ' 176' ' ' VAL . 9.3 tp -108.61 -23.97 11.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.313 -0.867 . . . . 1.39 109.907 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -178.33 174.41 46.68 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.942 -1.663 . . . . 0.38 108.942 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -129.43 122.44 29.36 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.588 -0.948 . . . . 0.46 108.992 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 12.9 mt -128.43 128.11 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.377 -0.971 . . . . 0.59 108.377 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 203' ' ' VAL . 47.7 p -141.3 146.52 36.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.483 -0.761 . . . . 0.67 111.467 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.461 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 2.8 m-20 -85.73 41.99 0.94 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -0.782 . . . . 2.24 109.501 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -107.54 116.04 31.24 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.387 -0.821 . . . . 1.11 109.727 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -87.63 65.01 3.63 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.797 -1.321 . . . . 1.63 109.797 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 88.5 -25.04 9.9 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.142 -1.183 . . . . 1.47 110.142 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.96 -34.09 3.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.162 -1.199 . . . . 5.24 109.607 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 20.8 p -152.06 75.92 1.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.549 -0.908 . . . . 2.92 108.549 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.9 p -80.04 5.1 15.07 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.331 -0.856 . . . . 1.6 109.813 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.629 ' HA ' HD12 ' A' ' 192' ' ' ILE . 82.3 t60 -51.3 -44.59 61.94 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.765 -1.209 . . . . 0.92 109.034 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.406 ' H ' HG22 ' A' ' 190' ' ' THR . 0.1 OUTLIER -56.36 -36.24 68.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.23 -0.919 . . . . 1.59 108.937 179.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.5 t -75.0 -37.71 61.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.869 . . . . 1.42 109.079 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 189' ' ' HIS . 88.6 mt -50.51 -32.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.159 -0.963 . . . . 1.41 108.647 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 6.5 mtm -71.78 -51.51 22.29 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 106.947 -1.501 . . . . 0.86 106.947 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.44 -39.01 66.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.071 -0.714 . . . . 0.59 109.071 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -69.18 -51.69 35.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 3.06 109.351 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.8 m -68.88 -36.62 78.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 0.73 109.344 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 199' ' ' LEU . 39.5 mt -86.83 3.69 44.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.179 -0.95 . . . . 0.67 108.667 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 52.75 2.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 1.49 110.873 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 197' ' ' LEU . 21.9 mt -64.74 169.37 5.35 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.654 -1.279 . . . . 0.64 107.751 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -90.38 143.94 3.87 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.16 1.907 . . . . 0.59 111.684 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.62 175.86 10.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.706 -1.246 . . . . 0.55 111.491 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.453 ' CD1' HD11 ' A' ' 220' ' ' LEU . 10.8 mt -150.78 155.01 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.786 -1.561 . . . . 0.63 106.786 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.6 m -143.51 -29.08 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 O-C-N 120.689 -1.257 . . . . 0.77 111.273 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.15 30.95 3.85 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.993 -1.243 . . . . 0.87 109.993 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.565 ' O ' ' N ' ' A' ' 207' ' ' SER . 3.2 p -61.61 -38.84 89.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.726 -1.455 . . . . 0.89 107.806 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.461 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 57.36 -33.43 0.02 OUTLIER Glycine 0 N--CA 1.498 2.769 0 CA-C-O 119.684 -0.509 . . . . 0.93 113.851 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 205' ' ' THR . 95.2 p -124.83 1.14 8.09 Favored 'General case' 0 N--CA 1.512 2.646 0 CA-C-N 119.613 1.706 . . . . 1.6 112.652 -177.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 t -65.44 -48.39 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.144 -1.597 . . . . 0.75 109.753 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 p -54.64 -16.1 2.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.884 -1.135 . . . . 0.84 110.045 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.1 t -104.13 11.72 34.77 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.316 -0.865 . . . . 1.61 109.65 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -142.25 -3.82 1.05 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.288 -0.882 . . . . 2.3 110.411 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.75 145.18 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.433 -0.792 . . . . 0.76 108.936 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -120.55 172.98 7.46 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.515 -1.661 . . . . 2.01 106.515 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 0.3 OUTLIER -74.25 141.13 45.38 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.722 -1.236 . . . . 2.19 109.801 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 81.33 -10.12 1.22 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.807 -0.558 . . . . 2.4 110.359 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -56.86 141.32 45.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.675 -1.265 . . . . 1.99 107.994 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -87.18 111.64 21.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.954 -1.091 . . . . 1.3 109.19 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 20.7 mt -121.41 168.32 11.81 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.992 0.901 . . . . 0.53 110.52 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.9 mt -140.46 123.56 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.192 -1.04 . . . . 0.6 108.192 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.453 HD11 ' CD1' ' A' ' 202' ' ' ILE . 15.1 tp -89.72 128.6 36.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.925 . . . . 0.57 109.169 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.27 -38.16 11.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.108 -0.995 . . . . 2.22 108.923 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 44.78 25.0 0.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.63 -0.669 . . . . 0.75 110.53 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.15 -62.24 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 106.981 -1.488 . . . . 0.92 106.981 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -87.59 14.46 8.31 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.95 -1.13 . . . . 2.36 107.95 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.64 57.66 3.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.68 -0.638 . . . . 1.42 109.677 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -156.76 151.8 26.17 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.024 -1.048 . . . . 1.97 110.833 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.55 137.54 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.901 -0.777 . . . . 0.65 108.901 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -107.14 131.72 53.82 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.21 -0.931 . . . . 0.97 109.273 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.6 t -103.79 118.19 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 0.67 109.802 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 50.87 69.62 2.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 1.45 109.989 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.96 157.97 23.96 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.66 2.24 . . . . 0.82 111.347 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 80.3 p -72.76 144.9 47.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 1.62 109.883 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.664 ' N ' HD22 ' A' ' 233' ' ' ASN . 0.8 OUTLIER -53.02 -27.72 20.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.43 -0.794 . . . . 2.6 109.742 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -64.54 -37.3 87.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 3.06 109.734 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 80.1 t -77.81 -36.16 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.243 -0.91 . . . . 1.14 109.137 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.37 -58.74 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 1.04 109.438 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 233' ' ' ASN . 2.5 m-20 -53.33 -36.53 61.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 2.54 109.51 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -67.24 -36.9 82.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 2.6 108.97 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 62.0 mtp -80.18 -34.6 37.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.409 -0.807 . . . . 1.23 109.463 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -54.87 -38.76 67.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 2.67 109.459 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.97 -57.21 4.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 1.66 109.689 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 73.9 t -58.74 -50.79 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.422 -0.799 . . . . 2.2 110.275 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.37 -58.41 7.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.943 -1.098 . . . . 3.0 110.148 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.27 -22.14 66.68 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.288 -0.882 . . . . 1.76 110.275 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -64.15 -26.58 68.6 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.182 -1.414 . . . . 2.78 107.182 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.1 t -72.1 -54.79 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.109 . . . . 2.06 108.004 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.62 -26.93 62.27 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.504 -0.924 . . . . 2.4 108.504 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 p -77.32 -22.94 51.13 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.072 -0.714 . . . . 2.87 109.072 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 108.757 -0.831 . . . . 3.41 108.757 179.664 . . . . . . . . 0 0 . 1 stop_ save_